
<html>
	<head>
		<meta http-equiv="Content-Type" content="text/html;charset=utf-8">	
		<style type="text/css">
			table {
			    border-collapse: collapse;
				font-family: arial, helvetica, sans-serif;
			}

			table, th, td {
			    border: 1px solid #C0C0C0;
				font-family: arial, helvetica, sans-serif;
			}
		</style>
	</head>
	<body><table class="tablesorter">
<thead><tr><th>Document Date</th><th>Contributor</th><th>Headline</th><th>Language</th><th>Pages</th><th>Tickers</th><th>Company Names</th><th>Category</th><th>Countries</th><th>Industries</th><th>Regions</th><th>Subjects</th><th>Report Styles</th><th>Author</th></tr>
</thead><tbody><tr class="even"><td class="leftalignment">01/17/2022</td><td class="leftalignment">Finlabo SIM Spa</td><td class="leftalignment">Merck - Finlabo Research Equity Report: Fundamental and Technical Analysis and 6 months performance forecast</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mauro Stampatori</td></tr>
<tr class="odd"><td class="leftalignment">01/15/2022</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">01/15/2022</td><td class="leftalignment">TheScreener</td><td class="leftalignment">Increased risk weighs on MERCK KGAA,  penalising its rating down to Slightly Negative</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/14/2022</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">Healthcare Pulse Check: Euro Credit Sector Update : US Healthcare Conference Round-Up</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">SASY.PA / ROG.S / NOVN.S / FMEG.DE / MRCG.DE / FREG.DE / GSK.L</td><td class="leftalignment">Sanofi SA / Roche Holding AG / Novartis AG / Fresenius Medical Care AG & Co KGaA / Merck KGaA / Fresenius SE & Co KGaA / GlaxoSmithKline PLC</td><td class="leftalignment">FIXED INCOME - CORPORATES</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / INDUSTRY REPORTS / Equity</td><td class="leftalignment">Danielle Ward / Mr. Adam Bodor</td></tr>
<tr class="even"><td class="leftalignment">01/13/2022</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Coverage Report : A summary of credit analyst recommendations in the Healthcare sector</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AMGN.O / BSX.N / BAX.N / BDX.N / BMY.N / CAH.N / CI.N / CVS.N / JNJ.N / LLY.N / MCK.N / MRK.N / TMO.N / DGX.N / HUM.N / GILD.O / UNH.N / LH.N / ABC.N / BIIB.O / ABBV.N / ZTS.N / PRGO.N / ANTM.N / VTRS.O</td><td class="leftalignment">Amgen Inc / Boston Scientific Corp / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Cardinal Health Inc / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / Thermo Fisher Scientific Inc / Quest Diagnostics Inc / Humana Inc / Gilead Sciences Inc / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / Amerisourcebergen Corp / Biogen Inc / Abbvie Inc / Zoetis Inc / Perrigo Company PLC / Anthem Inc / Viatris Inc</td><td class="leftalignment">FIXED INCOME - CORPORATES</td><td class="leftalignment">United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="odd"><td class="leftalignment">01/13/2022</td><td class="leftalignment">BNP Paribas Exane</td><td class="leftalignment">PHARMACEUTICALS & ESG : Go Bold or Go Home</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">ROG.S / AZN.L / SASY.PA / NOVOb.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR</td><td class="leftalignment">Roche Holding AG / AstraZeneca PLC / Sanofi SA / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Cosmetics & Personal Care</td><td class="leftalignment">Euroland / Europe / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Simon Mather, PHD / Mr. Gary Steventon</td></tr>
<tr class="even"><td class="leftalignment">01/13/2022</td><td class="leftalignment">FINAM</td><td class="leftalignment">2022 Could Be Successful for Merck</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Zareena Sayedova</td></tr>
<tr class="odd"><td class="leftalignment">01/13/2022</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck KGaA : Key takeaways from the 2022 J.P. Morgan Healthcare Conference</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Richard B. Vosser / James D. Gordon / Ms. Laerke Engkilde / Zain Ebrahim</td></tr>
<tr class="even"><td class="leftalignment">01/12/2022</td><td class="leftalignment">Sadif Analytics</td><td class="leftalignment">Will Merck & Co Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research SADIF</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Trefis</td><td class="leftalignment">Here's A Better Pharmaceutical Pick Over Merck Stock</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CARS / AN=US / MRK=US / LLY=US / PFE=US / BMY=US / HD=US / MCD=US / WEN=US / AGL=US / BLDP=US / AMZN=US / BLD=US / INCY=US / RUN=US / GILD=US / PLUG=US / NOVA=US / LOW=US / THC=US / TTWO=US / LEG=US / VMC=US / HUM=US / CVS=US / CI=US / MLM=US / UNH=US / KFY=US / AMED=US / AMN=US / SWIM=US / ARRY=US / BMRN=US / CBRL=US / KIDS=US / DRI=US / EXEL=US / FCN=US / GFF=US / ABG=US / IBP=US / MAS=US / MHK=US / ASGN=US / REGI=US / TRGP=US / TRUE=US / VRTX=US / EPD=US / CCRN=US / CNC=US / R=US / CNM=US / JAZZ=US / BE=US / DIN=US / ACVA=US / BCO=US / MOH=US / BIIB=US / TPX=US / EXP=US / BECN=US / TXRH=US / PLAY=US / DENN=US / BLDR=US / GMS=US / NSP=US / SIBN=US / SPWR=US / CMG=US / REX=US / PGTI=US / GPRE=US / ICFI=US / AWI=US / OC=US / CPRX=US / TAST=US / QSR=US / PRPL=US / LULU=US / IAA=US / ATSG=US / JACK=US / RCUS=US / TREX=US / GNRC=US / FBHS=US / ZNGA=US / ENPH=US / TILE=US / NDLS=US / PTCT=US / FATE=US / CNCE=US / 00770K202 / LOCO=US / OSH=US / UPLD=US / ANTM=US / SHAK=US / GDDY=US / SEDG=US / WING=US / SPNE=US / NVCR=US / 82982L103 / GXO=US / IRTC=US / CRSP=US / ANAB=US / JELD=US / DCPH=US / ALLO=US / FERG=US / AHCO=US / AZEK=US / SHLS=US / PRVA=US / SNPO=US / ROIV=US</td><td class="leftalignment">Cars.com Inc / AutoNation Inc / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / agilon health Inc / Ballard Power Systems Inc / Amazon.com Inc / TopBuild Corp / Incyte Corp / Sunrun Inc / Gilead Sciences Inc / Plug Power Inc / Sunnova Energy International Inc / Lowe's Companies Inc / Tenet Healthcare Corp / Take-Two Interactive Software Inc / Leggett & Platt Inc / Vulcan Materials Co / Humana Inc / CVS Health Corp / Cigna Corp / Martin Marietta Materials Inc / UnitedHealth Group Inc / Korn Ferry / Amedisys Inc / AMN Healthcare Services Inc / Latham Group Inc / Array Technologies Inc / Biomarin Pharmaceutical Inc / Cracker Barrel Old Country Store Inc / OrthoPediatrics Corp / Darden Restaurants Inc / Exelixis Inc / FTI Consulting Inc / Griffon Corp / Asbury Automotive Group Inc / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / ASGN Inc / Renewable Energy Group Inc / Targa Resources Corp / TrueCar Inc / Vertex Pharmaceuticals Inc / Enterprise Products Partners LP / Cross Country Healthcare Inc / Centene Corp / Ryder System Inc / Core & Main Inc / Jazz Pharmaceuticals PLC / Bloom Energy Corp / Dine Brands Global Inc / ACV Auctions Inc / Brinks Co / Molina Healthcare Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / SI-BONE Inc / SunPower Corp / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / ICF International Inc / Armstrong World Industries Inc / Owens Corning / Catalyst Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Lululemon Athletica Inc / IAA Inc / Air Transport Services Group Inc / Jack in the Box Inc / Arcus Biosciences Inc / Trex Company Inc / Generac Holdings Inc / Fortune Brands Home & Security Inc / Zynga Inc / Enphase Energy Inc / Interface Inc / Noodles & Co / PTC Therapeutics Inc / Fate Therapeutics Inc / Concert Pharmaceuticals Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Oak Street Health Inc / Upland Software Inc / Anthem Inc / Shake Shack Inc / GoDaddy Inc / Solaredge Technologies Inc / Wingstop Inc / SeaSpine Holdings Corp / Novocure Ltd / SiteOne Landscape Supply Inc / GXO Logistics Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / AnaptysBio Inc / JELD-WEN Holding Inc / Deciphera Pharmaceuticals Inc / Allogene Therapeutics Inc / Ferguson PLC / Adapthealth Corp / Azek Company Inc / Shoals Technologies Group Inc / Privia Health Group Inc / Snap One Holdings Corp / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2778844 / 2002305 / 2050832 / 2219224 / 2270726 / 2542049 / 2576941 / 2670519 / 2100920 / 2455965 / 2471950 / 2645409 / 2689560 / 2684703 / 7103065 / B00FWN1 / B19FQ48 / 2713317 / 2969637 / B3D7K31 / B23FN39 / B1XGNW4 / B0796X4 / B7TL820 / B7254K9 / B7VD3F2 / B85KFY9 / B8DPDT7 / BFLR866 / BS7K7C9 / BYZLV46 / BFZNYB7 / BK0VHF6 / BD9GVY0 / BFMXGR0 / BJJMGL2 / BKTNTR9 / BJ9NFQ3 / BZ1LFG7 / BYY88Y7 / BYSGPK2 / BDD1B07 / BMXXBD9 / BNKGXX2 / BJ62Z18 / BL53KF5 / BK6L288 / BMBSNX0</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Abbott Laboratories / Ameren Corp / CMS Energy Corp / Walt Disney Co / Dominion Energy Inc / Exelixis Inc / Exelon Corp / FirstEnergy Corp / Biogen Inc / Incyte Corp / NiSource Inc / PG&E Corp / Pfizer Inc / Novartis AG / Alnylam Pharmaceuticals Inc / Amicus Therapeutics Inc / ACADIA Pharmaceuticals Inc / DICK'S Sporting Goods Inc / Discovery Inc / Lululemon Athletica Inc / Insulet Corp / Dexcom Inc / Meta Platforms Inc / AxoGen Inc / Duke Energy Corp / Five Below Inc / Sarepta Therapeutics Inc / Twitter Inc / Nevro Corp / InflaRx NV / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / Zai Lab Ltd / Evergy Inc / Fox Corp / ViacomCBS Inc / Neoleukin Therapeutics Inc / Roku Inc / Alphabet Inc / ViewRay Inc / Rubius Therapeutics Inc / Figs Inc / Verve Therapeutics Inc / Ultragenyx Pharmaceutical Inc / F45 Training Holdings Inc / Beam Therapeutics Inc / IronNet Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BMY.N / CNX / CP / DHI / DVN / FOR / HFC / KBH / LEN / MDC / MGY / MPC / MRK.N / MTH / NSC / NVR / PFE.N / PHM.N / PSX / TOL / TPH / VLO / PBF / TTWO.O / AMD.O / ILMN.O / CCS.N / ZNGA.O / TMHC.K / LGIH.O / CYAD.O / NVCR.O / OMF / ADAP.O / EDIT.O / INSP.K / FTCH.K</td><td class="leftalignment">Bristol-Myers Squibb Co / CNX Resources Corp / Canadian Pacific Railway Ltd / D R Horton Inc / Devon Energy Corp / Forestar Group Inc / HollyFrontier Corp / KB Home / Lennar Corp / MDC Holdings Inc / Magnolia Oil & Gas Corp / Marathon Petroleum Corp / Merck & Co Inc / Meritage Homes Corp / Norfolk Southern Corp / NVR Inc / Pfizer Inc / Pultegroup Inc / Phillips 66 / Toll Brothers Inc / Tri Pointe Homes Inc (Delaware) / Valero Energy Corp / PBF Energy Inc / Take-Two Interactive Software Inc / Advanced Micro Devices Inc / Illumina Inc / Century Communities Inc / Zynga Inc / Taylor Morrison Home Corp / LGI Homes Inc / Celyad Oncology SA / Novocure Ltd / OneMain Holdings Inc / Adaptimmune Therapeutics PLC / Editas Medicine Inc / Inspire Medical Systems Inc / Farfetch Ltd</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Cayman Islands / United Kingdom / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HOLT Healthcare: Idea Generation Handbook - Finding Global Healthcare Opportunities in the New Year</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ANTM.N / TMO.N / MRK.N / UNH.N</td><td class="leftalignment">Anthem Inc / Thermo Fisher Scientific Inc / Merck & Co Inc / UnitedHealth Group Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / INDUSTRY REPORTS / QUANANTITATIVE/TECH RESEARCH / Equity</td><td class="leftalignment">Steven Bock / Sophia Graeff Buhl-Nielsen / Angelo Policicchio / HOLT Americas / HOLT Europe</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PAHC-US -  Dividend Quality Analysis, for the period ended September 22,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PAHC.O / ADM / LLY / MRK / ICCC.O / HSKA.O / ZTS</td><td class="leftalignment">Phibro Animal Health Corp / Archer-Daniels-Midland Co / Eli Lilly and Co / Merck & Co Inc / ImmuCell Corp / Heska Corp / Zoetis Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 31, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">BMY/MRK: BMY Guidance Helps Bring Expectations Down—MRK Focus on BD Well Ahead of Keytruda LOE</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK.N / BMY.N</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech Nightcap: Partnerships are good for Pharma/LC biotech but investors looking for M&A</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK=US / PFE=US / BMY=US / INCY=US / GILD=US / BMRN=US / VRTX=US / BIIB=US / RCUS=US / PTCT=US / FATE=US / ROIV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Bristol-Myers Squibb Co / Incyte Corp / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Arcus Biosciences Inc / PTC Therapeutics Inc / Fate Therapeutics Inc / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">MRK: Takeaways From the Presentation; All Eyes on Upcoming Keytruda Revenue Gap</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">MarketGrader</td><td class="leftalignment">MarketGrader Research Report on Merck KGaA</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Trefis</td><td class="leftalignment">What's Happening With Bristol Myers Squibb Stock?</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">making sense of adj lung readout</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Spending In The U.S. Seems Misguided, But We Still Believe In European Value</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0231112063 / US0463531089 / US7170811035 / US58933Y1055</td><td class="leftalignment">Amarin Corporation PLC / AstraZeneca PLC / Pfizer Inc / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ken C. Cacciatore / Stacy Ku, Ph.D. / Georgi Yordanov, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">NLTX - BUY - Merck Clinical Collaboration Incrementally Positive; Near-Term Focus Remains on Initial NL-201 Data & Potential Read-Throughs from NKTR</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / BJ9NFQ3 / 2778844</td><td class="leftalignment">Merck & Co Inc / Neoleukin Therapeutics Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D. / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Keytruda Adjuvant NSCLC Data May Have Outperformed Tecentriq</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK=US / INTC=US / TWTR=US / ADI=US / AMD=US / AMZN=US / INCY=US / TXN=US / NVDA=US / MPWR=US / CRM=US / DIOD=US / XLNX=US / BYD=US / TTMI=US / MGM=US / MANH=US / PENN=US / APH=US / ARW=US / AVGO=US / AVT=US / BMRN=US / COLL=US / EXEL=US / MCHP=US / REGN=US / APPN=US / BDSI=US / TPX=US / CZR=US / APP=US / BDC=US / XM=US / TEL=US / PRPL=US / OLO=US / NXPI=US / QTWO=US / FIVN=US / COUP=US / HUBS=US / WK=US / ON=US / ARGX=US / SMAR=US / APLT=US / DKNG=US / BALY=US / USER=US</td><td class="leftalignment">Merck & Co Inc / Intel Corp / Twitter Inc / Analog Devices Inc / Advanced Micro Devices Inc / Amazon.com Inc / Incyte Corp / Texas Instruments Inc / NVIDIA Corp / Monolithic Power Systems Inc / Salesforce.Com Inc / Diodes Inc / Xilinx Inc / Boyd Gaming Corp / TTM Technologies Inc / MGM Resorts International / Manhattan Associates Inc / Penn National Gaming Inc / Amphenol Corp / Arrow Electronics Inc / Broadcom Inc / Avnet Inc / Biomarin Pharmaceutical Inc / Collegium Pharmaceutical Inc / Exelixis Inc / Microchip Technology Inc / Regeneron Pharmaceuticals Inc / Appian Corp / BioDelivery Sciences International Inc / Tempur Sealy International Inc / Caesars Entertainment Inc / Applovin Corp / Belden Inc / Qualtrics International Inc / TE Connectivity Ltd / Purple Innovation Inc / Olo Inc / NXP Semiconductors NV / Q2 Holdings Inc / Five9 Inc / Coupa Software Inc / HubSpot Inc / Workiva Inc / ON Semiconductor Corp / argenx SE / Smartsheet Inc / Applied Therapeutics Inc / DraftKings Inc / Bally's Corp / UserTesting Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - January 10, 2022</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">US0188021085 / US0236081024 / US0255371017 / US0311621009 / US1101221083 / US1258961002 / US1264081035 / US1270971039 / US1475281036 / US22160K1051 / US2333311072 / US25179M1036 / US25746U1097 / US26875P1012 / US29364G1031 / US30161N1019 / US30231G1022 / US3755581036 / US4062161017 / US45337C1027 / US4592001014 / US5010441013 / US5324571083 / US56418H1005 / US6267171022 / US64125C1099 / US65473P1057 / US6558441084 / US6745991058 / US7170811035 / US7237871071 / US7445731067 / US75281A1097 / US75886F1075 / US7703231032 / AN8068571086 / US8168511090 / US8425871071 / US8454671095 / US87612E1064 / US8851601018 / US9078181081 / US92276F1003 / US92532F1003 / US9746371007 / US98389B1008 / CA1363751027 / CA4530384086 / CA5649051078 / CA1363851017 / US1667641005 / US5658491064 / CA0636711016 / US0017441017 / US20825C1045 / US15189T1079 / US2274831047 / US09062X1037 / CA67072Q1046 / CA2265331074 / US6293775085 / US0534841012 / US1011211018 / US2644115055 / CA6993202069 / CA0906971035 / CA4495861060 / US42809H1077 / BMG383271050 / US4219461047 / US49427F1084 / US89785X1019 / US2120151012 / US38500T1016 / US26884L1098 / CA22576C1014 / CA8672241079 / US58933Y1055 / CA15135U1093 / CA69946Q1046 / US65339F1012 / US78454L1008 / CA5527041084 / CA9237251058 / CA07317Q1054 / CA00208D4084 / CA2927661025 / CA0985461049 / CA7170461064 / CA00829Q1019 / US26441C2044 / CA89156V1067 / US69327R1014 / US72919P2020 / CA4013393042 / CA1348082035 / CA96467A2002 / CA87505Y4094 / CA3565001086 / US70509V1008 / CA04682R1073 / US5764852050 / US29355A1079 / US25278X1090 / CA4882951060 / US71943U1043 / US60468T1051 / US03674X1063 / CA14150G4007 / CA7397211086 / US65341B1061 / US29444U7000 / US30040W1080 / US83417M1045 / US4278255009 / US92939U1060 / US86771W1053 / US0130911037 / US2057683029 / US13462K1097 / US15136A1025 / GB00BDSFG982 / CA46016U1084 / US92840M1027 / US05722G1004 / US12653C1080 / CA35905B1076 / US00191U1025 / US83200N1037 / US87484T1088 / US0937121079 / US08579X1019 / CA7241121077 / CA6744822033 / US86745K1043 / US69047Q1022 / CA4220961078 / CA84678A1021 / US5168062058 / US13123X5086 / CA89055A2039 / US0412421085 / US62955J1034 / US1651677353 / US03743Q1085 / CA00791P1071 / US1374041093</td><td class="leftalignment">Alliant Energy Corp / Ameren Corp / American Electric Power Company Inc / Amgen Inc / Bristol-Myers Squibb Co / CMS Energy Corp / CSX Corp / Coterra Energy Inc / Caseys General Stores Inc / Costco Wholesale Corp / DTE Energy Co / Devon Energy Corp / Dominion Energy Inc / EOG Resources Inc / Entergy Corp / Exelon Corp / Exxon Mobil Corp / Gilead Sciences Inc / Halliburton Co / Incyte Corp / International Business Machines Corp / Kroger Co / Eli Lilly and Co / ManpowerGroup Inc / Murphy Oil Corp / Neurocrine Biosciences Inc / NiSource Inc / Norfolk Southern Corp / Occidental Petroleum Corp / Pfizer Inc / Pioneer Natural Resources Co / Public Service Enterprise Group Inc / Range Resources Corp / Regeneron Pharmaceuticals Inc / Robert Half International Inc / Schlumberger NV / Sempra Energy / Southern Co / Southwestern Energy Co / Target Corp / Thor Industries Inc / Union Pacific Corp / Ventas Inc / Vertex Pharmaceuticals Inc / Winnebago Industries Inc / Xcel Energy Inc / Canadian National Railway Co / Imperial Oil Ltd / Maple Leaf Foods Inc / Canadian Natural Resources Ltd / Chevron Corp / Marathon Oil Corp / Bank of Montreal / AMN Healthcare Services Inc / Conocophillips / CenterPoint Energy Inc / Cross Country Healthcare Inc / Biogen Inc / Nuvista Energy Ltd / Crew Energy Inc / NRG Energy Inc / Avalonbay Communities Inc / Boston Properties Inc / Duke Realty Corp / Paramount Resources Ltd / Birchcliff Energy Ltd / IGM Financial Inc / Hess Corp / GeoPark Ltd / Healthcare Realty Trust Inc / Kilroy Realty Corp / TrueBlue Inc / Continental Resources Inc / Gran Tierra Energy Inc / EQT Corp / Crescent Point Energy Corp / Suncor Energy Inc / Merck & Co Inc / Cenovus Energy Inc / Parex Resources Inc / Nextera Energy Inc / SM Energy Co / MEG Energy Corp / Vermilion Energy Inc / Baytex Energy Corp / ARC Resources Ltd / Enerplus Corp / Bonterra Energy Corp / Peyto Exploration & Development Corp / Africa Oil Corp / Duke Energy Corp / Tourmaline Oil Corp / PDC Energy Inc / Plug Power Inc / Guardian Capital Group Ltd / Canacol Energy Ltd / Whitecap Resources Inc / Tamarack Valley Energy Ltd / Freehold Royalties Ltd / Pebblebrook Hotel Trust / Athabasca Oil Corp / Matador Resources Co / Enphase Energy Inc / Diamondback Energy Inc / Kelt Exploration Ltd / Physicians Realty Trust / Mirati Therapeutics Inc / Antero Resources Corp / Cardinal Energy Ltd (Alberta) / Prairiesky Royalty Ltd / Nextera Energy Partners LP / Equinix Inc / Eversource Energy / Solaredge Technologies Inc / Hersha Hospitality Trust / WEC Energy Group Inc / Sunrun Inc / Albertsons Companies Inc / Comstock Resources Inc / Camping World Holdings Inc / Centennial Resource Development Inc / TechnipFMC PLC / International Petroleum Corp / Vistra Corp / Baker Hughes Co / CNX Resources Corp / Frontera Energy Corp / ASGN Inc / Smartsheet Inc / Talos Energy Inc / Bloom Energy Corp / Berry Corporation (Bry) / Pipestone Energy Corp / Obsidian Energy Ltd / Sunnova Energy International Inc / Ovintiv Inc / Headwater Exploration Inc / Spartan Delta Corp / Laredo Petroleum Inc / Callon Petroleum Co / Topaz Energy Corp / Arko Corp. / Nov Inc / Chesapeake Energy Corp / APA Corp (US) / Advantage Energy Ltd / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United Kingdom / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">India Pharma Sector - Quick Take - Dr. Reddy's: Double digit share in Vascepa now, could benefit further from recent court ruling on 'skinny label'</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REDY.NS / CIPL.BO / REDY.BO / ARBN.BO / SUN.BO / NOVN.S / MRCG.DE / GLEN.BO / FREG.DE / LUPN.BO / AMRN.OQ / ENDP.OQ / HIK.L / TEVA.N / MYX.AX / TARO.N / IQV.N / VTRS.OQ</td><td class="leftalignment">Dr Reddy's Laboratories Ltd / Cipla Ltd / Dr Reddy's Laboratories Ltd / Aurobindo Pharma Ltd / Sun Pharmaceutical Industries Ltd / Novartis AG / Merck KGaA / Glenmark Pharmaceuticals Ltd / Fresenius SE & Co KGaA / Lupin Ltd / Amarin Corporation PLC / Endo International PLC / Hikma Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Mayne Pharma Group Ltd / Taro Pharmaceutical Industries Ltd / IQVIA Holdings Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / Germany / United Kingdom / India / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Anubhav Aggarwal / Sayantan Maji</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">European Healthcare Credit : 2022 Sector Outlook</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">AZN.L / SASY.PA / ROG.S / NOVN.S / FMEG.DE / MRCG.DE / FREG.DE / GSK.L</td><td class="leftalignment">AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / Fresenius Medical Care AG & Co KGaA / Merck KGaA / Fresenius SE & Co KGaA / GlaxoSmithKline PLC</td><td class="leftalignment">FIXED INCOME - CORPORATES</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Israel / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Danielle Ward / Mr. Adam Bodor</td></tr>
<tr class="odd"><td class="leftalignment">01/09/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Merck Agreement: Solid Win for ABSI & Tx-Enabling Platform Technologies</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK.N / US00091E1091 / US58933Y1055 / US1920051067 / US57777K1060 / ABSI.OQ / US1920031010</td><td class="leftalignment">Merck & Co Inc / Absci Corp / Merck & Co Inc / Codexis Inc / MaxCyte Inc / Absci Corp / Codex DNA Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Max Masucci / Stephanie Yan</td></tr>
<tr class="even"><td class="leftalignment">01/09/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Pipeline Pulse - Total Number Of Drugs Up 3% YoY; PIII Assets At Historic High</td><td class="leftalignment">English</td><td class="rightalignment">140</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">01/09/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 9.2% Above Pre-Pandemic Base- Week 90</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US -  Dividend Quality Analysis, for the period ended December 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O / BIOb / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US -  Dividend Quality Analysis, for the period ended January 07,2022.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">IDRA-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">IDRA.O / ABT / JNJ / MRK / PFE / AMGN.O / AGEN.O / LGND.O / BIIB.O / DVAX.O / CLDX.O</td><td class="leftalignment">Idera Pharmaceuticals Inc / Abbott Laboratories / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / Agenus Inc / Ligand Pharmaceuticals Inc / Biogen Inc / Dynavax Technologies Corp / Celldex Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NNVC-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">NNVC.K / BMY / MRK / GILD.O / NBY / GSK / BCRX.O / NVAX.O / CMRX.O</td><td class="leftalignment">NanoViricides Inc / Bristol-Myers Squibb Co / Merck & Co Inc / Gilead Sciences Inc / NovaBay Pharmaceuticals Inc / GlaxoSmithKline PLC / BioCryst Pharmaceuticals Inc / Novavax Inc / Chimerix Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SYN-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">SYN / ABT / MRK / PFE / AZN.O / BIIB.O / TEVA.K</td><td class="leftalignment">Synthetic Biologics Inc / Abbott Laboratories / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Biogen Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">The Cowen Edge - January 7, 2022</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">NL0000226223 / DE0006231004 / US0028241000 / US00846U1016 / US00971T1016 / US0116591092 / US0231351067 / US0378331005 / US0382221051 / US0463531089 / US0718131099 / US0758871091 / US1011371077 / US1101221083 / US1266501006 / US1727551004 / US22284P1057 / US28176E1082 / US3021301094 / US3156161024 / US37733W1053 / US4364401012 / US4433201062 / US4456581077 / US4781601046 / US5150981018 / US5324571083 / US5951121038 / US66987V1098 / US6701002056 / US6795801009 / US7140461093 / US7170811035 / US7392761034 / US7475251036 / US7711951043 / US8168501018 / US8308791024 / US8447411088 / US8610121027 / US8740391003 / US8807701029 / US9029251066 / US91347P1057 / US92343V1044 / US9507551086 / US9581021055 / TW0002330008 / US87157D1090 / US4771431016 / US83088M1027 / US4198791018 / US80105N1054 / US20030N1019 / US6402681083 / US09062X1037 / US1572101053 / US0042251084 / US02043Q1076 / US2538681030 / US19239V3024 / US2090341072 / US12541W2098 / US00206R1023 / ACOR.OQ / US82706C1080 / US78709Y1055 / PAP310761054 / US75025X1000 / US01748X1028 / US2473617023 / US53261M1045 / US25470M1099 / US58933Y1055 / US34959E1091 / US1920051067 / US9100471096 / US03027X1000 / US30303M1027 / US9837931008 / US00287Y1091 / NL0010273215 / US81762P1021 / US8725901040 / US6974351057 / US23283R1005 / US8485771021 / US21240E1055 / US02376R1023 / US03937C1053 / US0465131078 / CA0089118776 / US22822V1017 / US74736K1016 / US29444U7000 / IE00BTN1Y115 / US00653A1079 / US12685J1051 / US02079K1079 / US05464T1043 / US00773U1088 / US16119P1084 / US36165L1089 / CA87241L1094 / US78410G1040 / US83304A1060 / US91325V1089 / US23753F1075 / US80689H1023 / US02156K1034 / US4990491049 / US87105L1044 / US57777K1060 / US11135F1012 / US5904791358 / US0197701065 / US0144421072 / US90353T1007 / US18915M1071 / US09203E1055 / CH0499880968 / KYG3902L1095 / US5502411037 / US35909R1086 / US25401T1088 / US20717M1036 / US1920031010 / US02080L1026 / US35909D1090 / US23284C1027 / US2935941078 / KYG393871085 / KYG4701H1092 / US86337R1032 / US10576N1028 / US4181001037 / AU0000185993</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / Abbott Laboratories / Agilent Technologies Inc / Akamai Technologies Inc / Alaska Air Group Inc / Amazon.com Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Baxter International Inc / Becton Dickinson and Co / Boston Scientific Corp / Bristol-Myers Squibb Co / CVS Health Corp / Cirrus Logic Inc / Covenant Logistics Group Inc / Edwards Lifesciences Corp / Expeditors International of Washington Inc / F5 Inc / GlaxoSmithKline PLC / Hologic Inc / Hub Group Inc / J B Hunt Transport Services Inc / Johnson & Johnson / Landstar System Inc / Eli Lilly and Co / Micron Technology Inc / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / PerkinElmer Inc / Pfizer Inc / Power Integrations Inc / Qualcomm Inc / Roche Holding AG / Semtech Corp / SkyWest Inc / Southwest Airlines Co / STMicroelectronics NV / Taiwan Semiconductor Manufacturing Co Ltd / Teradyne Inc / USA Truck Inc / Universal Display Corp / Verizon Communications Inc / Werner Enterprises Inc / Western Digital Corp / Taiwan Semiconductor Manufacturing Co Ltd / Synaptics Inc / JetBlue Airways Corp / Skyworks Solutions Inc / Hawaiian Holdings Inc / Sanofi SA / Comcast Corp / Nektar Therapeutics / Biogen Inc / CEVA Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Digital Realty Trust Inc / Cogent Communications Holdings Inc / Consolidated Communications Holdings Inc / CH Robinson Worldwide Inc / AT&T Inc / Acorda Therapeutics Inc / Silicon Motion Technology Corp / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Allegiant Travel Co / Delta Air Lines Inc / Limelight Networks Inc / DISH Network Corp / Merck & Co Inc / Fortinet Inc / Codexis Inc / United Airlines Holdings Inc / American Tower Corp / Meta Platforms Inc / XPO Logistics Inc / Abbvie Inc / ASML Holding NV / ServiceNow Inc / T-Mobile US Inc / Palo Alto Networks Inc / CyrusOne Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / ArcBest Corp / Atara Biotherapeutics Inc / Air Canada / Crown Castle International Corp / Qorvo Inc / Equinix Inc / Medtronic PLC / Adaptimmune Therapeutics PLC / Cable One Inc / Alphabet Inc / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Charter Communications Inc / GDS Holdings Ltd / TFI International Inc / SBA Communications Corp / Snap Inc / Uniti Group Inc / Daseke Inc / Schneider National Inc / Altice USA Inc / Knight-Swift Transportation Holdings Inc / Switch Inc / MaxCyte Inc / Broadcom Inc / Mesa Air Group Inc / Allogene Therapeutics Inc / Alector Inc / Uber Technologies Inc / Cloudflare Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA / GDS Holdings Ltd / Lumen Technologies Inc / Frontier Group Holdings Inc / DigitalBridge Group Inc / Confluent Inc / Codex DNA Inc / Alpha Teknova Inc / Frontier Communications Parent Inc / Cyxtera Technologies Inc / Enovix Corp / Globalfoundries Inc / IHS Holding Ltd / Stronghold Digital Mining Inc / Braze Inc / Hashicorp Inc / Iris Energy Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Mexico / Netherlands / Panama / Taiwan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Evan’s Weekly Dose of Targeted Therapy & Video - CMS AD NCD & JPM Preview</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - December 24, 2021 to January 7, 2022</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US8336351056 / US0091581068 / US0126531013 / US0234361089 / US0311621009 / US0536111091 / US1101221083 / US2017231034 / US2788651006 / US3755581036 / US3976241071 / US4128221086 / US4180561072 / US4282911084 / US4448591028 / US45337C1027 / US4601461035 / US5324571083 / US5463471053 / US56418H1005 / US5719032022 / US5770811025 / US64125C1099 / US6516391066 / US6703461052 / US6935061076 / US6951561090 / US7170811035 / US7310681025 / US7496851038 / US7549071030 / US75886F1075 / US7703231032 / US7802871084 / US8243481061 / US8581191009 / US9113121068 / US92276F1003 / US92532F1003 / US9621661043 / US98389B1008 / CA25822C2058 / CA1469001053 / CA0679011084 / CA9528451052 / US9129091081 / CA51925D1069 / CA13677F1018 / CA0641491075 / CA6330671034 / CA7800871021 / US0017441017 / US37940X1028 / US2274831047 / US09062X1037 / US46625H1005 / US0605051046 / US20451N1019 / US9604131022 / US0534841012 / US29476L1070 / US7588491032 / US2971781057 / US1331311027 / US1508701034 / US2538681030 / CA8911605092 / CA1360691010 / US1011211018 / US2644115055 / US9290421091 / US5543821012 / US8288061091 / US44107P1049 / US7376301039 / US57636Q1040 / CA1375761048 / US29472R1086 / US8666741041 / US74460D1090 / US59522J1034 / US9026531049 / US30225T1025 / US35471R1068 / US4219461047 / US5021751020 / US63633D1046 / US5500211090 / US89785X1019 / CA3518581051 / US92826C8394 / US58502B1061 / US58933Y1055 / NL0009434992 / US74340W1036 / US2296631094 / US92936U1097 / CA55903Q1046 / US76131N1019 / US70509V1008 / CA38045Y1025 / US16208T1025 / US78573L1061 / US74965L1017 / US23283R1005 / CA05577W2004 / US71943U1043 / US60468T1051 / US9660842041 / US02665T3068 / US45378A1060 / US11120U1051 / US02005N1000 / US1785871013 / CA45868C1095 / US14174T1079 / BMG0750C1082 / US8621211007 / US42225P5017 / US29444U7000 / US27616P1030 / US9840171030 / US6378701063 / US9741551033 / US1638511089 / US4278255009 / US96145D1054 / US70450Y1038 / CA8485101031 / US95040Q1040 / US8522341036 / 100607060 / US45688C1071 / US53223X1072 / US0441861046 / CA26829L1076 / US7005171050 / US43300A2033 / US46187W1071 / CA9628791027 / GB00BF3ZNS54 / US87105L1044 / CA53680Q2071 / US46590V1008 / CA2960061091 / US3610081057 / CA8585221051 / US29261A1007 / US00191U1025 / US83200N1037 / US48251W1045 / CA4039254079 / US53814L1089 / IE00BZ12WP82 / CA13000C2058 / US2605571031 / GB00BJT16S69 / US73757R1023 / US26614N1028 / US5012701026 / US42250P1030 / CA92625W5072 / US14316J1088 / US47012E4035 / US69526K1051 / CA67079A1021 / US15202L1070 / CA00076T1057 / US11135E2037 / US00848J1043 / BMG6964L1072 / US0708301041 / US71844V2016 / US27923Q1094 / AU0000193666 / US4576791085</td><td class="leftalignment">Sociedad Quimica y Minera de Chile SA / Air Products and Chemicals Inc / Albemarle Corp / Amedisys Inc / Amgen Inc / Avery Dennison Corp / Bristol-Myers Squibb Co / Commercial Metals Co / Ecolab Inc / Gilead Sciences Inc / Greif Inc / Harley-Davidson Inc / Hasbro Inc / Hexcel Corp / Humana Inc / Incyte Corp / International Paper Co / Eli Lilly and Co / Louisiana-Pacific Corp / ManpowerGroup Inc / Marriott International Inc / Mattel Inc / Neurocrine Biosciences Inc / Newmont Corporation / Nucor Corp / PPG Industries Inc / Packaging Corp of America / Pfizer Inc / Polaris Inc / RPM International Inc / Rayonier Inc / Regeneron Pharmaceuticals Inc / Robert Half International Inc / Royal Gold Inc / Sherwin-Williams Co / Steel Dynamics Inc / United Parcel Service Inc / Ventas Inc / Vertex Pharmaceuticals Inc / Weyerhaeuser Co / Xcel Energy Inc / Dorel Industries Inc / Cascades Inc / Barrick Gold Corp / West Fraser Timber Co Ltd / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / AMN Healthcare Services Inc / Global Payments Inc / Cross Country Healthcare Inc / Biogen Inc / JPMorgan Chase & Co / Bank of America Corp / Compass Minerals International Inc / Westlake Chemical Corp / Avalonbay Communities Inc / Equity Residential / Regency Centers Corp / Essex Property Trust Inc / Camden Property Trust / Celanese Corp / Digital Realty Trust Inc / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / Boston Properties Inc / Duke Realty Corp / Vornado Realty Trust / Macerich Co / Simon Property Group Inc / Host Hotels & Resorts Inc / Potlatchdeltic Corp / Mastercard Inc / Canfor Corp / Equity LifeStyle Properties Inc / Sun Communities Inc / Public Storage / Mid-America Apartment Communities Inc / UDR Inc / Extra Space Storage Inc / Franklin Street Properties Corp / Healthcare Realty Trust Inc / LTC Properties Inc / National Health Investors Inc / Lululemon Athletica Inc / TrueBlue Inc / Franco-Nevada Corp / Visa Inc / MEDNAX Inc / Merck & Co Inc / LyondellBasell Industries NV / Prologis Inc / CubeSmart / WP Carey Inc / MAG Silver Corp / Retail Opportunity Investments Corp / Pebblebrook Hotel Trust / GoGold Resources Inc / Chatham Lodging Trust / Sabra Health Care REIT Inc / RLJ Lodging Trust / CyrusOne Inc / BRP Inc / Physicians Realty Trust / Mirati Therapeutics Inc / Whitestone REIT / American Homes 4 Rent / Independence Realty Trust Inc / Brixmor Property Group Inc / Ally Financial Inc / City Office REIT Inc / Interfor Corp / CareTrust REIT Inc / Axalta Coating Systems Ltd / STORE Capital Corp / Healthcare Trust Of America Inc / Equinix Inc / Easterly Government Properties Inc / Xenia Hotels & Resorts Inc / National Storage Affiliates Trust / Wingstop Inc / Chemours Co / Hersha Hospitality Trust / Westrock Co / PayPal Holdings Inc / Spin Master Corp / Welltower Inc / Block Inc / First-Citizens Bank & Trust Co / Ingevity Corp / Life Storage Inc / Ashland Global Holdings Inc / ECN Capital Corp / Park Hotels & Resorts Inc / Hilton Worldwide Holdings Inc / Invitation Homes Inc / Wheaton Precious Metals Corp / Venator Materials PLC / Switch Inc / Lithium Americas Corp / JBG SMITH Properties / Ero Copper Corp / Funko Inc / Stelco Holdings Inc / Encompass Health Corp / ASGN Inc / Smartsheet Inc / KKR & Co Inc / H&R Real Estate Investment Trust / Livent Corp / Linde PLC / Calibre Mining Corp / Dow Inc / Tronox Holdings PLC / Postal Realty Trust Inc / Dupont De Nemours Inc / Kura Sushi USA Inc / Healthpeak Properties Inc / Victoria Gold Corp / Carlyle Group Inc / JAKKS Pacific Inc / Pactiv Evergreen Inc / Nuvei Corp / Centerspace / Abc Technologies Holdings Inc / Broadstone Net Lease Inc / Agiliti Inc / Paysafe Ltd / Bath & Body Works Inc / Phillips Edison & Co Inc / Ecovyst Inc / Allkem Ltd / Innovid Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Chile / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended December 31, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 771195104 / 58933Y10 / 00287Y10 / 45781M10 / G3910J11 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Roche Holding AG / Merck & Co Inc / Abbvie Inc / Innoviva Inc / GlaxoSmithKline PLC / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">MRK-ABSI collab to identify/make better protein drugs - spotlight on AI/synthetic biology</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - January 7, 2022</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">US8336351056 / US0126531013 / US0311621009 / US1101221083 / US3755581036 / US4448591028 / US45337C1027 / US5324571083 / US5463471053 / US5719032022 / US64125C1099 / US6516391066 / US7170811035 / US7549071030 / US75886F1075 / US7802871084 / US92276F1003 / US92532F1003 / US9621661043 / US98389B1008 / CA0679011084 / CA9528451052 / US09062X1037 / US9604131022 / US0534841012 / US29476L1070 / US7588491032 / US2538681030 / US1011211018 / US2644115055 / US5543821012 / US8288061091 / US44107P1049 / US7376301039 / CA1375761048 / US29472R1086 / US8666741041 / US74460D1090 / US9026531049 / US30225T1025 / US35471R1068 / US4219461047 / US63633D1046 / CA3518581051 / US58933Y1055 / NL0009434992 / US74340W1036 / US2296631094 / US92936U1097 / US70509V1008 / US16208T1025 / US78573L1061 / US71943U1043 / US60468T1051 / CA45868C1095 / US14174T1079 / US42225P5017 / US29444U7000 / US27616P1030 / US9840171030 / US6378701063 / US4278255009 / US95040Q1040 / US53223X1072 / US7005171050 / US43300A2033 / CA9628791027 / US87105L1044 / CA53680Q2071 / CA2960061091 / US53814L1089 / CA13000C2058 / US2605571031 / US73757R1023 / US5012701026 / US42250P1030 / CA92625W5072 / US15202L1070 / US11135E2037 / US0708301041 / AU0000193666</td><td class="leftalignment">Sociedad Quimica y Minera de Chile SA / Albemarle Corp / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Humana Inc / Incyte Corp / Eli Lilly and Co / Louisiana-Pacific Corp / Marriott International Inc / Neurocrine Biosciences Inc / Newmont Corporation / Pfizer Inc / Rayonier Inc / Regeneron Pharmaceuticals Inc / Royal Gold Inc / Ventas Inc / Vertex Pharmaceuticals Inc / Weyerhaeuser Co / Xcel Energy Inc / Barrick Gold Corp / West Fraser Timber Co Ltd / Biogen Inc / Westlake Chemical Corp / Avalonbay Communities Inc / Equity Residential / Regency Centers Corp / Digital Realty Trust Inc / Boston Properties Inc / Duke Realty Corp / Macerich Co / Simon Property Group Inc / Host Hotels & Resorts Inc / Potlatchdeltic Corp / Canfor Corp / Equity LifeStyle Properties Inc / Sun Communities Inc / Public Storage / UDR Inc / Extra Space Storage Inc / Franklin Street Properties Corp / Healthcare Realty Trust Inc / National Health Investors Inc / Franco-Nevada Corp / Merck & Co Inc / LyondellBasell Industries NV / Prologis Inc / CubeSmart / WP Carey Inc / Pebblebrook Hotel Trust / Chatham Lodging Trust / Sabra Health Care REIT Inc / Physicians Realty Trust / Mirati Therapeutics Inc / Interfor Corp / CareTrust REIT Inc / Healthcare Trust Of America Inc / Equinix Inc / Easterly Government Properties Inc / Xenia Hotels & Resorts Inc / National Storage Affiliates Trust / Hersha Hospitality Trust / Welltower Inc / Life Storage Inc / Park Hotels & Resorts Inc / Hilton Worldwide Holdings Inc / Wheaton Precious Metals Corp / Switch Inc / Lithium Americas Corp / Ero Copper Corp / Livent Corp / Calibre Mining Corp / Dow Inc / Postal Realty Trust Inc / Kura Sushi USA Inc / Healthpeak Properties Inc / Victoria Gold Corp / Centerspace / Broadstone Net Lease Inc / Bath & Body Works Inc / Allkem Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Chile / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ABSI: Existing Partner Merck Invests in a Second Collaboration</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRCG.DE / ABSI.OQ / 4503.T</td><td class="leftalignment">Merck KGaA / Absci Corp / Astellas Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Navigating the Virtual Circus: Expectations and Mgmt Qs for Next Week's Conf.</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">01/06/2022</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Merck: Exciting bolt-on acquisition to further strengthen the Life Science business</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">EVENT CALENDAR / GOVERNMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Falko Friedrichs / Herr Jan Koch / Sachin Gadilingappa</td></tr>
<tr class="even"><td class="leftalignment">01/06/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Modest price increases from MRK and AMGN's Tezspire WAC Price</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / AMGN.OQ / MRK=US / AMGN=US</td><td class="leftalignment">Merck & Co Inc / Amgen Inc / Merck & Co Inc / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">01/06/2022</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Merck & Co Inc (MRK) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">1053</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="even"><td class="leftalignment">01/06/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">2701271 / 2778844 / 2222631 / 2270726 / 2457864 / 2689560 / 2857817 / B3D7K31 / B7577T2 / BYZLV46 / BFZ1K46 / BFMXGR0 / BJJMGL2 / BYQHPK7 / BZ1LFG7 / BWY52P3 / BDVLM39 / BZ0P3Z5 / BJRFSB7 / BF3NP05 / BNTB3N8 / BN2RM92</td><td class="leftalignment">Costco Wholesale Corp / Merck & Co Inc / Cooper Companies Inc / Walt Disney Co / ImmunoGen Inc / PG&E Corp / Netflix Inc / Discovery Inc / Renewable Energy Group Inc / InflaRx NV / Spotify Technology SA / Evergy Inc / Fox Corp / Zymeworks Inc / Roku Inc / Blueprint Medicines Corp / argenx SE / Tegna Inc / Immunovant Inc / Mersana Therapeutics Inc / Vizio Holding Corp / Rain Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">01/06/2022</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">706</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Middle East</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="even"><td class="leftalignment">01/05/2022</td><td class="leftalignment">Kailash Concepts</td><td class="leftalignment">BUY & SELL Lists - Large Cap</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ABBV.N / AGNC.OQ / ALL.N / AXP.N / BA.N / BBY.N / CAH.N / CCK.N / CE.N / EOG.N / F.N / HIG.N / HLT.N / KEY.N / MRK.N / OXY.N / PFE.N / RHI.N / TMX.N / TOL.N / UAL.N / USB.N / VNT.N / ZEN.N / DIS.N / WLK.N / GD.N / CR.N / AFG.N / SPOT.N / AMG.N / RCL.N / IFF.N / DV.N / LH.N / FNF.N / DVN.N / OLN.N / TGT.N / RKT.N / SNV.N / AMP.N / HXL.N / AZO.N / FDS.N / EQT.N / ATO.N / HWM.N / BYD.N / DNB.N / HRL.N / SAM.N / ABC.N / JNPR.N / GME.N / TDY.N / COP.N / INTC.OQ / ORI.N / ADPT.OQ / AGL.N / CRUS.OQ / FAF.N / FISV.OQ / HOLX.OQ / KLAC.OQ / MKL.N / RJF.N / RGEN.OQ / SEIC.OQ / SF.N / FL.N / QCOM.OQ / NKTR.OQ / TPR.N / SRCL.OQ / MRCY.OQ / MRVL.OQ / ILMN.OQ / WOOF.OQ / WYNN.OQ / PA1436583006 / MNST.OQ / MOH.N / EXP.N / OSH.N / LVS.N / OC.N / FRPT.OQ / BX.N / NVR.N / WRB.N / MRNA.OQ / CLH.N / AI.N / AVGO.OQ / NXPI.OQ / BAH.N / CZR.OQ / TRGP.N / MSP.N / HII.N / Z.OQ / TRIP.OQ / ALSN.N / FB.OQ / BERY.N / FANG.OQ / WEX.N / RNG.N / NCLH.N / FIVN.OQ / SYF.N / CFG.N / ANTM.N / LBRDK.O / TDOC.N / RUN.OQ / PEN.N / USFD.N / TWLO.N / VVV.N / COUP.OQ / UAA.N / OKTA.OQ / CVNA.N / ROKU.OQ / KDP.N / PLAN.N / NFE.OQ / LYFT.O / BYND.OQ / UBER.N / CRWD.OQ / TXG.OQ / PTON.OQ / SPCE.N / AZEK.N / DKNG.OQ / APA.OQ / VRM.OQ / LMND.N / NCNO.OQ / JAMF.OQ / BEPC.N / DCT.OQ / PLTR.N / SHC.OQ / SKLZ.N / CLVT.N / SGFY.N / VMEO.OQ / FIGS.N</td><td class="leftalignment">Abbvie Inc / AGNC Investment Corp / Allstate Corp / American Express Co / Boeing Co / Best Buy Co Inc / Cardinal Health Inc / Crown Holdings Inc / Celanese Corp / EOG Resources Inc / Ford Motor Co / Hartford Financial Services Group Inc / Hilton Worldwide Holdings Inc / KeyCorp / Merck & Co Inc / Occidental Petroleum Corp / Pfizer Inc / Robert Half International Inc / Terminix Global Holdings Inc / Toll Brothers Inc / United Airlines Holdings Inc / US Bancorp / Vontier Corp / Zendesk Inc / Walt Disney Co / Westlake Chemical Corp / General Dynamics Corp / Crane Co / American Financial Group Inc / Spotify Technology SA / Affiliated Managers Group Inc / Royal Caribbean Cruises Ltd / International Flavors & Fragrances Inc / DoubleVerify Holdings Inc / Laboratory Corporation of America Holdings / Fidelity National Financial Inc / Devon Energy Corp / Olin Corp / Target Corp / Rocket Companies Inc / Synovus Financial Corp / Ameriprise Financial Inc / Hexcel Corp / Autozone Inc / Factset Research Systems Inc / EQT Corp / Atmos Energy Corp / Howmet Aerospace Inc / Boyd Gaming Corp / Dun & Bradstreet Holdings Inc / Hormel Foods Corp / Boston Beer Company Inc / Amerisourcebergen Corp / Juniper Networks Inc / GameStop Corp / Teledyne Technologies Inc / Conocophillips / Intel Corp / Old Republic International Corp / Adaptive Biotechnologies Corp / agilon health Inc / Cirrus Logic Inc / First American Financial Corp / Fiserv Inc / Hologic Inc / KLA Corp / Markel Corp / Raymond James Financial Inc / Repligen Corp / SEI Investments Co / Stifel Financial Corp / Foot Locker Inc / Qualcomm Inc / Nektar Therapeutics / Tapestry Inc / Stericycle Inc / Mercury Systems Inc / Marvell Technology Inc / Illumina Inc / Petco Health and Wellness Company Inc / Wynn Resorts Ltd / Carnival Corp / Monster Beverage Corp / Molina Healthcare Inc / Eagle Materials Inc / Oak Street Health Inc / Las Vegas Sands Corp / Owens Corning / Freshpet Inc / Blackstone Inc / NVR Inc / W R Berkley Corp / Moderna Inc / Clean Harbors Inc / C3.ai Inc / Broadcom Inc / NXP Semiconductors NV / Booz Allen Hamilton Holding Corp / Caesars Entertainment Inc / Targa Resources Corp / Datto Holding Corp / Huntington Ingalls Industries Inc / Zillow Group Inc / Tripadvisor Inc / Allison Transmission Holdings Inc / Meta Platforms Inc / Berry Global Group Inc / Diamondback Energy Inc / WEX Inc / RingCentral Inc / Norwegian Cruise Line Holdings Ltd / Five9 Inc / Synchrony Financial / Citizens Financial Group Inc / Anthem Inc / Liberty Broadband Corp / Teladoc Health Inc / Sunrun Inc / Penumbra Inc / US Foods Holding Corp / Twilio Inc / Valvoline Inc / Coupa Software Inc / Under Armour Inc / Okta Inc / Carvana Co / Roku Inc / Keurig Dr Pepper Inc / Anaplan Inc / New Fortress Energy Inc / Lyft Inc / Beyond Meat Inc / Uber Technologies Inc / CrowdStrike Holdings Inc / 10X Genomics Inc / Peloton Interactive Inc / Virgin Galactic Holdings Inc / Azek Company Inc / DraftKings Inc / APA Corp (US) / Vroom Inc / Lemonade Inc / nCino Inc / Jamf Holding Corp / Brookfield Renewable Corp / Duck Creek Technologies Inc / Palantir Technologies Inc / Sotera Health Co / Skillz Inc / CLARIVATE PLC / Signify Health Inc / Vimeo Inc / Figs Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / United Kingdom / Liberia / Luxembourg / Netherlands / Panama / United States / Jersey</td><td class="leftalignment">Aerospace / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Consumer / Containers & Packing / Defense / Electrical / Electronics / Financial Services / Food / Healthcare / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Oil & Gas / Internet</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/05/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">RAIN - BUY - New Milademetan (MDM2i) Combo Study To Initiate In 2H22 With Clinical Supply Agreement With Roche</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BN2RM92 / 2778844</td><td class="leftalignment">Rain Therapeutics Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/05/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AAP / AR / AZO / BBY / BMY.N / BP.N / CHD / CL / CLR / CLX / CNX / COP / CPE / CVX / DVN / EL / EOG / EQT / FND / HD / HES / KMB / KO / LLY.N / LOW / MGY / MRK.N / MRO / MUR / OLN / OXY / PFE.N / PG / PXD / RH / RRC / SLB.N / SM / SPB / STZ / SWN / TAP.N / W / WLK / WLL / WSM / CNQ.TO / GILD.O / AMGN.O / HAL.N / EPC / MGM.N / SU.TO / BBBY.O / XOM / LBRT.N / PENN.O / LPI / REGN.O / VRTX.O / TSCO.O / COCO.O / SMG.N / WYNN.O / MNST.O / ORLY.O / WOOF.O / BIIB.O / NOV.N / RDSb / NOG.A / CZR.O / BKR.N / ESTE.K / MTDR.K / PDCE.O / AMBA.O / FANG.O / ABBV.N / GTLS.N / COTY.K / CIVI.K / TCON.O / CDEV.O / CVNA.K / IOVA.O / EYE.O / PEP.O / INSP.K / KDP.N / AVRO.O / BRY.O / NWL.O / FLTRF.L / OAS.O / OVV.N / DKNG.O / VRM.O / CTRA.K / GRWG.O / SFT.O / BALY.N / RSI.N / HYFM.O / CHK.O / JOAN.O / ZVIA.N / WEBR.N</td><td class="leftalignment">Advance Auto Parts Inc / Antero Resources Corp / Autozone Inc / Best Buy Co Inc / Bristol-Myers Squibb Co / BP PLC / Church & Dwight Co Inc / Colgate-Palmolive Co / Continental Resources Inc / Clorox Co / CNX Resources Corp / Conocophillips / Callon Petroleum Co / Chevron Corp / Devon Energy Corp / Estee Lauder Companies Inc / EOG Resources Inc / EQT Corp / Floor & Decor Holdings Inc / Home Depot Inc / Hess Corp / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lowe's Companies Inc / Magnolia Oil & Gas Corp / Merck & Co Inc / Marathon Oil Corp / Murphy Oil Corp / Olin Corp / Occidental Petroleum Corp / Pfizer Inc / Procter & Gamble Co / Pioneer Natural Resources Co / RH / Range Resources Corp / Schlumberger NV / SM Energy Co / Spectrum Brands Holdings Inc / Constellation Brands Inc / Southwestern Energy Co / Molson Coors Beverage Co / Wayfair Inc / Westlake Chemical Corp / Whiting Petroleum Corp / Williams-Sonoma Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Amgen Inc / Halliburton Co / Edgewell Personal Care Co / MGM Resorts International / Suncor Energy Inc / Bed Bath & Beyond Inc / Exxon Mobil Corp / Liberty Oilfield Services Inc / Penn National Gaming Inc / Laredo Petroleum Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Tractor Supply Co / Vita Coco Company Inc / Scotts Miracle-Gro Co / Wynn Resorts Ltd / Monster Beverage Corp / O'Reilly Automotive Inc / Petco Health and Wellness Company Inc / Biogen Inc / Nov Inc / Royal Dutch Shell PLC / Northern Oil and Gas Inc / Caesars Entertainment Inc / Baker Hughes Co / Earthstone Energy Inc / Matador Resources Co / PDC Energy Inc / Ambarella Inc / Diamondback Energy Inc / Abbvie Inc / Chart Industries Inc / Coty Inc / Civitas Resources Inc / TRACON Pharmaceuticals Inc / Centennial Resource Development Inc / Carvana Co / Iovance Biotherapeutics Inc / National Vision Holdings Inc / PepsiCo Inc / Inspire Medical Systems Inc / Keurig Dr Pepper Inc / AVROBIO Inc / Berry Corporation (Bry) / Newell Brands Inc / Flutter Entertainment PLC / Oasis Petroleum Inc / Ovintiv Inc / DraftKings Inc / Vroom Inc / Coterra Energy Inc / GrowGeneration Corp / Shift Technologies Inc / Bally's Corp / Rush Street Interactive Inc / Hydrofarm Holdings Group Inc / Chesapeake Energy Corp / Joann Inc / Zevia PBC / Weber Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / Ireland / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Biopharma—Feedback From our Recent Launch; Slides attached–CC TMRW (1/5) 10:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">BMY.N / LLY.N / MRK.N / PFE.N / GILD.O / AMGN.O / REGN.O / VRTX.O / BIIB.O / ABBV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / China / Croatia / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">January "Monthly Controversies" report & '22 Outlook</td><td class="leftalignment">English</td><td class="rightalignment">163</td><td class="leftalignment">US0311621009 / US09062X1037 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2778844 / 2206657 / 2270726 / 2684703 / 7103065 / B067BM3 / 2857817 / B02R1L6 / B7TL820 / B7254K9 / BHC8X90 / BD8DJ71 / BJ2Z0H2 / BDT5KT5 / BYSGPK2 / BYXR425 / BGDQ8B3 / BMYRFV6 / BPH0546 / BMHRMK1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Coca-Cola Co / Walt Disney Co / Pfizer Inc / Novartis AG / Molson Coors Beverage Co / Netflix Inc / ALLETE Inc / Meta Platforms Inc / AxoGen Inc / Novo Nordisk A/S / Snap Inc / Pinterest Inc / Inspire Medical Systems Inc / ViewRay Inc / RH / Axonics Inc / Procept Biorobotics Corp / Life Time Group Holdings Inc / Vita Coco Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">2022 Global Pharmaceuticals Outlook: Relative P/E Valuation Attractive to Value Investors, but Slowing Growth, 2026+ Patent Cliff, & Limited 2022 Catalysts Likely Caps Upside</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">0989529 / 2126335 / 5671735 / 0925288 / 2516152 / 2778844 / 7103065 / BHC8X90</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Sanofi SA / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">EU Pharma & Biotech : Party on: Pharma bull run isn't over, sector fundamentals remain positive</td><td class="leftalignment">English</td><td class="rightalignment">339</td><td class="leftalignment">AZN.L / GSK.L / RECI.MI / STDM.PA / SASY.PA / ROG.S / LUN.CO / NOVOb.CO / NOVN.S / MRCG.DE / LONN.S / SATG.DE / MORG.DE / DPH.L / ARGX.O / UCB.BR / ONT.L / SATG_p.DE / GLPG.AS / IPN.PA / HIK.L / GRLS.MC / ABCA.L / BAYGn.DE / GRFS.O / GRLSbn.MC / ARGX.BR / MOLN.S / GLPG.O / IDIA.S / MOR.O / TAK.N / GMAB.CO / MOLN.O</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Recordati Industria Chimica e Farmaceutica SpA / Sartorius Stedim Biotech SA / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Lonza Group AG / Sartorius AG / MorphoSys AG / Dechra Pharmaceuticals PLC / argenx SE / Ucb SA / Oxford Nanopore Technologies PLC / Sartorius AG / Galapagos NV / Ipsen SA / Hikma Pharmaceuticals PLC / Grifols SA / Abcam PLC / Bayer AG / Grifols SA / Grifols SA / argenx SE / Molecular Partners AG / Galapagos NV / Idorsia Ltd / MorphoSys AG / Takeda Pharmaceutical Co Ltd / Genmab A/S / Molecular Partners AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Richard B. Vosser / James D. Gordon / Ms. Laerke Engkilde / Zain Ebrahim</td></tr>
<tr class="even"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 24, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">112</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">20 Events In 2022 That Could Change Practice, Alter Companies, Move Stocks</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US6402681083 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Nektar Therapeutics / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jan 4 2022</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">FR0000120271 / GB0007980591 / US00971T1016 / US0116591092 / US0463531089 / US0556221044 / US1101221083 / US30231G1022 / US37733W1053 / US4062161017 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / AN8068571086 / US8308791024 / US8447411088 / US91913Y1001 / US92343V1044 / US1667641005 / US89151E1091 / US4771431016 / US4198791018 / US80105N1054 / US20030N1019 / LU0156801721 / US6402681083 / US88031M1099 / US09062X1037 / US0042251084 / US02043Q1076 / GB00B03MLX29 / US2538681030 / US19239V3024 / RDSa.AS / US2090341072 / US00206R1023 / US1314761032 / PAP310761054 / US01748X1028 / US2473617023 / US53261M1045 / US25470M1099 / US00507V1098 / US58933Y1055 / US88160R1014 / US9100471096 / US0995021062 / US4361061082 / US56585A1025 / US03027X1000 / US7185461040 / US69318G1067 / US00287Y1091 / US98978V1035 / US81762P1021 / US8725901040 / US23283R1005 / US8485771021 / US21240E1055 / US02376R1023 / US69888T2078 / US0465131078 / CA0089118776 / US22822V1017 / US29444U7000 / US00653A1079 / US12685J1051 / US05464T1043 / US00773U1088 / US16119P1084 / US36165L1089 / GB00BDSFG982 / US78410G1040 / US91325V1089 / US05722G1004 / US24665A1034 / US02156K1034 / US87105L1044 / US5904791358 / US28414H1032 / US0197701065 / US0144421072 / US09203E1055 / CH0499880968 / US15872M1045 / KYG3902L1095 / US62955J1034 / US5502411037 / US25401T1088 / US20717M1036 / US35909D1090 / KYG4701H1092 / US10576N1028 / US4181001037</td><td class="leftalignment">TotalEnergies SE / BP PLC / Akamai Technologies Inc / Alaska Air Group Inc / AstraZeneca PLC / BP PLC / Bristol-Myers Squibb Co / Exxon Mobil Corp / GlaxoSmithKline PLC / Halliburton Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Schlumberger NV / SkyWest Inc / Southwest Airlines Co / Valero Energy Corp / Verizon Communications Inc / Chevron Corp / TotalEnergies SE / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Comcast Corp / Tenaris SA / Nektar Therapeutics / Tenaris SA / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Royal Dutch Shell PLC / Digital Realty Trust Inc / Cogent Communications Holdings Inc / Royal Dutch Shell PLC / Consolidated Communications Holdings Inc / AT&T Inc / Calumet Specialty Products Partners LP / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Limelight Networks Inc / DISH Network Corp / Activision Blizzard Inc / Merck & Co Inc / Tesla Inc / United Airlines Holdings Inc / Booz Allen Hamilton Holding Corp / HollyFrontier Corp / Marathon Petroleum Corp / American Tower Corp / Phillips 66 / PBF Energy Inc / Abbvie Inc / Zoetis Inc / ServiceNow Inc / T-Mobile US Inc / CyrusOne Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Par Pacific Holdings Inc / Atara Biotherapeutics Inc / Air Canada / Crown Castle International Corp / Equinix Inc / Adaptimmune Therapeutics PLC / Cable One Inc / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Charter Communications Inc / GDS Holdings Ltd / TechnipFMC PLC / SBA Communications Corp / Uniti Group Inc / Baker Hughes Co / Delek US Holdings Inc / Altice USA Inc / Switch Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Allogene Therapeutics Inc / Alector Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA / ChampionX Corp / GDS Holdings Ltd / Nov Inc / Lumen Technologies Inc / DigitalBridge Group Inc / Confluent Inc / Frontier Communications Parent Inc / IHS Holding Ltd / Braze Inc / Hashicorp Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Luxembourg / Mexico / Panama / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">01/03/2022</td><td class="leftalignment">The Insight Partners</td><td class="leftalignment">Merck & Co., Inc. in Global Virus-like Particles Market, Company SWOT Analysis and Profile</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/01/2022</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">12/31/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Merck increases 1.8% in FY 2021</td><td class="leftalignment">English</td><td class="rightalignment">66</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">12/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Merck down 5.0% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">HZNP-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">HZNP.O / MRK / PFE / AMGN.O / RDY / AZN.O / RDUS.O</td><td class="leftalignment">Horizon Therapeutics PLC / Merck & Co Inc / Pfizer Inc / Amgen Inc / Dr Reddy's Laboratories Ltd / AstraZeneca PLC / Radius Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / India / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">VRTX-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">VRTX.O / BMY / JNJ / MRK / GILD.O / ENTA.O / ABBV.K / ENZN.PK</td><td class="leftalignment">Vertex Pharmaceuticals Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Gilead Sciences Inc / Enanta Pharmaceuticals Inc / Abbvie Inc / Enzon Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O / BIOb / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ZTS-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ZTS / LLY / MRK / PFE / ICCC.O / HSKA.O / PAHC.O / SNY.O</td><td class="leftalignment">Zoetis Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / ImmuCell Corp / Heska Corp / Phibro Animal Health Corp / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Six-bagger Merck soars 63% in FY 2021</td><td class="leftalignment">English</td><td class="rightalignment">54</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Merck jumps 21% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Quick Thoughts, Who's Gonna Get The Love And Who Could Feel The Pain in 2022</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">HCM / JNJ / LLY / MRK / PFE / US02043Q1076 / IMAB</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alnylam Pharmaceuticals Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">MarketLine</td><td class="leftalignment">Merck KGaA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report</td><td class="leftalignment">English</td><td class="rightalignment">874</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">Germany</td><td class="leftalignment">Chemicals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / TUESDAY / STRATEGIC ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">MarketLine Independent Re</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">MarketLine</td><td class="leftalignment">Merck & Co., Inc.</td><td class="leftalignment">English</td><td class="rightalignment">205</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / TUESDAY / STRATEGIC ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">MarketLine Independent Re</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">MarketLine</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">English</td><td class="rightalignment">97</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">Germany</td><td class="leftalignment">Chemicals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / TUESDAY / STRATEGIC ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">MarketLine Independent Re</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">MarketLine</td><td class="leftalignment">Merck & Co., Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report</td><td class="leftalignment">English</td><td class="rightalignment">1009</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / TUESDAY / STRATEGIC ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">MarketLine Independent Re</td></tr>
<tr class="even"><td class="leftalignment">12/29/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Merck KGaA</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">12/29/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Merck KGaA Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">12/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US Company reports financial results for the quarter ended October 03,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2778844 / 2002305 / 2973821 / 2542049 / 2689560 / 2684703 / 7103065 / B125XQ6 / B1XGNW4 / B0796X4 / BTN1Y11 / BFNR303 / BF3W461</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Abbott Laboratories / Alliant Energy Corp / Dominion Energy Inc / PG&E Corp / Pfizer Inc / Novartis AG / Portland General Electric Co / Insulet Corp / Dexcom Inc / Medtronic PLC / Northwest Natural Holding Co / Tandem Diabetes Care Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">12/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - Read through of Kintor's Ph3 COVID drug failure to China biotech</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N / PFE.N / BGNE.OQ / IMAB.OQ</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Beigene Ltd / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">12/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 17, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">12/27/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Race to the Bottom? Which Biopharma Has Most LOE Risk in 2025-30 Period?</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">71708110 / 92532F10 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / G3910J11</td><td class="leftalignment">Pfizer Inc / Vertex Pharmaceuticals Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">Australia / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Daniel Tarjan, Ph.D. / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">12/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">12/24/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - December 17 to 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US02553E1064 / US0311621009 / US0530151036 / US0584981064 / US0936711052 / US1101221083 / US2017231034 / US2371941053 / US3647601083 / US3703341046 / US3755581036 / US45337C1027 / US5324571083 / US5951121038 / US64125C1099 / US6541061031 / US6556641008 / US6703461052 / US7043261079 / US7170811035 / US75886F1075 / US7782961038 / US8000131040 / US8168511090 / US8270481091 / US8354951027 / US8581191009 / US8589121081 / US8725401090 / US9170471026 / US9182041080 / US92276F1003 / US92532F1003 / US9746371007 / CA1249003098 / CA8029121057 / CA30150P1099 / CA1469001053 / CA9528451052 / US9129091081 / CA51925D1069 / CA13677F1018 / CA0636711016 / CA0641491075 / CA6330671034 / CA7800871021 / US2283681060 / US2274831047 / US09062X1037 / US0534841012 / US29476L1070 / US2971781057 / CA8911605092 / CA1360691010 / US74144T1088 / US1011211018 / US2644115055 / US9290421091 / CA6445351068 / US9043111072 / US7376301039 / CA1375761048 / US9026531049 / US25960P1093 / US49427F1084 / CA3499151080 / US5500211090 / US02913V1035 / US90384S3031 / US3886891015 / US58933Y1055 / US18538R1032 / US74340W1036 / US6936561009 / US7512121010 / CA07380N1042 / CA96145A2002 / US4440971095 / US78573L1061 / GB00B11DNM70 / US60468T1051 / US1220171060 / US2921041065 / US1785871013 / CA45868C1095 / US14174T1079 / US96145D1054 / US72703H1014 / US95040Q1040 / CA26829L1076 / US7495271071 / CA9628791027 / US8760301072 / US8608971078 / US63845R1077 / CA8585221051 / US03843E1047 / KYG370921069 / VGG1890L1076 / US73757R1023 / US76156B1070 / US88339P1012 / CA29446Y5020 / US70614W1009 / CA04302L1004 / US82575P1075 / US26484T1060 / US15202L1070 / US60646V1052 / US0708301041 / US9264001028 / US89269P1030 / US94770D1028 / US53190C1027 / US1374041093</td><td class="leftalignment">American Eagle Outfitters Inc / Amgen Inc / Automatic Data Processing Inc / Ball Corp / H & R Block Inc / Bristol-Myers Squibb Co / Commercial Metals Co / Darden Restaurants Inc / Gap Inc / General Mills Inc / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Micron Technology Inc / Neurocrine Biosciences Inc / Nike Inc / Nordstrom Inc / Nucor Corp / Paychex Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Sanderson Farms Inc / Sempra Energy / Silgan Holdings Inc / Sonoco Products Co / Steel Dynamics Inc / Stericycle Inc / TJX Companies Inc / Urban Outfitters Inc / VF Corp / Ventas Inc / Vertex Pharmaceuticals Inc / Winnebago Industries Inc / CCL Industries Inc / Saputo Inc / Exco Technologies Ltd / Cascades Inc / West Fraser Timber Co Ltd / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Bank of Montreal / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / Crown Holdings Inc / Cross Country Healthcare Inc / Biogen Inc / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / T Rowe Price Group Inc / Boston Properties Inc / Duke Realty Corp / Vornado Realty Trust / New Gold Inc / Under Armour Inc / Potlatchdeltic Corp / Canfor Corp / UDR Inc / Douglas Emmett Inc / Kilroy Realty Corp / Fortuna Silver Mines Inc / Lululemon Athletica Inc / American Public Education Inc / Ulta Beauty Inc / Graphic Packaging Holding Co / Merck & Co Inc / Clearwater Paper Corp / Prologis Inc / PVH Corp / Ralph Lauren Corp / Bear Creek Mining Corp / Westshore Terminals Investment Corp / Hudson Pacific Properties Inc / Sabra Health Care REIT Inc / Horizonte Minerals PLC / Mirati Therapeutics Inc / Burlington Stores Inc / Empire State Realty Trust Inc / City Office REIT Inc / Interfor Corp / CareTrust REIT Inc / Westrock Co / Planet Fitness Inc / Welltower Inc / ECN Capital Corp / REV Group Inc / Wheaton Precious Metals Corp / Tapestry Inc / Stitch Fix Inc / National Vision Holdings Inc / Stelco Holdings Inc / Aquestive Therapeutics Inc / Galaxy Digital Holdings Ltd / Capri Holdings Ltd / Postal Realty Trust Inc / Revolve Group Inc / RealReal Inc / Equinox Gold Corp / Peloton Interactive Inc / Artemis Gold Inc / Sibanye Stillwater Ltd / Dun & Bradstreet Holdings Inc / Centerspace / Mister Car Wash Inc / Bath & Body Works Inc / Victoria's Secret & Co / Traeger Inc / Weber Inc / Life Time Group Holdings Inc / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / United States / Virgin Islands, British / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/23/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Timing and Language in EUA Affirms Unfavorable Positioning for Molnupiravir</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">58933Y10</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="even"><td class="leftalignment">12/23/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Going Viral Chapter 7, MRK Moves In with MOVe-OUT</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">12/23/2021</td><td class="leftalignment">Smart Insider</td><td class="leftalignment">Merck Kgaa: 1 director</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / ECONOMIC INDICATORS / FUNDAMENTAL ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Company Snapshot</td></tr>
<tr class="even"><td class="leftalignment">12/23/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Merck & Co., Inc.(MRK) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">58933Y105</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">12/23/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Merck & Co., Inc.(MRK) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">58933Y105</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">12/23/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">There’s No Biopharma Without M&A; Dip in Deals in 2021 Does Not Make a Trend</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">71708110 / 92532F10 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / G3910J11</td><td class="leftalignment">Pfizer Inc / Vertex Pharmaceuticals Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">Australia / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Daniel Tarjan, Ph.D. / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">12/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Dec 22 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">DE0006969603 / US09061G1013 / US0311621009 / US0718131099 / US1101221083 / US1311931042 / US1985161066 / US2435371073 / US3755581036 / US45253H1014 / US45337C1027 / US4781601046 / US64125C1099 / US6541061031 / US66987V1098 / US75886F1075 / US7782961038 / US8006771062 / US8305661055 / US8725401090 / US87612E1064 / US9021041085 / US9139031002 / US9182041080 / US92532F1003 / US3448491049 / US6402681083 / US21036P1084 / US2533931026 / US09062X1037 / US0042251084 / US02043Q1076 / US9043111072 / BREMBRACNOR4 / US4103451021 / US03152W1099 / US5500211090 / US36315X1019 / US58933Y1055 / US46333X1081 / US13100M5094 / DE000A1EWWW0 / US29082A1079 / US40412C1018 / US6936561009 / US7512121010 / US00287Y1091 / US09609G1004 / US8036071004 / US4576693075 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US00847X1046 / US60468T1051 / US1220171060 / US4277461020 / US90400D1081 / NL0010696654 / US0396971071 / US78667J1088 / US2681582019 / US09627Y1091 / US81750R1023 / US37890U1088 / US50127T1097 / US05464T1043 / US4622221004 / US28106W1036 / US87164F1057 / US00773U1088 / US5588681057 / CH0334081137 / BMG637AM1024 / US01345P1066 / US74967X1037 / US6904691010 / US04016X1019 / US76243J1051 / US4622601007 / US5011471027 / US03753U1060 / US77313F1066 / US4380831077 / US2997341035 / US80706P1030 / US89610F1012 / US01671P1003 / US9842411095 / US39868T1051 / US0197701065 / US98585X1046 / US68570P1012 / US85205L1070 / US92764N1028 / US7027121000 / US0843101017 / US75943R1023 / US02875D1090 / US07373B1098 / US56854Q2003 / US81181C1045 / US74006W1080 / US55406W1036 / US30260D1037 / US38870X1046 / KYG7614L1095 / US98422T1007 / US01675A1097</td><td class="leftalignment">Puma SE / Biomarin Pharmaceutical Inc / Amgen Inc / Baxter International Inc / Bristol-Myers Squibb Co / Callaway Golf Co / Columbia Sportswear Co / Deckers Outdoor Corp / Gilead Sciences Inc / ImmunoGen Inc / Incyte Corp / Johnson & Johnson / Neurocrine Biosciences Inc / Nike Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Sangamo Therapeutics Inc / Skechers USA Inc / TJX Companies Inc / Target Corp / II-VI Inc / Universal Health Services Inc / VF Corp / Vertex Pharmaceuticals Inc / Foot Locker Inc / Nektar Therapeutics / Constellation Brands Inc / DICK'S Sporting Goods Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Under Armour Inc / Embraer SA / HanesBrands Inc / Amicus Therapeutics Inc / Lululemon Athletica Inc / Galapagos NV / Merck & Co Inc / Ironwood Pharmaceuticals Inc / Calix Inc / Adidas AG / Embraer SA / HCA Healthcare Inc / PVH Corp / Ralph Lauren Corp / Abbvie Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Insmed Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Agios Pharmaceuticals Inc / Mirati Therapeutics Inc / Burlington Stores Inc / Heron Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Uniqure NV / Ardelyx Inc / SAGE Therapeutics Inc / Dynavax Technologies Corp / Blueprint Medicines Corp / Seres Therapeutics Inc / Global Blood Therapeutics Inc / Kura Oncology Inc / Axsome Therapeutics Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Syndax Pharmaceuticals Inc / Adverum Biotechnologies Inc / Madrigal Pharmaceuticals Inc / CRISPR Therapeutics AG / Myovant Sciences Ltd / Albireo Pharma Inc / RH / Ovid Therapeutics Inc / argenx SE / Rhythm Pharmaceuticals Inc / Iovance Biotherapeutics Inc / Krystal Biotech Inc / Apellis Pharmaceuticals Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Tricida Inc / Allakos Inc / Y-mAbs Therapeutics Inc / Gritstone bio Inc / Allogene Therapeutics Inc / Yeti Holdings Inc / Orchard Therapeutics PLC / SpringWorks Therapeutics Inc / Vir Biotechnology Inc / Passage Bio Inc / Berkeley Lights Inc / Relay Therapeutics Inc / American Outdoor Brands Inc / Beam Global / Marinus Pharmaceuticals Inc / Seagen Inc / Praxis Precision Medicines Inc / MYT Netherlands Parent BV / Figs Inc / Graphite Bio Inc / Rockley Photonics Holdings Ltd / Xilio Therapeutics Inc / Allbirds Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Brazil / Switzerland / Cayman Islands / Germany / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">12/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Immuno-Oncology in December: Roundup of Recent Presentations and Insights</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">640268108 / 771195104 / 58933Y10 / 09075V10 / N0104510 / 31189P10 / 45781K20 / 46565G10 / 95075A10 / 15673T10</td><td class="leftalignment">Nektar Therapeutics / Roche Holding AG / Merck & Co Inc / BioNTech SE / Affimed NV / Fate Therapeutics Inc / Innate Pharma SA / Iteos Therapeutics Inc / Werewolf Therapeutics Inc / Century Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / France / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daina Graybosch, Ph.D. / Jeffrey La Rosa / Dilip Joseph</td></tr>
<tr class="odd"><td class="leftalignment">12/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IPN.PA: Ipsen - Model update on US Somatuline competition</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">IPN.PA / CIPL.BO / RECI.MI / LUN.CO / NOVN.S / MRCG.DE / LONN.S / UCB.BR / ORNBV.HE / ALM.MC / GRLS.MC / GMAB.CO</td><td class="leftalignment">Ipsen SA / Cipla Ltd / Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Novartis AG / Merck KGaA / Lonza Group AG / Ucb SA / Orion Oyj / Almirall SA / Grifols SA / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / India / Italy</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">12/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Top 10 Potential Surprises Of 2022</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">US09062X1037 / US89610F1012 / US09061G1013 / US0311621009 / US1101221083 / US3755581036 / US45253H1014 / US45337C1027 / US4781601046 / US64125C1099 / US66987V1098 / US75886F1075 / US8006771062 / US92532F1003 / US6402681083 / US21036P1084 / US0042251084 / US02043Q1076 / US03152W1099 / US36315X1019 / US58933Y1055 / US46333X1081 / US00287Y1091 / US09609G1004 / US8036071004 / US4576693075 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US00847X1046 / US60468T1051 / US4277461020 / US90400D1081 / NL0010696654 / US0396971071 / US78667J1088 / US2681582019 / US09627Y1091 / US81750R1023 / US37890U1088 / US50127T1097 / US05464T1043 / US4622221004 / US28106W1036 / US87164F1057 / US00773U1088 / US5588681057 / CH0334081137 / BMG637AM1024 / US01345P1066 / US6904691010 / US04016X1019 / US76243J1051 / US4622601007 / US5011471027 / US03753U1060 / US77313F1066 / US4380831077 / US2997341035 / US80706P1030 / US01671P1003 / US9842411095 / US39868T1051 / US0197701065 / US68570P1012 / US85205L1070 / US92764N1028 / US7027121000 / US75943R1023 / US56854Q2003 / US81181C1045 / US74006W1080 / US38870X1046 / US98422T1007</td><td class="leftalignment">Biogen Inc / Tricida Inc / Biomarin Pharmaceutical Inc / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / ImmunoGen Inc / Incyte Corp / Johnson & Johnson / Neurocrine Biosciences Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Nektar Therapeutics / Constellation Brands Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Amicus Therapeutics Inc / Galapagos NV / Merck & Co Inc / Ironwood Pharmaceuticals Inc / Abbvie Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Insmed Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Agios Pharmaceuticals Inc / Mirati Therapeutics Inc / Heron Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Uniqure NV / Ardelyx Inc / SAGE Therapeutics Inc / Dynavax Technologies Corp / Blueprint Medicines Corp / Seres Therapeutics Inc / Global Blood Therapeutics Inc / Kura Oncology Inc / Axsome Therapeutics Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Syndax Pharmaceuticals Inc / Adverum Biotechnologies Inc / Madrigal Pharmaceuticals Inc / CRISPR Therapeutics AG / Myovant Sciences Ltd / Albireo Pharma Inc / Ovid Therapeutics Inc / argenx SE / Rhythm Pharmaceuticals Inc / Iovance Biotherapeutics Inc / Krystal Biotech Inc / Apellis Pharmaceuticals Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Allakos Inc / Y-mAbs Therapeutics Inc / Gritstone bio Inc / Allogene Therapeutics Inc / Orchard Therapeutics PLC / SpringWorks Therapeutics Inc / Vir Biotechnology Inc / Passage Bio Inc / Relay Therapeutics Inc / Marinus Pharmaceuticals Inc / Seagen Inc / Praxis Precision Medicines Inc / Graphite Bio Inc / Xilio Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="odd"><td class="leftalignment">12/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2640147 / 2778844 / 2219224 / 2270726 / 2542049 / 2317087 / 2455965 / 2689560 / 2684703 / 7103065 / 2713317 / 2857817 / B125XQ6 / BHC8X90 / BJJMGL2 / BKTNTR9 / BJXBP30 / BYYWPW6 / BZ1LFG7 / BYY88Y7 / BNTB3N8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Nike Inc / Merck & Co Inc / CMS Energy Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Biogen Inc / PG&E Corp / Pfizer Inc / Novartis AG / ACADIA Pharmaceuticals Inc / Netflix Inc / Portland General Electric Co / Novo Nordisk A/S / Fox Corp / ViacomCBS Inc / Turning Point Therapeutics Inc / Beigene Ltd / Roku Inc / Alphabet Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 10, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">743</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Middle East</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HOLT Bayer Segmental Valuation: Potential attractive upside from improvements in Crop Sciences</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BAYGN.DE / CL.N / FMC.N / JNJ.N / VILM.PA / PG.N / AZN.L / SASY.PA / NOVOB.CO / BEIG.DE / MRCG.DE / NUF.AX / GSK.L / KWSG.DE / UPLL.NS / CTVA.N / RKT.L</td><td class="leftalignment">Bayer AG / Colgate-Palmolive Co / FMC Corp / Johnson & Johnson / Vilmorin & Cie SA / Procter & Gamble Co / AstraZeneca PLC / Sanofi SA / Novo Nordisk A/S / Beiersdorf AG / Merck KGaA / Nufarm Ltd / GlaxoSmithKline PLC / KWS SAAT SE & Co KgaA / UPL Ltd / Corteva Inc / Reckitt Benckiser Group PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Germany / Denmark / France / United Kingdom / India / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Sophia Graeff Buhl-Nielsen / HOLT Europe / Emilie Fung</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IPN.PA: Ipsen - In-license of elafibranor for rare liver disease  CSe 60% POS $600m, NPV Eu2.67/share</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">IPN.PA / RECI.MI / LUN.CO / MRCG.DE / LONN.S / UCB.BR / ICPT.OQ / ORNBV.HE / ALM.MC / VIFN.S / GMAB.CO</td><td class="leftalignment">Ipsen SA / Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Intercept Pharmaceuticals Inc / Orion Oyj / Almirall SA / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">12/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.8% Above Pre-Pandemic Base- Week 89</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">12/18/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Merck & Co Inc (MRK) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">1161</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MKKGY-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MKKGY.PK / ONTX.O / OMHE.PK / OILS.CD / ONPH.PK</td><td class="leftalignment">Merck KGaA / Onconova Therapeutics Inc / Omni Health Inc / Nextleaf Solutions Ltd / Oncology Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Germany / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Johnson & Johnson Stock Is Likely To See Higher Levels In The Near Term</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Will Pfizer Stock See Higher Levels After A Large 18% Rise In A Month?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N / JNJ.N / MRK.N / RHHBY.PK</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Merck & Co Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Evan’s Weekly Dose of Targeted Therapy & Video - ASH & 2022 Outlook Edition</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended December 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 66987V10 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / 45781M10 / G3910J11 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / Innoviva Inc / GlaxoSmithKline PLC / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">62</td><td class="leftalignment">IL0006290147 / US00724F1012 / US0311621009 / US0383361039 / US0584981064 / US1101221083 / US31428X1063 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US81211K1007 / US8581191009 / US92532F1003 / CA59162N1096 / CA5394811015 / CA2918434077 / US9129091081 / CA1349211054 / US7665596034 / US09062X1037 / US02043Q1076 / US3546131018 / US74144T1088 / US09247X1019 / US40637H1095 / CA1375761048 / CA0966311064 / CA6179141065 / CA1999101001 / CA7669101031 / CA2271071094 / CA46071W2058 / BMG491BT1088 / IE00B4BNMY34 / US58933Y1055 / CA0985461049 / JE00B4T3BW64 / US00287Y1091 / CA0194561027 / CA04315L1058 / US09609G1004 / CA3874371147 / CA16141A1030 / IE00B4Q5ZN47 / CA8661201167 / CA38045Y1025 / CA6674951059 / US6951271005 / US45845P1084 / CA0266951064 / CA58546R1091 / CA17039A1066 / US60468T1051 / US45378A1060 / US31189P1021 / CA72820F1036 / IE00BJ3V9050 / US03820J1007 / CA26153P1045 / CA1264621006 / US78667J1088 / IE00BQPVQZ61 / US92686J1060 / CA8310211005 / CA82621K1021 / CA83179X1087 / CA05329M1041 / US4622221004 / CA49410M1023 / US5588681057 / US68404V1008 / US03753U1060 / CA46136U1030 / IL0011417206 / US92645B1035 / US03168L1052 / US2997341035 / CA05585D1033 / US80706P1030 / US03836N1037 / US48251W1045 / CA0717341071 / CA60448E1034 / US76029N1063 / US03843E1047 / CA4039254079 / US04335A1051 / US50015M1099 / US03990B1017 / CA2849025093 / US62921N1054 / CA7426943006 / US61775R1059 / US09260D1072 / US03768E1055 / US71722W1071 / CA92625W5072 / CA31890B1031 / US14316J1088 / US80810D1037 / US6544051096 / IL0011326795 / CA67079A1021 / US12529R1077 / US3773201062 / CA33843T1084 / US92556V1061 / CA00288U1066 / CA65342N3159 / US67080N1019 / US24343R1068 / US4718711033 / US1374041093</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Adobe Inc / Amgen Inc / Aptargroup Inc / Ball Corp / Bristol-Myers Squibb Co / FedEx Corp / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Sealed Air Corp / Steel Dynamics Inc / Vertex Pharmaceuticals Inc / Metro Inc / Loblaw Companies Ltd / Empire Company Ltd / United States Steel Corp / Canadian Apartment Properties Real Estate Investment Trust / Rigel Pharmaceuticals Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Franklin Resources Inc / T Rowe Price Group Inc / BlackRock Inc / Halozyme Therapeutics Inc / Canfor Corp / Boardwalk Real Estate Investment Trust / Morguard Real Estate Investment Trust / Cominar Real Estate Investment Trust / RioCan Real Estate Investment Trust / Crombie Real Estate Investment Trust / InterRent Real Estate Investment Trust / Invesco Ltd / Accenture PLC / Merck & Co Inc / Bonterra Energy Corp / Glencore PLC / Abbvie Inc / Allied Properties Real Estate Investment Trust / Artis Real Estate Investment Trust / bluebird bio Inc / Granite Real Estate Investment Trust / Chartwell Retirement Residences / Jazz Pharmaceuticals PLC / Summit Industrial Income REIT / GoGold Resources Inc / NorthWest Healthcare Properties REIT / Pacira Biosciences Inc / Intercept Pharmaceuticals Inc / American Hotel Income Properties REIT LP / Melcor Real Estate Investment Trust / Choice Properties Real Estate Investment Trust / Mirati Therapeutics Inc / Independence Realty Trust Inc / Fate Therapeutics Inc / Plaza Retail REIT / Endo International PLC / Applied Genetic Technologies Corp / Dream Office Real Estate Investment Trust / CT Real Estate Investment Trust / SAGE Therapeutics Inc / Horizon Therapeutics PLC / Viking Therapeutics Inc / Slate Office REIT / Sienna Senior Living Inc / SmartCentres Real Estate Investment Trust / Automotive Properties Real Estate Investment Trust / Ionis Pharmaceuticals Inc / Killam Apartment REIT / Madrigal Pharmaceuticals Inc / OptiNose Inc / Apellis Pharmaceuticals Inc / Invesque Inc / Sol Gel Technologies Ltd / Victory Capital Holdings Inc / Amneal Pharmaceuticals Inc / Evelo Biosciences Inc / BSR Real Estate Investment Trust / Scholar Rock Holding Corp / Aptinyx Inc / KKR & Co Inc / Bausch Health Companies Inc / Minto Apartment Real Estate Investment Trust / Replimune Group Inc / Aquestive Therapeutics Inc / H&R Real Estate Investment Trust / Arvinas Inc / Kodiak Sciences Inc / Ares Management Corp / Eldorado Gold Corp / NGM Biopharmaceuticals Inc / PRO Real Estate Investment Trust / Morphic Holding Inc / Blackstone Inc / Apollo Global Management Inc / Phathom Pharmaceuticals Inc / Victoria Gold Corp / First Capital Real Estate Investment Trust / Carlyle Group Inc / Schrodinger Inc / 9 Meters Biopharma Inc / PolyPid Ltd / Nuvei Corp / C4 Therapeutics Inc / Glatfelter Corp / Flagship Communities Real Estate Investment Trust / Viatris Inc / Abcellera Biologics Inc / Nexus Real Estate Investment Trust / Nuvation Bio Inc / Decibel Therapeutics Inc / Jasper Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Biopharma Growth Crisis? Lower & Slower Growth Ahead as Major LOEs Loom</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">92532F10 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / G3910J11</td><td class="leftalignment">Vertex Pharmaceuticals Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">Australia / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Daniel Tarjan, Ph.D. / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback - Read-across on FDA approvability of Chinese of PD-(L)1s</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AZN.L / ROG.S / BMY.N / LLY.N / MRK.N / SASY.PA / GSK.L / BGNE.OQ</td><td class="leftalignment">AstraZeneca PLC / Roche Holding AG / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Sanofi SA / GlaxoSmithKline PLC / Beigene Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">2022 BioPharma Outlook: A Light at the End of the Tunnel as Sector Sentiment Likely to Improve</td><td class="leftalignment">English</td><td class="rightalignment">89</td><td class="leftalignment">IL0006290147 / US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US7665596034 / US09062X1037 / US02043Q1076 / US40637H1095 / US58933Y1055 / US00287Y1091 / US09609G1004 / IE00B4Q5ZN47 / US6951271005 / US45845P1084 / US60468T1051 / US31189P1021 / IE00BJ3V9050 / US03820J1007 / US78667J1088 / IE00BQPVQZ61 / US92686J1060 / US4622221004 / US5588681057 / US68404V1008 / US03753U1060 / IL0011417206 / US03168L1052 / US2997341035 / US80706P1030 / US03836N1037 / CA0717341071 / US76029N1063 / US03843E1047 / US04335A1051 / US50015M1099 / US62921N1054 / US61775R1059 / US71722W1071 / US80810D1037 / US6544051096 / IL0011326795 / US12529R1077 / US92556V1061 / CA00288U1066 / US67080N1019 / US24343R1068 / US4718711033 / US1374041093</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / Merck & Co Inc / Abbvie Inc / bluebird bio Inc / Jazz Pharmaceuticals PLC / Pacira Biosciences Inc / Intercept Pharmaceuticals Inc / Mirati Therapeutics Inc / Fate Therapeutics Inc / Endo International PLC / Applied Genetic Technologies Corp / SAGE Therapeutics Inc / Horizon Therapeutics PLC / Viking Therapeutics Inc / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / OptiNose Inc / Apellis Pharmaceuticals Inc / Sol Gel Technologies Ltd / Amneal Pharmaceuticals Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Aptinyx Inc / Bausch Health Companies Inc / Replimune Group Inc / Aquestive Therapeutics Inc / Arvinas Inc / Kodiak Sciences Inc / NGM Biopharmaceuticals Inc / Morphic Holding Inc / Phathom Pharmaceuticals Inc / Schrodinger Inc / 9 Meters Biopharma Inc / PolyPid Ltd / C4 Therapeutics Inc / Viatris Inc / Abcellera Biologics Inc / Nuvation Bio Inc / Decibel Therapeutics Inc / Jasper Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Mr. Gary Nachman / Matthew Luchini</td></tr>
<tr class="odd"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Biotechnology - ASH 2021: potential winners start to emerge</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">FR0000120578 / GB0009252882 / DK0010272202 / CH0012032048 / CH0012005267 / US1101221083 / US5324571083 / US7170811035 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Sanofi SA / GlaxoSmithKline PLC / Genmab A/S / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Xian Deng</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GMAB.CO: Genmab - Model update and thoughts post ASH</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">GMAB.CO / JNJ.N / RECI.MI / LUN.CO / MRCG.DE / LONN.S / UCB.BR / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / ABBV.N</td><td class="leftalignment">Genmab A/S / Johnson & Johnson / Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">12/16/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck KGaA : Key takeaways from our 2021 Conference Call with the CEO of Electronics</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Richard B. Vosser / James D. Gordon / Ms. Laerke Engkilde / Zain Ebrahim</td></tr>
<tr class="even"><td class="leftalignment">12/15/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Q3 2021: Merck EPS soars 560.9%</td><td class="leftalignment">English</td><td class="rightalignment">58</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">12/15/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Merck climbs 12.1% from 5 week low</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Kepler Cheuvreux</td><td class="leftalignment">Germany | Best Ideas | The Great Volatility</td><td class="leftalignment">English</td><td class="rightalignment">113</td><td class="leftalignment">A4Y.DE / ARLG.DE / ALVG.DE / BMWG.DE / CBKG.DE / HEIG.DE / HNKG.DE / HOTG.DE / LHAG.DE / RWEG.DE / SGCG.DE / VOWG_p.DE / DEZG.DE / DUEG.DE / CONG.DE / NAFG.DE / TKAG.DE / SIEGn.DE / DBKGn.DE / SAPG.DE / SKBG.DE / BEIG.DE / PV.DE / FMEG.DE / MRCG.DE / KRNG.DE / BDTG.DE / PSHG_p.DE / IFXGn.DE / JUNG_p.DE / GFTG.DE / MLPG.DE / SZGG.DE / FREG.DE / GBFG.DE / PUMG.DE / VOSG.DE / RHMG.DE / ADAG.DE / RAAG.DE / FIEG.DE / DPWGn.DE / QIA.DE / DEQGn.DE / DB1Gn.DE / KTAG.DE / NDXG.DE / FRAG.DE / AFXG.DE / EVDG.DE / SATG_p.DE / TTKG.DE / CWCG.DE / OHBG.DE / DRWG_p.DE / TEGG.DE / LEOGn.DE / KWSG.DE / ZILGn.DE / SBSG.DE / HAGG.DE / LXSG.DE / MTXGn.DE / TUIGn.DE / G1AG.DE / BYWGnx.DE / KCOGn.DE / B5AG.DE / SY1G.DE / KSBG_p.DE / DWNG.DE / AOXG.DE / WACGn.DE / GXIG.DE / DAIGn.DE / HHFGn.DE / ZO1G.DE / EONGn.DE / TTRGn.DE / ADNGk.DE / BAYGn.DE / BNRGn.DE / BASFn.DE / SAXG.DE / DR0G.DE / ADSGn.DE / SHLG.DE / BEZ.DE / NOEJ.DE / SDFGn.DE / 2HR.DE / BOSSn.DE / LEGn.DE / CLIQ.DE / EVKn.DE / SANT1.DE / DBANn.DE / KGX.DE / PSMGn.DE / DICn.DE / GYC.DE / FYB.DE / STAB.DE / ZALG.DE / HLE.DE / GLJn.DE / PBBG.DE / ADJ.DE / VNAn.DE / M12.DE / 1COV.DE / SHA_p.DE / HBH.DE / HLAG.DE / G24n.DE / BNNn.DE / AT1.DE / UN01.DE / VQTG.DE / SAEG.DE / ILM1k.DE / CCAG.DE / CECG.DE / B4B.DE / DHER.DE / HFGG.DE / BFSA.DE / VAR1.DE / M0Y.DE / INS2.DE / DWSG.DE / PATGn.DE / CYR.DE / CSQG.DE / JENGn.DE / KBX.DE / LINI.DE / 8TRA.DE / M8G.DE / COP1n.DE / SFQ.DE / ENR1n.DE / JDC.DE / C0M.DE / VTWRn.DE / SYAB.DE / NVM.DE / VTSCn.DE / DTGGe.DE</td><td class="leftalignment">Accentro Real Estate AG / Aareal Bank AG / Allianz SE / Bayerische Motoren Werke AG / Commerzbank AG / HeidelbergCement AG / Henkel AG & Co KGaA / Hochtief AG / Deutsche Lufthansa AG / Rwe AG / SGL Carbon SE / Volkswagen AG / DEUTZ AG / Duerr AG / Continental AG / Aurubis AG / thyssenkrupp AG / Siemens AG / Deutsche Bank AG / SAP SE / Koenig & Bauer AG / Beiersdorf AG / Pfeiffer Vacuum Technology AG / Fresenius Medical Care AG & Co KGaA / Merck KGaA / Krones AG / Bertrandt AG / Porsche Automobil Holding SE / Infineon Technologies AG / Jungheinrich AG / GFT Technologies SE / MLP SE / Salzgitter AG / Fresenius SE & Co KGaA / Bilfinger SE / Puma SE / Vossloh AG / Rheinmetall AG / ADVA Optical Networking SE / Rational AG / Fielmann AG / Deutsche Post AG / Qiagen NV / Deutsche EuroShop AG / Deutsche Boerse AG / Knaus Tabbert AG / Nordex SE / Fraport AG Frankfurt Airport Services Worldwide / Carl Zeiss Meditec AG / Cts Eventim AG & Co KgaA / Sartorius AG / Takkt AG / Cewe Stiftung & Co KGaA / OHB SE / Draegerwerk AG & Co KGaA / TAG Immobilien AG / Leoni AG / KWS SAAT SE & Co KgaA / Elringklinger AG / Stratec SE / Hensoldt AG / Lanxess AG / MTU Aero Engines AG / TUI AG / GEA Group AG / BayWa AG / Kloeckner & Co SE / Bauer AG / Symrise AG / KSB SE & Co KGaA / Deutsche Wohnen SE / alstria office REIT AG / Wacker Neuson SE / Gerresheimer AG / Daimler AG / Hamburger Hafen und Logistik AG / Zooplus AG / E.ON SE / technotrans SE / adesso SE / Bayer AG / Brenntag SE / BASF SE / Stroeer SE & Co KgaA / Deutsche Rohstoff AG / Adidas AG / Siemens Healthineers AG / Berentzen Gruppe AG / Norma Group SE / K&S AG / H&R GmbH & Co KgaA / Hugo Boss AG / LEG Immobilien SE / CLIQ Digital AG / Evonik Industries AG / S&T AG / Deutsche Beteiligungs AG / Kion Group AG / Prosiebensat 1 Media SE / DIC Asset AG / Grand City Properties SA / Formycon AG / Stabilus SA / Zalando SE / HELLA GmbH & Co KGaA / Grenke AG / Deutsche Pfandbriefbank AG / Adler Group SA / Vonovia SE / M1 Kliniken AG / Covestro AG / Schaeffler AG / Hornbach Holding AG & Co KGaA / Hapag Lloyd AG / Scout24 SE / BRAIN Biotech AG / Aroundtown SA / Uniper SE / va Q tec AG / Shop Apotheke Europe NV / Medios AG / Corestate Capital Holding SA / Ceconomy AG / Metro AG / Delivery Hero SE / Hellofresh SE / Befesa SA / Varta AG / Mynaric AG / Instone Real Estate Group SE / DWS Group GmbH & Co KgaA / Patrizia AG / Cyan AG / Creditshelf AG / Jenoptik AG / Knorr Bremse AG / Linde PLC / Traton SE / Media and Games Invest SE / CompuGroup Medical SE & Co KgaA / Saf-Holland Se / Siemens Energy AG / JDC Group AG / Compleo Charging Solutions AG / Vantage Towers AG / Synlab AG / Novem Group SA / Vitesco Technologies Group AG / Daimler Truck Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Austria / Germany / Ireland / Luxembourg / Malta / Netherlands</td><td class="leftalignment">Aerospace / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Building & Building Materials / Chemicals / Consumer / Defense / Energy / Financial Services / Food / Healthcare / Info. Tech./Computers / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Manufacturing / Media / Metals & Minerals / Pharmaceuticals / Real Estate / Retailing / Services / Telecommunications / Transportation / Utilities / Oil & Gas</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Herr Oliver Reinberg, CFA</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AZN-US -  Dividend Quality Analysis, for the period ended September 13,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AZN.O / ABT / BMY / JNJ / LLY / MRK / NVS / PFE / GSK / BIIB.O / SNY.O</td><td class="leftalignment">AstraZeneca PLC / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Biogen Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">PFE Data Net Positive for Protease Inhibitor Antivirals, Net Negative for MRK</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK.N / 58933Y10 / 29251M10 / 04683R10 / 01626L10</td><td class="leftalignment">Merck & Co Inc / Merck & Co Inc / Enanta Pharmaceuticals Inc / Atea Pharmaceuticals Inc / Aligos Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Roanna C. Ruiz / Daina Graybosch, Ph.D. / Dilip Joseph</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">US1264081035 / US3755581036 / US45337C1027 / US5324571083 / US6745991058 / US7170811035 / US75886F1075 / US20825C1045 / CA56501R1064 / CA8667961053 / CA39138C1068 / US26884L1098 / US58933Y1055 / US69327R1014 / CA21750U1012 / US31189P1021 / US86771W1053 / US03753U1060 / US03843E1047 / CA45075E1043 / US86745K1043 / US30205M1018</td><td class="leftalignment">CSX Corp / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Occidental Petroleum Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Conocophillips / Manulife Financial Corp / Sun Life Financial Inc / Great-West Lifeco Inc / EQT Corp / Merck & Co Inc / PDC Energy Inc / Copper Mountain Mining Corp / Fate Therapeutics Inc / Sunrun Inc / Apellis Pharmaceuticals Inc / Aquestive Therapeutics Inc / iA Financial Corporation Inc / Sunnova Energy International Inc / Exicure Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2008154 / 2778844 / 2050832 / 2270726 / 2829515 / 2689560 / 2684703 / 2048804 / 7103065 / 2857817 / B3D7K31 / BCZS820 / BBGVT40 / BFLR866 / BFZNYB7 / BKVDFF7 / BFZ1K46 / BMYML02 / BFMXGR0 / BJJMGL2 / BKTNTR9 / BZ05388 / BJVR9Y9 / BYY88Y7 / BG0Q4Y1 / BNTB3N8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Adobe Inc / Merck & Co Inc / Ameren Corp / Walt Disney Co / Edison International / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Novartis AG / Netflix Inc / Discovery Inc / Fate Therapeutics Inc / News Corp / Twitter Inc / Allogene Therapeutics Inc / Oric Pharmaceuticals Inc / Spotify Technology SA / DraftKings Inc / Evergy Inc / Fox Corp / ViacomCBS Inc / Global Blood Therapeutics Inc / iHeartMedia Inc / Alphabet Inc / Exicure Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Pharmaceuticals - 2022: Let's hope it's a good one</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US5324571083 / US7170811035 / US58933Y1055 / US00287Y1091 / DK0060534915</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Merck & Co Inc / Abbvie Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Equity Strategy: 2022 Research Outlook: Themes, Sectors and Styles</td><td class="leftalignment">English</td><td class="rightalignment">292</td><td class="leftalignment">0006.HK / 0522.HK / 1038.HK / 2330.TW / 6481.T / 6503.T / 6954.T / 7203.T / AEGN.AS / AKZO.AS / ALSO.PA / ALVG.DE / APD.N / ASML.AS / ASSAB.ST / ATCOA.ST / BAC.N / BAER.S / BARC.L / BNPP.PA / BT.L / C.N / CCL.N / CL.N / COF.N / CPG.L / CRDI.MI / CRH.I / CRST.L / DCC.L / DGE.L / DNB.OL / EDP.LS / ELE.MC / EOG.N / ERICB.ST / EXHO.PA / F.N / GE.N / HEIN.AS / HSBA.L / IBM.N / ITV.L / KGF.L / KO.N / KPN.AS / KSP.I / LLOY.L / LOIM.PA / LVMH.PA / MAN.N / MDT.N / OREP.PA / PHG.AS / PNN.L / PRTP.PA / PRU.L / PUBP.PA / RAND.AS / RIO.AX / ROR.L / RYA.I / SCHN.PA / SEBA.ST / SECUB.ST / SHBA.ST / SMIN.L / SOGN.PA / SOLB.BR / SSABA.ST / STAN.L / STM.PA / SWMA.ST / TCL.AX / TW.L / VERB.VI / VNT.N / VOD.L / VWS.CO / WLSNC.AS / SSE.L / STERV.HE / AA.N / PG.N / X.N / ROK.N / AZN.L / 6861.T / AAL.L / SASY.PA / TKAG.DE / GFNORTEO.MX / DRI.N / ABBN.S / GEBN.S / SU.TO / SIEGN.DE / MCD.N / SYY.N / VLO.N / XOM.N / NOKIA.HE / ENEI.MI / MRCG.DE / DTEGN.DE / BBVA.MC / IFXGN.DE / HOLMB.ST / GIVN.S / CARLB.CO / NG.L / 2408.TW / ADEN.S / VFC.N / UHR.S / EZJ.L / DPWGN.DE / EQT.N / IG.MI / EUFI.PA / TEL2B.ST / 2454.TW / CLF.N / KBC.BR / CVX.N / CAGR.PA / REL.L / 000063.SZ / ALFA.ST / ITRK.L / 3034.TW / COP.N / HAYS.L / INTC.OQ / AMAT.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / FL.N / MCHP.OQ / STLD.OQ / AMZN.OQ / AMKR.OQ / NVDA.OQ / GPN.N / NFLX.OQ / 6239.TW / COLOB.CO / MAERSKB.CO / SGSN.S / 6723.T / TXN.OQ / LISP.S / SLHN.S / 005930.KS / STMN.S / SCHP.S / AEL.N / FM.TO / 6268.T / INGA.AS / ALX.AX / 0981.HK / NESN.S / KNEBV.HE / G1AG.DE / DISCA.OQ / TNET.BR / MS.N / FIS.N / LEGD.PA / HOLN.S / KBR.N / SWEDA.ST / ISP.MI / PRY.MI / MNDI.L / BVI.PA / 3800.HK / 002185.SZ / CAJ.AX / DAN.N / WRT1V.HE / EONGN.DE / ARYN.S / ABI.BR / UPM.HE / CVE.TO / MU.OQ / 0486.HK / BNRGN.DE / BTS.BK / ORON.S / TSLA.OQ / 002460.SZ / 002415.SZ / 002466.SZ / NXPI.OQ / APAM.AS / CABK.MC / VAC.N / 4966.TWO / SLM.OQ / FANG.OQ / O2DN.DE / OCI.AS / 8150.TW / NCLH.N / GOOGL.OQ / APPS.MC / NN.AS / SYF.N / SSPG.L / BABA.N / KEYS.N / AUTOA.L / CLNX.MC / ABND.AS / CSPC.L / UBSG.S / PAGE.L / ASRNL.AS / ATKR.N / TWNK.OQ / TECKB.TO / HGV.N / KCRA.HE / FORTUM.HE / SGREN.MC / FERG.L / ORSTED.CO / HFGG.DE / FB.PS / EAF.N / 300750.SZ / EPIRA.ST / EPRT.N / CWK.N / KBX.DE / VRRM.OQ / ORGO.OQ / MNRL.N / PRX.AS / VRLA.PA / DQ.ZY / 2222.SE / SITM.OQ / 3714.TW / RKT.L / GJFG.OL</td><td class="leftalignment">Power Assets Holdings Ltd / ASM Pacific Technology Ltd / CK Infrastructure Holdings Ltd / Taiwan Semiconductor Manufacturing Co Ltd / THK Co Ltd / Mitsubishi Electric Corp / Fanuc Corp / Toyota Motor Corp / Aegon NV / Akzo Nobel NV / Alstom SA / Allianz SE / Air Products and Chemicals Inc / ASML Holding NV / Assa Abloy AB / Atlas Copco AB / Bank of America Corp / Julius Baer Gruppe AG / Barclays PLC / BNP Paribas SA / BT Group PLC / Citigroup Inc / Carnival Corp / Colgate-Palmolive Co / Capital One Financial Corp / Compass Group PLC / UniCredit SpA / CRH PLC / Crest Nicholson Holdings PLC / DCC PLC / Diageo PLC / DNB Bank ASA / EDP Energias de Portugal SA / Endesa SA / EOG Resources Inc / Telefonaktiebolaget LM Ericsson / Sodexo SA / Ford Motor Co / General Electric Co / Heineken NV / HSBC Holdings PLC / International Business Machines Corp / ITV PLC / Kingfisher PLC / Coca-Cola Co / Koninklijke KPN NV / Kingspan Group PLC / Lloyds Banking Group PLC / Klepierre SA / LVMH Moet Hennessy Louis Vuitton SE / ManpowerGroup Inc / Medtronic PLC / L'Oreal SA / Koninklijke Philips NV / Pennon Group PLC / Kering SA / Prudential PLC / Publicis Groupe SA / Randstad NV / Rio Tinto Ltd / Rotork PLC / Ryanair Holdings PLC / Schneider Electric SE / Skandinaviska Enskilda Banken AB / Securitas AB / Svenska Handelsbanken AB / Smiths Group PLC / Societe Generale SA / Solvay SA / SSAB AB / Standard Chartered PLC / STMicroelectronics NV / Swedish Match AB / Transurban Group / Taylor Wimpey PLC / Verbund AG / Vontier Corp / Vodafone Group PLC / Vestas Wind Systems A/S / Wolters Kluwer NV / SSE PLC / Stora Enso Oyj / Alcoa Corp / Procter & Gamble Co / United States Steel Corp / Rockwell Automation Inc / AstraZeneca PLC / Keyence Corp / Anglo American PLC / Sanofi SA / thyssenkrupp AG / Grupo Financiero Banorte SAB de CV / Darden Restaurants Inc / Abb Ltd / Geberit AG / Suncor Energy Inc / Siemens AG / McDonald's Corp / Sysco Corp / Valero Energy Corp / Exxon Mobil Corp / Nokia Oyj / Enel SpA / Merck KGaA / Deutsche Telekom AG / Banco Bilbao Vizcaya Argentaria SA / Infineon Technologies AG / Holmen AB / Givaudan SA / Carlsberg A/S / National Grid PLC / Nanya Technology Corp / Adecco Group AG / VF Corp / Swatch Group AG / Easyjet PLC / Deutsche Post AG / EQT Corp / Italgas SpA / Eurofins Scientific SE / Tele2 AB / MediaTek Inc / Cleveland-Cliffs Inc / KBC Groep NV / Chevron Corp / Credit Agricole SA / Relx PLC / ZTE Corp / Alfa Laval AB / Intertek Group PLC / Novatek Microelectronics Corp / Conocophillips / Hays PLC / Intel Corp / Applied Materials Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Foot Locker Inc / Microchip Technology Inc / Steel Dynamics Inc / Amazon.com Inc / Amkor Technology Inc / NVIDIA Corp / Global Payments Inc / Netflix Inc / Powertech Technology Inc / Coloplast A/S / AP Moeller - Maersk A/S / SGS SA / Renesas Electronics Corp / Texas Instruments Inc / Chocoladefabriken Lindt & Spruengli AG / Swiss Life Holding AG / Samsung Electronics Co Ltd / Straumann Holding AG / Schindler Holding AG / American Equity Investment Life Holding Co / First Quantum Minerals Ltd / Nabtesco Corp / ING Groep NV / Atlas Arteria Group / Semiconductor Manufacturing International Corp / Nestle SA / Kone Oyj / GEA Group AG / Discovery Inc / Telenet Group Holding NV / Morgan Stanley / Fidelity National Information Services Inc / Legrand SA / Holcim AG / KBR Inc / Swedbank AB / Intesa Sanpaolo SpA / Prysmian SpA / Mondi PLC / Bureau Veritas SA / GCL-Poly Energy Holdings Ltd / Tianshui Huatian Technology Co Ltd / Capitol Health Ltd / Dana Inc / Wartsila Oyj Abp / E.ON SE / Aryzta AG / Anheuser Busch Inbev SA / UPM-Kymmene Oyj / Cenovus Energy Inc / Micron Technology Inc / OK Rusal MKPAO / Brenntag SE / BTS Group Holdings PCL / Orior AG / Tesla Inc / Ganfeng Lithium Co Ltd / Hangzhou Hikvision Digital Technology Co Ltd / Tianqi Lithium Corp / NXP Semiconductors NV / Aperam SA / Caixabank SA / Marriott Vacations Worldwide Corp / Parade Technologies Ltd / SLM Corp / Diamondback Energy Inc / Telefonica Deutschland Holding AG / OCI NV / ChipMOS Technologies Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Applus Services SA / NN Group NV / Synchrony Financial / SSP Group PLC / Alibaba Group Holding Ltd / Keysight Technologies Inc / Auto Trader Group PLC / Cellnex Telecom SA / ABN Amro Bank NV / Countryside Properties PLC / UBS Group AG / Pagegroup PLC / ASR Nederland NV / Atkore Inc / Hostess Brands Inc / Teck Resources Ltd / Hilton Grand Vacations Inc / Konecranes Abp / Fortum Oyj / Siemens Gamesa Renewable Energy SA / Ferguson PLC / Orsted A/S / Hellofresh SE / San Miguel Food and Beverage Inc / GrafTech International Ltd / Contemporary Amperex Technology Co Ltd / Epiroc AB / Essential Properties Realty Trust Inc / Cushman & Wakefield PLC / Knorr Bremse AG / Verra Mobility Corp / Organogenesis Holdings Inc / Brigham Minerals Inc / Prosus NV / Verallia SAS / Daqo New Energy Corp / Saudi Arabian Oil Co / SiTime Corp / Ennostar Inc / Reckitt Benckiser Group PLC / Gjensidige Forsikring ASA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Austria / Belgium / Bermuda / Canada / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Hong Kong / Ireland / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Netherlands / Norway / Panama / Philippines / Portugal / Russian Federation / Saudi Arabia / Sweden / Thailand / Taiwan / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Mr. Andrew W. Garthwaite / Mr Robert C. Griffiths / Asim Ali / Nasr Islam / Marc el Koussa</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Merck & Co. , Inc.</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LLY-US -  Dividend Quality Analysis, for the period ended December 10,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY / BMY / JNJ / MRK / NVS / PFE / AMGN.O / GSK / AZN.O / ABBV.K / SNY.O</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">ASH Day 3: Wrap Up and Regeneron Investor Call Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">REGN.OQ / US3755581036 / US45337C1027 / US5324571083 / US75886F1075 / US58933Y1055 / US31189P1021 / US03753U1060</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Fate Therapeutics Inc / Apellis Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Matthew Luchini</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 3, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Kepler Cheuvreux</td><td class="leftalignment">Merck KGAA | 1K | Buy | Further upgrades, remains one to own</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David P. Evans</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 13, 2021</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">US0311621009 / US0394831020 / US0536111091 / US1101221083 / US1266501006 / US3755581036 / US3976241071 / US45337C1027 / US5324571083 / US5719032022 / US64125C1099 / US65473P1057 / US7170811035 / US7445731067 / US75886F1075 / US92276F1003 / US92532F1003 / US98389B1008 / CA51925D1069 / US09062X1037 / US15135B1017 / US0534841012 / US29476L1070 / US2971781057 / US44107P1049 / US74460D1090 / US9026531049 / US30225T1025 / US58933Y1055 / US65339F1012 / US2296631094 / US09609G1004 / US70509V1008 / US16208T1025 / US60468T1051 / US14174T1079 / US9840171030 / US30040W1080 / US6378701063 / US4278255009 / US95040Q1040 / US53223X1072 / US7005171050 / US43300A2033 / US03753U1060 / US04335A1051 / US15202L1070 / US4718711033 / US1374041093 / CA24477T1003 / CA22289D1078</td><td class="leftalignment">Amgen Inc / Archer-Daniels-Midland Co / Avery Dennison Corp / Bristol-Myers Squibb Co / CVS Health Corp / Gilead Sciences Inc / Greif Inc / Incyte Corp / Eli Lilly and Co / Marriott International Inc / Neurocrine Biosciences Inc / NiSource Inc / Pfizer Inc / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / Ventas Inc / Vertex Pharmaceuticals Inc / Xcel Energy Inc / Laurentian Bank of Canada / Biogen Inc / Centene Corp / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Host Hotels & Resorts Inc / Public Storage / UDR Inc / Extra Space Storage Inc / Merck & Co Inc / Nextera Energy Inc / CubeSmart / bluebird bio Inc / Pebblebrook Hotel Trust / Chatham Lodging Trust / Mirati Therapeutics Inc / CareTrust REIT Inc / Xenia Hotels & Resorts Inc / Eversource Energy / National Storage Affiliates Trust / Hersha Hospitality Trust / Welltower Inc / Life Storage Inc / Park Hotels & Resorts Inc / Hilton Worldwide Holdings Inc / Apellis Pharmaceuticals Inc / Arvinas Inc / Centerspace / Jasper Therapeutics Inc / Candel Therapeutics Inc / Definity Financial Corp / Coveo Solutions Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AJG / ALL / AM / AMT / AR / AXP / BA.N / BAX / BMY.N / CB / CCI / CLR / CNC.N / CNX / COO / CPE / CPK / CRM.N / CVS.N / D / DG / DGX / DK / DLR / DVN / DY / EOG / EQT / HD / HEP / HIG / IFF / KNX / LOW / MCHP.O / MGY / MMP / MRK.N / MRO / OKE / OLN / OXY / PFE.N / PGR / PNM / PXD / QCOM.O / RKT / RMBS.O / RNG / RRC / SJI / SLG / SM / SWN / T / TFX / TOL / USM / WES / WLK / WLL / ASND.O / AMZN.O / GILD.O / ET / AMGN.O / EW / IRM / MGM.N / ADBE.O / PAA.N / SBAC.O / MXL / ADI.O / VZ / NWN / ARNA.O / SMTC.O / SLAB.O / SNPS.O / DLTR.O / BYD.N / ARGX.O / PENN.O / ISRG.O / LPI / CHDN.O / REGN.O / VRTX.O / MRVL.O / SMG.N / WYNN.O / SIVB.O / DIOD.O / ACGL.O / EQIX.O / OMCL.O / SWKS.O / BIIB.O / DKL / LVS.N / CDNS.O / CNSL.O / CLMT.O / CCOI.O / NOG.A / WRB.N / TSLA.O / NXPI.O / CZR.O / HZNP.O / ESTE.K / MTDR.K / TRGP.K / PDCE.O / AMBA.O / FANG.O / MPLX.K / ABBV.N / PFSI.K / PSXP.K / LGIH.O / FIVN.O / RXDX.O / AFMD.O / SHLX.K / NVRO.K / QRVO.O / CIVI.K / PBFX.K / ON.O / CYAD.O / GBT.O / TMUS.O / RRR.O / EVBG.O / UNIT.O / CLLS.O / CDEV.O / WDAY.O / HESM.K / RYTM.O / SWCH.K / APLS.O / EGHT.K / AUTL.O / BRY.O / KZR.O / AXNX.O / SWAV.O / ZM.O / FLTRF.L / RTLR.O / MORF.O / CABA.O / OAS.O / OVV.N / PGEN.O / BEAM.O / DKNG.O / ZI.O / CTRA.K / GRWG.O / 45258J102 / NWE.O / LUMN.K / BALY.N / ALGM.O / RSI.N / HYFM.O / GRCL.O / CHK.O / HMPT.O / DBRG.N / BLND.N / YOU.N / WKME.O / KLTR.O / WOLF.N / RIVN.O</td><td class="leftalignment">Arthur J Gallagher & Co / Allstate Corp / Antero Midstream Corp / American Tower Corp / Antero Resources Corp / American Express Co / Boeing Co / Baxter International Inc / Bristol-Myers Squibb Co / Chubb Ltd / Crown Castle International Corp / Continental Resources Inc / Centene Corp / CNX Resources Corp / Cooper Companies Inc / Callon Petroleum Co / Chesapeake Utilities Corp / Salesforce.Com Inc / CVS Health Corp / Dominion Energy Inc / Dollar General Corp / Quest Diagnostics Inc / Delek US Holdings Inc / Digital Realty Trust Inc / Devon Energy Corp / Dycom Industries Inc / EOG Resources Inc / EQT Corp / Home Depot Inc / Holly Energy Partners LP / Hartford Financial Services Group Inc / International Flavors & Fragrances Inc / Knight-Swift Transportation Holdings Inc / Lowe's Companies Inc / Microchip Technology Inc / Magnolia Oil & Gas Corp / Magellan Midstream Partners LP / Merck & Co Inc / Marathon Oil Corp / ONEOK Inc / Olin Corp / Occidental Petroleum Corp / Pfizer Inc / Progressive Corp / PNM Resources Inc / Pioneer Natural Resources Co / Qualcomm Inc / Rocket Companies Inc / Rambus Inc / RingCentral Inc / Range Resources Corp / South Jersey Industries Inc / SL Green Realty Corp / SM Energy Co / Southwestern Energy Co / AT&T Inc / Teleflex Inc / Toll Brothers Inc / United States Cellular Corp / Western Midstream Partners LP / Westlake Chemical Corp / Whiting Petroleum Corp / Ascendis Pharma A/S / Amazon.com Inc / Gilead Sciences Inc / Energy Transfer LP / Amgen Inc / Edwards Lifesciences Corp / Iron Mountain Inc / MGM Resorts International / Adobe Inc / Plains All American Pipeline LP / SBA Communications Corp / Maxlinear Inc / Analog Devices Inc / Verizon Communications Inc / Northwest Natural Holding Co / Arena Pharmaceuticals Inc / Semtech Corp / Silicon Laboratories Inc / Synopsys Inc / Dollar Tree Inc / Boyd Gaming Corp / argenx SE / Penn National Gaming Inc / Intuitive Surgical Inc / Laredo Petroleum Inc / Churchill Downs Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Marvell Technology Inc / Scotts Miracle-Gro Co / Wynn Resorts Ltd / SVB Financial Group / Diodes Inc / Arch Capital Group Ltd / Equinix Inc / Omnicell Inc / Skyworks Solutions Inc / Biogen Inc / Delek Logistics Partners LP / Las Vegas Sands Corp / Cadence Design Systems Inc / Consolidated Communications Holdings Inc / Calumet Specialty Products Partners LP / Cogent Communications Holdings Inc / Northern Oil and Gas Inc / W R Berkley Corp / Tesla Inc / NXP Semiconductors NV / Caesars Entertainment Inc / Horizon Therapeutics PLC / Earthstone Energy Inc / Matador Resources Co / Targa Resources Corp / PDC Energy Inc / Ambarella Inc / Diamondback Energy Inc / MPLX LP / Abbvie Inc / PennyMac Financial Services Inc / Phillips 66 Partners LP / LGI Homes Inc / Five9 Inc / Prometheus Biosciences Inc / Affimed NV / Shell Midstream Partners LP / Nevro Corp / Qorvo Inc / Civitas Resources Inc / PBF Logistics LP / ON Semiconductor Corp / Celyad Oncology SA / Global Blood Therapeutics Inc / T-Mobile US Inc / Red Rock Resorts Inc / Everbridge Inc / Uniti Group Inc / Cellectis SA / Centennial Resource Development Inc / Workday Inc / Hess Midstream LP / Rhythm Pharmaceuticals Inc / Switch Inc / Apellis Pharmaceuticals Inc / 8x8 Inc / Autolus Therapeutics PLC / Berry Corporation (Bry) / Kezar Life Sciences Inc / Axonics Inc / Shockwave Medical Inc / Zoom Video Communications Inc / Flutter Entertainment PLC / Rattler Midstream LP / Morphic Holding Inc / Cabaletta Bio Inc / Oasis Petroleum Inc / Ovintiv Inc / Precigen Inc / Beam Therapeutics Inc / DraftKings Inc / ZoomInfo Technologies Inc / Coterra Energy Inc / GrowGeneration Corp / Immunovant Inc / NorthWestern Corp / Lumen Technologies Inc / Bally's Corp / Allegro Microsystems Inc / Rush Street Interactive Inc / Hydrofarm Holdings Group Inc / Gracell Biotechnologies Inc / Chesapeake Energy Corp / Home Point Capital Inc / DigitalBridge Group Inc / Blend Labs Inc / Clear Secure Inc / Walkme Ltd / Kaltura Inc / Wolfspeed Inc / Rivian Automotive Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - Read-through of Roche's TIGIT OS data: Benefiting BeiGene's global ambition</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BGNE.OQ / BMY.N / PFE.N / AZN.L / ROG.S / NOVN.S / MRCG.DE / GSK.L / GILD.OQ / 1801.HK / GMAB.CO / IMAB.OQ</td><td class="leftalignment">Beigene Ltd / Bristol-Myers Squibb Co / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Gilead Sciences Inc / Innovent Biologics Inc / Genmab A/S / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">12/12/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">ASH Day 1: Some Encouraging Updates, but We Expect Limited Impact to Shares</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US1101221083 / US3755581036 / US45337C1027 / US75886F1075 / US58933Y1055 / US09609G1004 / US03753U1060</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Merck & Co Inc / bluebird bio Inc / Apellis Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Matthew Luchini</td></tr>
<tr class="odd"><td class="leftalignment">12/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.7% Above Pre-Pandemic Base- Week 88</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Insights from CITYSCAPE and our Recent Discussion with Genentech</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">11012210 / 37555810 / M2572210 / 640268108 / 771195104 / 58933Y10 / 00653A107 / 58949210 / 09075V10 / 07725L10 / G3910J11 / 81181C10 / 46565G10 / 03969F10 / 05370A10</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Compugen Ltd / Nektar Therapeutics / Roche Holding AG / Merck & Co Inc / Adaptimmune Therapeutics PLC / Mereo Biopharma Group PLC / BioNTech SE / Beigene Ltd / GlaxoSmithKline PLC / Seagen Inc / Iteos Therapeutics Inc / Arcus Biosciences Inc / Avidity Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daina Graybosch, Ph.D. / Geoffrey Porges, MBBS / Andrew Berens, M.D. / Jeffrey La Rosa / Dilip Joseph / Na Sun / Anna Baran, CFA / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Weekly Highlights—December 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AJG / ALL / AM / AR / BA.N / BAX / BMY.N / CB / CLR / CNX / COO / CPK / CRM.N / D / DG / DK / DVN / EOG / EQT / HD / HEP / HIG / LOW / MMP / MRK.N / OKE / OLN / OXY / PFE.N / PGR / RRC / SJI / SLG / SWN / WES / ASND.O / AMZN.O / GILD.O / ET / AMGN.O / EW / PAA.N / ADI.O / NWN / ARNA.O / ARGX.O / ISRG.O / REGN.O / VRTX.O / SMG.N / SIVB.O / ACGL.O / OMCL.O / BIIB.O / DKL / CLMT.O / WRB.N / TSLA.O / HZNP.O / TRGP.K / FANG.O / MPLX.K / ABBV.N / PSXP.K / LGIH.O / RXDX.O / SHLX.K / NVRO.K / CIVI.K / PBFX.K / CDEV.O / HESM.K / RYTM.O / APLS.O / BRY.O / KZR.O / AXNX.O / SWAV.O / RTLR.O / MORF.O / CABA.O / CTRA.K / GRWG.O / 45258J102 / HYFM.O / CHK.O / RIVN.O</td><td class="leftalignment">Arthur J Gallagher & Co / Allstate Corp / Antero Midstream Corp / Antero Resources Corp / Boeing Co / Baxter International Inc / Bristol-Myers Squibb Co / Chubb Ltd / Continental Resources Inc / CNX Resources Corp / Cooper Companies Inc / Chesapeake Utilities Corp / Salesforce.Com Inc / Dominion Energy Inc / Dollar General Corp / Delek US Holdings Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Home Depot Inc / Holly Energy Partners LP / Hartford Financial Services Group Inc / Lowe's Companies Inc / Magellan Midstream Partners LP / Merck & Co Inc / ONEOK Inc / Olin Corp / Occidental Petroleum Corp / Pfizer Inc / Progressive Corp / Range Resources Corp / South Jersey Industries Inc / SL Green Realty Corp / Southwestern Energy Co / Western Midstream Partners LP / Ascendis Pharma A/S / Amazon.com Inc / Gilead Sciences Inc / Energy Transfer LP / Amgen Inc / Edwards Lifesciences Corp / Plains All American Pipeline LP / Analog Devices Inc / Northwest Natural Holding Co / Arena Pharmaceuticals Inc / argenx SE / Intuitive Surgical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Scotts Miracle-Gro Co / SVB Financial Group / Arch Capital Group Ltd / Omnicell Inc / Biogen Inc / Delek Logistics Partners LP / Calumet Specialty Products Partners LP / W R Berkley Corp / Tesla Inc / Horizon Therapeutics PLC / Targa Resources Corp / Diamondback Energy Inc / MPLX LP / Abbvie Inc / Phillips 66 Partners LP / LGI Homes Inc / Prometheus Biosciences Inc / Shell Midstream Partners LP / Nevro Corp / Civitas Resources Inc / PBF Logistics LP / Centennial Resource Development Inc / Hess Midstream LP / Rhythm Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Berry Corporation (Bry) / Kezar Life Sciences Inc / Axonics Inc / Shockwave Medical Inc / Rattler Midstream LP / Morphic Holding Inc / Cabaletta Bio Inc / Coterra Energy Inc / GrowGeneration Corp / Immunovant Inc / Hydrofarm Holdings Group Inc / Chesapeake Energy Corp / Rivian Automotive Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / Denmark / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Adam Muro / Alexandra Green / Dian Yuan</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ABT / ACI / AIG / AJG / ALC / ALL / AM / AMAT.O / AMT / AON / AR / ARW / BA.N / BAX / BDX / BEP / BK / BMY.N / BP.N / BSX / CB / CLR / CMA / CNX / COO / COP / COST.O / CPK / CRM.N / CVX / D / DG / DK / DVN / EOG / EQT / F.N / FITB.O / GM.N / HD / HEP / HES / HFC / HIG / INTC.O / JNJ / KLAC.O / KR / LNC / LOW / LRCX.O / MCHP.O / MDT / MET / MMC / MMP / MPC / MRK.N / MUR / NTRS.O / OGE / OKE / OLN / OXY / PEN / PFE.N / PGR / PNC / PRU / PSX / QCOM.O / RE / RKT / RMBS.O / RNG / RNR / RRC / SJI / SLB.N / SLG / STT / SWN / SYK / TFC / TFX / TRV / VLO / WES / WMB / WMT / XLNX.O / ASND.O / AMZN.O / CNQ.TO / GILD.O / ET / AMGN.O / EW / BRO / AAPL.O / CSCO.O / HAL.N / NVDA.O / SU.TO / XOM / PAA.N / PBF / MXL / LBRT.N / IART.O / AMD.O / ADI.O / NWN / NTAP.O / ARNA.O / BJ.N / SMTC.O / SLAB.O / SNPS.O / ARGX.O / AXS / ISRG.O / REGN.O / VRTX.O / MU.O / MRVL.O / HPQ / HPE / AVGO.O / BE.N / SMG.N / FCEL.OQ / PLUG.OQ / SIVB.O / BLUE.O / DIOD.O / MMSI.O / ACGL.O / MKSI.O / OMCL.O / SWKS.O / BIIB.O / DKL / VIAC.O / NOV.N / BLDP.OQ / RDSb / DXCM.O / CDNS.O / STX.O / CLMT.O / CVLT.O / PODD.O / TNDM.OQ / WRB.N / JNPR.K / TSLA.O / NXPI.O / LUNG.O / BKR.N / HZNP.O / WDC.O / TRGP.K / AMBA.O / FANG.O / MPLX.K / UIHC.O / ABBV.N / GTLS.N / VOYA.K / PFSI.K / RNA.O / PSXP.K / FATE.O / LGIH.O / RXDX.O / ANET.K / AFMD.O / SHLX.K / NVRO.K / QRVO.O / CIVI.K / PBFX.K / ON.O / GKOS.K / ZBH / CYAD.O / PSTG.K / NVCR.O / IONS.O / WLTW.O / EDIT.O / NTLA.O / NTNX.O / CLLS.O / CDEV.O / BHF.O / IOVA.O / HESM.K / RYTM.O / APLS.O / EQH / AVT.O / INSP.K / AUTL.O / BRY.O / KZR.O / STRO.O / AXNX.O / DELL.K / SWAV.O / RTLR.O / MORF.O / CHWY.K / BRP.O / CABA.O / PGEN.O / NARI.O / AVNT.K / CTRA.K / BEPC.K / GRWG.O / 45258J102 / ASO.O / EAR.O / ROOT.O / ALGM.O / HYFM.O / GRCL.O / CHK.O / HMPT.O / NPCE.O / RYAN.N / RXST.O / WOLF.N / ARBE.O / RIVN.O</td><td class="leftalignment">Abbott Laboratories / Albertsons Companies Inc / American International Group Inc / Arthur J Gallagher & Co / Alcon AG / Allstate Corp / Antero Midstream Corp / Applied Materials Inc / American Tower Corp / Aon PLC / Antero Resources Corp / Arrow Electronics Inc / Boeing Co / Baxter International Inc / Becton Dickinson and Co / Brookfield Renewable Partners LP / Bank of New York Mellon Corp / Bristol-Myers Squibb Co / BP PLC / Boston Scientific Corp / Chubb Ltd / Continental Resources Inc / Comerica Inc / CNX Resources Corp / Cooper Companies Inc / Conocophillips / Costco Wholesale Corp / Chesapeake Utilities Corp / Salesforce.Com Inc / Chevron Corp / Dominion Energy Inc / Dollar General Corp / Delek US Holdings Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Ford Motor Co / Fifth Third Bancorp / General Motors Co / Home Depot Inc / Holly Energy Partners LP / Hess Corp / HollyFrontier Corp / Hartford Financial Services Group Inc / Intel Corp / Johnson & Johnson / KLA Corp / Kroger Co / Lincoln National Corp / Lowe's Companies Inc / Lam Research Corp / Microchip Technology Inc / Medtronic PLC / MetLife Inc / Marsh & McLennan Companies Inc / Magellan Midstream Partners LP / Marathon Petroleum Corp / Merck & Co Inc / Murphy Oil Corp / Northern Trust Corp / OGE Energy Corp / ONEOK Inc / Olin Corp / Occidental Petroleum Corp / Penumbra Inc / Pfizer Inc / Progressive Corp / PNC Financial Services Group Inc / Prudential Financial Inc / Phillips 66 / Qualcomm Inc / Everest Re Group Ltd / Rocket Companies Inc / Rambus Inc / RingCentral Inc / Renaissancere Holdings Ltd / Range Resources Corp / South Jersey Industries Inc / Schlumberger NV / SL Green Realty Corp / State Street Corp / Southwestern Energy Co / Stryker Corp / Truist Financial Corp / Teleflex Inc / Travelers Companies Inc / Valero Energy Corp / Western Midstream Partners LP / Williams Companies Inc / Walmart Inc / Xilinx Inc / Ascendis Pharma A/S / Amazon.com Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Energy Transfer LP / Amgen Inc / Edwards Lifesciences Corp / Brown & Brown Inc / Apple Inc / Cisco Systems Inc / Halliburton Co / NVIDIA Corp / Suncor Energy Inc / Exxon Mobil Corp / Plains All American Pipeline LP / PBF Energy Inc / Maxlinear Inc / Liberty Oilfield Services Inc / Integra Lifesciences Holdings Corp / Advanced Micro Devices Inc / Analog Devices Inc / Northwest Natural Holding Co / NetApp Inc / Arena Pharmaceuticals Inc / BJ's Wholesale Club Holdings Inc / Semtech Corp / Silicon Laboratories Inc / Synopsys Inc / argenx SE / AXIS Capital Holdings Ltd / Intuitive Surgical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Micron Technology Inc / Marvell Technology Inc / HP Inc / Hewlett Packard Enterprise Co / Broadcom Inc / Bloom Energy Corp / Scotts Miracle-Gro Co / Fuelcell Energy Inc / Plug Power Inc / SVB Financial Group / bluebird bio Inc / Diodes Inc / Merit Medical Systems Inc / Arch Capital Group Ltd / MKS Instruments Inc / Omnicell Inc / Skyworks Solutions Inc / Biogen Inc / Delek Logistics Partners LP / ViacomCBS Inc / Nov Inc / Ballard Power Systems Inc / Royal Dutch Shell PLC / Dexcom Inc / Cadence Design Systems Inc / Seagate Technology Holdings PLC / Calumet Specialty Products Partners LP / Commvault Systems Inc / Insulet Corp / Tandem Diabetes Care Inc / W R Berkley Corp / Juniper Networks Inc / Tesla Inc / NXP Semiconductors NV / Pulmonx Corp / Baker Hughes Co / Horizon Therapeutics PLC / Western Digital Corp / Targa Resources Corp / Ambarella Inc / Diamondback Energy Inc / MPLX LP / United Insurance Holdings Corp / Abbvie Inc / Chart Industries Inc / Voya Financial Inc / PennyMac Financial Services Inc / Avidity Biosciences Inc / Phillips 66 Partners LP / Fate Therapeutics Inc / LGI Homes Inc / Prometheus Biosciences Inc / Arista Networks Inc / Affimed NV / Shell Midstream Partners LP / Nevro Corp / Qorvo Inc / Civitas Resources Inc / PBF Logistics LP / ON Semiconductor Corp / Glaukos Corp / Zimmer Biomet Holdings Inc / Celyad Oncology SA / Pure Storage Inc / Novocure Ltd / Ionis Pharmaceuticals Inc / Willis Towers Watson PLC / Editas Medicine Inc / Intellia Therapeutics Inc / Nutanix Inc / Cellectis SA / Centennial Resource Development Inc / Brighthouse Financial Inc / Iovance Biotherapeutics Inc / Hess Midstream LP / Rhythm Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Equitable Holdings Inc / Avnet Inc / Inspire Medical Systems Inc / Autolus Therapeutics PLC / Berry Corporation (Bry) / Kezar Life Sciences Inc / Sutro Biopharma Inc / Axonics Inc / Dell Technologies Inc / Shockwave Medical Inc / Rattler Midstream LP / Morphic Holding Inc / Chewy Inc / BRP Group Inc / Cabaletta Bio Inc / Precigen Inc / Inari Medical Inc / Avient Corp / Coterra Energy Inc / Brookfield Renewable Corp / GrowGeneration Corp / Immunovant Inc / Academy Sports and Outdoors Inc / Eargo Inc / Root Inc / Allegro Microsystems Inc / Hydrofarm Holdings Group Inc / Gracell Biotechnologies Inc / Chesapeake Energy Corp / Home Point Capital Inc / Neuropace Inc / Ryan Specialty Group Holdings Inc / Rxsight Inc / Wolfspeed Inc / Arbe Robotics Ltd / Rivian Automotive Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Evan’s Weekly Dose of Targeted Therapy & Video Link - ASH & Launch Feedback</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended December 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">AZN / 71708110 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / G3910J11 / 45845P10</td><td class="leftalignment">AstraZeneca PLC / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">JNJ / LLY / MRK / PFE / ARAV</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Aravive Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">12/09/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Marka falls 9.6% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRKP.WA</td><td class="leftalignment">Marka SA w restrukturyzacji</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Poland</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AJG / ALL / AR / BMY.N / CB / CNX / DOW / DVN / EOG / EQT / HIG / LH / MRK.N / PFE.N / PGR / RRC / SWN / GILD.O / AMGN.O / EW / REGN.O / VRTX.O / ACGL.O / BIIB.O / SBNY.O / WRB.N / FANG.O / ABBV.N / LGIH.O / AFMD.O / ROKU.O / CTRA.K / CHK.O / VZIO.N</td><td class="leftalignment">Arthur J Gallagher & Co / Allstate Corp / Antero Resources Corp / Bristol-Myers Squibb Co / Chubb Ltd / CNX Resources Corp / Dow Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Hartford Financial Services Group Inc / Laboratory Corporation of America Holdings / Merck & Co Inc / Pfizer Inc / Progressive Corp / Range Resources Corp / Southwestern Energy Co / Gilead Sciences Inc / Amgen Inc / Edwards Lifesciences Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Arch Capital Group Ltd / Biogen Inc / Signature Bank / W R Berkley Corp / Diamondback Energy Inc / Abbvie Inc / LGI Homes Inc / Affimed NV / Roku Inc / Coterra Energy Inc / Chesapeake Energy Corp / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Morning Research Highlights—December 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AJG / ALL / AR / BMY.N / CB / CNX / DOW / DVN / EOG / EQT / HIG / MRK.N / PFE.N / PGR / RRC / SWN / GILD.O / AMGN.O / EW / REGN.O / VRTX.O / ACGL.O / BIIB.O / SBNY.O / WRB.N / FANG.O / ABBV.N / LGIH.O / ROKU.O / CTRA.K / CHK.O / VZIO.N</td><td class="leftalignment">Arthur J Gallagher & Co / Allstate Corp / Antero Resources Corp / Bristol-Myers Squibb Co / Chubb Ltd / CNX Resources Corp / Dow Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Hartford Financial Services Group Inc / Merck & Co Inc / Pfizer Inc / Progressive Corp / Range Resources Corp / Southwestern Energy Co / Gilead Sciences Inc / Amgen Inc / Edwards Lifesciences Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Arch Capital Group Ltd / Biogen Inc / Signature Bank / W R Berkley Corp / Diamondback Energy Inc / Abbvie Inc / LGI Homes Inc / Roku Inc / Coterra Energy Inc / Chesapeake Energy Corp / Vizio Holding Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Adam Muro / Alexandra Green / Dian Yuan</td></tr>
<tr class="odd"><td class="leftalignment">12/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">MRK: Key Takeaways from Our Biopharma Spotlight: Global Large Cap Event</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">58933Y10</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AJG / BMY.N / EMN / H / KO / LLY.N / MRK.N / OLN / PFE.N / PK / RKT / S.N / SWK / ASND.O / AMZN.O / HT / GILD.O / AMGN.O / EW / ARNA.O / CHH.N / GSK.N / ARGX.O / BMRN.O / REGN.O / VRTX.O / DOL.TO / SIVB.O / BIIB.O / SHO.N / HST.N / HZNP.O / SRPT.O / RHP.N / ABBV.N / PFSI.K / QURE.O / RXDX.O / XHR.N / APLE.N / RYTM.O / SFIX.O / APLS.O / KZR.O / MORF.O / CABA.O / 45258J102 / HMPT.O</td><td class="leftalignment">Arthur J Gallagher & Co / Bristol-Myers Squibb Co / Eastman Chemical Co / Hyatt Hotels Corp / Coca-Cola Co / Eli Lilly and Co / Merck & Co Inc / Olin Corp / Pfizer Inc / Park Hotels & Resorts Inc / Rocket Companies Inc / SentinelOne Inc / Stanley Black & Decker Inc / Ascendis Pharma A/S / Amazon.com Inc / Hersha Hospitality Trust / Gilead Sciences Inc / Amgen Inc / Edwards Lifesciences Corp / Arena Pharmaceuticals Inc / Choice Hotels International Inc / GlaxoSmithKline PLC / argenx SE / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Dollarama Inc / SVB Financial Group / Biogen Inc / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / Horizon Therapeutics PLC / Sarepta Therapeutics Inc / Ryman Hospitality Properties Inc / Abbvie Inc / PennyMac Financial Services Inc / Uniqure NV / Prometheus Biosciences Inc / Xenia Hotels & Resorts Inc / Apple Hospitality REIT Inc / Rhythm Pharmaceuticals Inc / Stitch Fix Inc / Apellis Pharmaceuticals Inc / Kezar Life Sciences Inc / Morphic Holding Inc / Cabaletta Bio Inc / Immunovant Inc / Home Point Capital Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">The Skies Are Clearing but Stock Selection Still Important</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">BMY.N / MRK.N / PFE.N / GILD.O / AMGN.O / REGN.O / VRTX.O / BIIB.O / ABBV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / China / Croatia / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRK: Keytruda LOE Concerns Are Putting Cart Before the Horse; Initiating at Overweight</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">PFE: The COVID Play with Near-Term Upside & Durable COVID Business; Initiate at Overweight</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">PFE.N / MRK.N / ASND.O / GSK.N / BMRN.O / REGN.O / SRPT.O / ABBV.N / QURE.O</td><td class="leftalignment">Pfizer Inc / Merck & Co Inc / Ascendis Pharma A/S / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sarepta Therapeutics Inc / Abbvie Inc / Uniqure NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / United Kingdom / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">December 2021 "Monthly Controversies" Report</td><td class="leftalignment">English</td><td class="rightalignment">165</td><td class="leftalignment">US0311621009 / US09062X1037 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Kepler Cheuvreux</td><td class="leftalignment">Europe | Best Ideas | Séance with Paul Volcker</td><td class="leftalignment">English</td><td class="rightalignment">89</td><td class="leftalignment">A2.MI / III.L / ABF.L / ACCP.PA / ACS.MC / AEGN.AS / AIRP.PA / AKZO.AS / ALSO.PA / ALV.N / ALVG.DE / ANA.MC / ASMI.AS / ASML.AS / ATCOa.ST / AXAF.PA / BAER.S / BMWG.DE / BNPP.PA / BP.L / CAPP.PA / CARR.PA / CAST.ST / CBKG.DE / CPG.L / CSGN.S / DANO.PA / DAST.PA / DGE.L / DNB.OL / DSMN.AS / EDP.LS / ELE.MC / ELUXb.ST / ENI.MI / EPED.PA / ERICb.ST / ERST.VI / EURA.PA / EXHO.PA / GASI.MI / GFCP.PA / HEIG.DE / HEIN.AS / HEXAb.ST / HMb.ST / HRMS.PA / IBE.MC / IETB.BR / ITV.L / KYGa.I / LHAG.DE / LOIM.PA / LVMH.PA / MDBI.MI / MICP.PA / NIBEb.ST / OREP.PA / ORK.OL / PERP.PA / PHG.AS / PSON.L / PUBP.PA / RAND.AS / RCOP.PA / RECI.MI / RENA.PA / REP.MC / RR.L / RWEG.DE / RYA.I / SAMPO.HE / SBRY.L / SCAb.ST / SCHN.PA / SEBF.PA / SKAb.ST / SOGN.PA / SOLB.BR / STDM.PA / STM.MI / INF.L / INVEa.ST / CONG.DE / AIR.PA / AZN.L / FER.MC / SASY.PA / ABBN.S / GEBN.S / SIEGn.DE / DBKGn.DE / SAPG.DE / NOVOb.CO / NOVN.S / BEIG.DE / FMEG.DE / NOKIA.HE / ENEI.MI / MRCG.DE / NOD.OL / BBVA.MC / IFXGn.DE / LONN.S / GIVN.S / FREG.DE / PUMG.DE / AXFO.ST / ADEN.S / BANB.S / CLN.S / RAAG.DE / DPWGn.DE / QIA.DE / GSK.L / EUFI.PA / DB1Gn.DE / ITX.MC / SOIT.PA / FRAG.DE / AFXG.DE / KBC.BR / EVDG.DE / GN.CO / SATG_p.DE / SRG.MI / AMA.MC / GETIb.ST / DANSKE.CO / ORP.PA / REL.L / ALFA.ST / ITRK.L / DSV.CO / ENAG.MC / SOF.BR / IHG.L / COLOb.CO / MAERSKb.CO / SGSN.S / KNIN.S / LOGN.S / BARN.S / LISN.S / SCHP.S / INGA.AS / NESN.S / BIOX.PA / EMMN.S / NESTE.HE / SAF.PA / KNEBV.HE / ELI.BR / G1AG.DE / JMT.LS / EDF.PA / IPN.PA / BALDb.ST / PGHN.S / LEGD.PA / CFR.S / AKE.PA / HOLN.S / HUSQb.ST / HELN.S / GALP.LS / SIKA.S / SALM.OL / ATL.MI / SGRO.L / GBLB.BR / SOON.S / DAIGn.DE / CPRI.MI / BAES.L / GRLS.MC / GETP.PA / DIAS.MI / AMPF.MI / AVANZ.ST / BVI.PA / FLUI.MC / EDPR.LS / EONGn.DE / ABI.BR / BAYGn.DE / AGES.BR / CHRH.CO / EDEN.PA / BASFn.DE / OCDO.L / PNDORA.CO / ADSGn.DE / RBIV.VI / SHLG.DE / ICAG.MC / OCI.AS / EVKn.DE / RRTL.DE / ORAN.PA / KGX.DE / SAGAb.ST / MONC.MI / STAB.DE / ENX.PA / FBK.MI / ARGX.BR / CNHI.K / AENA.MC / CLNX.MC / INWT.MI / ENGIE.PA / 1COV.DE / HLAG.DE / G24n.DE / AMUN.PA / ABNd.AS / BMED.MI / RACE.MI / ELISA.HE / ASRNL.AS / AD.AS / FORTUM.HE / KESKOB.HE / SBBb.ST / ESSITYb.ST / SGREN.MC / ORSTED.CO / HFGG.DE / DWSG.DE / EQNR.OL / ADYEN.AS / NTGY.MC / KBX.DE / ESLX.PA / LINI.DE / MOWI.OL / DEMANT.CO / EMBRACb.ST / LUNE.ST / JDEP.AS / ENR1n.DE / STLA.MI / RKT.L / ANE.MC</td><td class="leftalignment">A2A SpA / 3i Group PLC / Associated British Foods PLC / Accor SA / ACS Actividades de Construccion y Servicios SA / Aegon NV / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Akzo Nobel NV / Alstom SA / Autoliv Inc / Allianz SE / Acciona SA / ASM International NV / ASML Holding NV / Atlas Copco AB / AXA SA / Julius Baer Gruppe AG / Bayerische Motoren Werke AG / BNP Paribas SA / BP PLC / Capgemini SE / Carrefour SA / Castellum AB / Commerzbank AG / Compass Group PLC / Credit Suisse Group AG / Danone SA / Dassault Systemes SE / Diageo PLC / DNB Bank ASA / Koninklijke DSM NV / EDP Energias de Portugal SA / Endesa SA / Electrolux AB / Eni SpA / Faurecia SE / Telefonaktiebolaget LM Ericsson / Erste Group Bank AG / Eurazeo SE / Sodexo SA / Assicurazioni Generali SpA / Gecina SA / HeidelbergCement AG / Heineken NV / Hexagon AB / H & M Hennes & Mauritz AB / Hermes International SCA / Iberdrola SA / D'Ieteren Group NV / ITV PLC / Kerry Group PLC / Deutsche Lufthansa AG / Klepierre SA / LVMH Moet Hennessy Louis Vuitton SE / Mediobanca Banca di Credito Finanziario SpA / Compagnie Generale des Etablissements Michelin SCA / Nibe Industrier AB / L'Oreal SA / Orkla ASA / Pernod Ricard SA / Koninklijke Philips NV / Pearson PLC / Publicis Groupe SA / Randstad NV / Remy Cointreau SA / Recordati Industria Chimica e Farmaceutica SpA / Renault SA / Repsol SA / Rolls-Royce Holdings PLC / Rwe AG / Ryanair Holdings PLC / Sampo plc / J Sainsbury PLC / Svenska Cellulosa SCA AB / Schneider Electric SE / SEB SA / Skanska AB / Societe Generale SA / Solvay SA / Sartorius Stedim Biotech SA / STMicroelectronics NV / Informa PLC / Investor AB / Continental AG / Airbus SE / AstraZeneca PLC / Ferrovial SA / Sanofi SA / Abb Ltd / Geberit AG / Siemens AG / Deutsche Bank AG / SAP SE / Novo Nordisk A/S / Novartis AG / Beiersdorf AG / Fresenius Medical Care AG & Co KGaA / Nokia Oyj / Enel SpA / Merck KGaA / Nordic Semiconductor ASA / Banco Bilbao Vizcaya Argentaria SA / Infineon Technologies AG / Lonza Group AG / Givaudan SA / Fresenius SE & Co KGaA / Puma SE / Axfood AB / Adecco Group AG / Bachem Holding AG / Clariant AG / Rational AG / Deutsche Post AG / Qiagen NV / GlaxoSmithKline PLC / Eurofins Scientific SE / Deutsche Boerse AG / Industria de Diseno Textil SA / Soitec SA / Fraport AG Frankfurt Airport Services Worldwide / Carl Zeiss Meditec AG / KBC Groep NV / Cts Eventim AG & Co KgaA / GN Store Nord A/S / Sartorius AG / Snam SpA / Amadeus IT Group SA / Getinge AB / Danske Bank A/S / Orpea SA / Relx PLC / Alfa Laval AB / Intertek Group PLC / DSV A/S / Enagas SA / Sofina SA / InterContinental Hotels Group PLC / Coloplast A/S / AP Moeller - Maersk A/S / SGS SA / Kuehne und Nagel International AG / Logitech International SA / Barry Callebaut AG / Chocoladefabriken Lindt & Spruengli AG / Schindler Holding AG / ING Groep NV / Nestle SA / Biomerieux SA / Emmi AG / Neste Oyj / Safran SA / Kone Oyj / Elia Group SA / GEA Group AG / Jeronimo Martins SGPS SA / Electricite de France SA / Ipsen SA / Fastighets AB Balder / Partners Group Holding AG / Legrand SA / Compagnie Financiere Richemont SA / Arkema SA / Holcim AG / Husqvarna AB / Helvetia Holding AG / Galp Energia SGPS SA / Sika AG / SalMar ASA / Atlantia SpA / SEGRO PLC / Groep Brussel Lambert NV / Sonova Holding AG / Daimler AG / Davide Campari Milano NV / BAE Systems PLC / Grifols SA / Getlink SE / DiaSorin SpA / Amplifon SpA / Avanza Bank Holding AB / Bureau Veritas SA / Fluidra SA / EDP Renovaveis SA / E.ON SE / Anheuser Busch Inbev SA / Bayer AG / Ageas SA / Chr Hansen Holding A/S / Edenred SE / BASF SE / Ocado Group PLC / Pandora A/S / Adidas AG / Raiffeisen Bank International AG / Siemens Healthineers AG / International Consolidated Airlines Group SA / OCI NV / Evonik Industries AG / RTL Group SA / Orange SA / Kion Group AG / Sagax AB / Moncler SpA / Stabilus SA / Euronext NV / FinecoBank Banca Fineco SpA / argenx SE / CNH Industrial NV / Aena SME SA / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Engie SA / Covestro AG / Hapag Lloyd AG / Scout24 SE / Amundi SA / ABN Amro Bank NV / Banca Mediolanum SpA / Ferrari NV / Elisa Oyj / ASR Nederland NV / Koninklijke Ahold Delhaize NV / Fortum Oyj / Kesko Oyj / Samhallsbyggnadsbolaget I Norden AB / Essity AB (publ) / Siemens Gamesa Renewable Energy SA / Orsted A/S / Hellofresh SE / DWS Group GmbH & Co KgaA / Equinor ASA / Adyen NV / Naturgy Energy Group SA / Knorr Bremse AG / EssilorLuxottica SA / Linde PLC / Mowi ASA / Demant A/S / Embracer Group AB / Lundin Energy AB / JDE Peets NV / Siemens Energy AG / Stellantis NV / Reckitt Benckiser Group PLC / Corporacion Acciona Energias Renovables SA</td><td class="leftalignment"></td><td class="leftalignment">Austria / Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Italy / Luxembourg / Netherlands / Norway / Portugal / Sweden / United States</td><td class="leftalignment">Aerospace / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Building & Building Materials / Chemicals / Consumer / Defense / Energy / Financial Services / Food / Healthcare / Household Products / Info. Tech./Computers / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Manufacturing / Media / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Real Estate / Retailing / Services / Telecommunications / Transportation / Utilities / Oil & Gas</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">M. Arnaud Girod</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">58</td><td class="leftalignment">US0091581068 / US0311621009 / US1101221083 / US2017231034 / US2372661015 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US8718291078 / US8851601018 / US9078181081 / US9111631035 / US92532F1003 / US9746371007 / CA29250N1050 / CA1247651088 / CA2918434077 / US09062X1037 / BMG169621056 / US6293775085 / US12008R1077 / US1252691001 / CA6179141065 / US58933Y1055 / US65339F1012 / CA04364G1063 / CA0805581091 / CA38045Y1025 / US85208M1027 / US60468T1051 / US2383371091 / US1638511089 / US4622221004 / US13462K1097 / US8608971078 / US80810D1037 / US92719V1008 / US1374041093</td><td class="leftalignment">Air Products and Chemicals Inc / Amgen Inc / Bristol-Myers Squibb Co / Commercial Metals Co / Darling Ingredients Inc / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Sysco Corp / Thor Industries Inc / Union Pacific Corp / United Natural Foods Inc / Vertex Pharmaceuticals Inc / Winnebago Industries Inc / Enbridge Inc / CAE Inc / Empire Company Ltd / Biogen Inc / Bunge Ltd / NRG Energy Inc / Builders FirstSource Inc / CF Industries Holdings Inc / Morguard Real Estate Investment Trust / Merck & Co Inc / Nextera Energy Inc / Ascot Resources Ltd / Belo Sun Mining Corp / GoGold Resources Inc / Sprouts Farmers Market Inc / Mirati Therapeutics Inc / Dave & Buster's Entertainment Inc / Chemours Co / Ionis Pharmaceuticals Inc / Camping World Holdings Inc / Stitch Fix Inc / Schrodinger Inc / Vimeo Inc / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Highlights from Our Prostate Cancer KOL Call on the Shifting Landscape and Opportunity for Emerging Therapeutics</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">5671735 / 0989529 / 2778844 / 2475833 / 2576941 / 2684703 / 2730190 / 7103065 / BFDV8K0 / BGCYWN8 / BKVDFF7 / BDZ30Q0</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Merck & Co Inc / Johnson & Johnson / Exelixis Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / MacroGenics Inc / Xencor Inc / Oric Pharmaceuticals Inc / Arvinas Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Mr. Seamus Fernandez / Paul Jeng, Ph.D. / Yige Guo, Ph.D. / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Clover Biopharmaceuticals: New report: A global COVID vaccine supplier from pandemic to endemic . Initiating Coverage with OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2197.HK / MRK.N / PFE.N</td><td class="leftalignment">Clover Biopharmaceuticals Ltd / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Feedback From Our Launch: PFE’s Longer-Term COVID Benefit Clearer w/ Omicron</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">PFE.N / US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US -  Dividend Quality Analysis, for the period ended December 06,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">JNJ-US -  Dividend Quality Analysis, for the period ended December 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">JNJ / ABT / LLY / MDT / MRK / NVS / PFE / SYK / GILD.O / GSK / SNY.O</td><td class="leftalignment">Johnson & Johnson / Abbott Laboratories / Eli Lilly and Co / Medtronic PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / Stryker Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Islatravir Development Curtailed By Toxicity</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 7, 2021</td><td class="leftalignment">English</td><td class="rightalignment">47</td><td class="leftalignment">US02553E1064 / US1101221083 / US2017231034 / US3647601083 / US3755581036 / US45337C1027 / US5324571083 / US6541061031 / US6556641008 / US6703461052 / US6819191064 / US68389X1054 / US7170811035 / US75886F1075 / US7782961038 / US8581191009 / US8725401090 / US8851601018 / US9170471026 / US9182041080 / CA8787422044 / CA87971M1032 / US9129091081 / US02043Q1076 / US9043111072 / US5500211090 / US90384S3031 / CA22576C1014 / US58933Y1055 / US6936561009 / US7512121010 / US98986T1088 / US00287Y1091 / US09609G1004 / CA1348082035 / CA96467A2002 / IE00B4Q5ZN47 / CA3748252069 / US31189P1021 / US1220171060 / US14174T1079 / US72703H1014 / US8760301072 / US8608971078 / US03753U1060 / US63845R1077 / CA8585221051 / US76029N1063 / VGG1890L1076 / US76156B1070 / US88339P1012 / US70614W1009 / US80810D1037 / CA2674881040 / US78440X8048 / US44891N2080 / CA00791P1071 / US60646V1052 / US0708301041 / US9264001028 / US89269P1030 / US94770D1028 / US4718711033 / US53190C1027 / CA0156581070</td><td class="leftalignment">American Eagle Outfitters Inc / Bristol-Myers Squibb Co / Commercial Metals Co / Gap Inc / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Nike Inc / Nordstrom Inc / Nucor Corp / Omnicom Group Inc / Oracle Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Steel Dynamics Inc / TJX Companies Inc / Thor Industries Inc / Urban Outfitters Inc / VF Corp / Teck Resources Ltd / Telus Corp / United States Steel Corp / Alnylam Pharmaceuticals Inc / Under Armour Inc / Lululemon Athletica Inc / Ulta Beauty Inc / Crescent Point Energy Corp / Merck & Co Inc / PVH Corp / Ralph Lauren Corp / Zynga Inc / Abbvie Inc / bluebird bio Inc / Canacol Energy Ltd / Whitecap Resources Inc / Jazz Pharmaceuticals PLC / Gibson Energy Inc / Fate Therapeutics Inc / Burlington Stores Inc / CareTrust REIT Inc / Planet Fitness Inc / Tapestry Inc / Stitch Fix Inc / Apellis Pharmaceuticals Inc / National Vision Holdings Inc / Stelco Holdings Inc / Replimune Group Inc / Capri Holdings Ltd / Revolve Group Inc / RealReal Inc / Peloton Interactive Inc / Schrodinger Inc / Dye & Durham Ltd / SL Green Realty Corp / IAC/Interactivecorp / Advantage Energy Ltd / Mister Car Wash Inc / Bath & Body Works Inc / Victoria's Secret & Co / Traeger Inc / Weber Inc / Jasper Therapeutics Inc / Life Time Group Holdings Inc / Algoma Steel Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2868165 / 2126335 / 2516152 / 2778844 / 2219224 / 2216850 / 2270726 / 2542049 / 2272476 / 2317087 / 2670519 / 2328915 / 2684703 / 2440637 / 7103065 / 2713317 / 2857817 / B125XQ6 / B3D7K31 / B1XGNW4 / 2855930 / B3P93Y7 / B0796X4 / BYVFC94 / BZBY005 / BJ2Z0H2 / BFZ1K46 / BYXJQG9 / BZ1LFG7 / BYY88Y7 / BF3W461 / BMC5RV6 / BMDJ397 / BF0QTY9 / BMDW0R3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Sysco Corp / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / CMS Energy Corp / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Dollar Tree Inc / Entergy Corp / Exelon Corp / Nextera Energy Inc / Pfizer Inc / CenterPoint Energy Inc / Novartis AG / ACADIA Pharmaceuticals Inc / Netflix Inc / Portland General Electric Co / Discovery Inc / Insulet Corp / Overstock.com Inc / Anheuser Busch Inbev SA / Dexcom Inc / US Foods Holding Corp / Merus NV / Pinterest Inc / Spotify Technology SA / Spire Inc / Roku Inc / Alphabet Inc / Tandem Diabetes Care Inc / Adicet Bio Inc / Bolt Biotherapeutics Inc / Chicken Soup for The Soul Entertainment Inc / Weave Communications Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / France / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">MRK: Downgrading to NEUTRAL; Removing Islatravir (HIV) Exacerbates Low Pipeline Visibility, Keytruda Concentration; Pure Capital Allocation Story Now</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">2778844</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: Korea Contract Manufacturing Sector - Investor feedback on our sector initiation; good place to hide amid Omicron concerns</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">207940.KS / 302440.KS / MRK.N / PFE.N / GSK.L / 006280.KS</td><td class="leftalignment">Samsung Biologics Co Ltd / SK Bioscience Co Ltd / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / Green Cross Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Korea, Republic of / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Kailash Concepts</td><td class="leftalignment">BUY & SELL Lists - Large Cap</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ABBV.N / AGNC.OQ / AIG.N / ALL.N / AXP.N / BA.N / C.N / CAH.N / CE.N / CF.N / COF.N / EOG.N / F.N / HIG.N / HLT.N / MRK.N / OXY.N / PFE.N / PM.N / PNW.N / TMX.N / TRV.N / UAL.N / USB.N / VNT.N / ZEN.N / NUE.N / HAL.N / DIS.N / WLK.N / GD.N / CR.N / AFG.N / R.N / RCL.N / ADM.N / IFF.N / LH.N / EMR.N / PCG.N / DVN.N / OLN.N / TGT.N / RKT.N / DVA.N / AZO.N / FDS.N / EQT.N / ATO.N / HWM.N / BYD.N / UGI.N / DNB.N / GPC.N / MKC.N / HRL.N / SAM.N / CLF.N / ABC.N / GME.N / TDY.N / COP.N / INTC.OQ / ADPT.OQ / AGL.N / CRUS.OQ / FAF.N / FISV.OQ / HOLX.OQ / KLAC.OQ / MKL.N / RGEN.OQ / SF.N / VMI.N / FL.N / POOL.OQ / TPR.N / UHAL.OQ / PEGA.OQ / LAMR.OQ / STLD.OQ / SRCL.OQ / MRCY.OQ / WTFC.OQ / NUAN.OQ / WYNN.OQ / PA1436583006 / MNST.OQ / OSH.N / LVS.N / OC.N / FRPT.OQ / BX.N / PODD.OQ / VMW.N / NVR.N / WRB.N / MRNA.OQ / CLH.N / AI.N / TRGP.N / Z.OQ / TRIP.OQ / WEN.OQ / BERY.N / WEX.N / RNG.N / WIX.OQ / ARMK.N / NCLH.N / FIVN.OQ / CFG.N / ANTM.N / LBRDK.O / TDOC.N / RUN.OQ / PEN.N / SITE.N / TWLO.N / VVV.N / TTD.OQ / COUP.OQ / OKTA.OQ / CVNA.N / JHG.N / ROKU.OQ / PFG.OQ / XEL.OQ / QRTEA.OQ / CTRA.N / NFE.OQ / LYFT.O / BYND.OQ / UBER.N / FSLY.N / TXG.OQ / PTON.OQ / SPCE.N / AZEK.N / WTRG.N / DKNG.OQ / APA.OQ / FOUR.N / VRM.OQ / LMND.N / BEPC.N / DCT.OQ / PLTR.N / SHC.OQ / SKLZ.N / CLVT.N / SGFY.N / CHPT.N</td><td class="leftalignment">Abbvie Inc / AGNC Investment Corp / American International Group Inc / Allstate Corp / American Express Co / Boeing Co / Citigroup Inc / Cardinal Health Inc / Celanese Corp / CF Industries Holdings Inc / Capital One Financial Corp / EOG Resources Inc / Ford Motor Co / Hartford Financial Services Group Inc / Hilton Worldwide Holdings Inc / Merck & Co Inc / Occidental Petroleum Corp / Pfizer Inc / Philip Morris International Inc / Pinnacle West Capital Corp / Terminix Global Holdings Inc / Travelers Companies Inc / United Airlines Holdings Inc / US Bancorp / Vontier Corp / Zendesk Inc / Nucor Corp / Halliburton Co / Walt Disney Co / Westlake Chemical Corp / General Dynamics Corp / Crane Co / American Financial Group Inc / Ryder System Inc / Royal Caribbean Cruises Ltd / Archer-Daniels-Midland Co / International Flavors & Fragrances Inc / Laboratory Corporation of America Holdings / Emerson Electric Co / PG&E Corp / Devon Energy Corp / Olin Corp / Target Corp / Rocket Companies Inc / DaVita Inc / Autozone Inc / Factset Research Systems Inc / EQT Corp / Atmos Energy Corp / Howmet Aerospace Inc / Boyd Gaming Corp / UGI Corp / Dun & Bradstreet Holdings Inc / Genuine Parts Co / McCormick & Company Inc / Hormel Foods Corp / Boston Beer Company Inc / Cleveland-Cliffs Inc / Amerisourcebergen Corp / GameStop Corp / Teledyne Technologies Inc / Conocophillips / Intel Corp / Adaptive Biotechnologies Corp / agilon health Inc / Cirrus Logic Inc / First American Financial Corp / Fiserv Inc / Hologic Inc / KLA Corp / Markel Corp / Repligen Corp / Stifel Financial Corp / Valmont Industries Inc / Foot Locker Inc / Pool Corp / Tapestry Inc / Amerco / Pegasystems Inc / Lamar Advertising Co / Steel Dynamics Inc / Stericycle Inc / Mercury Systems Inc / Wintrust Financial Corp / Nuance Communications Inc / Wynn Resorts Ltd / Carnival Corp / Monster Beverage Corp / Oak Street Health Inc / Las Vegas Sands Corp / Owens Corning / Freshpet Inc / Blackstone Inc / Insulet Corp / VMware Inc / NVR Inc / W R Berkley Corp / Moderna Inc / Clean Harbors Inc / C3.ai Inc / Targa Resources Corp / Zillow Group Inc / Tripadvisor Inc / Wendys Co / Berry Global Group Inc / WEX Inc / RingCentral Inc / Wix.Com Ltd / Aramark / Norwegian Cruise Line Holdings Ltd / Five9 Inc / Citizens Financial Group Inc / Anthem Inc / Liberty Broadband Corp / Teladoc Health Inc / Sunrun Inc / Penumbra Inc / SiteOne Landscape Supply Inc / Twilio Inc / Valvoline Inc / Trade Desk Inc / Coupa Software Inc / Okta Inc / Carvana Co / Janus Henderson Group PLC / Roku Inc / Principal Financial Group Inc / Xcel Energy Inc / Qurate Retail Inc / Coterra Energy Inc / New Fortress Energy Inc / Lyft Inc / Beyond Meat Inc / Uber Technologies Inc / Fastly Inc / 10X Genomics Inc / Peloton Interactive Inc / Virgin Galactic Holdings Inc / Azek Company Inc / Essential Utilities Inc / DraftKings Inc / APA Corp (US) / Shift4 Payments Inc / Vroom Inc / Lemonade Inc / Brookfield Renewable Corp / Duck Creek Technologies Inc / Palantir Technologies Inc / Sotera Health Co / Skillz Inc / CLARIVATE PLC / Signify Health Inc / ChargePoint Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / United Kingdom / Israel / Liberia / Panama / United States / Jersey</td><td class="leftalignment">Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Consumer / Containers & Packing / Defense / Electrical / Electronics / Engineering & Construction / Financial Services / Food / Healthcare / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Transportation / Utilities / Wholesale / Oil & Gas / Internet</td><td class="leftalignment">Africa / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Additional Islatravir Trial Pause Challenging for Merck's HIV Ambition</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US58933Y1055 / US3755581036</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">CG Capital</td><td class="leftalignment">PDSB/NCI Trial Recruitment Resumes; Reiterate OUTPERFORM Rating, Price Target of $18</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PDSB=US / MRK-U</td><td class="leftalignment">PDS Biotechnology Corp / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Team Coverage</td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Litchfield Hills Research, LLC</td><td class="leftalignment">Acquisition by Predictive Oncology advances patient centric therapies – Reiterate Buy and $5 PT</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">POAI.OQ / 4502.T / MRK.N / PFE.N / SNY.N / AZN.L / AZN.N / ROG.S / SYK.N / GSK.L / GSK.N / DXR.A / QBIO.PK / MYGN.OQ / BAYGN.DE / ZBH.N / CODX.OQ / DE000BAY0199 / ANPC.OQ</td><td class="leftalignment">Predictive Oncology Inc / Takeda Pharmaceutical Co Ltd / Merck & Co Inc / Pfizer Inc / Sanofi SA / AstraZeneca PLC / AstraZeneca PLC / Roche Holding AG / Stryker Corp / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Daxor Corp / Q BioMed Inc / Myriad Genetics Inc / Bayer AG / Zimmer Biomet Holdings Inc / Co-Diagnostics Inc / Bayer AG / AnPac Bio-Medical Science Co Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Japan / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS / SMALL CAPITAL / GROWTH</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Theodore R. O'Neill</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 26, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">STARTING IN 30 MINUTES: KOL Call on Prostate Cancer Landscape and Emerging Therapeutics</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2023607 / 2778844 / 2475833 / 2576941 / 2684703 / 2730190 / 7103065 / BFDV8K0 / BGCYWN8 / BKVDFF7 / BDZ30Q0</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Amgen Inc / Merck & Co Inc / Johnson & Johnson / Exelixis Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / MacroGenics Inc / Xencor Inc / Oric Pharmaceuticals Inc / Arvinas Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Mr. Seamus Fernandez / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">BNP Paribas Exane</td><td class="leftalignment">PHARMACEUTICALS : Hit me with your best shot</td><td class="leftalignment">English</td><td class="rightalignment">76</td><td class="leftalignment">ROG.S / AZN.L / SASY.PA / NOVOb.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / SFZN.S / IPN.PA</td><td class="leftalignment">Roche Holding AG / AstraZeneca PLC / Sanofi SA / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Siegfried Holding AG / Ipsen SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Cosmetics & Personal Care</td><td class="leftalignment">Euroland / Europe / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Simon Mather, PHD / Mr. Gary Steventon</td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">2021 ASH Preview and Itinerary Planner</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US7170811035 / US75886F1075 / US02043Q1076 / US58933Y1055 / US00287Y1091 / US09609G1004 / IE00B4Q5ZN47 / US31189P1021 / US03753U1060 / US80810D1037 / US4718711033</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc / bluebird bio Inc / Jazz Pharmaceuticals PLC / Fate Therapeutics Inc / Apellis Pharmaceuticals Inc / Schrodinger Inc / Jasper Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Georgia / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Mr. Gary Nachman / Matthew Luchini / Evan Hua</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">2000019 / 2023607 / 2486813 / 2778844 / 2065159 / 2270726 / 2542049 / 2317087 / 2632003 / 2657802 / 2689560 / 2684703 / 2048804 / 2730190 / 2440637 / 2829601 / 7103065 / 2857817 / B02R1L6 / B5B1S13 / B7TL820 / B7VD3F2 / B7JYSG3 / BBGVT40 / BDZCRX3 / BFLR866 / BFZCHN7 / BXDZ9Z0 / BD8DJ71 / BJ2Z0H2 / BZ8FPH3 / BYZM6C2 / BFZ1K46 / BMYML02 / BLGJ610 / BJJMGL2 / BKTNTR9 / BGSP7M9 / BJVR9Y9 / BYY88Y7 / BRJ3GY4 / BMDCDP2 / BN7K304 / BNTB3N8 / BKPGJQ1 / BNKGXX2 / BMDW0R3 / BYQBFJ8</td><td class="leftalignment">Amazon.com Inc / Amgen Inc / Kellogg Co / Merck & Co Inc / Autodesk Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / New York Times Co / OGE Energy Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Southern Co / Novartis AG / Netflix Inc / ALLETE Inc / Dollar General Corp / Meta Platforms Inc / Duke Energy Corp / Guidewire Software Inc / News Corp / RingCentral Inc / Twitter Inc / Wix.Com Ltd / Shopify Inc / Snap Inc / Pinterest Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Spotify Technology SA / DraftKings Inc / Warner Music Group Corp / Fox Corp / ViacomCBS Inc / Zoom Video Communications Inc / iHeartMedia Inc / Alphabet Inc / Xenon Pharmaceuticals Inc / Bigcommerce Holdings Inc / Academy Sports and Outdoors Inc / Vizio Holding Corp / Squarespace Inc / Verve Therapeutics Inc / Weave Communications Inc / Arrowhead Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">RECI.MI: Recordati - EUSA acquisition extends rare disease franchise to niche oncology</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">RECI.MI / LUN.CO / MRCG.DE / LONN.S / UCB.BR / UTHR.OQ / IPN.PA / ORNBV.HE / ALM.MC / BGNE.OQ / 6160.HK / GMAB.CO</td><td class="leftalignment">Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / United Therapeutics Corp / Ipsen SA / Orion Oyj / Almirall SA / Beigene Ltd / Beigene Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Cayman Islands / Germany / Denmark / Spain / Finland / France / Italy / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">MERGER/ACQUISITION/DIVESTITURE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">12/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.5% Above Pre-Pandemic Base- Week 87</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Is A Rise Imminent For Bristol Myers Squibb Stock?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/03/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - November 26 to December 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">IL0002810146 / IL0006290147 / US0091581068 / US02553E1064 / US0383361039 / US0536111091 / US0584981064 / US1264081035 / US2017231034 / US2441991054 / US25179M1036 / US2788651006 / US30231G1022 / US31428X1063 / US3154051003 / US3647601083 / US4180561072 / US4282911084 / US4433201062 / US4456581077 / US4523081093 / US5010441013 / US5324571083 / US56418H1005 / US5770811025 / US5949181045 / US64125C1099 / US6516391066 / US6541061031 / US6556641008 / US6558441084 / US6703461052 / US6935061076 / US7170811035 / US7496851038 / US75886F1075 / US7703231032 / US7782961038 / US7802871084 / US81211K1007 / US8243481061 / US8581191009 / US8725401090 / US9078181081 / US9113121068 / US91324P1021 / US9170471026 / US9182041080 / US92532F1003 / CA53278L1076 / CA1363751027 / CA59162N1096 / CA29250N1050 / CA5394811015 / CA0977512007 / CA30150P1099 / CA1247651088 / CA2908761018 / CA5592224011 / CA0084741085 / CA0679011084 / CA1363851017 / CA2499061083 / US1667641005 / CA13645T1003 / US9129091081 / CA51925D1069 / CA13677F1018 / CA0641491075 / CA6330671034 / CA7800871021 / US0017441017 / US20825C1045 / US2274831047 / CA5734591046 / US09062X1037 / NO0010208051 / US49446R1095 / CA98462Y1007 / US79466L3024 / US9604131022 / CA5503721063 / US29476L1070 / US7588491032 / US1508701034 / CA8911605092 / CA1360691010 / CA8935781044 / US8288061091 / US44107P1049 / US12541W2098 / US9043111072 / US3137472060 / US29472R1086 / US8666741041 / CA32076V1031 / GB00B1FW5029 / US5021751020 / US63633D1046 / CA14068G1046 / US5500211090 / US89785X1019 / US90384S3031 / CA3518581051 / US91912E1055 / CA8672241079 / US58933Y1055 / CA25675T1075 / CA15135U1093 / US2566771059 / CA14042M1023 / NL0009434992 / CA9237251058 / CA07317Q1054 / US18538R1032 / CA00208D4084 / CA2927661025 / US61945C1036 / JE00B4T3BW64 / US6936561009 / US7512121010 / US71922G2093 / CA7063271034 / CA4932711001 / CA89156V1067 / CA55903Q1046 / CA96145A2002 / US70509V1008 / CA04682R1073 / US78573L1061 / US8486371045 / CA87262K1057 / US08579W1036 / US23283R1005 / CA05577W2004 / US1220171060 / US11120U1051 / CA68827L1013 / US78667J1088 / CA0089118776 / BMG0750C1082 / US1638511089 / US92939U1060 / CA8485101031 / US86771W1053 / US72703H1014 / US4622221004 / US45688C1071 / US0441861046 / US7005171050 / CA87241L1094 / US6792951054 / CA9628791027 / GB00BF3ZNS54 / US8760301072 / US8608971078 / US63845R1077 / CA8585221051 / CA67077M1086 / US98980G1022 / US00191U1025 / US83200N1037 / IE00BZ12WP82 / VGG1890L1076 / US28618M1062 / US2605571031 / GB00BJT16S69 / CA87807B1076 / CA14179V5036 / US26614N1028 / US76156B1070 / JE00BJ1F3079 / US88339P1012 / US86745K1043 / US70614W1009 / US69047Q1022 / MHY0436Q1098 / US03750L1098 / JE00BMVMZ478 / US1651677353 / US24343R1068 / CA00076T1057 / US90364P1057 / US11135E2037 / US5738741041 / US60646V1052 / US0708301041 / US9264001028 / US27923Q1094 / US89269P1030 / US94770D1028 / US53190C1027 / US04302A1043</td><td class="leftalignment">Icl Group Ltd / Teva Pharmaceutical Industries Ltd / Air Products and Chemicals Inc / American Eagle Outfitters Inc / Aptargroup Inc / Avery Dennison Corp / Ball Corp / CSX Corp / Commercial Metals Co / Deere & Co / Devon Energy Corp / Ecolab Inc / Exxon Mobil Corp / FedEx Corp / Ferro Corp / Gap Inc / Hasbro Inc / Hexcel Corp / Hub Group Inc / J B Hunt Transport Services Inc / Illinois Tool Works Inc / Kroger Co / Eli Lilly and Co / ManpowerGroup Inc / Mattel Inc / Microsoft Corp / Neurocrine Biosciences Inc / Newmont Corporation / Nike Inc / Nordstrom Inc / Norfolk Southern Corp / Nucor Corp / PPG Industries Inc / Pfizer Inc / RPM International Inc / Regeneron Pharmaceuticals Inc / Robert Half International Inc / Ross Stores Inc / Royal Gold Inc / Sealed Air Corp / Sherwin-Williams Co / Steel Dynamics Inc / TJX Companies Inc / Union Pacific Corp / United Parcel Service Inc / UnitedHealth Group Inc / Urban Outfitters Inc / VF Corp / Vertex Pharmaceuticals Inc / Linamar Corp / Canadian National Railway Co / Metro Inc / Enbridge Inc / Loblaw Companies Ltd / Bombardier Inc / Exco Technologies Ltd / CAE Inc / Emera Inc / Magna International Inc / Agnico Eagle Mines Ltd / Barrick Gold Corp / Canadian Natural Resources Ltd / Descartes Systems Group Inc / Chevron Corp / Canadian Pacific Railway Ltd / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / AMN Healthcare Services Inc / Conocophillips / Cross Country Healthcare Inc / Martinrea International Inc / Biogen Inc / Yara International ASA / Kimco Realty Corp / Yamana Gold Inc / Salesforce.Com Inc / Westlake Chemical Corp / Lundin Mining Corp / Equity Residential / Regency Centers Corp / Celanese Corp / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / Transcontinental Inc / Simon Property Group Inc / Host Hotels & Resorts Inc / CH Robinson Worldwide Inc / Under Armour Inc / Federal Realty Investment Trust / Equity LifeStyle Properties Inc / Sun Communities Inc / First Majestic Silver Corp / Hochschild Mining PLC / LTC Properties Inc / National Health Investors Inc / Capstone Mining Corp / Lululemon Athletica Inc / TrueBlue Inc / Ulta Beauty Inc / Franco-Nevada Corp / Vale SA / Suncor Energy Inc / Merck & Co Inc / Dollarama Inc / Cenovus Energy Inc / Dollar General Corp / Capital Power Corp / LyondellBasell Industries NV / Vermilion Energy Inc / Baytex Energy Corp / Clearwater Paper Corp / ARC Resources Ltd / Enerplus Corp / Mosaic Co / Glencore PLC / PVH Corp / Ralph Lauren Corp / PhosAgro PAO / Pembina Pipeline Corp / Keyera Corp / Tourmaline Oil Corp / MAG Silver Corp / Westshore Terminals Investment Corp / Pebblebrook Hotel Trust / Athabasca Oil Corp / Sabra Health Care REIT Inc / Splunk Inc / TMX Group Ltd / Berry Global Group Inc / CyrusOne Inc / BRP Inc / Burlington Stores Inc / Brixmor Property Group Inc / Osisko Gold Royalties Ltd / SAGE Therapeutics Inc / Air Canada / Axalta Coating Systems Ltd / Chemours Co / WEC Energy Group Inc / Spin Master Corp / Sunrun Inc / Planet Fitness Inc / Ionis Pharmaceuticals Inc / Ingevity Corp / Ashland Global Holdings Inc / Park Hotels & Resorts Inc / TFI International Inc / Okta Inc / Wheaton Precious Metals Corp / Venator Materials PLC / Tapestry Inc / Stitch Fix Inc / National Vision Holdings Inc / Stelco Holdings Inc / Nutrien Ltd / Zscaler Inc / ASGN Inc / Smartsheet Inc / Linde PLC / Capri Holdings Ltd / Element Solutions Inc / Dow Inc / Tronox Holdings PLC / TC Energy Corp / Cargojet Inc / Dupont De Nemours Inc / Revolve Group Inc / Amcor PLC / RealReal Inc / Sunnova Energy International Inc / Peloton Interactive Inc / Ovintiv Inc / Atlas Corp / Apartment Income REIT Corp / Atotech Ltd / Chesapeake Energy Corp / Decibel Therapeutics Inc / Abc Technologies Holdings Inc / UiPath Inc / Broadstone Net Lease Inc / Marvell Technology Inc / Mister Car Wash Inc / Bath & Body Works Inc / Victoria's Secret & Co / Ecovyst Inc / Traeger Inc / Weber Inc / Life Time Group Holdings Inc / Arteris Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Brazil / Canada / United Kingdom / Ireland / Israel / Netherlands / Norway / Russian Federation / United States / Virgin Islands, British / Marshall Islands / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended November 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">AZN / 11012210 / 71708110 / 00846U10 / 88162420 / 37555810 / 03116210 / 66987V10 / 75886F10 / 53245710 / 09062X10 / 478160104 / 30161Q104 / 80105N10 / NOVO B / 771195104 / 58933Y10 / 00287Y10 / 45781M10 / G3910J11 / 45845P10</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Pfizer Inc / Agilent Technologies Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Biogen Inc / Johnson & Johnson / Exelixis Inc / Sanofi SA / Novo Nordisk A/S / Roche Holding AG / Merck & Co Inc / Abbvie Inc / Innoviva Inc / GlaxoSmithKline PLC / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">KOL Call Starting in 30 Mins, We're Talking Lipids and Blockbuster Opportunity for New Lipids Treatments</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">5671735 / 0989529 / 2023607 / 2778844 / 2730190 / 7103065 / BHC8X90 / BNKGXX2</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Amgen Inc / Merck & Co Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Novo Nordisk A/S / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Debjit Chattopadhyay, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">REMINDER: KOL Call on Prostate Cancer Landscape and Emerging Therapeutics at 10:00 AM ET on December 6th, 2021</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2023607 / 2778844 / 2475833 / 2576941 / 2684703 / 2730190 / 7103065 / BFDV8K0 / BGCYWN8 / BKVDFF7 / BDZ30Q0</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Amgen Inc / Merck & Co Inc / Johnson & Johnson / Exelixis Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / MacroGenics Inc / Xencor Inc / Oric Pharmaceuticals Inc / Arvinas Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Mr. Seamus Fernandez / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/02/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">German Stock Ideas - November 2021: Adding Merck, Shop Apotheke & Flatex</td><td class="leftalignment">English</td><td class="rightalignment">62</td><td class="leftalignment">MRCG.DE / SAEG.DE / HEIG.DE / SAPG.DE / COKG.DE / BAYGn.DE / AM3D.DE / PBBG.DE / JSTG.DE / FTKn.DE</td><td class="leftalignment">Merck KGaA / Shop Apotheke Europe NV / HeidelbergCement AG / SAP SE / Cancom SE / Bayer AG / SLM Solutions Group AG / Deutsche Pfandbriefbank AG / JOST Werke AG / flatexDEGIRO AG</td><td class="leftalignment"></td><td class="leftalignment">Germany / Netherlands</td><td class="leftalignment">Automotive / Banks / Building & Building Materials / Consumer / Financial Services / Healthcare / Household Products / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Leisure & Entertainment / Manufacturing / Media / Pharmaceuticals / Retailing / Technology / Telecommunications / Wholesale / Internet</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Herr Tim Rokossa / Herr Uwe Schupp, CFA / Mr. Falko Friedrichs / Lars Vom-Cleff / Frau Mengxian Sun / Herr. Nicolai Kempf / Herr Johannes Schaller / Matthias Pfeifenberger</td></tr>
<tr class="even"><td class="leftalignment">12/02/2021</td><td class="leftalignment">SOVA Capital Limited</td><td class="leftalignment">SOVA Capital: Equity Market Daily (12/2/2021)</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ALRS / LSNG / MSRS / RSTI / FEES / MRKP / MRKU / MRKZ / MRKV / GLTR=GB / FEES=GB / GLTRL / FEESL / RSTI=GB / RSTIP / MRKC=DE</td><td class="leftalignment">AK Alrosa PAO / Rosseti Lenenergo PAO / Rosseti Moskovskiy Region PAO / Rossiyskiye Seti PAO / FSK YeES PAO / Rosseti Tsentr I Privolzh'ye PAO / Mezhregional'naya Raspredelitel'naya Setevaya Kompaniya Urala OAO / Rosseti Severo-Zapad PAO / Rosseti Volga PAO / Globaltrans Investment PLC / FSK YeES PAO / Globaltrans Investment PLC / FSK YeES PAO / Rossiyskiye Seti PAO / Rossiyskiye Seti PAO / Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Cyprus / Germany / Russian Federation</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Artem Zaigrin / Kleimenova Maria / Mr. Tayts Matvey / Mr. Yuriy A. Vlasov</td></tr>
<tr class="odd"><td class="leftalignment">12/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / LSI=US / PFE=US / BMY=US / IP=US / GILD=US / PEB=US / H=US / CRM=US / MTN=US / MAR=US / TNL=US / HLT=US / AKR=US / APH=US / CHH=US / CSTR=US / DRH=US / REGN=US / ROLL=US / VRTX=US / CVX=US / PSA=US / SPG=US / SNOW=US / SGMS=US / FBK=US / MTCH=US / SRC=US / AUTL=US / BRX=US / PNFP=US / IGMS=US / STRO=US / BIIB=US / EXR=US / BECN=US / SHO=US / PLAY=US / HST=US / WH=US / IAC=US / EPRT=US / HGV=US / RLJ=US / VAC=US / CUBE=US / SPLK=US / RHP=US / ABBV=US / FATE=US / 00770K202 / AFMD=US / BVH=US / NSA=US / EDIT=US / NTLA=US / PK=US / PLYA=US / OKTA=US / ALLO=US / ESTC=US / HARP=US / CRWD=US / GMAB=US / NCNO=US / CELU=US / DHT.UN=CA / REPX=US / ROIV=US</td><td class="leftalignment">Merck & Co Inc / Life Storage Inc / Pfizer Inc / Bristol-Myers Squibb Co / International Paper Co / Gilead Sciences Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Salesforce.Com Inc / Vail Resorts Inc / Marriott International Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Acadia Realty Trust / Amphenol Corp / Choice Hotels International Inc / CapStar Financial Holdings Inc / Diamondrock Hospitality Co / Regeneron Pharmaceuticals Inc / RBC Bearings Inc / Vertex Pharmaceuticals Inc / Chevron Corp / Public Storage / Simon Property Group Inc / Snowflake Inc. / Scientific Games Corp / FB Financial Corp / Match Group Inc / Spirit Realty Capital Inc / Autolus Therapeutics PLC / Brixmor Property Group Inc / Pinnacle Financial Partners Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Extra Space Storage Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Host Hotels & Resorts Inc / Wyndham Hotels & Resorts Inc / IAC/Interactivecorp / Essential Properties Realty Trust Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / CubeSmart / Splunk Inc / Ryman Hospitality Properties Inc / Abbvie Inc / Fate Therapeutics Inc / Aemetis Inc / Affimed NV / Bluegreen Vacations Holding Corp / National Storage Affiliates Trust / Editas Medicine Inc / Intellia Therapeutics Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Okta Inc / Allogene Therapeutics Inc / Elastic NV / Harpoon Therapeutics Inc / CrowdStrike Holdings Inc / Genmab A/S / nCino Inc / Celularity Inc / Dri Healthcare Trust / Riley Exploration Permian Inc / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: ASH Planner Highlights 200+ Datapoints Not To Be Missed + Late Breakers</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / PFE=US / BMY=US / GILD=US / REGN=US / AUTL=US / IGMS=US / STRO=US / ABBV=US / FATE=US / AFMD=US / EDIT=US / NTLA=US / ALLO=US / HARP=US / GMAB=US / CELU=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Autolus Therapeutics PLC / IGM Biosciences Inc / Sutro Biopharma Inc / Abbvie Inc / Fate Therapeutics Inc / Affimed NV / Editas Medicine Inc / Intellia Therapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Genmab A/S / Celularity Inc</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Billal Jahangiri / Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ZTS-US -  Dividend Quality Analysis, for the period ended December 01,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ZTS / LLY / MRK / PFE / ICCC.O / HSKA.O / PAHC.O / SNY.O</td><td class="leftalignment">Zoetis Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / ImmuCell Corp / Heska Corp / Phibro Animal Health Corp / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What's Next For Merck Stock After FDA Advisors Back Its Covid-19 Pill?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Sign Up for Hearty Fridays - KOL Call Series: 12/3 at 11:30am ET, We're Talking Lipids and Blockbuster Opportunity for New Lipids Treatments</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">5671735 / 0989529 / 2023607 / 2778844 / 2730190 / 7103065 / BHC8X90 / BNKGXX2</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Amgen Inc / Merck & Co Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Novo Nordisk A/S / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Debjit Chattopadhyay, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRK.N - Event Transcript of Merck & Co Inc conference call, Dec. 01, 2021 / 10:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">As Expected, Adcom Approves Molnupiravir EUA, Raises Questions Re: Benefit/Risk</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Big Biopharma Will Have $500Bn in Gross Cash to Deploy YE22 - Get Set for M&A</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AZN / 71708110 / 92532F10 / 37555810 / 03116210 / 75886F10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / 09075V10 / 60770K10 / G3910J11</td><td class="leftalignment">AstraZeneca PLC / Pfizer Inc / Vertex Pharmaceuticals Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / BioNTech SE / Moderna Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">Germany / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Daniel Tarjan, Ph.D. / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">0989529 / 2000019 / 2778844 / 2437071 / 2219224 / 2190750 / 2216850 / 2270726 / 2317087 / 2328915 / 2455965 / 2457864 / 2638625 / 2684703 / B067BM3 / 2857817 / B7TL820 / BDZCRX3 / BZ07BW4 / BYRY499 / BNGY4Q0 / BD9GVY0 / BZ1LFB2 / BZ00V34 / BJ2Z0H2 / BFZ1K46 / BLGJ610 / BKTNTR9 / BJVR9Y9 / BYY88Y7 / BDZ30Q0 / BMPRZV5 / BN7K304 / BNNTQY0 / BP7KZP7 / BMHRMK1 / BP81RH5</td><td class="leftalignment">AstraZeneca PLC / Amazon.com Inc / Merck & Co Inc / Biomarin Pharmaceutical Inc / CMS Energy Corp / Chesapeake Utilities Corp / Consolidated Edison Inc / Walt Disney Co / Entergy Corp / Nextera Energy Inc / Biogen Inc / ImmunoGen Inc / National Beverage Corp / Pfizer Inc / Molson Coors Beverage Co / Netflix Inc / Meta Platforms Inc / RingCentral Inc / Monster Beverage Corp / Kraft Heinz Co / Nextera Energy Partners LP / Zai Lab Ltd / Deciphera Pharmaceuticals Inc / Zscaler Inc / Pinterest Inc / Spotify Technology SA / Warner Music Group Corp / ViacomCBS Inc / iHeartMedia Inc / Alphabet Inc / Arvinas Inc / Kymera Therapeutics Inc / Academy Sports and Outdoors Inc / Oatly Group AB / Monte Rosa Therapeutics Inc / Vita Coco Company Inc / Allbirds Inc</td><td class="leftalignment"></td><td class="leftalignment">China / Cayman Islands / United Kingdom / Luxembourg / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Close Vote Reflects Doubts about Molnupiravir Risk Benefit; PFE Should Be OK</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">PFE.N / 71708110 / 58933Y10 / 29251M10 / 04683R10</td><td class="leftalignment">Pfizer Inc / Pfizer Inc / Merck & Co Inc / Enanta Pharmaceuticals Inc / Atea Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Geoffrey Porges, MBBS / Ms. Roanna C. Ruiz / Dilip Joseph / Na Sun / Anna Baran, CFA / Daniel Tarjan, Ph.D. / Jeffrey La Rosa</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">MRK: Molnupiravir AdComm Only Slightly in Favor of EUA; We Think Authorization Is Likely for a Somewhat Limited Market</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2778844</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">European MedTech & Services: 2022 Outlook: The Year of Normalization?</td><td class="leftalignment">English</td><td class="rightalignment">81</td><td class="leftalignment">PHG.AS / FMEG.DE / MRCG.DE / EVTG.DE / LONN.S / FREG.DE / AFXG.DE / SATG_p.DE / SBSG.DE / STMN.S / GXIG.DE / QGEN.N / SOON.S / BAYGn.DE / SHLG.DE / BNNn.DE / GALE.S / ALCC.S / SYAB.DE</td><td class="leftalignment">Koninklijke Philips NV / Fresenius Medical Care AG & Co KGaA / Merck KGaA / Evotec SE / Lonza Group AG / Fresenius SE & Co KGaA / Carl Zeiss Meditec AG / Sartorius AG / Stratec SE / Straumann Holding AG / Gerresheimer AG / Qiagen NV / Sonova Holding AG / Bayer AG / Siemens Healthineers AG / BRAIN Biotech AG / Galenica AG / Alcon AG / Synlab AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / Germany / Netherlands</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">CREDIT</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Falko Friedrichs / Herr Jan Koch / Sachin Gadilingappa</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">The Insight Partners</td><td class="leftalignment">Merck & Co., Inc. in Global Hematuria Treatment Market, Company SWOT Analysis and Profile</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">MRK - Molnupiravir: 9hr FDA AdCom meeting summarized in 4 pages (13:10 vote not exactly a glowing endorsement)</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Merck climbs 9.1% from 3 week low</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Molnupiravir's FDA AdCom Votes Favorably (13:10) but Challenges Highlighted</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US58933Y1055 / US7170811035</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Monthly: Merck (MRK: $74.91) loses $33 billion in MCap in November, biggest drop in Pharmaceuticals sector</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Is A Rise Imminent For Merck Stock After An 8% Fall In A Month?</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Merck & Co., Inc.(MRK) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">58933Y105</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2936921 / 2126335 / 2516152 / 2000019 / 2778844 / 2050832 / 2190750 / 2216850 / 2270726 / 2317087 / 2670519 / 2328915 / 2415204 / 2684703 / 7103065 / 2857817 / B3D7K31 / B7TL820 / B7VD3F2 / BDZCRX3 / BFLR866 / BVVN4Q8 / BXDZ9Z0 / BMYML02 / BFMXGR0 / BKTNTR9 / BWY52P3 / BYY88Y7 / BD6JX35 / BM8MM05 / BYQCZ35 / BD5GSZ4</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Walmart Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Ameren Corp / Chesapeake Utilities Corp / Consolidated Edison Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / Hawaiian Electric Industries Inc / Pfizer Inc / Novartis AG / Netflix Inc / Discovery Inc / Meta Platforms Inc / Duke Energy Corp / RingCentral Inc / Twitter Inc / Eversource Energy / Shopify Inc / DraftKings Inc / Evergy Inc / ViacomCBS Inc / Blueprint Medicines Corp / Alphabet Inc / Krystal Biotech Inc / Madison Square Garden Entertainment Corp / Madison Square Garden Sports Corp / Infrastructure and Energy Alternatives Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">207940.KS: Samsung Biologics Co., Ltd. - A focused large-scale biologics specialist</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">207940.KS / 4901.T / BAX.N / JNJ.N / PFE.N / TMO.N / AZN.L / SASY.PA / ROG.S / DHR.N / 1177.HK / TEVA.TA / MRCG.DE / LONN.S / SATG.DE / BANB.S / GSK.L / NVS.N / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / NVAX.OQ / 005930.KS / 000100.KS / 008930.KS / SFZN.S / BIIB.OQ / 006280.KS / TEVA.N / EBS.N / MRNA.OQ / 068270.KS / 1099.HK / 032830.KS / 128940.KS / ABBV.N / CTLT.N / 196170.KQ / 028260.KS / 2269.HK / 091990.KQ / 302440.KS</td><td class="leftalignment">Samsung Biologics Co Ltd / Fujifilm Holdings Corp / Baxter International Inc / Johnson & Johnson / Pfizer Inc / Thermo Fisher Scientific Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Danaher Corp / Sino Biopharmaceutical Ltd / Teva Pharmaceutical Industries Ltd / Merck KGaA / Lonza Group AG / Sartorius AG / Bachem Holding AG / GlaxoSmithKline PLC / Novartis AG / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Novavax Inc / Samsung Electronics Co Ltd / Yuhan Corp / Hanmi Science Co Ltd / Siegfried Holding AG / Biogen Inc / Green Cross Corp / Teva Pharmaceutical Industries Ltd / Emergent BioSolutions Inc / Moderna Inc / Celltrion Inc / Sinopharm Group Co Ltd / Samsung Life Insurance Co Ltd / Hanmi Pharm Co Ltd / Abbvie Inc / Catalent Inc / Alteogen Inc / Samsung C&T Corp / WuXi Biologics (Cayman) Inc / Celltrion Healthcare Co Ltd / SK Bioscience Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / France / United Kingdom / Israel / Japan / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">302440.KS: SK Bioscience Co., Ltd. - A rising vaccine manufacturing and development powerhouse</td><td class="leftalignment">English</td><td class="rightalignment">51</td><td class="leftalignment">302440.KS / 4502.T / 4901.T / BAX.N / JNJ.N / PFE.N / TMO.N / AZN.L / SASY.PA / DHR.N / 1177.HK / MRCG.DE / LONN.S / SATG.DE / BANB.S / GSK.L / NVAX.OQ / 000100.KS / 008930.KS / 006120.KS / 069620.KS / SFZN.S / 006280.KS / EBS.N / INO.OQ / MRNA.OQ / 068270.KS / 1099.HK / 034730.KS / 128940.KS / CTLT.N / 196170.KQ / 207940.KS / 2269.HK / 091990.KQ / 326030.KS / CVAC.OQ / PPGN.S / 2197.HK</td><td class="leftalignment">SK Bioscience Co Ltd / Takeda Pharmaceutical Co Ltd / Fujifilm Holdings Corp / Baxter International Inc / Johnson & Johnson / Pfizer Inc / Thermo Fisher Scientific Inc / AstraZeneca PLC / Sanofi SA / Danaher Corp / Sino Biopharmaceutical Ltd / Merck KGaA / Lonza Group AG / Sartorius AG / Bachem Holding AG / GlaxoSmithKline PLC / Novavax Inc / Yuhan Corp / Hanmi Science Co Ltd / SK Discovery Co Ltd / Daewoong Pharma / Siegfried Holding AG / Green Cross Corp / Emergent BioSolutions Inc / Inovio Pharmaceuticals Inc / Moderna Inc / Celltrion Inc / Sinopharm Group Co Ltd / SK Inc / Hanmi Pharm Co Ltd / Catalent Inc / Alteogen Inc / Samsung Biologics Co Ltd / WuXi Biologics (Cayman) Inc / Celltrion Healthcare Co Ltd / SK Biopharmaceuticals Co Ltd / CureVac NV / PolyPeptide Group AG / Clover Biopharmaceuticals Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / France / United Kingdom / Japan / Korea, Republic of / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">006280.KS: Green Cross Corp - A committed CMO player within Korean large pharmas</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">006280.KS / BAX.N / JNJ.N / PFE.N / TMO.N / AZN.L / SASY.PA / DHR.N / 1177.HK / MRCG.DE / LONN.S / SATG.DE / BANB.S / GSK.L / APNJ.J / NVAX.OQ / SFZN.S / 005250.KS / EBS.N / MRNA.OQ / 068270.KS / 1099.HK / CTLT.N / 207940.KS / 2269.HK / 302440.KS</td><td class="leftalignment">Green Cross Corp / Baxter International Inc / Johnson & Johnson / Pfizer Inc / Thermo Fisher Scientific Inc / AstraZeneca PLC / Sanofi SA / Danaher Corp / Sino Biopharmaceutical Ltd / Merck KGaA / Lonza Group AG / Sartorius AG / Bachem Holding AG / GlaxoSmithKline PLC / Aspen Pharmacare Holdings Ltd / Novavax Inc / Siegfried Holding AG / Green Cross Holdings / Emergent BioSolutions Inc / Moderna Inc / Celltrion Inc / Sinopharm Group Co Ltd / Catalent Inc / Samsung Biologics Co Ltd / WuXi Biologics (Cayman) Inc / SK Bioscience Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / France / United Kingdom / Korea, Republic of / United States / South Africa</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Korea Contract Manufacturing Sector: Visible growth pathways for Korean CMOs</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">207940.KS / 302440.KS / BAX.N / JNJ.N / PFE.N / TMO.N / AZN.L / SASY.PA / DHR.N / 1177.HK / MRCG.DE / LONN.S / SATG.DE / BANB.S / GSK.L / NVAX.OQ / SFZN.S / 006280.KS / EBS.N / MRNA.OQ / 1099.HK / CTLT.N / 2269.HK</td><td class="leftalignment">Samsung Biologics Co Ltd / SK Bioscience Co Ltd / Baxter International Inc / Johnson & Johnson / Pfizer Inc / Thermo Fisher Scientific Inc / AstraZeneca PLC / Sanofi SA / Danaher Corp / Sino Biopharmaceutical Ltd / Merck KGaA / Lonza Group AG / Sartorius AG / Bachem Holding AG / GlaxoSmithKline PLC / Novavax Inc / Siegfried Holding AG / Green Cross Corp / Emergent BioSolutions Inc / Moderna Inc / Sinopharm Group Co Ltd / Catalent Inc / WuXi Biologics (Cayman) Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / France / United Kingdom / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">HSBC</td><td class="leftalignment">European Corporate Credit Quarterly:-Looking ahead to 2022 – solid ground</td><td class="leftalignment">English</td><td class="rightalignment">92</td><td class="leftalignment">AIRP.PA / AKZO.AS / ASML.AS / BATS.L / BMWG.DE / BOUY.PA / BP.L / BT.L / CAPP.PA / CARR.PA / CPG.L / CRH.I / DANO.PA / DAST.PA / DGE.L / DSMN.AS / ENI.MI / ERICb.ST / EXHO.PA / HEIG.DE / HEIN.AS / IBE.MC / KPN.AS / LVMH.PA / MICP.PA / MRCG.F / NXT.L / OMVV.VI / PERP.PA / PHG.AS / PRTP.PA / PUBP.PA / RENA.PA / REP.MC / RYA.I / SAPG.F / SCHN.PA / SGEF.PA / SGOB.PA / SOLB.BR / TEF.MC / TSCO.L / ULVR.L / VOD.L / VOLVb.ST / WLSNc.AS / WPP.L / VOWG_p.DE / CONG.DE / AZN.L / AAL.L / SASY.PA / ROG.S / SIEGn.DE / NOVN.S / ENEI.MI / DTEGn.DE / IFXGn.DE / CARLb.CO / FREG.DE / TELA.VI / EZJ.L / DPWGn.DE / TEL.OL / GSK.L / TELIA.ST / REL.L / IHG.L / NESN.S / SESFd.PA / LXSG.DE / BTGGg.F / RDSa.L / EDF.PA / CFR.S / VIV.PA / HOLN.S / MNDI.L / DAIGn.DE / ABI.BR / UPM.HE / BAYGn.DE / BASFn.DE / GLEN.L / EVKn.DE / ORAN.PA / AIRG.DE / ENGIE.PA / IMB.L / AD.AS / FORTUM.HE / ORSTED.CO / EQNR.OL / NTGY.MC / STLA.MI / RKT.L / TTEF.PA</td><td class="leftalignment">L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Akzo Nobel NV / ASML Holding NV / British American Tobacco PLC / Bayerische Motoren Werke AG / Bouygues SA / BP PLC / BT Group PLC / Capgemini SE / Carrefour SA / Compass Group PLC / CRH PLC / Danone SA / Dassault Systemes SE / Diageo PLC / Koninklijke DSM NV / Eni SpA / Telefonaktiebolaget LM Ericsson / Sodexo SA / HeidelbergCement AG / Heineken NV / Iberdrola SA / Koninklijke KPN NV / LVMH Moet Hennessy Louis Vuitton SE / Compagnie Generale des Etablissements Michelin SCA / Merck KGaA / Next PLC / OMV AG / Pernod Ricard SA / Koninklijke Philips NV / Kering SA / Publicis Groupe SA / Renault SA / Repsol SA / Ryanair Holdings PLC / SAP SE / Schneider Electric SE / Vinci SA / Compagnie de Saint Gobain SA / Solvay SA / Telefonica SA / Tesco PLC / Unilever PLC / Vodafone Group PLC / Volvo AB / Wolters Kluwer NV / WPP PLC / Volkswagen AG / Continental AG / AstraZeneca PLC / Anglo American PLC / Sanofi SA / Roche Holding AG / Siemens AG / Novartis AG / Enel SpA / Deutsche Telekom AG / Infineon Technologies AG / Carlsberg A/S / Fresenius SE & Co KGaA / Telekom Austria AG / Easyjet PLC / Deutsche Post AG / Telenor ASA / GlaxoSmithKline PLC / Telia Company AB / Relx PLC / InterContinental Hotels Group PLC / Nestle SA / SES SA / Lanxess AG / Bertelsmann SE & Co KGaA / Royal Dutch Shell PLC / Electricite de France SA / Compagnie Financiere Richemont SA / Vivendi SE / Holcim AG / Mondi PLC / Daimler AG / Anheuser Busch Inbev SA / UPM-Kymmene Oyj / Bayer AG / BASF SE / Glencore PLC / Evonik Industries AG / Orange SA / Airbus SE / Engie SA / Imperial Brands PLC / Koninklijke Ahold Delhaize NV / Fortum Oyj / Orsted A/S / Equinor ASA / Naturgy Energy Group SA / Stellantis NV / Reckitt Benckiser Group PLC / TotalEnergies SE</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">Austria / Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / Norway / Sweden / United States / Jersey</td><td class="leftalignment">Aerospace / Air Transportation / Apparel & Textiles / Automotive / Beverages & Tobacco / Broadcasting & Cable / Building & Building Materials / Chemicals / Cosmetics & Personal Care / Defense / Electrical / Electronics / Engineering & Construction / Environmental Services / Food / Healthcare / Industrial Materials / Info. Tech./Software / Lodging & Restaurants / Machinery / Manufacturing / Media / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Publishing / Retailing / Semiconductors / Services / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / FIXED INCOME / MARKET COMMENT / HIGH YIELD BONDS / CREDIT / BOND</td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Jonathan R. White / Song Jin Lee / Dominic A. Kini / Tom Russell</td></tr>
<tr class="even"><td class="leftalignment">11/29/2021</td><td class="leftalignment">SPDB International Securities Limited</td><td class="leftalignment">浦银国际研究：Omicron变异株来袭：全球疫情添新变数</td><td class="leftalignment">Chinese</td><td class="rightalignment">9</td><td class="leftalignment">MRNA=US / MRK=US / 6185=HK / BNTX=US / 9939=HK / 2137=HK</td><td class="leftalignment">Moderna Inc / Merck & Co Inc / CanSino Biologics Inc / BioNTech SE / Kintor Pharmaceutical Ltd / Brii Biosciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">China / Cayman Islands / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Ryan Hu / Ms. Sharon Lam</td></tr>
<tr class="odd"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">This Pharmaceuticals Stock Is A Better Pick Over Bristol Myers Squibb</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 19, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">11/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Chase a Check (Vol. 2) — Biopharma/MedTech Cash Runway Map</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">11012210 / 71708110 / 37555810 / 00422510 / 771195104 / 03152W10 / 58933Y10 / 02311120 / 45766930 / 80360710 / 05463X10 / 31572Q80 / 00653A107 / 04351P101 / XERS / 98401F10 / 04004760 / 21232630 / 05337M104 / 23283X20 / 45773010 / 05358830 / 38942Q10 / 76029N10 / 41358P10 / N9006410 / 98420N10 / 58949210 / 90041T10 / 09627Y10 / Y9530810 / 30052C10 / 09075V10 / 00289Y10 / 09609G10 / 75901B10 / 05464T10 / 05156V10 / 75615P10 / 16383L10 / 55609910 / 01438T10 / 74374N10 / G3910J11 / H0026310 / 00847X10 / 24344T10 / 98978L20 / 04685N10 / 13089P10 / 34633R10 / 38341P10 / 43906K10 / 46565G10 / 50127T10 / 61776010 / 60468T10 / 03969F10 / 05370A10 / 78116T10 / 76155X10 / 98887Q10 / 98943L10 / 45845P10 / 4525EP10 / 78667J10 / 46116X10 / 90400D10 / 69014510 / 35961610 / 55886810 / 05454B10 / 04539610 / 45249V10 / 80405P10 / 75955J40 / 56400P70 / 87808K10 / 87166L10 / 03836N10 / 23257D10 / 28617K10 / 03824M10 / 36322Q10 / N4444510 / 45258J10 / 56854Q20 / 74623710 / H9060V101 / 89422G10 / 82939910 / 87410C10 / 36870G10 / 64128810 / 28036F10 / N5749R10 / 24343R10 / 52634L10 / 49705R10 / 85209E10 / 25056L10 / 09770210 / 82835W10 / 78349D10 / 68386J20 / 30315R10 / 37230320 / 14203810 / 29251M10 / 81064810 / G637AM10 / 04683R10 / 01626L10 / 20752310 / 28623U10 / 28658R10 / 38870X10</td><td class="leftalignment">Bristol-Myers Squibb Co / Pfizer Inc / Gilead Sciences Inc / ACADIA Pharmaceuticals Inc / Roche Holding AG / Amicus Therapeutics Inc / Merck & Co Inc / Amarin Corporation PLC / Insmed Inc / Sarepta Therapeutics Inc / AxoGen Inc / FibroGen Inc / Adaptimmune Therapeutics PLC / Ascendis Pharma A/S / Xeris Biopharma Holdings Inc / Xencor Inc / Arena Pharmaceuticals Inc / ContraFect Corp / Avadel Pharmaceuticals PLC / Cytosorbents Corp / Inspire Medical Systems Inc / Aveo Pharmaceuticals Inc / Graybug Vision Inc / Replimune Group Inc / Harpoon Therapeutics Inc / Uniqure NV / Xenon Pharmaceuticals Inc / Mereo Biopharma Group PLC / Turning Point Therapeutics Inc / Blueprint Medicines Corp / WAVE Life Sciences Ltd / Evolus Inc / BioNTech SE / Abeona Therapeutics Inc / bluebird bio Inc / Regenxbio Inc / Axsome Therapeutics Inc / Aurinia Pharmaceuticals Inc / Reata Pharmaceuticals Inc / ChemoCentryx Inc / MacroGenics Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / GlaxoSmithKline PLC / AC Immune SA / Agios Pharmaceuticals Inc / Deciphera Pharmaceuticals Inc / Zogenix Inc / Athenex Inc / Calithera Biosciences Inc / Forma Therapeutics Holdings Inc / Gossamer Bio Inc / HOOKIPA Pharma Inc / Iteos Therapeutics Inc / Kura Oncology Inc / MorphoSys AG / Mirati Therapeutics Inc / Arcus Biosciences Inc / Avidity Biosciences Inc / Rubius Therapeutics Inc / Revolution Medicines Inc / Zai Lab Ltd / Zentalis Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Immunic Inc / SAGE Therapeutics Inc / Intra-Cellular Therapies Inc / Ultragenyx Pharmaceutical Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Madrigal Pharmaceuticals Inc / Axcella Health Inc / Assembly Biosciences Inc / Imara Inc / Satsuma Pharmaceuticals Inc / Relmada Therapeutics Inc / MannKind Corp / TCR2 Therapeutics Inc / Synlogic Inc / Aptinyx Inc / Cymabay Therapeutics Inc / Eledon Pharmaceuticals Inc / Applied Molecular Transport Inc. / Galecto Inc / Immatics NV / Immunovant Inc / Marinus Pharmaceuticals Inc / PureTech Health PLC / VectivBio Holding AG / Travere Therapeutics Inc / Sio Gene Therapies Inc / Talaris Therapeutics Inc / Gemini Therapeutics Inc / Neuropace Inc / Edgewise Therapeutics Inc / Merus NV / Decibel Therapeutics Inc / LENSAR Inc / Kinnate Biopharma Inc / Spruce Biosciences Inc / Design Therapeutics Inc / Bolt Biotherapeutics Inc / Silverback Therapeutics Inc / Rxsight Inc / Opthea Ltd / F-Star Therapeutics Inc / Genmab A/S / Caribou Biosciences Inc / Enanta Pharmaceuticals Inc / scPharmaceuticals Inc / Myovant Sciences Ltd / Atea Pharmaceuticals Inc / Aligos Therapeutics Inc / Connect Biopharma Holdings Ltd / Elevation Oncology Inc / Eliem Therapeutics Inc / Graphite Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Netherlands / Singapore / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mani Foroohar, M.D. / Joseph P. Schwartz / Mr. Thomas J. Smith / Geoffrey Porges, MBBS / Greco Song, Ph.D. / Priya Sachdeva / Rudy Li, Ph.D. / Jeffrey La Rosa / Will Soghikian / Mike Kratky, CFA / Anna Baran, CFA / Ms. Danielle J. Antalffy / Andrew Berens, M.D. / Mr. Rick Bienkowski, Ph.D. / Jonathan Chang, Ph.D., CFA / Mr. Marc Goodman / Daina Graybosch, Ph.D. / Christopher Liu, Pharm.D. / Ms. Roanna C. Ruiz</td></tr>
<tr class="even"><td class="leftalignment">11/29/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - November 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">US02553E1064 / US2441991054 / US25179M1036 / US3647601083 / US5324571083 / US6541061031 / US6556641008 / US7170811035 / US75886F1075 / US7782961038 / US8725401090 / US9170471026 / US9182041080 / CA1363851017 / US20825C1045 / US49446R1095 / US29476L1070 / US7588491032 / US8288061091 / US44107P1049 / US9043111072 / US3137472060 / US29472R1086 / US8666741041 / US63633D1046 / US5500211090 / US90384S3031 / CA8672241079 / US58933Y1055 / CA15135U1093 / CA00208D4084 / CA2927661025 / US6936561009 / US7512121010 / CA89156V1067 / US70509V1008 / US78573L1061 / US23283R1005 / CA0266951064 / US1220171060 / US86771W1053 / US72703H1014 / US7005171050 / US8760301072 / US8608971078 / US63845R1077 / VGG1890L1076 / US76156B1070 / US88339P1012 / US86745K1043 / US70614W1009 / US69047Q1022 / US03750L1098 / US1651677353 / US24343R1068 / US11135E2037 / US60646V1052 / US0708301041 / US9264001028 / US89269P1030 / US94770D1028 / US53190C1027</td><td class="leftalignment">American Eagle Outfitters Inc / Deere & Co / Devon Energy Corp / Gap Inc / Eli Lilly and Co / Nike Inc / Nordstrom Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / TJX Companies Inc / Urban Outfitters Inc / VF Corp / Canadian Natural Resources Ltd / Conocophillips / Kimco Realty Corp / Equity Residential / Regency Centers Corp / Simon Property Group Inc / Host Hotels & Resorts Inc / Under Armour Inc / Federal Realty Investment Trust / Equity LifeStyle Properties Inc / Sun Communities Inc / National Health Investors Inc / Lululemon Athletica Inc / Ulta Beauty Inc / Suncor Energy Inc / Merck & Co Inc / Cenovus Energy Inc / ARC Resources Ltd / Enerplus Corp / PVH Corp / Ralph Lauren Corp / Tourmaline Oil Corp / Pebblebrook Hotel Trust / Sabra Health Care REIT Inc / CyrusOne Inc / American Hotel Income Properties REIT LP / Burlington Stores Inc / Sunrun Inc / Planet Fitness Inc / Park Hotels & Resorts Inc / Tapestry Inc / Stitch Fix Inc / National Vision Holdings Inc / Capri Holdings Ltd / Revolve Group Inc / RealReal Inc / Sunnova Energy International Inc / Peloton Interactive Inc / Ovintiv Inc / Apartment Income REIT Corp / Chesapeake Energy Corp / Decibel Therapeutics Inc / Broadstone Net Lease Inc / Mister Car Wash Inc / Bath & Body Works Inc / Victoria's Secret & Co / Traeger Inc / Weber Inc / Life Time Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">11/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Molnupiravir EUA Likely; AdCom Discussion Will Likely Highlight Weaknesses</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">58933Y10</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="even"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">KOLs: Molnupiravir Data Trend Expected, EUA And Last-Line Therapy Place Likely</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">2778844 / 2931034 / BXDZ9Z0 / BM8NHS1 / BP81RH5 / BNV08M7</td><td class="leftalignment">Merck & Co Inc / Vertex Pharmaceuticals Inc / Shopify Inc / Adagio Therapeutics Inc / Allbirds Inc / Arhaus Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - Omicron variant: Mutation comparison suggesting potential for high transmissibility and immune evasion</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">JNJ.N / AZN.L / MRCG.DE / PFIZ.NS / 1877.HK</td><td class="leftalignment">Johnson & Johnson / AstraZeneca PLC / Merck KGaA / Pfizer Ltd / Shanghai Junshi Biosciences Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Germany / United Kingdom / India / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">11/28/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Trefis Report: Merck - $100 Trefis Price Estimate</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.5% Above Pre-Pandemic Base- Week 86</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">11/27/2021</td><td class="leftalignment">New Constructs, LLC</td><td class="leftalignment">Merck & Co., Inc.: Credit Rating - Unbiased Research Based on Superior Data</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY / COMPANY UPDATE / COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/27/2021</td><td class="leftalignment">New Constructs, LLC</td><td class="leftalignment">MRK: Forensic Stock Earnings & Valuation</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY / COMPANY UPDATE / COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/26/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Omicron Variant: What We Know, What We Don’t, and the Impact on Our Coverage</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US5324571083 / US7170811035 / US75886F1075 / US58933Y1055</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States / South Africa</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for MRK. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">58933Y105</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">11/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Not to be Alarmist but Nu is Alarming – and Good for PFE and Other Incumbents</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">PFE.N / 71708110 / 75886F10 / 58933Y10</td><td class="leftalignment">Pfizer Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Anna Baran, CFA / Daniel Tarjan, Ph.D. / Na Sun / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="even"><td class="leftalignment">11/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">COVID/scope Real-Time Update: Emerging Nu Strain Should Remind of Caution, Not Necessarily Cause Panic</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N / PFE.N / GILD.O / INCY.O / ENTA.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Incyte Corp / Enanta Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / South Africa</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Brian Abrahams, MD / Stephen Mallon / Leonid Timashev</td></tr>
<tr class="odd"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Kepler Cheuvreux</td><td class="leftalignment">Credit Research | Europe | Corporate hybrid monitor</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">CNA.L / DANO.PA / EDP.LS / ENI.MI / IBE.MC / LENV.VI / LHAG.DE / OMVV.VI / REP.MC / RWEG.DE / SOLB.BR / TEF.MC / VOD.L / WBSV.VI / VOWG_p.DE / FER.MC / ENEI.MI / MRCG.DE / VIE.PA / EUFI.PA / TELIA.ST / ABGV.VI / SESFd.PA / LXSG.DE / ELI.BR / EDPR.LS / SEVI.PA / EVKn.DE / ORAN.PA / GYC.DE / ENGIE.PA / VNAn.DE / ORSTED.CO / URW.AS / TTEF.PA</td><td class="leftalignment">Centrica PLC / Danone SA / EDP Energias de Portugal SA / Eni SpA / Iberdrola SA / Lenzing AG / Deutsche Lufthansa AG / OMV AG / Repsol SA / Rwe AG / Solvay SA / Telefonica SA / Vodafone Group PLC / Wienerberger AG / Volkswagen AG / Ferrovial SA / Enel SpA / Merck KGaA / Veolia Environnement SA / Eurofins Scientific SE / Telia Company AB / Porr AG / SES SA / Lanxess AG / Elia Group SA / EDP Renovaveis SA / Suez SA / Evonik Industries AG / Orange SA / Grand City Properties SA / Engie SA / Vonovia SE / Orsted A/S / Unibail-Rodamco-Westfield SE / TotalEnergies SE</td><td class="leftalignment"></td><td class="leftalignment">Austria / Belgium / Germany / Denmark / Spain / France / United Kingdom / Italy / Luxembourg / Portugal / Sweden</td><td class="leftalignment">Air Transportation / Automotive / Building & Building Materials / Chemicals / Energy / Food / Media / Pharmaceuticals / Real Estate / Services / Telecommunications / Utilities</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Equity Strategy: How worried should we be about COVID?</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">CCL.N / PFE.N / RYA.I / RCL.N / MRCG.DE / EZJ.L / GILD.OQ / NCLH.N</td><td class="leftalignment">Carnival Corp / Pfizer Inc / Ryanair Holdings PLC / Royal Caribbean Cruises Ltd / Merck KGaA / Easyjet PLC / Gilead Sciences Inc / Norwegian Cruise Line Holdings Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Germany / United Kingdom / Ireland / Liberia / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / Investment Strategy / Equity</td><td class="leftalignment">Mr. Andrew W. Garthwaite / Mr Robert C. Griffiths / Asim Ali / Nasr Islam / Marc el Koussa</td></tr>
<tr class="odd"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck KGaA: Ownership Timelines & Shareholder Analytics (November 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">11/25/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">Healthcare Pulse Check: Euro Credit Sector Update : Generics results, M&A reports and portfolio announcements</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AZN.L / ROG.S / NOVN.S / MRCG.DE</td><td class="leftalignment">AstraZeneca PLC / Roche Holding AG / Novartis AG / Merck KGaA</td><td class="leftalignment">FIXED INCOME - HIGH YIELD</td><td class="leftalignment">Switzerland / Germany / United Kingdom / Netherlands / Sweden / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Danielle Ward / Mr. Adam Bodor</td></tr>
<tr class="odd"><td class="leftalignment">11/24/2021</td><td class="leftalignment">Access to Medicine Foundation</td><td class="leftalignment">Antimicrobial Resistance  Benchmark 2021</td><td class="leftalignment">English</td><td class="rightalignment">189</td><td class="leftalignment">4507.T / ABT.N / JNJ.N / MRK.N / PFE.N / SASY.PA / NOVN.S / TEVA.TA / GSK.L / CIPL.NS / SUN.NS / ARBN.NS / ALKE.NS / VTRS.OQ</td><td class="leftalignment">Shionogi & Co Ltd / Abbott Laboratories / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Sanofi SA / Novartis AG / Teva Pharmaceutical Industries Ltd / GlaxoSmithKline PLC / Cipla Ltd / Sun Pharmaceutical Industries Ltd / Aurobindo Pharma Ltd / Alkem Laboratories Ltd / Viatris Inc</td><td class="leftalignment">INDUSTRY OVERVIEW</td><td class="leftalignment">Brazil / Switzerland / China / Germany / France / United Kingdom / India / Israel / Japan / United States / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Team Index</td></tr>
<tr class="even"><td class="leftalignment">11/24/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AIN / MRK=US / LLY=US / PFE=US / ADI=US / MDT=US / NVDA=US / MPWR=US / DIOD=US / AIR=US / ATRO=US / AVGO=US / B=US / CBRL=US / ELY=US / CW=US / DCO=US / HEI=US / HXL=US / MRCY=US / MCHP=US / PLAN=US / ROLL=US / TGI=US / VSEC=US / GOLF=US / BKNG=US / SPR=US / MOG.A=US / TDG=US / KTOS=US / JACK=US / NXPI=US / WWD=US / ABBV=US / FATE=US / AFMD=US / ON=US / AJRD=US / BWXT=US / MAXR=US / LHX=US / SPCE=US</td><td class="leftalignment">Albany International Corp / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Analog Devices Inc / Medtronic PLC / NVIDIA Corp / Monolithic Power Systems Inc / Diodes Inc / AAR Corp / Astronics Corp / Broadcom Inc / Barnes Group Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Curtiss-Wright Corp / Ducommun Inc / HEICO Corp / Hexcel Corp / Mercury Systems Inc / Microchip Technology Inc / Anaplan Inc / RBC Bearings Inc / Triumph Group Inc / VSE Corp / Acushnet Holdings Corp / Booking Holdings Inc / Spirit AeroSystems Holdings Inc / Moog Inc / TransDigm Group Inc / Kratos Defense and Security Solutions Inc / Jack in the Box Inc / NXP Semiconductors NV / Woodward Inc / Abbvie Inc / Fate Therapeutics Inc / Affimed NV / ON Semiconductor Corp / Aerojet Rocketdyne Holdings Inc / BWX Technologies Inc / Maxar Technologies Inc / L3harris Technologies Inc / Virgin Galactic Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">United Arab Emirates / Argentina / Australia / Belgium / Brazil / Canada / Switzerland / China / Germany / Egypt / Spain / France / United Kingdom / Greece / Hong Kong / India / Ireland / Iran, Islamic Republic of / Italy / Japan / Korea, Republic of / Kuwait / Mexico / Mali / Malaysia / Nigeria / Netherlands / Norway / New Zealand / Philippines / Poland / Russian Federation / Saudi Arabia / Singapore / Slovakia / Sweden / Thailand / Turkey / Taiwan / United States / Vietnam / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMMODITY RESEARCH / COMPANY (EQUITY) REPORTS / ECONOMIC REPORTS / FIXED INCOME/DEBT RESEARCH / FOREIGN EXCHANGE / CURRENCIES / INDUSTRY REPORTS / MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Research Digest / Investment Strategy</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/24/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Technical Slowdown</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">FR0000121972 / BE0003739530 / FR0000121667 / DE0006599905 / GB0002374006 / DE0006602006 / DE0006048432 / IT0000062072 / DE0005785802 / DE0006231004 / DE0007164600 / CH0009002962 / DE0006452907 / DE0005470306 / GB00B03MLX29 / CH0038863350 / DE000ENAG999 / DE000PAH0038 / DE000KSAG888 / DK0060448595 / NL0012169213 / DE000SHL1006 / IE00BZ12WP82 / DE000A2YN900 / DE000A2LQ884</td><td class="leftalignment">Schneider Electric SE / Ucb SA / EssilorLuxottica SA / Merck KGaA / Diageo PLC / GEA Group AG / Henkel AG & Co KGaA / Assicurazioni Generali SpA / Fresenius Medical Care AG & Co KGaA / Infineon Technologies AG / SAP SE / Barry Callebaut AG / Nemetschek SE / Cts Eventim AG & Co KgaA / Royal Dutch Shell PLC / Nestle SA / E.ON SE / Porsche Automobil Holding SE / K&S AG / Coloplast A/S / Qiagen NV / Siemens Healthineers AG / Linde PLC / TeamViewer AG / AUTO1 Group SE</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / Ireland / Italy / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Equity</td><td class="leftalignment">Herr. Achim Matzke / Frau Petra von Kerssenbrock / Herr Thorsten Grisse</td></tr>
<tr class="even"><td class="leftalignment">11/24/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Technischer Slowdown</td><td class="leftalignment">German</td><td class="rightalignment">41</td><td class="leftalignment">FR0000121972 / BE0003739530 / FR0000121667 / DE0006599905 / GB0002374006 / DE0006602006 / DE0006048432 / IT0000062072 / DE0005785802 / DE0006231004 / DE0007164600 / CH0009002962 / DE0006452907 / DE0005470306 / GB00B03MLX29 / CH0038863350 / DE000ENAG999 / DE000PAH0038 / DE000KSAG888 / DK0060448595 / NL0012169213 / DE000SHL1006 / IE00BZ12WP82 / DE000A2YN900 / DE000A2LQ884</td><td class="leftalignment">Schneider Electric SE / Ucb SA / EssilorLuxottica SA / Merck KGaA / Diageo PLC / GEA Group AG / Henkel AG & Co KGaA / Assicurazioni Generali SpA / Fresenius Medical Care AG & Co KGaA / Infineon Technologies AG / SAP SE / Barry Callebaut AG / Nemetschek SE / Cts Eventim AG & Co KgaA / Royal Dutch Shell PLC / Nestle SA / E.ON SE / Porsche Automobil Holding SE / K&S AG / Coloplast A/S / Qiagen NV / Siemens Healthineers AG / Linde PLC / TeamViewer AG / AUTO1 Group SE</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / Ireland / Italy / Netherlands</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Herr. Achim Matzke / Frau Petra von Kerssenbrock / Herr Thorsten Grisse</td></tr>
<tr class="odd"><td class="leftalignment">11/24/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">0925288 / 2936921 / 2360326 / 2000019 / 2094670 / 2293819 / 2778844 / 2050832 / 2065159 / 2270726 / 2272476 / 2317087 / 2641827 / 2689560 / 2680905 / 2684703 / 2746711 / 2138158 / 2989301 / 2857817 / 2951452 / B3D7K31 / 2855930 / B7TL820 / BF311Y5 / B7VD3F2 / B95N910 / BFLR866 / BTN1Y11 / BJ1FD74 / BWTN5N1 / BFD20M9 / BJJMGL2 / BYXJQG9 / BKTNTR9 / BGSP7M9 / BZ1LFG7 / BYY88Y7 / BNTB3N8 / BD5GSZ4 / BMFPHK2 / BL6G4S4</td><td class="leftalignment">GlaxoSmithKline PLC / Walmart Inc / Gap Inc / Amazon.com Inc / Best Buy Co Inc / eBay Inc / Merck & Co Inc / Ameren Corp / Autodesk Inc / Walt Disney Co / Dollar Tree Inc / Entergy Corp / Nordstrom Inc / PG&E Corp / PPL Corp / Pfizer Inc / Ross Stores Inc / Sempra Energy / TJX Companies Inc / Netflix Inc / J M Smucker Co / Discovery Inc / Overstock.com Inc / Meta Platforms Inc / Burlington Stores Inc / Duke Energy Corp / PTC Inc / Twitter Inc / Medtronic PLC / Revolve Group Inc / ETSY Inc / Farfetch Ltd / Fox Corp / Spire Inc / ViacomCBS Inc / Zoom Video Communications Inc / Roku Inc / Alphabet Inc / Vizio Holding Corp / Infrastructure and Energy Alternatives Inc / ThredUp Inc / Poshmark Inc</td><td class="leftalignment"></td><td class="leftalignment">United Arab Emirates / Argentina / Australia / Belgium / Brazil / Canada / Switzerland / China / Cayman Islands / Germany / Egypt / Spain / France / United Kingdom / Greece / Hong Kong / India / Ireland / Iran, Islamic Republic of / Italy / Japan / Korea, Republic of / Kuwait / Mali / Malaysia / Nigeria / Netherlands / Norway / New Zealand / Poland / Russian Federation / Saudi Arabia / Singapore / Slovakia / Sweden / Thailand / Turkey / Taiwan / United States / Vietnam / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMMODITY RESEARCH / COMPANY (EQUITY) REPORTS / ECONOMIC REPORTS / FIXED INCOME/DEBT RESEARCH / FOREIGN EXCHANGE / CURRENCIES / INDUSTRY REPORTS / MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Research Digest / Investment Strategy</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">11/24/2021</td><td class="leftalignment">The Business Research Company</td><td class="leftalignment">Merck & Co., Inc. (Merck) Company Briefing (COVID 19 Update)</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Department of Research</td></tr>
<tr class="odd"><td class="leftalignment">11/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH: Increased Caution Warranted as Second Islatravir Trial Paused; Competitor GSK HIV Event Next Week</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GSK.L / 0925288 / 2778844</td><td class="leftalignment">GlaxoSmithKline PLC / GlaxoSmithKline PLC / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">11/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Model Update and raising price targets for ABBV, LLY, MRK, PFE</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK.N / ABBV=US / LLY=US / PFE.N / MRK=US / PFE=US</td><td class="leftalignment">Merck & Co Inc / Abbvie Inc / Eli Lilly and Co / Pfizer Inc / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">11/23/2021</td><td class="leftalignment">Societe Generale</td><td class="leftalignment">Merck and Co Inc. (Buy, TP=$115) - 12m target upgrade - Keep walking the walk - J. Smith (4p)</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America / Global</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Justin S. Smith / Florent Cespedes / Dinesh Choudhary</td></tr>
<tr class="even"><td class="leftalignment">11/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2681511 / 2000019 / 2023607 / 2293819 / 2778844 / 2050832 / 2026242 / 2270726 / 2317087 / 2670519 / 2415204 / 2623911 / 2684703 / 2967589 / 7103065 / 2170473 / 2857817 / B3D7K31 / 2855930 / BBPK0J0 / BZ07BW4 / BZ1LFB2 / BJ1FD74 / BWTN5N1 / BFD20M9 / BFZ1K46 / BYXJQG9 / BKTNTR9 / BYY88Y7 / BJMLSD2 / BD5GSZ4 / BM8NHS1 / BP2P6L0 / BMFPHK2 / BL6G4S4</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / PepsiCo Inc / Amazon.com Inc / Amgen Inc / eBay Inc / Merck & Co Inc / Ameren Corp / American Electric Power Company Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Hawaiian Electric Industries Inc / Neurocrine Biosciences Inc / Pfizer Inc / Williams-Sonoma Inc / Novartis AG / Constellation Brands Inc / Netflix Inc / Discovery Inc / Overstock.com Inc / Mirati Therapeutics Inc / Monster Beverage Corp / Deciphera Pharmaceuticals Inc / Revolve Group Inc / ETSY Inc / Farfetch Ltd / Spotify Technology SA / Spire Inc / ViacomCBS Inc / Alphabet Inc / Karuna Therapeutics Inc / Infrastructure and Energy Alternatives Inc / Adagio Therapeutics Inc / Tango Therapeutics Inc / ThredUp Inc / Poshmark Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck & Co Inc: Ownership Timelines & Shareholder Analytics (November 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 12, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Merck & Co (MRK US) - Reinvesting for the future</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="even"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRCG.DE - Event Transcript of Merck KGaA conference call, Nov. 22, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">0989529 / 0925288 / 2126335 / 2000019 / 2008154 / 2640147 / 2778844 / 2437071 / 2219224 / 2216850 / 2542049 / 2317087 / 2345022 / 2459020 / 2630513 / 2684703 / 2707677 / 2746711 / 2829601 / 2980906 / 2503529 / B00FWN1 / B2R3PV1 / B3D7K31 / B7TL820 / B7JYSG3 / B87ZMX0 / BFZCHN7 / BNGY4Q0 / BXDZ9Z0 / BK0VHF6 / BD9GVY0 / BFZ1K46 / BYXJQG9 / BJFSR99 / BKTNTR9 / BYQHPK7 / BYY88Y7 / BMH0MR7 / BDZ30Q0 / BMG75B4 / BN4RD42 / BMGGJK8 / BKPGJQ1 / BM8NHS1 / BNV0RN1</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Amazon.com Inc / Adobe Inc / Nike Inc / Merck & Co Inc / Biomarin Pharmaceutical Inc / CMS Energy Corp / Consolidated Edison Inc / Dominion Energy Inc / Entergy Corp / Macy's Inc / Intuit Inc / New Jersey Resources Corp / Pfizer Inc / Public Service Enterprise Group Inc / Ross Stores Inc / Southern Co / Foot Locker Inc / World Wrestling Entertainment Inc / Alnylam Pharmaceuticals Inc / American Water Works Company Inc / Discovery Inc / Meta Platforms Inc / Guidewire Software Inc / Palo Alto Networks Inc / Wix.Com Ltd / Nextera Energy Partners LP / Shopify Inc / IDEAYA Biosciences Inc / Zai Lab Ltd / Spotify Technology SA / Spire Inc / Revance Therapeutics Inc / ViacomCBS Inc / Zymeworks Inc / Alphabet Inc / Zendesk Inc / Arvinas Inc / Inventiva SA / CureVac NV / Valneva SE / Squarespace Inc / Adagio Therapeutics Inc / Portillos Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / France / United Kingdom / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback: Merck KGaA Pharma R&D Investor event</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AZN.L / MRCG.DE / GSK.L</td><td class="leftalignment">AstraZeneca PLC / Merck KGaA / GlaxoSmithKline PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Shanghai Junshi Biosciences Co., Ltd: US government's additional purchase order of Lilly's COVID cocktail therapy indicates continued demand for array of COVID therapies . Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">1877.HK / LLY.N / PFE.N / MRCG.DE / 207940.KS</td><td class="leftalignment">Shanghai Junshi Biosciences Co Ltd / Eli Lilly and Co / Pfizer Inc / Merck KGaA / Samsung Biologics Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Germany / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">11/21/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Video Call to Discuss New and Existing Treatments For Pulmonary Arterial Hypertension (PAH) on Dec. 7 at 1PM EST</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">JNJ / MRK / PFE / INSM / US38341P1021</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Insmed Inc / Gossamer Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">11/21/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Video Call to Discuss What To Expect From RSV Vaccines and Treatments In Development, December 3 at 11:00 AM EST</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">CDTX / JNJ / MRK / PFE / ARDS</td><td class="leftalignment">Cidara Therapeutics Inc / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Aridis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">11/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.6% Above Pre-Pandemic Base- Week 85</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">11/20/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck KGaA: Investor Targeting - November 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Will The Rally In Pfizer Stock Continue After A Large 21% Rise In A Month?</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / JNJ.N / MRK.N / RHHBY.PK</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Merck & Co Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/19/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">choppy waters on high profile HIV program</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - November 12 to 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">GB0007188757 / CA4509131088 / AU000000CIA2 / US8336351056 / GB0000456144 / US0311621009 / US0341641035 / US0351282068 / US0383361039 / US0394831020 / US0530151036 / US1101221083 / US1564311082 / US1924461023 / US2017231034 / US2310211063 / US3755581036 / US38059T1060 / US4227041062 / US45337C1027 / US4891701009 / US5324571083 / US64125C1099 / US6516391066 / US6703461052 / US67066G1040 / US7170811035 / US75886F1075 / US7782961038 / US7802871084 / US8581191009 / US87612E1064 / US9024941034 / US92532F1003 / US9311421039 / CA13321L1085 / CA59162N1096 / CA5394811015 / CA4296951094 / CA9611485090 / CA85472N1096 / CA90457D1006 / CA4609191032 / CA5649051078 / CA6979001089 / CA78460T1057 / CA8787422044 / CA0679011084 / US9129091081 / CA3039011026 / CA1349211054 / CA8765111064 / US0017441017 / CA3359341052 / CA09950M3003 / CA00762V1094 / US2274831047 / US35671D8570 / AU000000FMG4 / US09062X1037 / BMG169621056 / US20451N1019 / CA98462Y1007 / CA56501R1064 / CA4969024047 / CA5503721063 / CA4436281022 / US1011211018 / CA6445351068 / CA95083R1001 / CA0906971035 / US8666741041 / CA0209361009 / CA32076V1031 / CA2483561072 / GB00B1FW5029 / CA0966311064 / CA29258Y1034 / CA4369131079 / CA3499151080 / GB00B1XZS820 / CA14068G1046 / CA82835P1036 / CA3518581051 / BMG162521014 / US00507V1098 / GB00B2QPKJ12 / CA86828P1036 / US91912E1055 / US1921085049 / IE00B4BNMY34 / US58933Y1055 / CA07317Q1054 / CA00208D4084 / CA66510M2040 / CA0985461049 / JE00B4T3BW64 / US74340W1036 / US95058W1009 / CA54928Q1081 / CA00829Q1019 / AU000000EVN4 / JE00B5TT1872 / US09609G1004 / US98138H1014 / CA78165J1057 / CA55903Q1046 / CA04364G1063 / CA7852461093 / CA3449112018 / CA07380N1042 / CA3807381049 / CA0805581091 / CA9323971023 / CA16141A1030 / CA6752221037 / CA21750U1012 / CA80013R2063 / CA04016A1012 / CA11777Q2099 / CA38045Y1025 / CA6674951059 / CA04682R1073 / US16208T1025 / CA89531J1093 / GB00B11DNM70 / US29355A1079 / US8486371045 / US6974351057 / US08579W1036 / CA5054401073 / US23283R1005 / CA33812R1091 / US60468T1051 / CA46579R1047 / CA65340P1062 / US31189P1021 / US03674X1063 / US11120U1051 / CA92938W2022 / CA68827L1013 / CA30606C1086 / CA5503711080 / US29444U7000 / CA74273V1067 / CA82621K1021 / AU000000S320 / CA0115321089 / CA83179X1087 / CA83125J1049 / CA05329M1041 / US72703H1014 / CA8283631015 / CY0106002112 / CA19239C1068 / AU000000NST8 / CA17040T3001 / CA4991131083 / CA6882811046 / CA8910546032 / US5588681057 / CA31730E1016 / CA89621C1059 / US0441861046 / US15136A1025 / US0138721065 / CA68634K1066 / GB00B67KBV28 / US75134P3038 / CA86816U1066 / US93627C1018 / US7045511000 / CA75601Y1007 / CA9628791027 / CY0103562118 / CA7847301032 / CA15713J1049 / CA53680Q2071 / US68404V1008 / LU1701428291 / CA2960061091 / CA8585221051 / CA46136U1030 / US00191U1025 / US3843135084 / US76029N1063 / US08579X1019 / KYG370921069 / CA38119T8077 / CA13000C2058 / CA72765Q8829 / CA2849025093 / US63253R2013 / AU0000018236 / CA7426943006 / CA33767E2024 / CA57776F4050 / US26614N1028 / CA5625684025 / CA48086P1009 / US2681501092 / CA29446Y5020 / AU0000004772 / CA92625W5072 / FR0013467479 / CA59124U6051 / US82575P1075 / MHY0436Q1098 / CA4220961078 / CA3901437093 / CA36352H1001 / US6544051096 / US03940R1077 / CA70137W1086 / US44862P1093 / US05478C1053 / US7501021056 / CA33843T1084 / CA9004352071 / US3680361090 / CA64782A1075 / US87969B1017 / US03750L1098 / CA36261G1028 / CA65401N1078 / US11135E2037 / CA55292X1087 / AU0000143729 / US00848J1043 / US05356F1057 / CA53227W1059 / CA65532M6062 / CA00791P1071 / CA24874B1085 / GB00BL6K5J42 / CA66979W8429 / US45828L1089 / US0708301041 / US9264001028 / US98955K1043 / US89269P1030 / US9778521024 / US4718711033 / US1374041093 / 116833187</td><td class="leftalignment">Rio Tinto PLC / IAMGOLD Corp / Champion Iron Ltd / Sociedad Quimica y Minera de Chile SA / Antofagasta PLC / Amgen Inc / Andersons Inc / AngloGold Ashanti Ltd / Aptargroup Inc / Archer-Daniels-Midland Co / Automatic Data Processing Inc / Bristol-Myers Squibb Co / Century Aluminum Co / Cognizant Technology Solutions Corp / Commercial Metals Co / Cummins Inc / Gilead Sciences Inc / Gold Fields Ltd / Hecla Mining Co / Incyte Corp / Kennametal Inc / Eli Lilly and Co / Neurocrine Biosciences Inc / Newmont Corporation / Nucor Corp / NVIDIA Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Royal Gold Inc / Steel Dynamics Inc / Target Corp / Tyson Foods Inc / Vertex Pharmaceuticals Inc / Walmart Inc / Cameco Corp / Metro Inc / Loblaw Companies Ltd / High Liner Foods Inc / George Weston Ltd / Stantec Inc / Uni-Select Inc / Intertape Polymer Group Inc / Maple Leaf Foods Inc / Pan American Silver Corp / SNC-Lavalin Group Inc / Teck Resources Ltd / Barrick Gold Corp / United States Steel Corp / Fairfax Financial Holdings Ltd / Canadian Apartment Properties Real Estate Investment Trust / Taseko Mines Ltd / AMN Healthcare Services Inc / First Quantum Minerals Ltd / Boralex Inc / Aecon Group Inc / Cross Country Healthcare Inc / Freeport-McMoRan Inc / Fortescue Metals Group Ltd / Biogen Inc / Bunge Ltd / Compass Minerals International Inc / Yamana Gold Inc / Manulife Financial Corp / Kinross Gold Corp / Lundin Mining Corp / Hudbay Minerals Inc / Boston Properties Inc / New Gold Inc / Wesdome Gold Mines Ltd / Birchcliff Energy Ltd / Sun Communities Inc / Altius Minerals Corp / First Majestic Silver Corp / Denison Mines Corp / Hochschild Mining PLC / Boardwalk Real Estate Investment Trust / Endeavour Silver Corp / Home Capital Group Inc / Fortuna Silver Mines Inc / Anglo American PLC / Capstone Mining Corp / Silvercorp Metals Inc / Franco-Nevada Corp / Brookfield Infrastructure Partners LP / Activision Blizzard Inc / Fresnillo PLC / Superior Plus Corp / Vale SA / Coeur Mining Inc / Accenture PLC / Merck & Co Inc / Baytex Energy Corp / ARC Resources Ltd / Northern Dynasty Minerals Ltd / Bonterra Energy Corp / Glencore PLC / Prologis Inc / Wendys Co / Lucara Diamond Corp / Africa Oil Corp / Evolution Mining Ltd / Centamin PLC / bluebird bio Inc / Workday Inc / Rupert Resources Ltd / MAG Silver Corp / Ascot Resources Ltd / Sabina Gold & Silver Corp / Foran Mining Corp / Bear Creek Mining Corp / Gold Standard Ventures Corp / Belo Sun Mining Corp / Wallbridge Mining Company Ltd / Chartwell Retirement Residences / OceanaGold Corp / Copper Mountain Mining Corp / Sandstorm Gold Ltd / Argonaut Gold Inc / B2Gold Corp / GoGold Resources Inc / NorthWest Healthcare Properties REIT / Athabasca Oil Corp / Chatham Lodging Trust / Trevali Mining Corp / Horizonte Minerals PLC / Enphase Energy Inc / Splunk Inc / Palo Alto Networks Inc / Berry Global Group Inc / Labrador Iron Ore Royalty Corp / CyrusOne Inc / Fission Uranium Corp / Mirati Therapeutics Inc / Ivanhoe Mines Ltd / Nexgen Energy Ltd / Fate Therapeutics Inc / Antero Resources Corp / Brixmor Property Group Inc / WSP Global Inc / Osisko Gold Royalties Ltd / Falco Resources Ltd / Lundin Gold Inc / Equinix Inc / Probe Metals Inc / Sienna Senior Living Inc / South32 Ltd / Alamos Gold Inc / SmartCentres Real Estate Investment Trust / Sleep Country Canada Holdings Inc / Automotive Properties Real Estate Investment Trust / Planet Fitness Inc / Silvercrest Metals Inc / Atalaya Mining PLC / Cogeco Communications Inc / Northern Star Resources Ltd / Chorus Aviation Inc / K92 Mining Inc / Osisko Mining Inc / Torex Gold Resources Inc / Madrigal Pharmaceuticals Inc / Filo Mining Corp / Trilogy Metals Inc / Ashland Global Holdings Inc / Centennial Resource Development Inc / Alcoa Corp / Orla Mining Ltd / Central Asia Metals PLC / Ramaco Resources Inc / Superior Gold Inc / Warrior Met Coal Inc / Peabody Energy Corp / Real Matters Inc / Wheaton Precious Metals Corp / Tharisa PLC / SSR Mining Inc / CES Energy Solutions Corp / Lithium Americas Corp / OptiNose Inc / Nexa Resources SA / Ero Copper Corp / Stelco Holdings Inc / Invesque Inc / ASGN Inc / GrafTech International Ltd / Replimune Group Inc / Berry Corporation (Bry) / Galaxy Digital Holdings Ltd / Golden Star Resources Ltd / Calibre Mining Corp / Platinum Group Metals Ltd / Eldorado Gold Corp / NAK Kazatomprom AO / Nickel Mines Ltd / PRO Real Estate Investment Trust / FirstService Corp / Maverix Metals Inc / Dupont De Nemours Inc / Mandalay Resources Corp / Josemaria Resources Inc / Dynatrace Inc / Equinox Gold Corp / Adriatic Metals PLC / Victoria Gold Corp / Constellium SE / Metalla Royalty & Streaming Ltd / Sibanye Stillwater Ltd / Atlas Corp / Headwater Exploration Inc / Great Bear Resources Ltd / Galiano Gold Inc / 9 Meters Biopharma Inc / Arch Resources Inc / Parkland Corp / Hycroft Mining Holding Corporation / Azek Company Inc / Rackspace Technology Inc / Flagship Communities Real Estate Investment Trust / Turquoise Hill Resources Ltd / Gatos Silver Inc / New Pacific Metals Corp / Telos Corp / Apartment Income REIT Corp / G Mining Ventures Corp / Nickel 28 Capital Corp / Broadstone Net Lease Inc / MDA Ltd / Sunrise Energy Metals Ltd / Agiliti Inc / Aveanna Healthcare Holdings Inc / LifeWorks Inc / Nomad Royalty Company Ltd / Advantage Energy Ltd / dentalcorp Holdings Ltd / Endeavour Mining PLC / Nouveau Monde Graphite Inc / Integral Ad Science Holding Corp / Bath & Body Works Inc / Victoria's Secret & Co / Zevia PBC / Traeger Inc / Wolfspeed Inc / Jasper Therapeutics Inc / Candel Therapeutics Inc / NextSource Materials Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Chile / Cayman Islands / Cyprus / France / United Kingdom / Ireland / Kazakhstan / Luxembourg / United States / South Africa / Marshall Islands / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">11/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended November 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH: Questions Raised on MRK's Islatravir from 8507 Combination Update Likely to Improve Sentiment Around GSK's Competitive Positioning in HIV</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK.N / GSK.L / 0925288 / 2778844</td><td class="leftalignment">Merck & Co Inc / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">11/19/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - November 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">64</td><td class="leftalignment">US8336351056 / US0311621009 / US0383361039 / US1101221083 / US1270971039 / US1924461023 / US25179M1036 / US30231G1022 / US3755581036 / US4062161017 / US45337C1027 / US5324571083 / US64125C1099 / US6745991058 / US7170811035 / US7237871071 / US75281A1097 / US75886F1075 / US7782961038 / AN8068571086 / US81211K1007 / US89531P1057 / US92532F1003 / CA9611485090 / US1667641005 / US5658491064 / US20825C1045 / US09062X1037 / US42809H1077 / US58933Y1055 / US09609G1004 / US98138H1014 / US34964C1062 / US6974351057 / US08579W1036 / US60468T1051 / US03674X1063 / US2057683029 / GB00BDSFG982 / US87484T1088 / US26614N1028 / US69047Q1022 / US05478C1053 / CA33843T1084 / US62955J1034 / US1651677353 / US45828L1089 / US1374041093</td><td class="leftalignment">Sociedad Quimica y Minera de Chile SA / Amgen Inc / Aptargroup Inc / Bristol-Myers Squibb Co / Coterra Energy Inc / Cognizant Technology Solutions Corp / Devon Energy Corp / Exxon Mobil Corp / Gilead Sciences Inc / Halliburton Co / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Occidental Petroleum Corp / Pfizer Inc / Pioneer Natural Resources Co / Range Resources Corp / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Schlumberger NV / Sealed Air Corp / Trex Company Inc / Vertex Pharmaceuticals Inc / George Weston Ltd / Chevron Corp / Marathon Oil Corp / Conocophillips / Biogen Inc / Hess Corp / Merck & Co Inc / bluebird bio Inc / Workday Inc / Fortune Brands Home & Security Inc / Palo Alto Networks Inc / Berry Global Group Inc / Mirati Therapeutics Inc / Antero Resources Corp / Comstock Resources Inc / TechnipFMC PLC / Talos Energy Inc / Dupont De Nemours Inc / Ovintiv Inc / Azek Company Inc / Flagship Communities Real Estate Investment Trust / Nov Inc / Chesapeake Energy Corp / Integral Ad Science Holding Corp / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Chile / United Kingdom / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">US Healthcare Reform: Impact of Build Back Better on global branded pharma</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">4502.T / 4503.T / BMY.N / JNJ.N / LLY.N / PFE.N / RECI.MI / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / 4768.T / GSK.L / UCB.BR / AMGN.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / BIIB.OQ / IPN.PA / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Otsuka Corp / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Israel / Italy / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Herr. Christoph Gretler / Mr. Matt S. Miksic / Mr. Fumiyoshi Sakai / Mr. Tiago Fauth</td></tr>
<tr class="odd"><td class="leftalignment">11/18/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Bullish on BioPharma as We Emerge From COVID-19: Finding Alpha in the Sector That Saved the World</td><td class="leftalignment">English</td><td class="rightalignment">74</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">11/18/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">CORRECTION: Initiating at Mkt: Waiting for the Encore After Keytruda</td><td class="leftalignment">English</td><td class="rightalignment">64</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Merck to Acquire Acceleron Pharma Inc. - “Merck aspire to be the premier research-intensive biopharmaceutical company in the world”</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH / PORTFOLIO STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="even"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Merck & Co., Inc. (MRK) - Strong hopes from COVID-19 antiviral drug</td><td class="leftalignment">English</td><td class="rightalignment">47</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH / PORTFOLIO STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="odd"><td class="leftalignment">11/17/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SITC 2021 Immuno-Oncology Round-up</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">M2572210 / 58933Y10 / 09075V10 / N0104510 / 37242740 / 45781K20 / 09770210 / 82835W10 / 30315R10 / 37230320</td><td class="leftalignment">Compugen Ltd / Merck & Co Inc / BioNTech SE / Affimed NV / Genocea Biosciences Inc / Innate Pharma SA / Bolt Biotherapeutics Inc / Silverback Therapeutics Inc / F-Star Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / France / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Jeffrey La Rosa / Dilip Joseph</td></tr>
<tr class="even"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">2434209 / 2936921 / 2126335 / 2000019 / 2778844 / 2270726 / 2317087 / 2455965 / 2684703 / 2829601 / 2822019 / B1HMF22 / 2857817 / B7TL820 / B65SQW4 / B7VD3F2 / BFDV8K0 / B87ZMX0 / BDZCRX3 / B424494 / BFLR866 / BQPVQZ6 / BYVY8G0 / BYZLV46 / BZBY005 / BD8DJ71 / BGCYWN8 / BFZ1K46 / BLGJ610 / BJJMGL2 / BFNR303 / BYQHPK7 / BZ1LFG7 / BYY88Y7 / BKX9VD3 / BDVLM39 / BF3N4P3 / BMPRZV5 / BGDQ8B3 / 021513106 / BMDJ397 / BMZ9Z11 / BNGJQZ8 / BP96C52</td><td class="leftalignment">Home Depot Inc / Walmart Inc / Bristol-Myers Squibb Co / Amazon.com Inc / Merck & Co Inc / Walt Disney Co / Entergy Corp / Biogen Inc / Pfizer Inc / Southern Co / Advance Auto Parts Inc / First Solar Inc / Netflix Inc / Meta Platforms Inc / Enphase Energy Inc / Duke Energy Corp / MacroGenics Inc / Palo Alto Networks Inc / RingCentral Inc / Splunk Inc / Twitter Inc / Horizon Therapeutics PLC / Alphabet Inc / InflaRx NV / Merus NV / Snap Inc / Xencor Inc / Spotify Technology SA / Warner Music Group Corp / Fox Corp / Northwest Natural Holding Co / Zymeworks Inc / Roku Inc / Alphabet Inc / Arcutis Biotherapeutics Inc / argenx SE / Arena Pharmaceuticals Inc / Kymera Therapeutics Inc / Axonics Inc / Alto Ingredients Inc / Bolt Biotherapeutics Inc / Prometheus Biosciences Inc / Porch Group Inc / Surrozen Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Grab Your mAb - Assuming Coverage of Three Innovative Antibody Platforms: We Are BUY on MGNX ($30 PT) and MRUS ($44 PT); NEUTRAL on ZYME</td><td class="leftalignment">English</td><td class="rightalignment">86</td><td class="leftalignment">BFDV8K0 / BZBY005 / ZYME.N / 2778844 / 2457864 / BGCYWN8 / BYQHPK7 / BYYWPW6</td><td class="leftalignment">MacroGenics Inc / Merus NV / Zymeworks Inc / Merck & Co Inc / ImmunoGen Inc / Xencor Inc / Zymeworks Inc / Beigene Ltd</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Paul Jeng, Ph.D. / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MEDX.S: medmix - Feedback from Credit Suisse Equity Forum Switzerland 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MEDX.S / MRCG.DE</td><td class="leftalignment">Medmix Ltd / Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany</td><td class="leftalignment">Conglomerates / Manufacturing</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr. Christoph Gretler / Herr Patrick Laager</td></tr>
<tr class="odd"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HOLT Healthcare: AstraZeneca- Most attractive valuation in HOLT in 5-years</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AZN.L / BMY.N / JNJ.N / LLY.N / PFE.N / SASY.PA / NOVOB.CO / MRCG.DE / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Sanofi SA / Novo Nordisk A/S / Merck KGaA / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Sophia Graeff Buhl-Nielsen / HOLT Europe / Emilie Fung</td></tr>
<tr class="even"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Movers & Shakers: Our Thoughts on Potential Upcoming Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">87</td><td class="leftalignment">GRAY / JNJ / MRK / INSM / CKPT / BSLN / AYTU / EYPT / EOLS / OSMT / EFTR</td><td class="leftalignment">Graybug Vision Inc / Johnson & Johnson / Merck & Co Inc / Insmed Inc / Checkpoint Therapeutics Inc / Basilea Pharmaceutica AG / Aytu Biopharma Inc / EyePoint Pharmaceuticals Inc / Evolus Inc / Osmotica Pharmaceuticals PLC / eFFECTOR Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BOLT - BUY - Competitor Setbacks Set Stage For BOLT Update at ESMO-IO (12/8-11)</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BMDJ397 / 2126335 / 2778844</td><td class="leftalignment">Bolt Biotherapeutics Inc / Bristol-Myers Squibb Co / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D. / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Will Johnson & Johnson Stock See Higher Levels After Its Split Announcement?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Litchfield Hills Research, LLC</td><td class="leftalignment">Patient centric drug development co. POAI reports 3Q21 - Reiterate Buy and $5 PT</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">POAI.OQ / 4502.T / MRK.N / PFE.N / SNY.N / AZN.L / AZN.N / ROG.S / SYK.N / GSK.L / GSK.N / DXR.A / QBIO.PK / MYGN.OQ / BAYGN.DE / ZBH.N / CODX.OQ / DE000BAY0199 / ANPC.OQ</td><td class="leftalignment">Predictive Oncology Inc / Takeda Pharmaceutical Co Ltd / Merck & Co Inc / Pfizer Inc / Sanofi SA / AstraZeneca PLC / AstraZeneca PLC / Roche Holding AG / Stryker Corp / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Daxor Corp / Q BioMed Inc / Myriad Genetics Inc / Bayer AG / Zimmer Biomet Holdings Inc / Co-Diagnostics Inc / Bayer AG / AnPac Bio-Medical Science Co Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Japan / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS / SMALL CAPITAL / GROWTH</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Theodore R. O'Neill</td></tr>
<tr class="even"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2360326 / 2126335 / 2516152 / 2778844 / 2050832 / 2270726 / 2542049 / 2317087 / 2328915 / 2345022 / 2100920 / 2630513 / 2657802 / 2689560 / 2684703 / 2707677 / 2825933 / 7103065 / B00FWN1 / 2822019 / 2857817 / B3D7K31 / 2390817 / B65LWX6 / B7TL820 / B7VD3F2 / BCZS820 / BVVN4Q8 / BTF8CF0 / BYZLV46 / BK0VHF6 / BD8DJ71 / BL2HYY7 / BFZ1K46 / BMYML02 / BLGJ610 / BJJMGL2 / BYXJQG9 / BKTNTR9 / BJ9NFQ3 / BYY88Y7 / BDRW1L7 / BNGJQZ8 / BMHR7K6 / BNNTQY0 / BL98755 / BL53KF5 / BP0TJN7 / BPH0546 / BMV6Y64</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Gap Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Ameren Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Nextera Energy Inc / Macy's Inc / FirstEnergy Corp / New Jersey Resources Corp / OGE Energy Corp / PG&E Corp / Pfizer Inc / Public Service Enterprise Group Inc / South Jersey Industries Inc / Novartis AG / Alnylam Pharmaceuticals Inc / Advance Auto Parts Inc / Netflix Inc / Discovery Inc / Gray Television Inc / O'Reilly Automotive Inc / Meta Platforms Inc / Duke Energy Corp / Fate Therapeutics Inc / Eversource Energy / Restaurant Brands International Inc / InflaRx NV / IDEAYA Biosciences Inc / Snap Inc / Casper Sleep Inc / Spotify Technology SA / DraftKings Inc / Warner Music Group Corp / Fox Corp / Spire Inc / ViacomCBS Inc / Neoleukin Therapeutics Inc / Alphabet Inc / AnaptysBio Inc / Porch Group Inc / Impel Neuropharma Inc / Oatly Group AB / Beachbody Company Inc / F45 Training Holdings Inc / Xponential Fitness Inc / Life Time Group Holdings Inc / Xilio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / Luxembourg / Netherlands / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Next-Gen Interleukin Primer - Cranking Up the Thermostat as Winter Weather Approaches</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">5671735 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2457864 / 2471950 / 2730190 / 7103065 / 2982924 / B6RS2B3 / BCZS820 / BFDV8K0 / BBPK0J0 / B7F2TY6 / BFZNYB7 / BK0VHF6 / BDHF4K6 / BZBY005 / BZ1LFB2 / BKS3SM8 / BMQ5T49 / BGCYWN8 / BWFKZT2 / BKVDFF7 / BG31GH0 / BJXBP30 / BYQHPK7 / BYYWPW6 / BJ9NFQ3 / BWY52P3 / BL71K91 / BDZ30Q0 / BWY4XV3 / BN2R582 / BDD1B07 / BMPRZV5 / BMC5RV6 / BF3NP05 / BMDJ397 / BN2RM92 / BLF0CW7 / BP7KZP7 / BMW5084 / BNLYJ60 / BNLYBF3 / BMVBZF5 / BP2P6L0 / BMV6Y64</td><td class="leftalignment">Sanofi SA / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / ImmunoGen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Novartis AG / Spectrum Pharmaceuticals Inc / Clovis Oncology Inc / Fate Therapeutics Inc / MacroGenics Inc / Mirati Therapeutics Inc / Puma Biotechnology Inc / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / CRISPR Therapeutics AG / Merus NV / Deciphera Pharmaceuticals Inc / IGM Biosciences Inc / Zentalis Pharmaceuticals Inc / Xencor Inc / Cellectis SA / Oric Pharmaceuticals Inc / Y-mAbs Therapeutics Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Beigene Ltd / Neoleukin Therapeutics Inc / Blueprint Medicines Corp / Revolution Medicines Inc / Arvinas Inc / Adaptimmune Therapeutics PLC / Relay Therapeutics Inc / Rubius Therapeutics Inc / Kymera Therapeutics Inc / Adicet Bio Inc / Mersana Therapeutics Inc / Bolt Biotherapeutics Inc / Rain Therapeutics Inc / Repare Therapeutics Inc / Monte Rosa Therapeutics Inc / PMV Pharmaceuticals Inc / Imago BioSciences Inc / Erasca Inc / Immuneering Corp / Tango Therapeutics Inc / Xilio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Paul Jeng, Ph.D. / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ALM.MC: Almirall - 3Q21 - Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">ALM.MC / LLY.N / RECI.MI / AZN.L / LUN.CO / MRCG.DE / LONN.S / UCB.BR / IPN.PA / ORNBV.HE / GRLS.MC / VIFN.S / GMAB.CO</td><td class="leftalignment">Almirall SA / Eli Lilly and Co / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Ipsen SA / Orion Oyj / Grifols SA / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Italy / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Elizabeth Walton / Mr. Dominic Lunn / Harry Thomas Da Sephton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 5, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">cracking the code on ORAL PCSK9</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">U.S. Elective Surgery</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">ABMD=US / MRK=US / PFE=US / INSP=US / SYK=US / DHR=US / CNMD=US / EW=US / INMD=US / ISRG=US / NVST=US / RGEN=US / ALGN=US / AVTR=US / BIO=US / DXCM=US / PODD=US / TNDM=US / PCRX=US / GMED=US / CTLT=US / PEN=US / PGNY=US</td><td class="leftalignment">ABIOMED Inc / Merck & Co Inc / Pfizer Inc / Inspire Medical Systems Inc / Stryker Corp / Danaher Corp / Conmed Corp / Edwards Lifesciences Corp / Inmode Ltd / Intuitive Surgical Inc / Envista Holdings Corp / Repligen Corp / Align Technology Inc / Avantor Inc / Bio Rad Laboratories Inc / Dexcom Inc / Insulet Corp / Tandem Diabetes Care Inc / Pacira Biosciences Inc / Globus Medical Inc / Catalent Inc / Penumbra Inc / Progyny Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Industrial Materials</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment">INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Bhavya Joshi / Mr. Rajan Gupta</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Here's Why Roche Stock May Continue To Trend Higher</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">RHHBY.PK / JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Roche Holding AG / Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Drug Pricing Reform Proposal: Is This The Long-Awaited Clearing Event?</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Merck: Attractive setup for continued outperformance in 2022</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">CREDIT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Falko Friedrichs / Herr Jan Koch / Sachin Gadilingappa</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck KGaA: Peer Group Analytics - Q3 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">11/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.9% Above Pre-Pandemic Base- Week 84</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">11/13/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck KGaA: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">11/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended November 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">11/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Starting in 30 MINS: 10:00 am ET, We're Talking PAH Market, Merck/Acceleron, and $5B+ Opportunity for New Treatments</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N / 5671735 / 0989529 / 2023607 / 2778844 / 2730190 / 7103065 / BHC8X90 / BNKGXX2</td><td class="leftalignment">Merck & Co Inc / Sanofi SA / AstraZeneca PLC / Amgen Inc / Merck & Co Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Novo Nordisk A/S / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Debjit Chattopadhyay, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">11/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK=US / BMY=US / HD=US / AMZN=US / T=US / AMT=US / PEB=US / H=US / LOW=US / ENR=US / VRM=US / EXPE=US / LEG=US / W=US / FLO=US / ARRY=US / BLL=US / CCK=US / DRH=US / EPC=US / SAFE=US / MAPS=US / MHK=US / HOOK=US / SFT=US / SNAP=US / TRIP=US / WIX=US / PSA=US / CGEN=US / BKNG=US / FB=US / KRT=US / MTCH=US / WRE=US / AUTL=US / OGN / PTON=US / STRO=US / BIIB=US / TPX=US / APP=US / SHO=US / HST=US / PGTI=US / PRPL=US / WH=US / UTZ=US / INSE / CLDT=US / NXPI=US / RLJ=US / FBHS=US / ANGI=US / RHP=US / GOOGL=US / 00770K202 / BABA=US / CMPR=US / RLMD=US / GDDY=US / SQ=US / PK=US / GDS=US / CVNA=US / IOVA=US / SFIX=US / ROOT=US / FTDR=US / SITC=US / LYFT=US / UBER=US / TCRR=US / XAIR=US / GMAB=US / NGMS=US / HYFM=US / PRVA=US / VMEO=US / MNTV=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Home Depot Inc / Amazon.com Inc / AT&T Inc / American Tower Corp / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Lowe's Companies Inc / Energizer Holdings Inc / Vroom Inc / Expedia Group Inc / Leggett & Platt Inc / Wayfair Inc / Flowers Foods Inc / Array Technologies Inc / Ball Corp / Crown Holdings Inc / Diamondrock Hospitality Co / Edgewell Personal Care Co / Safehold Inc / WM Technology Inc / Mohawk Industries Inc / HOOKIPA Pharma Inc / Shift Technologies Inc / Snap Inc / Tripadvisor Inc / Wix.Com Ltd / Public Storage / Compugen Ltd / Booking Holdings Inc / Meta Platforms Inc / Karat Packaging Inc / Match Group Inc / Washington Real Estate Investment Trust / Autolus Therapeutics PLC / Organon & Co / Peloton Interactive Inc / Sutro Biopharma Inc / Biogen Inc / Tempur Sealy International Inc / Applovin Corp / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / PGT Innovations Inc / Purple Innovation Inc / Wyndham Hotels & Resorts Inc / UTZ Brands Inc / Inspired Entertainment Inc / Chatham Lodging Trust / NXP Semiconductors NV / RLJ Lodging Trust / Fortune Brands Home & Security Inc / Angi Inc / Ryman Hospitality Properties Inc / Alphabet Inc / Aemetis Inc / Alibaba Group Holding Ltd / Cimpress PLC / Relmada Therapeutics Inc / GoDaddy Inc / Block Inc / Park Hotels & Resorts Inc / GDS Holdings Ltd / Carvana Co / Iovance Biotherapeutics Inc / Stitch Fix Inc / Root Inc / Frontdoor Inc / Site Centers Corp / Lyft Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / Beyond Air Inc / Genmab A/S / NeoGames SA / Hydrofarm Holdings Group Inc / Privia Health Group Inc / Vimeo Inc / Momentive Global Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Denmark / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Top Of The Charts - A review of the week's best reads</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">ABF.L / ITV.L / JMAT.L / KSP.I / MKS.L / PSON.L / RWEG.F / SAPJ.J / SWMA.ST / TEF.MC / TUPRS.IS / ADML.L / SIEGN.DE / MRCG.DE / LONN.S / BANB.S / FLS.CO / HAYS.L / BCVN.S / COLOB.CO / TECN.S / UMI.BR / SUN.S / LEHN.S / ASOS.L / LXSG.DE / CGCBV.HE / ETL.PA / BCHN.S / KCOGN.DE / SIKA.S / GXIG.DE / FXPO.L / CLTN.S / DLGD.L / MOLN.S / AUTOA.L / KCRA.HE / JUSTJ.L / SGREN.MC / MEDA.S / SOKM.IS / SFOR.L / ADEA.OL / GMAB.CO / STEMS.L / HUGEP.WA / UMG.AS / MEDX.S</td><td class="leftalignment">Associated British Foods PLC / ITV PLC / Johnson Matthey PLC / Kingspan Group PLC / Marks and Spencer Group PLC / Pearson PLC / Rwe AG / Sappi Ltd / Swedish Match AB / Telefonica SA / Turkiye Petrol Rafinerileri AS / Admiral Group PLC / Siemens AG / Merck KGaA / Lonza Group AG / Bachem Holding AG / FLSmidth & Co A/S / Hays PLC / Banque Cantonale Vaudoise / Coloplast A/S / Tecan Group AG / Umicore SA / Sulzer AG / Lem Holding SA / ASOS PLC / Lanxess AG / Cargotec Corp / Eutelsat Communications SA / Burckhardt Compression Holding AG / Kloeckner & Co SE / Sika AG / Gerresheimer AG / Ferrexpo PLC / Coltene Holding AG / Direct Line Insurance Group PLC / Molecular Partners AG / Auto Trader Group PLC / Konecranes Abp / Just Group PLC / Siemens Gamesa Renewable Energy SA / Medartis Holding AG / Sok Marketler Ticaret AS / S4 Capital PLC / Adevinta ASA / Genmab A/S / SThree PLC / Huuuge Inc / Universal Music Group NV / Medmix Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Netherlands / Norway / Poland / Sweden / Turkey / United States / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Joelle Anamooto Natzkoff / Mr. Richard A. Kersley / Hafsa Yasir</td></tr>
<tr class="odd"><td class="leftalignment">11/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRCG.DE: Merck KGaA - 3Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">MRCG.DE / 4063.T / 4185.T / A.N / BDX.N / LLY.N / RECI.MI / STDM.PA / TMO.N / WAT.N / DHR.N / LUN.CO / GLW.N / MTD.N / LONN.S / PKI.N / UCB.BR / TECH.OQ / CCMP.OQ / ENTG.OQ / IPN.PA / ORNBV.HE / QGEN.N / ALM.MC / WAFGN.DE / GMAB.CO</td><td class="leftalignment">Merck KGaA / Shin-Etsu Chemical Co Ltd / JSR Corp / Agilent Technologies Inc / Becton Dickinson and Co / Eli Lilly and Co / Recordati Industria Chimica e Farmaceutica SpA / Sartorius Stedim Biotech SA / Thermo Fisher Scientific Inc / Waters Corp / Danaher Corp / H Lundbeck A/S / Corning Inc / Mettler-Toledo International Inc / Lonza Group AG / PerkinElmer Inc / Ucb SA / Bio-Techne Corp / CMC Materials Inc / Entegris Inc / Ipsen SA / Orion Oyj / Qiagen NV / Almirall SA / Siltronic AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/12/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck KGaA : Strong growth set to continue in 2022, raising PT to €245</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Richard B. Vosser / James D. Gordon / Ms. Laerke Engkilde / Zain Ebrahim</td></tr>
<tr class="odd"><td class="leftalignment">11/12/2021</td><td class="leftalignment">HSBC</td><td class="leftalignment">Merck KGaA (MRK GR):-Hold: Stellar Life Sciences growth, but 2022 comps will be tougher</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRCG.F</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">COMPANY / COMPANY REPORT / ESTIMATE CHANGES / FORECASTS / EQUITY / REPORTING RESULTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Stephen McGarry / Ms. Julie Mead</td></tr>
<tr class="even"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Merck Group</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE / OPERATING RESULTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="odd"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Kepler Cheuvreux</td><td class="leftalignment">Merck KGAA | AO | Buy | Guidance raise from a range of sources, more core than Covid</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David P. Evans</td></tr>
<tr class="even"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Earnings Recap: Updating Our Model, All Eyes On STRO-002 Update</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">STRO=US / MRK=US / BMY=US</td><td class="leftalignment">Sutro Biopharma Inc / Merck & Co Inc / Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene / Billal Jahangiri</td></tr>
<tr class="odd"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRCG.DE - Event Transcript of Merck KGaA conference call, Nov. 11, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Merck: 3Q first take: in line with strong prerelease; guidance raise confirmed</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Falko Friedrichs / Herr Jan Koch / Sachin Gadilingappa</td></tr>
<tr class="odd"><td class="leftalignment">11/11/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck KGaA : 3Q'21 1st Take: FY'21 guidance raise mainly driven by better underlying performance in Life Science and Healthcare</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Richard B. Vosser / James D. Gordon / Ms. Laerke Engkilde / Zain Ebrahim / Mr. Tycho W. Peterson</td></tr>
<tr class="even"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / LLY=US / LSI=US / AMGN=US / BMY=US / DIS=US / MCD=US / WEN=US / PLD=US / BLDP=US / AMZN=US / GILD=US / PEB=US / REI=US / PLUG=US / H=US / V=US / MTN=US / ENR=US / VRM=US / MAR=US / TNL=US / HLT=US / AKR=US / HUM=US / EQR=US / AMK=US / SWIM=US / CBRL=US / CHH=US / DRI=US / DRH=US / MAIN=US / NTST=US / PDM=US / SGMO=US / SHOP=US / FORG=US / VRTX=US / WIX=US / FOUR=US / AEL=US / GPN=US / HIW=US / SNV=US / ADC=US / FRT=US / INTA=US / OHI=US / SRC=US / REG=US / ENSG=US / BRX=US / DIN=US / ACVA=US / MQ / CRD.B=US / APP=US / SHO=US / PLAY=US / DENN=US / ESMT=US / SCPL=US / CMG=US / HST=US / MA=US / RPRX=US / GPRE=US / OC=US / CPRX=US / TAST=US / QSR=US / LUMN=US / WH=US / JACK=US / UTZ=US / BLND=US / HGV=US / SBRA=US / APTS=US / RLJ=US / VAC=US / ZNGA=US / SPLK=US / MEIP=US / RHP=US / NDLS=US / VRNS=US / 00770K202 / LOCO=US / AFMD=US / BVH=US / SHAK=US / CHCT=US / WING=US / MCFT=US / SQ=US / WVE=US / PK=US / PLYA=US / OKTA=US / ROOT=US / BTAI=US / AMTB=US / LSPD=US / ARQT=US / TSHA / DASH=US / AFRM=US / SHLS=US / HLLY=US / OLPX=US / GTLB=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Life Storage Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / McDonald's Corp / Wendys Co / Prologis Inc / Ballard Power Systems Inc / Amazon.com Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / Ring Energy Inc / Plug Power Inc / Hyatt Hotels Corp / Visa Inc / Vail Resorts Inc / Energizer Holdings Inc / Vroom Inc / Marriott International Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Acadia Realty Trust / Humana Inc / Equity Residential / AssetMark Financial Holdings Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Choice Hotels International Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Main Street Capital Corp / Netstreit Corp / Piedmont Office Realty Trust Inc / Sangamo Therapeutics Inc / Shopify Inc / ForgeRock Inc / Vertex Pharmaceuticals Inc / Wix.Com Ltd / Shift4 Payments Inc / American Equity Investment Life Holding Co / Global Payments Inc / Highwoods Properties Inc / Synovus Financial Corp / Agree Realty Corp / Federal Realty Investment Trust / Intapp Inc / Omega Healthcare Investors Inc / Spirit Realty Capital Inc / Regency Centers Corp / Ensign Group Inc / Brixmor Property Group Inc / Dine Brands Global Inc / ACV Auctions Inc / Marqeta Inc / Crawford & Co / Applovin Corp / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / EngageSmart Inc / Sciplay Corp / Chipotle Mexican Grill Inc / Host Hotels & Resorts Inc / Mastercard Inc / Royalty Pharma PLC / Green Plains Inc / Owens Corning / Catalyst Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Lumen Technologies Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / UTZ Brands Inc / Blend Labs Inc / Hilton Grand Vacations Inc / Sabra Health Care REIT Inc / Preferred Apartment Communities Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Zynga Inc / Splunk Inc / MEI Pharma Inc / Ryman Hospitality Properties Inc / Noodles & Co / Varonis Systems Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Affimed NV / Bluegreen Vacations Holding Corp / Shake Shack Inc / Community Healthcare Trust Inc / Wingstop Inc / Mastercraft Boat Holdings Inc / Block Inc / WAVE Life Sciences Ltd / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Okta Inc / Root Inc / BioXcel Therapeutics Inc / Amerant Bancorp Inc / Lightspeed Commerce Inc / Arcutis Biotherapeutics Inc / Taysha Gene Therapies Inc / DoorDash Inc / Affirm Holdings Inc / Shoals Technologies Group Inc / Holley Inc / Olaplex Holdings Inc / GitLab Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / Netherlands / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">4031976 / 0989529 / 2516152 / 2000019 / 2023607 / 2640147 / 2778844 / 2222631 / 2270726 / 2542049 / 2684703 / 4595739 / 2857817 / 2982924 / B7TL820 / BCZS820 / BBPK0J0 / BDZCRX3 / BFLR866 / BFZCHN7 / BYVYD43 / BF4VBS8 / BFZNYB7 / BDHF4K6 / BJXBP41 / BMQ5T49 / BYY88Y7 / BL71K91 / BYP71H7 / BRJ3GY4 / BN2R582 / BYQCZ35 / BMPRZV5 / BMC5RV6 / BFY7DC4 / BNTB3N8 / BMFPJK6 / BN2RM92 / BMGGJK8 / BMF1LH5 / BMXXBD9 / BLF0CW7 / BP7KZP7 / BNLYJ60 / BNLYBF3 / BMDTR28</td><td class="leftalignment">Adidas AG / AstraZeneca PLC / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Nike Inc / Merck & Co Inc / Cooper Companies Inc / Walt Disney Co / Dominion Energy Inc / Pfizer Inc / Genmab A/S / Netflix Inc / Spectrum Pharmaceuticals Inc / Meta Platforms Inc / Fate Therapeutics Inc / Mirati Therapeutics Inc / RingCentral Inc / Twitter Inc / Wix.Com Ltd / Performance Food Group Co / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Alcon AG / Zentalis Pharmaceuticals Inc / Alphabet Inc / Revolution Medicines Inc / National Vision Holdings Inc / Xenon Pharmaceuticals Inc / Relay Therapeutics Inc / Madison Square Garden Sports Corp / Kymera Therapeutics Inc / Adicet Bio Inc / Altimmune Inc / Vizio Holding Corp / ACV Auctions Inc / Rain Therapeutics Inc / Valneva SE / Honest Company Inc / Figs Inc / Repare Therapeutics Inc / Monte Rosa Therapeutics Inc / Imago BioSciences Inc / Erasca Inc / First Watch Restaurant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRCG.DE: Merck KGaA - 3Q21 Initial Diagnosis</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRCG.DE / LLY.N / GSK.L</td><td class="leftalignment">Merck KGaA / Eli Lilly and Co / GlaxoSmithKline PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">LUN.CO: Lundbeck - 3Q21 - Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">LUN.CO / 4502.T / RECI.MI / ROG.S / MRCG.DE / LONN.S / UCB.BR / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / VIFN.S / GMAB.CO</td><td class="leftalignment">H Lundbeck A/S / Takeda Pharmaceutical Co Ltd / Recordati Industria Chimica e Farmaceutica SpA / Roche Holding AG / Merck KGaA / Lonza Group AG / Ucb SA / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy / Japan</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Elizabeth Walton / Mr. Dominic Lunn / Harry Thomas Da Sephton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MEDX.S: Medmix - Mixing growth and repositioning opportunities: initiate at Outperform</td><td class="leftalignment">English</td><td class="rightalignment">62</td><td class="leftalignment">MEDX.S / ABT.N / BDX.N / EL.N / LLY.N / LVMH.PA / MDT.N / OREP.PA / PG.N / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / MMM.N / MRCG.DE / WST.N / GSK.L / ATR.N / UCB.BR / AMGN.OQ / NDSN.OQ / PDCO.OQ / XRAY.OQ / HSIC.OQ / SUN.S / FIN.S / DAE.S / YPSN.S / GXIG.DE / CLTN.S / ABBV.N / COTY.N / SFSN.S / SENSI.S / AVTR.N / NVST.N</td><td class="leftalignment">Medmix Ltd / Abbott Laboratories / Becton Dickinson and Co / Estee Lauder Companies Inc / Eli Lilly and Co / LVMH Moet Hennessy Louis Vuitton SE / Medtronic PLC / L'Oreal SA / Procter & Gamble Co / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / 3M Co / Merck KGaA / West Pharmaceutical Services Inc / GlaxoSmithKline PLC / Aptargroup Inc / Ucb SA / Amgen Inc / Nordson Corp / Patterson Companies Inc / DENTSPLY SIRONA Inc / Henry Schein Inc / Sulzer AG / Georg Fischer AG / Daetwyler Holding AG / Ypsomed Holding AG / Gerresheimer AG / Coltene Holding AG / Abbvie Inc / Coty Inc / SFS Group AG / Sensirion Holding AG / Avantor Inc / Envista Holdings Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Conglomerates / Manufacturing</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr. Christoph Gretler / Herr Patrick Laager</td></tr>
<tr class="odd"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HCM: HUTCHMED (China) Limited - Three targeted oncology drugs present bright globalisation prospect; initiate with OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">0013.HK / HCM.OQ / 1093.HK / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / 1177.HK / MRCG.DE / NVS.N / AMGN.OQ / INCY.OQ / RIGL.OQ / RO.S / BSLN.S / 600276.SS / 4568.T / 002422.SZ / ABBV.N / EPZM.OQ / BGNE.OQ / TPB.N / 300558.SZ / 6160.HK / 1801.HK / IMAB.OQ</td><td class="leftalignment">HUTCHMED (China) Ltd / HUTCHMED (China) Ltd / CSPC Pharmaceutical Group Ltd / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Sino Biopharmaceutical Ltd / Merck KGaA / Novartis AG / Amgen Inc / Incyte Corp / Rigel Pharmaceuticals Inc / Roche Holding AG / Basilea Pharmaceutica AG / Jiangsu Hengrui Pharmaceuticals Co Ltd / Daiichi Sankyo Co Ltd / Sichuan Kelun Pharmaceutical Co Ltd / Abbvie Inc / Epizyme Inc / Beigene Ltd / Turning Point Brands Inc / Betta Pharmaceuticals Co Ltd / Beigene Ltd / Innovent Biologics Inc / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / France / United Kingdom / Hong Kong / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">11/10/2021</td><td class="leftalignment">MarketGrader</td><td class="leftalignment">MarketGrader Research Report on Merck KGaA</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Common threads from investor feedback on Treg competitive landscape</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN=US / LLY=US / MRK=US / BMY=US / GILD=US / SGMO=US</td><td class="leftalignment">Amgen Inc / Eli Lilly and Co / Merck & Co Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Sangamo Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Nicole Germino / Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">11/10/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SITC clinical abstract takeaways for BNTX, CGEN, MRK, and NKTR</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N / 22UAy.DE / CGEN.TA / NKTR.OQ / M2572210 / 640268108 / 58933Y10 / 09075V10 / 30315R10 / 37230320</td><td class="leftalignment">Merck & Co Inc / BioNTech SE / Compugen Ltd / Nektar Therapeutics / Compugen Ltd / Nektar Therapeutics / Merck & Co Inc / BioNTech SE / F-Star Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / France / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="odd"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">MRK=US / BSX=US / LLY=US / BMY=US / OXY=US / AMD=US / RRC=US / IP=US / MDT=US / DVN=US / INCY=US / GILD=US / NVDA=US / APA=US / CPE=US / EOG=US / REI=US / PLUG=US / CRM=US / XOM=US / CRK=US / WLL=US / PXD=US / IGT=US / MGY=US / SWN=US / SCOR=US / MUR=US / MRO=US / ESS=US / CLI=US / DV=US / AVGO=US / BLL=US / BNL=US / ENV=US / ELY=US / CTRA=US / CNX=US / CCK=US / EQT=US / GPOR=US / DOC=US / HOOK=US / REGI=US / TRIP=US / TGI=US / CVX=US / CGEN=US / SGMS=US / BDN=US / OFC=US / CUZ=US / PRI=US / DCP=US / EGP=US / FR=US / JAZZ=US / KIM=US / NHI=US / PRA=US / DRE=US / NLS=US / COP=US / MRNS=US / PTON=US / MMP=US / BIIB=US / RNG=US / APTX=US / NUVA=US / EXR=US / WRK=US / CLR=US / PRPL=US / SEAS=US / TIL=US / NOG=US / RCUS=US / HTA=US / OLO=US / AR=US / OAS=US / HGV=US / ESTE=US / CUBE=US / MTDR=US / PDCE=US / FANG=US / MODN=US / CNCE=US / VNOM=US / CIVI=US / OSH=US / VCEL=US / GSBD=US / NSA=US / EVBG=US / CDEV=US / VRNA=US / SBOW=US / IOVA=US / CARG=US / SAIL=US / COLD=US / FSK=US / RPAY=US / GMAB=US / GOCO=US / PNTG=US / OVV=US / CRMD.US / AZYO=US / ABNB=US / DASH=US / SHLS=US / ROCC=US / DHT.UN=CA / REPX=US / MNTV=US / DNUT=US / PYCR=US / PKG=U / 00152K101</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Bristol-Myers Squibb Co / Occidental Petroleum Corp / Advanced Micro Devices Inc / Range Resources Corp / International Paper Co / Medtronic PLC / Devon Energy Corp / Incyte Corp / Gilead Sciences Inc / NVIDIA Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Plug Power Inc / Salesforce.Com Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / International Game Technology PLC / Magnolia Oil & Gas Corp / Southwestern Energy Co / Comscore Inc / Murphy Oil Corp / Marathon Oil Corp / Essex Property Trust Inc / Veris Residential Inc / DoubleVerify Holdings Inc / Broadcom Inc / Ball Corp / Bunzl plc / Envestnet Inc / Callaway Golf Co / Coterra Energy Inc / CNX Resources Corp / Crown Holdings Inc / EQT Corp / Gulfport Energy Corp / Physicians Realty Trust / HOOKIPA Pharma Inc / Renewable Energy Group Inc / Tripadvisor Inc / Triumph Group Inc / Chevron Corp / Compugen Ltd / Scientific Games Corp / Brandywine Realty Trust / Corporate Office Properties Trust / Cousins Properties Inc / Primerica Inc / DCP Midstream LP / Eastgroup Properties Inc / First Industrial Realty Trust Inc / Jazz Pharmaceuticals PLC / Kimco Realty Corp / National Health Investors Inc / ProAssurance Corp / Duke Realty Corp / Nautilus Inc / Conocophillips / Marinus Pharmaceuticals Inc / Peloton Interactive Inc / Magellan Midstream Partners LP / Biogen Inc / RingCentral Inc / Aptinyx Inc / NuVasive Inc / Extra Space Storage Inc / Westrock Co / Continental Resources Inc / Purple Innovation Inc / SeaWorld Entertainment Inc / Instil Bio Inc / Northern Oil and Gas Inc / Arcus Biosciences Inc / Healthcare Trust Of America Inc / Olo Inc / Antero Resources Corp / Oasis Petroleum Inc / Hilton Grand Vacations Inc / Earthstone Energy Inc / CubeSmart / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Model N Inc / Concert Pharmaceuticals Inc / Viper Energy Partners LP / Civitas Resources Inc / Oak Street Health Inc / Vericel Corp / Goldman Sachs BDC Inc / National Storage Affiliates Trust / Everbridge Inc / Centennial Resource Development Inc / Verona Pharma PLC / SilverBow Resources Inc / Iovance Biotherapeutics Inc / CarGurus Inc / SailPoint Technologies Holdings Inc / Americold Realty Trust / FS KKR Capital Corp / Repay Holdings Corp / Genmab A/S / Gohealth Inc / Pennant Group Inc / Ovintiv Inc / CorMedix Inc / Aziyo Biologics Inc / Airbnb Inc / DoorDash Inc / Shoals Technologies Group Inc / Ranger Oil Corp / Dri Healthcare Trust / Riley Exploration Permian Inc / Momentive Global Inc / Krispy Kreme Inc / Paycor HCM Inc / Packaging Corp of America / AKA Brands Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / United Kingdom / Ireland / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ORNBV.HE: Orion - Increasing Nubeqa on Bayer read-across</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BAYGn.DE / ORNBV.HE / RECI.MI / LUN.CO / MRCG.DE / LONN.S / UCB.BR / IPN.PA / ALM.MC / GRLS.MC / GMAB.CO</td><td class="leftalignment">Bayer AG / Orion Oyj / Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Ipsen SA / Almirall SA / Grifols SA / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck KGaA: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">RAIN - BUY - R&D Day Takeaways; Prioritizing Bigger Merkel Cell Carcinoma (MCC) Opp'ty with MDM2 Inhibitor over Niche Intimal Sarcoma</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BN2RM92 / 2778844 / 2684703</td><td class="leftalignment">Rain Therapeutics Inc / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRNA-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRNA.O / JNJ / MRK / NVS / ALNY.O / ARWR.O / ATHX.O / RGLS.O / MON.O</td><td class="leftalignment">Moderna Inc / Johnson & Johnson / Merck & Co Inc / Novartis AG / Alnylam Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Athersys Inc / Regulus Therapeutics Inc / Monument Circle Acquisition Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN / BMY / GILD / JNJ / LLY / MRK / PFE / ACRS / UTHR / ACRX / BIIB / ABBV / AERI / ALDX</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Aclaris Therapeutics Inc / United Therapeutics Corp / AcelRx Pharmaceuticals Inc / Biogen Inc / Abbvie Inc / Aerie Pharmaceuticals Inc / Aldeyra Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">SPEAKER ADDED: Please Join Our KOL Video Call to Discuss New and Existing Treatments For Pulmonary Arterial Hypertension (PAH) on Dec. 7 at 1PM EST</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">JNJ / MRK / PFE / INSM / US38341P1021</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Insmed Inc / Gossamer Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">SITC Abs: COM701 Triplet Combo Is Safe. Await Efficacy Data In The Poster</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CGEN=US / MRK=US / BMY=US / RCUS=US</td><td class="leftalignment">Compugen Ltd / Merck & Co Inc / Bristol-Myers Squibb Co / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene / Billal Jahangiri</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2778844 / 2732635 / 2229126 / 2270726 / 2345022 / 2121352 / 2459202 / 2613990 / 2515030 / 2630085 / 2684703 / 2862532 / 2943523 / 2931034 / 7103065 / B0X7DZ3 / 2713317 / 2857817 / 2951452 / 2598246 / B44C366 / B7TL820 / B8L2798 / BBPK0J0 / BDZCRX3 / B95WG16 / BS7K7C9 / BYVFC94 / BYQHP96 / BF5L3T2 / BJLT387 / BJLKVS6 / BZB1XF2 / BYZR4X4 / BJ5FZ74 / BGCYWN8 / BZ8FPH3 / BKVDFF7 / BFXC911 / BHZSB82 / BDH65C8 / BP3YM85 / BL95N25 / BYY88Y7 / BKC9SX3 / BD6JX35 / BKS3RS7 / BYTJZL1 / BDD1B07 / BFY7DC4 / BKPGJQ1 / BFYVZ75 / BF0QTY9 / BMW15J8 / BYYGK12</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / AutoNation Inc / Columbia Sportswear Co / Walt Disney Co / Macy's Inc / Group 1 Automotive Inc / IDEXX Laboratories Inc / Illumina Inc / Lithia Motors Inc / Neogen Corp / Pfizer Inc / E W Scripps Co / Penske Automotive Group Inc / Vertex Pharmaceuticals Inc / Novartis AG / Chipotle Mexican Grill Inc / ACADIA Pharmaceuticals Inc / Netflix Inc / J M Smucker Co / Neogenomics Inc / Heska Corp / Meta Platforms Inc / Hemisphere Media Group Inc / Mirati Therapeutics Inc / RingCentral Inc / Zoetis Inc / Nevro Corp / US Foods Holding Corp / Floor & Decor Holdings Inc / Elanco Animal Health Inc / Avantor Inc / Phathom Pharmaceuticals Inc / Tactile Systems Technology Inc / Axsome Therapeutics Inc / Adaptive Biotechnologies Corp / Xencor Inc / Editas Medicine Inc / Oric Pharmaceuticals Inc / Guardant Health Inc / Covetrus Inc / PetIQ Inc / Trupanion Inc / Phibro Animal Health Corp / Alphabet Inc / Arcturus Therapeutics Holdings Inc / Krystal Biotech Inc / 10X Genomics Inc / Zogenix Inc / Rubius Therapeutics Inc / Altimmune Inc / Squarespace Inc / Seelos Therapeutics Inc / Chicken Soup for The Soul Entertainment Inc / Renalytix PLC / TPI Composites Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare sector - Pfizer's Paxlovid expected to have limited impact on near-term vaccine demand; China small-molecule COVID drugs under active development</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / MRCG.DE / CRL.N / 2269.HK</td><td class="leftalignment">Pfizer Inc / Merck KGaA / Charles River Laboratories International Inc / WuXi Biologics (Cayman) Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / Germany / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Will Pfizer Stock Continue To Rise?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">PFE.N / JNJ.N / MRK.N / RHHBY.PK</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Merck & Co Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck & Co Inc: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">RUBY - BUY - Several Data Updates for RTX-240 and RTX-321 on Track for YE21 or 1Q22; CMO Departs for CEO Job</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BDD1B07 / 2778844</td><td class="leftalignment">Rubius Therapeutics Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Paul Jeng, Ph.D. / Yige Guo, Ph.D. / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Sign Up for Hearty Fridays - KOL Call Series: 11/12 at 10:00 am ET, We're Talking PAH Market, Merck/Acceleron, and $5B+ Opportunity for New Treatments</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N / 5671735 / 0989529 / 2023607 / 2778844 / 2730190 / 7103065 / BHC8X90 / BNKGXX2</td><td class="leftalignment">Merck & Co Inc / Sanofi SA / AstraZeneca PLC / Amgen Inc / Merck & Co Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Novo Nordisk A/S / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Debjit Chattopadhyay, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 29, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Our Top-Read and Most Differentiated Notes</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK.N / PFE.N / GILD.O / JAZZ.O / VRTX.O / BLU.N / BIIB.O / PCRX.O / ABBV.N / ENTA.O / ITCI.O / XENE.O / GMDA.OQ / MTCR.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Jazz Pharmaceuticals PLC / Vertex Pharmaceuticals Inc / BELLUS Health Inc / Biogen Inc / Pacira Biosciences Inc / Abbvie Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc / Xenon Pharmaceuticals Inc / Gamida Cell Ltd / Metacrine Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">BNP Paribas Exane</td><td class="leftalignment">MEDICAL TECHNOLOGIES / PHARMACEUTICALS : Antivirals: a tough pill for Life Science to swallow?</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ROG.S / STDM.PA / MRCG.DE / QIA.DE / SATG_p.DE / RGEN.OQ / SFZN.S / BIOX.PA / DIAS.MI</td><td class="leftalignment">Roche Holding AG / Sartorius Stedim Biotech SA / Merck KGaA / Qiagen NV / Sartorius AG / Repligen Corp / Siegfried Holding AG / Biomerieux SA / DiaSorin SpA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Italy / Netherlands / United States</td><td class="leftalignment">Cosmetics & Personal Care</td><td class="leftalignment">Euroland / Europe / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">M. Hugo Solvet / Ms Luisa Hector</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">2681511 / 2000019 / 2486813 / 2778844 / 2973821 / 2050832 / 2732635 / 2942605 / 2216850 / 2270726 / 2542049 / 2317087 / 2515030 / 2657802 / 2680905 / 2684703 / 2440637 / 2573083 / 2138158 / 2825933 / 2829601 / 2980906 / 2503529 / 2212922 / 2857817 / B125XQ6 / B0T7YX2 / B02R1L6 / 2983563 / B2R3PV1 / B1XGNW4 / B5B2106 / 2390817 / B7TL820 / B4MG4Z6 / B783TY6 / B7VD3F2 / BBPK0J0 / BBGVT40 / B95N910 / B7577T2 / BCGCR79 / BFZCHN7 / BYY8XK8 / BQPVQZ6 / BYZLV46 / BXDZ9Z0 / BF5L3T2 / BJT1RW7 / BD9GVY0 / BZ1LFB2 / BQT3XY6 / BJ2Z0H2 / BWFKZT2 / BMYML02 / BFNR303 / BZ8VJQ8 / BKTNTR9 / BK6N347 / BJVR9Y9 / BD6D4Y5 / BYY88Y7 / BDVLM39 / BMDCDP2 / BJRFSB7 / BD72R64 / BKPGJQ1 / BM8NHS1 / BMYRFV6</td><td class="leftalignment">PepsiCo Inc / Amazon.com Inc / Kellogg Co / Merck & Co Inc / Alliant Energy Corp / Ameren Corp / AutoNation Inc / Avista Corp / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Lithia Motors Inc / OGE Energy Corp / PPL Corp / Pfizer Inc / CenterPoint Energy Inc / Sangamo Therapeutics Inc / Sempra Energy / South Jersey Industries Inc / Southern Co / Foot Locker Inc / World Wrestling Entertainment Inc / NRG Energy Inc / Netflix Inc / Portland General Electric Co / Live Nation Entertainment Inc / ALLETE Inc / Carmax Inc / American Water Works Company Inc / Insulet Corp / Fortinet Inc / Gray Television Inc / Meta Platforms Inc / AMC Networks Inc / Aptiv PLC / Duke Energy Corp / Mirati Therapeutics Inc / News Corp / PTC Inc / Renewable Energy Group Inc / Sprouts Farmers Market Inc / Wix.Com Ltd / WEC Energy Group Inc / Horizon Therapeutics PLC / InflaRx NV / Shopify Inc / Elanco Animal Health Inc / Lyft Inc / Zai Lab Ltd / Deciphera Pharmaceuticals Inc / Cyberark Software Ltd / Pinterest Inc / Cellectis SA / DraftKings Inc / Northwest Natural Holding Co / Vistra Corp / ViacomCBS Inc / Uber Technologies Inc / iHeartMedia Inc / Altair Engineering Inc / Alphabet Inc / argenx SE / Bigcommerce Holdings Inc / Immunovant Inc / Liberty Media Corp / Squarespace Inc / Adagio Therapeutics Inc / Procept Biorobotics Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / France / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Pfizer / Merck : Oral COVID-19 Antivirals And What They Mean For PFE And MRK</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: South Korea - Green Cross Corp: Readacross from Pfizer's oral COVID Ph-2/3 data; Green Cross. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">006280.KS / PFE.N / MRK.N / REGN.OQ / 068270.KS</td><td class="leftalignment">Green Cross Corp / Pfizer Inc / Merck & Co Inc / Regeneron Pharmaceuticals Inc / Celltrion Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Korea, Republic of / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: South Korea - Celltrion Inc: Readacross from Pfizer's oral COVID Ph-2/3 data (Celltrion Inc). Maintain UNDERPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">068270.KS / PFE.N / MRK.N / REGN.OQ</td><td class="leftalignment">Celltrion Inc / Pfizer Inc / Merck & Co Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: South Korea - Celltrion Healthcare Co Ltd: Readacross from Pfizer's oral COVID Ph-2/3 data (Celltrion Healthcare). Maintain NEUTRAL</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">091990.KQ / PFE.N / MRK.N / REGN.OQ</td><td class="leftalignment">Celltrion Healthcare Co Ltd / Pfizer Inc / Merck & Co Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: Korea Biologics Sector - Readacross from Pfizer's oral COVID Ph-2/3 data; what additional data should we expect in near future</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">068270.KS / 091990.KQ / PFE.N / LLY.N / MRK.N / GSK.L / REGN.OQ / 006280.KS</td><td class="leftalignment">Celltrion Inc / Celltrion Healthcare Co Ltd / Pfizer Inc / Eli Lilly and Co / Merck & Co Inc / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Green Cross Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Korea, Republic of / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Merck KGaA</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">11/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Video Call to Discuss New and Existing Treatments For Pulmonary Arterial Hypertension (PAH) on Dec. 7 at 1PM EST</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">JNJ / MRK / PFE / INSM</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Insmed Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">11/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Video Call to Discuss What To Expect From RSV Vaccines and Treatments In Development, December 3 at 11:00 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">CDTX / JNJ / MRK / PFE / ARDS</td><td class="leftalignment">Cidara Therapeutics Inc / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Aridis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">11/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.7% Above Pre-Pandemic Base- Week 83</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">11/06/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Flow of Funds Report for Merck KGaA - prepared by Wright Investors Service</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">European MedTech & Services: First take on the potential impact of the Pfizer Covid drug news</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRCG.DE / LONN.S / SATG_p.DE / SBSG.DE / QGEN.N / SHLG.DE / SYAB.DE</td><td class="leftalignment">Merck KGaA / Lonza Group AG / Sartorius AG / Stratec SE / Qiagen NV / Siemens Healthineers AG / Synlab AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Netherlands</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">EVENT CALENDAR / GOVERNMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Falko Friedrichs / Herr Jan Koch / Sachin Gadilingappa</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">PFE, MRK - The COVID see-saw (buzz saw?) continues with new oral data from Pfizer</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US58933Y1055 / US7170811035</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">11012210 / 71708110 / 00846U10 / 88162420 / 04635310 / 37555810 / 03116210 / 66987V10 / 75886F10 / 53245710 / 09062X10 / 478160104 / 30161Q104 / 771195104 / 58933Y10 / 00287Y10 / 45781M10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Bristol-Myers Squibb Co / Pfizer Inc / Agilent Technologies Inc / Teva Pharmaceutical Industries Ltd / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Biogen Inc / Johnson & Johnson / Exelixis Inc / Roche Holding AG / Merck & Co Inc / Abbvie Inc / Innoviva Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">PFE Sets New Bar for COVID-19 Antivirals; Positive Readthrough to Enanta's '235</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ENTA.OQ / PFE.N / 71708110 / 58933Y10 / 29251M10 / 04683R10</td><td class="leftalignment">Enanta Pharmaceuticals Inc / Pfizer Inc / Pfizer Inc / Merck & Co Inc / Enanta Pharmaceuticals Inc / Atea Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Roanna C. Ruiz</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">CoroNation Update: Taking the Crown (Again?) - PFE's Oral Antiviral Spikes the Ball With Impressive Results; Pressuring MRK and COVID Antibody Cos</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N / 2778844 / BM8NHS1</td><td class="leftalignment">Merck & Co Inc / Merck & Co Inc / Adagio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Evan B. Wang / Tarun Soni</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">THIS MORNING: KOL Video Call to Discuss SITC 2021 & ASH 2021 Abstracts at 11:30 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">HCM / JNJ / LLY / MRK / PFE / ARAV / IMAB</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Aravive Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">European Healthcare Credit : Q321 follow-up appointment</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">AZN.L / SASY.PA / ROG.S / NOVN.S / FMEG.DE / MRCG.DE / FREG.DE / GSK.L</td><td class="leftalignment">AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / Fresenius Medical Care AG & Co KGaA / Merck KGaA / Fresenius SE & Co KGaA / GlaxoSmithKline PLC</td><td class="leftalignment">FIXED INCOME - CORPORATES</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Danielle Ward / Mr. Adam Bodor</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">0925288 / 2486813 / 2778844 / 2050832 / 2045623 / 2942605 / 2111955 / 2219224 / 2206657 / 2216850 / 2222631 / 2317087 / 2670519 / 2613990 / 2471950 / 2632003 / 2645409 / 2657802 / 2680905 / 2730190 / 2440637 / 2799351 / 2825933 / 2829601 / 2980906 / 2503529 / 2783815 / B1HMF22 / 2212922 / 2857817 / B02R1L6 / B2R3PV1 / B3D7K31 / 2598246 / 2390817 / B44C366 / B783TY6 / B7VD3F2 / BCZS820 / B95N910 / B95WG16 / BZ07BW4 / BVVN4Q8 / BFZNYB7 / BKS3SM8 / BJ1FD74 / BKTHM05 / BR4T3B3 / BJ2Z0H2 / BYZM6C2 / BFMXGR0 / BJJMGL2 / BZ8VJQ8 / BFXC911 / BKTNTR9 / BZ05388 / BJVR9Y9 / BYYWPW6 / BHZSB82 / BD6D4Y5 / BJ9NFQ3 / BZ1LFG7 / BGT3960 / BYY88Y7 / BYSGPK2 / BKX9VD3 / BZ0P3Z5 / BJMLSD2 / BYSFJV8 / BYTJZL1 / BWY4XV3 / BJTJGC4 / BDRW1L7 / BF3N4P3 / BQXZP64 / BMDCDP2 / BYXB1Y8 / BGDQ8B3 / BD8QGD5 / BD72R64 / BLR6S36 / BN2S6Y8 / BKVK9N4</td><td class="leftalignment">GlaxoSmithKline PLC / Kellogg Co / Merck & Co Inc / Ameren Corp / ANSYS Inc / Avista Corp / Borgwarner Inc / CMS Energy Corp / Coca-Cola Co / Consolidated Edison Inc / Cooper Companies Inc / Entergy Corp / Exelon Corp / Illumina Inc / Incyte Corp / New York Times Co / NiSource Inc / OGE Energy Corp / PPL Corp / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Sinclair Broadcast Group Inc / South Jersey Industries Inc / Southern Co / Foot Locker Inc / World Wrestling Entertainment Inc / Zimmer Biomet Holdings Inc / First Solar Inc / NRG Energy Inc / Netflix Inc / ALLETE Inc / American Water Works Company Inc / Discovery Inc / Neogenomics Inc / Gray Television Inc / Heska Corp / Aptiv PLC / Duke Energy Corp / Fate Therapeutics Inc / PTC Inc / Zoetis Inc / Monster Beverage Corp / Eversource Energy / Allogene Therapeutics Inc / IGM Biosciences Inc / Revolve Group Inc / Passage Bio Inc / HubSpot Inc / Pinterest Inc / Intellia Therapeutics Inc / Evergy Inc / Fox Corp / Vistra Corp / Guardant Health Inc / ViacomCBS Inc / Global Blood Therapeutics Inc / iHeartMedia Inc / Beigene Ltd / Covetrus Inc / Altair Engineering Inc / Neoleukin Therapeutics Inc / Roku Inc / Orchard Therapeutics PLC / Alphabet Inc / ViewRay Inc / Arcutis Biotherapeutics Inc / Tegna Inc / Karuna Therapeutics Inc / Planet Fitness Inc / Zogenix Inc / Adaptimmune Therapeutics PLC / Kontoor Brands Inc / AnaptysBio Inc / Arena Pharmaceuticals Inc / Wayfair Inc / Bigcommerce Holdings Inc / Sunrun Inc / Axonics Inc / Liberty Media Corp / Liberty Media Corp / Longboard Pharmaceuticals Inc / Talaris Therapeutics Inc / European Wax Center Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Merck best performer of DAX Index in 2021</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What's Next For Merck Stock After An Upbeat Q3?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Societe Generale</td><td class="leftalignment">Merck KGaA (Hold, TP=€204) - Corporate news - FY21 guidance raised after a strong 3Q, driven once again by Life Science - F. Cespedes (1p)</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Global</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Florent Cespedes / Justin S. Smith / Manas Sarkar</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Kepler Cheuvreux</td><td class="leftalignment">Merck KGAA | Buy | Onwards and upwards, outlook raised again</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David P. Evans</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">DD-US -  Dividend Quality Analysis, for the period ended September 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">APD / DOW / EMN / FMC / MRK / PPG / BASFY.PK / GT.O / MON.O</td><td class="leftalignment">Air Products and Chemicals Inc / Dow Inc / Eastman Chemical Co / FMC Corp / Merck & Co Inc / PPG Industries Inc / BASF SE / Goodyear Tire & Rubber Co / Monument Circle Acquisition Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Germany / India / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BMY-US -  Dividend Quality Analysis, for the period ended November 01,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / JNJ / LLY / MRK / NVS / PFE / AMGN.O / AZN.O / BIIB.O / ABBV.K / SNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / AstraZeneca PLC / Biogen Inc / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck KGaA : 3Q'21 Pre-announcement: Strong 3Q and FY'21 guidance raise implies 4% upgrades to FY'21 Cons. EPS (pre) at the midpoint</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Richard B. Vosser / James D. Gordon / Ms. Laerke Engkilde / Zain Ebrahim / Mr. Tycho W. Peterson</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Merck: 3Q beat and another guidance raise</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Falko Friedrichs / Herr Jan Koch / Sachin Gadilingappa</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">DD-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">APD / DOW / EMN / FMC / MRK / PPG / BASFY.PK / GT.O / MON.O</td><td class="leftalignment">Air Products and Chemicals Inc / Dow Inc / Eastman Chemical Co / FMC Corp / Merck & Co Inc / PPG Industries Inc / BASF SE / Goodyear Tire & Rubber Co / Monument Circle Acquisition Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Germany / India / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">2021 ESMO-IO Planner</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">45337C10 / 04635310 / 03116210 / 640268108 / 58933Y10 / 76029N10 / 09075V10 / 45781K20 / 59045L10 / N4444510 / N5749R10 / 09770210 / 82835W10 / 37230320</td><td class="leftalignment">Incyte Corp / AstraZeneca PLC / Amgen Inc / Nektar Therapeutics / Merck & Co Inc / Replimune Group Inc / BioNTech SE / Innate Pharma SA / Mersana Therapeutics Inc / Immatics NV / Merus NV / Bolt Biotherapeutics Inc / Silverback Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daina Graybosch, Ph.D. / Jonathan Chang, Ph.D., CFA / Andrew Berens, M.D. / Jeffrey La Rosa / Dilip Joseph / Faisal Khurshid / Nick Huang / Christopher Liu, Pharm.D. / Ken Shields</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRCG.DE: Merck KGaA - Pre-announce 3Q21 and raise FY21 guidance</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRCG.DE / GSK.L</td><td class="leftalignment">Merck KGaA / GlaxoSmithKline PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GMAB.CO: Genmab - Model update and updated 3Q21 preview</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GMAB.CO / JNJ.N / RECI.MI / ROG.S / LUN.CO / MRCG.DE / LONN.S / UCB.BR / IPN.PA / ORNBV.HE / ALM.MC / HZNP.OQ / ABBV.N</td><td class="leftalignment">Genmab A/S / Johnson & Johnson / Recordati Industria Chimica e Farmaceutica SpA / Roche Holding AG / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Ipsen SA / Orion Oyj / Almirall SA / Horizon Therapeutics PLC / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Ireland / Italy / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">1952.HK: Everest Medicines - 2021 CIC Live takeaways</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">1952.HK / MRCG.DE / GILD.OQ</td><td class="leftalignment">Everest Medicines Ltd / Merck KGaA / Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">Valens Equity Insights and Inflections - 2021 11 02</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">MRK.N / APD.N / BDX.N / CL.N / CRM.N / GE.N / SO.N / D.N / DE.N / LEN.N / ORCL.N / ADSK.OQ / GILD.OQ / ICE.N / FIS.N / CME.OQ / POST.N / NOW.N / SNOW.N / ZG.OQ / DASH.N</td><td class="leftalignment">Merck & Co Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / Colgate-Palmolive Co / Salesforce.Com Inc / General Electric Co / Southern Co / Dominion Energy Inc / Deere & Co / Lennar Corp / Oracle Corp / Autodesk Inc / Gilead Sciences Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / CME Group Inc / Post Holdings Inc / ServiceNow Inc / Snowflake Inc. / Zillow Group Inc / DoorDash Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Agriculture / Biotechnology / Building & Building Materials / Chemicals / Financial Services / Food / Healthcare / Household Products / Info. Tech./Software / Machinery / Media / Pharmaceuticals / Technology / Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Valens Research</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck KGaA : Pre 3Q'21 Cons. Comparison: JPMe 5% above Cons. 3Q EPS (pre); Updated 2021 Cons in the middle of expected guidance range</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Richard B. Vosser / James D. Gordon / Ms. Laerke Engkilde / Zain Ebrahim / Mr. Tycho W. Peterson</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Is Pfizer Stock Set To See Higher Levels Post Q3 Results?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">PFE.N / JNJ.N / MRK.N / RHHBY.PK</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Merck & Co Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Merck & Co., Inc.(MRK) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">58933Y105</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">FISV=US / MRK=US / WMB=US / LLY=US / PFE=US / AMGN=US / BMY=US / KO=US / MCD=US / OXY=US / ADI=US / RRC=US / GBT=US / WEN=US / DVN=US / INCY=US / TXN=US / GILD=US / APA=US / CPE=US / EOG=US / REI=US / XOM=US / CRK=US / WLL=US / PXD=US / DIOD=US / MGY=US / SWN=US / SCOR=US / MUR=US / MRO=US / EXPE=US / LEG=US / SEIC=US / KFRC=US / AMK=US / BNL=US / CBRL=US / ENV=US / CTRA=US / CNX=US / DRI=US / EQT=US / EXEL=US / GPOR=US / HZO=US / MCHP=US / REGI=US / SBAC=US / SSNC=US / TRIP=US / WIX=US / CVX=US / PSA=US / SPG=US / CGEN=US / BKNG=US / ADC=US / CUZ=US / VNO=US / CRTO=US / COP=US / BRX=US / DIN=US / MGNI=US / OGN / JRVR=US / BIIB=US / TXRH=US / PLAY=US / DENN=US / NSP=US / CMG=US / REX=US / FIS=US / GPRE=US / AMRX=US / TAST=US / QSR=US / CLR=US / TIL=US / NOG=US / EPRT=US / JACK=US / RCUS=US / GNRC=US / AR=US / OAS=US / NXPI=US / LPLA=US / ESTE=US / BCEI=US / MTDR=US / PDCE=US / RHP=US / FANG=US / ABBV=US / NDLS=US / ANIP=US / FATE=US / VRNS=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / ON=US / BWXT=US / WING=US / MCFT=US / WLTW=US / GXO=US / CDEV=US / CRSP=US / TRVG=US / JELD=US / SBOW=US / IOVA=US / FOCS=US / HARP=US / TCRR=US / NXTC=US / GMAB=US / PNTG=US / OVV=US / ZI=US / VTRS=US / ABNB=US / CELU=US / ROCC=US / REPX=US</td><td class="leftalignment">Fiserv Inc / Merck & Co Inc / Williams Companies Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Coca-Cola Co / McDonald's Corp / Occidental Petroleum Corp / Analog Devices Inc / Range Resources Corp / Global Blood Therapeutics Inc / Wendys Co / Devon Energy Corp / Incyte Corp / Texas Instruments Inc / Gilead Sciences Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Diodes Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Comscore Inc / Murphy Oil Corp / Marathon Oil Corp / Expedia Group Inc / Leggett & Platt Inc / SEI Investments Co / Kforce Inc / AssetMark Financial Holdings Inc / Bunzl plc / Cracker Barrel Old Country Store Inc / Envestnet Inc / Coterra Energy Inc / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Exelixis Inc / Gulfport Energy Corp / MarineMax Inc / Microchip Technology Inc / Renewable Energy Group Inc / SBA Communications Corp / SS&C Technologies Holdings Inc / Tripadvisor Inc / Wix.Com Ltd / Chevron Corp / Public Storage / Simon Property Group Inc / Compugen Ltd / Booking Holdings Inc / Agree Realty Corp / Cousins Properties Inc / Vornado Realty Trust / Criteo SA / Conocophillips / Brixmor Property Group Inc / Dine Brands Global Inc / Magnite Inc / Organon & Co / James River Group Holdings Ltd / Biogen Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Fidelity National Information Services Inc / Green Plains Inc / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Instil Bio Inc / Northern Oil and Gas Inc / Essential Properties Realty Trust Inc / Jack in the Box Inc / Arcus Biosciences Inc / Generac Holdings Inc / Antero Resources Corp / Oasis Petroleum Inc / NXP Semiconductors NV / LPL Financial Holdings Inc / Earthstone Energy Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Abbvie Inc / Noodles & Co / ANI Pharmaceuticals Inc / Fate Therapeutics Inc / Varonis Systems Inc / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / ON Semiconductor Corp / BWX Technologies Inc / Wingstop Inc / Mastercraft Boat Holdings Inc / Willis Towers Watson PLC / GXO Logistics Inc / Centennial Resource Development Inc / CRISPR Therapeutics AG / Trivago NV / JELD-WEN Holding Inc / SilverBow Resources Inc / Iovance Biotherapeutics Inc / Focus Financial Partners Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / NextCure Inc / Genmab A/S / Pennant Group Inc / Ovintiv Inc / ZoomInfo Technologies Inc / Viatris Inc / Airbnb Inc / Celularity Inc / Ranger Oil Corp / Riley Exploration Permian Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">2021 SITC Late-Breakers Added – Updated Planner</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">45337C10 / 75886F10 / 640268108 / 58933Y10 / 98401F10 / 58949210 / 09075V10 / 60770K10 / 55609910 / 98887Q10 / N4444510 / 30315R10 / 37230320 / 95075A10</td><td class="leftalignment">Incyte Corp / Regeneron Pharmaceuticals Inc / Nektar Therapeutics / Merck & Co Inc / Xencor Inc / Mereo Biopharma Group PLC / BioNTech SE / Moderna Inc / MacroGenics Inc / Zai Lab Ltd / Immatics NV / F-Star Therapeutics Inc / Genmab A/S / Werewolf Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / Denmark / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daina Graybosch, Ph.D. / Anna Baran, CFA / Jonathan Chang, Ph.D., CFA / Geoffrey Porges, MBBS / Jeffrey La Rosa / Dilip Joseph / Faisal Khurshid / Nick Huang / Na Sun / Daniel Tarjan, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2434209 / 2126335 / 2516152 / 2000019 / 2778844 / 2045623 / 2206657 / 2270726 / 2829515 / 2317087 / 2670519 / 2100920 / 2623911 / 2689560 / 2684703 / 2048804 / 7103065 / B125XQ6 / B2R3PV1 / B5B2106 / B3SWPT2 / B7TL820 / BBGVT40 / B95N910 / BVVN4Q8 / BD3W133 / BJLT387 / BK7Y2V9 / BD8DJ71 / BMYML02 / BFMXGR0 / BJJMGL2 / BKTNTR9 / BGSP7M9 / BD6D4Y5 / BYY88Y7 / BZ0P3Z5 / BMG75B4 / BN0XTW4 / BFY7DC4 / BNTB3N8 / BMW15J8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Home Depot Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / ANSYS Inc / Coca-Cola Co / Walt Disney Co / Edison International / Entergy Corp / Exelon Corp / FirstEnergy Corp / Neurocrine Biosciences Inc / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Novartis AG / Portland General Electric Co / American Water Works Company Inc / Fortinet Inc / Ameresco Inc / Meta Platforms Inc / News Corp / PTC Inc / Eversource Energy / Keurig Dr Pepper Inc / Avantor Inc / Akero Therapeutics Inc / Snap Inc / DraftKings Inc / Evergy Inc / Fox Corp / ViacomCBS Inc / Zoom Video Communications Inc / Altair Engineering Inc / Alphabet Inc / Tegna Inc / Inventiva SA / Orphazyme A/S / Altimmune Inc / Vizio Holding Corp / Renalytix PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Trefis Report: Merck - $97.61 Trefis Price Estimate</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Merck advances 15% in past quarter; Sector Gamma AS surges 78.5%</td><td class="leftalignment">English</td><td class="rightalignment">86</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">MacroRisk Analytics/EconomicInvestor</td><td class="leftalignment">The Economy Matters for MRK</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">58933Y105</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Streetwise Reports</td><td class="leftalignment">Diversified Bio-Pharma Firm Gains FDA Approval for Adrenocorticotropic Hormone Gel for Multiple Indications</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">ANIP.OQ / MRK.N</td><td class="leftalignment">ANI Pharmaceuticals Inc / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY / INDUSTRY / INVESTMENT STRATEGY / MARKET ANALYSIS / GOVERNMENT RELATIONS/REGULATIONS / INDUSTRY OVERVIEW / MARKET COMMENT / COMMENTARY / OVERVIEW / SECTOR / EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 22, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, MRK</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES / PRICE / RATINGS CHANGES</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David H. Toung / Mr. Jasper Hellweg</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: UPDATED SITC Planner Highlights 60+ Datapoints Not To Be Missed + Late Breakers</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRK=US / BMY=US / INCY=US / GILD=US / EXEL=US / CGEN=US / TIL=US / RCUS=US / ABBV=US / FATE=US / CRSP=US / IOVA=US / HARP=US / TCRR=US / NXTC=US / GMAB=US / CELU=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Incyte Corp / Gilead Sciences Inc / Exelixis Inc / Compugen Ltd / Instil Bio Inc / Arcus Biosciences Inc / Abbvie Inc / Fate Therapeutics Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / NextCure Inc / Genmab A/S / Celularity Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Billal Jahangiri / Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Guotai JunAn (HK) Retail Rsch</td><td class="leftalignment">默克 Merck-有望首个上市的新冠口服药静候 FDA 批准-11/01/2021</td><td class="leftalignment">Chinese</td><td class="rightalignment">2</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Chloe Kim</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2936921 / 2126335 / 2000019 / 2778844 / 2026242 / 2219224 / 2270726 / 2317087 / 2100920 / 2457864 / 2459020 / 2048804 / 2829601 / 2931034 / 2181334 / 7103065 / 2783815 / 2713317 / 2857817 / B125XQ6 / B3P93Y7 / B7TL820 / B7254K9 / B7VD3F2 / BFLR866 / BFH3N85 / BTN1Y11 / BXDZ9Z0 / BHC8X90 / BD8DJ71 / BJJMGL2 / BYXJQG9 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BD6JX35 / BMH0MR7 / BDZ30Q0 / BJTJGC4 / BMPRZV5 / BGDQ8B3 / BNTB3N8 / BNGJQZ8 / BP7KZP7 / BF0QTY9 / BPH0546</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Walmart Inc / Bristol-Myers Squibb Co / Amazon.com Inc / Merck & Co Inc / American Electric Power Company Inc / CMS Energy Corp / Walt Disney Co / Entergy Corp / FirstEnergy Corp / ImmunoGen Inc / Intuit Inc / Pinnacle West Capital Corp / Southern Co / Vertex Pharmaceuticals Inc / Check Point Software Technologies Ltd / Novartis AG / Zimmer Biomet Holdings Inc / ACADIA Pharmaceuticals Inc / Netflix Inc / Portland General Electric Co / Anheuser Busch Inbev SA / Meta Platforms Inc / AxoGen Inc / Duke Energy Corp / Twitter Inc / Veeva Systems Inc / Medtronic PLC / Shopify Inc / Novo Nordisk A/S / Snap Inc / Fox Corp / Spire Inc / ViacomCBS Inc / Roku Inc / Alphabet Inc / Krystal Biotech Inc / Zendesk Inc / Arvinas Inc / Kontoor Brands Inc / Kymera Therapeutics Inc / Axonics Inc / Vizio Holding Corp / Porch Group Inc / Monte Rosa Therapeutics Inc / Chicken Soup for The Soul Entertainment Inc / Life Time Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Denmark / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRCG.DE: Merck KGaA - 3Q21 results preview</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRCG.DE / LLY.N / ROG.S / GSK.L</td><td class="leftalignment">Merck KGaA / Eli Lilly and Co / Roche Holding AG / GlaxoSmithKline PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">10/30/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck & Co Inc: Information Content of Earnings Releases 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">10/30/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Merck & Co Inc Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">10/30/2021</td><td class="leftalignment">TheScreener</td><td class="leftalignment">With a more favourable environment, MERCK & COMPANY improves to Slightly Positive</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Merck up 7.6% from 1 week low</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Marka increases 4.0% in 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRKP.WA</td><td class="leftalignment">Marka SA w restrukturyzacji</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Poland</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">PFE Maternal RSV Vax Data Shows Impressive Newborn Protection</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">PFE.N / AZN / 71708110 / 04635310 / 478160104 / 58933Y10 / 60770K10 / G3910J11 / F5548N10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / Merck & Co Inc / Moderna Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Daniel Tarjan, Ph.D. / Anna Baran, CFA / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Healthcare : 3Q21 Earnings (ABBV, BAX, GILD, LH, MRK) — What Mattered for Credit</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N / ABBV.N / GILD.OQ / LH.N / BAX.N / GILD.O</td><td class="leftalignment">Merck & Co Inc / Abbvie Inc / Gilead Sciences Inc / Laboratory Corporation of America Holdings / Baxter International Inc / Gilead Sciences Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Video Call to Discuss SITC 2021 & ASH 2021 Abstracts on Friday, November 5 at 11:30 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">HCM / JNJ / LLY / MRK / PFE / ARAV / IMAB</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Aravive Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Video Call to Discuss What To Expect From RSV Vaccines and Treatments In Development, December 3 at 11:00 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">CDTX / JNJ / MRK / PFE / ARDS</td><td class="leftalignment">Cidara Therapeutics Inc / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Aridis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Video Call to Discuss New and Existing Treatments For Pulmonary Arterial Hypertension (PAH) on Dec. 7 at 1PM EST</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">INSM / JNJ / MRK / PFE</td><td class="leftalignment">Insmed Inc / Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Primer Ahead Of Today's KOL Call On Discounted Pricing Strategies For Anti-PD-(L)1s; What To Know</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">LLY / MRK / CKPT / US3755581036 / US45337C1027 / US75886F1075 / US88322Q1085 / US03969F1093</td><td class="leftalignment">Eli Lilly and Co / Merck & Co Inc / Checkpoint Therapeutics Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / TG Therapeutics Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Jennifer M. Kim / Louise Chen / Brandon Folkes, CFA / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">SGEN - BUY - Strong Momentum Continues as All Three Commercial Products Beat in 3Q, Guidance Raised</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">0925288 / 2778844 / 2684703</td><td class="leftalignment">GlaxoSmithKline PLC / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D. / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">MRK: Increasing Ests. For Molnupiravir & Gardasil Post 3Q21 Results; Increasing Our PT to $98/share</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2778844</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRK=US / CACI=US / LLY=US / PFE=US / ADI=US / AMD=US / IP=US / AGL=US / AMZN=US / INCY=US / TXN=US / GILD=US / AMT=US / PEB=US / BC=US / MPWR=US / CONE=US / V=US / NOVA=US / CHKP=US / IART=US / XLNX=US / TRMK=US / TNL=US / CMCSA=US / CI=US / W=US / WTFC=US / APH=US / AVT=US / CNX=US / CPRT=US / DVA=US / EQT=US / EXPO=US / FCN=US / AJG=US / LH=US / TREE=US / MHK=US / TEAM=US / NTST=US / ASGN=US / REGN=US / SLGN=US / VSEC=US / WEX=US / FOUR=US / CFR=US / CPT=US / OFC=US / CUZ=US / MAA=US / WRE=US / AMSF=US / VICI=US / ACVA=US / MD=US / MOH=US / FLT=US / TPX=US / KAR=US / TXRH=US / BAH=US / MPW=US / KBR=US / MA=US / SAIA=US / PAG=US / TEL=US / TAST=US / EIG=US / PRPL=US / EHC=US / IAA=US / WH=US / RCUS=US / KNSL=US / AR=US / NXPI=US / NLSN=US / LKQ=US / PTCT=US / 00770K202 / CMPR=US / GDDY=US / ETSY=US / SPNE=US / ARGX=US / NVCR=US / WLTW=US / KDP=US / FTDR=US / EB=US / ARQT=US / AIRC=US / HYFM=US / CELU=US</td><td class="leftalignment">Merck & Co Inc / CACI International Inc / Eli Lilly and Co / Pfizer Inc / Analog Devices Inc / Advanced Micro Devices Inc / International Paper Co / agilon health Inc / Amazon.com Inc / Incyte Corp / Texas Instruments Inc / Gilead Sciences Inc / American Tower Corp / Pebblebrook Hotel Trust / Brunswick Corp / Monolithic Power Systems Inc / CyrusOne Inc / Visa Inc / Sunnova Energy International Inc / Check Point Software Technologies Ltd / Integra Lifesciences Holdings Corp / Xilinx Inc / Trustmark Corp / Travel + Leisure Co / Comcast Corp / Cigna Corp / Wayfair Inc / Wintrust Financial Corp / Amphenol Corp / Avnet Inc / CNX Resources Corp / Copart Inc / DaVita Inc / EQT Corp / Exponent Inc / FTI Consulting Inc / Arthur J Gallagher & Co / Laboratory Corporation of America Holdings / Lendingtree Inc / Mohawk Industries Inc / Atlassian Corporation PLC / Netstreit Corp / ASGN Inc / Regeneron Pharmaceuticals Inc / Silgan Holdings Inc / VSE Corp / WEX Inc / Shift4 Payments Inc / Cullen/Frost Bankers Inc / Camden Property Trust / Corporate Office Properties Trust / Cousins Properties Inc / Mid-America Apartment Communities Inc / Washington Real Estate Investment Trust / Amerisafe Inc / VICI Properties Inc / ACV Auctions Inc / MEDNAX Inc / Molina Healthcare Inc / Fleetcor Technologies Inc / Tempur Sealy International Inc / KAR Auction Services Inc / Texas Roadhouse Inc / Booz Allen Hamilton Holding Corp / Medical Properties Trust Inc / KBR Inc / Mastercard Inc / Saia Inc / Penske Automotive Group Inc / TE Connectivity Ltd / Carrols Restaurant Group Inc / Employers Holdings Inc / Purple Innovation Inc / Encompass Health Corp / IAA Inc / Wyndham Hotels & Resorts Inc / Arcus Biosciences Inc / Kinsale Capital Group Inc / Antero Resources Corp / NXP Semiconductors NV / Nielsen Holdings PLC / LKQ Corp / PTC Therapeutics Inc / Aemetis Inc / Cimpress PLC / GoDaddy Inc / ETSY Inc / SeaSpine Holdings Corp / argenx SE / Novocure Ltd / Willis Towers Watson PLC / Keurig Dr Pepper Inc / Frontdoor Inc / Eventbrite Inc / Arcutis Biotherapeutics Inc / Apartment Income REIT Corp / Hydrofarm Holdings Group Inc / Celularity Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">5671735 / 2516152 / 2681511 / 2000019 / 2550707 / 2778844 / 2002305 / 2003698 / 2026242 / 2219224 / 2206657 / 2229126 / 2270726 / 2317087 / 2328915 / 2345022 / 2048804 / 2730190 / 2440637 / 2829601 / 2842255 / 2853688 / 2098876 / 2503529 / 2181334 / 2971029 / B00FWN1 / B067BM3 / 2212922 / 2216991 / 2857817 / B3P93Y7 / B0796X4 / B65LWX6 / B4N0JJ6 / B7TL820 / BFLR866 / BFH3N85 / BVVN4Q8 / BD3W133 / BXDZ9Z0 / BJLT387 / BD8DJ71 / BJ2Z0H2 / BFZ1K46 / BMYML02 / BJJMGL2 / BYXJQG9 / BWY52P3 / BYY88Y7 / BMH0MR7 / BDVLM39 / BMG75B4 / BQXZP64 / BJRFSB7 / BD5GSZ4 / BNGJQZ8 / BJ9N563</td><td class="leftalignment">Sanofi SA / Eli Lilly and Co / PepsiCo Inc / Amazon.com Inc / McDonald's Corp / Merck & Co Inc / Abbott Laboratories / ABIOMED Inc / American Electric Power Company Inc / CMS Energy Corp / Coca-Cola Co / Columbia Sportswear Co / Walt Disney Co / Entergy Corp / Nextera Energy Inc / Macy's Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Southern Co / Starbucks Corp / Stryker Corp / Yum! Brands Inc / World Wrestling Entertainment Inc / Check Point Software Technologies Ltd / LKQ Corp / Alnylam Pharmaceuticals Inc / Molson Coors Beverage Co / NRG Energy Inc / Tempur Sealy International Inc / Netflix Inc / Anheuser Busch Inbev SA / Dexcom Inc / O'Reilly Automotive Inc / Visteon Corp / Meta Platforms Inc / Twitter Inc / Veeva Systems Inc / Eversource Energy / Keurig Dr Pepper Inc / Shopify Inc / Avantor Inc / Snap Inc / Pinterest Inc / Spotify Technology SA / DraftKings Inc / Fox Corp / Spire Inc / Blueprint Medicines Corp / Alphabet Inc / Zendesk Inc / argenx SE / Inventiva SA / Wayfair Inc / Immunovant Inc / Infrastructure and Energy Alternatives Inc / Porch Group Inc / Sunnova Energy International Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / France / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">3Q21: Beat and Raise Follows a String of Positive News</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">58933Y10 / 71708110</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">RECI.MI: Recordati - 3Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">RECI.MI / LUN.CO / MRCG.DE / LONN.S / UCB.BR / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / VIFN.S / GMAB.CO</td><td class="leftalignment">Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">MRK - MRK: 3Q21 Full Postview: monster quarter, molnu excitement</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck & Co., Inc. : Post 3Q21 Model Update</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck KGaA : 3Q'21 Results Preview: Strong quarter, though expected FY'21 guidance raise appears partially anticipated by BBG Cons.</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Richard B. Vosser / James D. Gordon / Ms. Laerke Engkilde / Zain Ebrahim / Mr. Tycho W. Peterson</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Merck & Co</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE / OPERATING RESULTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GSK-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GSK / MRK / NVS / PFE / AZN.O / DVAX.O / THRX.O / TEVA.K / SNY.O</td><td class="leftalignment">GlaxoSmithKline PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / AstraZeneca PLC / Dynavax Technologies Corp / Theseus Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVS-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NVS / ABT / BMY / JNJ / MRK / PFE / GSK / AZN.O / BAYRY.PK / TEVA.K / SNY.O</td><td class="leftalignment">Novartis AG / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Bayer AG / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">IDRA-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">IDRA.O / ABT / JNJ / MRK / PFE / AMGN.O / AGEN.O / LGND.O / BIIB.O / DVAX.O / CLDX.O</td><td class="leftalignment">Idera Pharmaceuticals Inc / Abbott Laboratories / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / Agenus Inc / Ligand Pharmaceuticals Inc / Biogen Inc / Dynavax Technologies Corp / Celldex Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NNVC-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">NNVC.K / BMY / MRK / GILD.O / NBY / GSK / BCRX.O / NVAX.O / CMRX.O</td><td class="leftalignment">NanoViricides Inc / Bristol-Myers Squibb Co / Merck & Co Inc / Gilead Sciences Inc / NovaBay Pharmaceuticals Inc / GlaxoSmithKline PLC / BioCryst Pharmaceuticals Inc / Novavax Inc / Chimerix Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SYN-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">SYN / ABT / MRK / PFE / AZN.O / BIIB.O / TEVA.K</td><td class="leftalignment">Synthetic Biologics Inc / Abbott Laboratories / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Biogen Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck & Co., Inc. : 3Q Takeaways: Strong Quarter Led by Gardasil, Molnupiravir Supports Upside to Street Consensus</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">MRK - MRK 3Q21 - They said what?!  Highlights from conf call…and our impressions</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">3Q21 beat and raise; potential top-line contribution from oral COVID drug in 2022</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Strong 3Q21, Solid Execution And Robust Outlook For 2021+ Should Drive Stock Higher</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">strong quarter ... call focus likely on molnupiravir & Chinese PD1s</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck & Co., Inc. : 3Q First Impressions: Solid Qtrly Beat/Raise On Blowout Gardasil Results</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q3 Beat & Raise; Molnupiravir Could Add Upside</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on October 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">SBUX.OQ / BAX.N / BP.L / CMS.N / EMN.N / HIG.N / IBM.N / MO.N / MRK.N / NEM.N / NOC.N / SLB.N / SWK.N / TAP.N / TXT.N / HAL.N / TFX.N / FE.N / CAT.N / YUM.N / SYK.N / LH.N / ITW.N / XOM.N / HSY.N / AMT.N / RMD.N / LIN.N / WST.N / DVA.N / RSG.N / AJG.N / MCO.N / MHK.N / AOS.N / ABMD.OQ / AAPL.OQ / HBAN.OQ / MSFT.OQ / TROW.OQ / GILD.OQ / AMZN.OQ / VRSN.OQ / CMCSA.OQ / 0700.HK / MPWR.OQ / DXCM.OQ / RDSa.L / ICE.N / MA.N / 9999.HK / BIO.N / NLSN.N / BKR.N / LKQ.OQ / WDC.OQ / FTV.N / XEL.OQ / CBRE.N / LYFT.OQ / PINS.N / BYND.OQ / UBER.N / ZM.OQ / 9988.HK / CARR.N / 9618.HK / AEP.OQ / ABNB.OQ / WTY.F</td><td class="leftalignment">Starbucks Corp / Baxter International Inc / BP PLC / CMS Energy Corp / Eastman Chemical Co / Hartford Financial Services Group Inc / International Business Machines Corp / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Northrop Grumman Corp / Schlumberger NV / Stanley Black & Decker Inc / Molson Coors Beverage Co / Textron Inc / Halliburton Co / Teleflex Inc / FirstEnergy Corp / Caterpillar Inc / Yum! Brands Inc / Stryker Corp / Laboratory Corporation of America Holdings / Illinois Tool Works Inc / Exxon Mobil Corp / Hershey Co / American Tower Corp / Resmed Inc / Linde PLC / West Pharmaceutical Services Inc / DaVita Inc / Republic Services Inc / Arthur J Gallagher & Co / Moody's Corp / Mohawk Industries Inc / A O Smith Corp / ABIOMED Inc / Apple Inc / Huntington Bancshares Inc / Microsoft Corp / T Rowe Price Group Inc / Gilead Sciences Inc / Amazon.com Inc / Verisign Inc / Comcast Corp / Tencent Holdings Ltd / Monolithic Power Systems Inc / Dexcom Inc / Royal Dutch Shell PLC / Intercontinental Exchange Inc / Mastercard Inc / NetEase Inc / Bio Rad Laboratories Inc / Nielsen Holdings PLC / Baker Hughes Co / LKQ Corp / Western Digital Corp / Fortive Corp / Xcel Energy Inc / CBRE Group Inc / Lyft Inc / Pinterest Inc / Beyond Meat Inc / Uber Technologies Inc / Zoom Video Communications Inc / Alibaba Group Holding Ltd / Carrier Global Corp / JD.Com Inc / American Electric Power Company Inc / Airbnb Inc / Willis Towers Watson PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United Kingdom / Ireland / United States / Curaçao</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q3 Beat, Guidance Raised</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRK.N - Event Brief of Merck & Co Inc conference call, Oct. 28, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRK.N - Event Transcript of Merck & Co Inc conference call, Oct. 28, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">MRK: Beat & Raise Quarter Driven by Keytruda & Gardasil (Stocking & Demand); Sales-Driven EPS Leverage Modestly Bolstered by Tax Benefit</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2778844</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Sunrise And Smiles, First Look At 3Q21 Sales And EPS Beat</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for MRK</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">LLY: Model Update Post 3Q21 Earnings</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2516152 / 5671735 / 0989529 / 0925288 / 2126335 / 2778844 / 7103065 / BHC8X90</td><td class="leftalignment">Eli Lilly and Co / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US -  Dividend Quality Analysis, for the period ended September 29,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O / BIOb / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US -  Dividend Quality Analysis, for the period ended October 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">JNJ-US -  Dividend Quality Analysis, for the period ended September 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">JNJ / ABT / LLY / MDT / MRK / NVS / PFE / SYK / GILD.O / GSK / SNY.O</td><td class="leftalignment">Johnson & Johnson / Abbott Laboratories / Eli Lilly and Co / Medtronic PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / Stryker Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What To Expect From Bristol Myers Squibb Stock After Q3 Results?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What To Expect From Merck's Q3?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AIN / MRK=US / BMY=US / HD=US / KO=US / MCD=US / PG=US / WEN=US / MDT=US / PD=US / T=US / DT=US / BLD=US / INCY=US / CPE=US / H=US / LOW=US / ENR=US / HSII=US / BRO=US / MAR=US / EXPE=US / LEG=US / VMC=US / HLT=US / NWL=US / MLM=US / FLO=US / STZ=US / KFY=US / SWIM=US / CBRL=US / CENT=US / CHD=US / CSTR=US / CCK=US / DRI=US / EPC=US / GFF=US / IBP=US / NOW=US / MAS=US / MHK=US / MCRI=US / TEAM=US / OI=US / REGI=US / SMG=US / TRIP=US / POST=US / SNOW=US / CGEN=US / BKNG=US / BDN=US / CNM=US / FB=US / GBCI=US / REG=US / BE=US / DIN=US / MGPI=US / MNST=US / NOMD=US / TPX=US / EXP=US / BECN=US / PLAY=US / BAH=US / FRPT=US / DENN=US / THS=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / ELF=US / AWI=US / OC=US / SAIC=US / TAST=US / QSR=US / PRPL=US / NOG=US / JACK=US / RCUS=US / AAN=US / UTZ=US / TREX=US / RLJ=US / FBHS=US / MTDR=US / SPLK=US / TILE=US / IBTX=US / TMUS=US / NDLS=US / CNCE=US / QURE=US / GOOGL=US / 00770K202 / LOCO=US / NEWR=US / SHAK=US / WING=US / ARGX=US / 82982L103 / EVBG=US / TRVG=US / ANAB=US / JELD=US / AYX=US / PETQ=US / KDP=US / SITC=US / ESTC=US / APLT=US / FERG=US / DDOG=US / BRBR=US / GMAB=US / IMVT=US / REYN=US / AZEK=US / AZYO=US / ABNB=US / HYFM=US / 67421J108 / DNUT=US / SNPO=US / EWCZ=US / PKG=U / ROIV=US</td><td class="leftalignment">Albany International Corp / Merck & Co Inc / Bristol-Myers Squibb Co / Home Depot Inc / Coca-Cola Co / McDonald's Corp / Procter & Gamble Co / Wendys Co / Medtronic PLC / PagerDuty Inc / AT&T Inc / Dynatrace Inc / TopBuild Corp / Incyte Corp / Callon Petroleum Co / Hyatt Hotels Corp / Lowe's Companies Inc / Energizer Holdings Inc / Heidrick & Struggles International Inc / Brown & Brown Inc / Marriott International Inc / Expedia Group Inc / Leggett & Platt Inc / Vulcan Materials Co / Hilton Worldwide Holdings Inc / Newell Brands Inc / Martin Marietta Materials Inc / Flowers Foods Inc / Constellation Brands Inc / Korn Ferry / Latham Group Inc / Cracker Barrel Old Country Store Inc / Central Garden & Pet Co / Church & Dwight Co Inc / CapStar Financial Holdings Inc / Crown Holdings Inc / Darden Restaurants Inc / Edgewell Personal Care Co / Griffon Corp / Installed Building Products Inc / ServiceNow Inc / Masco Corp / Mohawk Industries Inc / Monarch Casino & Resort Inc / Atlassian Corporation PLC / O-I Glass Inc / Renewable Energy Group Inc / Scotts Miracle-Gro Co / Tripadvisor Inc / Post Holdings Inc / Snowflake Inc. / Compugen Ltd / Booking Holdings Inc / Brandywine Realty Trust / Core & Main Inc / Meta Platforms Inc / Glacier Bancorp Inc / Regency Centers Corp / Bloom Energy Corp / Dine Brands Global Inc / MGP Ingredients Inc / Monster Beverage Corp / Nomad Foods Ltd / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Booz Allen Hamilton Holding Corp / Freshpet Inc / Denny's Corp / TreeHouse Foods Inc / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / elf Beauty Inc / Armstrong World Industries Inc / Owens Corning / Science Applications International Corp / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Northern Oil and Gas Inc / Jack in the Box Inc / Arcus Biosciences Inc / Aaron's Company Inc / UTZ Brands Inc / Trex Company Inc / RLJ Lodging Trust / Fortune Brands Home & Security Inc / Matador Resources Co / Splunk Inc / Interface Inc / Independent Bank Group Inc / T-Mobile US Inc / Noodles & Co / Concert Pharmaceuticals Inc / Uniqure NV / Alphabet Inc / Aemetis Inc / El Pollo Loco Holdings Inc / New Relic Inc / Shake Shack Inc / Wingstop Inc / argenx SE / SiteOne Landscape Supply Inc / Everbridge Inc / Trivago NV / AnaptysBio Inc / JELD-WEN Holding Inc / Alteryx Inc / PetIQ Inc / Keurig Dr Pepper Inc / Site Centers Corp / Elastic NV / Applied Therapeutics Inc / Ferguson PLC / Datadog Inc / Bellring Brands Inc / Genmab A/S / Immunovant Inc / Reynolds Consumer Products Inc / Azek Company Inc / Aziyo Biologics Inc / Airbnb Inc / Hydrofarm Holdings Group Inc / Oatly Group AB / Krispy Kreme Inc / Snap One Holdings Corp / European Wax Center Inc / Packaging Corp of America / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">The Insight Partners</td><td class="leftalignment">Merck KGaA in Global Tert Butanol Market, Company SWOT Analysis and Profile</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK=DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Chemicals / Industrial Materials</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2434209 / 2126335 / 2516152 / 2000019 / 2778844 / 2050832 / 2026242 / 2270726 / 2542049 / 2317087 / 2100920 / 2455965 / 2684703 / 2799351 / 2503529 / 7103065 / 2857817 / B125XQ6 / B3D7K31 / B03PGL4 / B7TL820 / B7VD3F2 / BFLR866 / BVVN4Q8 / BQPVQZ6 / BD8DJ71 / BJFSR88 / BJ2Z0H2 / BJJMGL2 / BFXC911 / BKTNTR9 / BYY88Y7 / BFYVZ75 / BP96C52 / BMDTR28</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Home Depot Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Ameren Corp / American Electric Power Company Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / FirstEnergy Corp / Biogen Inc / Pfizer Inc / Sinclair Broadcast Group Inc / World Wrestling Entertainment Inc / Novartis AG / Netflix Inc / Portland General Electric Co / Discovery Inc / NorthWestern Corp / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Eversource Energy / Horizon Therapeutics PLC / Snap Inc / Uniqure NV / Pinterest Inc / Fox Corp / Guardant Health Inc / ViacomCBS Inc / Alphabet Inc / Seelos Therapeutics Inc / Surrozen Inc / First Watch Restaurant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">Healthcare Pulse Check: Euro Credit Sector Update : Supply constraints and labour costs loom; early Q3 reporters appear immune</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">MRCG.DE / GSK.L</td><td class="leftalignment">Merck KGaA / GlaxoSmithKline PLC</td><td class="leftalignment">FIXED INCOME - HIGH YIELD</td><td class="leftalignment">Germany / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / FOREIGN EXCHANGE / CURRENCIES / INDUSTRY REPORTS / Equity</td><td class="leftalignment">Danielle Ward / Mr. Adam Bodor</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">JNJ-US Company reports financial results for the quarter ended October 04,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ / ABT / LLY / MDT / MRK / NVS / PFE / SYK / GILD.O / GSK / SNY.O</td><td class="leftalignment">Johnson & Johnson / Abbott Laboratories / Eli Lilly and Co / Medtronic PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / Stryker Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Video Call to Discuss New and Existing Treatments For Pulmonary Arterial Hypertension (PAH) on Dec. 7 at 1PM EST</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">JNJ / MRK / PFE / INSM</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Insmed Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 15, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Positive Islatravir PIII Results Bode Well For Potential Long-Acting Combos</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US3755581036 / US58933Y1055</td><td class="leftalignment">Gilead Sciences Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tyler M. Van Buren / Tara Bancroft, Ph.D. / Brittany Woods, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Model Updated In Advance Of Q3 Results And Other Upcoming Events</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">10/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">THIS FRIDAY: Please Join Our KOL Video Call to Discuss Discounted Pricing Strategies for PD-1/PD-L1 Inhibitors at 1:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK / CKPT</td><td class="leftalignment">Merck & Co Inc / Checkpoint Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Jennifer M. Kim / Louise Chen / Brandon Folkes, CFA / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">10/24/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.3% Above Pre-Pandemic Base- Week 81</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">10/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">NEW SPEAKER ADDED: Please Join Our KOL Video Call to Discuss SITC 2021 and ASH 2021 Abstracts on Friday, November 5 at 11:30 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">HCM / JNJ / LLY / MRK / PFE / ARAV / IMAB</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Aravive Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">0989529 / 2000019 / 2778844 / 2732635 / 2113393 / 2216850 / 2270726 / 2317087 / 2328915 / 2367480 / 2515030 / 2684703 / 2440637 / 2862532 / 2138158 / 2825933 / 2900335 / B0X7DZ3 / B3D7K31 / 2598246 / B7TL820 / B8L2798 / BFLR866 / BVVN4Q8 / BNGY4Q0 / BXDZ9Z0 / BD9GVY0 / BD8DJ71 / BR4T3B3 / BJ2Z0H2 / BFZ1K46 / BZ1LFG7 / BYY88Y7 / BKX9VD3 / BD6JX35 / BNGJQZ8 / BMGGJK8 / BMW15J8 / BYYGK12</td><td class="leftalignment">AstraZeneca PLC / Amazon.com Inc / Merck & Co Inc / AutoNation Inc / Boston Beer Company Inc / Consolidated Edison Inc / Walt Disney Co / Entergy Corp / Nextera Energy Inc / Genuine Parts Co / Lithia Motors Inc / Pfizer Inc / CenterPoint Energy Inc / E W Scripps Co / Sempra Energy / South Jersey Industries Inc / Tractor Supply Co / Chipotle Mexican Grill Inc / Discovery Inc / Neogenomics Inc / Meta Platforms Inc / Hemisphere Media Group Inc / Twitter Inc / Eversource Energy / Nextera Energy Partners LP / Shopify Inc / Zai Lab Ltd / Snap Inc / HubSpot Inc / Pinterest Inc / Spotify Technology SA / Roku Inc / Alphabet Inc / Arcutis Biotherapeutics Inc / Krystal Biotech Inc / Porch Group Inc / Valneva SE / Renalytix PLC / TPI Composites Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">10/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Pneu Appreciation for Pneumococcal Franchise After ACIP Win</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">58933Y10</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="even"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Merck & Co. , Inc.</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Top of the Charts - A review of the week's best reads</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">BARC.L / HSBA.L / LLOY.L / PHG.AS / PSON.L / RWEG.F / VWS.CO / AZN.L / SASY.PA / MRCG.DE / FROTO.IS / LONN.S / NG.L / HNRGN.DE / NKT.CO / NWG.L / MAERSKB.CO / ASOS.L / DRX.L / MONY.L / TRIFOR.CO / EONGN.DE / BOOH.L / DHER.DE / SGREN.MC / MEDA.S / EPIRA.ST / MOVE.S / ADEA.OL / NETW.L / PRX.AS / JETJ.L / GJFG.OL</td><td class="leftalignment">Barclays PLC / HSBC Holdings PLC / Lloyds Banking Group PLC / Koninklijke Philips NV / Pearson PLC / Rwe AG / Vestas Wind Systems A/S / AstraZeneca PLC / Sanofi SA / Merck KGaA / Ford Otomotiv Sanayi AS / Lonza Group AG / National Grid PLC / Hannover Rueck SE / Nkt A/S / Natwest Group PLC / AP Moeller - Maersk A/S / ASOS PLC / Drax Group PLC / Moneysupermarket.Com Group PLC / Trifork Holding AG / E.ON SE / boohoo group plc / Delivery Hero SE / Siemens Gamesa Renewable Energy SA / Medartis Holding AG / Epiroc AB / Medacta Group SA / Adevinta ASA / Network International Holdings PLC / Prosus NV / Just Eat Takeaway.com NV / Gjensidige Forsikring ASA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Austria / Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Italy / Netherlands / Norway / Sweden / Turkey / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Joelle Anamooto Natzkoff / Mr. Richard A. Kersley / Hafsa Yasir</td></tr>
<tr class="even"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IPN.PA: Ipsen - 3Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">IPN.PA / RECI.MI / LUN.CO / NOVN.S / MRCG.DE / LONN.S / UCB.BR / EXEL.OQ / ORNBV.HE / ALM.MC / GRLS.MC / VIFN.S / GMAB.CO</td><td class="leftalignment">Ipsen SA / Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Novartis AG / Merck KGaA / Lonza Group AG / Ucb SA / Exelixis Inc / Orion Oyj / Almirall SA / Grifols SA / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Video Call to Discuss Discounted Pricing Strategies for PD-1/PD-L1 Inhibitors on Friday, October 29 at 1:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">CKPT / MRK</td><td class="leftalignment">Checkpoint Therapeutics Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Jennifer M. Kim / Louise Chen / Brandon Folkes, CFA / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">10/21/2021</td><td class="leftalignment">CG Capital</td><td class="leftalignment">Recruitment Suspension PDSB/NCI Trial Non-Event; Reiterate Buy, $18</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PDSB=US / MRK=US</td><td class="leftalignment">PDS Biotechnology Corp / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Team Coverage</td></tr>
<tr class="odd"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ACIP Pneumococcal Update: PFE's PCV20 Doesn't Land a Preferred Recommendation, but No Follow Up Shot w/ MRK's Pneumovax Supports Winner Take All View</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2778844</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Evan B. Wang / Tarun Soni</td></tr>
<tr class="even"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / BMY=US / TWTR=US / EFX=US / AMZN=US / T=US / BLD=US / KMI=US / CMA=US / PEB=US / SLG=US / BC=US / H=US / TRU=US / CONE=US / V=US / MTN=US / VZ=US / CCI=US / THC=US / MAR=US / UMPQ=US / LSTR=US / TNL=US / HLT=US / WTFC=US / AIR=US / ELY=US / FUN=US / CHH=US / DRH=US / EEFT=US / HAS=US / IBP=US / HZO=US / MAS=US / MAT=US / PII=US / SNAP=US / THO=US / WW=US / WGO=US / GOLF=US / PYPL=US / FMBI=US / FB=US / FR=US / NLS=US / NFLX=US / STRO=US / BIIB=US / EXP=US / BECN=US / SHO=US / DENN=US / XM=US / GMS=US / HST=US / MA=US / SIX=US / AWI=US / OC=US / WH=US / SEAS=US / CWH=US / JACK=US / HGV=US / RLJ=US / VAC=US / MTDR=US / SPLK=US / RHP=US / TILE=US / FOXF=US / FATE=US / MBUU=US / GOOGL=US / AFMD=US / ANTM=US / BVH=US / MCFT=US / SQ=US / CRSP=US / PK=US / 50189K103 / PLYA=US / FNKO=US / LAZY=US / HWC=US / ALLO=US / TCRR=US / FERG=US / XAIR=US / ONEW=US / SQSP=US / HLLY=US / PKG=U</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Twitter Inc / Equifax Inc / Amazon.com Inc / AT&T Inc / TopBuild Corp / Kinder Morgan Inc / Comerica Inc / Pebblebrook Hotel Trust / SL Green Realty Corp / Brunswick Corp / Hyatt Hotels Corp / TransUnion / CyrusOne Inc / Visa Inc / Vail Resorts Inc / Verizon Communications Inc / Crown Castle International Corp / Tenet Healthcare Corp / Marriott International Inc / Umpqua Holdings Corp / Landstar System Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Wintrust Financial Corp / AAR Corp / Callaway Golf Co / Cedar Fair LP / Choice Hotels International Inc / Diamondrock Hospitality Co / Euronet Worldwide Inc / Hasbro Inc / Installed Building Products Inc / MarineMax Inc / Masco Corp / Mattel Inc / Polaris Inc / Snap Inc / Thor Industries Inc / WW International Inc / Winnebago Industries Inc / Acushnet Holdings Corp / PayPal Holdings Inc / First Midwest Bancorp Inc / Meta Platforms Inc / First Industrial Realty Trust Inc / Nautilus Inc / Netflix Inc / Sutro Biopharma Inc / Biogen Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Denny's Corp / Qualtrics International Inc / GMS Inc / Host Hotels & Resorts Inc / Mastercard Inc / Six Flags Entertainment Corp / Armstrong World Industries Inc / Owens Corning / Wyndham Hotels & Resorts Inc / SeaWorld Entertainment Inc / Camping World Holdings Inc / Jack in the Box Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Matador Resources Co / Splunk Inc / Ryman Hospitality Properties Inc / Interface Inc / Fox Factory Holding Corp / Fate Therapeutics Inc / Malibu Boats Inc / Alphabet Inc / Affimed NV / Anthem Inc / Bluegreen Vacations Holding Corp / Mastercraft Boat Holdings Inc / Block Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / LCI Industries / Playa Hotels & Resorts NV / Funko Inc / Lazydays Holdings Inc / Hancock Whitney Corp / Allogene Therapeutics Inc / TCR2 Therapeutics Inc / Ferguson PLC / Beyond Air Inc / OneWater Marine Inc / Squarespace Inc / Holley Inc / Packaging Corp of America</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Engaging serial killer (NK) cells to target cancer - Initiating with a Buy, PT $10/sh</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">AFMD=US / MRK=US / BMY=US / STRO=US / FATE=US</td><td class="leftalignment">Affimed NV / Merck & Co Inc / Bristol-Myers Squibb Co / Sutro Biopharma Inc / Fate Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Srikripa Devarakonda, PHD / Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ORNBV.HE: Orion - 3Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ORNBV.HE / RECI.MI / LUN.CO / MRCG.DE / LONN.S / UCB.BR / IPN.PA / ALM.MC / GRLS.MC / BAYGN.DE / VIFN.S / GMAB.CO</td><td class="leftalignment">Orion Oyj / Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Ipsen SA / Almirall SA / Grifols SA / Bayer AG / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharmaceuticals: 'Safe harbor' in a cost-inflation storm</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AZN.L / SASY.PA / PFE.N / RECI.MI / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / LONN.S / GSK.L / UCB.BR / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / 207940.KS / GMAB.CO</td><td class="leftalignment">AstraZeneca PLC / Sanofi SA / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Lonza Group AG / GlaxoSmithKline PLC / Ucb SA / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Samsung Biologics Co Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Italy / Korea, Republic of / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Equity Strategy: A part of the barbell: upgrade big cap pharma [slide deck]</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / MRCG.DE / VIFN.S</td><td class="leftalignment">AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Merck KGaA / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Mr. Andrew W. Garthwaite / Mr Robert C. Griffiths / Asim Ali / Nasr Islam</td></tr>
<tr class="odd"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Equity Strategy: A part of the barbell: upgrade big cap pharma</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / MRCG.DE / VIFN.S</td><td class="leftalignment">AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Merck KGaA / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / PORTFOLIO/ASSET STRATEGIES / Investment Strategy / Equity</td><td class="leftalignment">Mr. Andrew W. Garthwaite / Mr Robert C. Griffiths / Asim Ali / Nasr Islam</td></tr>
<tr class="even"><td class="leftalignment">10/21/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">ACIP Endorsement of PCV15 Trims Upside for PFE, Still Plenty of Opp'ty; PT $50</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">71708110 / 58933Y10</td><td class="leftalignment">Pfizer Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">MRK Pneumo Recovers to Equal Footing From ACIP, Expanded Indications for All</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK.N / 71708110 / 58933Y10</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Daniel Tarjan, Ph.D. / Dilip Joseph / Na Sun / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Sector Report - High Yield Health Care: Italy - one of the leading pharmaceutical markets</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">AMPF.MI / PFE.N / AZN.L / SASY.PA / MRCG.DE / GSK.L</td><td class="leftalignment">Amplifon SpA / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Merck KGaA / GlaxoSmithKline PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Italy / United States</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Conglomerates / Consumer / Cosmetics & Personal Care / Defense / Electrical / Electronics / Engineering & Construction / Environmental Services / Food / Healthcare / Household Products / Industrial Materials / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Photography / Publishing / Railroads / Retailing / Services / Shipping & Shipbuilding / Tire & Rubber / Transportation / Internet / Marketing</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CREDIT</td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / INDUSTRY REPORTS / Equity</td><td class="leftalignment">Frau Silke Stegemann</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">CG Capital</td><td class="leftalignment">Current Dip Buying Opportunity; Reiterate OUTPERFORM Rating-Target $18</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PDSB=US / MRK=US / SSKN=US</td><td class="leftalignment">PDS Biotechnology Corp / Merck & Co Inc / STRATA Skin Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Team Coverage</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Merck & Co., Inc.(MRK) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">58933Y105</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">2000019 / 2778844 / 2216850 / 2270726 / 2542049 / 2317087 / 2328915 / 2515030 / 2684703 / 2048804 / 2138158 / 2825933 / 2829601 / 4595739 / B1HMF22 / B1Y9TB3 / 2857817 / 2983563 / B3D7K31 / B28TS42 / 2949758 / B7TL820 / BP4GNK9 / BYZLV46 / BD8DJ71 / BKTNTR9 / BJVR9Y9 / BZ1LFG7 / BYY88Y7 / BDZ30Q0 / BN2R582 / BLBLMD5 / BMDJ085 / BNTB3N8 / BWC52Q6</td><td class="leftalignment">Amazon.com Inc / Merck & Co Inc / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Nextera Energy Inc / Lithia Motors Inc / Pfizer Inc / Pinnacle West Capital Corp / Sempra Energy / South Jersey Industries Inc / Southern Co / Genmab A/S / First Solar Inc / Danone SA / Netflix Inc / Carmax Inc / Discovery Inc / Ulta Beauty Inc / Nexstar Media Group Inc / Meta Platforms Inc / SAGE Therapeutics Inc / InflaRx NV / Snap Inc / ViacomCBS Inc / iHeartMedia Inc / Roku Inc / Alphabet Inc / Arvinas Inc / Relay Therapeutics Inc / Array Technologies Inc / Shoals Technologies Group Inc / Vizio Holding Corp / Solaredge Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Denmark / France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Korea Healthcare Sector - Readacross from JNJ 3Q21 results and Roche/Atea's Ph-2 update on oral COVID drug candidate</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">068270.KS / 091990.KQ / JNJ.N / MRK.N / PFE.N / AMGN.OQ / 000100.KS / RO.S / 006280.KS / MRNA.OQ</td><td class="leftalignment">Celltrion Inc / Celltrion Healthcare Co Ltd / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / Yuhan Corp / Roche Holding AG / Green Cross Corp / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Korea, Republic of / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">CoroNation Update: Laterals from AVIR AT-527 MOONSONG Results</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2778844 / 2684703</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Evan B. Wang / Tarun Soni</td></tr>
<tr class="even"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck & Co Inc: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Oct 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MOGa / HEI.N / FR0000054470 / BE0165385973 / US0079031078 / US0123481089 / US01741R1023 / US0311621009 / US0382221051 / US0463531089 / US0970231058 / US0997241064 / US1101221083 / US1442851036 / US2358511028 / US2855121099 / US3695501086 / US37733W1053 / US4228061093 / US4282911084 / US4385161066 / US4523271090 / US4781601046 / US5128071082 / US5324571083 / US5398301094 / US55306N1046 / US5949181045 / US6668071029 / US66987V1098 / US6701002056 / US7170811035 / US7475251036 / US7711951043 / US8356993076 / US8740541094 / US8835561023 / US8968181011 / US91307C1027 / US9807451037 / CA0977512007 / IL0010824113 / JP3435000009 / US92343X1000 / US80105N1054 / US1167941087 / US6098391054 / US8936411003 / US8485741099 / US00507V1098 / CA9609083097 / CA0585861085 / US58933Y1055 / US5218652049 / US34959E1091 / US1920051067 / US88160R1014 / US69404D1081 / US29082A1079 / US92839U2069 / US4464131063 / JE00B783TY65 / US03027X1000 / US98986T1088 / US29414B1044 / US00287Y1091 / US98978V1035 / US81762P1021 / US72919P2020 / US6974351057 / US63009R1095 / US29664W1053 / US60468T1051 / NL0010696654 / US9222801022 / US09062W2044 / US98936J1016 / US04523Y1055 / US22822V1017 / US30050B1017 / GB00BZ09BD16 / US98138J2069 / US07725L1026 / US90138F1021 / US78410G1040 / US23355L1061 / US03236M2008 / US98980G1022 / US92336X1090 / US2575541055 / US01671P1003 / US28414H1032 / US90184D1000 / IL0011571556 / US03828A1016 / US22788C1053 / US5024311095 / US88025U1097 / US18915M1071 / US85205L1070 / US1567271093 / US4432011082 / US75513E1010 / US6541101050 / GB00BMVP7Y09 / US75943R1023 / US8334451098 / US03044L1052 / US22041X1028 / US38246G1085 / US33813J1060 / US81578P1066 / US00810F1066 / US72815L1070 / US67080N1019 / LU2314763264 / US49926T1043 / US90089L1089 / US90364P1057 / US68622V1061 / US23954D1090 / US81730H1095 / US28489L1044 / US30049H1023 / IL0011786154 / US3696043013 / US75340L1044 / US00091E1091 / CA50202P1053 / US45254E1073 / IL0011794802 / US34631B1017 / US90240B1061 / IL0011796625 / US00152K1016 / US8852601090 / US1095041000 / US2297901009</td><td class="leftalignment">Moog Inc / HEICO Corp / Ubisoft Entertainment SA / Melexis NV / Advanced Micro Devices Inc / Albany International Corp / Allegheny Technologies Inc / Amgen Inc / Applied Materials Inc / AstraZeneca PLC / Boeing Co / Borgwarner Inc / Bristol-Myers Squibb Co / Carpenter Technology Corp / Danaher Corp / Electronic Arts Inc / General Dynamics Corp / GlaxoSmithKline PLC / HEICO Corp / Hexcel Corp / Honeywell International Inc / Illumina Inc / Johnson & Johnson / Lam Research Corp / Eli Lilly and Co / Lockheed Martin Corp / MKS Instruments Inc / Microsoft Corp / Northrop Grumman Corp / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Qualcomm Inc / Roche Holding AG / Sony Group Corp / Take-Two Interactive Software Inc / Thermo Fisher Scientific Inc / Triumph Group Inc / United Therapeutics Corp / Woodward Inc / Bombardier Inc / Check Point Software Technologies Ltd / Sony Group Corp / Verint Systems Inc / Sanofi SA / Bruker Corp / Monolithic Power Systems Inc / TransDigm Group Inc / Spirit AeroSystems Holdings Inc / Activision Blizzard Inc / Westport Fuel Systems Inc / Ballard Power Systems Inc / Merck & Co Inc / Lear Corp / Fortinet Inc / Codexis Inc / Tesla Inc / Pacific Biosciences of California Inc / Embraer SA / Visteon Corp / Huntington Ingalls Industries Inc / Aptiv PLC / American Tower Corp / Zynga Inc / Epam Systems Inc / Abbvie Inc / Zoetis Inc / ServiceNow Inc / Plug Power Inc / Palo Alto Networks Inc / NanoString Technologies Inc / Esperion Therapeutics Inc / Mirati Therapeutics Inc / Uniqure NV / Varonis Systems Inc / BioLife Solutions Inc / Zendesk Inc / Aspen Aerogels Inc / Crown Castle International Corp / Evolent Health Inc / Atlassian Corporation PLC / Workhorse Group Inc / Beigene Ltd / Twilio Inc / SBA Communications Corp / DXC Technology Co / Amyris Inc / Zscaler Inc / Veoneer Inc / Domo Inc / Allakos Inc / Elanco Animal Health Inc / Twist Bioscience Corp / Tufin Software Technologies Ltd / Applied Therapeutics Inc / CrowdStrike Holdings Inc / L3harris Technologies Inc / 10X Genomics Inc / Cloudflare Inc / SpringWorks Therapeutics Inc / Cerence Inc / Howmet Aerospace Inc / Raytheon Technologies Corp / Nikola Corp / Royalty Pharma PLC / Relay Therapeutics Inc / Snowflake Inc. / American Well Corp / Corsair Gaming Inc / Goodrx Holdings Inc / Fisker Inc / Seer Inc / AerSale Corp / Playtika Holding Corp / Nuvation Bio Inc / Arrival SA / Knowbe4 Inc / TuSimple Holdings Inc / UiPath Inc / Organon & Co / Day One Biopharmaceuticals Inc / SentinelOne Inc / Electric Last Mile Solutions Inc / Evolv Technologies Holdings Inc / REE Automotive Ltd / General Electric Co / Rapid Micro Biosystems Inc / Absci Corp / Li-Cycle Holdings Corp / Immuneering Corp / Cellebrite DI Ltd / ForgeRock Inc / Tyra Biosciences Inc / Arbe Robotics Ltd / AKA Brands Holding Corp / Thorne Healthtech Inc / Brilliant Earth Group Inc / Cue Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Brazil / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Japan / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2550707 / 2486813 / 2778844 / 2050832 / 2270726 / 2542049 / 2317087 / 2328915 / 2100920 / 2366799 / 2684703 / 2048804 / 2440637 / 2799351 / 2825933 / 2842255 / 2931034 / 7103065 / B01SD70 / 2857817 / B125XQ6 / B3D7K31 / B4N0JJ6 / B7TL820 / B783TY6 / BFLR866 / BNGY4Q0 / BD8DJ71 / BJLKVS6 / BKTHM05 / BYZR4X4 / BMYML02 / BJJMGL2 / BYXJQG9 / BYY88Y7 / BYNQ369 / BNTB3N8 / BMGGJK8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / McDonald's Corp / Kellogg Co / Merck & Co Inc / Ameren Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Gentex Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / Sinclair Broadcast Group Inc / South Jersey Industries Inc / Starbucks Corp / Vertex Pharmaceuticals Inc / Novartis AG / Domino's Pizza Inc / Netflix Inc / Portland General Electric Co / Discovery Inc / Visteon Corp / Meta Platforms Inc / Aptiv PLC / Twitter Inc / Nextera Energy Partners LP / Snap Inc / Phathom Pharmaceuticals Inc / Passage Bio Inc / Axsome Therapeutics Inc / DraftKings Inc / Fox Corp / Spire Inc / Alphabet Inc / Albertsons Companies Inc / Vizio Holding Corp / Valneva SE</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q3:21 Results Preview</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US98978V1035 / US28414H1032 / GB00BMVP7Y09 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Zoetis Inc / Elanco Animal Health Inc / Royalty Pharma PLC / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 8, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">3Q21 EPS preview - model changes & updated perspectives</td><td class="leftalignment">English</td><td class="rightalignment">80</td><td class="leftalignment">US0311621009 / US09062X1037 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">10/17/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Will Johnson & Johnson Stock Rise After Q3 Results?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/17/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.1% Above Pre-Pandemic Base- Week 80</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Healthcare Large Cap 3Q21 Earnings Preview Conference Call TODAY, October 15 at 10:00am ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">HCM / JNJ / LLY / MRK / PFE / ZTS / IMAB</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Zoetis Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">COVID mAbs Still Have Billions in Sales Ahead Despite Orals</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AZN / 04635310 / 75886F10 / 2137 / 58933Y10 / G3910J11</td><td class="leftalignment">AstraZeneca PLC / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Brii Biosciences Ltd / Merck & Co Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Daniel Tarjan, Ph.D. / Na Sun / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / V / 5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2023607 / 2778844 / 2026242 / 2437071 / 2280220 / 2270726 / 2317087 / 2576941 / 2455965 / 2471950 / 2623911 / 2632003 / 2048804 / 2730190 / 2825933 / 2931034 / 4595739 / B00FWN1 / B1F76F9 / B19FQ48 / 2713317 / B01SD70 / 2857817 / B3D7K31 / B7TL820 / BBFL7S1 / B8DPDT7 / BQPVQZ6 / BXDZ9Z0 / BZ1LFB2 / BD8DJ71 / BMQ5T49 / BFZ1K46 / BJJMGL2 / BKTNTR9 / BZ05388 / BDFZSP1 / BK6N347 / BFWK4R7 / BYYWPW6 / BWY52P3 / BYY88Y7 / BDZ30Q0 / BYTJZL1 / BNRQM83 / BJ62Z18</td><td class="leftalignment">American Express Co / Visa Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Merck & Co Inc / American Electric Power Company Inc / Biomarin Pharmaceutical Inc / DTE Energy Co / Walt Disney Co / Entergy Corp / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / New York Times Co / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / South Jersey Industries Inc / Vertex Pharmaceuticals Inc / Genmab A/S / Alnylam Pharmaceuticals Inc / Western Union Co / Amicus Therapeutics Inc / ACADIA Pharmaceuticals Inc / Domino's Pizza Inc / Netflix Inc / Discovery Inc / Meta Platforms Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Horizon Therapeutics PLC / Shopify Inc / Deciphera Pharmaceuticals Inc / Snap Inc / Zentalis Pharmaceuticals Inc / Spotify Technology SA / Fox Corp / ViacomCBS Inc / Global Blood Therapeutics Inc / Okta Inc / Uber Technologies Inc / PagSeguro Digital Ltd / Beigene Ltd / Blueprint Medicines Corp / Alphabet Inc / Arvinas Inc / Zogenix Inc / Petco Health and Wellness Company Inc / Ultragenyx Pharmaceutical Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Denmark / France / United Kingdom / Ireland / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">What's Next in Biotech: RNA-Targeting Small Molecule Drugs? Non-Canonical Roles of Estrogen Receptor (ER) as an RNA Binding Protein</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2778844 / 2576941 / 2455965 / 2684703 / 2931034 / BMQ5T49 / BDZ30Q0</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Exelixis Inc / Biogen Inc / Pfizer Inc / Vertex Pharmaceuticals Inc / Zentalis Pharmaceuticals Inc / Arvinas Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Debjit Chattopadhyay, Ph.D. / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">3Q21 Global Biopharma Preview: Lackluster 3Q Results Won’t Shake Deteriorating Investor Sentiment, but There’s Value Here</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">0989529 / 2126335 / 5671735 / 0925288 / 2516152 / 2778844 / 7103065 / BHC8X90</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Sanofi SA / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">10/13/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Movers & Shakers: Our Thoughts on Potential Upcoming Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">88</td><td class="leftalignment">ALKS / JAZZ / JNJ / MRK / OPTN / INSM / ANIP / MNKD / ZTS</td><td class="leftalignment">Alkermes Plc / Jazz Pharmaceuticals PLC / Johnson & Johnson / Merck & Co Inc / OptiNose Inc / Insmed Inc / ANI Pharmaceuticals Inc / MannKind Corp / Zoetis Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">10/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2023607 / 2778844 / 2050832 / 2206657 / 2317087 / 2684703 / 2799351 / 2825933 / 2900335 / 7103065 / 2712013 / B121557 / 2857817 / 2598246 / B3SWPT2 / B7TL820 / BCZS820 / B7577T2 / BVVN4Q8 / BFZNYB7 / BDHF4K6 / BZ1LFB2 / BR4T3B3 / BZ8VJQ8 / BJFSR99 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BN4RD42 / BNTB3N8 / BMVBZF5 / 120483382</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Merck & Co Inc / Ameren Corp / Coca-Cola Co / Entergy Corp / Pfizer Inc / Sinclair Broadcast Group Inc / South Jersey Industries Inc / Tractor Supply Co / Novartis AG / Global Payments Inc / Mastercard Inc / Netflix Inc / Neogenomics Inc / Ameresco Inc / Meta Platforms Inc / Fate Therapeutics Inc / Renewable Energy Group Inc / Eversource Energy / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Deciphera Pharmaceuticals Inc / HubSpot Inc / Vistra Corp / Revance Therapeutics Inc / ViacomCBS Inc / Roku Inc / Alphabet Inc / CureVac NV / Vizio Holding Corp / Immuneering Corp / Procept Biorobotics Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">10/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">LONN.S: Lonza - 2021 Capital Markets Day - key takeaways</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">LONN.S / A.N / RECI.MI / TMO.N / AZN.L / DHR.N / LUN.CO / MRCG.DE / SATG.DE / CRL.N / UCB.BR / RGEN.OQ / SFZN.S / IPN.PA / ORNBV.HE / ALM.MC / MRNA.OQ / 068270.KS / CTLT.N / 207940.KS / 2269.HK / 091990.KQ / GMAB.CO / PPGN.S</td><td class="leftalignment">Lonza Group AG / Agilent Technologies Inc / Recordati Industria Chimica e Farmaceutica SpA / Thermo Fisher Scientific Inc / AstraZeneca PLC / Danaher Corp / H Lundbeck A/S / Merck KGaA / Sartorius AG / Charles River Laboratories International Inc / Ucb SA / Repligen Corp / Siegfried Holding AG / Ipsen SA / Orion Oyj / Almirall SA / Moderna Inc / Celltrion Inc / Catalent Inc / Samsung Biologics Co Ltd / WuXi Biologics (Cayman) Inc / Celltrion Healthcare Co Ltd / Genmab A/S / PolyPeptide Group AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Italy / Korea, Republic of / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Elizabeth Walton / Ms Jo Walton / Mr. Dominic Lunn / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">10/12/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck KGaA : Key takeaways from our 2021 Conference Call with the CEO of Healthcare</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Richard B. Vosser / James D. Gordon / Ms. Laerke Engkilde / Zain Ebrahim / Mr. Tycho W. Peterson</td></tr>
<tr class="odd"><td class="leftalignment">10/12/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Video Call to Discuss SITC 2021 and ASH 2021 Abstracts on Friday, November 5 at 11:30 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">HCM / JNJ / LLY / MRK / ARAV / IMAB</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Aravive Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">10/12/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Video Call to Discuss What To Expect From RSV Vaccines and Treatments In Development, December 3 at 11:00 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">CDTX / JNJ / MRK / PFE / ARDS</td><td class="leftalignment">Cidara Therapeutics Inc / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Aridis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">10/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 1, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">10/11/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Merck increases 4.4% in 2021</td><td class="leftalignment">English</td><td class="rightalignment">80</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">10/11/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GSK-US -  Dividend Quality Analysis, for the period ended October 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GSK / MRK / NVS / PFE / AZN.O / DVAX.O / THRX.O / TEVA.K / SNY.O</td><td class="leftalignment">GlaxoSmithKline PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / AstraZeneca PLC / Dynavax Technologies Corp / Theseus Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Video Call to Discuss SITC 2021 & ASH 2021 Abstracts on Friday, November 5 at 11:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">HCM / JNJ / LLY / MRK / PFE / ARAV / IMAB</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Aravive Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">NEW SPEAKER ADDED: Please Join Our KOL Video Call to Discuss PDUFA VII & BsUFA III on Wednesday, October 13 at 1:00 PM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">COLL / JAZZ / JNJ / LLY / MRK / ACRS / ACRX / ARDS</td><td class="leftalignment">Collegium Pharmaceutical Inc / Jazz Pharmaceuticals PLC / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / Aridis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">V / 2000019 / 2023607 / 2778844 / 2045623 / 2065159 / 2270726 / 2829515 / 2317087 / 2328915 / 2415204 / 2455965 / 2459020 / 2689560 / 2138158 / 2825933 / 2928683 / 2857817 / B7TL820 / B7VD3F2 / BBPK0J0 / B87ZMX0 / B95N910 / BDZCRX3 / BFZCHN7 / BYZLV46 / BXDZ9Z0 / BZ00V34 / BR4T3B3 / BLGJ610 / BDFZSP1 / BGSP7M9 / BFWK4R7 / BL95N25 / BD6D4Y5 / BWY52P3 / BYY88Y7 / BL71K91 / BN2R582 / BM8MM05 / BMDCDP2 / BKPGJQ1 / BLF0CW7 / BJLV8T9 / 120483382</td><td class="leftalignment">Visa Inc / Amazon.com Inc / Amgen Inc / Merck & Co Inc / ANSYS Inc / Autodesk Inc / Walt Disney Co / Edison International / Entergy Corp / Nextera Energy Inc / Hawaiian Electric Industries Inc / Biogen Inc / Intuit Inc / PG&E Corp / Sempra Energy / South Jersey Industries Inc / VF Corp / Netflix Inc / Meta Platforms Inc / Duke Energy Corp / Mirati Therapeutics Inc / Palo Alto Networks Inc / PTC Inc / RingCentral Inc / Wix.Com Ltd / InflaRx NV / Shopify Inc / Zscaler Inc / HubSpot Inc / Warner Music Group Corp / Okta Inc / Zoom Video Communications Inc / PagSeguro Digital Ltd / Phibro Animal Health Corp / Altair Engineering Inc / Blueprint Medicines Corp / Alphabet Inc / Revolution Medicines Inc / Relay Therapeutics Inc / Madison Square Garden Entertainment Corp / Bigcommerce Holdings Inc / Squarespace Inc / Repare Therapeutics Inc / Celldex Therapeutics Inc / Procept Biorobotics Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">10/10/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.0% Above Pre-Pandemic Base- Week 79</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Healthcare Large Cap 3Q21 Earnings Preview Conference Call on Friday, October 15 at 10:00am ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">HCM / JNJ / LLY / MRK / PFE / ZTS / IMAB</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Zoetis Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Healthcare Small/Mid Cap 3Q21 Earnings Preview Conference Call on Friday, October 22 at 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ALKS / GRAY / JAZZ / JNJ / LLY / MRK / ACRS / ACRX / MNKD / AERI</td><td class="leftalignment">Alkermes Plc / Graybug Vision Inc / Jazz Pharmaceuticals PLC / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / MannKind Corp / Aerie Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">10/08/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">COVID pill mutation risk & why we aren't as concerned</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat / Jonathan Miller</td></tr>
<tr class="odd"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Merck & Co (MRK US) - Positive progression</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="even"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">October 2021 "Monthly Controversies" Report</td><td class="leftalignment">English</td><td class="rightalignment">166</td><td class="leftalignment">US0311621009 / US09062X1037 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">10/08/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Video Call to Discuss PDUFA VII & BsUFA III on Wednesday, October 13 at 1:00 PM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ALKS / GRAY / JAZZ / JNJ / MRK / ACRS / ACRX / MNKD / BCYC</td><td class="leftalignment">Alkermes Plc / Graybug Vision Inc / Jazz Pharmaceuticals PLC / Johnson & Johnson / Merck & Co Inc / Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / MannKind Corp / Bicycle Therapeutics PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Societe Generale</td><td class="leftalignment">Pharmaceuticals & Biotechnology - ESG conference feedback</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AZN.L / BAYGn.DE / SASY.PA / NOVN.S / FMEG.DE / MRCG.DE / GSK.L / IPN.PA</td><td class="leftalignment">AstraZeneca PLC / Bayer AG / Sanofi SA / Novartis AG / Fresenius Medical Care AG & Co KGaA / Merck KGaA / GlaxoSmithKline PLC / Ipsen SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">EQUITY</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Florent Cespedes / Justin S. Smith / Ms. Delphine Le Louet</td></tr>
<tr class="even"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / BSX=US / BMY=US / BXP=US / AMZN=US / GL=US / SLG=US / BC=US / CRK=US / HSII=US / VRM=US / MAR=US / EXPE=US / TTWO=US / ATVI=US / CLI=US / CI=US / KFY=US / AIZ=US / EXEL=US / HZO=US / PDM=US / RARE=US / HOOK=US / REGN=US / SGMO=US / SHOP=US / STRA=US / SNAP=US / TRIP=US / VRTX=US / WIX=US / CGEN=US / HIW=US / BKNG=US / BDN=US / OFC=US / CUZ=US / EPR=US / FB=US / MTCH=US / PRA=US / VNO=US / WRE=US / AMSF=US / AUTL=US / MRNS=US / PTON=US / IGMS=US / JRVR=US / STRO=US / MOH=US / APP=US / EIG=US / APEI=US / TIL=US / NOG=US / KNSL=US / RLJ=US / ANGI=US / EA=US / ABBV=US / MBUU=US / GOOGL=US / BABA=US / CMPR=US / DEA=US / GDDY=US / MCFT=US / LOB=US / PEN=US / SQ=US / CVNA=US / IOVA=US / SFIX=US / FTDR=US / ALLO=US / ESTC=US / HARP=US / LYFT=US / UBER=US / TCRR=US / LSPD=US / PLMR=US / NXTC=US / GMAB=US / ONEW=US / VMEO=US / MNTV=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Bristol-Myers Squibb Co / Boston Properties Inc / Amazon.com Inc / Globe Life Inc / SL Green Realty Corp / Brunswick Corp / Comstock Resources Inc / Heidrick & Struggles International Inc / Vroom Inc / Marriott International Inc / Expedia Group Inc / Take-Two Interactive Software Inc / Activision Blizzard Inc / Veris Residential Inc / Cigna Corp / Korn Ferry / Assurant Inc / Exelixis Inc / MarineMax Inc / Piedmont Office Realty Trust Inc / Ultragenyx Pharmaceutical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Shopify Inc / Strategic Education Inc / Snap Inc / Tripadvisor Inc / Vertex Pharmaceuticals Inc / Wix.Com Ltd / Compugen Ltd / Highwoods Properties Inc / Booking Holdings Inc / Brandywine Realty Trust / Corporate Office Properties Trust / Cousins Properties Inc / EPR Properties / Meta Platforms Inc / Match Group Inc / ProAssurance Corp / Vornado Realty Trust / Washington Real Estate Investment Trust / Amerisafe Inc / Autolus Therapeutics PLC / Marinus Pharmaceuticals Inc / Peloton Interactive Inc / IGM Biosciences Inc / James River Group Holdings Ltd / Sutro Biopharma Inc / Molina Healthcare Inc / Applovin Corp / Employers Holdings Inc / American Public Education Inc / Instil Bio Inc / Northern Oil and Gas Inc / Kinsale Capital Group Inc / RLJ Lodging Trust / Angi Inc / Electronic Arts Inc / Abbvie Inc / Malibu Boats Inc / Alphabet Inc / Alibaba Group Holding Ltd / Cimpress PLC / Easterly Government Properties Inc / GoDaddy Inc / Mastercraft Boat Holdings Inc / Live Oak Bancshares Inc / Penumbra Inc / Block Inc / Carvana Co / Iovance Biotherapeutics Inc / Stitch Fix Inc / Frontdoor Inc / Allogene Therapeutics Inc / Elastic NV / Harpoon Therapeutics Inc / Lyft Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / Lightspeed Commerce Inc / Palomar Holdings Inc / NextCure Inc / Genmab A/S / OneWater Marine Inc / Vimeo Inc / Momentive Global Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Denmark / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Hot or Not? Checking The Temperature of SMID Oncology Subgroups</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK=US / BMY=US / EXEL=US / HOOK=US / REGN=US / CGEN=US / AUTL=US / IGMS=US / STRO=US / TIL=US / IOVA=US / ALLO=US / HARP=US / TCRR=US / NXTC=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Exelixis Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Compugen Ltd / Autolus Therapeutics PLC / IGM Biosciences Inc / Sutro Biopharma Inc / Instil Bio Inc / Iovance Biotherapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / NextCure Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United Kingdom / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Billal Jahangiri</td></tr>
<tr class="even"><td class="leftalignment">10/07/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Merck jumps 35% in 2021</td><td class="leftalignment">English</td><td class="rightalignment">55</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">10/07/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma : 3Q Earnings And Beyond – Inline Results But Several Major Launches On The Horizon</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">ABBV.N / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CAPITALIZATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">10/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">KOL Positive on Molnupiravir, Intrigued by Pfizer, Points of Caution on Atea</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AVIR.OQ / PFE.N / 71708110 / 58933Y10 / 04683R10</td><td class="leftalignment">Atea Pharmaceuticals Inc / Pfizer Inc / Pfizer Inc / Merck & Co Inc / Atea Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Ms. Roanna C. Ruiz / Dilip Joseph</td></tr>
<tr class="odd"><td class="leftalignment">10/07/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">European MedTech & Services: COVID-19 testing impact in 3Q for companies under coverage</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRCG.DE / SATG_p.DE / SBSG.DE / QGEN.N / SHLG.DE / GALE.S / SYAB.DE</td><td class="leftalignment">Merck KGaA / Sartorius AG / Stratec SE / Qiagen NV / Siemens Healthineers AG / Galenica AG / Synlab AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / United Kingdom / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">ACCOUNTING / COMPLIANCE</td><td class="leftalignment">INDUSTRY REPORTS / INTERNAL REPORTS / Equity</td><td class="leftalignment">Mr. Falko Friedrichs / Herr Jan Koch / Sachin Gadilingappa</td></tr>
<tr class="even"><td class="leftalignment">10/07/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Initiating At Neutral: Current Asset Mix Gives Us Pause</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">68622V106 / 717081103 / 031162100 / 09062X103 / 881624209 / 75886F107 / 216648402 / 58933Y105 / 00287Y109 / G30401106 / G97822103 / 03168L105 / 071734107 / 30048L104 / 92556V106</td><td class="leftalignment">Organon & Co / Pfizer Inc / Amgen Inc / Biogen Inc / Teva Pharmaceutical Industries Ltd / Regeneron Pharmaceuticals Inc / Cooper Companies Inc / Merck & Co Inc / Abbvie Inc / Endo International PLC / Perrigo Company PLC / Amneal Pharmaceuticals Inc / Bausch Health Companies Inc / Evofem Biosciences Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">David A. Amsellem / Zachary Sachar / Isaac C. Somekh</td></tr>
<tr class="odd"><td class="leftalignment">10/06/2021</td><td class="leftalignment">Kepler Cheuvreux</td><td class="leftalignment">Best Ideas | Europe | Treat or trick?</td><td class="leftalignment">English</td><td class="rightalignment">64</td><td class="leftalignment">A2.MI / AALB.AS / ACCP.PA / AEGN.AS / AIRP.PA / AKZO.AS / ALSO.PA / ALVG.DE / ASMI.AS / ASML.AS / AXAF.PA / BAER.S / BMWG.DE / BNPP.PA / BOUY.PA / BP.L / CAPP.PA / CARR.PA / CBKG.DE / CPG.L / CRDI.MI / CRH.I / CSGN.S / DAMA.PA / DANO.PA / DAST.PA / DGE.L / DSMN.AS / ENI.MI / ERICb.ST / ERST.VI / EURA.PA / EXHO.PA / FOUG.PA / GFCP.PA / HEIG.DE / HEIN.AS / HNKG.DE / HRMS.PA / ITV.L / LHAG.DE / LOIM.PA / LVMH.PA / MGGT.L / MWDP.PA / OMVV.VI / OREP.PA / PERP.PA / PHG.AS / PRTP.PA / PUBP.PA / RAND.AS / RCOP.PA / RECI.MI / REP.MC / RR.L / RWEG.DE / SAN.MC / SBRY.L / SEBF.PA / SGEF.PA / SGOB.PA / SOGN.PA / SOLB.BR / STM.MI / TCFP.PA / TEF.MC / TSCO.L / TTE / UBIP.PA / VERB.VI / VOLVb.ST / WLSNc.AS / WPP.L / ZURN.S / VOWG_p.DE / AIR.PA / AZN.L / SASY.PA / TKAG.DE / ROG.S / GEBN.S / LUN.CO / DBKGn.DE / SAPG.DE / NOVOb.CO / NOVN.S / BEIG.DE / FMEG.DE / NOKIA.HE / ENEI.MI / MRCG.DE / BBVA.MC / WDPP.BR / PSHG_p.DE / IFXGn.DE / GIVN.S / CARLb.CO / FREG.DE / PUMG.DE / VIE.PA / ADEN.S / CLN.S / UHR.S / DPWGn.DE / QIA.DE / GSK.L / EUFI.PA / DB1Gn.DE / ITX.MC / SOIT.PA / FRAG.DE / AFXG.DE / DLG.MI / UCB.BR / KBC.BR / GN.CO / SRG.MI / CAGR.PA / AM.PA / ORP.PA / ITRK.L / BRBY.L / TENR.MI / HRA.MI / SGSN.S / KNIN.S / TLIT.MI / UMI.BR / SLHN.S / LOGN.S / FIN.S / TEMN.S / STMN.S / BARN.S / LISN.S / SCHP.S / INGA.AS / BALN.S / NESN.S / TRN.MI / EMSN.S / BIOX.PA / LXSG.DE / SAF.PA / MTXGn.DE / RDSa.AS / G1AG.DE / EDF.PA / IPN.PA / MT.AS / CFR.S / VIV.PA / AKE.PA / ADP.PA / HOLN.S / SIKA.S / SY1G.DE / ISP.MI / DWNG.DE / PRY.MI / ATL.MI / SOON.S / DAIGn.DE / CPRI.MI / BOLL.PA / GRLS.MC / GETP.PA / ITPG.MI / DIAS.MI / AMPF.MI / BVI.PA / ICAD.PA / SEVI.PA / EONGn.DE / ABI.BR / EXOR.MI / BAYGn.DE / BNRGn.DE / AGES.BR / EDEN.PA / BASFn.DE / 1913.HK / EVKn.DE / ORAN.PA / ENX.PA / IMCD.AS / CNHI.K / CLNX.MC / INWT.MI / ENGIE.PA / AMUN.PA / ABNd.AS / HLAG.F / AT1.DE / VACN.S / LIGHT.AS / AD.AS / UN01.DE / FORTUM.HE / VIFN.S / DHER.F / DWSG.F / URW.AS / ADYEN.AS / ESLX.PA / LINI.DE / MOWI.OL / DEMANT.CO / ALCC.S / CVO.PA / TEPRF.PA / FDJ.PA / JDEP.AS / ULVR.AS / VTWRn.DE / UMG.AS</td><td class="leftalignment">A2A SpA / Aalberts NV / Accor SA / Aegon NV / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Akzo Nobel NV / Alstom SA / Allianz SE / ASM International NV / ASML Holding NV / AXA SA / Julius Baer Gruppe AG / Bayerische Motoren Werke AG / BNP Paribas SA / Bouygues SA / BP PLC / Capgemini SE / Carrefour SA / Commerzbank AG / Compass Group PLC / UniCredit SpA / CRH PLC / Credit Suisse Group AG / Somfy SA / Danone SA / Dassault Systemes SE / Diageo PLC / Koninklijke DSM NV / Eni SpA / Telefonaktiebolaget LM Ericsson / Erste Group Bank AG / Eurazeo SE / Sodexo SA / Eiffage SA / Gecina SA / HeidelbergCement AG / Heineken NV / Henkel AG & Co KGaA / Hermes International SCA / ITV PLC / Deutsche Lufthansa AG / Klepierre SA / LVMH Moet Hennessy Louis Vuitton SE / Meggitt PLC / Wendel SE / OMV AG / L'Oreal SA / Pernod Ricard SA / Koninklijke Philips NV / Kering SA / Publicis Groupe SA / Randstad NV / Remy Cointreau SA / Recordati Industria Chimica e Farmaceutica SpA / Repsol SA / Rolls-Royce Holdings PLC / Rwe AG / Banco Santander SA / J Sainsbury PLC / SEB SA / Vinci SA / Compagnie de Saint Gobain SA / Societe Generale SA / Solvay SA / STMicroelectronics NV / Thales SA / Telefonica SA / Tesco PLC / TotalEnergies SE / Ubisoft Entertainment SA / Verbund AG / Volvo AB / Wolters Kluwer NV / WPP PLC / Zurich Insurance Group AG / Volkswagen AG / Airbus SE / AstraZeneca PLC / Sanofi SA / thyssenkrupp AG / Roche Holding AG / Geberit AG / H Lundbeck A/S / Deutsche Bank AG / SAP SE / Novo Nordisk A/S / Novartis AG / Beiersdorf AG / Fresenius Medical Care AG & Co KGaA / Nokia Oyj / Enel SpA / Merck KGaA / Banco Bilbao Vizcaya Argentaria SA / Warehouses de Pauw NV / Porsche Automobil Holding SE / Infineon Technologies AG / Givaudan SA / Carlsberg A/S / Fresenius SE & Co KGaA / Puma SE / Veolia Environnement SA / Adecco Group AG / Clariant AG / Swatch Group AG / Deutsche Post AG / Qiagen NV / GlaxoSmithKline PLC / Eurofins Scientific SE / Deutsche Boerse AG / Industria de Diseno Textil SA / Soitec SA / Fraport AG Frankfurt Airport Services Worldwide / Carl Zeiss Meditec AG / De' Longhi SpA / Ucb SA / KBC Groep NV / GN Store Nord A/S / Snam SpA / Credit Agricole SA / Dassault Aviation SA / Orpea SA / Intertek Group PLC / Burberry Group PLC / Tenaris SA / Hera SpA / SGS SA / Kuehne und Nagel International AG / Telecom Italia SpA / Umicore SA / Swiss Life Holding AG / Logitech International SA / Georg Fischer AG / Temenos AG / Straumann Holding AG / Barry Callebaut AG / Chocoladefabriken Lindt & Spruengli AG / Schindler Holding AG / ING Groep NV / Baloise Holding AG / Nestle SA / Terna Rete Elettrica Nazionale SpA / Ems Chemie Holding AG / Biomerieux SA / Lanxess AG / Safran SA / MTU Aero Engines AG / Royal Dutch Shell PLC / GEA Group AG / Electricite de France SA / Ipsen SA / ArcelorMittal SA / Compagnie Financiere Richemont SA / Vivendi SE / Arkema SA / Aeroports de Paris SA / Holcim AG / Sika AG / Symrise AG / Intesa Sanpaolo SpA / Deutsche Wohnen SE / Prysmian SpA / Atlantia SpA / Sonova Holding AG / Daimler AG / Davide Campari Milano NV / Bollore SE / Grifols SA / Getlink SE / Interpump Group SpA / DiaSorin SpA / Amplifon SpA / Bureau Veritas SA / Icade SA / Suez SA / E.ON SE / Anheuser Busch Inbev SA / Exor NV / Bayer AG / Brenntag SE / Ageas SA / Edenred SE / BASF SE / Prada SpA / Evonik Industries AG / Orange SA / Euronext NV / IMCD NV / CNH Industrial NV / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Engie SA / Amundi SA / ABN Amro Bank NV / Hapag Lloyd AG / Aroundtown SA / VAT Group AG / Signify NV / Koninklijke Ahold Delhaize NV / Uniper SE / Fortum Oyj / Vifor Pharma AG / Delivery Hero SE / DWS Group GmbH & Co KgaA / Unibail-Rodamco-Westfield SE / Adyen NV / EssilorLuxottica SA / Linde PLC / Mowi ASA / Demant A/S / Alcon AG / Covivio SA / Teleperformance SE / La Francaise des Jeux SA / JDE Peets NV / Unilever PLC / Vantage Towers AG / Universal Music Group NV</td><td class="leftalignment"></td><td class="leftalignment">Austria / Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Italy / Luxembourg / Netherlands / Norway / Sweden / Jersey</td><td class="leftalignment">Aerospace / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Building & Building Materials / Chemicals / Consumer / Defense / Energy / Financial Services / Food / Healthcare / Household Products / Info. Tech./Computers / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Manufacturing / Media / Metals & Minerals / Pharmaceuticals / Real Estate / Retailing / Services / Telecommunications / Transportation / Utilities / Oil & Gas</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">M. Arnaud Girod</td></tr>
<tr class="even"><td class="leftalignment">10/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Our SITC Planner Highlights 60+ Datapoints Not To Be Missed</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MRK=US / BMY=US / GILD=US / EXEL=US / CGEN=US / TIL=US / RCUS=US / ABBV=US / FATE=US / CRSP=US / IOVA=US / HARP=US / TCRR=US / NXTC=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Exelixis Inc / Compugen Ltd / Instil Bio Inc / Arcus Biosciences Inc / Abbvie Inc / Fate Therapeutics Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / NextCure Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Billal Jahangiri / Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">RSVP For RSV Vaccines And Treatments, Our Deep Dive Suggests Many Potential Blockbuster Opportunities</td><td class="leftalignment">English</td><td class="rightalignment">51</td><td class="leftalignment">CDTX / JNJ / MRK / PFE / GB0009252882 / ARDS / US6700024010</td><td class="leftalignment">Cidara Therapeutics Inc / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / Aridis Pharmaceuticals Inc / Novavax Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / MCD=US / WEN=US / MDT=US / PATH=US / CBRL=US / DRI=US / MHK=US / REGI=US / SAGE=US / OPT=US / CGEN=US / KRT=US / APPN=US / DIN=US / OGN / BIIB=US / NUVA=US / PLAY=US / DENN=US / CMG=US / REX=US / GPRE=US / AWI=US / AMRX=US / TAST=US / QSR=US / JACK=US / PCRX=US / ESTE=US / TILE=US / NDLS=US / FEYE=US / ARCB=US / 00770K202 / LOCO=US / SHAK=US / WING=US / CRMD.US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / McDonald's Corp / Wendys Co / Medtronic PLC / UiPath Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Mohawk Industries Inc / Renewable Energy Group Inc / SAGE Therapeutics Inc / Opthea Ltd / Compugen Ltd / Karat Packaging Inc / Appian Corp / Dine Brands Global Inc / Organon & Co / Biogen Inc / NuVasive Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Chipotle Mexican Grill Inc / REX American Resources Corp / Green Plains Inc / Armstrong World Industries Inc / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Jack in the Box Inc / Pacira Biosciences Inc / Earthstone Energy Inc / Interface Inc / Noodles & Co / Mandiant Inc / ArcBest Corp / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / CorMedix Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AXP / 5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2486813 / 2778844 / 2280220 / 2270726 / 2542049 / 2317087 / 2630085 / 2657802 / 2684703 / 2048804 / 2730190 / 7103065 / B121557 / 2857817 / B3D7K31 / B03PGL4 / B7TL820 / B7VD3F2 / B7577T2 / BFLR866 / BVVN4Q8 / BD8DJ71 / BJ2Z0H2 / BGCYWN8 / BYZM6C2 / BJJMGL2 / BZ1LFG7 / BYY88Y7 / BRJ3GY4 / BD72R64 / BNTB3N8 / BMW5LX6</td><td class="leftalignment">American Express Co / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Kellogg Co / Merck & Co Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Neogen Corp / OGE Energy Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / Novartis AG / Mastercard Inc / Netflix Inc / Discovery Inc / NorthWestern Corp / Meta Platforms Inc / Duke Energy Corp / Renewable Energy Group Inc / Twitter Inc / Eversource Energy / Snap Inc / Pinterest Inc / Xencor Inc / Intellia Therapeutics Inc / Fox Corp / Roku Inc / Alphabet Inc / Xenon Pharmaceuticals Inc / Liberty Media Corp / Vizio Holding Corp / Eliem Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharmaceuticals: Model Book</td><td class="leftalignment">English</td><td class="rightalignment">91</td><td class="leftalignment">RECI.MI / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / LONN.S / GSK.L / UCB.BR / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / VIFN.S / GMAB.CO</td><td class="leftalignment">Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Lonza Group AG / GlaxoSmithKline PLC / Ucb SA / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Italy</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Fr. Barbora Blaha / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston / Herr. Christoph Gretler</td></tr>
<tr class="odd"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: Korea Biologics Sector - Merck's molnupiravir data and read-across to Celltrion stocks</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRCG.DE / 068270.KS / 091990.KQ / LLY.N / PFE.N / ROG.S / GSK.L / REGN.OQ / NVAX.OQ / INO.OQ / MRNA.OQ / CVAC.OQ / ABCL.OQ</td><td class="leftalignment">Merck KGaA / Celltrion Inc / Celltrion Healthcare Co Ltd / Eli Lilly and Co / Pfizer Inc / Roche Holding AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Novavax Inc / Inovio Pharmaceuticals Inc / Moderna Inc / CureVac NV / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / United Kingdom / Korea, Republic of / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Here's Why Merck Stock May Continue To Rise</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">FAB Securities</td><td class="leftalignment">Merck & Co. Inc.-US Market – Stock Picks-10/04/2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">With Acceleron Acquisition Merck Stock Is Likely To See A Multiple Revision</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 24, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / OGN / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Organon & Co / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Stock Looks Fully Valued Based On Opportunities And Risks</td><td class="leftalignment">English</td><td class="rightalignment">98</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Streetwise Reports</td><td class="leftalignment">Merck and Ridgeback Post Interim Data From Phase 3 Antiviral Drug Trial Showing 50% Reductions in Hospitalizations and Deaths in Mild and Moderate COV</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY / INDUSTRY / INVESTMENT STRATEGY / MARKET ANALYSIS / GOVERNMENT RELATIONS/REGULATIONS / INDUSTRY OVERVIEW / MARKET COMMENT / COMMENTARY / OVERVIEW / SECTOR / EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">2021 SITC Planner – IO and Emerging Oncology</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">M2572210 / 640268108 / 58933Y10 / 00653A107 / 98401F10 / 76029N10 / 41358P10 / 09075V10 / N0104510 / 31189P10 / 46565G10 / 78116T10 / 98887Q10 / 87808K10 / N4444510 / 09770210 / 30315R10 / 37230320 / 95075A10</td><td class="leftalignment">Compugen Ltd / Nektar Therapeutics / Merck & Co Inc / Adaptimmune Therapeutics PLC / Xencor Inc / Replimune Group Inc / Harpoon Therapeutics Inc / BioNTech SE / Affimed NV / Fate Therapeutics Inc / Iteos Therapeutics Inc / Rubius Therapeutics Inc / Zai Lab Ltd / TCR2 Therapeutics Inc / Immatics NV / Bolt Biotherapeutics Inc / F-Star Therapeutics Inc / Genmab A/S / Werewolf Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / Denmark / United Kingdom / Hong Kong / Israel / Japan / Netherlands / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daina Graybosch, Ph.D. / Jonathan Chang, Ph.D., CFA / Jeffrey La Rosa / Faisal Khurshid</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Molnupiravir Ignites MRK; PT to $104</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">58933Y10</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">Industrials Calendar : October-December 2021</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">ACF / AIRP.PA / BAX.N / BDX.N / BHP.AX / BMWG.DE / BMY.N / CC.N / CCK.N / CCL.N / CE.N / CRH.L / DSMN.AS / EPED.PA / F.N / FGP.L / GM.N / GOG.L / HEIG.DE / JNJ.N / LHAG.DE / LLY.N / MCK.N / MRK.N / MWDP.PA / NEX.L / PFE.N / PLOF.PA / RENA.PA / RIO.AX / RR.L / RYA.I / SAPJ.J / SAS.ST / SCHN.PA / SGC.L / SGOB.PA / SMIN.L / SOLB.BR / SYD.AX / TCFP.PA / TMO.N / VLLP.PA / VOLVb.ST / VOWG.DE / WBSV.VI / STERV.HE / AIRF.PA / CONG.DE / AZN.L / AMGN.O / AAL.L / SASY.PA / TKAG.DE / ROG.S / SIEGn.F / NOVN.S / MG.TO / FMEG.DE / BZU.MI / MRCG.DE / MGA.N / PSHG_p.DE / OI.N / BLL.N / GLAX.NS / PKI.N / FREG.DE / RXL.PA / EZJ.L / SUP.N / GSK.L / ESI.N / CC@US / MHK.N / TAMO.BO / FLWS.O / VOES.VI / MT.N / LXSG.DE / HUN.N / SAF.PA / TUIGn.DE / MT.AS / LEGD.PA / TEVA.N / SKG.I / MNDI.L / DAIGn.DE / BAES.L / BAYGn.DE / BASFn.DE / GLEN.L / CAR.O / SDFGn.DE / METSB.HE / LKQ.O / XPO.N / GT.O / ABBV.N / GEST.MC / EVKn.DE / CSTM.N / CTLT.N / EUCAR.PA / ZBH.N / 1COV.DE / HLAG.DE / NVGR.LS / ADNT.N / BHC.N / VTRS.O / HON.O</td><td class="leftalignment">Acrow Formwork and Construction Services Ltd / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Baxter International Inc / Becton Dickinson and Co / BHP Group Ltd / Bayerische Motoren Werke AG / Bristol-Myers Squibb Co / Chemours Co / Crown Holdings Inc / Carnival Corp / Celanese Corp / CRH PLC / Koninklijke DSM NV / Faurecia SE / Ford Motor Co / FirstGroup PLC / General Motors Co / Go-Ahead Group PLC / HeidelbergCement AG / Johnson & Johnson / Deutsche Lufthansa AG / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / Wendel SE / National Express Group PLC / Pfizer Inc / Compagnie Plastic Omnium SE / Renault SA / Rio Tinto Ltd / Rolls-Royce Holdings PLC / Ryanair Holdings PLC / Sappi Ltd / SAS AB / Schneider Electric SE / Stagecoach Group PLC / Compagnie de Saint Gobain SA / Smiths Group PLC / Solvay SA / Sydney Airport / Thales SA / Thermo Fisher Scientific Inc / Vallourec SA / Volvo AB / Volkswagen AG / Wienerberger AG / Stora Enso Oyj / Air France KLM SA / Continental AG / AstraZeneca PLC / Amgen Inc / Anglo American PLC / Sanofi SA / thyssenkrupp AG / Roche Holding AG / Siemens AG / Novartis AG / Magna International Inc / Fresenius Medical Care AG & Co KGaA / Buzzi Unicem SpA / Merck KGaA / Magna International Inc / Porsche Automobil Holding SE / O-I Glass Inc / Ball Corp / GlaxoSmithKline Pharmaceuticals Ltd / PerkinElmer Inc / Fresenius SE & Co KGaA / Rexel SA / Easyjet PLC / Superior Industries International Inc / GlaxoSmithKline PLC / Element Solutions Inc / Chemours Co / Mohawk Industries Inc / Tata Motors Ltd / 1-800-Flowers.Com Inc / voestalpine AG / ArcelorMittal SA / Lanxess AG / Huntsman Corp / Safran SA / TUI AG / ArcelorMittal SA / Legrand SA / Teva Pharmaceutical Industries Ltd / Smurfit Kappa Group PLC / Mondi PLC / Daimler AG / BAE Systems PLC / Bayer AG / BASF SE / Glencore PLC / Avis Budget Group Inc / K&S AG / Metsa Board Oyj / LKQ Corp / XPO Logistics Inc / Goodyear Tire & Rubber Co / Abbvie Inc / Gestamp Automocion SA / Evonik Industries AG / Constellium SE / Catalent Inc / Europcar Mobility Group SA / Zimmer Biomet Holdings Inc / Covestro AG / Hapag Lloyd AG / Navigator Company SA / Adient PLC / Bausch Health Companies Inc / Viatris Inc / Honeywell International Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">Australia / Austria / Belgium / Canada / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Hong Kong / India / Ireland / Israel / Italy / Luxembourg / Netherlands / Norway / Panama / Portugal / Sweden / United States / South Africa / Jersey</td><td class="leftalignment">Aerospace / Air Transportation / Automotive / Biotechnology / Building & Building Materials / Chemicals / Conglomerates / Consumer / Containers & Packing / Defense / Electrical / Energy / Engineering & Construction / Financial Services / Healthcare / Household Products / Industrial Materials / Leisure & Entertainment / Lodging & Restaurants / Machinery / Manufacturing / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Railroads / Retailing / Shipping & Shipbuilding / Tire & Rubber / Transportation / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Danielle Ward / Benjamin Defay / Stephanie Vincent / Ed McGuinness / Mr. Adam Bodor</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Over or Underreaction? SVBL Analysts on Molnupiravir and Its Impact</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">91390310 / 75991610 / 91324P10 / 71708110 / 44485910 / 88355610 / 94184810 / 04635310 / 75886F10 / 53245710 / 02343610 / 50187A10 / 58933Y10 / 88033G40 / 87918A10 / 03675210 / 40412C10 / 67181A10 / 42226A10 / 68269G10 / 09075V10 / 60770K10 / G3910J11 / 05370A10 / F5548N10 / 00288U10 / 00404A10 / 12552310 / 04683R10</td><td class="leftalignment">Universal Health Services Inc / Repligen Corp / UnitedHealth Group Inc / Pfizer Inc / Humana Inc / Thermo Fisher Scientific Inc / Waters Corp / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Amedisys Inc / LHC Group Inc / Merck & Co Inc / Tenet Healthcare Corp / Teladoc Health Inc / Anthem Inc / HCA Healthcare Inc / Oak Street Health Inc / Healthequity Inc / 1Life Healthcare Inc / BioNTech SE / Moderna Inc / GlaxoSmithKline PLC / Avidity Biosciences Inc / Sanofi SA / Abcellera Biologics Inc / Acadia Healthcare Company Inc / Cigna Corp / Atea Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Germany / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Mr. Whit Mayo / Stephanie Davis, CFA / Mr. Puneet Souda / Ms. Roanna C. Ruiz</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Daily Credit Briefing</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">ERG.MI / GM.N / 7203.T / BMWG.DE / MRK.N / VOWG.DE / US2283681060 / ORAN.PA / NL00150001Q9</td><td class="leftalignment">ERG SpA / General Motors Co / Toyota Motor Corp / Bayerische Motoren Werke AG / Merck & Co Inc / Volkswagen AG / Crown Holdings Inc / Orange SA / Stellantis NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / France / United Kingdom / Italy / Japan / Netherlands / Sweden / United States</td><td class="leftalignment">Advertising / Aerospace / Air Transportation / Apparel & Textiles / Appliances / Automotive / Biotechnology / Broadcasting & Cable / Building & Building Materials / Conglomerates / Consumer / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Healthcare / Household Products / Industrial Materials / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Photography / Publishing / Railroads / Retailing / Shipping & Shipbuilding / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS / CREDIT</td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Herr. Ulrich Scholz, CFA / Herr Sven Kreitmair, CFA / Herr Jonathan Schroer / Frau Silke Stegemann / Herr Christian Aust / Herr. Stefan Kolek / Herr Tobias Keller</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">V / 2259101 / 2681511 / 2000019 / 2486813 / 2778844 / 2206657 / 2280220 / 2270726 / 2542049 / 2829515 / 2317087 / 2670519 / 2345022 / 2459020 / 2689560 / 2048804 / 2440637 / B0X7DZ3 / B1F76F9 / 2212922 / B1Y9TB3 / 2216991 / 2857817 / 2598246 / B7TL820 / B7VD3F2 / B7JYSG3 / B7577T2 / BVVN4Q8 / BD3W133 / BD8DJ71 / BJ1FD74 / BJLKVS6 / BNFWR44 / BFZ1K46 / BJJMGL2 / BZ8VJQ8 / BFXC911 / BKTNTR9 / BGSP7M9 / BHRWS81 / BZ1LFG7 / BYY88Y7 / BRJ3GY4 / BM8MM05 / BQXZP64 / BM8NHS1 / BF0QTY9 / BMW15J8</td><td class="leftalignment">Visa Inc / Target Corp / PepsiCo Inc / Amazon.com Inc / Kellogg Co / Merck & Co Inc / Coca-Cola Co / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Edison International / Entergy Corp / Exelon Corp / Macy's Inc / Intuit Inc / PG&E Corp / Pinnacle West Capital Corp / CenterPoint Energy Inc / Chipotle Mexican Grill Inc / Western Union Co / NRG Energy Inc / Danone SA / Tempur Sealy International Inc / Netflix Inc / Neogenomics Inc / Meta Platforms Inc / Duke Energy Corp / Guidewire Software Inc / Renewable Energy Group Inc / Eversource Energy / Keurig Dr Pepper Inc / Snap Inc / Revolve Group Inc / Phathom Pharmaceuticals Inc / Worldline SA / Spotify Technology SA / Fox Corp / Vistra Corp / Guardant Health Inc / ViacomCBS Inc / Zoom Video Communications Inc / Levi Strauss & Co / Roku Inc / Alphabet Inc / Xenon Pharmaceuticals Inc / Madison Square Garden Entertainment Corp / Wayfair Inc / Adagio Therapeutics Inc / Chicken Soup for The Soul Entertainment Inc / Renalytix PLC</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - Impact of Merck's COVID small molecule drug molnupiravir on China healthcare</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / GSK.L / REGN.OQ / 2269.HK</td><td class="leftalignment">Merck & Co Inc / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / WuXi Biologics (Cayman) Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HOLT European Specialist Picks Q4 2021</td><td class="leftalignment">English</td><td class="rightalignment">62</td><td class="leftalignment">AUDK.LU / EVOG.ST / AXAF.PA / BAER.S / HEIN.AS / IMI.L / KYGA.I / LGEN.L / OMVV.VI / SAPG.F / SEBA.ST / AZN.L / AAL.L / NOVOB.CO / BEIG.DE / ENEI.MI / MRCG.DE / PUMG.DE / ANDR.VI / SCHP.S / SAF.PA / BUCN.S / GL9.I / SHLG.DE / ZALG.DE / AMUN.PA / TMV.DE / HOLN.PA</td><td class="leftalignment">RTL Group SA / Evolution AB (publ) / AXA SA / Julius Baer Gruppe AG / Heineken NV / IMI PLC / Kerry Group PLC / Legal & General Group PLC / OMV AG / SAP SE / Skandinaviska Enskilda Banken AB / AstraZeneca PLC / Anglo American PLC / Novo Nordisk A/S / Beiersdorf AG / Enel SpA / Merck KGaA / Puma SE / Andritz AG / Schindler Holding AG / Safran SA / Bucher Industries AG / Glanbia PLC / Siemens Healthineers AG / Zalando SE / Amundi SA / TeamViewer AG / Holcim AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Austria / Switzerland / Germany / Denmark / France / United Kingdom / Ireland / Italy / Luxembourg / Netherlands / Sweden</td><td class="leftalignment">Beverages & Tobacco / Consumer / Energy / Financial Services / Food / Healthcare / Industrial Materials / Info. Tech./Computers / Manufacturing / Telecommunications / Utilities</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Helen Booth / HOLT Europe</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Merck KGaA</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">10/03/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Nuanced KOL Commentary On The Narcolepsy And Idiopathic Hypersomnia Landscape</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">58933Y105 / G50871105 / 05337M104 / 413197104</td><td class="leftalignment">Merck & Co Inc / Jazz Pharmaceuticals PLC / Avadel Pharmaceuticals PLC / Harmony Biosciences Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">David A. Amsellem / Zachary Sachar / Isaac C. Somekh</td></tr>
<tr class="odd"><td class="leftalignment">10/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Questions for Management 10.3.21</td><td class="leftalignment">English</td><td class="rightalignment">82</td><td class="leftalignment">00365410 / 28176E10 / 62855J10 / 01988P10 / 00282410 / 45337C10 / 75991610 / 09061G10 / 86366710 / 71708110 / 00846U10 / 44485910 / 45253H10 / 07181310 / 10113710 / 04635310 / 43644010 / 64125C10 / 37555810 / 15678210 / 03116210 / 75886F10 / 46120E60 / 11679410 / M2572210 / 45232710 / 02343610 / 09062X10 / 01625510 / 30063P10 / 478160104 / 640268108 / 075887109 / 00422510 / 02043Q10 / 67070410 / 40637H10 / 207410101 / 205306103 / 45784P10 / 25213110 / 50187A10 / 58502B10 / 04963C20 / 03152W10 / 64049M20 / 58933Y10 / 02311120 / 14161910 / G0176710 / 45766930 / G5087110 / 80360710 / 74051N10 / 05463X10 / 45780L10 / 82621J10 / 31572Q80 / 87918A10 / 46185L10 / 00653A107 / 04351P101 / 03675210 / 75046920 / 00287Y10 / 40412C10 / G5960L10 / 46222210 / 18946410 / 04004760 / 21232630 / 04280A10 / 05337M104 / 23283X20 / 40131M10 / 604749101 / 63230710 / 71944F10 / 45773010 / 05358830 / 38942Q10 / 76029N10 / 41358P10 / N9006410 / 67181A10 / 42226A10 / 68269G10 / 00437E10 / 74939710 / 58949210 / 09627Y10 / 68071010 / 30052C10 / 09075V10 / 60770K10 / 74340E10 / 42225T10 / 00289Y10 / 00773U10 / 01981810 / 05455M10 / 09609G10 / 10806X10 / 45826J10 / 75901B10 / 77313F10 / 05464T10 / 05156V10 / 75615P10 / 16383L10 / 55609910 / N0104510 / 14843C10 / 01438T10 / 74374N10 / 51654410 / 31189P10 / 07725L10 / H0026310 / 00847X10 / 24344T10 / 29428V10 / 37890U10 / 81181C10 / G1119610 / 40422M10 / 04685N10 / 13089P10 / 34633R10 / 37242740 / 38341P10 / 43906K10 / 45781K20 / 46565G10 / 48576U10 / 50127T10 / 61776010 / 60468T10 / 03969F10 / 05370A10 / 78116T10 / 76155X10 / 45845P10 / 4525EP10 / 78667J10 / 82710M10 / 46116X10 / 74366E10 / 37957720 / 22905030 / G8807B10 / 90400D10 / 64157F10 / 74766Q10 / 69014510 / 35961610 / 55886810 / 05454B10 / 49232710 / 22663K10 / 05465P10 / 00461U10 / 04539610 / 81727U10 / 59045L10 / 01671P10 / 68621F10 / 45249V10 / F4373810 / 45332Y10 / 80405P10 / N4482110 / 75955J40 / 56400P70 / 28255910 / 87808K10 / 87166L10 / 03836N10 / 23257D10 / 40434H20 / 28617K10 / 29446K10 / 83422E10 / 03824M10 / N1976T10 / 36322Q10 / N4444510 / 45258J10 / 48349710 / 56854Q20 / 65343C10 / 74623710 / 75974E10 / 16961L10 / 65443P10 / 82939910 / 87410C10 / 19240Q20 / 00288U10 / 36870G10 / 64128810 / 00404A10 / N6960510 / 28036F10 / 51506910 / N5749R10 / 24343R10 / 75629V10 / 26622P10 / 52634L10 / 23003110 / 49705R10 / 38246G10 / 85209E10 / 25056L10 / 09770210 / 82835W10 / N5151710 / 78349D10 / 68386J20 / 30315R10 / 37230320 / 14203810 / 75382E10 / 29251M10 / 81064810 / G637AM10 / 15117B20 / 00038020 / 82489T10 / 00653Q10 / 12552310 / 04683R10 / 01626L10 / 20752310 / 28623U10 / 28658R10 / 38870X10 / 95075A10 / 15673T10 / 60853G10 / 87427V10</td><td class="leftalignment">ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Allscripts Healthcare Solutions Inc / Abbott Laboratories / Incyte Corp / Repligen Corp / Biomarin Pharmaceutical Inc / Stryker Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / ImmunoGen Inc / Baxter International Inc / Boston Scientific Corp / AstraZeneca PLC / Hologic Inc / Neurocrine Biosciences Inc / Gilead Sciences Inc / Cerner Corp / Amgen Inc / Regeneron Pharmaceuticals Inc / Intuitive Surgical Inc / Bruker Corp / Compugen Ltd / Illumina Inc / Amedisys Inc / Biogen Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Nektar Therapeutics / Becton Dickinson and Co / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / NuVasive Inc / Halozyme Therapeutics Inc / Conmed Corp / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / LHC Group Inc / MEDNAX Inc / AtriCure Inc / Amicus Therapeutics Inc / Neogenomics Inc / Merck & Co Inc / Amarin Corporation PLC / Cardiovascular Systems Inc / Alkermes Plc / Insmed Inc / Jazz Pharmaceuticals PLC / Sarepta Therapeutics Inc / Premier Inc / AxoGen Inc / Inogen Inc / Sientra Inc / FibroGen Inc / Teladoc Health Inc / Invitae Corp / Adaptimmune Therapeutics PLC / Ascendis Pharma A/S / Anthem Inc / Radius Health Inc / Abbvie Inc / HCA Healthcare Inc / Medtronic PLC / Ionis Pharmaceuticals Inc / Clovis Oncology Inc / Arena Pharmaceuticals Inc / ContraFect Corp / Arrowhead Pharmaceuticals Inc / Avadel Pharmaceuticals PLC / Cytosorbents Corp / Guardant Health Inc / Mirum Pharmaceuticals Inc / Natera Inc / Phreesia Inc / Inspire Medical Systems Inc / Aveo Pharmaceuticals Inc / Graybug Vision Inc / Replimune Group Inc / Harpoon Therapeutics Inc / Uniqure NV / Oak Street Health Inc / Healthequity Inc / 1Life Healthcare Inc / Accolade Inc / R1 RCM Inc / Mereo Biopharma Group PLC / Blueprint Medicines Corp / Olink Holding AB (publ) / Evolus Inc / BioNTech SE / Moderna Inc / Progyny Inc / Health Catalyst Inc / Abeona Therapeutics Inc / Adverum Biotechnologies Inc / Allovir Inc / AVROBIO Inc / bluebird bio Inc / BridgeBio Pharma Inc / Intellia Therapeutics Inc / Regenxbio Inc / Rocket Pharmaceuticals Inc / Axsome Therapeutics Inc / Aurinia Pharmaceuticals Inc / Reata Pharmaceuticals Inc / ChemoCentryx Inc / MacroGenics Inc / Affimed NV / Castle Biosciences Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Lantheus Holdings Inc / Fate Therapeutics Inc / Beigene Ltd / AC Immune SA / Agios Pharmaceuticals Inc / Deciphera Pharmaceuticals Inc / Epizyme Inc / Global Blood Therapeutics Inc / Seagen Inc / Biohaven Pharmaceutical Holding Company Ltd / H Lundbeck A/S / Athenex Inc / Calithera Biosciences Inc / Forma Therapeutics Holdings Inc / Genocea Biosciences Inc / Gossamer Bio Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Iteos Therapeutics Inc / Karyopharm Therapeutics Inc / Kura Oncology Inc / MorphoSys AG / Mirati Therapeutics Inc / Arcus Biosciences Inc / Avidity Biosciences Inc / Rubius Therapeutics Inc / Revolution Medicines Inc / Intercept Pharmaceuticals Inc / Immunic Inc / SAGE Therapeutics Inc / Silk Road Medical Inc / Intra-Cellular Therapies Inc / Protagonist Therapeutics Inc / Globus Medical Inc / Cryoport Inc / Theravance Biopharma Inc / Ultragenyx Pharmaceutical Inc / Nevro Corp / Quanterix Corp / Outset Medical Inc / Fulcrum Therapeutics Inc / Madrigal Pharmaceuticals Inc / Axcella Health Inc / Keros Therapeutics Inc / Crinetics Pharmaceuticals Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Senseonics Holdings Inc / Mersana Therapeutics Inc / Allakos Inc / Organogenesis Holdings Inc / Imara Inc / Genfit SA / Inari Medical Inc / Satsuma Pharmaceuticals Inc / InflaRx NV / Relmada Therapeutics Inc / MannKind Corp / 89Bio Inc / TCR2 Therapeutics Inc / Synlogic Inc / Aptinyx Inc / Cymabay Therapeutics Inc / HTG Molecular Diagnostics Inc / Eledon Pharmaceuticals Inc / Equillium Inc / Solid Biosciences Inc / Applied Molecular Transport Inc. / Centogene NV / Galecto Inc / Immatics NV / Immunovant Inc / Kalvista Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / NextGen Healthcare Inc / PureTech Health PLC / Reneo Pharmaceuticals Inc / Chinook Therapeutics Inc / 908 Devices Inc. / Sio Gene Therapies Inc / Talaris Therapeutics Inc / Cogent Biosciences Inc / Abcellera Biologics Inc / Gemini Therapeutics Inc / Neuropace Inc / Acadia Healthcare Company Inc / Pharvaris NV / Edgewise Therapeutics Inc / Landos Biopharma Inc / Merus NV / Decibel Therapeutics Inc / Recursion Pharmaceuticals Inc / Doximity Inc / LENSAR Inc / Cullinan Oncology Inc / Kinnate Biopharma Inc / Goodrx Holdings Inc / Spruce Biosciences Inc / Design Therapeutics Inc / Bolt Biotherapeutics Inc / Silverback Therapeutics Inc / LAVA Therapeutics NV / Rxsight Inc / Opthea Ltd / F-Star Therapeutics Inc / Genmab A/S / Caribou Biosciences Inc / Rapt Therapeutics Inc / Enanta Pharmaceuticals Inc / scPharmaceuticals Inc / Myovant Sciences Ltd / Celldex Therapeutics Inc / Abcam PLC / Shockwave Medical Inc / Adapthealth Corp / Cigna Corp / Atea Pharmaceuticals Inc / Aligos Therapeutics Inc / Connect Biopharma Holdings Ltd / Elevation Oncology Inc / Eliem Therapeutics Inc / Graphite Bio Inc / Werewolf Therapeutics Inc / Century Therapeutics Inc / Molecular Partners AG / Talkspace Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Sweden / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="even"><td class="leftalignment">10/03/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 7.6% Above Pre-Pandemic Base- Week 78</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">10/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">India Pharma Sector - Quick Take - Molnupiravir could be a significant opportunity for multiple Indian companies</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CIPL.BO / SUN.BO / PFE.N / REDY.BO / ARBN.BO / TORP.BO / MRCG.DE / NATP.BO / DIVI.BO / VTRS.OQ</td><td class="leftalignment">Cipla Ltd / Sun Pharmaceutical Industries Ltd / Pfizer Inc / Dr Reddy's Laboratories Ltd / Aurobindo Pharma Ltd / Torrent Pharmaceuticals Ltd / Merck KGaA / Natco Pharma Ltd / Divi's Laboratories Ltd / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / India / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Anubhav Aggarwal / Sayantan Maji</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">MRK, PFE, ROG: Molnupiravir – good data; what does it mean for MRK?</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US58933Y1055 / US7170811035 / ROG.S / CH0012032048</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Roche Holding AG / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck & Co., Inc. : Molnupiravir Success an Important Step Towards Addressing COVID; Potentially Significant Sales Oppty for MRK</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">What's Next in Biotech? Anti-TIGIT + CD40 + PD1 - Recipe for IO Success in Pancreatic Cancer?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2778844 / BYYWPW6</td><td class="leftalignment">Merck & Co Inc / Beigene Ltd</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Paul Jeng, Ph.D. / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">game changer in COVID?</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat / Jonathan Miller</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">MRK Data Lets Some Air Out of COVID Vaccine Bubble</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK.N / 60770K10 / 71708110 / MRNA.OQ / 58933Y10 / 09075V10</td><td class="leftalignment">Merck & Co Inc / Moderna Inc / Pfizer Inc / Moderna Inc / Merck & Co Inc / BioNTech SE</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mani Foroohar, M.D. / Greco Song, Ph.D. / Mr. Rick Bienkowski, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">MRK: Molnupiravir's MOVe-OUT Success Paves Way for EUA Filing & Provides First-Mover Advantage</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2778844</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended September 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">COVID/scope Realtime Update: MRK Data Brightens Light At End Of COVID Tunnel - Implications For Our Space</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N / GILD.O / INCY.O / BIIB.O / ENTA.O / PTCT.O / ITCI.O</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc / Incyte Corp / Biogen Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Merck Stopping Molnupiravir Phase 3 Study Early A Positive for AT-527</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK.N / 04683R10 / 58933Y10 / AVIR.OQ</td><td class="leftalignment">Merck & Co Inc / Atea Pharmaceuticals Inc / Merck & Co Inc / Atea Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Roanna C. Ruiz</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">MRK Wins with Oral COVID Treatment</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">58933Y10</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Going Viral Chapter 2, Molnupiravir Could Be First Oral, Take Home COVID-19 Treatment</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Oct 1 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">VSAT / FR0000120271 / GB0007980591 / US00846U1016 / US0556221044 / US1271903049 / US22160K1051 / US2358511028 / US30231G1022 / US3647601083 / US45253H1014 / US4698141078 / US87612E1064 / US8835561023 / US9311421039 / US9418481035 / US1667641005 / US89151E1091 / US5645631046 / US1167941087 / US09062X1037 / US0042251084 / US02043Q1076 / GB00B03MLX29 / RDSa.AS / ACOR.OQ / US48242W1062 / US79546E1047 / US90384S3031 / US58933Y1055 / US92335C1062 / US0995021062 / LU0914713705 / US69327R1014 / US38046C1099 / US63009R1095 / US8086251076 / US5253271028 / US4277461020 / US0465131078 / CA89620X5064 / US9314271084 / US00653A1079 / US30050B1017 / US05464T1043 / US00773U1088 / US26856L1035 / US45782B1044 / US74967X1037 / CA1350861060 / US05351X1019 / US68373M1071 / US0197701065 / US0144421072 / US70202L1026 / US88025U1097 / US4833791035 / US09203E1055 / US92537N1081 / CH0499880968 / US0843101017 / US75943R1023 / US81578P1066 / US65443P1021 / US55406W1036 / US82933R1005 / US89142B1070 / US92747V1061 / US00032Q1040</td><td class="leftalignment">ViaSat Inc / TotalEnergies SE / BP PLC / Agilent Technologies Inc / BP PLC / CACI International Inc / Costco Wholesale Corp / Danaher Corp / Exxon Mobil Corp / Gap Inc / ImmunoGen Inc / Jacobs Engineering Group Inc / Target Corp / Thermo Fisher Scientific Inc / Walmart Inc / Waters Corp / Chevron Corp / TotalEnergies SE / ManTech International Corp / Bruker Corp / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Royal Dutch Shell PLC / Royal Dutch Shell PLC / Acorda Therapeutics Inc / KBR Inc / Sally Beauty Holdings Inc / Ulta Beauty Inc / Merck & Co Inc / Vera Bradley Inc / Booz Allen Hamilton Holding Corp / Intelsat SA / PDC Energy Inc / Gogo Inc / NanoString Technologies Inc / Science Applications International Corp / Leidos Holdings Inc / Heron Therapeutics Inc / Atara Biotherapeutics Inc / Pfizer Inc / Walgreens Boots Alliance Inc / Adaptimmune Therapeutics PLC / Evolent Health Inc / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / elf Beauty Inc / Inseego Corp / RH / Canada Goose Holdings Inc / Avaya Holdings Corp / Opera Ltd / Allogene Therapeutics Inc / Alector Inc / Parsons Corp / 10X Genomics Inc / Kaleyra Inc / Black Diamond Therapeutics Inc / Vertiv Holdings Co / ADC Therapeutics SA / Berkeley Lights Inc / Relay Therapeutics Inc / Seer Inc / 908 Devices Inc. / MYT Netherlands Parent BV / Singular Genomics Systems Inc / Torrid Holdings Inc / Vintage Wine Estates Inc / Aadi Bioscience Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US / GBT=US / AMZN=US / AKAM=US / VRM=US / EXPE=US / MGM=US / W=US / RARE=US / REGI=US / SHOP=US / SNAP=US / TRIP=US / WIX=US / SAGE=US / BKNG=US / CFR=US / FB=US / MTCH=US / ATRS=US / MRNS=US / PTON=US / JRVR=US / STRO=US / CZR=US / APTX=US / APP=US / TXRH=US / CPRX=US / LLNW=US / OLO=US / ANGI=US / EA=US / PDCE=US / NDLS=US / CNCE=US / GOOGL=US / FIVN=US / 00770K202 / BABA=US / CMPR=US / SHAK=US / RLMD=US / GDDY=US / VKTX=US / WING=US / ARGX=US / SQ=US / WVE=US / AXSM=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ANAB=US / CVNA=US / VRNA=US / SFIX=US / FTDR=US / ARVN=US / LYFT=US / UBER=US / CRMD.US / TSHA / DHT.UN=CA / VMEO=US / MNTV=US</td><td class="leftalignment">Merck & Co Inc / Global Blood Therapeutics Inc / Amazon.com Inc / Akamai Technologies Inc / Vroom Inc / Expedia Group Inc / MGM Resorts International / Wayfair Inc / Ultragenyx Pharmaceutical Inc / Renewable Energy Group Inc / Shopify Inc / Snap Inc / Tripadvisor Inc / Wix.Com Ltd / SAGE Therapeutics Inc / Booking Holdings Inc / Cullen/Frost Bankers Inc / Meta Platforms Inc / Match Group Inc / Antares Pharma Inc / Marinus Pharmaceuticals Inc / Peloton Interactive Inc / James River Group Holdings Ltd / Sutro Biopharma Inc / Caesars Entertainment Inc / Aptinyx Inc / Applovin Corp / Texas Roadhouse Inc / Catalyst Pharmaceuticals Inc / Limelight Networks Inc / Olo Inc / Angi Inc / Electronic Arts Inc / PDC Energy Inc / Noodles & Co / Concert Pharmaceuticals Inc / Alphabet Inc / Five9 Inc / Aemetis Inc / Alibaba Group Holding Ltd / Cimpress PLC / Shake Shack Inc / Relmada Therapeutics Inc / GoDaddy Inc / Viking Therapeutics Inc / Wingstop Inc / argenx SE / Block Inc / WAVE Life Sciences Ltd / Axsome Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / AnaptysBio Inc / Carvana Co / Verona Pharma PLC / Stitch Fix Inc / Frontdoor Inc / Arvinas Inc / Lyft Inc / Uber Technologies Inc / CorMedix Inc / Taysha Gene Therapies Inc / Dri Healthcare Trust / Vimeo Inc / Momentive Global Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AXP / 2516152 / 2778844 / 2732635 / 2270726 / 2317087 / 2328915 / 2345022 / 2100920 / 2457864 / 2459020 / 2515030 / 2048804 / 2440637 / 2857817 / 2983563 / B3D7K31 / B7TL820 / B7JYSG3 / B7577T2 / BVVN4Q8 / BYW36M8 / BK0VHF6 / BZ1LFB2 / BJ5FZ74 / BFZ1K46 / BLGJ610 / BKTNTR9 / BGSP7M9 / BJXBP30 / BZ1LFG7 / BKS3RS7 / BZ0P3Z5 / BN2R582 / BFY7DC4 / BNTB3N8 / BLF0CW7 / BF0QTY9</td><td class="leftalignment">American Express Co / Eli Lilly and Co / Merck & Co Inc / AutoNation Inc / Walt Disney Co / Entergy Corp / Nextera Energy Inc / Macy's Inc / FirstEnergy Corp / ImmunoGen Inc / Intuit Inc / Lithia Motors Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / Netflix Inc / Carmax Inc / Discovery Inc / Meta Platforms Inc / Guidewire Software Inc / Renewable Energy Group Inc / Eversource Energy / PayPal Holdings Inc / IDEAYA Biosciences Inc / Deciphera Pharmaceuticals Inc / Adaptive Biotechnologies Corp / Spotify Technology SA / Warner Music Group Corp / ViacomCBS Inc / Zoom Video Communications Inc / Turning Point Therapeutics Inc / Roku Inc / 10X Genomics Inc / Tegna Inc / Relay Therapeutics Inc / Altimmune Inc / Vizio Holding Corp / Repare Therapeutics Inc / Chicken Soup for The Soul Entertainment Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">MRK: XLRN Acquisition Makes Sense but Not Without Risk...Is This the Start of MRK's Long-Awaited Acquisition Spree?</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">2778844</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Merck advances 16% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">09/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Acceleron Purchase Marks a Big Return to CV for MRK</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">58933Y10</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck & Co., Inc. : BizDev Priorities Unchanged Post Acceleron Announcement</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">09/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Merck down 2.6% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Downgrading To Market Perform; MRK To Acquire XLRN For $180/Share</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK.N / US58933Y1055</td><td class="leftalignment">Merck & Co Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Gabriel Schneider, M.D. / Brendan Smith, Ph.D. / Eve Reilly, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">09/30/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">MRK - Highlights from investor call on XLRN</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Acceleron Acquisition Good Step on Necessary Journey Toward Diversification</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US58933Y1055 / MRK.N</td><td class="leftalignment">Merck & Co Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">09/30/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">really like this Acceleron deal</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat / Jonathan Miller</td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">MRK - MRK: Beyond XLRN, where to from here?!</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">09/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Merck & Co. Extending Cytokine Deal Bodes Well for Sutro Bipharma</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / STRO=US / MRK=US</td><td class="leftalignment">Merck & Co Inc / Sutro Biopharma Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene / Billal Jahangiri</td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Euro Credit Pilot - Good news priced in (September 2021)</td><td class="leftalignment">English</td><td class="rightalignment">56</td><td class="leftalignment">US88579Y1010 / AEGN.AS / AIRP.PA / AKZO.AS / ALSO.PA / ALV.N / ALVG.DE / ANZ.AX / APD.N / ASML.AS / ATCOA.ST / AXAF.PA / BAC.N / BARC.L / BKT.MC / BMWG.DE / BNPP.PA / BNS.TO / BOUY.PA / BP.L / BT.L / C.N / CAPP.PA / CARR.PA / CBA.AX / CBKG.DE / CCH.L / CM.TO / CNPP.PA / CRH.I / DANO.PA / DEO.N / DSMN.AS / EDP.LS / ENI.MI / ERICb.ST / ERST.VI / FREG.F / GASI.MI / GE.N / GM.N / HEIG.F / HEIN.AS / HSBA.L / IBE.MC / IBM.N / KPN.AS / LLOY.L / LVMH.PA / MAP.MC / MDBI.MI / MGA / MICP.PA / MRK.N / PRTP.PA / SAN.MC / T.N / CONG.DE / AZN.L / AMGN.O / FER.MC / AAL.L / GS.N / ACE.MI / DBKGn.DE / MCD.N / FMEG.DE / BZU.MI / ENEI.MI / MRCG.DE / DTEGn.F / BBVA.MC / BTI.N / IFXGn.DE / FR0000064578 / FR0000035081 / ISS.CO / CARLb.CO / ADEN.S / HNRGn.DE / DPWGn.DE / IG.MI / GSK.L / BAB.L / AMXL.MX / EUFI.PA / JCDX.PA / GB0008220112 / SE0000455057 / US1101221083 / US2987361092 / US3377381088 / US4943681035 / US5949181045 / JP3116000005 / CAGR.PA / AMA.MC / DANSKE.CO / CH0013841017 / ARLG.DE / ENAG.MC / AV.L / US20030N1019 / US02209S1033 / EBKG.DE / JYSK.CO / MAERSKb.CO / HRA.MI / CAIV.VI / US46625H1005 / INGA.AS / LXSG.DE / BTGGg.F / GB0033986497 / ELI.BR / EDF.PA / ETL.PA / GAZP.MM / US31620M1062 / AKE.PA / ISP.MI / DWNG.DE / DK0060079531 / AU000000GMG2 / SABE.MC / CNE1000001Z5 / CNE1000002H1 / FR0010690156 / BNRGN.DE / IREE.MI / CNE100000KC0 / CABK.MC / US03027X1000 / LEGN.DE / GYC.DE / 1COV.DE / IMB.L / SE0009922164 / BIRG.I / BMG2178K1009 / BAWG.VI / LU0251710041 / AT0000BAWAG2 / AIBG.I / AIG.A / NL00150006R6</td><td class="leftalignment">3M Co / Aegon NV / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Akzo Nobel NV / Alstom SA / Autoliv Inc / Allianz SE / Australia and New Zealand Banking Group Ltd / Air Products and Chemicals Inc / ASML Holding NV / Atlas Copco AB / AXA SA / Bank of America Corp / Barclays PLC / Bankinter SA / Bayerische Motoren Werke AG / BNP Paribas SA / Bank of Nova Scotia / Bouygues SA / BP PLC / BT Group PLC / Citigroup Inc / Capgemini SE / Carrefour SA / Commonwealth Bank of Australia / Commerzbank AG / Coca Cola HBC AG / Canadian Imperial Bank of Commerce / CNP Assurances SA / CRH PLC / Danone SA / Diageo PLC / Koninklijke DSM NV / EDP Energias de Portugal SA / Eni SpA / Telefonaktiebolaget LM Ericsson / Erste Group Bank AG / Fresenius SE & Co KGaA / Assicurazioni Generali SpA / General Electric Co / General Motors Co / HeidelbergCement AG / Heineken NV / HSBC Holdings PLC / Iberdrola SA / International Business Machines Corp / Koninklijke KPN NV / Lloyds Banking Group PLC / LVMH Moet Hennessy Louis Vuitton SE / Mapfre SA / Mediobanca Banca di Credito Finanziario SpA / Magna International Inc / Compagnie Generale des Etablissements Michelin SCA / Merck & Co Inc / Kering SA / Banco Santander SA / AT&T Inc / Continental AG / AstraZeneca PLC / Amgen Inc / Ferrovial SA / Anglo American PLC / Goldman Sachs Group Inc / Acea SpA / Deutsche Bank AG / McDonald's Corp / Fresenius Medical Care AG & Co KGaA / Buzzi Unicem SpA / Enel SpA / Merck KGaA / Deutsche Telekom AG / Banco Bilbao Vizcaya Argentaria SA / British American Tobacco PLC / Infineon Technologies AG / Covivio SA / Icade SA / Iss A/S / Carlsberg A/S / Adecco Group AG / Hannover Rueck SE / Deutsche Post AG / Italgas SpA / GlaxoSmithKline PLC / Babcock International Group PLC / America Movil SAB de CV / Eurofins Scientific SE / JCDecaux SA / DS Smith PLC / Fastighets AB Balder / Bristol-Myers Squibb Co / Euronet Worldwide Inc / Fiserv Inc / Kimberly-Clark Corp / Microsoft Corp / Asahi Group Holdings Ltd / Credit Agricole SA / Amadeus IT Group SA / Danske Bank A/S / Lonza Group AG / Aareal Bank AG / Enagas SA / Aviva PLC / Comcast Corp / Altria Group Inc / EnBW Energie Baden Wuerttemberg AG / Jyske Bank A/S / AP Moeller - Maersk A/S / Hera SpA / CA Immobilien Anlagen AG / JPMorgan Chase & Co / ING Groep NV / Lanxess AG / Bertelsmann SE & Co KGaA / ITV PLC / Elia Group SA / Electricite de France SA / Eutelsat Communications SA / Gazprom PAO / Fidelity National Information Services Inc / Arkema SA / Intesa Sanpaolo SpA / Deutsche Wohnen SE / DSV A/S / Goodman Group / Banco de Sabadell SA / Bank of China Ltd / China Construction Bank Corp / Aeroports de Paris SA / Brenntag SE / Iren SpA / China National Chemical Engineering Co Ltd / Caixabank SA / American Tower Corp / LEG Immobilien SE / Grand City Properties SA / Covestro AG / Imperial Brands PLC / Essity AB (publ) / Bank of Ireland Group PLC / CK Infrastructure Holdings Ltd / BAWAG Group AG / CPI Property Group SA / BAWAG Group AG / Aib Group PLC / American International Group Inc / Ctp NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Austria / Belgium / Bermuda / Canada / Switzerland / China / Czech Republic / Germany / Denmark / Spain / Finland / France / United Kingdom / Greece / Hungary / Ireland / Italy / Japan / Luxembourg / Mexico / Netherlands / Norway / New Zealand / Poland / Portugal / Russian Federation / Slovakia / Sweden / United States / Jersey</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment">MISCELLANEOUS / CHANGE IN RECOMMENDATION / MODELS / PORTFOLIO STRATEGY / CREDIT</td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / Research Digest / Equity</td><td class="leftalignment">Herr Gianfranco Arcovito / Herr Christian Aust / Herr Tobias Keller / Herr. Stefan Kolek / Herr Sven Kreitmair, CFA / Herr. Franz Rudolf / Herr Jonathan Schroer / Frau. Jana Schuler / Frau Silke Stegemann / Herr Natalie Tehrani Monfared / Herr. Michael Teig</td></tr>
<tr class="odd"><td class="leftalignment">09/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">MRK $180/sh Offer In Line With Market Expectations; PT to $180</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK.N / 58933Y10</td><td class="leftalignment">Merck & Co Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Daniel Tarjan, Ph.D. / Anna Baran, CFA / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Get Pumped, Acquisition Of Acceleron Expands MRK's Footprint in Cardiovascular Disease</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">09/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / AMGN=US / CMA=US / PEB=US / AKAM=US / H=US / MTN=US / CHKP=US / PB=US / VRM=US / EWBC=US / TRMK=US / MAR=US / UMPQ=US / TNL=US / HLT=US / WTFC=US / BL=US / CHH=US / CSTR=US / DRH=US / ABG=US / OI=US / PACW=US / SFT=US / WAL=US / HTH=US / BXS=US / CFB=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / ABCB=US / BOKF=US / FBK=US / ASB=US / SSB=US / RF=US / CATY=US / FFIN=US / GBCI=US / SBSI=US / UCBI=US / PNFP=US / SBCF=US / BIIB=US / TCBI=US / FNB=US / FHN=US / SHO=US / RNST=US / SIBN=US / HST=US / CADE=US / WH=US / HTA=US / HGV=US / SBRA=US / RLJ=US / VAC=US / PANW=US / RHP=US / ABBV=US / IBTX=US / LOB=US / ACBI=US / ZS=US / EDIT=US / PK=US / PLYA=US / CVNA=US / NCNA=US / MBIN=US / HWC=US / OZK=US / AMTB=US / CRWD=US / FERG=US / ARQT=US / ABNB=US / SSBK=US</td><td class="leftalignment">Merck & Co Inc / Amgen Inc / Comerica Inc / Pebblebrook Hotel Trust / Akamai Technologies Inc / Hyatt Hotels Corp / Vail Resorts Inc / Check Point Software Technologies Ltd / Prosperity Bancshares Inc / Vroom Inc / East West Bancorp Inc / Trustmark Corp / Marriott International Inc / Umpqua Holdings Corp / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Wintrust Financial Corp / Blackline Inc / Choice Hotels International Inc / CapStar Financial Holdings Inc / Diamondrock Hospitality Co / Asbury Automotive Group Inc / O-I Glass Inc / PacWest Bancorp / Shift Technologies Inc / Western Alliance Bancorp / Hilltop Holdings Inc / Cadence Bank / Crossfirst Bankshares Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / FB Financial Corp / Associated Banc-Corp / SouthState Corp / Regions Financial Corp / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Southside Bancshares Inc / United Community Banks Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / Biogen Inc / Texas Capital Bancshares Inc / FNB Corp / First Horizon Corp / Sunstone Hotel Investors Inc / Renasant Corp / SI-BONE Inc / Host Hotels & Resorts Inc / Cadence Bank / Wyndham Hotels & Resorts Inc / Healthcare Trust Of America Inc / Hilton Grand Vacations Inc / Sabra Health Care REIT Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Palo Alto Networks Inc / Ryman Hospitality Properties Inc / Abbvie Inc / Independent Bank Group Inc / Live Oak Bancshares Inc / Atlantic Capital Bancshares Inc / Zscaler Inc / Editas Medicine Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Carvana Co / NuCana PLC / Merchants Bancorp / Hancock Whitney Corp / Bank Ozk / Amerant Bancorp Inc / CrowdStrike Holdings Inc / Ferguson PLC / Arcutis Biotherapeutics Inc / Airbnb Inc / Southern States Bancshares Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">More Serotypes and Less Shots Are Better So Pfizer Wins in PCV</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">PFE.N / 71708110 / 58933Y10</td><td class="leftalignment">Pfizer Inc / Pfizer Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Daniel Tarjan, Ph.D. / Na Sun / Anna Baran, CFA / Dilip Joseph</td></tr>
<tr class="odd"><td class="leftalignment">09/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ORNBV.HE: Orion - Updated forecasts ahead of 3Q21 results</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">ORNBV.HE / RECI.MI / LUN.CO / MRCG.DE / LONN.S / UCB.BR / IPN.PA / ALM.MC / GRLS.MC / BAYGN.DE / VIFN.S / GMAB.CO</td><td class="leftalignment">Orion Oyj / Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Ipsen SA / Almirall SA / Grifols SA / Bayer AG / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Merck & Co., Inc. SEPTEMPBER 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="odd"><td class="leftalignment">09/30/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Merck KGaA SEPTEMPBER 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="even"><td class="leftalignment">09/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">XLRN deal could close & help diversify MRK's portfolio; addressing key investor questions</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">09/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">COVID-19: Updates on global vaccine rollouts, variants, boosters and waning immunity</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">JNJ.N / LLY.N / PFE.N / AZN.L / MRCG.DE / LONN.S / GSK.L / NVAX.OQ / 1099.HK</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Merck KGaA / Lonza Group AG / GlaxoSmithKline PLC / Novavax Inc / Sinopharm Group Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Germany / United Kingdom / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">09/28/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What's Next For Bristol Myers Squibb Stock After An 11% Fall In A Month?</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/28/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Low-Complexity and High Diversification, XLRN Is a Start</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">58933Y10 / MRK.N</td><td class="leftalignment">Merck & Co Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="even"><td class="leftalignment">09/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2094670 / 2778844 / 2270726 / 2317087 / 2328915 / 2100920 / 2459020 / 2657802 / 2689560 / 2684703 / 2707677 / 2730190 / 2862532 / 2138158 / 2799351 / 2829601 / 7103065 / 2857817 / 2390817 / B7TL820 / B7JYSG3 / B8L2798 / B7577T2 / B8DPDT7 / BFLR866 / BVVN4Q8 / BK0VHF6 / BD8DJ71 / BGCYWN8 / BFZ1K46 / BJJMGL2 / BYXJQG9 / BKTNTR9 / BGSP7M9 / BJVR9Y9 / BZ1LFG7 / BYY88Y7 / BZ0P3Z5 / BP84RX0 / BGKG6M3 / BF3N4P3 / BMV31Q4 / BNNTQY0 / BJ62Z18</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Best Buy Co Inc / Merck & Co Inc / Walt Disney Co / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Intuit Inc / OGE Energy Corp / PG&E Corp / Pfizer Inc / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / E W Scripps Co / Sempra Energy / Sinclair Broadcast Group Inc / Southern Co / Novartis AG / Netflix Inc / Gray Television Inc / Meta Platforms Inc / Guidewire Software Inc / Hemisphere Media Group Inc / Renewable Energy Group Inc / Sarepta Therapeutics Inc / Twitter Inc / Eversource Energy / IDEAYA Biosciences Inc / Snap Inc / Xencor Inc / Spotify Technology SA / Fox Corp / Spire Inc / ViacomCBS Inc / Zoom Video Communications Inc / iHeartMedia Inc / Roku Inc / Alphabet Inc / Tegna Inc / Townsquare Media Inc / StoneCo Ltd / Arena Pharmaceuticals Inc / Audacy Inc / Oatly Group AB / Ultragenyx Pharmaceutical Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Luxembourg / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Therapeutic Categories Outlook</td><td class="leftalignment">English</td><td class="rightalignment">3956</td><td class="leftalignment">US0311621009 / US0463531089 / US1101221083 / US30161Q1040 / US3755581036 / US37733W1053 / US4781601046 / US5324571083 / US66987V1098 / US7170811035 / US75886F1075 / US7711951043 / US91307C1027 / US92532F1003 / US80105N1054 / US09062X1037 / US58933Y1055 / IE00BJ3V9050</td><td class="leftalignment">Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Exelixis Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Sanofi SA / Biogen Inc / Merck & Co Inc / Endo International PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Health Care Team</td></tr>
<tr class="even"><td class="leftalignment">09/28/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">MRK - MRK: Supposed XLRN deal a step towards addressing the bear case</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">09/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 17, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">09/27/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Sep 27 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">FR0000120578 / GB0009895292 / GB0009252882 / BE0165385973 / CH0012032048 / CH0012005267 / US0116591092 / US0234361089 / US0463531089 / US0997241064 / US1101221083 / US1264081035 / US22284P1057 / US23918K1088 / US3021301094 / US31428X1063 / US37733W1053 / US4433201062 / US4448591028 / US4456581077 / US4781601046 / US5150981018 / US5324571083 / US6558441084 / US66987V1098 / US6701002056 / US6795801009 / US7170811035 / US7711951043 / US8308791024 / US8356993076 / US8447411088 / US9029251066 / US9078181081 / US9113121068 / US91324P1021 / US9139031002 / US9507551086 / CA1363751027 / JP3435000009 / CA13645T1003 / US4771431016 / US4198791018 / US80105N1054 / US60855R1005 / US15135B1017 / US50187A1079 / US0491642056 / US12541W2098 / US78709Y1055 / PAP310761054 / US75025X1000 / NL0000687663 / US01748X1028 / US2473617023 / US00922R1059 / CA9609083097 / CA0585861085 / US58933Y1055 / US5218652049 / US88160R1014 / US9100471096 / US92839U2069 / US40412C1018 / JE00B783TY65 / US9837931008 / US00287Y1091 / NL0010273215 / US98978V1035 / US72919P2020 / US00912X3026 / US00404A1097 / US8485771021 / US21240E1055 / US02376R1023 / DK0060534915 / US03937C1053 / CA0089118776 / US0367521038 / US86881A1007 / US98138J2069 / CA87241L1094 / US74967X1037 / US23753F1075 / US80689H1023 / US4990491049 / US92336X1090 / US5904791358 / US28414H1032 / US1255231003 / US1567271093 / US26142R1041 / US6541101050 / US67181A1079 / US33813J1060 / US18914F1030 / US55406W1036 / US6877931096 / US82671G1004 / US45784A1043 / LU2314763264 / US90089L1089 / US01625V1044 / US74276R1023 / US00857U1079 / US92337R1014 / US68622V1061 / US53228F1012 / US28489L1044 / US10920V1070 / US13781Y1038 / US28623U1016 / IL0011786154 / CA50202P1053 / US14171W1036</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Melexis NV / Roche Holding AG / Novartis AG / Alaska Air Group Inc / Amedisys Inc / AstraZeneca PLC / Borgwarner Inc / Bristol-Myers Squibb Co / CSX Corp / Covenant Logistics Group Inc / DaVita Inc / Expeditors International of Washington Inc / FedEx Corp / GlaxoSmithKline PLC / Hub Group Inc / Humana Inc / J B Hunt Transport Services Inc / Johnson & Johnson / Landstar System Inc / Eli Lilly and Co / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / Pfizer Inc / Roche Holding AG / SkyWest Inc / Sony Group Corp / Southwest Airlines Co / USA Truck Inc / Union Pacific Corp / United Parcel Service Inc / UnitedHealth Group Inc / Universal Health Services Inc / Werner Enterprises Inc / Canadian National Railway Co / Sony Group Corp / Canadian Pacific Railway Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Molina Healthcare Inc / Centene Corp / LHC Group Inc / Atlas Air Worldwide Holdings Inc / CH Robinson Worldwide Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / AerCap Holdings NV / Allegiant Travel Co / Delta Air Lines Inc / Air Transport Services Group Inc / Westport Fuel Systems Inc / Ballard Power Systems Inc / Merck & Co Inc / Lear Corp / Tesla Inc / United Airlines Holdings Inc / Visteon Corp / HCA Healthcare Inc / Aptiv PLC / XPO Logistics Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / Plug Power Inc / Air Lease Corp / Acadia Healthcare Company Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Novo Nordisk A/S / ArcBest Corp / Air Canada / Anthem Inc / Surgery Partners Inc / Workhorse Group Inc / TFI International Inc / RH / Daseke Inc / Schneider National Inc / Knight-Swift Transportation Holdings Inc / Veoneer Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Cigna Corp / Cerence Inc / DraftKings Inc / Nikola Corp / Oak Street Health Inc / Fisker Inc / Clover Health Investments Corp / MYT Netherlands Parent BV / Oscar Health Inc / Signify Health Inc / InnovAge Holding Corp / Arrival SA / TuSimple Holdings Inc / Alignment Healthcare Inc / Privia Health Group Inc / agilon health Inc / Vera Therapeutics Inc / Organon & Co / Lifestance Health Group Inc / Electric Last Mile Solutions Inc / Bright Health Group Inc / Cano Health Inc / Elevation Oncology Inc / REE Automotive Ltd / Li-Cycle Holdings Corp / CareMax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Denmark / France / United Kingdom / Japan / Luxembourg / Mexico / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">09/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">0989529 / 2000019 / 2008154 / 2486813 / 2778844 / 2222631 / 2317087 / 2328915 / 2459020 / 2680905 / 2705198 / 2707677 / 2440637 / 2862532 / 2799351 / B3D7K31 / 2390817 / B7TL820 / B8L2798 / B7577T2 / B8DPDT7 / BFH3N85 / BVVN4Q8 / BXDZ9Z0 / BR4T3B3 / BYZM6C2 / BLGJ610 / BGSP7M9 / BJVR9Y9 / BZ1LFG7 / BYY88Y7 / BZ0P3Z5 / BRJ3GY4 / BP84RX0 / BGKG6M3 / BNTB3N8 / BMV31Q4 / BMBP1Q0 / BMW5084 / BP2P6L0</td><td class="leftalignment">AstraZeneca PLC / Amazon.com Inc / Adobe Inc / Kellogg Co / Merck & Co Inc / Cooper Companies Inc / Entergy Corp / Nextera Energy Inc / Intuit Inc / PPL Corp / Progress Software Corp / Public Service Enterprise Group Inc / CenterPoint Energy Inc / E W Scripps Co / Sinclair Broadcast Group Inc / Discovery Inc / Gray Television Inc / Meta Platforms Inc / Hemisphere Media Group Inc / Renewable Energy Group Inc / Sarepta Therapeutics Inc / Veeva Systems Inc / Eversource Energy / Shopify Inc / HubSpot Inc / Intellia Therapeutics Inc / Warner Music Group Corp / Zoom Video Communications Inc / iHeartMedia Inc / Roku Inc / Alphabet Inc / Tegna Inc / Xenon Pharmaceuticals Inc / Townsquare Media Inc / StoneCo Ltd / Vizio Holding Corp / Audacy Inc / Flywire Corp / PMV Pharmaceuticals Inc / Tango Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">09/26/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 7.2% Above Pre-Pandemic Base- Week 77</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">09/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">09/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ALKS / AMRN / CDTX / CERS / COLL / JNJ / MRK / ACRS / BDSI / ACRX / ANIP / ARDS / BSLN / ARAV / AXGN / AERI / CFRX / ARQT</td><td class="leftalignment">Alkermes Plc / Amarin Corporation PLC / Cidara Therapeutics Inc / Cerus Corp / Collegium Pharmaceutical Inc / Johnson & Johnson / Merck & Co Inc / Aclaris Therapeutics Inc / BioDelivery Sciences International Inc / AcelRx Pharmaceuticals Inc / ANI Pharmaceuticals Inc / Aridis Pharmaceuticals Inc / Basilea Pharmaceutica AG / Aravive Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / ContraFect Corp / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">09/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended September 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">09/23/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Immuno-Oncology Round-up from ESMO 2021</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">640268108 / 771195104 / 58933Y10 / 09075V10 / 09770210 / 82835W10</td><td class="leftalignment">Nektar Therapeutics / Roche Holding AG / Merck & Co Inc / BioNTech SE / Bolt Biotherapeutics Inc / Silverback Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / France / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Jeffrey La Rosa / Dilip Joseph</td></tr>
<tr class="odd"><td class="leftalignment">09/22/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Should You Buy Merck Stock At $72?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">DD: DuPont de Nemours, Inc. - Semiconductor Technologies Teach-in Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">DD.N / 4186.T / 4901.T / MRCG.DE / CCMP.OQ / ENTG.OQ</td><td class="leftalignment">Dupont De Nemours Inc / Tokyo Ohka Kogyo Co Ltd / Fujifilm Holdings Corp / Merck KGaA / CMC Materials Inc / Entegris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Japan / United States</td><td class="leftalignment">Chemicals / Industrial Materials</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. John F. Walsh, Jr / Tamjid Chowdhury / Jing Zhang</td></tr>
<tr class="odd"><td class="leftalignment">09/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Early-Stage IO: The Debate of the 2020s in the Spotlight at ESMO</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">58933Y10</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="even"><td class="leftalignment">09/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Post-ESMO 2021: NSCLC MEDACorp Pulse Call Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">04635310 / 03116210 / 478160104 / 58933Y10 / 90041T10 / 55609910 / 45781K20 / 46565G10 / 60468T10 / 03969F10 / 23003110</td><td class="leftalignment">AstraZeneca PLC / Amgen Inc / Johnson & Johnson / Merck & Co Inc / Turning Point Therapeutics Inc / MacroGenics Inc / Innate Pharma SA / Iteos Therapeutics Inc / Mirati Therapeutics Inc / Arcus Biosciences Inc / Cullinan Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Andrew Berens, M.D. / Jonathan Chang, Ph.D., CFA / Daina Graybosch, Ph.D. / Christopher Liu, Pharm.D. / Faisal Khurshid / Dilip Joseph / Ken Shields / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CARS / MRK=US / HD=US / MCD=US / ADI=US / WEN=US / BXP=US / BLD=US / TXN=US / GILD=US / PEB=US / SLG=US / H=US / MTN=US / LOW=US / IGT=US / BYD=US / MAR=US / LEG=US / TNL=US / VMC=US / MGM=US / HLT=US / PENN=US / MLM=US / AMN=US / SWIM=US / ARW=US / AVT=US / CBRL=US / CHH=US / DRI=US / DRH=US / GFF=US / IBP=US / MAS=US / MCHP=US / MHK=US / MCRI=US / PACW=US / REGN=US / REGI=US / SLGN=US / SGMS=US / CCRN=US / CNM=US / COP=US / DIN=US / MRNS=US / RRR=US / TPX=US / EXP=US / CZR=US / KAR=US / BECN=US / SHO=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / HST=US / PGTI=US / GPRE=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / WH=US / JACK=US / TREX=US / HGV=US / RLJ=US / VAC=US / FBHS=US / RHP=US / TILE=US / NDLS=US / 00770K202 / LOCO=US / SHAK=US / WING=US / EDIT=US / 82982L103 / PK=US / JELD=US / PLYA=US / ROKU=US / DCPH=US / KOD=US / FERG=US / DKNG=US / AZEK=US / BALY=US / SNPO=US</td><td class="leftalignment">Cars.com Inc / Merck & Co Inc / Home Depot Inc / McDonald's Corp / Analog Devices Inc / Wendys Co / Boston Properties Inc / TopBuild Corp / Texas Instruments Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / SL Green Realty Corp / Hyatt Hotels Corp / Vail Resorts Inc / Lowe's Companies Inc / International Game Technology PLC / Boyd Gaming Corp / Marriott International Inc / Leggett & Platt Inc / Travel + Leisure Co / Vulcan Materials Co / MGM Resorts International / Hilton Worldwide Holdings Inc / Penn National Gaming Inc / Martin Marietta Materials Inc / AMN Healthcare Services Inc / Latham Group Inc / Arrow Electronics Inc / Avnet Inc / Cracker Barrel Old Country Store Inc / Choice Hotels International Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Griffon Corp / Installed Building Products Inc / Masco Corp / Microchip Technology Inc / Mohawk Industries Inc / Monarch Casino & Resort Inc / PacWest Bancorp / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / Silgan Holdings Inc / Scientific Games Corp / Cross Country Healthcare Inc / Core & Main Inc / Conocophillips / Dine Brands Global Inc / Marinus Pharmaceuticals Inc / Red Rock Resorts Inc / Tempur Sealy International Inc / Eagle Materials Inc / Caesars Entertainment Inc / KAR Auction Services Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Host Hotels & Resorts Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / Trex Company Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Fortune Brands Home & Security Inc / Ryman Hospitality Properties Inc / Interface Inc / Noodles & Co / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / Editas Medicine Inc / SiteOne Landscape Supply Inc / Park Hotels & Resorts Inc / JELD-WEN Holding Inc / Playa Hotels & Resorts NV / Roku Inc / Deciphera Pharmaceuticals Inc / Kodiak Sciences Inc / Ferguson PLC / DraftKings Inc / Azek Company Inc / Bally's Corp / Snap One Holdings Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2681511 / 2023607 / 2778844 / 2026242 / 2270726 / 2317087 / 2100920 / 2689560 / 2684703 / 2730190 / 2842255 / 2098876 / 7103065 / B121557 / 2769796 / 2857817 / B7TL820 / B4MG4Z6 / BBPK0J0 / B7577T2 / B8DPDT7 / BVVN4Q8 / BYVY8G0 / BYW36M8 / BHC8X90 / BFMXGR0 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BNTB3N8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / PepsiCo Inc / Amgen Inc / Merck & Co Inc / American Electric Power Company Inc / Walt Disney Co / Entergy Corp / FirstEnergy Corp / PG&E Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Starbucks Corp / Yum! Brands Inc / Novartis AG / Mastercard Inc / Fidelity National Information Services Inc / Netflix Inc / Meta Platforms Inc / AMC Networks Inc / Mirati Therapeutics Inc / Renewable Energy Group Inc / Sarepta Therapeutics Inc / Eversource Energy / Alphabet Inc / PayPal Holdings Inc / Novo Nordisk A/S / Evergy Inc / ViacomCBS Inc / Roku Inc / Alphabet Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Berenberg German Corporate Conference - Day 1 Review</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">DE0006599905 / DE0005439004 / DE0005104400 / DE0005810055 / DE0006219934 / DE0006452907 / DE0005493365 / DE000LEG1110 / DE000A1ML7J1 / DE000PSM7770 / DE000KGX8881 / DE000FTG1111 / DE000A2E4K43 / LU1673108939 / DE000A161408 / LU2010095458 / DE000A3H3LL2</td><td class="leftalignment">Merck KGaA / Continental AG / Atoss Software AG / Deutsche Boerse AG / Jungheinrich AG / Nemetschek SE / Hypoport SE / LEG Immobilien SE / Vonovia SE / Prosiebensat 1 Media SE / Kion Group AG / flatexDEGIRO AG / Delivery Hero SE / Aroundtown SA / Hellofresh SE / Global Fashion Group SA / Vantage Towers AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Luxembourg</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">James Gilmour</td></tr>
<tr class="even"><td class="leftalignment">09/21/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Merck & Co Inc (MRK) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">992</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Equity Strategy: Credit remains the risk to equity</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">ACCP.PA / AIRP.PA / ALVG.DE / BOUY.PA / EDP.LS / ERICB.ST / HLMA.L / IBE.MC / IBM.N / KYGA.I / PNN.L / RTO.L / SN.L / SWMA.ST / T.N / UBIP.PA / ULVR.L / WLSNC.AS / SSE.L / AZN.L / SASY.PA / DUK.N / XOM.N / MRCG.DE / LONN.S / IG.MI / CVX.N / COLOB.CO / BARN.S / SCHP.S / TRN.MI / KNEBV.HE / ADP.PA / ERIC.OQ / EXPN.L / SY1G.DE / PBF.N / ZO1G.DE / UPM.HE / BAYGN.F / FHZN.S / AGES.BR / OCDO.L / DKSH.S / O2DN.DE / ELIOR.PA / ELISA.HE / FORTUM.HE</td><td class="leftalignment">Accor SA / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Allianz SE / Bouygues SA / EDP Energias de Portugal SA / Telefonaktiebolaget LM Ericsson / Halma PLC / Iberdrola SA / International Business Machines Corp / Kerry Group PLC / Pennon Group PLC / Rentokil Initial PLC / Smith & Nephew PLC / Swedish Match AB / AT&T Inc / Ubisoft Entertainment SA / Unilever PLC / Wolters Kluwer NV / SSE PLC / AstraZeneca PLC / Sanofi SA / Duke Energy Corp / Exxon Mobil Corp / Merck KGaA / Lonza Group AG / Italgas SpA / Chevron Corp / Coloplast A/S / Barry Callebaut AG / Schindler Holding AG / Terna Rete Elettrica Nazionale SpA / Kone Oyj / Aeroports de Paris SA / Telefonaktiebolaget LM Ericsson / Experian PLC / Symrise AG / PBF Energy Inc / Zooplus AG / UPM-Kymmene Oyj / Bayer AG / Flughafen Zuerich AG / Ageas SA / Ocado Group PLC / DKSH Holding AG / Telefonica Deutschland Holding AG / Elior Group SA / Elisa Oyj / Fortum Oyj</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Italy / Netherlands / Portugal / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / Investment Strategy / Equity</td><td class="leftalignment">Mr. Andrew W. Garthwaite / Mr Robert C. Griffiths / Asim Ali / Nasr Islam</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">ESMO updates: growing Keytruda by going earlier in disease and expanding the pipeline</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRK.N - Event Transcript of Merck & Co Inc conference call, Sep. 20, 2021 / 4:30PM ET</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 10, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Moving Right Along, Study Achieves Preliminary Safety Benchmark</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PDSB / MRK</td><td class="leftalignment">PDS Biotechnology Corp / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Merck: New investment/expansion plan in Electronics is a clear positive</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">INVESTMENT STRATEGY / MANAGEMENT / MERGER/ACQUISITION/DIVESTITURE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Falko Friedrichs / Herr Jan Koch / Sachin Gadilingappa</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">REMINDER: Veterinary Macro and Top Positioned AH Companies Coming Out of the Pandemic - Today, 9/20 at 1 PM ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2778844 / B95WG16</td><td class="leftalignment">Merck & Co Inc / Zoetis Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. David M. Westenberg</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">More ESMO Abstracts From The Weekend</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US0463531089 / US66987V1098 / US80105N1054 / US58933Y1055</td><td class="leftalignment">AstraZeneca PLC / Novartis AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Encouraging Libtayo NSCLC Chemo Combo; Can it Catch Keytruda?</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">75886F10 / 58933Y10 / F5548N10</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Merck & Co Inc / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">V / 0989529 / 2126335 / 2681511 / 2000019 / 2023607 / 2640147 / 2778844 / 2270726 / 2542049 / 2829515 / 2317087 / 2576941 / 2689560 / 2684703 / 2440637 / B1F76F9 / B121557 / 2857817 / 2983563 / B5B2106 / 2982924 / BBPK0J0 / B95N910 / B7577T2 / BFLR866 / BVVN4Q8 / BYNZGK1 / BZ1LFB2 / BKS3SM8 / BNFWR44 / BMQ5T49 / BKVDFF7 / BLGJ610 / BFMXGR0 / BJJMGL2 / BKTNTR9 / BD6JX35 / BN2R582 / BQXZP64 / BLF0CW7 / BMVBZF5</td><td class="leftalignment">Visa Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / PepsiCo Inc / Amazon.com Inc / Amgen Inc / Nike Inc / Merck & Co Inc / Walt Disney Co / Dominion Energy Inc / Edison International / Entergy Corp / Exelixis Inc / PG&E Corp / Pfizer Inc / CenterPoint Energy Inc / Western Union Co / Mastercard Inc / Netflix Inc / Carmax Inc / Fortinet Inc / Spectrum Pharmaceuticals Inc / Mirati Therapeutics Inc / PTC Inc / Renewable Energy Group Inc / Twitter Inc / Eversource Energy / Block Inc / Deciphera Pharmaceuticals Inc / IGM Biosciences Inc / Worldline SA / Zentalis Pharmaceuticals Inc / Oric Pharmaceuticals Inc / Warner Music Group Corp / Evergy Inc / Fox Corp / ViacomCBS Inc / Krystal Biotech Inc / Relay Therapeutics Inc / Wayfair Inc / Repare Therapeutics Inc / Immuneering Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">MRK: Mid-Quarter Model Update; Lowering PT from $100 to $90 as Patent Expirations & COVID-Related Slowdown Warrant DCF Valuation Focus on 2030</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2778844</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">630</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Middle East</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GRLS.MC: Grifols - Strong rationale for Biotest acquisition</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">GRLS.MC / 4502.T / CSL.AX / JNJ.N / RECI.MI / STDM.PA / LUN.CO / MRCG.DE / LONN.S / QIA.DE / UCB.BR / HOLX.OQ / 006280.KS / 002007.SZ / IPN.PA / ORNBV.HE / ALM.MC / DIAS.MI / VIFN.S / ARGX.OQ</td><td class="leftalignment">Grifols SA / Takeda Pharmaceutical Co Ltd / CSL Ltd / Johnson & Johnson / Recordati Industria Chimica e Farmaceutica SpA / Sartorius Stedim Biotech SA / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Qiagen NV / Ucb SA / Hologic Inc / Green Cross Corp / Hualan Biological Engineering Inc / Ipsen SA / Orion Oyj / Almirall SA / DiaSorin SpA / Vifor Pharma AG / argenx SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / China / Germany / Denmark / Spain / Finland / France / Italy / Japan / Korea, Republic of / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment">MERGER/ACQUISITION/DIVESTITURE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Ms Jo Walton / Elizabeth Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">09/19/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Movers & Shakers: Our Thoughts on Potential Upcoming Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">83</td><td class="leftalignment">JNJ / AMRN / CDTX / GRAY / HCM / LLY / MRK / MSB / PFE / ACRS / CKPT / SPRO / ZTS / OMER / AERI / SCYX / LPCN / FBIO / AYTU / EYPT / PDSB / ARQT / IMAB / VYNE</td><td class="leftalignment">Johnson & Johnson / Amarin Corporation PLC / Cidara Therapeutics Inc / Graybug Vision Inc / HUTCHMED (China) Ltd / Eli Lilly and Co / Merck & Co Inc / Mesoblast Ltd / Pfizer Inc / Aclaris Therapeutics Inc / Checkpoint Therapeutics Inc / Spero Therapeutics Inc / Zoetis Inc / Omeros Corp / Aerie Pharmaceuticals Inc / SCYNEXIS Inc / Lipocine Inc / Fortress Biotech Inc / Aytu Biopharma Inc / EyePoint Pharmaceuticals Inc / PDS Biotechnology Corp / Arcutis Biotherapeutics Inc / I-Mab / Vyne Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">09/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">ESMO Abstracts From The Weekend</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0463531089 / US58933Y1055</td><td class="leftalignment">AstraZeneca PLC / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">09/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials Remain Stable Amidst Delta - Week 76</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LLY-US -  Dividend Quality Analysis, for the period ended September 10,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY / BMY / JNJ / MRK / NVS / PFE / AMGN.O / GSK / AZN.O / ABBV.K / SNY.O</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Going Viral, What An Oral Drug For COVID-19 Could Mean For MRK; Thoughts On Molnupiravir</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended September 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Sep 17 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US00846U1016 / US0463531089 / US1101221083 / US2435371073 / US5324571083 / US6541061031 / US66987V1098 / US7170811035 / US7711951043 / US9418481035 / US3448491049 / US80105N1054 / US2533931026 / FI0009013296 / US9043111072 / US58933Y1055 / US5560991094 / US64104Y1064 / US30057T1051 / US89377M1099 / US0843101017</td><td class="leftalignment">Agilent Technologies Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Deckers Outdoor Corp / Eli Lilly and Co / Nike Inc / Novartis AG / Pfizer Inc / Roche Holding AG / Waters Corp / Foot Locker Inc / Sanofi SA / DICK'S Sporting Goods Inc / Neste Oyj / Under Armour Inc / Merck & Co Inc / MacroGenics Inc / Neste Oyj / Evoqua Water Technologies Corp / Transmedics Group Inc / Berkeley Lights Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Finland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Our Take On Data In ESMO Abstracts Ahead Of The Weekend</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US0463531089 / US1101221083 / US5324571083 / US66987V1098 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Novartis AG / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">V / 2516152 / 2681511 / 2000019 / 2023607 / 2008154 / 2497406 / 2778844 / 2216850 / 2270726 / 2317087 / 2328915 / 2100920 / 2459020 / 2689560 / 2707677 / 2730190 / 2212922 / 2857817 / B3D7K31 / B5B2106 / B7TL820 / BBPK0J0 / B87ZMX0 / B7577T2 / B424494 / BFLR866 / BVVN4Q8 / BYW36M8 / BF4VBS8 / BXDZ9Z0 / BF5L3T2 / BYNZGK1 / BZ00V34 / BZ1LFG7 / BYY88Y7 / BRJ3GY4 / BM8NHS1</td><td class="leftalignment">Visa Inc / Eli Lilly and Co / PepsiCo Inc / Amazon.com Inc / Amgen Inc / Adobe Inc / Kroger Co / Merck & Co Inc / Consolidated Edison Inc / Walt Disney Co / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Intuit Inc / PG&E Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / NRG Energy Inc / Netflix Inc / Discovery Inc / Fortinet Inc / Meta Platforms Inc / Mirati Therapeutics Inc / Palo Alto Networks Inc / Renewable Energy Group Inc / Splunk Inc / Twitter Inc / Eversource Energy / PayPal Holdings Inc / BioXcel Therapeutics Inc / Shopify Inc / Elanco Animal Health Inc / Block Inc / Zscaler Inc / Roku Inc / Alphabet Inc / Xenon Pharmaceuticals Inc / Adagio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Top of the Charts - A review of the week's best reads</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AHT.L / BMY.N / CSL.AX / ELE.MC / HSX.L / IBE.MC / JD.L / JNJ.N / KOMN.S / KSP.I / PRTP.PA / SAN.MC / SAPJ.J / STM.PA / AZN.L / AAL.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / BAMI.MI / NOVN.S / FMEG.DE / ENEI.MI / MRCG.DE / BBVA.MC / BANB.S / GSK.L / ITX.MC / FLS.CO / PFIZ.NS / REGN.OQ / GILD.OQ / MAERSKB.CO / IFCN.S / BIIB.OQ / LXSG.DE / DRX.L / ISP.MI / ALM.MC / FXPO.L / SOON.S / GRLS.MC / SABE.MC / BAYGN.DE / 0486.HK / PHNX.L / OCDO.L / CABK.MC / CDR.WA / ABBV.N / OCI.AS / ELIOR.PA / SKIN.S / G24N.DE / LANDI.S / KAPQ.L / MOVE.S / GMAB.CO / JETJ.L / PPGN.S</td><td class="leftalignment">Ashtead Group PLC / Bristol-Myers Squibb Co / CSL Ltd / Endesa SA / Hiscox Ltd / Iberdrola SA / JD Sports Fashion PLC / Johnson & Johnson / Komax Holding AG / Kingspan Group PLC / Kering SA / Banco Santander SA / Sappi Ltd / STMicroelectronics NV / AstraZeneca PLC / Anglo American PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Banco BPM SpA / Novartis AG / Fresenius Medical Care AG & Co KGaA / Enel SpA / Merck KGaA / Banco Bilbao Vizcaya Argentaria SA / Bachem Holding AG / GlaxoSmithKline PLC / Industria de Diseno Textil SA / FLSmidth & Co A/S / Pfizer Ltd / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / AP Moeller - Maersk A/S / Inficon Holding AG / Biogen Inc / Lanxess AG / Drax Group PLC / Intesa Sanpaolo SpA / Almirall SA / Ferrexpo PLC / Sonova Holding AG / Grifols SA / Banco de Sabadell SA / Bayer AG / OK Rusal MKPAO / Phoenix Group Holdings PLC / Ocado Group PLC / Caixabank SA / CD Projekt SA / Abbvie Inc / OCI NV / Elior Group SA / Cassiopea SpA / Scout24 SE / Landis+Gyr Group AG / NAK Kazatomprom AO / Medacta Group SA / Genmab A/S / Just Eat Takeaway.com NV / PolyPeptide Group AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Austria / Belgium / Bermuda / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / India / Ireland / Italy / Kazakhstan / Netherlands / Norway / Poland / Russian Federation / Sweden / Turkey / United States / South Africa</td><td class="leftalignment">Apparel & Textiles / Banks / Biotechnology / Building & Building Materials / Chemicals / Consumer / Electronics / Energy / Financial Services / Food / Healthcare / Industrial Materials / Info. Tech./Computers / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Manufacturing / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Retailing / Semiconductors / Shipping & Shipbuilding / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Joelle Anamooto Natzkoff / Mr. Richard A. Kersley / Samuel Burgess</td></tr>
<tr class="even"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Here's Why Pfizer Stock Can Rebound After Falling Nearly 15% From Its Peak Last Month</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N / JNJ.N / MRK.N / RHHBY.PK</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Merck & Co Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Will Johnson & Johnson Stock Rebound After A 4% Fall In A Week?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What's Next For Merck Stock After A 5% Fall In A Week?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Merck & Co., Inc.(MRK) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">58933Y105</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">09/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">MGC018 Data Maturing Positively; Daiichi DS-7300 Data Next</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">55609910 / 45337C10 / 45253H10 / 58933Y10 / 98887Q10</td><td class="leftalignment">MacroGenics Inc / Incyte Corp / ImmunoGen Inc / Merck & Co Inc / Zai Lab Ltd</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jonathan Chang, Ph.D., CFA / Faisal Khurshid</td></tr>
<tr class="odd"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / BSX=US / LLY=US / AMGN=US / BMY=US / HD=US / MDT=US / GILD=US / PEB=US / H=US / MTN=US / LOW=US / IGT=US / MAR=US / ADS=US / TTWO=US / TNL=US / ATVI=US / HLT=US / CLI=US / CHH=US / DRH=US / EXEL=US / MHK=US / HOOK=US / REGN=US / SGMO=US / TRIP=US / SGMS=US / CNM=US / MTCH=US / IGMS=US / STRO=US / APP=US / SHO=US / HST=US / WH=US / TIL=US / HGV=US / RLJ=US / VAC=US / ZNGA=US / EA=US / RHP=US / TILE=US / AERI=US / BWXT=US / PEN=US / IBEX=US / TTD=US / PK=US / PLYA=US / CVNA=US / NCNA=US / DCPH=US / GSKY=US / BTAI=US / TCRR=US / GMAB=US / RBLX=US / MNTV=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / Medtronic PLC / Gilead Sciences Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Lowe's Companies Inc / International Game Technology PLC / Marriott International Inc / Alliance Data Systems Corp / Take-Two Interactive Software Inc / Travel + Leisure Co / Activision Blizzard Inc / Hilton Worldwide Holdings Inc / Veris Residential Inc / Choice Hotels International Inc / Diamondrock Hospitality Co / Exelixis Inc / Mohawk Industries Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Tripadvisor Inc / Scientific Games Corp / Core & Main Inc / Match Group Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Applovin Corp / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / Wyndham Hotels & Resorts Inc / Instil Bio Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Zynga Inc / Electronic Arts Inc / Ryman Hospitality Properties Inc / Interface Inc / Aerie Pharmaceuticals Inc / BWX Technologies Inc / Penumbra Inc / Ibex Ltd / Trade Desk Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Carvana Co / NuCana PLC / Deciphera Pharmaceuticals Inc / GreenSky Inc / BioXcel Therapeutics Inc / TCR2 Therapeutics Inc / Genmab A/S / Roblox Corp / Momentive Global Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Denmark / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Cross-Sector - 10th Annual German Corporate Conference</td><td class="leftalignment">English</td><td class="rightalignment">264</td><td class="leftalignment">DE0005785604 / DE0006599905 / DE0007235301 / DE0008404005 / DE0008430026 / DE0006048432 / DE0005439004 / DE0006305006 / DE0007030009 / DE0006047004 / DE0005785802 / DE0005557508 / DE0005313704 / DE0007236101 / DE0008402215 / DE0006464506 / DE0007231326 / DE0005552004 / DE0005104400 / DE0005810055 / DE0007165607 / DE0006219934 / DE0005565204 / DE0005772206 / DE0005493092 / DE0005232805 / DE0005089031 / DE0005545503 / DE0006452907 / DE0007461006 / DE0005419105 / DE0007446007 / DE0005470306 / DE0007231334 / DE0008303504 / DE0007480204 / DE0006095003 / DE0005220909 / DE0005470405 / DE0007203705 / DE000A0D9PT0 / DE000TUAG000 / DE000WCH8881 / DE000A0JC8S7 / DE000SYM9999 / DE000WACK012 / DE000PAT1AG3 / DE000A0JK2A8 / DE000A0LD6E6 / DE000A0TGJ55 / DE000A0LD2U1 / DE000A0ETBQ4 / DE000ENAG999 / DE000A0WMPJ6 / DE0005493365 / DE000A0Z23Q5 / DE000BAY0017 / DE000A0Z2ZZ5 / DE000A1DAHH0 / DE000BASF111 / DE000A1EWWW0 / DE000KSAG888 / DE000LEG1110 / DE000A1ML7J1 / DE000A1X3XX4 / DE000PSM7770 / DE000KGX8881 / LU0775917882 / DE000EVNK013 / DE000A1X3W00 / FI4000106299 / DE000A161N30 / LU1066226637 / DE000STRA555 / CH0303692047 / DE000WAF3001 / DE000HLAG475 / DE000UNSE018 / DE000A1MMCC8 / DE0006636681 / NL0012044747 / DE000FTG1111 / NL0012169213 / LU1296758029 / DE000A2DAM03 / DE000BFB0019 / DE000A14KRD3 / LU1673108939 / DE000A161408 / LU1704650164 / DE000A0STSQ8 / DE000A2G9MZ9 / DE000A2GS5D8 / DE000A0N4N52 / DE000A14KEB5 / DE000A2NB601 / DE000A2G9LL1 / DE000A2N4H07 / DE000KBX1006 / LU2010095458 / DE000A2YNT30 / DE000A2YPDD0 / US09075V1026 / DE000ZEAL241 / DE000A2P4LJ5 / NL0015436031 / US91823Y1091 / DE000ENER6Y0 / DE000A2QEFA1 / DE000A3H2333 / DE000A255F11 / DE000A3H3LL2 / DE000A3CQ7F4 / DE000A3CSAE2 / DE000A3E5D56</td><td class="leftalignment">Fresenius SE & Co KGaA / Merck KGaA / SGL Carbon SE / Allianz SE / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / Henkel AG & Co KGaA / Continental AG / DEUTZ AG / Rheinmetall AG / HeidelbergCement AG / Fresenius Medical Care AG & Co KGaA / Deutsche Telekom AG / Carl Zeiss Meditec AG / Siemens AG / Hannover Rueck SE / Leifheit AG / Sixt SE / Deutsche Post AG / Atoss Software AG / Deutsche Boerse AG / Sartorius AG / Jungheinrich AG / Duerr AG / Fielmann AG / Borussia Dortmund GmbH & Co KGaA / Bertrandt AG / United Internet AG / 1&1 AG / Nemetschek SE / PVA TePla AG / Cancom SE / Takkt AG / Cts Eventim AG & Co KgaA / Sixt SE / TAG Immobilien AG / Deutsche EuroShop AG / Encavis AG / Nexus AG / Lanxess AG / SNP Schneider Neureither & Partner SE / MTU Aero Engines AG / TUI AG / Wacker Chemie AG / Datagroup SE / Symrise AG / Wacker Neuson SE / Patrizia AG / AURELIUS Equity Opportunities SE & Co KgaA / Gerresheimer AG / Varta AG / alstria office REIT AG / MBB SE / E.ON SE / Aixtron SE / Hypoport SE / adesso SE / Bayer AG / freenet AG / Brenntag SE / BASF SE / Adidas AG / K&S AG / LEG Immobilien SE / Vonovia SE / DIC Asset AG / Prosiebensat 1 Media SE / Kion Group AG / Grand City Properties SA / Evonik Industries AG / Medigene AG / Multitude SE / Grenke AG / Stabilus SA / Stratec SE / EDAG Engineering Group AG / Siltronic AG / Hapag Lloyd AG / Uniper SE / Medios AG / va Q tec AG / Shop Apotheke Europe NV / flatexDEGIRO AG / Qiagen NV / Corestate Capital Holding SA / Aumann AG / Metro AG / Deutsche Konsum REIT-AG / Aroundtown SA / Hellofresh SE / Befesa SA / M1 Kliniken AG / Stemmer Imaging AG / Dermapharm Holding SE / Nfon AG / Home24 SE / Jenoptik AG / Deutsche Industrie REIT-AG / Westwing Group AG / Knorr Bremse AG / Global Fashion Group SA / AlzChem Group AG / VIB Vermoegen AG / BioNTech SE / ZEAL Network SE / PharmaSGP Holding SE / CureVac NV / VIA Optronics AG / Siemens Energy AG / Fashionette AG / Hamborner REIT AG / Friedrich Vorwerk Group SE / Vantage Towers AG / Bike24 Holding AG / Mister Spex SE / Fuchs Petrolub SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Finland / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment">Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Automotive / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Defense / Electrical / Electronics / Financial Services / Food / Healthcare / Household Products / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Services / Shipping & Shipbuilding / Technology / Telecommunications / Utilities</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Scott J. Bardo, PHD / Michael Benedict / Mr. Robert Berg / Sebastian Bray, CFA / Philip Buller / Mr Thomas Burlton / Mr. Andrew E. E. Buscaglia / Mr. Fulvio Cazzol / Frau Catharina Claes / Herr Jack Cummings / Herr Thomas Davies / Xian Deng / Ms. Kathryn Fear / Mr. Andrew Fisher / William Fitzalan Howard / Charlotte Friedrichs / Herr Gustav Froberg / Mr. Usman M. Ghazi / Mr. Harry F. Goad / Mr. Andrew P. Gollan / Stuart Gordon / Romain Gourvil / Christoph Greulich / Herr Michael Healy / Mrs. Luisa C. Hector, PHD / Mr. Michael I. Huttner / Mr. Tom M. Jones / Mr. Kai Klose, CIIA / Hr. Philippe Lorrain / Anthony Manning / Herr George McWhirter / Gal Munda / Mr. Gerhard Orgonas, CFA / Herr. Benjamin Pfannes-Varrow / Herr. Trion Reid / Mr. Graham Renwick / Mr. Peter G. Richardson / Mr. Zhiqiang Shu / Ms. Sarah Simon / Wolfgang Specht / Lawson Steele / Herr Lasse Stueben / Adrien Tamagno / Mr. James Targett, CFA</td></tr>
<tr class="odd"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck & Co Inc: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist Securities ESMO Planner Highlights 130+ Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRK=US / LLY=US / AMGN=US / BMY=US / GILD=US / EXEL=US / HOOK=US / REGN=US / IGMS=US / STRO=US / TIL=US / NCNA=US / DCPH=US / BTAI=US / TCRR=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Exelixis Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Instil Bio Inc / NuCana PLC / Deciphera Pharmaceuticals Inc / BioXcel Therapeutics Inc / TCR2 Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Billal Jahangiri / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Merck KGaA</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Will Roche Stock Rebound After A 3% Fall In A Week?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">RHHBY.PK / JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Roche Holding AG / Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">V / 5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2023607 / 2778844 / 2026242 / 2270726 / 2317087 / 2670519 / 2328915 / 2459020 / 2689560 / 2684703 / 2440637 / 7103065 / B121557 / 2212922 / 2857817 / 2982924 / B7VD3F2 / BFDV8K0 / BBPK0J0 / B95N910 / BVVN4Q8 / BYW36M8 / BZ1LFB2 / BJXBP30 / BYQHPK7 / BYYWPW6 / BZ1LFG7 / BJDX8Y8 / BWY4XV3 / BGT0PL8 / BNTB3N8 / BMGGJK8</td><td class="leftalignment">Visa Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Merck & Co Inc / American Electric Power Company Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / Intuit Inc / PG&E Corp / Pfizer Inc / CenterPoint Energy Inc / Novartis AG / Mastercard Inc / NRG Energy Inc / Netflix Inc / Spectrum Pharmaceuticals Inc / Duke Energy Corp / MacroGenics Inc / Mirati Therapeutics Inc / PTC Inc / Eversource Energy / PayPal Holdings Inc / Deciphera Pharmaceuticals Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Beigene Ltd / Roku Inc / Mirum Pharmaceuticals Inc / Adaptimmune Therapeutics PLC / DiaMedica Therapeutics Inc / Vizio Holding Corp / Valneva SE</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Healthcare Sector: AI, Blockchain, Cloud and Data Analytics: Transforming healthcare landscape</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">ACCD.OQ / TDOC.N / ABT.N / CAH.N / CIPL.BO / HDBK.BO / IBM.N / JNJ.N / MCK.N / REDY.BO / RELI.BO / AZN.L / SASY.PA / ROG.S / UNH.N / SUN.BO / NOVN.S / MRCG.DE / 0241.HK / CADI.BO / 0966.HK / GSK.L / OMI.N / ABC.N / LUPN.BO / APLH.NS / 0728.HK / PFIZ.NS / AAPL.OQ / CERN.OQ / MSFT.OQ / AMZN.OQ / MDRX.OQ / 600718.SS / 0700.HK / 1833.HK / 2318.HK / BIDU.OQ / 601318.SS / MULT3.SA / CHNG.OQ / 1099.HK / 601607.SS / 300003.SZ / 600998.SS / 2607.HK / 300253.SZ / ABBV.N / GOOGL.OQ / 3320.HK / 1810.HK / AAF.L / ONEM.OQ / 6618.HK / GDRX.OQ / AMWL.N / TLMD.OQ / CLOV.OQ / HIMS.N / OSCR.N / 9888.HK / PRVA.OQ</td><td class="leftalignment">Accolade Inc / Teladoc Health Inc / Abbott Laboratories / Cardinal Health Inc / Cipla Ltd / HDFC Bank Ltd / International Business Machines Corp / Johnson & Johnson / Mckesson Corp / Dr Reddy's Laboratories Ltd / Reliance Industries Ltd / AstraZeneca PLC / Sanofi SA / Roche Holding AG / UnitedHealth Group Inc / Sun Pharmaceutical Industries Ltd / Novartis AG / Merck KGaA / Alibaba Health Information Technology Ltd / Cadila Healthcare Ltd / China Taiping Insurance Holdings Co Ltd / GlaxoSmithKline PLC / Owens & Minor Inc / Amerisourcebergen Corp / Lupin Ltd / Apollo Hospitals Enterprise Ltd / China Telecom Corp Ltd / Pfizer Ltd / Apple Inc / Cerner Corp / Microsoft Corp / Amazon.com Inc / Allscripts Healthcare Solutions Inc / Neusoft Corp / Tencent Holdings Ltd / Ping An Healthcare and Technology Co Ltd / Ping An Insurance Group Co of China Ltd / Baidu Inc / Ping An Insurance Group Co of China Ltd / Multiplan Empreendimentos Imobiliarios SA / Change Healthcare Inc / Sinopharm Group Co Ltd / Shanghai Pharmaceuticals Holding Co Ltd / Lepu Medical Technology Beijing Co Ltd / Jointown Pharmaceutical Group Co Ltd / Shanghai Pharmaceuticals Holding Co Ltd / Winning Health Technology Group Co Ltd / Abbvie Inc / Alphabet Inc / China Resources Pharmaceutical Group Ltd / Xiaomi Corp / Airtel Africa PLC / 1Life Healthcare Inc / JD Health International Inc / Goodrx Holdings Inc / American Well Corp / Soc Telemed Inc / Clover Health Investments Corp / Hims & Hers Health Inc / Oscar Health Inc / Baidu Inc / Privia Health Group Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Brazil / Switzerland / China / Cayman Islands / Germany / France / United Kingdom / Hong Kong / India / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Jailendra P. Singh / Mr. Yang Huang / Mr. Anubhav Aggarwal / Adam Heussner / Jing Yang / Sayantan Maji</td></tr>
<tr class="even"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">US healthcare reform back in focus: Build Back Better includes direct negotiation</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">4502.T / BMY.N / CSL.AX / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / 4768.T / GSK.L / UCB.BR / REGN.OQ / GILD.OQ / INCY.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / IPN.PA / TEVA.N / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Otsuka Corp / GlaxoSmithKline PLC / Ucb SA / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - ESMO0 2021 first impression (Part 3): Zai lab, Alphamab, Akeso, and Hutchmed</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY.N / AZN.L / MRCG.DE / 600276.SS / MGNX.OQ / HCM.OQ / ZLAB.OQ / 1801.HK / 1877.HK</td><td class="leftalignment">Bristol-Myers Squibb Co / AstraZeneca PLC / Merck KGaA / Jiangsu Hengrui Pharmaceuticals Co Ltd / MacroGenics Inc / HUTCHMED (China) Ltd / Zai Lab Ltd / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / Germany / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRK.N - Event Transcript of Merck & Co Inc conference call, Sep. 13, 2021 / 11:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 03, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Merck: All set for continued outperformance</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">CREDIT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Falko Friedrichs / Herr Jan Koch / Sachin Gadilingappa</td></tr>
<tr class="odd"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - ESMO 2021 first impression (Part 2): Hengrui, CSPC, and Sino Biopharm</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">1093.HK / 1177.HK / 600276.SS / MRCG.DE</td><td class="leftalignment">CSPC Pharmaceutical Group Ltd / Sino Biopharmaceutical Ltd / Jiangsu Hengrui Pharmaceuticals Co Ltd / Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / Germany / Hong Kong</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">China insulin VBP moves forward: Tendering expected Oct/Nov for early 2022 implementation</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / FMEG.DE / MRCG.DE / GSK.L / BAYGN.DE</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Fresenius Medical Care AG & Co KGaA / Merck KGaA / GlaxoSmithKline PLC / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Trefis Report: Merck - $91.16 Trefis Price Estimate</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Merck KGaA Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">09/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Catalyst Tracker 9.12.21: Highlights Top Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">61</td><td class="leftalignment">09061G10 / 71708110 / 87936910 / 640268108 / 45784P10 / 25213110 / 03152W10 / 58933Y10 / 45766930 / 92337F10 / 87918A10 / 00287Y10 / G5960L10 / 05337M104 / 40131M10 / 604749101 / 45773010 / 98420N10 / 90041T10 / 68071010 / 74340E10 / 01981810 / 10806X10 / 16383L10 / 55609910 / 14843C10 / 01438T10 / G3910J11 / 34633R10 / 43906K10 / 45781K20 / 60468T10 / 03969F10 / F5548N10 / 45845P10 / 82710M10 / G8807B10 / 90400D10 / 01671P10 / 56400P70 / 87808K10 / N4444510 / 15912K10 / 87410C10 / 09770210 / 82835W10 / G637AM10</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Pfizer Inc / Teleflex Inc / Nektar Therapeutics / Insulet Corp / Dexcom Inc / Amicus Therapeutics Inc / Merck & Co Inc / Insmed Inc / Veracyte Inc / Teladoc Health Inc / Abbvie Inc / Medtronic PLC / Avadel Pharmaceuticals PLC / Guardant Health Inc / Mirum Pharmaceuticals Inc / Inspire Medical Systems Inc / Xenon Pharmaceuticals Inc / Turning Point Therapeutics Inc / Olink Holding AB (publ) / Progyny Inc / Allovir Inc / BridgeBio Pharma Inc / ChemoCentryx Inc / MacroGenics Inc / Castle Biosciences Inc / Aldeyra Therapeutics Inc / GlaxoSmithKline PLC / Forma Therapeutics Holdings Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Mirati Therapeutics Inc / Arcus Biosciences Inc / Sanofi SA / Intercept Pharmaceuticals Inc / Silk Road Medical Inc / Theravance Biopharma Inc / Ultragenyx Pharmaceutical Inc / Allakos Inc / MannKind Corp / TCR2 Therapeutics Inc / Immatics NV / Change Healthcare Inc / Talaris Therapeutics Inc / Bolt Biotherapeutics Inc / Silverback Therapeutics Inc / Myovant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Netherlands / Sweden / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="even"><td class="leftalignment">09/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.6% Above Pre-Pandemic Base- Week 75</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">09/10/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ALKS / AMRN / CDTX / CERS / COLL / COX / EBS / GRAY / HCM / JAZZ / JNJ / LLY / MRK / MSB / OPTN / PFE / RMTI / SIBN / ACRS / SMTI / CKPT / BDSI / UBX / ACRX / ARDX / ANIP / ARDS / CUTR / BSLN / MNKD / RANI / ARAV / AVTX / SPRO / ZTS / RDHL / OMER / AXGN / TXMD / HRTX / TRVN / SCYX / EGRX / LPCN / CFRX / FBIO / SPNE / JAGX / AYTU / VRAY / VERU / EYPT / EOLS / PDSB / ETTX / HGEN / ARQT / IMAB / PCVX / SRGA / VYNE / AZYO</td><td class="leftalignment">Alkermes Plc / Amarin Corporation PLC / Cidara Therapeutics Inc / Cerus Corp / Collegium Pharmaceutical Inc / Nicox SA / Emergent BioSolutions Inc / Graybug Vision Inc / HUTCHMED (China) Ltd / Jazz Pharmaceuticals PLC / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Mesoblast Ltd / OptiNose Inc / Pfizer Inc / Rockwell Medical Inc / SI-BONE Inc / Aclaris Therapeutics Inc / Sanara Medtech Inc / Checkpoint Therapeutics Inc / BioDelivery Sciences International Inc / UNITY Biotechnology Inc / AcelRx Pharmaceuticals Inc / Ardelyx Inc / ANI Pharmaceuticals Inc / Aridis Pharmaceuticals Inc / Cutera Inc / Basilea Pharmaceutica AG / MannKind Corp / Rani Therapeutics Holdings Inc / Aravive Inc / Avalo Therapeutics Inc / Spero Therapeutics Inc / Zoetis Inc / Redhill Biopharma Ltd / Omeros Corp / AxoGen Inc / TherapeuticsMD Inc / Heron Therapeutics Inc / Trevena Inc / SCYNEXIS Inc / Eagle Pharmaceuticals Inc / Lipocine Inc / ContraFect Corp / Fortress Biotech Inc / SeaSpine Holdings Corp / Jaguar Health Inc / Aytu Biopharma Inc / ViewRay Inc / Veru Inc / EyePoint Pharmaceuticals Inc / Evolus Inc / PDS Biotechnology Corp / Entasis Therapeutics Holdings Inc / Humanigen Inc / Arcutis Biotherapeutics Inc / I-Mab / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Aziyo Biologics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">09/10/2021</td><td class="leftalignment">Kepler Cheuvreux</td><td class="leftalignment">Merck KGAA | Buy | Thoughts after a positive CMD</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David P. Evans</td></tr>
<tr class="odd"><td class="leftalignment">09/10/2021</td><td class="leftalignment">Societe Generale</td><td class="leftalignment">Merck KGaA (Hold, TP=€204) - 12m target upgrade - CMD feedback: mid-term guidance raised, driven by Life Science - F. Cespedes (5p)</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Florent Cespedes / Justin S. Smith / Manas Sarkar</td></tr>
<tr class="even"><td class="leftalignment">09/10/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended September 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">09/10/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Daily Credit Briefing</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">IG.MI / RWEG.DE / BMWG.DE / EPED.PA / VOWG.DE / MRCG.DE / EDF.PA</td><td class="leftalignment">Italgas SpA / Rwe AG / Bayerische Motoren Werke AG / Faurecia SE / Volkswagen AG / Merck KGaA / Electricite de France SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Brazil / Germany / Spain / France / Italy / Luxembourg</td><td class="leftalignment">Advertising / Aerospace / Air Transportation / Apparel & Textiles / Appliances / Automotive / Biotechnology / Broadcasting & Cable / Building & Building Materials / Conglomerates / Consumer / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Healthcare / Household Products / Industrial Materials / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Photography / Publishing / Railroads / Retailing / Shipping & Shipbuilding / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS / CREDIT</td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Herr. Ulrich Scholz, CFA / Herr Christian Aust / Herr Sven Kreitmair, CFA / Frau Silke Stegemann / Herr Gianfranco Arcovito / Herr. Stefan Kolek</td></tr>
<tr class="even"><td class="leftalignment">09/10/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Merck KGaA (MRK GY) - Increasing investment to drive future growth</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="odd"><td class="leftalignment">09/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRCG.DE: Merck KGaA - Key takeaways from 2021 CMD</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRCG.DE / 2330.TW / 4063.T / 4185.T / A.N / BDX.N / PFE.N / PHG.AS / RECI.MI / STDM.PA / TMO.N / WAT.N / DHR.N / LUN.CO / GLW.N / MTD.N / LONN.S / PKI.N / WST.N / GSK.L / UCB.BR / INTC.OQ / RGEN.OQ / TECH.OQ / CCMP.OQ / ENTG.OQ / 005930.KS / IPN.PA / ORNBV.HE / QGEN.N / ALM.MC / GRLS.MC / WAFGN.DE / VIFN.S / GMAB.CO</td><td class="leftalignment">Merck KGaA / Taiwan Semiconductor Manufacturing Co Ltd / Shin-Etsu Chemical Co Ltd / JSR Corp / Agilent Technologies Inc / Becton Dickinson and Co / Pfizer Inc / Koninklijke Philips NV / Recordati Industria Chimica e Farmaceutica SpA / Sartorius Stedim Biotech SA / Thermo Fisher Scientific Inc / Waters Corp / Danaher Corp / H Lundbeck A/S / Corning Inc / Mettler-Toledo International Inc / Lonza Group AG / PerkinElmer Inc / West Pharmaceutical Services Inc / GlaxoSmithKline PLC / Ucb SA / Intel Corp / Repligen Corp / Bio-Techne Corp / CMC Materials Inc / Entegris Inc / Samsung Electronics Co Ltd / Ipsen SA / Orion Oyj / Qiagen NV / Almirall SA / Grifols SA / Siltronic AG / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Italy / Japan / Korea, Republic of / Netherlands / Taiwan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">09/09/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck KGaA : CMD 2021 highlights strengthening medium-term growth profile, which remains undervalued</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Richard B. Vosser / James D. Gordon / Ms. Laerke Engkilde / Zain Ebrahim</td></tr>
<tr class="odd"><td class="leftalignment">09/09/2021</td><td class="leftalignment">Kepler Cheuvreux</td><td class="leftalignment">Merck KGAA | Buy | Top-line forecasts still going up, even off a high base</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David P. Evans</td></tr>
<tr class="even"><td class="leftalignment">09/09/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck KGaA : New 2025 targets provided with CMD imply 4% upside to Cons. Revenues at the midpoint (+8% vs. JPMe)</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Richard B. Vosser / James D. Gordon / Ms. Laerke Engkilde / Zain Ebrahim</td></tr>
<tr class="odd"><td class="leftalignment">09/09/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Merck: Growth accelerates until 2025; new mid-term targets above expectations</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">INVESTMENT STRATEGY / MANAGEMENT / MERGER/ACQUISITION/DIVESTITURE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Falko Friedrichs / Herr Jan Koch / Sachin Gadilingappa</td></tr>
<tr class="even"><td class="leftalignment">09/09/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRCG.DE - Event Transcript of Merck KGaA conference call, Sep. 09, 2021 / 4:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">55</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma: World Lung (WCLC) & ESMO cancer conference preview</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BMY.N / JNJ.N / AZN.L / SASY.PA / ROG.S / NOVN.S / MRCG.DE / REGN.OQ / SGEN.OQ / 4568.T / GMAB.CO</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / Merck KGaA / Regeneron Pharmaceuticals Inc / Seagen Inc / Daiichi Sankyo Co Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">09/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK / HCM / JNJ / LLY / PFE / BSLN / IMAB</td><td class="leftalignment">Merck & Co Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Basilea Pharmaceutica AG / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">09/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ZTS-US -  Dividend Quality Analysis, for the period ended September 01,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ZTS / LLY / MRK / PFE / ICCC.O / HSKA.O / PAHC.O / SNY.O</td><td class="leftalignment">Zoetis Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / ImmuCell Corp / Heska Corp / Phibro Animal Health Corp / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">09/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US -  Dividend Quality Analysis, for the period ended September 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">09/08/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Merck & Co (MRK US) - Concentrating on Merck</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="even"><td class="leftalignment">09/08/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Sector Flash - Health Care: Vaccination is not enough - spotlight on COVID-19 drugs</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GSK.L / PFE.N / AZN.L / SASY.PA / MRCG.DE / JP3463000004</td><td class="leftalignment">GlaxoSmithKline PLC / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Merck KGaA / Takeda Pharmaceutical Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Japan / United States</td><td class="leftalignment">Aerospace / Air Transportation / Biotechnology / Conglomerates / Defense / Electrical / Engineering & Construction / Environmental Services / Healthcare / Industrial Materials / Machinery / Pharmaceuticals / Railroads / Shipping & Shipbuilding / Transportation</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment">CREDIT</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Frau Silke Stegemann</td></tr>
<tr class="odd"><td class="leftalignment">09/08/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">KOL Call Takeaways: IBD Still a Big Market for JAKs, 2L+ Was Always the Spot</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">71708110 / 09062X10 / 478160104 / 640268108 / 58933Y10 / 00287Y10 / 38341P10 / 4525EP10 / 74366E10 / G8807B10 / 00461U10 / 51506910</td><td class="leftalignment">Pfizer Inc / Biogen Inc / Johnson & Johnson / Nektar Therapeutics / Merck & Co Inc / Abbvie Inc / Gossamer Bio Inc / Immunic Inc / Protagonist Therapeutics Inc / Theravance Biopharma Inc / Aclaris Therapeutics Inc / Landos Biopharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / Hong Kong / Israel / Japan / Luxembourg / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Mr. Thomas J. Smith / Anna Baran, CFA / Na Sun / Mike Kratky, CFA / Nat Charoensook, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">09/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2367026 / 2126335 / 2516152 / 2000019 / 2778844 / 2973821 / 2270726 / 2317087 / 2670519 / 2328915 / 2689560 / 2684703 / 2048804 / 2829601 / 7103065 / B1F76F9 / 2857817 / B3D7K31 / BCZS820 / BFDV8K0 / BVVN4Q8 / BYW36M8 / BJLT387 / BD8DJ71 / BJ5FZ74 / BFZ1K46 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BWY4XV3 / BMG5660 / BMHR7K6 / BP0TJN7</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / General Mills Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Alliant Energy Corp / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Novartis AG / Western Union Co / Netflix Inc / Discovery Inc / Fate Therapeutics Inc / MacroGenics Inc / Eversource Energy / PayPal Holdings Inc / Avantor Inc / Snap Inc / Adaptive Biotechnologies Corp / Spotify Technology SA / ViacomCBS Inc / Roku Inc / Alphabet Inc / Adaptimmune Therapeutics PLC / Joann Inc / Impel Neuropharma Inc / Xponential Fitness Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Equity Strategy: Regional strategy: increasingly relevant. Add to GEM; Europe is our top overweight</td><td class="leftalignment">English</td><td class="rightalignment">102</td><td class="leftalignment">0941.HK / 1171.HK / 2301.TW / 2303.TW / 2823.TW / 4503.T / 6502.T / 6754.T / 6758.T / 6954.T / 6963.T / 6981.T / 7203.T / 7269.T / 7453.T / 8035.T / 9983.T / ABB.BO / ABF.L / AHT.L / ALFAA.MX / ALVG.DE / ASML.AS / ASSAB.ST / BATS.L / BDEV.L / BOY.L / BT.L / BWY.L / CCC.L / CCH.L / DGE.L / ELM.L / HEIN.AS / ITV.L / JD.L / JMAT.L / KGF.L / LART.BO / MKS.L / OREP.PA / PRTP.PA / RAND.AS / RDW.L / RR.L / RTO.L / SAN.MC / SBI.BO / SCHN.PA / SNR.L / SOGN.PA / STM.PA / SWMA.ST / TW.L / ULVR.L / VOD.L / WEIR.L / SSE.L / INF.L / PG.N / 6594.T / 6861.T / TKAG.DE / GFNORTEO.MX / ABBN.S / SIEGN.DE / INFY.BO / ENEI.MI / MRCG.DE / NKE.N / IFXGN.DE / 0857.HK / 6506.T / 2408.TW / RWA.L / EZJ.L / 0883.HK / DB1GN.DE / ITX.MC / BLK.N / 2454.TW / 2264.T / AVV.L / SRG.MI / 2882.TW / TDY.N / REL.L / 2890.TW / ALFA.ST / 3034.TW / 600188.SS / AAPL.OQ / AMAT.OQ / MSFT.OQ / AMZN.OQ / NFLX.OQ / 600519.SS / 6723.T / 010950.KS / 005930.KS / 006400.KS / 005490.KS / 035250.KS / 000270.KS / 005380.KS / 008770.KS / 032640.KS / LOGN.S / BARN.S / 0993.HK / UBBW.BO / 006280.KS / 000120.KS / 600309.SS / 035720.KS / 0700.HK / CG.TO / ULTC.BO / 0939.HK / ASOS.L / ICLR.OQ / 600438.SS / BIDU.OQ / 3436.T / HOLN.S / 090430.KS / 3481.TW / SKG.I / 2020.HK / AXBK.BO / 601939.SS / BAES.L / GRLS.MC / VCTX.L / GL9.I / 601857.SS / FLUI.MC / 3092.T / ZO1G.DE / 105560.KS / AVGO.OQ / 002353.SZ / BNRGN.DE / BASFN.DE / ICAG.L / 139480.KS / 4966.TWO / ALPEKA.MX / O2DN.DE / TERRA13.MX / BOOH.L / GOOGL.OQ / APPS.MC / JD.OQ / BMEB.L / FBK.MI / ONTEX.BR / BABA.N / PINFRAL.MX / 3697.T / 300415.SZ / AENA.MC / CLNX.MC / WAFGN.DE / INWT.MI / RACE.N / AMUN.PA / 145020.KQ / IMB.L / PAGE.L / KCRA.HE / VIFN.S / 603501.SS / ESSITYB.ST / HFGG.DE / 253450.KQ / INS2.DE / 4063.NG / FB.PS / BANH.BO / 3711.TW / AVST.L / 1810.HK / PDD.OQ / 316140.KS / DQ.ZY / ENR1N.DE / ANE.MC</td><td class="leftalignment">China Mobile Ltd / Yankuang Energy Group Co Ltd / Lite-On Technology Corp / United Microelectronics Corp / China Life Insurance Co Ltd / Astellas Pharma Inc / Toshiba Corp / Anritsu Corp / Sony Group Corp / Fanuc Corp / Rohm Co Ltd / Murata Manufacturing Co Ltd / Toyota Motor Corp / Suzuki Motor Corp / Ryohin Keikaku Co Ltd / Tokyo Electron Ltd / Fast Retailing Co Ltd / ABB India Ltd / Associated British Foods PLC / Ashtead Group PLC / Alfa SAB de CV / Allianz SE / ASML Holding NV / Assa Abloy AB / British American Tobacco PLC / Barratt Developments P L C / Bodycote PLC / BT Group PLC / Bellway PLC / Computacenter PLC / Coca Cola HBC AG / Diageo PLC / Elementis PLC / Heineken NV / ITV PLC / JD Sports Fashion PLC / Johnson Matthey PLC / Kingfisher PLC / Larsen & Toubro Ltd / Marks and Spencer Group PLC / L'Oreal SA / Kering SA / Randstad NV / Redrow PLC / Rolls-Royce Holdings PLC / Rentokil Initial PLC / Banco Santander SA / State Bank of India / Schneider Electric SE / Senior PLC / Societe Generale SA / STMicroelectronics NV / Swedish Match AB / Taylor Wimpey PLC / Unilever PLC / Vodafone Group PLC / Weir Group PLC / SSE PLC / Informa PLC / Procter & Gamble Co / Nidec Corp / Keyence Corp / thyssenkrupp AG / Grupo Financiero Banorte SAB de CV / Abb Ltd / Siemens AG / Infosys Ltd / Enel SpA / Merck KGaA / Nike Inc / Infineon Technologies AG / PetroChina Co Ltd / Yaskawa Electric Corp / Nanya Technology Corp / Robert Walters PLC / Easyjet PLC / CNOOC Ltd / Deutsche Boerse AG / Industria de Diseno Textil SA / BlackRock Inc / MediaTek Inc / Morinaga Milk Industry Co Ltd / AVEVA Group PLC / Snam SpA / Cathay Financial Holding Co Ltd / Teledyne Technologies Inc / Relx PLC / Sinopac Financial Holdings Co Ltd / Alfa Laval AB / Novatek Microelectronics Corp / Yankuang Energy Group Co Ltd / Apple Inc / Applied Materials Inc / Microsoft Corp / Amazon.com Inc / Netflix Inc / Kweichow Moutai Co Ltd / Renesas Electronics Corp / S-Oil Corp / Samsung Electronics Co Ltd / Samsung SDI Co Ltd / Posco / Kangwon Land Inc / Kia Corp / Hyundai Motor Co / Hotel Shilla Co Ltd / LG Uplus Corp / Logitech International SA / Barry Callebaut AG / Huarong International Financial Holdings Ltd / United Breweries Ltd / Green Cross Corp / CJ Logistics Corp / Wanhua Chemical Group Co Ltd / Kakao Corp / Tencent Holdings Ltd / Centerra Gold Inc / UltraTech Cement Ltd / China Construction Bank Corp / ASOS PLC / ICON PLC / Tongwei Co Ltd / Baidu Inc / Sumco Corp / Holcim AG / AmorePacific Corp / Innolux Corp / Smurfit Kappa Group PLC / ANTA Sports Products Ltd / Axis Bank Ltd / China Construction Bank Corp / BAE Systems PLC / Grifols SA / Victrex PLC / Glanbia PLC / PetroChina Co Ltd / Fluidra SA / ZOZO Inc / Zooplus AG / KB Financial Group Inc / Broadcom Inc / Yantai Jereh Oilfield Services Group Co Ltd / Brenntag SE / BASF SE / International Consolidated Airlines Group SA / E-Mart Inc / Parade Technologies Ltd / Alpek SAB de CV / Telefonica Deutschland Holding AG / CI Banco SA Institucion de Banca Multiple FF/00939 / boohoo group plc / Alphabet Inc / Applus Services SA / JD.Com Inc / B&M European Value Retail SA / FinecoBank Banca Fineco SpA / Ontex Group NV / Alibaba Group Holding Ltd / Promotora y Operadora de Infraestructura SAB de CV / Shift Inc / Guangdong Yizumi Precision Machinery Co Ltd / Aena SME SA / Cellnex Telecom SA / Siltronic AG / Infrastrutture Wireless Italiane SpA / Ferrari NV / Amundi SA / Hugel Inc / Imperial Brands PLC / Pagegroup PLC / Konecranes Abp / Vifor Pharma AG / Will Semiconductor Co Ltd Shanghai / Essity AB (publ) / Hellofresh SE / Studio Dragon Corp / Instone Real Estate Group SE / Shin-Etsu Chemical Co Ltd / San Miguel Food and Beverage Inc / Bandhan Bank Ltd / ASE Technology Holding Co Ltd / Avast PLC / Xiaomi Corp / Pinduoduo Inc / Woori Financial Group Inc / Daqo New Energy Corp / Siemens Energy AG / Corporacion Acciona Energias Renovables SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / China / Cayman Islands / Germany / Spain / Finland / France / United Kingdom / Hong Kong / India / Ireland / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Netherlands / Philippines / Sweden / Taiwan / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / Investment Strategy / Equity</td><td class="leftalignment">Mr. Andrew W. Garthwaite / Mr Robert C. Griffiths / Mr Mengyuan Yuan / Asim Ali / Nasr Islam</td></tr>
<tr class="even"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">The Highlights; What We'll Be Watching At ESMO Next Week</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK / HCM / JNJ / LLY / PFE / BSLN / IMAB</td><td class="leftalignment">Merck & Co Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Basilea Pharmaceutica AG / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">China / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 27, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">09/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Sep 7 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">FR0000120578 / GB0009895292 / FR0000054470 / GB0009252882 / DE0006969603 / US09061G1013 / CH0012032048 / CH0012005267 / US0116591092 / US0311621009 / US0463531089 / US1101221083 / US1311931042 / US14149Y1082 / US1985161066 / US2435371073 / US2855121099 / US3377381088 / US3755581036 / US37733W1053 / US45337C1027 / US5324571083 / US58155Q1031 / US6541061031 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US7782961038 / US8305661055 / US8308791024 / US8447411088 / US8725401090 / US8740541094 / US9182041080 / US03073E1055 / US3448491049 / US37940X1028 / US4771431016 / US4198791018 / US80105N1054 / US2533931026 / US09062X1037 / US9043111072 / US31620M1062 / US1314761032 / US4103451021 / PAP310761054 / US29089Q1058 / US01748X1028 / US2473617023 / US5500211090 / US00507V1098 / DE000A0DJ6J9 / US58933Y1055 / US9100471096 / DE000A1EWWW0 / US6936561009 / US7512121010 / JE00B783TY65 / US98986T1088 / US00287Y1091 / US85916J4094 / US41068X1000 / US8485771021 / US21240E1055 / US1220171060 / US02376R1023 / DK0060534915 / CA0089118776 / US83417M1045 / US00653A1079 / VGG312491084 / US5904791358 / US98585X1046 / US89377M1099 / US26142R1041 / US02875D1090 / US04271T1007 / US82489W1071 / US30320C1036 / US1241551027 / US30260D1037 / US68622V1061</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Ubisoft Entertainment SA / GlaxoSmithKline PLC / Puma SE / Biomarin Pharmaceutical Inc / Roche Holding AG / Novartis AG / Alaska Air Group Inc / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Callaway Golf Co / Cardinal Health Inc / Columbia Sportswear Co / Deckers Outdoor Corp / Electronic Arts Inc / Fiserv Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Incyte Corp / Eli Lilly and Co / Mckesson Corp / Nike Inc / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Ross Stores Inc / Skechers USA Inc / SkyWest Inc / Southwest Airlines Co / TJX Companies Inc / Take-Two Interactive Software Inc / VF Corp / Amerisourcebergen Corp / Foot Locker Inc / Global Payments Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / DICK'S Sporting Goods Inc / Biogen Inc / Under Armour Inc / Fidelity National Information Services Inc / Calumet Specialty Products Partners LP / HanesBrands Inc / Copa Holdings SA / Emergent BioSolutions Inc / Allegiant Travel Co / Delta Air Lines Inc / Lululemon Athletica Inc / Activision Blizzard Inc / SMA Solar Technology AG / Merck & Co Inc / United Airlines Holdings Inc / Adidas AG / PVH Corp / Ralph Lauren Corp / Aptiv PLC / Zynga Inc / Abbvie Inc / Stereotaxis Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Burlington Stores Inc / American Airlines Group Inc / Novo Nordisk A/S / Air Canada / Solaredge Technologies Inc / Adaptimmune Therapeutics PLC / Establishment Labs Holdings Inc / Mesa Air Group Inc / Yeti Holdings Inc / Transmedics Group Inc / DraftKings Inc / American Outdoor Brands Inc / Array Technologies Inc / Shoals Technologies Group Inc / FTC Solar Inc / Butterfly Network Inc / Figs Inc / Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / France / United Kingdom / Mexico / Panama / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GMAB.CO: Genmab - Balance of pipeline optionality & investment in R&D/commercial</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">GMAB.CO / JNJ.N / RECI.MI / SASY.PA / LUN.CO / NOVN.S / MRCG.DE / LONN.S / UCB.BR / REGN.OQ / SGEN.OQ / IPN.PA / ORNBV.HE / HALO.OQ / ALM.MC / GRLS.MC / HZNP.OQ / ABBV.N / CTLT.N / VIFN.S</td><td class="leftalignment">Genmab A/S / Johnson & Johnson / Recordati Industria Chimica e Farmaceutica SpA / Sanofi SA / H Lundbeck A/S / Novartis AG / Merck KGaA / Lonza Group AG / Ucb SA / Regeneron Pharmaceuticals Inc / Seagen Inc / Ipsen SA / Orion Oyj / Halozyme Therapeutics Inc / Almirall SA / Grifols SA / Horizon Therapeutics PLC / Abbvie Inc / Catalent Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Ireland / Italy / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">09/07/2021</td><td class="leftalignment">HSBC</td><td class="leftalignment">European Corporate Credit Quarterly:-Autumn 2021 – Dialling back</td><td class="leftalignment">English</td><td class="rightalignment">91</td><td class="leftalignment">AIRP.PA / AKZO.AS / ASML.AS / BATS.L / BMWG.DE / BOUY.PA / BP.L / BT.L / CAPP.PA / CARR.PA / CPG.L / CRH.I / DANO.PA / DAST.PA / DGE.L / DSMN.AS / ENI.MI / ERICb.ST / EXHO.PA / HEIG.DE / HEIN.AS / IBE.MC / KPN.AS / LVMH.PA / MICP.PA / MRCG.F / NXT.L / OMVV.VI / PERP.PA / PHG.AS / PRTP.PA / PUBP.PA / RENA.PA / REP.MC / RYA.I / SAPG.F / SCHN.PA / SGEF.PA / SGOB.PA / SOLB.BR / TEF.MC / TSCO.L / ULVR.L / VOD.L / VOLVb.ST / WLSNc.AS / WPP.L / VOWG_p.DE / CONG.DE / AZN.L / AAL.L / SASY.PA / ROG.S / SIEGn.DE / NOVN.S / ENEI.MI / DTEGn.DE / IFXGn.DE / CARLb.CO / FREG.DE / TELA.VI / EZJ.L / DPWGn.DE / TEL.OL / GSK.L / TELIA.ST / REL.L / IHG.L / NESN.S / SESFd.PA / LXSG.DE / BTGGg.F / RDSa.L / EDF.PA / CFR.S / VIV.PA / HOLN.S / MNDI.L / DAIGn.DE / ABI.BR / UPM.HE / BAYGn.DE / BASFn.DE / GLEN.L / EVKn.DE / ORAN.PA / AIRG.DE / ENGIE.PA / IMB.L / AD.AS / FORTUM.HE / ORSTED.CO / EQNR.OL / NTGY.MC / STLA.MI / RKT.L</td><td class="leftalignment">L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Akzo Nobel NV / ASML Holding NV / British American Tobacco PLC / Bayerische Motoren Werke AG / Bouygues SA / BP PLC / BT Group PLC / Capgemini SE / Carrefour SA / Compass Group PLC / CRH PLC / Danone SA / Dassault Systemes SE / Diageo PLC / Koninklijke DSM NV / Eni SpA / Telefonaktiebolaget LM Ericsson / Sodexo SA / HeidelbergCement AG / Heineken NV / Iberdrola SA / Koninklijke KPN NV / LVMH Moet Hennessy Louis Vuitton SE / Compagnie Generale des Etablissements Michelin SCA / Merck KGaA / Next PLC / OMV AG / Pernod Ricard SA / Koninklijke Philips NV / Kering SA / Publicis Groupe SA / Renault SA / Repsol SA / Ryanair Holdings PLC / SAP SE / Schneider Electric SE / Vinci SA / Compagnie de Saint Gobain SA / Solvay SA / Telefonica SA / Tesco PLC / Unilever PLC / Vodafone Group PLC / Volvo AB / Wolters Kluwer NV / WPP PLC / Volkswagen AG / Continental AG / AstraZeneca PLC / Anglo American PLC / Sanofi SA / Roche Holding AG / Siemens AG / Novartis AG / Enel SpA / Deutsche Telekom AG / Infineon Technologies AG / Carlsberg A/S / Fresenius SE & Co KGaA / Telekom Austria AG / Easyjet PLC / Deutsche Post AG / Telenor ASA / GlaxoSmithKline PLC / Telia Company AB / Relx PLC / InterContinental Hotels Group PLC / Nestle SA / SES SA / Lanxess AG / Bertelsmann SE & Co KGaA / Royal Dutch Shell PLC / Electricite de France SA / Compagnie Financiere Richemont SA / Vivendi SE / Holcim AG / Mondi PLC / Daimler AG / Anheuser Busch Inbev SA / UPM-Kymmene Oyj / Bayer AG / BASF SE / Glencore PLC / Evonik Industries AG / Orange SA / Airbus SE / Engie SA / Imperial Brands PLC / Koninklijke Ahold Delhaize NV / Fortum Oyj / Orsted A/S / Equinor ASA / Naturgy Energy Group SA / Stellantis NV / Reckitt Benckiser Group PLC</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">Austria / Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / Norway / Sweden / United States / Jersey</td><td class="leftalignment">Aerospace / Air Transportation / Apparel & Textiles / Automotive / Beverages & Tobacco / Broadcasting & Cable / Building & Building Materials / Chemicals / Cosmetics & Personal Care / Defense / Electrical / Electronics / Engineering & Construction / Environmental Services / Food / Healthcare / Industrial Materials / Info. Tech./Software / Lodging & Restaurants / Machinery / Manufacturing / Media / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Publishing / Retailing / Semiconductors / Services / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / FIXED INCOME / MARKET COMMENT / HIGH YIELD BONDS / CREDIT / BOND</td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Jonathan R. White / Song Jin Lee / Dominic A. Kini / Tom Russell</td></tr>
<tr class="even"><td class="leftalignment">09/06/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Q2 2021: Merck EPS plummets 85%</td><td class="leftalignment">English</td><td class="rightalignment">55</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">09/06/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Merck climbs 20% from 5 week low</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">09/06/2021</td><td class="leftalignment">BNP Paribas Exane</td><td class="leftalignment">MERCK KGAA (=): CMD focus: Capacity, Capex & COVID comps.</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Cosmetics & Personal Care</td><td class="leftalignment">Euroland / Europe / Global</td><td class="leftalignment">ESTIMATE CHANGES</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms Luisa Hector</td></tr>
<tr class="odd"><td class="leftalignment">09/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.6% Above Pre-Pandemic Base- Week 74</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">09/03/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Trefis Report: Merck - $91.16 Trefis Price Estimate</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">09/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">09/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">2021 Virtual ESMO Planner—IO and Emerging Oncology</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">45337C10 / 04635310 / 478160104 / 640268108 / 58933Y10 / 55609910 / N0104510 / G3910J11 / 24344T10 / 04685N10 / 45781K20 / 46565G10 / 48576U10 / 50127T10 / 60468T10 / 03969F10 / 98887Q10 / 87808K10 / 09770210 / 82835W10 / N5151710 / 30315R10 / 37230320</td><td class="leftalignment">Incyte Corp / AstraZeneca PLC / Johnson & Johnson / Nektar Therapeutics / Merck & Co Inc / MacroGenics Inc / Affimed NV / GlaxoSmithKline PLC / Deciphera Pharmaceuticals Inc / Athenex Inc / Innate Pharma SA / Iteos Therapeutics Inc / Karyopharm Therapeutics Inc / Kura Oncology Inc / Mirati Therapeutics Inc / Arcus Biosciences Inc / Zai Lab Ltd / TCR2 Therapeutics Inc / Bolt Biotherapeutics Inc / Silverback Therapeutics Inc / LAVA Therapeutics NV / F-Star Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">China / Cayman Islands / Denmark / France / United Kingdom / Hong Kong / Israel / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daina Graybosch, Ph.D. / Jonathan Chang, Ph.D., CFA / Jeffrey La Rosa / Dilip Joseph / Faisal Khurshid</td></tr>
<tr class="even"><td class="leftalignment">08/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Merck climbs 17.2% from 4 week low</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/31/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Merck Group</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="even"><td class="leftalignment">08/31/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Will Bristol Myers Squibb Stock Rebound After A 4% Fall Last Week?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Research Digest</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/31/2021</td><td class="leftalignment">Litchfield Hills Research, LLC</td><td class="leftalignment">Advancing personalized medical treatment using AI – POAI – reports 2Q21 and strong balance sheet – Reiterate Buy and $5 PT</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">POAI.OQ / 4502.T / MRK.N / PFE.N / SNY.N / AZN.L / AZN.N / ROG.S / SYK.N / GSK.L / GSK.N / DXR.A / QBIO.PK / MYGN.OQ / BAYGN.DE / ZBH.N / CODX.OQ / DE000BAY0199 / ANPC.OQ</td><td class="leftalignment">Predictive Oncology Inc / Takeda Pharmaceutical Co Ltd / Merck & Co Inc / Pfizer Inc / Sanofi SA / AstraZeneca PLC / AstraZeneca PLC / Roche Holding AG / Stryker Corp / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Daxor Corp / Q BioMed Inc / Myriad Genetics Inc / Bayer AG / Zimmer Biomet Holdings Inc / Co-Diagnostics Inc / Bayer AG / AnPac Bio-Medical Science Co Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Japan / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS / SMALL CAPITAL / GROWTH</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Theodore R. O'Neill</td></tr>
<tr class="even"><td class="leftalignment">08/31/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK=US / HD=US / MCD=US / WEN=US / BLD=US / LOW=US / HSII=US / LEG=US / KFRC=US / VMC=US / MLM=US / DV=US / KFY=US / AMN=US / SWIM=US / CBRL=US / DRI=US / GFF=US / IBP=US / MAN=US / MAS=US / MHK=US / ASGN=US / REGI=US / RHI=US / SHOP=US / CCRN=US / CNM=US / DIN=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / NSP=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / JACK=US / TREX=US / FBHS=US / TILE=US / NDLS=US / 00770K202 / COUP=US / LOCO=US / SHAK=US / WING=US / 82982L103 / GDS=US / JELD=US / FERG=US / AZEK=US / RSKD=US / SNPO=US</td><td class="leftalignment">Merck & Co Inc / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / Lowe's Companies Inc / Heidrick & Struggles International Inc / Leggett & Platt Inc / Kforce Inc / Vulcan Materials Co / Martin Marietta Materials Inc / DoubleVerify Holdings Inc / Korn Ferry / AMN Healthcare Services Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / ManpowerGroup Inc / Masco Corp / Mohawk Industries Inc / ASGN Inc / Renewable Energy Group Inc / Robert Half International Inc / Shopify Inc / Cross Country Healthcare Inc / Core & Main Inc / Dine Brands Global Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Interface Inc / Noodles & Co / Aemetis Inc / Coupa Software Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / SiteOne Landscape Supply Inc / GDS Holdings Ltd / JELD-WEN Holding Inc / Ferguson PLC / Azek Company Inc / Riskified Ltd / Snap One Holdings Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/31/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2681511 / 2000019 / 2778844 / 2002305 / 2026242 / 2113434 / 2216850 / 2270726 / 2829515 / 2317087 / 2670519 / 2328915 / 2100920 / 2689560 / 2684703 / 2048804 / 2138158 / 2799351 / 2829601 / 2503529 / 7103065 / 2212922 / 2857817 / BDZCRX3 / BFH3N85 / BVVN4Q8 / BJJMGL2 / BKTNTR9 / BZ1LFG7 / BGKG6M3 / BNTB3N8 / BP8GHT2 / BLF0CW7 / BM8NHS1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / PepsiCo Inc / Amazon.com Inc / Merck & Co Inc / Abbott Laboratories / American Electric Power Company Inc / Boston Scientific Corp / Consolidated Edison Inc / Walt Disney Co / Edison International / Entergy Corp / Exelon Corp / Nextera Energy Inc / FirstEnergy Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Sempra Energy / Sinclair Broadcast Group Inc / Southern Co / World Wrestling Entertainment Inc / Novartis AG / NRG Energy Inc / Netflix Inc / RingCentral Inc / Veeva Systems Inc / Eversource Energy / Fox Corp / ViacomCBS Inc / Roku Inc / StoneCo Ltd / Vizio Holding Corp / Vascular Biogenics Ltd / Repare Therapeutics Inc / Adagio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">08/31/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Merck & Co. , Inc.</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">2Q21 Model Update</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What's Happening With Merck Stock?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 20, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Aug 30 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US0079731008 / US0116591092 / US0126531013 / US0382221051 / US0463531089 / US1101221083 / US1925761066 / US37733W1053 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US8807701029 / US91347P1057 / AU000000LYC6 / US4771431016 / US4198791018 / US80105N1054 / US3463751087 / US90385V1070 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US00287Y1091 / NL0010273215 / US8485771021 / US21240E1055 / US02376R1023 / DK0060534915 / CA0089118776 / KYG4740B1059 / CA53680Q2071 / SE0009414576 / US5904791358 / US53814L1089 / US5533681012 / US58406B1035 / US68622V1061</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Advanced Energy Industries Inc / Alaska Air Group Inc / Albemarle Corp / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cohu Inc / GlaxoSmithKline PLC / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Teradyne Inc / Universal Display Corp / Lynas Rare Earths Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / FormFactor Inc / Ultra Clean Holdings Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Abbvie Inc / ASML Holding NV / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Novo Nordisk A/S / Air Canada / Ichor Holdings Ltd / Lithium Americas Corp / Oncopeptides AB / Mesa Air Group Inc / Livent Corp / Mp Materials Corp / MedAvail Holdings Inc / Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">08/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.8% Above Pre-Pandemic Base- Week 73</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">08/28/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck KGaA: Ownership Timelines & Shareholder Analytics (August 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">08/27/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">08/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ROG.S: Roche - Tecentriq voluntarily withdrawn from US market in TNBC</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ROG.S / MRK.N / AZN.L</td><td class="leftalignment">Roche Holding AG / Merck & Co Inc / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr Matthew J. Weston / Ms Jo Walton</td></tr>
<tr class="odd"><td class="leftalignment">08/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma: Novartis: CANOPY-1 P3 topline readout in 1L NSCLC expected in late 3Q/early 4Q21</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">NOVN.S / BMY.N / MRK.N / SASY.PA / ROG.S / REGN.OQ</td><td class="leftalignment">Novartis AG / Bristol-Myers Squibb Co / Merck & Co Inc / Sanofi SA / Roche Holding AG / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">08/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">JNJ / MRK / US03152W1099 / US00289Y1073 / US8162121045 / ZAE000185005 / US8163073005</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Amicus Therapeutics Inc / Abeona Therapeutics Inc / Selecta Biosciences Inc / Ascendis Health Ltd / SelectQuote Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Africa / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">08/26/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">After The Recent 4% Fall Will Pfizer Stock Rebound To Make Fresh Highs?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N / JNJ.N / MRK.N / RHHBY.PK</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Merck & Co Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/26/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">ESMO: 5 Key Titles And What To Watch For In The Presentations</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US0463531089 / US7711951043 / US58933Y1055</td><td class="leftalignment">AstraZeneca PLC / Roche Holding AG / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">The Latest Vaxneuvance Data Support Supplemental Regulatory Licensure Application Before the End of the Year For Pediatrics</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Warburg Research GmbH</td><td class="leftalignment">Coverage eingestellt</td><td class="leftalignment">German</td><td class="rightalignment">6</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr Ulrich Huwald</td></tr>
<tr class="even"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Warburg Research GmbH</td><td class="leftalignment">Coverage discontinued</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr Ulrich Huwald</td></tr>
<tr class="odd"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Aug 13</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">08/24/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Merck & Co., Inc.(MRK) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">58933Y105</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/24/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2486813 / 2778844 / 2973821 / 2216850 / 2270726 / 2542049 / 2317087 / 2328915 / 2100920 / 2459020 / 2680905 / 2684703 / 2048804 / 2503529 / 7103065 / B125XQ6 / B0T7YX2 / 2949758 / B7577T2 / BFZCHN7 / BVVN4Q8 / BYVY8G0 / BYW36M8 / BYNZGK1 / BYZR4X4 / BMYML02 / BKTNTR9 / BD72R64 / 021513106 / BN4NJG4 / BKPGJQ1 / BMVBZF5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Kellogg Co / Merck & Co Inc / Alliant Energy Corp / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Intuit Inc / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / World Wrestling Entertainment Inc / Novartis AG / Portland General Electric Co / Live Nation Entertainment Inc / Nexstar Media Group Inc / Renewable Energy Group Inc / Wix.Com Ltd / Eversource Energy / Alphabet Inc / PayPal Holdings Inc / Block Inc / Axsome Therapeutics Inc / DraftKings Inc / ViacomCBS Inc / Liberty Media Corp / Alto Ingredients Inc / Freeline Therapeutics Holdings PLC / Squarespace Inc / Immuneering Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 13, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">CADL: A Later-Stage Oncolytic Viral Immunotherapy Platform; Initiating with an Outperform, $15 TP</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">ABT.N / BMY.N / MRK.N / AZN.L / NOVN.S / GSK.L / 601607.SS / 2607.HK / ALXO.OQ / IKNA.OQ</td><td class="leftalignment">Abbott Laboratories / Bristol-Myers Squibb Co / Merck & Co Inc / AstraZeneca PLC / Novartis AG / GlaxoSmithKline PLC / Shanghai Pharmaceuticals Holding Co Ltd / Shanghai Pharmaceuticals Holding Co Ltd / ALX Oncology Holdings Inc / Ikena Oncology Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Judah C. Frommer / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">08/22/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck & Co Inc: Ownership Timelines & Shareholder Analytics (August 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">08/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.3% Above Pre-Pandemic Base- Week 72</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">08/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">India Pharma Sector - Quick Take - DRL: Suboxone market share gain comes at high margin</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LUPN.BO / REDY.BO / CIPL.BO / MRK.N / ARBN.BO / SUN.BO / CADI.BO / GLEN.BO / GSK.L / ENDP.OQ / HIK.L / TEVA.N / PRGO.N / INDV.L / SRID.BO</td><td class="leftalignment">Lupin Ltd / Dr Reddy's Laboratories Ltd / Cipla Ltd / Merck & Co Inc / Aurobindo Pharma Ltd / Sun Pharmaceutical Industries Ltd / Cadila Healthcare Ltd / Glenmark Pharmaceuticals Ltd / GlaxoSmithKline PLC / Endo International PLC / Hikma Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Perrigo Company PLC / Indivior PLC / Strides Pharma Science Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / India / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Anubhav Aggarwal / Sayantan Maji</td></tr>
<tr class="odd"><td class="leftalignment">08/21/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Merck & Co., Inc. (MRK) - Strong and focused after Organon spin-off</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="even"><td class="leftalignment">08/20/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">VNDA-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">VNDA.O / BMY / JNJ / LLY / MRK / NVS / PFE / TTNP.O</td><td class="leftalignment">Vanda Pharmaceuticals Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Titan Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/20/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/20/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Merck increases 4.5% in past quarter; Institutional Ownership down 4%</td><td class="leftalignment">English</td><td class="rightalignment">79</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">08/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Suspending Research Coverage</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / FLXN.O / AGRX.O / AMRX.N / AQST.O / OSMT.O / 269796108 / VTRS.OQ</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Pacira Biosciences Inc / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc / Osmotica Pharmaceuticals PLC / Eagle Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">08/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 13, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">08/19/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Trefis Report: Merck - $91.16 Trefis Price Estimate</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/19/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Will The Gains Continue For Johnson & Johnson Stock After A 7% Rise In A Month?</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/19/2021</td><td class="leftalignment">Vermilion Technical Research</td><td class="leftalignment">Booster Shots - Charts highlighted: K, KMB, GEO, NKTX, MRK, ALXO, EGRX, NRC, PCVX, AEP, D, ES, ETR, and SO</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK.N / ALXO.OQ / D.N / EGRX.OQ / ES.N / ETR.N / GEO.MI / K.N / KMB.N / NKTX.OQ / PCVX.OQ / SO.N / NRC.HN / AEP.OQ</td><td class="leftalignment">Merck & Co Inc / ALX Oncology Holdings Inc / Dominion Energy Inc / Eagle Pharmaceuticals Inc / Eversource Energy / Entergy Corp / Geox SpA / Kellogg Co / Kimberly-Clark Corp / Nkarta Inc / Vaxcyte Inc / Southern Co / Danh Khoi Group JSC / American Electric Power Company Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Italy / United States / Vietnam</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">STRATEGY / TECHNICAL ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David P. Nicoski, CMT</td></tr>
<tr class="even"><td class="leftalignment">08/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">LUN.CO: Lundbeck - 2Q21 Second Opinion & post-results management feedback</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">LUN.CO / RECI.MI / MRCG.DE / LONN.S / UCB.BR / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / VIFN.S / GMAB.CO</td><td class="leftalignment">H Lundbeck A/S / Recordati Industria Chimica e Farmaceutica SpA / Merck KGaA / Lonza Group AG / Ucb SA / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">08/18/2021</td><td class="leftalignment">The Insight Partners</td><td class="leftalignment">Merck Kgaa In Final_Global Epithelial Cell Culture Media Market Market, Company SWOT Analysis and Profile</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK=DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">VSC-DE Company reports financial results for the half-year ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">VSCk.DE / MRCG.DE / MORG.DE / BIOG.DE / PA8G.DE / T5OG.DE / MF6G.DE / MDG1k.DE</td><td class="leftalignment">4Sc AG / Merck KGaA / MorphoSys AG / Biotest AG / Paion AG / CytoTools AG / Magforce AG / Medigene AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LGND-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LGND.O / BAX / BMY / JNJ / LLY / MRK / PFE / AMGN.O / GSK / SPPI.O</td><td class="leftalignment">Ligand Pharmaceuticals Inc / Baxter International Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Spectrum Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">XNCR-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">XNCR.O / JNJ / MRK / AMGN.O / SGEN.O / ABBV.K / MGNX.O</td><td class="leftalignment">Xencor Inc / Johnson & Johnson / Merck & Co Inc / Amgen Inc / Seagen Inc / Abbvie Inc / MacroGenics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/17/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Merck & Co</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="even"><td class="leftalignment">08/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CORT-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CORT.O / BMY / JNJ / LLY / MRK / NVS / PFE / BMRN.O / ESPR.O / MNKD.O</td><td class="leftalignment">Corcept Therapeutics Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Biomarin Pharmaceutical Inc / Esperion Therapeutics Inc / MannKind Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / BSX=US / LLY=US / HD=US / MCD=US / WEN=US / MDT=US / PEB=US / H=US / CRM=US / HLT=US / CBRL=US / CHH=US / DRI=US / DRH=US / MRCY=US / PCTY=US / REGI=US / CNM=US / KIM=US / DIN=US / INST=US / STRO=US / RNG=US / BECN=US / SHO=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / HST=US / GPRE=US / TAST=US / QSR=US / KTOS=US / NMTR=US / JACK=US / BLND=US / RLJ=US / GMED=US / RHP=US / NDLS=US / FATE=US / FIVN=US / 00770K202 / LOCO=US / NVRO=US / WK=US / SHAK=US / AJRD=US / BWXT=US / WING=US / SPNE=US / 82982L103 / CRSP=US / PK=US / PLYA=US / MAXR=US / ALLO=US / OSMT=US / FERG=US / LHX=US / SPCE=US / DKNG=US / TSHA / RBLX=US / REPX=US / 67421J108 / PYCR=US / GAMB=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Home Depot Inc / McDonald's Corp / Wendys Co / Medtronic PLC / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Salesforce.Com Inc / Hilton Worldwide Holdings Inc / Cracker Barrel Old Country Store Inc / Choice Hotels International Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Mercury Systems Inc / Paylocity Holding Corp / Renewable Energy Group Inc / Core & Main Inc / Kimco Realty Corp / Dine Brands Global Inc / Instructure Holdings Inc / Sutro Biopharma Inc / RingCentral Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Host Hotels & Resorts Inc / Green Plains Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Kratos Defense and Security Solutions Inc / 9 Meters Biopharma Inc / Jack in the Box Inc / Blend Labs Inc / RLJ Lodging Trust / Globus Medical Inc / Ryman Hospitality Properties Inc / Noodles & Co / Fate Therapeutics Inc / Five9 Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Nevro Corp / Workiva Inc / Shake Shack Inc / Aerojet Rocketdyne Holdings Inc / BWX Technologies Inc / Wingstop Inc / SeaSpine Holdings Corp / SiteOne Landscape Supply Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Maxar Technologies Inc / Allogene Therapeutics Inc / Osmotica Pharmaceuticals PLC / Ferguson PLC / L3harris Technologies Inc / Virgin Galactic Holdings Inc / DraftKings Inc / Taysha Gene Therapies Inc / Roblox Corp / Riley Exploration Permian Inc / Oatly Group AB / Paycor HCM Inc / Gambling.com Group Ltd</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Ireland / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Timelines Got Slightly Softer, But We're Still Optimistic On Platform Validation Over Next 12 Months</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">STRO=US / MRK=US</td><td class="leftalignment">Sutro Biopharma Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene / Billal Jahangiri</td></tr>
<tr class="odd"><td class="leftalignment">08/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2486813 / 2778844 / 2026242 / 2270726 / 2829515 / 2670519 / 2328915 / 2689560 / 2684703 / 2829601 / 2503529 / 7103065 / B17HG57 / B0T7YX2 / B7VD3F2 / BVVN4Q8 / BYVY8G0 / BYW36M8 / BYNZGK1 / BK1KWF7 / BMYML02 / BLGJ610 / BYXJQG9 / BKTNTR9 / BD72R64 / BP8GHT2 / BMHR7K6 / BNNTQY0 / BP0TJN7</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Kellogg Co / Merck & Co Inc / American Electric Power Company Inc / Walt Disney Co / Edison International / Exelon Corp / Nextera Energy Inc / PG&E Corp / Pfizer Inc / Southern Co / World Wrestling Entertainment Inc / Novartis AG / Cardiovascular Systems Inc / Live Nation Entertainment Inc / Duke Energy Corp / Eversource Energy / Alphabet Inc / PayPal Holdings Inc / Block Inc / Grocery Outlet Holding Corp / DraftKings Inc / Warner Music Group Corp / Spire Inc / ViacomCBS Inc / Liberty Media Corp / Vascular Biogenics Ltd / Impel Neuropharma Inc / Oatly Group AB / Xponential Fitness Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">08/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SOPH: SOPHiA Genetics - Tests Positive with Data-Driven Precision Medicine; Initiate with an Outperform Rating</td><td class="leftalignment">English</td><td class="rightalignment">56</td><td class="leftalignment">SOPH.OQ / 4503.T / A.N / GE.N / LLY.N / MRK.N / PHG.AS / TMO.N / AZN.L / SASY.PA / ROG.S / DHR.N / NOVN.S / PKI.N / ADPT.OQ / MYGN.OQ / BLUE.OQ / ILMN.OQ / EXAS.OQ / FINA.PA / QGEN.N / SLP.OQ / BAYGN.DE / SHLG.DE / PACB.OQ / VEEV.N / VCYT.OQ / SEER3.SA / NSTG.OQ / PINFRAL.MX / NVTA.N / NTRA.OQ / TPB.N / TWLO.N / IQV.N / CNTG.OQ / ABCL.OQ / CERT.OQ</td><td class="leftalignment">Sophia Genetics SA / Astellas Pharma Inc / Agilent Technologies Inc / General Electric Co / Eli Lilly and Co / Merck & Co Inc / Koninklijke Philips NV / Thermo Fisher Scientific Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Danaher Corp / Novartis AG / PerkinElmer Inc / Adaptive Biotechnologies Corp / Myriad Genetics Inc / bluebird bio Inc / Illumina Inc / Exact Sciences Corp / Immobiliere Dassault SA / Qiagen NV / Simulations Plus Inc / Bayer AG / Siemens Healthineers AG / Pacific Biosciences of California Inc / Veeva Systems Inc / Veracyte Inc / Ser Educacional SA / NanoString Technologies Inc / Promotora y Operadora de Infraestructura SAB de CV / Invitae Corp / Natera Inc / Turning Point Brands Inc / Twilio Inc / IQVIA Holdings Inc / Centogene NV / Abcellera Biologics Inc / Certara Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Brazil / Canada / Switzerland / Germany / France / United Kingdom / Japan / Mexico / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Katie A. Tryhane</td></tr>
<tr class="odd"><td class="leftalignment">08/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">TARO-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">TARO.K / JNJ / MRK / NVS / PFE / GSK / TEVA.K</td><td class="leftalignment">Taro Pharmaceutical Industries Ltd / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 6, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">08/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - August 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AEP.N / AES.N / ALV.N / BOX.N / CL.N / CNA.L / EIX.N / EL.N / F.N / FSR.N / GM.N / KMB.N / KO.N / MO.N / MRK.N / NEM.N / PNW.N / SO.N / T.N / VC.N / PEP.N / BFb.N / PG.N / FNV.N / CPB.N / TEN.N / CMCSA.O / THC.N / DUK.N / AGI.N / BWA.N / LEA.N / K.N / DISH.O / CLX.N / CAG.N / GIS.N / PCG.N / HSY.N / EPC.N / ADCT.N / SBAC.O / AMT.N / CONE.O / VZ.N / HCA.N / CYH.N / XEL.N / STZ.N / AMP.N / APH.N / CHTR.O / AXL.N / CHD.N / NWN.N / BC.N / SAM.N / ENR.N / TEL.N / CPK.N / PII.N / ST.N / SR.N / PLUG.OQ / SEM.N / SGEN.OQ / MNST.O / RGLD.O / CASY.O / AMED.O / PAAS.O / ATDb.TO / GOLD.N / SKE.V / CG.TO / DLR.N / SJW.N / BKD.N / CCOI.O / HOG.N / AUY.N / IVZ.N / BGS.N / OSK.TO / DAN.N / ADUS.OQ / EGO.N / SBB.TO / AR.TO / SPB.N / NEE.N / CHNG.O / SIL.TO / NXT.AX / PVG.TO / FHI.N / MSP.N / MTOR.N / ACHC.O / QLYS.O / MDLZ.OQ / APAM.N / TSLA.N / PRMW.N / TMUS.N / DOO.TO / COTY.N / BEP.N / AGIO.O / FLXN.O / AENA.MC / SGRY.O / RACE.MI / MP1.AX / OR.N / TTD.O / ADNT.N / AQN.N / UNIT.O / WPM.N / WOW.N / ORSTED.CO / SAIL.N / APTV.N / VCTR.N / VNE.N / KDP.N / OSMT.O / NWL.O / NBSE.OQ / GMAB.O / CRNC.OQ / PNTG.OQ / NLOK.O / WTRG.N / REYN.O / IGIC.OQ / NKLA.OQ / GOCO.O / JAMF.O / LUMN.N / PLTR.N / BSY.O / GATO.N / MCFE.OQ / RIDE.OQ / NUVB.N / NAPA.N / OSO.N / TSP.OQ / AVAH.OQ / TFPM.TO / OTLY.O / XMTR.OQ / EVCM.O / RYAN.N / BASE.OQ / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Autoliv Inc / Box Inc / Colgate-Palmolive Co / Centrica PLC / Edison International / Estee Lauder Companies Inc / Ford Motor Co / Fisker Inc / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Pinnacle West Capital Corp / Southern Co / AT&T Inc / Visteon Corp / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Franco-Nevada Corp / Campbell Soup Co / Tenneco Inc / Comcast Corp / Tenet Healthcare Corp / Duke Energy Corp / Alamos Gold Inc / Borgwarner Inc / Lear Corp / Kellogg Co / DISH Network Corp / Clorox Co / Conagra Brands Inc / General Mills Inc / PG&E Corp / Hershey Co / Edgewell Personal Care Co / ADC Therapeutics SA / SBA Communications Corp / American Tower Corp / CyrusOne Inc / Verizon Communications Inc / HCA Healthcare Inc / Community Health Systems Inc / Xcel Energy Inc / Constellation Brands Inc / Ameriprise Financial Inc / Amphenol Corp / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Brunswick Corp / Boston Beer Company Inc / Energizer Holdings Inc / TE Connectivity Ltd / Chesapeake Utilities Corp / Polaris Inc / Sensata Technologies Holding PLC / Spire Inc / Plug Power Inc / Select Medical Holdings Corp / Seagen Inc / Monster Beverage Corp / Royal Gold Inc / Caseys General Stores Inc / Amedisys Inc / Pan American Silver Corp / Alimentation Couche-Tard Inc / Barrick Gold Corp / Skeena Resources Ltd / Centerra Gold Inc / Digital Realty Trust Inc / SJW Group / Brookdale Senior Living Inc / Cogent Communications Holdings Inc / Harley-Davidson Inc / Yamana Gold Inc / Invesco Ltd / B&G Foods Inc / Osisko Mining Inc / Dana Inc / Addus Homecare Corp / Eldorado Gold Corp / Sabina Gold & Silver Corp / Argonaut Gold Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / Change Healthcare Inc / Silvercrest Metals Inc / NEXTDC Ltd / Pretium Resources Inc / Federated Hermes Inc / Datto Holding Corp / Meritor Inc / Acadia Healthcare Company Inc / Qualys Inc / Mondelez International Inc / Artisan Partners Asset Management Inc / Tesla Inc / Primo Water Corp / T-Mobile US Inc / BRP Inc / Coty Inc / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / Pacira Biosciences Inc / Aena SME SA / Surgery Partners Inc / Ferrari NV / Megaport Ltd / Osisko Gold Royalties Ltd / Trade Desk Inc / Adient PLC / Algonquin Power & Utilities Corp / Uniti Group Inc / Wheaton Precious Metals Corp / WideOpenWest Inc / Orsted A/S / SailPoint Technologies Holdings Inc / Aptiv PLC / Victory Capital Holdings Inc / Veoneer Inc / Keurig Dr Pepper Inc / Osmotica Pharmaceuticals PLC / Newell Brands Inc / NeuBase Therapeutics Inc / Genmab A/S / Cerence Inc / Pennant Group Inc / NortonLifeLock Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / International General Insurance Holdings Ltd / Nikola Corp / Gohealth Inc / Jamf Holding Corp / Lumen Technologies Inc / Palantir Technologies Inc / Bentley Systems Inc / Gatos Silver Inc / Mcafee Corp / Lordstown Motors Corp / Nuvation Bio Inc / Duckhorn Portfolio Inc / Olo Inc / TuSimple Holdings Inc / Aveanna Healthcare Holdings Inc / Triple Flag Precious Metals Corp / Oatly Group AB / Xometry Inc / EverCommerce Inc / Ryan Specialty Group Holdings Inc / Couchbase Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Denmark / Spain / United Kingdom / Ireland / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ME: Sitting on a Genome Mine: Initiate with an Outperform Rating and $13 Target Price</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">ME.OQ / BMY.N / MRK.N / ROG.S / LH.N / MRCG.DE / GSK.L / GILD.OQ / MYGN.OQ / ILMN.OQ / SGEN.OQ / ALM.MC / NVTA.N / NTRA.OQ / BGNE.OQ / 6160.HK</td><td class="leftalignment">23andMe Holding Co. / Bristol-Myers Squibb Co / Merck & Co Inc / Roche Holding AG / Laboratory Corporation of America Holdings / Merck KGaA / GlaxoSmithKline PLC / Gilead Sciences Inc / Myriad Genetics Inc / Illumina Inc / Seagen Inc / Almirall SA / Invitae Corp / Natera Inc / Beigene Ltd / Beigene Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Spain / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Tiago Fauth / Mr. Thomas Deal / Jonathan Woo</td></tr>
<tr class="odd"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ABSI: Paving a New Way in Drug Discovery; Initiate with an Outperform Rating, $40 Target Price</td><td class="leftalignment">English</td><td class="rightalignment">62</td><td class="leftalignment">ABSI.OQ / MRK.N / ABCL.OQ</td><td class="leftalignment">Absci Corp / Merck & Co Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Mr. Thomas Deal / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">08/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">08/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK.N / FLXN.O / OSMT.O</td><td class="leftalignment">Merck & Co Inc / Pacira Biosciences Inc / Osmotica Pharmaceuticals PLC</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">08/15/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.5% Above Pre-Pandemic Base- Week 71</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">08/14/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck KGaA: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Guotai JunAn (HK) Retail Rsch</td><td class="leftalignment">默克 Merk & Co.-二季度业绩强劲，销售额有望持续增长-08/13/2021</td><td class="leftalignment">Chinese</td><td class="rightalignment">2</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Chloe Kim</td></tr>
<tr class="odd"><td class="leftalignment">08/13/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Marka in bottom 8% performers of Polish market in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRKP.WA</td><td class="leftalignment">Marka SA w restrukturyzacji</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Poland</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Good Way To Start The Summer Weekend; FDA Approval Of Welireg (Belzutifan) Underscores Potential Blockbuster Opportunity</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">08/13/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 6, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">08/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending August 6, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / MNKD.OQ / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / MannKind Corp / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Societe Generale</td><td class="leftalignment">Merck and Co Inc. (Buy, TP=$105) - 12m target upgrade - Patience is usually rewarded - J. Smith (5p)</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Justin S. Smith / Florent Cespedes / Dinesh Choudhary</td></tr>
<tr class="even"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Summer May Be Ending, but Things Are Heating Up for Innate Immunity Drug Development: Featuring Top 10 Hot Targets in Neuro/Immunology</td><td class="leftalignment">English</td><td class="rightalignment">112</td><td class="leftalignment">0925288 / 2126335 / 2516152 / 2778844 / 2369174 / 2455965 / 7103065 / BGCYWN8 / BMPRZV5 / BJLV8T9</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / Biogen Inc / Novartis AG / Xencor Inc / Kymera Therapeutics Inc / Celldex Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yatin Suneja / Debjit Chattopadhyay, Ph.D. / Mr. Etzer Darout / Mr. Seamus Fernandez / Mr. Eddie Hickman, Ph.D. / Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IPN.PA: Ipsen - Surprise palovarotene FDA filing withdrawal</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">IPN.PA / RECI.MI / LUN.CO / MRCG.DE / LONN.S / UCB.BR / ORNBV.HE / ALM.MC / GRLS.MC / VIFN.S / GMAB.CO</td><td class="leftalignment">Ipsen SA / Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Orion Oyj / Almirall SA / Grifols SA / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">08/12/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">EBS-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EBS / MRK / PFE / GSK / XOMA.O / SIGA.O / CLDX.O / CMRX.O / SNGX.O / TEVA.K</td><td class="leftalignment">Emergent BioSolutions Inc / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / XOMA Corp / SIGA Technologies Inc / Celldex Therapeutics Inc / Chimerix Inc / Soligenix Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/12/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">EXEL-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EXEL.O / BMY / JNJ / MRK / PFE / AMGN.O / GSK / CRIS.O / AVEO.O / SNY.O</td><td class="leftalignment">Exelixis Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Curis Inc / Aveo Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/12/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, MRK</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David H. Toung / Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/12/2021</td><td class="leftalignment">Kepler Cheuvreux</td><td class="leftalignment">Merck KGAA | Buy | Durability underlined, forecasts still rising</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David P. Evans</td></tr>
<tr class="even"><td class="leftalignment">08/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">0989529 / 2023607 / 2486813 / 2778844 / 2190750 / 2270726 / 2328915 / 2100920 / 2415204 / 2689560 / 2684703 / 2829601 / 2931034 / 2503529 / 4595739 / B1F76F9 / B0T7YX2 / B3D7K31 / B4MG4Z6 / B3NXMJ9 / BFZCHN7 / BYVY8G0 / BYVFC94 / BYW36M8 / BQT3XY6 / BMYML02 / BLGJ610 / BJJMGL2 / BKTNTR9 / BYY88Y7 / BL71K91 / BRJ3GY4 / BLBLMD5 / BD72R64 / BMC8SQ7 / BMZ9Z11 / BMFPJK6 / BD5GSZ4 / BMBP1Q0</td><td class="leftalignment">AstraZeneca PLC / Amgen Inc / Kellogg Co / Merck & Co Inc / Chesapeake Utilities Corp / Walt Disney Co / Nextera Energy Inc / FirstEnergy Corp / Hawaiian Electric Industries Inc / PG&E Corp / Pfizer Inc / Southern Co / Vertex Pharmaceuticals Inc / World Wrestling Entertainment Inc / Genmab A/S / Western Union Co / Live Nation Entertainment Inc / Discovery Inc / AMC Networks Inc / Wendys Co / Wix.Com Ltd / Alphabet Inc / US Foods Holding Corp / PayPal Holdings Inc / Cyberark Software Ltd / DraftKings Inc / Warner Music Group Corp / Fox Corp / ViacomCBS Inc / Alphabet Inc / Revolution Medicines Inc / Xenon Pharmaceuticals Inc / Array Technologies Inc / Liberty Media Corp / BTRS Holdings Inc / Prometheus Biosciences Inc / ACV Auctions Inc / Infrastructure and Energy Alternatives Inc / Flywire Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">08/11/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck KGaA: Peer Group Analytics - Q2 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">08/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">V / 2868165 / 2000019 / 2486813 / 2778844 / 2732635 / 2113393 / 2270726 / 2328915 / 2515030 / 2689560 / 2684703 / 2048804 / 2440637 / 2862532 / 2829601 / 2503529 / B0T7YX2 / B7TL820 / B7VD3F2 / BFLR866 / BFZCHN7 / BYVY8G0 / BYZLV46 / BF4VBS8 / BK0VHF6 / BJLKVS6 / BKDS4H5 / BL2HYY7 / BKVDFF7 / BMYML02 / BZ1LFG7 / BYNQ369 / BK71LV3 / BD72R64 / BFY7DC4 / BMDJ085 / BNTB3N8 / BN2RM92 / BMGGJK8 / BKPGJQ1 / BMBP1Q0</td><td class="leftalignment">Visa Inc / Sysco Corp / Amazon.com Inc / Kellogg Co / Merck & Co Inc / AutoNation Inc / Boston Beer Company Inc / Walt Disney Co / Nextera Energy Inc / Lithia Motors Inc / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / E W Scripps Co / Southern Co / World Wrestling Entertainment Inc / Live Nation Entertainment Inc / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Wix.Com Ltd / Alphabet Inc / InflaRx NV / BioXcel Therapeutics Inc / IDEAYA Biosciences Inc / Phathom Pharmaceuticals Inc / Bill.com Holdings Inc / Casper Sleep Inc / Oric Pharmaceuticals Inc / DraftKings Inc / Roku Inc / Albertsons Companies Inc / Relmada Therapeutics Inc / Liberty Media Corp / Altimmune Inc / Shoals Technologies Group Inc / Vizio Holding Corp / Rain Therapeutics Inc / Valneva SE / Squarespace Inc / Flywire Corp</td><td class="leftalignment"></td><td class="leftalignment">France / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">08/11/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ZTS-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ZTS / LLY / MRK / PFE / ICCC.O / HSKA.O / PAHC.O / SNY.O</td><td class="leftalignment">Zoetis Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / ImmuCell Corp / Heska Corp / Phibro Animal Health Corp / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/11/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRNA-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRNA.O / JNJ / MRK / NVS / ALNY.O / ARWR.O / ATHX.O / RGLS.O / MON.O</td><td class="leftalignment">Moderna Inc / Johnson & Johnson / Merck & Co Inc / Novartis AG / Alnylam Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Athersys Inc / Regulus Therapeutics Inc / Monument Circle Acquisition Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Merck & Co., Inc.(MRK) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">58933Y105</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Equita SIM</td><td class="leftalignment">EQUITA SIM: MERCK (BUY; Unchanged) - 2Q21 results</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Gianmarco Bonacina</td></tr>
<tr class="odd"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / DIS=US / HD=US / MCD=US / OXY=US / RRC=US / WEN=US / T=US / BLD=US / DVN=US / APA=US / CPE=US / EOG=US / REI=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / ENR=US / MGY=US / SWN=US / SCOR=US / MUR=US / SPOT=US / MRO=US / LEG=US / VMC=US / EQR=US / MLM=US / DISH=US / SWIM=US / CBRL=US / ELY=US / CNX=US / DRI=US / EQT=US / GFF=US / GPOR=US / IBP=US / MAS=US / MHK=US / REGI=US / CVX=US / SGMS=US / BKNG=US / DCP=US / NHI=US / PRA=US / NLS=US / COP=US / DIN=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SCPL=US / CMG=US / PGTI=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / CLR=US / PNNT=US / PRPL=US / APEI=US / NOG=US / JACK=US / TREX=US / AR=US / OAS=US / BLND=US / APTS=US / ESTE=US / FBHS=US / BCEI=US / MTDR=US / PDCE=US / FANG=US / TILE=US / MODN=US / NDLS=US / HTRG=US / VNOM=US / 70806A106 / LOCO=US / OSH=US / SHAK=US / GSBD=US / WING=US / CABO=US / AXSM=US / 82982L103 / TTD=US / EVBG=US / CDEV=US / PVAC=US / ANAB=US / JELD=US / SBOW=US / SAIL=US / RTLR=US / FERG=US / RPAY=US / PNTG=US / OVV=US / DKNG=US / AZEK=US / PAYA=US / AZYO=US / BALY=US / VTRS=US / REPX=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Walt Disney Co / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Wendys Co / AT&T Inc / TopBuild Corp / Devon Energy Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Energizer Holdings Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Comscore Inc / Murphy Oil Corp / Spotify Technology SA / Marathon Oil Corp / Leggett & Platt Inc / Vulcan Materials Co / Equity Residential / Martin Marietta Materials Inc / DISH Network Corp / Latham Group Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Griffon Corp / Gulfport Energy Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / Chevron Corp / Scientific Games Corp / Booking Holdings Inc / DCP Midstream LP / National Health Investors Inc / ProAssurance Corp / Nautilus Inc / Conocophillips / Dine Brands Global Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Sciplay Corp / Chipotle Mexican Grill Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Pennantpark Investment Corp / Purple Innovation Inc / American Public Education Inc / Northern Oil and Gas Inc / Jack in the Box Inc / Trex Company Inc / Antero Resources Corp / Oasis Petroleum Inc / Blend Labs Inc / Preferred Apartment Communities Inc / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Interface Inc / Model N Inc / Noodles & Co / Heritage Insurance Holdings Inc / Viper Energy Partners LP / PennantPark Floating Rate Capital Ltd / El Pollo Loco Holdings Inc / Oak Street Health Inc / Shake Shack Inc / Goldman Sachs BDC Inc / Wingstop Inc / Cable One Inc / Axsome Therapeutics Inc / SiteOne Landscape Supply Inc / Trade Desk Inc / Everbridge Inc / Centennial Resource Development Inc / Ranger Oil Corp / AnaptysBio Inc / JELD-WEN Holding Inc / SilverBow Resources Inc / SailPoint Technologies Holdings Inc / Rattler Midstream LP / Ferguson PLC / Repay Holdings Corp / Pennant Group Inc / Ovintiv Inc / DraftKings Inc / Azek Company Inc / Paya Holdings Inc / Aziyo Biologics Inc / Bally's Corp / Viatris Inc / Riley Exploration Permian Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Luxembourg / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2486813 / 2778844 / 2973821 / 2050832 / 2280220 / 2542049 / 2829515 / 2670519 / 2328915 / 2689560 / 2684703 / 2829601 / 2503529 / 7103065 / B0T7YX2 / B570P91 / BBFL7S1 / B7VD3F2 / B8L2798 / BFDV8K0 / BBPK0J0 / BQPVQZ6 / BYVY8G0 / BYW36M8 / BYQHP96 / BF5L3T2 / BYNZGK1 / BD9GVY0 / BKS3SM8 / BYZR4X4 / BYQNYR5 / BMYML02 / BLGJ610 / BYXJQG9 / BJXBP30 / BZ1LFG7 / BKC9SX3 / BD6JX35 / BDVLM39 / BZ0P3Z5 / BYSFJV8 / BYTJZL1 / BWY4XV3 / BDD1B07 / BDRW1L7 / BF3N4P3 / BJRFSB7 / BD72R64 / BLR6S36 / BNTB3N8 / BMV31Q4 / BKPGJQ1 / BFYVZ75 / BNLYJ60 / BNLYBF3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Kellogg Co / Merck & Co Inc / Alliant Energy Corp / Ameren Corp / DTE Energy Co / Dominion Energy Inc / Edison International / Exelon Corp / Nextera Energy Inc / PG&E Corp / Pfizer Inc / Southern Co / World Wrestling Entertainment Inc / Novartis AG / Live Nation Entertainment Inc / Lear Corp / bluebird bio Inc / Duke Energy Corp / Hemisphere Media Group Inc / MacroGenics Inc / Mirati Therapeutics Inc / Horizon Therapeutics PLC / Alphabet Inc / PayPal Holdings Inc / Floor & Decor Holdings Inc / Elanco Animal Health Inc / Block Inc / Zai Lab Ltd / IGM Biosciences Inc / Axsome Therapeutics Inc / Senseonics Holdings Inc / DraftKings Inc / Warner Music Group Corp / Spire Inc / Turning Point Therapeutics Inc / Roku Inc / Arcturus Therapeutics Holdings Inc / Krystal Biotech Inc / argenx SE / Tegna Inc / Planet Fitness Inc / Zogenix Inc / Adaptimmune Therapeutics PLC / Rubius Therapeutics Inc / AnaptysBio Inc / Arena Pharmaceuticals Inc / Immunovant Inc / Liberty Media Corp / Longboard Pharmaceuticals Inc / Vizio Holding Corp / Audacy Inc / Squarespace Inc / Seelos Therapeutics Inc / Imago BioSciences Inc / Erasca Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ERAS (BUY) - ERASe CAncer with a Deep RAS/MAPK-Focused Pipeline - Initiating Coverage with a BUY Rating and $25 PT</td><td class="leftalignment">English</td><td class="rightalignment">95</td><td class="leftalignment">BNLYBF3 / 5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2369174 / 2455965 / 2684703 / 2573083 / 2931034 / 7103065 / 2713317 / BBFL7S1 / BBPK0J0 / BD9GVY0 / BDHF4K6 / BZ1LFB2 / BZ8FPH3 / BWY52P3 / BL71K91 / BDZ30Q0 / BN2R582 / BMPRZV5 / BMDJ397 / BN2RM92 / BP7KZP7</td><td class="leftalignment">Erasca Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Gilead Sciences Inc / Biogen Inc / Pfizer Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Novartis AG / ACADIA Pharmaceuticals Inc / bluebird bio Inc / Mirati Therapeutics Inc / Zai Lab Ltd / CRISPR Therapeutics AG / Deciphera Pharmaceuticals Inc / Editas Medicine Inc / Blueprint Medicines Corp / Revolution Medicines Inc / Arvinas Inc / Relay Therapeutics Inc / Kymera Therapeutics Inc / Bolt Biotherapeutics Inc / Rain Therapeutics Inc / Monte Rosa Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharma Food for Thought : US healthcare in FY22 Budget Resolution bill & latest touted FDA Commissioner candidate tough views on pricing</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">4502.T / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / UCB.BR / AMGN.OQ / REGN.OQ / GILD.OQ / INCY.OQ / BMRN.OQ / BIIB.OQ / IPN.PA / TEVA.N / ALM.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Almirall SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">RUBY (BUY) - First Patient Dosed in RTX-240 Keytruda Combo Study; Pipeline on Track for Several Disclosures Around YE21/Early '22</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BDD1B07 / 2778844</td><td class="leftalignment">Rubius Therapeutics Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 30, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Merck KGaA (MRK GY) - Q2 second opinion: firing on all cylinders</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Jul 30</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">08/08/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.4% Above Pre-Pandemic Base- Week 70</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">HZNP-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">HZNP.O / MRK / PFE / AMGN.O / RDY / AZN.O / RDUS.O</td><td class="leftalignment">Horizon Therapeutics PLC / Merck & Co Inc / Pfizer Inc / Amgen Inc / Dr Reddy's Laboratories Ltd / AstraZeneca PLC / Radius Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / India / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">DD-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">APD / DOW / EMN / FMC / MRK / PPG / BASFY.PK / GT.O / MON.O</td><td class="leftalignment">Air Products and Chemicals Inc / Dow Inc / Eastman Chemical Co / FMC Corp / Merck & Co Inc / PPG Industries Inc / BASF SE / Goodyear Tire & Rubber Co / Monument Circle Acquisition Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Germany / India / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">VRTX-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">VRTX.O / BMY / JNJ / MRK / GILD.O / ENTA.O / ABBV.K / ENZN.PK</td><td class="leftalignment">Vertex Pharmaceuticals Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Gilead Sciences Inc / Enanta Pharmaceuticals Inc / Abbvie Inc / Enzon Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AZN-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AZN.O / ABT / BMY / JNJ / LLY / MRK / NVS / PFE / GSK / BIIB.O / SNY.O</td><td class="leftalignment">AstraZeneca PLC / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Biogen Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O / BIOb / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LLY-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY / BMY / JNJ / MRK / NVS / PFE / AMGN.O / GSK / AZN.O / ABBV.K / SNY.O</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BMY-US -  Dividend Quality Analysis, for the period ended August 02,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / JNJ / LLY / MRK / NVS / PFE / AMGN.O / AZN.O / BIIB.O / ABBV.K / SNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / AstraZeneca PLC / Biogen Inc / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Merck: Roadshow feedback</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">INVESTMENT STRATEGY / MANAGEMENT / MERGER/ACQUISITION/DIVESTITURE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Falko Friedrichs / Herr Jan Koch / Sachin Gadilingappa</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended July 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">The Earlier the Better; How We're Thinking About the Adjuvant Stage II Melanoma Opportunity for Keytruda</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending July 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / MNKD.OQ / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / MannKind Corp / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Societe Generale</td><td class="leftalignment">Merck KGaA (Hold, TP=€190) - 12m target upgrade - Stronger 2Q thanks to Life Science; FY guidance increase - F. Cespedes (6p)</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Florent Cespedes / Justin S. Smith / Manas Sarkar</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Daily Credit Briefing</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">BLL.N / SAPJ.J / ALVG.DE / SPMI.MI / CONG.DE / BAMI.MI / MRCG.DE / DPWGn.DE / INGA.AS / VNAN.DE / 1COV.DE / ADNT.N</td><td class="leftalignment">Ball Corp / Sappi Ltd / Allianz SE / Saipem SpA / Continental AG / Banco BPM SpA / Merck KGaA / Deutsche Post AG / ING Groep NV / Vonovia SE / Covestro AG / Adient PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Ireland / Italy / Netherlands / Russian Federation / United States / South Africa</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Services / Shipping & Shipbuilding / Telecommunications / Tire & Rubber / Transportation / Internet / Marketing</td><td class="leftalignment">Africa / Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS / CREDIT</td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Frau. Jana Schuler / Herr Christian Aust / Herr Jonathan Schroer / Herr Sven Kreitmair, CFA / Frau Silke Stegemann / Sergey Bolshakov / Herr. Michael Teig / Herr. Franz Rudolf / Herr Natalie Tehrani Monfared</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck & Co Inc: Information Content of Earnings Releases 2015-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">AXP / V / 4031976 / 5671735 / 2023607 / 2486813 / 2640147 / 2778844 / 2002305 / 2003698 / 2050832 / 2045623 / 2942605 / 2544960 / 2219224 / 2206657 / 2216850 / 2037170 / 2317087 / 2576941 / 2670519 / 2328915 / 2342034 / 2613990 / 2471950 / 2630513 / 2645409 / 2657802 / 2689560 / 2680905 / 2684703 / 2048804 / 2730190 / 2440637 / 2138158 / 2825933 / 2829601 / 2928683 / 2503529 / B1F76F9 / 2212922 / B19FQ48 / B0T7YX2 / B02R1L6 / 2390817 / B7TL820 / B4MG4Z6 / B783TY6 / B7VD3F2 / BBPK0J0 / BBGVT40 / B7577T2 / BDZCRX3 / B95WG16 / BZ07BW4 / BYZLV46 / BYNZGK1 / BZBY005 / BD8DJ71 / BJ1FD74 / BKTHM05 / BR4T3B3 / BMYML02 / BFMXGR0 / BJJMGL2 / BFNR303 / BYXJQG9 / BZ8VJQ8 / BJFSR99 / BFXC911 / BKTNTR9 / BJVR9Y9 / BYWMQJ2 / BYYWPW6 / BHZSB82 / BP3YM85 / BD6D4Y5 / BJ9NFQ3 / BZ1LFG7 / BYY88Y7 / BF3W461 / BYSGPK2 / BKX9VD3 / BJDX8Y8 / BYWVTY5 / BMVWYW8 / BDZ30Q0 / BJMLSD2 / BYTJZL1 / BJTJGC4 / BG0Q4Y1 / BF3N4P3 / BQXZP64 / BMDCDP2 / BYXB1Y8 / BGDQ8B3 / BD72R64 / BNTB3N8 / BMGGJK8 / BKPGJQ1 / BJLV8T9</td><td class="leftalignment">American Express Co / Visa Inc / Adidas AG / Sanofi SA / Amgen Inc / Kellogg Co / Nike Inc / Merck & Co Inc / Abbott Laboratories / ABIOMED Inc / Ameren Corp / ANSYS Inc / Avista Corp / Beasley Broadcast Group Inc / CMS Energy Corp / Coca-Cola Co / Consolidated Edison Inc / 8x8 Inc / Entergy Corp / Exelixis Inc / Exelon Corp / Nextera Energy Inc / Fiserv Inc / Illumina Inc / Incyte Corp / New Jersey Resources Corp / NiSource Inc / OGE Energy Corp / PG&E Corp / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Sempra Energy / South Jersey Industries Inc / Southern Co / VF Corp / World Wrestling Entertainment Inc / Western Union Co / NRG Energy Inc / Amicus Therapeutics Inc / Live Nation Entertainment Inc / ALLETE Inc / Gray Television Inc / Meta Platforms Inc / AMC Networks Inc / Aptiv PLC / Duke Energy Corp / Mirati Therapeutics Inc / News Corp / Renewable Energy Group Inc / RingCentral Inc / Zoetis Inc / Monster Beverage Corp / InflaRx NV / Block Inc / Merus NV / Snap Inc / Revolve Group Inc / Passage Bio Inc / HubSpot Inc / DraftKings Inc / Evergy Inc / Fox Corp / Northwest Natural Holding Co / Spire Inc / Vistra Corp / Revance Therapeutics Inc / Guardant Health Inc / ViacomCBS Inc / iHeartMedia Inc / Alteryx Inc / Beigene Ltd / Covetrus Inc / Trupanion Inc / Altair Engineering Inc / Neoleukin Therapeutics Inc / Roku Inc / Alphabet Inc / Tandem Diabetes Care Inc / ViewRay Inc / Arcutis Biotherapeutics Inc / Mirum Pharmaceuticals Inc / CytomX Therapeutics Inc / Protara Therapeutics Inc / Arvinas Inc / Karuna Therapeutics Inc / Zogenix Inc / Kontoor Brands Inc / Exicure Inc / Arena Pharmaceuticals Inc / Wayfair Inc / Bigcommerce Holdings Inc / Sunrun Inc / Axonics Inc / Liberty Media Corp / Vizio Holding Corp / Valneva SE / Squarespace Inc / Celldex Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / France / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Merck: The journey is far from over; raising TP to €220</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">CREDIT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Falko Friedrichs / Herr Jan Koch / Sachin Gadilingappa</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRCG.DE: Merck KGaA - 2Q21 Second Opinion; Increase TP to Eu200</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">MRCG.DE / 4063.T / 4185.T / 4901.T / A.N / BDX.N / RECI.MI / STDM.PA / TMO.N / WAT.N / DHR.N / LUN.CO / GLW.N / MTD.N / LONN.S / PKI.N / GSK.L / UCB.BR / TECH.OQ / CCMP.OQ / ENTG.OQ / IPN.PA / ORNBV.HE / QGEN.N / ALM.MC / VIFN.S / GMAB.CO</td><td class="leftalignment">Merck KGaA / Shin-Etsu Chemical Co Ltd / JSR Corp / Fujifilm Holdings Corp / Agilent Technologies Inc / Becton Dickinson and Co / Recordati Industria Chimica e Farmaceutica SpA / Sartorius Stedim Biotech SA / Thermo Fisher Scientific Inc / Waters Corp / Danaher Corp / H Lundbeck A/S / Corning Inc / Mettler-Toledo International Inc / Lonza Group AG / PerkinElmer Inc / GlaxoSmithKline PLC / Ucb SA / Bio-Techne Corp / CMC Materials Inc / Entegris Inc / Ipsen SA / Orion Oyj / Qiagen NV / Almirall SA / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">HSBC</td><td class="leftalignment">Merck KGaA (MRK GR):-Upgrade to Hold: Life Science driving growth</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRCG.F / BAYGn.DE</td><td class="leftalignment">Merck KGaA / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">COMPANY / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES / RATINGS CHANGES / CHANGE IN RECOMMENDATION / FORECASTS / EQUITY / REPORTING RESULTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Stephen McGarry / Ms. Julie Mead</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck KGaA : Strong sustainable growth which continues to be undervalued, raising PT to €220</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Richard B. Vosser / James D. Gordon / Ms. Laerke Engkilde / Zain Ebrahim</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Merck & Co</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Stage II Melanoma Benefit Further Differentiates Keytruda</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GBP: Libtayo Meets the Bar to Compete w/ MRK's Keytruda in Lung Cancer; Similar Results Suggest an Uphill Battle, but Opens Biggest PD1 Market</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N / 5671735 / 2778844 / 2730190</td><td class="leftalignment">Merck & Co Inc / Sanofi SA / Merck & Co Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Mr. Yatin Suneja</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Kepler Cheuvreux</td><td class="leftalignment">Merck KGAA | Buy | Outlook raised delivered above expectations, and it is not just COVID</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David P. Evans</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRCG.DE - Event Transcript of Merck KGaA conference call, Aug. 05, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / T=US / DVN=US / CMA=US / GILD=US / PEB=US / APA=US / CPE=US / EOG=US / H=US / V=US / MTN=US / CRK=US / WLL=US / PB=US / MGY=US / EWBC=US / TRMK=US / MAR=US / UMPQ=US / MRO=US / TNL=US / KFRC=US / VMC=US / MGM=US / HLT=US / UNM=US / CVS=US / RCL=US / UNH=US / MAC=US / WTFC=US / AIZ=US / AMED=US / AMN=US / APH=US / FUN=US / CENT=US / KIDS=US / CHH=US / CSTR=US / CW=US / DRH=US / EEFT=US / MPLX=US / DOC=US / ASGN=US / OKE=US / PACW=US / RHI=US / SGMO=US / SMG=US / TGI=US / WAL=US / HTH=US / BXS=US / CCRN=US / FNF=US / BKNG=US / CFB=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / ABCB=US / BOKF=US / DCP=US / FRT=US / FBK=US / JAZZ=US / MTCH=US / ASB=US / SSB=US / SPR=US / RF=US / CRTO=US / CATY=US / FFIN=US / GBCI=US / SBSI=US / EVOP=US / UCBI=US / VICI=US / ECPG=US / MGP=US / PNFP=US / SBCF=US / BDSI=US / JRVR=US / RPD=US / BIIB=US / FLT=US / TCBI=US / FNB=US / FHN=US / KAR=US / BDC=US / SHO=US / RNST=US / LHCG=US / CHNG=US / HST=US / MA=US / GPRE=US / ELF=US / WU=US / TEL=US / CADE=US / WH=US / IAC=US / PSN=US / JACK=US / SWI=US / VRSK=US / OAS=US / HGV=US / SBRA=US / RLJ=US / ESTE=US / VAC=US / ANGI=US / EA=US / PDCE=US / GMED=US / RHP=US / FANG=US / ABBV=US / IBTX=US / TMUS=US / FATE=US / TSLX=US / HUBS=US / VCEL=US / NVRO=US / UPLD=US / GDDY=US / ETSY=US / LOB=US / EVRI=US / ACBI=US / EDIT=US / 82982L103 / VVV=US / PK=US / PVAC=US / TVTY=US / 50189K103 / PLYA=US / SBOW=US / PETQ=US / ROKU=US / MBIN=US / MAXR=US / EOLS=US / HWC=US / OZK=US / FTDR=US / ALLO=US / AMTB=US / UBER=US / RTLR=US / IMVT=US / 100017125</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / AT&T Inc / Devon Energy Corp / Comerica Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Hyatt Hotels Corp / Visa Inc / Vail Resorts Inc / Comstock Resources Inc / Whiting Petroleum Corp / Prosperity Bancshares Inc / Magnolia Oil & Gas Corp / East West Bancorp Inc / Trustmark Corp / Marriott International Inc / Umpqua Holdings Corp / Marathon Oil Corp / Travel + Leisure Co / Kforce Inc / Vulcan Materials Co / MGM Resorts International / Hilton Worldwide Holdings Inc / Unum Group / CVS Health Corp / Royal Caribbean Cruises Ltd / UnitedHealth Group Inc / Macerich Co / Wintrust Financial Corp / Assurant Inc / Amedisys Inc / AMN Healthcare Services Inc / Amphenol Corp / Cedar Fair LP / Central Garden & Pet Co / OrthoPediatrics Corp / Choice Hotels International Inc / CapStar Financial Holdings Inc / Curtiss-Wright Corp / Diamondrock Hospitality Co / Euronet Worldwide Inc / MPLX LP / Physicians Realty Trust / ASGN Inc / ONEOK Inc / PacWest Bancorp / Robert Half International Inc / Sangamo Therapeutics Inc / Scotts Miracle-Gro Co / Triumph Group Inc / Western Alliance Bancorp / Hilltop Holdings Inc / Cadence Bank / Cross Country Healthcare Inc / Fidelity National Financial Inc / Booking Holdings Inc / Crossfirst Bankshares Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / DCP Midstream LP / Federal Realty Investment Trust / FB Financial Corp / Jazz Pharmaceuticals PLC / Match Group Inc / Associated Banc-Corp / SouthState Corp / Spirit AeroSystems Holdings Inc / Regions Financial Corp / Criteo SA / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Southside Bancshares Inc / EVO Payments Inc / United Community Banks Inc / VICI Properties Inc / Encore Capital Group Inc / MGM Growth Properties LLC / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / BioDelivery Sciences International Inc / James River Group Holdings Ltd / Rapid7 Inc / Biogen Inc / Fleetcor Technologies Inc / Texas Capital Bancshares Inc / FNB Corp / First Horizon Corp / KAR Auction Services Inc / Belden Inc / Sunstone Hotel Investors Inc / Renasant Corp / LHC Group Inc / Change Healthcare Inc / Host Hotels & Resorts Inc / Mastercard Inc / Green Plains Inc / elf Beauty Inc / Western Union Co / TE Connectivity Ltd / Cadence Bank / Wyndham Hotels & Resorts Inc / IAC/Interactivecorp / Parsons Corp / Jack in the Box Inc / SolarWinds Corp / Verisk Analytics Inc / Oasis Petroleum Inc / Hilton Grand Vacations Inc / Sabra Health Care REIT Inc / RLJ Lodging Trust / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Angi Inc / Electronic Arts Inc / PDC Energy Inc / Globus Medical Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Abbvie Inc / Independent Bank Group Inc / T-Mobile US Inc / Fate Therapeutics Inc / Sixth Street Specialty Lending Inc / HubSpot Inc / Vericel Corp / Nevro Corp / Upland Software Inc / GoDaddy Inc / ETSY Inc / Live Oak Bancshares Inc / Everi Holdings Inc / Atlantic Capital Bancshares Inc / Editas Medicine Inc / SiteOne Landscape Supply Inc / Valvoline Inc / Park Hotels & Resorts Inc / Ranger Oil Corp / Tivity Health Inc / LCI Industries / Playa Hotels & Resorts NV / SilverBow Resources Inc / PetIQ Inc / Roku Inc / Merchants Bancorp / Maxar Technologies Inc / Evolus Inc / Hancock Whitney Corp / Bank Ozk / Frontdoor Inc / Allogene Therapeutics Inc / Amerant Bancorp Inc / Uber Technologies Inc / Rattler Midstream LP / Immunovant Inc / SVB Financial Group</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / France / Ireland / Liberia / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck KGaA : 2Q'21 1st Take: Very strong quarter and FY'21 guidance raised and outlook for 2022 also likely to require upgrades</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Richard B. Vosser / James D. Gordon / Ms. Laerke Engkilde / Zain Ebrahim / Mr. Tycho W. Peterson</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRCG.DE: Merck KGaA - 2Q21 Initial Diagnosis</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">XNCR (BUY) – 2Q Wrap-Up: On Track for Clinical Updates of XmAb717 and Plamotamab by YE; Maintain BUY</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BGCYWN8 / 2778844 / 5531000</td><td class="leftalignment">Xencor Inc / Merck & Co Inc / MorphoSys AG</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Etzer Darout / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Pfizer Stock Has Risen 11% In A Month But Will The Gains Continue?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">PFE.N / JNJ.N / MRK.N / RHHBY.PK</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Merck & Co Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech: SMID-Cap Oncology Take-Aways From Big-Cap 2Q21 Earnings</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / GILD=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Kepler Cheuvreux</td><td class="leftalignment">Merck KGAA | Buy | Earnings hikes set to continue</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David P. Evans</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">0989529 / 0925288 / 2434209 / 2516152 / 2681511 / 2000019 / 2023607 / 2486813 / 2778844 / 2229126 / 2208073 / 2270726 / 2829515 / 2670519 / 2328915 / 2100920 / 2471950 / 2623911 / 2657802 / 2689560 / 2684703 / 2048804 / 2707677 / 2730190 / 2829601 / 2853688 / 7103065 / 2783815 / 2712013 / B00FWN1 / B0PZN11 / B121557 / 2769796 / 2857817 / B0T7YX2 / B2R3PV1 / B3D7K31 / B4Y1MH7 / 2390817 / B44C366 / B3SWPT2 / B4V9661 / BJ0KXV4 / BDZCRX3 / BFLR866 / BFZCHN7 / BYY8XK8 / BYVY8G0 / BTF8CF0 / BP4GNK9 / BYW36M8 / BYNZGK1 / BJT1RW7 / BD9GVY0 / BJF8Q81 / BZ1LFB2 / BR4T3B3 / BJ2Z0H2 / BLGJ610 / BJJMGL2 / BZ05388 / BDT5KT5 / BKC9SX3 / BFWGXQ7 / BP84RX0 / 021513106 / BNTB3N8</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Home Depot Inc / Eli Lilly and Co / PepsiCo Inc / Amazon.com Inc / Amgen Inc / Kellogg Co / Merck & Co Inc / Columbia Sportswear Co / Copart Inc / Walt Disney Co / Edison International / Exelon Corp / Nextera Energy Inc / FirstEnergy Corp / Incyte Corp / Neurocrine Biosciences Inc / OGE Energy Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / Southern Co / Stryker Corp / Novartis AG / Zimmer Biomet Holdings Inc / Global Payments Inc / Alnylam Pharmaceuticals Inc / Under Armour Inc / Mastercard Inc / Fidelity National Information Services Inc / Netflix Inc / Live Nation Entertainment Inc / American Water Works Company Inc / Discovery Inc / KAR Auction Services Inc / Gray Television Inc / Heska Corp / Ameresco Inc / Ralph Lauren Corp / ONE Gas Inc / RingCentral Inc / Twitter Inc / Wix.Com Ltd / WEC Energy Group Inc / Alphabet Inc / Restaurant Brands International Inc / SAGE Therapeutics Inc / PayPal Holdings Inc / Block Inc / Lyft Inc / Zai Lab Ltd / IAA Inc / Deciphera Pharmaceuticals Inc / HubSpot Inc / Pinterest Inc / Warner Music Group Corp / Fox Corp / Global Blood Therapeutics Inc / Inspire Medical Systems Inc / Arcturus Therapeutics Holdings Inc / Container Store Group Inc / Townsquare Media Inc / Alto Ingredients Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GRLS.MC: Grifols - Increasing visibility on plasma collection-reiterate Outperform, raise TP to Eu27</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">GRLS.MC / 4502.T / CSL.AX / JNJ.N / RECI.MI / LUN.CO / MRCG.DE / LONN.S / UCB.BR / 006280.KS / 002007.SZ / IPN.PA / ORNBV.HE / ALM.MC / VIFN.S / ARGX.OQ / GMAB.CO</td><td class="leftalignment">Grifols SA / Takeda Pharmaceutical Co Ltd / CSL Ltd / Johnson & Johnson / Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Green Cross Corp / Hualan Biological Engineering Inc / Ipsen SA / Orion Oyj / Almirall SA / Vifor Pharma AG / argenx SE / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / China / Germany / Denmark / Spain / Finland / France / Italy / Japan / Korea, Republic of / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / 5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2778844 / 2270726 / 2542049 / 2829515 / 2328915 / 2100920 / 2415204 / 2689560 / 2684703 / 2829601 / 7103065 / 2712013 / B1HMF22 / B125XQ6 / B3SWPT2 / BCZS820 / BDZCRX3 / BFLR866 / BVVN4Q8 / BQPVQZ6 / BYVY8G0 / BYNZGK1 / BJLT387 / BZB1XF2 / BR4T3B3 / BYXJQG9 / BGSP7M9 / BZ1LFG7 / BDVLM39 / BG0Q4Y1 / BJRFSB7 / BMZ9Z11 / BNTB3N8 / BWC52Q6 / BJ62Z18</td><td class="leftalignment">American Express Co / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Walt Disney Co / Dominion Energy Inc / Edison International / Nextera Energy Inc / FirstEnergy Corp / Hawaiian Electric Industries Inc / PG&E Corp / Pfizer Inc / Southern Co / Novartis AG / Global Payments Inc / First Solar Inc / Portland General Electric Co / Ameresco Inc / Fate Therapeutics Inc / RingCentral Inc / Twitter Inc / Eversource Energy / Horizon Therapeutics PLC / Alphabet Inc / Block Inc / Avantor Inc / Tactile Systems Technology Inc / HubSpot Inc / Spire Inc / Zoom Video Communications Inc / Roku Inc / argenx SE / Exicure Inc / Immunovant Inc / Prometheus Biosciences Inc / Vizio Holding Corp / Solaredge Technologies Inc / Ultragenyx Pharmaceutical Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">UCB.BR: UCB - 1H21 second opinion</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">UCB.BR / RECI.MI / LUN.CO / MRCG.DE / LONN.S / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / GMAB.CO</td><td class="leftalignment">Ucb SA / Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 23, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Morning Bite Flash</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">DE0005785604 / DE0006599905 / DE0007235301 / DE0008232125 / DE0005439004 / DE0006305006 / DE0005785802 / DK0010272632 / DE0005313704 / NL0000009538 / DE0007037129 / DE0007231326 / DE0007042301 / DE0005552004 / DE0006632003 / DE0005772206 / DE0006916604 / DE0007165631 / CH0012549785 / DE0007856023 / CH0012280076 / DE0005408884 / FI0009013403 / CH0024638196 / IT0004056880 / DE000A0LD6E6 / GB00B1YPC344 / DE000BAY0017 / DK0060448595 / DE000A13SX22 / LU1066226637 / DE000STRA555 / CH0303692047 / DE000HLAG475 / DK0060738599 / NL0012169213 / CH0364749348 / DE000JST4000 / DE000A2GS5D8 / DE000SHL1006 / DE000A2JNWZ9 / ATFREQUENT09 / US09075V1026</td><td class="leftalignment">Fresenius SE & Co KGaA / Merck KGaA / SGL Carbon SE / Deutsche Lufthansa AG / Continental AG / DEUTZ AG / Fresenius Medical Care AG & Co KGaA / GN Store Nord A/S / Carl Zeiss Meditec AG / Koninklijke Philips NV / Rwe AG / Sixt SE / Rhoen Klinikum AG / Deutsche Post AG / MorphoSys AG / Fielmann AG / Pfeiffer Vacuum Technology AG / Sartorius AG / Sonova Holding AG / Elringklinger AG / Straumann Holding AG / Leoni AG / Kone Oyj / Schindler Holding AG / Amplifon SpA / Gerresheimer AG / Fuller Smith & Turner PLC / Bayer AG / Coloplast A/S / HELLA GmbH & Co KGaA / Stabilus SA / Stratec SE / EDAG Engineering Group AG / Hapag Lloyd AG / Demant A/S / Qiagen NV / Vifor Pharma AG / JOST Werke AG / Dermapharm Holding SE / Siemens Healthineers AG / Akasol AG / Frequentis AG / BioNTech SE</td><td class="leftalignment"></td><td class="leftalignment">Austria / Switzerland / Germany / Denmark / Finland / United Kingdom / Italy / Luxembourg / Netherlands</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Herr. Ingo-Martin Schachel, CFA</td></tr>
<tr class="even"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRCG.DE: Merck KGaA - 2Q21 results preview</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRCG.DE / LLY.N</td><td class="leftalignment">Merck KGaA / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">08/01/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck & Co Inc: Peer Group Analytics - Q2 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">08/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">08/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.8% Above Pre-Pandemic Base- Week 69</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Merck climbs 19.1% from 7 week low</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Merck (MRK: $76.87) wipes off $2 billion in MCap in July, highest loser in Pharmaceuticals sector</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Portfolio Manager's Weekly - July 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">NL0000226223 / FR0000120578 / GB0009895292 / DE0006231004 / GB0009252882 / CH0012032048 / CH0012005267 / US0079031078 / US0378331005 / US0382221051 / US0463531089 / US1101221083 / US1727551004 / US1985161066 / US2435371073 / US2546871060 / US37733W1053 / US4581401001 / US4824801009 / US5012421013 / US5128071082 / US5184151042 / US5324571083 / US5370081045 / US55306N1046 / US5719032022 / US5951121038 / US6541061031 / US6549022043 / US66987V1098 / US6701002056 / US67066G1040 / US7170811035 / US7392761034 / US7475251036 / US7711951043 / US8610121027 / US8807701029 / US9282981086 / US9581021055 / US83088M1027 / US80105N1054 / US1572101053 / US6098391054 / US9043111072 / US82706C1080 / US5500211090 / US25470F1049 / US58933Y1055 / US4485791028 / US25470F3029 / US00164V1035 / US30212P3038 / US8969452015 / US00287Y1091 / NL0010273215 / US55405Y1001 / KYG037AX1015 / DK0060534915 / US74736K1016 / KYG4740B1059 / LGFb / US89686D1054 / US43300A2033 / LGFa / VGG273581030 / US09857L1089 / US11135F1012 / US98585X1046 / US35137L1052 / US70614W1009 / US89677Q1076 / US92556H2067 / GB00BMVP7Y09 / US0090661010 / US5738741041 / IE00BKVD2N49 / US30260D1037 / US68622V1061 / US81730H1095 / US89142B1070 / US69120X1072 / US30049H1023</td><td class="leftalignment">STMicroelectronics NV / Sanofi SA / AstraZeneca PLC / Infineon Technologies AG / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Advanced Micro Devices Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cirrus Logic Inc / Columbia Sportswear Co / Deckers Outdoor Corp / Walt Disney Co / GlaxoSmithKline PLC / Intel Corp / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Lattice Semiconductor Corp / Eli Lilly and Co / Littelfuse Inc / MKS Instruments Inc / Marriott International Inc / Micron Technology Inc / Nike Inc / Nokia Oyj / Novartis AG / Novo Nordisk A/S / NVIDIA Corp / Pfizer Inc / Power Integrations Inc / Qualcomm Inc / Roche Holding AG / STMicroelectronics NV / Teradyne Inc / Vishay Intertechnology Inc / Western Digital Corp / Skyworks Solutions Inc / Sanofi SA / CEVA Inc / Monolithic Power Systems Inc / Under Armour Inc / Silicon Motion Technology Corp / Lululemon Athletica Inc / Discovery Inc / Merck & Co Inc / Hyatt Hotels Corp / Discovery Inc / AMC Networks Inc / Expedia Group Inc / Tripadvisor Inc / Abbvie Inc / ASML Holding NV / MACOM Technology Solutions Holdings Inc / Ambarella Inc / Novo Nordisk A/S / Qorvo Inc / Ichor Holdings Ltd / Lions Gate Entertainment Corp / Trivago NV / Hilton Worldwide Holdings Inc / Lions Gate Entertainment Corp / Despegar.com Corp / Booking Holdings Inc / Broadcom Inc / Yeti Holdings Inc / Fox Corp / Peloton Interactive Inc / Trip.com Group Ltd / ViacomCBS Inc / Royalty Pharma PLC / Airbnb Inc / Marvell Technology Inc / Seagate Technology Holdings PLC / Figs Inc / Organon & Co / SentinelOne Inc / Torrid Holdings Inc / Owlet Inc / Evolv Technologies Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / Finland / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended July 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending July 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / MNKD.OQ / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / MannKind Corp / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">V / 5671735 / 0989529 / 2000019 / 2778844 / 2045623 / 2219224 / 2216850 / 2270726 / 2829515 / 2567116 / 2670519 / 2328915 / 2100920 / 2369174 / 2689560 / 2730190 / 2829601 / 2098876 / 2931034 / 2503529 / 5531000 / 7123870 / 2971029 / B121557 / B067BM3 / B1Y9TB3 / 2216991 / B3P93Y7 / B5B2106 / B6197Q2 / B03PGL4 / B0796X4 / B65LWX6 / B4N0JJ6 / B7TL820 / BCBVTX1 / BFDV8K0 / B95N910 / BFLR866 / BYW36M8 / BD3W133 / BXDZ9Z0 / BJLT387 / BDHF4K6 / BNFWR44 / BJ2Z0H2 / BFZ1K46 / BLGJ610 / BJJMGL2 / BKTNTR9 / BYYWPW6 / BWY52P3 / BYNQ369 / BMH0MR7 / BDVLM39 / BFY7DC4 / BJ9N563 / BMBP1Q0 / BJLV8T9</td><td class="leftalignment">Visa Inc / Sanofi SA / AstraZeneca PLC / Amazon.com Inc / Merck & Co Inc / ANSYS Inc / CMS Energy Corp / Consolidated Edison Inc / Walt Disney Co / Edison International / Edwards Lifesciences Corp / Exelon Corp / Nextera Energy Inc / FirstEnergy Corp / Gilead Sciences Inc / PG&E Corp / Regeneron Pharmaceuticals Inc / Southern Co / Yum! Brands Inc / Vertex Pharmaceuticals Inc / World Wrestling Entertainment Inc / MorphoSys AG / Nestle SA / LKQ Corp / Mastercard Inc / Molson Coors Beverage Co / Danone SA / Tempur Sealy International Inc / Anheuser Busch Inbev SA / Fortinet Inc / Generac Holdings Inc / NorthWestern Corp / Dexcom Inc / O'Reilly Automotive Inc / Visteon Corp / Meta Platforms Inc / Agios Pharmaceuticals Inc / MacroGenics Inc / PTC Inc / Twitter Inc / PayPal Holdings Inc / Keurig Dr Pepper Inc / Shopify Inc / Avantor Inc / CRISPR Therapeutics AG / Worldline SA / Pinterest Inc / Spotify Technology SA / Warner Music Group Corp / Fox Corp / ViacomCBS Inc / Beigene Ltd / Blueprint Medicines Corp / Albertsons Companies Inc / Zendesk Inc / argenx SE / Altimmune Inc / Sunnova Energy International Inc / Flywire Corp / Celldex Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">CSGN.S / ELE.MC / IP.N / MAS.N / MO.N / MRK.N / TOTF.PA / VC.N / SSE.L / AVB.N / TRI.N / GILD.O / CMCSA.O / AAL.L / HBAN.O / TRP.TO / SU.TO / CTXS.O / YUM.N / VLO.N / DV.N / HSY.N / SGMO.O / CYH.N / CINF.O / RRC.N / EQT.N / RSG.N / WSP.TO / BC.N / MAA.N / ARCC.O / AJG.N / VRTX.O / FTT.TO / MCO.N / GPK.N / CFR.N / MEOH.O / SWN.N / NTCT.OQ / ADS.N / SGEN.OQ / SIGI.O / COLB.O / ACGL.O / ICPT.O / STN.TO / TIH.TO / SNC.TO / DLR.N / TXRH.O / 416515104 / RDSb.L / DRX.L / MA.N / MERC.O / EHTH.O / AUY.N / 550372106 / CLR.N / ENSG.O / INPP.L / AAV.TO / EGO.N / CVE.TO / FTNT.O / NLSN.N / VCRA.N / RFP.N / FFHu.TO / FANG.O / TMUS.N / GWB.N / TRHC.OQ / SPGI.N / FTV.N / TWLO.N / KNSL.OQ / UN01.DE / CRSP.OQ / INVH.N / NEXA.TO / NTGY.MC / KDP.N / NXGN.O / CARR.N / 900435207</td><td class="leftalignment">Credit Suisse Group AG / Endesa SA / International Paper Co / Masco Corp / Altria Group Inc / Merck & Co Inc / TotalEnergies SE / Visteon Corp / SSE PLC / Avalonbay Communities Inc / Thomson Reuters Corp / Gilead Sciences Inc / Comcast Corp / Anglo American PLC / Huntington Bancshares Inc / TC Energy Corp / Suncor Energy Inc / Citrix Systems Inc / Yum! Brands Inc / Valero Energy Corp / DoubleVerify Holdings Inc / Hershey Co / Sangamo Therapeutics Inc / Community Health Systems Inc / Cincinnati Financial Corp / Range Resources Corp / EQT Corp / Republic Services Inc / WSP Global Inc / Brunswick Corp / Mid-America Apartment Communities Inc / Ares Capital Corp / Arthur J Gallagher & Co / Vertex Pharmaceuticals Inc / Finning International Inc / Moody's Corp / Graphic Packaging Holding Co / Cullen/Frost Bankers Inc / Methanex Corp / Southwestern Energy Co / Netscout Systems Inc / Alliance Data Systems Corp / Seagen Inc / Selective Insurance Group Inc / Columbia Banking System Inc / Arch Capital Group Ltd / Intercept Pharmaceuticals Inc / Stantec Inc / Toromont Industries Ltd / SNC-Lavalin Group Inc / Digital Realty Trust Inc / Texas Roadhouse Inc / Hartford Financial Services Group Inc / Royal Dutch Shell PLC / Drax Group PLC / Mastercard Inc / Mercer International Inc / eHealth Inc / Yamana Gold Inc / Lundin Mining Corp / Continental Resources Inc / Ensign Group Inc / International Public Partnerships Ltd / Advantage Energy Ltd / Eldorado Gold Corp / Cenovus Energy Inc / Fortinet Inc / Nielsen Holdings PLC / Vocera Communications Inc / Resolute Forest Products Inc / Fairfax Financial Holdings Ltd / Diamondback Energy Inc / T-Mobile US Inc / Great Western Bancorp Inc / Tabula Rasa HealthCare Inc / S&P Global Inc / Fortive Corp / Twilio Inc / Kinsale Capital Group Inc / Uniper SE / CRISPR Therapeutics AG / Invitation Homes Inc / Nexa Resources SA / Naturgy Energy Group SA / Keurig Dr Pepper Inc / NextGen Healthcare Inc / Carrier Global Corp / Turquoise Hill Resources Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Germany / Spain / United Kingdom / Luxembourg / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">SGEN (BUY) - Outlook Improving on Significant Beat in 2Q, Pipeline Optionality; Guide Reaffirmed</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK.N / 2778844</td><td class="leftalignment">Merck & Co Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Price Action: July 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AIG.N / APD.N / BDX.N / BR.N / CF.N / CI.N / CL.N / CVS.N / DD.N / ED.N / EOG.N / GM.N / LLY.N / MCK.N / MRK.N / STE.N / WMB.N / SPG.N / PG.N / PXD.N / MET.N / ETN.N / DUK.N / DIS.N / CMI.N / D.N / PH.N / CAT.N / TSN.N / SYY.N / IFF.N / VNO.N / ITW.N / EMR.N / XOM.N / RMD.N / LIN.N / BLL.N / JCI.N / PSA.N / AWK.N / LEG.N / AME.N / VTR.N / CVX.N / PRU.N / L.N / COP.N / AMGN.OQ / ATVI.OQ / REGN.OQ / TT.N / IDXX.OQ / MCHP.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / EBAY.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / GPN.N / MNST.OQ / CMCSA.OQ / MOS.N / VIAC.OQ / FIS.N / TDG.N / AON.N / ES.N / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / FANG.OQ / ABBV.N / ZTS.N / PRGO.N / MAR.OQ / NCLH.N / ANET.N / ZBH.N / KHC.OQ / APTV.N / BKNG.OQ / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / Broadridge Financial Solutions Inc / CF Industries Holdings Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / General Motors Co / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / STERIS plc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Walt Disney Co / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Illinois Tool Works Inc / Emerson Electric Co / Exxon Mobil Corp / Resmed Inc / Linde PLC / Ball Corp / Johnson Controls International PLC / Public Storage / American Water Works Company Inc / Leggett & Platt Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / IDEXX Laboratories Inc / Microchip Technology Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / eBay Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Global Payments Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / ViacomCBS Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aon PLC / Eversource Energy / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Perrigo Company PLC / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Arista Networks Inc / Zimmer Biomet Holdings Inc / Kraft Heinz Co / Aptiv PLC / Booking Holdings Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4528.T: Ono Pharmaceutical - 1Q results solid, but company still tainted by bribery scandal</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">4528.T / BMY.N / MRK.N</td><td class="leftalignment">Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4528.T: 小野薬品工業 - 1Q決算：好決算だが、みそぎが未達</td><td class="leftalignment">Japanese</td><td class="rightalignment">6</td><td class="leftalignment">4528.T / BMY.N / MRK.N</td><td class="leftalignment">Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">RECI.MI: Recordati - 2Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">RECI.MI / 4503.T / LUN.CO / MRCG.DE / LONN.S / UCB.BR / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / VIFN.S / GMAB.CO</td><td class="leftalignment">Recordati Industria Chimica e Farmaceutica SpA / Astellas Pharma Inc / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy / Japan</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Ms Jo Walton / Elizabeth Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IPN.PA: Ipsen - 2Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IPN.PA / RECI.MI / LUN.CO / NOVN.S / MRCG.DE / LONN.S / UCB.BR / ORNBV.HE / ALM.MC / GRLS.MC / VIFN.S / GMAB.CO</td><td class="leftalignment">Ipsen SA / Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Novartis AG / Merck KGaA / Lonza Group AG / Ucb SA / Orion Oyj / Almirall SA / Grifols SA / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">MRK - MRK: 2Q21 Full Postview: About in-line; quiet</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">58933Y105</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck & Co., Inc. : 2Q Takeaways - Solid Core Franchise Results, Bizdev Remains A Focus Point</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Its Clearer Than Ever Now, New Donanemab Data Supports Its Best-In-Class Potential</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY / MRK</td><td class="leftalignment">Eli Lilly and Co / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GSK-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GSK / MRK / NVS / PFE / AZN.O / DVAX.O / TEVA.K / SNY.O</td><td class="leftalignment">GlaxoSmithKline PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / AstraZeneca PLC / Dynavax Technologies Corp / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US Company reports financial results for the quarter ended July 04,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">2Q, Growth Focus for Slimmed Down Merck</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">58933Y10</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Relatively uneventful 2Q fails to provide a spark, though easing pandemic impact is encouraging</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q2 Sales And EPS Beat Estimates; 2021 Guidance Narrowed</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">biz dev is high on agenda</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">In MRK We Trust; See Opportunities For Growth And Value Creation Post Solid 2Q21</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck & Co., Inc. : 2Q First Impressions: Solid Core Franchise Performance, No Major Surprises With Standalone Guidance</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on July 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PINS.N / BAX.N / BP.L / CMS.N / EIX.N / HLT.N / IBM.N / IP.N / MAS.N / MO.N / MRK.N / NOC.N / SLB.N / SO.N / TAP.N / TXT.N / HAL.N / TFX.N / WAB.N / YUM.N / VLO.N / LH.N / XOM.N / HSY.N / AMT.N / MTD.N / MLM.N / WST.N / EW.N / RSG.N / AJG.N / MHK.N / AOS.N / AAPL.OQ / HBAN.OQ / KLAC.OQ / MSFT.OQ / TROW.OQ / SBUX.OQ / GILD.OQ / CTXS.OQ / AMZN.OQ / VRTX.OQ / SWKS.OQ / CMCSA.OQ / 0700.HK / DXCM.OQ / RDSa.L / ICE.N / MA.N / 9999.HK / ES.N / BIO.N / ABI.BR / FTNT.OQ / NLSN.N / BKR.N / LKQ.OQ / TMUS.OQ / SPGI.N / FTV.N / XEL.OQ / WELL.N / CBRE.N / LYFT.OQ / BYND.OQ / UBER.N / ZM.OQ / 9988.HK / CARR.N / 9618.HK / ABNB.OQ</td><td class="leftalignment">Pinterest Inc / Baxter International Inc / BP PLC / CMS Energy Corp / Edison International / Hilton Worldwide Holdings Inc / International Business Machines Corp / International Paper Co / Masco Corp / Altria Group Inc / Merck & Co Inc / Northrop Grumman Corp / Schlumberger NV / Southern Co / Molson Coors Beverage Co / Textron Inc / Halliburton Co / Teleflex Inc / Westinghouse Air Brake Technologies Corp / Yum! Brands Inc / Valero Energy Corp / Laboratory Corporation of America Holdings / Exxon Mobil Corp / Hershey Co / American Tower Corp / Mettler-Toledo International Inc / Martin Marietta Materials Inc / West Pharmaceutical Services Inc / Edwards Lifesciences Corp / Republic Services Inc / Arthur J Gallagher & Co / Mohawk Industries Inc / A O Smith Corp / Apple Inc / Huntington Bancshares Inc / KLA Corp / Microsoft Corp / T Rowe Price Group Inc / Starbucks Corp / Gilead Sciences Inc / Citrix Systems Inc / Amazon.com Inc / Vertex Pharmaceuticals Inc / Skyworks Solutions Inc / Comcast Corp / Tencent Holdings Ltd / Dexcom Inc / Royal Dutch Shell PLC / Intercontinental Exchange Inc / Mastercard Inc / NetEase Inc / Eversource Energy / Bio Rad Laboratories Inc / Anheuser Busch Inbev SA / Fortinet Inc / Nielsen Holdings PLC / Baker Hughes Co / LKQ Corp / T-Mobile US Inc / S&P Global Inc / Fortive Corp / Xcel Energy Inc / Welltower Inc / CBRE Group Inc / Lyft Inc / Beyond Meat Inc / Uber Technologies Inc / Zoom Video Communications Inc / Alibaba Group Holding Ltd / Carrier Global Corp / JD.Com Inc / Airbnb Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Cayman Islands / United Kingdom / United States / Curaçao</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">MRK: Sales Beat Driven by Gardasil & Animal Health; EPS Lower Due to Op Margin But Offset by Tax Benefit</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2778844</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q2 EPS, Sales Beat Estimates; 2021 Sales Guidance Narrowed, EPS Ex-OGN In Line</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MRK - no major surprises with 2Q as results and updated full-year guidance (ex-OGN) both largely in line; call at 8AM ET</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daniel Busby</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRK.N - Event Brief of Merck & Co Inc conference call, Jul. 29, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRK.N - Event Transcript of Merck & Co Inc conference call, Jul. 29, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">First Look At Standalone 2Q21 Results, Topline Beat and Strong Outlook for Rest Of The Year</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback: Notes from GSK management meeting</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GSK.L / MRK.N / PFE.N / SASY.PA / CVAC.OQ</td><td class="leftalignment">GlaxoSmithKline PLC / Merck & Co Inc / Pfizer Inc / Sanofi SA / CureVac NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: U.S. vs. ROW: July 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BDX.N / CF.N / CI.N / CL.N / CVS.N / DD.N / ED.N / EOG.N / GM.N / LLY.N / MCK.N / MO.N / MRK.N / PFE.N / SO.N / STE.N / WMB.N / SPG.N / PG.N / PXD.N / MET.N / ETN.N / DUK.N / CMI.N / D.N / PH.N / CAT.N / RCL.N / TSN.N / SYY.N / IFF.N / VNO.N / ITW.N / EMR.N / XOM.N / AMT.N / RMD.N / LIN.N / BLL.N / JCI.N / PSA.N / EW.N / AWK.N / LEG.N / AME.N / VTR.N / CVX.N / PRU.N / L.N / COP.N / AMGN.OQ / KLAC.OQ / ATVI.OQ / TROW.OQ / REGN.OQ / TT.N / IDXX.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / EBAY.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / ICE.N / FIS.N / TDG.N / AON.N / ES.N / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / FANG.OQ / ABBV.N / ZTS.N / PRGO.N / MAR.OQ / NCLH.N / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / CF Industries Holdings Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / General Motors Co / Eli Lilly and Co / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Pfizer Inc / Southern Co / STERIS plc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Royal Caribbean Cruises Ltd / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Illinois Tool Works Inc / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Ball Corp / Johnson Controls International PLC / Public Storage / Edwards Lifesciences Corp / American Water Works Company Inc / Leggett & Platt Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / KLA Corp / Activision Blizzard Inc / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / IDEXX Laboratories Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / eBay Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aon PLC / Eversource Energy / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Perrigo Company PLC / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Ireland / Liberia / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - 2Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">GSK.L / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / BAYGN.DE / ABBV.N</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for MRK</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CORT-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CORT.O / BMY / JNJ / LLY / MRK / NVS / PFE / BMRN.O / ESPR.O / MNKD.O</td><td class="leftalignment">Corcept Therapeutics Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Biomarin Pharmaceutical Inc / Esperion Therapeutics Inc / MannKind Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Earnings Beat In Cards For Merck's Q2?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jul 28 2021</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">BE0165385973 / US0079031078 / US0123481089 / US0311621009 / US0323325045 / US0378331005 / US0382221051 / US0463531089 / US0997241064 / US1101221083 / US1265011056 / US1985161066 / US2435371073 / US37733W1053 / US45167R1041 / US4657411066 / US48203R1041 / US5128071082 / US5324571083 / US5370081045 / US55306N1046 / US5949181045 / US6541061031 / US66987V1098 / US6745991058 / US7170811035 / US7237871071 / US7711951043 / US8552441094 / US8636671013 / US8807701029 / US9113121068 / US9282981086 / US98956P1021 / US00508Y1029 / US4198791018 / US80105N1054 / US6098391054 / US6866881021 / US12541W2098 / US9043111072 / US42330P1075 / US3364331070 / US5500211090 / US92826C8394 / US00507V1098 / DE000A0DJ6J9 / CA9609083097 / CA0585861085 / US58933Y1055 / US5218652049 / US13100M5094 / US88160R1014 / US92839U2069 / US8676524064 / JE00B783TY65 / US00287Y1091 / US72919P2020 / US5764852050 / US29355A1079 / US41068X1000 / IE00BLS09M33 / US83417M1045 / US89400J1079 / US87918A1051 / US02079K1079 / US98138J2069 / US87266J1043 / CH0371153492 / US92336X1090 / US0937121079 / US04206A1016 / KY30744W1070 / US98585X1046 / US35952H6018 / US76156B1070 / US86150R1077 / US88339P1012 / US70614W1009 / US1567271093 / US69047Q1022 / US75513E1010 / US6541101050 / US04271T1007 / US33813J1060 / US74767V1098 / US62955J1034 / US73739W1045 / US55406W1036 / US82489W1071 / US03783T1034 / LU2314763264 / US90089L1089 / US30320C1036 / US83089J1088 / US30260D1037</td><td class="leftalignment">Melexis NV / Advanced Micro Devices Inc / Albany International Corp / Amgen Inc / Amtech Systems Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Borgwarner Inc / Bristol-Myers Squibb Co / CTS Corp / Columbia Sportswear Co / Deckers Outdoor Corp / GlaxoSmithKline PLC / IDEX Corp / Itron Inc / Juniper Networks Inc / Lam Research Corp / Eli Lilly and Co / Littelfuse Inc / MKS Instruments Inc / Microsoft Corp / Nike Inc / Novartis AG / Occidental Petroleum Corp / Pfizer Inc / Pioneer Natural Resources Co / Roche Holding AG / Starbucks Corp / Stryker Corp / Teradyne Inc / United Parcel Service Inc / Vishay Intertechnology Inc / Zimmer Biomet Holdings Inc / Acuity Brands Inc / Hawaiian Holdings Inc / Sanofi SA / Monolithic Power Systems Inc / Ormat Technologies Inc / CH Robinson Worldwide Inc / Under Armour Inc / Helix Energy Solutions Group Inc / First Solar Inc / Lululemon Athletica Inc / Visa Inc / Activision Blizzard Inc / SMA Solar Technology AG / Westport Fuel Systems Inc / Ballard Power Systems Inc / Merck & Co Inc / Lear Corp / Calix Inc / Tesla Inc / Visteon Corp / SunPower Corp / Aptiv PLC / Abbvie Inc / Plug Power Inc / Matador Resources Co / Enphase Energy Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Pentair PLC / Solaredge Technologies Inc / TransUnion / Teladoc Health Inc / Alphabet Inc / Workhorse Group Inc / TPI Composites Inc / Landis+Gyr Group AG / Veoneer Inc / Bloom Energy Corp / Arlo Technologies Inc / Farfetch Ltd / Yeti Holdings Inc / Fuelcell Energy Inc / Revolve Group Inc / Stoke Therapeutics Inc / RealReal Inc / Peloton Interactive Inc / Cerence Inc / Ovintiv Inc / Raytheon Technologies Corp / Nikola Corp / Array Technologies Inc / Fisker Inc / Quantumscape Corp / Nov Inc / Poshmark Inc / MYT Netherlands Parent BV / Shoals Technologies Group Inc / AppHarvest Inc / Arrival SA / TuSimple Holdings Inc / FTC Solar Inc / Skywater Technology Inc / Figs Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Style Comparisons: July 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BA.N / BDX.N / BMY.N / CF.N / CI.N / CL.N / CVS.N / DD.N / ED.N / EOG.N / GM.N / LLY.N / MCK.N / MO.N / MRK.N / NSC.N / PFE.N / SO.N / STE.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / MET.N / ETN.N / DUK.N / CMI.N / D.N / PH.N / CAT.N / RCL.N / MCD.N / TSN.N / IFF.N / VNO.N / ITW.N / EMR.N / XOM.N / AMT.N / RMD.N / LIN.N / BLL.N / JCI.N / PSA.N / EW.N / AWK.N / LEG.N / AME.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / COP.N / AMGN.OQ / AAPL.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / AON.N / ES.N / CME.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / NCLH.N / GOOGL.OQ / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / CF Industries Holdings Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / General Motors Co / Eli Lilly and Co / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Norfolk Southern Corp / Pfizer Inc / Southern Co / STERIS plc / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Royal Caribbean Cruises Ltd / McDonald's Corp / Tyson Foods Inc / International Flavors & Fragrances Inc / Vornado Realty Trust / Illinois Tool Works Inc / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Ball Corp / Johnson Controls International PLC / Public Storage / Edwards Lifesciences Corp / American Water Works Company Inc / Leggett & Platt Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Apple Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Aon PLC / Eversource Energy / CME Group Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / France / Ireland / Liberia / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">LONN.S: Lonza - Growing faster for longer; Raise TP to SFr750 and reiterate Outperform</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">LONN.S / A.N / RECI.MI / TMO.N / DHR.N / LUN.CO / MRCG.DE / SATG.DE / PKI.N / BANB.S / CRL.N / UCB.BR / SFZN.S / IPN.PA / ORNBV.HE / GXIG.DE / ALM.MC / GRLS.MC / MRNA.OQ / 068270.KS / CTLT.N / PINFRAL.MX / 207940.KS / 2269.HK / GMAB.CO / PPGN.S</td><td class="leftalignment">Lonza Group AG / Agilent Technologies Inc / Recordati Industria Chimica e Farmaceutica SpA / Thermo Fisher Scientific Inc / Danaher Corp / H Lundbeck A/S / Merck KGaA / Sartorius AG / PerkinElmer Inc / Bachem Holding AG / Charles River Laboratories International Inc / Ucb SA / Siegfried Holding AG / Ipsen SA / Orion Oyj / Gerresheimer AG / Almirall SA / Grifols SA / Moderna Inc / Celltrion Inc / Catalent Inc / Promotora y Operadora de Infraestructura SAB de CV / Samsung Biologics Co Ltd / WuXi Biologics (Cayman) Inc / Genmab A/S / PolyPeptide Group AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Cayman Islands / Germany / Denmark / Spain / Finland / France / Italy / Korea, Republic of / Mexico / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr Matthew J. Weston / Ms Jo Walton / Elizabeth Walton / Mr. Dominic Lunn / European Pharma Team</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Pharma Pipelines: Number of Pharma Pipeline Candidates Up 15% YoY</td><td class="leftalignment">English</td><td class="rightalignment">129</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck KGaA : Pre 2Q'21 Cons. Comparison: JPMe 5% above Cons. 2Q EPS (pre); Updated 2021 Cons in the middle of expected guidance range</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Richard B. Vosser / James D. Gordon / Ms. Laerke Engkilde / Zain Ebrahim / Mr. Tycho W. Peterson</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Cantor Healthcare Small/Mid Cap 2Q21 Earnings Preview Conference Call On Friday, July 30 at 10:00am ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ACRS / ALKS / AMRN / CDTX / CERS / COLL / COX / EBS / GRAY / HCM / JAZZ / JNJ / LLY / MRK / MSB / NOVN / OPTN / RMTI / SIBN / SMTI / CKPT / BDSI / UBX / ACRX / ARDX / ANIP / CERC / ARDS / CUTR / BSLN / MNKD / ARAV / SPRO / ZTS / OMER / AXGN / TXMD / HRTX / TRVN / AERI / SCYX / EGRX / LPCN / CFRX / FBIO / SPNE / JAGX / AYTU / VRAY / VERU / EYPT / EOLS / PDSB / ETTX / HGEN / ARQT / IMAB / PCVX / SRGA / VYNE / AZYO</td><td class="leftalignment">Aclaris Therapeutics Inc / Alkermes Plc / Amarin Corporation PLC / Cidara Therapeutics Inc / Cerus Corp / Collegium Pharmaceutical Inc / Nicox SA / Emergent BioSolutions Inc / Graybug Vision Inc / HUTCHMED (China) Ltd / Jazz Pharmaceuticals PLC / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Mesoblast Ltd / Novan Inc / OptiNose Inc / Rockwell Medical Inc / SI-BONE Inc / Sanara Medtech Inc / Checkpoint Therapeutics Inc / BioDelivery Sciences International Inc / UNITY Biotechnology Inc / AcelRx Pharmaceuticals Inc / Ardelyx Inc / ANI Pharmaceuticals Inc / Avalo Therapeutics Inc / Aridis Pharmaceuticals Inc / Cutera Inc / Basilea Pharmaceutica AG / MannKind Corp / Aravive Inc / Spero Therapeutics Inc / Zoetis Inc / Omeros Corp / AxoGen Inc / TherapeuticsMD Inc / Heron Therapeutics Inc / Trevena Inc / Aerie Pharmaceuticals Inc / SCYNEXIS Inc / Eagle Pharmaceuticals Inc / Lipocine Inc / ContraFect Corp / Fortress Biotech Inc / SeaSpine Holdings Corp / Jaguar Health Inc / Aytu Biopharma Inc / ViewRay Inc / Veru Inc / EyePoint Pharmaceuticals Inc / Evolus Inc / PDS Biotechnology Corp / Entasis Therapeutics Holdings Inc / Humanigen Inc / Arcutis Biotherapeutics Inc / I-Mab / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Aziyo Biologics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Will Roche's Stock Rebound After A 4% Fall Following Its H1 Results?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">RHHBY.PK / JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Roche Holding AG / Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What To Expect From Bristol Myers Squibb Stock After Q2 Results?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Keytruda Gets Two Pieces Of Good News In TNBC</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Is Pfizer Stock Set To See Higher Levels Post Q2 Results?</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">PFE.N / JNJ.N / MRK.N / RHHBY.PK</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Merck & Co Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">TNBC Data And Full Approval Underscore Peak Sales Potential Of Keytruda Is Underappreciated</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Morning Bite Flash</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">DE0006599905 / DE0006632003 / DE0005565204</td><td class="leftalignment">Merck KGaA / MorphoSys AG / Duerr AG</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Herr. Ingo-Martin Schachel, CFA</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AIN / MRK=US / LLY=US / PFE=US / BMY=US / HD=US / INTC=US / MCD=US / AMD=US / RRC=US / WEN=US / PD=US / AMZN=US / DT=US / BLD=US / TEVA=US / NVDA=US / PEB=US / LOW=US / CHKP=US / HSII=US / CHRS=US / BRO=US / SPOT=US / LEG=US / VMC=US / HLT=US / MLM=US / KFY=US / SWIM=US / BNL=US / CBRL=US / DRI=US / ENDP=US / AJG=US / GFF=US / HAS=US / HXL=US / IBP=US / TREE=US / NOW=US / MAS=US / MEDP=US / MHK=US / TEAM=US / NTST=US / PRGO=US / REGI=US / ROLL=US / SNOW=US / BXS=US / CFB=US / LCI=US / ADC=US / BDN=US / FB=US / SSB=US / CATY=US / GBCI=US / DIN=US / BIIB=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / CADE=US / TAST=US / QSR=US / PRPL=US / LUMN=US / APEI=US / TIL=US / EPRT=US / JACK=US / ZTS=US / TREX=US / AR=US / RLJ=US / FBHS=US / SPLK=US / ABBV=US / TILE=US / NDLS=US / QURE=US / 00770K202 / LOCO=US / NEWR=US / SHAK=US / WING=US / ACBI=US / WLTW=US / 82982L103 / PVAC=US / ANAB=US / JELD=US / AYX=US / IOVA=US / ARVN=US / ESTC=US / FERG=US / DDOG=US / AZEK=US / BALY=US / DBRG=US</td><td class="leftalignment">Albany International Corp / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Home Depot Inc / Intel Corp / McDonald's Corp / Advanced Micro Devices Inc / Range Resources Corp / Wendys Co / PagerDuty Inc / Amazon.com Inc / Dynatrace Inc / TopBuild Corp / Teva Pharmaceutical Industries Ltd / NVIDIA Corp / Pebblebrook Hotel Trust / Lowe's Companies Inc / Check Point Software Technologies Ltd / Heidrick & Struggles International Inc / Coherus BioSciences Inc / Brown & Brown Inc / Spotify Technology SA / Leggett & Platt Inc / Vulcan Materials Co / Hilton Worldwide Holdings Inc / Martin Marietta Materials Inc / Korn Ferry / Latham Group Inc / Bunzl plc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Endo International PLC / Arthur J Gallagher & Co / Griffon Corp / Hasbro Inc / Hexcel Corp / Installed Building Products Inc / Lendingtree Inc / ServiceNow Inc / Masco Corp / Medpace Holdings Inc / Mohawk Industries Inc / Atlassian Corporation PLC / Netstreit Corp / Perrigo Company PLC / Renewable Energy Group Inc / RBC Bearings Inc / Snowflake Inc. / Cadence Bank / Crossfirst Bankshares Inc / Lannett Company Inc / Agree Realty Corp / Brandywine Realty Trust / Meta Platforms Inc / SouthState Corp / Cathay General Bancorp / Glacier Bancorp Inc / Dine Brands Global Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Lumen Technologies Inc / American Public Education Inc / Instil Bio Inc / Essential Properties Realty Trust Inc / Jack in the Box Inc / Zoetis Inc / Trex Company Inc / Antero Resources Corp / RLJ Lodging Trust / Fortune Brands Home & Security Inc / Splunk Inc / Abbvie Inc / Interface Inc / Noodles & Co / Uniqure NV / Aemetis Inc / El Pollo Loco Holdings Inc / New Relic Inc / Shake Shack Inc / Wingstop Inc / Atlantic Capital Bancshares Inc / Willis Towers Watson PLC / SiteOne Landscape Supply Inc / Ranger Oil Corp / AnaptysBio Inc / JELD-WEN Holding Inc / Alteryx Inc / Iovance Biotherapeutics Inc / Arvinas Inc / Elastic NV / Ferguson PLC / Datadog Inc / Azek Company Inc / Bally's Corp / DigitalBridge Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">BNP Paribas Exane</td><td class="leftalignment">MERCK KGAA (=): Part of the Process</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Cosmetics & Personal Care</td><td class="leftalignment">Euroland / Europe / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gary Steventon / Mr. Richard J. Parkes, PHD / Mr. Simon Mather, PHD</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Merck & Co Inc Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AXP / 5671735 / 0989529 / 0925288 / 2434209 / 2126335 / 2516152 / 2681511 / 2550707 / 2778844 / 2973821 / 2026242 / 2270726 / 2829515 / 2328915 / 2100920 / 2344922 / 2689560 / 2684703 / 2829601 / 2842255 / 2098876 / 2181334 / 7103065 / 7123870 / B0X7DZ3 / B01SD70 / B125XQ6 / B3D7K31 / B7TL820 / B4MG4Z6 / BFLR866 / B3NXMJ9 / BNGY4Q0 / BYVY8G0 / BTF8CF0 / BXDZ9Z0 / BJLFHW7 / BD8DJ71 / BJFSR88 / BYXJQG9 / BKTNTR9 / BDH65C8 / BMH0MR7 / BYSFJV8 / BMBP1Q0 / BL98755</td><td class="leftalignment">American Express Co / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Home Depot Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / PepsiCo Inc / McDonald's Corp / Merck & Co Inc / Alliant Energy Corp / American Electric Power Company Inc / Walt Disney Co / Edison International / Nextera Energy Inc / FirstEnergy Corp / Jack in the Box Inc / PG&E Corp / Pfizer Inc / Southern Co / Starbucks Corp / Yum! Brands Inc / Check Point Software Technologies Ltd / Novartis AG / Nestle SA / Chipotle Mexican Grill Inc / Domino's Pizza Inc / Portland General Electric Co / Discovery Inc / Meta Platforms Inc / AMC Networks Inc / Twitter Inc / Wendys Co / Nextera Energy Partners LP / Alphabet Inc / Restaurant Brands International Inc / Shopify Inc / Chewy Inc / Snap Inc / Uniqure NV / Spire Inc / ViacomCBS Inc / PetIQ Inc / Zendesk Inc / Planet Fitness Inc / Flywire Corp / Beachbody Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ANTO.L / CE.N / EMN.N / MRK.N / PFE.N / RWEG.DE / CHKP.O / UHS.N / AAL.L / HSY.N / RMD.N / IG.MI / ENDP.O / BRO.N / LTC.N / FFIV.O / FM.TO / 35671D857 / HICL.L / TEVA.N / CS.TO / 550372106 / VALE.N / BHPB.L / LYB.N / PCH.O / ABBV.N / TSLA.N / QURE.O / CIA.TO / AGRX.O / NEXA.TO / CDMO.OQ / KDP.N / TFII.N / 900435207</td><td class="leftalignment">Antofagasta PLC / Celanese Corp / Eastman Chemical Co / Merck & Co Inc / Pfizer Inc / Rwe AG / Check Point Software Technologies Ltd / Universal Health Services Inc / Anglo American PLC / Hershey Co / Resmed Inc / Italgas SpA / Endo International PLC / Brown & Brown Inc / LTC Properties Inc / F5 Inc / First Quantum Minerals Ltd / Freeport-McMoRan Inc / HICL Infrastructure PLC / Teva Pharmaceutical Industries Ltd / Capstone Mining Corp / Lundin Mining Corp / Vale SA / BHP Group PLC / LyondellBasell Industries NV / Potlatchdeltic Corp / Abbvie Inc / Tesla Inc / Uniqure NV / Champion Iron Ltd / Agile Therapeutics Inc / Nexa Resources SA / Avid Bioservices Inc / Keurig Dr Pepper Inc / TFI International Inc / Turquoise Hill Resources Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Brazil / Canada / Germany / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Revisions: July 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BA.N / BDX.N / BMY.N / BSX.N / CB.N / CF.N / CI.N / CL.N / CVS.N / DD.N / ED.N / EOG.N / FLT.N / GE.N / GM.N / LLY.N / LMT.N / MCK.N / MO.N / MRK.N / NSC.N / PFE.N / SO.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / MET.N / ETN.N / DUK.N / CMI.N / D.N / PH.N / CAT.N / MCD.N / TSN.N / IFF.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / XOM.N / AMT.N / RMD.N / LIN.N / SHW.N / BLL.N / JCI.N / VFC.N / PSA.N / V.N / EW.N / AWK.N / LEG.N / AME.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / COP.N / AMGN.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / PPL.TO / ES.N / CME.OQ / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / NCLH.N / GOOGL.OQ / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / RTX.N / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / CF Industries Holdings Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / Fleetcor Technologies Inc / General Electric Co / General Motors Co / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Norfolk Southern Corp / Pfizer Inc / Southern Co / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / McDonald's Corp / Tyson Foods Inc / International Flavors & Fragrances Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Sherwin-Williams Co / Ball Corp / Johnson Controls International PLC / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Leggett & Platt Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Pembina Pipeline Corp / Eversource Energy / CME Group Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / France / Ireland / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Jul 16: Focus on Almirall's US TRx trends</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">ALM.MC / 4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Almirall SA / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / India / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">EXEL-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EXEL.O / BMY / JNJ / MRK / PFE / AMGN.O / GSK / CRIS.O / AVEO.O / SNY.O</td><td class="leftalignment">Exelixis Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Curis Inc / Aveo Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS / ALKS / AMRN / CDTX / CERS / COLL / COX / EBS / GRAY / HCM / JAZZ / JNJ / LLY / MRK / MSB / NOVN / PFE / RMTI / SIBN / SMTI / CKPT / BDSI / UBX / ACRX / ARDX / ANIP / CERC / ARDS / CUTR / BSLN / MNKD / ARAV / SPRO / ZTS / OMER / AXGN / TXMD / HRTX / TRVN / AERI / SCYX / LPCN / CFRX / FBIO / SPNE / JAGX / AYTU / VRAY / VERU / EYPT / EOLS / PDSB / ETTX / HGEN / ARQT / IMAB / PCVX / SRGA / VYNE / AZYO</td><td class="leftalignment">Aclaris Therapeutics Inc / Alkermes Plc / Amarin Corporation PLC / Cidara Therapeutics Inc / Cerus Corp / Collegium Pharmaceutical Inc / Nicox SA / Emergent BioSolutions Inc / Graybug Vision Inc / HUTCHMED (China) Ltd / Jazz Pharmaceuticals PLC / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Mesoblast Ltd / Novan Inc / Pfizer Inc / Rockwell Medical Inc / SI-BONE Inc / Sanara Medtech Inc / Checkpoint Therapeutics Inc / BioDelivery Sciences International Inc / UNITY Biotechnology Inc / AcelRx Pharmaceuticals Inc / Ardelyx Inc / ANI Pharmaceuticals Inc / Avalo Therapeutics Inc / Aridis Pharmaceuticals Inc / Cutera Inc / Basilea Pharmaceutica AG / MannKind Corp / Aravive Inc / Spero Therapeutics Inc / Zoetis Inc / Omeros Corp / AxoGen Inc / TherapeuticsMD Inc / Heron Therapeutics Inc / Trevena Inc / Aerie Pharmaceuticals Inc / SCYNEXIS Inc / Lipocine Inc / ContraFect Corp / Fortress Biotech Inc / SeaSpine Holdings Corp / Jaguar Health Inc / Aytu Biopharma Inc / ViewRay Inc / Veru Inc / EyePoint Pharmaceuticals Inc / Evolus Inc / PDS Biotechnology Corp / Entasis Therapeutics Holdings Inc / Humanigen Inc / Arcutis Biotherapeutics Inc / I-Mab / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Aziyo Biologics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Assuming coverage of ABBV, BMY, LLY, MRK, and PFE</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK.N / ABBV=US / BMY=US / LLY.N / PFE.N / MRK=US / LLY=US / PFE=US</td><td class="leftalignment">Merck & Co Inc / Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 16, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">European Healthcare Credit : Healthy appetite for M&A as pandemic cares subside – Midyear sector outlook</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">AZN.L / SASY.PA / ROG.S / NOVN.S / FMEG.DE / MRCG.DE / FREG.DE / GSK.L</td><td class="leftalignment">AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / Fresenius Medical Care AG & Co KGaA / Merck KGaA / Fresenius SE & Co KGaA / GlaxoSmithKline PLC</td><td class="leftalignment">FIXED INCOME - CORPORATES</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Israel / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / INDUSTRY REPORTS / Equity</td><td class="leftalignment">Danielle Ward</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Q2 due 5 August - Strong Q2 expected</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr Daniel Wendorff</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / ENDP.O / TEVA.N / ABBV.N / AGRX.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Agile Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">R&D Pentathlon: Which Pharma's R&D Is Faster, Higher, Stronger?- Ahead of Curve</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">US00287Y1091 / GB0009895292 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / GB00BMVP7Y09 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Royalty Pharma PLC / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ALM.MC: Almirall - 2Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ALM.MC / RECI.MI / LUN.CO / MRCG.DE / LONN.S / UCB.BR / IPN.PA / ORNBV.HE / GMAB.CO</td><td class="leftalignment">Almirall SA / Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Ipsen SA / Orion Oyj / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: July 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AEE.N / AES.N / AIG.N / AXP.N / BA.N / BAX.N / BDX.N / BMY.N / BSX.N / CAH.N / CB.N / CI.N / CL.N / CNC.N / CVS.N / DD.N / ECL.N / ED.N / EOG.N / F.N / FLT.N / GE.N / GM.N / KMB.N / LLY.N / LMT.N / MCK.N / MO.N / MRK.N / NSC.N / OXY.N / PEG.N / PFE.N / SO.N / TEL.PS / TMO.N / WMB.N / SPG.N / PG.N / WY.N / PXD.N / HUM.N / UHS.N / MET.N / ADML.L / ETN.N / DUK.N / CMI.N / D.N / GD.N / PH.N / K.N / CAT.N / MCD.N / IFF.N / YUM.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / VMC.N / WEC.N / XOM.N / AMT.N / RMD.N / LIN.N / SHW.N / PKG.N / BLL.N / GWW.N / JCI.N / AMP.N / VFC.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / LEG.N / CHD.N / AME.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / COP.N / CNP.N / HAYS.L / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / ZBRA.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / PPL.TO / ES.N / CME.OQ / MSCI.N / VRSK.OQ / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / WDC.OQ / NOW.N / FANG.OQ / ABBV.N / ZTS.N / CDW.OQ / MAR.OQ / NCLH.N / GOOGL.OQ / ANET.N / QRVO.OQ / ETSY.OQ / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / IQV.N / APTV.N / XEL.OQ / BKNG.OQ / WELL.N / FB.PS / CBOE.Z / CTVA.N / EXC.OQ / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">Ameren Corp / AES Corp / American International Group Inc / American Express Co / Boeing Co / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cardinal Health Inc / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Centene Corp / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Consolidated Edison Inc / EOG Resources Inc / Ford Motor Co / Fleetcor Technologies Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Norfolk Southern Corp / Occidental Petroleum Corp / Public Service Enterprise Group Inc / Pfizer Inc / Southern Co / PLDT Inc / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Universal Health Services Inc / MetLife Inc / Admiral Group PLC / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / General Dynamics Corp / Parker-Hannifin Corp / Kellogg Co / Caterpillar Inc / McDonald's Corp / International Flavors & Fragrances Inc / Yum! Brands Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Vulcan Materials Co / WEC Energy Group Inc / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Ball Corp / W W Grainger Inc / Johnson Controls International PLC / Ameriprise Financial Inc / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Leggett & Platt Inc / Church & Dwight Co Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Conocophillips / CenterPoint Energy Inc / Hays PLC / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Zebra Technologies Corp / F5 Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Pembina Pipeline Corp / Eversource Energy / CME Group Inc / MSCI Inc / Verisk Analytics Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Western Digital Corp / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / CDW Corp / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / Qorvo Inc / ETSY Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / IQVIA Holdings Inc / Aptiv PLC / Xcel Energy Inc / Booking Holdings Inc / Welltower Inc / San Miguel Food and Beverage Inc / Cboe Global Markets Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ABOS: A Differentiated A  Approach; Initiate with an Outperform Rating, $26 Target Price</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">ABOS.OQ / 4523.T / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / ROG.S / NOVN.S / AMGN.OQ / BIIB.OQ / PRTA.OQ / ACIU.OQ</td><td class="leftalignment">Acumen Pharmaceuticals Inc / Eisai Co Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / Novartis AG / Amgen Inc / Biogen Inc / Prothena Corporation PLC / AC Immune SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Ireland / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Judah C. Frommer / Mark Connolly / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Zai Lab: Incyte's PD-1's regulatory setback not expected to significantly impact ZLAB materially. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">INCY.OQ / ZLAB.OQ / BMY.N / MRK.N / 1877.HK</td><td class="leftalignment">Incyte Corp / Zai Lab Ltd / Bristol-Myers Squibb Co / Merck & Co Inc / Shanghai Junshi Biosciences Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">07/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">07/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.7% Above Pre-Pandemic Base- Week 68</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVS-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NVS / ABT / BMY / JNJ / MRK / PFE / GSK / AZN.O / BAYRY.PK / TEVA.K / SNY.O</td><td class="leftalignment">Novartis AG / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Bayer AG / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">JNJ-US Company reports financial results for the quarter ended July 04,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ / ABT / LLY / MDT / MRK / NVS / PFE / SYK / GILD.O / GSK / SNY.O</td><td class="leftalignment">Johnson & Johnson / Abbott Laboratories / Eli Lilly and Co / Medtronic PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / Stryker Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending July 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / MNKD.OQ / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / MannKind Corp / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended July 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Top of the Charts - A review of the week's best reads</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">2308.TW / 4502.T / AKZO.AS / ATCOA.ST / BA.N / BARC.L / CPG.L / CSL.AX / DNB.OL / EDP.LS / ELUXB.ST / ERICB.ST / HEIN.AS / HSBA.L / III.L / JNJ.N / LGEN.L / LLOY.L / LLY.N / PFE.N / RR.L / RYA.I / SAN.MC / SAPJ.J / SCHN.PA / SHBA.ST / SN.L / SOGN.PA / STAN.L / TW.L / ULVR.L / WLSNC.AS / WTB.L / AIR.PA / AZN.L / SASY.PA / TKAG.DE / ROG.S / LUN.CO / NOVN.S / ENEI.MI / MRCG.DE / DTEGN.F / UHR.S / NZYMB.CO / GSK.L / NEXS.PA / NKT.CO / UCB.BR / AMA.MC / ALFA.ST / AER.N / TOP.CO / NWG.L / MAERSKB.CO / KNIN.S / RIEN.S / LOGN.S / BEAN.S / IFCN.S / STMN.S / INGA.AS / YAR.OL / ASOS.L / PGHN.S / RMG.L / WCHG.DE / AKE.PA / TEVA.N / HOLN.S / KCOGN.DE / ERIC.OQ / MBTN.S / SKG.I / PRY.MI / ALM.MC / GRLS.MC / ZO1G.DE / BKGH.L / BNRGN.DE / AGES.BR / BASFN.DE / SHLG.DE / DKSH.S / ABBV.N / OCI.AS / FDEV.L / FBK.MI / UBSG.S / COTNE.S / ENPLQ.L / MEDA.S / SFOR.L / DEMANT.CO / MOVE.S / NWG.N</td><td class="leftalignment">Delta Electronics Inc / Takeda Pharmaceutical Co Ltd / Akzo Nobel NV / Atlas Copco AB / Boeing Co / Barclays PLC / Compass Group PLC / CSL Ltd / DNB Bank ASA / EDP Energias de Portugal SA / Electrolux AB / Telefonaktiebolaget LM Ericsson / Heineken NV / HSBC Holdings PLC / 3i Group PLC / Johnson & Johnson / Legal & General Group PLC / Lloyds Banking Group PLC / Eli Lilly and Co / Pfizer Inc / Rolls-Royce Holdings PLC / Ryanair Holdings PLC / Banco Santander SA / Sappi Ltd / Schneider Electric SE / Svenska Handelsbanken AB / Smith & Nephew PLC / Societe Generale SA / Standard Chartered PLC / Taylor Wimpey PLC / Unilever PLC / Wolters Kluwer NV / Whitbread PLC / Airbus SE / AstraZeneca PLC / Sanofi SA / thyssenkrupp AG / Roche Holding AG / H Lundbeck A/S / Novartis AG / Enel SpA / Merck KGaA / Deutsche Telekom AG / Swatch Group AG / Novozymes A/S / GlaxoSmithKline PLC / Nexans SA / Nkt A/S / Ucb SA / Amadeus IT Group SA / Alfa Laval AB / AerCap Holdings NV / Topdanmark A/S / Natwest Group PLC / AP Moeller - Maersk A/S / Kuehne und Nagel International AG / Rieter Holding AG / Logitech International SA / Belimo Holding AG / Inficon Holding AG / Straumann Holding AG / ING Groep NV / Yara International ASA / ASOS PLC / Partners Group Holding AG / Royal Mail PLC / Wacker Chemie AG / Arkema SA / Teva Pharmaceutical Industries Ltd / Holcim AG / Kloeckner & Co SE / Telefonaktiebolaget LM Ericsson / Meyer Burger Technology AG / Smurfit Kappa Group PLC / Prysmian SpA / Almirall SA / Grifols SA / Zooplus AG / Berkeley Group Holdings PLC / Brenntag SE / Ageas SA / BASF SE / Siemens Healthineers AG / DKSH Holding AG / Abbvie Inc / OCI NV / Frontier Developments PLC / FinecoBank Banca Fineco SpA / UBS Group AG / Comet Holding AG / En+ Group MKPAO / Medartis Holding AG / S4 Capital PLC / Demant A/S / Medacta Group SA / Natwest Group PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / Norway / Portugal / Russian Federation / Sweden / Taiwan / United States / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Joelle Anamooto Natzkoff / Mr. Richard A. Kersley / Samuel Burgess</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: July 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ABT.N / AEE.N / AES.N / AIG.N / AXP.N / BA.N / BDX.N / BMY.N / BSX.N / CB.N / CI.N / CL.N / CVS.N / DD.N / EOG.N / GE.N / GM.N / KMB.N / LLY.N / LMT.N / MCK.N / MO.N / MRK.N / NSC.N / PEG.N / PFE.N / SLB.N / SO.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / UHS.N / MET.N / ETN.N / DUK.N / DHR.N / CMI.N / ROP.N / CAT.N / UNP.N / MCD.N / IFF.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / XOM.N / AMT.N / RMD.N / LIN.N / SHW.N / PKG.N / BLL.N / JCI.N / AMP.N / VFC.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / LEG.N / TWTR.N / AME.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / HAYS.L / INTC.OQ / AMGN.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / ANSS.OQ / AMZN.OQ / TTWO.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / PPL.TO / ES.N / CME.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / GOOGL.OQ / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / EXC.OQ / RTX.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / Ameren Corp / AES Corp / American International Group Inc / American Express Co / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / EOG Resources Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / Schlumberger NV / Southern Co / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Universal Health Services Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Danaher Corp / Cummins Inc / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Ball Corp / Johnson Controls International PLC / Ameriprise Financial Inc / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Leggett & Platt Inc / Twitter Inc / AMETEK Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Hays PLC / Intel Corp / Amgen Inc / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Pembina Pipeline Corp / Eversource Energy / CME Group Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Alphabet Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Exelon Corp / Raytheon Technologies Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ROG.S: Roche - 2Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ROG.S / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / NOVOB.CO / NOVN.S / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">Roche Holding AG / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck KGaA : 2Q'21 Results Preview: Strong quarter, expected FY'21 guidance raise implies c.3% upgrades to BBG Consensus EPS (pre)</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Richard B. Vosser / James D. Gordon / Ms. Laerke Engkilde / Zain Ebrahim / Mr. Tycho W. Peterson</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">CALL THIS MORNING To Discuss Where The Pandemic Is Headed And the Future of COVID-19 Vaccines/ Treatments at 11AM ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">JNJ / LLY / MRK / PFE / CERC / AYTU / HGEN / IMAB</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Avalo Therapeutics Inc / Aytu Biopharma Inc / Humanigen Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest</td><td class="leftalignment">Louise Chen / Ms. Jennifer M. Kim / Brandon Folkes, CFA / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Price Action: July 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CL.N / COF.N / CVS.N / DD.N / DOW.N / EOG.N / FCX.N / GE.N / GM.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MCK.N / MMC.N / MO.N / MRK.N / NEM.N / NSC.N / PEG.N / PFE.N / SLB.N / SO.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / UHS.N / MET.N / ETN.N / DHR.N / CMI.N / ROP.N / CAT.N / UNP.N / MCD.N / VNO.N / SYK.N / UPS.N / WM.N / MMM.N / EMR.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / JCI.N / DHI.N / AMP.N / VFC.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / LEG.N / TWTR.N / AME.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / HAYS.L / INTC.OQ / AMGN.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / SIVB.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / ANSS.OQ / AMZN.OQ / TTWO.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / DLR.N / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / ES.N / CME.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / GOOGL.OQ / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / BKNG.OQ / FB.PS / EXC.OQ / RTX.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Dow Inc / EOG Resources Inc / Freeport-McMoRan Inc / General Electric Co / General Motors Co / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Mckesson Corp / Marsh & McLennan Companies Inc / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / Schlumberger NV / Southern Co / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Universal Health Services Inc / MetLife Inc / Eaton Corporation PLC / Danaher Corp / Cummins Inc / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / Johnson Controls International PLC / D R Horton Inc / Ameriprise Financial Inc / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Leggett & Platt Inc / Twitter Inc / AMETEK Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Hays PLC / Intel Corp / Amgen Inc / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / SVB Financial Group / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Biogen Inc / Mosaic Co / Digital Realty Trust Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Eversource Energy / CME Group Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Alphabet Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Booking Holdings Inc / San Miguel Food and Beverage Inc / Exelon Corp / Raytheon Technologies Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVN.S: Novartis - 2Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">NOVN.S / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">Novartis AG / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - BeiGene: Novartis unveiling a rich BLA filing plan for PD-1, further supporting BeiGene globalisation progress. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BGNE.OQ / 6160.HK / NOVN.S / BMY.N / JNJ.N / LLY.N / MRK.N / ROG.S / UTHR.OQ / 1801.HK / 1877.HK</td><td class="leftalignment">Beigene Ltd / Beigene Ltd / Novartis AG / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Roche Holding AG / United Therapeutics Corp / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global ESG Research: What ESG investors buy and sell</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">0270.HK / 2330.TW / ALVG.DE / ASML.AS / CRDA.L / DANO.PA / HDBK.BO / IBE.MC / IMI.L / MRK.N / OREP.PA / RAND.AS / SAPG.F / SCHN.PA / TMO.N / ULVR.L / VWS.CO / PG.N / AZN.L / SASY.PA / ROG.S / DHR.N / UNH.N / PH.N / SIEGN.DE / INFY.BO / NOVOB.CO / HD.N / LOW.N / WM.N / ITW.N / AMT.N / IFXGN.DE / LIN.N / DPWGN.DE / V.N / AWK.N / ACN.N / EUFI.PA / 2454.TW / DSV.CO / 1211.HK / GOCP.BO / 1477.TW / ADBE.OQ / AMGN.OQ / AAPL.OQ / MSFT.OQ / TT.N / AMZN.OQ / TXN.OQ / 005930.KS / 006400.KS / 051910.KS / 051900.KS / 035420.KS / NESN.S / 0700.HK / 2318.HK / 0939.HK / 2382.HK / BIDU.OQ / TAL.N / SBER.MM / MA.N / 601318.SS / SOON.S / 601939.SS / 0968.HK / GNRC.N / TSLA.OQ / NXPI.OQ / 002594.SZ / XYL.N / EPAM.N / GOOGL.OQ / JD.OQ / BABA.N / SEDG.OQ / LIGHT.AS / KCRA.HE / ORSTED.CO / 3690.HK / CCEPC.AS</td><td class="leftalignment">Guangdong Investment Ltd / Taiwan Semiconductor Manufacturing Co Ltd / Allianz SE / ASML Holding NV / Croda International PLC / Danone SA / HDFC Bank Ltd / Iberdrola SA / IMI PLC / Merck & Co Inc / L'Oreal SA / Randstad NV / SAP SE / Schneider Electric SE / Thermo Fisher Scientific Inc / Unilever PLC / Vestas Wind Systems A/S / Procter & Gamble Co / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Danaher Corp / UnitedHealth Group Inc / Parker-Hannifin Corp / Siemens AG / Infosys Ltd / Novo Nordisk A/S / Home Depot Inc / Lowe's Companies Inc / Waste Management Inc / Illinois Tool Works Inc / American Tower Corp / Infineon Technologies AG / Linde PLC / Deutsche Post AG / Visa Inc / American Water Works Company Inc / Accenture PLC / Eurofins Scientific SE / MediaTek Inc / DSV A/S / BYD Co Ltd / Godrej Consumer Products Ltd / Makalot Industrial Co Ltd / Adobe Inc / Amgen Inc / Apple Inc / Microsoft Corp / Trane Technologies PLC / Amazon.com Inc / Texas Instruments Inc / Samsung Electronics Co Ltd / Samsung SDI Co Ltd / LG Chem Ltd / LG Household & Healthcare Ltd / Naver Corp / Nestle SA / Tencent Holdings Ltd / Ping An Insurance Group Co of China Ltd / China Construction Bank Corp / Sunny Optical Technology Group Co Ltd / Baidu Inc / TAL Education Group / Sberbank Rossii PAO / Mastercard Inc / Ping An Insurance Group Co of China Ltd / Sonova Holding AG / China Construction Bank Corp / Xinyi Solar Holdings Ltd / Generac Holdings Inc / Tesla Inc / NXP Semiconductors NV / BYD Co Ltd / Xylem Inc / Epam Systems Inc / Alphabet Inc / JD.Com Inc / Alibaba Group Holding Ltd / Solaredge Technologies Inc / Signify NV / Konecranes Abp / Orsted A/S / Meituan / Coca-Cola Europacific Partners PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Hong Kong / India / Ireland / Korea, Republic of / Luxembourg / Netherlands / Russian Federation / Taiwan / United States</td><td class="leftalignment">Conglomerates / Manufacturing</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity / Environmental, Social, Governance</td><td class="leftalignment">Eugene Klerk / Akanksha Kharbanda / Ms. Betty Jiang / Phineas Glover / Bahar Sezer Longworth</td></tr>
<tr class="odd"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Company Of The Day: Merck</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">MRK.N / PFE.N</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: U.S. vs. ROW: July 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CCI.N / CL.N / COF.N / DD.N / DOW.N / FCX.N / GE.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MMC.N / MO.N / MRK.N / NEM.N / NSC.N / PEG.N / PFE.N / PM.N / SLB.N / SO.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / UHS.N / ETN.N / DHR.N / CMI.N / ROP.N / CAT.N / UNP.N / MCD.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / JCI.N / DHI.N / AMP.N / VFC.N / KMI.N / EFX.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / LEG.N / TWTR.N / AME.N / MTB.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / HAYS.L / INTC.OQ / AMGN.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / NTRS.OQ / TROW.OQ / SIVB.OQ / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / DFS.N / O.N / AMZN.OQ / TTWO.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / ISRG.OQ / EQIX.OQ / GPN.N / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / DLR.N / MKTX.OQ / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / STX.AX / ADP.PA / ES.N / CME.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / PSX.N / NOW.N / FANG.OQ / ABBV.N / GOOGL.OQ / ANET.N / ANTM.N / ZBH.N / PYPL.OQ / TMUS.OQ / CSX.OQ / FB.PS / RTX.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Capital One Financial Corp / Dupont De Nemours Inc / Dow Inc / Freeport-McMoRan Inc / General Electric Co / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / Philip Morris International Inc / Schlumberger NV / Southern Co / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Universal Health Services Inc / Eaton Corporation PLC / Danaher Corp / Cummins Inc / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / Johnson Controls International PLC / D R Horton Inc / Ameriprise Financial Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Leggett & Platt Inc / Twitter Inc / AMETEK Inc / M&T Bank Corp / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Hays PLC / Intel Corp / Amgen Inc / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / Northern Trust Corp / T Rowe Price Group Inc / SVB Financial Group / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Discover Financial Services / Realty Income Corp / Amazon.com Inc / Take-Two Interactive Software Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Intuitive Surgical Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Mosaic Co / Digital Realty Trust Inc / Marketaxess Holdings Inc / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Aeroports de Paris SA / Eversource Energy / CME Group Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Alphabet Inc / Arista Networks Inc / Anthem Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / T-Mobile US Inc / CSX Corp / San Miguel Food and Beverage Inc / Raytheon Technologies Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SNY-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">SNY.O / ABT / BMY / JNJ / LLY / MRK / NVO / NVS / PFE / GSK / TEVA.K</td><td class="leftalignment">Sanofi SA / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novo Nordisk A/S / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What To Expect From Johnson & Johnson In Q2?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">2Q21 EPS preview - model changes & updated perspectives</td><td class="leftalignment">English</td><td class="rightalignment">79</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jul 20 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">NL0000226223 / DE0006231004 / DE0007164600 / US00724F1012 / US0079031078 / US0231351067 / US02553E1064 / US0382221051 / US0463531089 / US1005571070 / US1101221083 / US1265011056 / US1266501006 / US14149Y1082 / US1727551004 / US17275R1023 / US1924461023 / US22160K1051 / US2545431015 / US2910111044 / US30226D1063 / US3156161024 / US3647601083 / US37733W1053 / US4456581077 / US45167R1041 / US4567881085 / US4581401001 / US48203R1041 / US4824801009 / US5002551043 / US5128071082 / US5184151042 / US5261071071 / US5324571083 / US5370081045 / US55306N1046 / US5719032022 / US58155Q1031 / US5949181045 / US5950171042 / US5951121038 / US6556641008 / US66987V1098 / US6701002056 / US67066G1040 / US6821891057 / US68389X1054 / US7170811035 / US7274931085 / US7392761034 / US7475251036 / US7711951043 / US7782961038 / US8030542042 / US8168501018 / US8269191024 / US8610121027 / US8725401090 / US87612E1064 / US9282981086 / US9311421039 / US9581021055 / US9839191015 / IL0010824113 / US03073E1055 / US83088M1027 / US80105N1054 / US21036P1084 / US1572101053 / US79466L3024 / US6098391054 / US82706C1080 / US55616P1049 / US88076W1036 / US90384S3031 / IE00B4BNMY34 / US58933Y1055 / US4485791028 / US34959E1091 / NL0009538784 / US03027X1000 / US30212P3038 / US8969452015 / US29414B1044 / US00287Y1091 / US98978V1035 / US5017971046 / US81762P1021 / US98138H1014 / US55405Y1001 / US8486371045 / US6974351057 / KYG037AX1015 / US9222801022 / US98936J1016 / US0404131064 / US0396971071 / LU0974299876 / IL0011334468 / US4435731009 / US0994061002 / US64829B1008 / US22822V1017 / US74736K1016 / US74624M1027 / GB00BZ09BD16 / US90138F1021 / IE00BY7QL619 / US89686D1054 / US43300A2033 / US78410G1040 / US02156B1035 / US23355L1061 / US6792951054 / US03782L1017 / US8760301072 / US76674Q1076 / VGG273581030 / US09354A1007 / US09857L1089 / US98980G1022 / US11135F1012 / US2575541055 / US29260V1052 / US28414H1032 / CA64079L1058 / KY30744W1070 / US69553P1003 / IL0011571556 / US22788C1053 / US39874R1014 / US18915M1071 / US89677Q1076 / IE00BK9ZQ967 / US39813G1094 / US14448C1045 / GB00BMVP7Y09 / US8334451098 / US07373B1098 / US86646P1030 / US74767V1098 / US0090661010 / US7761531083 / US55406W1036 / US15961R1059 / US49926T1043 / US90364P1057 / US5738741041 / US68622V1061 / IL0011762130 / US20717M1036 / US02080L1026 / IE000GID8VI0 / US28623U1016 / US38870X1046</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / SAP SE / Adobe Inc / Advanced Micro Devices Inc / Amazon.com Inc / American Eagle Outfitters Inc / Applied Materials Inc / AstraZeneca PLC / Boston Beer Company Inc / Bristol-Myers Squibb Co / CTS Corp / CVS Health Corp / Cardinal Health Inc / Cirrus Logic Inc / Cisco Systems Inc / Cognizant Technology Solutions Corp / Costco Wholesale Corp / Diodes Inc / Emerson Electric Co / Extreme Networks Inc / F5 Inc / Gap Inc / GlaxoSmithKline PLC / J B Hunt Transport Services Inc / IDEX Corp / Infosys Ltd / Intel Corp / Juniper Networks Inc / KLA Corp / Kohls Corp / Lam Research Corp / Lattice Semiconductor Corp / Lennox International Inc / Eli Lilly and Co / Littelfuse Inc / MKS Instruments Inc / Marriott International Inc / Mckesson Corp / Microsoft Corp / Microchip Technology Inc / Micron Technology Inc / Nordstrom Inc / Novartis AG / Novo Nordisk A/S / NVIDIA Corp / ON Semiconductor Corp / Oracle Corp / Pfizer Inc / Plantronics Inc / Power Integrations Inc / Qualcomm Inc / Roche Holding AG / Ross Stores Inc / SAP SE / Semtech Corp / Silicon Laboratories Inc / STMicroelectronics NV / TJX Companies Inc / Target Corp / Vishay Intertechnology Inc / Walmart Inc / Western Digital Corp / Xilinx Inc / Check Point Software Technologies Ltd / Amerisourcebergen Corp / Skyworks Solutions Inc / Sanofi SA / Constellation Brands Inc / CEVA Inc / Salesforce.Com Inc / Monolithic Power Systems Inc / Silicon Motion Technology Corp / Macy's Inc / Teradata Corp / Ulta Beauty Inc / Accenture PLC / Merck & Co Inc / Hyatt Hotels Corp / Fortinet Inc / NXP Semiconductors NV / American Tower Corp / Expedia Group Inc / Tripadvisor Inc / Epam Systems Inc / Abbvie Inc / Zoetis Inc / Bath & Body Works Inc / ServiceNow Inc / Workday Inc / MACOM Technology Solutions Holdings Inc / Splunk Inc / Palo Alto Networks Inc / Ambarella Inc / Varonis Systems Inc / Zendesk Inc / Arista Networks Inc / Ardelyx Inc / Globant SA / Cyberark Software Ltd / HubSpot Inc / Boot Barn Holdings Inc / New Relic Inc / Crown Castle International Corp / Qorvo Inc / Pure Storage Inc / Atlassian Corporation PLC / Twilio Inc / Johnson Controls International PLC / Trivago NV / Hilton Worldwide Holdings Inc / SBA Communications Corp / Alteryx Inc / DXC Technology Co / Okta Inc / Appian Corp / Tapestry Inc / Rimini Street Inc / Despegar.com Corp / Blink Charging Co / Booking Holdings Inc / Zscaler Inc / Broadcom Inc / Domo Inc / Endava PLC / Elanco Animal Health Inc / Neptune Wellness Solutions Inc / Farfetch Ltd / PagerDuty Inc / Tufin Software Technologies Ltd / CrowdStrike Holdings Inc / Grocery Outlet Holding Corp / Cloudflare Inc / Trip.com Group Ltd / Trane Technologies PLC / Grid Dynamics Holdings Inc / Carrier Global Corp / Royalty Pharma PLC / Snowflake Inc. / Beam Global / Sumo Logic Inc / Quantumscape Corp / Airbnb Inc / Romeo Power Inc / MYT Netherlands Parent BV / ChargePoint Holdings Inc / Knowbe4 Inc / UiPath Inc / Marvell Technology Inc / Organon & Co / Monday.Com Ltd / Confluent Inc / Alpha Teknova Inc / GH Research PLC / Elevation Oncology Inc / Graphite Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Luxembourg / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AIN / AN=US / MRK=US / LLY=US / PEP=US / PFE=US / AMGN=US / CAG=US / HD=US / KO=US / MCD=US / TWTR=US / CL=US / PG=US / WEN=US / PLD=US / T=US / BLD=US / INCY=US / TEVA=US / APA=US / LOW=US / ENR=US / CHRS=US / BRO=US / LEG=US / ATVI=US / VMC=US / NWL=US / MLM=US / FLO=US / STZ=US / DISH=US / WTFC=US / AIR=US / SWIM=US / ATRO=US / B=US / BMRN=US / CBRL=US / CENT=US / CHD=US / CW=US / DRI=US / DCO=US / EPC=US / AJG=US / GFF=US / HAIN=US / HEI=US / HXL=US / IBP=US / MAS=US / MRCY=US / MHK=US / PACW=US / REGI=US / ROLL=US / SMG=US / SNAP=US / TGI=US / VSEC=US / WIX=US / POST=US / ZION=US / FB=US / FBK=US / SPR=US / NTRA=US / DIN=US / MGP=US / MGPI=US / MNST=US / NOMD=US / RPD=US / RNG=US / TPX=US / MOG.A=US / EXP=US / BECN=US / PLAY=US / FRPT=US / DENN=US / THS=US / BLDR=US / GMS=US / CMG=US / REX=US / TDG=US / PGTI=US / GPRE=US / ELF=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / KTOS=US / TIL=US / JACK=US / AAN=US / UTZ=US / TREX=US / WWD=US / FBHS=US / TILE=US / NDLS=US / FIVN=US / 00770K202 / LOCO=US / NVRO=US / SHAK=US / AJRD=US / BWXT=US / WING=US / WLTW=US / 82982L103 / JELD=US / IOVA=US / PETQ=US / MAXR=US / KDP=US / FERG=US / LHX=US / BRBR=US / REYN=US / SPCE=US / AZEK=US / VTRS=US / HYFM=US / 67421J108</td><td class="leftalignment">Albany International Corp / AutoNation Inc / Merck & Co Inc / Eli Lilly and Co / PepsiCo Inc / Pfizer Inc / Amgen Inc / Conagra Brands Inc / Home Depot Inc / Coca-Cola Co / McDonald's Corp / Twitter Inc / Colgate-Palmolive Co / Procter & Gamble Co / Wendys Co / Prologis Inc / AT&T Inc / TopBuild Corp / Incyte Corp / Teva Pharmaceutical Industries Ltd / APA Corp (US) / Lowe's Companies Inc / Energizer Holdings Inc / Coherus BioSciences Inc / Brown & Brown Inc / Leggett & Platt Inc / Activision Blizzard Inc / Vulcan Materials Co / Newell Brands Inc / Martin Marietta Materials Inc / Flowers Foods Inc / Constellation Brands Inc / DISH Network Corp / Wintrust Financial Corp / AAR Corp / Latham Group Inc / Astronics Corp / Barnes Group Inc / Biomarin Pharmaceutical Inc / Cracker Barrel Old Country Store Inc / Central Garden & Pet Co / Church & Dwight Co Inc / Curtiss-Wright Corp / Darden Restaurants Inc / Ducommun Inc / Edgewell Personal Care Co / Arthur J Gallagher & Co / Griffon Corp / Hain Celestial Group Inc / HEICO Corp / Hexcel Corp / Installed Building Products Inc / Masco Corp / Mercury Systems Inc / Mohawk Industries Inc / PacWest Bancorp / Renewable Energy Group Inc / RBC Bearings Inc / Scotts Miracle-Gro Co / Snap Inc / Triumph Group Inc / VSE Corp / Wix.Com Ltd / Post Holdings Inc / Zions Bancorporation NA / Meta Platforms Inc / FB Financial Corp / Spirit AeroSystems Holdings Inc / Natera Inc / Dine Brands Global Inc / MGM Growth Properties LLC / MGP Ingredients Inc / Monster Beverage Corp / Nomad Foods Ltd / Rapid7 Inc / RingCentral Inc / Tempur Sealy International Inc / Moog Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / TreeHouse Foods Inc / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / TransDigm Group Inc / PGT Innovations Inc / Green Plains Inc / elf Beauty Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Kratos Defense and Security Solutions Inc / Instil Bio Inc / Jack in the Box Inc / Aaron's Company Inc / UTZ Brands Inc / Trex Company Inc / Woodward Inc / Fortune Brands Home & Security Inc / Interface Inc / Noodles & Co / Five9 Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Nevro Corp / Shake Shack Inc / Aerojet Rocketdyne Holdings Inc / BWX Technologies Inc / Wingstop Inc / Willis Towers Watson PLC / SiteOne Landscape Supply Inc / JELD-WEN Holding Inc / Iovance Biotherapeutics Inc / PetIQ Inc / Maxar Technologies Inc / Keurig Dr Pepper Inc / Ferguson PLC / L3harris Technologies Inc / Bellring Brands Inc / Reynolds Consumer Products Inc / Virgin Galactic Holdings Inc / Azek Company Inc / Viatris Inc / Hydrofarm Holdings Group Inc / Oatly Group AB</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Israel / Luxembourg / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q2:21 Results Preview</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US98978V1035 / US28414H1032 / GB00BMVP7Y09 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Zoetis Inc / Elanco Animal Health Inc / Royalty Pharma PLC / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma - 2Q21 Quarterly Prep Pack</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / LONN.S / GSK.L / UCB.BR / IPN.PA / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S / GMAB.CO</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Lonza Group AG / GlaxoSmithKline PLC / Ucb SA / Ipsen SA / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Israel / Italy / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Future Forecasts: July 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CCI.N / CL.N / COF.N / DOW.N / FCX.N / GE.N / IBM.N / JNJ.N / KMB.N / KO.N / LMT.N / LUV.N / MMC.N / MO.N / MRK.N / NEM.N / NSC.N / OMC.N / PFE.N / PM.N / PPG.N / SLB.N / SO.N / TMO.N / TRV.N / WMB.N / SPG.N / PG.N / PXD.N / UHS.N / HAL.N / ETN.N / DHR.N / DOV.N / ROP.N / CAT.N / UNP.N / MCD.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / HCA.N / JCI.N / DHI.N / AMP.N / VFC.N / KMI.N / EFX.N / V.N / EW.N / ARE.N / PLD.N / TWTR.N / MTB.N / CVX.N / MCO.N / RF.N / HAYS.L / INTC.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / NTRS.OQ / TROW.OQ / SIVB.OQ / SBUX.OQ / IDXX.OQ / QCOM.OQ / GILD.OQ / DFS.N / O.N / AMZN.OQ / TTWO.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / ISRG.OQ / EQIX.OQ / GPN.N / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / DLR.N / MKTX.OQ / NDAQ.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / ES.N / CME.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / KEY.TO / NOW.N / FANG.OQ / ABBV.N / GOOGL.OQ / ANET.N / SYF.N / CFG.N / ANTM.N / PYPL.OQ / TMUS.OQ / CSX.OQ / FB.PS / UAL.OQ / RTX.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Capital One Financial Corp / Dow Inc / Freeport-McMoRan Inc / General Electric Co / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Lockheed Martin Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Norfolk Southern Corp / Omnicom Group Inc / Pfizer Inc / Philip Morris International Inc / PPG Industries Inc / Schlumberger NV / Southern Co / Thermo Fisher Scientific Inc / Travelers Companies Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Universal Health Services Inc / Halliburton Co / Eaton Corporation PLC / Danaher Corp / Dover Corp / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / HCA Healthcare Inc / Johnson Controls International PLC / D R Horton Inc / Ameriprise Financial Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Prologis Inc / Twitter Inc / M&T Bank Corp / Chevron Corp / Moody's Corp / Regions Financial Corp / Hays PLC / Intel Corp / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Northern Trust Corp / T Rowe Price Group Inc / SVB Financial Group / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Gilead Sciences Inc / Discover Financial Services / Realty Income Corp / Amazon.com Inc / Take-Two Interactive Software Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Intuitive Surgical Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Mosaic Co / Digital Realty Trust Inc / Marketaxess Holdings Inc / Nasdaq Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Eversource Energy / CME Group Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Keyera Corp / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Alphabet Inc / Arista Networks Inc / Synchrony Financial / Citizens Financial Group Inc / Anthem Inc / PayPal Holdings Inc / T-Mobile US Inc / CSX Corp / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Raytheon Technologies Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ORNBV.HE: Orion - 2Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">ORNBV.HE / RECI.MI / LUN.CO / MRCG.DE / LONN.S / UCB.BR / IPN.PA / ALM.MC / GRLS.MC / BAYGN.DE / VIFN.S / GMAB.CO</td><td class="leftalignment">Orion Oyj / Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Ipsen SA / Almirall SA / Grifols SA / Bayer AG / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Stock Looks Fully Valued Based On Opportunities And Risks</td><td class="leftalignment">English</td><td class="rightalignment">97</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Pharmaceutical Industry Pulse</td><td class="leftalignment">English</td><td class="rightalignment">1205</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US00287Y1091 / US98978V1035 / US28414H1032 / GB00BMVP7Y09 / US68622V1061</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Abbvie Inc / Zoetis Inc / Elanco Animal Health Inc / Royalty Pharma PLC / Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck KGaA: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 09, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck & Co Inc: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Merck & Co., Inc.(MRK) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">58933Y105</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jul 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">FR0000121014 / FR0000054470 / US0028241000 / US0079731008 / US0116591092 / US0382221051 / US0463531089 / US1101221083 / US1567821046 / US1925761066 / US22284P1057 / US2855121099 / US2944291051 / US3021301094 / US3377381088 / US37733W1053 / US4433201062 / US4456581077 / US4781601046 / US4824801009 / US5012421013 / US5128071082 / US5150981018 / US5324571083 / US55306N1046 / US5763231090 / US66987V1098 / US6701002056 / US6795801009 / US7170811035 / US74762E1029 / US7711951043 / US8308791024 / US8447411088 / US8740541094 / US8807701029 / US9029251066 / US91347P1057 / US91913Y1001 / US92343V1044 / US9507551086 / US37940X1028 / US4771431016 / US4198791018 / US2948216088 / US80105N1054 / US20030N1019 / US21036P1084 / US3463751087 / US90385V1070 / US12541W2098 / US00206R1023 / US31620M1062 / US1314761032 / US57636Q1040 / US78709Y1055 / PAP310761054 / US75025X1000 / US3364331070 / US01748X1028 / US2473617023 / US25470M1099 / US7181721090 / US92826C8394 / US00507V1098 / DE000A0DJ6J9 / US58933Y1055 / US39304D1028 / US9100471096 / US3390411052 / US4361061082 / US56585A1025 / US8676524064 / US98986T1088 / US7185461040 / US9837931008 / US96208T1043 / US69318G1067 / US00287Y1091 / NL0010273215 / US98978V1035 / US8725901040 / US29355A1079 / PR30040P1032 / US69366J2006 / US00847X1046 / US8485771021 / US21240E1055 / CH0210483332 / US90184L1026 / US02376R1023 / US03937C1053 / KYG8807B1068 / US69888T2078 / US94419L1017 / CA0089118776 / US83417M1045 / US09627Y1091 / US12685J1051 / US89400J1079 / US70450Y1038 / CA1380351009 / US8522341036 / US16119P1084 / KYG4740B1059 / CA87241L1094 / GB00BDSFG982 / US83304A1060 / US23753F1075 / US80689H1023 / US05722G1004 / US24665A1034 / US02156K1034 / US4990491049 / US26927E1047 / US46571Y1073 / US74275G1076 / US5904791358 / CA39342L1085 / US28414H1032 / KY30744W1070 / US26142R1041 / US22041X1028 / CA67079A1021 / US04271T1007 / US11778X1046 / US72815L1070 / US55406W1036 / US82489W1071 / US30320C1036 / BMG6964L1072 / US20717M1036 / US61225M1027</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / Ubisoft Entertainment SA / Abbott Laboratories / Advanced Energy Industries Inc / Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cerner Corp / Cohu Inc / Covenant Logistics Group Inc / Electronic Arts Inc / Equifax Inc / Expeditors International of Washington Inc / Fiserv Inc / GlaxoSmithKline PLC / Hub Group Inc / J B Hunt Transport Services Inc / Johnson & Johnson / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Landstar System Inc / Eli Lilly and Co / MKS Instruments Inc / MasTec Inc / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / Pfizer Inc / Quanta Services Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Take-Two Interactive Software Inc / Teradyne Inc / USA Truck Inc / Universal Display Corp / Valero Energy Corp / Verizon Communications Inc / Werner Enterprises Inc / Global Payments Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Telefonaktiebolaget LM Ericsson / Sanofi SA / Comcast Corp / Constellation Brands Inc / FormFactor Inc / Ultra Clean Holdings Inc / CH Robinson Worldwide Inc / AT&T Inc / Fidelity National Information Services Inc / Calumet Specialty Products Partners LP / Mastercard Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / First Solar Inc / Allegiant Travel Co / Delta Air Lines Inc / DISH Network Corp / Philip Morris International Inc / Visa Inc / Activision Blizzard Inc / SMA Solar Technology AG / Merck & Co Inc / Green Dot Corp / United Airlines Holdings Inc / Fleetcor Technologies Inc / HollyFrontier Corp / Marathon Petroleum Corp / SunPower Corp / Zynga Inc / Phillips 66 / XPO Logistics Inc / WEX Inc / PBF Energy Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / T-Mobile US Inc / Enphase Energy Inc / Evertec Inc / PTC Therapeutics Inc / Agios Pharmaceuticals Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Compagnie Financiere Richemont SA / Twitter Inc / American Airlines Group Inc / ArcBest Corp / Theravance Biopharma Inc / Par Pacific Holdings Inc / Wayfair Inc / Air Canada / Solaredge Technologies Inc / Blueprint Medicines Corp / Cable One Inc / TransUnion / PayPal Holdings Inc / Canopy Growth Corp / Block Inc / Charter Communications Inc / Ichor Holdings Ltd / TFI International Inc / TechnipFMC PLC / Snap Inc / Daseke Inc / Schneider National Inc / Baker Hughes Co / Delek US Holdings Inc / Altice USA Inc / Knight-Swift Transportation Holdings Inc / EVO Payments Inc / I3 Verticals Inc / Priority Technology Holdings Inc / Mesa Air Group Inc / Green Thumb Industries Inc / Elanco Animal Health Inc / Farfetch Ltd / DraftKings Inc / Corsair Gaming Inc / Nuvei Corp / Array Technologies Inc / BTRS Holdings Inc / Playtika Holding Corp / MYT Netherlands Parent BV / Shoals Technologies Group Inc / FTC Solar Inc / Paysafe Ltd / Confluent Inc / Monte Rosa Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / Puerto Rico / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2778844 / 2002305 / 2026242 / 2216850 / 2270726 / 2829515 / 2670519 / 2328915 / 2459020 / 2730190 / 2440637 / 2829601 / B067BM3 / 2857817 / B1XGNW4 / B0796X4 / B7TL820 / BTN1Y11 / BS7K7C9 / BYW36M8 / BZBY005 / BJ5FZ74 / BLGJ610 / BJJMGL2 / BKTNTR9 / BJVR9Y9 / BF3W461 / BDZ30Q0 / BMPRZV5 / BMC8SQ7 / BP7KZP7</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Abbott Laboratories / American Electric Power Company Inc / Consolidated Edison Inc / Walt Disney Co / Edison International / Exelon Corp / Nextera Energy Inc / Intuit Inc / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Southern Co / Molson Coors Beverage Co / Netflix Inc / Insulet Corp / Dexcom Inc / Meta Platforms Inc / Medtronic PLC / Nevro Corp / PayPal Holdings Inc / Merus NV / Adaptive Biotechnologies Corp / Warner Music Group Corp / Fox Corp / ViacomCBS Inc / iHeartMedia Inc / Tandem Diabetes Care Inc / Arvinas Inc / Kymera Therapeutics Inc / BTRS Holdings Inc / Monte Rosa Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ABF.L / AEP.N / AES.N / ALV.N / CB.N / CCK.N / CL.N / DFDS.CO / EIX.N / EL.N / F.N / FOUG.PA / GM.N / GPS.N / KMB.N / KO.N / MO.N / MRK.N / NA / NEM.N / PD.N / PFE.N / PPG.N / RWEG.DE / SO.N / T.N / WMT.N / SSE.L / PEP.N / BFb.N / PG.N / CPB.N / CMCSA.O / THC.N / UHS.N / FER.MC / MET.N / DUK.N / DIS.N / LEA.N / K.N / DISH.O / CLX.N / CAG.N / MRO.N / GIS.N / EPC.N / KGC.N / BBVA.MC / JAZZ.O / SHW.N / NG.L / VZ.N / STT.N / HCA.N / CYH.N / XEL.N / STZ.N / RRC.N / FISV.O / EQT.N / V.N / CPT.N / ROST.O / CHTR.O / RPM.N / CHD.N / NWN.N / SAM.N / BMRN.O / ENR.N / CEY.L / NCR.N / GPK.N / ALFA.ST / ENDP.O / MEOH.O / CPK.N / SWN.N / SR.N / SGEN.OQ / GPN.N / MNST.O / GOLD.N / TFC.N / FHN.N / EDV.TO / DLR.N / VIAC.O / 427866108 / WAL.N / EDF.PA / DISCA.O / SJW.N / CMG.N / FIS.N / CFR.S / ADP.PA / TEVA.N / MA.N / CLR.N / BGS.N / HOCM.L / GETP.PA / FRES.L / EDPR.LS / NGD.A / SWI.N / SPB.N / NEE.N / MTDR.N / XYL.N / SPLK.OQ / MDLZ.OQ / ADT.N / FANG.O / ABBV.N / PRGO.N / PRMW.N / TMUS.N / VOYA.N / COTY.N / FOXA.OQ / PRTA.O / BEP.N / COUP.N / BTG.N / HQY.OQ / ZALG.DE / AXTA.N / GBT.OQ / RUN.O / SQ.N / MESO.O / SRENH.S / AZRE.N / TTD.O / GDS.O / LGFB.N / OKTA.OQ / WOW.N / ATUS.N / AQUA.N / SAIL.N / AMRX.N / NTGY.MC / KDP.N / NWL.O / GMAB.O / DOCU.N / PEAK.N / AZEK.N / WTRG.N / REYN.O / CARR.N / FOUR.N / NRIX.OQ / LUMN.N / LSEG.L / WFG.N / AFRM.O / NAPA.N / OTLY.O / BHG.N / FA.OQ / TRMR.OQ / 120681711</td><td class="leftalignment">Associated British Foods PLC / American Electric Power Company Inc / AES Corp / Autoliv Inc / Chubb Ltd / Crown Holdings Inc / Colgate-Palmolive Co / DFDS AS / Edison International / Estee Lauder Companies Inc / Ford Motor Co / Eiffage SA / General Motors Co / Gap Inc / Kimberly-Clark Corp / Coca-Cola Co / Altria Group Inc / Merck & Co Inc / National Bank of Canada / Newmont Corporation / PagerDuty Inc / Pfizer Inc / PPG Industries Inc / Rwe AG / Southern Co / AT&T Inc / Walmart Inc / SSE PLC / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Campbell Soup Co / Comcast Corp / Tenet Healthcare Corp / Universal Health Services Inc / Ferrovial SA / MetLife Inc / Duke Energy Corp / Walt Disney Co / Lear Corp / Kellogg Co / DISH Network Corp / Clorox Co / Conagra Brands Inc / Marathon Oil Corp / General Mills Inc / Edgewell Personal Care Co / Kinross Gold Corp / Banco Bilbao Vizcaya Argentaria SA / Jazz Pharmaceuticals PLC / Sherwin-Williams Co / National Grid PLC / Verizon Communications Inc / State Street Corp / HCA Healthcare Inc / Community Health Systems Inc / Xcel Energy Inc / Constellation Brands Inc / Range Resources Corp / Fiserv Inc / EQT Corp / Visa Inc / Camden Property Trust / Ross Stores Inc / Charter Communications Inc / RPM International Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / Energizer Holdings Inc / Centamin PLC / NCR Corp / Graphic Packaging Holding Co / Alfa Laval AB / Endo International PLC / Methanex Corp / Chesapeake Utilities Corp / Southwestern Energy Co / Spire Inc / Seagen Inc / Global Payments Inc / Monster Beverage Corp / Barrick Gold Corp / Truist Financial Corp / First Horizon Corp / Endeavour Mining PLC / Digital Realty Trust Inc / ViacomCBS Inc / Hershey Co / Western Alliance Bancorp / Electricite de France SA / Discovery Inc / SJW Group / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Compagnie Financiere Richemont SA / Aeroports de Paris SA / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Continental Resources Inc / B&G Foods Inc / Hochschild Mining PLC / Getlink SE / Fresnillo PLC / EDP Renovaveis SA / New Gold Inc / SolarWinds Corp / Spectrum Brands Holdings Inc / Nextera Energy Inc / Matador Resources Co / Xylem Inc / Splunk Inc / Mondelez International Inc / ADT Inc / Diamondback Energy Inc / Abbvie Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / Voya Financial Inc / Coty Inc / Fox Corp / Prothena Corporation PLC / Brookfield Renewable Partners LP / Coupa Software Inc / B2Gold Corp / Healthequity Inc / Zalando SE / Axalta Coating Systems Ltd / Global Blood Therapeutics Inc / Sunrun Inc / Block Inc / Mesoblast Ltd / Swiss Re AG / Azure Power Global Ltd / Trade Desk Inc / GDS Holdings Ltd / Lions Gate Entertainment Corp / Okta Inc / WideOpenWest Inc / Altice USA Inc / Evoqua Water Technologies Corp / SailPoint Technologies Holdings Inc / Amneal Pharmaceuticals Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Newell Brands Inc / Genmab A/S / DocuSign Inc / Healthpeak Properties Inc / Azek Company Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Carrier Global Corp / Shift4 Payments Inc / Nurix Therapeutics Inc / Lumen Technologies Inc / London Stock Exchange Group PLC / West Fraser Timber Co Ltd / Affirm Holdings Inc / Duckhorn Portfolio Inc / Oatly Group AB / Bright Health Group Inc / First Advantage Corp / Tremor International Ltd / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Mauritius / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: July 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BAX.N / BMY.N / BSX.N / CB.N / CCI.N / CL.N / CNC.N / COF.N / DOW.N / ECL.N / F.N / FCX.N / GE.N / IBM.N / JNJ.N / KMB.N / KO.N / LMT.N / LUV.N / MMC.N / MO.N / MRK.N / NEM.N / NSC.N / OMC.N / PFE.N / PM.N / PPG.N / SLB.N / SO.N / TEL.PS / TMO.N / TRV.N / WMB.N / SPG.N / PG.N / WY.N / PXD.N / HUM.N / NUE.N / UHS.N / HAL.N / ADML.L / ETN.N / DHR.N / FE.N / GD.N / DOV.N / ROP.N / CAT.N / IPG.N / UNP.N / MCD.N / YUM.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / WHR.N / LIN.N / SHW.N / PKG.N / GWW.N / VZ.N / STT.N / HCA.N / JCI.N / DHI.N / AMP.N / VFC.N / KMI.N / EFX.N / V.N / EW.N / ARE.N / PLD.N / CHD.N / TWTR.N / MTB.N / CVX.N / MCO.N / RF.N / HAYS.L / INTC.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / JBHT.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / NTRS.OQ / TROW.OQ / SIVB.OQ / ZION.OQ / SBUX.OQ / IDXX.OQ / QCOM.OQ / GILD.OQ / DFS.N / TSCO.OQ / O.N / POOL.OQ / AMZN.OQ / TTWO.OQ / VRSN.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ISRG.OQ / EQIX.OQ / ALGN.OQ / GPN.N / FITB.OQ / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / DLR.N / MKTX.OQ / LVS.N / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / ES.N / NVR.N / CME.OQ / MSCI.N / SCHW.N / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / KEY.TO / BKR.N / NOW.N / FANG.OQ / ABBV.N / GOOGL.OQ / ANET.N / SYF.N / CFG.N / ANTM.N / PYPL.OQ / CSX.OQ / IQV.N / XEL.OQ / WELL.N / FB.PS / UAL.OQ / RTX.N / CARR.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Baxter International Inc / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Centene Corp / Capital One Financial Corp / Dow Inc / Ecolab Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Lockheed Martin Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Norfolk Southern Corp / Omnicom Group Inc / Pfizer Inc / Philip Morris International Inc / PPG Industries Inc / Schlumberger NV / Southern Co / PLDT Inc / Thermo Fisher Scientific Inc / Travelers Companies Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Nucor Corp / Universal Health Services Inc / Halliburton Co / Admiral Group PLC / Eaton Corporation PLC / Danaher Corp / FirstEnergy Corp / General Dynamics Corp / Dover Corp / Roper Technologies Inc / Caterpillar Inc / Interpublic Group of Companies Inc / Union Pacific Corp / McDonald's Corp / Yum! Brands Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Whirlpool Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / W W Grainger Inc / Verizon Communications Inc / State Street Corp / HCA Healthcare Inc / Johnson Controls International PLC / D R Horton Inc / Ameriprise Financial Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Prologis Inc / Church & Dwight Co Inc / Twitter Inc / M&T Bank Corp / Chevron Corp / Moody's Corp / Regions Financial Corp / Hays PLC / Intel Corp / Apple Inc / Cerner Corp / Fiserv Inc / J B Hunt Transport Services Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Northern Trust Corp / T Rowe Price Group Inc / SVB Financial Group / Zions Bancorporation NA / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Gilead Sciences Inc / Discover Financial Services / Tractor Supply Co / Realty Income Corp / Pool Corp / Amazon.com Inc / Take-Two Interactive Software Inc / Verisign Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Intuitive Surgical Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Mosaic Co / Digital Realty Trust Inc / Marketaxess Holdings Inc / Las Vegas Sands Corp / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Eversource Energy / NVR Inc / CME Group Inc / MSCI Inc / Charles Schwab Corp / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Keyera Corp / Baker Hughes Co / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Alphabet Inc / Arista Networks Inc / Synchrony Financial / Citizens Financial Group Inc / Anthem Inc / PayPal Holdings Inc / CSX Corp / IQVIA Holdings Inc / Xcel Energy Inc / Welltower Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AMRX.N</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Amneal Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">07/18/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Movers & Shakers: Our Thoughts on Potential Upcoming Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">83</td><td class="leftalignment">ACRS / ALKS / AMRN / CDTX / CERS / COLL / COX / EBS / GRAY / HCM / JAZZ / JNJ / LLY / MRK / MSB / NOVN / PFE / RMTI / SIBN / SMTI / CKPT / BDSI / UBX / ACRX / ARDX / ANIP / CERC / ARDS / CUTR / BSLN / MNKD / ARAV / SPRO / ZTS / OMER / AXGN / TXMD / HRTX / TRVN / AERI / SCYX / EGRX / LPCN / CFRX / FBIO / SPNE / JAGX / AYTU / VRAY / VERU / EYPT / EOLS / PDSB / ETTX / HGEN / ARQT / IMAB / PCVX / SRGA / VYNE / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / Alkermes Plc / Amarin Corporation PLC / Cidara Therapeutics Inc / Cerus Corp / Collegium Pharmaceutical Inc / Nicox SA / Emergent BioSolutions Inc / Graybug Vision Inc / HUTCHMED (China) Ltd / Jazz Pharmaceuticals PLC / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Mesoblast Ltd / Novan Inc / Pfizer Inc / Rockwell Medical Inc / SI-BONE Inc / Sanara Medtech Inc / Checkpoint Therapeutics Inc / BioDelivery Sciences International Inc / UNITY Biotechnology Inc / AcelRx Pharmaceuticals Inc / Ardelyx Inc / ANI Pharmaceuticals Inc / Avalo Therapeutics Inc / Aridis Pharmaceuticals Inc / Cutera Inc / Basilea Pharmaceutica AG / MannKind Corp / Aravive Inc / Spero Therapeutics Inc / Zoetis Inc / Omeros Corp / AxoGen Inc / TherapeuticsMD Inc / Heron Therapeutics Inc / Trevena Inc / Aerie Pharmaceuticals Inc / SCYNEXIS Inc / Eagle Pharmaceuticals Inc / Lipocine Inc / ContraFect Corp / Fortress Biotech Inc / SeaSpine Holdings Corp / Jaguar Health Inc / Aytu Biopharma Inc / ViewRay Inc / Veru Inc / EyePoint Pharmaceuticals Inc / Evolus Inc / PDS Biotechnology Corp / Entasis Therapeutics Holdings Inc / Humanigen Inc / Arcutis Biotherapeutics Inc / I-Mab / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">07/18/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Nice Way To End The Week, VAXNEUVANCE Approval Opens An Opportunity For MRK</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK / PFE / PCVX</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Vaxcyte Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">07/18/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.6% Above Pre-Pandemic Base- Week 67</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">2Q21 Global Biopharma Preview: Group Fundamentals Solid & Valuations Improving but Don't Look for Big 2Q Beats</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">0989529 / 2126335 / 5671735 / 0925288 / 2516152 / 2778844 / 7103065 / BHC8X90</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Sanofi SA / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Keytruda Adjuvant TNBC Survival Data Robust; Submitted To FDA For Review</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending July 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / MNKD.OQ / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / MannKind Corp / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Biopharma / IQVIA Script Trends for the Week Ended July 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">THIS MORNING: Please Join Our Large-Cap 2Q21 Earnings Preview Conference Call On July 16 At 11AM ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE / HCM / JNJ / LLY / MRK / ZTS / IMAB</td><td class="leftalignment">Pfizer Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Zoetis Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Argument for IO in Neoadjuvant Setting Strengthens</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">58933Y10</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="odd"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Morning Bite Flash</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">DE0007100000 / DE0006599905 / DE0006602006 / DE0007030009 / DE0007037129 / DE0007165607 / DE0005470306 / DE0007165631 / DE0008019001 / AT0000730007 / DE0006062144 / DE000A161408 / DE000HAG0005</td><td class="leftalignment">Daimler AG / Merck KGaA / GEA Group AG / Rheinmetall AG / Rwe AG / Sartorius AG / Cts Eventim AG & Co KgaA / Sartorius AG / Deutsche Pfandbriefbank AG / Andritz AG / Covestro AG / Hellofresh SE / Hensoldt AG</td><td class="leftalignment"></td><td class="leftalignment">Austria / Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Herr. Ingo-Martin Schachel, CFA</td></tr>
<tr class="odd"><td class="leftalignment">07/14/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Video Call to Discuss the Future of COVID-19 Vaccines & Treatments on Thursday, July 22 at 11AM ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">JNJ / LLY / MRK / CERC / AYTU / HGEN / IMAB</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Avalo Therapeutics Inc / Aytu Biopharma Inc / Humanigen Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Ms. Jennifer M. Kim / Brandon Folkes, CFA / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">07/14/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Cessation of our Top Ideas</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">DE0006599905 / DE0006602006 / DE0007100000 / DE0007030009 / DE0007037129 / DE0007165607 / DE0005470306 / DE0007165631 / DE0008019001 / DE0006062144 / DE000A161408</td><td class="leftalignment">Merck KGaA / GEA Group AG / Daimler AG / Rheinmetall AG / Rwe AG / Sartorius AG / Cts Eventim AG & Co KgaA / Sartorius AG / Deutsche Pfandbriefbank AG / Covestro AG / Hellofresh SE</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Manufacturing / Utilities</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Oliver Metzger</td></tr>
<tr class="odd"><td class="leftalignment">07/14/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / PEP=US / CAG=US / MCD=US / WEN=US / DGX=US / PAA=US / FMS=US / THC=US / BRO=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / CBRL=US / CYH=US / DRI=US / DVA=US / LH=US / CNC=US / MKL=US / ENSG=US / DIN=US / MD=US / JRVR=US / PRG=US / MOH=US / FNB=US / PLAY=US / DENN=US / LHCG=US / CHNG=US / CMG=US / TAST=US / QSR=US / EHC=US / PAGP=US / JACK=US / UTZ=US / 45665G303 / KNSL=US / PCRX=US / SPLK=US / NDLS=US / LOCO=US / OSH=US / ANTM=US / SHAK=US / GDDY=US / WING=US / IRTC=US / TVTY=US / MAXR=US / LAZY=US / AHCO=US / PNTG=US / OPCH=US / SPCE=US / ZI=US / AFRM=US / AVAH=US</td><td class="leftalignment">Merck & Co Inc / PepsiCo Inc / Conagra Brands Inc / McDonald's Corp / Wendys Co / Quest Diagnostics Inc / Plains All American Pipeline LP / Fresenius Medical Care AG & Co KGaA / Tenet Healthcare Corp / Brown & Brown Inc / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / Cracker Barrel Old Country Store Inc / Community Health Systems Inc / Darden Restaurants Inc / DaVita Inc / Laboratory Corporation of America Holdings / Centene Corp / Markel Corp / Ensign Group Inc / Dine Brands Global Inc / MEDNAX Inc / James River Group Holdings Ltd / PROG Holdings Inc / Molina Healthcare Inc / FNB Corp / Dave & Buster's Entertainment Inc / Denny's Corp / LHC Group Inc / Change Healthcare Inc / Chipotle Mexican Grill Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Encompass Health Corp / Plains GP Holdings LP / Jack in the Box Inc / UTZ Brands Inc / Infinity Pharmaceuticals Inc / Kinsale Capital Group Inc / Pacira Biosciences Inc / Splunk Inc / Noodles & Co / El Pollo Loco Holdings Inc / Oak Street Health Inc / Anthem Inc / Shake Shack Inc / GoDaddy Inc / Wingstop Inc / iRhythm Technologies Inc / Tivity Health Inc / Maxar Technologies Inc / Lazydays Holdings Inc / Adapthealth Corp / Pennant Group Inc / Option Care Health Inc / Virgin Galactic Holdings Inc / ZoomInfo Technologies Inc / Affirm Holdings Inc / Aveanna Healthcare Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Germany / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">ALV.N / CL.N / EDP.LS / EL.N / F.N / FLS.N / FSR.N / GE.N / GM.N / GOG.L / IBE.MC / JPM.N / KMB.N / KO.N / MO.N / MRK.N / VC.N / PEP.N / PG.N / TEN.N / ETN.N / DHR.N / BWA.N / LEA.N / WCC.N / DOV.N / IEX.N / ROP.N / K.N / GS.N / CLX.N / HON.N / VLO.N / MMM.N / EMR.N / EPC.N / RMD.N / GWW.N / JCI.N / APH.N / AXL.N / CHD.N / AME.N / BC.N / DK.N / SAM.N / ENR.N / TEL.N / COP.N / FRC.N / GGG.N / PNR.N / PII.N / ST.N / TT.N / MNST.O / NVT.N / 427866108 / EDF.PA / MWA.N / HOG.N / CLR.N / BGS.N / DAN.N / PBF.N / VALE.N / SPB.N / BHPB.L / MTOR.N / MPC.N / HFC.N / XYL.N / PSX.N / MDLZ.OQ / FANG.O / TSLA.N / FLOW.N / PRMW.N / COTY.N / LB.N / CIA.TO / FTV.N / ATKR.N / PARR.N / ADNT.N / AQUA.N / APTV.N / GTES.N / VNE.N / NTGY.MC / KDP.N / NWL.O / CRNC.OQ / EPAC.N / REYN.O / TFII.N / CARR.N / NKLA.OQ / APA.OQ / RIDE.OQ / TSP.OQ / OTLY.O / 120681711</td><td class="leftalignment">Autoliv Inc / Colgate-Palmolive Co / EDP Energias de Portugal SA / Estee Lauder Companies Inc / Ford Motor Co / Flowserve Corp / Fisker Inc / General Electric Co / General Motors Co / Go-Ahead Group PLC / Iberdrola SA / JPMorgan Chase & Co / Kimberly-Clark Corp / Coca-Cola Co / Altria Group Inc / Merck & Co Inc / Visteon Corp / PepsiCo Inc / Procter & Gamble Co / Tenneco Inc / Eaton Corporation PLC / Danaher Corp / Borgwarner Inc / Lear Corp / Wesco International Inc / Dover Corp / IDEX Corp / Roper Technologies Inc / Kellogg Co / Goldman Sachs Group Inc / Clorox Co / Honeywell International Inc / Valero Energy Corp / 3M Co / Emerson Electric Co / Edgewell Personal Care Co / Resmed Inc / W W Grainger Inc / Johnson Controls International PLC / Amphenol Corp / American Axle & Manufacturing Holdings Inc / Church & Dwight Co Inc / AMETEK Inc / Brunswick Corp / Delek US Holdings Inc / Boston Beer Company Inc / Energizer Holdings Inc / TE Connectivity Ltd / Conocophillips / First Republic Bank / Graco Inc / Pentair PLC / Polaris Inc / Sensata Technologies Holding PLC / Trane Technologies PLC / Monster Beverage Corp / nVent Electric PLC / Hershey Co / Electricite de France SA / Mueller Water Products Inc / Harley-Davidson Inc / Continental Resources Inc / B&G Foods Inc / Dana Inc / PBF Energy Inc / Vale SA / Spectrum Brands Holdings Inc / BHP Group PLC / Meritor Inc / Marathon Petroleum Corp / HollyFrontier Corp / Xylem Inc / Phillips 66 / Mondelez International Inc / Diamondback Energy Inc / Tesla Inc / SPX FLOW Inc / Primo Water Corp / Coty Inc / Bath & Body Works Inc / Champion Iron Ltd / Fortive Corp / Atkore Inc / Par Pacific Holdings Inc / Adient PLC / Evoqua Water Technologies Corp / Aptiv PLC / Gates Industrial Corporation PLC / Veoneer Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Newell Brands Inc / Cerence Inc / Enerpac Tool Group Corp / Reynolds Consumer Products Inc / TFI International Inc / Carrier Global Corp / Nikola Corp / APA Corp (US) / Lordstown Motors Corp / TuSimple Holdings Inc / Oatly Group AB / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Brazil / Canada / Switzerland / Spain / France / United Kingdom / Ireland / Portugal / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">07/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Closer look at the 2Q set-up; OGN spinoff and COVID-19 bring lower than normal visibility</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">07/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">LONN.S: Lonza - 1H21 Results Preview - CS in line for 1H21, 4%  ahead on EPS by FY23E</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LONN.S / ROG.S / MRCG.DE / NZYMB.CO / MRNA.OQ / 207940.KS</td><td class="leftalignment">Lonza Group AG / Roche Holding AG / Merck KGaA / Novozymes A/S / Moderna Inc / Samsung Biologics Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / Korea, Republic of / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Ms Jo Walton / Elizabeth Walton / Mr Matthew J. Weston / Fr. Barbora Blaha</td></tr>
<tr class="odd"><td class="leftalignment">07/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Updating estimates to reflect continuing operations (ex-Organon)</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser</td></tr>
<tr class="even"><td class="leftalignment">07/13/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GSK-US -  Dividend Quality Analysis, for the period ended July 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GSK / MRK / NVS / PFE / AZN.O / DVAX.O / TEVA.K / SNY.O</td><td class="leftalignment">GlaxoSmithKline PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / AstraZeneca PLC / Dynavax Technologies Corp / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">07/13/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Updating Model For Organon Spin-Off And COVID Headwind in 2Q21</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">07/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / HD=US / INTC=US / MCD=US / OXY=US / ADI=US / AMD=US / RRC=US / WEN=US / AMZN=US / BLD=US / DVN=US / TXN=US / TEVA=US / NVDA=US / APA=US / CPE=US / EOG=US / REI=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / PB=US / DIOD=US / MGY=US / SWN=US / XLNX=US / MUR=US / CHRS=US / BRO=US / UMPQ=US / MRO=US / LEG=US / TTMI=US / VMC=US / MLM=US / APH=US / SWIM=US / ARW=US / AVGO=US / AVT=US / CBRL=US / CERN=US / CNX=US / DRI=US / EQT=US / GFF=US / IBP=US / MAN=US / MAS=US / MCHP=US / MHK=US / PACW=US / REGI=US / ST=US / WAL=US / CVX=US / BXS=US / SNV=US / FB=US / CATY=US / COP=US / DIN=US / BIIB=US / TCBI=US / TPX=US / FNB=US / EXP=US / FHN=US / BDC=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / TEL=US / OC=US / AMRX=US / TAST=US / QSR=US / CLR=US / PRPL=US / NOG=US / IAC=US / JACK=US / TREX=US / AR=US / OAS=US / NXPI=US / ESTE=US / FBHS=US / ANGI=US / BCEI=US / MTDR=US / PDCE=US / FANG=US / TILE=US / NDLS=US / GOOGL=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / ON=US / WING=US / WLTW=US / EDIT=US / 82982L103 / CDEV=US / PVAC=US / JELD=US / SBOW=US / MPWR-US / HWC=US / OZK=US / RTLR=US / FERG=US / GMAB=US / OVV=US / AZEK=US / VTRS=US / VMEO=US / REPX=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / Intel Corp / McDonald's Corp / Occidental Petroleum Corp / Analog Devices Inc / Advanced Micro Devices Inc / Range Resources Corp / Wendys Co / Amazon.com Inc / TopBuild Corp / Devon Energy Corp / Texas Instruments Inc / Teva Pharmaceutical Industries Ltd / NVIDIA Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Prosperity Bancshares Inc / Diodes Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Xilinx Inc / Murphy Oil Corp / Coherus BioSciences Inc / Brown & Brown Inc / Umpqua Holdings Corp / Marathon Oil Corp / Leggett & Platt Inc / TTM Technologies Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Amphenol Corp / Latham Group Inc / Arrow Electronics Inc / Broadcom Inc / Avnet Inc / Cracker Barrel Old Country Store Inc / Cerner Corp / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Griffon Corp / Installed Building Products Inc / ManpowerGroup Inc / Masco Corp / Microchip Technology Inc / Mohawk Industries Inc / PacWest Bancorp / Renewable Energy Group Inc / Sensata Technologies Holding PLC / Western Alliance Bancorp / Chevron Corp / Cadence Bank / Synovus Financial Corp / Meta Platforms Inc / Cathay General Bancorp / Conocophillips / Dine Brands Global Inc / Biogen Inc / Texas Capital Bancshares Inc / Tempur Sealy International Inc / FNB Corp / Eagle Materials Inc / First Horizon Corp / Belden Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / TE Connectivity Ltd / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Purple Innovation Inc / Northern Oil and Gas Inc / IAC/Interactivecorp / Jack in the Box Inc / Trex Company Inc / Antero Resources Corp / Oasis Petroleum Inc / NXP Semiconductors NV / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Angi Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Interface Inc / Noodles & Co / Alphabet Inc / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / ON Semiconductor Corp / Wingstop Inc / Willis Towers Watson PLC / Editas Medicine Inc / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / Ranger Oil Corp / JELD-WEN Holding Inc / SilverBow Resources Inc / Monolithic Power Systems Inc / Hancock Whitney Corp / Bank Ozk / Rattler Midstream LP / Ferguson PLC / Genmab A/S / Ovintiv Inc / Azek Company Inc / Viatris Inc / Vimeo Inc / Riley Exploration Permian Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/13/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma : 2Q Earnings Preview - Easy Comps and Receding COVID-19 Headwinds</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">ABBV.N / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">07/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Animal Tracks: Survey Says: Robust Vet Demand Continues in 2Q; Highlight ZTS Innovation</td><td class="leftalignment">English</td><td class="rightalignment">65</td><td class="leftalignment">IDXX.OQ / ZTS.N / MRK.N / VIRB.PA / DPH.L / ABC.N / PDCO.OQ / HSIC.OQ / AMZN.OQ / HSKA.OQ / PETS.OQ / BAYGN.DE / PAHC.OQ / ELAN.N / CVET.OQ / CHWY.N</td><td class="leftalignment">IDEXX Laboratories Inc / Zoetis Inc / Merck & Co Inc / Virbac SA / Dechra Pharmaceuticals PLC / Amerisourcebergen Corp / Patterson Companies Inc / Henry Schein Inc / Amazon.com Inc / Heska Corp / Petmed Express Inc / Bayer AG / Phibro Animal Health Corp / Elanco Animal Health Inc / Covetrus Inc / Chewy Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS.O / ACRX.O / EBS / HCM.L / JNJ / LLY / MRK / PFE / ALKS.O / JAZZ.O / CERS.O / OPTN.O / NCOX.PA / COLL.O / RMTI.O / AMRN.O / BDSI.O / CUTR.O / BSLN.S / MNKD.O / ZTS / OMER.O / SPRO.O / ANIP.O / AXGN.O / AERI.O / HRTX.O / TRVN.O / EGRX.O / SCYX.O / ARDX.O / LPCN.O / CFRX.O / CDTX.O / SPNE.O / FBIO.O / MESO.O / CERC.O / VRAY.O / VERU.O / TXMD.O / AYTU.O / CKPT.O / EYPT.O / UBX.O / EOLS.O / ARDS.O / ARAV.O / SIBN.O / ETTX.O / ARQT.O / PCVX.O / SRGA.O / VYNE.O / HGEN.O / AZYO.O / GRAY.O / IMAB.O / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / Emergent BioSolutions Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Cerus Corp / OptiNose Inc / Nicox SA / Collegium Pharmaceutical Inc / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Cutera Inc / Basilea Pharmaceutica AG / MannKind Corp / Zoetis Inc / Omeros Corp / Spero Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / Ardelyx Inc / Lipocine Inc / ContraFect Corp / Cidara Therapeutics Inc / SeaSpine Holdings Corp / Fortress Biotech Inc / Mesoblast Ltd / Avalo Therapeutics Inc / ViewRay Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Checkpoint Therapeutics Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Evolus Inc / Aridis Pharmaceuticals Inc / Aravive Inc / SI-BONE Inc / Entasis Therapeutics Holdings Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Humanigen Inc / Aziyo Biologics Inc / Graybug Vision Inc / I-Mab / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 02, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">Industrials Calendar : July-September 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">NOVN.S / MRCG.DE / GLAX.NS / SUP.N / FLWS.O</td><td class="leftalignment">Novartis AG / Merck KGaA / GlaxoSmithKline Pharmaceuticals Ltd / Superior Industries International Inc / 1-800-Flowers.Com Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">Australia / Austria / Belgium / Canada / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Hong Kong / India / Ireland / Israel / Italy / Luxembourg / Netherlands / Norway / Portugal / Sweden / United States / South Africa</td><td class="leftalignment">Aerospace / Air Transportation / Automotive / Biotechnology / Building & Building Materials / Consumer / Containers & Packing / Defense / Healthcare / Industrial Materials / Manufacturing / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Railroads / Retailing / Shipping & Shipbuilding / Transportation</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Danielle Ward / Benjamin Defay / Stephanie Vincent / Mr. William W. Wade / Ed McGuinness / Mr. Adam Bodor</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Merck KgaA – Notes from the Road: Mgmt meeting takeaways</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Vijay M. Kumar</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AEP.N / AES.N / AXP.N / CCI.N / CI.N / COF.N / CVS.N / EDP.LS / EIX.N / ELE.MC / IBE.MC / IP.N / MRK.N / NA / PB.N / PFE.N / REP.MC / SO.N / T.N / ZION.O / PEP.N / CMA.N / WY.N / HUM.N / CFP.TO / GILD.O / CMCSA.O / AMGN.O / INCY.O / DUK.N / HBAN.O / UNH.N / NICE.O / CAG.N / PCG.N / CONE.O / VZ.N / VLY.N / SNV.N / PACW.O / FISV.O / V.N / AWK.N / NBIX.O / NWN.N / STL.N / VRTX.O / NCR.N / CPE.N / CFR.N / BLU.N / CPK.N / FRC.N / WBS.N / FCF.N / DFS.N / ADS.N / SGEN.OQ / GPN.N / PFS.N / FFBC.O / PBCT.O / SIVB.O / WSBC.O / HOOK.O / CASY.O / BOKF.O / BCRX.O / COLB.O / WTFC.O / ICPT.O / EQIX.O / TCBI.O / ATDb.TO / BIIB.O / SJ.TO / MTL.TO / FHN.N / DPZ.N / DLR.N / ACAD.O / WEF.TO / WAL.N / DISCA.O / SJW.N / BKD.N / CMG.N / FIS.N / ISBC.O / MA.N / GALP.LS / INO.OQ / HOMB.O / AND.TO / INPP.L / NEE.N / NXT.AX / PCH.O / CJT.TO / CFX.TO / BKU.N / PCRX.O / IFP.TO / WTE.TO / SLM.OQ / RFP.N / SRPT.O / ALLY.N / NYCB.N / ENTA.O / TMUS.N / PTCT.O / BEP.N / ONB.OQ / KPTI.O / XNCR.OQ / ITCI.O / FLXN.O / AGRX.O / SYF.N / GWB.N / ANTM.N / ASB.N / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / PYPL.OQ / GBT.OQ / MP1.AX / PVAC.O / CADE.N / OVID.O / ATNX.O / 05971J102 / ITRM.O / NTGY.MC / PRVB.O / GMDA.OQ / LSPD.TO / NBSE.OQ / KRTX.OQ / MORF.OQ / APRE.OQ / IGMS.O / ETNB.O / WTRG.N / TFII.N / FOUR.N / DCT.O / SPRB.OQ / MTCR.O / WFG.N / TASK.O</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / American Express Co / Crown Castle International Corp / Cigna Corp / Capital One Financial Corp / CVS Health Corp / EDP Energias de Portugal SA / Edison International / Endesa SA / Iberdrola SA / International Paper Co / Merck & Co Inc / National Bank of Canada / Prosperity Bancshares Inc / Pfizer Inc / Repsol SA / Southern Co / AT&T Inc / Zions Bancorporation NA / PepsiCo Inc / Comerica Inc / Weyerhaeuser Co / Humana Inc / Canfor Corp / Gilead Sciences Inc / Comcast Corp / Amgen Inc / Incyte Corp / Duke Energy Corp / Huntington Bancshares Inc / UnitedHealth Group Inc / Nice Ltd / Conagra Brands Inc / PG&E Corp / CyrusOne Inc / Verizon Communications Inc / Valley National Bancorp / Synovus Financial Corp / PacWest Bancorp / Fiserv Inc / Visa Inc / American Water Works Company Inc / Neurocrine Biosciences Inc / Northwest Natural Holding Co / Sterling Bancorp / Vertex Pharmaceuticals Inc / NCR Corp / Callon Petroleum Co / Cullen/Frost Bankers Inc / BELLUS Health Inc / Chesapeake Utilities Corp / First Republic Bank / Webster Financial Corp / First Commonwealth Financial Corp / Discover Financial Services / Alliance Data Systems Corp / Seagen Inc / Global Payments Inc / Provident Financial Services Inc / First Financial Bancorp / People's United Financial Inc / SVB Financial Group / WesBanco Inc / HOOKIPA Pharma Inc / Caseys General Stores Inc / BOK Financial Corp / BioCryst Pharmaceuticals Inc / Columbia Banking System Inc / Wintrust Financial Corp / Intercept Pharmaceuticals Inc / Equinix Inc / Texas Capital Bancshares Inc / Alimentation Couche-Tard Inc / Biogen Inc / Stella-Jones Inc / Mullen Group Ltd / First Horizon Corp / Domino's Pizza Inc / Digital Realty Trust Inc / ACADIA Pharmaceuticals Inc / Western Forest Products Inc / Western Alliance Bancorp / Discovery Inc / SJW Group / Brookdale Senior Living Inc / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Investors Bancorp Inc / Mastercard Inc / Galp Energia SGPS SA / Inovio Pharmaceuticals Inc / Home BancShares Inc / Andlauer Healthcare Group Inc / International Public Partnerships Ltd / Nextera Energy Inc / NEXTDC Ltd / Potlatchdeltic Corp / Cargojet Inc / Canfor Pulp Products Inc / BankUnited Inc / Pacira Biosciences Inc / Interfor Corp / Westshore Terminals Investment Corp / SLM Corp / Resolute Forest Products Inc / Sarepta Therapeutics Inc / Ally Financial Inc / New York Community Bancorp Inc / Enanta Pharmaceuticals Inc / T-Mobile US Inc / PTC Therapeutics Inc / Brookfield Renewable Partners LP / Old National Bancorp / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Pacira Biosciences Inc / Agile Therapeutics Inc / Synchrony Financial / Great Western Bancorp Inc / Anthem Inc / Associated Banc-Corp / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / PayPal Holdings Inc / Global Blood Therapeutics Inc / Megaport Ltd / Ranger Oil Corp / Cadence Bank / Ovid Therapeutics Inc / Athenex Inc / Cadence Bank / Iterum Therapeutics PLC / Naturgy Energy Group SA / Provention Bio Inc / Gamida Cell Ltd / Lightspeed Commerce Inc / NeuBase Therapeutics Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Aprea Therapeutics Inc / IGM Biosciences Inc / 89Bio Inc / Essential Utilities Inc / TFI International Inc / Shift4 Payments Inc / Duck Creek Technologies Inc / Spruce Biosciences Inc / Metacrine Inc / West Fraser Timber Co Ltd / Taskus Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Spain / Ireland / Israel / Portugal / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Jul 02, 2021: Focus on Shingrix trends</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">US Healthcare policy: new and updated democrat proposals: Biden drug proposals via EO; Pelosi & Wyden seek legislative approach</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">4502.T / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / REGN.OQ / GILD.OQ / INCY.OQ / BMRN.OQ / BIIB.OQ / IPN.PA / TEVA.N / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">07/11/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK.N / PFE.N / PCRX.O / FLXN.O / AGRX.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Pacira Biosciences Inc / Pacira Biosciences Inc / Agile Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">07/11/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.8% Above Pre-Pandemic Base- Week 66</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended July 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">07/09/2021</td><td class="leftalignment">Vermilion Technical Research</td><td class="leftalignment">Int'l Compass: Mixed Market Environment Continues As Yields Break Down; Actionable Themes: Health Care & Real Estate</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AFXG.DE / ALVG.DE / MRK.N / ROG.S / GSK.L / 9969.T / COLOb.CO / TECN.S / REC.OL / DIVI.NS / 7780.T / ALKE.NS / CTEC.L / GLAD.NS</td><td class="leftalignment">Carl Zeiss Meditec AG / Allianz SE / Merck & Co Inc / Roche Holding AG / GlaxoSmithKline PLC / Shokubun Co Ltd / Coloplast A/S / Tecan Group AG / REC Silicon ASA / Divi's Laboratories Ltd / Menicon Co Ltd / Alkem Laboratories Ltd / ConvaTec Group PLC / Gland Pharma Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / United Kingdom / India / Japan / Norway / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">STRATEGY / TECHNICAL ANALYSIS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">David P. Nicoski, CMT</td></tr>
<tr class="odd"><td class="leftalignment">07/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending July 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / MNKD.OQ / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / MannKind Corp / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">07/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">DD-US -  Dividend Quality Analysis, for the period ended June 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">APD / DOW / EMN / FMC / MRK / PPG / BASFY.PK / GT.O / MON.O</td><td class="leftalignment">Air Products and Chemicals Inc / Dow Inc / Eastman Chemical Co / FMC Corp / Merck & Co Inc / PPG Industries Inc / BASF SE / Goodyear Tire & Rubber Co / Monument Circle Acquisition Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Germany / India / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">07/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US -  Dividend Quality Analysis, for the period ended June 29,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US -  Dividend Quality Analysis, for the period ended July 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">07/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Large-Cap 2Q21 Earnings Preview Conference Call On July 16 At 11AM ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE / ZTS / HCM.L / JNJ / LLY / MRK / IMAB.O</td><td class="leftalignment">Pfizer Inc / Zoetis Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">07/08/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Merck & Co Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">07/07/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Merck up 7% from 1 week low</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Merck & Co., Inc.(MRK) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">58933Y105</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Kepler Cheuvreux</td><td class="leftalignment">Pharma & biotech | COVID vaccines against Delta: still preventing deaths but not the spread</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ABVX.PA / ADOC.PA / RECI.MI / VIRB.PA / TRNG.PA / AZN.L / SASY.PA / ROG.S / KARO.ST / LUN.CO / NOVOb.CO / NOVN.S / MRCG.DE / LONN.S / GSK.L / GNS.L / UCB.BR / NCOX.PA / BSLN.S / GLPG.AS / IPN.PA / SANN.S / IPH.PA / ALM.MC / VLS.PA / GRLS.MC / ROVI.MC / HBMN.S / BION.S / SOBIV.ST / DBV.PA / NANOB.PA / FYB.DE / ALCJ.PA / FALG.PA / GNFT.PA / ARGX.BR / ALQGC.PA / BOTHE.BR / CYAD.BR / OSE.PA / ALBPS.PA / MITRA.BR / BNNn.DE / PHARN.PA / LYS.PA / VIFN.S / GALE.S / OXUR.BR / MEDCL.PA / ALCC.S / OPTOMED.HE / NANOFH.HE / FARON.HE / ALONX.PA / HEALTH.HE</td><td class="leftalignment">Abivax SA / Adocia SA / Recordati Industria Chimica e Farmaceutica SpA / Virbac SA / Transgene SA / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Karo Pharma AB / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Lonza Group AG / GlaxoSmithKline PLC / Genus PLC / Ucb SA / Nicox SA / Basilea Pharmaceutica AG / Galapagos NV / Ipsen SA / Santhera Pharmaceuticals Holding AG / Innate Pharma SA / Almirall SA / Valneva SE / Grifols SA / Laboratorios Farmaceuticos ROVI SA / HBM Healthcare Investments AG / BB Biotech AG / Swedish Orphan Biovitrum AB (publ) / DBV Technologies SA / Nanobiotix SA / Formycon AG / Crossject SA / Fermentalg SA / Genfit SA / argenx SE / Quantum Genomics SA / Bone Therapeutics SA / Celyad Oncology SA / OSE Immunotherapeutics SA / Biophytis SA / Mithra Pharmaceuticals SA / BRAIN Biotech AG / Pharnext SA / Lysogene SA / Vifor Pharma AG / Galenica AG / Oxurion NV / Medincell SA / Alcon AG / Optomed Plc / Nanoform Finland Plc / Faron Pharmaceuticals Oy / Onxeo SA / Nightingale Health Oyj</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Italy / Netherlands / Sweden</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. David P. Evans</td></tr>
<tr class="even"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Technical Ideas for H2 2021</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">FR0000121972 / FR0000121485 / FR0000120073 / DE0005785604 / DE0006070006 / FR0000121667 / DE0006599905 / DE0005190003 / DE0008232125 / GB0002374006 / FI0009003727 / NL0000009538 / DE0006969603 / DE0007164600 / DE0005552004 / DE0006632003 / IT0003128367 / DE0007664039 / DE000SYM9999 / DE000PAH0038 / CH0045159024 / DE000A1DAHH0 / DE000A1EWWW0 / DE000A1PHFF7 / DK0060534915 / GB00BH4HKS39 / SE0007691613 / IE00BZ12WP82 / GB00BJFFLV09 / DE000A2YN900</td><td class="leftalignment">Schneider Electric SE / Kering SA / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Fresenius SE & Co KGaA / Hochtief AG / EssilorLuxottica SA / Merck KGaA / Bayerische Motoren Werke AG / Deutsche Lufthansa AG / Diageo PLC / Wartsila Oyj Abp / Koninklijke Philips NV / Puma SE / SAP SE / Deutsche Post AG / MorphoSys AG / Enel SpA / Volkswagen AG / Symrise AG / Porsche Automobil Holding SE / Compagnie Financiere Richemont SA / Brenntag SE / Adidas AG / Hugo Boss AG / Novo Nordisk A/S / Vodafone Group PLC / Dometic Group AB (publ) / Linde PLC / Croda International PLC / TeamViewer AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / Finland / France / United Kingdom / Ireland / Italy / Netherlands / Sweden</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Equity</td><td class="leftalignment">Herr. Achim Matzke / Frau Petra von Kerssenbrock / Herr Thorsten Grisse</td></tr>
<tr class="odd"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Technische Ideen für H2 2021</td><td class="leftalignment">German</td><td class="rightalignment">41</td><td class="leftalignment">FR0000121972 / FR0000121485 / FR0000120073 / DE0005785604 / DE0006070006 / FR0000121667 / DE0006599905 / DE0005190003 / DE0008232125 / GB0002374006 / FI0009003727 / NL0000009538 / DE0006969603 / DE0007164600 / DE0005552004 / DE0006632003 / IT0003128367 / US12626K2033 / DE0007664039 / DE000SYM9999 / DE000PAH0038 / CH0045159024 / DE000A1DAHH0 / DE000A1EWWW0 / DE000A1PHFF7 / DK0060534915 / GB00BH4HKS39 / SE0007691613 / IE00BZ12WP82 / GB00BJFFLV09 / DE000A2YN900</td><td class="leftalignment">Schneider Electric SE / Kering SA / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Fresenius SE & Co KGaA / Hochtief AG / EssilorLuxottica SA / Merck KGaA / Bayerische Motoren Werke AG / Deutsche Lufthansa AG / Diageo PLC / Wartsila Oyj Abp / Koninklijke Philips NV / Puma SE / SAP SE / Deutsche Post AG / MorphoSys AG / Enel SpA / CRH PLC / Volkswagen AG / Symrise AG / Porsche Automobil Holding SE / Compagnie Financiere Richemont SA / Brenntag SE / Adidas AG / Hugo Boss AG / Novo Nordisk A/S / Vodafone Group PLC / Dometic Group AB (publ) / Linde PLC / Croda International PLC / TeamViewer AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / Finland / France / United Kingdom / Ireland / Italy / Netherlands / Sweden</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Herr. Achim Matzke / Frau Petra von Kerssenbrock / Herr Thorsten Grisse</td></tr>
<tr class="even"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HOLT U.S. Specialist Ideas Q3 2021</td><td class="leftalignment">English</td><td class="rightalignment">49</td><td class="leftalignment">GOOGL.OQ / ORLY.OQ / ABT.N / BSX.N / EOG.N / FMC.N / JPM.N / LMT.N / MAS.N / MRK.N / PGR.N / DRI.N / HSY.N / PKG.N / MLM.N / HCA.N / CW.N / MSFT.OQ / TROW.OQ / ST.N / ICE.N / MA.N / BKR.N / CDW.OQ / BURL.N / SYF.N / KEYS.N / ANTM.N / FTV.N</td><td class="leftalignment">Alphabet Inc / O'Reilly Automotive Inc / Abbott Laboratories / Boston Scientific Corp / EOG Resources Inc / FMC Corp / JPMorgan Chase & Co / Lockheed Martin Corp / Masco Corp / Merck & Co Inc / Progressive Corp / Darden Restaurants Inc / Hershey Co / Packaging Corp of America / Martin Marietta Materials Inc / HCA Healthcare Inc / Curtiss-Wright Corp / Microsoft Corp / T Rowe Price Group Inc / Sensata Technologies Holding PLC / Intercontinental Exchange Inc / Mastercard Inc / Baker Hughes Co / CDW Corp / Burlington Stores Inc / Synchrony Financial / Keysight Technologies Inc / Anthem Inc / Fortive Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Beverages & Tobacco / Consumer / Energy / Financial Services / Food / Healthcare / Industrial Materials / Info. Tech./Computers / Manufacturing / Telecommunications</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Equity</td><td class="leftalignment">John Talbott / Steven Bock / Sarah Sprole / Kaitlyn Korich / Vadim Vintsevsky / Brendan Munson / Maxwell Bartuch / HOLT Americas</td></tr>
<tr class="odd"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HOLT: Sanofi- Indications of pipeline turnaround overlooked</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">SASY.PA / AZN.L / ROG.S / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / BAYGN.DE</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Sophia Graeff Buhl-Nielsen / HOLT Europe</td></tr>
<tr class="even"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">COVID-19 pandemic overview: July 2021 update</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">4507.T / JNJ.N / PFE.N / AZN.L / SASY.PA / MRCG.DE / LONN.S / GSK.L / NVAX.OQ / INO.OQ / MRNA.OQ / 1099.HK / CVAC.OQ</td><td class="leftalignment">Shionogi & Co Ltd / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Merck KGaA / Lonza Group AG / GlaxoSmithKline PLC / Novavax Inc / Inovio Pharmaceuticals Inc / Moderna Inc / Sinopharm Group Co Ltd / CureVac NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Brazil / Switzerland / Chile / China / Germany / France / United Kingdom / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 25, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Continue To Ride Johnson & Johnson Stock For Higher Levels</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK=US / LLY=US / OXY=US / RRC=US / T=US / DVN=US / TXN=US / PEB=US / APA=US / CPE=US / EOG=US / REI=US / CRM=US / VZ=US / XOM=US / CRK=US / WLL=US / PXD=US / MGY=US / SWN=US / MUR=US / BYD=US / MRO=US / MGM=US / MANH=US / PENN=US / W=US / STZ=US / AMED=US / ENV=US / COLL=US / CNX=US / DRH=US / EQT=US / HZO=US / MCRI=US / ASGN=US / PLAN=US / PCTY=US / REGN=US / SGMO=US / TRIP=US / VRTX=US / WAL=US / WIX=US / CVX=US / CGEN=US / SGMS=US / SIVB=US / FRT=US / COP=US / MGNI=US / BDSI=US / PTON=US / BIIB=US / CZR=US / TXRH=US / SHO=US / XM=US / BLDR=US / SCPL=US / HST=US / CLR=US / PRPL=US / NOG=US / JACK=US / AR=US / OAS=US / RLJ=US / ESTE=US / BCEI=US / MTDR=US / PDCE=US / RHP=US / FANG=US / GTT=US / GOOGL=US / VNOM=US / HUBS=US / VCEL=US / UPLD=US / PRAH=US / WBA=US / SHAK=US / BWXT=US / WING=US / NVCR=US / TTD=US / CDEV=US / PK=US / PVAC=US / SBOW=US / IOVA=US / BTAI=US / UBER=US / CRWD=US / OVV=US / SPCE=US / ZI=US / TSHA / 96758W101 / BALY=US / REPX=US / 100017125</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Occidental Petroleum Corp / Range Resources Corp / AT&T Inc / Devon Energy Corp / Texas Instruments Inc / Pebblebrook Hotel Trust / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Salesforce.Com Inc / Verizon Communications Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Boyd Gaming Corp / Marathon Oil Corp / MGM Resorts International / Manhattan Associates Inc / Penn National Gaming Inc / Wayfair Inc / Constellation Brands Inc / Amedisys Inc / Envestnet Inc / Collegium Pharmaceutical Inc / CNX Resources Corp / Diamondrock Hospitality Co / EQT Corp / MarineMax Inc / Monarch Casino & Resort Inc / ASGN Inc / Anaplan Inc / Paylocity Holding Corp / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Tripadvisor Inc / Vertex Pharmaceuticals Inc / Western Alliance Bancorp / Wix.Com Ltd / Chevron Corp / Compugen Ltd / Scientific Games Corp / SVB Financial Group / Federal Realty Investment Trust / Conocophillips / Magnite Inc / BioDelivery Sciences International Inc / Peloton Interactive Inc / Biogen Inc / Caesars Entertainment Inc / Texas Roadhouse Inc / Sunstone Hotel Investors Inc / Qualtrics International Inc / Builders FirstSource Inc / Sciplay Corp / Host Hotels & Resorts Inc / Continental Resources Inc / Purple Innovation Inc / Northern Oil and Gas Inc / Jack in the Box Inc / Antero Resources Corp / Oasis Petroleum Inc / RLJ Lodging Trust / Earthstone Energy Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / GTT Communications Inc / Alphabet Inc / Viper Energy Partners LP / HubSpot Inc / Vericel Corp / Upland Software Inc / Prahova Estival 2002 SA / Walgreens Boots Alliance Inc / Shake Shack Inc / BWX Technologies Inc / Wingstop Inc / Novocure Ltd / Trade Desk Inc / Centennial Resource Development Inc / Park Hotels & Resorts Inc / Ranger Oil Corp / SilverBow Resources Inc / Iovance Biotherapeutics Inc / BioXcel Therapeutics Inc / Uber Technologies Inc / CrowdStrike Holdings Inc / Ovintiv Inc / Virgin Galactic Holdings Inc / ZoomInfo Technologies Inc / Taysha Gene Therapies Inc / WideOpenWest Inc / Bally's Corp / Riley Exploration Permian Inc / SVB Financial Group</td><td class="leftalignment"></td><td class="leftalignment">Israel / Romania / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 6, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AEP.N / AES.N / BARC.L / CCI.N / CMS.N / CNA.L / EIX.N / HSBA.L / LLOY.L / MRK.N / PD.N / PEG.N / PFE.N / PNN.L / SO.N / STO.AX / T.N / SSE.L / CNQ.TO / CMCSA.O / SJRb.TO / RCIb.TO / DUK.N / FE.N / PCG.N / PPL.N / JAZZ.O / GIBa.TO / CONE.O / NG.L / VZ.N / EXEL.O / ALA.TO / EXC.N / RRC.N / EQT.N / ADSK.O / EPD.N / AWK.N / NWN.N / FTS.TO / FRAG.DE / BMRN.O / OPTN.O / REGN.O / EMA.TO / ENAG.MC / CU.TO / COP.N / ENDP.O / CPK.N / CRC.N / LNG.A / NWG.L / RGLD.O / EQIX.O / DPM.TO / MNKD.OQ / DLR.N / SCL.TO / RDSb.L / DISCA.O / SJW.N / DRX.L / TEVA.N / H.TO / PPL.TO / CBRO.L / ARX.TO / CVE.TO / NEE.N / TOU.TO / CFX.TO / FRU.TO / PCRX.O / CTT.N / TVE.TO / ABBV.N / PRGO.N / TMUS.N / BEP.N / AGIO.O / AGRX.O / EVA.N / WRK.N / MESO.O / MTRO.L / TWLO.N / AZRE.N / AKERBP.OL / SAND.N / AQN.N / OKTA.OQ / AMRX.N / AQST.O / 269796108 / ZM.O / FSLY.N / DOCU.N / VMUK.L / PAGPA.L / WTRG.N / AKES.OL / ASAN.N / COUR.N / TASK.O</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Barclays PLC / Crown Castle International Corp / CMS Energy Corp / Centrica PLC / Edison International / HSBC Holdings PLC / Lloyds Banking Group PLC / Merck & Co Inc / PagerDuty Inc / Public Service Enterprise Group Inc / Pfizer Inc / Pennon Group PLC / Southern Co / Santos Ltd / AT&T Inc / SSE PLC / Canadian Natural Resources Ltd / Comcast Corp / Shaw Communications Inc / Rogers Communications Inc / Duke Energy Corp / FirstEnergy Corp / PG&E Corp / PPL Corp / Jazz Pharmaceuticals PLC / CGI Inc / CyrusOne Inc / National Grid PLC / Verizon Communications Inc / Exelixis Inc / AltaGas Ltd / Exelon Corp / Range Resources Corp / EQT Corp / Autodesk Inc / Enterprise Products Partners LP / American Water Works Company Inc / Northwest Natural Holding Co / Fortis Inc / Fraport AG Frankfurt Airport Services Worldwide / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Emera Inc / Enagas SA / Canadian Utilities Ltd / Conocophillips / Endo International PLC / Chesapeake Utilities Corp / California Resources Corp / Cheniere Energy Inc / Natwest Group PLC / Royal Gold Inc / Equinix Inc / Dundee Precious Metals Inc / MannKind Corp / Digital Realty Trust Inc / Shawcor Ltd / Royal Dutch Shell PLC / Discovery Inc / SJW Group / Drax Group PLC / Teva Pharmaceutical Industries Ltd / Hydro One Ltd / Pembina Pipeline Corp / Close Brothers Group PLC / ARC Resources Ltd / Cenovus Energy Inc / Nextera Energy Inc / Tourmaline Oil Corp / Canfor Pulp Products Inc / Freehold Royalties Ltd / Pacira Biosciences Inc / CatchMark Timber Trust Inc / Tamarack Valley Energy Ltd / Abbvie Inc / Perrigo Company PLC / T-Mobile US Inc / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / Agile Therapeutics Inc / Enviva Inc / Westrock Co / Mesoblast Ltd / Metro Bank PLC / Twilio Inc / Azure Power Global Ltd / Aker BP ASA / Sandstorm Gold Ltd / Algonquin Power & Utilities Corp / Okta Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc / Eagle Pharmaceuticals Inc / Zoom Video Communications Inc / Fastly Inc / DocuSign Inc / Virgin Money UK PLC / Paragon Banking Group PLC / Essential Utilities Inc / Aker Solutions ASA / Asana Inc / Coursera Inc / Taskus Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Germany / Spain / United Kingdom / Ireland / Israel / Mauritius / Norway / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">07/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending June 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / MNKD.OQ / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / MannKind Corp / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">DD: Viewing DuPont Through a Multi-Industry Lens; Focus on ROIC, FCF Conversion, and the Cycle; Assuming Coverage with a Neutral Rating</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">DD.N / 4063.T / 7203.T / ALB.N / APD.N / CC.N / CE.N / DOW.N / ECL.N / EMN.N / F.N / GM.N / PPG.N / SOLB.BR / TEL.PS / UNVR.JK / ROK.N / ETN.N / WLK.N / ITW.N / MMM.N / EMR.N / XOM.N / MRCG.DE / NUF.AX / OLN.N / SHW.N / ASH.N / ESI.N / PCAR.OQ / CMCSA.OQ / LXSG.DE / OC.N / BAYGN.DE / BASFN.DE / LYB.N / MSI.N / KEY.TO / XYL.N / AXTA.N / PQG.N / AQUA.N / APTV.N / LTHM.N / CTVA.N / HON.OQ</td><td class="leftalignment">Dupont De Nemours Inc / Shin-Etsu Chemical Co Ltd / Toyota Motor Corp / Albemarle Corp / Air Products and Chemicals Inc / Chemours Co / Celanese Corp / Dow Inc / Ecolab Inc / Eastman Chemical Co / Ford Motor Co / General Motors Co / PPG Industries Inc / Solvay SA / PLDT Inc / Unilever Indonesia Tbk PT / Rockwell Automation Inc / Eaton Corporation PLC / Westlake Chemical Corp / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / Merck KGaA / Nufarm Ltd / Olin Corp / Sherwin-Williams Co / Ashland Global Holdings Inc / Element Solutions Inc / Paccar Inc / Comcast Corp / Lanxess AG / Owens Corning / Bayer AG / BASF SE / LyondellBasell Industries NV / Motorola Solutions Inc / Keyera Corp / Xylem Inc / Axalta Coating Systems Ltd / Ecovyst Inc / Evoqua Water Technologies Corp / Aptiv PLC / Livent Corp / Corteva Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Germany / Indonesia / Ireland / Japan / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment">Chemicals / Industrial Materials</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. John F. Walsh, Jr / Tamjid Chowdhury / Jing Zhang</td></tr>
<tr class="odd"><td class="leftalignment">07/05/2021</td><td class="leftalignment">Corporate Watchdog Reports</td><td class="leftalignment">Watchdog Report: MRK - Now with Critical / Key Audit Matters</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Burke</td></tr>
<tr class="even"><td class="leftalignment">07/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.5% Above Pre-Pandemic Base- Week 65</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/02/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended June 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK=US / BMY=US / OXY=US / RRC=US / GBT=US / DVN=US / TXN=US / GILD=US / PEB=US / APA=US / CPE=US / EOG=US / REI=US / H=US / MTN=US / XOM=US / CRK=US / WLL=US / PXD=US / DIOD=US / MGY=US / SWN=US / MUR=US / MAR=US / MRO=US / TNL=US / HLT=US / W=US / STZ=US / AMED=US / CHH=US / CNX=US / DRH=US / EQT=US / MHK=US / RARE=US / TRIP=US / VRTX=US / CVX=US / SAGE=US / CGEN=US / VNO=US / COP=US / MRNS=US / PTON=US / BIIB=US / APTX=US / SHO=US / HST=US / CPRX=US / CLR=US / WH=US / NOG=US / RCUS=US / AR=US / OAS=US / HGV=US / NXPI=US / RLJ=US / ESTE=US / VAC=US / BCEI=US / MTDR=US / PDCE=US / RHP=US / FANG=US / CNCE=US / VNOM=US / RLMD=US / VKTX=US / ARGX=US / WVE=US / AXSM=US / EDIT=US / NTLA=US / ADVM=US / CDEV=US / CRSP=US / PK=US / PVAC=US / ANAB=US / PLYA=US / VRNA=US / SBOW=US / ARVN=US / OVV=US / CRMD.US / TSHA / 96758W101</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Occidental Petroleum Corp / Range Resources Corp / Global Blood Therapeutics Inc / Devon Energy Corp / Texas Instruments Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Hyatt Hotels Corp / Vail Resorts Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Diodes Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Marriott International Inc / Marathon Oil Corp / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Wayfair Inc / Constellation Brands Inc / Amedisys Inc / Choice Hotels International Inc / CNX Resources Corp / Diamondrock Hospitality Co / EQT Corp / Mohawk Industries Inc / Ultragenyx Pharmaceutical Inc / Tripadvisor Inc / Vertex Pharmaceuticals Inc / Chevron Corp / SAGE Therapeutics Inc / Compugen Ltd / Vornado Realty Trust / Conocophillips / Marinus Pharmaceuticals Inc / Peloton Interactive Inc / Biogen Inc / Aptinyx Inc / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / Catalyst Pharmaceuticals Inc / Continental Resources Inc / Wyndham Hotels & Resorts Inc / Northern Oil and Gas Inc / Arcus Biosciences Inc / Antero Resources Corp / Oasis Petroleum Inc / Hilton Grand Vacations Inc / NXP Semiconductors NV / RLJ Lodging Trust / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Concert Pharmaceuticals Inc / Viper Energy Partners LP / Relmada Therapeutics Inc / Viking Therapeutics Inc / argenx SE / WAVE Life Sciences Ltd / Axsome Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Centennial Resource Development Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / Ranger Oil Corp / AnaptysBio Inc / Playa Hotels & Resorts NV / Verona Pharma PLC / SilverBow Resources Inc / Arvinas Inc / Ovintiv Inc / CorMedix Inc / Taysha Gene Therapies Inc / WideOpenWest Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Israel / Netherlands / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Really Committed: €400M/Yr for mRNA Flu, COVID, Maybe RSV; Cautious COVID View</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">F5548N10 / 71708110 / 58933Y10 / 09075V10 / 60770K10 / G3910J11</td><td class="leftalignment">Sanofi SA / Pfizer Inc / Merck & Co Inc / BioNTech SE / Moderna Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">Germany / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">IO Nuggets: Insight Into The Expression & Function of PVRIG & TIGIT</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CGEN=US / MRK=US / BMY=US / GILD=US / RCUS=US</td><td class="leftalignment">Compugen Ltd / Merck & Co Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene</td></tr>
<tr class="even"><td class="leftalignment">07/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CAS.TO / DANO.PA / MRK.N / PFE.N / ULVR.L / SSE.L / SJRb.TO / GIS.N / JAZZ.O / NG.L / STZ.N / PVH.N / OPTN.O / PFG.N / COP.N / ENDP.O / AMED.O / NESN.S / MNKD.OQ / DRX.L / TEVA.N / CLW.N / ENV.N / PCRX.O / RFP.N / ABBV.N / KPT.TO / PRGO.N / FLXN.O / AGRX.O / AMRX.N / VRCA.OQ / NTGY.MC / AQST.O / OSMT.O / 269796108 / VTRS.OQ / OTLY.O</td><td class="leftalignment">Cascades Inc / Danone SA / Merck & Co Inc / Pfizer Inc / Unilever PLC / SSE PLC / Shaw Communications Inc / General Mills Inc / Jazz Pharmaceuticals PLC / National Grid PLC / Constellation Brands Inc / PVH Corp / OptiNose Inc / Principal Financial Group Inc / Conocophillips / Endo International PLC / Amedisys Inc / Nestle SA / MannKind Corp / Drax Group PLC / Teva Pharmaceutical Industries Ltd / Clearwater Paper Corp / Envestnet Inc / Pacira Biosciences Inc / Resolute Forest Products Inc / Abbvie Inc / KP Tissue Inc / Perrigo Company PLC / Pacira Biosciences Inc / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Verrica Pharmaceuticals Inc / Naturgy Energy Group SA / Aquestive Therapeutics Inc / Osmotica Pharmaceuticals PLC / Eagle Pharmaceuticals Inc / Viatris Inc / Oatly Group AB</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / China / Spain / France / United Kingdom / Ireland / Israel / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">07/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Our top catalysts for 2H2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / MNKD.OQ / TEVA.N / PCRX.O / ABBV.N / PRGO.N / FLXN.O / AGRX.O / AMRX.N / VRCA.OQ / AQST.O / OSMT.O / 269796108 / VTRS.OQ</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / MannKind Corp / Teva Pharmaceutical Industries Ltd / Pacira Biosciences Inc / Abbvie Inc / Perrigo Company PLC / Pacira Biosciences Inc / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Verrica Pharmaceuticals Inc / Aquestive Therapeutics Inc / Osmotica Pharmaceuticals PLC / Eagle Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HOLT European Specialist Picks Q3 2021</td><td class="leftalignment">English</td><td class="rightalignment">63</td><td class="leftalignment">KGF.L / PRTP.PA / ABF.L / ALVG.DE / AXAF.PA / IBE.MC / IMI.L / JMAT.L / KYGA.I / REP.MC / SEBA.ST / AAL.L / SASY.PA / NOVOB.CO / BEIG.DE / MRCG.DE / KOG.OL / SCHP.S / INGA.AS / ASOS.L / GL9.I / SHLG.DE / RRTL.DE / VALMT.HE / UBSG.S / AT1.DE / ESSITYB.ST / HARG.BA / TMV.DE</td><td class="leftalignment">Kingfisher PLC / Kering SA / Associated British Foods PLC / Allianz SE / AXA SA / Iberdrola SA / IMI PLC / Johnson Matthey PLC / Kerry Group PLC / Repsol SA / Skandinaviska Enskilda Banken AB / Anglo American PLC / Sanofi SA / Novo Nordisk A/S / Beiersdorf AG / Merck KGaA / Kongsberg Gruppen ASA / Schindler Holding AG / ING Groep NV / ASOS PLC / Glanbia PLC / Siemens Healthineers AG / RTL Group SA / Valmet Oyj / UBS Group AG / Aroundtown SA / Essity AB (publ) / Holcim Argentina SA / TeamViewer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Argentina / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Luxembourg / Netherlands / Norway / Sweden</td><td class="leftalignment">Beverages & Tobacco / Consumer / Energy / Financial Services / Food / Healthcare / Industrial Materials / Info. Tech./Computers / Manufacturing / Telecommunications / Utilities</td><td class="leftalignment">Euroland / Europe / Latin America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Helen Booth / HOLT Europe / Hiten Patel</td></tr>
<tr class="odd"><td class="leftalignment">06/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Merck climbs 12% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Merck shares post best quarter in three quarters</td><td class="leftalignment">English</td><td class="rightalignment">82</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">06/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Merck gains 6.9% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jun 30 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0028241000 / US0463531089 / US1011371077 / US1101221083 / US37733W1053 / US4663671091 / US92343V1044 / US20030N1019 / US2533931026 / US00206R1023 / US25470M1099 / US58933Y1055 / US8725901040 / US12685J1051 / US16119P1084 / US02156K1034 / US4622601007 / US98980G1022 / US68570P1012 / US4432011082 / US03476J1079</td><td class="leftalignment">Abbott Laboratories / AstraZeneca PLC / Boston Scientific Corp / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Jack in the Box Inc / Verizon Communications Inc / Comcast Corp / DICK'S Sporting Goods Inc / AT&T Inc / DISH Network Corp / Merck & Co Inc / T-Mobile US Inc / Cable One Inc / Charter Communications Inc / Altice USA Inc / Iovance Biotherapeutics Inc / Zscaler Inc / Orchard Therapeutics PLC / Howmet Aerospace Inc / Angion Biomedica Corp</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">06/30/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Highlights From Cowen ADA 2021 KOL Call</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US58933Y1055</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Ms. Kathleen M. Miner, R.Ph., CFA</td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Merck & Co., Inc. JUNE 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="odd"><td class="leftalignment">06/30/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Merck KGaA JUNE 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="even"><td class="leftalignment">06/29/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Drug Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">53</td><td class="leftalignment">US00461U1051 / US5288723027 / US4525253062 / US5160121019 / US62855J1043 / US6388423021 / US74838J1016 / US75886F1075 / US92532F1003 / US68554V1089 / US6402681083 / US09060J1060 / CA87402A1084 / US58933Y1055 / US92345Y1064 / US42805E3062 / US48576U1060 / CA4990531069 / US71742Q1067 / US0453961080 / CA68620P1018 / US5165441032 / US98978L2043 / US53222K2050 / US4622221004 / US44842L1035 / US1710774076 / US64049K1043 / US92556V1061 / US0547548745 / US92941V2097</td><td class="leftalignment">Aclaris Therapeutics Inc / Lexicon Pharmaceuticals Inc / ImmuCell Corp / Lannett Company Inc / Myriad Genetics Inc / Natural Alternatives International Inc / Quidel Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / OraSure Technologies Inc / Nektar Therapeutics / BioDelivery Sciences International Inc / Taiga Building Products Ltd / Merck & Co Inc / Verisk Analytics Inc / Heska Corp / Karyopharm Therapeutics Inc / Knight Therapeutics Inc / Phibro Animal Health Corp / Assembly Biosciences Inc / OrganiGram Holdings Inc / Lantheus Holdings Inc / Zogenix Inc / LifeVantage Corp / Ionis Pharmaceuticals Inc / HUTCHMED (China) Ltd / Chromadex Corp / Neoleukin Therapeutics Inc / Viatris Inc / Aytu Biopharma Inc / Vyne Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PAHC-US -  Dividend Quality Analysis, for the period ended June 23,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PAHC.O / ADM / LLY / MRK / ICCC.O / HSKA.O / ZTS</td><td class="leftalignment">Phibro Animal Health Corp / Archer-Daniels-Midland Co / Eli Lilly and Co / Merck & Co Inc / ImmuCell Corp / Heska Corp / Zoetis Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 18, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">ACIP Meeting Favors PCV20, Broadened Shingrix Use; Formal Votes In Fall</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US37733W1053 / US58933Y1055</td><td class="leftalignment">GlaxoSmithKline PLC / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jun 28 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0116591092 / US02553E1064 / US0463531089 / US1101221083 / US1924221039 / US3695501086 / US37733W1053 / US4781601046 / US5002551043 / US5324571083 / US66987V1098 / US6701002056 / US7043261079 / US7170811035 / US75886F1075 / US7711951043 / US8308791024 / US8447411088 / US87612E1064 / US8832031012 / CA0977512007 / US4771431016 / US4198791018 / US80105N1054 / US31620M1062 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US29082A1079 / US00287Y1091 / US98978V1035 / US8485771021 / US21240E1055 / US02376R1023 / CA0089118776 / US70450Y1038 / US5588681057 / US8760301072 / US5904791358 / US28414H1032 / US76156B1070 / US88339P1012 / US26142R1041 / US12769G1004 / CA67079A1021 / US05875B1061 / US73739W1045 / BMG6964L1072</td><td class="leftalignment">Alaska Air Group Inc / American Eagle Outfitters Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cognex Corp / General Dynamics Corp / GlaxoSmithKline PLC / Johnson & Johnson / Kohls Corp / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Paychex Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Target Corp / Textron Inc / Bombardier Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Fidelity National Information Services Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Embraer SA / Abbvie Inc / Zoetis Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Air Canada / PayPal Holdings Inc / Madrigal Pharmaceuticals Inc / Tapestry Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Revolve Group Inc / RealReal Inc / DraftKings Inc / Caesars Entertainment Inc / Nuvei Corp / Bally's Corp / Poshmark Inc / Paysafe Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Brazil / Canada / Switzerland / Denmark / France / United Kingdom / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AEP.N / AES.N / CCI.N / EDP.LS / EIX.N / ELE.MC / IBE.MC / IP.N / MRK.N / PD.N / PFE.N / PNN.L / RWEG.DE / SO.N / T.N / SSE.L / DRE.N / TRI.N / GILD.O / CMCSA.O / AMGN.O / INCY.O / DUK.N / REE.MC / GIS.N / JAZZ.O / CONE.O / NG.L / VZ.N / EXEL.O / KMX.N / AWK.N / NWN.N / BMRN.O / REGN.O / ENAG.MC / ENDP.O / CPK.N / PEGA.OQ / SEM.N / CASY.O / EQIX.O / ATDb.TO / BIIB.O / DLR.N / WEF.TO / ALNY.O / DISCA.O / SJW.N / DRX.L / TEVA.N / SLRS.MC / EONGn.DE / BHPB.L / NEE.N / CIO.N / SPLK.OQ / ABBV.N / TMUS.N / PRTA.O / BEP.N / ESNT.N / NEP.N / DEA.N / 78667J108 / EDIT.O / NTLA.O / TWLO.N / UN01.DE / NTNX.O / CRSP.OQ / GREG.MC / VST.N / ORSTED.CO / EHC.N / SMAR.N / DBX.O / CWEN.N / OSMT.O / 269796108 / ZM.O / FSLY.N / GMAB.O / DOCU.N / WTRG.N / BEAM.O / IGIC.OQ</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Crown Castle International Corp / EDP Energias de Portugal SA / Edison International / Endesa SA / Iberdrola SA / International Paper Co / Merck & Co Inc / PagerDuty Inc / Pfizer Inc / Pennon Group PLC / Rwe AG / Southern Co / AT&T Inc / SSE PLC / Duke Realty Corp / Thomson Reuters Corp / Gilead Sciences Inc / Comcast Corp / Amgen Inc / Incyte Corp / Duke Energy Corp / Red Electrica Corporacion SA / General Mills Inc / Jazz Pharmaceuticals PLC / CyrusOne Inc / National Grid PLC / Verizon Communications Inc / Exelixis Inc / Carmax Inc / American Water Works Company Inc / Northwest Natural Holding Co / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Enagas SA / Endo International PLC / Chesapeake Utilities Corp / Pegasystems Inc / Select Medical Holdings Corp / Caseys General Stores Inc / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Digital Realty Trust Inc / Western Forest Products Inc / Alnylam Pharmaceuticals Inc / Discovery Inc / SJW Group / Drax Group PLC / Teva Pharmaceutical Industries Ltd / Solaria Energia y Medio Ambiente SA / E.ON SE / BHP Group PLC / Nextera Energy Inc / City Office REIT Inc / Splunk Inc / Abbvie Inc / T-Mobile US Inc / Prothena Corporation PLC / Brookfield Renewable Partners LP / Essent Group Ltd / Nextera Energy Partners LP / Easterly Government Properties Inc / SAGE Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Twilio Inc / Uniper SE / Nutanix Inc / CRISPR Therapeutics AG / Grenergy Renovables SA / Vistra Corp / Orsted A/S / Encompass Health Corp / Smartsheet Inc / Dropbox Inc / Clearway Energy Inc / Osmotica Pharmaceuticals PLC / Eagle Pharmaceuticals Inc / Zoom Video Communications Inc / Fastly Inc / Genmab A/S / DocuSign Inc / Essential Utilities Inc / Beam Therapeutics Inc / International General Insurance Holdings Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Germany / Denmark / Spain / United Kingdom / Ireland / Israel / Portugal / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Pharmaceuticals - Learn your ADC</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">FR0000120578 / DE0006599905 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US5324571083 / US7170811035 / US58933Y1055 / US00287Y1091 / DK0060534915</td><td class="leftalignment">Sanofi SA / Merck KGaA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Merck & Co Inc / Abbvie Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Jun 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">46</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ / MNK.N^J20</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc / Mallinckrodt PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">06/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">RPTX - Synthetic Lethal Targeting of DNA Damage "Repare"; Initiating Coverage with a BUY Rating and $46 Price Target</td><td class="leftalignment">English</td><td class="rightalignment">49</td><td class="leftalignment">BLF0CW7 / 0989529 / 0925288 / 2126335 / 2516152 / 2778844 / 2684703 / B6RS2B3 / BK0VHF6 / BMQ5T49 / BWY52P3</td><td class="leftalignment">Repare Therapeutics Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Clovis Oncology Inc / IDEAYA Biosciences Inc / Zentalis Pharmaceuticals Inc / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / ENDP.O / TEVA.N / ABBV.N / OSMT.O / 269796108</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Osmotica Pharmaceuticals PLC / Eagle Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">06/27/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.6% Above Pre-Pandemic Base- Week 64</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/25/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Merck lifts 10% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">51</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">06/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">PFE/MRK - Takeaways from today's ACIP session on pneumococcal vaccines; important vote on recommendations coming in October</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">MRK.N / PFE.N</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daniel Busby</td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Portfolio Manager's Weekly - June 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">NL0000226223 / DE0006231004 / US0378331005 / US0382221051 / US1727551004 / US37733W1053 / US4523271090 / US5261071071 / US5951121038 / US7170811035 / US7392761034 / US7475251036 / US8168501018 / US8610121027 / US8807701029 / US91347P1057 / US9581021055 / US87157D1090 / US83088M1027 / US80105N1054 / US1572101053 / US82706C1080 / US79546E1047 / US58933Y1055 / NL0010273215 / US74736K1016 / IE00BY7QL619 / US11135F1012 / IE00BK9ZQ967 / US14448C1045 / US6833731044 / US55406W1036 / US1241551027 / US30260D1037 / US82933R1005</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / Apple Inc / Applied Materials Inc / Cirrus Logic Inc / GlaxoSmithKline PLC / Illumina Inc / Lennox International Inc / Micron Technology Inc / Pfizer Inc / Power Integrations Inc / Qualcomm Inc / Semtech Corp / STMicroelectronics NV / Teradyne Inc / Universal Display Corp / Western Digital Corp / Synaptics Inc / Skyworks Solutions Inc / Sanofi SA / CEVA Inc / Silicon Motion Technology Corp / Sally Beauty Holdings Inc / Merck & Co Inc / ASML Holding NV / Qorvo Inc / Johnson Controls International PLC / Broadcom Inc / Trane Technologies PLC / Carrier Global Corp / Ontrak Inc / MYT Netherlands Parent BV / Butterfly Network Inc / Figs Inc / Singular Genomics Systems Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">06/25/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended June 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending June 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS.OQ / ACRX.OQ / 0013.HK / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BDSI.OQ / CUTR.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / OMER.OQ / ARDX.OQ / ZTS.N / ANIP.OQ / AXGN.OQ / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / LPCN.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / CERC.OQ / SPNE.OQ / CKPT.OQ / VERU.OQ / TXMD.OQ / AYTU.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / IMAB.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / AZYO.OQ / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Cutera Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Lipocine Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / Avalo Therapeutics Inc / SeaSpine Holdings Corp / Checkpoint Therapeutics Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / I-Mab / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Aziyo Biologics Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Guotai JunAn (HK) Retail Rsch</td><td class="leftalignment">默克 Merk & Co.-K 药和新冠药物前景明朗，料全年业绩强劲-06/24/2021</td><td class="leftalignment">Chinese</td><td class="rightalignment">2</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Chloe Kim</td></tr>
<tr class="odd"><td class="leftalignment">06/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">What’s Implied by Vague TIGIT Comments? Sounds Like 10% Delta, More for Triplet</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">03969F10 / M2572210 / 771195104 / 58933Y10</td><td class="leftalignment">Arcus Biosciences Inc / Compugen Ltd / Roche Holding AG / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">06/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Encouraging ARC-7 TIGIT Read-through to CGEN, ITOS and MRK</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">37555810 / M2572210 / 771195104 / 58933Y10 / 58949210 / 46565G10 / 03969F10</td><td class="leftalignment">Gilead Sciences Inc / Compugen Ltd / Roche Holding AG / Merck & Co Inc / Mereo Biopharma Group PLC / Iteos Therapeutics Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Jeffrey La Rosa / Dilip Joseph</td></tr>
<tr class="odd"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - Key takeaways from New GSK</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">GSK.L / JNJ.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / GILD.OQ / HALO.OQ / BAYGN.DE / CVAC.OQ</td><td class="leftalignment">GlaxoSmithKline PLC / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Gilead Sciences Inc / Halozyme Therapeutics Inc / Bayer AG / CureVac NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">06/24/2021</td><td class="leftalignment">The Wall Street Transcript</td><td class="leftalignment">Risk/Reward Equation Points to Picks in Malls, Homebuilding, Pharma</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ALL.N / AXP.N / BAC.N / JPM.N / MRK.N / PFE.N / SPG.N / PGR.N / LEN.N / HD.N / TGT.N / DHI.N / MAC.N / AMGN.OQ / AAPL.OQ / COST.OQ / AMZN.OQ / CRI.N / GOOG.OQ / CMG.N / CLR.N / NVR.N / UBER.N</td><td class="leftalignment">Allstate Corp / American Express Co / Bank of America Corp / JPMorgan Chase & Co / Merck & Co Inc / Pfizer Inc / Simon Property Group Inc / Progressive Corp / Lennar Corp / Home Depot Inc / Target Corp / D R Horton Inc / Macerich Co / Amgen Inc / Apple Inc / Costco Wholesale Corp / Amazon.com Inc / Carter's Inc / Alphabet Inc / Chipotle Mexican Grill Inc / Continental Resources Inc / NVR Inc / Uber Technologies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">No Industry</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / ASSET MANAGEMENT / ECONOMIC ANALYSIS / FUNDAMENTAL ANALYSIS / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">The Wall St Transcript</td></tr>
<tr class="odd"><td class="leftalignment">06/23/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Merck soars 397.6% from 2 week low</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">06/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">2000019 / 2778844 / 2222631 / 2280220 / 2270726 / 2542049 / 2342034 / 2369174 / 2829601 / 2857817 / 2951452 / B3D7K31 / B7TL820 / B7VD3F2 / B424494 / BYVYD43 / BD8DJ71 / BJFSR88 / BKDS4H5 / BNFWR44 / BKTNTR9 / BYY88Y7</td><td class="leftalignment">Amazon.com Inc / Merck & Co Inc / Cooper Companies Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Fiserv Inc / Gilead Sciences Inc / Southern Co / Netflix Inc / J M Smucker Co / Discovery Inc / Meta Platforms Inc / Duke Energy Corp / Splunk Inc / Performance Food Group Co / Snap Inc / Uniqure NV / Bill.com Holdings Inc / Worldline SA / ViacomCBS Inc / Alphabet Inc</td><td class="leftalignment"></td><td class="leftalignment">France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">06/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">600276.SS: Jiangsu Hengrui Medicine Co. Ltd - Deep-dive for innovative drug pipeline supporting upside; reiterate OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">600276.SS / 1093.HK / 4503.T / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / 1177.HK / NOVN.S / GSK.L / GILD.OQ / INCY.OQ / 600267.SS / 0867.HK / 4568.T / 3933.HK / BAYGN.DE / 0460.HK / 601607.SS / 002422.SZ / 300003.SZ / 2607.HK / ABBV.N / 1513.HK / 2186.HK / 1530.HK / 1558.HK / BGNE.OQ / 300558.SZ / ZLAB.OQ / 6160.HK / 1801.HK / 1877.HK</td><td class="leftalignment">Jiangsu Hengrui Pharmaceuticals Co Ltd / CSPC Pharmaceutical Group Ltd / Astellas Pharma Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Sino Biopharmaceutical Ltd / Novartis AG / GlaxoSmithKline PLC / Gilead Sciences Inc / Incyte Corp / Zhejiang Hisun Pharmaceutical Co Ltd / China Medical System Holdings Ltd / Daiichi Sankyo Co Ltd / United Laboratories International Holdings Ltd / Bayer AG / Sihuan Pharmaceutical Holdings Group Ltd / Shanghai Pharmaceuticals Holding Co Ltd / Sichuan Kelun Pharmaceutical Co Ltd / Lepu Medical Technology Beijing Co Ltd / Shanghai Pharmaceuticals Holding Co Ltd / Abbvie Inc / Livzon Pharmaceutical Group Inc / Luye Pharma Group Ltd / 3SBio Inc / YiChang HEC ChangJiang Pharmaceutical Co Ltd / Beigene Ltd / Betta Pharmaceuticals Co Ltd / Zai Lab Ltd / Beigene Ltd / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / China / Cayman Islands / Germany / France / United Kingdom / Hong Kong / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">06/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">MRK: Highlights from Our Guggenheim BioPharma Strategy Series Discussion with Dr. Dean Li, EVP & President of Merck Research Laboratories</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2778844</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">More Positive Signals for RSV; COVID Protein Subunits Coming of Age</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">F5548N10 / 71708110 / 04635310 / 58933Y10 / 09075V10 / G3910J11</td><td class="leftalignment">Sanofi SA / Pfizer Inc / AstraZeneca PLC / Merck & Co Inc / BioNTech SE / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">Germany / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">06/22/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Drug Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">US00461U1051 / US5288723027 / US4525253062 / US5160121019 / US62855J1043 / US6388423021 / US74838J1016 / US75886F1075 / US92532F1003 / US68554V1089 / US6402681083 / US09060J1060 / CA87402A1084 / US58933Y1055 / US92345Y1064 / US42805E3062 / US48576U1060 / CA4990531069 / US71742Q1067 / US0453961080 / CA68620P1018 / US5165441032 / US98978L2043 / US53222K2050 / US4622221004 / US44842L1035 / US1710774076 / US64049K1043 / US92556V1061 / US0547548745 / US92941V2097</td><td class="leftalignment">Aclaris Therapeutics Inc / Lexicon Pharmaceuticals Inc / ImmuCell Corp / Lannett Company Inc / Myriad Genetics Inc / Natural Alternatives International Inc / Quidel Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / OraSure Technologies Inc / Nektar Therapeutics / BioDelivery Sciences International Inc / Taiga Building Products Ltd / Merck & Co Inc / Verisk Analytics Inc / Heska Corp / Karyopharm Therapeutics Inc / Knight Therapeutics Inc / Phibro Animal Health Corp / Assembly Biosciences Inc / OrganiGram Holdings Inc / Lantheus Holdings Inc / Zogenix Inc / LifeVantage Corp / Ionis Pharmaceuticals Inc / HUTCHMED (China) Ltd / Chromadex Corp / Neoleukin Therapeutics Inc / Viatris Inc / Aytu Biopharma Inc / Vyne Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">06/22/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRK.N - Event Transcript of Merck & Co Inc conference call, Jun. 22, 2021 / 9:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - CS forecasts 2.2% CAGR Rev Growth to 2030 range of 0% to 6.4% based on R&D success</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">GSK.L / BMY.N / CL.N / JNJ.N / LLY.N / MRK.N / OREP.PA / PFE.N / ULVR.L / PG.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / BEIG.DE / ABBV.N / RKT.L</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Colgate-Palmolive Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / L'Oreal SA / Pfizer Inc / Unilever PLC / Procter & Gamble Co / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Beiersdorf AG / Abbvie Inc / Reckitt Benckiser Group PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Ms Jo Walton / Elizabeth Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 11, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending June 11, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Societe Generale</td><td class="leftalignment">Pharmaceuticals & Biotechnology - Cancer expert event feedback: impressive industry execution continues</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">AZN.L / NOVN.S / MRK.N / ROG.S</td><td class="leftalignment">AstraZeneca PLC / Novartis AG / Merck & Co Inc / Roche Holding AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / INDUSTRY REPORTS / Equity</td><td class="leftalignment">Florent Cespedes / Justin S. Smith / Manas Sarkar</td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jun 21 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0079731008 / US0116591092 / US0382221051 / US0463531089 / US1101221083 / US1925761066 / US37733W1053 / US4523271090 / US4781601046 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US8807701029 / US91347P1057 / US4771431016 / US4198791018 / US80105N1054 / US3463751087 / US90385V1070 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US34959E1091 / US9100471096 / US00287Y1091 / NL0010273215 / US98978V1035 / US8485771021 / US21240E1055 / US02376R1023 / US70438V1061 / CA0089118776 / US07725L1026 / KYG4740B1059 / US8760301072 / US5904791358 / US28414H1032 / US46583P1021 / US26142R1041 / US83089J1088 / US1241551027 / US30260D1037 / US82933R1005 / US23954D1090</td><td class="leftalignment">Advanced Energy Industries Inc / Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cohu Inc / GlaxoSmithKline PLC / Illumina Inc / Johnson & Johnson / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Teradyne Inc / Universal Display Corp / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / FormFactor Inc / Ultra Clean Holdings Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / Fortinet Inc / United Airlines Holdings Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Paylocity Holding Corp / Air Canada / Beigene Ltd / Ichor Holdings Ltd / Tapestry Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Iveric Bio Inc / DraftKings Inc / Skywater Technology Inc / Butterfly Network Inc / Figs Inc / Singular Genomics Systems Inc / Day One Biopharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">06/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AEP.N / AES.N / BB.N / CAS.TO / CCI.N / CCK.N / CL.N / EIX.N / EL.N / FOUG.PA / GPS.N / IP.N / KMB.N / KO.N / MRK.N / PD.N / PFE.N / PNN.L / SGEF.PA / SO.N / SVT.L / T.N / VIEV.VI / SSE.L / PEP.N / BFb.N / PG.N / CFP.TO / GILD.O / FNV.N / CPB.N / CMCSA.O / THC.N / DUK.N / LEA.N / REE.MC / K.N / DISH.O / ADBE.O / CLX.N / CAG.N / GIS.N / EPC.N / AMT.N / JAZZ.O / CONE.O / NG.L / VZ.N / STZ.N / FISV.O / AWK.N / CHD.N / NWN.N / APT.AX / SAM.N / FRAG.DE / ENR.N / NCR.N / GPK.N / ENAG.MC / ENDP.O / CPK.N / PEGA.OQ / GPN.N / MNST.O / EQIX.O / 02209S103 / TRN.MI / MNKD.OQ / 427866108 / SJW.N / FIS.N / ADP.PA / ATL.MI / BGS.N / GETP.PA / SPB.N / FHZN.S / TXG.TO / NEE.N / SLS.TO / PCH.O / XYL.N / MDLZ.OQ / PRMW.N / VOYA.N / COTY.N / BEP.N / 81762P102 / CEQP.N / ESNT.N / BTG.N / NEP.N / HQY.OQ / AENA.MC / WRK.N / GBT.OQ / RUN.O / TRHC.OQ / AZRE.N / NTNX.O / VST.N / AQUA.N / SAIL.N / DBX.O / AMRX.N / NTGY.MC / KDP.N / CWEN.N / NWL.O / LSPD.TO / 269796108 / PEAK.N / AZEK.N / WTRG.N / REYN.O / IGIC.OQ / FOUR.N / ZI.O / IBEX.O / LUMN.N / NVEIu.TO / PUBM.O / WFG.N / AFRM.O / NAPA.N / OTLY.O / FLYW.O / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / BlackBerry Ltd / Cascades Inc / Crown Castle International Corp / Crown Holdings Inc / Colgate-Palmolive Co / Edison International / Estee Lauder Companies Inc / Eiffage SA / Gap Inc / International Paper Co / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / PagerDuty Inc / Pfizer Inc / Pennon Group PLC / Vinci SA / Southern Co / Severn Trent PLC / AT&T Inc / Flughafen Wien AG / SSE PLC / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Canfor Corp / Gilead Sciences Inc / Franco-Nevada Corp / Campbell Soup Co / Comcast Corp / Tenet Healthcare Corp / Duke Energy Corp / Lear Corp / Red Electrica Corporacion SA / Kellogg Co / DISH Network Corp / Adobe Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / Edgewell Personal Care Co / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / National Grid PLC / Verizon Communications Inc / Constellation Brands Inc / Fiserv Inc / American Water Works Company Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Afterpay Ltd / Boston Beer Company Inc / Fraport AG Frankfurt Airport Services Worldwide / Energizer Holdings Inc / NCR Corp / Graphic Packaging Holding Co / Enagas SA / Endo International PLC / Chesapeake Utilities Corp / Pegasystems Inc / Global Payments Inc / Monster Beverage Corp / Equinix Inc / Altria Group Inc / Terna Rete Elettrica Nazionale SpA / MannKind Corp / Hershey Co / SJW Group / Fidelity National Information Services Inc / Aeroports de Paris SA / Atlantia SpA / B&G Foods Inc / Getlink SE / Spectrum Brands Holdings Inc / Flughafen Zuerich AG / Torex Gold Resources Inc / Nextera Energy Inc / Solaris Resources Inc / Potlatchdeltic Corp / Xylem Inc / Mondelez International Inc / Primo Water Corp / Voya Financial Inc / Coty Inc / Brookfield Renewable Partners LP / ServiceNow Inc / Crestwood Equity Partners LP / Essent Group Ltd / B2Gold Corp / Nextera Energy Partners LP / Healthequity Inc / Aena SME SA / Westrock Co / Global Blood Therapeutics Inc / Sunrun Inc / Tabula Rasa HealthCare Inc / Azure Power Global Ltd / Nutanix Inc / Vistra Corp / Evoqua Water Technologies Corp / SailPoint Technologies Holdings Inc / Dropbox Inc / Amneal Pharmaceuticals Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Clearway Energy Inc / Newell Brands Inc / Lightspeed Commerce Inc / Eagle Pharmaceuticals Inc / Healthpeak Properties Inc / Azek Company Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / International General Insurance Holdings Ltd / Shift4 Payments Inc / ZoomInfo Technologies Inc / Ibex Ltd / Lumen Technologies Inc / Nuvei Corp / PubMatic Inc / West Fraser Timber Co Ltd / Affirm Holdings Inc / Duckhorn Portfolio Inc / Oatly Group AB / Flywire Corp / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Austria / Bermuda / Canada / Switzerland / Germany / Spain / France / United Kingdom / Ireland / Italy / Mauritius / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">RSV: Large, Unmet Market Offers Investment Opportunities - Ahead Of The Curve</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">US58933Y1055 / US37733W1053 / US7170811035 / US80105N1054</td><td class="leftalignment">Merck & Co Inc / GlaxoSmithKline PLC / Pfizer Inc / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Ms. Kathleen M. Miner, R.Ph., CFA</td></tr>
<tr class="odd"><td class="leftalignment">06/21/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">633</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Middle East</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="even"><td class="leftalignment">06/20/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Does The Valuation Gap Between Merck Stock And Zoetis Make Sense?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/20/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Is There More Room For Growth In Roche Stock After A 12% Rise In A Month?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">RHHBY.PK / JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Roche Holding AG / Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / ENDP.O / MNKD.OQ / AMRX.N / 269796108</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / Endo International PLC / MannKind Corp / Amneal Pharmaceuticals Inc / Eagle Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">06/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.4% Above Pre-Pandemic Base- Week 63</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/18/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Trefis Report: Merck - $98.61 Trefis Price Estimate</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/18/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Marka climbs 17% in 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRKP.WA</td><td class="leftalignment">Marka SA w restrukturyzacji</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Poland</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">06/18/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 6.18.21</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">00365410 / 28176E10 / 62855J10 / 00282410 / 75991610 / 71708110 / 00846U10 / 44485910 / 12665010 / 07181310 / 10113710 / 88355610 / 04635310 / 43644010 / 87936910 / 37555810 / 75886F10 / 53245710 / 46120E60 / 11679410 / 45232710 / 01625510 / 30063P10 / 478160104 / 075887109 / 60855R10 / 205306103 / 45784P10 / 25213110 / 04963C20 / 64049M20 / 58933Y10 / 14161910 / 45766930 / 80360710 / 92337F10 / 09073M104 / 82621J10 / 92346J10 / G5960L10 / 23283X20 / 40131M10 / 89853L10 / 71944F10 / 42226A10 / 68269G10 / 58949210 / 09075V10 / 60770K10 / 05156V10 / 01438T10 / 74374N10 / 31189P10 / 07725L10 / G3910J11 / 37242740 / 43906K10 / 45781K20 / 48576U10 / F5548N10 / 45845P10 / 4525EP10 / 22905030 / G8807B10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 05465P10 / 00461U10 / 04539610 / F4373810 / N4482110 / 28255910 / 29446K10 / N1976T10 / 36322Q10 / 74623710 / 15912K10 / 69512710 / 00288U10 / 90184D10</td><td class="leftalignment">ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Abbott Laboratories / Repligen Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Thermo Fisher Scientific Inc / AstraZeneca PLC / Hologic Inc / Teleflex Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Intuitive Surgical Inc / Bruker Corp / Illumina Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Becton Dickinson and Co / Molina Healthcare Inc / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Insmed Inc / Sarepta Therapeutics Inc / Veracyte Inc / Bio-Techne Corp / Sientra Inc / Vericel Corp / Medtronic PLC / Cytosorbents Corp / Guardant Health Inc / T2 Biosystems Inc / Phreesia Inc / Healthequity Inc / 1Life Healthcare Inc / Mereo Biopharma Group PLC / BioNTech SE / Moderna Inc / Aurinia Pharmaceuticals Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Genocea Biosciences Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Karyopharm Therapeutics Inc / Sanofi SA / Intercept Pharmaceuticals Inc / Immunic Inc / Cryoport Inc / Theravance Biopharma Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Genfit SA / InflaRx NV / 89Bio Inc / Equillium Inc / Centogene NV / Galecto Inc / PureTech Health PLC / Change Healthcare Inc / Pacira Biosciences Inc / Abcellera Biologics Inc / Twist Bioscience Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="odd"><td class="leftalignment">06/18/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Is Pfizer Stock A Better Bet Compared To Eli Lilly?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">PFE.N / JNJ.N / MRK.N / RHHBY.PK</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Merck & Co Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/18/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Merck & Co Inc (MRK) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">963</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">06/18/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended June 11, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">06/18/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck KGaA: Peer Group Analytics - Q1 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">06/17/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Euro Credit Pilot - Credit remains solid (June 2021)</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">US88579Y1010 / AEGN.AS / AIRP.PA / AKZO.AS / ALSO.PA / ALV.N / ALVG.DE / ANZ.AX / APD.N / ASML.AS / ATCOA.ST / AXAF.PA / BAC.N / BARC.L / BKT.MC / BMWG.DE / BNPP.PA / BNS.TO / BOUY.PA / BP.L / BT.L / C.N / CAPP.PA / CARR.PA / CBA.AX / CBKG.DE / CCH.L / CM.TO / CNPP.PA / CRH.I / DANO.PA / DEO.N / DSMN.AS / EDP.LS / ENI.MI / ERICb.ST / ERST.VI / FREG.F / GASI.MI / GE.N / GM.N / HEIG.F / HEIN.AS / HSBA.L / IBE.MC / IBM.N / KPN.AS / LLOY.L / LVMH.PA / MAP.MC / MDBI.MI / MGA / MICP.PA / MOLB.BU / MRK.N / MUVGn.DE / NAB.AX / PRTP.PA / SAN.MC / T.N / CONG.DE / AZN.L / AMGN.O / FER.MC / AAL.L / GS.N / ACE.MI / DBKGn.DE / MCD.N / FMEG.DE / BZU.MI / ENEI.MI / MRCG.DE / DTEGn.F / BBVA.MC / BTI.N / IFXGn.DE / FR0000064578 / FR0000035081 / ISS.CO / CARLb.CO / ADEN.S / HNRGn.DE / DPWGn.DE / IG.MI / GSK.L / BAB.L / AMXL.MX / EUFI.PA / JCDX.PA / GB0008220112 / SE0000455057 / US1101221083 / US2987361092 / US3377381088 / US4943681035 / US5949181045 / JP3116000005 / CAGR.PA / AMA.MC / DANSKE.CO / CH0013841017 / ARLG.DE / ENAG.MC / AV.L / US20030N1019 / US02209S1033 / EBKG.DE / JYSK.CO / MAERSKb.CO / HRA.MI / CAIV.VI / US46625H1005 / INGA.AS / LXSG.DE / BTGGg.F / GB0033986497 / JP3885780001 / MTXGn.DE / ELI.BR / EDF.PA / ETL.PA / MS.N / GAZP.MM / US31620M1062 / AKE.PA / ISP.MI / DWNG.DE / DK0060079531 / AU000000GMG2 / SABE.MC / CNE1000001Z5 / CNE1000002H1 / FR0010690156 / BNRGN.DE / IREE.MI / CNE100000KC0 / CABK.MC / US03027X1000 / MDLZ.OQ / LEGN.DE / GYC.DE / 1COV.DE / IMB.L / SE0009922164 / BIRG.I / BMG2178K1009 / BAWG.VI / LU0251710041 / AT0000BAWAG2 / AIBG.I / AIG.A / NL00150006R6</td><td class="leftalignment">3M Co / Aegon NV / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Akzo Nobel NV / Alstom SA / Autoliv Inc / Allianz SE / Australia and New Zealand Banking Group Ltd / Air Products and Chemicals Inc / ASML Holding NV / Atlas Copco AB / AXA SA / Bank of America Corp / Barclays PLC / Bankinter SA / Bayerische Motoren Werke AG / BNP Paribas SA / Bank of Nova Scotia / Bouygues SA / BP PLC / BT Group PLC / Citigroup Inc / Capgemini SE / Carrefour SA / Commonwealth Bank of Australia / Commerzbank AG / Coca Cola HBC AG / Canadian Imperial Bank of Commerce / CNP Assurances SA / CRH PLC / Danone SA / Diageo PLC / Koninklijke DSM NV / EDP Energias de Portugal SA / Eni SpA / Telefonaktiebolaget LM Ericsson / Erste Group Bank AG / Fresenius SE & Co KGaA / Assicurazioni Generali SpA / General Electric Co / General Motors Co / HeidelbergCement AG / Heineken NV / HSBC Holdings PLC / Iberdrola SA / International Business Machines Corp / Koninklijke KPN NV / Lloyds Banking Group PLC / LVMH Moet Hennessy Louis Vuitton SE / Mapfre SA / Mediobanca Banca di Credito Finanziario SpA / Magna International Inc / Compagnie Generale des Etablissements Michelin SCA / MOL Magyar Olajes Gazipari Nyrt / Merck & Co Inc / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / National Australia Bank Ltd / Kering SA / Banco Santander SA / AT&T Inc / Continental AG / AstraZeneca PLC / Amgen Inc / Ferrovial SA / Anglo American PLC / Goldman Sachs Group Inc / Acea SpA / Deutsche Bank AG / McDonald's Corp / Fresenius Medical Care AG & Co KGaA / Buzzi Unicem SpA / Enel SpA / Merck KGaA / Deutsche Telekom AG / Banco Bilbao Vizcaya Argentaria SA / British American Tobacco PLC / Infineon Technologies AG / Covivio SA / Icade SA / Iss A/S / Carlsberg A/S / Adecco Group AG / Hannover Rueck SE / Deutsche Post AG / Italgas SpA / GlaxoSmithKline PLC / Babcock International Group PLC / America Movil SAB de CV / Eurofins Scientific SE / JCDecaux SA / DS Smith PLC / Fastighets AB Balder / Bristol-Myers Squibb Co / Euronet Worldwide Inc / Fiserv Inc / Kimberly-Clark Corp / Microsoft Corp / Asahi Group Holdings Ltd / Credit Agricole SA / Amadeus IT Group SA / Danske Bank A/S / Lonza Group AG / Aareal Bank AG / Enagas SA / Aviva PLC / Comcast Corp / Altria Group Inc / EnBW Energie Baden Wuerttemberg AG / Jyske Bank A/S / AP Moeller - Maersk A/S / Hera SpA / CA Immobilien Anlagen AG / JPMorgan Chase & Co / ING Groep NV / Lanxess AG / Bertelsmann SE & Co KGaA / ITV PLC / Mizuho Financial Group Inc / MTU Aero Engines AG / Elia Group SA / Electricite de France SA / Eutelsat Communications SA / Morgan Stanley / Gazprom PAO / Fidelity National Information Services Inc / Arkema SA / Intesa Sanpaolo SpA / Deutsche Wohnen SE / DSV A/S / Goodman Group / Banco de Sabadell SA / Bank of China Ltd / China Construction Bank Corp / Aeroports de Paris SA / Brenntag SE / Iren SpA / China National Chemical Engineering Co Ltd / Caixabank SA / American Tower Corp / Mondelez International Inc / LEG Immobilien SE / Grand City Properties SA / Covestro AG / Imperial Brands PLC / Essity AB (publ) / Bank of Ireland Group PLC / CK Infrastructure Holdings Ltd / BAWAG Group AG / CPI Property Group SA / BAWAG Group AG / Aib Group PLC / American International Group Inc / Ctp NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Austria / Belgium / Bermuda / Canada / Switzerland / China / Czech Republic / Germany / Denmark / Spain / Finland / France / United Kingdom / Greece / Hungary / Ireland / Italy / Japan / Luxembourg / Mexico / Netherlands / Norway / New Zealand / Poland / Portugal / Russian Federation / Slovakia / Sweden / United States / Jersey</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment">MISCELLANEOUS / CHANGE IN RECOMMENDATION / MODELS / PORTFOLIO STRATEGY / CREDIT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Herr Gianfranco Arcovito / Herr Christian Aust / Herr Tobias Keller / Herr. Stefan Kolek / Herr Sven Kreitmair, CFA / Frau Silke Stegemann / Herr Natalie Tehrani Monfared / Herr. Michael Teig</td></tr>
<tr class="even"><td class="leftalignment">06/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ELAN: Fetches Kindred in Pet Biotech Deal</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">ELAN.N / MRK.N / ZTS.N</td><td class="leftalignment">Elanco Animal Health Inc / Merck & Co Inc / Zoetis Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">MERGER/ACQUISITION/DIVESTITURE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">JNJ-US -  Dividend Quality Analysis, for the period ended June 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">JNJ / ABT / LLY / MDT / MRK / NVS / PFE / SYK / GILD.O / GSK / SNY.O</td><td class="leftalignment">Johnson & Johnson / Abbott Laboratories / Eli Lilly and Co / Medtronic PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / Stryker Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">UnivDatos Market Insights (UMI)</td><td class="leftalignment">Company Profile: Agilent Technologies-2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRK=DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Australia / Germany / India / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE / MERGER/ACQUISITION/DIVESTITURE / OPERATIONS / OPERATING RESULTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">univdatos Co / UMI Team</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">GSK Licensing Deal Hugely Validating for EOS-448 and TIGIT</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">11012210 / 45337C10 / 71708110 / 04635310 / 37555810 / 03116210 / 66987V10 / 75886F10 / 53245710 / M2572210 / 09062X10 / 478160104 / 640268108 / 771195104 / 58933Y10 / 92337C10 / 04651310 / 75046920 / 00287Y10 / 98401F10 / ITOS.OQ / 58949210 / 09627Y10 / 07725L10 / G3910J11 / 81181C10 / K3967W10 / 46565G10 / 61776010 / 03969F10 / F5548N10 / 48111610</td><td class="leftalignment">Bristol-Myers Squibb Co / Incyte Corp / Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Compugen Ltd / Biogen Inc / Johnson & Johnson / Nektar Therapeutics / Roche Holding AG / Merck & Co Inc / Verastem Inc / Atara Biotherapeutics Inc / Radius Health Inc / Abbvie Inc / Xencor Inc / Iteos Therapeutics Inc / Mereo Biopharma Group PLC / Blueprint Medicines Corp / Beigene Ltd / GlaxoSmithKline PLC / Seagen Inc / Genmab A/S / Iteos Therapeutics Inc / MorphoSys AG / Arcus Biosciences Inc / Sanofi SA / Jounce Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Daina Graybosch, Ph.D. / Geoffrey Porges, MBBS / Jeffrey La Rosa / Anna Baran, CFA</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Pharmaceuticals - Pay for performance: CEO compensation</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">FR0000120578 / DE0006599905 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US5324571083 / US7170811035 / US58933Y1055 / US00287Y1091 / DK0060534915</td><td class="leftalignment">Sanofi SA / Merck KGaA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Merck & Co Inc / Abbvie Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Organon : Portfolio Evolution Will Take Time; Initiating Coverage With A Neutral Rating, $38 PT</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">OGN.N / MRK.N</td><td class="leftalignment">Organon & Co / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRCG.DE: Merck KGaA - Credit Suisse Fireside chat with Healthcare CEO Peter Guenter</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRCG.DE / NOVN.S</td><td class="leftalignment">Merck KGaA / Novartis AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Drug Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">US00461U1051 / US5288723027 / US4525253062 / US5160121019 / US62855J1043 / US6388423021 / US74838J1016 / US75886F1075 / US92532F1003 / US68554V1089 / US6402681083 / US09060J1060 / CA87402A1084 / US58933Y1055 / US92345Y1064 / US42805E3062 / US6951271005 / US48576U1060 / CA4990531069 / US03209R1032 / US0453961080 / CA68620P1018 / US98978L2043 / US53222K2050 / US4622221004 / US44842L1035 / US1710774076 / US64049K1043 / US92556V1061 / US0547548745 / US92941V2097 / US04546C2052</td><td class="leftalignment">Aclaris Therapeutics Inc / Lexicon Pharmaceuticals Inc / ImmuCell Corp / Lannett Company Inc / Myriad Genetics Inc / Natural Alternatives International Inc / Quidel Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / OraSure Technologies Inc / Nektar Therapeutics / BioDelivery Sciences International Inc / Taiga Building Products Ltd / Merck & Co Inc / Verisk Analytics Inc / Heska Corp / Pacira Biosciences Inc / Karyopharm Therapeutics Inc / Knight Therapeutics Inc / Amphastar Pharmaceuticals Inc / Assembly Biosciences Inc / OrganiGram Holdings Inc / Zogenix Inc / LifeVantage Corp / Ionis Pharmaceuticals Inc / HUTCHMED (China) Ltd / Chromadex Corp / Neoleukin Therapeutics Inc / Viatris Inc / Aytu Biopharma Inc / Vyne Therapeutics Inc / Assertio Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">KOL Video Call To Discuss New and Emerging Heme Malignancy and Solid Tumor Treatments, Wednesday June 30th at 11AM ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ARAV.O / IMAB.O / HCM.L / JNJ / LLY / MRK / PFE / BSLN.S / HGEN.O</td><td class="leftalignment">Aravive Inc / I-Mab / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Basilea Pharmaceutica AG / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 04, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">CALL STARTING SOON: to Discuss European Hematology Association (EHA) Highlights at 11:00 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N / JNJ.N / 0715.HK / LLY.N / PFE.N / IMAB.OQ / HGEN.OQ</td><td class="leftalignment">Merck & Co Inc / Johnson & Johnson / China Oceanwide Holdings Ltd / Eli Lilly and Co / Pfizer Inc / I-Mab / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Bristol Myers Squibb Stock Remains Undervalued After Positive Data From Clinical Trials</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jun 14 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0116591092 / US02553E1064 / US0463531089 / US09058V1035 / US1101221083 / US37733W1053 / US45337C1027 / US4663671091 / US4781601046 / US5002551043 / US5324571083 / US66987V1098 / US6701002056 / US7010941042 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US9699041011 / US4771431016 / US4198791018 / US80105N1054 / PAP310761054 / US01748X1028 / US2473617023 / US90384S3031 / US58933Y1055 / US9100471096 / US00287Y1091 / US98978V1035 / IE00B4Q5ZN47 / US8485771021 / US21240E1055 / CA05156V1022 / US02376R1023 / IE00BQPVQZ61 / CA0089118776 / US07725L1026 / US74967X1037 / US5904791358 / US28414H1032 / US0144421072 / US98420X1037 / US26142R1041</td><td class="leftalignment">Alaska Air Group Inc / American Eagle Outfitters Inc / AstraZeneca PLC / BioCryst Pharmaceuticals Inc / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Incyte Corp / Jack in the Box Inc / Johnson & Johnson / Kohls Corp / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Parker-Hannifin Corp / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Williams-Sonoma Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Ulta Beauty Inc / Merck & Co Inc / United Airlines Holdings Inc / Abbvie Inc / Zoetis Inc / Jazz Pharmaceuticals PLC / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Aurinia Pharmaceuticals Inc / American Airlines Group Inc / Horizon Therapeutics PLC / Air Canada / Beigene Ltd / RH / Mesa Air Group Inc / Elanco Animal Health Inc / Alector Inc / X4 Pharmaceuticals Inc / DraftKings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US / PFE=US / HD=US / GBT=US / BLD=US / INCY=US / LOW=US / ADS=US / LEG=US / VMC=US / MLM=US / SWIM=US / COLL=US / GFF=US / IBP=US / MAS=US / MHK=US / REGI=US / VRTX=US / WAL=US / AUTL=US / BDSI=US / OGN / BIIB=US / TPX=US / EXP=US / BECN=US / BLDR=US / GMS=US / PGTI=US / GPRE=US / AWI=US / OC=US / PRPL=US / APEI=US / ZTS=US / TREX=US / FBHS=US / MEIP=US / ABBV=US / TILE=US / PTCT=US / 00770K202 / 82982L103 / CRSP=US / JELD=US / FOCS=US / AXNX=US / FERG=US / ZI=US / AZEK=US / 67421J108</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Home Depot Inc / Global Blood Therapeutics Inc / TopBuild Corp / Incyte Corp / Lowe's Companies Inc / Alliance Data Systems Corp / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Latham Group Inc / Collegium Pharmaceutical Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / Vertex Pharmaceuticals Inc / Western Alliance Bancorp / Autolus Therapeutics PLC / BioDelivery Sciences International Inc / Organon & Co / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Builders FirstSource Inc / GMS Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Purple Innovation Inc / American Public Education Inc / Zoetis Inc / Trex Company Inc / Fortune Brands Home & Security Inc / MEI Pharma Inc / Abbvie Inc / Interface Inc / PTC Therapeutics Inc / Aemetis Inc / SiteOne Landscape Supply Inc / CRISPR Therapeutics AG / JELD-WEN Holding Inc / Focus Financial Partners Inc / Axonics Inc / Ferguson PLC / ZoomInfo Technologies Inc / Azek Company Inc / Oatly Group AB</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Daily Credit Briefing</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">EDF.PA / FREG.F / PFE.N / AZN.L / SASY.PA / FMEG.DE / MRCG.DE / DANSKE.CO / SE0009922164</td><td class="leftalignment">Electricite de France SA / Fresenius SE & Co KGaA / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Fresenius Medical Care AG & Co KGaA / Merck KGaA / Danske Bank A/S / Essity AB (publ)</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Denmark / France / United Kingdom / Ireland / Italy / Sweden / United States</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Conglomerates / Consumer / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Services / Shipping & Shipbuilding / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS / CREDIT</td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Herr. Ulrich Scholz, CFA / Herr Sven Kreitmair, CFA / Frau Silke Stegemann / Herr Tobias Keller / Herr. Stefan Kolek</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">To RSV or Not to RSV? Prevention Could Generate $10bn in Vaccine Sales 2030</td><td class="leftalignment">English</td><td class="rightalignment">51</td><td class="leftalignment">G3910J11 / F5548N10 / 71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / 60770K10</td><td class="leftalignment">GlaxoSmithKline PLC / Sanofi SA / Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AEP.N / AES.N / CCI.N / CL.N / CMS.N / CRM.N / CVS.N / EIX.N / EL.N / KMB.N / KO.N / MRK.N / PD.N / PFE.N / RWEG.DE / SO.N / T.N / PEP.N / AVB.N / EQR.N / BFb.N / PG.N / HUM.N / CPB.N / CMCSA.O / FER.MC / UNH.N / K.N / DISH.O / CLX.N / CAG.N / GIS.N / PPL.N / EPC.N / SBAC.O / AMT.N / CONE.O / NG.L / VZ.N / HCA.N / STZ.N / AMP.N / FISV.O / ADSK.O / V.N / CPT.N / CHTR.O / AWK.N / CHD.N / ESS.N / NWN.N / UDR.N / SUI.N / MAA.N / SAM.N / FRAG.DE / ENR.N / NCR.N / ENDP.O / TYL.N / PEGA.OQ / AMH.N / GPN.N / MNST.O / CASY.O / JCOM.O / ATDb.TO / 02209S103 / MNKD.OQ / DLR.N / ELS.N / 427866108 / WEF.TO / SJW.N / FIS.N / MA.N / ATL.MI / IVZ.N / BGS.N / SPB.N / NEE.N / NXT.AX / FHI.N / RFP.N / MDLZ.OQ / APAM.N / PRMW.N / TMUS.N / COTY.N / BEP.N / WIX.O / COUP.N / 03835T200 / WRK.N / SGRY.O / SQ.N / SCWX.O / TWLO.N / INVH.N / ROOT.TO / ORSTED.CO / VCTR.N / SMAR.N / DBX.O / AMRX.N / KDP.N / ESTC.N / NWL.O / ZM.O / FSLY.N / DOCU.N / WTRG.N / REYN.O / FOUR.N / DCT.O / ASAN.N / SUMO.O / WFG.N / AFRM.O / NAPA.N / COUR.N / PATH.N / SQSP.N / OTLY.O / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Crown Castle International Corp / Colgate-Palmolive Co / CMS Energy Corp / Salesforce.Com Inc / CVS Health Corp / Edison International / Estee Lauder Companies Inc / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / PagerDuty Inc / Pfizer Inc / Rwe AG / Southern Co / AT&T Inc / PepsiCo Inc / Avalonbay Communities Inc / Equity Residential / Brown-Forman Corp / Procter & Gamble Co / Humana Inc / Campbell Soup Co / Comcast Corp / Ferrovial SA / UnitedHealth Group Inc / Kellogg Co / DISH Network Corp / Clorox Co / Conagra Brands Inc / General Mills Inc / PPL Corp / Edgewell Personal Care Co / SBA Communications Corp / American Tower Corp / CyrusOne Inc / National Grid PLC / Verizon Communications Inc / HCA Healthcare Inc / Constellation Brands Inc / Ameriprise Financial Inc / Fiserv Inc / Autodesk Inc / Visa Inc / Camden Property Trust / Charter Communications Inc / American Water Works Company Inc / Church & Dwight Co Inc / Essex Property Trust Inc / Northwest Natural Holding Co / UDR Inc / Sun Communities Inc / Mid-America Apartment Communities Inc / Boston Beer Company Inc / Fraport AG Frankfurt Airport Services Worldwide / Energizer Holdings Inc / NCR Corp / Endo International PLC / Tyler Technologies Inc / Pegasystems Inc / American Homes 4 Rent / Global Payments Inc / Monster Beverage Corp / Caseys General Stores Inc / Ziff Davis Inc / Alimentation Couche-Tard Inc / Altria Group Inc / MannKind Corp / Digital Realty Trust Inc / Equity LifeStyle Properties Inc / Hershey Co / Western Forest Products Inc / SJW Group / Fidelity National Information Services Inc / Mastercard Inc / Atlantia SpA / Invesco Ltd / B&G Foods Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / NEXTDC Ltd / Federated Hermes Inc / Resolute Forest Products Inc / Mondelez International Inc / Artisan Partners Asset Management Inc / Primo Water Corp / T-Mobile US Inc / Coty Inc / Brookfield Renewable Partners LP / Wix.Com Ltd / Coupa Software Inc / Aptose Biosciences Inc / Westrock Co / Surgery Partners Inc / Block Inc / SecureWorks Corp / Twilio Inc / Invitation Homes Inc / Roots Corp / Orsted A/S / Victory Capital Holdings Inc / Smartsheet Inc / Dropbox Inc / Amneal Pharmaceuticals Inc / Keurig Dr Pepper Inc / Elastic NV / Newell Brands Inc / Zoom Video Communications Inc / Fastly Inc / DocuSign Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Shift4 Payments Inc / Duck Creek Technologies Inc / Asana Inc / Sumo Logic Inc / West Fraser Timber Co Ltd / Affirm Holdings Inc / Duckhorn Portfolio Inc / Coursera Inc / UiPath Inc / Squarespace Inc / Oatly Group AB / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Germany / Denmark / Spain / United Kingdom / Ireland / Israel / Italy / Netherlands / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Our spin on spins</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">OGN / MRK=US / PFE=US / ZTS=US / ABBV=US</td><td class="leftalignment">Organon & Co / Merck & Co Inc / Pfizer Inc / Zoetis Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser</td></tr>
<tr class="odd"><td class="leftalignment">06/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK.N / PFE.N / ENDP.O / MNKD.OQ / AMRX.N</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Endo International PLC / MannKind Corp / Amneal Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">06/13/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Catalyst Tracker 6.13.21: Highlights Top Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">55</td><td class="leftalignment">00282410 / 71708110 / 00846U10 / 10113710 / 92532F10 / 88355610 / 87936910 / 37555810 / M2572210 / 45232710 / 30063P10 / 98956P10 / 67070410 / 45784P10 / 58933Y10 / 00653A107 / 04351P101 / 00287Y10 / 04004760 / 04280A10 / 40131M10 / 604749101 / 98420N10 / 42226A10 / 90041T10 / 74340E10 / 87337910 / 45826J10 / 55609910 / 74374N10 / 31189P10 / G3910J11 / H0026310 / 24344T10 / 92857F10 / 04685N10 / 34633R10 / 46565G10 / 60468T10 / 03969F10 / 78667J10 / 64157F10 / 55886810 / 49232710 / 75955J40 / 87808K10 / 87166L10 / 89422G10</td><td class="leftalignment">Abbott Laboratories / Pfizer Inc / Agilent Technologies Inc / Boston Scientific Corp / Vertex Pharmaceuticals Inc / Thermo Fisher Scientific Inc / Teleflex Inc / Gilead Sciences Inc / Compugen Ltd / Illumina Inc / Exact Sciences Corp / Zimmer Biomet Holdings Inc / NuVasive Inc / Insulet Corp / Merck & Co Inc / Adaptimmune Therapeutics PLC / Ascendis Pharma A/S / Abbvie Inc / Arena Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Guardant Health Inc / Mirum Pharmaceuticals Inc / Xenon Pharmaceuticals Inc / Healthequity Inc / Turning Point Therapeutics Inc / Progyny Inc / Tabula Rasa HealthCare Inc / Intellia Therapeutics Inc / MacroGenics Inc / Provention Bio Inc / Fate Therapeutics Inc / GlaxoSmithKline PLC / AC Immune SA / Deciphera Pharmaceuticals Inc / Vocera Communications Inc / Athenex Inc / Forma Therapeutics Holdings Inc / Iteos Therapeutics Inc / Mirati Therapeutics Inc / Arcus Biosciences Inc / SAGE Therapeutics Inc / Nevro Corp / Madrigal Pharmaceuticals Inc / Keros Therapeutics Inc / Relmada Therapeutics Inc / TCR2 Therapeutics Inc / Synlogic Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / United Kingdom / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="odd"><td class="leftalignment">06/13/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6% Above Pre-Pandemic Base - Week 62</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">LUPN.BO: Lupin Ltd - Quick Take - Warning Letter at Somerset - Low contribution but may dampen market confidence</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LUPN.BO / CIPL.BO / MRK.N / GSK.L / ENDP.OQ / TEVA.N / PRGO.N</td><td class="leftalignment">Lupin Ltd / Cipla Ltd / Merck & Co Inc / GlaxoSmithKline PLC / Endo International PLC / Teva Pharmaceutical Industries Ltd / Perrigo Company PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / India / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Anubhav Aggarwal / Sayantan Maji</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended June 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">06/11/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending June 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Merck KGaA: In der technischen Neubewertung</td><td class="leftalignment">German</td><td class="rightalignment">4</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Herr. Achim Matzke / Frau Petra von Kerssenbrock / Herr Thorsten Grisse</td></tr>
<tr class="even"><td class="leftalignment">06/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma: Five key takeaways from our GU (prostate, renal & bladder) expert call</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">NOVN.S / MRCG.DE / ORNBV.HE / BAYGN.DE</td><td class="leftalignment">Novartis AG / Merck KGaA / Orion Oyj / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Finland / United Kingdom</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Movers & Shakers: Our Thoughts on Potential Upcoming Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">75</td><td class="leftalignment">ACRS.O / ACRX.O / EBS / HCM.L / JNJ / LLY / MRK / PFE / ALKS.O / JAZZ.O / CERS.O / OPTN.O / NCOX.PA / COLL.O / RMTI.O / AMRN.O / BDSI.O / CUTR.O / BSLN.S / MNKD.O / SIBN.MM / ZTS / OMER.O / SPRO.O / ANIP.O / AXGN.O / AERI.O / HRTX.O / TRVN.O / EGRX.O / SCYX.O / ARDX.O / CFRX.O / CDTX.O / SPNE.O / FBIO.O / MESO.O / CERC.O / VRAY.O / VERU.O / TXMD.O / AYTU.O / CKPT.O / EYPT.O / UBX.O / EOLS.O / ARDS.O / ARAV.O / ETTX.O / ARQT.O / PCVX.O / SRGA.O / VYNE.O / HGEN.O / AZYO.O / GRAY.O / IMAB.O / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / Emergent BioSolutions Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Cerus Corp / OptiNose Inc / Nicox SA / Collegium Pharmaceutical Inc / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Cutera Inc / Basilea Pharmaceutica AG / MannKind Corp / Gazprom Neft' PAO / Zoetis Inc / Omeros Corp / Spero Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / Ardelyx Inc / ContraFect Corp / Cidara Therapeutics Inc / SeaSpine Holdings Corp / Fortress Biotech Inc / Mesoblast Ltd / Avalo Therapeutics Inc / ViewRay Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Checkpoint Therapeutics Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Evolus Inc / Aridis Pharmaceuticals Inc / Aravive Inc / Entasis Therapeutics Holdings Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Humanigen Inc / Aziyo Biologics Inc / Graybug Vision Inc / I-Mab / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Russian Federation / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma: Five key takeaways from ASCO Lung cancer expert call</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">JNJ.N / MRK.N / AZN.L / SASY.PA / ROG.S</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr. Matt S. Miksic / Vik Chopra</td></tr>
<tr class="odd"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS.OQ / ACRX.OQ / 0013.HK / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BDSI.OQ / CUTR.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / OMER.OQ / ARDX.OQ / ZTS.N / ANIP.OQ / AXGN.OQ / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / CERC.OQ / SPNE.OQ / CKPT.OQ / VERU.OQ / TXMD.OQ / AYTU.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / IMAB.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / AZYO.OQ / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Cutera Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / Avalo Therapeutics Inc / SeaSpine Holdings Corp / Checkpoint Therapeutics Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / I-Mab / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Aziyo Biologics Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">MRK ASCO Call Highlights; MRK Standalone Model Updated</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">PFE receives FDA approval for PREVNAR 20 in adults; next up is a potential MRK V114 approval in July and October ACIP meeting</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">MRK.N / PFE.N</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daniel Busby</td></tr>
<tr class="even"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Kepler Cheuvreux</td><td class="leftalignment">OSE Immunotherapeutics | Is there more to OSE than Tedopi?</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">AZN.L / GSK.L / OSE.PA / SASY.PA / ROG.S / MRCG.DE / VLS.PA</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / OSE Immunotherapeutics SA / Sanofi SA / Roche Holding AG / Merck KGaA / Valneva SE</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / France / United Kingdom</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">M. Pierre-Alexandr Desir</td></tr>
<tr class="odd"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LSI=US / PFE=US / AMGN=US / BMY=US / GBT=US / BLD=US / INCY=US / GL=US / GILD=US / PAA=US / CHRS=US / LEG=US / VMC=US / MLM=US / PATH=US / BNL=US / DRI=US / ENDP=US / IBP=US / MHK=US / NTST=US / REGN=US / THO=US / VRTX=US / HIW=US / BDN=US / PRI=US / EGP=US / KIM=US / MAA=US / UDR=US / DRE=US / AUTL=US / DIN=US / OGN / BCO=US / TPX=US / EXP=US / BECN=US / TXRH=US / BLDR=US / PGTI=US / OC=US / KTOS=US / TREX=US / OLO=US / APTS=US / MEIP=US / ABBV=US / TILE=US / HTRG=US / DEA=US / 82982L103 / CRSP=US / YEXT=US / COLD=US / EOLS=US / UBER=US / GMAB=US / AZEK=US / VTRS=US / DASH=US</td><td class="leftalignment">Merck & Co Inc / Life Storage Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / TopBuild Corp / Incyte Corp / Globe Life Inc / Gilead Sciences Inc / Plains All American Pipeline LP / Coherus BioSciences Inc / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / UiPath Inc / Bunzl plc / Darden Restaurants Inc / Endo International PLC / Installed Building Products Inc / Mohawk Industries Inc / Netstreit Corp / Regeneron Pharmaceuticals Inc / Thor Industries Inc / Vertex Pharmaceuticals Inc / Highwoods Properties Inc / Brandywine Realty Trust / Primerica Inc / Eastgroup Properties Inc / Kimco Realty Corp / Mid-America Apartment Communities Inc / UDR Inc / Duke Realty Corp / Autolus Therapeutics PLC / Dine Brands Global Inc / Organon & Co / Brinks Co / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Builders FirstSource Inc / PGT Innovations Inc / Owens Corning / Kratos Defense and Security Solutions Inc / Trex Company Inc / Olo Inc / Preferred Apartment Communities Inc / MEI Pharma Inc / Abbvie Inc / Interface Inc / Heritage Insurance Holdings Inc / Easterly Government Properties Inc / SiteOne Landscape Supply Inc / CRISPR Therapeutics AG / Yext Inc / Americold Realty Trust / Evolus Inc / Uber Technologies Inc / Genmab A/S / Azek Company Inc / Viatris Inc / DoorDash Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">ASCO: Puts and Takes for Keytruda</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">58933Y10 / 71708110 / 04635310</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / AstraZeneca PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="odd"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">V / 0989529 / 0925288 / 2126335 / 2000019 / 2023607 / 2778844 / 2973821 / 2026242 / 2219224 / 2270726 / 2829515 / 2317087 / 2342034 / 2455965 / 2471950 / 2689560 / 2680905 / 2684703 / 2705198 / 2707677 / 2829601 / 4595739 / 7103065 / B02R1L6 / B7TL820 / BBFL7S1 / B7VD3F2 / BFLR866 / BYVY8G0 / BYZLV46 / BXDZ9Z0 / BNFWR44 / BFMXGR0 / BKTNTR9 / BZ1LFG7 / BN7K304 / BMHR7K6</td><td class="leftalignment">Visa Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Amazon.com Inc / Amgen Inc / Merck & Co Inc / Alliant Energy Corp / American Electric Power Company Inc / CMS Energy Corp / Walt Disney Co / Edison International / Entergy Corp / Fiserv Inc / Biogen Inc / Incyte Corp / PG&E Corp / PPL Corp / Pfizer Inc / Progress Software Corp / Public Service Enterprise Group Inc / Southern Co / Genmab A/S / Novartis AG / ALLETE Inc / Meta Platforms Inc / bluebird bio Inc / Duke Energy Corp / Twitter Inc / Alphabet Inc / InflaRx NV / Shopify Inc / Worldline SA / Evergy Inc / ViacomCBS Inc / Roku Inc / Academy Sports and Outdoors Inc / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist EHA Planner v2.0 Highlights 100+ Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / GBT=US / INCY=US / GILD=US / REGN=US / VRTX=US / AUTL=US / MEIP=US / ABBV=US / CRSP=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Incyte Corp / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Autolus Therapeutics PLC / MEI Pharma Inc / Abbvie Inc / CRISPR Therapeutics AG / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Mr. Gregg Gilbert / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="odd"><td class="leftalignment">06/09/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck & Co., Inc. : Revisiting The Story Post Spin - Strong Growth Outlook With Keytruda LOE Overly Reflected</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">06/09/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck & Co., Inc. : Revisiting The Story Post Spin - Strong Growth Outlook With Keytruda LOE Overly Reflected</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: Eisai - Holds online briefing on approval of Aduhelm for Alzheimer's; may not fully penetrate clinical setting until 2022 or thereafter</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">4523.T / CI.N / CVS.N / MRK.N / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Cigna Corp / CVS Health Corp / Merck & Co Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: エーザイ - アルツハイマー型認知症治療薬ADUHELM承認についてオンライン説明会開催、治療現場への本格浸透は2022年以降となろう</td><td class="leftalignment">Japanese</td><td class="rightalignment">7</td><td class="leftalignment">4523.T / CI.N / CVS.N / MRK.N / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Cigna Corp / CVS Health Corp / Merck & Co Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - ASCO 2021: Key takeaways (Part 5)</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">600276.SS / MRK.N / AZN.L</td><td class="leftalignment">Jiangsu Hengrui Pharmaceuticals Co Ltd / Merck & Co Inc / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="even"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Merck KGaA</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">06/09/2021</td><td class="leftalignment">HSBC</td><td class="leftalignment">European Corporate Credit Quarterly:-Summer 2021 – Averages & Opportunities</td><td class="leftalignment">English</td><td class="rightalignment">82</td><td class="leftalignment">ACCP.PA / AIRP.PA / AKZO.AS / ASML.AS / BATS.L / BMWG.DE / BOUY.PA / BP.L / BT.L / CAPP.PA / CARR.PA / CPG.L / CRH.I / DANO.PA / DAST.PA / DGE.L / DSMN.AS / ENI.MI / ERICb.ST / EXHO.PA / HEIG.DE / HEIN.AS / IBE.MC / KPN.AS / LVMH.PA / MICP.PA / MRCG.F / NXT.L / OMVV.VI / PERP.PA / PHG.AS / PRTP.PA / PUBP.PA / RENA.PA / REP.MC / RYA.I / SAPG.F / SCHN.PA / SGEF.PA / SGOB.PA / SOLB.BR / TEF.MC / TOTF.PA / TSCO.L / ULVR.L / VLOF.PA / VOD.L / VOLVb.ST / WLSNc.AS / WPP.L / VOWG_p.DE / CONG.DE / AZN.L / AAL.L / SASY.PA / ROG.S / ABBN.S / SIEGn.DE / NOVN.S / ENEI.MI / DTEGn.DE / IFXGn.DE / CARLb.CO / FREG.DE / TELA.VI / EZJ.L / DPWGn.DE / TEL.OL / GSK.L / TELIA.ST / REL.L / IHG.L / NESN.S / SESFd.PA / LXSG.DE / BTGGg.F / RDSa.L / EDF.PA / CFR.S / VIV.PA / HOLN.S / MNDI.L / DAIGn.DE / ABI.BR / UPM.HE / BAYGn.DE / BASFn.DE / GLEN.L / EVKn.DE / ORAN.PA / AIRG.DE / ENGIE.PA / IMB.L / AD.AS / FORTUM.HE / ORSTED.CO / EQNR.OL / NTGY.MC / ARRD.DE / STLA.MI / RKT.L</td><td class="leftalignment">Accor SA / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Akzo Nobel NV / ASML Holding NV / British American Tobacco PLC / Bayerische Motoren Werke AG / Bouygues SA / BP PLC / BT Group PLC / Capgemini SE / Carrefour SA / Compass Group PLC / CRH PLC / Danone SA / Dassault Systemes SE / Diageo PLC / Koninklijke DSM NV / Eni SpA / Telefonaktiebolaget LM Ericsson / Sodexo SA / HeidelbergCement AG / Heineken NV / Iberdrola SA / Koninklijke KPN NV / LVMH Moet Hennessy Louis Vuitton SE / Compagnie Generale des Etablissements Michelin SCA / Merck KGaA / Next PLC / OMV AG / Pernod Ricard SA / Koninklijke Philips NV / Kering SA / Publicis Groupe SA / Renault SA / Repsol SA / Ryanair Holdings PLC / SAP SE / Schneider Electric SE / Vinci SA / Compagnie de Saint Gobain SA / Solvay SA / Telefonica SA / TotalEnergies SE / Tesco PLC / Unilever PLC / Valeo SE / Vodafone Group PLC / Volvo AB / Wolters Kluwer NV / WPP PLC / Volkswagen AG / Continental AG / AstraZeneca PLC / Anglo American PLC / Sanofi SA / Roche Holding AG / Abb Ltd / Siemens AG / Novartis AG / Enel SpA / Deutsche Telekom AG / Infineon Technologies AG / Carlsberg A/S / Fresenius SE & Co KGaA / Telekom Austria AG / Easyjet PLC / Deutsche Post AG / Telenor ASA / GlaxoSmithKline PLC / Telia Company AB / Relx PLC / InterContinental Hotels Group PLC / Nestle SA / SES SA / Lanxess AG / Bertelsmann SE & Co KGaA / Royal Dutch Shell PLC / Electricite de France SA / Compagnie Financiere Richemont SA / Vivendi SE / Holcim AG / Mondi PLC / Daimler AG / Anheuser Busch Inbev SA / UPM-Kymmene Oyj / Bayer AG / BASF SE / Glencore PLC / Evonik Industries AG / Orange SA / Airbus SE / Engie SA / Imperial Brands PLC / Koninklijke Ahold Delhaize NV / Fortum Oyj / Orsted A/S / Equinor ASA / Naturgy Energy Group SA / ArcelorMittal SA / Stellantis NV / Reckitt Benckiser Group PLC</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">Austria / Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / Norway / Sweden / United States / Jersey</td><td class="leftalignment">Aerospace / Air Transportation / Apparel & Textiles / Automotive / Beverages & Tobacco / Broadcasting & Cable / Building & Building Materials / Chemicals / Cosmetics & Personal Care / Defense / Electrical / Electronics / Engineering & Construction / Environmental Services / Food / Healthcare / Industrial Materials / Info. Tech./Software / Lodging & Restaurants / Machinery / Manufacturing / Media / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Publishing / Retailing / Semiconductors / Services / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / FIXED INCOME / MARKET COMMENT / HIGH YIELD BONDS / CREDIT / BOND</td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Jonathan R. White / Song Jin Lee / Dominic A. Kini / Tom Russell</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Merck & Co</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Time to take a look – reiterate Buy</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">OGN / MRK=US / VTRS=US</td><td class="leftalignment">Organon & Co / Merck & Co Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Merck & Co., Inc.(MRK) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">58933Y105</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">MRK: ASCO Event Highlights Growing Base of Novel Oncology Assets; Investors Ignoring Potential for a Softer Post-LoE Keytruda Landing</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2778844</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Kepler Cheuvreux</td><td class="leftalignment">Pharma & biotech | Extraordinary Alzheimers action from the FDA</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABVX.PA / ADOC.PA / RECI.MI / VIRB.PA / TRNG.PA / AZN.L / SASY.PA / ROG.S / KARO.ST / LUN.CO / NOVOb.CO / NOVN.S / MRCG.DE / LONN.S / GSK.L / GNS.L / UCB.BR / NCOX.PA / BSLN.S / GLPG.AS / IPN.PA / SANN.S / IPH.PA / ALM.MC / VLS.PA / GRLS.MC / ROVI.MC / HBMN.S / BION.S / DBV.PA / NANOB.PA / FYB.DE / ALCJ.PA / FALG.PA / GNFT.PA / ARGX.BR / ALQGC.PA / BOTHE.BR / CYAD.BR / OSE.PA / ALBPS.PA / MITRA.BR / BNNn.DE / PHARN.PA / LYS.PA / VIFN.S / GALE.S / OXUR.BR / MEDCL.PA / ALCC.S / OPTOMED.HE / NANOFH.HE / FARON.HE / ALONX.PA / HEALTH.HE</td><td class="leftalignment">Abivax SA / Adocia SA / Recordati Industria Chimica e Farmaceutica SpA / Virbac SA / Transgene SA / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Karo Pharma AB / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Lonza Group AG / GlaxoSmithKline PLC / Genus PLC / Ucb SA / Nicox SA / Basilea Pharmaceutica AG / Galapagos NV / Ipsen SA / Santhera Pharmaceuticals Holding AG / Innate Pharma SA / Almirall SA / Valneva SE / Grifols SA / Laboratorios Farmaceuticos ROVI SA / HBM Healthcare Investments AG / BB Biotech AG / DBV Technologies SA / Nanobiotix SA / Formycon AG / Crossject SA / Fermentalg SA / Genfit SA / argenx SE / Quantum Genomics SA / Bone Therapeutics SA / Celyad Oncology SA / OSE Immunotherapeutics SA / Biophytis SA / Mithra Pharmaceuticals SA / BRAIN Biotech AG / Pharnext SA / Lysogene SA / Vifor Pharma AG / Galenica AG / Oxurion NV / Medincell SA / Alcon AG / Optomed Plc / Nanoform Finland Plc / Faron Pharmaceuticals Oy / Onxeo SA / Nightingale Health Oyj</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Italy / Netherlands / Sweden</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. David P. Evans</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / AMZN=US / BLD=US / INCY=US / TEVA=US / MTN=US / LOW=US / PB=US / CHRS=US / LEG=US / VMC=US / MLM=US / AIR=US / SWIM=US / CBRL=US / CSTR=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / PACW=US / REGN=US / REGI=US / FOUR=US / CGEN=US / FMBI=US / SNV=US / SIVB=US / ABCB=US / FBK=US / SSB=US / RF=US / FFIN=US / GBCI=US / DIN=US / PNFP=US / SBCF=US / BIIB=US / TPX=US / EXP=US / BDC=US / BECN=US / PLAY=US / RNST=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / JACK=US / CLNY=US / TREX=US / FBHS=US / BCEI=US / ABBV=US / TILE=US / IBTX=US / NDLS=US / FATE=US / 00770K202 / COUP=US / LOCO=US / HQY=US / SHAK=US / WING=US / ARGX=US / ACBI=US / SQ=US / 82982L103 / TVTY=US / JELD=US / SFIX=US / HWC=US / BTAI=US / LSPD=US / FERG=US / OPCH=US / ARQT=US / AZEK=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / Amazon.com Inc / TopBuild Corp / Incyte Corp / Teva Pharmaceutical Industries Ltd / Vail Resorts Inc / Lowe's Companies Inc / Prosperity Bancshares Inc / Coherus BioSciences Inc / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / AAR Corp / Latham Group Inc / Cracker Barrel Old Country Store Inc / CapStar Financial Holdings Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / PacWest Bancorp / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / Shift4 Payments Inc / Compugen Ltd / First Midwest Bancorp Inc / Synovus Financial Corp / SVB Financial Group / Ameris Bancorp / FB Financial Corp / SouthState Corp / Regions Financial Corp / First Financial Bankshares Inc / Glacier Bancorp Inc / Dine Brands Global Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Belden Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Renasant Corp / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / DigitalBridge Group Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Civitas Resources Inc / Abbvie Inc / Interface Inc / Independent Bank Group Inc / Noodles & Co / Fate Therapeutics Inc / Aemetis Inc / Coupa Software Inc / El Pollo Loco Holdings Inc / Healthequity Inc / Shake Shack Inc / Wingstop Inc / argenx SE / Atlantic Capital Bancshares Inc / Block Inc / SiteOne Landscape Supply Inc / Tivity Health Inc / JELD-WEN Holding Inc / Stitch Fix Inc / Hancock Whitney Corp / BioXcel Therapeutics Inc / Lightspeed Commerce Inc / Ferguson PLC / Option Care Health Inc / Arcutis Biotherapeutics Inc / Azek Company Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / 5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2778844 / 2973821 / 2065159 / 2216850 / 2270726 / 2542049 / 2829515 / 2576941 / 2328915 / 2455965 / 2457864 / 2689560 / 2684703 / 2048804 / 2705198 / 2707677 / 2730190 / 2138158 / 2829601 / 7103065 / B02R1L6 / B7TL820 / BBFL7S1 / BBGVT40 / BYVY8G0 / BP4GNK9 / BYNZGK1 / BJ2Z0H2 / BMQ5T49 / BFMXGR0 / BFNR303 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BDVLM39 / BP8XZL1 / BMG5660</td><td class="leftalignment">American Express Co / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Alliant Energy Corp / Autodesk Inc / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Edison International / Exelixis Inc / Nextera Energy Inc / Biogen Inc / ImmunoGen Inc / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Progress Software Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / Sempra Energy / Southern Co / Novartis AG / ALLETE Inc / Meta Platforms Inc / bluebird bio Inc / News Corp / Alphabet Inc / SAGE Therapeutics Inc / Block Inc / Pinterest Inc / Zentalis Pharmaceuticals Inc / Evergy Inc / Northwest Natural Holding Co / ViacomCBS Inc / Roku Inc / Alphabet Inc / argenx SE / Healthequity Inc / Joann Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ALB.N / BATS.L / CCK.N / CNA.L / CWK.L / DFDS.CO / DGE.L / EL.N / IBE.MC / KMB.N / KO.N / L.TO / MRK.N / RENA.PA / PEP.N / VOWG_p.DE / BFb.N / PG.N / CONG.DE / WY.N / CFP.TO / CPB.N / LPX.N / ENB.TO / CSX.N / UNP.N / CLX.N / CAG.N / GIS.N / EPC.N / OI.N / BLL.N / SGMO.O / MDRX.O / STZ.N / ADSK.O / SLGN.O / ALU.AX / TYL.N / HOOK.O / ICPT.O / ATDb.TO / EMPA.TO / BIIB.O / RUS.TO / SAP.TO / MFI.TO / 02209S103 / NESN.S / ACAD.O / WEF.TO / SJW.N / BVIC.L / ATL.MI / DAIGn.DE / GETP.PA / PCH.O / CFX.TO / IFP.TO / RFP.N / SRPT.O / MDLZ.OQ / BERY.N / PRTA.O / KPTI.O / XNCR.OQ / ITCI.O / COUP.N / FLXN.O / HQY.OQ / GWB.N / AXTA.N / FEVR.L / CTRE.O / WBA.N / 78667J108 / SGRY.O / IONS.O / RACE.MI / IMB.L / TRHC.OQ / ATZ.TO / ADNT.N / STLC.TO / EAF.N / ITRM.O / PRVB.O / LSPD.TO / 269796108 / MNRL.N / KRTX.OQ / SLQT.N / ALOO.O / WFG.N / NAPA.N / TSP.OQ</td><td class="leftalignment">Albemarle Corp / British American Tobacco PLC / Crown Holdings Inc / Centrica PLC / Cranswick PLC / DFDS AS / Diageo PLC / Estee Lauder Companies Inc / Iberdrola SA / Kimberly-Clark Corp / Coca-Cola Co / Loblaw Companies Ltd / Merck & Co Inc / Renault SA / PepsiCo Inc / Volkswagen AG / Brown-Forman Corp / Procter & Gamble Co / Continental AG / Weyerhaeuser Co / Canfor Corp / Campbell Soup Co / Louisiana-Pacific Corp / Enbridge Inc / CSX Corp / Union Pacific Corp / Clorox Co / Conagra Brands Inc / General Mills Inc / Edgewell Personal Care Co / O-I Glass Inc / Ball Corp / Sangamo Therapeutics Inc / Allscripts Healthcare Solutions Inc / Constellation Brands Inc / Autodesk Inc / Silgan Holdings Inc / Altium Ltd / Tyler Technologies Inc / HOOKIPA Pharma Inc / Intercept Pharmaceuticals Inc / Alimentation Couche-Tard Inc / Empire Company Ltd / Biogen Inc / Russel Metals Inc / Saputo Inc / Maple Leaf Foods Inc / Altria Group Inc / Nestle SA / ACADIA Pharmaceuticals Inc / Western Forest Products Inc / SJW Group / Britvic PLC / Atlantia SpA / Daimler AG / Getlink SE / Potlatchdeltic Corp / Canfor Pulp Products Inc / Interfor Corp / Resolute Forest Products Inc / Sarepta Therapeutics Inc / Mondelez International Inc / Berry Global Group Inc / Prothena Corporation PLC / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Coupa Software Inc / Pacira Biosciences Inc / Healthequity Inc / Great Western Bancorp Inc / Axalta Coating Systems Ltd / Fevertree Drinks PLC / CareTrust REIT Inc / Walgreens Boots Alliance Inc / SAGE Therapeutics Inc / Surgery Partners Inc / Ionis Pharmaceuticals Inc / Ferrari NV / Imperial Brands PLC / Tabula Rasa HealthCare Inc / Aritzia Inc / Adient PLC / Stelco Holdings Inc / GrafTech International Ltd / Iterum Therapeutics PLC / Provention Bio Inc / Lightspeed Commerce Inc / Eagle Pharmaceuticals Inc / Brigham Minerals Inc / Karuna Therapeutics Inc / SelectQuote Inc / Allogene Therapeutics Inc / West Fraser Timber Co Ltd / Duckhorn Portfolio Inc / TuSimple Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Italy / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - ASCO 2021: Key takeaways (Part 4)</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY.N / MRK.N / ROG.S / NOVN.S / BAYGN.DE / 1801.HK / 1877.HK</td><td class="leftalignment">Bristol-Myers Squibb Co / Merck & Co Inc / Roche Holding AG / Novartis AG / Bayer AG / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck & Co., Inc. : ASCO Takeaways - Keytruda and Broader Oncology Pipeline Well Positioned, Solid Data in Adjuvant RCC</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Takeaways from ASCO oncology event; updating our model post-OGN spinoff</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Key takes from MRK’s ASCO event</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK=US / BMY=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BAYRY-US -  Dividend Quality Analysis, for the period ended May 10,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BAYRY.PK / JNJ / LLY / MRK / NVS / PFE / GSK / REGN.O / NKTR.O / TEVA.K / SNY.O</td><td class="leftalignment">Bayer AG / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Nektar Therapeutics / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SNY-US -  Dividend Quality Analysis, for the period ended May 26,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">SNY.O / ABT / BMY / JNJ / LLY / MRK / NVO / NVS / PFE / GSK / TEVA.K</td><td class="leftalignment">Sanofi SA / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novo Nordisk A/S / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US -  Dividend Quality Analysis, for the period ended June 04,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Seeing The Forest Through The Trees, ASCO Takeaways Highlight MRK's Broad Oncology Portfolio</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRK.N - Event Transcript of Merck & Co Inc conference call, Jun. 07, 2021 / 6:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 28, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Latest ASP data provides some insight into biosimilar price trends</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">CALL STARTING SOON: KOL Video Call To Discuss ASCO Highlights at 12PM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ARAV.O / IMAB.O / HCM / JNJ / LLY / MRK / PFE / GILD.O / US75886F1075 / BSLN.S / HTBX.O / MBIO.O</td><td class="leftalignment">Aravive Inc / I-Mab / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Basilea Pharmaceutica AG / Heat Biologics Inc / Mustang Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRK.N - Event Transcript of Merck & Co Inc conference call, Jun. 07, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">KOL Video Call To Discuss New and Emerging Heme Malignancy and Solid Tumor Treatments, Wednesday June 30th at 11AM ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ARAV.OQ / IMAB.OQ / 0013.HK / JNJ.N / LLY.N / MRK.N / PFE.N / BSLN.S / HGEN.OQ</td><td class="leftalignment">Aravive Inc / I-Mab / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Basilea Pharmaceutica AG / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH: ASCO Plenary Session Discussants Support Our Positive Views of AZN, MRK, and NOVN's Results</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK.N / AZN.L / NOVN.S / 0989529 / 2778844 / 7103065</td><td class="leftalignment">Merck & Co Inc / AstraZeneca PLC / Novartis AG / AstraZeneca PLC / Merck & Co Inc / Novartis AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - June 7 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">BE0165385973 / US0091581068 / US00971T1016 / US0116591092 / US0311621009 / US0323325045 / US0463531089 / US0997241064 / US1101221083 / US17275R1023 / US2310211063 / US34354P1057 / US37733W1053 / US45167R1041 / US4523271090 / US45337C1027 / US4657411066 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7010941042 / US7170811035 / US7711951043 / US7766961061 / US8308791024 / US8447411088 / US8835561023 / US92343V1044 / US9427491025 / CA8265161064 / US30063P1057 / US00508Y1029 / US4771431016 / US4198791018 / US80105N1054 / US64111Q1040 / US1281261099 / US79466L3024 / US6866881021 / US2538681030 / US00206R1023 / US6247581084 / PAP310761054 / US16115Q3083 / US3364331070 / US01748X1028 / US2473617023 / US53261M1045 / US90384S3031 / US1940141062 / DE000A0DJ6J9 / CA9609083097 / CA0585861085 / US58933Y1055 / US5218652049 / US88160R1014 / US9100471096 / US69404D1081 / US92839U2069 / US8676524064 / JE00B783TY65 / US98419M1009 / US00287Y1091 / US98978V1035 / US8725901040 / US72919P2020 / US64051T1007 / US29355A1079 / US23283R1005 / US41068X1000 / US8485771021 / US21240E1055 / US5560991094 / US02376R1023 / IE00BLS09M33 / US0404131064 / CA0089118776 / US29444U7000 / US46185L1035 / US83417M1045 / US6323071042 / US98138J2069 / US45073V1089 / US34959J1088 / US87266J1043 / US36165L1089 / US45782B1044 / NL0012169213 / US87105L1044 / US8760301072 / US30057T1051 / US4622601007 / US05351X1019 / CH0371153492 / US92336X1090 / US0937121079 / US5904791358 / US28414H1032 / KY30744W1070 / US40131M1099 / US35952H6018 / US71535D1063 / US1567271093 / US23725P2092 / US92537N1081 / US26142R1041 / US6541101050 / US12233L1070 / US04271T1007 / KYG3902L1095 / US5502411037 / US55406W1036 / US82489W1071 / US03783T1034 / LU2314763264 / US90089L1089 / US30320C1036</td><td class="leftalignment">Melexis NV / Air Products and Chemicals Inc / Akamai Technologies Inc / Alaska Air Group Inc / Amgen Inc / Amtech Systems Inc / AstraZeneca PLC / Borgwarner Inc / Bristol-Myers Squibb Co / Cisco Systems Inc / Cummins Inc / Flowserve Corp / GlaxoSmithKline PLC / IDEX Corp / Illumina Inc / Incyte Corp / Itron Inc / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Parker-Hannifin Corp / Pfizer Inc / Roche Holding AG / Roper Technologies Inc / SkyWest Inc / Southwest Airlines Co / Thermo Fisher Scientific Inc / Verizon Communications Inc / Watts Water Technologies Inc / Sierra Wireless Inc / Exact Sciences Corp / Acuity Brands Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / NETGEAR Inc / CalAmp Corp / Salesforce.Com Inc / Ormat Technologies Inc / Digital Realty Trust Inc / AT&T Inc / Mueller Water Products Inc / Copa Holdings SA / Chart Industries Inc / First Solar Inc / Allegiant Travel Co / Delta Air Lines Inc / Limelight Networks Inc / Ulta Beauty Inc / Colfax Corp / SMA Solar Technology AG / Westport Fuel Systems Inc / Ballard Power Systems Inc / Merck & Co Inc / Lear Corp / Tesla Inc / United Airlines Holdings Inc / Pacific Biosciences of California Inc / Visteon Corp / SunPower Corp / Aptiv PLC / Xylem Inc / Abbvie Inc / Zoetis Inc / T-Mobile US Inc / Plug Power Inc / NeoPhotonics Corp / Enphase Energy Inc / CyrusOne Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / MacroGenics Inc / American Airlines Group Inc / Pentair PLC / Arista Networks Inc / Air Canada / Equinix Inc / Invitae Corp / Solaredge Technologies Inc / Natera Inc / Workhorse Group Inc / ITT Inc / Fortive Corp / TPI Composites Inc / GDS Holdings Ltd / Inseego Corp / Qiagen NV / Switch Inc / Tapestry Inc / Evoqua Water Technologies Corp / Iovance Biotherapeutics Inc / Avaya Holdings Corp / Landis+Gyr Group AG / Veoneer Inc / Bloom Energy Corp / Mesa Air Group Inc / Elanco Animal Health Inc / Farfetch Ltd / Guardant Health Inc / Fuelcell Energy Inc / Personalis Inc / Cerence Inc / DarioHealth Corp / Vertiv Holdings Co / DraftKings Inc / Nikola Corp / Burning Rock Biotech Ltd / Array Technologies Inc / GDS Holdings Ltd / Lumen Technologies Inc / MYT Netherlands Parent BV / Shoals Technologies Group Inc / AppHarvest Inc / Arrival SA / TuSimple Holdings Inc / FTC Solar Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Luxembourg / Mexico / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">ASCO Highlights In Pharma From The Weekend</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US1101221083 / US66987V1098 / US7711951043 / US58933Y1055</td><td class="leftalignment">Bristol-Myers Squibb Co / Novartis AG / Roche Holding AG / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Ms. Kathleen M. Miner, R.Ph., CFA</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">FISV=US / MRK=US / LLY=US / PEP=US / AMGN=US / CAG=US / KO=US / CL=US / PG=US / T=US / INCY=US / GILD=US / ENR=US / MANH=US / NWL=US / FLO=US / STZ=US / PATH=US / ENV=US / CENT=US / CHD=US / COLL=US / EPC=US / HAIN=US / REGN=US / SMG=US / FOUR=US / POST=US / GPN=US / SNV=US / AUTL=US / MGNI=US / MGPI=US / BDSI=US / MNST=US / NOMD=US / BIIB=US / FRPT=US / DENN=US / THS=US / FIS=US / ELF=US / TIL=US / AAN=US / UTZ=US / OLO=US / MEIP=US / ABBV=US / FATE=US / COUP=US / SQ=US / NTLA=US / IOVA=US / PETQ=US / EQH=US / KDP=US / BTAI=US / HARP=US / LSPD=US / RPAY=US / BRBR=US / GMAB=US / REYN=US / ZI=US / BIGC=US / HYFM=US</td><td class="leftalignment">Fiserv Inc / Merck & Co Inc / Eli Lilly and Co / PepsiCo Inc / Amgen Inc / Conagra Brands Inc / Coca-Cola Co / Colgate-Palmolive Co / Procter & Gamble Co / AT&T Inc / Incyte Corp / Gilead Sciences Inc / Energizer Holdings Inc / Manhattan Associates Inc / Newell Brands Inc / Flowers Foods Inc / Constellation Brands Inc / UiPath Inc / Envestnet Inc / Central Garden & Pet Co / Church & Dwight Co Inc / Collegium Pharmaceutical Inc / Edgewell Personal Care Co / Hain Celestial Group Inc / Regeneron Pharmaceuticals Inc / Scotts Miracle-Gro Co / Shift4 Payments Inc / Post Holdings Inc / Global Payments Inc / Synovus Financial Corp / Autolus Therapeutics PLC / Magnite Inc / MGP Ingredients Inc / BioDelivery Sciences International Inc / Monster Beverage Corp / Nomad Foods Ltd / Biogen Inc / Freshpet Inc / Denny's Corp / TreeHouse Foods Inc / Fidelity National Information Services Inc / elf Beauty Inc / Instil Bio Inc / Aaron's Company Inc / UTZ Brands Inc / Olo Inc / MEI Pharma Inc / Abbvie Inc / Fate Therapeutics Inc / Coupa Software Inc / Block Inc / Intellia Therapeutics Inc / Iovance Biotherapeutics Inc / PetIQ Inc / Equitable Holdings Inc / Keurig Dr Pepper Inc / BioXcel Therapeutics Inc / Harpoon Therapeutics Inc / Lightspeed Commerce Inc / Repay Holdings Corp / Bellring Brands Inc / Genmab A/S / Reynolds Consumer Products Inc / ZoomInfo Technologies Inc / Bigcommerce Holdings Inc / Hydrofarm Holdings Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / United Kingdom / Luxembourg / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 2000019 / 2023607 / 2778844 / 2216850 / 2280220 / 2317087 / 2576941 / 2328915 / 2455965 / 2457864 / 2471950 / 2689560 / 2048804 / 2707677 / 2829601 / 2712013 / B1HMF22 / B03L311 / 2857817 / B125XQ6 / B1GKCH1 / B02R1L6 / B3D7K31 / B1XGNW4 / B0796X4 / B7TL820 / BCZS820 / BFDV8K0 / BBPK0J0 / B95N910 / BDZCRX3 / B424494 / B59DK93 / BFZCHN7 / BTN1Y11 / B6XZN93 / BXDZ9Z0 / BFZNYB7 / BD9GVY0 / BZBY005 / BFXCLC6 / BZ1LFB2 / BD8DJ71 / BQT3XY6 / BJLKVS6 / BYQNYR5 / BR4T3B3 / BMQ5T49 / BKVDFF7 / BLGJ610 / BFMXGR0 / BGSP7M9 / BYYWPW6 / BZ1LFG7 / BWY52P3 / BYY88Y7 / BL71K91 / BWY4XV3 / BN2R582 / BMDCDP2 / BGJRH57 / BYP0CD9 / BMDJ085 / BMDJ397 / BLP5YB5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Amazon.com Inc / Amgen Inc / Merck & Co Inc / Consolidated Edison Inc / DTE Energy Co / Entergy Corp / Exelixis Inc / Nextera Energy Inc / Biogen Inc / ImmunoGen Inc / Incyte Corp / PG&E Corp / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Southern Co / Global Payments Inc / First Solar Inc / Ormat Technologies Inc / Netflix Inc / Portland General Electric Co / Canadian Solar Inc / ALLETE Inc / Discovery Inc / Insulet Corp / Dexcom Inc / Meta Platforms Inc / Fate Therapeutics Inc / MacroGenics Inc / Mirati Therapeutics Inc / PTC Inc / RingCentral Inc / Splunk Inc / SunPower Corp / Wix.Com Ltd / Medtronic PLC / Brookfield Renewable Partners LP / Shopify Inc / Allogene Therapeutics Inc / Zai Lab Ltd / Merus NV / Elastic NV / Deciphera Pharmaceuticals Inc / Snap Inc / Cyberark Software Ltd / Phathom Pharmaceuticals Inc / Senseonics Holdings Inc / HubSpot Inc / Zentalis Pharmaceuticals Inc / Oric Pharmaceuticals Inc / Warner Music Group Corp / Evergy Inc / Zoom Video Communications Inc / Beigene Ltd / Roku Inc / Blueprint Medicines Corp / Alphabet Inc / Revolution Medicines Inc / Adaptimmune Therapeutics PLC / Relay Therapeutics Inc / Bigcommerce Holdings Inc / Clearway Energy Inc / Avangrid Inc / Shoals Technologies Group Inc / Bolt Biotherapeutics Inc / Atlantica Sustainable Infrastructure PLC</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 7, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AEP.N / AES.N / CL.N / CRM.N / DFDS.CO / EIX.N / EL.N / F.N / GM.N / IBE.MC / KMB.N / KO.N / MAS.N / MRK.N / NA / PD.N / PEG.N / SO.N / PEP.N / BFb.N / PG.N / CPB.N / AMGN.O / LEA.N / K.N / CLX.N / CAG.N / GIS.N / EPC.N / JAZZ.O / CONE.O / STZ.N / EXC.N / FISV.O / V.N / AWK.N / CHD.N / NWN.N / SAM.N / FRAG.DE / ENR.N / MHK.N / NCR.N / ENAG.MC / ENDP.O / CPK.N / ST.N / SWN.N / GPN.N / MNST.O / EQIX.O / 02209S103 / MNKD.OQ / DLR.N / 427866108 / BLDR.O / SJW.N / FIS.N / TEVA.N / BGS.N / GETP.PA / PHR.N / SPB.N / NEE.N / NXT.AX / PCRX.O / MDLZ.OQ / ABBV.N / TSLA.N / PRMW.N / COTY.N / DOOR.N / ESNT.N / SCWX.O / VST.N / APTV.N / SMAR.N / KDP.N / ESTC.N / NWL.O / ZM.O / CRNC.OQ / AZEK.N / WTRG.N / REYN.O / CARR.N / FOUR.N / ASAN.N / SUMO.O / VTRS.OQ / NAPA.N / PATH.N / DBM.TO / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Colgate-Palmolive Co / Salesforce.Com Inc / DFDS AS / Edison International / Estee Lauder Companies Inc / Ford Motor Co / General Motors Co / Iberdrola SA / Kimberly-Clark Corp / Coca-Cola Co / Masco Corp / Merck & Co Inc / National Bank of Canada / PagerDuty Inc / Public Service Enterprise Group Inc / Southern Co / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Campbell Soup Co / Amgen Inc / Lear Corp / Kellogg Co / Clorox Co / Conagra Brands Inc / General Mills Inc / Edgewell Personal Care Co / Jazz Pharmaceuticals PLC / CyrusOne Inc / Constellation Brands Inc / Exelon Corp / Fiserv Inc / Visa Inc / American Water Works Company Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Boston Beer Company Inc / Fraport AG Frankfurt Airport Services Worldwide / Energizer Holdings Inc / Mohawk Industries Inc / NCR Corp / Enagas SA / Endo International PLC / Chesapeake Utilities Corp / Sensata Technologies Holding PLC / Southwestern Energy Co / Global Payments Inc / Monster Beverage Corp / Equinix Inc / Altria Group Inc / MannKind Corp / Digital Realty Trust Inc / Hershey Co / Builders FirstSource Inc / SJW Group / Fidelity National Information Services Inc / Teva Pharmaceutical Industries Ltd / B&G Foods Inc / Getlink SE / Phreesia Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / NEXTDC Ltd / Pacira Biosciences Inc / Mondelez International Inc / Abbvie Inc / Tesla Inc / Primo Water Corp / Coty Inc / Masonite International Corp / Essent Group Ltd / SecureWorks Corp / Vistra Corp / Aptiv PLC / Smartsheet Inc / Keurig Dr Pepper Inc / Elastic NV / Newell Brands Inc / Zoom Video Communications Inc / Cerence Inc / Azek Company Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Carrier Global Corp / Shift4 Payments Inc / Asana Inc / Sumo Logic Inc / Viatris Inc / Duckhorn Portfolio Inc / UiPath Inc / Doman Building Materials Group Ltd / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ROG.S: Roche - ASCO 2021: Tecentriq in adjuvant lung cancer likely practice changing in a limited population</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ROG.S / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / NOVOB.CO / NOVN.S / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">Roche Holding AG / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AZN.L: AstraZeneca - ASCO 2021 weekend takeaways</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AZN.L / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVN.S: Novartis - ASCO 2021 Weekend highlights</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">NOVN.S / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">Novartis AG / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GMAB.CO: Genmab - ASCO 2021 weekend takeaways: incremental updates for epcoritamab</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GMAB.CO / RECI.MI / ROG.S / LUN.CO / MRCG.DE / LONN.S / UCB.BR / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC</td><td class="leftalignment">Genmab A/S / Recordati Industria Chimica e Farmaceutica SpA / Roche Holding AG / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - ASCO 2021: Key takeaway from weekend presentations (Part 2)</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">JNJ.N / MRK.N / 600276.SS / MRTX.OQ / BGNE.OQ / ZLAB.OQ / 1877.HK</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Mirati Therapeutics Inc / Beigene Ltd / Zai Lab Ltd / Shanghai Junshi Biosciences Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - ASCO 2021: Key takeaway from weekend presentations (Part 1)</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">4502.T / BMY.N / MRK.N / AMGN.OQ / 600276.SS / ZLAB.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Merck & Co Inc / Amgen Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Zai Lab Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="odd"><td class="leftalignment">06/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / JAZZ.O / ENDP.O / MNKD.OQ / TEVA.N / PCRX.O / ABBV.N / VTRS.OQ</td><td class="leftalignment">Merck & Co Inc / Jazz Pharmaceuticals PLC / Endo International PLC / MannKind Corp / Teva Pharmaceutical Industries Ltd / Pacira Biosciences Inc / Abbvie Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">06/06/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6% Above Pre-Pandemic Base - Week 61</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Lowering estimates to reflect Organon separation; PT to $93; Maintain Buy</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Portfolio Manager's Weekly - June 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">FR0000120073 / DE0006231004 / US0079031078 / US0091581068 / US0530151036 / US0970231058 / US1005571070 / US1264081035 / US1727551004 / US1924461023 / US22284P1057 / US2310211063 / US2371941053 / US2545431015 / US3021301094 / US3377381088 / US4433201062 / US4456581077 / US4567881085 / US4581401001 / US4663671091 / US5150981018 / US5324571083 / US5801351017 / US6558441084 / US67066G1040 / US6795801009 / US7043261079 / US8552441094 / US9029251066 / US9078181081 / US9507551086 / CA1363751027 / CA13645T1003 / US37940X1028 / US9884981013 / US21036P1084 / US09062X1037 / US1572101053 / US25754A2015 / US0042251084 / US02043Q1076 / US60871R2094 / US12541W2098 / US31620M1062 / US1696561059 / US78709Y1055 / US75025X1000 / US16115Q3083 / US3020811044 / US92932M1018 / US87874R1005 / BMG3922B1072 / IE00B4BNMY34 / US58933Y1055 / US95058W1009 / US29414B1044 / US9837931008 / US98978V1035 / US72919P2020 / KYG037AX1015 / US70438V1061 / US70432V1026 / US03937C1053 / US98936J1016 / LU0974299876 / US0465131078 / US64829B1008 / CA76131D1033 / US8190471016 / US00653A1079 / US9741551033 / US70450Y1038 / US05464T1043 / US8522341036 / US00773U1088 / US90138F1021 / US2067871036 / CA87241L1094 / CA35805P1071 / US23753F1075 / US23355L1061 / US80689H1023 / US03782L1017 / US4990491049 / US89854H1023 / US15677J1088 / US46571Y1073 / US2575541055 / US0937121079 / US29260V1052 / US28414H1032 / US0197701065 / IE00BZ12WP82 / US0144421072 / US09203E1055 / US39813G1094 / CH0499880968 / US90364P1057 / US92719V1008</td><td class="leftalignment">L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Infineon Technologies AG / Advanced Micro Devices Inc / Air Products and Chemicals Inc / Automatic Data Processing Inc / Boeing Co / Boston Beer Company Inc / CSX Corp / Cirrus Logic Inc / Cognizant Technology Solutions Corp / Covenant Logistics Group Inc / Cummins Inc / Darden Restaurants Inc / Diodes Inc / Expeditors International of Washington Inc / Fiserv Inc / Hub Group Inc / J B Hunt Transport Services Inc / Infosys Ltd / Intel Corp / Jack in the Box Inc / Landstar System Inc / Eli Lilly and Co / McDonald's Corp / Norfolk Southern Corp / NVIDIA Corp / Old Dominion Freight Line Inc / Paychex Inc / Starbucks Corp / USA Truck Inc / Union Pacific Corp / Werner Enterprises Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Global Payments Inc / Yum! Brands Inc / Constellation Brands Inc / Biogen Inc / CEVA Inc / Domino's Pizza Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Molson Coors Beverage Co / CH Robinson Worldwide Inc / Fidelity National Information Services Inc / Chipotle Mexican Grill Inc / Saia Inc / Radiant Logistics Inc / Chart Industries Inc / Exlservice Holdings Inc / WNS (Holdings) Ltd / TechTarget Inc / Genpact Ltd / Accenture PLC / Merck & Co Inc / Wendys Co / Epam Systems Inc / XPO Logistics Inc / Zoetis Inc / Plug Power Inc / Ambarella Inc / Paylocity Holding Corp / Paycom Software Inc / ArcBest Corp / Zendesk Inc / Globant SA / Atara Biotherapeutics Inc / New Relic Inc / Restaurant Brands International Inc / Shake Shack Inc / Adaptimmune Therapeutics PLC / Wingstop Inc / PayPal Holdings Inc / Axsome Therapeutics Inc / Block Inc / Adverum Biotechnologies Inc / Twilio Inc / Conduent Inc / TFI International Inc / Freshii Inc / Daseke Inc / DXC Technology Co / Schneider National Inc / Appian Corp / Knight-Swift Transportation Holdings Inc / TTEC Holdings Inc / Ceridian HCM Holding Inc / I3 Verticals Inc / Domo Inc / Bloom Energy Corp / Endava PLC / Elanco Animal Health Inc / Allogene Therapeutics Inc / Linde PLC / Alector Inc / Black Diamond Therapeutics Inc / Grid Dynamics Holdings Inc / ADC Therapeutics SA / UiPath Inc / Vimeo Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Germany / France / United Kingdom / India / Ireland / Luxembourg / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended May 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending May 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - June 4 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">DE0006231004 / US0028241000 / US0079031078 / US0231351067 / US0382221051 / US0463531089 / US0530151036 / US1005571070 / US1101221083 / US1265011056 / US1727551004 / US1924461023 / US2545431015 / US4567881085 / US4581401001 / US4781601046 / US5012421013 / US5370081045 / US55306N1046 / US5950171042 / US66987V1098 / US67066G1040 / US6795801009 / US7043261079 / US8269191024 / US8610121027 / US91347P1057 / US9581021055 / US37940X1028 / US87157D1090 / US83088M1027 / US21036P1084 / US6098391054 / US60871R2094 / US31620M1062 / US82706C1080 / US78709Y1055 / US1717793095 / US3020811044 / US92932M1018 / US87874R1005 / BMG3922B1072 / US5500211090 / US64110D1046 / IE00B4BNMY34 / US58933Y1055 / US39304D1028 / US29414B1044 / US96208T1043 / NL0010273215 / US81762P1021 / US2908462037 / US55405Y1001 / KYG037AX1015 / US03823U1025 / US8086251076 / US70438V1061 / US70432V1026 / US03937C1053 / LU0974299876 / US94419L1017 / US40434L1052 / GB00BZ09BD16 / US98138J2069 / US2067871036 / US87968A1043 / US02156B1035 / US23355L1061 / US76674Q1076 / US7625441040 / US89854H1023 / US98980G1022 / US11135F1012 / US15677J1088 / US29260V1052 / US69553P1003 / US22788C1053 / US39813G1094 / US86646P1030 / CA67079A1021 / US8808811074 / US15961R1059 / US90364P1057 / US83089J1088 / US44891N2080 / US92719V1008</td><td class="leftalignment">Infineon Technologies AG / Abbott Laboratories / Advanced Micro Devices Inc / Amazon.com Inc / Applied Materials Inc / AstraZeneca PLC / Automatic Data Processing Inc / Boston Beer Company Inc / Bristol-Myers Squibb Co / CTS Corp / Cirrus Logic Inc / Cognizant Technology Solutions Corp / Diodes Inc / Infosys Ltd / Intel Corp / Johnson & Johnson / Kulicke and Soffa Industries Inc / Littelfuse Inc / MKS Instruments Inc / Microchip Technology Inc / Novartis AG / NVIDIA Corp / Old Dominion Freight Line Inc / Paychex Inc / Silicon Laboratories Inc / STMicroelectronics NV / Universal Display Corp / Western Digital Corp / Global Payments Inc / Synaptics Inc / Skyworks Solutions Inc / Constellation Brands Inc / Monolithic Power Systems Inc / Molson Coors Beverage Co / Fidelity National Information Services Inc / Silicon Motion Technology Corp / Saia Inc / Ciena Corp / Exlservice Holdings Inc / WNS (Holdings) Ltd / TechTarget Inc / Genpact Ltd / Lululemon Athletica Inc / NetApp Inc / Accenture PLC / Merck & Co Inc / Green Dot Corp / Epam Systems Inc / WEX Inc / ASML Holding NV / ServiceNow Inc / EMCORE Corp / MACOM Technology Solutions Holdings Inc / Ambarella Inc / Applied Optoelectronics Inc / Science Applications International Corp / Paylocity Holding Corp / Paycom Software Inc / ArcBest Corp / Globant SA / Wayfair Inc / HP Inc / Atlassian Corporation PLC / Workhorse Group Inc / Conduent Inc / Tellurian Inc / Alteryx Inc / DXC Technology Co / Rimini Street Inc / Ribbon Communications Inc / TTEC Holdings Inc / Zscaler Inc / Broadcom Inc / Ceridian HCM Holding Inc / Endava PLC / PagerDuty Inc / CrowdStrike Holdings Inc / Grid Dynamics Holdings Inc / Sumo Logic Inc / Nuvei Corp / Terns Pharmaceuticals Inc / ChargePoint Holdings Inc / UiPath Inc / Skywater Technology Inc / IAC/Interactivecorp / Vimeo Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Germany / United Kingdom / India / Ireland / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">ASCO 2021: Late-Breaking Pharma Abstracts And Our Take On The Data</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US0463531089 / US1101221083 / US66987V1098 / US58933Y1055</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Novartis AG / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Ms. Kathleen M. Miner, R.Ph., CFA</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">0989529 / 2126335 / 2516152 / 2496113 / 2023607 / 2778844 / 2973821 / 2216850 / 2222631 / 2270726 / 2317087 / 2670519 / 2328915 / 2680905 / 2707677 / 2829601 / 7103065 / 2857817 / 2951452 / B0T7YX2 / B02R1L6 / B3D7K31 / B23FN39 / B7TL820 / B85KFY9 / B7JYSG3 / BBPK0J0 / BJ0KXV4 / B424494 / BYVY8G0 / BYW36M8 / BXDZ9Z0 / BKS3SM8 / BZ1HM42 / BFZ1K46 / BFMXGR0 / BJJMGL2 / BFWK4R7 / BL71K91 / BK71LY6 / BDRW1L7 / BKF9DQ8 / BNG3RZ7 / BMDJ085 / BMG5660 / BP8GHT2</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Kohls Corp / Amgen Inc / Merck & Co Inc / Alliant Energy Corp / Consolidated Edison Inc / Cooper Companies Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / PPL Corp / Public Service Enterprise Group Inc / Southern Co / Novartis AG / Netflix Inc / J M Smucker Co / Live Nation Entertainment Inc / ALLETE Inc / Discovery Inc / Lululemon Athletica Inc / Meta Platforms Inc / Five Below Inc / Guidewire Software Inc / Mirati Therapeutics Inc / ONE Gas Inc / Splunk Inc / Alphabet Inc / PayPal Holdings Inc / Shopify Inc / IGM Biosciences Inc / Adyen NV / Spotify Technology SA / Evergy Inc / Fox Corp / PagSeguro Digital Ltd / Revolution Medicines Inc / WW International Inc / AnaptysBio Inc / Phreesia Inc / Leslie's Inc / Shoals Technologies Group Inc / Joann Inc / Vascular Biogenics Ltd</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ASCO 2021 Late-Breakers Highlight Practice Changing Adjuvant Results from MRK/AZN's Lynparza in BRCA+ Breast Cancer & MRK's Keytruda in Kidney Cancer</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK.N / AZN.L / 0989529 / 2126335 / 2778844 / 7103065</td><td class="leftalignment">Merck & Co Inc / AstraZeneca PLC / AstraZeneca PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Novartis AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - ASCO 2021 late breaking abstract released: Junshi's toripalimab improves survival in 1L nasopharyngeal cancer</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY.N / MRK.N / AZN.L / NOVN.S / 600276.SS / BGNE.OQ / 1877.HK</td><td class="leftalignment">Bristol-Myers Squibb Co / Merck & Co Inc / AstraZeneca PLC / Novartis AG / Jiangsu Hengrui Pharmaceuticals Co Ltd / Beigene Ltd / Shanghai Junshi Biosciences Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma: ASCO 2021 late breaking abstracts: First impressions</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N / AZN.L / ROG.S / NOVN.S</td><td class="leftalignment">Merck & Co Inc / AstraZeneca PLC / Roche Holding AG / Novartis AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Litchfield Hills Research, LLC</td><td class="leftalignment">AI focused biotech, Predictive Oncology, advances on plan - reiterate Buy and $5 PT</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">POAI.OQ / 4502.T / MRK.N / PFE.N / SNY.N / AZN.L / AZN.N / ROG.S / SYK.N / GSK.L / GSK.N / DXR.A / QBIO.PK / MYGN.OQ / BAYGN.DE / ZBH.N / CODX.OQ / DE000BAY0199 / ANPC.OQ</td><td class="leftalignment">Predictive Oncology Inc / Takeda Pharmaceutical Co Ltd / Merck & Co Inc / Pfizer Inc / Sanofi SA / AstraZeneca PLC / AstraZeneca PLC / Roche Holding AG / Stryker Corp / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Daxor Corp / Q BioMed Inc / Myriad Genetics Inc / Bayer AG / Zimmer Biomet Holdings Inc / Co-Diagnostics Inc / Bayer AG / AnPac Bio-Medical Science Co Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Japan / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS / SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Theodore R. O'Neill</td></tr>
<tr class="even"><td class="leftalignment">06/03/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Daily Credit Briefing</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BOUY.PA / ORSTED.CO / PFE.N / AZN.L / MRCG.DE / MOSS.NS</td><td class="leftalignment">Bouygues SA / Orsted A/S / Pfizer Inc / AstraZeneca PLC / Merck KGaA / Motherson Sumi Systems Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / India / United States</td><td class="leftalignment">Aerospace / Air Transportation / Biotechnology / Conglomerates / Defense / Electrical / Energy / Engineering & Construction / Environmental Services / Healthcare / Industrial Materials / Machinery / Pharmaceuticals / Railroads / Shipping & Shipbuilding / Telecommunications / Transportation / Utilities / Oil & Gas</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS / CREDIT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Research Digest</td><td class="leftalignment">Herr. Ulrich Scholz, CFA / Herr Jonathan Schroer / Frau Silke Stegemann / Herr Sven Kreitmair, CFA</td></tr>
<tr class="odd"><td class="leftalignment">06/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Updating Model Post-Spinoff</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">58933Y10</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="even"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Merck KGaA</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - New report: ASCO 2021 calendar-China biotech presentations to watch</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">1093.HK / BMY.N / JNJ.N / MRK.N / AZN.L / ROG.S / NOVN.S / AMGN.OQ / 600276.SS / 4568.T / MRTX.OQ / BGNE.OQ / ZLAB.OQ / 6160.HK / 1801.HK / 1877.HK / IMAB.OQ</td><td class="leftalignment">CSPC Pharmaceutical Group Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / AstraZeneca PLC / Roche Holding AG / Novartis AG / Amgen Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Daiichi Sankyo Co Ltd / Mirati Therapeutics Inc / Beigene Ltd / Zai Lab Ltd / Beigene Ltd / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / United Kingdom / Hong Kong / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="even"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">China Healthcare Sector: ASCO 2021 calendar: China biotech presentations to watch</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">1093.HK / BMY.N / JNJ.N / MRK.N / AZN.L / ROG.S / NOVN.S / AMGN.OQ / 600276.SS / 4568.T / MRTX.OQ / BGNE.OQ / ZLAB.OQ / 6160.HK / 1801.HK / 1877.HK / IMAB.OQ</td><td class="leftalignment">CSPC Pharmaceutical Group Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / AstraZeneca PLC / Roche Holding AG / Novartis AG / Amgen Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Daiichi Sankyo Co Ltd / Mirati Therapeutics Inc / Beigene Ltd / Zai Lab Ltd / Beigene Ltd / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / United Kingdom / Hong Kong / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="odd"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck KGaA: Ownership Timelines & Shareholder Analytics (May 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Morning Bite Flash</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">FR0000120578 / BE0003739530 / DE0006599905 / GB0009895292 / BE0003470755 / CH0010645932 / GB0009252882 / CH0012032113 / CH0012005267 / US0311621009 / US8835561023 / DE0007074007 / DE0007165631 / CH0013841017 / DE0005470405 / NL0000009827 / DE000WCH8881 / DE000SYM9999 / LU0775917882 / GB00BJFFLV09</td><td class="leftalignment">Sanofi SA / Ucb SA / Merck KGaA / AstraZeneca PLC / Solvay SA / Givaudan SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Amgen Inc / Thermo Fisher Scientific Inc / KWS SAAT SE & Co KgaA / Sartorius AG / Lonza Group AG / Lanxess AG / Koninklijke DSM NV / Wacker Chemie AG / Symrise AG / Grand City Properties SA / Croda International PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / Germany / France / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Herr. Ingo-Martin Schachel, CFA</td></tr>
<tr class="odd"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Not running out of steam</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">DE0006599905 / FR0000120578 / BE0003739530 / GB0009895292 / BE0003470755 / CH0010645932 / GB0009252882 / CH0012032113 / CH0012005267 / US0311621009 / US8835561023 / DE0007165631 / CH0013841017 / DE0005470405 / NL0000009827 / DE000WCH8881 / DE000SYM9999 / GB00BJFFLV09</td><td class="leftalignment">Merck KGaA / Sanofi SA / Ucb SA / AstraZeneca PLC / Solvay SA / Givaudan SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Amgen Inc / Thermo Fisher Scientific Inc / Sartorius AG / Lonza Group AG / Lanxess AG / Koninklijke DSM NV / Wacker Chemie AG / Symrise AG / Croda International PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / China / Germany / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Herr Daniel Wendorff</td></tr>
<tr class="even"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / BLD=US / INCY=US / KMI=US / V=US / LOW=US / HSII=US / LEG=US / KFRC=US / VMC=US / MLM=US / KFY=US / AMN=US / SWIM=US / CBRL=US / DRI=US / GFF=US / IBP=US / MAN=US / MAS=US / MRCY=US / MHK=US / ASGN=US / REGI=US / RHI=US / SMG=US / SHOP=US / TRIP=US / CGEN=US / CCRN=US / PYPL=US / AVTR=US / CRTO=US / NFLX=US / DIN=US / PTON=US / RNG=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / NSP=US / CMG=US / REX=US / MA=US / PGTI=US / GPRE=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / KTOS=US / NXGN=US / JACK=US / TREX=US / FBHS=US / ABBV=US / TILE=US / NDLS=US / PTCT=US / CEQP=US / FATE=US / VCYT=US / 00770K202 / LOCO=US / SHAK=US / BWXT=US / WING=US / 100095108 / 82982L103 / IRTC=US / JELD=US / ROKU=US / SYNH=US / MAXR=US / BTAI=US / FERG=US / LHX=US / IMVT=US / ARQT=US / SPCE=US / FBRX=US / AZEK=US / AFRM=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / Incyte Corp / Kinder Morgan Inc / Visa Inc / Lowe's Companies Inc / Heidrick & Struggles International Inc / Leggett & Platt Inc / Kforce Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Korn Ferry / AMN Healthcare Services Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / ManpowerGroup Inc / Masco Corp / Mercury Systems Inc / Mohawk Industries Inc / ASGN Inc / Renewable Energy Group Inc / Robert Half International Inc / Scotts Miracle-Gro Co / Shopify Inc / Tripadvisor Inc / Compugen Ltd / Cross Country Healthcare Inc / PayPal Holdings Inc / Avantor Inc / Criteo SA / Netflix Inc / Dine Brands Global Inc / Peloton Interactive Inc / RingCentral Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Mastercard Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Kratos Defense and Security Solutions Inc / NextGen Healthcare Inc / Jack in the Box Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Abbvie Inc / Interface Inc / Noodles & Co / PTC Therapeutics Inc / Crestwood Equity Partners LP / Fate Therapeutics Inc / Veracyte Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / BWX Technologies Inc / Wingstop Inc / Bank of America Corp / SiteOne Landscape Supply Inc / iRhythm Technologies Inc / JELD-WEN Holding Inc / Roku Inc / Syneos Health Inc / Maxar Technologies Inc / BioXcel Therapeutics Inc / Ferguson PLC / L3harris Technologies Inc / Immunovant Inc / Arcutis Biotherapeutics Inc / Virgin Galactic Holdings Inc / Forte Biosciences Inc / Azek Company Inc / Affirm Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/02/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Daily Credit Briefing</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">OMVV.VI / SHBA.ST / VOLVB.ST / AMGN.O / MRCG.DE / SWEDA.ST</td><td class="leftalignment">OMV AG / Svenska Handelsbanken AB / Volvo AB / Amgen Inc / Merck KGaA / Swedbank AB</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Austria / Germany / Israel / Sweden / United States</td><td class="leftalignment">Advertising / Aerospace / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Biotechnology / Broadcasting & Cable / Building & Building Materials / Conglomerates / Consumer / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Financial Services / Healthcare / Household Products / Industrial Materials / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Shipping & Shipbuilding / Tire & Rubber / Transportation / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS / CREDIT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Research Digest</td><td class="leftalignment">Herr Christian Aust / Herr Sven Kreitmair, CFA / Frau Silke Stegemann / Herr. Franz Rudolf / Herr. Stefan Kolek / Herr Gianfranco Arcovito / Herr. Michael Teig</td></tr>
<tr class="even"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Initiating at Buy, $48 PT</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">100095108 / MRK=US</td><td class="leftalignment">Bank of America Corp / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser</td></tr>
<tr class="odd"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: May 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AR.N / AXP.N / BAC.N / BAX.N / BDX.N / BSX.N / C.N / CAH.N / CC.N / CL.N / COF.N / CRM.N / ECL.N / EIX.N / EOG.N / F.N / FCX.N / FDX.N / GE.N / GPS.N / IBM.N / JNJ.N / JPM.N / KMB.N / LLY.N / LMT.N / MRK.N / SC.N / T.N / U.N / WFC.N / WMT.N / SPG.N / PG.N / NUE.N / AAL.L / DHR.N / DIS.N / UNH.N / D.N / FE.N / URI.N / DE.N / CAT.N / MGM.N / SPOT.N / GS.N / CLX.N / HD.N / LOW.N / MRO.N / UPS.N / PCG.N / XOM.N / DVN.N / AMT.N / NKE.N / LIN.N / OLN.N / IT.N / TGT.N / AVY.N / RKT.N / BLL.N / VZ.N / MUR.N / KSS.N / HRB.N / ORCL.N / VFC.N / NRG.N / PWR.N / NEU.N / COG.N / V.N / HWM.N / ACN.N / WSM.N / HAE.N / PVH.N / LB.TO / BLK.N / CVX.N / IRM.N / NCR.N / INTC.OQ / CTSH.OQ / ABMD.OQ / ADPT.OQ / ADBE.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / JKHY.OQ / HOLX.OQ / LRCX.OQ / MSFT.OQ / REGN.OQ / ROL.N / SIVB.OQ / QDEL.OQ / QCOM.OQ / INTU.OQ / GILD.OQ / DFS.N / INCY.OQ / PENN.OQ / TPR.N / CTXS.OQ / STLD.OQ / AMZN.OQ / LNG.A / MRCY.OQ / NVDA.OQ / SBAC.OQ / BMRN.OQ / PACW.OQ / TREE.OQ / BLUE.OQ / ARRY.OQ / ALGN.OQ / GPN.N / FITB.OQ / VRTX.OQ / NFLX.OQ / DKS.N / TXN.OQ / CMCSA.OQ / BIIB.OQ / TPX.N / SBNY.OQ / ACAD.OQ / MOS.N / MKTX.OQ / MPWR.OQ / WAL.N / MS.N / FIS.N / STX.AX / RPRX.OQ / HES.N / MA.N / AWI.N / FSLR.OQ / CNK.N / IVZ.N / CLR.N / TDC.N / ES.N / MRNA.OQ / AVGO.OQ / VRSK.OQ / SCHW.N / FTNT.OQ / GNRC.N / NEE.N / TSLA.OQ / LPLA.OQ / Z.OQ / AMD.OQ / SLM.OQ / ENPH.OQ / GWRE.N / SPLK.OQ / NOW.N / SRPT.OQ / ALLY.N / FANG.OQ / BFAM.N / PRGO.N / COTY.N / LDOS.N / RNG.N / COMM.OQ / GOOGL.OQ / PAYC.N / SAGE.OQ / HUBS.N / TDOC.N / PYPL.OQ / GBT.OQ / PEN.N / NVCR.OQ / SQ.N / IONS.OQ / IAC.OQ / TTD.OQ / COUP.OQ / UAA.N / AYX.N / DXC.N / CVNA.N / VST.N / IOVA.OQ / ROKU.OQ / QRTEA.OQ / FB.PS / CPRI.N / PINS.N / FSLY.N / LHX.N / PTON.OQ / NLOK.OQ / LMND.N / AMWL.N / VTRS.OQ / HON.OQ</td><td class="leftalignment">Antero Resources Corp / American Express Co / Bank of America Corp / Baxter International Inc / Becton Dickinson and Co / Boston Scientific Corp / Citigroup Inc / Cardinal Health Inc / Chemours Co / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ecolab Inc / Edison International / EOG Resources Inc / Ford Motor Co / Freeport-McMoRan Inc / FedEx Corp / General Electric Co / Gap Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Kimberly-Clark Corp / Eli Lilly and Co / Lockheed Martin Corp / Merck & Co Inc / Santander Consumer USA Holdings Inc / AT&T Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Simon Property Group Inc / Procter & Gamble Co / Nucor Corp / Anglo American PLC / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Dominion Energy Inc / FirstEnergy Corp / United Rentals Inc / Deere & Co / Caterpillar Inc / MGM Resorts International / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / United Parcel Service Inc / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Nike Inc / Linde PLC / Olin Corp / Gartner Inc / Target Corp / Avery Dennison Corp / Rocket Companies Inc / Ball Corp / Verizon Communications Inc / Murphy Oil Corp / Kohls Corp / H & R Block Inc / Oracle Corp / VF Corp / NRG Energy Inc / Quanta Services Inc / NewMarket Corp / Coterra Energy Inc / Visa Inc / Howmet Aerospace Inc / Accenture PLC / Williams-Sonoma Inc / Haemonetics Corp / PVH Corp / Laurentian Bank of Canada / BlackRock Inc / Chevron Corp / Iron Mountain Inc / NCR Corp / Intel Corp / Cognizant Technology Solutions Corp / ABIOMED Inc / Adaptive Biotechnologies Corp / Adobe Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / Jack Henry & Associates Inc / Hologic Inc / Lam Research Corp / Microsoft Corp / Regeneron Pharmaceuticals Inc / Rollins Inc / SVB Financial Group / Quidel Corp / Qualcomm Inc / Intuit Inc / Gilead Sciences Inc / Discover Financial Services / Incyte Corp / Penn National Gaming Inc / Tapestry Inc / Citrix Systems Inc / Steel Dynamics Inc / Amazon.com Inc / Cheniere Energy Inc / Mercury Systems Inc / NVIDIA Corp / SBA Communications Corp / Biomarin Pharmaceutical Inc / PacWest Bancorp / Lendingtree Inc / bluebird bio Inc / Array Technologies Inc / Align Technology Inc / Global Payments Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / DICK'S Sporting Goods Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Tempur Sealy International Inc / Signature Bank / ACADIA Pharmaceuticals Inc / Mosaic Co / Marketaxess Holdings Inc / Monolithic Power Systems Inc / Western Alliance Bancorp / Morgan Stanley / Fidelity National Information Services Inc / Strike Energy Ltd / Royalty Pharma PLC / Hess Corp / Mastercard Inc / Armstrong World Industries Inc / First Solar Inc / Cinemark Holdings Inc / Invesco Ltd / Continental Resources Inc / Teradata Corp / Eversource Energy / Moderna Inc / Broadcom Inc / Verisk Analytics Inc / Charles Schwab Corp / Fortinet Inc / Generac Holdings Inc / Nextera Energy Inc / Tesla Inc / LPL Financial Holdings Inc / Zillow Group Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Guidewire Software Inc / Splunk Inc / ServiceNow Inc / Sarepta Therapeutics Inc / Ally Financial Inc / Diamondback Energy Inc / Bright Horizons Family Solutions Inc / Perrigo Company PLC / Coty Inc / Leidos Holdings Inc / RingCentral Inc / CommScope Holding Company Inc / Alphabet Inc / Paycom Software Inc / SAGE Therapeutics Inc / HubSpot Inc / Teladoc Health Inc / PayPal Holdings Inc / Global Blood Therapeutics Inc / Penumbra Inc / Novocure Ltd / Block Inc / Ionis Pharmaceuticals Inc / IAC/Interactivecorp / Trade Desk Inc / Coupa Software Inc / Under Armour Inc / Alteryx Inc / DXC Technology Co / Carvana Co / Vistra Corp / Iovance Biotherapeutics Inc / Roku Inc / Qurate Retail Inc / San Miguel Food and Beverage Inc / Capri Holdings Ltd / Pinterest Inc / Fastly Inc / L3harris Technologies Inc / Peloton Interactive Inc / NortonLifeLock Inc / Lemonade Inc / American Well Corp / Viatris Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / United Kingdom / Ireland / Luxembourg / Philippines / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AZN.L: AstraZeneca - Focus on Enhertu - next catalyst has $1bn potential, but remain cautious on HER2 low</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">AZN.L / MRK.N / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / GSK.L / SGEN.OQ / 4568.T / BAYGN.DE</td><td class="leftalignment">AstraZeneca PLC / Merck & Co Inc / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Seagen Inc / Daiichi Sankyo Co Ltd / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">EBS-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EBS / MRK / PFE / GSK / XOMA.O / SIGA.O / CLDX.O / CMRX.O / SNGX.O / TEVA.K</td><td class="leftalignment">Emergent BioSolutions Inc / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / XOMA Corp / SIGA Technologies Inc / Celldex Therapeutics Inc / Chimerix Inc / Soligenix Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 21, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended May 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - June 1 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US0116591092 / US0970231058 / US5002551043 / US5324571083 / US6556641008 / US8308791024 / US8447411088 / US4771431016 / US4198791018 / US09062X1037 / US0042251084 / US02043Q1076 / PAP310761054 / US01748X1028 / US2473617023 / US5500211090 / US58933Y1055 / US9100471096 / US98419M1009 / US98978V1035 / US8485771021 / US21240E1055 / US02376R1023 / US0465131078 / CA0089118776 / US00653A1079 / US05464T1043 / US00773U1088 / US5904791358 / US28414H1032 / US0197701065 / US0144421072 / US09203E1055 / CH0499880968</td><td class="leftalignment">Alaska Air Group Inc / Boeing Co / Kohls Corp / Eli Lilly and Co / Nordstrom Inc / SkyWest Inc / Southwest Airlines Co / JetBlue Airways Corp / Hawaiian Holdings Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Lululemon Athletica Inc / Merck & Co Inc / United Airlines Holdings Inc / Xylem Inc / Zoetis Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Atara Biotherapeutics Inc / Air Canada / Adaptimmune Therapeutics PLC / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Allogene Therapeutics Inc / Alector Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / China / United Kingdom / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AEP.N / AES.N / AKER.OL / BMO.TO / CAS.TO / CL.N / CM.TO / CRM.N / EDP.LS / EIX.N / EL.N / ELE.MC / IBE.MC / IP.N / KMB.N / KO.N / MRK.N / NA.TO / PD.N / PEG.N / PFE.N / RYN.N / SO.N / STO.AX / T.N / T.TO / TD.TO / PEP.N / DRE.N / FR.N / TRI.N / BFb.N / PG.N / WY.N / CFP.TO / CNQ.TO / GILD.O / CPB.N / LPX.N / CMCSA.O / AMGN.O / INCY.O / AAL.L / DUK.N / TRP.TO / K.N / DT.N / ADBE.O / SU.TO / CLX.N / CAG.N / DV.N / GIS.N / EPC.N / MGA.N / AMT.N / JAZZ.O / CONE.O / VZ.N / HCA.N / STZ.N / EXC.N / FISV.O / EQT.N / ADSK.O / EPD.N / AWK.N / EGP.N / PLD.N / NBIX.O / CHD.N / NWN.N / WSP.TO / SAM.N / ENR.N / VRTX.O / JHX.AX / CEY.L / NCR.N / VRNT.O / COP.N / CNP.N / WCN.N / CPK.N / DOL.TO / TYL.N / CRC.N / LNG.A / NTCT.OQ / GPN.N / MNST.O / EFX.TO / CCLb.TO / CASY.O / PCTY.O / ICPT.O / EQIX.O / ATDb.TO / BIIB.O / TIH.TO / 02209S103 / NTR.N / DLR.N / SCL.TO / ACAD.O / 427866108 / WEF.TO / RDSb.L / BAM.N / SJW.N / DRX.L / FIS.N / CSU.TO / MERC.O / 3IN.L / BGS.N / PPL.TO / HOCM.L / ARX.TO / UTL.N / CLW.N / VALE.N / IFC.TO / CVE.TO / ADN.TO / SPB.N / NEE.N / TOU.TO / NXT.AX / PCH.O / CFX.TO / FRU.TO / SXY.AX / CTT.N / STAG.N / IFP.TO / PXT.TO / POLYP.L / EFN.TO / SPLK.OQ / RFP.N / SRPT.O / PANW.N / MDLZ.OQ / ABBV.N / KPT.TO / PRMW.N / TMUS.N / COTY.N / PRTA.O / BEP.N / 81762P102 / CFF.TO / COUP.N / VRNS.O / QTWO.N / RYAM.N / HUBS.N / QSR.N / CAR.AX / 78667J108 / EVA.N / GLPG.O / WRK.N / IONS.O / NTNX.O / GDS.O / AQN.N / OKTA.OQ / WPM.N / ZS.OQ / SMAR.N / VRCA.OQ / ITRM.O / NTGY.MC / KDP.N / ESTC.N / NWL.O / ZM.O / MORF.OQ / CRWD.O / PING.N / FCR_u.TO / REYN.O / GFL.N / FOUR.N / ZI.O / AKES.OL / PLTR.N / ASAN.N / WFG.N / AFRM.O / TEEC.L / NAPA.N / PATH.N / AVAH.OQ / GIP.V / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Aker ASA / Bank of Montreal / Cascades Inc / Colgate-Palmolive Co / Canadian Imperial Bank of Commerce / Salesforce.Com Inc / EDP Energias de Portugal SA / Edison International / Estee Lauder Companies Inc / Endesa SA / Iberdrola SA / International Paper Co / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / National Bank of Canada / PagerDuty Inc / Public Service Enterprise Group Inc / Pfizer Inc / Rayonier Inc / Southern Co / Santos Ltd / AT&T Inc / Telus Corp / Toronto-Dominion Bank / PepsiCo Inc / Duke Realty Corp / First Industrial Realty Trust Inc / Thomson Reuters Corp / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canfor Corp / Canadian Natural Resources Ltd / Gilead Sciences Inc / Campbell Soup Co / Louisiana-Pacific Corp / Comcast Corp / Amgen Inc / Incyte Corp / Anglo American PLC / Duke Energy Corp / TC Energy Corp / Kellogg Co / Dynatrace Inc / Adobe Inc / Suncor Energy Inc / Clorox Co / Conagra Brands Inc / DoubleVerify Holdings Inc / General Mills Inc / Edgewell Personal Care Co / Magna International Inc / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / Verizon Communications Inc / HCA Healthcare Inc / Constellation Brands Inc / Exelon Corp / Fiserv Inc / EQT Corp / Autodesk Inc / Enterprise Products Partners LP / American Water Works Company Inc / Eastgroup Properties Inc / Prologis Inc / Neurocrine Biosciences Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / WSP Global Inc / Boston Beer Company Inc / Energizer Holdings Inc / Vertex Pharmaceuticals Inc / James Hardie Industries PLC / Centamin PLC / NCR Corp / Verint Systems Inc / Conocophillips / CenterPoint Energy Inc / Waste Connections Inc / Chesapeake Utilities Corp / Dollarama Inc / Tyler Technologies Inc / California Resources Corp / Cheniere Energy Inc / Netscout Systems Inc / Global Payments Inc / Monster Beverage Corp / Enerflex Ltd / CCL Industries Inc / Caseys General Stores Inc / Paylocity Holding Corp / Intercept Pharmaceuticals Inc / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Toromont Industries Ltd / Altria Group Inc / Nutrien Ltd / Digital Realty Trust Inc / Shawcor Ltd / ACADIA Pharmaceuticals Inc / Hershey Co / Western Forest Products Inc / Royal Dutch Shell PLC / Brookfield Asset Management Inc / SJW Group / Drax Group PLC / Fidelity National Information Services Inc / Constellation Software Inc / Mercer International Inc / 3I Infrastructure PLC / B&G Foods Inc / Pembina Pipeline Corp / Hochschild Mining PLC / ARC Resources Ltd / Unitil Corp / Clearwater Paper Corp / Vale SA / Intact Financial Corp / Cenovus Energy Inc / Acadian Timber Corp / Spectrum Brands Holdings Inc / Nextera Energy Inc / Tourmaline Oil Corp / NEXTDC Ltd / Potlatchdeltic Corp / Canfor Pulp Products Inc / Freehold Royalties Ltd / Senex Energy Ltd / CatchMark Timber Trust Inc / STAG Industrial Inc / Interfor Corp / Parex Resources Inc / Polymetal International PLC / Element Fleet Management Corp / Splunk Inc / Resolute Forest Products Inc / Sarepta Therapeutics Inc / Palo Alto Networks Inc / Mondelez International Inc / Abbvie Inc / KP Tissue Inc / Primo Water Corp / T-Mobile US Inc / Coty Inc / Prothena Corporation PLC / Brookfield Renewable Partners LP / ServiceNow Inc / Conifex Timber Inc / Coupa Software Inc / Varonis Systems Inc / Q2 Holdings Inc / Rayonier Advanced Materials Inc / HubSpot Inc / Restaurant Brands International Inc / Carsales.Com Ltd / SAGE Therapeutics Inc / Enviva Inc / Galapagos NV / Westrock Co / Ionis Pharmaceuticals Inc / Nutanix Inc / GDS Holdings Ltd / Algonquin Power & Utilities Corp / Okta Inc / Wheaton Precious Metals Corp / Zscaler Inc / Smartsheet Inc / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Elastic NV / Newell Brands Inc / Zoom Video Communications Inc / Morphic Holding Inc / CrowdStrike Holdings Inc / Ping Identity Holding Corp / First Capital Real Estate Investment Trust / Reynolds Consumer Products Inc / GFL Environmental Inc / Shift4 Payments Inc / ZoomInfo Technologies Inc / Aker Solutions ASA / Palantir Technologies Inc / Asana Inc / West Fraser Timber Co Ltd / Affirm Holdings Inc / Triple Point Energy Efficiency Infrastructure Company Plc / Duckhorn Portfolio Inc / UiPath Inc / Aveanna Healthcare Holdings Inc / Green Impact Partners Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Brazil / Canada / Cayman Islands / Spain / United Kingdom / Ireland / Netherlands / Norway / Portugal / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Animal Health A Near $37B WW Market Poised For Continued +4-6% Growth</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">US58933Y1055 / US5324571083 / US98978V1035 / US28414H1032</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Merck (MRK: EUR147.55) rises for a second consecutive month, a two-month rise of 2%</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">05/31/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Video Call To Discuss ASCO Highlights, Monday, June 7 at 12PM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">IMAB.O / JNJ / LLY / MRK / PFE / US3755581036 / BSLN / HCM.O / MBIO.O</td><td class="leftalignment">I-Mab / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Basilea Pharmaceutica AG / HUTCHMED (China) Ltd / Mustang Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">05/31/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / ABBV.N / VRCA.OQ</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / Abbvie Inc / Verrica Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">05/31/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Morning Bite Flash</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">FR0000120073 / DE0007100000 / DE0006599905 / DE0006602006 / DE0007030009 / DE0007037129 / DE0005470306 / DE0007165631 / DE0008019001 / DE000A0HN5C6 / DE0006062144 / DE000A161408</td><td class="leftalignment">L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Daimler AG / Merck KGaA / GEA Group AG / Rheinmetall AG / Rwe AG / Cts Eventim AG & Co KgaA / Sartorius AG / Deutsche Pfandbriefbank AG / Deutsche Wohnen SE / Covestro AG / Hellofresh SE</td><td class="leftalignment"></td><td class="leftalignment">China / Germany / France</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Herr. Ingo-Martin Schachel, CFA</td></tr>
<tr class="even"><td class="leftalignment">05/31/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review and outlook (31 May): Focus on Astellas, Eisai, Terumo</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">4503.T / 4523.T / 4543.T / 4502.T / 4507.T / 4519.T / 4528.T / BMY.N / MRK.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Astellas Pharma Inc / Eisai Co Ltd / Terumo Corp / Takeda Pharmaceutical Co Ltd / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Merck & Co Inc / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">05/31/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（5月31日～）: アステラス製薬、エーザイ、テルモなどに注目したい</td><td class="leftalignment">Japanese</td><td class="rightalignment">9</td><td class="leftalignment">4503.T / 4523.T / 4502.T / 4507.T / 4519.T / 4528.T / 4543.T / BMY.N / MRK.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Astellas Pharma Inc / Eisai Co Ltd / Takeda Pharmaceutical Co Ltd / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Merck & Co Inc / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">05/30/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6% Above Pre-Pandemic Base - Week 60</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-DE -  Dividend Quality Analysis, for the period ended April 28,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRCG.DE / COPN.S / ALM.MC / BAYGn.DE</td><td class="leftalignment">Merck KGaA / Cosmo Pharmaceuticals NV / Almirall SA / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Spain / Netherlands</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/28/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Merck (MRK: $75.89) drops 2% on high volatility in May 2021</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 5.28.21</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">ABT / 00365410 / 28176E10 / 62855J10 / 75991610 / 71708110 / 00846U10 / 44485910 / 12665010 / 07181310 / 10113710 / 88355610 / 04635310 / 43644010 / 87936910 / 37555810 / 75886F10 / 53245710 / 46120E60 / 11679410 / 45232710 / 01625510 / 30063P10 / 478160104 / 075887109 / 60855R10 / 205306103 / 45784P10 / 25213110 / 04963C20 / 64049M20 / 58933Y10 / 14161910 / 45766930 / 80360710 / 92337F10 / 09073M104 / 82621J10 / 92346J10 / G5960L10 / 23283X20 / 40131M10 / 89853L10 / 71944F10 / 42226A10 / 68269G10 / 09075V10 / 60770K10 / 05156V10 / 01438T10 / 74374N10 / 31189P10 / 07725L10 / G3910J11 / 37242740 / 43906K10 / 45781K20 / 48576U10 / F5548N10 / 45845P10 / 4525EP10 / 22905030 / G8807B10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 05465P10 / 00461U10 / 04539610 / F4373810 / N4482110 / 28255910 / 29446K10 / N1976T10 / 36322Q10 / 74623710 / 15912K10 / 69512710</td><td class="leftalignment">Abbott Laboratories / ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Repligen Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Thermo Fisher Scientific Inc / AstraZeneca PLC / Hologic Inc / Teleflex Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Intuitive Surgical Inc / Bruker Corp / Illumina Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Becton Dickinson and Co / Molina Healthcare Inc / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Insmed Inc / Sarepta Therapeutics Inc / Veracyte Inc / Bio-Techne Corp / Sientra Inc / Vericel Corp / Medtronic PLC / Cytosorbents Corp / Guardant Health Inc / T2 Biosystems Inc / Phreesia Inc / Healthequity Inc / 1Life Healthcare Inc / BioNTech SE / Moderna Inc / Aurinia Pharmaceuticals Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Genocea Biosciences Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Karyopharm Therapeutics Inc / Sanofi SA / Intercept Pharmaceuticals Inc / Immunic Inc / Cryoport Inc / Theravance Biopharma Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Genfit SA / InflaRx NV / 89Bio Inc / Equillium Inc / Centogene NV / Galecto Inc / PureTech Health PLC / Change Healthcare Inc / Pacira Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="even"><td class="leftalignment">05/28/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Merck KGaA (MRK GY) - Processing the upgrades</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending May 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">05/27/2021</td><td class="leftalignment">UnivDatos Market Insights (UMI)</td><td class="leftalignment">Company Profile: Tencent-2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">null / MRK=US / MRK=DE</td><td class="leftalignment">One 97 Communications Ltd / Merck & Co Inc / Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">China / Germany / India / United States</td><td class="leftalignment">Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE / MERGER/ACQUISITION/DIVESTITURE / OPERATIONS / OPERATING RESULTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">univdatos Co / UMI Team</td></tr>
<tr class="odd"><td class="leftalignment">05/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">ALV.N / BMO.TO / F.N / FCL.AX / MRK.N / PFE.N / TOL.N / AMGN.O / SU.TO / JAZZ.O / SGMO.O / NG.L / V.N / EXPE.O / WSM.N / EPAY.O / ANF.N / APT.AX / JKHY.O / VRTX.O / NCR.N / SSNC.O / ENDP.O / SKY.N / GPN.N / DKS.N / FIS.N / TEVA.N / AEO.N / ATL.MI / WDAY.N / ABBV.N / WIX.O / ZG.O / SQ.N / NTNX.O / OKTA.OQ / DXC.N / CVNA.N / RDFN.O / 00183L102 / ORSTED.CO / CARG.O / Z1P.AX / COLD.N / BKNG.O / VRCA.OQ / NXGN.O / LSPD.TO / LYFT.O / 269796108 / UBER.N / FVRR.N / SZL.AX / FOUR.N / IBEX.O / NVEIu.TO / ABNB.OQ / DASH.N / AFRM.O / PSFE.N / AVAH.OQ</td><td class="leftalignment">Autoliv Inc / Bank of Montreal / Ford Motor Co / FINEOS Corporation Holdings PLC / Merck & Co Inc / Pfizer Inc / Toll Brothers Inc / Amgen Inc / Suncor Energy Inc / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / National Grid PLC / Visa Inc / Expedia Group Inc / Williams-Sonoma Inc / Bottomline Technologies Inc / Abercrombie & Fitch Co / Afterpay Ltd / Jack Henry & Associates Inc / Vertex Pharmaceuticals Inc / NCR Corp / SS&C Technologies Holdings Inc / Endo International PLC / Skyline Champion Corp / Global Payments Inc / DICK'S Sporting Goods Inc / Fidelity National Information Services Inc / Teva Pharmaceutical Industries Ltd / American Eagle Outfitters Inc / Atlantia SpA / Workday Inc / Abbvie Inc / Wix.Com Ltd / Zillow Group Inc / Block Inc / Nutanix Inc / Okta Inc / DXC Technology Co / Carvana Co / Redfin Corp / Angi Inc / Orsted A/S / CarGurus Inc / Zip Co Ltd / Americold Realty Trust / Booking Holdings Inc / Verrica Pharmaceuticals Inc / NextGen Healthcare Inc / Lightspeed Commerce Inc / Lyft Inc / Eagle Pharmaceuticals Inc / Uber Technologies Inc / Fiverr International Ltd / Sezzle Inc / Shift4 Payments Inc / Ibex Ltd / Nuvei Corp / Airbnb Inc / DoorDash Inc / Affirm Holdings Inc / Paysafe Ltd / Aveanna Healthcare Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Denmark / United Kingdom / Ireland / Israel / Italy / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">05/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Top near-term catalysts to watch</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / ENDP.O / TEVA.N / ABBV.N / VRCA.OQ / 269796108</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Verrica Pharmaceuticals Inc / Eagle Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">05/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ASND: GH Launch: Looking Beyond Near-Term Expectations</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">ASND.OQ / PFE.N / ROG.S / NOVOB.CO / MRCG.DE / IPN.PA</td><td class="leftalignment">Ascendis Pharma A/S / Pfizer Inc / Roche Holding AG / Novo Nordisk A/S / Merck KGaA / Ipsen SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Mr. Thomas Deal / Roger Xu / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">05/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ORNBV.HE: Orion - Capital Markets Day: Limited new information, M&A needed to meet 2025 targets</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">ORNBV.HE / RECI.MI / LUN.CO / MRCG.DE / LONN.S / UCB.BR / IPN.PA / ALM.MC / GRLS.MC / BAYGN.DE / GMAB.CO</td><td class="leftalignment">Orion Oyj / Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Ipsen SA / Almirall SA / Grifols SA / Bayer AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Ms Jo Walton / Elizabeth Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">05/26/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Merck & Co., Inc. (MRK) - Negative impact from COVID-19 is expected</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="even"><td class="leftalignment">05/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / AMZN=US / T=US / INCY=US / GILD=US / VZ=US / CHRS=US / EWBC=US / MANH=US / MLM=US / DV=US / WTFC=US / AIZ=US / CBRL=US / ELY=US / EXEL=US / HEI=US / MAIN=US / OKE=US / HOOK=US / REGN=US / GOLF=US / CGEN=US / CFB=US / SNV=US / SIVB=US / ABCB=US / FB=US / FBK=US / SSB=US / GBCI=US / NLS=US / PNFP=US / SBCF=US / JRVR=US / STRO=US / RNG=US / IAC=US / RCUS=US / CLNY=US / KNSL=US / MEIP=US / ABBV=US / IBTX=US / TMUS=US / FATE=US / TSLX=US / ACBI=US / ZS=US / CRSP=US / IOVA=US / ATNX=US / DCPH=US / BTAI=US / OZK=US / FTDR=US / ALLO=US / HARP=US / UBER=US / GMAB=US / AVAH=US / VMEO=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Amazon.com Inc / AT&T Inc / Incyte Corp / Gilead Sciences Inc / Verizon Communications Inc / Coherus BioSciences Inc / East West Bancorp Inc / Manhattan Associates Inc / Martin Marietta Materials Inc / DoubleVerify Holdings Inc / Wintrust Financial Corp / Assurant Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Exelixis Inc / HEICO Corp / Main Street Capital Corp / ONEOK Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Acushnet Holdings Corp / Compugen Ltd / Crossfirst Bankshares Inc / Synovus Financial Corp / SVB Financial Group / Ameris Bancorp / Meta Platforms Inc / FB Financial Corp / SouthState Corp / Glacier Bancorp Inc / Nautilus Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / James River Group Holdings Ltd / Sutro Biopharma Inc / RingCentral Inc / IAC/Interactivecorp / Arcus Biosciences Inc / DigitalBridge Group Inc / Kinsale Capital Group Inc / MEI Pharma Inc / Abbvie Inc / Independent Bank Group Inc / T-Mobile US Inc / Fate Therapeutics Inc / Sixth Street Specialty Lending Inc / Atlantic Capital Bancshares Inc / Zscaler Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Athenex Inc / Deciphera Pharmaceuticals Inc / BioXcel Therapeutics Inc / Bank Ozk / Frontdoor Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Uber Technologies Inc / Genmab A/S / Aveanna Healthcare Holdings Inc / Vimeo Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Denmark / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist Securities ASCO Planner v2.0 Highlights ~200 Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / GILD=US / CHRS=US / EXEL=US / HOOK=US / REGN=US / CGEN=US / STRO=US / RCUS=US / MEIP=US / ABBV=US / FATE=US / CRSP=US / IOVA=US / ATNX=US / DCPH=US / BTAI=US / ALLO=US / HARP=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Gilead Sciences Inc / Coherus BioSciences Inc / Exelixis Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Compugen Ltd / Sutro Biopharma Inc / Arcus Biosciences Inc / MEI Pharma Inc / Abbvie Inc / Fate Therapeutics Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Athenex Inc / Deciphera Pharmaceuticals Inc / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Mr. Gregg Gilbert / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="even"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Merck Group</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="even"><td class="leftalignment">05/25/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Merck strengthens 4.8% in past quarter; Institutional Ownership steady</td><td class="leftalignment">English</td><td class="rightalignment">78</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRK.N - Event Transcript of Merck & Co Inc conference call, May 25, 2021 / 9:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 14, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Drug Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">53</td><td class="leftalignment">US00461U1051 / US5288723027 / US4525253062 / US5160121019 / US62855J1043 / US6388423021 / US74838J1016 / US75886F1075 / US92532F1003 / US68554V1089 / US09060J1060 / US02043Q1076 / CA87402A1084 / US58933Y1055 / US92345Y1064 / US42805E3062 / US48576U1060 / US2697961082 / CA4990531069 / US03209R1032 / US0453961080 / CA68620P1018 / US98978L2043 / CA1380351009 / US53222K2050 / US4622221004 / US44842L1035 / US1710774076 / US64049K1043 / US92556V1061 / US0547548745 / US92941V2097</td><td class="leftalignment">Aclaris Therapeutics Inc / Lexicon Pharmaceuticals Inc / ImmuCell Corp / Lannett Company Inc / Myriad Genetics Inc / Natural Alternatives International Inc / Quidel Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / OraSure Technologies Inc / BioDelivery Sciences International Inc / Alnylam Pharmaceuticals Inc / Taiga Building Products Ltd / Merck & Co Inc / Verisk Analytics Inc / Heska Corp / Karyopharm Therapeutics Inc / Eagle Pharmaceuticals Inc / Knight Therapeutics Inc / Amphastar Pharmaceuticals Inc / Assembly Biosciences Inc / OrganiGram Holdings Inc / Zogenix Inc / Canopy Growth Corp / LifeVantage Corp / Ionis Pharmaceuticals Inc / HUTCHMED (China) Ltd / Chromadex Corp / Neoleukin Therapeutics Inc / Viatris Inc / Aytu Biopharma Inc / Vyne Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Equita SIM</td><td class="leftalignment">EQUITA SIM: MERCK (BUY; Unchanged) - 1Q21 results</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Gianmarco Bonacina</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">KOL Video Call on New and Emerging Heme Malignancy Treatments | 5/27 @ 11am ET</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US62818Q1040 / MRKR.OQ / 0013.HK / JNJ.N / LLY.N / MRK.N / PFE.N / BSLN.S / ARAV.OQ / IMAB.OQ / HGEN.OQ</td><td class="leftalignment">Mustang Bio Inc / Marker Therapeutics Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Basilea Pharmaceutica AG / Aravive Inc / I-Mab / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Kristen Kluska</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US / PFE=US / INTC=US / ADI=US / AMD=US / AMZN=US / TXN=US / NVDA=US / H=US / CRM=US / IART=US / DIOD=US / XLNX=US / TTMI=US / EQR=US / FLO=US / ARCC=US / PATH=US / APH=US / ARW=US / AVGO=US / AVT=US / COLL=US / DRH=US / MAIN=US / MCHP=US / ORCC=US / ROLL=US / ST=US / BDSI=US / BIIB=US / BDC=US / AINV=US / SHO=US / BAH=US / REX=US / HST=US / TEL=US / PNNT=US / AGS=US / NXPI=US / PCRX=US / RHP=US / AERI=US / GOOGL=US / TSLX=US / 70806A106 / WK=US / ON=US / GSBD=US / LOB=US / NTLA=US / PK=US / PLYA=US / MPWR-US / SMAR=US / FSK=US / SPCE=US / FSKR=US / VTRS=US / PRVA=US / AVAH=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Intel Corp / Analog Devices Inc / Advanced Micro Devices Inc / Amazon.com Inc / Texas Instruments Inc / NVIDIA Corp / Hyatt Hotels Corp / Salesforce.Com Inc / Integra Lifesciences Holdings Corp / Diodes Inc / Xilinx Inc / TTM Technologies Inc / Equity Residential / Flowers Foods Inc / Ares Capital Corp / UiPath Inc / Amphenol Corp / Arrow Electronics Inc / Broadcom Inc / Avnet Inc / Collegium Pharmaceutical Inc / Diamondrock Hospitality Co / Main Street Capital Corp / Microchip Technology Inc / Owl Rock Capital Corp / RBC Bearings Inc / Sensata Technologies Holding PLC / BioDelivery Sciences International Inc / Biogen Inc / Belden Inc / Apollo Investment Corp / Sunstone Hotel Investors Inc / Booz Allen Hamilton Holding Corp / REX American Resources Corp / Host Hotels & Resorts Inc / TE Connectivity Ltd / Pennantpark Investment Corp / PlayAGS Inc / NXP Semiconductors NV / Pacira Biosciences Inc / Ryman Hospitality Properties Inc / Aerie Pharmaceuticals Inc / Alphabet Inc / Sixth Street Specialty Lending Inc / PennantPark Floating Rate Capital Ltd / Workiva Inc / ON Semiconductor Corp / Goldman Sachs BDC Inc / Live Oak Bancshares Inc / Intellia Therapeutics Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Monolithic Power Systems Inc / Smartsheet Inc / FS KKR Capital Corp / Virgin Galactic Holdings Inc / FS KKR Capital Corp / Viatris Inc / Privia Health Group Inc / Aveanna Healthcare Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - May 24 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">NL0000226223 / DE0006231004 / US0079031078 / US0079731008 / US0116591092 / US0311001004 / US0311621009 / US0378331005 / US0382221051 / US0463531089 / US1101221083 / US1727551004 / US1925761066 / US37733W1053 / US4581401001 / US4781601046 / US4824801009 / US5012421013 / US5128071082 / US5184151042 / US5324571083 / US5370081045 / US55306N1046 / US5951121038 / US66987V1098 / US6701002056 / US67066G1040 / US7170811035 / US7392761034 / US7475251036 / US7711951043 / US7782961038 / US8308791024 / US8447411088 / US8610121027 / US8807701029 / US91347P1057 / US9282981086 / US9581021055 / US9699041011 / US4771431016 / US83088M1027 / US4198791018 / US80105N1054 / US3463751087 / US1572101053 / US90385V1070 / US79466L3024 / US6098391054 / US82706C1080 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US0995021062 / US7512121010 / US00287Y1091 / NL0010273215 / US98978V1035 / US98138H1014 / US55405Y1001 / US8486371045 / KYG037AX1015 / US8485771021 / US21240E1055 / CH0210483332 / US02376R1023 / CA0089118776 / US74736K1016 / IE00BTN1Y115 / CA1380351009 / US40434L1052 / KYG4740B1059 / US74967X1037 / US11135F1012 / US2575541055 / US5904791358 / US28414H1032 / US24703L2025 / US85205L1070 / US75943R1023 / US8334451098 / US5738741041 / US30320C1036 / US83089J1088 / IE00BKVD2N49</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / Advanced Micro Devices Inc / Advanced Energy Industries Inc / Alaska Air Group Inc / AMETEK Inc / Amgen Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cirrus Logic Inc / Cohu Inc / GlaxoSmithKline PLC / Intel Corp / Johnson & Johnson / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Lattice Semiconductor Corp / Eli Lilly and Co / Littelfuse Inc / MKS Instruments Inc / Micron Technology Inc / Novartis AG / Novo Nordisk A/S / NVIDIA Corp / Pfizer Inc / Power Integrations Inc / Qualcomm Inc / Roche Holding AG / Ross Stores Inc / SkyWest Inc / Southwest Airlines Co / STMicroelectronics NV / Teradyne Inc / Universal Display Corp / Vishay Intertechnology Inc / Western Digital Corp / Williams-Sonoma Inc / JetBlue Airways Corp / Skyworks Solutions Inc / Hawaiian Holdings Inc / Sanofi SA / FormFactor Inc / CEVA Inc / Ultra Clean Holdings Inc / Salesforce.Com Inc / Monolithic Power Systems Inc / Silicon Motion Technology Corp / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Booz Allen Hamilton Holding Corp / Ralph Lauren Corp / Abbvie Inc / ASML Holding NV / Zoetis Inc / Workday Inc / MACOM Technology Solutions Holdings Inc / Splunk Inc / Ambarella Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Compagnie Financiere Richemont SA / American Airlines Group Inc / Air Canada / Qorvo Inc / Medtronic PLC / Canopy Growth Corp / HP Inc / Ichor Holdings Ltd / RH / Broadcom Inc / Domo Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Dell Technologies Inc / SpringWorks Therapeutics Inc / Relay Therapeutics Inc / Snowflake Inc. / Marvell Technology Inc / FTC Solar Inc / Skywater Technology Inc / Seagate Technology Holdings PLC</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Highlights in Melanoma and Early Phase IO from our ASCO KOL Preview Day</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">75886F10 / 640268108 / 58933Y10 / G0176710 / 76029N10</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Nektar Therapeutics / Merck & Co Inc / Alkermes Plc / Replimune Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Jonathan Chang, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">RSV Could Be the Next $10bn Vaccine Market. Who’s Best Positioned?</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">71708110 / 04635310 / 75886F10 / 478160104 / 58933Y10 / 60770K10 / G3910J11 / F5548N10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Johnson & Johnson / Merck & Co Inc / Moderna Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Highlights in NSCLC from our ASCO KOL Preview Day</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">03116210 / 478160104 / 58933Y10 / 74587V10 / 41358P10 / 09627Y10 / N0104510 / 60468T10</td><td class="leftalignment">Amgen Inc / Johnson & Johnson / Merck & Co Inc / Puma Biotechnology Inc / Harpoon Therapeutics Inc / Blueprint Medicines Corp / Affimed NV / Mirati Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Andrew Berens, M.D. / Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Jonathan Chang, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AXP / 5671735 / 0989529 / 2126335 / 2516152 / 2778844 / 2973821 / 2270726 / 2670519 / 2369174 / 2459020 / 2657802 / 2048804 / 2829601 / 2928683 / 2980906 / 7103065 / B125XQ6 / B0T7YX2 / B02R1L6 / B3D7K31 / 2949758 / B7TL820 / BCZS820 / B87ZMX0 / BYVY8G0 / BXDZ9Z0 / BYNZGK1 / BFZNYB7 / BDHF4K6 / BHC8X90 / BD8DJ71 / BWFKZT2 / BFMXGR0 / BKTNTR9 / BMDJ085</td><td class="leftalignment">American Express Co / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Alliant Energy Corp / Walt Disney Co / Exelon Corp / Gilead Sciences Inc / Intuit Inc / OGE Energy Corp / Pinnacle West Capital Corp / Southern Co / VF Corp / Foot Locker Inc / Novartis AG / Portland General Electric Co / Live Nation Entertainment Inc / ALLETE Inc / Discovery Inc / Nexstar Media Group Inc / Meta Platforms Inc / Fate Therapeutics Inc / Palo Alto Networks Inc / Alphabet Inc / Shopify Inc / Block Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Novo Nordisk A/S / Snap Inc / Cellectis SA / Evergy Inc / ViacomCBS Inc / Shoals Technologies Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AEP.N / AES.N / ANTO.L / BAC.N / BK.N / C.N / CL.N / CMS.N / COF.N / CRM.N / EIX.N / EL.N / FGP.L / FITB.O / JPM.N / KEY.N / KMB.N / KO.N / MRK.N / NTRS.O / PEG.N / PFE.N / PNC.N / RWEG.DE / SO.N / T.N / USB.N / WFC.N / PEP.N / CMA.N / BFb.N / PG.N / WY.N / CFP.TO / CPB.N / CMCSA.O / CHKP.O / AAL.L / DUK.N / HBAN.O / D.N / K.N / DT.N / DISH.O / ADBE.O / CLX.N / CAG.N / SUN.N / GIS.N / PAA.N / EPC.N / AMT.N / VZ.N / STT.N / HCA.N / EXEL.O / XEL.N / ARNA.O / STZ.N / VFC.N / GEL.N / EXC.N / FISV.O / ADSK.O / V.N / EPD.N / CHTR.O / AWK.N / ARE.N / CHD.N / NWN.N / MTB.N / VTR.N / SAM.N / BMRN.O / REGN.O / ENR.N / NCR.N / GFI.N / VRNT.O / RF.N / CNP.N / APF.L / BKH.N / CPK.N / FRC.N / SR.N / WES.N / LTC.N / AMH.N / LNG.A / NTCT.OQ / SGEN.OQ / GPN.N / MNST.O / SIVB.O / CASY.O / MMP.N / ATDb.TO / TFC.N / DCP.N / 02209S103 / CWX.TO / EDR.N / 427866108 / WEF.TO / MPW.N / RDSb.L / DISCA.O / SJW.N / BKD.N / FIS.N / MA.N / BGS.N / EDPR.LS / UTL.N / VALE.N / SPB.N / NEE.N / PCH.O / TRGP.N / IFP.TO / ACHC.O / RFP.N / PANW.N / MDLZ.OQ / SMLP.N / WDAY.N / MPLX.N / PRMW.N / TMUS.N / COTY.N / PRTA.O / DOC.N / BEP.N / 81762P102 / CEQP.N / COUP.N / ENLC.N / RYAM.N / CFG.N / CAPL.N / SHLX.N / CTRE.O / PYPL.OQ / SGRY.O / SQ.N / MESO.O / NTNX.O / GDS.O / INVH.N / UNIT.O / OKTA.OQ / ATNX.O / WELL.N / ZS.OQ / KDP.N / ETRN.N / NWL.O / ZM.O / GMAB.O / PEAK.N / DHC.O / WTRG.N / REYN.O / IGIC.OQ / FOUR.N / NRIX.OQ / LUMN.N / WFG.N / NUVB.N / NAPA.N / OSO.N / AVAH.OQ / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Antofagasta PLC / Bank of America Corp / Bank of New York Mellon Corp / Citigroup Inc / Colgate-Palmolive Co / CMS Energy Corp / Capital One Financial Corp / Salesforce.Com Inc / Edison International / Estee Lauder Companies Inc / FirstGroup PLC / Fifth Third Bancorp / JPMorgan Chase & Co / KeyCorp / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / Northern Trust Corp / Public Service Enterprise Group Inc / Pfizer Inc / PNC Financial Services Group Inc / Rwe AG / Southern Co / AT&T Inc / US Bancorp / Wells Fargo & Co / PepsiCo Inc / Comerica Inc / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canfor Corp / Campbell Soup Co / Comcast Corp / Check Point Software Technologies Ltd / Anglo American PLC / Duke Energy Corp / Huntington Bancshares Inc / Dominion Energy Inc / Kellogg Co / Dynatrace Inc / DISH Network Corp / Adobe Inc / Clorox Co / Conagra Brands Inc / Sunoco LP / General Mills Inc / Plains All American Pipeline LP / Edgewell Personal Care Co / American Tower Corp / Verizon Communications Inc / State Street Corp / HCA Healthcare Inc / Exelixis Inc / Xcel Energy Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / VF Corp / Genesis Energy LP / Exelon Corp / Fiserv Inc / Autodesk Inc / Visa Inc / Enterprise Products Partners LP / Charter Communications Inc / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / M&T Bank Corp / Ventas Inc / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / NCR Corp / Gold Fields Ltd / Verint Systems Inc / Regions Financial Corp / CenterPoint Energy Inc / Anglo Pacific Group PLC / Black Hills Corp / Chesapeake Utilities Corp / First Republic Bank / Spire Inc / Western Midstream Partners LP / LTC Properties Inc / American Homes 4 Rent / Cheniere Energy Inc / Netscout Systems Inc / Seagen Inc / Global Payments Inc / Monster Beverage Corp / SVB Financial Group / Caseys General Stores Inc / Magellan Midstream Partners LP / Alimentation Couche-Tard Inc / Truist Financial Corp / DCP Midstream LP / Altria Group Inc / Doman Building Materials Group Ltd / Endeavor Group Holdings Inc / Hershey Co / Western Forest Products Inc / Medical Properties Trust Inc / Royal Dutch Shell PLC / Discovery Inc / SJW Group / Brookdale Senior Living Inc / Fidelity National Information Services Inc / Mastercard Inc / B&G Foods Inc / EDP Renovaveis SA / Unitil Corp / Vale SA / Spectrum Brands Holdings Inc / Nextera Energy Inc / Potlatchdeltic Corp / Targa Resources Corp / Interfor Corp / Acadia Healthcare Company Inc / Resolute Forest Products Inc / Palo Alto Networks Inc / Mondelez International Inc / Summit Midstream Partners LP / Workday Inc / MPLX LP / Primo Water Corp / T-Mobile US Inc / Coty Inc / Prothena Corporation PLC / Physicians Realty Trust / Brookfield Renewable Partners LP / ServiceNow Inc / Crestwood Equity Partners LP / Coupa Software Inc / EnLink Midstream LLC / Rayonier Advanced Materials Inc / Citizens Financial Group Inc / Crossamerica Partners LP / Shell Midstream Partners LP / CareTrust REIT Inc / PayPal Holdings Inc / Surgery Partners Inc / Block Inc / Mesoblast Ltd / Nutanix Inc / GDS Holdings Ltd / Invitation Homes Inc / Uniti Group Inc / Okta Inc / Athenex Inc / Welltower Inc / Zscaler Inc / Keurig Dr Pepper Inc / Equitrans Midstream Corp / Newell Brands Inc / Zoom Video Communications Inc / Genmab A/S / Healthpeak Properties Inc / Diversified Healthcare Trust / Essential Utilities Inc / Reynolds Consumer Products Inc / International General Insurance Holdings Ltd / Shift4 Payments Inc / Nurix Therapeutics Inc / Lumen Technologies Inc / West Fraser Timber Co Ltd / Nuvation Bio Inc / Duckhorn Portfolio Inc / Olo Inc / Aveanna Healthcare Holdings Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Cayman Islands / Germany / Denmark / Spain / United Kingdom / Ireland / Israel / United States / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Highlights in Genitourinary Cancers from our ASCO KOL Preview Day</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">03116210 / 58933Y10 / 41358P10 / 55609910 / 81181C10 / 03969F10</td><td class="leftalignment">Amgen Inc / Merck & Co Inc / Harpoon Therapeutics Inc / MacroGenics Inc / Seagen Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Jonathan Chang, Ph.D., CFA / Daina Graybosch, Ph.D. / Geoffrey Porges, MBBS / Andrew Berens, M.D.</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Global Pharma Model Sweep: Reopening and Washington Headwinds Should Abate in 2H21 as Key Potential Catalysts Approach</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">0989529 / 2126335 / 5671735 / 0925288 / 2516152 / 2778844 / 7103065 / BHC8X90</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Sanofi SA / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Organon spin = Opportunity</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">MRK=US / PFE=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser</td></tr>
<tr class="even"><td class="leftalignment">05/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">05/23/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6% Above Pre-Pandemic Level - Week 60</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/22/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck KGaA: Ownership Timelines & Shareholder Analytics (May 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">05/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">MRK: Post the Separation of OGN.WI from MRK, the Upside Case in MRK.WI Is Equally if not More Compelling</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">2778844</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">05/21/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Healthcare : Updated Credit Views from the "USD HG Coverage and Rating Report"</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ABC.N / AMGN.O / BAX.N / BDX.N / BMY.N / BSX.N / CAH.N / CI.N / JNJ.N / LLY.N / MCK.N / MRK.N / DGX.N / HUM.N / GILD.O / UNH.N / LH.N / BIIB.O / ZTS.N / PRGO.N / ANTM.N / VTRS.O</td><td class="leftalignment">Amerisourcebergen Corp / Amgen Inc / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cardinal Health Inc / Cigna Corp / Johnson & Johnson / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / Quest Diagnostics Inc / Humana Inc / Gilead Sciences Inc / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / Biogen Inc / Zoetis Inc / Perrigo Company PLC / Anthem Inc / Viatris Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="odd"><td class="leftalignment">05/21/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended May 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">05/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending May 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">05/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - May 21 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US0382221051 / US4523271090 / US5002551043 / CA1363751027 / CA13645T1003 / US58933Y1055 / US7512121010 / US5017971046 / US78667J1088 / US50127T1097 / US87164F1057 / US8760301072 / US09354A1007 / KY30744W1070 / US62921N1054 / US07373B1098 / US74767V1098 / US7761531083 / US55406W1036 / US15961R1059 / US90364P1057</td><td class="leftalignment">Applied Materials Inc / Illumina Inc / Kohls Corp / Canadian National Railway Co / Canadian Pacific Railway Ltd / Merck & Co Inc / Ralph Lauren Corp / Bath & Body Works Inc / SAGE Therapeutics Inc / Kura Oncology Inc / Syndax Pharmaceuticals Inc / Tapestry Inc / Blink Charging Co / Farfetch Ltd / NGM Biopharmaceuticals Inc / Beam Global / Quantumscape Corp / Romeo Power Inc / MYT Netherlands Parent BV / ChargePoint Holdings Inc / UiPath Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Roche / Novartis / Merck KGaA / Sanofi : Key Takeaways From Our 2021 US Multiple Sclerosis Survey</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRCG.DE / NOVN.S / ROG.S / SASY.PA</td><td class="leftalignment">Merck KGaA / Novartis AG / Roche Holding AG / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Richard B. Vosser / James D. Gordon / Ms. Laerke Engkilde / Zain Ebrahim</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">V114 Posts Positive Topline Results In Pediatric Patients; YE Filing On Track</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, MRK</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES / PRICE / RATINGS CHANGES</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David H. Toung</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">MRK Still Leading For Pediatric PCV, Neck And Neck With PFE For Adult Indication</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Video Call To Discuss ASCO Highlights, Monday, June 7th at 11AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ARAV.O / IMAB.O / HCM.L / JNJ / LLY / MRK / PFE / GILD.O / BSLN.S / MRKR.O / MBIO.O</td><td class="leftalignment">Aravive Inc / I-Mab / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Basilea Pharmaceutica AG / Marker Therapeutics Inc / Mustang Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">ASCO 2021: Key Abstracts And Our Take On The Data</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">US0463531089 / US1101221083 / US5324571083 / US66987V1098 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Novartis AG / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Ms. Kathleen M. Miner, R.Ph., CFA</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">ASCO Round 1: Immuno-Oncology Abstract Highlights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">04635310 / M2572210 / 640268108 / 58933Y10 / G0176710 / 31189P10 / 37242740 / 46565G10 / 03969F10</td><td class="leftalignment">AstraZeneca PLC / Compugen Ltd / Nektar Therapeutics / Merck & Co Inc / Alkermes Plc / Fate Therapeutics Inc / Genocea Biosciences Inc / Iteos Therapeutics Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">2021 Guggenheim ASCO Abstracts Review: Few Surprises Overall, but BMY's Relatlimab Looks Additive to Us</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BMY.N / 5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2684703 / 7103065 / BD9GVY0</td><td class="leftalignment">Bristol-Myers Squibb Co / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Pfizer Inc / Novartis AG / Zai Lab Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Equity Strategy: Continental Europe - upgrade to overweight; potentially becoming a longer-term investment</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">ACX.MC / AIRP.PA / ALSO.PA / ALVG.DE / APD.N / ASML.AS / ASSAB.ST / AXAF.PA / BNPP.PA / DSMN.AS / ELE.MC / HEIN.AS / IBE.MC / INRN.S / KPN.AS / KSP.I / KYGA.I / OTER.AT / PRTP.PA / RAND.AS / RYA.I / SAN.MC / SCHN.PA / SWMA.ST / ULVR.L / VWS.CO / TKAG.DE / ABBN.S / SIEGN.DE / ENEI.MI / MRCG.DE / DTEGN.DE / IFXGN.DE / LIN.N / GIVN.S / NG.L / VIE.PA / ADEN.S / EUFI.PA / DB1GN.DE / NDXG.DE / NEXS.PA / NKT.CO / SRG.MI / AMS.S / ALFA.ST / BCVN.S / KNIN.S / UMI.BR / IFCN.S / INGA.AS / NESN.S / YPSN.S / ICLR.OQ / WCHG.DE / HOLN.S / MBTN.S / ISP.MI / SKG.I / PRY.MI / GRLS.MC / GL9.I / BVI.PA / FLUI.MC / HOCN.S / SEVI.PA / ARYN.S / BNRGN.DE / BASFN.DE / ICAG.L / O2DN.DE / APPS.MC / FBK.MI / AENA.MC / CLNX.MC / INWT.MI / AMUN.PA / UBSG.S / VACN.S / VIFN.S / SGREN.MC / ORSTED.CO / HFGG.DE / BSMXB.MX / INS2.DE / DWSG.DE</td><td class="leftalignment">Acerinox SA / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Alstom SA / Allianz SE / Air Products and Chemicals Inc / ASML Holding NV / Assa Abloy AB / AXA SA / BNP Paribas SA / Koninklijke DSM NV / Endesa SA / Heineken NV / Iberdrola SA / Interroll Holding AG / Koninklijke KPN NV / Kingspan Group PLC / Kerry Group PLC / Hellenic Telecommunications Organization SA / Kering SA / Randstad NV / Ryanair Holdings PLC / Banco Santander SA / Schneider Electric SE / Swedish Match AB / Unilever PLC / Vestas Wind Systems A/S / thyssenkrupp AG / Abb Ltd / Siemens AG / Enel SpA / Merck KGaA / Deutsche Telekom AG / Infineon Technologies AG / Linde PLC / Givaudan SA / National Grid PLC / Veolia Environnement SA / Adecco Group AG / Eurofins Scientific SE / Deutsche Boerse AG / Nordex SE / Nexans SA / Nkt A/S / Snam SpA / ams AG / Alfa Laval AB / Banque Cantonale Vaudoise / Kuehne und Nagel International AG / Umicore SA / Inficon Holding AG / ING Groep NV / Nestle SA / Ypsomed Holding AG / ICON PLC / Wacker Chemie AG / Holcim AG / Meyer Burger Technology AG / Intesa Sanpaolo SpA / Smurfit Kappa Group PLC / Prysmian SpA / Grifols SA / Glanbia PLC / Bureau Veritas SA / Fluidra SA / Hochdorf Holding AG / Suez SA / Aryzta AG / Brenntag SE / BASF SE / International Consolidated Airlines Group SA / Telefonica Deutschland Holding AG / Applus Services SA / FinecoBank Banca Fineco SpA / Aena SME SA / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Amundi SA / UBS Group AG / VAT Group AG / Vifor Pharma AG / Siemens Gamesa Renewable Energy SA / Orsted A/S / Hellofresh SE / Banco Santander Mexico SA Institucion de Banca Multiple Grupo Financiero Santand / Instone Real Estate Group SE / DWS Group GmbH & Co KgaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Austria / Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Greece / Ireland / Italy / Luxembourg / Mexico / Netherlands / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Mr. Andrew W. Garthwaite / Mr Robert C. Griffiths / Mr Mengyuan Yuan / Asim Ali / Timothy O'Sullivan</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Drug Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">55</td><td class="leftalignment">US00461U1051 / US5288723027 / US5160121019 / US62855J1043 / US6388423021 / US74838J1016 / US75886F1075 / US91307C1027 / US92532F1003 / US68554V1089 / US09060J1060 / US02043Q1076 / CA87402A1084 / US58933Y1055 / US92345Y1064 / US42805E3062 / US48576U1060 / US2697961082 / US03209R1032 / US14167L1035 / US0453961080 / CA68620P1018 / US98978L2043 / CA1380351009 / US53222K2050 / BSP733981026 / US4622221004 / US44842L1035 / US1710774076 / US64049K1043 / US04537Y1091 / US92556V1061 / US0547548745 / US92941V2097</td><td class="leftalignment">Aclaris Therapeutics Inc / Lexicon Pharmaceuticals Inc / Lannett Company Inc / Myriad Genetics Inc / Natural Alternatives International Inc / Quidel Corp / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / OraSure Technologies Inc / BioDelivery Sciences International Inc / Alnylam Pharmaceuticals Inc / Taiga Building Products Ltd / Merck & Co Inc / Verisk Analytics Inc / Heska Corp / Karyopharm Therapeutics Inc / Eagle Pharmaceuticals Inc / Amphastar Pharmaceuticals Inc / CareDx Inc / Assembly Biosciences Inc / OrganiGram Holdings Inc / Zogenix Inc / Canopy Growth Corp / LifeVantage Corp / Nymox Pharmaceutical Corp / Ionis Pharmaceuticals Inc / HUTCHMED (China) Ltd / Chromadex Corp / Neoleukin Therapeutics Inc / Aspira Women's Health Inc / Viatris Inc / Aytu Biopharma Inc / Vyne Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bahamas / Canada / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Where To Find Sun And Fun At ASCO This Year</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">ARAV.O / PFE / JNJ / LLY / MRK / BSLN.S / HCM.O / HGEN.O / IMAB.O</td><td class="leftalignment">Aravive Inc / Pfizer Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Basilea Pharmaceutica AG / HUTCHMED (China) Ltd / Humanigen Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Merck KGaA</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Movers & Shakers: Our Thoughts on Potential Upcoming Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">73</td><td class="leftalignment">ACRS.O / ACRX.O / EBS / JNJ / LLY / MRK / PFE / ALKS.O / JAZZ.O / CERS.O / OPTN.O / NCOX.PA / COLL.O / RMTI.O / AMRN.O / BDSI.O / BSLN.S / MNKD.O / ZTS / OMER.O / SPRO.O / ANIP.O / AXGN.O / AERI.O / HRTX.O / TRVN.O / EGRX.O / SCYX.O / ARDX.O / CFRX.O / CDTX.O / SPNE.O / FBIO.O / MESO.O / HCM.O / VRAY.O / VERU.O / TXMD.O / AYTU.O / CKPT.O / EYPT.O / UBX.O / EOLS.O / ARDS.O / ARAV.O / SIBN.O / ETTX.O / ARQT.O / PCVX.O / SRGA.O / HGEN.O / AZYO.O / IMAB.O / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / Emergent BioSolutions Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Cerus Corp / OptiNose Inc / Nicox SA / Collegium Pharmaceutical Inc / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Zoetis Inc / Omeros Corp / Spero Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / Ardelyx Inc / ContraFect Corp / Cidara Therapeutics Inc / SeaSpine Holdings Corp / Fortress Biotech Inc / Mesoblast Ltd / HUTCHMED (China) Ltd / ViewRay Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Checkpoint Therapeutics Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Evolus Inc / Aridis Pharmaceuticals Inc / Aravive Inc / SI-BONE Inc / Entasis Therapeutics Holdings Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Aziyo Biologics Inc / I-Mab / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck & Co Inc: Ownership Timelines & Shareholder Analytics (May 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Societe Generale</td><td class="leftalignment">Merck KGaA (Hold, TP=€149) - EPS upgrade - COVID-19 drives stronger demand for Life Science – TP €135 => €149 - F. Cespedes (5p)</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Florent Cespedes / Justin S. Smith / Manas Sarkar</td></tr>
<tr class="odd"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">KOL Video Call To Discuss New and Emerging Heme Malignancy Treatments, Thursday May 27th at 11AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ARAV.O / IMAB.O / JNJ / LLY / MRK / PFE / GILD.O / BSLN.S / HCM.O / MRKR.O / MBIO.O / HGEN.O</td><td class="leftalignment">Aravive Inc / I-Mab / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Basilea Pharmaceutica AG / HUTCHMED (China) Ltd / Marker Therapeutics Inc / Mustang Bio Inc / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PRCH / MRK / INVZ / DRIO / TSHA</td><td class="leftalignment">Porch Group Inc / Merck & Co Inc / Innoviz Technologies Ltd / DarioHealth Corp / Taysha Gene Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Merck & Co. , Inc.</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">05/18/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck & Co., Inc. : Takeaways from Sell-Side Mgmt Meeting</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">05/18/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Call With Management Offered New Perspectives</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/18/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">What's New At MRK, Takeaways From Management Meeting Support Our Positive Thesis</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">05/18/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HON: Honeywell International Inc. - Honeywell Beyond Tech Forum - Day 1</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">HON.OQ / CRM.N / IBM.N / MRCG.DE / 005930.KS / GOOGL.OQ</td><td class="leftalignment">Honeywell International Inc / Salesforce.Com Inc / International Business Machines Corp / Merck KGaA / Samsung Electronics Co Ltd / Alphabet Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Korea, Republic of / United States</td><td class="leftalignment">Conglomerates / Manufacturing</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. John F. Walsh, Jr / Tamjid Chowdhury / Jing Zhang</td></tr>
<tr class="even"><td class="leftalignment">05/18/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ZTS-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ZTS / LLY / MRK / PFE / ICCC.O / HSKA.O / PAHC.O / SNY.O</td><td class="leftalignment">Zoetis Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / ImmuCell Corp / Heska Corp / Phibro Animal Health Corp / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 07, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - May 17 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0116591092 / US0463531089 / US1101221083 / US1311931042 / US17275R1023 / US37733W1053 / US5324571083 / US5398301094 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US3448491049 / US4771431016 / US4198791018 / US80105N1054 / US00206R1023 / PAP310761054 / US29089Q1058 / US01748X1028 / US2473617023 / US25470F1049 / US58933Y1055 / US9100471096 / US00287Y1091 / US09609G1004 / US8485771021 / US21240E1055 / US02376R1023 / US70432V1026 / CA0089118776 / US23355L1061 / US81141R1005 / US5904791358 / US49926T1043 / US90364P1057 / US83089J1088 / US98985X1000</td><td class="leftalignment">Alaska Air Group Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Callaway Golf Co / Cisco Systems Inc / GlaxoSmithKline PLC / Eli Lilly and Co / Lockheed Martin Corp / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Foot Locker Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / AT&T Inc / Copa Holdings SA / Emergent BioSolutions Inc / Allegiant Travel Co / Delta Air Lines Inc / Discovery Inc / Merck & Co Inc / United Airlines Holdings Inc / Abbvie Inc / bluebird bio Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Paycom Software Inc / Air Canada / DXC Technology Co / Sea Ltd / Mesa Air Group Inc / Knowbe4 Inc / UiPath Inc / Skywater Technology Inc / Zymergen Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / DIS=US / TWTR=US / GBT=US / CL=US / AMZN=US / T=US / EBAY=US / INCY=US / GILD=US / VZ=US / IGT=US / VRM=US / BYD=US / SPOT=US / EXPE=US / MGM=US / AKR=US / PENN=US / W=US / DV=US / AMK=US / PATH=US / COLL=US / TREE=US / NOW=US / MCRI=US / REGN=US / SNAP=US / TRIP=US / TRUE=US / VRTX=US / WIX=US / PSA=US / SNOW=US / SGMS=US / NET=US / HIW=US / PYPL=US / BKNG=US / EGP=US / FB=US / MTCH=US / AUTL=US / BDSI=US / RRR=US / PTON=US / BIIB=US / RNG=US / CZR=US / EXR=US / GMS=US / PGTI=US / WH=US / TIL=US / IAC=US / 45665G303 / OLO=US / NLSN=US / ANGI=US / MEIP=US / SSTK=US / ABBV=US / VOYA=US / PTCT=US / FATE=US / GOOGL=US / COUP=US / BABA=US / CMPR=US / VCEL=US / GDDY=US / ETSY=US / ARGX=US / ZG=US / SQ=US / WVE=US / MIME=US / TTD=US / CRSP=US / TRVG=US / GDS=US / CVNA=US / YEXT=US / IOVA=US / RDFN=US / ROKU=US / CARG=US / SFIX=US / ROOT=US / COLD=US / FTDR=US / SVMK=US / EB=US / SITC=US / AMTB=US / LYFT=US / UBER=US / GMAB=US / DKNG=US / CRMD.US / BALY=US / ABNB=US / DASH=US / NGMS=US / COUR-US / KNBE=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Twitter Inc / Global Blood Therapeutics Inc / Colgate-Palmolive Co / Amazon.com Inc / AT&T Inc / eBay Inc / Incyte Corp / Gilead Sciences Inc / Verizon Communications Inc / International Game Technology PLC / Vroom Inc / Boyd Gaming Corp / Spotify Technology SA / Expedia Group Inc / MGM Resorts International / Acadia Realty Trust / Penn National Gaming Inc / Wayfair Inc / DoubleVerify Holdings Inc / AssetMark Financial Holdings Inc / UiPath Inc / Collegium Pharmaceutical Inc / Lendingtree Inc / ServiceNow Inc / Monarch Casino & Resort Inc / Regeneron Pharmaceuticals Inc / Snap Inc / Tripadvisor Inc / TrueCar Inc / Vertex Pharmaceuticals Inc / Wix.Com Ltd / Public Storage / Snowflake Inc. / Scientific Games Corp / Cloudflare Inc / Highwoods Properties Inc / PayPal Holdings Inc / Booking Holdings Inc / Eastgroup Properties Inc / Meta Platforms Inc / Match Group Inc / Autolus Therapeutics PLC / BioDelivery Sciences International Inc / Red Rock Resorts Inc / Peloton Interactive Inc / Biogen Inc / RingCentral Inc / Caesars Entertainment Inc / Extra Space Storage Inc / GMS Inc / PGT Innovations Inc / Wyndham Hotels & Resorts Inc / Instil Bio Inc / IAC/Interactivecorp / Infinity Pharmaceuticals Inc / Olo Inc / Nielsen Holdings PLC / Angi Inc / MEI Pharma Inc / Shutterstock Inc / Abbvie Inc / Voya Financial Inc / PTC Therapeutics Inc / Fate Therapeutics Inc / Alphabet Inc / Coupa Software Inc / Alibaba Group Holding Ltd / Cimpress PLC / Vericel Corp / GoDaddy Inc / ETSY Inc / argenx SE / Zillow Group Inc / Block Inc / WAVE Life Sciences Ltd / Mimecast Ltd / Trade Desk Inc / CRISPR Therapeutics AG / Trivago NV / GDS Holdings Ltd / Carvana Co / Yext Inc / Iovance Biotherapeutics Inc / Redfin Corp / Roku Inc / CarGurus Inc / Stitch Fix Inc / Root Inc / Americold Realty Trust / Frontdoor Inc / Momentive Global Inc / Eventbrite Inc / Site Centers Corp / Amerant Bancorp Inc / Lyft Inc / Uber Technologies Inc / Genmab A/S / DraftKings Inc / CorMedix Inc / Bally's Corp / Airbnb Inc / DoorDash Inc / NeoGames SA / Coursera Inc / Knowbe4 Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / Cayman Islands / Denmark / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/17/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AEP.N / AES.N / AXAF.PA / CL.N / DFDS.CO / EIX.N / EL.N / KMB.N / KO.N / MRK.N / MUVGn.DE / NA / PEG.N / PFE.N / SCOR.PA / SO.N / T.N / PEP.N / BFb.N / PG.N / GILD.O / CPB.N / CMCSA.O / CHKP.O / INCY.O / DUK.N / K.N / DISH.O / CTXS.O / CLX.N / CAG.N / DV.N / GIS.N / EPC.N / SBAC.O / KGC.N / JAZZ.O / CONE.O / NG.L / VZ.N / STZ.N / AMP.N / EXC.N / FISV.O / AWK.N / CHD.N / NWN.N / JKHY.O / SAM.N / OPTN.O / ENR.N / NCR.N / NET.N / SSNC.O / ENAG.MC / CNP.N / ENDP.O / CPK.N / GPN.N / MNST.O / IMGN.O / HOOK.O / BLUE.O / CASY.O / FFIV.O / EQIX.O / ATDb.TO / 02209S103 / MNKD.OQ / DLR.N / 427866108 / SJW.N / FIS.N / CVLT.O / 3IN.L / IVZ.N / BGS.N / RENE.LS / BEZG.L / GETP.PA / INO.OQ / UTL.N / NGD.A / FTNT.O / SPB.N / NEE.N / FHI.N / TWO.N / PCRX.O / PANW.N / QLYS.O / MDLZ.OQ / APAM.N / ABBV.N / PRGO.N / PRMW.N / TMUS.N / COTY.N / BEP.N / AGIO.O / KPTI.O / FLXN.O / AGRX.O / RPD.O / SQ.N / MIME.OQ / SRENH.S / MP1.AX / OR.N / CRSP.OQ / UNIT.O / GREG.MC / DXC.N / ROOT.TO / VCTR.N / AMRX.N / VRCA.OQ / NTGY.MC / KDP.N / XERS.O / AQST.O / OSMT.O / NWL.O / 269796108 / PING.N / DDOG.O / APRE.OQ / NLOK.O / REYN.O / FOUR.N / RXT.OQ / IBEX.O / LUMN.N / PLTR.N / ALOO.O / VTRS.OQ / TIXT.TO / AFRM.O / NAPA.N / PATH.N / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / AXA SA / Colgate-Palmolive Co / DFDS AS / Edison International / Estee Lauder Companies Inc / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / National Bank of Canada / Public Service Enterprise Group Inc / Pfizer Inc / Scor SE / Southern Co / AT&T Inc / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Gilead Sciences Inc / Campbell Soup Co / Comcast Corp / Check Point Software Technologies Ltd / Incyte Corp / Duke Energy Corp / Kellogg Co / DISH Network Corp / Citrix Systems Inc / Clorox Co / Conagra Brands Inc / DoubleVerify Holdings Inc / General Mills Inc / Edgewell Personal Care Co / SBA Communications Corp / Kinross Gold Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / National Grid PLC / Verizon Communications Inc / Constellation Brands Inc / Ameriprise Financial Inc / Exelon Corp / Fiserv Inc / American Water Works Company Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Jack Henry & Associates Inc / Boston Beer Company Inc / OptiNose Inc / Energizer Holdings Inc / NCR Corp / Cloudflare Inc / SS&C Technologies Holdings Inc / Enagas SA / CenterPoint Energy Inc / Endo International PLC / Chesapeake Utilities Corp / Global Payments Inc / Monster Beverage Corp / ImmunoGen Inc / HOOKIPA Pharma Inc / bluebird bio Inc / Caseys General Stores Inc / F5 Inc / Equinix Inc / Alimentation Couche-Tard Inc / Altria Group Inc / MannKind Corp / Digital Realty Trust Inc / Hershey Co / SJW Group / Fidelity National Information Services Inc / Commvault Systems Inc / 3I Infrastructure PLC / Invesco Ltd / B&G Foods Inc / Ren Redes Energeticas Nacionais SGPS SA / Beazley PLC / Getlink SE / Inovio Pharmaceuticals Inc / Unitil Corp / New Gold Inc / Fortinet Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / Federated Hermes Inc / Two Harbors Investment Corp / Pacira Biosciences Inc / Palo Alto Networks Inc / Qualys Inc / Mondelez International Inc / Artisan Partners Asset Management Inc / Abbvie Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / Coty Inc / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / Karyopharm Therapeutics Inc / Pacira Biosciences Inc / Agile Therapeutics Inc / Rapid7 Inc / Block Inc / Mimecast Ltd / Swiss Re AG / Megaport Ltd / Osisko Gold Royalties Ltd / CRISPR Therapeutics AG / Uniti Group Inc / Grenergy Renovables SA / DXC Technology Co / Roots Corp / Victory Capital Holdings Inc / Amneal Pharmaceuticals Inc / Verrica Pharmaceuticals Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Osmotica Pharmaceuticals PLC / Newell Brands Inc / Eagle Pharmaceuticals Inc / Ping Identity Holding Corp / Datadog Inc / Aprea Therapeutics Inc / NortonLifeLock Inc / Reynolds Consumer Products Inc / Shift4 Payments Inc / Rackspace Technology Inc / Ibex Ltd / Lumen Technologies Inc / Palantir Technologies Inc / Allogene Therapeutics Inc / Viatris Inc / Telus International Cda Inc / Affirm Holdings Inc / Duckhorn Portfolio Inc / UiPath Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Portugal / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">05/17/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma : MRK / BMY – Our Latest Thoughts of PD-1 Landscape; Market Model Update</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRK.N / BMY.N</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Merck: More upside potential ahead</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">CREDIT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Falko Friedrichs / Herr Jan Koch / Sachin Gadilingappa</td></tr>
<tr class="odd"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Everest Medicines: Trodelvy potential China approval expected YE21; Potential first Trop2 ADC in China with high commercial potential. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">1952.HK / 1093.HK / PFE.N / AZN.L / MRCG.DE / GILD.OQ / 4568.T / 002422.SZ</td><td class="leftalignment">Everest Medicines Ltd / CSPC Pharmaceutical Group Ltd / Pfizer Inc / AstraZeneca PLC / Merck KGaA / Gilead Sciences Inc / Daiichi Sankyo Co Ltd / Sichuan Kelun Pharmaceutical Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / Germany / United Kingdom / Hong Kong / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="even"><td class="leftalignment">05/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Questions for Management 5.16.21</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">ABT / ACAD / 00365410 / 28176E10 / 62855J10 / 01988P10 / 45337C10 / 75991610 / 09061G10 / 86366710 / 71708110 / 00846U10 / 45253H10 / 12665010 / 07181310 / 10113710 / 92532F10 / 88355610 / 35802910 / 94184810 / 04635310 / 43644010 / 76115210 / 64125C10 / 87936910 / 37555810 / 15678210 / 03116210 / 66987V10 / 75886F10 / 46120E60 / M2572210 / 45232710 / 09062X10 / 01625510 / 30063P10 / 478160104 / 98956P10 / 159864107 / 640268108 / 075887109 / 02043Q10 / 67070410 / 207410101 / 205306103 / 45784P10 / 25213110 / 04963C20 / 03152W10 / 64049M20 / 58933Y10 / 14161910 / G0176710 / 45766930 / G5087110 / 80360710 / 74051N10 / 92337F10 / 05463X10 / 45780L10 / 92247510 / 09073M104 / 82621J10 / 31572Q80 / 87918A10 / 46185L10 / 00653A107 / 04351P101 / 75046920 / 74587V10 / 00287Y10 / 92346J10 / 98401F10 / 46071F10 / G5960L10 / 46222210 / 18946410 / 04004760 / 04280A10 / 92686J10 / 05337M104 / 23283X20 / 40131M10 / 63230710 / 89853L10 / 71944F10 / 45773010 / 05358830 / 38942Q10 / 76029N10 / 41358P10 / N9006410 / 42226A10 / 68269G10 / 00437E10 / 74939710 / 90041T10 / 09627Y10 / 68071010 / Y9530810 / 30052C10 / 09075V10 / 60770K10 / 74340E10 / 42225T10 / 87337910 / 00289Y10 / 00773U10 / 01981810 / 05455M10 / 09609G10 / 10806X10 / 45826J10 / 75901B10 / 77313F10 / 05464T10 / 05156V10 / 75615P10 / 16383L10 / 55609910 / N0104510 / 14843C10 / 01438T10 / 74374N10 / 51654410 / 31189P10 / 07725L10 / G3910J11 / H0026310 / 00847X10 / 24344T10 / 29428V10 / 37890U10 / 81181C10 / G1119610 / 40422M10 / 98978L20 / 92857F10 / 04685N10 / 13089P10 / 34633R10 / K3967W10 / 37242740 / 38341P10 / 43906K10 / 45781K20 / 46565G10 / 48576U10 / 50127T10 / 61776010 / 60468T10 / 03969F10 / 05370A10 / 78116T10 / 76155X10 / F5548N10 / 98887Q10 / 45845P10 / 4525EP10 / 78667J10 / 82710M10 / 46116X10 / 74366E10 / 37957720 / 22905030 / G8807B10 / 90400D10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 55886810 / 05454B10 / 49232710 / 22663K10 / 05465P10 / 00461U10 / 04539610 / 81727U10 / 59045L10 / 01671P10 / 68621F10 / 45249V10 / F4373810 / 80405P10 / N4482110 / 92765F10 / 75955J40 / 56400P70 / 28255910 / 87808K10 / 87166L10 / 03836N10 / 23257D10 / 40434H20 / 28617K10 / 29446K10 / 83422E10 / 03824M10 / N1976T10 / 23306J10 / 34385P10 / 36322Q10 / N4444510 / 45258J10 / 48349710 / 56854Q20 / 65343C10 / 74623710 / 75974E10 / H9060V101</td><td class="leftalignment">Abbott Laboratories / ACADIA Pharmaceuticals Inc / ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Allscripts Healthcare Solutions Inc / Incyte Corp / Repligen Corp / Biomarin Pharmaceutical Inc / Stryker Corp / Pfizer Inc / Agilent Technologies Inc / ImmunoGen Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Vertex Pharmaceuticals Inc / Thermo Fisher Scientific Inc / Fresenius Medical Care AG & Co KGaA / Waters Corp / AstraZeneca PLC / Hologic Inc / Resmed Inc / Neurocrine Biosciences Inc / Teleflex Inc / Gilead Sciences Inc / Cerner Corp / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Intuitive Surgical Inc / Compugen Ltd / Illumina Inc / Biogen Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Zimmer Biomet Holdings Inc / Charles River Laboratories International Inc / Nektar Therapeutics / Becton Dickinson and Co / Alnylam Pharmaceuticals Inc / NuVasive Inc / Conmed Corp / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Amicus Therapeutics Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Alkermes Plc / Insmed Inc / Jazz Pharmaceuticals PLC / Sarepta Therapeutics Inc / Premier Inc / Veracyte Inc / AxoGen Inc / Inogen Inc / Veeva Systems Inc / Bio-Techne Corp / Sientra Inc / FibroGen Inc / Teladoc Health Inc / Invitae Corp / Adaptimmune Therapeutics PLC / Ascendis Pharma A/S / Radius Health Inc / Puma Biotechnology Inc / Abbvie Inc / Vericel Corp / Xencor Inc / Intersect Ent Inc / Medtronic PLC / Ionis Pharmaceuticals Inc / Clovis Oncology Inc / Arena Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Viking Therapeutics Inc / Avadel Pharmaceuticals PLC / Cytosorbents Corp / Guardant Health Inc / Natera Inc / T2 Biosystems Inc / Phreesia Inc / Inspire Medical Systems Inc / Aveo Pharmaceuticals Inc / Graybug Vision Inc / Replimune Group Inc / Harpoon Therapeutics Inc / Uniqure NV / Healthequity Inc / 1Life Healthcare Inc / Accolade Inc / R1 RCM Inc / Turning Point Therapeutics Inc / Blueprint Medicines Corp / Olink Holding AB (publ) / WAVE Life Sciences Ltd / Evolus Inc / BioNTech SE / Moderna Inc / Progyny Inc / Health Catalyst Inc / Tabula Rasa HealthCare Inc / Abeona Therapeutics Inc / Adverum Biotechnologies Inc / Allovir Inc / AVROBIO Inc / bluebird bio Inc / BridgeBio Pharma Inc / Intellia Therapeutics Inc / Regenxbio Inc / Rocket Pharmaceuticals Inc / Axsome Therapeutics Inc / Aurinia Pharmaceuticals Inc / Reata Pharmaceuticals Inc / ChemoCentryx Inc / MacroGenics Inc / Affimed NV / Castle Biosciences Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Lantheus Holdings Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / AC Immune SA / Agios Pharmaceuticals Inc / Deciphera Pharmaceuticals Inc / Epizyme Inc / Global Blood Therapeutics Inc / Seagen Inc / Biohaven Pharmaceutical Holding Company Ltd / H Lundbeck A/S / Zogenix Inc / Vocera Communications Inc / Athenex Inc / Calithera Biosciences Inc / Forma Therapeutics Holdings Inc / Genmab A/S / Genocea Biosciences Inc / Gossamer Bio Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Iteos Therapeutics Inc / Karyopharm Therapeutics Inc / Kura Oncology Inc / MorphoSys AG / Mirati Therapeutics Inc / Arcus Biosciences Inc / Avidity Biosciences Inc / Rubius Therapeutics Inc / Revolution Medicines Inc / Sanofi SA / Zai Lab Ltd / Intercept Pharmaceuticals Inc / Immunic Inc / SAGE Therapeutics Inc / Silk Road Medical Inc / Intra-Cellular Therapies Inc / Protagonist Therapeutics Inc / Globus Medical Inc / Cryoport Inc / Theravance Biopharma Inc / Ultragenyx Pharmaceutical Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Madrigal Pharmaceuticals Inc / Axcella Health Inc / Keros Therapeutics Inc / Crinetics Pharmaceuticals Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Senseonics Holdings Inc / Mersana Therapeutics Inc / Allakos Inc / Organogenesis Holdings Inc / Imara Inc / Genfit SA / Satsuma Pharmaceuticals Inc / InflaRx NV / Viracta Therapeutics Inc / Relmada Therapeutics Inc / MannKind Corp / 89Bio Inc / TCR2 Therapeutics Inc / Synlogic Inc / Aptinyx Inc / Cymabay Therapeutics Inc / HTG Molecular Diagnostics Inc / Eledon Pharmaceuticals Inc / Equillium Inc / Solid Biosciences Inc / Applied Molecular Transport Inc. / Centogene NV / DBV Technologies SA / Fluidigm Corp / Galecto Inc / Immatics NV / Immunovant Inc / Kalvista Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / NextGen Healthcare Inc / PureTech Health PLC / Reneo Pharmaceuticals Inc / VectivBio Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Singapore / Sweden / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="odd"><td class="leftalignment">05/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / MNKD.OQ / PCRX.O / ABBV.N / PRGO.N / FLXN.O / AGRX.O / AMRX.N / VRCA.OQ / XERS.O / AQST.O / OSMT.O / 269796108 / VTRS.OQ</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / MannKind Corp / Pacira Biosciences Inc / Abbvie Inc / Perrigo Company PLC / Pacira Biosciences Inc / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Verrica Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Osmotica Pharmaceuticals PLC / Eagle Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">05/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6% Above Pre-Pandemic Level- Week 59</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck KGaA: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 5.14.21</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">ABT / 00365410 / 28176E10 / 62855J10 / 75991610 / 71708110 / 00846U10 / 44485910 / 12665010 / 07181310 / 10113710 / 88355610 / 04635310 / 43644010 / 87936910 / 37555810 / 75886F10 / 53245710 / 46120E60 / 11679410 / 45232710 / 01625510 / 30063P10 / 478160104 / 075887109 / 60855R10 / 205306103 / 45784P10 / 25213110 / 04963C20 / 64049M20 / 58933Y10 / 14161910 / 45766930 / 80360710 / 92337F10 / 09073M104 / 82621J10 / 92346J10 / G5960L10 / 23283X20 / 40131M10 / 89853L10 / 71944F10 / 42226A10 / 68269G10 / 09075V10 / 60770K10 / 05156V10 / 01438T10 / 74374N10 / 31189P10 / 07725L10 / G3910J11 / 37242740 / 43906K10 / 45781K20 / 48576U10 / F5548N10 / 45845P10 / 4525EP10 / 22905030 / G8807B10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 05465P10 / 00461U10 / 04539610 / F4373810 / N4482110 / 28255910 / 29446K10 / N1976T10 / 36322Q10 / 74623710 / 15912K10 / 69512710</td><td class="leftalignment">Abbott Laboratories / ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Repligen Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Thermo Fisher Scientific Inc / AstraZeneca PLC / Hologic Inc / Teleflex Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Intuitive Surgical Inc / Bruker Corp / Illumina Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Becton Dickinson and Co / Molina Healthcare Inc / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Insmed Inc / Sarepta Therapeutics Inc / Veracyte Inc / Bio-Techne Corp / Sientra Inc / Vericel Corp / Medtronic PLC / Cytosorbents Corp / Guardant Health Inc / T2 Biosystems Inc / Phreesia Inc / Healthequity Inc / 1Life Healthcare Inc / BioNTech SE / Moderna Inc / Aurinia Pharmaceuticals Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Genocea Biosciences Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Karyopharm Therapeutics Inc / Sanofi SA / Intercept Pharmaceuticals Inc / Immunic Inc / Cryoport Inc / Theravance Biopharma Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Genfit SA / InflaRx NV / 89Bio Inc / Equillium Inc / Centogene NV / Galecto Inc / PureTech Health PLC / Change Healthcare Inc / Pacira Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist EHA Planner v1.0 Highlights 100+ Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / GBT=US / INCY=US / GILD=US / REGN=US / VRTX=US / AUTL=US / MEIP=US / ABBV=US / CRSP=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Incyte Corp / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Autolus Therapeutics PLC / MEI Pharma Inc / Abbvie Inc / CRISPR Therapeutics AG / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Mr. Gregg Gilbert / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for MRK. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">58933Y105</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended May 7, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">ASCO 2021: More Key Abstracts</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0463531089 / US1101221083 / US66987V1098 / US7170811035 / US7711951043 / US58933Y1055</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Novartis AG / Pfizer Inc / Roche Holding AG / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Ms. Kathleen M. Miner, R.Ph., CFA</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending May 7, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - May 14 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">FR0000121014 / US02553E1064 / US0382221051 / US0463531089 / US1005571070 / US1101221083 / US1264081035 / US22160K1051 / US2546871060 / US3647601083 / US5002551043 / US6556641008 / US6558441084 / US66987V1098 / US7170811035 / US7274931085 / US7711951043 / US7782961038 / US8725401090 / US87612E1064 / US9078181081 / US9311421039 / CA1363751027 / CA13645T1003 / US21036P1084 / US19239V3024 / US55616P1049 / US90384S3031 / US58933Y1055 / US30212P3038 / US5017971046 / US60468T1051 / US09062W2044 / LU0974299876 / US0994061002 / US64829B1008 / US4622221004 / US74967X1037 / CA1350861060 / IL0011407140 / US8760301072 / US6085501095 / US09354A1007 / US09857L1089 / US4380831077 / US03836N1037 / US05455M1009 / KY30744W1070 / US7172241090 / CA89788C1041 / US39874R1014 / US24984K1051 / US85205L1070 / US1266541028 / US7602731025 / US05380C1027 / US65487U1088 / US75943R1023 / US38246G1085 / US0090661010 / US7761531083 / US55406W1036 / US8808811074 / US6877931096 / US35909R1086 / US45175G1085</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / American Eagle Outfitters Inc / Applied Materials Inc / AstraZeneca PLC / Boston Beer Company Inc / Bristol-Myers Squibb Co / CSX Corp / Costco Wholesale Corp / Walt Disney Co / Gap Inc / Kohls Corp / Nordstrom Inc / Norfolk Southern Corp / Novartis AG / Pfizer Inc / Plantronics Inc / Roche Holding AG / Ross Stores Inc / TJX Companies Inc / Target Corp / Union Pacific Corp / Walmart Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Constellation Brands Inc / Cogent Communications Holdings Inc / Macy's Inc / Ulta Beauty Inc / Merck & Co Inc / Expedia Group Inc / Bath & Body Works Inc / Mirati Therapeutics Inc / BioLife Solutions Inc / Globant SA / Boot Barn Holdings Inc / New Relic Inc / Ionis Pharmaceuticals Inc / RH / Canada Goose Holdings Inc / Urogen Pharma Ltd / Tapestry Inc / Molecular Templates Inc / Blink Charging Co / Booking Holdings Inc / Homology Medicines Inc / Aptinyx Inc / AVROBIO Inc / Farfetch Ltd / PhaseBio Pharmaceuticals Inc / Trulieve Cannabis Corp / Grocery Outlet Holding Corp / DermTech Inc / SpringWorks Therapeutics Inc / CV Sciences Inc / Repare Therapeutics Inc / AVITA Medical Inc / Nkarta Inc / Relay Therapeutics Inc / Goodrx Holdings Inc / Airbnb Inc / Romeo Power Inc / MYT Netherlands Parent BV / Terns Pharmaceuticals Inc / Oscar Health Inc / Frontier Group Holdings Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / France / United Kingdom / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">BNP Paribas Exane</td><td class="leftalignment">MERCK KGAA (=): Capacity is king</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Cosmetics & Personal Care</td><td class="leftalignment">Euroland / Europe / Global</td><td class="leftalignment">ESTIMATE CHANGES / QUARTERLY INCOME STATEMENT / PROFIT / REPORTING RESULTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Richard J. Parkes, PHD / Mr. Simon Mather, PHD / Mr. Gary Steventon</td></tr>
<tr class="odd"><td class="leftalignment">05/13/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Priming The Keytruda Pump With Yet Another Opportunity</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">05/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRCG.DE: Merck KGaA - 1Q21 - Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRCG.DE / 4063.T / 4185.T / 4901.T / A.N / BDX.N / LLY.N / PFE.N / RECI.MI / STDM.PA / TMO.N / WAT.N / ROG.S / DHR.N / LUN.CO / GLW.N / MTD.N / LONN.S / PKI.N / WST.N / UCB.BR / TECH.OQ / CCMP.OQ / ENTG.OQ / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / MRNA.OQ / VIFN.S / 2269.HK / GMAB.CO</td><td class="leftalignment">Merck KGaA / Shin-Etsu Chemical Co Ltd / JSR Corp / Fujifilm Holdings Corp / Agilent Technologies Inc / Becton Dickinson and Co / Eli Lilly and Co / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / Sartorius Stedim Biotech SA / Thermo Fisher Scientific Inc / Waters Corp / Roche Holding AG / Danaher Corp / H Lundbeck A/S / Corning Inc / Mettler-Toledo International Inc / Lonza Group AG / PerkinElmer Inc / West Pharmaceutical Services Inc / Ucb SA / Bio-Techne Corp / CMC Materials Inc / Entegris Inc / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Moderna Inc / Vifor Pharma AG / WuXi Biologics (Cayman) Inc / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Cayman Islands / Germany / Denmark / Spain / Finland / France / Italy / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">05/13/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">JPM Global BioPharma : 2021 US Multiple Sclerosis Survey Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">SASY.PA / ROG.S / NOVN.S / MRCG.DE / BIIB.O / TGTX.O / ATRA.O</td><td class="leftalignment">Sanofi SA / Roche Holding AG / Novartis AG / Merck KGaA / Biogen Inc / TG Therapeutics Inc / Atara Biotherapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Richard B. Vosser / James Scott / Ms. Tessa Romero / Cory W. Kasimov / Mr. Eric Joseph / Anupam Rama / Hannah Adeoye / Mr. Rahul K. Agarwal / James D. Gordon / Ms. Laerke Engkilde / Zain Ebrahim</td></tr>
<tr class="even"><td class="leftalignment">05/13/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck KGaA : Significant Life Science driven upgrades for 2021 and beyond - Price Target increased to €165</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Richard B. Vosser / James D. Gordon / Ms. Laerke Engkilde / Zain Ebrahim</td></tr>
<tr class="odd"><td class="leftalignment">05/12/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Annual Update - Merck down 7.6% from 1 week high</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">05/12/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Merck KGaA (& DHR, TMO) – Beats & Raises Life Sci Guide; COVID assumptions compa</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US2358511028 / DE0006599905 / US8835561023</td><td class="leftalignment">Danaher Corp / Merck KGaA / Thermo Fisher Scientific Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Vijay M. Kumar</td></tr>
<tr class="odd"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Kepler Cheuvreux</td><td class="leftalignment">Merck KGaA | Broad-based outperformance</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David P. Evans</td></tr>
<tr class="even"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Final Q1; Life Science the key driver</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr Daniel Wendorff</td></tr>
<tr class="odd"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Warburg Research GmbH</td><td class="leftalignment">Q1-Ergebnisse: Life Science und Sondereffekte sorgen für starken Jahresauftakt</td><td class="leftalignment">German</td><td class="rightalignment">13</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr Ulrich Huwald</td></tr>
<tr class="even"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRCG.DE - Event Transcript of Merck KGaA conference call, May 12, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Merck: 1Q first take - strong across the board</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Falko Friedrichs / Herr Jan Koch / Sachin Gadilingappa</td></tr>
<tr class="even"><td class="leftalignment">05/12/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck KGaA : 1Q'21 1st Take: Driven by organic growth in Electronics/Life Sciences & lower Healthcare costs</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Richard B. Vosser / James D. Gordon / Ms. Laerke Engkilde / Zain Ebrahim / Mr. Tycho W. Peterson</td></tr>
<tr class="odd"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Warburg Research GmbH</td><td class="leftalignment">Q1 results: Life Science and one-offs provide for strong start to the year</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr Ulrich Huwald</td></tr>
<tr class="even"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: Eisai - 4Q results: A mix of expectations and uncertainties for FY3/22 onward</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">4523.T / MRK.N / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Merck & Co Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: エーザイ - 4Q決算：22/3期以降の業績は期待と不確実性が混在する</td><td class="leftalignment">Japanese</td><td class="rightalignment">6</td><td class="leftalignment">4523.T / MRK.N / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Merck & Co Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRCG.DE: Merck KGaA - 1Q21 Initial Diagnosis take 2</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">LUN.CO: Lundbeck - 1Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">LUN.CO / RECI.MI / MRCG.DE / LONN.S / UCB.BR / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / VIFN.S / GMAB.CO</td><td class="leftalignment">H Lundbeck A/S / Recordati Industria Chimica e Farmaceutica SpA / Merck KGaA / Lonza Group AG / Ucb SA / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">05/11/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Merck & Co</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="odd"><td class="leftalignment">05/11/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Drug Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">US00461U1051 / US5288723027 / US5160121019 / US62855J1043 / US6388423021 / US74838J1016 / US92532F1003 / US68554V1089 / US09060J1060 / US02043Q1076 / CA87402A1084 / US58933Y1055 / US92345Y1064 / US63009R1095 / US48576U1060 / US03209R1032 / US14167L1035 / US0453961080 / CA68620P1018 / US98978L2043 / CA1380351009 / US53222K2050 / BSP733981026 / US4622221004 / US45781M1018 / US44842L1035 / US1710774076 / US04537Y1091 / US92556V1061 / US0547548745 / US92941V2097</td><td class="leftalignment">Aclaris Therapeutics Inc / Lexicon Pharmaceuticals Inc / Lannett Company Inc / Myriad Genetics Inc / Natural Alternatives International Inc / Quidel Corp / Vertex Pharmaceuticals Inc / OraSure Technologies Inc / BioDelivery Sciences International Inc / Alnylam Pharmaceuticals Inc / Taiga Building Products Ltd / Merck & Co Inc / Verisk Analytics Inc / NanoString Technologies Inc / Karyopharm Therapeutics Inc / Amphastar Pharmaceuticals Inc / CareDx Inc / Assembly Biosciences Inc / OrganiGram Holdings Inc / Zogenix Inc / Canopy Growth Corp / LifeVantage Corp / Nymox Pharmaceutical Corp / Ionis Pharmaceuticals Inc / Innoviva Inc / HUTCHMED (China) Ltd / Chromadex Corp / Aspira Women's Health Inc / Viatris Inc / Aytu Biopharma Inc / Vyne Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bahamas / Canada / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">05/11/2021</td><td class="leftalignment">UnivDatos Market Insights (UMI)</td><td class="leftalignment">Cancer Immunotherapy Market: Current Analysis and Forecast (2021-2027)</td><td class="leftalignment">English</td><td class="rightalignment">261</td><td class="leftalignment">FACT=US / MRK=US / PFE=US / AMGN=US / BMY=US / A=US / NOVN=CH / AZN=GB / BLUE=US / null / 500680=IN / 506820=IN / ABBV=US / CNTO=US</td><td class="leftalignment">Freedom Acquisition I Corp / Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Agilent Technologies Inc / Novartis AG / AstraZeneca PLC / bluebird bio Inc / One 97 Communications Ltd / Pfizer Ltd / Astrazeneca Pharma India Ltd / Abbvie Inc / Centor Energy Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / China / Cayman Islands / Germany / Spain / France / United Kingdom / India / Italy / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW / MERGER/ACQUISITION/DIVESTITURE / OPERATIONS / OPERATING RESULTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">univdatos Co / UMI Team</td></tr>
<tr class="odd"><td class="leftalignment">05/11/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / OXY=US / ICLR=US / WEN=US / BLD=US / INCY=US / TEVA=US / KMI=US / CMA=US / REI=US / PLUG=US / CRM=US / LOW=US / ENR=US / FMS=US / VRM=US / CHRS=US / MAR=US / LEG=US / VMC=US / MLM=US / CBRL=US / ELY=US / CHH=US / CSGP=US / DRI=US / GFF=US / IBP=US / NOW=US / MAS=US / MPLX=US / MHK=US / SHOP=US / GOLF=US / SAGE=US / SPG=US / EPD=US / SGMS=US / BKNG=US / NLS=US / DIN=US / MGNI=US / PTON=US / RNG=US / TCBI=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SCPL=US / CMG=US / PGTI=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / APEI=US / WH=US / JACK=US / TREX=US / APTS=US / FBHS=US / BCEI=US / ABBV=US / TILE=US / NDLS=US / LOCO=US / OSH=US / VCEL=US / SHAK=US / GSBD=US / WING=US / SQ=US / AXSM=US / 82982L103 / TTD=US / EVBG=US / JELD=US / ATNX=US / SWCH=US / SAIL=US / EQH=US / BTAI=US / SVMK=US / PLMR=US / FERG=US / RPAY=US / ARQT=US / REYN=US / SPCE=US / FBRX=US / AZEK=US / BALY=US / VTRS=US / ABNB=US / AFRM=US / RBLX=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / ICON PLC / Wendys Co / TopBuild Corp / Incyte Corp / Teva Pharmaceutical Industries Ltd / Kinder Morgan Inc / Comerica Inc / Ring Energy Inc / Plug Power Inc / Salesforce.Com Inc / Lowe's Companies Inc / Energizer Holdings Inc / Fresenius Medical Care AG & Co KGaA / Vroom Inc / Coherus BioSciences Inc / Marriott International Inc / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Choice Hotels International Inc / CoStar Group Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / ServiceNow Inc / Masco Corp / MPLX LP / Mohawk Industries Inc / Shopify Inc / Acushnet Holdings Corp / SAGE Therapeutics Inc / Simon Property Group Inc / Enterprise Products Partners LP / Scientific Games Corp / Booking Holdings Inc / Nautilus Inc / Dine Brands Global Inc / Magnite Inc / Peloton Interactive Inc / RingCentral Inc / Texas Capital Bancshares Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Sciplay Corp / Chipotle Mexican Grill Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / American Public Education Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / Trex Company Inc / Preferred Apartment Communities Inc / Fortune Brands Home & Security Inc / Civitas Resources Inc / Abbvie Inc / Interface Inc / Noodles & Co / El Pollo Loco Holdings Inc / Oak Street Health Inc / Vericel Corp / Shake Shack Inc / Goldman Sachs BDC Inc / Wingstop Inc / Block Inc / Axsome Therapeutics Inc / SiteOne Landscape Supply Inc / Trade Desk Inc / Everbridge Inc / JELD-WEN Holding Inc / Athenex Inc / Switch Inc / SailPoint Technologies Holdings Inc / Equitable Holdings Inc / BioXcel Therapeutics Inc / Momentive Global Inc / Palomar Holdings Inc / Ferguson PLC / Repay Holdings Corp / Arcutis Biotherapeutics Inc / Reynolds Consumer Products Inc / Virgin Galactic Holdings Inc / Forte Biosciences Inc / Azek Company Inc / Bally's Corp / Viatris Inc / Airbnb Inc / Affirm Holdings Inc / Roblox Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Germany / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2023607 / 2778844 / 2973821 / 2219224 / 2175672 / 2222631 / 2037170 / 2328915 / 2369174 / 2415204 / 2457864 / 2657802 / 2689560 / 2684703 / 2048804 / 2440637 / 2862532 / 4595739 / 7103065 / B1F76F9 / B121557 / B19FQ48 / B125XQ6 / B7TL820 / B4MG4Z6 / B7VD3F2 / BJ0XLZ3 / BDZCRX3 / BFH3N85 / BFZCHN7 / BVVN4Q8 / BYVY8G0 / BYVFC94 / BF4VBS8 / BK0VHF6 / BD9GVY0 / BJXPS33 / BD8DJ71 / BJFSR88 / BYZR4X4 / BP7RS48 / BKVDFF7 / BYXJQG9 / BZ1LFG7 / BL71K91 / BD6JX35 / BZ0P3Z5 / BYTJZL1 / BDD1B07 / BKT6B38 / BF3N4P3 / BM8MM05 / BLBLMD5 / BNG3RZ7 / BMDJ085 / BLR6S36</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Alliant Energy Corp / CMS Energy Corp / Cardinal Health Inc / Cooper Companies Inc / 8x8 Inc / Nextera Energy Inc / Gilead Sciences Inc / Hawaiian Electric Industries Inc / ImmunoGen Inc / OGE Energy Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / E W Scripps Co / Genmab A/S / Novartis AG / Western Union Co / Mastercard Inc / Amicus Therapeutics Inc / Portland General Electric Co / Meta Platforms Inc / AMC Networks Inc / Duke Energy Corp / Heron Therapeutics Inc / RingCentral Inc / Veeva Systems Inc / Wix.Com Ltd / Eversource Energy / Alphabet Inc / US Foods Holding Corp / BioXcel Therapeutics Inc / IDEAYA Biosciences Inc / Zai Lab Ltd / BELLUS Health Inc / Snap Inc / Uniqure NV / Axsome Therapeutics Inc / Intersect Ent Inc / Oric Pharmaceuticals Inc / Spire Inc / Roku Inc / Revolution Medicines Inc / Krystal Biotech Inc / Tegna Inc / Zogenix Inc / Rubius Therapeutics Inc / SmileDirectClub Inc / Arena Pharmaceuticals Inc / Madison Square Garden Entertainment Corp / Array Technologies Inc / Leslie's Inc / Shoals Technologies Group Inc / Longboard Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">05/11/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Merck & Co (MRK US) - Q1 second opinion: pipeline news building</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="even"><td class="leftalignment">05/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4528.T: Ono Pharmaceutical - Strong 4Q FY3/21 results; share price gains only likely after trial proceedings complete</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">4528.T / MRK.N / ROG.S</td><td class="leftalignment">Ono Pharmaceutical Co Ltd / Merck & Co Inc / Roche Holding AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">05/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4528.T: 小野薬品工業 - 4Q決算：好決算、株価は訴訟結審待ちか</td><td class="leftalignment">Japanese</td><td class="rightalignment">6</td><td class="leftalignment">4528.T / MRK.N / ROG.S</td><td class="leftalignment">Ono Pharmaceutical Co Ltd / Merck & Co Inc / Roche Holding AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">05/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ALM.MC: Almirall - 1Q21 Second Opinion: Raising TP to Eu14 (from Eu12)</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">ALM.MC / RECI.MI / LUN.CO / MRCG.DE / LONN.S / UCB.BR / IPN.PA / ORNBV.HE / GRLS.MC / VIFN.S / GMAB.CO</td><td class="leftalignment">Almirall SA / Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Ipsen SA / Orion Oyj / Grifols SA / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">FY2020 Annual Report: Merck Net Profit up 51%</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Apr 30, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Video Call on Current and Emerging Cardiovascular Disease Treatments Thursday, May 20 at 11 AM EST</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMRN.O / JNJ / LLY / MRK / MSB / PFE</td><td class="leftalignment">Amarin Corporation PLC / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Mesoblast Ltd / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - May 10 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0079731008 / US0116591092 / US0382221051 / US0463531089 / US1101221083 / US1925761066 / US2371941053 / US37733W1053 / US4663671091 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US5801351017 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US8552441094 / US8807701029 / US91347P1057 / US9884981013 / US4771431016 / US4198791018 / US80105N1054 / US3463751087 / US90385V1070 / US25754A2015 / US1696561059 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / DE000A1EWWW0 / US95058W1009 / US00287Y1091 / NL0010273215 / LU0914713705 / US38046C1099 / US8485771021 / US21240E1055 / US02376R1023 / CA0089118776 / CA76131D1033 / US8190471016 / US9741551033 / US45782B1044 / KYG4740B1059 / CA35805P1071 / US05351X1019 / US68373M1071 / US5904791358 / IE00BZ12WP82 / US4833791035 / US92556H2067 / US92537N1081 / US26142R1041 / US38246G1085 / US90089L1089</td><td class="leftalignment">Advanced Energy Industries Inc / Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cohu Inc / Darden Restaurants Inc / GlaxoSmithKline PLC / Jack in the Box Inc / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / McDonald's Corp / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Starbucks Corp / Teradyne Inc / Universal Display Corp / Yum! Brands Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / FormFactor Inc / Ultra Clean Holdings Inc / Domino's Pizza Inc / Chipotle Mexican Grill Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Adidas AG / Wendys Co / Abbvie Inc / ASML Holding NV / Intelsat SA / Gogo Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Air Canada / Restaurant Brands International Inc / Shake Shack Inc / Wingstop Inc / Inseego Corp / Ichor Holdings Ltd / Freshii Inc / Avaya Holdings Corp / Opera Ltd / Mesa Air Group Inc / Linde PLC / Kaleyra Inc / ViacomCBS Inc / Vertiv Holdings Co / DraftKings Inc / Goodrx Holdings Inc / TuSimple Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Luxembourg / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Life Science Tools & Diagnostics: Top Questions for Management Teams</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">4502.T / BMY.N / CI.N / CVS.N / GE.N / MCK.N / MRK.N / PFE.N / TMO.N / WMT.N / DGX.N / AZN.L / ROG.S / DHR.N / UNH.N / LH.N / MMM.N / CRL.N / IDXX.OQ / XRAY.OQ / HSIC.OQ / AMZN.OQ / ALGN.OQ / STMN.S / PETS.OQ / ICLR.OQ / QGEN.N / BAYGN.DE / ZTS.N / PAHC.OQ / LNTH.OQ / ANTM.N / WBA.OQ / MEDP.OQ / FLGT.O / IQV.N / SYNH.OQ / ELAN.N / CVET.OQ / AVTR.N / CHWY.N / SDC.OQ / NVST.N / CNTG.OQ / MRVI.OQ / CERT.OQ / OCDX.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / General Electric Co / Mckesson Corp / Merck & Co Inc / Pfizer Inc / Thermo Fisher Scientific Inc / Walmart Inc / Quest Diagnostics Inc / AstraZeneca PLC / Roche Holding AG / Danaher Corp / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / 3M Co / Charles River Laboratories International Inc / IDEXX Laboratories Inc / DENTSPLY SIRONA Inc / Henry Schein Inc / Amazon.com Inc / Align Technology Inc / Straumann Holding AG / Petmed Express Inc / ICON PLC / Qiagen NV / Bayer AG / Zoetis Inc / Phibro Animal Health Corp / Lantheus Holdings Inc / Anthem Inc / Walgreens Boots Alliance Inc / Medpace Holdings Inc / Fulgent Genetics Inc / IQVIA Holdings Inc / Syneos Health Inc / Elanco Animal Health Inc / Covetrus Inc / Avantor Inc / Chewy Inc / SmileDirectClub Inc / Envista Holdings Corp / Centogene NV / Maravai LifeSciences Holdings Inc / Certara Inc / Ortho Clinical Diagnostics Holdings PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / United Kingdom / Ireland / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="odd"><td class="leftalignment">05/09/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck & Co Inc: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">05/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Trial Activity Holding Steady - Week 58</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">HZNP-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">HZNP.O / MRK / PFE / AMGN.O / RDY / AZN.O / RDUS.O</td><td class="leftalignment">Horizon Therapeutics PLC / Merck & Co Inc / Pfizer Inc / Amgen Inc / Dr Reddy's Laboratories Ltd / AstraZeneca PLC / Radius Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / India / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">IDRA-US - Fundamental Analysis, for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">IDRA.O / ABT / JNJ / MRK / PFE / AMGN.O / AGEN.O / LGND.O / BIIB.O / DVAX.O / CLDX.O</td><td class="leftalignment">Idera Pharmaceuticals Inc / Abbott Laboratories / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / Agenus Inc / Ligand Pharmaceuticals Inc / Biogen Inc / Dynavax Technologies Corp / Celldex Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 5.7.21</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">ABT / 00365410 / 28176E10 / 62855J10 / 75991610 / 71708110 / 00846U10 / 44485910 / 12665010 / 07181310 / 10113710 / 88355610 / 04635310 / 43644010 / 87936910 / 37555810 / 75886F10 / 53245710 / 46120E60 / 11679410 / 45232710 / 01625510 / 30063P10 / 478160104 / 075887109 / 60855R10 / 205306103 / 45784P10 / 25213110 / 04963C20 / 64049M20 / 58933Y10 / 14161910 / 45766930 / 80360710 / 92337F10 / 09073M104 / 82621J10 / 92346J10 / G5960L10 / 23283X20 / 40131M10 / 89853L10 / 71944F10 / 42226A10 / 68269G10 / 09075V10 / 60770K10 / 05156V10 / 01438T10 / 74374N10 / 31189P10 / 07725L10 / G3910J11 / 37242740 / 43906K10 / 45781K20 / 48576U10 / F5548N10 / 45845P10 / 4525EP10 / 22905030 / G8807B10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 05465P10 / 00461U10 / 04539610 / F4373810 / N4482110 / 28255910 / 29446K10 / N1976T10 / 36322Q10 / 74623710 / 15912K10 / 69512710</td><td class="leftalignment">Abbott Laboratories / ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Repligen Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Thermo Fisher Scientific Inc / AstraZeneca PLC / Hologic Inc / Teleflex Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Intuitive Surgical Inc / Bruker Corp / Illumina Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Becton Dickinson and Co / Molina Healthcare Inc / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Insmed Inc / Sarepta Therapeutics Inc / Veracyte Inc / Bio-Techne Corp / Sientra Inc / Vericel Corp / Medtronic PLC / Cytosorbents Corp / Guardant Health Inc / T2 Biosystems Inc / Phreesia Inc / Healthequity Inc / 1Life Healthcare Inc / BioNTech SE / Moderna Inc / Aurinia Pharmaceuticals Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Genocea Biosciences Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Karyopharm Therapeutics Inc / Sanofi SA / Intercept Pharmaceuticals Inc / Immunic Inc / Cryoport Inc / Theravance Biopharma Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Genfit SA / InflaRx NV / 89Bio Inc / Equillium Inc / Centogene NV / Galecto Inc / PureTech Health PLC / Change Healthcare Inc / Pacira Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending Apr 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended April 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Should You Buy Pfizer For 25% Gains?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">PFE.N / JNJ.N / MRK.N / RHHBY.PK</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Merck & Co Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Merck & Co., Inc.(MRK) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">58933Y105</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Morning Bite Flash</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">DE0006070006 / DE0006599905 / FI0009007132 / DE0005439004 / DE0006305006 / DE0007236101 / DE0007042301 / DE0006219934 / DE0007165631 / CH0012549785 / DE0007856023 / DE0007664039 / AT0000A0E9W5 / DE000A1EWWW0 / DE000TLX1005 / DE000A1X3XX4 / DE000EVNK013 / DE000UNSE018 / DE000A2GS5D8 / IE00BZ12WP82 / US09075V1026 / NL0015436031 / DE000HAG0005</td><td class="leftalignment">Hochtief AG / Merck KGaA / Fortum Oyj / Continental AG / DEUTZ AG / Siemens AG / Rhoen Klinikum AG / Jungheinrich AG / Sartorius AG / Sonova Holding AG / Elringklinger AG / Volkswagen AG / S&T AG / Adidas AG / Talanx AG / DIC Asset AG / Evonik Industries AG / Uniper SE / Dermapharm Holding SE / Linde PLC / BioNTech SE / CureVac NV / Hensoldt AG</td><td class="leftalignment"></td><td class="leftalignment">Austria / Switzerland / Germany / Finland / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Herr. Ingo-Martin Schachel, CFA</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Sector Flash - Health Care: Proposal to waive intellectual property rights for COVID-19 vaccines</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRCG.DE / PFE.N / SASY.PA</td><td class="leftalignment">Merck KGaA / Pfizer Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United States</td><td class="leftalignment">Aerospace / Air Transportation / Biotechnology / Conglomerates / Defense / Electrical / Engineering & Construction / Environmental Services / Healthcare / Industrial Materials / Machinery / Pharmaceuticals / Railroads / Shipping & Shipbuilding / Transportation</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CREDIT</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Frau Silke Stegemann</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">AXP / 2516152 / 2486813 / 2778844 / 2973821 / 2045623 / 2219224 / 2175672 / 2216850 / 2576941 / 2670519 / 2345022 / 2459202 / 2459020 / 2378534 / 2630513 / 2645409 / 2657802 / 2680905 / 2684703 / 2048804 / 2707677 / 2730190 / 2440637 / 2416962 / 2138158 / 2799351 / 2825933 / 5531000 / 7103065 / 2212922 / 2769796 / 2857817 / B125XQ6 / B0T7YX2 / B02R1L6 / B3P93Y7 / B44C366 / B7TL820 / B783TY6 / BBPK0J0 / BBGVT40 / B95N910 / BDZCRX3 / B8DPDT7 / BFLR866 / B6WXT12 / B95WG16 / BZ07BW4 / BYVY8G0 / BYW36M8 / BF09HX3 / BYNZGK1 / BJT1RW7 / BZBY005 / BKS3SM8 / BQT3XY6 / BJ1FD74 / BJFSR88 / BKDS4H5 / BR4T3B3 / BWFKZT2 / BKVDFF7 / BFMXGR0 / BJJMGL2 / BFXC911 / BKTNTR9 / BK6N347 / BJVR9Y9 / BYWMQJ2 / BHZSB82 / BL95N25 / BD6D4Y5 / BZ1LFG7 / BYY88Y7 / BYSGPK2 / BJDX8Y8 / BYWVTY5 / BMVWYW8 / BJMLSD2 / BYQBFS7 / BYSFJV8 / BKWD3M9 / BYTJZL1 / BX7RSN3 / BYNPPC6 / BWY4XV3 / BJTJGC4 / BKLCX50 / BYQCZ35 / BQXZP64 / BGDW0N7 / BMPRZV5 / BGT0PL8 / BLBLMD5 / BNTB3N8</td><td class="leftalignment">American Express Co / Eli Lilly and Co / Kellogg Co / Merck & Co Inc / Alliant Energy Corp / ANSYS Inc / CMS Energy Corp / Cardinal Health Inc / Consolidated Edison Inc / Exelixis Inc / Exelon Corp / Macy's Inc / IDEXX Laboratories Inc / Intuit Inc / Mckesson Corp / New Jersey Resources Corp / NiSource Inc / OGE Energy Corp / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Henry Schein Inc / Sempra Energy / Sinclair Broadcast Group Inc / South Jersey Industries Inc / MorphoSys AG / Novartis AG / NRG Energy Inc / Fidelity National Information Services Inc / Netflix Inc / Portland General Electric Co / Live Nation Entertainment Inc / ALLETE Inc / Anheuser Busch Inbev SA / Heska Corp / Meta Platforms Inc / Aptiv PLC / Mirati Therapeutics Inc / News Corp / PTC Inc / RingCentral Inc / Sarepta Therapeutics Inc / Twitter Inc / TherapeuticsMD Inc / Zoetis Inc / Monster Beverage Corp / Alphabet Inc / PayPal Holdings Inc / Tapestry Inc / Block Inc / Lyft Inc / Merus NV / IGM Biosciences Inc / Cyberark Software Ltd / Revolve Group Inc / Uniqure NV / Bill.com Holdings Inc / HubSpot Inc / Cellectis SA / Oric Pharmaceuticals Inc / Evergy Inc / Fox Corp / Guardant Health Inc / ViacomCBS Inc / Uber Technologies Inc / iHeartMedia Inc / Alteryx Inc / Covetrus Inc / Phibro Animal Health Corp / Altair Engineering Inc / Roku Inc / Alphabet Inc / ViewRay Inc / Mirum Pharmaceuticals Inc / CytomX Therapeutics Inc / Protara Therapeutics Inc / Karuna Therapeutics Inc / Tabula Rasa HealthCare Inc / Planet Fitness Inc / Progyny Inc / Zogenix Inc / Collegium Pharmaceutical Inc / DENTSPLY SIRONA Inc / Adaptimmune Therapeutics PLC / Kontoor Brands Inc / Health Catalyst Inc / Madison Square Garden Sports Corp / Wayfair Inc / Trevena Inc / Kymera Therapeutics Inc / DiaMedica Therapeutics Inc / Array Technologies Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Germany / France / United Kingdom / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AZN.L: AstraZeneca - POSEIDON: Imfinzi + treme + chemo triplet show survival benefit in 1L lung cancer</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AZN.L / BMY.N / MRK.N / SASY.PA / ROG.S / REGN.OQ</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Sanofi SA / Roche Holding AG / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ZTS: Diagnosing 1Q: Following up with ZTS and 10Q Takes</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">ZTS.N / MRK.N / IDXX.OQ / ELAN.N</td><td class="leftalignment">Zoetis Inc / Merck & Co Inc / IDEXX Laboratories Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">RECI.MI: Recordati - CMD Feedback and 1Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">RECI.MI / LUN.CO / NOVN.S / MRCG.DE / LONN.S / UCB.BR / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / VIFN.S / GMAB.CO</td><td class="leftalignment">Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Novartis AG / Merck KGaA / Lonza Group AG / Ucb SA / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">MRTX (NEUTRAL) - Mgmt Takeaways Post-Earnings Highlight Upcoming 2H 2021 Adagrasib Milestones; Maintain NEUTRAL</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BBPK0J0 / 2516152 / 2778844 / 7103065</td><td class="leftalignment">Mirati Therapeutics Inc / Eli Lilly and Co / Merck & Co Inc / Novartis AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">What to make out of a temporary patent waiver on corona vaccines?</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US09075V1026 / DE0006599905 / DE0007165631 / DE000A2GS5D8 / NL0015436031</td><td class="leftalignment">BioNTech SE / Merck KGaA / Sartorius AG / Dermapharm Holding SE / CureVac NV</td><td class="leftalignment"></td><td class="leftalignment">Germany / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr Daniel Wendorff</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">2434209 / 2778844 / 2050832 / 2045623 / 2942605 / 2111955 / 2219224 / 2190750 / 2216850 / 2280220 / 2270726 / 2542049 / 2670519 / 2328915 / 2369174 / 2623911 / 2632003 / 2645409 / 2657802 / 2689560 / 2048804 / 2707677 / 2440637 / 2573083 / 2138158 / 2799351 / 2829601 / 4595739 / 5531000 / 2795393 / 2712013 / B1F76F9 / B121557 / 2769796 / 2713317 / 2857817 / B125XQ6 / B2R3PV1 / B4Y1MH7 / 2598246 / 2390817 / B3SWPT2 / B7TL820 / BFRTDG1 / B7254K9 / BBFL7S1 / BCZS820 / B8L2798 / BJ0KXV4 / BDZCRX3 / BQPVQZ6 / BYVY8G0 / BS7K7C9 / BYVYD43 / BYW36M8 / BFZNYB7 / BJXBP41 / BQT3XY6 / BKDS4H5 / BKTHM05 / BZ1HM42 / BJ5FZ74 / BR4T3B3 / BGCYWN8 / BZ8FPH3 / BLGJ610 / BFMXGR0 / BJJMGL2 / BFNR303 / BZ05388 / BJXBP30 / BYWMQJ2 / BYQHPK7 / BYYWPW6 / BDH65C8 / BJ9NFQ3 / BK71LY6 / BF3W461 / BKS3RS7 / BD8Q1B8 / BF3N4P3 / BZ4CHH2 / BLBLMD5 / BNG3RZ7 / BN4NJG4 / BD5GSZ4</td><td class="leftalignment">Home Depot Inc / Merck & Co Inc / Ameren Corp / ANSYS Inc / Avista Corp / Borgwarner Inc / CMS Energy Corp / Chesapeake Utilities Corp / Consolidated Edison Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Exelon Corp / Nextera Energy Inc / Gilead Sciences Inc / Neurocrine Biosciences Inc / New York Times Co / NiSource Inc / OGE Energy Corp / PG&E Corp / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / CenterPoint Energy Inc / Sangamo Therapeutics Inc / Sempra Energy / Sinclair Broadcast Group Inc / Southern Co / Genmab A/S / MorphoSys AG / Amerisourcebergen Corp / Global Payments Inc / Western Union Co / Mastercard Inc / Fidelity National Information Services Inc / ACADIA Pharmaceuticals Inc / Netflix Inc / Portland General Electric Co / American Water Works Company Inc / KAR Auction Services Inc / Neogenomics Inc / Gray Television Inc / Ameresco Inc / Meta Platforms Inc / Aerie Pharmaceuticals Inc / AxoGen Inc / bluebird bio Inc / Fate Therapeutics Inc / Hemisphere Media Group Inc / ONE Gas Inc / RingCentral Inc / Horizon Therapeutics PLC / Alphabet Inc / Nevro Corp / Performance Food Group Co / PayPal Holdings Inc / Allogene Therapeutics Inc / Alcon AG / Cyberark Software Ltd / Bill.com Holdings Inc / Passage Bio Inc / Adyen NV / Adaptive Biotechnologies Corp / HubSpot Inc / Xencor Inc / Editas Medicine Inc / Warner Music Group Corp / Evergy Inc / Fox Corp / Northwest Natural Holding Co / Global Blood Therapeutics Inc / Turning Point Therapeutics Inc / Alteryx Inc / Zymeworks Inc / Beigene Ltd / PetIQ Inc / Neoleukin Therapeutics Inc / WW International Inc / Tandem Diabetes Care Inc / 10X Genomics Inc / Tivity Health Inc / Arena Pharmaceuticals Inc / Soleno Therapeutics Inc / Array Technologies Inc / Leslie's Inc / Freeline Therapeutics Holdings PLC / Infrastructure and Energy Alternatives Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GMAB.CO: Genmab - 1Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">GMAB.CO / JNJ.N / PFE.N / RECI.MI / ROG.S / LUN.CO / NOVN.S / MRCG.DE / LONN.S / UCB.BR / REGN.OQ / SGEN.OQ / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / HZNP.OQ / ABBV.N / VIFN.S</td><td class="leftalignment">Genmab A/S / Johnson & Johnson / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / Roche Holding AG / H Lundbeck A/S / Novartis AG / Merck KGaA / Lonza Group AG / Ucb SA / Regeneron Pharmaceuticals Inc / Seagen Inc / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Horizon Therapeutics PLC / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Ireland / Italy / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Positive IO Read-Through from Keytruda Success in HER2+ Gastric Cancer</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK.N / 58933Y10</td><td class="leftalignment">Merck & Co Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Daina Graybosch, Ph.D. / Jeffrey La Rosa / Dilip Joseph</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BMY-US -  Dividend Quality Analysis, for the period ended May 03,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / JNJ / LLY / MRK / NVS / PFE / AMGN.O / AZN.O / BIIB.O / ABBV.K / SNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / AstraZeneca PLC / Biogen Inc / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">XNCR (BUY) – 1Q Wrap-Up: Upcoming Trial Initiations & Data Updates Within Our Expectations; Maintain BUY</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BGCYWN8 / 2778844 / 5531000</td><td class="leftalignment">Xencor Inc / Merck & Co Inc / MorphoSys AG</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Etzer Darout / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Surprise Win for Pembrolizumab in 1L Her2+ Gastric Cancer</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">58933Y10</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US Company reports financial results for the quarter ended April 04,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">The Insight Partners</td><td class="leftalignment">Merck Kgaa (Mrk) In Organoids Market, Company SWOT Analysis and Profile</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">The Insight Partners</td><td class="leftalignment">Merck & Co. Inc. (Mrk) In Systemic Aspergillosis And Systemic Candidasis Market, Company SWOT Analysis and Profile</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Infinata</td><td class="leftalignment">Merck KGaA - Company Report</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Middle East</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Infinata</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Infinata</td><td class="leftalignment">Merck & Co., Inc. - Company Report</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Infinata</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Excellent Q1 prelims, guidance raised</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr Daniel Wendorff</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Kepler Cheuvreux</td><td class="leftalignment">Merck KGaA | 2021 guidance raised ahead of Q1 results</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Dariusz Ubik</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Morning Bite Flash</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">DE0006599905 / NL0000235190 / DE0006231004 / DE0008402215 / DE0005552004 / DE000BASF111 / CH0126881561 / DE000A1PHFF7 / DE000A1H8BV3 / DE000A1ML7J1 / DK0060738599 / DE000A161408 / DE000A2YN900 / DE000ENER6Y0 / DE000A3H2200</td><td class="leftalignment">Merck KGaA / Airbus SE / Infineon Technologies AG / Hannover Rueck SE / Deutsche Post AG / BASF SE / Swiss Re AG / Hugo Boss AG / Norma Group SE / Vonovia SE / Demant A/S / Hellofresh SE / TeamViewer AG / Siemens Energy AG / Nagarro SE</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / Netherlands</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Herr. Ingo-Martin Schachel, CFA</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Merck: Strong 1Q pre-release and guidance raise</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Falko Friedrichs / Herr Jan Koch / Sachin Gadilingappa</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Daily Credit Briefing</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AIRP.PA / AXAF.PA / DSMN.AS / GM.N / MRCG.DE / IFXGn.DE / HNRGn.DE / DPWGn.DE / TRAFINBN91N3 / CPRI.MI / RACE.MI / NL00150001Q9</td><td class="leftalignment">L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / AXA SA / Koninklijke DSM NV / General Motors Co / Merck KGaA / Infineon Technologies AG / Hannover Rueck SE / Deutsche Post AG / QNB Finansbank AS / Davide Campari Milano NV / Ferrari NV / Stellantis NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Germany / France / Italy / Netherlands / Turkey / Ukraine / United States</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS / CREDIT</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Herr. Ulrich Scholz, CFA / Herr Christian Aust / Herr Jonathan Schroer / Herr Sven Kreitmair, CFA / Frau Silke Stegemann / Sergey Bolshakov / Herr Natalie Tehrani Monfared / Herr Gianfranco Arcovito / Herr. Stefan Kolek</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Animal Tracks: 1Q EPS Drivers in Animal Health; Sustained Strength in Companion Animal; Positive on ZTS, ELAN into 1Q Prints</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">CVET.OQ / ELAN.N / ZTS.N / CL.N / LLY.N / MRK.N / TSCO.L / VIRB.PA / GIS.N / DPH.L / GNS.L / SJM.N / IDXX.OQ / PDCO.OQ / TSCO.OQ / NEOG.OQ / HSKA.OQ / WOOF.OQ / PETS.OQ / NESN.S / FRPT.OQ / CVSG.L / ZO1G.DE / BAYGN.DE / CENTA.OQ / PETSP.L / PAHC.OQ / KINO.JK / TRUP.OQ / CHWY.N</td><td class="leftalignment">Covetrus Inc / Elanco Animal Health Inc / Zoetis Inc / Colgate-Palmolive Co / Eli Lilly and Co / Merck & Co Inc / Tesco PLC / Virbac SA / General Mills Inc / Dechra Pharmaceuticals PLC / Genus PLC / J M Smucker Co / IDEXX Laboratories Inc / Patterson Companies Inc / Tractor Supply Co / Neogen Corp / Heska Corp / Petco Health and Wellness Company Inc / Petmed Express Inc / Nestle SA / Freshpet Inc / CVS Group PLC / Zooplus AG / Bayer AG / Central Garden & Pet Co / Pets at Home Group PLC / Phibro Animal Health Corp / Kino Indonesia Tbk PT / Trupanion Inc / Chewy Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Indonesia / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRCG.DE: Merck KGaA - 1Q21 Initial Diagnosis</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GRLS.MC: Grifols - 1Q21 results: Reiterate Outperform TP Eu25</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GRLS.MC / 4502.T / CSL.AX / JNJ.N / RECI.MI / LUN.CO / MRCG.DE / LONN.S / UCB.BR / 006280.KS / 002007.SZ / IPN.PA / ORNBV.HE / ALM.MC / VIFN.S / ARGX.OQ / GMAB.CO</td><td class="leftalignment">Grifols SA / Takeda Pharmaceutical Co Ltd / CSL Ltd / Johnson & Johnson / Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Green Cross Corp / Hualan Biological Engineering Inc / Ipsen SA / Orion Oyj / Almirall SA / Vifor Pharma AG / argenx SE / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / China / Germany / Denmark / Spain / Finland / France / Italy / Japan / Korea, Republic of / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck KGaA : 1Q'21 Pre-announcement: Strong 1Q and FY'21 guidance raise implies c.12% upgrades to Cons. EPS (pre)</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Richard B. Vosser / James D. Gordon / Ms. Laerke Engkilde / Zain Ebrahim / Mr. Tycho W. Peterson</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">VRTX-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">VRTX.O / BMY / JNJ / MRK / GILD.O / ENTA.O / ABBV.K / ENZN.PK</td><td class="leftalignment">Vertex Pharmaceuticals Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Gilead Sciences Inc / Enanta Pharmaceuticals Inc / Abbvie Inc / Enzon Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Drug Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">US00461U1051 / US5288723027 / US4525253062 / US5160121019 / US62855J1043 / US6388423021 / US74838J1016 / US75886F1075 / US91307C1027 / US92532F1003 / US68554V1089 / US09060J1060 / US02043Q1076 / CA87402A1084 / US58933Y1055 / US42805E3062 / US88322Q1085 / US1635722093 / US63009R1095 / US48576U1060 / US00847L1008 / US03209R1032 / US14167L1035 / US0453961080 / CA68620P1018 / US98978L2043 / CA1380351009 / US53222K2050 / US4622221004 / US45781M1018 / CA0717341071 / US04537Y1091 / US92556V1061 / US0547548745 / US92941V2097</td><td class="leftalignment">Aclaris Therapeutics Inc / Lexicon Pharmaceuticals Inc / ImmuCell Corp / Lannett Company Inc / Myriad Genetics Inc / Natural Alternatives International Inc / Quidel Corp / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / OraSure Technologies Inc / BioDelivery Sciences International Inc / Alnylam Pharmaceuticals Inc / Taiga Building Products Ltd / Merck & Co Inc / Heska Corp / TG Therapeutics Inc / Chembio Diagnostics Inc / NanoString Technologies Inc / Karyopharm Therapeutics Inc / Agile Therapeutics Inc / Amphastar Pharmaceuticals Inc / CareDx Inc / Assembly Biosciences Inc / OrganiGram Holdings Inc / Zogenix Inc / Canopy Growth Corp / LifeVantage Corp / Ionis Pharmaceuticals Inc / Innoviva Inc / Bausch Health Companies Inc / Aspira Women's Health Inc / Viatris Inc / Aytu Biopharma Inc / Vyne Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck KGaA : Pre 1Q'21 Consensus Comparison: JPMe c.5% below Cons. EPS (pre) for 1Q; 2021 Cons. captured by expected guidance ranges</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Richard B. Vosser / James D. Gordon / Ms. Laerke Engkilde / Zain Ebrahim / Mr. Tycho W. Peterson</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Organon Success Keyed To Nexplanon And Ability To Restock Portfolio Through M&A</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRK=US / WMB=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / OXY=US / RRC=US / WEN=US / MDT=US / BLD=US / DVN=US / INCY=US / GILD=US / APA=US / CPE=US / EOG=US / REI=US / VZ=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / DIOD=US / MGY=US / SWN=US / SCOR=US / MUR=US / CHRS=US / MRO=US / LEG=US / KFRC=US / VMC=US / MLM=US / CBRL=US / CNX=US / DRI=US / EQT=US / EXEL=US / GFF=US / IBP=US / HZO=US / MAS=US / MHK=US / HOOK=US / REGN=US / REGI=US / RHI=US / WIX=US / CVX=US / SAGE=US / PSA=US / EPD=US / CGEN=US / BXS=US / SNV=US / ADC=US / CUZ=US / OHI=US / VNO=US / CRTO=US / COP=US / BRX=US / DIN=US / STRO=US / TPX=US / EXP=US / FHN=US / CDLX=US / BECN=US / SHO=US / PLAY=US / FRPT=US / DENN=US / BLDR=US / GMS=US / NSP=US / SIBN=US / KBR=US / CMG=US / REX=US / CCOI=US / XPO=US / PGTI=US / GPRE=US / AWI=US / OC=US / TAST=US / QSR=US / CLR=US / PRPL=US / NOG=US / IAC=US / EPRT=US / JACK=US / RCUS=US / CLNY=US / TREX=US / AR=US / NLSN=US / WWD=US / ESTE=US / FBHS=US / ANGI=US / BCEI=US / MTDR=US / MEIP=US / PDCE=US / GMED=US / RHP=US / FANG=US / ABBV=US / TILE=US / NDLS=US / FATE=US / VRNS=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / ON=US / SEDG=US / BWXT=US / WING=US / SPNE=US / CABO=US / ACBI=US / AXSM=US / 82982L103 / CDEV=US / CRSP=US / PVAC=US / JELD=US / CVNA=US / SBOW=US / IOVA=US / ATNX=US / ROKU=US / SWCH=US / DCPH=US / MAXR=US / BTAI=US / FTDR=US / SVMK=US / ALLO=US / KOD=US / HARP=US / RTLR=US / FERG=US / GMAB=US / OVV=US / ARQT=US / ZI=US / AZEK=US</td><td class="leftalignment">Merck & Co Inc / Williams Companies Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Wendys Co / Medtronic PLC / TopBuild Corp / Devon Energy Corp / Incyte Corp / Gilead Sciences Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Verizon Communications Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Diodes Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Comscore Inc / Murphy Oil Corp / Coherus BioSciences Inc / Marathon Oil Corp / Leggett & Platt Inc / Kforce Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Cracker Barrel Old Country Store Inc / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Exelixis Inc / Griffon Corp / Installed Building Products Inc / MarineMax Inc / Masco Corp / Mohawk Industries Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / Robert Half International Inc / Wix.Com Ltd / Chevron Corp / SAGE Therapeutics Inc / Public Storage / Enterprise Products Partners LP / Compugen Ltd / Cadence Bank / Synovus Financial Corp / Agree Realty Corp / Cousins Properties Inc / Omega Healthcare Investors Inc / Vornado Realty Trust / Criteo SA / Conocophillips / Brixmor Property Group Inc / Dine Brands Global Inc / Sutro Biopharma Inc / Tempur Sealy International Inc / Eagle Materials Inc / First Horizon Corp / Cardlytics Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / SI-BONE Inc / KBR Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Cogent Communications Holdings Inc / XPO Logistics Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Purple Innovation Inc / Northern Oil and Gas Inc / IAC/Interactivecorp / Essential Properties Realty Trust Inc / Jack in the Box Inc / Arcus Biosciences Inc / DigitalBridge Group Inc / Trex Company Inc / Antero Resources Corp / Nielsen Holdings PLC / Woodward Inc / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Angi Inc / Civitas Resources Inc / Matador Resources Co / MEI Pharma Inc / PDC Energy Inc / Globus Medical Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Abbvie Inc / Interface Inc / Noodles & Co / Fate Therapeutics Inc / Varonis Systems Inc / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / ON Semiconductor Corp / Solaredge Technologies Inc / BWX Technologies Inc / Wingstop Inc / SeaSpine Holdings Corp / Cable One Inc / Atlantic Capital Bancshares Inc / Axsome Therapeutics Inc / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / CRISPR Therapeutics AG / Ranger Oil Corp / JELD-WEN Holding Inc / Carvana Co / SilverBow Resources Inc / Iovance Biotherapeutics Inc / Athenex Inc / Roku Inc / Switch Inc / Deciphera Pharmaceuticals Inc / Maxar Technologies Inc / BioXcel Therapeutics Inc / Frontdoor Inc / Momentive Global Inc / Allogene Therapeutics Inc / Kodiak Sciences Inc / Harpoon Therapeutics Inc / Rattler Midstream LP / Ferguson PLC / Genmab A/S / Ovintiv Inc / Arcutis Biotherapeutics Inc / ZoomInfo Technologies Inc / Azek Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Apr 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">4502.T / BMY.N / JNJ.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / SUN.BO / NOVOB.CO / NOVN.S / 4768.T / GSK.L / UCB.BR / AMGN.OQ / ALKS.OQ / GILD.OQ / UTHR.OQ / BIIB.OQ / 4568.T / TEVA.N / ALM.MC / BAYGN.DE / 4578.T / ABBV.N</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Otsuka Corp / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Alkermes Plc / Gilead Sciences Inc / United Therapeutics Corp / Biogen Inc / Daiichi Sankyo Co Ltd / Teva Pharmaceutical Industries Ltd / Almirall SA / Bayer AG / Otsuka Holdings Co Ltd / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: April 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ALB.N / AN.N / AR.N / AXP.N / BAC.N / BAX.N / BDX.N / BSX.N / C.N / CL.N / CNC.N / COF.N / CRM.N / ED.N / EIX.N / EOG.N / FCX.N / GE.N / GM.N / GPS.N / IBM.N / JPM.N / KMB.N / KO.N / LLY.N / LMT.N / MRK.N / OXY.N / TXT.N / U.N / WFC.N / WMT.N / SPG.N / PG.N / NUE.N / DHR.N / DIS.N / UNH.N / FE.N / URI.N / DE.N / CAT.N / SPOT.N / AMG.N / GS.N / CLX.N / HON.N / HD.N / LOW.N / MRO.N / JWN.N / UPS.N / PCG.N / XOM.N / DVN.N / AMT.N / RMD.N / NKE.N / LIN.N / OLN.N / TGT.N / AVY.N / PKI.N / VZ.N / NYT.N / KSS.N / HRB.N / ORCL.N / KMX.N / PWR.N / COG.N / V.N / HWM.N / ACN.N / WSM.N / AIV.N / HAE.N / LB.TO / BLK.N / CVX.N / MHK.N / NWS.AX / IRM.N / NCR.N / INTC.OQ / ADPT.OQ / ADBE.OQ / AAPL.OQ / AMAT.OQ / ADSK.OQ / CSCO.OQ / COHR.OQ / HOLX.OQ / LRCX.OQ / MSFT.OQ / PII.N / REGN.OQ / SIVB.OQ / XLNX.OQ / QDEL.OQ / QCOM.OQ / GILD.OQ / DFS.N / INCY.OQ / PENN.OQ / TPR.N / CTXS.OQ / VSAT.OQ / AMZN.OQ / TTWO.OQ / MRCY.OQ / NVDA.OQ / BMRN.OQ / PACW.OQ / EXPE.OQ / TREE.OQ / MRVL.OQ / BLUE.OQ / ARRY.OQ / ALGN.OQ / SGEN.OQ / FITB.OQ / VRTX.OQ / NFLX.OQ / DKS.N / CMCSA.OQ / BIIB.OQ / SNX.N / TPX.N / SBNY.OQ / AGO.N / ACAD.OQ / MOS.N / MKTX.OQ / DXCM.OQ / WAL.N / MS.N / STX.AX / MA.N / AWI.N / FSLR.OQ / IVZ.N / CLR.N / QGEN.N / TDC.N / SATS.OQ / MRNA.OQ / NWSA.OQ / AGCO.N / AVGO.OQ / VRSK.OQ / SCHW.N / FTNT.OQ / GNRC.N / TSLA.OQ / NXPI.OQ / ADSGN.F / LPLA.OQ / AMD.OQ / XYL.N / SLM.OQ / ENPH.OQ / TRIP.OQ / GWRE.N / SPLK.OQ / NOW.N / SRPT.OQ / ALLY.N / FANG.OQ / BFAM.N / PRGO.N / COTY.N / RNG.N / MAR.OQ / PTC.OQ / GOOGL.OQ / PAYC.N / EQC.N / HUBS.N / ETSY.OQ / PYPL.OQ / GBT.OQ / PEN.N / NVCR.OQ / TMUS.OQ / SQ.N / IONS.OQ / RETA.OQ / TWLO.N / COUP.OQ / CDEV.OQ / AYX.N / CVNA.N / VST.N / IOVA.OQ / ROKU.OQ / PEP.OQ / ZS.OQ / FB.PS / STNE.OQ / CPRI.N / PINS.N / FSLY.N / LHX.N / PTON.OQ / NLOK.OQ / RTX.N / CARR.N / LMND.N / AMWL.N / VTRS.OQ</td><td class="leftalignment">Albemarle Corp / AutoNation Inc / Antero Resources Corp / American Express Co / Bank of America Corp / Baxter International Inc / Becton Dickinson and Co / Boston Scientific Corp / Citigroup Inc / Colgate-Palmolive Co / Centene Corp / Capital One Financial Corp / Salesforce.Com Inc / Consolidated Edison Inc / Edison International / EOG Resources Inc / Freeport-McMoRan Inc / General Electric Co / General Motors Co / Gap Inc / International Business Machines Corp / JPMorgan Chase & Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Merck & Co Inc / Occidental Petroleum Corp / Textron Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Simon Property Group Inc / Procter & Gamble Co / Nucor Corp / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / FirstEnergy Corp / United Rentals Inc / Deere & Co / Caterpillar Inc / Spotify Technology SA / Affiliated Managers Group Inc / Goldman Sachs Group Inc / Clorox Co / Honeywell International Inc / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / Nordstrom Inc / United Parcel Service Inc / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Resmed Inc / Nike Inc / Linde PLC / Olin Corp / Target Corp / Avery Dennison Corp / PerkinElmer Inc / Verizon Communications Inc / New York Times Co / Kohls Corp / H & R Block Inc / Oracle Corp / Carmax Inc / Quanta Services Inc / Coterra Energy Inc / Visa Inc / Howmet Aerospace Inc / Accenture PLC / Williams-Sonoma Inc / Apartment Investment and Management Co / Haemonetics Corp / Laurentian Bank of Canada / BlackRock Inc / Chevron Corp / Mohawk Industries Inc / News Corp / Iron Mountain Inc / NCR Corp / Intel Corp / Adaptive Biotechnologies Corp / Adobe Inc / Apple Inc / Applied Materials Inc / Autodesk Inc / Cisco Systems Inc / Coherent Inc / Hologic Inc / Lam Research Corp / Microsoft Corp / Polaris Inc / Regeneron Pharmaceuticals Inc / SVB Financial Group / Xilinx Inc / Quidel Corp / Qualcomm Inc / Gilead Sciences Inc / Discover Financial Services / Incyte Corp / Penn National Gaming Inc / Tapestry Inc / Citrix Systems Inc / ViaSat Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Mercury Systems Inc / NVIDIA Corp / Biomarin Pharmaceutical Inc / PacWest Bancorp / Expedia Group Inc / Lendingtree Inc / Marvell Technology Inc / bluebird bio Inc / Array Technologies Inc / Align Technology Inc / Seagen Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / DICK'S Sporting Goods Inc / Comcast Corp / Biogen Inc / TD Synnex Corp / Tempur Sealy International Inc / Signature Bank / Assured Guaranty Ltd / ACADIA Pharmaceuticals Inc / Mosaic Co / Marketaxess Holdings Inc / Dexcom Inc / Western Alliance Bancorp / Morgan Stanley / Strike Energy Ltd / Mastercard Inc / Armstrong World Industries Inc / First Solar Inc / Invesco Ltd / Continental Resources Inc / Qiagen NV / Teradata Corp / EchoStar Corp / Moderna Inc / News Corp / AGCO Corp / Broadcom Inc / Verisk Analytics Inc / Charles Schwab Corp / Fortinet Inc / Generac Holdings Inc / Tesla Inc / NXP Semiconductors NV / Adidas AG / LPL Financial Holdings Inc / Advanced Micro Devices Inc / Xylem Inc / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Guidewire Software Inc / Splunk Inc / ServiceNow Inc / Sarepta Therapeutics Inc / Ally Financial Inc / Diamondback Energy Inc / Bright Horizons Family Solutions Inc / Perrigo Company PLC / Coty Inc / RingCentral Inc / Marriott International Inc / PTC Inc / Alphabet Inc / Paycom Software Inc / Equity Commonwealth / HubSpot Inc / ETSY Inc / PayPal Holdings Inc / Global Blood Therapeutics Inc / Penumbra Inc / Novocure Ltd / T-Mobile US Inc / Block Inc / Ionis Pharmaceuticals Inc / Reata Pharmaceuticals Inc / Twilio Inc / Coupa Software Inc / Centennial Resource Development Inc / Alteryx Inc / Carvana Co / Vistra Corp / Iovance Biotherapeutics Inc / Roku Inc / PepsiCo Inc / Zscaler Inc / San Miguel Food and Beverage Inc / StoneCo Ltd / Capri Holdings Ltd / Pinterest Inc / Fastly Inc / L3harris Technologies Inc / Peloton Interactive Inc / NortonLifeLock Inc / Raytheon Technologies Corp / Carrier Global Corp / Lemonade Inc / American Well Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Cayman Islands / Germany / Ireland / Luxembourg / Netherlands / Philippines / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">All Eyes On Covid-19 Vaccine Contribution As Pfizer Reports Its Q1</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">PFE.N / JNJ.N / MRK.N / RHHBY.PK</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Merck & Co Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">MRK - MRK: Organon spin-off – will it be Upjohn-lite?</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">58933Y105</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck & Co Inc: Information Content of Earnings Releases 2015-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AZN-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AZN.O / ABT / BMY / JNJ / LLY / MRK / NVS / PFE / GSK / BIIB.O / SNY.O</td><td class="leftalignment">AstraZeneca PLC / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Biogen Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Key takes from MRK’s Organon Investor Day</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">New Spin On Things, Takeaways From Investor Day Forecasts Sunshine And Blue Skies</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What Bristol Myers Squibb's Q1 Results Say About Its Stock</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What?s Next For Merck Stock After A 5% Drop Following Q1 Miss?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist ASCO Planner v1.0 Highlights ~200 Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / GILD=US / CHRS=US / EXEL=US / HOOK=US / REGN=US / CGEN=US / STRO=US / RCUS=US / MEIP=US / ABBV=US / FATE=US / CRSP=US / IOVA=US / ATNX=US / DCPH=US / BTAI=US / ALLO=US / HARP=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Gilead Sciences Inc / Coherus BioSciences Inc / Exelixis Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Compugen Ltd / Sutro Biopharma Inc / Arcus Biosciences Inc / MEI Pharma Inc / Abbvie Inc / Fate Therapeutics Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Athenex Inc / Deciphera Pharmaceuticals Inc / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Mr. Gregg Gilbert / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Apr 23, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRK.N - Event Transcript of Merck & Co Inc conference call, May 03, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Morning Bite Flash</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">DE0006599905 / DE0006452907 / KR7005930003 / DE000A0ETBQ4 / CH0126881561 / DE000A0MZ4B0 / DE000A161N30 / LU1066226637 / DK0060094928 / DE000SHL1006</td><td class="leftalignment">Merck KGaA / Nemetschek SE / Samsung Electronics Co Ltd / MBB SE / Swiss Re AG / Delignit AG / Grenke AG / Stabilus SA / Orsted A/S / Siemens Healthineers AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / Korea, Republic of / Luxembourg</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Herr. Ingo-Martin Schachel, CFA</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - May 3 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">MOGa / US0116591092 / US0231351067 / US0463531089 / US0758871091 / US1101221083 / US14149Y1082 / US37733W1053 / US4234521015 / US5324571083 / US58155Q1031 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US03073E1055 / US4771431016 / US4198791018 / US80105N1054 / US09062X1037 / US0042251084 / US02043Q1076 / ACOR.OQ / US5380341090 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US7185461040 / US69318G1067 / US00287Y1091 / US55345K1034 / US8485771021 / US21240E1055 / US02376R1023 / US94419L1017 / US0465131078 / CA0089118776 / US00653A1079 / US05464T1043 / US00773U1088 / GB00BDSFG982 / US7493971052 / US02156B1035 / US5904791358 / US0197701065 / US0144421072 / US5024311095 / US70614W1009 / US09203E1055 / US26142R1041 / CH0499880968 / US15872M1045 / US44891N1090 / US69353Y1038 / US62955J1034</td><td class="leftalignment">Moog Inc / Alaska Air Group Inc / Amazon.com Inc / AstraZeneca PLC / Becton Dickinson and Co / Bristol-Myers Squibb Co / Cardinal Health Inc / GlaxoSmithKline PLC / Helmerich and Payne Inc / Eli Lilly and Co / Mckesson Corp / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Amerisourcebergen Corp / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Acorda Therapeutics Inc / Live Nation Entertainment Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Phillips 66 / PBF Energy Inc / Abbvie Inc / MRC Global Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Wayfair Inc / Atara Biotherapeutics Inc / Air Canada / Adaptimmune Therapeutics PLC / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / TechnipFMC PLC / R1 RCM Inc / Alteryx Inc / Mesa Air Group Inc / Allogene Therapeutics Inc / Alector Inc / L3harris Technologies Inc / Peloton Interactive Inc / Black Diamond Therapeutics Inc / DraftKings Inc / ADC Therapeutics SA / ChampionX Corp / IAC/Interactivecorp / PMV Pharmaceuticals Inc / Nov Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / PFE=US / BMY=US / GBT=US / CL=US / AMZN=US / DVN=US / GILD=US / EOG=US / REI=US / CHTR=US / XOM=US / WLL=US / PXD=US / HSII=US / SWN=US / VRM=US / MRO=US / EXPE=US / KFRC=US / MANH=US / NWL=US / W=US / DISH=US / KFY=US / AMN=US / B=US / BMRN=US / COLL=US / EXPO=US / GFF=US / LH=US / TREE=US / MAN=US / HZO=US / MHK=US / ASGN=US / RARE=US / RHI=US / SGMO=US / STRA=US / SNAP=US / THO=US / TRIP=US / VRTX=US / WIX=US / WGO=US / CVX=US / SAGE=US / CCRN=US / BKNG=US / CFR=US / FB=US / ENSG=US / AMSF=US / VICI=US / MGP=US / BDSI=US / MRNS=US / PTON=US / PRG=US / BIIB=US / MOG.A=US / APTX=US / NUVA=US / WMG=US / AAWW=US / NSP=US / CPRX=US / EIG=US / QSR=US / CLR=US / TIL=US / NOG=US / CWH=US / RCUS=US / KNSL=US / OLO=US / ESTE=US / ANGI=US / FANG=US / ABBV=US / GLPI=US / CNCE=US / GOOGL=US / FIVN=US / HTRG=US / BABA=US / CMPR=US / WK=US / RLMD=US / GDDY=US / ETSY=US / VKTX=US / ARGX=US / NVCR=US / WVE=US / AXSM=US / EDIT=US / NTLA=US / ADVM=US / EVBG=US / CRSP=US / PVAC=US / ANAB=US / JELD=US / CVNA=US / VRNA=US / SBOW=US / IOVA=US / SFIX=US / LAZY=US / FTDR=US / SVMK=US / ARVN=US / ALLO=US / LYFT=US / UBER=US / TCRR=US / LHX=US / OVV=US / ONEW=US / CRMD.US / DASH=US / COUR-US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Colgate-Palmolive Co / Amazon.com Inc / Devon Energy Corp / Gilead Sciences Inc / EOG Resources Inc / Ring Energy Inc / Charter Communications Inc / Exxon Mobil Corp / Whiting Petroleum Corp / Pioneer Natural Resources Co / Heidrick & Struggles International Inc / Southwestern Energy Co / Vroom Inc / Marathon Oil Corp / Expedia Group Inc / Kforce Inc / Manhattan Associates Inc / Newell Brands Inc / Wayfair Inc / DISH Network Corp / Korn Ferry / AMN Healthcare Services Inc / Barnes Group Inc / Biomarin Pharmaceutical Inc / Collegium Pharmaceutical Inc / Exponent Inc / Griffon Corp / Laboratory Corporation of America Holdings / Lendingtree Inc / ManpowerGroup Inc / MarineMax Inc / Mohawk Industries Inc / ASGN Inc / Ultragenyx Pharmaceutical Inc / Robert Half International Inc / Sangamo Therapeutics Inc / Strategic Education Inc / Snap Inc / Thor Industries Inc / Tripadvisor Inc / Vertex Pharmaceuticals Inc / Wix.Com Ltd / Winnebago Industries Inc / Chevron Corp / SAGE Therapeutics Inc / Cross Country Healthcare Inc / Booking Holdings Inc / Cullen/Frost Bankers Inc / Meta Platforms Inc / Ensign Group Inc / Amerisafe Inc / VICI Properties Inc / MGM Growth Properties LLC / BioDelivery Sciences International Inc / Marinus Pharmaceuticals Inc / Peloton Interactive Inc / PROG Holdings Inc / Biogen Inc / Moog Inc / Aptinyx Inc / NuVasive Inc / Warner Music Group Corp / Atlas Air Worldwide Holdings Inc / Insperity Inc / Catalyst Pharmaceuticals Inc / Employers Holdings Inc / Restaurant Brands International Inc / Continental Resources Inc / Instil Bio Inc / Northern Oil and Gas Inc / Camping World Holdings Inc / Arcus Biosciences Inc / Kinsale Capital Group Inc / Olo Inc / Earthstone Energy Inc / Angi Inc / Diamondback Energy Inc / Abbvie Inc / Gaming and Leisure Properties Inc / Concert Pharmaceuticals Inc / Alphabet Inc / Five9 Inc / Heritage Insurance Holdings Inc / Alibaba Group Holding Ltd / Cimpress PLC / Workiva Inc / Relmada Therapeutics Inc / GoDaddy Inc / ETSY Inc / Viking Therapeutics Inc / argenx SE / Novocure Ltd / WAVE Life Sciences Ltd / Axsome Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Everbridge Inc / CRISPR Therapeutics AG / Ranger Oil Corp / AnaptysBio Inc / JELD-WEN Holding Inc / Carvana Co / Verona Pharma PLC / SilverBow Resources Inc / Iovance Biotherapeutics Inc / Stitch Fix Inc / Lazydays Holdings Inc / Frontdoor Inc / Momentive Global Inc / Arvinas Inc / Allogene Therapeutics Inc / Lyft Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / L3harris Technologies Inc / Ovintiv Inc / OneWater Marine Inc / CorMedix Inc / DoorDash Inc / Coursera Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AEP.N / AES.N / AKER.OL / ALV.N / CL.N / ED.N / EL.N / ENI.MI / F.N / FLS.N / GM.N / KMB.N / KO.N / MRK.N / MSFT.O / NA / PFE.N / REP.MC / SO.N / STO.AX / T.N / TRV.N / VC.N / PEP.N / AVB.N / TRI.N / BFb.N / PG.N / WY.N / CNQ.TO / CPB.N / TEN.N / CMCSA.O / CHKP.O / AMGN.O / ETN.N / BWA.N / LEA.N / WCC.N / K.N / DT.N / DISH.O / SU.TO / CTXS.O / CLX.N / CAG.N / GIS.N / EMR.N / PCG.N / EPC.N / SBAC.O / AMT.N / JAZZ.O / CONE.O / GWW.N / VZ.N / EXEL.O / JCI.N / STZ.N / APH.N / FISV.O / EQT.N / EPD.N / CPT.N / CHTR.O / AXL.N / AWK.N / CHD.N / AME.N / BC.N / SAM.N / BMRN.O / OPTN.O / REGN.O / ENR.N / MHK.N / SM.N / NCR.N / NET.N / TEL.N / COP.N / ENDP.O / PII.N / ST.N / SWN.N / TT.N / LNG.A / SGEN.OQ / GPN.N / PFS.N / MNST.O / EFX.TO / WSBC.O / CASY.O / PCTY.O / FFIV.O / EQIX.O / ATDb.TO / 02209S103 / NVT.N / DLR.N / SCL.TO / 427866108 / MPW.N / RDSb.L / DRX.L / FIS.N / CCOI.O / MWA.N / HOG.N / MERC.O / BGS.N / PPL.TO / TDC.N / ENSG.O / DAN.N / ARX.TO / FTNT.O / SPB.N / NEE.N / LYB.N / TOU.TO / FRU.TO / PCRX.O / MTOR.N / PXT.TO / XYL.N / PSX.N / HTGC.N / FFHu.TO / MDLZ.OQ / APAM.N / ABBV.N / TSLA.N / PRMW.N / TMUS.N / COTY.N / PTCT.O / AGIO.O / PAYC.N / AGRX.O / SHLX.N / QSR.N / EVA.N / PYPL.OQ / AROC.N / SQ.N / WVE.OQ / MIME.OQ / OMF.N / MESO.O / IONS.O / RACE.MI / ADVM.OQ / TWLO.N / KNSL.OQ / ADNT.N / JELD.N / VST.N / ATUS.N / AQUA.N / APTV.N / GTES.N / WELL.N / BSIG.N / AMRX.N / VNE.N / KDP.N / AQST.O / CWEN.N / NWL.O / NBSE.OQ / PING.N / DDOG.O / CRNC.OQ / EPAC.N / 2222.SE / REYN.O / NKLA.OQ / FOUR.N / AKES.OL / NRIX.OQ / NAPA.N / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Aker ASA / Autoliv Inc / Colgate-Palmolive Co / Consolidated Edison Inc / Estee Lauder Companies Inc / Eni SpA / Ford Motor Co / Flowserve Corp / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / Microsoft Corp / National Bank of Canada / Pfizer Inc / Repsol SA / Southern Co / Santos Ltd / AT&T Inc / Travelers Companies Inc / Visteon Corp / PepsiCo Inc / Avalonbay Communities Inc / Thomson Reuters Corp / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canadian Natural Resources Ltd / Campbell Soup Co / Tenneco Inc / Comcast Corp / Check Point Software Technologies Ltd / Amgen Inc / Eaton Corporation PLC / Borgwarner Inc / Lear Corp / Wesco International Inc / Kellogg Co / Dynatrace Inc / DISH Network Corp / Suncor Energy Inc / Citrix Systems Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / Emerson Electric Co / PG&E Corp / Edgewell Personal Care Co / SBA Communications Corp / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / W W Grainger Inc / Verizon Communications Inc / Exelixis Inc / Johnson Controls International PLC / Constellation Brands Inc / Amphenol Corp / Fiserv Inc / EQT Corp / Enterprise Products Partners LP / Camden Property Trust / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / AMETEK Inc / Brunswick Corp / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Mohawk Industries Inc / SM Energy Co / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Conocophillips / Endo International PLC / Polaris Inc / Sensata Technologies Holding PLC / Southwestern Energy Co / Trane Technologies PLC / Cheniere Energy Inc / Seagen Inc / Global Payments Inc / Provident Financial Services Inc / Monster Beverage Corp / Enerflex Ltd / WesBanco Inc / Caseys General Stores Inc / Paylocity Holding Corp / F5 Inc / Equinix Inc / Alimentation Couche-Tard Inc / Altria Group Inc / nVent Electric PLC / Digital Realty Trust Inc / Shawcor Ltd / Hershey Co / Medical Properties Trust Inc / Royal Dutch Shell PLC / Drax Group PLC / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / Mueller Water Products Inc / Harley-Davidson Inc / Mercer International Inc / B&G Foods Inc / Pembina Pipeline Corp / Teradata Corp / Ensign Group Inc / Dana Inc / ARC Resources Ltd / Fortinet Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / LyondellBasell Industries NV / Tourmaline Oil Corp / Freehold Royalties Ltd / Pacira Biosciences Inc / Meritor Inc / Parex Resources Inc / Xylem Inc / Phillips 66 / Hercules Capital Inc / Fairfax Financial Holdings Ltd / Mondelez International Inc / Artisan Partners Asset Management Inc / Abbvie Inc / Tesla Inc / Primo Water Corp / T-Mobile US Inc / Coty Inc / PTC Therapeutics Inc / Agios Pharmaceuticals Inc / Paycom Software Inc / Agile Therapeutics Inc / Shell Midstream Partners LP / Restaurant Brands International Inc / Enviva Inc / PayPal Holdings Inc / Archrock Inc / Block Inc / WAVE Life Sciences Ltd / Mimecast Ltd / OneMain Holdings Inc / Mesoblast Ltd / Ionis Pharmaceuticals Inc / Ferrari NV / Adverum Biotechnologies Inc / Twilio Inc / Kinsale Capital Group Inc / Adient PLC / JELD-WEN Holding Inc / Vistra Corp / Altice USA Inc / Evoqua Water Technologies Corp / Aptiv PLC / Gates Industrial Corporation PLC / Welltower Inc / Brightsphere Investment Group Inc / Amneal Pharmaceuticals Inc / Veoneer Inc / Keurig Dr Pepper Inc / Aquestive Therapeutics Inc / Clearway Energy Inc / Newell Brands Inc / NeuBase Therapeutics Inc / Ping Identity Holding Corp / Datadog Inc / Cerence Inc / Enerpac Tool Group Corp / Saudi Arabian Oil Co / Reynolds Consumer Products Inc / Nikola Corp / Shift4 Payments Inc / Aker Solutions ASA / Nurix Therapeutics Inc / Duckhorn Portfolio Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / China / Spain / United Kingdom / Ireland / Israel / Italy / Netherlands / Norway / Saudi Arabia / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">2021 Guggenheim ASCO Preview and Planner – Key Updates Across Our Global Pharma / Biotech Coverage</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2684703 / 7103065 / BD9GVY0</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Pfizer Inc / Novartis AG / Zai Lab Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Major Pharmaceuticals : Thoughts As We Wrap Up A Difficult 1Q Earnings Season</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / ABBV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">05/02/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Trefis Report: Merck - $101 Trefis Price Estimate</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Trimming estimates post-1Q results; Maintain Buy</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser</td></tr>
<tr class="odd"><td class="leftalignment">05/02/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / PCRX.O / AGRX.O / AMRX.N / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Pacira Biosciences Inc / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">05/02/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Activity Remains Positive - Week 57</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/01/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck & Co Inc: Peer Group Analytics - Q1 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">05/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Merck (MRK:EUR146.15) rises for a second consecutive month, a two-month rise of 10%</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Trefis Report: Merck - $101 Trefis Price Estimate</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Merck (MRK:$74.50) drops 3%, trailing 95% of stocks</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Q1 due 12 May - Solid start expected</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">DE0006599905 / KR7005930003</td><td class="leftalignment">Merck KGaA / Samsung Electronics Co Ltd</td><td class="leftalignment"></td><td class="leftalignment">Germany / Korea, Republic of</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr Daniel Wendorff</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Portfolio Manager's Weekly - April 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US2546871060 / US87157D1090 / US25470F1049 / US58933Y1055 / US25470F3029 / US00164V1035 / US7512121010 / LGFb / LGFa / US35137L1052 / US92556H2067 / US35909R1086</td><td class="leftalignment">Walt Disney Co / Synaptics Inc / Discovery Inc / Merck & Co Inc / Discovery Inc / AMC Networks Inc / Ralph Lauren Corp / Lions Gate Entertainment Corp / Lions Gate Entertainment Corp / Fox Corp / ViacomCBS Inc / Frontier Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Merck KGaA (MRK GY) - Change of guard at Q1</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending Apr 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended April 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Chemical Snippets : Solvay (TOP IDEA) - positive read on soda ash demand; Croda: competition in lipids ramping up faster and more...</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CRDA.L / DSMN.AS / SOLB.BR / MRCG.DE / 600309.SS / BASFn.DE / EVKn.F / 1COV.DE</td><td class="leftalignment">Croda International PLC / Koninklijke DSM NV / Solvay SA / Merck KGaA / Wanhua Chemical Group Co Ltd / BASF SE / Evonik Industries AG / Covestro AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / China / Germany / United Kingdom / Netherlands</td><td class="leftalignment">Chemicals / Healthcare / Industrial Materials / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Chetan Udeshi, CFA / Jayanth Challapalli / Daniel Lieto</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">2021 Virtual ASCO Planner</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">45337C10 / 75991610 / 71708110 / 45253H10 / 04635310 / 37555810 / 03116210 / 75886F10 / M2572210 / 45232710 / 30063P10 / 478160104 / 640268108 / 30161Q104 / 64049M20 / 58933Y10 / G0176710 / 53220K50 / 92337F10 / 46185L10 / 00653A107 / 74587V10 / 00287Y10 / 98401F10 / 18946410 / 40131M10 / 58490H10 / 63230710 / 05358830 / 76029N10 / 41358P10 / 09627Y10 / 09075V10 / 09609G10 / 55609910 / N0104510 / 31189P10 / 07725L10 / G3910J11 / 24344T10 / 29428V10 / 81181C10 / 04685N10 / 13089P10 / 22101510 / 34633R10 / K3967W10 / 37242740 / 38341P10 / 43906K10 / 45781K20 / 46565G10 / 48576U10 / 50127T10 / 61776010 / 60468T10 / 03969F10 / 05370A10 / 78116T10 / 76155X10 / F5548N10 / 89620X50 / 98887Q10 / 98943L10 / 98985W10</td><td class="leftalignment">Incyte Corp / Repligen Corp / Pfizer Inc / ImmunoGen Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Compugen Ltd / Illumina Inc / Exact Sciences Corp / Johnson & Johnson / Nektar Therapeutics / Exelixis Inc / Neogenomics Inc / Merck & Co Inc / Alkermes Plc / Ligand Pharmaceuticals Inc / Veracyte Inc / Invitae Corp / Adaptimmune Therapeutics PLC / Puma Biotechnology Inc / Abbvie Inc / Xencor Inc / Clovis Oncology Inc / Guardant Health Inc / Medicenna Therapeutics Corp / Natera Inc / Aveo Pharmaceuticals Inc / Replimune Group Inc / Harpoon Therapeutics Inc / Blueprint Medicines Corp / BioNTech SE / bluebird bio Inc / MacroGenics Inc / Affimed NV / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Deciphera Pharmaceuticals Inc / Epizyme Inc / Seagen Inc / Athenex Inc / Calithera Biosciences Inc / Corvus Pharmaceuticals Inc / Forma Therapeutics Holdings Inc / Genmab A/S / Genocea Biosciences Inc / Gossamer Bio Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Iteos Therapeutics Inc / Karyopharm Therapeutics Inc / Kura Oncology Inc / MorphoSys AG / Mirati Therapeutics Inc / Arcus Biosciences Inc / Avidity Biosciences Inc / Rubius Therapeutics Inc / Revolution Medicines Inc / Sanofi SA / Pfizer Inc / Zai Lab Ltd / Zentalis Pharmaceuticals Inc / Zymeworks Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Jonathan Chang, Ph.D., CFA / Daina Graybosch, Ph.D. / Andrew Berens, M.D. / Geoffrey Porges, MBBS / Mani Foroohar, M.D. / Mr. Puneet Souda</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MRK=US / BMY=US / MCD=US / TWTR=US / ICLR=US / AMZN=US / GILD=US / AMT=US / PEB=US / BC=US / CONE=US / V=US / IGT=US / SWN=US / TRMK=US / TNL=US / MDRX=US / AKR=US / AFL=US / HUM=US / CMCSA=US / RCL=US / AMED=US / BMRN=US / CHD=US / CNX=US / DRI=US / DVA=US / EEFT=US / EXPO=US / FCN=US / AJG=US / TREE=US / MHK=US / TEAM=US / NTST=US / OKE=US / SMG=US / VSEC=US / VRTX=US / WEX=US / OPT=US / SGMS=US / ADC=US / AVTR=US / CPT=US / OFC=US / CUZ=US / KIM=US / MKL=US / SSB=US / ENSG=US / AMSF=US / MMP=US / MOH=US / TPX=US / TXRH=US / DLR=US / MPW=US / KBR=US / CCOI=US / MA=US / GPRE=US / WU=US / PAG=US / EHTH=US / CLR=US / LLNW=US / WH=US / AGS=US / SWI=US / KNSL=US / AR=US / HGV=US / CUBE=US / FBHS=US / MTDR=US / SPLK=US / LKQ=US / ABBV=US / NDLS=US / FIVN=US / 00770K202 / CMPR=US / ZG=US / EVRI=US / WLTW=US / ADVM=US / VVV=US / VRNA=US / RDFN=US / MBIN=US / SYNH=US / KDP=US / SITC=US / OVV=US / ONEW=US / AIRC=US / HYFM=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / McDonald's Corp / Twitter Inc / ICON PLC / Amazon.com Inc / Gilead Sciences Inc / American Tower Corp / Pebblebrook Hotel Trust / Brunswick Corp / CyrusOne Inc / Visa Inc / International Game Technology PLC / Southwestern Energy Co / Trustmark Corp / Travel + Leisure Co / Allscripts Healthcare Solutions Inc / Acadia Realty Trust / Aflac Inc / Humana Inc / Comcast Corp / Royal Caribbean Cruises Ltd / Amedisys Inc / Biomarin Pharmaceutical Inc / Church & Dwight Co Inc / CNX Resources Corp / Darden Restaurants Inc / DaVita Inc / Euronet Worldwide Inc / Exponent Inc / FTI Consulting Inc / Arthur J Gallagher & Co / Lendingtree Inc / Mohawk Industries Inc / Atlassian Corporation PLC / Netstreit Corp / ONEOK Inc / Scotts Miracle-Gro Co / VSE Corp / Vertex Pharmaceuticals Inc / WEX Inc / Opthea Ltd / Scientific Games Corp / Agree Realty Corp / Avantor Inc / Camden Property Trust / Corporate Office Properties Trust / Cousins Properties Inc / Kimco Realty Corp / Markel Corp / SouthState Corp / Ensign Group Inc / Amerisafe Inc / Magellan Midstream Partners LP / Molina Healthcare Inc / Tempur Sealy International Inc / Texas Roadhouse Inc / Digital Realty Trust Inc / Medical Properties Trust Inc / KBR Inc / Cogent Communications Holdings Inc / Mastercard Inc / Green Plains Inc / Western Union Co / Penske Automotive Group Inc / eHealth Inc / Continental Resources Inc / Limelight Networks Inc / Wyndham Hotels & Resorts Inc / PlayAGS Inc / SolarWinds Corp / Kinsale Capital Group Inc / Antero Resources Corp / Hilton Grand Vacations Inc / CubeSmart / Fortune Brands Home & Security Inc / Matador Resources Co / Splunk Inc / LKQ Corp / Abbvie Inc / Noodles & Co / Five9 Inc / Aemetis Inc / Cimpress PLC / Zillow Group Inc / Everi Holdings Inc / Willis Towers Watson PLC / Adverum Biotechnologies Inc / Valvoline Inc / Verona Pharma PLC / Redfin Corp / Merchants Bancorp / Syneos Health Inc / Keurig Dr Pepper Inc / Site Centers Corp / Ovintiv Inc / OneWater Marine Inc / Apartment Income REIT Corp / Hydrofarm Holdings Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / United Kingdom / Ireland / Liberia / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">V / 2126335 / 2000019 / 2486813 / 2778844 / 2003698 / 2026242 / 2437071 / 2219224 / 2229126 / 2317087 / 2345022 / 2369174 / 2459020 / 2689560 / 2440637 / 2138158 / 2829601 / 2931034 / 2971029 / B00FWN1 / B121557 / B067BM3 / 2769796 / 2216991 / 2857817 / B125XQ6 / B3D7K31 / B1HJLW5 / B5B2106 / B0796X4 / B65LWX6 / B4N0JJ6 / B7TL820 / BCBVTX1 / BFDV8K0 / B95N910 / BFLR866 / B76LYJ2 / BYRY499 / BVVN4Q8 / BF4VBS8 / BD3W133 / BXDZ9Z0 / BYNZGK1 / BJLKVS6 / BFZ1K46 / BMYML02 / BP3YM85 / BWY52P3 / BMH0MR7 / BM8MM05 / BYXR425 / BLBLMD5 / 021513106</td><td class="leftalignment">Visa Inc / Bristol-Myers Squibb Co / Amazon.com Inc / Kellogg Co / Merck & Co Inc / ABIOMED Inc / American Electric Power Company Inc / Biomarin Pharmaceutical Inc / CMS Energy Corp / Columbia Sportswear Co / Entergy Corp / Macy's Inc / Gilead Sciences Inc / Intuit Inc / PG&E Corp / CenterPoint Energy Inc / Sempra Energy / Southern Co / Vertex Pharmaceuticals Inc / LKQ Corp / Alnylam Pharmaceuticals Inc / Mastercard Inc / Molson Coors Beverage Co / Fidelity National Information Services Inc / Tempur Sealy International Inc / Netflix Inc / Portland General Electric Co / Discovery Inc / Emergent BioSolutions Inc / Fortinet Inc / Dexcom Inc / O'Reilly Automotive Inc / Visteon Corp / Meta Platforms Inc / Agios Pharmaceuticals Inc / MacroGenics Inc / PTC Inc / Twitter Inc / Vocera Communications Inc / Kraft Heinz Co / Eversource Energy / BioXcel Therapeutics Inc / Keurig Dr Pepper Inc / Shopify Inc / Block Inc / Phathom Pharmaceuticals Inc / Spotify Technology SA / DraftKings Inc / Trupanion Inc / Blueprint Medicines Corp / Zendesk Inc / Madison Square Garden Entertainment Corp / RH / Array Technologies Inc / Alto Ingredients Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Checkpoint Wave Meets FDA in Three-Day ODAC</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">58933Y10</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Jeffrey La Rosa / Dilip Joseph</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">1Q21: Pandemic Makes for a Choppy Quarter, but Stage Set for Growth</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">58933Y10</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - April 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">AFL.N / BCE.TO / BP.L / DGE.L / EL.N / ENI.MI / IP.N / MRK.N / NA / REP.MC / SRCL.O / TOTF.PA / ULVR.L / VC.N / GILD.O / SJRb.TO / RCIb.TO / FER.MC / CLS.N / CTXS.O / MCD.N / AEM.N / XOM.N / OLN.N / MDRX.O / CINF.O / FISV.O / V.N / ARE.N / CHD.N / SLGN.O / WSP.TO / BC.N / KRC.N / MAA.N / VTR.N / AJG.N / BMRN.O / VRTX.O / CVX.N / FTT.TO / CFR.N / MEOH.O / WCN.N / MKL.N / ADS.N / SGEN.OQ / GPN.N / SIGI.O / ORLY.O / COLB.O / AMED.O / STN.TO / TIH.TO / SNC.TO / 02209S103 / NVT.N / DPZ.N / TXRH.O / NESTE.HE / 427866108 / RDSb.L / ALNY.O / FIS.N / ISBC.O / MA.N / MERC.O / GALP.LS / 550372106 / ATL.MI / CLR.N / ENSG.O / PBF.N / SWI.N / AAV.TO / EGO.N / FTNT.O / SMSS.L / FBHS.N / ACHC.O / VCRA.N / RFP.N / FFHu.TO / MDLZ.OQ / TMHC.N / AGIO.O / GWB.N / EVA.N / PYPL.OQ / SQ.N / FTV.N / ATKR.N / KNSL.OQ / SAND.N / INVH.N / ORSTED.CO / NEXA.TO / GSHD.O / KDP.N / BHC.N / MORF.OQ / PEAK.N / 2222.SE / DHC.O / OVV.N / CARR.N / FOUR.N / NRIX.OQ</td><td class="leftalignment">Aflac Inc / BCE Inc / BP PLC / Diageo PLC / Estee Lauder Companies Inc / Eni SpA / International Paper Co / Merck & Co Inc / National Bank of Canada / Repsol SA / Stericycle Inc / TotalEnergies SE / Unilever PLC / Visteon Corp / Gilead Sciences Inc / Shaw Communications Inc / Rogers Communications Inc / Ferrovial SA / Celestica Inc / Citrix Systems Inc / McDonald's Corp / Agnico Eagle Mines Ltd / Exxon Mobil Corp / Olin Corp / Allscripts Healthcare Solutions Inc / Cincinnati Financial Corp / Fiserv Inc / Visa Inc / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Silgan Holdings Inc / WSP Global Inc / Brunswick Corp / Kilroy Realty Corp / Mid-America Apartment Communities Inc / Ventas Inc / Arthur J Gallagher & Co / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Chevron Corp / Finning International Inc / Cullen/Frost Bankers Inc / Methanex Corp / Waste Connections Inc / Markel Corp / Alliance Data Systems Corp / Seagen Inc / Global Payments Inc / Selective Insurance Group Inc / O'Reilly Automotive Inc / Columbia Banking System Inc / Amedisys Inc / Stantec Inc / Toromont Industries Ltd / SNC-Lavalin Group Inc / Altria Group Inc / nVent Electric PLC / Domino's Pizza Inc / Texas Roadhouse Inc / Neste Oyj / Hershey Co / Royal Dutch Shell PLC / Alnylam Pharmaceuticals Inc / Fidelity National Information Services Inc / Investors Bancorp Inc / Mastercard Inc / Mercer International Inc / Galp Energia SGPS SA / Lundin Mining Corp / Atlantia SpA / Continental Resources Inc / Ensign Group Inc / PBF Energy Inc / SolarWinds Corp / Advantage Energy Ltd / Eldorado Gold Corp / Fortinet Inc / Smart Metering Systems PLC / Fortune Brands Home & Security Inc / Acadia Healthcare Company Inc / Vocera Communications Inc / Resolute Forest Products Inc / Fairfax Financial Holdings Ltd / Mondelez International Inc / Taylor Morrison Home Corp / Agios Pharmaceuticals Inc / Great Western Bancorp Inc / Enviva Inc / PayPal Holdings Inc / Block Inc / Fortive Corp / Atkore Inc / Kinsale Capital Group Inc / Sandstorm Gold Ltd / Invitation Homes Inc / Orsted A/S / Nexa Resources SA / Goosehead Insurance Inc / Keurig Dr Pepper Inc / Bausch Health Companies Inc / Morphic Holding Inc / Healthpeak Properties Inc / Saudi Arabian Oil Co / Diversified Healthcare Trust / Ovintiv Inc / Carrier Global Corp / Shift4 Payments Inc / Nurix Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / Spain / Finland / France / United Kingdom / Ireland / Italy / Luxembourg / Portugal / Saudi Arabia / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GSK-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GSK / MRK / NVS / PFE / AZN.O / DVAX.O / TEVA.K / SNY.O</td><td class="leftalignment">GlaxoSmithKline PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / AstraZeneca PLC / Dynavax Technologies Corp / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LLY-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY / BMY / JNJ / MRK / NVS / PFE / AMGN.O / GSK / AZN.O / ABBV.K / SNY.O</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVS-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NVS / ABT / BMY / JNJ / MRK / PFE / GSK / AZN.O / BAYRY.PK / TEVA.K / SNY.O</td><td class="leftalignment">Novartis AG / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Bayer AG / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">MRK - MRK: 1Q21 Full Postview: Stuck (what will change the narrative?)</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">58933Y105</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Healthcare : 1Q21 Earnings Highlights — What Mattered for Credit (BAX, BMY, GILD, LH, MRK, TMO)</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK.N / BAX.N / BMY.N / GILD.OQ / LH.N / TMO.N / GILD.O</td><td class="leftalignment">Merck & Co Inc / Baxter International Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Laboratory Corporation of America Holdings / Thermo Fisher Scientific Inc / Gilead Sciences Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: April 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AES.N / BDX.N / CI.N / CL.N / CVS.N / ED.N / EL.N / GM.N / MRK.N / PFE.N / TMO.N / WMB.N / MET.N / MCD.N / EMR.N / WEC.N / XOM.N / LIN.N / AWK.N / VTR.N / CVX.N / COP.N / ATVI.OQ / REGN.OQ / O.N / AMZN.OQ / CHTR.OQ / CMCSA.OQ / FIS.N / ABBV.N / ZTS.N / PYPL.OQ / TMUS.OQ / BKNG.OQ</td><td class="leftalignment">AES Corp / Becton Dickinson and Co / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Consolidated Edison Inc / Estee Lauder Companies Inc / General Motors Co / Merck & Co Inc / Pfizer Inc / Thermo Fisher Scientific Inc / Williams Companies Inc / MetLife Inc / McDonald's Corp / Emerson Electric Co / WEC Energy Group Inc / Exxon Mobil Corp / Linde PLC / American Water Works Company Inc / Ventas Inc / Chevron Corp / Conocophillips / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Realty Income Corp / Amazon.com Inc / Charter Communications Inc / Comcast Corp / Fidelity National Information Services Inc / Abbvie Inc / Zoetis Inc / PayPal Holdings Inc / T-Mobile US Inc / Booking Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pandemic overhang continues to weigh on shares; focus will now pivot to near-term Organon spinoff</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck & Co., Inc. : 1Q Takeaways: Expecting A Strong 2H Recovery As COVID-19 Headwinds Subside</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">SGEN (BUY) - Small 1Q Revenue Miss, But Early Stage Pipeline Starts to Emerge as Key Growth Driver With SEA-CD40 Data Guided for 2H21</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">0989529 / 2126335 / 2778844 / 2684703</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : 1Q Earnings Season: Read-Through from MRK's Results</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK.N / GILD.O / AMGN.O / REGN.O / SGEN.O / CLVS.O</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / Clovis Oncology Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Cory W. Kasimov / Mr. Turner Kufe / James Scott / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">1Q pressured by COVID headwinds; 2021 outlook intact; Maintain Buy</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">early pipeline visibility to improve in coming months</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">MRK - MRK 1Q21 - They said what?!  Highlights from conf call…and our impressions</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">58933Y105</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck & Co., Inc. : 1Q First Impressions: COVID Headwinds Greater Than Anticipated But Expecting Healthy Recovery From Here</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Products And Pipeline Are The Keys To Unlocking Value For Shares, Still Like Stock Despite 1Q21 Miss</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q1 Sales And EPS Below Estimates; 2021 Guidance Reiterated</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on Apr 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMZN.OQ / BAX.N / BMY.N / CMS.N / EMN.N / IP.N / METR.KL / MO.N / MRK.N / NEM.N / NOC.N / SO.N / TAP.N / TMO.N / TXT.N / TFX.N / PH.N / WAB.N / CAT.N / MCD.N / LH.N / HSY.N / AMT.N / WST.N / DVA.N / COG.N / CHD.N / TWTR.N / AJG.N / MHK.N / AOS.N / ABMD.OQ / KLAC.OQ / TROW.OQ / GILD.OQ / DISH.OQ / CTXS.OQ / PTEN.OQ / VRTX.OQ / SWKS.OQ / CMCSA.OQ / DPZ.N / DXCM.OQ / RDSa.L / ICE.N / MA.N / BIO.N / FTNT.OQ / GNRC.N / FBHS.N / LKQ.OQ / WDC.OQ / KHC.OQ / WLTW.OQ / SPGI.N / FTV.N / XEL.OQ / CBRE.N / CARR.N / MCDG.MU</td><td class="leftalignment">Amazon.com Inc / Baxter International Inc / Bristol-Myers Squibb Co / CMS Energy Corp / Eastman Chemical Co / International Paper Co / MKH Bhd / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Northrop Grumman Corp / Southern Co / Molson Coors Beverage Co / Thermo Fisher Scientific Inc / Textron Inc / Teleflex Inc / Parker-Hannifin Corp / Westinghouse Air Brake Technologies Corp / Caterpillar Inc / McDonald's Corp / Laboratory Corporation of America Holdings / Hershey Co / American Tower Corp / West Pharmaceutical Services Inc / DaVita Inc / Coterra Energy Inc / Church & Dwight Co Inc / Twitter Inc / Arthur J Gallagher & Co / Mohawk Industries Inc / A O Smith Corp / ABIOMED Inc / KLA Corp / T Rowe Price Group Inc / Gilead Sciences Inc / DISH Network Corp / Citrix Systems Inc / Patterson-UTI Energy Inc / Vertex Pharmaceuticals Inc / Skyworks Solutions Inc / Comcast Corp / Domino's Pizza Inc / Dexcom Inc / Royal Dutch Shell PLC / Intercontinental Exchange Inc / Mastercard Inc / Bio Rad Laboratories Inc / Fortinet Inc / Generac Holdings Inc / Fortune Brands Home & Security Inc / LKQ Corp / Western Digital Corp / Kraft Heinz Co / Willis Towers Watson PLC / S&P Global Inc / Fortive Corp / Xcel Energy Inc / CBRE Group Inc / Carrier Global Corp / Mallinckrodt PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Ireland / Malaysia / United States</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MRK misses 1Q on the top and bottom line but reaffirms full-year revenue and EPS guidance; Organon spinoff now expected on June 2</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daniel Busby</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">MRK: 2021 Guidance Maintained Despite Rough 1Q; May 3 Organon Investor Day Up Next, One Month Ahead of Spin</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2778844</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q1 EPS, Revenue Miss; 2021 Guidance Reiterated</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRK.N - Event Brief of Merck & Co Inc conference call, Apr. 29, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRK.N - Event Transcript of Merck & Co Inc conference call, Apr. 29, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Despite 1Q21 Miss, We Should Focus On What Lies Beneath</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 29 2021</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">DE0006969603 / US0378331005 / US0382221051 / US0463531089 / US0530151036 / US0970231058 / US1011371077 / US1101221083 / US2254471012 / US2786421030 / US30226D1063 / US3695501086 / US4364401012 / US4824801009 / US5128071082 / US5951121038 / US66987V1098 / US7170811035 / US7475251036 / US7711951043 / US7766961061 / US8168501018 / US8269191024 / US9021041085 / US91347P1057 / US9507551086 / US9581021055 / CA1363751027 / US89151E1091 / CA13645T1003 / US9884981013 / US83088M1027 / US88031M1099 / US3463751087 / US90385V1070 / FI0009013296 / US19239V3024 / RDSa.AS / US9043111072 / US82706C1080 / US78709Y1055 / US1717793095 / US48242W1062 / NL0000687663 / US64110D1046 / US2120151012 / US58933Y1055 / US13100M5094 / IE00B58JVZ52 / US30303M1027 / US75972A3014 / NL0010273215 / US81762P1021 / US5764852050 / US23283R1005 / US03674X1063 / CA89620X5064 / US74736K1016 / US29444U7000 / US87918A1051 / US74624M1027 / US00773U1088 / US90138F1021 / US64104Y1064 / KYG4740B1059 / US02156K1034 / US03753U1060 / US05351X1019 / US05352A1007 / US88339P1012 / US69047Q1022 / US92537N1081 / US15872M1045 / US03044L1052 / US5738741041</td><td class="leftalignment">Puma SE / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Automatic Data Processing Inc / Boeing Co / Boston Scientific Corp / Bristol-Myers Squibb Co / Wolfspeed Inc / eBay Inc / Extreme Networks Inc / General Dynamics Corp / Hologic Inc / KLA Corp / Lam Research Corp / Micron Technology Inc / Novartis AG / Pfizer Inc / Qualcomm Inc / Roche Holding AG / Roper Technologies Inc / Semtech Corp / Silicon Laboratories Inc / II-VI Inc / Universal Display Corp / Werner Enterprises Inc / Western Digital Corp / Canadian National Railway Co / TotalEnergies SE / Canadian Pacific Railway Ltd / Yum! Brands Inc / Skyworks Solutions Inc / Tenaris SA / FormFactor Inc / Ultra Clean Holdings Inc / Neste Oyj / Cogent Communications Holdings Inc / Royal Dutch Shell PLC / Under Armour Inc / Silicon Motion Technology Corp / Saia Inc / Ciena Corp / KBR Inc / AerCap Holdings NV / NetApp Inc / Continental Resources Inc / Merck & Co Inc / Calix Inc / Seagate Technology Holdings PLC / Meta Platforms Inc / Renewable Energy Group Inc / ASML Holding NV / ServiceNow Inc / Matador Resources Co / CyrusOne Inc / Antero Resources Corp / Pfizer Inc / Qorvo Inc / Equinix Inc / Teladoc Health Inc / Pure Storage Inc / Adverum Biotechnologies Inc / Twilio Inc / Neste Oyj / Ichor Holdings Ltd / Altice USA Inc / Apellis Pharmaceuticals Inc / Avaya Holdings Corp / Avantor Inc / RealReal Inc / Ovintiv Inc / Vertiv Holdings Co / ChampionX Corp / American Well Corp / Marvell Technology Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Finland / France / United Kingdom / Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">ASCO 2021: Key Abstract Titles And What To Watch For</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US0463531089 / US1101221083 / US66987V1098 / US7170811035 / US7711951043 / US58933Y1055</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Novartis AG / Pfizer Inc / Roche Holding AG / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Ms. Kathleen M. Miner, R.Ph., CFA</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: April 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BA.N / BDX.N / CL.N / CVS.N / EL.N / GM.N / MRK.N / PFE.N / TMO.N / WMB.N / MET.N / MCD.N / YUM.N / EMR.N / WEC.N / XOM.N / LIN.N / AWK.N / CVX.N / COP.N / AAPL.OQ / ATVI.OQ / MSFT.OQ / REGN.OQ / QCOM.OQ / AMZN.OQ / CHTR.OQ / CMCSA.OQ / FIS.N / ABBV.N / ZTS.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / BKNG.OQ / FB.PS</td><td class="leftalignment">Boeing Co / Becton Dickinson and Co / Colgate-Palmolive Co / CVS Health Corp / Estee Lauder Companies Inc / General Motors Co / Merck & Co Inc / Pfizer Inc / Thermo Fisher Scientific Inc / Williams Companies Inc / MetLife Inc / McDonald's Corp / Yum! Brands Inc / Emerson Electric Co / WEC Energy Group Inc / Exxon Mobil Corp / Linde PLC / American Water Works Company Inc / Chevron Corp / Conocophillips / Apple Inc / Activision Blizzard Inc / Microsoft Corp / Regeneron Pharmaceuticals Inc / Qualcomm Inc / Amazon.com Inc / Charter Communications Inc / Comcast Corp / Fidelity National Information Services Inc / Abbvie Inc / Zoetis Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Booking Holdings Inc / San Miguel Food and Beverage Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - 1Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">GSK.L / AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / MRCG.DE / GILD.OQ / BAYGN.DE</td><td class="leftalignment">GlaxoSmithKline PLC / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Merck KGaA / Gilead Sciences Inc / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SASY.PA: Sanofi - 1Q21 Results Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">SASY.PA / AZN.L / ROG.S / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / REGN.OQ / MRNA.OQ / BAYGN.DE</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Moderna Inc / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for MRK</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Earnings Beat In Cards For Merck's Q1?</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Trefis Report: Merck - $101 Trefis Price Estimate</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">MRK - MRK 1Q21 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">58933Y105</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Getting Pumped About Cardiovascular Drugs</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">MRK.N / PFE.N / JNJ.N / LLY.N / AMRN.OQ / MSB.AX</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Johnson & Johnson / Eli Lilly and Co / Amarin Corporation PLC / Mesoblast Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Core Business Suffers Painful Price Erosion – Will Lumakras Be Enough? MP, $230</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">03116210 / 58933Y10</td><td class="leftalignment">Amgen Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: April 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BA.N / CL.N / CVS.N / EL.N / GM.N / LLY.N / MRK.N / PFE.N / TMO.N / WMB.N / MET.N / MCD.N / EMR.N / WEC.N / XOM.N / V.N / CVX.N / COP.N / AAPL.OQ / ATVI.OQ / MSFT.OQ / QCOM.OQ / AMZN.OQ / CHTR.OQ / TXN.OQ / CMCSA.OQ / NOW.N / ABBV.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / BKNG.OQ / FB.PS</td><td class="leftalignment">Boeing Co / Colgate-Palmolive Co / CVS Health Corp / Estee Lauder Companies Inc / General Motors Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Thermo Fisher Scientific Inc / Williams Companies Inc / MetLife Inc / McDonald's Corp / Emerson Electric Co / WEC Energy Group Inc / Exxon Mobil Corp / Visa Inc / Chevron Corp / Conocophillips / Apple Inc / Activision Blizzard Inc / Microsoft Corp / Qualcomm Inc / Amazon.com Inc / Charter Communications Inc / Texas Instruments Inc / Comcast Corp / ServiceNow Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Booking Holdings Inc / San Miguel Food and Beverage Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">006280.KS: Green Cross Corp - Quick Take: 1Q21 review -Uneventful results; ongoing restructuring efforts, while maintain our working thesis on vaccine CMO initiative</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">006280.KS / MRK.N / MRNA.OQ</td><td class="leftalignment">Green Cross Corp / Merck & Co Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Korea, Republic of / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ORNBV.HE: Orion - 1Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">ORNBV.HE / RECI.MI / LUN.CO / MRCG.DE / LONN.S / UCB.BR / IPN.PA / ALM.MC / GRLS.MC / VIFN.S / GMAB.CO</td><td class="leftalignment">Orion Oyj / Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Ipsen SA / Almirall SA / Grifols SA / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">Valens Equity Insights and Inflections - 2021 04 27</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">LGIH.OQ / XOM.N / MRK.N / PFE.N / CLX.N / HIW.N / DK.N / ENR.N / CSCO.OQ / QCOM.OQ / SHOO.OQ / LYV.N / SIX.N / VAC.N / LDOS.N / PUMP.N / PEP.OQ / GO.OQ / PTON.OQ / MSGS.N / ABNB.OQ</td><td class="leftalignment">LGI Homes Inc / Exxon Mobil Corp / Merck & Co Inc / Pfizer Inc / Clorox Co / Highwoods Properties Inc / Delek US Holdings Inc / Energizer Holdings Inc / Cisco Systems Inc / Qualcomm Inc / Steven Madden Ltd / Live Nation Entertainment Inc / Six Flags Entertainment Corp / Marriott Vacations Worldwide Corp / Leidos Holdings Inc / ProPetro Holding Corp / PepsiCo Inc / Grocery Outlet Holding Corp / Peloton Interactive Inc / Madison Square Garden Sports Corp / Airbnb Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Apparel & Textiles / Beverages & Tobacco / Building & Building Materials / Household Products / Leisure & Entertainment / Lodging & Restaurants / Media / Pharmaceuticals / Real Estate / Semiconductors / Technology / Telecommunications / Oil & Gas</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Valens Research</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck KGaA : 1Q'21 Results Preview: Strong quarter driven by Life Science, FY'21 guidance implies limited change to BBG Consensus</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Richard B. Vosser / James D. Gordon / Sarita Kapila / Ms. Laerke Engkilde / Mr. Tycho W. Peterson</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Markings on the Wall - Growing Conviction on Potential Differentiation of LUM-201 in Pediatric Growth Deficiency</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LUMO.O / MRK</td><td class="leftalignment">Lumos Pharma Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Charles C. Duncan, Ph.D. / Mr. Pete Stavropoulos</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS.O / ACRX.O / AMRN / EBS / JNJ / LLY / MRK / PFE / ALKS.O / JAZZ.O / CERS.O / OPTN.O / NCOX.PA / COLL.O / RMTI.O / BDSI.O / BSLN.S / MNKD.O / ZTS / OMER.O / SPRO.O / ANIP.O / AXGN.O / AERI.O / HRTX.O / TRVN.O / EGRX.O / SCYX.O / ARDX.O / ALDX.O / CFRX.O / CDTX.O / SPNE.O / FBIO.O / MESO.O / HCM.O / VRAY.O / VERU.O / TXMD.O / AYTU.O / CKPT.O / EYPT.O / UBX.O / EOLS / ARDS.O / ARAV.O / SIBN.O / ETTX.O / ARQT.O / PCVX.O / SRGA.O / VYNE.O / HGEN.O / AZYO.O / GRAY.O / IMAB.O / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / Amarin Corporation PLC / Emergent BioSolutions Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Cerus Corp / OptiNose Inc / Nicox SA / Collegium Pharmaceutical Inc / Rockwell Medical Inc / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Zoetis Inc / Omeros Corp / Spero Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / Ardelyx Inc / Aldeyra Therapeutics Inc / ContraFect Corp / Cidara Therapeutics Inc / SeaSpine Holdings Corp / Fortress Biotech Inc / Mesoblast Ltd / HUTCHMED (China) Ltd / ViewRay Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Checkpoint Therapeutics Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Evolus Inc / Aridis Pharmaceuticals Inc / Aravive Inc / SI-BONE Inc / Entasis Therapeutics Holdings Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Humanigen Inc / Aziyo Biologics Inc / Graybug Vision Inc / I-Mab / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRK=US / LLY=US / PEP=US / PFE=US / AMGN=US / BMY=US / DIS=US / HD=US / KO=US / MCD=US / OXY=US / TWTR=US / RRC=US / CL=US / WEN=US / PLD=US / AMZN=US / BLD=US / DVN=US / INCY=US / KMI=US / APA=US / CPE=US / EOG=US / DGX=US / REI=US / XOM=US / CRK=US / LOW=US / WLL=US / CHKP=US / PXD=US / ENR=US / HSII=US / MGY=US / SWN=US / MUR=US / BRO=US / BYD=US / MRO=US / LEG=US / HCA=US / VMC=US / MGM=US / PENN=US / NWL=US / MLM=US / FLO=US / KFY=US / ARCC=US / CBRL=US / CENT=US / CHD=US / CNX=US / DRI=US / EPC=US / EQT=US / GFF=US / HAIN=US / IBP=US / SAFE=US / TREE=US / MAIN=US / MAS=US / MEDP=US / MHK=US / MCRI=US / ORCC=US / PACW=US / REGN=US / REGI=US / SBAC=US / SMG=US / SSNC=US / SNAP=US / VRTX=US / CVX=US / POST=US / BXS=US / BKNG=US / FBK=US / FR=US / FFIN=US / COP=US / VICI=US / DIN=US / MGP=US / MGPI=US / MNST=US / RRR=US / NOMD=US / TPX=US / FNB=US / EXP=US / CZR=US / NUVA=US / AINV=US / BECN=US / PLAY=US / FRPT=US / DENN=US / THS=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / ELF=US / AWI=US / OC=US / CADE=US / TAST=US / QSR=US / CLR=US / PNNT=US / PRPL=US / NOG=US / JACK=US / AAN=US / TREX=US / AR=US / NXPI=US / ESTE=US / FBHS=US / BCEI=US / MTDR=US / PDCE=US / FANG=US / ABBV=US / TILE=US / NDLS=US / GLPI=US / TSLX=US / 00770K202 / VNOM=US / 70806A106 / LOCO=US / ANTM=US / SHAK=US / AJRD=US / GSBD=US / WING=US / ARGX=US / 82982L103 / CDEV=US / PVAC=US / JELD=US / SBOW=US / PETQ=US / ROKU=US / CARG=US / COLD=US / EOLS=US / KDP=US / OZK=US / FSK=US / LYFT=US / RTLR=US / FERG=US / BRBR=US / OVV=US / ARQT=US / REYN=US / DKNG=US / FSKR=US / AZEK=US / BALY=US / HYFM=US / 100073616</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / PepsiCo Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Home Depot Inc / Coca-Cola Co / McDonald's Corp / Occidental Petroleum Corp / Twitter Inc / Range Resources Corp / Colgate-Palmolive Co / Wendys Co / Prologis Inc / Amazon.com Inc / TopBuild Corp / Devon Energy Corp / Incyte Corp / Kinder Morgan Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Quest Diagnostics Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Check Point Software Technologies Ltd / Pioneer Natural Resources Co / Energizer Holdings Inc / Heidrick & Struggles International Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Brown & Brown Inc / Boyd Gaming Corp / Marathon Oil Corp / Leggett & Platt Inc / HCA Healthcare Inc / Vulcan Materials Co / MGM Resorts International / Penn National Gaming Inc / Newell Brands Inc / Martin Marietta Materials Inc / Flowers Foods Inc / Korn Ferry / Ares Capital Corp / Cracker Barrel Old Country Store Inc / Central Garden & Pet Co / Church & Dwight Co Inc / CNX Resources Corp / Darden Restaurants Inc / Edgewell Personal Care Co / EQT Corp / Griffon Corp / Hain Celestial Group Inc / Installed Building Products Inc / Safehold Inc / Lendingtree Inc / Main Street Capital Corp / Masco Corp / Medpace Holdings Inc / Mohawk Industries Inc / Monarch Casino & Resort Inc / Owl Rock Capital Corp / PacWest Bancorp / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / SBA Communications Corp / Scotts Miracle-Gro Co / SS&C Technologies Holdings Inc / Snap Inc / Vertex Pharmaceuticals Inc / Chevron Corp / Post Holdings Inc / Cadence Bank / Booking Holdings Inc / FB Financial Corp / First Industrial Realty Trust Inc / First Financial Bankshares Inc / Conocophillips / VICI Properties Inc / Dine Brands Global Inc / MGM Growth Properties LLC / MGP Ingredients Inc / Monster Beverage Corp / Red Rock Resorts Inc / Nomad Foods Ltd / Tempur Sealy International Inc / FNB Corp / Eagle Materials Inc / Caesars Entertainment Inc / NuVasive Inc / Apollo Investment Corp / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / TreeHouse Foods Inc / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / elf Beauty Inc / Armstrong World Industries Inc / Owens Corning / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Pennantpark Investment Corp / Purple Innovation Inc / Northern Oil and Gas Inc / Jack in the Box Inc / Aaron's Company Inc / Trex Company Inc / Antero Resources Corp / NXP Semiconductors NV / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Abbvie Inc / Interface Inc / Noodles & Co / Gaming and Leisure Properties Inc / Sixth Street Specialty Lending Inc / Aemetis Inc / Viper Energy Partners LP / PennantPark Floating Rate Capital Ltd / El Pollo Loco Holdings Inc / Anthem Inc / Shake Shack Inc / Aerojet Rocketdyne Holdings Inc / Goldman Sachs BDC Inc / Wingstop Inc / argenx SE / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / Ranger Oil Corp / JELD-WEN Holding Inc / SilverBow Resources Inc / PetIQ Inc / Roku Inc / CarGurus Inc / Americold Realty Trust / Evolus Inc / Keurig Dr Pepper Inc / Bank Ozk / FS KKR Capital Corp / Lyft Inc / Rattler Midstream LP / Ferguson PLC / Bellring Brands Inc / Ovintiv Inc / Arcutis Biotherapeutics Inc / Reynolds Consumer Products Inc / DraftKings Inc / FS KKR Capital Corp / Azek Company Inc / Bally's Corp / Hydrofarm Holdings Group Inc / Kimco Realty Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / Luxembourg / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2434209 / 2126335 / 2516152 / 2778844 / 2219224 / 2270726 / 2542049 / 2317087 / 2328915 / 2100920 / 2613990 / 2630513 / 2689560 / 2684703 / 2440637 / 2825933 / 2829601 / 7103065 / B121557 / 2212922 / 2857817 / B125XQ6 / B2R3PV1 / BH65L93 / BYVY8G0 / BJFSR88 / BNFWR44 / BYZR4X4 / BFZ1K46 / BJJMGL2 / BZ8VJQ8 / BKTNTR9 / BJ9NFQ3 / BYNQ369 / BMH0MR7 / BQXZP64 / BLBLMD5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Home Depot Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / CMS Energy Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Illumina Inc / New Jersey Resources Corp / PG&E Corp / Pfizer Inc / CenterPoint Energy Inc / South Jersey Industries Inc / Southern Co / Novartis AG / Mastercard Inc / NRG Energy Inc / Netflix Inc / Portland General Electric Co / American Water Works Company Inc / Seacoast Banking Corporation of Florida / Alphabet Inc / Uniqure NV / Worldline SA / Axsome Therapeutics Inc / Spotify Technology SA / Fox Corp / Vistra Corp / ViacomCBS Inc / Neoleukin Therapeutics Inc / Albertsons Companies Inc / Zendesk Inc / Wayfair Inc / Array Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: April 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BA.N / CL.N / CVS.N / EL.N / LLY.N / MRK.N / PFE.N / TMO.N / WMB.N / MCD.N / WEC.N / XOM.N / V.N / CVX.N / COP.N / AAPL.OQ / ATVI.OQ / MSFT.OQ / QCOM.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / TXN.OQ / CMCSA.OQ / CDNS.OQ / TSLA.OQ / NXPI.OQ / NOW.N / ABBV.N / GOOGL.OQ / TMUS.OQ / FB.PS / OTIS.N</td><td class="leftalignment">Boeing Co / Colgate-Palmolive Co / CVS Health Corp / Estee Lauder Companies Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Thermo Fisher Scientific Inc / Williams Companies Inc / McDonald's Corp / WEC Energy Group Inc / Exxon Mobil Corp / Visa Inc / Chevron Corp / Conocophillips / Apple Inc / Activision Blizzard Inc / Microsoft Corp / Qualcomm Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Texas Instruments Inc / Comcast Corp / Cadence Design Systems Inc / Tesla Inc / NXP Semiconductors NV / ServiceNow Inc / Abbvie Inc / Alphabet Inc / T-Mobile US Inc / San Miguel Food and Beverage Inc / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Netherlands / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Apr 16, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Merck sheds $11 billion in MCap in 2021, steepest loss in Pharmaceuticals sector</td><td class="leftalignment">English</td><td class="rightalignment">79</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Post Split, Remainco Growth Appears Average, OGN Well Below; M&A Key For Both</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Transcript from Expert call on LAG-3 inhibitors and BMY’s relatlimab</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">BMY=US / MRK=US / AMGN=US / INCY=US / REGN=US</td><td class="leftalignment">Bristol-Myers Squibb Co / Merck & Co Inc / Amgen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 26 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">FR0000054470 / US00971T1016 / US0116591092 / US0311621009 / US0378331005 / US0463531089 / US0718131099 / US1101221083 / US1266501006 / US2855121099 / US37733W1053 / US45337C1027 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / AN8068571086 / US8308791024 / US8447411088 / US8636671013 / US8740541094 / US98956P1021 / US4771431016 / US4198791018 / US80105N1054 / US2538681030 / US0491642056 / PAP310761054 / NL0000687663 / US01748X1028 / US2473617023 / US53261M1045 / US00922R1059 / US00507V1098 / US58933Y1055 / US9100471096 / US98986T1088 / US00287Y1091 / US00912X3026 / US23283R1005 / US8485771021 / US21240E1055 / US02376R1023 / CA0089118776 / US29444U7000 / US20717E1010 / US36165L1089 / US87105L1044 / US8760301072 / US19626G1085 / US5904791358 / CH0499880968 / US22041X1028 / US72815L1070 / US35909R1086</td><td class="leftalignment">Ubisoft Entertainment SA / Akamai Technologies Inc / Alaska Air Group Inc / Amgen Inc / Apple Inc / AstraZeneca PLC / Baxter International Inc / Bristol-Myers Squibb Co / CVS Health Corp / Electronic Arts Inc / GlaxoSmithKline PLC / Incyte Corp / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Schlumberger NV / SkyWest Inc / Southwest Airlines Co / Stryker Corp / Take-Two Interactive Software Inc / Zimmer Biomet Holdings Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Digital Realty Trust Inc / Atlas Air Worldwide Holdings Inc / Copa Holdings SA / AerCap Holdings NV / Allegiant Travel Co / Delta Air Lines Inc / Limelight Networks Inc / Air Transport Services Group Inc / Activision Blizzard Inc / Merck & Co Inc / United Airlines Holdings Inc / Zynga Inc / Abbvie Inc / Air Lease Corp / CyrusOne Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Air Canada / Equinix Inc / Conformis Inc / GDS Holdings Ltd / Switch Inc / Tapestry Inc / DigitalBridge Group Inc / Mesa Air Group Inc / ADC Therapeutics SA / Corsair Gaming Inc / Playtika Holding Corp / Frontier Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - April 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AEP.N / AES.N / AFL.N / AIG.N / ALV.N / AXP.N / BAC.N / BK.N / C.N / CAS.TO / CB.N / CCI.N / CL.N / COF.N / EIX.N / EL.N / F.N / FITB.O / FOUG.PA / GM.N / IP.N / JPM.N / KEY.N / KMB.N / KO.N / MMC.N / MRK.N / MSFT.O / NTRS.O / PNC.N / SGEF.PA / SO.N / T.N / TRV.N / USB.N / VC.N / WFC.N / ZION.O / PEP.N / BFb.N / PG.N / FNV.N / CPB.N / TEN.N / CMCSA.O / THC.N / MET.N / DUK.N / BWA.N / LEA.N / K.N / DISH.O / GS.N / CLX.N / CAG.N / HON.N / WM.N / UNM.N / GIS.N / PCG.N / EPC.N / JAZZ.O / VZ.N / STT.N / HCA.N / STZ.N / CINF.O / LNC.N / APH.N / FISV.O / V.N / CHTR.O / AXL.N / AWK.N / RSG.N / CHD.N / NWN.N / MTB.N / BC.N / KRC.N / SAM.N / AJG.N / ENR.N / PFG.N / PRU.N / NCR.N / NET.N / TEL.N / SSNC.O / RF.N / CNP.N / WCN.N / CPK.N / MKL.N / BRO.N / PII.N / RLI.N / ST.N / ADS.N / GPN.N / MNST.O / FFBC.O / PBCT.O / SIGI.O / ACGL.O / TFC.N / 02209S103 / 416515104 / 427866108 / MS.N / FIS.N / 025676206 / TEVA.N / MA.N / HOG.N / AON.N / BGS.N / PPL.TO / TDC.N / DAN.N / WRB.N / 759351604 / CLW.N / SPB.N / NEE.N / NXT.AX / MTOR.N / RFP.N / FFHu.TO / MDLZ.OQ / ALLY.N / ABBV.N / KPT.TO / TSLA.N / PRMW.N / VOYA.N / COTY.N / 81762P102 / VRNS.O / RYAM.N / CFG.N / ANTM.N / RPD.O / RACE.MI / MP1.AX / TWLO.N / AZRE.N / KNSL.OQ / ADNT.N / GDS.O / VST.N / BHF.O / ORSTED.CO / SAIL.N / APTV.N / EQH.N / GSHD.O / VNE.N / KDP.N / CWEN.N / NWL.O / CRNC.OQ / WTRG.N / REYN.O / IGIC.OQ / GFL.N / NKLA.OQ / FOUR.N / NAPA.N / PSFE.N / OSO.N / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Aflac Inc / American International Group Inc / Autoliv Inc / American Express Co / Bank of America Corp / Bank of New York Mellon Corp / Citigroup Inc / Cascades Inc / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Capital One Financial Corp / Edison International / Estee Lauder Companies Inc / Ford Motor Co / Fifth Third Bancorp / Eiffage SA / General Motors Co / International Paper Co / JPMorgan Chase & Co / KeyCorp / Kimberly-Clark Corp / Coca-Cola Co / Marsh & McLennan Companies Inc / Merck & Co Inc / Microsoft Corp / Northern Trust Corp / PNC Financial Services Group Inc / Vinci SA / Southern Co / AT&T Inc / Travelers Companies Inc / US Bancorp / Visteon Corp / Wells Fargo & Co / Zions Bancorporation NA / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Franco-Nevada Corp / Campbell Soup Co / Tenneco Inc / Comcast Corp / Tenet Healthcare Corp / MetLife Inc / Duke Energy Corp / Borgwarner Inc / Lear Corp / Kellogg Co / DISH Network Corp / Goldman Sachs Group Inc / Clorox Co / Conagra Brands Inc / Honeywell International Inc / Waste Management Inc / Unum Group / General Mills Inc / PG&E Corp / Edgewell Personal Care Co / Jazz Pharmaceuticals PLC / Verizon Communications Inc / State Street Corp / HCA Healthcare Inc / Constellation Brands Inc / Cincinnati Financial Corp / Lincoln National Corp / Amphenol Corp / Fiserv Inc / Visa Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Republic Services Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / M&T Bank Corp / Brunswick Corp / Kilroy Realty Corp / Boston Beer Company Inc / Arthur J Gallagher & Co / Energizer Holdings Inc / Principal Financial Group Inc / Prudential Financial Inc / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / SS&C Technologies Holdings Inc / Regions Financial Corp / CenterPoint Energy Inc / Waste Connections Inc / Chesapeake Utilities Corp / Markel Corp / Brown & Brown Inc / Polaris Inc / Rli Corp / Sensata Technologies Holding PLC / Alliance Data Systems Corp / Global Payments Inc / Monster Beverage Corp / First Financial Bancorp / People's United Financial Inc / Selective Insurance Group Inc / Arch Capital Group Ltd / Truist Financial Corp / Altria Group Inc / Hartford Financial Services Group Inc / Hershey Co / Morgan Stanley / Fidelity National Information Services Inc / American Equity Investment Life Holding Co / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Harley-Davidson Inc / Aon PLC / B&G Foods Inc / Pembina Pipeline Corp / Teradata Corp / Dana Inc / W R Berkley Corp / Reinsurance Group of America Inc / Clearwater Paper Corp / Spectrum Brands Holdings Inc / Nextera Energy Inc / NEXTDC Ltd / Meritor Inc / Resolute Forest Products Inc / Fairfax Financial Holdings Ltd / Mondelez International Inc / Ally Financial Inc / Abbvie Inc / KP Tissue Inc / Tesla Inc / Primo Water Corp / Voya Financial Inc / Coty Inc / ServiceNow Inc / Varonis Systems Inc / Rayonier Advanced Materials Inc / Citizens Financial Group Inc / Anthem Inc / Rapid7 Inc / Ferrari NV / Megaport Ltd / Twilio Inc / Azure Power Global Ltd / Kinsale Capital Group Inc / Adient PLC / GDS Holdings Ltd / Vistra Corp / Brighthouse Financial Inc / Orsted A/S / SailPoint Technologies Holdings Inc / Aptiv PLC / Equitable Holdings Inc / Goosehead Insurance Inc / Veoneer Inc / Keurig Dr Pepper Inc / Clearway Energy Inc / Newell Brands Inc / Cerence Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / International General Insurance Holdings Ltd / GFL Environmental Inc / Nikola Corp / Shift4 Payments Inc / Duckhorn Portfolio Inc / Paysafe Ltd / Olo Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Mauritius / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: April 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AXP.N / BA.N / CL.N / EL.N / KMB.N / LLY.N / MRK.N / SLB.N / TMO.N / WMB.N / MCD.N / HON.N / WEC.N / XOM.N / V.N / CVX.N / RF.N / AAPL.OQ / MSFT.OQ / QCOM.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / TXN.OQ / CMCSA.OQ / CDNS.OQ / TSLA.OQ / NXPI.OQ / NOW.N / ABBV.N / GOOGL.OQ / FB.PS / OTIS.N</td><td class="leftalignment">American Express Co / Boeing Co / Colgate-Palmolive Co / Estee Lauder Companies Inc / Kimberly-Clark Corp / Eli Lilly and Co / Merck & Co Inc / Schlumberger NV / Thermo Fisher Scientific Inc / Williams Companies Inc / McDonald's Corp / Honeywell International Inc / WEC Energy Group Inc / Exxon Mobil Corp / Visa Inc / Chevron Corp / Regions Financial Corp / Apple Inc / Microsoft Corp / Qualcomm Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Texas Instruments Inc / Comcast Corp / Cadence Design Systems Inc / Tesla Inc / NXP Semiconductors NV / ServiceNow Inc / Abbvie Inc / Alphabet Inc / San Miguel Food and Beverage Inc / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">India Pharma Sector - Quick Take - Lupin: Volume ramp-up in Albuterol still slow; witnessing market share loss in Levothyroxine and Glumetza</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CIPL.BO / LUPN.NS / SUN.BO / MRK.N / NOVN.S / GSK.L / CIPL.NS / LUPN.BO / ENDP.OQ / SUN.NS / TEVA.N / PRGO.N</td><td class="leftalignment">Cipla Ltd / Lupin Ltd / Sun Pharmaceutical Industries Ltd / Merck & Co Inc / Novartis AG / GlaxoSmithKline PLC / Cipla Ltd / Lupin Ltd / Endo International PLC / Sun Pharmaceutical Industries Ltd / Teva Pharmaceutical Industries Ltd / Perrigo Company PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / India / Ireland / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Anubhav Aggarwal / Sayantan Maji</td></tr>
<tr class="even"><td class="leftalignment">04/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">04/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK.N / JAZZ.O / TEVA.N / ABBV.N</td><td class="leftalignment">Merck & Co Inc / Jazz Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">04/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Three Peas in a Podcast, Please Join Our Weekly Discussion on How Potential Catalysts and Events Could Impact Our Covered Companies</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ACRS.OQ / ACRX.OQ / 0013.HK / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BDSI.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / OMER.OQ / ARDX.OQ / ZTS.N / ANIP.OQ / AXGN.OQ / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / CKPT.OQ / VERU.OQ / TXMD.OQ / AYTU.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / IMAB.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / AZYO.OQ / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Checkpoint Therapeutics Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / I-Mab / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Aziyo Biologics Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/25/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma 1Q Earnings Season : What to Watch for the Week Ahead (LLY, BMY, MRK, ABBV)</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK.N / ABBV.N / BMY.N / LLY.N / PFE.N</td><td class="leftalignment">Merck & Co Inc / Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Christopher T. Schott, CFA / Xiling Chen / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">04/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials Maintain Momentum - Week 56</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending Apr 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRCG.DE - Event Transcript of Merck KGaA conference call, Apr. 23, 2021 / 4:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">EXEL: 1L HCC Preview: Mixed VEGF Data Provide Opportunity for Cabometyx Cross-Trial Superiority</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">EXEL.OQ / 4502.T / 4523.T / MRK.N / AZN.L / IPN.PA</td><td class="leftalignment">Exelixis Inc / Takeda Pharmaceutical Co Ltd / Eisai Co Ltd / Merck & Co Inc / AstraZeneca PLC / Ipsen SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Bradley P. Canino</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IPN.PA: Ipsen - 1Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">IPN.PA / RECI.MI / LUN.CO / MRCG.DE / LONN.S / UCB.BR / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / VIFN.S / GMAB.CO</td><td class="leftalignment">Ipsen SA / Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Israel / Italy / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">S3 Partners</td><td class="leftalignment">S3 Analytics: Biotech - Pharma Short Selling Recap</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AZN.L / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / GSK.L / AMGN.OQ / CVM.A / CHRS.OQ / REGN.OQ / GILD.OQ / NVAX.OQ / UTHR.OQ / BMRN.OQ / ESPR.OQ / EXAS.OQ / VRTX.OQ / BIIB.OQ / CRTX.OQ / MNKD.OQ / RPRX.OQ / JAZZ.OQ / INO.OQ / MRNA.OQ / OMER.OQ / CYDY.PK / ABBV.N / ZTS.N / SRNE.OQ / HRTX.OQ / NVTA.N / IONS.OQ / EDIT.OQ / MDGL.OQ / KALA.OQ / VXRT.OQ / TLRY.OQ / 6160.HK / IGMS.OQ / OCGN.OQ / BEAM.OQ / PGEN.OQ / NRIX.OQ / 22UAy.DE / IBRX.OQ</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / Amgen Inc / CEL-SCI Corp / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Novavax Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Esperion Therapeutics Inc / Exact Sciences Corp / Vertex Pharmaceuticals Inc / Biogen Inc / Cortexyme Inc / MannKind Corp / Royalty Pharma PLC / Jazz Pharmaceuticals PLC / Inovio Pharmaceuticals Inc / Moderna Inc / Omeros Corp / Cytodyn Inc / Abbvie Inc / Zoetis Inc / Sorrento Therapeutics Inc / Heron Therapeutics Inc / Invitae Corp / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Madrigal Pharmaceuticals Inc / Kala Pharmaceuticals Inc / Vaxart Inc / Tilray Brands Inc / Beigene Ltd / IGM Biosciences Inc / Ocugen Inc / Beam Therapeutics Inc / Precigen Inc / Nurix Therapeutics Inc / BioNTech SE / Immunitybio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Germany / United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ihor Dusaniwsky</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">JNJ-US Company reports financial results for the quarter ended April 04,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ / ABT / LLY / MDT / MRK / NVS / PFE / SYK / GILD.O / GSK / SNY.O</td><td class="leftalignment">Johnson & Johnson / Abbott Laboratories / Eli Lilly and Co / Medtronic PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / Stryker Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Bracketing Exposure Of Big Cap Pharma To Biden Tax Reform Proposal</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">ECONOMIC REPORTS / INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/21/2021</td><td class="leftalignment">valuationLAB AG</td><td class="leftalignment">“Growing the base” Cresemba shines, cancer pipeline growing apace</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">BSLN=CH / MRK=US / LLY=US / PFE=US / 4503=JP / ROG=CH</td><td class="leftalignment">Basilea Pharmaceutica AG / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Astellas Pharma Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Bob Pooler</td></tr>
<tr class="odd"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 21 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0028241000 / US02553E1064 / US0378331005 / US0463531089 / US1101221083 / US1264081035 / US2435371073 / US25179M1036 / US28176E1082 / US2944291051 / US3377381088 / US37733W1053 / US4282911084 / US4781601046 / US5324571083 / US5398301094 / US6541061031 / US6558441084 / US66987V1098 / US6701002056 / US7170811035 / US7237871071 / US7711951043 / US87612E1064 / US9078181081 / US92532F1003 / US9311421039 / CA1363751027 / CA13645T1003 / US37940X1028 / US64110L1061 / US80105N1054 / US2533931026 / US31620M1062 / US82706C1080 / US57636Q1040 / US4103451021 / US92826C8394 / US58933Y1055 / US78454L1008 / US39304D1028 / US3390411052 / US96208T1043 / US00287Y1091 / NL0010273215 / US69327R1014 / US5764852050 / PR30040P1032 / US89400J1079 / US70450Y1038 / US8522341036 / US15136A1025 / US8760301072 / US2997341035 / US26927E1047 / US46571Y1073 / VGG312491084 / US74275G1076 / US98585X1046 / US69047Q1022 / US13123X5086 / CA67079A1021</td><td class="leftalignment">Abbott Laboratories / American Eagle Outfitters Inc / Apple Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / Deckers Outdoor Corp / Devon Energy Corp / Edwards Lifesciences Corp / Equifax Inc / Fiserv Inc / GlaxoSmithKline PLC / Hexcel Corp / Johnson & Johnson / Eli Lilly and Co / Lockheed Martin Corp / Nike Inc / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Pioneer Natural Resources Co / Roche Holding AG / Target Corp / Union Pacific Corp / Vertex Pharmaceuticals Inc / Walmart Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Global Payments Inc / Netflix Inc / Sanofi SA / DICK'S Sporting Goods Inc / Fidelity National Information Services Inc / Silicon Motion Technology Corp / Mastercard Inc / HanesBrands Inc / Visa Inc / Merck & Co Inc / SM Energy Co / Green Dot Corp / Fleetcor Technologies Inc / WEX Inc / Abbvie Inc / ASML Holding NV / PDC Energy Inc / Matador Resources Co / Evertec Inc / TransUnion / PayPal Holdings Inc / Block Inc / Centennial Resource Development Inc / Tapestry Inc / Evelo Biosciences Inc / EVO Payments Inc / I3 Verticals Inc / Establishment Labs Holdings Inc / Priority Technology Holdings Inc / Yeti Holdings Inc / Ovintiv Inc / Callon Petroleum Co / Nuvei Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Netherlands / Puerto Rico / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">N=54 prescriber poll on JAK inhibitors in atopic dermatitis</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">04/20/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Merck & Co Inc Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">04/20/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">Autos, Basic Resources, Healthcare & Transport Calendar : April - June 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACF / AIRP.PA / BAX.N / BDX.N / BHP.AX / BMWG.DE / BMY.N / CC.N / CCK.N / CCL.N / CE.N / CRH.I / DSMN.AS / EPED.PA / F.N / FGP.L / GM.N / GOG.L / HEIG.DE / JNJ.N / LHAG.DE / LLY.N / MCK.N / MRK.N / MWDP.PA / NEX.L / PFE.N / PLOF.PA / RENA.PA / RIO.AX / RR.L / RYA.I / SAPJ.J / SAS.ST / SCHN.PA / SGC.L / SGOB.PA / SMIN.L / SOLB.BR / SYD.AX / TCFP.PA / TMO.N / VLLP.PA / VOLVb.ST / VOWG.DE / WBSV.VI / STERV.HE / AIRF.PA / CONG.DE / AZN.L / AMGN.O / AAL.L / SASY.PA / TKAG.DE / ROG.S / SIEGn.F / HON.N / NOVN.S / MG.TO / FMEG.DE / BZU.MI / MRCG.DE / MGA.N / PSHG_p.DE / OI.N / BLL.N / GLAX.NS / PKI.N / FREG.DE / RXL.PA / EZJ.L / SUP.N / GSK.L / ESI.N / CC@US / MHK.N / TAMO.BO / FLWS.O / VOES.VI / MT.N / LXSG.DE / HUN.N / SAF.PA / TUIGn.DE / LEGD.PA / TEVA.N / SKG.I / MNDI.L / DAIGn.DE / BAES.L / BAYGn.DE / BASFn.DE / GLEN.L / CAR.O / SDFGn.DE / METSB.HE / LKQ.O / XPO.N / GT.O / ABBV.N / GEST.MC / CSTM.N / EVKn.F / CTLT.N / EUCAR.PA / ZBH.N / 1COV.DE / HLAG.DE / NVGR.LS / ADNT.N / BHC.N / VTRS.O</td><td class="leftalignment">Acrow Formwork and Construction Services Ltd / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Baxter International Inc / Becton Dickinson and Co / BHP Group Ltd / Bayerische Motoren Werke AG / Bristol-Myers Squibb Co / Chemours Co / Crown Holdings Inc / Carnival Corp / Celanese Corp / CRH PLC / Koninklijke DSM NV / Faurecia SE / Ford Motor Co / FirstGroup PLC / General Motors Co / Go-Ahead Group PLC / HeidelbergCement AG / Johnson & Johnson / Deutsche Lufthansa AG / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / Wendel SE / National Express Group PLC / Pfizer Inc / Compagnie Plastic Omnium SE / Renault SA / Rio Tinto Ltd / Rolls-Royce Holdings PLC / Ryanair Holdings PLC / Sappi Ltd / SAS AB / Schneider Electric SE / Stagecoach Group PLC / Compagnie de Saint Gobain SA / Smiths Group PLC / Solvay SA / Sydney Airport / Thales SA / Thermo Fisher Scientific Inc / Vallourec SA / Volvo AB / Volkswagen AG / Wienerberger AG / Stora Enso Oyj / Air France KLM SA / Continental AG / AstraZeneca PLC / Amgen Inc / Anglo American PLC / Sanofi SA / thyssenkrupp AG / Roche Holding AG / Siemens AG / Honeywell International Inc / Novartis AG / Magna International Inc / Fresenius Medical Care AG & Co KGaA / Buzzi Unicem SpA / Merck KGaA / Magna International Inc / Porsche Automobil Holding SE / O-I Glass Inc / Ball Corp / GlaxoSmithKline Pharmaceuticals Ltd / PerkinElmer Inc / Fresenius SE & Co KGaA / Rexel SA / Easyjet PLC / Superior Industries International Inc / GlaxoSmithKline PLC / Element Solutions Inc / Chemours Co / Mohawk Industries Inc / Tata Motors Ltd / 1-800-Flowers.Com Inc / voestalpine AG / ArcelorMittal SA / Lanxess AG / Huntsman Corp / Safran SA / TUI AG / Legrand SA / Teva Pharmaceutical Industries Ltd / Smurfit Kappa Group PLC / Mondi PLC / Daimler AG / BAE Systems PLC / Bayer AG / BASF SE / Glencore PLC / Avis Budget Group Inc / K&S AG / Metsa Board Oyj / LKQ Corp / XPO Logistics Inc / Goodyear Tire & Rubber Co / Abbvie Inc / Gestamp Automocion SA / Constellium SE / Evonik Industries AG / Catalent Inc / Europcar Mobility Group SA / Zimmer Biomet Holdings Inc / Covestro AG / Hapag Lloyd AG / Navigator Company SA / Adient PLC / Bausch Health Companies Inc / Viatris Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">Australia / Austria / Belgium / Canada / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Hong Kong / India / Ireland / Israel / Italy / Luxembourg / Netherlands / Norway / Panama / Portugal / Sweden / United States / South Africa / Jersey</td><td class="leftalignment">Aerospace / Air Transportation / Automotive / Biotechnology / Building & Building Materials / Chemicals / Conglomerates / Consumer / Containers & Packing / Defense / Electrical / Energy / Engineering & Construction / Financial Services / Healthcare / Household Products / Industrial Materials / Leisure & Entertainment / Lodging & Restaurants / Machinery / Manufacturing / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Railroads / Retailing / Shipping & Shipbuilding / Tire & Rubber / Transportation / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Danielle Ward / Benjamin Defay / Stephanie Vincent / Mr. William W. Wade / Jemma Permalloo / Ed McGuinness / Mr. Adam Bodor</td></tr>
<tr class="odd"><td class="leftalignment">04/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">DE=US / TME=US / MRK=US / LLY=US / MSFT=US / INSP=US / DNLI=US / NVDA=US / RMD=US / SPOT=US / TTWO=US / ATVI=US / HEAR=US / PHG=US / SAGE=US / GME=US / MTCH=US / NFLX=US / BIIB=US / ALNY=US / 700-HK=US / UBI-PAR=US / TCEHY=US / ZNGA=US / EA=US / YY=US / LOVE=US / MOMO=US / SPXC=US / LIVN=US / IQ=US / BILI=US / HUYA=US / DOYU=US / TARA=US / CRSR=US / PLTK=US</td><td class="leftalignment">Deere & Co / Tencent Music Entertainment Group / Merck & Co Inc / Eli Lilly and Co / Microsoft Corp / Inspire Medical Systems Inc / Denali Therapeutics Inc / NVIDIA Corp / Resmed Inc / Spotify Technology SA / Take-Two Interactive Software Inc / Activision Blizzard Inc / Turtle Beach Corp / Koninklijke Philips NV / SAGE Therapeutics Inc / GameStop Corp / Match Group Inc / Netflix Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Tencent Holdings Ltd / Ubisoft Entertainment SA / Tencent Holdings Ltd / Zynga Inc / Electronic Arts Inc / JOYY Inc / Lovesac Co / Hello Group Inc / SPX Corp / LivaNova PLC / iQIYI Inc / Bilibili Inc / HUYA Inc / Douyu International Holdings Ltd / Protara Therapeutics Inc / Corsair Gaming Inc / Playtika Holding Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment">Biotechnology / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Machinery / Pharmaceuticals / Retailing / Semiconductors</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Upcoming Biopharma Regulatory Events to Watch Given Tougher Environment</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / INCY=US / GILD=US / MOR=DE / AZN=US / GSK=US / ALKS=US / BMRN=US / ICPT=US / VRTX=US / SGEN=US / SAGE=US / PRVB=US / SNY=US / BIIB=US / ACAD=US / ALNY=US / MNKD=US / FOLD=US / IFRX=US / ASND=US / CCXI=US / FGEN=US / ABBV=US / MRTX=US / MGNX=US / ITCI=US / QURE=US / AUPH=US / BPMC=US / AXSM=US / RETA=US / BHVN=US / BBIO=US / MIRM=US / GMAB=US / TVTX=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Incyte Corp / Gilead Sciences Inc / MorphoSys AG / AstraZeneca PLC / GlaxoSmithKline PLC / Alkermes Plc / Biomarin Pharmaceutical Inc / Intercept Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Seagen Inc / SAGE Therapeutics Inc / Provention Bio Inc / Sanofi SA / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / MannKind Corp / Amicus Therapeutics Inc / InflaRx NV / Ascendis Pharma A/S / ChemoCentryx Inc / FibroGen Inc / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / Intra-Cellular Therapies Inc / Uniqure NV / Aurinia Pharmaceuticals Inc / Blueprint Medicines Corp / Axsome Therapeutics Inc / Reata Pharmaceuticals Inc / Biohaven Pharmaceutical Holding Company Ltd / BridgeBio Pharma Inc / Mirum Pharmaceuticals Inc / Genmab A/S / Travere Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Germany / Denmark / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IKNA: Targeted Oncology Company with Attractive Novel Therapy Candidates; Initiating with an Outperform Rating and a $30 Target Price</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">IKNA.OQ / 4502.T / 4528.T / BMY.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVN.S / GSK.L / AMGN.OQ / INCY.OQ / A2.MI / BAYGN.DE / MRTX.OQ</td><td class="leftalignment">Ikena Oncology Inc / Takeda Pharmaceutical Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Incyte Corp / A2A SpA / Bayer AG / Mirati Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Italy / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Yunhee Park / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Can Johnson & Johnson Stock Rise Post Q1 Results?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">FINAM</td><td class="leftalignment">Merck & Co останется лидером в сегменте онкологии</td><td class="leftalignment">Russian</td><td class="rightalignment">12</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Alexander Kovalev</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">SBUX=US / SQ=US / MGA=US / MRK=US / BSX=US / ABT=US / AMGN=US / CAT=US / TWTR=US / WM=US / BWA=US / MDT=US / GNSS=US / RUN=US / FCEL=US / PLUG=US / NVS=US / SMTC=US / MMC=US / TSM=US / HON=US / EXPE=US / JCI=US / DE=US / PGR=US / RSG=US / ALB=US / AMSC=US / ARRY=US / ATRC=US / AVNT=US / CMI=US / CREE=US / EW=US / AJG=US / LINK=US / ITRI=US / NVAX=US / PRGO=US / KWR=US / ROK=US / SNAP=US / TRMB=US / AYI=US / BKNG=US / FB=US / NEP=US / VMT=US / CRTO=US / ICAD=US / OSTK=US / BE=US / APPN=US / CLH=US / WCN=US / AON=US / ISR=US / CORT=US / ENS=US / GOOG=US / TWIN=US / ORA=US / AMRS=US / PERI=US / SPWR=US / CSIQ=US / FSLR=US / PUBM=US / DAN=US / WPRT=US / NEO=US / AGCO=US / 005930-KR=US / TSLA=US / AMRC=US / ENPH=US / HASI=US / CNHI=US / CHGG=US / NVRO=US / SEDG=US / AQMS=US / WKHS=US / ROKU=US / APTV=US / SAIL=US / VOW3-DE=US / CWEN=US / GRWG=US / TMDX=US / NKLA=US / XPEV=US / VLDR=US / VTRS=US / SHLS=US / CHPT=US / AEVA=US / IBRX=US / SCHNEIDER=US / 120248964</td><td class="leftalignment">Starbucks Corp / Block Inc / Magna International Inc / Merck & Co Inc / Boston Scientific Corp / Abbott Laboratories / Amgen Inc / Caterpillar Inc / Twitter Inc / Waste Management Inc / Borgwarner Inc / Medtronic PLC / Genasys Inc / Sunrun Inc / Fuelcell Energy Inc / Plug Power Inc / Novartis AG / Semtech Corp / Marsh & McLennan Companies Inc / Taiwan Semiconductor Manufacturing Co Ltd / Honeywell International Inc / Expedia Group Inc / Johnson Controls International PLC / Deere & Co / Progressive Corp / Republic Services Inc / Albemarle Corp / American Superconductor Corp / Array Technologies Inc / AtriCure Inc / Avient Corp / Cummins Inc / Wolfspeed Inc / Edwards Lifesciences Corp / Arthur J Gallagher & Co / Interlink Electronics Inc / Itron Inc / Novavax Inc / Perrigo Company PLC / Quaker Chemical Corp / Rockwell Automation Inc / Snap Inc / Trimble Inc / Acuity Brands Inc / Booking Holdings Inc / Meta Platforms Inc / Nextera Energy Partners LP / Vmoto Ltd / Criteo SA / ICAD Inc / Overstock.com Inc / Bloom Energy Corp / Appian Corp / Clean Harbors Inc / Waste Connections Inc / Aon PLC / IsoRay Inc / Corcept Therapeutics Inc / EnerSys / Alphabet Inc / Twin Disc Inc / Ormat Technologies Inc / Amyris Inc / Perion Network Ltd / SunPower Corp / Canadian Solar Inc / First Solar Inc / PubMatic Inc / Dana Inc / Westport Fuel Systems Inc / Neogenomics Inc / AGCO Corp / Farfetch Ltd / Tesla Inc / Ameresco Inc / Enphase Energy Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / CNH Industrial NV / Chegg Inc / Nevro Corp / Solaredge Technologies Inc / Aqua Metals Inc / Workhorse Group Inc / Roku Inc / Aptiv PLC / SailPoint Technologies Holdings Inc / Volkswagen AG / Clearway Energy Inc / GrowGeneration Corp / Transmedics Group Inc / Nikola Corp / Xpeng Inc / Velodyne Lidar Inc / Viatris Inc / Shoals Technologies Group Inc / ChargePoint Holdings Inc / Aeva Technologies Inc / Immunitybio Inc / Schneider Electric Infrastructure Ltd / Frontier Communications Parent Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / France / India / Ireland / Israel / Netherlands / Taiwan / United States / Jersey</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Electrical / Financial Services / Healthcare / Lodging & Restaurants / Retailing / Semiconductors</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - April 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AEP.N / AES.N / ALV.N / ANTO.L / BAC.N / BK.N / BP.L / C.N / CCI.N / CL.N / EIX.N / EL.N / ENI.MI / F.N / GM.N / JNJ.N / JPM.N / KMB.N / KO.N / MRK.N / NA / PFE.N / PNC.N / REP.MC / RIO.L / SO.N / T.N / TOTF.PA / VC.N / PEP.N / BFb.N / PG.N / CFP.TO / CPB.N / TEN.N / CMCSA.O / CHKP.O / AMGN.O / INCY.O / THC.N / UHS.N / AAL.L / DUK.N / UNH.N / BWA.N / LEA.N / K.N / DISH.O / GS.N / CLX.N / CAG.N / GIS.N / PCG.N / XOM.N / EPC.N / SBAC.O / AMT.N / JAZZ.O / BOL.ST / CONE.O / VZ.N / STT.N / HCA.N / CYH.N / ARNA.O / STZ.N / APH.N / FISV.O / V.N / CHTR.O / AXL.N / AWK.N / CHD.N / NWN.N / BC.N / SAM.N / REGN.O / ENR.N / CVX.N / NCR.N / TEL.N / CNP.N / APF.L / ENDP.O / BLU.N / CPK.N / PII.N / ST.N / GPN.N / MNST.O / CASY.O / ICPT.O / EQIX.O / ATDb.TO / 02209S103 / DLR.N / NESTE.HE / 416515104 / 427866108 / WEF.TO / WAL.N / RDSb.L / SJW.N / MS.N / FIS.N / MA.N / HOG.N / GALP.LS / 3IN.L / ATL.MI / BGS.N / PPL.TO / SLRS.MC / DAN.N / VALE.N / SPB.N / BHPB.L / NEE.N / CAML.L / PCRX.O / MTOR.N / GLEN.L / IFP.TO / MDLZ.OQ / ALLY.N / FANG.O / ABBV.N / TSLA.N / PRMW.N / TMUS.N / COTY.N / 81762P102 / CFF.TO / PTC.O / BTG.N / CFG.N / GLPG.O / TDOC.N / RACE.MI / TWLO.N / ADNT.N / VST.N / APTV.N / VNE.N / KDP.N / CWEN.N / OSMT.O / NWL.O / MORF.OQ / CRNC.OQ / 2222.SE / ETNB.O / WTRG.N / REYN.O / NKLA.OQ / FOUR.N / RXT.OQ / LUMN.N / MTCR.O / TLMD.OQ / WFG.N / AFRM.O / NAPA.N / CARE.TO / OSO.N / DSEY.O / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Autoliv Inc / Antofagasta PLC / Bank of America Corp / Bank of New York Mellon Corp / BP PLC / Citigroup Inc / Crown Castle International Corp / Colgate-Palmolive Co / Edison International / Estee Lauder Companies Inc / Eni SpA / Ford Motor Co / General Motors Co / Johnson & Johnson / JPMorgan Chase & Co / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / National Bank of Canada / Pfizer Inc / PNC Financial Services Group Inc / Repsol SA / Rio Tinto PLC / Southern Co / AT&T Inc / TotalEnergies SE / Visteon Corp / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Canfor Corp / Campbell Soup Co / Tenneco Inc / Comcast Corp / Check Point Software Technologies Ltd / Amgen Inc / Incyte Corp / Tenet Healthcare Corp / Universal Health Services Inc / Anglo American PLC / Duke Energy Corp / UnitedHealth Group Inc / Borgwarner Inc / Lear Corp / Kellogg Co / DISH Network Corp / Goldman Sachs Group Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / PG&E Corp / Exxon Mobil Corp / Edgewell Personal Care Co / SBA Communications Corp / American Tower Corp / Jazz Pharmaceuticals PLC / Boliden AB / CyrusOne Inc / Verizon Communications Inc / State Street Corp / HCA Healthcare Inc / Community Health Systems Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / Amphenol Corp / Fiserv Inc / Visa Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Brunswick Corp / Boston Beer Company Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Chevron Corp / NCR Corp / TE Connectivity Ltd / CenterPoint Energy Inc / Anglo Pacific Group PLC / Endo International PLC / BELLUS Health Inc / Chesapeake Utilities Corp / Polaris Inc / Sensata Technologies Holding PLC / Global Payments Inc / Monster Beverage Corp / Caseys General Stores Inc / Intercept Pharmaceuticals Inc / Equinix Inc / Alimentation Couche-Tard Inc / Altria Group Inc / Digital Realty Trust Inc / Neste Oyj / Hartford Financial Services Group Inc / Hershey Co / Western Forest Products Inc / Western Alliance Bancorp / Royal Dutch Shell PLC / SJW Group / Morgan Stanley / Fidelity National Information Services Inc / Mastercard Inc / Harley-Davidson Inc / Galp Energia SGPS SA / 3I Infrastructure PLC / Atlantia SpA / B&G Foods Inc / Pembina Pipeline Corp / Solaria Energia y Medio Ambiente SA / Dana Inc / Vale SA / Spectrum Brands Holdings Inc / BHP Group PLC / Nextera Energy Inc / Central Asia Metals PLC / Pacira Biosciences Inc / Meritor Inc / Glencore PLC / Interfor Corp / Mondelez International Inc / Ally Financial Inc / Diamondback Energy Inc / Abbvie Inc / Tesla Inc / Primo Water Corp / T-Mobile US Inc / Coty Inc / ServiceNow Inc / Conifex Timber Inc / PTC Inc / B2Gold Corp / Citizens Financial Group Inc / Galapagos NV / Teladoc Health Inc / Ferrari NV / Twilio Inc / Adient PLC / Vistra Corp / Aptiv PLC / Veoneer Inc / Keurig Dr Pepper Inc / Clearway Energy Inc / Osmotica Pharmaceuticals PLC / Newell Brands Inc / Morphic Holding Inc / Cerence Inc / Saudi Arabian Oil Co / 89Bio Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Nikola Corp / Shift4 Payments Inc / Rackspace Technology Inc / Lumen Technologies Inc / Metacrine Inc / Soc Telemed Inc / West Fraser Timber Co Ltd / Affirm Holdings Inc / Duckhorn Portfolio Inc / Dialogue Health Technologies Inc / Olo Inc / Diversey Holdings Ltd / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Brazil / Canada / Switzerland / Cayman Islands / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Netherlands / Portugal / Saudi Arabia / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US09061G1013 / US0028241000 / US0079731008 / US0116591092 / US0311621009 / US0382221051 / US0463531089 / US0556221044 / US1101221083 / US1924461023 / US1925761066 / US30161Q1040 / US30231G1022 / US3755581036 / US37733W1053 / US45337C1027 / US4567881085 / US4781601046 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US64125C1099 / US66987V1098 / US6701002056 / US7170811035 / US75886F1075 / US7711951043 / US8308791024 / US8447411088 / US8807701029 / US91307C1027 / US91347P1057 / US92532F1003 / US1667641005 / US89151E1091 / US4771431016 / US4198791018 / US2948216088 / US80105N1054 / US3463751087 / US09062X1037 / US90385V1070 / US0042251084 / US02043Q1076 / RDSa.AS / PAP310761054 / US16115Q3083 / US3020811044 / US29089Q1058 / US92932M1018 / US01748X1028 / US2473617023 / US87874R1005 / US03152W1099 / BMG3922B1072 / CH0102993182 / IE00B4BNMY34 / US58933Y1055 / US46333X1081 / US9100471096 / US03027X1000 / US29414B1044 / US00287Y1091 / NL0010273215 / US98978V1035 / US8036071004 / US4576693075 / US6951271005 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US8485771021 / US21240E1055 / US02376R1023 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / LU0974299876 / US78667J1088 / CA0089118776 / US2681582019 / US31572Q8087 / US22822V1017 / IE00BTN1Y115 / US09627Y1091 / US37890U1088 / US4622221004 / US07725L1026 / KYG4740B1059 / US2067871036 / US78410G1040 / US23355L1061 / IL0011407140 / US76243J1051 / US89854H1023 / US05351X1019 / US05455M1009 / US29260V1052 / US5904791358 / CA39342L1085 / US28414H1032 / US61775R1059 / US92537N1081 / US39813G1094 / US44891N1090 / US12769G1004 / US81181C1045 / US05875B1061</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Abbott Laboratories / Advanced Energy Industries Inc / Alaska Air Group Inc / Amgen Inc / Applied Materials Inc / AstraZeneca PLC / BP PLC / Bristol-Myers Squibb Co / Cognizant Technology Solutions Corp / Cohu Inc / Exelixis Inc / Exxon Mobil Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Incyte Corp / Infosys Ltd / Johnson & Johnson / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Neurocrine Biosciences Inc / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Teradyne Inc / United Therapeutics Corp / Universal Display Corp / Vertex Pharmaceuticals Inc / Chevron Corp / TotalEnergies SE / JetBlue Airways Corp / Hawaiian Holdings Inc / Telefonaktiebolaget LM Ericsson / Sanofi SA / FormFactor Inc / Biogen Inc / Ultra Clean Holdings Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Royal Dutch Shell PLC / Copa Holdings SA / Chart Industries Inc / Exlservice Holdings Inc / Emergent BioSolutions Inc / WNS (Holdings) Ltd / Allegiant Travel Co / Delta Air Lines Inc / TechTarget Inc / Amicus Therapeutics Inc / Genpact Ltd / TE Connectivity Ltd / Accenture PLC / Merck & Co Inc / Ironwood Pharmaceuticals Inc / United Airlines Holdings Inc / American Tower Corp / Epam Systems Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / Globant SA / SAGE Therapeutics Inc / Air Canada / Dynavax Technologies Corp / FibroGen Inc / Crown Castle International Corp / Medtronic PLC / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Ichor Holdings Ltd / Conduent Inc / SBA Communications Corp / DXC Technology Co / Urogen Pharma Ltd / Rhythm Pharmaceuticals Inc / TTEC Holdings Inc / Avaya Holdings Corp / AVROBIO Inc / Endava PLC / Mesa Air Group Inc / Green Thumb Industries Inc / Elanco Animal Health Inc / Morphic Holding Inc / Vertiv Holdings Co / Grid Dynamics Holdings Inc / IAC/Interactivecorp / Caesars Entertainment Inc / Seagen Inc / Bally's Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / India / Ireland / Israel / Luxembourg / Mexico / Netherlands / Panama / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">PD-(L)1 Market Model: Potential Price Erosion Offset By Adjuvant Visibility</td><td class="leftalignment">English</td><td class="rightalignment">79</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US7170811035 / US75886F1075 / US7711951043 / US80105N1054 / US58933Y1055 / US07725L1026</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Beigene Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Ms. Kathleen M. Miner, R.Ph., CFA</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N / JAZZ.O / PCRX.O</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / Pacira Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">BioPharma: RBC’s Rheum/Inflamm/Derm Day – Chronic Cough</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK.N / BLU.N</td><td class="leftalignment">Merck & Co Inc / BELLUS Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Gregory J. Renza, MD / Lisa Walter / Edwin Delfin / Daniel Busby / Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Luca Issi, PHD / Yinglu Zhang / Steve Daddeo / Leonid Timashev / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Pharmaceuticals - Zooming in: pharma out of favour, not out of mind</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">FR0000120578 / DE0006599905 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US5324571083 / US7170811035 / CH0013841017 / US58933Y1055 / US00287Y1091 / DK0060534915</td><td class="leftalignment">Sanofi SA / Merck KGaA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Lonza Group AG / Merck & Co Inc / Abbvie Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Xian Deng</td></tr>
<tr class="odd"><td class="leftalignment">04/18/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Paying It Forward With Better HIV Treatments</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">MRK / US3755581036</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">04/18/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Three Peas in a Podcast, Please Join Our Weekly Discussion on How Potential Catalysts and Events Could Impact Our Covered Companies</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ACRS.O / ACRX.O / EBS / HCM / JNJ / LLY / MRK / PFE / ALKS.O / JAZZ.O / CERS.O / OPTN.O / NCOX.PA / COLL.O / RMTI.O / AMRN.O / BDSI.O / BSLN.S / MNKD.O / ZTS / OMER.O / SPRO.O / ANIP.O / AXGN.O / AERI.O / HRTX.O / TRVN.O / EGRX.O / SCYX.O / ARDX.O / ALDX.O / CFRX.O / CDTX.O / SPNE.O / FBIO.O / MESO.O / VRAY.O / VERU.O / TXMD.O / AYTU.O / CKPT.O / EYPT.O / UBX.O / EOLS.O / ARDS.O / ARAV.O / SIBN.O / ETTX.O / ARQT.O / PCVX.O / SRGA.O / VYNE.O / HGEN.O / AZYO.O / GRAY.O / IMAB.O / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / Emergent BioSolutions Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Cerus Corp / OptiNose Inc / Nicox SA / Collegium Pharmaceutical Inc / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Zoetis Inc / Omeros Corp / Spero Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / Ardelyx Inc / Aldeyra Therapeutics Inc / ContraFect Corp / Cidara Therapeutics Inc / SeaSpine Holdings Corp / Fortress Biotech Inc / Mesoblast Ltd / ViewRay Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Checkpoint Therapeutics Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Evolus Inc / Aridis Pharmaceuticals Inc / Aravive Inc / SI-BONE Inc / Entasis Therapeutics Holdings Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Humanigen Inc / Aziyo Biologics Inc / Graybug Vision Inc / I-Mab / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/18/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 5% Above Pre-Pandemic Level - Week 55</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/17/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Small-cap Growth Next Up in the Rotation Line</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MRK=US / NVS=US / SMTC=US / MMC=US / PGR=US / AJG=US / NVAX=US / PRGO=US / KWR=US / OSTK=US / APPN=US / AON=US / CORT=US / NEO=US / SAIL=US / VTRS=US / IBRX=US</td><td class="leftalignment">Merck & Co Inc / Novartis AG / Semtech Corp / Marsh & McLennan Companies Inc / Progressive Corp / Arthur J Gallagher & Co / Novavax Inc / Perrigo Company PLC / Quaker Chemical Corp / Overstock.com Inc / Appian Corp / Aon PLC / Corcept Therapeutics Inc / Neogenomics Inc / SailPoint Technologies Holdings Inc / Viatris Inc / Immunitybio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Financial Services</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Investment Strategy / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 4.16.21</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / CPSI=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / OM=US / GNCA=US / TBPH=US / ALDX=US / ASMB=US / HQY=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Computer Programs and Systems Inc / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Outset Medical Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / Aldeyra Therapeutics Inc / Assembly Biosciences Inc / Healthequity Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--April 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">FSTX=US / GANX=US / MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / MDT=US / WMT=US / INCY=US / CMS=US / DGX=US / NVS=US / AZN=US / GSK=US / CRY=US / RAD=US / JNJ=US / HCA=US / UCB=BE / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / APLS=US / ATRC=US / CHE=US / CYH=US / EW=US / ISEE=US / GEN=US / ISRG=US / PHG=US / LH=US / PRVL=US / REGN=US / USPH=US / UHS=US / VRTX=US / SGEN=US / SAGE=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ICAD=US / ENSG=US / MD=US / SLF=US / IGMS=US / BIIB=US / ISR=US / SLP=US / MRNA=US / ALNY=US / GOOG=US / INO=US / LHCG=US / CHNG=US / OSCR=US / FOLD=US / EHC=US / TMDI=US / ADXN=US / SWAV=US / ADUS=US / SRNE=US / RGNX=US / ANVS=US / ACHC=US / PRTA=US / MRTX=US / MGNX=US / AERI=US / XNCR=US / TRVN=US / FLXN=US / CTRE=US / VBIV=US / WBA=US / NVTA=US / EVH=US / TDOC=US / NVCR=US / VYGR=US / MRUS=US / APVO=US / IRTC=US / CRSP=US / IOVA=US / MTEM=US / SYBX=US / NCNA=US / MDNA=US / ALLO=US / IDYA=US / BCYC=US / PSNL=US / ONCT=US / NBSE=US / DMTK=US / BNTX=US / PNTG=US / PASG=US / LYS=US / ORIC=US / INBX=US / TSHA=US / KDNY=US / SIOX=US</td><td class="leftalignment">F-Star Therapeutics Inc / Gain Therapeutics Inc / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Medtronic PLC / Walmart Inc / Incyte Corp / CMS Energy Corp / Quest Diagnostics Inc / Novartis AG / AstraZeneca PLC / GlaxoSmithKline PLC / CryoLife Inc / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Ucb SA / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Apellis Pharmaceuticals Inc / AtriCure Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Iveric Bio Inc / General Electric Co / Intuitive Surgical Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / Porvair PLC / Regeneron Pharmaceuticals Inc / US Physical Therapy Inc / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Seagen Inc / SAGE Therapeutics Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / ICAD Inc / Ensign Group Inc / MEDNAX Inc / Sun Life Financial Inc / IGM Biosciences Inc / Biogen Inc / IsoRay Inc / Simulations Plus Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / LHC Group Inc / Change Healthcare Inc / Oscar Health Inc / Amicus Therapeutics Inc / Encompass Health Corp / Titan Medical Inc / Addex Therapeutics Ltd / Shockwave Medical Inc / Addus Homecare Corp / Sorrento Therapeutics Inc / Regenxbio Inc / Annovis Bio Inc / Acadia Healthcare Company Inc / Prothena Corporation PLC / Mirati Therapeutics Inc / MacroGenics Inc / Aerie Pharmaceuticals Inc / Xencor Inc / Trevena Inc / Pacira Biosciences Inc / CareTrust REIT Inc / VBI Vaccines Inc / Walgreens Boots Alliance Inc / Invitae Corp / Evolent Health Inc / Teladoc Health Inc / Novocure Ltd / Voyager Therapeutics Inc / Merus NV / Aptevo Therapeutics Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Molecular Templates Inc / Synlogic Inc / NuCana PLC / Medicenna Therapeutics Corp / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / Bicycle Therapeutics PLC / Personalis Inc / Oncternal Therapeutics Inc / NeuBase Therapeutics Inc / DermTech Inc / BioNTech SE / Pennant Group Inc / Passage Bio Inc / Lysogene SA / Oric Pharmaceuticals Inc / Inhibrx Inc / Taysha Gene Therapies Inc / Chinook Therapeutics Inc / Sio Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Germany / France / United Kingdom / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What's Next For Roche's Stock?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">RHHBY.PK / JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Roche Holding AG / Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending Apr 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">April 2021 issue of "Monthly Controversies" report</td><td class="leftalignment">English</td><td class="rightalignment">171</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ACI=US / FSTX=US / AAPL=US / IBM=US / MRK=US / PFE=US / AMGN=US / BMY=US / DIS=US / INTC=US / MSFT=US / C=US / GLW=US / AMZN=US / QCOM=US / T=US / ORCL=US / VOD=US / WMT=US / INCY=US / BAC=US / USB=US / AMT=US / DOX=US / NVDA=US / GS=US / AKAM=US / CHTR=US / NICE=US / NVS=US / VZ=US / URI=US / TSM=US / CCI=US / UPS=US / AZN=US / GSK=US / JNJ=US / TTWO=US / ATVI=US / PNC=US / CMCSA=US / UNH=US / DISH=US / INTU=US / NUAN=US / APPS=US / HRB=US / CTL=US / CME=US / EGAN=US / EGHT=US / EQIX=US / HEAR=US / QUIK=US / REGN=US / SBAC=US / VG=US / WSC=US / RDWR=US / SNOW=US / NET=US / CRNT=US / RHHBY=US / GME=US / FB=US / NFLX=US / VRNT=US / TWLO=US / ERIC=US / IGMS=US / RNG=US / CEVA=US / MRNA=US / GOOG=US / DLR=US / VIAC=US / INO=US / HSBC=US / DISCA=US / PDD=US / CCOI=US / LLNW=US / LUMN=US / BBVA=US / 700-HK=US / UBI-PAR=US / TSLA=US / ZNGA=US / EA=US / TMUS=US / MGNX=US / GTT=US / XNCR=US / AVYA=US / GOOGL=US / TSLX=US / FIVN=US / BABA=US / NVTA=US / MRUS=US / APVO=US / DZSI=US / TEUM=US / ATUS=US / BILI=US / HUYA=US / ZM=US / FSLY=US / ONCT=US / CMBM=US / DMTK=US / BNTX=US / DKNG=US / INBX=US / KDNY=US / CRSR=US / RXT=US / ONDS=US / PLTK=US / DOCN=US</td><td class="leftalignment">Albertsons Companies Inc / F-Star Therapeutics Inc / Apple Inc / International Business Machines Corp / Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Intel Corp / Microsoft Corp / Citigroup Inc / Corning Inc / Amazon.com Inc / Qualcomm Inc / AT&T Inc / Oracle Corp / Vodafone Group PLC / Walmart Inc / Incyte Corp / Bank of America Corp / US Bancorp / American Tower Corp / Amdocs Ltd / NVIDIA Corp / Goldman Sachs Group Inc / Akamai Technologies Inc / Charter Communications Inc / Nice Ltd / Novartis AG / Verizon Communications Inc / United Rentals Inc / Taiwan Semiconductor Manufacturing Co Ltd / Crown Castle International Corp / United Parcel Service Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Take-Two Interactive Software Inc / Activision Blizzard Inc / PNC Financial Services Group Inc / Comcast Corp / UnitedHealth Group Inc / DISH Network Corp / Intuit Inc / Nuance Communications Inc / Digital Turbine Inc / H & R Block Inc / Lumen Technologies Inc / CME Group Inc / eGain Corp / 8x8 Inc / Equinix Inc / Turtle Beach Corp / QuickLogic Corp / Regeneron Pharmaceuticals Inc / SBA Communications Corp / Vonage Holdings Corp / Willscot Mobile Mini Holdings Corp / Radware Ltd / Snowflake Inc. / Cloudflare Inc / Ceragon Networks Ltd / Roche Holding AG / GameStop Corp / Meta Platforms Inc / Netflix Inc / Verint Systems Inc / Twilio Inc / Telefonaktiebolaget LM Ericsson / IGM Biosciences Inc / RingCentral Inc / CEVA Inc / Moderna Inc / Alphabet Inc / Digital Realty Trust Inc / ViacomCBS Inc / Inovio Pharmaceuticals Inc / HSBC Holdings PLC / Discovery Inc / Pinduoduo Inc / Cogent Communications Holdings Inc / Limelight Networks Inc / Lumen Technologies Inc / Banco Bilbao Vizcaya Argentaria SA / Tencent Holdings Ltd / Ubisoft Entertainment SA / Tesla Inc / Zynga Inc / Electronic Arts Inc / T-Mobile US Inc / MacroGenics Inc / GTT Communications Inc / Xencor Inc / Avaya Holdings Corp / Alphabet Inc / Sixth Street Specialty Lending Inc / Five9 Inc / Alibaba Group Holding Ltd / Invitae Corp / Merus NV / Aptevo Therapeutics Inc / DZS Inc / Pareteum Corp / Altice USA Inc / Bilibili Inc / HUYA Inc / Zoom Video Communications Inc / Fastly Inc / Oncternal Therapeutics Inc / Cambium Networks Corp / DermTech Inc / BioNTech SE / DraftKings Inc / Inhibrx Inc / Chinook Therapeutics Inc / Corsair Gaming Inc / Rackspace Technology Inc / Ondas Holdings Inc / Playtika Holding Corp / DigitalOcean Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / Germany / Spain / United Kingdom / Israel / Netherlands / Sweden / Taiwan / United States / Guernsey</td><td class="leftalignment">Banks / Biotechnology / Consumer / Financial Services / Healthcare / Info. Tech./Computers / Retailing / Semiconductors / Services / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 16 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0116591092 / US0463531089 / US1101221083 / US1264081035 / US1265011056 / US22284P1057 / US2254471012 / US2371941053 / US28176E1082 / US3021301094 / US37733W1053 / US4433201062 / US4456581077 / US4663671091 / US5150981018 / US5324571083 / US5370081045 / US5801351017 / US5951121038 / US6558441084 / US66987V1098 / US6701002056 / US6795801009 / US7134481081 / US7170811035 / US7392761034 / US7711951043 / US7782961038 / US8168501018 / US8308791024 / US8447411088 / US8552441094 / US8725401090 / US9029251066 / US9078181081 / US91324P1021 / US92343V1044 / US9282981086 / US9507551086 / US9581021055 / CA1363751027 / CA13645T1003 / US87157D1090 / US9884981013 / US4771431016 / US83088M1027 / US4198791018 / US80105N1054 / US25754A2015 / US12541W2098 / US00206R1023 / US1696561059 / US82706C1080 / US78709Y1055 / PAP310761054 / US75025X1000 / US01748X1028 / US64110D1046 / US58933Y1055 / IE00B58JVZ52 / US9100471096 / US95058W1009 / US9837931008 / US00287Y1091 / US98978V1035 / US8725901040 / US55405Y1001 / US69366J2006 / US8485771021 / US21240E1055 / US1220171060 / US02376R1023 / US03937C1053 / CA76131D1033 / US74736K1016 / US8190471016 / US9741551033 / CA1380351009 / US74624M1027 / US00938A1043 / CA87241L1094 / CA35805P1071 / CA22717L1013 / US23753F1075 / US80689H1023 / US4990491049 / US09354A1007 / CA88105E1088 / US88688T1007 / US5904791358 / CA39342L1085 / US28414H1032 / CA22587M1068 / CA89788C1041 / CA23126M1023 / CA86730L1094 / US24984K1051 / CA1973091079 / CA05156X8843 / GB00BMVP7Y09 / US07373B1098 / US56854Q2003 / ACRGau.CD / US3441741077 / US74767V1098 / US7761531083 / US03743Q1085 / US15961R1059</td><td class="leftalignment">Alaska Air Group Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / CTS Corp / Covenant Logistics Group Inc / Wolfspeed Inc / Darden Restaurants Inc / Edwards Lifesciences Corp / Expeditors International of Washington Inc / GlaxoSmithKline PLC / Hub Group Inc / J B Hunt Transport Services Inc / Jack in the Box Inc / Landstar System Inc / Eli Lilly and Co / Littelfuse Inc / McDonald's Corp / Micron Technology Inc / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / PepsiCo Inc / Pfizer Inc / Power Integrations Inc / Roche Holding AG / Ross Stores Inc / Semtech Corp / SkyWest Inc / Southwest Airlines Co / Starbucks Corp / TJX Companies Inc / USA Truck Inc / Union Pacific Corp / UnitedHealth Group Inc / Verizon Communications Inc / Vishay Intertechnology Inc / Werner Enterprises Inc / Western Digital Corp / Canadian National Railway Co / Canadian Pacific Railway Ltd / Synaptics Inc / Yum! Brands Inc / JetBlue Airways Corp / Skyworks Solutions Inc / Hawaiian Holdings Inc / Sanofi SA / Domino's Pizza Inc / CH Robinson Worldwide Inc / AT&T Inc / Chipotle Mexican Grill Inc / Silicon Motion Technology Corp / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Allegiant Travel Co / NetApp Inc / Merck & Co Inc / Seagate Technology Holdings PLC / United Airlines Holdings Inc / Wendys Co / XPO Logistics Inc / Abbvie Inc / Zoetis Inc / T-Mobile US Inc / MACOM Technology Solutions Holdings Inc / PTC Therapeutics Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Burlington Stores Inc / American Airlines Group Inc / ArcBest Corp / Restaurant Brands International Inc / Qorvo Inc / Shake Shack Inc / Wingstop Inc / Canopy Growth Corp / Pure Storage Inc / Airgain Inc / TFI International Inc / Freshii Inc / Cronos Group Inc / Daseke Inc / Schneider National Inc / Knight-Swift Transportation Holdings Inc / Blink Charging Co / Terrascend Corp / Tilray Brands Inc / Mesa Air Group Inc / Green Thumb Industries Inc / Elanco Animal Health Inc / Cresco Labs Inc / Trulieve Cannabis Corp / Curaleaf Holdings Inc / Sundial Growers Inc / DermTech Inc / Columbia Care Inc / Aurora Cannabis Inc / Royalty Pharma PLC / Beam Global / Marinus Pharmaceuticals Inc / Acreage Holdings Inc / Foghorn Therapeutics Inc. / Quantumscape Corp / Romeo Power Inc / APA Corp (US) / ChargePoint Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / PEP=US / AMGN=US / BMY=US / DIS=US / PLD=US / AMZN=US / CPE=US / VRM=US / BRO=US / EXPE=US / UNH=US / KIDS=US / AJG=US / MAN=US / REGN=US / SNAP=US / TRIP=US / WIX=US / BKNG=US / FB=US / KIM=US / PTON=US / STRO=US / BIIB=US / AAWW=US / CLNY=US / GDOT=US / PCRX=US / ANGI=US / SPLK=US / PTCT=US / VCYT=US / QURE=US / GOOGL=US / BABA=US / CMPR=US / GDDY=US / WLTW=US / CVNA=US / SFIX=US / FTDR=US / SVMK=US / HARP=US / LYFT=US / UBER=US / TCRR=US / GMAB=US / CRMD.US</td><td class="leftalignment">Merck & Co Inc / PepsiCo Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Prologis Inc / Amazon.com Inc / Callon Petroleum Co / Vroom Inc / Brown & Brown Inc / Expedia Group Inc / UnitedHealth Group Inc / OrthoPediatrics Corp / Arthur J Gallagher & Co / ManpowerGroup Inc / Regeneron Pharmaceuticals Inc / Snap Inc / Tripadvisor Inc / Wix.Com Ltd / Booking Holdings Inc / Meta Platforms Inc / Kimco Realty Corp / Peloton Interactive Inc / Sutro Biopharma Inc / Biogen Inc / Atlas Air Worldwide Holdings Inc / DigitalBridge Group Inc / Green Dot Corp / Pacira Biosciences Inc / Angi Inc / Splunk Inc / PTC Therapeutics Inc / Veracyte Inc / Uniqure NV / Alphabet Inc / Alibaba Group Holding Ltd / Cimpress PLC / GoDaddy Inc / Willis Towers Watson PLC / Carvana Co / Stitch Fix Inc / Frontdoor Inc / Momentive Global Inc / Harpoon Therapeutics Inc / Lyft Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / Genmab A/S / CorMedix Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Denmark / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q1:21 Results Preview</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US98978V1035 / US28414H1032 / GB00BMVP7Y09</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Zoetis Inc / Elanco Animal Health Inc / Royalty Pharma PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">AACR Takeaways: Rise Of The Immune-Cell Engagers (Biotech) (Updated)</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRK=US / AMGN=US / REGN=US / HARP=US / TCRR=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Avi Dahan</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">0925288 / 2681511 / 2008154 / 2778844 / 2219224 / 2270726 / 2317087 / 2670519 / 2100920 / 2459020 / 2689560 / 2440637 / 2170473 / B125XQ6 / B02R1L6 / B7TL820 / BJ3V905 / BFZCHN7 / BYVY8G0 / BYW36M8 / BXDZ9Z0 / BYNZGK1 / BLGJ610 / BFNR303 / BYXJQG9 / BMDCDP2 / BJNQGL0 / BLBLMD5 / BMC8SQ7</td><td class="leftalignment">GlaxoSmithKline PLC / PepsiCo Inc / Adobe Inc / Merck & Co Inc / CMS Energy Corp / Walt Disney Co / Entergy Corp / Exelon Corp / FirstEnergy Corp / Intuit Inc / PG&E Corp / CenterPoint Energy Inc / Constellation Brands Inc / Portland General Electric Co / ALLETE Inc / Meta Platforms Inc / Endo International PLC / Wix.Com Ltd / Alphabet Inc / PayPal Holdings Inc / Shopify Inc / Block Inc / Warner Music Group Corp / Northwest Natural Holding Co / Spire Inc / Bigcommerce Holdings Inc / Rite Aid Corp / Array Technologies Inc / BTRS Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY.N / JNJ.N / LLY.N / PFE.N / AZN.L / MRCG.DE / AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / MRNA.OQ / ACRX.OQ / ABBV.N / MGNX.OQ / SAGE.OQ / GRTX.OQ</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Merck KGaA / Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Moderna Inc / AcelRx Pharmaceuticals Inc / Abbvie Inc / MacroGenics Inc / SAGE Therapeutics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">BNP Paribas Exane</td><td class="leftalignment">PHARMACEUTICALS : In my defence</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">ROG.S / AZN.L / SASY.PA / NOVOb.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR</td><td class="leftalignment">Roche Holding AG / AstraZeneca PLC / Sanofi SA / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Cosmetics & Personal Care</td><td class="leftalignment">Euroland / Europe / Global</td><td class="leftalignment">INITIATING COVERAGE / INITIAL OPINION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Richard J. Parkes, PHD / Mr. Simon Mather, PHD / Mr. Gary Steventon</td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">AACR Takeaways: Rise Of The Immune-Cell Engagers</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / AMGN=US / REGN=US / HARP=US / TCRR=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Avi Dahan</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">A Potential North Star of Bispecific Antibody Engineering; Initiate at Outperform & $30 PT</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">FSTX=US / MRK=US / AMGN=US / BMY=US / INCY=US / NVS=US / GSK=US / REGN=US / RHHBY=US / IGMS=US / MGNX=US / XNCR=US / MRUS=US / APVO=US / INBX=US</td><td class="leftalignment">F-Star Therapeutics Inc / Merck & Co Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Novartis AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Roche Holding AG / IGM Biosciences Inc / MacroGenics Inc / Xencor Inc / Merus NV / Aptevo Therapeutics Inc / Inhibrx Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">MRK: Molnupiravir Advances to Ph 3 at High Dose in COVID Outpatients, While Discontinued Inpatient Development No Surprise...But Why So Slow?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2778844</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRNA=US / TSHA=US / MRK=US / NVS=US / AZN=US / LOGC=US / SGMO=US / FOLD=US / RGNX=US / SRPT=US / QURE=US / AGTC=US / NVTA=US / VYGR=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / KRYS=US / SLDB=US / RCKT=US / FIXX=US / MGTX=US / PASG=US / SIGHT:FP=FR / SIOX=US</td><td class="leftalignment">Moderna Inc / Taysha Gene Therapies Inc / Merck & Co Inc / Novartis AG / AstraZeneca PLC / LogicBio Therapeutics Inc / Sangamo Therapeutics Inc / Amicus Therapeutics Inc / Regenxbio Inc / Sarepta Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Invitae Corp / Voyager Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Krystal Biotech Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / MeiraGTx Holdings PLC / Passage Bio Inc / Gensight Biologics SA / Sio Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Korea, Republic of / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">MRNA (Buy, $182): Vaccines Day outlines path to build on mRNA-1273 successes</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA=US / MRK=US / AZN=US / LOGC=US / SGMO=US / FOLD=US / RGNX=US / QURE=US / AGTC=US / VYGR=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / 199800=KR / KRYS=US / SLDB=US / MGTX=US</td><td class="leftalignment">Moderna Inc / Merck & Co Inc / AstraZeneca PLC / LogicBio Therapeutics Inc / Sangamo Therapeutics Inc / Amicus Therapeutics Inc / Regenxbio Inc / Uniqure NV / Applied Genetic Technologies Corp / Voyager Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / ToolGen Inc / Krystal Biotech Inc / Solid Biosciences Inc / MeiraGTx Holdings PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / United Kingdom / Korea, Republic of / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / DR. Gbola B. Amusa,  MD, CFA, CFA</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MTEM=US / SPXC=US / AAPL=US / DELL=US / IBM=US / MRK=US / VECO=US / INTC=US / ADI=US / AMD=US / MSFT=US / C=US / AMZN=US / QCOM=US / ORCL=US / TXN=US / BAC=US / WFC=US / NVDA=US / GS=US / MPWR=US / JPM=US / STM=FR / SMTC=US / AZN=US / XLNX=US / KLAC=US / CSL=US / IEX=US / TTWO=US / LRCX=US / ATVI=US / ASML=US / LECO=US / DOV=US / APPS=US / AVGO=US / CRUS=US / DCI=US / EQIX=US / FLS=US / GGG=US / HEAR=US / ITT=US / IFX=US / NOW=US / MCHP=US / TEAM=US / PNR=US / SHOP=US / WTS=US / ACN=US / NET=US / GME=US / AOS=US / FB=US / SWKS=US / TWLO=US / CEVA=US / MRNA=US / GOOG=US / DLR=US / MWA=US / AIMC=US / VMW=US / 700-HK=US / UBI-PAR=US / TCEHY=US / MXL=US / NXPI=US / 2454-TW=US / XYL=US / ZNGA=US / EA=US / RXN=US / GOOGL=US / PAYC=US / BABA=US / HUBS=US / QRVO=US / ON=US / AKTS=US / MDB=US / BILI=US / HUYA=US / ESTC=US / UBER=US / FSLY=US / CRSR=US / RXT=US / ABNB=US / PLTK=US / DOCN=US</td><td class="leftalignment">Molecular Templates Inc / SPX Corp / Apple Inc / Dell Technologies Inc / International Business Machines Corp / Merck & Co Inc / Veeco Instruments Inc / Intel Corp / Analog Devices Inc / Advanced Micro Devices Inc / Microsoft Corp / Citigroup Inc / Amazon.com Inc / Qualcomm Inc / Oracle Corp / Texas Instruments Inc / Bank of America Corp / Wells Fargo & Co / NVIDIA Corp / Goldman Sachs Group Inc / Monolithic Power Systems Inc / JPMorgan Chase & Co / STMicroelectronics NV / Semtech Corp / AstraZeneca PLC / Xilinx Inc / KLA Corp / Carlisle Companies Inc / IDEX Corp / Take-Two Interactive Software Inc / Lam Research Corp / Activision Blizzard Inc / ASML Holding NV / Lincoln Electric Holdings Inc / Dover Corp / Digital Turbine Inc / Broadcom Inc / Cirrus Logic Inc / Donaldson Company Inc / Equinix Inc / Flowserve Corp / Graco Inc / Turtle Beach Corp / ITT Inc / Infineon Technologies AG / ServiceNow Inc / Microchip Technology Inc / Atlassian Corporation PLC / Pentair PLC / Shopify Inc / Watts Water Technologies Inc / Accenture PLC / Cloudflare Inc / GameStop Corp / A O Smith Corp / Meta Platforms Inc / Skyworks Solutions Inc / Twilio Inc / CEVA Inc / Moderna Inc / Alphabet Inc / Digital Realty Trust Inc / Mueller Water Products Inc / Altra Industrial Motion Corp / VMware Inc / Tencent Holdings Ltd / Ubisoft Entertainment SA / Tencent Holdings Ltd / Maxlinear Inc / NXP Semiconductors NV / MediaTek Inc / Xylem Inc / Zynga Inc / Electronic Arts Inc / Zurn Water Solutions Corp / Alphabet Inc / Paycom Software Inc / Alibaba Group Holding Ltd / HubSpot Inc / Qorvo Inc / ON Semiconductor Corp / Akoustis Technologies Inc / MongoDB Inc / Bilibili Inc / HUYA Inc / Elastic NV / Uber Technologies Inc / Fastly Inc / Corsair Gaming Inc / Rackspace Technology Inc / Airbnb Inc / Playtika Holding Corp / DigitalOcean Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Germany / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Financial Services / Info. Tech./Computers / Info. Tech./Software / Machinery / Semiconductors / Telecommunications</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - Elliott Advisors takes stake in GSK</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GSK.L / JNJ.N / LLY.N / PFE.N / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / MRCG.DE / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / BMRN.OQ / VRTX.OQ / BAYGN.DE</td><td class="leftalignment">GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Merck KGaA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Apr 02, 2021</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - TP cut from £14 to £13 on Fx driven EPS cut & lower than consensus dividend expectations</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">GSK.L / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / HIK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Hikma Pharmaceuticals PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">04/14/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Second Vaccine Day: Platform Starting to Shine</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRNA=US / MRK=US / AZN=US</td><td class="leftalignment">Moderna Inc / Merck & Co Inc / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Correction: A Guide to TIGIT Tickers and Trades in 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / GILD=US / CGEN=US / MREO=US / RCUS=US / BGNE=US / ITOS=US</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc / Compugen Ltd / Mereo Biopharma Group PLC / Arcus Biosciences Inc / Beigene Ltd / Iteos Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United Kingdom / Israel / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Daina Graybosch, PHD / Mr. Geoffrey Porges / Joseph P. Schwartz</td></tr>
<tr class="even"><td class="leftalignment">04/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2486813 / 2778844 / 2026242 / 2219224 / 2270726 / 2542049 / 2317087 / 2369174 / 2515030 / 2645409 / 2689560 / 2707677 / 2440637 / 2138158 / 2980906 / 2857817 / B125XQ6 / B3D7K31 / B1HJLW5 / B7TL820 / B7VD3F2 / BJ3V905 / BJ0XLZ3 / BFLR866 / BFZCHN7 / BVVN4Q8 / BQPVQZ6 / BYVY8G0 / BFNF1D6 / BD9GVY0 / BFMXGR0 / BYXJQG9 / BZ1LFG7 / BK71LY6 / BFFVVC1 / BLBLMD5 / BNTB3N8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Kellogg Co / Merck & Co Inc / American Electric Power Company Inc / CMS Energy Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Gilead Sciences Inc / Lithia Motors Inc / NiSource Inc / PG&E Corp / Public Service Enterprise Group Inc / CenterPoint Energy Inc / Sempra Energy / Foot Locker Inc / Netflix Inc / Portland General Electric Co / Discovery Inc / Emergent BioSolutions Inc / Meta Platforms Inc / Duke Energy Corp / Endo International PLC / Heron Therapeutics Inc / Twitter Inc / Wix.Com Ltd / Eversource Energy / Horizon Therapeutics PLC / Alphabet Inc / Amneal Pharmaceuticals Inc / Zai Lab Ltd / Evergy Inc / Spire Inc / Roku Inc / WW International Inc / Bausch Health Companies Inc / Array Technologies Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">04/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">1Q21 Global Biopharma Preview: Drug Pricing & Macro Remain Overhangs; Group Fundamentals Solid & Unchanged</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">0989529 / 2126335 / 5671735 / 0925288 / 2516152 / 2778844 / 7103065 / BHC8X90</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Sanofi SA / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">04/14/2021</td><td class="leftalignment">HSBC</td><td class="leftalignment">Merck KGaA (MRK GR):-Downgrade to Reduce: Growing strongly but more than in the price</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRCG.F</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">COMPANY / COMPANY UPDATE / COMPANY REPORT / EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Stephen McGarry / Ms. Julie Mead</td></tr>
<tr class="odd"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / OXY=US / RRC=US / WEN=US / BLD=US / DVN=US / INCY=US / TEVA=US / AMT=US / NVDA=US / APA=US / CPE=US / EOG=US / REI=US / VZ=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / CCI=US / MGY=US / SWN=US / MUR=US / CHRS=US / BRO=US / MRO=US / LEG=US / DISH=US / CBRL=US / CNX=US / DRI=US / EQT=US / GFF=US / IBP=US / MAS=US / MHK=US / REGI=US / SBAC=US / CVX=US / SAGE=US / BXS=US / MKL=US / COP=US / DIN=US / JRVR=US / BIIB=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / CADE=US / TAST=US / QSR=US / CLR=US / PRPL=US / NMTR=US / TIL=US / NOG=US / IAC=US / JACK=US / TREX=US / KNSL=US / AR=US / ESTE=US / FBHS=US / ANGI=US / BCEI=US / MTDR=US / PDCE=US / FANG=US / ABBV=US / TILE=US / TMUS=US / NDLS=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / WING=US / 82982L103 / CDEV=US / IRTC=US / CRSP=US / PVAC=US / JELD=US / SBOW=US / ALLO=US / LYFT=US / UBER=US / TCRR=US / RTLR=US / FERG=US / GMAB=US / OVV=US / ARQT=US / FBRX=US / AZEK=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Wendys Co / TopBuild Corp / Devon Energy Corp / Incyte Corp / Teva Pharmaceutical Industries Ltd / American Tower Corp / NVIDIA Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Verizon Communications Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Crown Castle International Corp / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Coherus BioSciences Inc / Brown & Brown Inc / Marathon Oil Corp / Leggett & Platt Inc / DISH Network Corp / Cracker Barrel Old Country Store Inc / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / SBA Communications Corp / Chevron Corp / SAGE Therapeutics Inc / Cadence Bank / Markel Corp / Conocophillips / Dine Brands Global Inc / James River Group Holdings Ltd / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Purple Innovation Inc / 9 Meters Biopharma Inc / Instil Bio Inc / Northern Oil and Gas Inc / IAC/Interactivecorp / Jack in the Box Inc / Trex Company Inc / Kinsale Capital Group Inc / Antero Resources Corp / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Angi Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Abbvie Inc / Interface Inc / T-Mobile US Inc / Noodles & Co / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Ranger Oil Corp / JELD-WEN Holding Inc / SilverBow Resources Inc / Allogene Therapeutics Inc / Lyft Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / Rattler Midstream LP / Ferguson PLC / Genmab A/S / Ovintiv Inc / Arcutis Biotherapeutics Inc / Forte Biosciences Inc / Azek Company Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Denmark / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Assessing pipeline value</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser</td></tr>
<tr class="odd"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">US Major Pharma – Assessing pipeline value and optionality</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / BMY=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">04/13/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma  : 1Q Earnings Preview – Many Moving Pieces But Underlying Trends Remain Healthy</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ABBV.N / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Animal Tracks: Survey Says: 1Q Vet Demand Purrs; Continuing Optimism into '21; Highlight ZTS Innovation; A Vet's Perspective on ELAN's Seresto</td><td class="leftalignment">English</td><td class="rightalignment">66</td><td class="leftalignment">MRK.N / VIRB.PA / WMT.N / DPH.L / ABC.N / IDXX.OQ / PDCO.OQ / HSIC.OQ / AMZN.OQ / HSKA.OQ / PETS.OQ / BAYGN.DE / ZTS.N / PAHC.OQ / ELAN.N / CVET.OQ / CHWY.N</td><td class="leftalignment">Merck & Co Inc / Virbac SA / Walmart Inc / Dechra Pharmaceuticals PLC / Amerisourcebergen Corp / IDEXX Laboratories Inc / Patterson Companies Inc / Henry Schein Inc / Amazon.com Inc / Heska Corp / Petmed Express Inc / Bayer AG / Zoetis Inc / Phibro Animal Health Corp / Elanco Animal Health Inc / Covetrus Inc / Chewy Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS.OQ / ACRX.OQ / 0715.HK / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BDSI.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / OMER.OQ / ARDX.OQ / ZTS.N / ANIP.OQ / AXGN.OQ / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / CKPT.OQ / VERU.OQ / TXMD.OQ / AYTU.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / IMAB.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / AZYO.OQ / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / China Oceanwide Holdings Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Checkpoint Therapeutics Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / I-Mab / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Aziyo Biologics Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Consensus Estimates May Be High For 1Q21 Given Tough YoY Comps and COVID Surge At Beginning of Year</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 12 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">US0116591092 / US0231351067 / US0463531089 / US1101221083 / US37733W1053 / US45253H1014 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US37940X1028 / US4771431016 / US64110L1061 / US4198791018 / US80105N1054 / US31620M1062 / US1696561059 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US3390411052 / US30303M1027 / US96208T1043 / US00287Y1091 / US8485771021 / US60468T1051 / US21240E1055 / US5560991094 / US02376R1023 / US38000Q1022 / JE00BLG2ZQ72 / CA0089118776 / US8190471016 / US02079K1079 / US07725L1026 / IE00BY7QL619 / US83304A1060 / US8760301072 / US67022C1062 / US6085501095 / US59045L1061 / US5904791358 / KY30744W1070 / US76156B1070 / US70614W1009 / US76155X1000 / US44891N1090 / US5015751044 / US55406W1036 / 120404208</td><td class="leftalignment">Alaska Air Group Inc / Amazon.com Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / ImmunoGen Inc / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Global Payments Inc / JetBlue Airways Corp / Netflix Inc / Hawaiian Holdings Inc / Sanofi SA / Fidelity National Information Services Inc / Chipotle Mexican Grill Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Fleetcor Technologies Inc / Meta Platforms Inc / WEX Inc / Abbvie Inc / Spirit Airlines Inc / Mirati Therapeutics Inc / Controladora Vuela Compania de Aviacion SAB de CV / MacroGenics Inc / American Airlines Group Inc / GlycoMimetics Inc / Quotient Ltd / Air Canada / Shake Shack Inc / Alphabet Inc / Beigene Ltd / Johnson Controls International PLC / Snap Inc / Tapestry Inc / NuCana PLC / Molecular Templates Inc / Mersana Therapeutics Inc / Mesa Air Group Inc / Farfetch Ltd / Revolve Group Inc / Peloton Interactive Inc / Revolution Medicines Inc / IAC/Interactivecorp / Kymera Therapeutics Inc / MYT Netherlands Parent BV / MedAvail Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Japan / Mexico / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / CACI=US / AMGN=US / CAG=US / DIS=US / DVN=US / INCY=US / GILD=US / BC=US / CRM=US / IGT=US / BYD=US / SPOT=US / MGM=US / PENN=US / BL=US / COLL=US / EXEL=US / HZO=US / MCRI=US / NTST=US / PII=US / HOOK=US / REGN=US / THO=US / WGO=US / CGEN=US / SGMS=US / MANT=US / CRTO=US / NFLX=US / AUTL=US / BDSI=US / RRR=US / IGMS=US / STRO=US / PRG=US / CZR=US / BAH=US / NSP=US / KBR=US / PGTI=US / ICFI=US / SAIC=US / CWH=US / PSN=US / RCUS=US / TREX=US / OLO=US / FBHS=US / ZNGA=US / MEIP=US / LDOS=US / FATE=US / MBUU=US / COUP=US / BABA=US / HUBS=US / MCFT=US / IRTC=US / CRSP=US / LGF.B=US / ROKU=US / NCNA=US / ALLO=US / TCRR=US / NXTC=US / GMAB=US / ONEW=US / DKNG=US / AZEK=US / NCNO=US / BALY=US / RBLX=US</td><td class="leftalignment">Merck & Co Inc / CACI International Inc / Amgen Inc / Conagra Brands Inc / Walt Disney Co / Devon Energy Corp / Incyte Corp / Gilead Sciences Inc / Brunswick Corp / Salesforce.Com Inc / International Game Technology PLC / Boyd Gaming Corp / Spotify Technology SA / MGM Resorts International / Penn National Gaming Inc / Blackline Inc / Collegium Pharmaceutical Inc / Exelixis Inc / MarineMax Inc / Monarch Casino & Resort Inc / Netstreit Corp / Polaris Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Thor Industries Inc / Winnebago Industries Inc / Compugen Ltd / Scientific Games Corp / ManTech International Corp / Criteo SA / Netflix Inc / Autolus Therapeutics PLC / BioDelivery Sciences International Inc / Red Rock Resorts Inc / IGM Biosciences Inc / Sutro Biopharma Inc / PROG Holdings Inc / Caesars Entertainment Inc / Booz Allen Hamilton Holding Corp / Insperity Inc / KBR Inc / PGT Innovations Inc / ICF International Inc / Science Applications International Corp / Camping World Holdings Inc / Parsons Corp / Arcus Biosciences Inc / Trex Company Inc / Olo Inc / Fortune Brands Home & Security Inc / Zynga Inc / MEI Pharma Inc / Leidos Holdings Inc / Fate Therapeutics Inc / Malibu Boats Inc / Coupa Software Inc / Alibaba Group Holding Ltd / HubSpot Inc / Mastercraft Boat Holdings Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Lions Gate Entertainment Corp / Roku Inc / NuCana PLC / Allogene Therapeutics Inc / TCR2 Therapeutics Inc / NextCure Inc / Genmab A/S / OneWater Marine Inc / DraftKings Inc / Azek Company Inc / nCino Inc / Bally's Corp / Roblox Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">AACR Take-aways: Attack Of The Cytokines</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK=US / IGMS=US / STRO=US</td><td class="leftalignment">Merck & Co Inc / IGM Biosciences Inc / Sutro Biopharma Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Avi Dahan</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - April 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AFL.N / AIG.N / ALV.N / AMAT.O / AMD.N / ANA.MC / CB.N / CCI.N / CRM.N / EIX.N / F.N / GM.N / LRCX.O / MMC.N / MRK.N / PB.N / PFE.N / SO.N / T.N / TRV.N / VC.N / ZION.O / CMA.N / CFP.TO / ASML.O / LPX.N / TEN.N / CMCSA.O / AMGN.O / MET.N / DUK.N / HBAN.O / BWA.N / LEA.N / NVDA.O / DISH.O / UNM.N / PCG.N / SBAC.O / AMT.N / CONE.O / ADI.O / VZ.N / VLY.N / SNV.N / EXEL.O / PACW.O / STZ.N / CINF.O / LNC.N / APH.N / FISV.O / SNPS.O / ADSK.O / V.N / AXL.N / AWK.N / NWN.N / BC.N / DB1Gn.DE / AJG.N / BMRN.O / STL.N / REGN.O / PFG.N / MU.O / PRU.N / NCR.N / TEL.N / CNP.N / ENDP.O / CFR.N / CPK.N / FRC.N / MKL.N / BRO.N / PII.N / RLI.N / ST.N / WBS.N / FCF.N / SGEN.OQ / GPN.N / PFS.N / FFBC.O / PBCT.O / SIGI.O / SIVB.O / WSBC.O / HOOK.O / CASY.O / BOKF.O / COLB.O / ACGL.O / WTFC.O / TCBI.O / ATDb.TO / FHN.N / DLR.N / 416515104 / WEF.TO / WAL.N / ALNY.O / DISCA.O / CDNS.O / FIS.N / 025676206 / ISBC.O / MA.N / HOG.N / AON.N / DAN.N / WRB.N / 759351604 / HOMB.O / NEE.N / BKU.N / PCRX.O / MTOR.N / IFP.TO / SPLK.OQ / PANW.N / FFHu.TO / NYCB.N / ABBV.N / TSLA.N / TMUS.N / VOYA.N / PRTA.O / ONB.OQ / 81762P102 / CFF.TO / XNCR.OQ / COUP.N / QURE.O / GWB.N / ASB.N / AENA.MC / RGNX.O / MESO.O / RACE.MI / ADVM.OQ / TWLO.N / KNSL.OQ / ADNT.N / UNIT.O / OKTA.OQ / CADE.N / ATUS.N / BHF.O / AY.O / APTV.N / 05971J102 / AMRX.N / EQH.N / GSHD.O / VNE.N / ESTC.N / FIXX.O / CRWD.O / GMAB.O / CRNC.OQ / IGIC.OQ / NKLA.OQ / FOUR.N / DCT.O / LUMN.N / WFG.N / NUVB.N / NAPA.N / OSO.N</td><td class="leftalignment">Aflac Inc / American International Group Inc / Autoliv Inc / Applied Materials Inc / Advanced Micro Devices Inc / Acciona SA / Chubb Ltd / Crown Castle International Corp / Salesforce.Com Inc / Edison International / Ford Motor Co / General Motors Co / Lam Research Corp / Marsh & McLennan Companies Inc / Merck & Co Inc / Prosperity Bancshares Inc / Pfizer Inc / Southern Co / AT&T Inc / Travelers Companies Inc / Visteon Corp / Zions Bancorporation NA / Comerica Inc / Canfor Corp / ASML Holding NV / Louisiana-Pacific Corp / Tenneco Inc / Comcast Corp / Amgen Inc / MetLife Inc / Duke Energy Corp / Huntington Bancshares Inc / Borgwarner Inc / Lear Corp / NVIDIA Corp / DISH Network Corp / Unum Group / PG&E Corp / SBA Communications Corp / American Tower Corp / CyrusOne Inc / Analog Devices Inc / Verizon Communications Inc / Valley National Bancorp / Synovus Financial Corp / Exelixis Inc / PacWest Bancorp / Constellation Brands Inc / Cincinnati Financial Corp / Lincoln National Corp / Amphenol Corp / Fiserv Inc / Synopsys Inc / Autodesk Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Northwest Natural Holding Co / Brunswick Corp / Deutsche Boerse AG / Arthur J Gallagher & Co / Biomarin Pharmaceutical Inc / Sterling Bancorp / Regeneron Pharmaceuticals Inc / Principal Financial Group Inc / Micron Technology Inc / Prudential Financial Inc / NCR Corp / TE Connectivity Ltd / CenterPoint Energy Inc / Endo International PLC / Cullen/Frost Bankers Inc / Chesapeake Utilities Corp / First Republic Bank / Markel Corp / Brown & Brown Inc / Polaris Inc / Rli Corp / Sensata Technologies Holding PLC / Webster Financial Corp / First Commonwealth Financial Corp / Seagen Inc / Global Payments Inc / Provident Financial Services Inc / First Financial Bancorp / People's United Financial Inc / Selective Insurance Group Inc / SVB Financial Group / WesBanco Inc / HOOKIPA Pharma Inc / Caseys General Stores Inc / BOK Financial Corp / Columbia Banking System Inc / Arch Capital Group Ltd / Wintrust Financial Corp / Texas Capital Bancshares Inc / Alimentation Couche-Tard Inc / First Horizon Corp / Digital Realty Trust Inc / Hartford Financial Services Group Inc / Western Forest Products Inc / Western Alliance Bancorp / Alnylam Pharmaceuticals Inc / Discovery Inc / Cadence Design Systems Inc / Fidelity National Information Services Inc / American Equity Investment Life Holding Co / Investors Bancorp Inc / Mastercard Inc / Harley-Davidson Inc / Aon PLC / Dana Inc / W R Berkley Corp / Reinsurance Group of America Inc / Home BancShares Inc / Nextera Energy Inc / BankUnited Inc / Pacira Biosciences Inc / Meritor Inc / Interfor Corp / Splunk Inc / Palo Alto Networks Inc / Fairfax Financial Holdings Ltd / New York Community Bancorp Inc / Abbvie Inc / Tesla Inc / T-Mobile US Inc / Voya Financial Inc / Prothena Corporation PLC / Old National Bancorp / ServiceNow Inc / Conifex Timber Inc / Xencor Inc / Coupa Software Inc / Uniqure NV / Great Western Bancorp Inc / Associated Banc-Corp / Aena SME SA / Regenxbio Inc / Mesoblast Ltd / Ferrari NV / Adverum Biotechnologies Inc / Twilio Inc / Kinsale Capital Group Inc / Adient PLC / Uniti Group Inc / Okta Inc / Cadence Bank / Altice USA Inc / Brighthouse Financial Inc / Atlantica Sustainable Infrastructure PLC / Aptiv PLC / Cadence Bank / Amneal Pharmaceuticals Inc / Equitable Holdings Inc / Goosehead Insurance Inc / Veoneer Inc / Elastic NV / Homology Medicines Inc / CrowdStrike Holdings Inc / Genmab A/S / Cerence Inc / International General Insurance Holdings Ltd / Nikola Corp / Shift4 Payments Inc / Duck Creek Technologies Inc / Lumen Technologies Inc / West Fraser Timber Co Ltd / Nuvation Bio Inc / Duckhorn Portfolio Inc / Olo Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / United Kingdom / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">AACR Takeaways - ZNTL In Investor's Focus Among Many Early and Mostly Preclinical Data Presentations Among Our Coverage</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ZNTL.OQ / 5671735 / 0989529 / 2023607 / 2778844 / 2369174 / 2457864 / 2471950 / 4595739 / 7103065 / 2982924 / BCBVTX1 / BFDV8K0 / BBPK0J0 / BFZNYB7 / BK0VHF6 / BDHF4K6 / BZBY005 / BKS3SM8 / BMQ5T49 / BGCYWN8 / BKVDFF7 / BJXBP30 / BYQHPK7 / BYYWPW6 / BJ9NFQ3 / BWY52P3 / BL71K91 / BN2R582 / BDD1B07 / BMPRZV5 / BMDJ397</td><td class="leftalignment">Zentalis Pharmaceuticals Inc / Sanofi SA / AstraZeneca PLC / Amgen Inc / Merck & Co Inc / Gilead Sciences Inc / ImmunoGen Inc / Incyte Corp / Genmab A/S / Novartis AG / Spectrum Pharmaceuticals Inc / Agios Pharmaceuticals Inc / MacroGenics Inc / Mirati Therapeutics Inc / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / CRISPR Therapeutics AG / Merus NV / IGM Biosciences Inc / Zentalis Pharmaceuticals Inc / Xencor Inc / Oric Pharmaceuticals Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Beigene Ltd / Neoleukin Therapeutics Inc / Blueprint Medicines Corp / Revolution Medicines Inc / Relay Therapeutics Inc / Rubius Therapeutics Inc / Kymera Therapeutics Inc / Bolt Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Mr. Etzer Darout / Mr. Seamus Fernandez / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biopharma: Latest Short Interest for US Biopharma: Large Caps Stable; ACRX and NBIX See Moderate Increases Among SMid Caps</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BMY.N / LLY.N / MRK.N / PFE.N / AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / ABBV.N / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Merck KGaA</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">04/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Three Peas in a Podcast, Please Join Our Weekly Discussion on How Potential Catalysts and Events Could Impact Our Covered Companies</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ACRS.OQ / ACRX.OQ / 0715.HK / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BDSI.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / OMER.OQ / ARDX.OQ / ZTS.N / ANIP.OQ / AXGN.OQ / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / CKPT.OQ / VERU.OQ / TXMD.OQ / AYTU.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / IMAB.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / AZYO.OQ / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / China Oceanwide Holdings Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Checkpoint Therapeutics Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / I-Mab / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Aziyo Biologics Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual Event to Discuss How Corporate Tax Increases Could Impact Pharma, THIS THURSDAY at 2PM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N / LLY.N / 0715.HK / JNJ.N / PFE.N / AMRN.OQ / IMAB.OQ / HGEN.OQ</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / China Oceanwide Holdings Ltd / Johnson & Johnson / Pfizer Inc / Amarin Corporation PLC / I-Mab / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">04/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Healthcare Large-Cap 1Q21 Earnings Preview Conference Call on Friday, 4/16 at 2:00pm ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / JNJ.N / 0715.HK / LLY.N / PFE.N / IMAB.OQ</td><td class="leftalignment">Merck & Co Inc / Johnson & Johnson / China Oceanwide Holdings Ltd / Eli Lilly and Co / Pfizer Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Movers & Shakers: Our Thoughts on Potential Upcoming Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">74</td><td class="leftalignment">ACRS.OQ / ACRX.OQ / 0715.HK / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BDSI.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / OMER.OQ / ARDX.OQ / ZTS.N / ANIP.OQ / AXGN.OQ / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / CKPT.OQ / VERU.OQ / TXMD.OQ / AYTU.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / IMAB.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / AZYO.OQ / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / China Oceanwide Holdings Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Checkpoint Therapeutics Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / I-Mab / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Aziyo Biologics Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">04/11/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / ENDP.O / PCRX.O / ABBV.N / AMRX.N</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Endo International PLC / Pacira Biosciences Inc / Abbvie Inc / Amneal Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">04/11/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 5% Above Pre-Pandemic Level - Week 54</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 4.9.21</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / CPSI=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / OM=US / GNCA=US / TBPH=US / ALDX=US / ASMB=US / HQY=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Computer Programs and Systems Inc / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Outset Medical Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / Aldeyra Therapeutics Inc / Assembly Biosciences Inc / Healthequity Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/09/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Apr 09 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">DMAC=US / ONCT=US / MRK=US / BSX=US / CSII=US / PFE=US / ABT=US / AMGN=US / BMY=US / MDT=US / ADCT=US / WMT=US / INCY=US / CMS=US / GILD=US / DGX=US / NVS=US / AZN=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ATRC=US / CHE=US / CYH=US / EW=US / EXAS=US / GEN=US / ISRG=US / LH=US / LIFE=US / RKT=US / USPH=US / UTHR=US / UHS=US / PRVB=US / CCRN=US / CNC=US / ACA=US / ICAD=US / ENSG=US / MD=US / SLF=US / BIIB=US / ACAD=US / GOOG=US / LHCG=US / CHNG=US / BNGO=US / TPTX=US / EHC=US / ATHX=US / TMDI=US / SWAV=US / ADUS=US / SRNE=US / IRWD=US / SLRX=US / ACHC=US / CCXI=US / TGTX=US / ABBV=US / CTRE=US / OTIC=US / VBLT=US / CLRB=US / WBA=US / SNPHY=US / NVTA=US / EVH=US / GKOS=US / BGNE=US / RETA=US / APVO=US / FLGT=US / IRTC=US / PLXP=US / CYCN=US / TMDX=US / KRTX=US / PNTG=US / NNOX=US / KDNY=US / TVTX=US / EVAX=US</td><td class="leftalignment">DiaMedica Therapeutics Inc / Oncternal Therapeutics Inc / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Medtronic PLC / ADC Therapeutics SA / Walmart Inc / Incyte Corp / CMS Energy Corp / Gilead Sciences Inc / Quest Diagnostics Inc / Novartis AG / AstraZeneca PLC / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / AtriCure Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Exact Sciences Corp / General Electric Co / Intuitive Surgical Inc / Laboratory Corporation of America Holdings / aTyr Pharma Inc / Rocket Companies Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Provention Bio Inc / Cross Country Healthcare Inc / Centene Corp / Arcosa Inc / ICAD Inc / Ensign Group Inc / MEDNAX Inc / Sun Life Financial Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alphabet Inc / LHC Group Inc / Change Healthcare Inc / Bionano Genomics Inc / Turning Point Therapeutics Inc / Encompass Health Corp / Athersys Inc / Titan Medical Inc / Shockwave Medical Inc / Addus Homecare Corp / Sorrento Therapeutics Inc / Ironwood Pharmaceuticals Inc / Salarius Pharmaceuticals Inc / Acadia Healthcare Company Inc / ChemoCentryx Inc / TG Therapeutics Inc / Abbvie Inc / CareTrust REIT Inc / Otonomy Inc / Vascular Biogenics Ltd / Cellectar Biosciences Inc / Walgreens Boots Alliance Inc / Santen Pharmaceutical Co Ltd / Invitae Corp / Evolent Health Inc / Glaukos Corp / Beigene Ltd / Reata Pharmaceuticals Inc / Aptevo Therapeutics Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / PLx Pharma Inc / Cyclerion Therapeutics Inc / Transmedics Group Inc / Karuna Therapeutics Inc / Pennant Group Inc / Nano-X Imaging Ltd / Chinook Therapeutics Inc / Travere Therapeutics Inc / Evaxion Biotech A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">04/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended April 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending Apr 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">04/09/2021</td><td class="leftalignment">BNP Paribas Exane</td><td class="leftalignment">1ST DILS CONFERENCE FEEDBACK : Putting Covid to the Test</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">ROG.S / EKTAb.ST / STDM.PA / MRCG.DE / QIA.DE / EUFI.PA / SATG_p.DE / SHLG.DE</td><td class="leftalignment">Roche Holding AG / Elekta AB (publ) / Sartorius Stedim Biotech SA / Merck KGaA / Qiagen NV / Eurofins Scientific SE / Sartorius AG / Siemens Healthineers AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / Luxembourg / Netherlands / Sweden</td><td class="leftalignment">Cosmetics & Personal Care</td><td class="leftalignment">Euroland / Europe / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">M. Julien Dormois / Mr. Julien Ouaddour / M. Hugo Solvet / Mr. Allen D. Wells</td></tr>
<tr class="odd"><td class="leftalignment">04/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Clinical Data for EOS-448 In Line with Other Anti-TIGIT Monoclonal Antibodies</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ITOS=US / MRK=US</td><td class="leftalignment">Iteos Therapeutics Inc / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Daina Graybosch, PHD</td></tr>
<tr class="even"><td class="leftalignment">04/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual Event to Discuss How Corporate Tax Increases Could Impact Pharma on Thursday, 4/15 at 2PM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N / LLY.N / 0715.HK / JNJ.N / PFE.N / AMRN.OQ / IMAB.OQ / HGEN.OQ</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / China Oceanwide Holdings Ltd / Johnson & Johnson / Pfizer Inc / Amarin Corporation PLC / I-Mab / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/08/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Keytruda Adj RCC Trial Stopped Early; KOLs Expect 'Fairly Big' Clinical Benefit</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/08/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck & Co., Inc. : Keytruda Scores Another Win with Early Readout on Adjuvant RCC</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">04/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Early Bird Catches More Worms; Positive Data Today Keeps Keytruda In The Lead In Adjuvant RCC</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">04/08/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Merck & Co Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">04/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">If You Build It, They May Not Come</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / LLY.N / 0715.HK / JNJ.N / PFE.N / AMRN.OQ / IMAB.OQ / HGEN.OQ</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / China Oceanwide Holdings Ltd / Johnson & Johnson / Pfizer Inc / Amarin Corporation PLC / I-Mab / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">04/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Starting in 30 mins — The Emerging Breast Cancer Landscape — Upcoming Enhertu HER2-Low Trial & Other Key Breast Cancer Trials</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2516152 / 2778844 / 2369174 / BFDV8K0 / BYQHPK7 / BYWVTY5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / MacroGenics Inc / Zymeworks Inc / CytomX Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Etzer Darout / Michael W. Schmidt, Ph.D., PHD / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Reminder: Doc Call on April 7th (Today) — The Emerging Breast Cancer Landscape — Upcoming Enhertu HER2-Low Trial & Other Key Breast Cancer Trials</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2516152 / 2778844 / 2369174 / BFDV8K0 / BYQHPK7 / BYWVTY5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / MacroGenics Inc / Zymeworks Inc / CytomX Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Etzer Darout / Michael W. Schmidt, Ph.D., PHD / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Making All The Right Moves</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ALKS.OQ / MRK.N</td><td class="leftalignment">Alkermes Plc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brandon Folkes, CFA / Louise Chen / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/07/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">ONCT=US / TMDI=US / MRK=US / NKE=US / BMY=US / INTC=US / AMD=US / MSFT=US / MDT=US / ADCT=US / INCY=US / GILD=US / NVDA=US / NVS=US / AZN=US / JNJ=US / TTWO=US / ATVI=US / PENN=US / HEAR=US / ISRG=US / GME=US / DKS=US / TH=US / BNGO=US / RSI=US / 700-HK=US / UBI-PAR=US / SRNE=US / SLRX=US / 2454-TW=US / ZNGA=US / EA=US / TGTX=US / ABBV=US / OTIC=US / CLRB=US / BGNE=US / APVO=US / FLGT=US / BILI=US / HUYA=US / ESTC=US / TMDX=US / DKNG=US / CRSR=US / PLTK=US / EVAX=US</td><td class="leftalignment">Oncternal Therapeutics Inc / Titan Medical Inc / Merck & Co Inc / Nike Inc / Bristol-Myers Squibb Co / Intel Corp / Advanced Micro Devices Inc / Microsoft Corp / Medtronic PLC / ADC Therapeutics SA / Incyte Corp / Gilead Sciences Inc / NVIDIA Corp / Novartis AG / AstraZeneca PLC / Johnson & Johnson / Take-Two Interactive Software Inc / Activision Blizzard Inc / Penn National Gaming Inc / Turtle Beach Corp / Intuitive Surgical Inc / GameStop Corp / DICK'S Sporting Goods Inc / Target Hospitality Corp / Bionano Genomics Inc / Rush Street Interactive Inc / Tencent Holdings Ltd / Ubisoft Entertainment SA / Sorrento Therapeutics Inc / Salarius Pharmaceuticals Inc / MediaTek Inc / Zynga Inc / Electronic Arts Inc / TG Therapeutics Inc / Abbvie Inc / Otonomy Inc / Cellectar Biosciences Inc / Beigene Ltd / Aptevo Therapeutics Inc / Fulgent Genetics Inc / Bilibili Inc / HUYA Inc / Elastic NV / Transmedics Group Inc / DraftKings Inc / Corsair Gaming Inc / Playtika Holding Corp / Evaxion Biotech A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment">Biotechnology / Consumer / Healthcare / Info. Tech./Computers / Info. Tech./Software / Retailing / Semiconductors / Services</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">DD-US -  Dividend Quality Analysis, for the period ended March 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">APD / DOW / EMN / FMC / HON / MRK / PPG / BASFY.PK / GT.O</td><td class="leftalignment">Air Products and Chemicals Inc / Dow Inc / Eastman Chemical Co / FMC Corp / Honeywell International Inc / Merck & Co Inc / PPG Industries Inc / BASF SE / Goodyear Tire & Rubber Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Germany / India / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">04/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Transferring Research Coverage</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / PCRX.O / ABBV.N / PRGO.N / FLXN.O / AGRX.O / AMRX.N / XERS.O / AQST.O / OSMT.O / 269796108</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Pacira Biosciences Inc / Abbvie Inc / Perrigo Company PLC / Pacira Biosciences Inc / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Osmotica Pharmaceuticals PLC / Eagle Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Starting in 30 Mins: Checkup with FTC Expert – New Challenges for Healthcare M&A or More of the Same?</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2516152 / 2778844 / 2369174 / BFDV8K0 / BYQHPK7 / BYWVTY5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / MacroGenics Inc / Zymeworks Inc / CytomX Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. David M. Westenberg / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 6 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MOGa / US0378331005 / US0463531089 / US1101221083 / US1570851014 / US1985161066 / US37733W1053 / US4523271090 / US5324571083 / US92343V1044 / US20030N1019 / US2533931026 / US00206R1023 / US25470M1099 / US58933Y1055 / US6936561009 / US7512121010 / US00287Y1091 / US8725901040 / US6951271005 / US4277461020 / JE00BLG2ZQ72 / US12685J1051 / US4622221004 / US16119P1084 / US02156K1034 / US1010441053 / US05351X1019 / US98585X1046 / US18453H1068 / US02875D1090 / US07373B1098 / US15961R1059 / 120248964</td><td class="leftalignment">Moog Inc / Apple Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cerus Corp / Columbia Sportswear Co / GlaxoSmithKline PLC / Illumina Inc / Eli Lilly and Co / Verizon Communications Inc / Comcast Corp / DICK'S Sporting Goods Inc / AT&T Inc / DISH Network Corp / Merck & Co Inc / PVH Corp / Ralph Lauren Corp / Abbvie Inc / T-Mobile US Inc / Pacira Biosciences Inc / Heron Therapeutics Inc / Quotient Ltd / Cable One Inc / Ionis Pharmaceuticals Inc / Charter Communications Inc / Altice USA Inc / Boston Omaha Corp / Avaya Holdings Corp / Yeti Holdings Inc / Clear Channel Outdoor Holdings Inc / American Outdoor Brands Inc / Beam Global / ChargePoint Holdings Inc / Frontier Communications Parent Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / MCD=US / WEN=US / TEVA=US / XOM=US / CHRS=US / RCL=US / CBRL=US / CCL=US / COLL=US / DRI=US / REGI=US / SHOP=US / STRA=US / BKNG=US / DIN=US / BDSI=US / PLAY=US / DENN=US / CMG=US / REX=US / GPRE=US / AMRX=US / TAST=US / QSR=US / APEI=US / JACK=US / CLNY=US / NCLH=US / NDLS=US / 00770K202 / COUP=US / LOCO=US / NVRO=US / WBA=US / SHAK=US / WING=US / SPNE=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / McDonald's Corp / Wendys Co / Teva Pharmaceutical Industries Ltd / Exxon Mobil Corp / Coherus BioSciences Inc / Royal Caribbean Cruises Ltd / Cracker Barrel Old Country Store Inc / Carnival Corp / Collegium Pharmaceutical Inc / Darden Restaurants Inc / Renewable Energy Group Inc / Shopify Inc / Strategic Education Inc / Booking Holdings Inc / Dine Brands Global Inc / BioDelivery Sciences International Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Chipotle Mexican Grill Inc / REX American Resources Corp / Green Plains Inc / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / American Public Education Inc / Jack in the Box Inc / DigitalBridge Group Inc / Norwegian Cruise Line Holdings Ltd / Noodles & Co / Aemetis Inc / Coupa Software Inc / El Pollo Loco Holdings Inc / Nevro Corp / Walgreens Boots Alliance Inc / Shake Shack Inc / Wingstop Inc / SeaSpine Holdings Corp / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Israel / Liberia / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Bracketing Risk Of Drug Price Reform On Pharma; Stage Setting For PE Re-Rating?</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: March 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ABT.N / APD.N / AXP.N / BA.N / BAC.N / BBY.N / BSX.N / C.N / CCL.N / CIT.N / CL.N / CMS.N / CRM.N / DAL.N / ED.N / EOG.N / FCX.N / FDX.N / GE.N / HLT.N / IBM.N / JNJ.N / JPM.N / KO.N / LLY.N / LMT.N / LUV.N / MRK.N / NEM.N / OXY.N / PNW.N / SGEF.PA / SLB.N / T.N / TMO.N / U.N / WFC.N / WMT.N / AVB.N / EQR.N / SPG.N / PG.N / PXD.N / W.N / ETR.N / AAL.L / DUK.N / DHR.N / DIS.N / UNH.N / D.N / FE.N / URI.N / DE.N / PGR.N / CAT.N / MGM.N / KIM.N / GS.N / CLX.N / MCD.N / HON.N / VLO.N / HD.N / MRO.N / JWN.N / XRX.N / WEC.N / XOM.N / DVN.N / AMT.N / NKE.N / VZ.N / MUR.N / KSS.N / HRB.N / ORCL.N / LNC.N / HP.N / SRE.N / KMI.N / PWR.N / V.N / OKE.N / BXP.N / ACN.N / PLD.N / TWTR.N / AIV.N / LB.TO / CVX.N / FTI.N / COP.N / INTC.OQ / ABMD.OQ / ADBE.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / REGN.OQ / ROL.N / RGLD.OQ / SIVB.OQ / TT.N / QDEL.OQ / IDXX.OQ / QCOM.OQ / GILD.OQ / COST.OQ / AMZN.OQ / ZBRA.OQ / NVDA.OQ / SBAC.OQ / EXPE.OQ / BLUE.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / NFLX.OQ / WYNN.OQ / CMCSA.OQ / BIIB.OQ / NXST.OQ / SBNY.OQ / VIAC.OQ / WAL.N / DISCA.OQ / CDNS.OQ / LYV.N / MS.N / TDG.N / HES.N / MA.N / SPR.N / M.N / TDC.N / TNDM.OQ / MRNA.OQ / SWI.N / AVGO.OQ / CLNY.N / VRSK.OQ / SCHW.N / MU.OQ / GNRC.N / TSLA.OQ / ADSGN.F / HHC.N / LPLA.OQ / MSI.N / MSP.N / SABR.OQ / HFC.N / HZNP.OQ / SLM.OQ / ENPH.OQ / TRIP.OQ / SPLK.OQ / SRPT.OQ / FANG.OQ / ABBV.N / WEX.N / COTY.N / MAR.OQ / ESRT.N / NCLH.N / GOOGL.OQ / HUBS.N / OUT.N / ETSY.OQ / PYPL.OQ / SQ.N / IAC.OQ / TWLO.N / TTD.OQ / UAA.N / PK.N / AYX.N / CVNA.N / ROKU.OQ / PEP.OQ / XEL.OQ / BKNG.OQ / ZS.OQ / FB.PS / UAL.OQ / LNT.OQ / CPRI.N / PINS.N / ZM.OQ / CRWD.OQ / SPCE.N / RTX.N / CARR.N / APA.OQ / LMND.N / AEP.OQ</td><td class="leftalignment">Abbott Laboratories / Air Products and Chemicals Inc / American Express Co / Boeing Co / Bank of America Corp / Best Buy Co Inc / Boston Scientific Corp / Citigroup Inc / Carnival Corp / First-Citizens Bank & Trust Co / Colgate-Palmolive Co / CMS Energy Corp / Salesforce.Com Inc / Delta Air Lines Inc / Consolidated Edison Inc / EOG Resources Inc / Freeport-McMoRan Inc / FedEx Corp / General Electric Co / Hilton Worldwide Holdings Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Merck & Co Inc / Newmont Corporation / Occidental Petroleum Corp / Pinnacle West Capital Corp / Vinci SA / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Avalonbay Communities Inc / Equity Residential / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Wayfair Inc / Entergy Corp / Anglo American PLC / Duke Energy Corp / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Dominion Energy Inc / FirstEnergy Corp / United Rentals Inc / Deere & Co / Progressive Corp / Caterpillar Inc / MGM Resorts International / Kimco Realty Corp / Goldman Sachs Group Inc / Clorox Co / McDonald's Corp / Honeywell International Inc / Valero Energy Corp / Home Depot Inc / Marathon Oil Corp / Nordstrom Inc / Xerox Holdings Corp / WEC Energy Group Inc / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Nike Inc / Verizon Communications Inc / Murphy Oil Corp / Kohls Corp / H & R Block Inc / Oracle Corp / Lincoln National Corp / Helmerich and Payne Inc / Sempra Energy / Kinder Morgan Inc / Quanta Services Inc / Visa Inc / ONEOK Inc / Boston Properties Inc / Accenture PLC / Prologis Inc / Twitter Inc / Apartment Investment and Management Co / Laurentian Bank of Canada / Chevron Corp / TechnipFMC PLC / Conocophillips / Intel Corp / ABIOMED Inc / Adobe Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Regeneron Pharmaceuticals Inc / Rollins Inc / Royal Gold Inc / SVB Financial Group / Trane Technologies PLC / Quidel Corp / IDEXX Laboratories Inc / Qualcomm Inc / Gilead Sciences Inc / Costco Wholesale Corp / Amazon.com Inc / Zebra Technologies Corp / NVIDIA Corp / SBA Communications Corp / Expedia Group Inc / bluebird bio Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Netflix Inc / Wynn Resorts Ltd / Comcast Corp / Biogen Inc / Nexstar Media Group Inc / Signature Bank / ViacomCBS Inc / Western Alliance Bancorp / Discovery Inc / Cadence Design Systems Inc / Live Nation Entertainment Inc / Morgan Stanley / TransDigm Group Inc / Hess Corp / Mastercard Inc / Spirit AeroSystems Holdings Inc / Macy's Inc / Teradata Corp / Tandem Diabetes Care Inc / Moderna Inc / SolarWinds Corp / Broadcom Inc / DigitalBridge Group Inc / Verisk Analytics Inc / Charles Schwab Corp / Micron Technology Inc / Generac Holdings Inc / Tesla Inc / Adidas AG / Howard Hughes Corp / LPL Financial Holdings Inc / Motorola Solutions Inc / Datto Holding Corp / Sabre Corp / HollyFrontier Corp / Horizon Therapeutics PLC / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Splunk Inc / Sarepta Therapeutics Inc / Diamondback Energy Inc / Abbvie Inc / WEX Inc / Coty Inc / Marriott International Inc / Empire State Realty Trust Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / HubSpot Inc / OUTFRONT Media Inc / ETSY Inc / PayPal Holdings Inc / Block Inc / IAC/Interactivecorp / Twilio Inc / Trade Desk Inc / Under Armour Inc / Park Hotels & Resorts Inc / Alteryx Inc / Carvana Co / Roku Inc / PepsiCo Inc / Xcel Energy Inc / Booking Holdings Inc / Zscaler Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Alliant Energy Corp / Capri Holdings Ltd / Pinterest Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Virgin Galactic Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / APA Corp (US) / Lemonade Inc / American Electric Power Company Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Germany / France / United Kingdom / Ireland / Panama / Philippines / United States / Virgin Islands, British / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck KGaA: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck & Co Inc: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Corporate Watchdog Reports</td><td class="leftalignment">Watchdog Report: MRK - Now with Critical / Key Audit Matters</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Burke</td></tr>
<tr class="even"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 26, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Invite: Checkup with FTC Expert on April 6th (Tomorrow) – New Challenges for Healthcare M&A or More of the Same?</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2516152 / 2778844 / 2369174 / BFDV8K0 / BYQHPK7 / BYWVTY5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / MacroGenics Inc / Zymeworks Inc / CytomX Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. David M. Westenberg / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">04/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended March 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">SPB=US / TSLA=US / AAPL=US / IBM=US / MRK=US / WMB=US / BSX=US / CSII=US / CSCO=US / ABT=US / AMGN=US / COST=US / INTC=US / KO=US / MCD=US / AMD=US / MSFT=US / MDT=US / K=US / AMZN=US / T=US / WMT=US / D=US / ED=US / NTRS=US / NVDA=US / AKAM=US / JPM=US / NVS=US / VZ=US / PBR=US / EL=US / SAP=US / URI=US / TSM=US / BAX=US / GSK=US / TTWO=US / LEG=US / LRCX=US / ATVI=US / KR=US / DLTR=US / EIX=US / CI=US / UNH=US / INTU=US / ABMD=US / ACI=US / ATRC=US / AVGO=US / HRB=US / CMI=US / CSGP=US / DHI=US / XRAY=US / DG=US / EW=US / EXAS=US / HEAR=US / ISRG=US / TREE=US / MS=US / MCO=US / ROK=US / ROP=US / HSIC=US / SJM=US / ALGN=US / GME=US / SIVB=US / ARE=US / O=US / SWKS=US / NFLX=US / MNST=US / PTON=US / SFM=US / DPZ=US / GOOG=US / DLR=US / MKTX=US / FRPT=US / FIS=US / RSI=US / QSR=US / BX=US / VMW=US / ULTA=US / KKR=US / SWAV=US / 700-HK=US / UBI-PAR=US / UTZ=US / 005930-KR=US / VRSK=US / TCEHY=US / NEE=US / MSCI=US / ZNGA=US / EA=US / ENPH=US / TMUS=US / NVTA=US / SQ=US / IRTC=US / UAA=US / OKTA=US / BILI=US / HUYA=US / UBER=US / TMDX=US / NLOK=US / DKNG=US / NNOX=US / CRSR=US / PLTK=US</td><td class="leftalignment">Spectrum Brands Holdings Inc / Tesla Inc / Apple Inc / International Business Machines Corp / Merck & Co Inc / Williams Companies Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Cisco Systems Inc / Abbott Laboratories / Amgen Inc / Costco Wholesale Corp / Intel Corp / Coca-Cola Co / McDonald's Corp / Advanced Micro Devices Inc / Microsoft Corp / Medtronic PLC / Kellogg Co / Amazon.com Inc / AT&T Inc / Walmart Inc / Dominion Energy Inc / Consolidated Edison Inc / Northern Trust Corp / NVIDIA Corp / Akamai Technologies Inc / JPMorgan Chase & Co / Novartis AG / Verizon Communications Inc / Petroleo Brasileiro SA Petrobras / Estee Lauder Companies Inc / SAP SE / United Rentals Inc / Taiwan Semiconductor Manufacturing Co Ltd / Baxter International Inc / GlaxoSmithKline PLC / Take-Two Interactive Software Inc / Leggett & Platt Inc / Lam Research Corp / Activision Blizzard Inc / Kroger Co / Dollar Tree Inc / Edison International / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / ABIOMED Inc / Albertsons Companies Inc / AtriCure Inc / Broadcom Inc / H & R Block Inc / Cummins Inc / CoStar Group Inc / D R Horton Inc / DENTSPLY SIRONA Inc / Dollar General Corp / Edwards Lifesciences Corp / Exact Sciences Corp / Turtle Beach Corp / Intuitive Surgical Inc / Lendingtree Inc / Morgan Stanley / Moody's Corp / Rockwell Automation Inc / Roper Technologies Inc / Henry Schein Inc / J M Smucker Co / Align Technology Inc / GameStop Corp / SVB Financial Group / Alexandria Real Estate Equities Inc / Realty Income Corp / Skyworks Solutions Inc / Netflix Inc / Monster Beverage Corp / Peloton Interactive Inc / Sprouts Farmers Market Inc / Domino's Pizza Inc / Alphabet Inc / Digital Realty Trust Inc / Marketaxess Holdings Inc / Freshpet Inc / Fidelity National Information Services Inc / Rush Street Interactive Inc / Restaurant Brands International Inc / Blackstone Inc / VMware Inc / Ulta Beauty Inc / KKR & Co Inc / Shockwave Medical Inc / Tencent Holdings Ltd / Ubisoft Entertainment SA / UTZ Brands Inc / Farfetch Ltd / Verisk Analytics Inc / Tencent Holdings Ltd / Nextera Energy Inc / MSCI Inc / Zynga Inc / Electronic Arts Inc / Enphase Energy Inc / T-Mobile US Inc / Invitae Corp / Block Inc / iRhythm Technologies Inc / Under Armour Inc / Okta Inc / Bilibili Inc / HUYA Inc / Uber Technologies Inc / Transmedics Group Inc / NortonLifeLock Inc / DraftKings Inc / Nano-X Imaging Ltd / Corsair Gaming Inc / Playtika Holding Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Brazil / Canada / Switzerland / Cayman Islands / Germany / United Kingdom / Ireland / Israel / Taiwan / United States</td><td class="leftalignment">Biotechnology / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Retailing / Semiconductors</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 5 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0116591092 / US0126531013 / US01741R1023 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7237871071 / US7711951043 / US8308791024 / US8447411088 / US4771431016 / US4198791018 / US80105N1054 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US88160R1014 / US9100471096 / US00287Y1091 / US00912X3026 / US8485771021 / US21240E1055 / US02376R1023 / CA0089118776 / US4622221004 / US26856L1035 / CA53680Q2071 / US74275G1076 / US5904791358 / US53814L1089 / US89377M1099 / US4432011082 / LU2314763264 / 120404208</td><td class="leftalignment">Alaska Air Group Inc / Albemarle Corp / Allegheny Technologies Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Pioneer Natural Resources Co / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / Tesla Inc / United Airlines Holdings Inc / Abbvie Inc / Air Lease Corp / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Air Canada / Ionis Pharmaceuticals Inc / elf Beauty Inc / Lithium Americas Corp / Priority Technology Holdings Inc / Mesa Air Group Inc / Livent Corp / Transmedics Group Inc / Howmet Aerospace Inc / Arrival SA / MedAvail Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Denmark / France / United Kingdom / Luxembourg / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">04/04/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">THIS FRIDAY: Please Join Our Virtual KOL Call to Discuss the Potential Role of, and Key Focus Areas for, ADCs in Oncology at 1 pm ET</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK / PFE</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">04/04/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Three Peas in a Podcast, Please Join Our Weekly Discussion on How Catalysts and Events Could Impact Our Covered Companies</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ACRS.O / ACRX.O / EBS / HCM.L / JNJ / LLY / MRK / PFE / ALKS.O / JAZZ.O / CERS.O / OPTN.O / NCOX.PA / COLL.O / RMTI.O / AMRN.O / BDSI.O / BSLN.S / MNKD.O / SIBN.MM / ZTS / OMER.O / SPRO.O / ANIP.O / AXGN.O / AERI.O / HRTX.O / TRVN.O / EGRX.O / SCYX.O / ARDX.O / ALDX.O / CFRX.O / CDTX.O / SPNE.O / FBIO.O / MESO.O / VRAY.O / VERU.O / TXMD.O / AYTU.O / CKPT.O / EYPT.O / UBX.O / EOLS.O / ARDS.O / ARAV.O / ETTX.O / ARQT.O / PCVX.O / SRGA.O / VYNE.O / HGEN.O / AZYO.O / GRAY.O / IMAB.O / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / Emergent BioSolutions Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Cerus Corp / OptiNose Inc / Nicox SA / Collegium Pharmaceutical Inc / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Gazprom Neft' PAO / Zoetis Inc / Omeros Corp / Spero Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / Ardelyx Inc / Aldeyra Therapeutics Inc / ContraFect Corp / Cidara Therapeutics Inc / SeaSpine Holdings Corp / Fortress Biotech Inc / Mesoblast Ltd / ViewRay Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Checkpoint Therapeutics Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Evolus Inc / Aridis Pharmaceuticals Inc / Aravive Inc / Entasis Therapeutics Holdings Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Humanigen Inc / Aziyo Biologics Inc / Graybug Vision Inc / I-Mab / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Russian Federation / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/03/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">NASDAQ Steadiness Still Underappreciated</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">AAPL=US / IBM=US / MRK=US / WMB=US / CSCO=US / COST=US / INTC=US / KO=US / MCD=US / AMD=US / MSFT=US / K=US / AMZN=US / T=US / D=US / ED=US / NTRS=US / NVDA=US / AKAM=US / JPM=US / NVS=US / VZ=US / PBR=US / EL=US / SAP=US / URI=US / BAX=US / GSK=US / TTWO=US / LEG=US / LRCX=US / DLTR=US / EIX=US / CI=US / UNH=US / ABMD=US / AVGO=US / HRB=US / CMI=US / CSGP=US / DHI=US / XRAY=US / EW=US / ISRG=US / TREE=US / MS=US / MCO=US / ROK=US / ROP=US / HSIC=US / SJM=US / ALGN=US / SIVB=US / ARE=US / O=US / SWKS=US / NFLX=US / MNST=US / PTON=US / DPZ=US / GOOG=US / DLR=US / MKTX=US / FIS=US / QSR=US / BX=US / VMW=US / KKR=US / VRSK=US / TCEHY=US / NEE=US / TSLA=US / MSCI=US / ENPH=US / TMUS=US / SQ=US / UAA=US / OKTA=US / UBER=US / NLOK=US</td><td class="leftalignment">Apple Inc / International Business Machines Corp / Merck & Co Inc / Williams Companies Inc / Cisco Systems Inc / Costco Wholesale Corp / Intel Corp / Coca-Cola Co / McDonald's Corp / Advanced Micro Devices Inc / Microsoft Corp / Kellogg Co / Amazon.com Inc / AT&T Inc / Dominion Energy Inc / Consolidated Edison Inc / Northern Trust Corp / NVIDIA Corp / Akamai Technologies Inc / JPMorgan Chase & Co / Novartis AG / Verizon Communications Inc / Petroleo Brasileiro SA Petrobras / Estee Lauder Companies Inc / SAP SE / United Rentals Inc / Baxter International Inc / GlaxoSmithKline PLC / Take-Two Interactive Software Inc / Leggett & Platt Inc / Lam Research Corp / Dollar Tree Inc / Edison International / Cigna Corp / UnitedHealth Group Inc / ABIOMED Inc / Broadcom Inc / H & R Block Inc / Cummins Inc / CoStar Group Inc / D R Horton Inc / DENTSPLY SIRONA Inc / Edwards Lifesciences Corp / Intuitive Surgical Inc / Lendingtree Inc / Morgan Stanley / Moody's Corp / Rockwell Automation Inc / Roper Technologies Inc / Henry Schein Inc / J M Smucker Co / Align Technology Inc / SVB Financial Group / Alexandria Real Estate Equities Inc / Realty Income Corp / Skyworks Solutions Inc / Netflix Inc / Monster Beverage Corp / Peloton Interactive Inc / Domino's Pizza Inc / Alphabet Inc / Digital Realty Trust Inc / Marketaxess Holdings Inc / Fidelity National Information Services Inc / Restaurant Brands International Inc / Blackstone Inc / VMware Inc / KKR & Co Inc / Verisk Analytics Inc / Tencent Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Enphase Energy Inc / T-Mobile US Inc / Block Inc / Under Armour Inc / Okta Inc / Uber Technologies Inc / NortonLifeLock Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Brazil / Canada / Switzerland / Cayman Islands / Germany / United Kingdom / United States</td><td class="leftalignment">Financial Services</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Kailash Concepts</td><td class="leftalignment">The Great Inflation:  Revisiting 1969 – 1984 and the Impact of Inflation on Equities</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ABT.N / APD.N / BA.N / CCI.N / ECL.N / EOG.N / JNJ.N / KO.N / MRK.N / NEM.N / PFE.N / PM.N / SLB.N / SO.N / WMT.N / PG.N / DUK.N / DIS.N / UNH.N / D.N / CAT.N / UNP.N / MCD.N / HON.N / HD.N / UPS.N / XOM.N / AMT.N / NKE.N / LIN.N / SHW.N / VZ.N / EXC.N / V.N / PLD.N / CVX.N / COP.N / AAPL.OQ / MSFT.OQ / COST.OQ / AMZN.OQ / NVDA.OQ / EQIX.OQ / CMCSA.OQ / GOOG.OQ / DLR.N / MA.N / NEE.N / TSLA.OQ / FB.OQ / GOOGL.OQ / PEP.OQ</td><td class="leftalignment">Abbott Laboratories / Air Products and Chemicals Inc / Boeing Co / Crown Castle International Corp / Ecolab Inc / EOG Resources Inc / Johnson & Johnson / Coca-Cola Co / Merck & Co Inc / Newmont Corporation / Pfizer Inc / Philip Morris International Inc / Schlumberger NV / Southern Co / Walmart Inc / Procter & Gamble Co / Duke Energy Corp / Walt Disney Co / UnitedHealth Group Inc / Dominion Energy Inc / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / Honeywell International Inc / Home Depot Inc / United Parcel Service Inc / Exxon Mobil Corp / American Tower Corp / Nike Inc / Linde PLC / Sherwin-Williams Co / Verizon Communications Inc / Exelon Corp / Visa Inc / Prologis Inc / Chevron Corp / Conocophillips / Apple Inc / Microsoft Corp / Costco Wholesale Corp / Amazon.com Inc / NVIDIA Corp / Equinix Inc / Comcast Corp / Alphabet Inc / Digital Realty Trust Inc / Mastercard Inc / Nextera Energy Inc / Tesla Inc / Meta Platforms Inc / Alphabet Inc / PepsiCo Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Ireland / United States / Curaçao</td><td class="leftalignment">Aerospace / Air Transportation / Apparel & Textiles / Automotive / Beverages & Tobacco / Broadcasting & Cable / Chemicals / Conglomerates / Defense / Healthcare / Household Products / Info. Tech./Peripheral / Info. Tech./Software / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Pharmaceuticals / Railroads / Real Estate / Retailing / Semiconductors / Technology / Telecommunications / Utilities / Oil & Gas</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Kailash Capital Kailash Capital</td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Reminder: Doc Call on April 7th — The Emerging Breast Cancer Landscape — Upcoming Enhertu HER2-Low Trial & Other Key Breast Cancer Trials</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2516152 / 2778844 / 2369174 / BFDV8K0 / BYQHPK7 / BYWVTY5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / MacroGenics Inc / Zymeworks Inc / CytomX Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / LLY.N / MRK.N / PFE.N / GSK.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRNA.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ / ABCL.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Moderna Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Merck strengthens 1.4% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/31/2021</td><td class="leftalignment">Societe Generale</td><td class="leftalignment">Merck KGaA (Hold, TP=€135) - ESG integration - A family-owned company with strong commitment to ESG - F. Cespedes (1p)</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Florent Cespedes / Justin S. Smith / Manas Sarkar</td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AZN-US -  Dividend Quality Analysis, for the period ended March 29,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AZN.O / ABT / BMY / JNJ / LLY / MRK / NVS / PFE / GSK / BIIB.O / SNY.O</td><td class="leftalignment">AstraZeneca PLC / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Biogen Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Merck drops 4.9% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Euro Credit Pilot - Technical factors sitting in the driver’s seat (March 2021)</td><td class="leftalignment">English</td><td class="rightalignment">54</td><td class="leftalignment">US88579Y1010 / AEGN.AS / AIRP.PA / AKZO.AS / ALSO.PA / ALV.N / ALVG.DE / ANZ.AX / APD.N / ASML.AS / ATCOA.ST / AXAF.PA / BAC.N / BARC.L / BKT.MC / BMWG.DE / BNPP.PA / BNS.TO / BOUY.PA / BP.L / BT.L / C.N / CAPP.PA / CARR.PA / CBA.AX / CBKG.DE / CCH.L / CM.TO / CNPP.PA / CRH.I / DANO.PA / DEO.N / DSMN.AS / EDP.LS / ENI.MI / ERICb.ST / ERST.VI / FREG.F / GASI.MI / GE.N / GM.N / HEIG.F / HEIN.AS / HSBA.L / IBE.MC / IBM.N / KPN.AS / LLOY.L / LVMH.PA / MAP.MC / MDBI.MI / MGA / MICP.PA / MOLB.BU / MRK.N / MUVGn.DE / PRTP.PA / SAN.MC / T.N / CONG.DE / AZN.L / AMGN.O / FER.MC / AAL.L / GS.N / ACE.MI / DBKGn.DE / MCD.N / FMEG.DE / BZU.MI / ENEI.MI / MRCG.DE / DTEGn.F / BBVA.MC / BTI.N / IFXGn.DE / FR0000064578 / FR0000035081 / ISS.CO / CARLb.CO / ADEN.S / HNRGn.DE / DPWGn.DE / IG.MI / GSK.L / BAB.L / AMXL.MX / EUFI.PA / JCDX.PA / GB0008220112 / SE0000455057 / US1101221083 / US2987361092 / US3377381088 / US4943681035 / US5949181045 / JP3116000005 / CAGR.PA / AMA.MC / DANSKE.CO / CH0013841017 / ARLG.DE / ENAG.MC / AV.L / US20030N1019 / US02209S1033 / EBKG.DE / JYSK.CO / MAERSKb.CO / HRA.MI / CAIV.VI / US46625H1005 / INGA.AS / LXSG.DE / BTGGg.F / GB0033986497 / JP3885780001 / MTXGn.DE / ELI.BR / EDF.PA / ETL.PA / MS.N / GAZP.MM / US31620M1062 / AKE.PA / ISP.MI / DWNG.DE / DK0060079531 / AU000000GMG2 / SABE.MC / CNE1000001Z5 / CNE1000002H1 / FR0010690156 / BNRGN.DE / IREE.MI / CNE100000KC0 / CABK.MC / US03027X1000 / MDLZ.OQ / LEGN.DE / GYC.DE / 1COV.DE / IMB.L / SE0009922164 / BIRG.I / BMG2178K1009 / BAWG.VI / LU0251710041 / AT0000BAWAG2 / AIBG.I / AIG.A</td><td class="leftalignment">3M Co / Aegon NV / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Akzo Nobel NV / Alstom SA / Autoliv Inc / Allianz SE / Australia and New Zealand Banking Group Ltd / Air Products and Chemicals Inc / ASML Holding NV / Atlas Copco AB / AXA SA / Bank of America Corp / Barclays PLC / Bankinter SA / Bayerische Motoren Werke AG / BNP Paribas SA / Bank of Nova Scotia / Bouygues SA / BP PLC / BT Group PLC / Citigroup Inc / Capgemini SE / Carrefour SA / Commonwealth Bank of Australia / Commerzbank AG / Coca Cola HBC AG / Canadian Imperial Bank of Commerce / CNP Assurances SA / CRH PLC / Danone SA / Diageo PLC / Koninklijke DSM NV / EDP Energias de Portugal SA / Eni SpA / Telefonaktiebolaget LM Ericsson / Erste Group Bank AG / Fresenius SE & Co KGaA / Assicurazioni Generali SpA / General Electric Co / General Motors Co / HeidelbergCement AG / Heineken NV / HSBC Holdings PLC / Iberdrola SA / International Business Machines Corp / Koninklijke KPN NV / Lloyds Banking Group PLC / LVMH Moet Hennessy Louis Vuitton SE / Mapfre SA / Mediobanca Banca di Credito Finanziario SpA / Magna International Inc / Compagnie Generale des Etablissements Michelin SCA / MOL Magyar Olajes Gazipari Nyrt / Merck & Co Inc / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / Kering SA / Banco Santander SA / AT&T Inc / Continental AG / AstraZeneca PLC / Amgen Inc / Ferrovial SA / Anglo American PLC / Goldman Sachs Group Inc / Acea SpA / Deutsche Bank AG / McDonald's Corp / Fresenius Medical Care AG & Co KGaA / Buzzi Unicem SpA / Enel SpA / Merck KGaA / Deutsche Telekom AG / Banco Bilbao Vizcaya Argentaria SA / British American Tobacco PLC / Infineon Technologies AG / Covivio SA / Icade SA / Iss A/S / Carlsberg A/S / Adecco Group AG / Hannover Rueck SE / Deutsche Post AG / Italgas SpA / GlaxoSmithKline PLC / Babcock International Group PLC / America Movil SAB de CV / Eurofins Scientific SE / JCDecaux SA / DS Smith PLC / Fastighets AB Balder / Bristol-Myers Squibb Co / Euronet Worldwide Inc / Fiserv Inc / Kimberly-Clark Corp / Microsoft Corp / Asahi Group Holdings Ltd / Credit Agricole SA / Amadeus IT Group SA / Danske Bank A/S / Lonza Group AG / Aareal Bank AG / Enagas SA / Aviva PLC / Comcast Corp / Altria Group Inc / EnBW Energie Baden Wuerttemberg AG / Jyske Bank A/S / AP Moeller - Maersk A/S / Hera SpA / CA Immobilien Anlagen AG / JPMorgan Chase & Co / ING Groep NV / Lanxess AG / Bertelsmann SE & Co KGaA / ITV PLC / Mizuho Financial Group Inc / MTU Aero Engines AG / Elia Group SA / Electricite de France SA / Eutelsat Communications SA / Morgan Stanley / Gazprom PAO / Fidelity National Information Services Inc / Arkema SA / Intesa Sanpaolo SpA / Deutsche Wohnen SE / DSV A/S / Goodman Group / Banco de Sabadell SA / Bank of China Ltd / China Construction Bank Corp / Aeroports de Paris SA / Brenntag SE / Iren SpA / China National Chemical Engineering Co Ltd / Caixabank SA / American Tower Corp / Mondelez International Inc / LEG Immobilien SE / Grand City Properties SA / Covestro AG / Imperial Brands PLC / Essity AB (publ) / Bank of Ireland Group PLC / CK Infrastructure Holdings Ltd / BAWAG Group AG / CPI Property Group SA / BAWAG Group AG / Aib Group PLC / American International Group Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Austria / Belgium / Bermuda / Canada / Switzerland / China / Czech Republic / Germany / Denmark / Spain / Finland / France / United Kingdom / Greece / Hungary / Ireland / Italy / Japan / Luxembourg / Mexico / Netherlands / Norway / New Zealand / Poland / Portugal / Russian Federation / Slovakia / Sweden / United States / Jersey</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment">MISCELLANEOUS / CHANGE IN RECOMMENDATION / MODELS / PORTFOLIO STRATEGY / CREDIT</td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / Equity</td><td class="leftalignment">Herr Gianfranco Arcovito / Herr Christian Aust / Herr Tobias Keller / Herr. Stefan Kolek / Herr Sven Kreitmair, CFA / Frau Silke Stegemann / Herr Natalie Tehrani Monfared / Herr. Michael Teig</td></tr>
<tr class="odd"><td class="leftalignment">03/31/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Three Peas In A Podcast, Please Join Our Weekly Discussion On How Catalysts and Events Could Impact Our Covered Companies</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ACRX.O / ARCS.PK / EBS / HCM.L / JNJ / LLY / MRK / PFE / ALKS.O / JAZZ.O / CERS.O / OPTN.O / NCOX.PA / COLL.O / RMTI.O / AMRN.O / BDSI.O / BSLN.S / MNKD.O / ZTS / OMER.O / SPRO.O / ANIP.O / AXGN.O / AERI.O / HRTX.O / TRVN.O / EGRX.O / SCYX.O / ARDX.O / ALDX.O / CFRX.O / CDTX.O / SPNE.O / FBIO.O / MESO.O / VRAY.O / VERU.O / TXMD.O / AYTU.O / CKPT.O / EYPT.O / UBX.O / EOLS.O / ARDS.O / ARAV.O / SIBN.O / ETTX.O / ARQT.O / PCVX.O / SRGA.O / VYNE.O / HGEN.O / AZYO.O / GRAY.O / IMAB.O / 120551486</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Arcis Resources Corp / Emergent BioSolutions Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Cerus Corp / OptiNose Inc / Nicox SA / Collegium Pharmaceutical Inc / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Zoetis Inc / Omeros Corp / Spero Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / Ardelyx Inc / Aldeyra Therapeutics Inc / ContraFect Corp / Cidara Therapeutics Inc / SeaSpine Holdings Corp / Fortress Biotech Inc / Mesoblast Ltd / ViewRay Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Checkpoint Therapeutics Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Evolus Inc / Aridis Pharmaceuticals Inc / Aravive Inc / SI-BONE Inc / Entasis Therapeutics Holdings Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Humanigen Inc / Aziyo Biologics Inc / Graybug Vision Inc / I-Mab / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">Kepler Cheuvreux</td><td class="leftalignment">Europe | SMID appeal</td><td class="leftalignment">English</td><td class="rightalignment">80</td><td class="leftalignment">AALB.AS / ACCP.PA / AKER.OL / ALV.N / ASMI.AS / ASML.AS / AVMD.PA / BILIa.ST / BOSN.AS / BP.L / CAPP.PA / CHBE.PA / CPG.L / DAST.PA / ELE.MC / ENI.MI / EPED.PA / EURA.PA / FUGRc.AS / HEIJ.AS / HEIN.AS / HMb.ST / HTG.L / IBE.MC / IMTP.PA / ITV.L / LAGA.PA / LENV.VI / LHAG.DE / LVMH.PA / MICP.PA / NAFG.F / NIBEb.ST / OMVV.VI / PRTP.PA / PSON.L / RAND.AS / RATOb.ST / RENA.PA / REP.MC / RYA.I / SAND.ST / SKFb.ST / SOLB.BR / STM.MI / TEF.MC / TOM.OL / TWKNc.AS / UBIP.PA / VLOF.PA / WTB.L / INF.L / STERV.HE / VOWG_p.DE / AIRF.PA / AML.L / NHH.MC / TRNG.PA / CONG.DE / ACCG.AS / AIR.PA / EMII.MI / AZN.L / KIPO.BR / CAF.MC / CTY1S.HE / NEKG.DE / NOVOb.CO / BAMI.MI / COL.MC / NOVN.S / PV.DE / RB.L / ENEI.MI / MRCG.DE / SNI.OL / DTEGn.DE / WDPP.BR / IFXGn.DE / LONN.S / HOLMb.ST / BOL.ST / OUT1V.HE / SZGG.DE / CARLb.CO / GBFG.DE / ADEN.S / CLN.S / ADAG.DE / RAAG.DE / UHR.S / VASN.AS / QIA.DE / TEL.OL / GSK.L / EUFI.PA / DB1Gn.DE / ATSV.VI / JM.ST / ITX.MC / JCDX.PA / DOCO.VI / UCB.BR / GN.CO / SATG_p.DE / SRG.MI / AMA.MC / AMS.S / CWCG.DE / ORP.PA / BITI.PA / RCSM.MI / COLOb.CO / SGSN.S / CAIV.VI / TECN.S / IMFI.VI / TLIT.MI / BAR.BR / LOGN.S / BEAN.S / FAG.ST / UTDI.DE / TRN.MI / SESFd.PA / BIOX.PA / GEO.MI / GOGL.OL / NESTE.HE / SBMO.AS / SAF.PA / MTXGn.DE / RDSa.AS / JMT.LS / MARR.MI / INDT.ST / BEFB.BR / MT.AS / ADP.PA / KCOGn.DE / SY1G.DE / INEA.PA / KSBG_p.DE / AOXG.DE / METEX.PA / PRY.MI / SALM.OL / ATL.MI / MOL.MI / GRLS.MC / SABE.MC / AOO.BR / GETP.PA / YAS.PA / GL9.I / ITPG.MI / DIAS.MI / AVANZ.ST / UBXN.S / BION.S / METN.S / UPM.HE / NOL.OL / FHZN.S / PNDORA.CO / ADSGn.DE / AMAV.VI / MEL.MC / 1913.HK / SFER.MI / CONIC.ST / OCI.AS / IDLA.PA / FNAC.PA / PSMGn.DE / DICn.DE / SCYR.MC / US.MI / BMKB.L / FYB.DE / FALG.PA / APPS.MC / ANIM.MI / ELIOR.PA / CATGR.PA / COFA.PA / NOS.LS / CONC.S / CERV.MI / FACC.VI / ZAL.OL / KAMBI.ST / ENTRA.OL / NP3.ST / ELIS.PA / OVS.MI / SPIE.PA / PANDXb.ST / PBBG.DE / TLGG.F / ADJ.DE / ATRLJb.ST / DOMETIC.ST / LHN.S / LDOF.MI / BONAVb.ST / AD.AS / AKERBP.OL / GREENY.BR / KINDsdb.ST / FTI.PA / TKOO.PA / AVTX.AS / SBBb.ST / CECG.DE / INTRUM.ST / BFSA.DE / YIT.HE / SALMON.OL / A4Y.DE / NTGY.MC / MEDCL.PA / WALWIL.OL / SHUR.BR / NYFO.ST / TEPRF.PA / K2Ab.ST / OKEA.OL / LUNE.ST / LOOMIS.ST / MOCORP.HE / OHT-ME.OL / CADLR.OL / KING-ME.OL / JDC.F / SCATC.OL / 100031605</td><td class="leftalignment">Aalberts NV / Accor SA / Aker ASA / Autoliv Inc / ASM International NV / ASML Holding NV / Dassault Aviation SA / Bilia AB / Koninklijke Boskalis Westminster NV / BP PLC / Capgemini SE / Beneteau SA / Compass Group PLC / Dassault Systemes SE / Endesa SA / Eni SpA / Faurecia SE / Eurazeo SE / Fugro NV / Heijmans NV / Heineken NV / H & M Hennes & Mauritz AB / Hunting PLC / Iberdrola SA / Imerys SA / ITV PLC / Lagardere SA / Lenzing AG / Deutsche Lufthansa AG / LVMH Moet Hennessy Louis Vuitton SE / Compagnie Generale des Etablissements Michelin SCA / Aurubis AG / Nibe Industrier AB / OMV AG / Kering SA / Pearson PLC / Randstad NV / Ratos AB / Renault SA / Repsol SA / Ryanair Holdings PLC / Sandvik AB / AB Skf / Solvay SA / STMicroelectronics NV / Telefonica SA / Tomra Systems ASA / TKH Group NV / Ubisoft Entertainment SA / Valeo SE / Whitbread PLC / Informa PLC / Stora Enso Oyj / Volkswagen AG / Air France KLM SA / Aston Martin Lagonda Global Holdings PLC / NH Hotel Group SA / Transgene SA / Continental AG / Accell Group NV / Airbus SE / Bper Banca SpA / AstraZeneca PLC / Kinepolis Group NV / Construcciones Y Auxiliar De Ferrocarriles SA / Citycon Oyj / Nemetschek SE / Novo Nordisk A/S / Banco BPM SpA / Inmobiliaria Colonial SOCIMI SA / Novartis AG / Pfeiffer Vacuum Technology AG / Reckitt Benckiser Group PLC / Enel SpA / Merck KGaA / Stolt-Nielsen Ltd / Deutsche Telekom AG / Warehouses de Pauw NV / Infineon Technologies AG / Lonza Group AG / Holmen AB / Boliden AB / Outokumpu Oyj / Salzgitter AG / Carlsberg A/S / Bilfinger SE / Adecco Group AG / Clariant AG / ADVA Optical Networking SE / Rational AG / Swatch Group AG / Vastned Retail NV / Qiagen NV / Telenor ASA / GlaxoSmithKline PLC / Eurofins Scientific SE / Deutsche Boerse AG / AT & S Austria Technologie & Systemtechnik AG / JM AB / Industria de Diseno Textil SA / JCDecaux SA / DO & CO AG / Ucb SA / GN Store Nord A/S / Sartorius AG / Snam SpA / Amadeus IT Group SA / ams AG / Cewe Stiftung & Co KGaA / Orpea SA / ABC Arbitrage SA / Rizzoli Corriere della Sera Mediagroup SpA / Coloplast A/S / SGS SA / CA Immobilien Anlagen AG / Tecan Group AG / Immofinanz AG / Telecom Italia SpA / Barco NV / Logitech International SA / Belimo Holding AG / Fagerhult AB / United Internet AG / Terna Rete Elettrica Nazionale SpA / SES SA / Biomerieux SA / Geox SpA / Golden Ocean Group Ltd / Neste Oyj / SBM Offshore NV / Safran SA / MTU Aero Engines AG / Royal Dutch Shell PLC / Jeronimo Martins SGPS SA / Marr SpA / Indutrade AB / Befimmo SA / ArcelorMittal SA / Aeroports de Paris SA / Kloeckner & Co SE / Symrise AG / Fonciere Inea SA / KSB SE & Co KGaA / alstria office REIT AG / Metabolic Explorer SA / Prysmian SpA / SalMar ASA / Atlantia SpA / Gruppo MutuiOnline SpA / Grifols SA / Banco de Sabadell SA / Aedifica NV / Getlink SE / Cast SA / Glanbia PLC / Interpump Group SpA / DiaSorin SpA / Avanza Bank Holding AB / U Blox Holding AG / BB Biotech AG / Metall Zug AG / UPM-Kymmene Oyj / Northern Ocean Ltd / Flughafen Zuerich AG / Pandora A/S / Adidas AG / AMAG Austria Metall AG / Melia Hotels International SA / Prada SpA / Salvatore Ferragamo SpA / Concentric AB / OCI NV / ID Logistics SAS / Fnac Darty SA / Prosiebensat 1 Media SE / DIC Asset AG / Sacyr SA / UnipolSai Assicurazioni SpA / Benchmark Holdings PLC / Formycon AG / Fermentalg SA / Applus Services SA / Anima Holding SpA / Elior Group SA / Catana Group SA / Coface SA / NOS SGPS SA / Bystronic AG / Cerved Group SpA / FACC AG / Zalaris ASA / Kambi Group PLC / Entra ASA / NP3 Fastigheter AB / Elis SA / OVS SpA / Spie SA / Pandox AB / Deutsche Pfandbriefbank AG / TLG Immobilien AG / Adler Group SA / Atrium Ljungberg AB / Dometic Group AB (publ) / Holcim AG / Leonardo SpA / Bonava AB (publ) / Koninklijke Ahold Delhaize NV / Aker BP ASA / Greenyard NV / Kindred Group PLC / TechnipFMC PLC / Tikehau Capital SCA / Avantium NV / Samhallsbyggnadsbolaget I Norden AB / Ceconomy AG / Intrum AB / Befesa SA / YIT Oyj / Salmones Camanchaca SA / Accentro Real Estate AG / Naturgy Energy Group SA / Medincell SA / Wallenius Wilhelmsen ASA / Shurgard Self Storage SA / Nyfosa AB / Teleperformance SE / K2A Knaust & Andersson Fastigheter AB (publ) / Okea ASA / Lundin Energy AB / Loomis AB / Metso Outotec Corp / Seaway 7 ASA / Cadeler A/S / Kingfish Company NV / JDC Group AG / Scatec ASA / Webuild SpA</td><td class="leftalignment"></td><td class="leftalignment">Austria / Belgium / Bermuda / Switzerland / Chile / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Italy / Luxembourg / Malta / Netherlands / Norway / Portugal / Sweden / United States</td><td class="leftalignment">Aerospace / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Building & Building Materials / Chemicals / Consumer / Defense / Energy / Financial Services / Food / Healthcare / Household Products / Info. Tech./Computers / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Manufacturing / Media / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Real Estate / Retailing / Services / Telecommunications / Transportation / Utilities / Oil & Gas</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Kathleen Gailliot</td></tr>
<tr class="odd"><td class="leftalignment">03/31/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SASY.PA: Sanofi - First look at THOR-707 - novel cancer immunotherapy</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">SASY.PA / LLY.N / MRK.N / AZN.L / ROG.S / NOVOB.CO / NOVN.S / GSK.L / AMGN.OQ / BAYGN.DE</td><td class="leftalignment">Sanofi SA / Eli Lilly and Co / Merck & Co Inc / AstraZeneca PLC / Roche Holding AG / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IPN.PA: Ipsen - Details of Advanz generic Somatuline strategy. Lower earnings on EU generic entry.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">IPN.PA / RECI.MI / LUN.CO / MRCG.DE / LONN.S / UCB.BR / ORNBV.HE / ALM.MC / GRLS.MC / VIFN.S / GMAB.CO</td><td class="leftalignment">Ipsen SA / Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Orion Oyj / Almirall SA / Grifols SA / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">03/31/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Merck & Co., Inc. MARCH 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Merck KGaA MARCH 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Marka rises for a third consecutive year, a three-year rise of 293%</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRKP.WA</td><td class="leftalignment">Marka SA w restrukturyzacji</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Poland</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Kepler Cheuvreux</td><td class="leftalignment">Europe | The roaring twenties?</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">ABF.L / ACCP.PA / AIRP.PA / AKZO.AS / ALSO.PA / ALV.N / ALVG.DE / ASMI.AS / ASML.AS / ASSAb.ST / ATCOa.ST / AVMD.PA / BAER.S / BMWG.DE / BOUY.PA / BP.L / CAPP.PA / CBKG.DE / CPG.L / CSGN.S / DAMA.PA / DANO.PA / DAST.PA / EDP.LS / ELE.MC / ENI.MI / EPED.PA / ERST.VI / EURA.PA / EXHO.PA / FOUG.PA / HEIN.AS / HEXAb.ST / HMb.ST / HOTG.DE / HRMS.PA / IBE.MC / ITV.L / KINVb.ST / KPN.AS / LHAG.DE / LOIM.PA / LVMH.PA / MICP.PA / NHY.OL / NIBEb.ST / OMVV.VI / PRTP.PA / PSON.L / RAND.AS / RCOP.PA / RENA.PA / REP.MC / RYA.I / SAND.ST / SBRY.L / SCHN.PA / SEBa.ST / SEBF.PA / SGOB.PA / SKFb.ST / SOGN.PA / SOLB.BR / STM.MI / TEF.MC / TOM.OL / TOTF.PA / UBIP.PA / VERB.VI / VLLP.PA / VLOF.PA / VOLVb.ST / VWS.CO / WTB.L / INF.L / STERV.HE / VOWG_p.DE / CONG.DE / AIR.PA / AZN.L / FER.MC / SASY.PA / TKAG.DE / ROG.S / ATOS.PA / REE.MC / ABBN.S / SIEGn.DE / DBKGn.DE / NEKG.DE / NOVOb.CO / VOPA.AS / NOVN.S / BEIG.DE / FMEG.DE / RB.L / ENEI.MI / MRCG.DE / DTEGn.DE / IFXGn.DE / LONN.S / HOLMb.ST / BOL.ST / GIVN.S / CARLb.CO / VIE.PA / ADEN.S / CLN.S / RAAG.DE / UHR.S / NZYMb.CO / EZJ.L / QIA.DE / TEL.OL / GSK.L / EUFI.PA / TEL2b.ST / DB1Gn.DE / ITX.MC / DLG.MI / UCB.BR / KBC.BR / GN.CO / SATG_p.DE / SRG.MI / AMA.MC / ORP.PA / ITRK.L / INDUc.ST / FPEG_p.DE / BRBY.L / TENR.MI / IHG.L / COLOb.CO / MAERSKb.CO / SGSN.S / TLIT.MI / UMI.BR / SLHN.S / LOGN.S / SCHP.S / UTDI.DE / INGA.AS / YAR.OL / BALN.S / TRN.MI / EMSN.S / BIOX.PA / VOES.VI / LXSG.DE / NESTE.HE / SAF.PA / KNEBV.HE / MTXGn.DE / ELI.BR / RDSa.AS / G1AG.DE / JMT.LS / EDF.PA / INDT.ST / BALDb.ST / MT.AS / LEGD.PA / CFR.S / WCHG.DE / AKE.PA / ADP.PA / GALP.LS / SY1G.DE / PRY.MI / SALM.OL / ATL.MI / GBLB.BR / SOON.S / DAIGn.DE / CPRI.MI / BOLL.PA / GRLS.MC / GETP.PA / DIAS.MI / AMPF.MI / BVI.PA / WRT1V.HE / EDPR.LS / EONGn.DE / ABI.BR / EXOR.MI / UPM.HE / BAYGn.DE / AGES.BR / BASFn.DE / PNDORA.CO / ADSGn.DE / RBIV.VI / ICAG.MC / 1913.HK / SHLG.F / O2Dn.DE / EVKn.DE / RRTL.DE / MONC.MI / US.MI / WLN.PA / FBK.MI / NN.AS / ARGX.BR / IMCD.AS / ZALG.DE / HLE.DE / AENA.MC / EVOG.ST / CLNX.MC / SBSTA.OL / VNAn.DE / 1COV.DE / PST.MI / ABNd.AS / HLAG.F / LHN.S / AT1.DE / VACN.S / ASRNL.AS / AD.AS / UN01.DE / AKERBP.OL / FORTUM.HE / KESKOB.HE / PIRC.MI / ORSTED.CO / HFGG.DE / VAR1.F / URW.AS / NTGY.MC / KBX.DE / ESLX.PA / MOWI.OL / ALCC.S / TEPRF.PA / 8TRA.DE / FDJ.PA / LUNE.ST / JDEP.AS / MOCORP.HE / GJES.OL / KING-ME.OL / ULVR.AS</td><td class="leftalignment">Associated British Foods PLC / Accor SA / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Akzo Nobel NV / Alstom SA / Autoliv Inc / Allianz SE / ASM International NV / ASML Holding NV / Assa Abloy AB / Atlas Copco AB / Dassault Aviation SA / Julius Baer Gruppe AG / Bayerische Motoren Werke AG / Bouygues SA / BP PLC / Capgemini SE / Commerzbank AG / Compass Group PLC / Credit Suisse Group AG / Somfy SA / Danone SA / Dassault Systemes SE / EDP Energias de Portugal SA / Endesa SA / Eni SpA / Faurecia SE / Erste Group Bank AG / Eurazeo SE / Sodexo SA / Eiffage SA / Heineken NV / Hexagon AB / H & M Hennes & Mauritz AB / Hochtief AG / Hermes International SCA / Iberdrola SA / ITV PLC / Kinnevik AB / Koninklijke KPN NV / Deutsche Lufthansa AG / Klepierre SA / LVMH Moet Hennessy Louis Vuitton SE / Compagnie Generale des Etablissements Michelin SCA / Norsk Hydro ASA / Nibe Industrier AB / OMV AG / Kering SA / Pearson PLC / Randstad NV / Remy Cointreau SA / Renault SA / Repsol SA / Ryanair Holdings PLC / Sandvik AB / J Sainsbury PLC / Schneider Electric SE / Skandinaviska Enskilda Banken AB / SEB SA / Compagnie de Saint Gobain SA / AB Skf / Societe Generale SA / Solvay SA / STMicroelectronics NV / Telefonica SA / Tomra Systems ASA / TotalEnergies SE / Ubisoft Entertainment SA / Verbund AG / Vallourec SA / Valeo SE / Volvo AB / Vestas Wind Systems A/S / Whitbread PLC / Informa PLC / Stora Enso Oyj / Volkswagen AG / Continental AG / Airbus SE / AstraZeneca PLC / Ferrovial SA / Sanofi SA / thyssenkrupp AG / Roche Holding AG / Atos SE / Red Electrica Corporacion SA / Abb Ltd / Siemens AG / Deutsche Bank AG / Nemetschek SE / Novo Nordisk A/S / Koninklijke Vopak NV / Novartis AG / Beiersdorf AG / Fresenius Medical Care AG & Co KGaA / Reckitt Benckiser Group PLC / Enel SpA / Merck KGaA / Deutsche Telekom AG / Infineon Technologies AG / Lonza Group AG / Holmen AB / Boliden AB / Givaudan SA / Carlsberg A/S / Veolia Environnement SA / Adecco Group AG / Clariant AG / Rational AG / Swatch Group AG / Novozymes A/S / Easyjet PLC / Qiagen NV / Telenor ASA / GlaxoSmithKline PLC / Eurofins Scientific SE / Tele2 AB / Deutsche Boerse AG / Industria de Diseno Textil SA / De' Longhi SpA / Ucb SA / KBC Groep NV / GN Store Nord A/S / Sartorius AG / Snam SpA / Amadeus IT Group SA / Orpea SA / Intertek Group PLC / Industrivarden AB / Fuchs Petrolub SE / Burberry Group PLC / Tenaris SA / InterContinental Hotels Group PLC / Coloplast A/S / AP Moeller - Maersk A/S / SGS SA / Telecom Italia SpA / Umicore SA / Swiss Life Holding AG / Logitech International SA / Schindler Holding AG / United Internet AG / ING Groep NV / Yara International ASA / Baloise Holding AG / Terna Rete Elettrica Nazionale SpA / Ems Chemie Holding AG / Biomerieux SA / voestalpine AG / Lanxess AG / Neste Oyj / Safran SA / Kone Oyj / MTU Aero Engines AG / Elia Group SA / Royal Dutch Shell PLC / GEA Group AG / Jeronimo Martins SGPS SA / Electricite de France SA / Indutrade AB / Fastighets AB Balder / ArcelorMittal SA / Legrand SA / Compagnie Financiere Richemont SA / Wacker Chemie AG / Arkema SA / Aeroports de Paris SA / Galp Energia SGPS SA / Symrise AG / Prysmian SpA / SalMar ASA / Atlantia SpA / Groep Brussel Lambert NV / Sonova Holding AG / Daimler AG / Davide Campari Milano NV / Bollore SE / Grifols SA / Getlink SE / DiaSorin SpA / Amplifon SpA / Bureau Veritas SA / Wartsila Oyj Abp / EDP Renovaveis SA / E.ON SE / Anheuser Busch Inbev SA / Exor NV / UPM-Kymmene Oyj / Bayer AG / Ageas SA / BASF SE / Pandora A/S / Adidas AG / Raiffeisen Bank International AG / International Consolidated Airlines Group SA / Prada SpA / Siemens Healthineers AG / Telefonica Deutschland Holding AG / Evonik Industries AG / RTL Group SA / Moncler SpA / UnipolSai Assicurazioni SpA / Worldline SA / FinecoBank Banca Fineco SpA / NN Group NV / argenx SE / IMCD NV / Zalando SE / HELLA GmbH & Co KGaA / Aena SME SA / Evolution AB (publ) / Cellnex Telecom SA / Schibsted ASA / Vonovia SE / Covestro AG / Poste Italiane SpA / ABN Amro Bank NV / Hapag Lloyd AG / Holcim AG / Aroundtown SA / VAT Group AG / ASR Nederland NV / Koninklijke Ahold Delhaize NV / Uniper SE / Aker BP ASA / Fortum Oyj / Kesko Oyj / Pirelli & C SpA / Orsted A/S / Hellofresh SE / Varta AG / Unibail-Rodamco-Westfield SE / Naturgy Energy Group SA / Knorr Bremse AG / EssilorLuxottica SA / Mowi ASA / Alcon AG / Teleperformance SE / Traton SE / La Francaise des Jeux SA / Lundin Energy AB / JDE Peets NV / Metso Outotec Corp / Gjensidige Forsikring ASA / Kingfish Company NV / Unilever PLC</td><td class="leftalignment"></td><td class="leftalignment">Austria / Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Italy / Luxembourg / Netherlands / Norway / Portugal / Sweden / United States</td><td class="leftalignment">Aerospace / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Building & Building Materials / Chemicals / Consumer / Defense / Energy / Financial Services / Food / Healthcare / Household Products / Info. Tech./Computers / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Manufacturing / Media / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Real Estate / Retailing / Services / Telecommunications / Transportation / Utilities / Oil & Gas</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">M. Arnaud Girod</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Should You Buy Bristol Myers Squibb Stock At $63?</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Reminder: Doc Call on April 7th — The Emerging Breast Cancer Landscape — Upcoming Enhertu HER2-Low Trial & Other Key Breast Cancer Trials</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2516152 / 2778844 / 2369174 / BFDV8K0 / BYQHPK7 / BYWVTY5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / MacroGenics Inc / Zymeworks Inc / CytomX Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / WEN=US / BLD=US / DVN=US / TEVA=US / CMA=US / APA=US / LOW=US / PB=US / CHRS=US / EWBC=US / TRMK=US / UMPQ=US / LEG=US / ATVI=US / WTFC=US / CBRL=US / CSTR=US / CNX=US / DRI=US / FCN=US / GFF=US / IBP=US / MAS=US / MHK=US / PACW=US / WAL=US / HTH=US / BXS=US / CFB=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / ABCB=US / BOKF=US / FBK=US / ASB=US / SSB=US / RF=US / CATY=US / FFIN=US / GBCI=US / SBSI=US / AUTL=US / UCBI=US / DIN=US / PNFP=US / SBCF=US / NOMD=US / TCBI=US / TPX=US / FNB=US / EXP=US / FHN=US / BECN=US / PLAY=US / RNST=US / DENN=US / BLDR=US / GMS=US / CMG=US / PGTI=US / AWI=US / OC=US / AMRX=US / CADE=US / TAST=US / QSR=US / PRPL=US / JACK=US / TREX=US / FBHS=US / TILE=US / IBTX=US / NDLS=US / MTNB=US / LOCO=US / SHAK=US / WING=US / LOB=US / ACBI=US / ZS=US / WVE=US / NTLA=US / 82982L103 / JELD=US / ROKU=US / MBIN=US / HWC=US / OZK=US / AMTB=US / TCRR=US / CRWD=US / FERG=US / AZEK=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / Devon Energy Corp / Teva Pharmaceutical Industries Ltd / Comerica Inc / APA Corp (US) / Lowe's Companies Inc / Prosperity Bancshares Inc / Coherus BioSciences Inc / East West Bancorp Inc / Trustmark Corp / Umpqua Holdings Corp / Leggett & Platt Inc / Activision Blizzard Inc / Wintrust Financial Corp / Cracker Barrel Old Country Store Inc / CapStar Financial Holdings Inc / CNX Resources Corp / Darden Restaurants Inc / FTI Consulting Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / PacWest Bancorp / Western Alliance Bancorp / Hilltop Holdings Inc / Cadence Bank / Crossfirst Bankshares Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / FB Financial Corp / Associated Banc-Corp / SouthState Corp / Regions Financial Corp / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Southside Bancshares Inc / Autolus Therapeutics PLC / United Community Banks Inc / Dine Brands Global Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / Nomad Foods Ltd / Texas Capital Bancshares Inc / Tempur Sealy International Inc / FNB Corp / Eagle Materials Inc / First Horizon Corp / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Renasant Corp / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Interface Inc / Independent Bank Group Inc / Noodles & Co / Matinas BioPharma Holdings Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / Live Oak Bancshares Inc / Atlantic Capital Bancshares Inc / Zscaler Inc / WAVE Life Sciences Ltd / Intellia Therapeutics Inc / SiteOne Landscape Supply Inc / JELD-WEN Holding Inc / Roku Inc / Merchants Bancorp / Hancock Whitney Corp / Bank Ozk / Amerant Bancorp Inc / TCR2 Therapeutics Inc / CrowdStrike Holdings Inc / Ferguson PLC / Azek Company Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / Singapore / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Pharmaceuticals - Introducing Berenberg DrugBank</td><td class="leftalignment">English</td><td class="rightalignment">123</td><td class="leftalignment">FR0000120578 / DE0006599905 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US5324571083 / US7170811035 / US58933Y1055 / US00287Y1091 / DK0060534915</td><td class="leftalignment">Sanofi SA / Merck KGaA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Merck & Co Inc / Abbvie Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">EXEL: 1L RCC Stalemate Averted; Initiate with an Outperform Rating, $30 TP</td><td class="leftalignment">English</td><td class="rightalignment">61</td><td class="leftalignment">EXEL.OQ / 4523.T / BMY.N / LLY.N / MRK.N / PFE.N / ROG.S / SGEN.OQ / BAYGN.DE / ZYME.N / GMAB.CO</td><td class="leftalignment">Exelixis Inc / Eisai Co Ltd / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Roche Holding AG / Seagen Inc / Bayer AG / Zymeworks Inc / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Bradley P. Canino</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SGEN: Time Has Come Today; Initiate with a Neutral Rating, $145 TP</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">SGEN.OQ / 4503.T / MRK.N / INCY.OQ / EXEL.OQ / CLVS.OQ / EPZM.OQ / MGNX.OQ / BPMC.OQ / BGNE.OQ / ZLAB.OQ / DCPH.OQ / 6160.HK / GMAB.CO</td><td class="leftalignment">Seagen Inc / Astellas Pharma Inc / Merck & Co Inc / Incyte Corp / Exelixis Inc / Clovis Oncology Inc / Epizyme Inc / MacroGenics Inc / Blueprint Medicines Corp / Beigene Ltd / Zai Lab Ltd / Deciphera Pharmaceuticals Inc / Beigene Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Denmark / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Bradley P. Canino</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ZYME: Zymeworks - OppHER2nities High and Low; Initiate with an Outperform Rating, $55 TP</td><td class="leftalignment">English</td><td class="rightalignment">63</td><td class="leftalignment">ZYME.N / BMY.N / JNJ.N / LLY.N / MRK.N / GSK.L / EXEL.OQ / 4568.T / BGNE.OQ / 6160.HK</td><td class="leftalignment">Zymeworks Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / GlaxoSmithKline PLC / Exelixis Inc / Daiichi Sankyo Co Ltd / Beigene Ltd / Beigene Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Bradley P. Canino</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AFMD: Affimed - It's Time to Get Engaged; Initiating with an Outperform Rating, $15 TP</td><td class="leftalignment">English</td><td class="rightalignment">56</td><td class="leftalignment">AFMD.OQ / BMY.N / MRK.N / AZN.L / ROG.S / SGEN.OQ</td><td class="leftalignment">Affimed NV / Bristol-Myers Squibb Co / Merck & Co Inc / AstraZeneca PLC / Roche Holding AG / Seagen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Bradley P. Canino</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Biotechnology: What's an Oncology Drug Worth? Data from a Decade of Oncology M&A</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">4502.T / 4503.T / BMY.N / LLY.N / MRK.N / PFE.N / SASY.PA / ROG.S / NOVN.S / MRCG.DE / 4768.T / GSK.L / AMGN.OQ / GILD.OQ / SGEN.OQ / 4568.T / JAZZ.OQ / BAYGN.DE / ABBV.N</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Sanofi SA / Roche Holding AG / Novartis AG / Merck KGaA / Otsuka Corp / GlaxoSmithKline PLC / Amgen Inc / Gilead Sciences Inc / Seagen Inc / Daiichi Sankyo Co Ltd / Jazz Pharmaceuticals PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Ireland / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Bradley P. Canino</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Healthcare: Immunoglobulin: long term growth 8% assured - Presentation</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">4502.T / CSL.AX / JNJ.N / RECI.MI / AZN.L / LUN.CO / MRCG.DE / LONN.S / UCB.BR / IPN.PA / ORNBV.HE / ALM.MC / VIFN.S / ARGX.OQ / GMAB.CO</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / CSL Ltd / Johnson & Johnson / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Ipsen SA / Orion Oyj / Almirall SA / Vifor Pharma AG / argenx SE / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston / Mr. Tiago Fauth / Ms. Gretel Janu</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GRLS.MC: Grifols - Feedback & push backs on our Upgrade to Outperform</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">GRLS.MC / 4502.T / CSL.AX / JNJ.N / RECI.MI / LUN.CO / MRCG.DE / LONN.S / UCB.BR / 002007.SZ / IPN.PA / ORNBV.HE / ALM.MC / VIFN.S / ARGX.OQ / GMAB.CO</td><td class="leftalignment">Grifols SA / Takeda Pharmaceutical Co Ltd / CSL Ltd / Johnson & Johnson / Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Hualan Biological Engineering Inc / Ipsen SA / Orion Oyj / Almirall SA / Vifor Pharma AG / argenx SE / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / Finland / France / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Merck & Co. , Inc.</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Drug Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">60</td><td class="leftalignment">US5288723027 / CA87402A1084 / US5160121019 / US62855J1043 / US6388423021 / US75886F1075 / US92532F1003 / US6402681083 / US09060J1060 / US02043Q1076 / US45665G3039 / US58933Y1055 / US42805E3062 / US88322Q1085 / US74345W1080 / US14888U1016 / US63009R1095 / US92337F1075 / US48576U1060 / US2697961082 / CA4990531069 / US00847L1008 / US03209R1032 / US14167L1035 / US0453961080 / CA68620P1018 / US98978L2043 / CA1380351009 / US00461U1051 / US53222K2050 / US4622221004 / US45781M1018 / US05368M1062 / US23725P2092 / US14147L1089 / US04537Y1091 / US92556V1061 / US0547548745</td><td class="leftalignment">Lexicon Pharmaceuticals Inc / Taiga Building Products Ltd / Lannett Company Inc / Myriad Genetics Inc / Natural Alternatives International Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Nektar Therapeutics / BioDelivery Sciences International Inc / Alnylam Pharmaceuticals Inc / Infinity Pharmaceuticals Inc / Merck & Co Inc / Heska Corp / TG Therapeutics Inc / Prophase Labs Inc / Catalyst Pharmaceuticals Inc / NanoString Technologies Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Eagle Pharmaceuticals Inc / Knight Therapeutics Inc / Agile Therapeutics Inc / Amphastar Pharmaceuticals Inc / CareDx Inc / Assembly Biosciences Inc / OrganiGram Holdings Inc / Zogenix Inc / Canopy Growth Corp / Aclaris Therapeutics Inc / LifeVantage Corp / Ionis Pharmaceuticals Inc / Innoviva Inc / Avid Bioservices Inc / DarioHealth Corp / Cardiff Oncology Inc / Aspira Women's Health Inc / Viatris Inc / Aytu Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">As Expected, TNBC Adjuvant/Neoadjuvant Approval Will Have To Wait for Future Interim Analysis</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 19, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 29 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0116591092 / US0463531089 / US1101221083 / US1264081035 / US22284P1057 / US3021301094 / US3695501086 / US37733W1053 / US4433201062 / US4456581077 / US5150981018 / US5324571083 / US6558441084 / US66987V1098 / US6701002056 / US6795801009 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US9029251066 / US9078181081 / US9507551086 / CA1363751027 / CA13645T1003 / US4771431016 / US4198791018 / US80105N1054 / US25754A2015 / US12541W2098 / US78709Y1055 / PAP310761054 / US75025X1000 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US9837931008 / US00287Y1091 / US09609G1004 / US8485771021 / US21240E1055 / US02376R1023 / US03937C1053 / CA0089118776 / US9314271084 / CA87241L1094 / US23753F1075 / US80689H1023 / US4990491049 / US80706P1030 / US5904791358 / US89377M1099 / CA23126M1023 / US65487U1088 / US75943R1023 / US6877931096</td><td class="leftalignment">Alaska Air Group Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / Covenant Logistics Group Inc / Expeditors International of Washington Inc / General Dynamics Corp / GlaxoSmithKline PLC / Hub Group Inc / J B Hunt Transport Services Inc / Landstar System Inc / Eli Lilly and Co / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / USA Truck Inc / Union Pacific Corp / Werner Enterprises Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Domino's Pizza Inc / CH Robinson Worldwide Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / XPO Logistics Inc / Abbvie Inc / bluebird bio Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / ArcBest Corp / Air Canada / Walgreens Boots Alliance Inc / TFI International Inc / Daseke Inc / Schneider National Inc / Knight-Swift Transportation Holdings Inc / Scholar Rock Holding Corp / Mesa Air Group Inc / Transmedics Group Inc / Curaleaf Holdings Inc / Nkarta Inc / Relay Therapeutics Inc / Oscar Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / China / Denmark / France / United Kingdom / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Here's Why Bristol Myers Squibb Stock Is Undervalued At $63</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AEP.N / AES.N / ALV.N / BAC.N / BK.N / CL.N / CP.TO / EIX.N / EL.N / EOG.N / FMS.N / KMB.N / KO.N / MRK.N / NTRS.O / PFE.N / SO.N / T.N / USB.N / WFC.N / PEP.N / BFb.N / PG.N / CPB.N / TEN.N / CMCSA.O / INCY.O / DUK.N / K.N / DT.N / ADBE.O / CLX.N / CAG.N / GIS.N / PCG.N / EPC.N / AMT.N / JAZZ.O / CONE.O / VZ.N / STT.N / STZ.N / APH.N / ADSK.O / AXL.N / AWK.N / NBIX.O / CHD.N / NWN.N / SAM.N / BMRN.O / OPTN.O / REGN.O / ENR.N / NET.N / TEL.N / CNP.N / ENDP.O / CPK.N / ST.N / SGEN.OQ / MNST.O / BLUE.O / BIIB.O / 02209S103 / DLR.N / ACAD.O / 427866108 / MS.N / TEVA.N / ATL.MI / BGS.N / SPB.N / NEE.N / ERF.TO / ACHC.O / SPLK.OQ / PANW.N / MDLZ.OQ / ABBV.N / TSLA.N / PRGO.N / PRMW.N / TMUS.N / COTY.N / PTCT.O / PRTA.O / AGIO.O / 81762P102 / LB.N / KPTI.O / ITCI.O / QURE.O / VRNS.O / AGRX.O / ANTM.N / 78667J108 / RGNX.O / WVE.OQ / IONS.O / TWLO.N / OKTA.OQ / VST.N / ATNX.O / SAIL.N / APTV.N / ZS.OQ / AMRX.N / KDP.N / XERS.O / AQST.O / MGTX.O / ESTC.N / NWL.O / NBSE.OQ / KRTX.OQ / CRWD.O / GMAB.O / PING.N / CRNC.OQ / WTRG.N / REYN.O / NKLA.OQ / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Autoliv Inc / Bank of America Corp / Bank of New York Mellon Corp / Colgate-Palmolive Co / Canadian Pacific Railway Ltd / Edison International / Estee Lauder Companies Inc / EOG Resources Inc / Fresenius Medical Care AG & Co KGaA / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / Northern Trust Corp / Pfizer Inc / Southern Co / AT&T Inc / US Bancorp / Wells Fargo & Co / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Campbell Soup Co / Tenneco Inc / Comcast Corp / Incyte Corp / Duke Energy Corp / Kellogg Co / Dynatrace Inc / Adobe Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / PG&E Corp / Edgewell Personal Care Co / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / Verizon Communications Inc / State Street Corp / Constellation Brands Inc / Amphenol Corp / Autodesk Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Neurocrine Biosciences Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Cloudflare Inc / TE Connectivity Ltd / CenterPoint Energy Inc / Endo International PLC / Chesapeake Utilities Corp / Sensata Technologies Holding PLC / Seagen Inc / Monster Beverage Corp / bluebird bio Inc / Biogen Inc / Altria Group Inc / Digital Realty Trust Inc / ACADIA Pharmaceuticals Inc / Hershey Co / Morgan Stanley / Teva Pharmaceutical Industries Ltd / Atlantia SpA / B&G Foods Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / Enerplus Corp / Acadia Healthcare Company Inc / Splunk Inc / Palo Alto Networks Inc / Mondelez International Inc / Abbvie Inc / Tesla Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / Coty Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / ServiceNow Inc / Bath & Body Works Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Uniqure NV / Varonis Systems Inc / Agile Therapeutics Inc / Anthem Inc / SAGE Therapeutics Inc / Regenxbio Inc / WAVE Life Sciences Ltd / Ionis Pharmaceuticals Inc / Twilio Inc / Okta Inc / Vistra Corp / Athenex Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Zscaler Inc / Amneal Pharmaceuticals Inc / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / MeiraGTx Holdings PLC / Elastic NV / Newell Brands Inc / NeuBase Therapeutics Inc / Karuna Therapeutics Inc / CrowdStrike Holdings Inc / Genmab A/S / Ping Identity Holding Corp / Cerence Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Nikola Corp / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Italy / Netherlands / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: Eisai - Annual CEO information briefing: targeting ecosystem and platform construction</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">4523.T / MRK.N / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Merck & Co Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: エーザイ - 恒例のインフォメーションミーティング、エコシステムとプラットフォーム構築を目指すという趣旨</td><td class="leftalignment">Japanese</td><td class="rightalignment">7</td><td class="leftalignment">4523.T / MRK.N / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Merck & Co Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">03/28/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">BLUE Blood, Ide-Cel Approval Is Positive For Heme Malignancy Drug Development</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">HGEN.O / IMAB.O / HCM.L / JNJ / LLY / MRK / PFE / US3755581036</td><td class="leftalignment">Humanigen Inc / I-Mab / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">03/28/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Call to Discuss The Potential Role Of, And Key Focus Areas For, ADCs In Oncology on Friday, April 9, 2021 at 1 pm ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK / PFE</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials Continue Upward Trend-Week 52</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Trefis Report: Merck - $99.95 Trefis Price Estimate</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Merck increases 5.9% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">51</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 3.26.21</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / OM=US / GNCA=US / TBPH=US / ALDX=US / ASMB=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Outset Medical Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / Aldeyra Therapeutics Inc / Assembly Biosciences Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Short interest positioning read</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK.N / TEVA.N / ABBV.N / PRGO.N</td><td class="leftalignment">Merck & Co Inc / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending Mar 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, MRK</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES / PRICE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. John D. Staszak, CFA</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended March 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">BNP Paribas Exane</td><td class="leftalignment">1ST DILS CEO CONFERENCE : Conference Guide</td><td class="leftalignment">English</td><td class="rightalignment">66</td><td class="leftalignment">ROG.S / EKTAb.ST / STDM.PA / MRCG.DE / QIA.DE / EUFI.PA / SATG_p.DE / BIOX.PA / SHLG.DE</td><td class="leftalignment">Roche Holding AG / Elekta AB (publ) / Sartorius Stedim Biotech SA / Merck KGaA / Qiagen NV / Eurofins Scientific SE / Sartorius AG / Biomerieux SA / Siemens Healthineers AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Germany / France / Luxembourg / Netherlands / Sweden / United States</td><td class="leftalignment">Cosmetics & Personal Care</td><td class="leftalignment">Euroland / Europe / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">M. Julien Dormois / Mr. Julien Ouaddour / M. Hugo Solvet / Mr. Allen D. Wells</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK=US / CACI=US / BMY=US / BXP=US / AMZN=US / SLG=US / VZ=US / CCI=US / HSII=US / VRM=US / EXPE=US / KFRC=US / MGM=US / CLI=US / DISH=US / KFY=US / AMN=US / DRI=US / MAN=US / MRCY=US / ASGN=US / PDM=US / HOOK=US / RHI=US / SNAP=US / TRIP=US / WIX=US / CGEN=US / HIW=US / CCRN=US / BKNG=US / BDN=US / OFC=US / CUZ=US / FB=US / VNO=US / WRE=US / PTON=US / IGMS=US / CZR=US / KBR=US / REX=US / SAIC=US / KTOS=US / ANGI=US / ABBV=US / TMUS=US / CEQP=US / FATE=US / GOOGL=US / BABA=US / CMPR=US / DEA=US / GDDY=US / AJRD=US / BWXT=US / OKTA=US / CVNA=US / SFIX=US / MAXR=US / EOLS=US / FTDR=US / SVMK=US / ALLO=US / HARP=US / LYFT=US / UBER=US / TCRR=US / NXTC=US / LHX=US / GMAB=US / SPCE=US</td><td class="leftalignment">Merck & Co Inc / CACI International Inc / Bristol-Myers Squibb Co / Boston Properties Inc / Amazon.com Inc / SL Green Realty Corp / Verizon Communications Inc / Crown Castle International Corp / Heidrick & Struggles International Inc / Vroom Inc / Expedia Group Inc / Kforce Inc / MGM Resorts International / Veris Residential Inc / DISH Network Corp / Korn Ferry / AMN Healthcare Services Inc / Darden Restaurants Inc / ManpowerGroup Inc / Mercury Systems Inc / ASGN Inc / Piedmont Office Realty Trust Inc / HOOKIPA Pharma Inc / Robert Half International Inc / Snap Inc / Tripadvisor Inc / Wix.Com Ltd / Compugen Ltd / Highwoods Properties Inc / Cross Country Healthcare Inc / Booking Holdings Inc / Brandywine Realty Trust / Corporate Office Properties Trust / Cousins Properties Inc / Meta Platforms Inc / Vornado Realty Trust / Washington Real Estate Investment Trust / Peloton Interactive Inc / IGM Biosciences Inc / Caesars Entertainment Inc / KBR Inc / REX American Resources Corp / Science Applications International Corp / Kratos Defense and Security Solutions Inc / Angi Inc / Abbvie Inc / T-Mobile US Inc / Crestwood Equity Partners LP / Fate Therapeutics Inc / Alphabet Inc / Alibaba Group Holding Ltd / Cimpress PLC / Easterly Government Properties Inc / GoDaddy Inc / Aerojet Rocketdyne Holdings Inc / BWX Technologies Inc / Okta Inc / Carvana Co / Stitch Fix Inc / Maxar Technologies Inc / Evolus Inc / Frontdoor Inc / Momentive Global Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Lyft Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / NextCure Inc / L3harris Technologies Inc / Genmab A/S / Virgin Galactic Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Denmark / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canadian Research at a Glance - March 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BAER.S / BARC.L / BB.N / BNPP.PA / CBKG.DE / CSGN.S / HSBA.L / JNJ.N / LLOY.L / MRK.N / PFE.N / SAN.MC / SOGN.PA / GILD.O / TA.TO / AMGN.O / DBKGn.DE / BBVA.MC / 0989529 / CVX.N / CAGR.PA / NWG.L / INGA.AS / TEVA.N / CS.TO / 443628102 / CBRO.L / GTE.TO / PXT.TO / ABBV.N / PRGO.N / GUD.TO / ABNd.AS / UBSG.S / MTRO.L / APR_U.TO / VMUK.L / PAGPA.L</td><td class="leftalignment">Julius Baer Gruppe AG / Barclays PLC / BlackBerry Ltd / BNP Paribas SA / Commerzbank AG / Credit Suisse Group AG / HSBC Holdings PLC / Johnson & Johnson / Lloyds Banking Group PLC / Merck & Co Inc / Pfizer Inc / Banco Santander SA / Societe Generale SA / Gilead Sciences Inc / TransAlta Corp / Amgen Inc / Deutsche Bank AG / Banco Bilbao Vizcaya Argentaria SA / AstraZeneca PLC / Chevron Corp / Credit Agricole SA / Natwest Group PLC / ING Groep NV / Teva Pharmaceutical Industries Ltd / Capstone Mining Corp / Hudbay Minerals Inc / Close Brothers Group PLC / Gran Tierra Energy Inc / Parex Resources Inc / Abbvie Inc / Perrigo Company PLC / Knight Therapeutics Inc / ABN Amro Bank NV / UBS Group AG / Metro Bank PLC / Automotive Properties Real Estate Investment Trust / Virgin Money UK PLC / Paragon Banking Group PLC</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Spain / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / BMY.N / MRK.N / PFE.N / AZN.L / REGN.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Yunhee Park / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">LUN.CO: Lundbeck - Focus on Alzheimer's agitation</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">LUN.CO / RECI.MI / MRCG.DE / LONN.S / 4768.T / UCB.BR / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / VIFN.S / GMAB.CO</td><td class="leftalignment">H Lundbeck A/S / Recordati Industria Chimica e Farmaceutica SpA / Merck KGaA / Lonza Group AG / Otsuka Corp / Ucb SA / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy / Japan</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">UK & European Research at a Glance - March 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ABF.L / AEGN.AS / AHT.L / ALVG.DE / AXAF.PA / BAER.S / BARC.L / BNPP.PA / BNZL.L / BOY.L / BRW.L / CBKG.DE / CNA.L / CNE.L / CPI.L / CSGN.S / CWK.L / DANO.PA / DCC.L / DFDS.CO / DPLM.L / ECM.L / FGP.L / FOUG.PA / GOG.L / HMSO.L / HSBA.L / HSX.L / HTG.L / IMI.L / JD.L / JNJ.N / JSG.L / LAND.L / LLOY.L / MKS.L / MRK.N / MUVGn.DE / NA / NEX.L / NXT.L / OREP.PA / OXB.L / PFE.N / PFG.L / PNN.L / PRU.L / ROR.L / RPS.L / RTO.L / SAN.MC / SGC.L / SGEF.PA / SLA.L / SMWH.L / SOGN.PA / SRP.L / TLW.L / TPK.L / TTG.L / ULVR.L / VIEV.VI / WKP.L / ZURN.S / RAT.L / GILD.O / AMGN.O / DBKGn.DE / ESP.L / BBVA.MC / ENT.L / JTC.L / BYG.L / MORG.DE / DPH.L / IG.MI / 0989529 / IGG.L / FRAG.DE / CVX.N / CAGR.PA / CEY.L / ENAG.MC / AV.L / WG.L / FLS.CO / ASC.L / HAYS.L / APF.L / COA.L / NWG.L / SGSN.S / RTN.L / INGA.AS / HSV.L / NESN.S / SPI.L / BRK.L / NESTE.HE / BUCN.S / KOS.N / PFC.L / BVIC.L / DUFN.S / LRE.L / HICL.L / TEVA.N / DNLM.L / OERL.S / MARS.L / DLN.L / DWNG.DE / 3IN.L / ATL.MI / HFG.L / MONY.L / RENE.LS / CBRO.L / SLRS.MC / HOCM.L / XPS.L / BEZG.L / ABCA.L / CVSG.L / VGP1.BR / GTE.TO / INPP.L / FHZN.S / PHNX.L / SUBC.OL / CAML.L / PXT.TO / SMSS.L / BOSSn.DE / CLINC.L / DLGD.L / ABBV.N / LMPL.L / PRGO.N / MGAMM.L / UKWG.L / BOOH.L / BBOXT.L / NN.AS / DC.L / MOLN.S / FEVR.L / SNNS.L / G24N.DE / AMUN.PA / GYM.L / ABNd.AS / CMCX.L / UBSG.S / SRENH.S / MTRO.L / PAGE.L / BFIT.AS / CTEC.L / IWG.L / TCAPI.L / TKOO.PA / GREG.MC / JUSTJ.L / IHR.L / DHER.DE / GRPG.I / FERG.L / SUPR.L / WHRW.L / AFM.L / RHIM.L / SDRY.L / ENOG.L / QLT.L / HNSA.ST / TMV.DE / VMUK.L / UPR.IR / PAGPA.L / FRAS.L / JETJ.L / 001306785 / DOCS.L / TEEC.L</td><td class="leftalignment">Associated British Foods PLC / Aegon NV / Ashtead Group PLC / Allianz SE / AXA SA / Julius Baer Gruppe AG / Barclays PLC / BNP Paribas SA / Bunzl plc / Bodycote PLC / Brewin Dolphin Holdings PLC / Commerzbank AG / Centrica PLC / Capricorn Energy PLC / Capita PLC / Credit Suisse Group AG / Cranswick PLC / Danone SA / DCC PLC / DFDS AS / Diploma PLC / Electrocomponents PLC / FirstGroup PLC / Eiffage SA / Go-Ahead Group PLC / Hammerson PLC / HSBC Holdings PLC / Hiscox Ltd / Hunting PLC / IMI PLC / JD Sports Fashion PLC / Johnson & Johnson / Johnson Service Group PLC / Land Securities Group PLC / Lloyds Banking Group PLC / Marks and Spencer Group PLC / Merck & Co Inc / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / National Bank of Canada / National Express Group PLC / Next PLC / L'Oreal SA / Oxford BioMedica PLC / Pfizer Inc / Provident Financial PLC / Pennon Group PLC / Prudential PLC / Rotork PLC / RPS Group PLC / Rentokil Initial PLC / Banco Santander SA / Stagecoach Group PLC / Vinci SA / Abrdn PLC / WH Smith PLC / Societe Generale SA / Serco Group PLC / Tullow Oil PLC / Travis Perkins PLC / TT electronics PLC / Unilever PLC / Flughafen Wien AG / Workspace Group PLC / Zurich Insurance Group AG / Rathbones Group PLC / Gilead Sciences Inc / Amgen Inc / Deutsche Bank AG / Empiric Student Property PLC / Banco Bilbao Vizcaya Argentaria SA / Entain PLC / Jtc PLC / Big Yellow Group PLC / MorphoSys AG / Dechra Pharmaceuticals PLC / Italgas SpA / AstraZeneca PLC / IG Group Holdings PLC / Fraport AG Frankfurt Airport Services Worldwide / Chevron Corp / Credit Agricole SA / Centamin PLC / Enagas SA / Aviva PLC / John Wood Group PLC / FLSmidth & Co A/S / ASOS PLC / Hays PLC / Anglo Pacific Group PLC / Coats Group PLC / Natwest Group PLC / SGS SA / Restaurant Group PLC / ING Groep NV / HomeServe PLC / Nestle SA / Spire Healthcare Group PLC / Brooks Macdonald Group PLC / Neste Oyj / Bucher Industries AG / Kosmos Energy Ltd / Petrofac Ltd / Britvic PLC / Dufry AG / Lancashire Holdings Ltd / HICL Infrastructure PLC / Teva Pharmaceutical Industries Ltd / Dunelm Group PLC / OC Oerlikon Corporation AG Pfaeffikon / Marston's PLC / Derwent London PLC / Deutsche Wohnen SE / 3I Infrastructure PLC / Atlantia SpA / Hilton Food Group PLC / Moneysupermarket.Com Group PLC / Ren Redes Energeticas Nacionais SGPS SA / Close Brothers Group PLC / Solaria Energia y Medio Ambiente SA / Hochschild Mining PLC / XPS Pensions Group PLC / Beazley PLC / Abcam PLC / CVS Group PLC / VGP NV / Gran Tierra Energy Inc / International Public Partnerships Ltd / Flughafen Zuerich AG / Phoenix Group Holdings PLC / Subsea 7 SA / Central Asia Metals PLC / Parex Resources Inc / Smart Metering Systems PLC / Hugo Boss AG / Clinigen Group PLC / Direct Line Insurance Group PLC / Abbvie Inc / Londonmetric Property PLC / Perrigo Company PLC / Morgan Advanced Materials PLC / Greencoat UK Wind PLC / boohoo group plc / Tritax Big Box Reit PLC / NN Group NV / Currys PLC / Molecular Partners AG / Fevertree Drinks PLC / Sanne Group PLC / Scout24 SE / Amundi SA / GYM Group PLC / ABN Amro Bank NV / CMC Markets PLC / UBS Group AG / Swiss Re AG / Metro Bank PLC / Pagegroup PLC / Basic Fit NV / ConvaTec Group PLC / IWG Plc / TP ICAP Group PLC / Tikehau Capital SCA / Grenergy Renovables SA / Just Group PLC / Impact Healthcare REIT PLC / Delivery Hero SE / Greencoat Renewables PLC / Ferguson PLC / Supermarket Income REIT PLC / Warehouse REIT PLC / Alpha Financial Markets Consulting PLC / RHI Magnesita NV / Superdry PLC / Energean PLC / Quilter PLC / Hansa Biopharma AB / TeamViewer AG / Virgin Money UK PLC / Uniphar PLC / Paragon Banking Group PLC / Frasers Group PLC / Just Eat Takeaway.com NV / Bureau Veritas SA / Dr Martens PLC / Triple Point Energy Efficiency Infrastructure Company Plc</td><td class="leftalignment"></td><td class="leftalignment">Austria / Belgium / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / Portugal / Sweden / United States / Isle of Man / Jersey / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">03/25/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-DE -  Dividend Quality Analysis, for the period ended June 03,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRCG.DE / COPN.S / ALM.MC / BAYGn.DE</td><td class="leftalignment">Merck KGaA / Cosmo Pharmaceuticals NV / Almirall SA / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Spain / Netherlands</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Sector Report - Corporate Hybrids: Moderate further spread tightening despite high new issue activity</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">ACCP.PA / BHP.AX / BP.L / BT.L / CASP.PA / EDP.LS / ENI.MI / IBE.MC / KPN.AS / LHAG.DE / OMVV.VI / RENA.PA / REP.MC / RWEG.DE / SGOB.PA / T.N / TEF.MC / TOTF.PA / VOD.L / VOLVB.ST / VOWG.DE / REE.MC / ENEI.MI / MRCG.DE / IFXGn.DE / SZUG.DE / AMXL.MX / EUFI.PA / LU0088087324 / EBKG.DE / TRN.MI / LXSG.DE / BTGGg.F / EDF.PA / AKE.PA / SEVI.PA / ORAN.PA / ORSTED.CO</td><td class="leftalignment">Accor SA / BHP Group Ltd / BP PLC / BT Group PLC / Casino Guichard Perrachon SA / EDP Energias de Portugal SA / Eni SpA / Iberdrola SA / Koninklijke KPN NV / Deutsche Lufthansa AG / OMV AG / Renault SA / Repsol SA / Rwe AG / Compagnie de Saint Gobain SA / AT&T Inc / Telefonica SA / TotalEnergies SE / Vodafone Group PLC / Volvo AB / Volkswagen AG / Red Electrica Corporacion SA / Enel SpA / Merck KGaA / Infineon Technologies AG / Suedzucker AG / America Movil SAB de CV / Eurofins Scientific SE / SES SA / EnBW Energie Baden Wuerttemberg AG / Terna Rete Elettrica Nazionale SpA / Lanxess AG / Bertelsmann SE & Co KGaA / Electricite de France SA / Arkema SA / Suez SA / Orange SA / Orsted A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Austria / Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Italy / Luxembourg / Mexico / Netherlands / Portugal / Sweden / United States</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment">CREDIT</td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / INDUSTRY REPORTS</td><td class="leftalignment">Herr. Stefan Kolek / Herr. Ulrich Scholz, CFA</td></tr>
<tr class="odd"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Intriguing first Phase 3 readout for LAG-3 inhibitor relatlimab</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BMY=US / MRK=US</td><td class="leftalignment">Bristol-Myers Squibb Co / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US / LSI=US / PFE=US / AMGN=US / KO=US / BLD=US / INCY=US / TEVA=US / PEB=US / H=US / MTN=US / CHRS=US / BRO=US / MAR=US / TNL=US / HLT=US / RCL=US / CCL=US / CHH=US / DRH=US / AJG=US / IBP=US / KBH=US / REGI=US / WGO=US / PSA=US / DCP=US / SBCF=US / APTX=US / EXR=US / BECN=US / SHO=US / GMS=US / HST=US / AWI=US / OC=US / WH=US / IAC=US / HGV=US / RLJ=US / VAC=US / CUBE=US / RHP=US / TILE=US / NCLH=US / NSA=US / PK=US / PLYA=US / FERG=US / OVV=US / ARQT=US / FBRX=US / BALY=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Life Storage Inc / Pfizer Inc / Amgen Inc / Coca-Cola Co / TopBuild Corp / Incyte Corp / Teva Pharmaceutical Industries Ltd / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Coherus BioSciences Inc / Brown & Brown Inc / Marriott International Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Royal Caribbean Cruises Ltd / Carnival Corp / Choice Hotels International Inc / Diamondrock Hospitality Co / Arthur J Gallagher & Co / Installed Building Products Inc / KB Home / Renewable Energy Group Inc / Winnebago Industries Inc / Public Storage / DCP Midstream LP / Seacoast Banking Corporation of Florida / Aptinyx Inc / Extra Space Storage Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / GMS Inc / Host Hotels & Resorts Inc / Armstrong World Industries Inc / Owens Corning / Wyndham Hotels & Resorts Inc / IAC/Interactivecorp / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / CubeSmart / Ryman Hospitality Properties Inc / Interface Inc / Norwegian Cruise Line Holdings Ltd / National Storage Affiliates Trust / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Ferguson PLC / Ovintiv Inc / Arcutis Biotherapeutics Inc / Forte Biosciences Inc / Bally's Corp / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Israel / Liberia / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">ESG Stratify™: Is Pharma at a positive ESG inflection point?</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N / GILD.O / AMGN.O / 0989529 / TEVA.N / ABBV.N / PRGO.N</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / AstraZeneca PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Sara Mahaffy / Mr. Daniel J. Busby / Steve Daddeo / James Hong</td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">COVID-19 Vaccines: Modelling EU export controls</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">4507.T / CRDA.L / JNJ.N / PFE.N / AZN.L / SASY.PA / MRCG.DE / WCKH.BO / LONN.S / GSK.L / NVAX.OQ / SFZN.S / INO.OQ / 1099.HK / EVKN.DE / CTLT.N / CVAC.OQ</td><td class="leftalignment">Shionogi & Co Ltd / Croda International PLC / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Merck KGaA / Wockhardt Ltd / Lonza Group AG / GlaxoSmithKline PLC / Novavax Inc / Siegfried Holding AG / Inovio Pharmaceuticals Inc / Sinopharm Group Co Ltd / Evonik Industries AG / Catalent Inc / CureVac NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Germany / France / United Kingdom / India / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS.O / ACRX.O / EBS / HCM / JNJ / LLY / MRK / PFE / ALKS.O / JAZZ.O / CERS.O / OPTN.O / UBX / COLL.O / RMTI.O / AMRN.O / BDSI.O / BSLN.S / MNKD.O / COX.F / ZTS / OMER.O / SPRO.O / ANIP.O / AXGN.O / AERI.O / HRTX.O / TRVN.O / EGRX.O / SCYX.O / ARDX.O / ALDX.O / CFRX.O / CDTX.O / SPNE.O / FBIO.O / MESO.O / VRAY.O / VERU.O / TXMD.O / CKPT.O / EYPT.O / EOLS.O / ARDS.O / ARAV.O / SIBN.O / ETTX.O / ARQT.O / PCVX.O / SRGA.O / VYNE.O / HGEN.O / AZYO.O / GRAY.O / IMAB.O / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / Emergent BioSolutions Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Cerus Corp / OptiNose Inc / UNITY Biotechnology Inc / Collegium Pharmaceutical Inc / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Colonial Coal International Corp / Zoetis Inc / Omeros Corp / Spero Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / Ardelyx Inc / Aldeyra Therapeutics Inc / ContraFect Corp / Cidara Therapeutics Inc / SeaSpine Holdings Corp / Fortress Biotech Inc / Mesoblast Ltd / ViewRay Inc / Veru Inc / TherapeuticsMD Inc / Checkpoint Therapeutics Inc / EyePoint Pharmaceuticals Inc / Evolus Inc / Aridis Pharmaceuticals Inc / Aravive Inc / SI-BONE Inc / Entasis Therapeutics Holdings Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Humanigen Inc / Aziyo Biologics Inc / Graybug Vision Inc / I-Mab / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Latest ASP data provides some insight into biosimilar price trends</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Conference Call to Discuss the Recent FDA Regulatory Landscape on CRLs and Delays TODAY @ 10am ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">JNJ / LLY / MRK / PFE / OMER.O / HGEN.O</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Omeros Corp / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ORVR3.SA: Orizon Valorização de Resíduos S.A. - Venturing the Green Transformation; Initiating with an Outperform Rating and a R$29.30 TP</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ORVR3.SA / ABT.N / CSNA3.SA / DD.N / ELET6.SA / JPM.N / MICP.PA / OREP.PA / SAN.MC / PG.N / ELET3.SA / ROG.S / WM.N / ENEI.MI / MRCG.DE / OI.N / BLL.N / CPFE3.SA / MT.N / ENBR3.SA / CYRE3.SA / CSMG3.SA / CESP6.SA / EQTL3.SA / BAYGN.DE / PAM.N / SWM.AX / TAEE11.SA / ALUP11.SA / ENGI11.SA / EGIE3.SA / SAPR11.SA / NEOE3.SA</td><td class="leftalignment">Orizon Valorizacao de Residuos SA / Abbott Laboratories / Companhia Siderurgica Nacional / Dupont De Nemours Inc / Centrais Eletricas Brasileiras SA / JPMorgan Chase & Co / Compagnie Generale des Etablissements Michelin SCA / L'Oreal SA / Banco Santander SA / Procter & Gamble Co / Centrais Eletricas Brasileiras SA / Roche Holding AG / Waste Management Inc / Enel SpA / Merck KGaA / O-I Glass Inc / Ball Corp / CPFL Energia SA / ArcelorMittal SA / EDP Energias do Brasil SA / Cyrela Brazil Realty SA Empreendimentos e Participacoes / Companhia de Saneamento de Minas Gerais Copasa MG / CESP Companhia Energetica de Sao Paulo / Equatorial Energia SA / Bayer AG / Pampa Energia SA / Seven West Media Ltd / Transmissora Alianca de Energia Eletrica SA / Alupar Investimento SA / Energisa SA / Engie Brasil Energia SA / Companhia de Saneamento do Parana Sanepar / Neoenergia SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Argentina / Australia / Brazil / Switzerland / Germany / Spain / France / Italy / Luxembourg / United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Sra. Carolina C. Carneiro / Rafael Nagano / Joao Rodrigues</td></tr>
<tr class="odd"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / OXY=US / RRC=US / WEN=US / T=US / BLD=US / DVN=US / TEVA=US / CMA=US / PEB=US / APA=US / CPE=US / EOG=US / REI=US / CHTR=US / H=US / MTN=US / VZ=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / PB=US / MGY=US / SWN=US / MUR=US / CHRS=US / MAR=US / UMPQ=US / MRO=US / LEG=US / TNL=US / HLT=US / HUM=US / CMCSA=US / DISH=US / WTFC=US / CBRL=US / ELY=US / CHH=US / CNX=US / CW=US / DRI=US / DRH=US / EQT=US / GFF=US / IBP=US / MAS=US / MRCY=US / MHK=US / REGI=US / GOLF=US / HTH=US / CVX=US / SIVB=US / ABCB=US / FBK=US / NHI=US / COP=US / DIN=US / BCO=US / TCBI=US / TPX=US / EXP=US / FHN=US / BECN=US / SHO=US / PLAY=US / DENN=US / BLDR=US / GMS=US / NSP=US / CMG=US / REX=US / HST=US / PGTI=US / GPRE=US / EHTH=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / CLR=US / PRPL=US / LUMN=US / NMTR=US / WH=US / NOG=US / JACK=US / UTZ=US / TREX=US / AR=US / HGV=US / SBRA=US / PCRX=US / RLJ=US / ESTE=US / VAC=US / FBHS=US / BCEI=US / MTDR=US / PDCE=US / RHP=US / FANG=US / TILE=US / TMUS=US / NDLS=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / WING=US / SPNE=US / CABO=US / WVE=US / WLTW=US / 82982L103 / CDEV=US / IRTC=US / PK=US / PVAC=US / JELD=US / PLYA=US / SBOW=US / MBIN=US / BTAI=US / RTLR=US / FERG=US / GOCO=US / OVV=US / AZEK=US / 96758W101 / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Wendys Co / AT&T Inc / TopBuild Corp / Devon Energy Corp / Teva Pharmaceutical Industries Ltd / Comerica Inc / Pebblebrook Hotel Trust / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Charter Communications Inc / Hyatt Hotels Corp / Vail Resorts Inc / Verizon Communications Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Prosperity Bancshares Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Coherus BioSciences Inc / Marriott International Inc / Umpqua Holdings Corp / Marathon Oil Corp / Leggett & Platt Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Humana Inc / Comcast Corp / DISH Network Corp / Wintrust Financial Corp / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Choice Hotels International Inc / CNX Resources Corp / Curtiss-Wright Corp / Darden Restaurants Inc / Diamondrock Hospitality Co / EQT Corp / Griffon Corp / Installed Building Products Inc / Masco Corp / Mercury Systems Inc / Mohawk Industries Inc / Renewable Energy Group Inc / Acushnet Holdings Corp / Hilltop Holdings Inc / Chevron Corp / SVB Financial Group / Ameris Bancorp / FB Financial Corp / National Health Investors Inc / Conocophillips / Dine Brands Global Inc / Brinks Co / Texas Capital Bancshares Inc / Tempur Sealy International Inc / Eagle Materials Inc / First Horizon Corp / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Host Hotels & Resorts Inc / PGT Innovations Inc / Green Plains Inc / eHealth Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Purple Innovation Inc / Lumen Technologies Inc / 9 Meters Biopharma Inc / Wyndham Hotels & Resorts Inc / Northern Oil and Gas Inc / Jack in the Box Inc / UTZ Brands Inc / Trex Company Inc / Antero Resources Corp / Hilton Grand Vacations Inc / Sabra Health Care REIT Inc / Pacira Biosciences Inc / RLJ Lodging Trust / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Fortune Brands Home & Security Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Interface Inc / T-Mobile US Inc / Noodles & Co / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / SeaSpine Holdings Corp / Cable One Inc / WAVE Life Sciences Ltd / Willis Towers Watson PLC / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / iRhythm Technologies Inc / Park Hotels & Resorts Inc / Ranger Oil Corp / JELD-WEN Holding Inc / Playa Hotels & Resorts NV / SilverBow Resources Inc / Merchants Bancorp / BioXcel Therapeutics Inc / Rattler Midstream LP / Ferguson PLC / Gohealth Inc / Ovintiv Inc / Azek Company Inc / WideOpenWest Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Israel / Netherlands / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GRLS.MC: Grifols - Upgrade to Outperform & raising TP to Eu25</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">CSL.AX / GRLS.MC / 4502.T / JNJ.N / RECI.MI / LUN.CO / MRCG.DE / LONN.S / UCB.BR / 006280.KS / 002007.SZ / IPN.PA / ORNBV.HE / ALM.MC / VIFN.S / ARGX.OQ / GMAB.CO / IMVT.OQ</td><td class="leftalignment">CSL Ltd / Grifols SA / Takeda Pharmaceutical Co Ltd / Johnson & Johnson / Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Green Cross Corp / Hualan Biological Engineering Inc / Ipsen SA / Orion Oyj / Almirall SA / Vifor Pharma AG / argenx SE / Genmab A/S / Immunovant Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / Finland / France / Italy / Japan / Korea, Republic of / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Mar 12, 2021: Focus on 1Q21 trends for EU Majors</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / RB.L / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Reckitt Benckiser Group PLC / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Societe Generale</td><td class="leftalignment">Merck and Co Inc. (Buy, TP=$100) - 12m target downgrade - A classic stock for widows and orphans - J. Smith (6p)</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Justin S. Smith / Florent Cespedes / Dinesh Choudhary</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Societe Generale</td><td class="leftalignment">Merck KGaA (Hold, TP=€135) - Rating reiterated - Strong Life Science and Electronics recovery, while Pharma is still in transition - F. Cespedes (5p)</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Florent Cespedes / Justin S. Smith / Manas Sarkar</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">FY2020 Annual Report: Merck Net Profit down 28.2%</td><td class="leftalignment">English</td><td class="rightalignment">60</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Merck & Co., Inc. (MRK) - Keytruda continues to be the “star”</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Powering Through It, First Look Into Adjuvant NSCLC For PD-1s; Read-throughs From Tecentriq's Positive IMpower010 Data To Keytruda</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Merck Stock Remains Significantly Undervalued At $77</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Doc Call on April 7th: The Emerging Breast Cancer Landscape – Upcoming Enhertu HER2-Low Trial & Other Key Breast Cancer Trials</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2516152 / 2778844 / 2369174 / BFDV8K0 / BYQHPK7 / BYWVTY5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / MacroGenics Inc / Zymeworks Inc / CytomX Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 12, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / BSX=US / PEP=US / BMY=US / CAG=US / DIS=US / KO=US / CL=US / PG=US / MDT=US / INCY=US / RUN=US / GILD=US / PEB=US / H=US / V=US / MTN=US / ENR=US / MAR=US / EXPE=US / TTWO=US / TNL=US / HLT=US / AKR=US / NWL=US / EQR=US / W=US / FLO=US / MAC=US / STZ=US / AIR=US / CENT=US / CHH=US / CHD=US / COLL=US / DRH=US / EPC=US / HAIN=US / NTST=US / SMG=US / TRIP=US / POST=US / BKNG=US / OFC=US / FRT=US / SRC=US / REG=US / MGPI=US / BDSI=US / MNST=US / NOMD=US / STRO=US / SHO=US / FRPT=US / THS=US / SPWR=US / SCPL=US / HST=US / MA=US / ELF=US / WH=US / RCUS=US / AAN=US / 45665G303 / HGV=US / RLJ=US / VAC=US / ZNGA=US / EA=US / ENPH=US / MEIP=US / RHP=US / PINC=US / GOOGL=US / COUP=US / ETSY=US / SEDG=US / NSA=US / TRVG=US / PK=US / PLYA=US / PETQ=US / ROKU=US / SMAR=US / KDP=US / BTAI=US / APLT=US / BRBR=US / REYN=US / ABNB=US / HYFM=US / 100073616</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / PepsiCo Inc / Bristol-Myers Squibb Co / Conagra Brands Inc / Walt Disney Co / Coca-Cola Co / Colgate-Palmolive Co / Procter & Gamble Co / Medtronic PLC / Incyte Corp / Sunrun Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Visa Inc / Vail Resorts Inc / Energizer Holdings Inc / Marriott International Inc / Expedia Group Inc / Take-Two Interactive Software Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Acadia Realty Trust / Newell Brands Inc / Equity Residential / Wayfair Inc / Flowers Foods Inc / Macerich Co / Constellation Brands Inc / AAR Corp / Central Garden & Pet Co / Choice Hotels International Inc / Church & Dwight Co Inc / Collegium Pharmaceutical Inc / Diamondrock Hospitality Co / Edgewell Personal Care Co / Hain Celestial Group Inc / Netstreit Corp / Scotts Miracle-Gro Co / Tripadvisor Inc / Post Holdings Inc / Booking Holdings Inc / Corporate Office Properties Trust / Federal Realty Investment Trust / Spirit Realty Capital Inc / Regency Centers Corp / MGP Ingredients Inc / BioDelivery Sciences International Inc / Monster Beverage Corp / Nomad Foods Ltd / Sutro Biopharma Inc / Sunstone Hotel Investors Inc / Freshpet Inc / TreeHouse Foods Inc / SunPower Corp / Sciplay Corp / Host Hotels & Resorts Inc / Mastercard Inc / elf Beauty Inc / Wyndham Hotels & Resorts Inc / Arcus Biosciences Inc / Aaron's Company Inc / Infinity Pharmaceuticals Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Zynga Inc / Electronic Arts Inc / Enphase Energy Inc / MEI Pharma Inc / Ryman Hospitality Properties Inc / Premier Inc / Alphabet Inc / Coupa Software Inc / ETSY Inc / Solaredge Technologies Inc / National Storage Affiliates Trust / Trivago NV / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / PetIQ Inc / Roku Inc / Smartsheet Inc / Keurig Dr Pepper Inc / BioXcel Therapeutics Inc / Applied Therapeutics Inc / Bellring Brands Inc / Reynolds Consumer Products Inc / Airbnb Inc / Hydrofarm Holdings Group Inc / Kimco Realty Corp</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Luxembourg / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 22 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0116591092 / US0126531013 / US0311621009 / US0463531089 / US1101221083 / US1264081035 / US22284P1057 / US3021301094 / US37733W1053 / US4433201062 / US4456581077 / US4581401001 / US4781601046 / US5150981018 / US5324571083 / US6558441084 / US66987V1098 / US6701002056 / US6795801009 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US9029251066 / US9078181081 / US9507551086 / CA1363751027 / CA13645T1003 / AU000000LYC6 / US4771431016 / US4198791018 / US80105N1054 / US3463751087 / US12541W2098 / US78709Y1055 / PAP310761054 / US75025X1000 / US01748X1028 / US2473617023 / US45784P1012 / US58933Y1055 / US9100471096 / US92335C1062 / US9837931008 / US00287Y1091 / NL0010273215 / US98978V1035 / US8485771021 / US21240E1055 / US02376R1023 / US03937C1053 / CA0089118776 / US00653A1079 / CA87241L1094 / US23753F1075 / US80689H1023 / US04016X1019 / US4990491049 / CA53680Q2071 / US02083G1004 / US09354A1007 / US5904791358 / US28414H1032 / US0197701065 / US53814L1089 / US07373B1098 / US5533681012 / US74767V1098 / US7761531083 / US15961R1059</td><td class="leftalignment">Alaska Air Group Inc / Albemarle Corp / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / Covenant Logistics Group Inc / Expeditors International of Washington Inc / GlaxoSmithKline PLC / Hub Group Inc / J B Hunt Transport Services Inc / Intel Corp / Johnson & Johnson / Landstar System Inc / Eli Lilly and Co / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / USA Truck Inc / Union Pacific Corp / Werner Enterprises Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Lynas Rare Earths Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / FormFactor Inc / CH Robinson Worldwide Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Allegiant Travel Co / Delta Air Lines Inc / Insulet Corp / Merck & Co Inc / United Airlines Holdings Inc / Vera Bradley Inc / XPO Logistics Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / ArcBest Corp / Air Canada / Adaptimmune Therapeutics PLC / TFI International Inc / Daseke Inc / Schneider National Inc / argenx SE / Knight-Swift Transportation Holdings Inc / Lithium Americas Corp / Alpine Immune Sciences Inc / Blink Charging Co / Mesa Air Group Inc / Elanco Animal Health Inc / Allogene Therapeutics Inc / Livent Corp / Beam Global / Mp Materials Corp / Quantumscape Corp / Romeo Power Inc / ChargePoint Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ALV.N / ANTO.L / BAC.N / BHP.AX / BK.N / C.N / CL.N / CP.TO / EDP.LS / EL.N / F.N / GM.N / JPM.N / KMB.N / KO.N / MRK.N / NCM.AX / NEM.N / NSC.N / PFE.N / RIO.AX / RIO.L / RSG.AX / T.N / VC.N / WFC.N / PEP.N / BFb.N / PG.N / GILD.O / FNV.N / CPB.N / TEN.N / AAL.L / CNR.TO / BWA.N / LEA.N / K.N / DT.N / DISH.O / CSX.N / TV.TO / UNP.N / GS.N / CLX.N / CAG.N / GIS.N / EPC.N / SBM.AX / AMT.N / BOL.ST / NG.L / VZ.N / STT.N / EXEL.O / STZ.N / APH.N / FISV.O / ADSK.O / V.N / AXL.N / ACN.N / NBIX.O / CHD.N / BC.N / SAM.N / BMRN.O / REGN.O / ENR.N / VRTX.O / NCR.N / NET.N / TEL.N / APF.L / PII.N / ST.N / HCC.N / GPN.N / MNST.O / BLUE.O / CASY.O / BCRX.O / EQIX.O / ATDb.TO / IGO.AX / FMG.AX / GOLD.N / FM.TO / RMS.AX / NST.AX / 02209S103 / 878742204 / RRL.AX / DLR.N / WSA.AX / 427866108 / ALNY.O / 35671D857 / MS.N / FIS.N / ARWR.O / MA.N / CS.TO / HOG.N / 443628102 / 550372106 / BGS.N / NCU.TO / SLR.AX / DAN.N / EDPR.LS / OZL.AX / SFR.AX / NGD.A / OGC.TO / VALE.N / SPB.N / BHPB.L / GOR.AX / CAML.L / PCRX.O / MTOR.N / GLEN.L / EVN.AX / SPLK.OQ / PANW.N / MDLZ.OQ / 505440107 / TSLA.N / PRMW.N / TMUS.N / COTY.N / PRTA.O / AGIO.O / 81762P102 / 46579R104 / VRNS.O / CIA.TO / S32.AX / PYPL.OQ / GBT.OQ / IONS.O / RACE.MI / ADVM.OQ / TWLO.N / ADNT.N / CRSP.OQ / PBYI.OQ / OKTA.OQ / SAIL.N / APTV.N / NEXA.TO / ZS.OQ / VNE.N / KDP.N / XERS.O / AQST.O / PRVB.O / ESTC.N / OSMT.O / NWL.O / CRWD.O / PING.N / CRNC.OQ / REYN.O / SBSW.N / NKLA.OQ / FOUR.N / SPRB.OQ / 900435207 / AFRM.O / TEEC.L / 120681711</td><td class="leftalignment">Autoliv Inc / Antofagasta PLC / Bank of America Corp / BHP Group Ltd / Bank of New York Mellon Corp / Citigroup Inc / Colgate-Palmolive Co / Canadian Pacific Railway Ltd / EDP Energias de Portugal SA / Estee Lauder Companies Inc / Ford Motor Co / General Motors Co / JPMorgan Chase & Co / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / Newcrest Mining Ltd / Newmont Corporation / Norfolk Southern Corp / Pfizer Inc / Rio Tinto Ltd / Rio Tinto PLC / Resolute Mining Ltd / AT&T Inc / Visteon Corp / Wells Fargo & Co / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Gilead Sciences Inc / Franco-Nevada Corp / Campbell Soup Co / Tenneco Inc / Anglo American PLC / Canadian National Railway Co / Borgwarner Inc / Lear Corp / Kellogg Co / Dynatrace Inc / DISH Network Corp / CSX Corp / Trevali Mining Corp / Union Pacific Corp / Goldman Sachs Group Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / Edgewell Personal Care Co / St Barbara Ltd / American Tower Corp / Boliden AB / National Grid PLC / Verizon Communications Inc / State Street Corp / Exelixis Inc / Constellation Brands Inc / Amphenol Corp / Fiserv Inc / Autodesk Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / Accenture PLC / Neurocrine Biosciences Inc / Church & Dwight Co Inc / Brunswick Corp / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Vertex Pharmaceuticals Inc / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Anglo Pacific Group PLC / Polaris Inc / Sensata Technologies Holding PLC / Warrior Met Coal Inc / Global Payments Inc / Monster Beverage Corp / bluebird bio Inc / Caseys General Stores Inc / BioCryst Pharmaceuticals Inc / Equinix Inc / Alimentation Couche-Tard Inc / IGO Ltd / Fortescue Metals Group Ltd / Barrick Gold Corp / First Quantum Minerals Ltd / Ramelius Resources Ltd / Northern Star Resources Ltd / Altria Group Inc / Teck Resources Ltd / Regis Resources Ltd / Digital Realty Trust Inc / Western Areas Ltd / Hershey Co / Alnylam Pharmaceuticals Inc / Freeport-McMoRan Inc / Morgan Stanley / Fidelity National Information Services Inc / Arrowhead Pharmaceuticals Inc / Mastercard Inc / Capstone Mining Corp / Harley-Davidson Inc / Hudbay Minerals Inc / Lundin Mining Corp / B&G Foods Inc / Nevada Copper Corp / Silver Lake Resources Ltd / Dana Inc / EDP Renovaveis SA / OZ Minerals Ltd / Sandfire Resources Ltd / New Gold Inc / OceanaGold Corp / Vale SA / Spectrum Brands Holdings Inc / BHP Group PLC / Gold Road Resources Ltd / Central Asia Metals PLC / Pacira Biosciences Inc / Meritor Inc / Glencore PLC / Evolution Mining Ltd / Splunk Inc / Palo Alto Networks Inc / Mondelez International Inc / Labrador Iron Ore Royalty Corp / Tesla Inc / Primo Water Corp / T-Mobile US Inc / Coty Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / ServiceNow Inc / Ivanhoe Mines Ltd / Varonis Systems Inc / Champion Iron Ltd / South32 Ltd / PayPal Holdings Inc / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Ferrari NV / Adverum Biotechnologies Inc / Twilio Inc / Adient PLC / CRISPR Therapeutics AG / Puma Biotechnology Inc / Okta Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Nexa Resources SA / Zscaler Inc / Veoneer Inc / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Provention Bio Inc / Elastic NV / Osmotica Pharmaceuticals PLC / Newell Brands Inc / CrowdStrike Holdings Inc / Ping Identity Holding Corp / Cerence Inc / Reynolds Consumer Products Inc / Sibanye Stillwater Ltd / Nikola Corp / Shift4 Payments Inc / Spruce Biosciences Inc / Turquoise Hill Resources Ltd / Affirm Holdings Inc / Triple Point Energy Efficiency Infrastructure Company Plc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Brazil / Canada / Switzerland / Cayman Islands / Spain / United Kingdom / Ireland / Luxembourg / Netherlands / Portugal / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ROG.S: Roche - Follow up on positive adjuvant lung Tecentriq data</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ROG.S / BMY.N / MRK.N / AZN.L</td><td class="leftalignment">Roche Holding AG / Bristol-Myers Squibb Co / Merck & Co Inc / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Equity Strategy: Regional strategy: downgrade GEM, add to Japan, the UK, Italy and Mexico</td><td class="leftalignment">English</td><td class="rightalignment">115</td><td class="leftalignment">2330.TW / 4502.T / 4503.T / 6502.T / 6754.T / 6758.T / 6954.T / 6963.T / 6981.T / 7203.T / 7269.T / 7453.T / 8035.T / 9983.T / ABB.BO / ACX.MC / ALVG.DE / BT.L / CRDA.L / DGE.L / ELE.MC / ELM.L / IBE.MC / INRN.S / ITV.L / KPN.AS / LART.BO / MO.N / OREP.PA / PM.N / RR.L / RTO.L / RWEG.F / RYA.I / SAN.MC / SAPG.F / SBI.BO / STM.PA / TISC.BO / ULVR.L / WEIR.L / WLSNC.AS / SSE.L / BRDT3.SA / PG.N / 6594.T / 6861.T / ARBN.BO / 9843.T / ABBN.S / SIEGN.DE / ENEI.MI / MRCG.DE / DTEGN.F / NKE.N / IFXGN.DE / GIVN.S / 6506.T / CLN.S / PBR.N / EZJ.L / ITX.MC / 2264.T / SRG.MI / TDY.N / REL.L / 8316.T / BCVN.S / GOCP.BO / AMAT.OQ / ROL.N / MRTI.BO / 6723.T / KNIN.S / 005930.KS / 051910.KS / BEAN.S / IFCN.S / SRTR.BO / YPSN.S / ASOS.L / LXSG.DE / SAF.PA / MTXGN.DE / MBTN.S / ISP.MI / VZN.S / AXBK.BO / FLUI.MC / HOCN.S / ARYN.S / VALE.N / AVGO.OQ / BNRGN.DE / BASFN.DE / ADSGN.F / CABK.MC / O2DN.DE / ORAN.PA / PSMGN.DE / APPS.MC / FBK.MI / ONTEX.BR / BABA.N / ZALG.DE / 3697.T / AENA.MC / CLNX.MC / INWT.MI / IMB.L / VACN.S / ESSITYB.ST / HFGG.DE / DWSG.DE / EPIRA.ST / BBAR.BA / ENR1N.DE / 120547773</td><td class="leftalignment">Taiwan Semiconductor Manufacturing Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Toshiba Corp / Anritsu Corp / Sony Group Corp / Fanuc Corp / Rohm Co Ltd / Murata Manufacturing Co Ltd / Toyota Motor Corp / Suzuki Motor Corp / Ryohin Keikaku Co Ltd / Tokyo Electron Ltd / Fast Retailing Co Ltd / ABB India Ltd / Acerinox SA / Allianz SE / BT Group PLC / Croda International PLC / Diageo PLC / Endesa SA / Elementis PLC / Iberdrola SA / Interroll Holding AG / ITV PLC / Koninklijke KPN NV / Larsen & Toubro Ltd / Altria Group Inc / L'Oreal SA / Philip Morris International Inc / Rolls-Royce Holdings PLC / Rentokil Initial PLC / Rwe AG / Ryanair Holdings PLC / Banco Santander SA / SAP SE / State Bank of India / STMicroelectronics NV / Tata Steel Ltd / Unilever PLC / Weir Group PLC / Wolters Kluwer NV / SSE PLC / Vibra Energia SA / Procter & Gamble Co / Nidec Corp / Keyence Corp / Aurobindo Pharma Ltd / Nitori Holdings Co Ltd / Abb Ltd / Siemens AG / Enel SpA / Merck KGaA / Deutsche Telekom AG / Nike Inc / Infineon Technologies AG / Givaudan SA / Yaskawa Electric Corp / Clariant AG / Petroleo Brasileiro SA Petrobras / Easyjet PLC / Industria de Diseno Textil SA / Morinaga Milk Industry Co Ltd / Snam SpA / Teledyne Technologies Inc / Relx PLC / Sumitomo Mitsui Financial Group Inc / Banque Cantonale Vaudoise / Godrej Consumer Products Ltd / Applied Materials Inc / Rollins Inc / Maruti Suzuki India Ltd / Renesas Electronics Corp / Kuehne und Nagel International AG / Samsung Electronics Co Ltd / LG Chem Ltd / Belimo Holding AG / Inficon Holding AG / Shriram Transport Finance Company Ltd / Ypsomed Holding AG / ASOS PLC / Lanxess AG / Safran SA / MTU Aero Engines AG / Meyer Burger Technology AG / Intesa Sanpaolo SpA / VZ Holding AG / Axis Bank Ltd / Fluidra SA / Hochdorf Holding AG / Aryzta AG / Vale SA / Broadcom Inc / Brenntag SE / BASF SE / Adidas AG / Caixabank SA / Telefonica Deutschland Holding AG / Orange SA / Prosiebensat 1 Media SE / Applus Services SA / FinecoBank Banca Fineco SpA / Ontex Group NV / Alibaba Group Holding Ltd / Zalando SE / Shift Inc / Aena SME SA / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Imperial Brands PLC / VAT Group AG / Essity AB (publ) / Hellofresh SE / DWS Group GmbH & Co KgaA / Epiroc AB / Banco Bbva Argentina SA / Siemens Energy AG / MFE-MEDIAFOREUROPE NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Argentina / Belgium / Brazil / Switzerland / China / Cayman Islands / Germany / Spain / France / United Kingdom / India / Ireland / Italy / Japan / Korea, Republic of / Netherlands / Sweden / Taiwan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / Investment Strategy / Equity</td><td class="leftalignment">Mr. Andrew W. Garthwaite / Mr Robert C. Griffiths / Mr Nicolas Wylenzek / Mr Mengyuan Yuan / Asim Ali / Timothy O'Sullivan</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GMAB.CO: Genmab - Call with arbitration expert; Worst-case scenario in consensus numbers</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GMAB.CO / JNJ.N / RECI.MI / LUN.CO / MRCG.DE / LONN.S / UCB.BR / ORNBV.HE / ALM.MC / GRLS.MC</td><td class="leftalignment">Genmab A/S / Johnson & Johnson / Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Orion Oyj / Almirall SA / Grifols SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / Italy / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">03/21/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Catalyst Tracker 3.21.21: Highlights Top Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">55</td><td class="leftalignment">MRK=US / ABT=US / AMGN=US / INSP=US / GILD=US / SAN=FR / ATRC=US / BLUE=US / CSTL=US / ILMN=US / TFX=US / PRVB=US / CGEN=US / BIIB=US / ACRS=US / ACAD=US / QTRX=US / FOLD=US / PODD=US / RCUS=US / SRPT=US / MRTX=US / MGNX=US / QURE=US / AFMD=US / NVRO=US / ZBH=US / LNTH=US / WVE=US / MRUS=US / RETA=US / BHVN=US / REPL=US / HARP=US / ETNB=US / KROS=US / FMTX=US / ITOS=US / CGEM=US</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Amgen Inc / Inspire Medical Systems Inc / Gilead Sciences Inc / Sanofi SA / AtriCure Inc / bluebird bio Inc / Castle Biosciences Inc / Illumina Inc / Teleflex Inc / Provention Bio Inc / Compugen Ltd / Biogen Inc / Aclaris Therapeutics Inc / ACADIA Pharmaceuticals Inc / Quanterix Corp / Amicus Therapeutics Inc / Insulet Corp / Arcus Biosciences Inc / Sarepta Therapeutics Inc / Mirati Therapeutics Inc / MacroGenics Inc / Uniqure NV / Affimed NV / Nevro Corp / Zimmer Biomet Holdings Inc / Lantheus Holdings Inc / WAVE Life Sciences Ltd / Merus NV / Reata Pharmaceuticals Inc / Biohaven Pharmaceutical Holding Company Ltd / Replimune Group Inc / Harpoon Therapeutics Inc / 89Bio Inc / Keros Therapeutics Inc / Forma Therapeutics Holdings Inc / Iteos Therapeutics Inc / Cullinan Oncology Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / Israel / Netherlands / Singapore / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / PCRX.O / XERS.O / AQST.O / OSMT.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Pacira Biosciences Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Osmotica Pharmaceuticals PLC</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">03/21/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Call to Discuss The Potential Role Of, And Key Focus Areas For, ADCs In Oncology on Friday, April 9, 2021 at 1 pm ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK / PFE</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Key Metrics Remain Above Pre-Pandemic Levels-Week 51</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Sutro is Well Poised to Grow Into $37 PT. Execution Will Support Product-Defines-Platform Thesis</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">STRO=US / MRK=US / BMY=US</td><td class="leftalignment">Sutro Biopharma Inc / Merck & Co Inc / Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene / Avi Dahan</td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Mar 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">BNGO=US / NBSE=US / MRK=US / CSII=US / PFE=US / ABT=US / AMGN=US / BMY=US / MDT=US / WMT=US / EPIX=US / CMS=US / DGX=US / SYK=US / IART=US / BAX=US / GSK=US / CRY=US / RAD=US / JNJ=US / MMSI=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ANGN=US / APLS=US / ATRC=US / CHE=US / CYH=US / COO=US / DRRX=US / EW=US / EXEL=US / GEN=US / ICPT=US / LH=US / LIFE=US / NBIX=US / USPH=US / UTHR=US / UHS=US / VRTX=US / OPT=US / PRVB=US / CGEN=US / CCRN=US / CNC=US / ACA=US / ENSG=US / ALPN=US / MIST=US / MD=US / SLF=US / ISR=US / SLP=US / MRNA=US / ACAD=US / MBRX=US / MNKD=US / GOOG=US / INO=US / LHCG=US / AGRX=US / CBAY=US / CHNG=US / INFI=US / TPTX=US / ORTX=US / PODD=US / EHC=US / NMTR=US / TNDM=US / SWAV=US / ASND=US / ADUS=US / ALPMY=US / ACHC=US / PRTA=US / ENTA=US / AGIO=US / FATE=US / AERI=US / TRVN=US / FLXN=US / MDWD=US / CTRE=US / ALDX=US / VBIV=US / XENT=US / AUPH=US / OTIC=US / VCEL=US / WBA=US / SNPHY=US / RLMD=US / EVH=US / GKOS=US / CFMS=US / CATB=US / IONS=US / VRAY=US / TCMD=US / AVDL=US / SRRA=US / SVRA=US / SLNO=US / URGN=US / VREX=US / IOVA=US / MTEM=US / VERU=US / KALA=US / MBIO=US / MDNA=US / MOTS=US / VCNX=US / CUE=US / MRKR=US / ORGO=US / PDSB=US / IDYA=US / BCYC=US / KRTX=US / XAIR=US / DMTK=US / ETNB=US / VERO=US / PNTG=US / AYLA=US / FMTX=US / NNOX=US / KDNY=US / VRDN=US / EVAX=US / SOBE=US</td><td class="leftalignment">Bionano Genomics Inc / NeuBase Therapeutics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Medtronic PLC / Walmart Inc / ESSA Pharma Inc / CMS Energy Corp / Quest Diagnostics Inc / Stryker Corp / Integra Lifesciences Holdings Corp / Baxter International Inc / GlaxoSmithKline PLC / CryoLife Inc / Rite Aid Corp / Johnson & Johnson / Merit Medical Systems Inc / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Angion Biomedica Corp / Apellis Pharmaceuticals Inc / AtriCure Inc / Chemed Corp / Community Health Systems Inc / Cooper Companies Inc / DURECT Corp / Edwards Lifesciences Corp / Exelixis Inc / Genesis Healthcare Inc / Intercept Pharmaceuticals Inc / Laboratory Corporation of America Holdings / aTyr Pharma Inc / Neurocrine Biosciences Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Opthea Ltd / Provention Bio Inc / Compugen Ltd / Cross Country Healthcare Inc / Centene Corp / Arcosa Inc / Ensign Group Inc / Alpine Immune Sciences Inc / Milestone Pharmaceuticals Inc / MEDNAX Inc / Sun Life Financial Inc / IsoRay Inc / Simulations Plus Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Moleculin Biotech Inc / MannKind Corp / Alphabet Inc / Inovio Pharmaceuticals Inc / LHC Group Inc / Agile Therapeutics Inc / Cymabay Therapeutics Inc / Change Healthcare Inc / Infinity Pharmaceuticals Inc / Turning Point Therapeutics Inc / Orchard Therapeutics PLC / Insulet Corp / Encompass Health Corp / 9 Meters Biopharma Inc / Tandem Diabetes Care Inc / Shockwave Medical Inc / Ascendis Pharma A/S / Addus Homecare Corp / Astellas Pharma Inc / Acadia Healthcare Company Inc / Prothena Corporation PLC / Enanta Pharmaceuticals Inc / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Aerie Pharmaceuticals Inc / Trevena Inc / Pacira Biosciences Inc / Mediwound Ltd / CareTrust REIT Inc / Aldeyra Therapeutics Inc / VBI Vaccines Inc / Intersect Ent Inc / Aurinia Pharmaceuticals Inc / Otonomy Inc / Vericel Corp / Walgreens Boots Alliance Inc / Santen Pharmaceutical Co Ltd / Relmada Therapeutics Inc / Evolent Health Inc / Glaukos Corp / Conformis Inc / Astria Therapeutics Inc / Ionis Pharmaceuticals Inc / ViewRay Inc / Tactile Systems Technology Inc / Avadel Pharmaceuticals PLC / Sierra Oncology Inc / Savara Inc / Soleno Therapeutics Inc / Urogen Pharma Ltd / Varex Imaging Corp / Iovance Biotherapeutics Inc / Molecular Templates Inc / Veru Inc / Kala Pharmaceuticals Inc / Mustang Bio Inc / Medicenna Therapeutics Corp / Motus GI Holdings Inc / Vaccinex Inc / Cue Biopharma Inc / Marker Therapeutics Inc / Organogenesis Holdings Inc / PDS Biotechnology Corp / IDEAYA Biosciences Inc / Bicycle Therapeutics PLC / Karuna Therapeutics Inc / Beyond Air Inc / DermTech Inc / 89Bio Inc / Venus Concept Inc / Pennant Group Inc / Ayala Pharmaceuticals Inc / Forma Therapeutics Holdings Inc / Nano-X Imaging Ltd / Chinook Therapeutics Inc / Viridian Therapeutics Inc / Evaxion Biotech A/S / AT&T Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Denmark / United Kingdom / Ireland / Israel / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canada Weekly Portfolio Manager's Summary</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABF.L / AEGN.AS / AES.N / AGL.AX / ALVG.DE / AMAT.O / AU.N / AXP.N / BAC.N / BCE.TO / BHP.AX / CBKG.DE / CCK.N / CI.N / CNE.L / CP.TO / CPG.L / CSGN.S / DANO.PA / DD.N / DFDS.CO / ED.N / EIX.N / ENI.MI / FLS.N / FOUG.PA / GPS.N / HSBA.L / L.TO / MICP.PA / MKS.L / MRK.N / MUVGn.DE / NA / NCM.AX / NSC.N / NXT.L / PPG.N / RAND.AS / RIO.AX / SCOR.PA / SECUb.ST / T.N / TD.TO / TLW.L / TOL.N / TRV.N / VOLVb.ST / WEIR.L / WFC.N / WMB.N / SSE.L / CMA.N / TRI.N / RAT.L / CONG.DE / WY.N / PXD.N / CFP.TO / CNQ.TO / GILD.O / CMCSA.O / SJRb.TO / TA.TO / RCIb.TO / AAPL.O / CNR.TO / AGI.N / QBRb.TO / DIS.N / WCC.N / DRI.N / DT.N / CSX.N / ABBN.S / IMO.TO / SU.TO / EAT.N / VLO.N / MFC.TO / XOM.N / CJRb.TO / WHR.N / NKE.N / MRU.TO / SHW.N / GWW.N / VZ.N / HCA.N / ADEN.S / STZ.N / AMP.N / EXC.N / AZO.N / V.N / CHTR.O / DLTR.O / DG.N / PLD.N / DK.N / IGG.L / ARE.TO / CVX.N / MU.O / MHK.N / CEY.L / CAR_u.TO / PSI.TO / NET.N / GPK.N / FLS.CO / COP.N / CPE.N / MEOH.O / DOL.TO / FRC.N / HCC.N / CCLb.TO / RGLD.O / SIVB.O / HOOK.O / ORLY.O / ACGL.O / TCBI.O / TCLa.TO / ATDb.TO / EMPA.TO / IGO.AX / SNC.TO / RUS.TO / CHE_u.TO / RTN.L / 02209S103 / NTR.N / DPZ.N / SPI.L / MOS.N / TXRH.O / VIAC.O / IAG.N / 416515104 / WSA.AX / WEF.TO / BUCN.S / MPW.N / BLDR.O / STX.O / 35671D857 / ALD.AX / TEVA.N / MA.N / MWA.N / CPX.TO / MARS.L / DWNG.DE / H.TO / IVZ.N / DAIGn.DE / CBRO.L / BEZG.L / ABCA.L / GETP.PA / PBF.N / SII.TO / OZL.AX / ABI.BR / SFR.AX / CLW.N / AND.TO / VALE.N / IFC.TO / CPG.TO / ADUS.OQ / BHPB.L / MEG.TO / WCP.TO / LYB.N / PCH.O / CJT.TO / IFP.TO / EVN.AX / PSX.N / BERY.N / DIR_u.TO / ABBV.N / TMUS.N / UKWG.L / BEP.N / 81762P102 / IBP.N / ENLC.N / ARES.N / BMEB.L / NEP.N / HQY.OQ / AXTA.N / S32.AX / CIGI.O / FSV.O / RAYa.TO / VNAn.DE / AMUN.PA / GYM.L / CMCX.L / BFIT.AS / TWLO.N / CTEC.L / CDEV.O / VST.N / WPM.N / JUSTJ.L / IHR.L / SUPR.L / ORSTED.CO / ENOG.L / MI_U.TO / CWEN.N / ESTC.N / NBSE.OQ / CRWD.O / 260557103 / WILD.TO / GFL.N / MOCORP.HE / 77311W101 / WFG.N / DHT_u.TO</td><td class="leftalignment">Associated British Foods PLC / Aegon NV / AES Corp / AGL Energy Ltd / Allianz SE / Applied Materials Inc / AngloGold Ashanti Ltd / American Express Co / Bank of America Corp / BCE Inc / BHP Group Ltd / Commerzbank AG / Crown Holdings Inc / Cigna Corp / Capricorn Energy PLC / Canadian Pacific Railway Ltd / Compass Group PLC / Credit Suisse Group AG / Danone SA / Dupont De Nemours Inc / DFDS AS / Consolidated Edison Inc / Edison International / Eni SpA / Flowserve Corp / Eiffage SA / Gap Inc / HSBC Holdings PLC / Loblaw Companies Ltd / Compagnie Generale des Etablissements Michelin SCA / Marks and Spencer Group PLC / Merck & Co Inc / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / National Bank of Canada / Newcrest Mining Ltd / Norfolk Southern Corp / Next PLC / PPG Industries Inc / Randstad NV / Rio Tinto Ltd / Scor SE / Securitas AB / AT&T Inc / Toronto-Dominion Bank / Tullow Oil PLC / Toll Brothers Inc / Travelers Companies Inc / Volvo AB / Weir Group PLC / Wells Fargo & Co / Williams Companies Inc / SSE PLC / Comerica Inc / Thomson Reuters Corp / Rathbones Group PLC / Continental AG / Weyerhaeuser Co / Pioneer Natural Resources Co / Canfor Corp / Canadian Natural Resources Ltd / Gilead Sciences Inc / Comcast Corp / Shaw Communications Inc / TransAlta Corp / Rogers Communications Inc / Apple Inc / Canadian National Railway Co / Alamos Gold Inc / Quebecor Inc / Walt Disney Co / Wesco International Inc / Darden Restaurants Inc / Dynatrace Inc / CSX Corp / Abb Ltd / Imperial Oil Ltd / Suncor Energy Inc / Brinker International Inc / Valero Energy Corp / Manulife Financial Corp / Exxon Mobil Corp / Corus Entertainment Inc / Whirlpool Corp / Nike Inc / Metro Inc / Sherwin-Williams Co / W W Grainger Inc / Verizon Communications Inc / HCA Healthcare Inc / Adecco Group AG / Constellation Brands Inc / Ameriprise Financial Inc / Exelon Corp / Autozone Inc / Visa Inc / Charter Communications Inc / Dollar Tree Inc / Dollar General Corp / Prologis Inc / Delek US Holdings Inc / IG Group Holdings PLC / Aecon Group Inc / Chevron Corp / Micron Technology Inc / Mohawk Industries Inc / Centamin PLC / Canadian Apartment Properties Real Estate Investment Trust / Pason Systems Inc / Cloudflare Inc / Graphic Packaging Holding Co / FLSmidth & Co A/S / Conocophillips / Callon Petroleum Co / Methanex Corp / Dollarama Inc / First Republic Bank / Warrior Met Coal Inc / CCL Industries Inc / Royal Gold Inc / SVB Financial Group / HOOKIPA Pharma Inc / O'Reilly Automotive Inc / Arch Capital Group Ltd / Texas Capital Bancshares Inc / Transcontinental Inc / Alimentation Couche-Tard Inc / Empire Company Ltd / IGO Ltd / SNC-Lavalin Group Inc / Russel Metals Inc / Chemtrade Logistics Income Fund / Restaurant Group PLC / Altria Group Inc / Nutrien Ltd / Domino's Pizza Inc / Spire Healthcare Group PLC / Mosaic Co / Texas Roadhouse Inc / ViacomCBS Inc / IAMGOLD Corp / Hartford Financial Services Group Inc / Western Areas Ltd / Western Forest Products Inc / Bucher Industries AG / Medical Properties Trust Inc / Builders FirstSource Inc / Seagate Technology Holdings PLC / Freeport-McMoRan Inc / Ampol Ltd / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Mueller Water Products Inc / Capital Power Corp / Marston's PLC / Deutsche Wohnen SE / Hydro One Ltd / Invesco Ltd / Daimler AG / Close Brothers Group PLC / Beazley PLC / Abcam PLC / Getlink SE / PBF Energy Inc / Sprott Inc / OZ Minerals Ltd / Anheuser Busch Inbev SA / Sandfire Resources Ltd / Clearwater Paper Corp / Andlauer Healthcare Group Inc / Vale SA / Intact Financial Corp / Crescent Point Energy Corp / Addus Homecare Corp / BHP Group PLC / MEG Energy Corp / Whitecap Resources Inc / LyondellBasell Industries NV / Potlatchdeltic Corp / Cargojet Inc / Interfor Corp / Evolution Mining Ltd / Phillips 66 / Berry Global Group Inc / Dream Industrial Real Estate Investment Trust / Abbvie Inc / T-Mobile US Inc / Greencoat UK Wind PLC / Brookfield Renewable Partners LP / ServiceNow Inc / Installed Building Products Inc / EnLink Midstream LLC / Ares Management Corp / B&M European Value Retail SA / Nextera Energy Partners LP / Healthequity Inc / Axalta Coating Systems Ltd / South32 Ltd / Colliers International Group Inc / FirstService Corp / Stingray Group Inc / Vonovia SE / Amundi SA / GYM Group PLC / CMC Markets PLC / Basic Fit NV / Twilio Inc / ConvaTec Group PLC / Centennial Resource Development Inc / Vistra Corp / Wheaton Precious Metals Corp / Just Group PLC / Impact Healthcare REIT PLC / Supermarket Income REIT PLC / Orsted A/S / Energean PLC / Minto Apartment Real Estate Investment Trust / Clearway Energy Inc / Elastic NV / NeuBase Therapeutics Inc / CrowdStrike Holdings Inc / Dow Inc / WildBrain Ltd / GFL Environmental Inc / Metso Outotec Corp / Rocket Companies Inc / West Fraser Timber Co Ltd / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Brazil / Canada / Switzerland / Germany / Denmark / Finland / France / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / Papua New Guinea / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Andre-Philippe Hardy, CFA</td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending Mar 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">619</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Middle East</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Merck & Co Inc (MRK) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">912</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended March 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US / LLY=US / AVB=US / AMZN=US / GILD=US / MTN=US / VRM=US / EXPE=US / ESS=US / EQR=US / AIR=US / AMN=US / HOOK=US / SNAP=US / TRIP=US / WIX=US / CCRN=US / BKNG=US / CPT=US / FB=US / MAA=US / UDR=US / NLS=US / PTON=US / BIIB=US / APTS=US / ANGI=US / IBTX=US / GOOGL=US / 00770K202 / BABA=US / CMPR=US / GDDY=US / NXRT=US / CVNA=US / SFIX=US / SYNH=US / BTAI=US / FTDR=US / SVMK=US / LYFT=US / UBER=US / AIRC=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Avalonbay Communities Inc / Amazon.com Inc / Gilead Sciences Inc / Vail Resorts Inc / Vroom Inc / Expedia Group Inc / Essex Property Trust Inc / Equity Residential / AAR Corp / AMN Healthcare Services Inc / HOOKIPA Pharma Inc / Snap Inc / Tripadvisor Inc / Wix.Com Ltd / Cross Country Healthcare Inc / Booking Holdings Inc / Camden Property Trust / Meta Platforms Inc / Mid-America Apartment Communities Inc / UDR Inc / Nautilus Inc / Peloton Interactive Inc / Biogen Inc / Preferred Apartment Communities Inc / Angi Inc / Independent Bank Group Inc / Alphabet Inc / Aemetis Inc / Alibaba Group Holding Ltd / Cimpress PLC / GoDaddy Inc / NexPoint Residential Trust Inc / Carvana Co / Stitch Fix Inc / Syneos Health Inc / BioXcel Therapeutics Inc / Frontdoor Inc / Momentive Global Inc / Lyft Inc / Uber Technologies Inc / Apartment Income REIT Corp</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / 0925288 / 2008154 / 2640147 / 2778844 / 2026242 / 2270726 / 2317087 / 2328915 / 2100920 / 2369174 / 2459020 / 2689560 / 2680905 / 2048804 / 2799351 / 2967589 / B1F76F9 / B121557 / B067BM3 / 2212922 / 2769796 / 2857817 / B5B1S13 / BBGVT40 / B87ZMX0 / B8DPDT7 / BFZCHN7 / BYNZGK1 / BFZ1K46 / BZ8VJQ8 / BKTNTR9</td><td class="leftalignment">American Express Co / GlaxoSmithKline PLC / Adobe Inc / Nike Inc / Merck & Co Inc / American Electric Power Company Inc / Walt Disney Co / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Gilead Sciences Inc / Intuit Inc / PG&E Corp / PPL Corp / Pinnacle West Capital Corp / Sinclair Broadcast Group Inc / Williams-Sonoma Inc / Western Union Co / Mastercard Inc / Molson Coors Beverage Co / NRG Energy Inc / Fidelity National Information Services Inc / Netflix Inc / Dollar General Corp / News Corp / Palo Alto Networks Inc / Sarepta Therapeutics Inc / Wix.Com Ltd / Block Inc / Spotify Technology SA / Vistra Corp / ViacomCBS Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Highlights from HIV KOL Discussion; Enthusiasm for Long Acting Category Broadly Positive for MRK/GILD Collaboration</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK.N / GILD.OQ / 0925288 / 2778844 / 2369174</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Merck & Co Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BIIB.OQ / INCY.OQ / LLY.N / MRK.N / AZN.L / SASY.PA / AMGN.OQ / REGN.OQ / ALKS.OQ / STSA.OQ / GILD.OQ / NBIX.OQ / VRTX.OQ / GLPG.AS / TEVA.N / MRNA.OQ / ACRX.OQ / ABBV.N / MRTX.OQ / MGNX.OQ / SAGE.OQ / ZBH.N / GRTX.OQ</td><td class="leftalignment">Biogen Inc / Incyte Corp / Eli Lilly and Co / Merck & Co Inc / AstraZeneca PLC / Sanofi SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Moderna Inc / AcelRx Pharmaceuticals Inc / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / SAGE Therapeutics Inc / Zimmer Biomet Holdings Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Transcript from Expert call on donanemab</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">LLY=US / MRK=US / BIIB=US / BTAI=US</td><td class="leftalignment">Eli Lilly and Co / Merck & Co Inc / Biogen Inc / BioXcel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">03/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Australian Research at a Glance - March 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ABF.L / AEGN.AS / AES.N / AGL.AX / ALVG.DE / AMAT.O / AU.N / AXP.N / BAC.N / BCE.TO / BHP.AX / CBKG.DE / CCK.N / CI.N / CNE.L / CP.TO / CPG.L / CSGN.S / DANO.PA / DD.N / DFDS.CO / ED.N / EIX.N / ENI.MI / FLS.N / FOUG.PA / GPS.N / HSBA.L / L.TO / MICP.PA / MKS.L / MRK.N / MUVGn.DE / NA / NCM.AX / NSC.N / NXT.L / PPG.N / RAND.AS / RIO.AX / SCOR.PA / SECUb.ST / T.N / TD.TO / TLW.L / TOL.N / TRV.N / VOLVb.ST / WEIR.L / WFC.N / WMB.N / SSE.L / CMA.N / RAT.L / CONG.DE / WY.N / PXD.N / CNQ.TO / GILD.O / CMCSA.O / TA.TO / RCIb.TO / AAPL.O / CNR.TO / AGI.N / QBRb.TO / DIS.N / WCC.N / DRI.N / DT.N / CSX.N / ABBN.S / IMO.TO / SU.TO / EAT.N / VLO.N / MFC.TO / XOM.N / CJRb.TO / WHR.N / NKE.N / MRU.TO / SHW.N / GWW.N / VZ.N / HCA.N / ADEN.S / STZ.N / AMP.N / EXC.N / AZO.N / V.N / CHTR.O / DLTR.O / DG.N / PLD.N / DK.N / IGG.L / ARE.TO / CVX.N / MU.O / MHK.N / CEY.L / CAR_u.TO / PSI.TO / NET.N / GPK.N / FLS.CO / COP.N / CPE.N / MEOH.O / DOL.TO / FRC.N / HCC.N / CCLb.TO / RGLD.O / SIVB.O / HOOK.O / ORLY.O / ACGL.O / TCBI.O / TCLa.TO / EMPA.TO / WEB.AX / IGO.AX / SNC.TO / RUS.TO / CHE_u.TO / RTN.L / 02209S103 / NTR.N / DPZ.N / SPI.L / MOS.N / TXRH.O / VIAC.O / IAG.N / 416515104 / WSA.AX / BUCN.S / MPW.N / BLDR.O / STX.O / 35671D857 / ALD.AX / TEVA.N / MA.N / MWA.N / CPX.TO / MARS.L / DWNG.DE / H.TO / IVZ.N / DAIGn.DE / CBRO.L / BEZG.L / ABCA.L / GETP.PA / PBF.N / SII.TO / OZL.AX / ABI.BR / SFR.AX / CLW.N / AND.TO / VALE.N / IFC.TO / CPG.TO / ADUS.OQ / BHPB.L / MEG.TO / WCP.TO / LYB.N / CJT.TO / EVN.AX / PSX.N / BERY.N / DIR_u.TO / ABBV.N / TMUS.N / UKWG.L / BEP.N / 81762P102 / IBP.N / ENLC.N / ARES.N / BMEB.L / NEP.N / HQY.OQ / AXTA.N / S32.AX / CIGI.O / FSV.O / RAYa.TO / VNAn.DE / AMUN.PA / GYM.L / CMCX.L / BFIT.AS / TWLO.N / CTEC.L / CDEV.O / VST.N / WPM.N / JUSTJ.L / IHR.L / SUPR.L / ORSTED.CO / ENOG.L / MI_U.TO / CWEN.N / ESTC.N / NBSE.OQ / CRWD.O / 260557103 / WILD.TO / MOCORP.HE / 77311W101 / DHT_u.TO</td><td class="leftalignment">Associated British Foods PLC / Aegon NV / AES Corp / AGL Energy Ltd / Allianz SE / Applied Materials Inc / AngloGold Ashanti Ltd / American Express Co / Bank of America Corp / BCE Inc / BHP Group Ltd / Commerzbank AG / Crown Holdings Inc / Cigna Corp / Capricorn Energy PLC / Canadian Pacific Railway Ltd / Compass Group PLC / Credit Suisse Group AG / Danone SA / Dupont De Nemours Inc / DFDS AS / Consolidated Edison Inc / Edison International / Eni SpA / Flowserve Corp / Eiffage SA / Gap Inc / HSBC Holdings PLC / Loblaw Companies Ltd / Compagnie Generale des Etablissements Michelin SCA / Marks and Spencer Group PLC / Merck & Co Inc / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / National Bank of Canada / Newcrest Mining Ltd / Norfolk Southern Corp / Next PLC / PPG Industries Inc / Randstad NV / Rio Tinto Ltd / Scor SE / Securitas AB / AT&T Inc / Toronto-Dominion Bank / Tullow Oil PLC / Toll Brothers Inc / Travelers Companies Inc / Volvo AB / Weir Group PLC / Wells Fargo & Co / Williams Companies Inc / SSE PLC / Comerica Inc / Rathbones Group PLC / Continental AG / Weyerhaeuser Co / Pioneer Natural Resources Co / Canadian Natural Resources Ltd / Gilead Sciences Inc / Comcast Corp / TransAlta Corp / Rogers Communications Inc / Apple Inc / Canadian National Railway Co / Alamos Gold Inc / Quebecor Inc / Walt Disney Co / Wesco International Inc / Darden Restaurants Inc / Dynatrace Inc / CSX Corp / Abb Ltd / Imperial Oil Ltd / Suncor Energy Inc / Brinker International Inc / Valero Energy Corp / Manulife Financial Corp / Exxon Mobil Corp / Corus Entertainment Inc / Whirlpool Corp / Nike Inc / Metro Inc / Sherwin-Williams Co / W W Grainger Inc / Verizon Communications Inc / HCA Healthcare Inc / Adecco Group AG / Constellation Brands Inc / Ameriprise Financial Inc / Exelon Corp / Autozone Inc / Visa Inc / Charter Communications Inc / Dollar Tree Inc / Dollar General Corp / Prologis Inc / Delek US Holdings Inc / IG Group Holdings PLC / Aecon Group Inc / Chevron Corp / Micron Technology Inc / Mohawk Industries Inc / Centamin PLC / Canadian Apartment Properties Real Estate Investment Trust / Pason Systems Inc / Cloudflare Inc / Graphic Packaging Holding Co / FLSmidth & Co A/S / Conocophillips / Callon Petroleum Co / Methanex Corp / Dollarama Inc / First Republic Bank / Warrior Met Coal Inc / CCL Industries Inc / Royal Gold Inc / SVB Financial Group / HOOKIPA Pharma Inc / O'Reilly Automotive Inc / Arch Capital Group Ltd / Texas Capital Bancshares Inc / Transcontinental Inc / Empire Company Ltd / Webjet Ltd / IGO Ltd / SNC-Lavalin Group Inc / Russel Metals Inc / Chemtrade Logistics Income Fund / Restaurant Group PLC / Altria Group Inc / Nutrien Ltd / Domino's Pizza Inc / Spire Healthcare Group PLC / Mosaic Co / Texas Roadhouse Inc / ViacomCBS Inc / IAMGOLD Corp / Hartford Financial Services Group Inc / Western Areas Ltd / Bucher Industries AG / Medical Properties Trust Inc / Builders FirstSource Inc / Seagate Technology Holdings PLC / Freeport-McMoRan Inc / Ampol Ltd / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Mueller Water Products Inc / Capital Power Corp / Marston's PLC / Deutsche Wohnen SE / Hydro One Ltd / Invesco Ltd / Daimler AG / Close Brothers Group PLC / Beazley PLC / Abcam PLC / Getlink SE / PBF Energy Inc / Sprott Inc / OZ Minerals Ltd / Anheuser Busch Inbev SA / Sandfire Resources Ltd / Clearwater Paper Corp / Andlauer Healthcare Group Inc / Vale SA / Intact Financial Corp / Crescent Point Energy Corp / Addus Homecare Corp / BHP Group PLC / MEG Energy Corp / Whitecap Resources Inc / LyondellBasell Industries NV / Cargojet Inc / Evolution Mining Ltd / Phillips 66 / Berry Global Group Inc / Dream Industrial Real Estate Investment Trust / Abbvie Inc / T-Mobile US Inc / Greencoat UK Wind PLC / Brookfield Renewable Partners LP / ServiceNow Inc / Installed Building Products Inc / EnLink Midstream LLC / Ares Management Corp / B&M European Value Retail SA / Nextera Energy Partners LP / Healthequity Inc / Axalta Coating Systems Ltd / South32 Ltd / Colliers International Group Inc / FirstService Corp / Stingray Group Inc / Vonovia SE / Amundi SA / GYM Group PLC / CMC Markets PLC / Basic Fit NV / Twilio Inc / ConvaTec Group PLC / Centennial Resource Development Inc / Vistra Corp / Wheaton Precious Metals Corp / Just Group PLC / Impact Healthcare REIT PLC / Supermarket Income REIT PLC / Orsted A/S / Energean PLC / Minto Apartment Real Estate Investment Trust / Clearway Energy Inc / Elastic NV / NeuBase Therapeutics Inc / CrowdStrike Holdings Inc / Dow Inc / WildBrain Ltd / Metso Outotec Corp / Rocket Companies Inc / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Brazil / Canada / Switzerland / Germany / Denmark / Finland / France / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / Papua New Guinea / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Up to 5 is Better Than 1 (Number of Recognized Tumor-Associated Antigens); Initiating at OW, $6 PT</td><td class="leftalignment">English</td><td class="rightalignment">66</td><td class="leftalignment">MRKR.O / MRK / PFE / US31189P1021</td><td class="leftalignment">Marker Therapeutics Inc / Merck & Co Inc / Pfizer Inc / Fate Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Kristen Kluska</td></tr>
<tr class="odd"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Doc Call Starting in 15 mins: The Emerging HIV Pipeline – KOL Takeaways from Recent Conferences and Market Developments</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">0925288 / 2126335 / 2778844 / 2475833 / 2369174 / 2684703</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Johnson & Johnson / Gilead Sciences Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Reminder: Doc Call on March 18th (Today): The Emerging HIV Pipeline – KOL Takeaways from Recent Conferences and Market Developments</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">0925288 / 2126335 / 2778844 / 2475833 / 2369174 / 2684703</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Johnson & Johnson / Gilead Sciences Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canadian Research at a Glance - March 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CNR.TO / ABF.L / AEGN.AS / AES.N / AGL.AX / ALV.N / ALVG.DE / AMAT.O / AU.N / AXP.N / BAC.N / BCE.TO / BHP.AX / CBKG.DE / CCK.N / CI.N / CNE.L / CP.TO / CPG.L / CSGN.S / DANO.PA / DD.N / DFDS.CO / ED.N / EIX.N / ENI.MI / F.N / FLS.N / FOUG.PA / GM.N / GPS.N / HSBA.L / L.TO / MICP.PA / MKS.L / MRK.N / MUVGn.DE / NA / NCM.AX / NSC.N / NXT.L / PPG.N / RAND.AS / RIO.AX / SCOR.PA / SECUb.ST / T.N / TD.TO / TLW.L / TOL.N / TRV.N / VC.N / VOLVb.ST / WEIR.L / WFC.N / WMB.N / SSE.L / CMA.N / RAT.L / CONG.DE / PXD.N / CNQ.TO / GILD.O / TEN.N / CMCSA.O / POW.TO / TA.TO / RCIb.TO / AAPL.O / AGI.N / QBRb.TO / DIS.N / BWA.N / LEA.N / WCC.N / DRI.N / DT.N / CSX.N / ABBN.S / IMO.TO / SU.TO / EAT.N / VLO.N / MFC.TO / GWO.TO / CJRb.TO / WHR.N / NKE.N / MRU.TO / SHW.N / GWW.N / VZ.N / HCA.N / ADEN.S / STZ.N / AMP.N / APH.N / EXC.N / AZO.N / V.N / CHTR.O / AXL.N / DLTR.O / DG.N / PLD.N / BC.N / DK.N / IGG.L / ARE.TO / CVX.N / MU.O / MHK.N / CEY.L / CAR_u.TO / PSI.TO / NET.N / TEL.N / GPK.N / FLS.CO / COP.N / CPE.N / MEOH.O / DOL.TO / FRC.N / PII.N / ST.N / HCC.N / CCLb.TO / RGLD.O / SIVB.O / HOOK.O / ORLY.O / ACGL.O / TCBI.O / TCLa.TO / ATDb.TO / EMPA.TO / IGO.AX / SNC.TO / RUS.TO / CHE_u.TO / RTN.L / 02209S103 / NTR.N / DPZ.N / SPI.L / MOS.N / TXRH.O / VIAC.O / IGM.TO / IAG.N / 416515104 / WSA.AX / BUCN.S / MPW.N / BLDR.O / STX.O / 35671D857 / ALD.AX / TEVA.N / MA.N / MWA.N / CPX.TO / HOG.N / MARS.L / DWNG.DE / H.TO / IVZ.N / DAIGn.DE / CBRO.L / BEZG.L / ABCA.L / GETP.PA / DAN.N / PBF.N / SII.TO / OZL.AX / ARX.TO / ABI.BR / SFR.AX / CLW.N / AND.TO / VALE.N / IFC.TO / CPG.TO / ADUS.OQ / BHPB.L / MEG.TO / WCP.TO / LYB.N / CJT.TO / MTOR.N / WTE.TO / EVN.AX / PSX.N / BERY.N / DIR_u.TO / ABBV.N / TSLA.N / TMUS.N / UKWG.L / ISV.TO / BEP.N / 81762P102 / IBP.N / PLC.TO / ENLC.N / ARES.N / BMEB.L / NEP.N / HQY.OQ / AXTA.N / S32.AX / CIGI.O / FSV.O / RAYa.TO / VNAn.DE / AMUN.PA / GYM.L / CMCX.L / BFIT.AS / TWLO.N / ADNT.N / CTEC.L / CDEV.O / VST.N / WPM.N / JUSTJ.L / IHR.L / SUPR.L / ORSTED.CO / APTV.N / ENOG.L / VNE.N / MI_U.TO / CWEN.N / ESTC.N / NBSE.OQ / CRWD.O / 260557103 / CRNC.OQ / WILD.TO / NKLA.OQ / MOCORP.HE / 77311W101 / TPZ.TO / DHT_u.TO</td><td class="leftalignment">Canadian National Railway Co / Associated British Foods PLC / Aegon NV / AES Corp / AGL Energy Ltd / Autoliv Inc / Allianz SE / Applied Materials Inc / AngloGold Ashanti Ltd / American Express Co / Bank of America Corp / BCE Inc / BHP Group Ltd / Commerzbank AG / Crown Holdings Inc / Cigna Corp / Capricorn Energy PLC / Canadian Pacific Railway Ltd / Compass Group PLC / Credit Suisse Group AG / Danone SA / Dupont De Nemours Inc / DFDS AS / Consolidated Edison Inc / Edison International / Eni SpA / Ford Motor Co / Flowserve Corp / Eiffage SA / General Motors Co / Gap Inc / HSBC Holdings PLC / Loblaw Companies Ltd / Compagnie Generale des Etablissements Michelin SCA / Marks and Spencer Group PLC / Merck & Co Inc / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / National Bank of Canada / Newcrest Mining Ltd / Norfolk Southern Corp / Next PLC / PPG Industries Inc / Randstad NV / Rio Tinto Ltd / Scor SE / Securitas AB / AT&T Inc / Toronto-Dominion Bank / Tullow Oil PLC / Toll Brothers Inc / Travelers Companies Inc / Visteon Corp / Volvo AB / Weir Group PLC / Wells Fargo & Co / Williams Companies Inc / SSE PLC / Comerica Inc / Rathbones Group PLC / Continental AG / Pioneer Natural Resources Co / Canadian Natural Resources Ltd / Gilead Sciences Inc / Tenneco Inc / Comcast Corp / Power Corporation of Canada / TransAlta Corp / Rogers Communications Inc / Apple Inc / Alamos Gold Inc / Quebecor Inc / Walt Disney Co / Borgwarner Inc / Lear Corp / Wesco International Inc / Darden Restaurants Inc / Dynatrace Inc / CSX Corp / Abb Ltd / Imperial Oil Ltd / Suncor Energy Inc / Brinker International Inc / Valero Energy Corp / Manulife Financial Corp / Great-West Lifeco Inc / Corus Entertainment Inc / Whirlpool Corp / Nike Inc / Metro Inc / Sherwin-Williams Co / W W Grainger Inc / Verizon Communications Inc / HCA Healthcare Inc / Adecco Group AG / Constellation Brands Inc / Ameriprise Financial Inc / Amphenol Corp / Exelon Corp / Autozone Inc / Visa Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / Dollar Tree Inc / Dollar General Corp / Prologis Inc / Brunswick Corp / Delek US Holdings Inc / IG Group Holdings PLC / Aecon Group Inc / Chevron Corp / Micron Technology Inc / Mohawk Industries Inc / Centamin PLC / Canadian Apartment Properties Real Estate Investment Trust / Pason Systems Inc / Cloudflare Inc / TE Connectivity Ltd / Graphic Packaging Holding Co / FLSmidth & Co A/S / Conocophillips / Callon Petroleum Co / Methanex Corp / Dollarama Inc / First Republic Bank / Polaris Inc / Sensata Technologies Holding PLC / Warrior Met Coal Inc / CCL Industries Inc / Royal Gold Inc / SVB Financial Group / HOOKIPA Pharma Inc / O'Reilly Automotive Inc / Arch Capital Group Ltd / Texas Capital Bancshares Inc / Transcontinental Inc / Alimentation Couche-Tard Inc / Empire Company Ltd / IGO Ltd / SNC-Lavalin Group Inc / Russel Metals Inc / Chemtrade Logistics Income Fund / Restaurant Group PLC / Altria Group Inc / Nutrien Ltd / Domino's Pizza Inc / Spire Healthcare Group PLC / Mosaic Co / Texas Roadhouse Inc / ViacomCBS Inc / IGM Financial Inc / IAMGOLD Corp / Hartford Financial Services Group Inc / Western Areas Ltd / Bucher Industries AG / Medical Properties Trust Inc / Builders FirstSource Inc / Seagate Technology Holdings PLC / Freeport-McMoRan Inc / Ampol Ltd / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Mueller Water Products Inc / Capital Power Corp / Harley-Davidson Inc / Marston's PLC / Deutsche Wohnen SE / Hydro One Ltd / Invesco Ltd / Daimler AG / Close Brothers Group PLC / Beazley PLC / Abcam PLC / Getlink SE / Dana Inc / PBF Energy Inc / Sprott Inc / OZ Minerals Ltd / ARC Resources Ltd / Anheuser Busch Inbev SA / Sandfire Resources Ltd / Clearwater Paper Corp / Andlauer Healthcare Group Inc / Vale SA / Intact Financial Corp / Crescent Point Energy Corp / Addus Homecare Corp / BHP Group PLC / MEG Energy Corp / Whitecap Resources Inc / LyondellBasell Industries NV / Cargojet Inc / Meritor Inc / Westshore Terminals Investment Corp / Evolution Mining Ltd / Phillips 66 / Berry Global Group Inc / Dream Industrial Real Estate Investment Trust / Abbvie Inc / Tesla Inc / T-Mobile US Inc / Greencoat UK Wind PLC / Information Services Corp / Brookfield Renewable Partners LP / ServiceNow Inc / Installed Building Products Inc / Park Lawn Corp / EnLink Midstream LLC / Ares Management Corp / B&M European Value Retail SA / Nextera Energy Partners LP / Healthequity Inc / Axalta Coating Systems Ltd / South32 Ltd / Colliers International Group Inc / FirstService Corp / Stingray Group Inc / Vonovia SE / Amundi SA / GYM Group PLC / CMC Markets PLC / Basic Fit NV / Twilio Inc / Adient PLC / ConvaTec Group PLC / Centennial Resource Development Inc / Vistra Corp / Wheaton Precious Metals Corp / Just Group PLC / Impact Healthcare REIT PLC / Supermarket Income REIT PLC / Orsted A/S / Aptiv PLC / Energean PLC / Veoneer Inc / Minto Apartment Real Estate Investment Trust / Clearway Energy Inc / Elastic NV / NeuBase Therapeutics Inc / CrowdStrike Holdings Inc / Dow Inc / Cerence Inc / WildBrain Ltd / Nikola Corp / Metso Outotec Corp / Rocket Companies Inc / Topaz Energy Corp / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Brazil / Canada / Switzerland / Germany / Denmark / Finland / France / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / Papua New Guinea / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ABF.L / AEGN.AS / AES.N / AGL.AX / ALV.N / ALVG.DE / AMAT.O / AU.N / AXP.N / BAC.N / BCE.TO / BHP.AX / CBKG.DE / CCK.N / CI.N / CNE.L / CP.TO / CPG.L / CSGN.S / DANO.PA / DD.N / DFDS.CO / ED.N / EIX.N / ENI.MI / F.N / FLS.N / FOUG.PA / GM.N / GPS.N / HSBA.L / KBH.N / L.TO / MICP.PA / MKS.L / MRK.N / MUVGn.DE / NA / NCM.AX / NSC.N / NXT.L / PD.N / PHM.N / PPG.N / RAND.AS / RIO.AX / SCOR.PA / SECUb.ST / T.N / TD.TO / TLW.L / TOL.N / TRV.N / VC.N / VOLVb.ST / WEIR.L / SSE.L / CMA.N / RAT.L / CONG.DE / PXD.N / CNQ.TO / GILD.O / TEN.N / CMCSA.O / TA.TO / RCIb.TO / AAPL.O / CNR.TO / AGI.N / QBRb.TO / DIS.N / BWA.N / LEA.N / WCC.N / DRI.N / DT.N / CSX.N / ABBN.S / IMO.TO / SU.TO / LEN.N / EAT.N / VLO.N / MFC.TO / CJRb.TO / NKE.N / MRU.TO / SHW.N / GWW.N / VZ.N / HCA.N / ADEN.S / DHI.N / STZ.N / AMP.N / APH.N / EXC.N / AZO.N / V.N / CHTR.O / AXL.N / DLTR.O / WSM.N / DG.N / PLD.N / BC.N / DK.N / IGG.L / AJG.N / ARE.TO / CVX.N / MU.O / MHK.N / CEY.L / CAR_u.TO / PSI.TO / NET.N / TEL.N / GPK.N / AVGO.O / FLS.CO / COP.N / CPE.N / MEOH.O / DOL.TO / FRC.N / PII.N / ST.N / SMTC.OQ / HCC.N / CCLb.TO / RGLD.O / SIVB.O / HOOK.O / ORLY.O / ACGL.O / TCBI.O / TCLa.TO / EMPA.TO / IGO.AX / SNC.TO / RUS.TO / CHE_u.TO / RTN.L / 02209S103 / NTR.N / DPZ.N / SPI.L / MOS.N / TXRH.O / VIAC.O / IAG.N / 416515104 / BUCN.S / MPW.N / BLDR.O / STX.O / 35671D857 / ALD.AX / TEVA.N / MA.N / MWA.N / CPX.TO / HOG.N / MARS.L / DWNG.DE / H.TO / IVZ.N / DAIGn.DE / CBRO.L / BEZG.L / ABCA.L / GETP.PA / DAN.N / PBF.N / SII.TO / OZL.AX / ABI.BR / SFR.AX / CLW.N / AND.TO / VALE.N / IFC.TO / CPG.TO / ADUS.OQ / BHPB.L / MEG.TO / WCP.TO / LYB.N / CJT.TO / MTOR.N / EVN.AX / PSX.N / SRPT.O / FIVE.OQ / BERY.N / DIR_u.TO / ABBV.N / TPH.N / TSLA.N / TMUS.N / UKWG.L / TMHC.N / BEP.N / 81762P102 / IBP.N / ENLC.N / ARES.N / AGRX.O / BMEB.L / NEP.N / HQY.OQ / AXTA.N / S32.AX / CIGI.O / FSV.O / TDOC.N / RAYa.TO / VNAn.DE / AMUN.PA / GYM.L / CMCX.L / BFIT.AS / TWLO.N / ADNT.N / CTEC.L / CDEV.O / VST.N / JUSTJ.L / IHR.L / SUPR.L / ORSTED.CO / APTV.N / ENOG.L / VNE.N / MI_U.TO / CWEN.N / ESTC.N / NBSE.OQ / CRWD.O / 260557103 / CRNC.OQ / NKLA.OQ / MOCORP.HE / 77311W101 / DFH.OQ / DHT_u.TO</td><td class="leftalignment">Associated British Foods PLC / Aegon NV / AES Corp / AGL Energy Ltd / Autoliv Inc / Allianz SE / Applied Materials Inc / AngloGold Ashanti Ltd / American Express Co / Bank of America Corp / BCE Inc / BHP Group Ltd / Commerzbank AG / Crown Holdings Inc / Cigna Corp / Capricorn Energy PLC / Canadian Pacific Railway Ltd / Compass Group PLC / Credit Suisse Group AG / Danone SA / Dupont De Nemours Inc / DFDS AS / Consolidated Edison Inc / Edison International / Eni SpA / Ford Motor Co / Flowserve Corp / Eiffage SA / General Motors Co / Gap Inc / HSBC Holdings PLC / KB Home / Loblaw Companies Ltd / Compagnie Generale des Etablissements Michelin SCA / Marks and Spencer Group PLC / Merck & Co Inc / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / National Bank of Canada / Newcrest Mining Ltd / Norfolk Southern Corp / Next PLC / PagerDuty Inc / Pultegroup Inc / PPG Industries Inc / Randstad NV / Rio Tinto Ltd / Scor SE / Securitas AB / AT&T Inc / Toronto-Dominion Bank / Tullow Oil PLC / Toll Brothers Inc / Travelers Companies Inc / Visteon Corp / Volvo AB / Weir Group PLC / SSE PLC / Comerica Inc / Rathbones Group PLC / Continental AG / Pioneer Natural Resources Co / Canadian Natural Resources Ltd / Gilead Sciences Inc / Tenneco Inc / Comcast Corp / TransAlta Corp / Rogers Communications Inc / Apple Inc / Canadian National Railway Co / Alamos Gold Inc / Quebecor Inc / Walt Disney Co / Borgwarner Inc / Lear Corp / Wesco International Inc / Darden Restaurants Inc / Dynatrace Inc / CSX Corp / Abb Ltd / Imperial Oil Ltd / Suncor Energy Inc / Lennar Corp / Brinker International Inc / Valero Energy Corp / Manulife Financial Corp / Corus Entertainment Inc / Nike Inc / Metro Inc / Sherwin-Williams Co / W W Grainger Inc / Verizon Communications Inc / HCA Healthcare Inc / Adecco Group AG / D R Horton Inc / Constellation Brands Inc / Ameriprise Financial Inc / Amphenol Corp / Exelon Corp / Autozone Inc / Visa Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / Dollar Tree Inc / Williams-Sonoma Inc / Dollar General Corp / Prologis Inc / Brunswick Corp / Delek US Holdings Inc / IG Group Holdings PLC / Arthur J Gallagher & Co / Aecon Group Inc / Chevron Corp / Micron Technology Inc / Mohawk Industries Inc / Centamin PLC / Canadian Apartment Properties Real Estate Investment Trust / Pason Systems Inc / Cloudflare Inc / TE Connectivity Ltd / Graphic Packaging Holding Co / Broadcom Inc / FLSmidth & Co A/S / Conocophillips / Callon Petroleum Co / Methanex Corp / Dollarama Inc / First Republic Bank / Polaris Inc / Sensata Technologies Holding PLC / Semtech Corp / Warrior Met Coal Inc / CCL Industries Inc / Royal Gold Inc / SVB Financial Group / HOOKIPA Pharma Inc / O'Reilly Automotive Inc / Arch Capital Group Ltd / Texas Capital Bancshares Inc / Transcontinental Inc / Empire Company Ltd / IGO Ltd / SNC-Lavalin Group Inc / Russel Metals Inc / Chemtrade Logistics Income Fund / Restaurant Group PLC / Altria Group Inc / Nutrien Ltd / Domino's Pizza Inc / Spire Healthcare Group PLC / Mosaic Co / Texas Roadhouse Inc / ViacomCBS Inc / IAMGOLD Corp / Hartford Financial Services Group Inc / Bucher Industries AG / Medical Properties Trust Inc / Builders FirstSource Inc / Seagate Technology Holdings PLC / Freeport-McMoRan Inc / Ampol Ltd / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Mueller Water Products Inc / Capital Power Corp / Harley-Davidson Inc / Marston's PLC / Deutsche Wohnen SE / Hydro One Ltd / Invesco Ltd / Daimler AG / Close Brothers Group PLC / Beazley PLC / Abcam PLC / Getlink SE / Dana Inc / PBF Energy Inc / Sprott Inc / OZ Minerals Ltd / Anheuser Busch Inbev SA / Sandfire Resources Ltd / Clearwater Paper Corp / Andlauer Healthcare Group Inc / Vale SA / Intact Financial Corp / Crescent Point Energy Corp / Addus Homecare Corp / BHP Group PLC / MEG Energy Corp / Whitecap Resources Inc / LyondellBasell Industries NV / Cargojet Inc / Meritor Inc / Evolution Mining Ltd / Phillips 66 / Sarepta Therapeutics Inc / Five Below Inc / Berry Global Group Inc / Dream Industrial Real Estate Investment Trust / Abbvie Inc / Tri Pointe Homes Inc (Delaware) / Tesla Inc / T-Mobile US Inc / Greencoat UK Wind PLC / Taylor Morrison Home Corp / Brookfield Renewable Partners LP / ServiceNow Inc / Installed Building Products Inc / EnLink Midstream LLC / Ares Management Corp / Agile Therapeutics Inc / B&M European Value Retail SA / Nextera Energy Partners LP / Healthequity Inc / Axalta Coating Systems Ltd / South32 Ltd / Colliers International Group Inc / FirstService Corp / Teladoc Health Inc / Stingray Group Inc / Vonovia SE / Amundi SA / GYM Group PLC / CMC Markets PLC / Basic Fit NV / Twilio Inc / Adient PLC / ConvaTec Group PLC / Centennial Resource Development Inc / Vistra Corp / Just Group PLC / Impact Healthcare REIT PLC / Supermarket Income REIT PLC / Orsted A/S / Aptiv PLC / Energean PLC / Veoneer Inc / Minto Apartment Real Estate Investment Trust / Clearway Energy Inc / Elastic NV / NeuBase Therapeutics Inc / CrowdStrike Holdings Inc / Dow Inc / Cerence Inc / Nikola Corp / Metso Outotec Corp / Rocket Companies Inc / Dream Finders Homes Inc / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Brazil / Canada / Switzerland / Germany / Denmark / Finland / France / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / Papua New Guinea / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Vet Survey: Macro Setup for the Year Looks Strong, Positive for Therapeutics, Diagnostics and Distribution</td><td class="leftalignment">English</td><td class="rightalignment">48</td><td class="leftalignment">2778844 / 2459202 / 2672689 / B44C366 / B95WG16 / BF5L3T2 / BHZSB82 / BDH65C8 / BP3YM85</td><td class="leftalignment">Merck & Co Inc / IDEXX Laboratories Inc / Patterson Companies Inc / Heska Corp / Zoetis Inc / Elanco Animal Health Inc / Covetrus Inc / PetIQ Inc / Trupanion Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. David M. Westenberg</td></tr>
<tr class="even"><td class="leftalignment">03/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">UK & European Research at a Glance - March 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABF.L / AEGN.AS / AES.N / AGL.AX / ALV.N / ALVG.DE / AMAT.O / AU.N / AXP.N / BAC.N / BCE.TO / BHP.AX / CBKG.DE / CCK.N / CI.N / CNE.L / CP.TO / CPG.L / CPI.L / CSGN.S / DANO.PA / DD.N / DFDS.CO / ED.N / EIX.N / ENI.MI / F.N / FLS.N / FOUG.PA / GM.N / GPS.N / HMb.ST / HSBA.L / JD.L / L.TO / MICP.PA / MKS.L / MRK.N / MUVGn.DE / NA / NCM.AX / NSC.N / NXT.L / PPG.N / RAND.AS / RIO.AX / SCOR.PA / SECUb.ST / SRP.L / T.N / TD.TO / TLW.L / TOL.N / TRV.N / VC.N / VOLVb.ST / WEIR.L / WFC.N / WMB.N / SSE.L / CMA.N / RAT.L / CONG.DE / PXD.N / CNQ.TO / GILD.O / TEN.N / CMCSA.O / TA.TO / RCIb.TO / AAPL.O / CNR.TO / AGI.N / QBRb.TO / DIS.N / BWA.N / LEA.N / WCC.N / DRI.N / DT.N / CSX.N / ABBN.S / IMO.TO / SU.TO / EAT.N / VLO.N / MFC.TO / CJRb.TO / WHR.N / NKE.N / MRU.TO / SHW.N / GWW.N / VZ.N / HCA.N / ADEN.S / STZ.N / AMP.N / APH.N / EXC.N / AZO.N / V.N / CHTR.O / AXL.N / DLTR.O / DG.N / PLD.N / BC.N / DK.N / IGG.L / ITX.MC / ARE.TO / CVX.N / MU.O / MHK.N / CEY.L / CAR_u.TO / PSI.TO / NET.N / TEL.N / GPK.N / FLS.CO / COP.N / CPE.N / MEOH.O / DOL.TO / FRC.N / PII.N / ST.N / HCC.N / CCLb.TO / RGLD.O / SIVB.O / HOOK.O / ORLY.O / ACGL.O / TCBI.O / TCLa.TO / EMPA.TO / IGO.AX / SNC.TO / RUS.TO / CHE_u.TO / RTN.L / 02209S103 / NTR.N / DPZ.N / SPI.L / MOS.N / TXRH.O / VIAC.O / IAG.N / 416515104 / WSA.AX / BUCN.S / MPW.N / BLDR.O / STX.O / 35671D857 / ALD.AX / TEVA.N / MA.N / MWA.N / CPX.TO / HOG.N / MARS.L / DWNG.DE / H.TO / IVZ.N / DAIGn.DE / CBRO.L / BEZG.L / ABCA.L / GETP.PA / DAN.N / PBF.N / SII.TO / OZL.AX / ABI.BR / SFR.AX / CLW.N / AND.TO / VALE.N / IFC.TO / CPG.TO / ADUS.OQ / PHNX.L / BHPB.L / MEG.TO / WCP.TO / LYB.N / CJT.TO / MTOR.N / EVN.AX / PSX.N / BERY.N / DIR_u.TO / ABBV.N / TSLA.N / TMUS.N / UKWG.L / BEP.N / 81762P102 / IBP.N / ENLC.N / ARES.N / BMEB.L / NEP.N / HQY.OQ / ZALG.DE / AXTA.N / S32.AX / CIGI.O / FSV.O / RAYa.TO / VNAn.DE / AMUN.PA / GYM.L / CMCX.L / BFIT.AS / TWLO.N / ADNT.N / CTEC.L / CDEV.O / VST.N / WPM.N / JUSTJ.L / IHR.L / SUPR.L / ORSTED.CO / APTV.N / ENOG.L / VNE.N / MI_U.TO / CWEN.N / ESTC.N / NBSE.OQ / CRWD.O / 260557103 / CRNC.OQ / MNG.L / WILD.TO / NKLA.OQ / MOCORP.HE / 77311W101 / DHT_u.TO</td><td class="leftalignment">Associated British Foods PLC / Aegon NV / AES Corp / AGL Energy Ltd / Autoliv Inc / Allianz SE / Applied Materials Inc / AngloGold Ashanti Ltd / American Express Co / Bank of America Corp / BCE Inc / BHP Group Ltd / Commerzbank AG / Crown Holdings Inc / Cigna Corp / Capricorn Energy PLC / Canadian Pacific Railway Ltd / Compass Group PLC / Capita PLC / Credit Suisse Group AG / Danone SA / Dupont De Nemours Inc / DFDS AS / Consolidated Edison Inc / Edison International / Eni SpA / Ford Motor Co / Flowserve Corp / Eiffage SA / General Motors Co / Gap Inc / H & M Hennes & Mauritz AB / HSBC Holdings PLC / JD Sports Fashion PLC / Loblaw Companies Ltd / Compagnie Generale des Etablissements Michelin SCA / Marks and Spencer Group PLC / Merck & Co Inc / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / National Bank of Canada / Newcrest Mining Ltd / Norfolk Southern Corp / Next PLC / PPG Industries Inc / Randstad NV / Rio Tinto Ltd / Scor SE / Securitas AB / Serco Group PLC / AT&T Inc / Toronto-Dominion Bank / Tullow Oil PLC / Toll Brothers Inc / Travelers Companies Inc / Visteon Corp / Volvo AB / Weir Group PLC / Wells Fargo & Co / Williams Companies Inc / SSE PLC / Comerica Inc / Rathbones Group PLC / Continental AG / Pioneer Natural Resources Co / Canadian Natural Resources Ltd / Gilead Sciences Inc / Tenneco Inc / Comcast Corp / TransAlta Corp / Rogers Communications Inc / Apple Inc / Canadian National Railway Co / Alamos Gold Inc / Quebecor Inc / Walt Disney Co / Borgwarner Inc / Lear Corp / Wesco International Inc / Darden Restaurants Inc / Dynatrace Inc / CSX Corp / Abb Ltd / Imperial Oil Ltd / Suncor Energy Inc / Brinker International Inc / Valero Energy Corp / Manulife Financial Corp / Corus Entertainment Inc / Whirlpool Corp / Nike Inc / Metro Inc / Sherwin-Williams Co / W W Grainger Inc / Verizon Communications Inc / HCA Healthcare Inc / Adecco Group AG / Constellation Brands Inc / Ameriprise Financial Inc / Amphenol Corp / Exelon Corp / Autozone Inc / Visa Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / Dollar Tree Inc / Dollar General Corp / Prologis Inc / Brunswick Corp / Delek US Holdings Inc / IG Group Holdings PLC / Industria de Diseno Textil SA / Aecon Group Inc / Chevron Corp / Micron Technology Inc / Mohawk Industries Inc / Centamin PLC / Canadian Apartment Properties Real Estate Investment Trust / Pason Systems Inc / Cloudflare Inc / TE Connectivity Ltd / Graphic Packaging Holding Co / FLSmidth & Co A/S / Conocophillips / Callon Petroleum Co / Methanex Corp / Dollarama Inc / First Republic Bank / Polaris Inc / Sensata Technologies Holding PLC / Warrior Met Coal Inc / CCL Industries Inc / Royal Gold Inc / SVB Financial Group / HOOKIPA Pharma Inc / O'Reilly Automotive Inc / Arch Capital Group Ltd / Texas Capital Bancshares Inc / Transcontinental Inc / Empire Company Ltd / IGO Ltd / SNC-Lavalin Group Inc / Russel Metals Inc / Chemtrade Logistics Income Fund / Restaurant Group PLC / Altria Group Inc / Nutrien Ltd / Domino's Pizza Inc / Spire Healthcare Group PLC / Mosaic Co / Texas Roadhouse Inc / ViacomCBS Inc / IAMGOLD Corp / Hartford Financial Services Group Inc / Western Areas Ltd / Bucher Industries AG / Medical Properties Trust Inc / Builders FirstSource Inc / Seagate Technology Holdings PLC / Freeport-McMoRan Inc / Ampol Ltd / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Mueller Water Products Inc / Capital Power Corp / Harley-Davidson Inc / Marston's PLC / Deutsche Wohnen SE / Hydro One Ltd / Invesco Ltd / Daimler AG / Close Brothers Group PLC / Beazley PLC / Abcam PLC / Getlink SE / Dana Inc / PBF Energy Inc / Sprott Inc / OZ Minerals Ltd / Anheuser Busch Inbev SA / Sandfire Resources Ltd / Clearwater Paper Corp / Andlauer Healthcare Group Inc / Vale SA / Intact Financial Corp / Crescent Point Energy Corp / Addus Homecare Corp / Phoenix Group Holdings PLC / BHP Group PLC / MEG Energy Corp / Whitecap Resources Inc / LyondellBasell Industries NV / Cargojet Inc / Meritor Inc / Evolution Mining Ltd / Phillips 66 / Berry Global Group Inc / Dream Industrial Real Estate Investment Trust / Abbvie Inc / Tesla Inc / T-Mobile US Inc / Greencoat UK Wind PLC / Brookfield Renewable Partners LP / ServiceNow Inc / Installed Building Products Inc / EnLink Midstream LLC / Ares Management Corp / B&M European Value Retail SA / Nextera Energy Partners LP / Healthequity Inc / Zalando SE / Axalta Coating Systems Ltd / South32 Ltd / Colliers International Group Inc / FirstService Corp / Stingray Group Inc / Vonovia SE / Amundi SA / GYM Group PLC / CMC Markets PLC / Basic Fit NV / Twilio Inc / Adient PLC / ConvaTec Group PLC / Centennial Resource Development Inc / Vistra Corp / Wheaton Precious Metals Corp / Just Group PLC / Impact Healthcare REIT PLC / Supermarket Income REIT PLC / Orsted A/S / Aptiv PLC / Energean PLC / Veoneer Inc / Minto Apartment Real Estate Investment Trust / Clearway Energy Inc / Elastic NV / NeuBase Therapeutics Inc / CrowdStrike Holdings Inc / Dow Inc / Cerence Inc / M&G PLC / WildBrain Ltd / Nikola Corp / Metso Outotec Corp / Rocket Companies Inc / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Brazil / Canada / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / Papua New Guinea / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Global Views on Recovery & Inflation</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">ABF.L / AEGN.AS / AES.N / AGL.AX / ALVG.DE / AMAT.O / AU.N / AXP.N / BAC.N / BCE.TO / BHP.AX / CBKG.DE / CCK.N / CI.N / CNE.L / CP.TO / CPG.L / CSGN.S / DANO.PA / DD.N / DFDS.CO / ED.N / EIX.N / ENI.MI / FLS.N / FOUG.PA / GPS.N / HSBA.L / L.TO / MICP.PA / MKS.L / MRK.N / MUVGn.DE / NA / NCM.AX / NSC.N / NXT.L / PPG.N / RAND.AS / RIO.AX / SCOR.PA / SECUb.ST / T.N / TD.TO / TLW.L / TOL.N / TRV.N / VOLVb.ST / WEIR.L / WFC.N / WMB.N / SSE.L / CMA.N / RAT.L / CONG.DE / WY.N / PXD.N / CNQ.TO / GILD.O / CMCSA.O / TA.TO / RCIb.TO / AAPL.O / CNR.TO / AGI.N / QBRb.TO / DIS.N / WCC.N / DRI.N / DT.N / CSX.N / ABBN.S / IMO.TO / SU.TO / EAT.N / VLO.N / MFC.TO / XOM.N / CJRb.TO / WHR.N / NKE.N / MRU.TO / SHW.N / GWW.N / VZ.N / HCA.N / ADEN.S / STZ.N / AMP.N / EXC.N / AZO.N / V.N / CHTR.O / DLTR.O / DG.N / PLD.N / DK.N / IGG.L / ARE.TO / CVX.N / MU.O / MHK.N / CEY.L / CAR_u.TO / PSI.TO / NET.N / GPK.N / FLS.CO / COP.N / CPE.N / MEOH.O / DOL.TO / FRC.N / HCC.N / CCLb.TO / RGLD.O / SIVB.O / HOOK.O / ORLY.O / ACGL.O / TCBI.O / TCLa.TO / EMPA.TO / IGO.AX / SNC.TO / RUS.TO / CHE_u.TO / RTN.L / 02209S103 / NTR.N / DPZ.N / SPI.L / MOS.N / TXRH.O / VIAC.O / IAG.N / 416515104 / WSA.AX / BUCN.S / MPW.N / BLDR.O / STX.O / 35671D857 / ALD.AX / TEVA.N / MA.N / MWA.N / CPX.TO / MARS.L / DWNG.DE / H.TO / IVZ.N / DAIGn.DE / CBRO.L / BEZG.L / ABCA.L / GETP.PA / PBF.N / SII.TO / OZL.AX / ABI.BR / SFR.AX / CLW.N / AND.TO / VALE.N / IFC.TO / CPG.TO / ADUS.OQ / BHPB.L / MEG.TO / WCP.TO / LYB.N / CJT.TO / EVN.AX / PSX.N / BERY.N / DIR_u.TO / ABBV.N / TMUS.N / UKWG.L / BEP.N / 81762P102 / IBP.N / ENLC.N / ARES.N / BMEB.L / NEP.N / HQY.OQ / AXTA.N / S32.AX / CIGI.O / FSV.O / RAYa.TO / VNAn.DE / AMUN.PA / GYM.L / CMCX.L / BFIT.AS / TWLO.N / CTEC.L / CDEV.O / VST.N / WPM.N / JUSTJ.L / IHR.L / SUPR.L / ORSTED.CO / ENOG.L / MI_U.TO / CWEN.N / ESTC.N / NBSE.OQ / CRWD.O / 260557103 / WILD.TO / MOCORP.HE / 77311W101 / DHT_u.TO</td><td class="leftalignment">Associated British Foods PLC / Aegon NV / AES Corp / AGL Energy Ltd / Allianz SE / Applied Materials Inc / AngloGold Ashanti Ltd / American Express Co / Bank of America Corp / BCE Inc / BHP Group Ltd / Commerzbank AG / Crown Holdings Inc / Cigna Corp / Capricorn Energy PLC / Canadian Pacific Railway Ltd / Compass Group PLC / Credit Suisse Group AG / Danone SA / Dupont De Nemours Inc / DFDS AS / Consolidated Edison Inc / Edison International / Eni SpA / Flowserve Corp / Eiffage SA / Gap Inc / HSBC Holdings PLC / Loblaw Companies Ltd / Compagnie Generale des Etablissements Michelin SCA / Marks and Spencer Group PLC / Merck & Co Inc / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / National Bank of Canada / Newcrest Mining Ltd / Norfolk Southern Corp / Next PLC / PPG Industries Inc / Randstad NV / Rio Tinto Ltd / Scor SE / Securitas AB / AT&T Inc / Toronto-Dominion Bank / Tullow Oil PLC / Toll Brothers Inc / Travelers Companies Inc / Volvo AB / Weir Group PLC / Wells Fargo & Co / Williams Companies Inc / SSE PLC / Comerica Inc / Rathbones Group PLC / Continental AG / Weyerhaeuser Co / Pioneer Natural Resources Co / Canadian Natural Resources Ltd / Gilead Sciences Inc / Comcast Corp / TransAlta Corp / Rogers Communications Inc / Apple Inc / Canadian National Railway Co / Alamos Gold Inc / Quebecor Inc / Walt Disney Co / Wesco International Inc / Darden Restaurants Inc / Dynatrace Inc / CSX Corp / Abb Ltd / Imperial Oil Ltd / Suncor Energy Inc / Brinker International Inc / Valero Energy Corp / Manulife Financial Corp / Exxon Mobil Corp / Corus Entertainment Inc / Whirlpool Corp / Nike Inc / Metro Inc / Sherwin-Williams Co / W W Grainger Inc / Verizon Communications Inc / HCA Healthcare Inc / Adecco Group AG / Constellation Brands Inc / Ameriprise Financial Inc / Exelon Corp / Autozone Inc / Visa Inc / Charter Communications Inc / Dollar Tree Inc / Dollar General Corp / Prologis Inc / Delek US Holdings Inc / IG Group Holdings PLC / Aecon Group Inc / Chevron Corp / Micron Technology Inc / Mohawk Industries Inc / Centamin PLC / Canadian Apartment Properties Real Estate Investment Trust / Pason Systems Inc / Cloudflare Inc / Graphic Packaging Holding Co / FLSmidth & Co A/S / Conocophillips / Callon Petroleum Co / Methanex Corp / Dollarama Inc / First Republic Bank / Warrior Met Coal Inc / CCL Industries Inc / Royal Gold Inc / SVB Financial Group / HOOKIPA Pharma Inc / O'Reilly Automotive Inc / Arch Capital Group Ltd / Texas Capital Bancshares Inc / Transcontinental Inc / Empire Company Ltd / IGO Ltd / SNC-Lavalin Group Inc / Russel Metals Inc / Chemtrade Logistics Income Fund / Restaurant Group PLC / Altria Group Inc / Nutrien Ltd / Domino's Pizza Inc / Spire Healthcare Group PLC / Mosaic Co / Texas Roadhouse Inc / ViacomCBS Inc / IAMGOLD Corp / Hartford Financial Services Group Inc / Western Areas Ltd / Bucher Industries AG / Medical Properties Trust Inc / Builders FirstSource Inc / Seagate Technology Holdings PLC / Freeport-McMoRan Inc / Ampol Ltd / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Mueller Water Products Inc / Capital Power Corp / Marston's PLC / Deutsche Wohnen SE / Hydro One Ltd / Invesco Ltd / Daimler AG / Close Brothers Group PLC / Beazley PLC / Abcam PLC / Getlink SE / PBF Energy Inc / Sprott Inc / OZ Minerals Ltd / Anheuser Busch Inbev SA / Sandfire Resources Ltd / Clearwater Paper Corp / Andlauer Healthcare Group Inc / Vale SA / Intact Financial Corp / Crescent Point Energy Corp / Addus Homecare Corp / BHP Group PLC / MEG Energy Corp / Whitecap Resources Inc / LyondellBasell Industries NV / Cargojet Inc / Evolution Mining Ltd / Phillips 66 / Berry Global Group Inc / Dream Industrial Real Estate Investment Trust / Abbvie Inc / T-Mobile US Inc / Greencoat UK Wind PLC / Brookfield Renewable Partners LP / ServiceNow Inc / Installed Building Products Inc / EnLink Midstream LLC / Ares Management Corp / B&M European Value Retail SA / Nextera Energy Partners LP / Healthequity Inc / Axalta Coating Systems Ltd / South32 Ltd / Colliers International Group Inc / FirstService Corp / Stingray Group Inc / Vonovia SE / Amundi SA / GYM Group PLC / CMC Markets PLC / Basic Fit NV / Twilio Inc / ConvaTec Group PLC / Centennial Resource Development Inc / Vistra Corp / Wheaton Precious Metals Corp / Just Group PLC / Impact Healthcare REIT PLC / Supermarket Income REIT PLC / Orsted A/S / Energean PLC / Minto Apartment Real Estate Investment Trust / Clearway Energy Inc / Elastic NV / NeuBase Therapeutics Inc / CrowdStrike Holdings Inc / Dow Inc / WildBrain Ltd / Metso Outotec Corp / Rocket Companies Inc / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Brazil / Canada / Switzerland / Germany / Denmark / Finland / France / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / Papua New Guinea / Sweden / United States / South Africa / Jersey</td><td class="leftalignment">Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Consumer / Containers & Packing / Electrical / Energy / Engineering & Construction / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Manufacturing / Media / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Wholesale / Oil & Gas / Internet</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Andrew E. Brooke / Mr. Christopher E. Carril / Michael W. Carroll, CFA / Gerard S. Cassidy / Mr. Richard B. Chamberlain / Mr. Maurice Choy / Scot Ciccarelli, CFA / Sam Crittenden, CFA / Ruairi Cullinane / Mike Dahl / Brian Abrahams, MD / Mr. Luke Davis / Mr. Sean W. Dodge, CFA / Mr. Deane Dray, CFA / Mark A. Dwelle, CFA / Mr. James Edwardes Jones / Mr. Mark L. Fielding / Kate Fitzsimons / Mr. Karl Green / Scott M. Hanold / Mr. Michael Harvey / Mr. Gordon Aitken / Mr. Matthew G. Hedberg / Mr. Kamran Hossain / Herr. Nick Housden / Alexander Jackson / Mr. Mandeep Jagpal / Mr. Paul Kaner / Mr. Sabahat Khan / Sebastian Kuenne, CFA / Geoffrey Kwan, CFA / Robert M. Kwan, CFA / Jon G. Arfstrom, CPA / Mr. Kenneth S. Lee / Mr. Julian Livingston-Booth / Mr. Matt Logan / Mr. Keith Mackey / Mr. Kutgun Maral / Drew McReynolds, CFA / Douglas M. Miehm / Darko Mihelic, CFA / Mr. Nik Modi / Frank G. Morgan / Jonathan Atkin / Mr. John B. Musk / Mr. Tom Narayan / Mme. Irene O. Nattel / Mr. Nelson Ng, CFA / Greg M. Pardy, CFA / Mr. Kaan Peker / Daniel R. R. Perlin, CFA / Mr. Paul C. Quinn / Mr. Gordon Ramsay / Anke Reingen / Mr. Ben E. Bathurst / Mr. TJ J. Schultz / Ms. Elvira Scotto, CFA / Walter N. Spracklin, CFA / Randall S. Stanicky, CFA / Mr. Al J. Stanton / Mr. Mitch T. Steves / Mr. Benjamin Toms / Mr. Shelby Tucker, CFA / Mr. Arun S. Viswanathan / Mr. Charles Weston / Mr. Pammi Bir, CPA / Mr. Josh M. Wolfson / Andrew D. Wong / Ms. Christine Zhou / Mr. Biraj Borkhataria / Mr. Tyler Broda, CFA</td></tr>
<tr class="even"><td class="leftalignment">03/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Reminder: Doc Call on March 18th (Tomorrow): The Emerging HIV Pipeline – KOL Takeaways from Recent Conferences and Market Developments</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">0925288 / 2126335 / 2778844 / 2475833 / 2369174 / 2684703</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Johnson & Johnson / Gilead Sciences Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Reminder: Doc Call on 18th March: The Emerging HIV Pipeline – KOL Takeaways from Recent Conferences and Market Developments</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">0925288 / 2126335 / 2778844 / 2475833 / 2369174 / 2684703</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Johnson & Johnson / Gilead Sciences Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">JNJ: Updated Intra-Qtr Analysis Shows Strong Growth Trends for JNJ's Major U.S. Pharma, But Shy of Our Estimates; Reiterate Outperform</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">JNJ.N / MRK.N</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Matt S. Miksic / Vik Chopra / Daniel Aversano</td></tr>
<tr class="odd"><td class="leftalignment">03/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: Revisiting the Current Situation at the FDA and Potential Implications for Biogen's Aducanumab</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB.OQ / MRK.N / REGN.OQ / FGEN.PS / ACHC.OQ</td><td class="leftalignment">Biogen Inc / Merck & Co Inc / Regeneron Pharmaceuticals Inc / First Gen Corp / Acadia Healthcare Company Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Philippines / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">03/17/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Should Investors Steer Clear of the Merck KGaA?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVS-US -  Dividend Quality Analysis, for the period ended March 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">NVS / ABT / BMY / JNJ / MRK / PFE / GSK / AZN.O / BAYRY.PK / TEVA.K / SNY.O</td><td class="leftalignment">Novartis AG / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Bayer AG / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SYN-US - Fundamental Analysis, for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">SYN / ABT / MRK / PFE / AZN.O / BIIB.O / TEVA.K</td><td class="leftalignment">Synthetic Biologics Inc / Abbott Laboratories / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Biogen Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">IDRA-US - Fundamental Analysis, for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">IDRA.O / ABT / JNJ / MRK / PFE / AMGN.O / AGEN.O / LGND.O / BIIB.O / DVAX.O / CLDX.O</td><td class="leftalignment">Idera Pharmaceuticals Inc / Abbott Laboratories / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / Agenus Inc / Ligand Pharmaceuticals Inc / Biogen Inc / Dynavax Technologies Corp / Celldex Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CORT-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CORT.O / BMY / JNJ / LLY / MRK / NVS / PFE / BMRN.O / ESPR.O / MNKD.O</td><td class="leftalignment">Corcept Therapeutics Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Biomarin Pharmaceutical Inc / Esperion Therapeutics Inc / MannKind Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck KGaA: Cash Conversion Cycle 2010-2020</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Doc Call on 18th March:  The Emerging HIV Pipeline – KOL Takeaways from Recent Conferences and Market Developments</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">0925288 / 2778844 / 2369174 / 2684703</td><td class="leftalignment">GlaxoSmithKline PLC / Merck & Co Inc / Gilead Sciences Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Rethinking Pharma Merger Reviews Could Create Some Headline Risks For The Industry</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / LLY.N / 0715.HK / JNJ.N / PFE.N / ZTS.N / IMAB.OQ</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / China Oceanwide Holdings Ltd / Johnson & Johnson / Pfizer Inc / Zoetis Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck KGaA: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">MRK Gilead Collaboration Solidifies Strength In HIV</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US58933Y1055 / GILD.OQ / US3755581036</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2778844 / 2026242 / 2942605 / 2317087 / 2328915 / 2342034 / 2369174 / 2630513 / 2684703 / 2048804 / 2980906 / 7103065 / B121557 / B1Y9TB3 / 2857817 / B2R3PV1 / B28TS42 / B7TL820 / B7VD3F2 / BVVN4Q8 / BYVY8G0 / BF4VBS8 / BP7RS48 / BFZ1K46 / BLGJ610 / BFMXGR0 / BZ8VJQ8 / BKTNTR9 / BDD1B07 / BP8XZL1 / BFY7DC4</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / American Electric Power Company Inc / Avista Corp / Entergy Corp / Nextera Energy Inc / Fiserv Inc / Gilead Sciences Inc / New Jersey Resources Corp / Pfizer Inc / Pinnacle West Capital Corp / Foot Locker Inc / Novartis AG / Mastercard Inc / Danone SA / Netflix Inc / American Water Works Company Inc / Ulta Beauty Inc / Meta Platforms Inc / Duke Energy Corp / Eversource Energy / Alphabet Inc / BioXcel Therapeutics Inc / Intersect Ent Inc / Spotify Technology SA / Warner Music Group Corp / Evergy Inc / Vistra Corp / ViacomCBS Inc / Rubius Therapeutics Inc / Healthequity Inc / Altimmune Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / WEN=US / T=US / BLD=US / TEVA=US / GILD=US / AMT=US / VZ=US / LOW=US / PB=US / CHRS=US / LEG=US / DISH=US / BNL=US / CBRL=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / REGN=US / REGI=US / SBAC=US / STOR=US / ABCB=US / ADC=US / BOKF=US / FFIN=US / DIN=US / BIIB=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / CADE=US / TAST=US / QSR=US / PRPL=US / EPRT=US / JACK=US / TREX=US / CUBE=US / FBHS=US / TILE=US / TMUS=US / NDLS=US / CNCE=US / LOCO=US / HQY=US / SHAK=US / RLMD=US / WING=US / ZG=US / 82982L103 / ANAB=US / JELD=US / RDFN=US / BTAI=US / OPCH=US / AZEK=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / AT&T Inc / TopBuild Corp / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / American Tower Corp / Verizon Communications Inc / Lowe's Companies Inc / Prosperity Bancshares Inc / Coherus BioSciences Inc / Leggett & Platt Inc / DISH Network Corp / Bunzl plc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / SBA Communications Corp / STORE Capital Corp / Ameris Bancorp / Agree Realty Corp / BOK Financial Corp / First Financial Bankshares Inc / Dine Brands Global Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Essential Properties Realty Trust Inc / Jack in the Box Inc / Trex Company Inc / CubeSmart / Fortune Brands Home & Security Inc / Interface Inc / T-Mobile US Inc / Noodles & Co / Concert Pharmaceuticals Inc / El Pollo Loco Holdings Inc / Healthequity Inc / Shake Shack Inc / Relmada Therapeutics Inc / Wingstop Inc / Zillow Group Inc / SiteOne Landscape Supply Inc / AnaptysBio Inc / JELD-WEN Holding Inc / Redfin Corp / BioXcel Therapeutics Inc / Option Care Health Inc / Azek Company Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Lenacapavir combo deal preserves flexibility in the long-term while accelerating timelines by two years</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US3755581036 / MRK</td><td class="leftalignment">Gilead Sciences Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4507.T: Shionogi - Virtual pharma tour; Shionogi is a Japanese leader in COVID-19 therapies and HIV franchise</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">4507.T / MRK.N / GILD.OQ / 2318.HK</td><td class="leftalignment">Shionogi & Co Ltd / Merck & Co Inc / Gilead Sciences Inc / Ping An Insurance Group Co of China Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4507.T: 塩野義製薬 - ヴァ―チャルファーマツアー開催、COVID-19治療とHIVフランチャイズで日本をリードする</td><td class="leftalignment">Japanese</td><td class="rightalignment">7</td><td class="leftalignment">4507.T / MRK.N / GILD.OQ / 2318.HK</td><td class="leftalignment">Shionogi & Co Ltd / Merck & Co Inc / Gilead Sciences Inc / Ping An Insurance Group Co of China Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 05, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck & Co., Inc. : GILD HIV Collaboration Highlights Significant Potential of Islatravir for Both Treatment and PrEP</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Paragon Intel</td><td class="leftalignment">WAT: CEO Batra Initiation 30-min Deep Dive Call 03/16 at 2PM</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">WAT.N / A.N / MRCG.F / TMO.N / 7701.T / DHR.N / PKI.N / BRKR.OQ</td><td class="leftalignment">Waters Corp / Agilent Technologies Inc / Merck KGaA / Thermo Fisher Scientific Inc / Shimadzu Corp / Danaher Corp / PerkinElmer Inc / Bruker Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Japan / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">MANAGEMENT</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Bill Campbell</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Lenacapavir and Islatravir Finally Hooking Up but Not Exclusive</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US / GILD=US</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Geoffrey Porges / Dr. Daina Graybosch, PHD</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MRK - our thoughts on today's HIV collaboration agreement with GILD following MRK's investor call this morning</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Randall S. Stanicky, CFA</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GILD & MRK Combine on First In Class Long Acting HIV Molecules; We're Positive on Deal Given HIV Competitive Dynamics</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2778844 / 2369174</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Etzer Darout / Mr. Seamus Fernandez / Paul Jeng, Ph.D. / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Intriguing collaboration with GILD on long-acting HIV treatments</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK=US / GILD.OQ / MRK.N / GILD=US</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc / Merck & Co Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Resounding themes from Chardan's Microbiome Medicines Summit (CMMS 2021)</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / BMY=US / GSK=US / JNJ=US / BMRN=US / EXAS=US / NESN=US / KLDO=US / DDDD=GB / MCRB=US / SYBX=US / FIXX=US / PHGE=US / FBRX=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Johnson & Johnson / Biomarin Pharmaceutical Inc / Exact Sciences Corp / Nestle SA / Kaleido Biosciences Inc / 4D Pharma PLC / Seres Therapeutics Inc / Synlogic Inc / Homology Medicines Inc / Biomx Inc / Forte Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">EVLO=US / ADAP=US / MRK=US / LLY=US / PFE=US / BMY=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / JNJ=US / BMRN=US / BLUE=US / ISEE=US / EXAS=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / NESN=US / KLDO=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / DDDD=GB / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / MCRB=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / SYBX=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PHGE=US / PASG=US / SIGHT:FP=FR / FBRX=US / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Evelo Biosciences Inc / Adaptimmune Therapeutics PLC / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Exact Sciences Corp / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / Nestle SA / Kaleido Biosciences Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / 4D Pharma PLC / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Seres Therapeutics Inc / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Synlogic Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Biomx Inc / Passage Bio Inc / Gensight Biologics SA / Forte Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">MRK And GILD HIV Collaboration Helps Improve Earnings Visibility in 2028+</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK / US3755581036</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRK.N - Event Brief of Merck & Co Inc conference call, Mar. 15, 2021 / 7:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRK.N - Event Transcript of Merck & Co Inc conference call, Mar. 15, 2021 / 7:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 15 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">FR0000054470 / BE0165385973 / US0079731008 / US0116591092 / US0320951017 / US0382221051 / US0463531089 / US0997241064 / US1101221083 / US1925761066 / US2371941053 / US2855121099 / US37733W1053 / US45167R1041 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US6284641098 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US8740541094 / US8793601050 / US8807701029 / US9021041085 / US91347P1057 / US4771431016 / US4198791018 / US80105N1054 / US0003752047 / US3463751087 / US90385V1070 / PAP310761054 / US01748X1028 / US2473617023 / US5500211090 / US00507V1098 / CA9609083097 / CA0585861085 / US58933Y1055 / US5218652049 / US88160R1014 / US9100471096 / US92839U2069 / JE00B783TY65 / US98986T1088 / US00287Y1091 / NL0010273215 / US72919P2020 / US8485771021 / US21240E1055 / US02376R1023 / CA0089118776 / US98138J2069 / US45073V1089 / KYG4740B1059 / US05351X1019 / US92336X1090 / US5904791358 / US1567271093 / US92537N1081 / US22041X1028 / US33813J1060 / US72815L1070</td><td class="leftalignment">Ubisoft Entertainment SA / Melexis NV / Advanced Energy Industries Inc / Alaska Air Group Inc / Amphenol Corp / Applied Materials Inc / AstraZeneca PLC / Borgwarner Inc / Bristol-Myers Squibb Co / Cohu Inc / Darden Restaurants Inc / Electronic Arts Inc / GlaxoSmithKline PLC / IDEX Corp / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Myers Industries Inc / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Take-Two Interactive Software Inc / Teledyne Technologies Inc / Teradyne Inc / II-VI Inc / Universal Display Corp / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Abb Ltd / FormFactor Inc / Ultra Clean Holdings Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Lululemon Athletica Inc / Activision Blizzard Inc / Westport Fuel Systems Inc / Ballard Power Systems Inc / Merck & Co Inc / Lear Corp / Tesla Inc / United Airlines Holdings Inc / Visteon Corp / Aptiv PLC / Zynga Inc / Abbvie Inc / ASML Holding NV / Plug Power Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Air Canada / Workhorse Group Inc / ITT Inc / Ichor Holdings Ltd / Avaya Holdings Corp / Veoneer Inc / Mesa Air Group Inc / Cerence Inc / Vertiv Holdings Co / Corsair Gaming Inc / Fisker Inc / Playtika Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">SVRA=US / TRVN=US / MRK=US / BSX=US / CSII=US / FDX=US / ABT=US / AMGN=US / BMY=US / CAT=US / WM=US / BWA=US / MDT=US / QCOM=US / T=US / DT=US / INCY=US / RUN=US / CG=US / BAC=US / GILD=US / FRC=US / MPWR=US / JPM=US / FCEL=US / PLUG=US / NVS=US / TROW=US / CRY=US / JCI=US / JNJ=US / DE=US / RSG=US / ALB=US / AMSC=US / ARNA=US / ARRY=US / ATRC=US / AVNT=US / CMI=US / CREE=US / DRI=US / DRRX=US / EW=US / INSM=US / ITRI=US / MS=US / ROK=US / TER=US / TRMB=US / RHHBY=US / SIVB=US / NEP=US / SWKS=US / ICAD=US / BE=US / CLH=US / WCN=US / BIIB=US / ISR=US / ENS=US / GOOG=US / TWIN=US / ORA=US / AMRS=US / PDD=US / SPWR=US / CSIQ=US / FSLR=US / ARAY=US / BX=US / DAN=US / WPRT=US / SWAV=US / AGCO=US / CPIX=US / TSLA=US / DANA=US / AMRC=US / PCRX=US / ENPH=US / SPLK=US / HASI=US / CNHI=US / HRTX=US / BABA=US / EKTAY=US / NEWR=US / SEDG=US / LIVN=US / AQMS=US / CERC=US / VRAY=US / WKHS=US / IRTC=US / VERU=US / ATXI=US / APTV=US / VOW3-DE=US / CWEN=US / ESTC=US / DDOG=US / BXRX=US / TARA=US / SUMO=US / VLDR=US / SHLS=US / CHPT=US / GOEV=US</td><td class="leftalignment">Savara Inc / Trevena Inc / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / FedEx Corp / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Caterpillar Inc / Waste Management Inc / Borgwarner Inc / Medtronic PLC / Qualcomm Inc / AT&T Inc / Dynatrace Inc / Incyte Corp / Sunrun Inc / Carlyle Group Inc / Bank of America Corp / Gilead Sciences Inc / First Republic Bank / Monolithic Power Systems Inc / JPMorgan Chase & Co / Fuelcell Energy Inc / Plug Power Inc / Novartis AG / T Rowe Price Group Inc / CryoLife Inc / Johnson Controls International PLC / Johnson & Johnson / Deere & Co / Republic Services Inc / Albemarle Corp / American Superconductor Corp / Arena Pharmaceuticals Inc / Array Technologies Inc / AtriCure Inc / Avient Corp / Cummins Inc / Wolfspeed Inc / Darden Restaurants Inc / DURECT Corp / Edwards Lifesciences Corp / Insmed Inc / Itron Inc / Morgan Stanley / Rockwell Automation Inc / Teradyne Inc / Trimble Inc / Roche Holding AG / SVB Financial Group / Nextera Energy Partners LP / Skyworks Solutions Inc / ICAD Inc / Bloom Energy Corp / Clean Harbors Inc / Waste Connections Inc / Biogen Inc / IsoRay Inc / EnerSys / Alphabet Inc / Twin Disc Inc / Ormat Technologies Inc / Amyris Inc / Pinduoduo Inc / SunPower Corp / Canadian Solar Inc / First Solar Inc / Accuray Inc / Blackstone Inc / Dana Inc / Westport Fuel Systems Inc / Shockwave Medical Inc / AGCO Corp / Cumberland Pharmaceuticals Inc / Tesla Inc / Dana Gas PJSC / Ameresco Inc / Pacira Biosciences Inc / Enphase Energy Inc / Splunk Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / CNH Industrial NV / Heron Therapeutics Inc / Alibaba Group Holding Ltd / Elekta AB (publ) / New Relic Inc / Solaredge Technologies Inc / LivaNova PLC / Aqua Metals Inc / Avalo Therapeutics Inc / ViewRay Inc / Workhorse Group Inc / iRhythm Technologies Inc / Veru Inc / Avenue Therapeutics Inc / Aptiv PLC / Volkswagen AG / Clearway Energy Inc / Elastic NV / Datadog Inc / Baudax Bio Inc / Protara Therapeutics Inc / Sumo Logic Inc / Velodyne Lidar Inc / Shoals Technologies Group Inc / ChargePoint Holdings Inc / Canoo Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Arab Emirates / Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Electrical / Financial Services / Healthcare / Info. Tech./Software / Lodging & Restaurants / Pharmaceuticals / Retailing / Semiconductors / Telecommunications</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Olinvyk . . . We Have Liftoff; Initiate at Perform</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">TRVN=US / MRK=US / BMY=US / NVS=US / JNJ=US / ARNA=US / DRRX=US / RHHBY=US / CPIX=US / PCRX=US / HRTX=US / CERC=US / VERU=US / ATXI=US / BXRX=US</td><td class="leftalignment">Trevena Inc / Merck & Co Inc / Bristol-Myers Squibb Co / Novartis AG / Johnson & Johnson / Arena Pharmaceuticals Inc / DURECT Corp / Roche Holding AG / Cumberland Pharmaceuticals Inc / Pacira Biosciences Inc / Heron Therapeutics Inc / Avalo Therapeutics Inc / Veru Inc / Avenue Therapeutics Inc / Baudax Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">ABF.L / AEP.N / ALV.N / AU.N / CAS.TO / CI.N / CL.N / CMS.N / EDP.LS / EIX.N / EL.N / F.N / FGP.L / GM.N / GOG.L / HMb.ST / IBE.MC / IP.N / JD.L / KBH.N / KMB.N / KO.N / MKS.L / MRK.N / NCM.AX / NEM.N / NXT.L / PD.N / PFE.N / PHM.N / RSG.AX / RYN.N / SO.N / T.N / TOL.N / VC.N / PEP.N / BFb.N / PG.N / WY.N / CFP.TO / GILD.O / FNV.N / CPB.N / LPX.N / TEN.N / CMCSA.O / AMGN.O / INCY.O / DUK.N / AGI.N / BWA.N / LEA.N / PNM.N / K.N / DT.N / DISH.O / LEN.N / CLX.N / CAG.N / GIS.N / AEM.N / EPC.N / SBM.AX / AMT.N / KGC.N / NKE.N / JAZZ.O / CONE.O / VZ.N / EXEL.O / DHI.N / STZ.N / APH.N / FISV.O / ADSK.O / V.N / AXL.N / AWK.N / CHD.N / NWN.N / BC.N / SAM.N / ITX.MC / BMRN.O / OPTN.O / REGN.O / ENR.N / JHX.AX / CEY.L / NCR.N / NET.N / TEL.N / GFI.N / ASC.L / CNP.N / ENDP.O / CPK.N / PII.N / ST.N / SEM.N / SGEN.OQ / GPN.N / MNST.O / RGLD.O / BLUE.O / CASY.O / EQIX.O / ATDb.TO / BIIB.O / GOLD.N / RMS.AX / NST.AX / 02209S103 / CWX.TO / RRL.AX / DLR.N / IAG.N / 427866108 / WEF.TO / FIS.N / ARWR.O / TEVA.N / MA.N / HOG.N / MERC.O / AUY.N / ATL.MI / BGS.N / HOCM.L / SLR.AX / ENSG.O / DAN.N / NOG.A / FRES.L / NGD.A / CLW.N / OGC.TO / ADUS.OQ / EGO.N / ADN.TO / SPB.N / NEE.N / GOR.AX / PCH.O / CFX.TO / PCRX.O / CTT.N / MTOR.N / IFP.TO / POLYP.L / EVN.AX / SPLK.OQ / RFP.N / BOSSn.DE / PANW.N / MDLZ.OQ / ABBV.N / KPT.TO / TPH.N / TSLA.N / PRGO.N / PRMW.N / TMUS.N / TMHC.N / COTY.N / PRTA.O / 81762P102 / CFF.TO / LB.N / KPTI.O / XNCR.OQ / VRNS.O / BOOH.L / BTG.N / AGRX.O / RYAM.N / ZALG.DE / 03835T200 / SHOP.N / WRK.N / SGRY.O / RACE.MI / TWLO.N / OR.N / ADNT.N / CRSP.OQ / GDS.O / SAND.N / AQN.N / OKTA.OQ / VST.N / WPM.N / KL.N / ATNX.O / SAIL.N / APTV.N / EHC.N / SDRY.L / ZS.OQ / AMRX.N / ITRM.O / VNE.N / NTGY.MC / KDP.N / XERS.O / AQST.O / FOCS.O / ESTC.N / GMDA.OQ / OSMT.O / NWL.O / OPI.OQ / CRWD.O / GMAB.O / PING.N / APRE.OQ / CRNC.OQ / IGMS.O / FRAS.L / REYN.O / SBSW.N / IGIC.OQ / NKLA.OQ / FOUR.N / GOCO.O / ALOO.O / MAX.N / WFG.N / AG1G.DE / 120291281 / 120681711</td><td class="leftalignment">Associated British Foods PLC / American Electric Power Company Inc / Autoliv Inc / AngloGold Ashanti Ltd / Cascades Inc / Cigna Corp / Colgate-Palmolive Co / CMS Energy Corp / EDP Energias de Portugal SA / Edison International / Estee Lauder Companies Inc / Ford Motor Co / FirstGroup PLC / General Motors Co / Go-Ahead Group PLC / H & M Hennes & Mauritz AB / Iberdrola SA / International Paper Co / JD Sports Fashion PLC / KB Home / Kimberly-Clark Corp / Coca-Cola Co / Marks and Spencer Group PLC / Merck & Co Inc / Newcrest Mining Ltd / Newmont Corporation / Next PLC / PagerDuty Inc / Pfizer Inc / Pultegroup Inc / Resolute Mining Ltd / Rayonier Inc / Southern Co / AT&T Inc / Toll Brothers Inc / Visteon Corp / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canfor Corp / Gilead Sciences Inc / Franco-Nevada Corp / Campbell Soup Co / Louisiana-Pacific Corp / Tenneco Inc / Comcast Corp / Amgen Inc / Incyte Corp / Duke Energy Corp / Alamos Gold Inc / Borgwarner Inc / Lear Corp / PNM Resources Inc / Kellogg Co / Dynatrace Inc / DISH Network Corp / Lennar Corp / Clorox Co / Conagra Brands Inc / General Mills Inc / Agnico Eagle Mines Ltd / Edgewell Personal Care Co / St Barbara Ltd / American Tower Corp / Kinross Gold Corp / Nike Inc / Jazz Pharmaceuticals PLC / CyrusOne Inc / Verizon Communications Inc / Exelixis Inc / D R Horton Inc / Constellation Brands Inc / Amphenol Corp / Fiserv Inc / Autodesk Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Brunswick Corp / Boston Beer Company Inc / Industria de Diseno Textil SA / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / James Hardie Industries PLC / Centamin PLC / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Gold Fields Ltd / ASOS PLC / CenterPoint Energy Inc / Endo International PLC / Chesapeake Utilities Corp / Polaris Inc / Sensata Technologies Holding PLC / Select Medical Holdings Corp / Seagen Inc / Global Payments Inc / Monster Beverage Corp / Royal Gold Inc / bluebird bio Inc / Caseys General Stores Inc / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Barrick Gold Corp / Ramelius Resources Ltd / Northern Star Resources Ltd / Altria Group Inc / Doman Building Materials Group Ltd / Regis Resources Ltd / Digital Realty Trust Inc / IAMGOLD Corp / Hershey Co / Western Forest Products Inc / Fidelity National Information Services Inc / Arrowhead Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Harley-Davidson Inc / Mercer International Inc / Yamana Gold Inc / Atlantia SpA / B&G Foods Inc / Hochschild Mining PLC / Silver Lake Resources Ltd / Ensign Group Inc / Dana Inc / Northern Oil and Gas Inc / Fresnillo PLC / New Gold Inc / Clearwater Paper Corp / OceanaGold Corp / Addus Homecare Corp / Eldorado Gold Corp / Acadian Timber Corp / Spectrum Brands Holdings Inc / Nextera Energy Inc / Gold Road Resources Ltd / Potlatchdeltic Corp / Canfor Pulp Products Inc / Pacira Biosciences Inc / CatchMark Timber Trust Inc / Meritor Inc / Interfor Corp / Polymetal International PLC / Evolution Mining Ltd / Splunk Inc / Resolute Forest Products Inc / Hugo Boss AG / Palo Alto Networks Inc / Mondelez International Inc / Abbvie Inc / KP Tissue Inc / Tri Pointe Homes Inc (Delaware) / Tesla Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / Taylor Morrison Home Corp / Coty Inc / Prothena Corporation PLC / ServiceNow Inc / Conifex Timber Inc / Bath & Body Works Inc / Karyopharm Therapeutics Inc / Xencor Inc / Varonis Systems Inc / boohoo group plc / B2Gold Corp / Agile Therapeutics Inc / Rayonier Advanced Materials Inc / Zalando SE / Aptose Biosciences Inc / Shopify Inc / Westrock Co / Surgery Partners Inc / Ferrari NV / Twilio Inc / Osisko Gold Royalties Ltd / Adient PLC / CRISPR Therapeutics AG / GDS Holdings Ltd / Sandstorm Gold Ltd / Algonquin Power & Utilities Corp / Okta Inc / Vistra Corp / Wheaton Precious Metals Corp / Kirkland Lake Gold Ltd / Athenex Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Encompass Health Corp / Superdry PLC / Zscaler Inc / Amneal Pharmaceuticals Inc / Iterum Therapeutics PLC / Veoneer Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Focus Financial Partners Inc / Elastic NV / Gamida Cell Ltd / Osmotica Pharmaceuticals PLC / Newell Brands Inc / Office Properties Income Trust / CrowdStrike Holdings Inc / Genmab A/S / Ping Identity Holding Corp / Aprea Therapeutics Inc / Cerence Inc / IGM Biosciences Inc / Frasers Group PLC / Reynolds Consumer Products Inc / Sibanye Stillwater Ltd / International General Insurance Holdings Ltd / Nikola Corp / Shift4 Payments Inc / Gohealth Inc / Allogene Therapeutics Inc / Mediaalpha Inc / West Fraser Timber Co Ltd / AUTO1 Group SE / Cenovus Energy Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / Spain / United Kingdom / Ireland / Israel / Italy / Netherlands / Portugal / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GILD: Gilead Sciences, Inc - Merck HIV Partnership: Follow-up from our call with Gilead management</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK.N / GILD.OQ</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback: GSK: Readacross from Merck/Gilead collaboration in HIV</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N / GILD.OQ / GSK.L / 4507.T / PFE.N</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Shionogi & Co Ltd / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GILD: Gilead Sciences, Inc - Gilead to partner with Merck on long-acting HIV combo therapy providing a logical path forward for the franchise</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK.N / GILD.OQ</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">03/14/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GSK-US -  Dividend Quality Analysis, for the period ended January 14,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GSK / MRK / NVS / PFE / AZN.O / DVAX.O / TEVA.K / SNY.O</td><td class="leftalignment">GlaxoSmithKline PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / AstraZeneca PLC / Dynavax Technologies Corp / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / ENDP.O / TEVA.N / PCRX.O / AGRX.O / AMRX.N / OSMT.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Pacira Biosciences Inc / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Osmotica Pharmaceuticals PLC</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">03/14/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">EBS-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">EBS / MRK / PFE / GSK / XOMA.O / SIGA.O / CLDX.O / CMRX.O / SNGX.O / TEVA.K</td><td class="leftalignment">Emergent BioSolutions Inc / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / XOMA Corp / SIGA Technologies Inc / Celldex Therapeutics Inc / Chimerix Inc / Soligenix Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/14/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Call to Discuss The Potential Role Of, And Key Focus Areas For, ADCs In Oncology on Friday, April 9, 2021 at 1 pm ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK / PFE</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: New Trial Starts Continue to Increase - Week 50</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Mar 12 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">OPT=US / VBIV=US / AAPL=US / MRK=US / BSX=US / PFE=US / ABT=US / BMY=US / MDT=US / AMZN=US / WMT=US / INSP=US / CMS=US / GILD=US / DGX=US / BBI=US / RMD=US / GSK=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ATRC=US / BLUE=US / CHE=US / CYH=US / EW=US / GEN=US / ISRG=US / LH=US / PHAR=US / REGN=US / USPH=US / UHS=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / MD=US / SLF=US / MRNS=US / BIIB=US / MRNA=US / ACAD=US / ALNY=US / GOOG=US / INO=US / LHCG=US / CHNG=US / EHC=US / NMTR=US / TMDI=US / SPRO=US / ASND=US / ADUS=US / ACHC=US / PRTA=US / OM=US / FLXN=US / CTRE=US / ALDX=US / XENT=US / WBA=US / EVH=US / ZBH=US / CATB=US / LIVN=US / CERC=US / AVDL=US / SRRA=US / SLNO=US / SYNH=US / FIXX=US / MRKR=US / GMDA=US / PDSB=US / TMDX=US / BCYC=US / KRTX=US / BNTX=US / PNTG=US</td><td class="leftalignment">Opthea Ltd / VBI Vaccines Inc / Apple Inc / Merck & Co Inc / Boston Scientific Corp / Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Medtronic PLC / Amazon.com Inc / Walmart Inc / Inspire Medical Systems Inc / CMS Energy Corp / Gilead Sciences Inc / Quest Diagnostics Inc / Brickell Biotech Inc / Resmed Inc / GlaxoSmithKline PLC / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / AtriCure Inc / bluebird bio Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Genesis Healthcare Inc / Intuitive Surgical Inc / Laboratory Corporation of America Holdings / Pharming Group NV / Regeneron Pharmaceuticals Inc / US Physical Therapy Inc / Universal Health Services Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Sun Life Financial Inc / Marinus Pharmaceuticals Inc / Biogen Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / LHC Group Inc / Change Healthcare Inc / Encompass Health Corp / 9 Meters Biopharma Inc / Titan Medical Inc / Spero Therapeutics Inc / Ascendis Pharma A/S / Addus Homecare Corp / Acadia Healthcare Company Inc / Prothena Corporation PLC / Outset Medical Inc / Pacira Biosciences Inc / CareTrust REIT Inc / Aldeyra Therapeutics Inc / Intersect Ent Inc / Walgreens Boots Alliance Inc / Evolent Health Inc / Zimmer Biomet Holdings Inc / Astria Therapeutics Inc / LivaNova PLC / Avalo Therapeutics Inc / Avadel Pharmaceuticals PLC / Sierra Oncology Inc / Soleno Therapeutics Inc / Syneos Health Inc / Homology Medicines Inc / Marker Therapeutics Inc / Gamida Cell Ltd / PDS Biotechnology Corp / Transmedics Group Inc / Bicycle Therapeutics PLC / Karuna Therapeutics Inc / BioNTech SE / Pennant Group Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 3.12.21</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / ALDX=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / Aldeyra Therapeutics Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Portfolio Manager's Weekly - March 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">FR0000121014 / US0028241000 / US00738A1060 / US00846U1016 / US0126531013 / US02553E1064 / US0311621009 / US0463531089 / US1101221083 / US17275R1023 / US22160K1051 / US2358511028 / US30226D1063 / US3156161024 / US3377381088 / US3647601083 / US3755581036 / US37733W1053 / US4364401012 / US4523271090 / US4781601046 / US48203R1041 / US5002551043 / US5324571083 / US6245801062 / US62855J1043 / US6549022043 / US6556641008 / US66987V1098 / US6701002056 / US7140461093 / US7170811035 / US75886F1075 / US87612E1064 / US8835561023 / US9021041085 / US91307C1027 / US9311421039 / US9418481035 / US30063P1057 / US37940X1028 / AU000000LYC6 / US2948216088 / US1167941087 / US31620M1062 / US57636Q1040 / US1717793095 / US79546E1047 / US55616P1049 / US90384S3031 / US92826C8394 / US58933Y1055 / US13100M5094 / US1920051067 / US9100471096 / US69404D1081 / US92335C1062 / US98978V1035 / US5017971046 / US64051T1007 / US45845P1084 / US69366J2006 / US63009R1095 / US03823U1025 / CH0210483332 / US09062W2044 / US0404131064 / US78667J1088 / US0994061002 / IE00BTN1Y115 / US46185L1035 / US6323071042 / US70450Y1038 / US72703H1014 / US8522341036 / US26856L1035 / US74967X1037 / NL0012169213 / CA1350861060 / US03236M2008 / US8760301072 / CA53680Q2071 / US74766Q1013 / US7625441040 / US09354A1007 / US26927E1047 / US46571Y1073 / VGG312491084 / KY30744W1070 / US40131M1099 / US53814L1089 / US90184D1000 / VGG1890L1076 / US05352A1007 / US76156B1070 / US71535D1063 / US39874R1014 / US00650F1093 / US88339P1012 / US24984K1051 / US88025U1097 / US30068X1037 / US92766K1060 / US14448C1045 / US12233L1070 / US57667L1070 / US0843101017 / US07373B1098 / CA67079A1021 / US5533681012 / US74767V1098 / US81578P1066 / US65443P1021 / US7761531083 / US73739W1045 / US55406W1036 / US12047B1052 / US15961R1059</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / Abbott Laboratories / ADTRAN Inc / Agilent Technologies Inc / Albemarle Corp / American Eagle Outfitters Inc / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cisco Systems Inc / Costco Wholesale Corp / Danaher Corp / Extreme Networks Inc / F5 Inc / Fiserv Inc / Gap Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Hologic Inc / Illumina Inc / Johnson & Johnson / Juniper Networks Inc / Kohls Corp / Eli Lilly and Co / Movado Group Inc / Myriad Genetics Inc / Nokia Oyj / Nordstrom Inc / Novartis AG / Novo Nordisk A/S / PerkinElmer Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Target Corp / Thermo Fisher Scientific Inc / II-VI Inc / United Therapeutics Corp / Walmart Inc / Waters Corp / Exact Sciences Corp / Global Payments Inc / Lynas Rare Earths Ltd / Telefonaktiebolaget LM Ericsson / Bruker Corp / Fidelity National Information Services Inc / Mastercard Inc / Ciena Corp / Sally Beauty Holdings Inc / Macy's Inc / Ulta Beauty Inc / Visa Inc / Merck & Co Inc / Calix Inc / Codexis Inc / United Airlines Holdings Inc / Pacific Biosciences of California Inc / Vera Bradley Inc / Zoetis Inc / Bath & Body Works Inc / NeoPhotonics Corp / Intercept Pharmaceuticals Inc / PTC Therapeutics Inc / NanoString Technologies Inc / Applied Optoelectronics Inc / Compagnie Financiere Richemont SA / BioLife Solutions Inc / Arista Networks Inc / SAGE Therapeutics Inc / Boot Barn Holdings Inc / Medtronic PLC / Invitae Corp / Natera Inc / PayPal Holdings Inc / Planet Fitness Inc / Block Inc / elf Beauty Inc / RH / Qiagen NV / Canada Goose Holdings Inc / Amyris Inc / Tapestry Inc / Lithium Americas Corp / Quanterix Corp / Ribbon Communications Inc / Blink Charging Co / EVO Payments Inc / I3 Verticals Inc / Establishment Labs Holdings Inc / Farfetch Ltd / Guardant Health Inc / Livent Corp / Twist Bioscience Corp / Capri Holdings Ltd / Avantor Inc / Revolve Group Inc / Personalis Inc / Grocery Outlet Holding Corp / Adaptive Biotechnologies Corp / RealReal Inc / DermTech Inc / 10X Genomics Inc / Exagen Inc / Virgin Galactic Holdings Inc / Carrier Global Corp / Burning Rock Biotech Ltd / Match Group Inc / Berkeley Lights Inc / Beam Global / Nuvei Corp / Mp Materials Corp / Quantumscape Corp / Seer Inc / 908 Devices Inc. / Romeo Power Inc / Poshmark Inc / MYT Netherlands Parent BV / Bumble Inc / ChargePoint Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / Denmark / Finland / France / United Kingdom / Ireland / Netherlands / Sweden / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending Mar 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended March 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Merck & Co., Inc.(MRK) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">58933Y105</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma : 2021 Catalysts - How We Are Thinking About Key Updates From Here</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / ABBV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback: FDA Advisory committee to review accelerated approvals in cancer</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BMY.N / MRK.N / AZN.L / ROG.S / FGEN.PS</td><td class="leftalignment">Bristol-Myers Squibb Co / Merck & Co Inc / AstraZeneca PLC / Roche Holding AG / First Gen Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Philippines / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">EU Pharma Feedback. Bayer CMD Day Two : Innovation and notes from breakout sessions</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">BAYGn.DE / JNJ.N / MRK.N / TMO.N / ROG.S / LONN.S / REGN.OQ / ORNBV.HE / ATRA.OQ / CTVA.N</td><td class="leftalignment">Bayer AG / Johnson & Johnson / Merck & Co Inc / Thermo Fisher Scientific Inc / Roche Holding AG / Lonza Group AG / Regeneron Pharmaceuticals Inc / Orion Oyj / Atara Biotherapeutics Inc / Corteva Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Finland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">03/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">What's The Lowdown On AACR This Year? Takeaways From Release Of Abstracts And Titles</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK / LLY / JNJ / PFE / HCM.O / IMAB.O</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Johnson & Johnson / Pfizer Inc / HUTCHMED (China) Ltd / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">03/11/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Here's Why Roche Looks Undervalued At $41</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">RHHBY.PK / JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Roche Holding AG / Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/10/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BDSI.OQ / BSLN.S / MNKD.OQ / DRRX.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / OMER.OQ / VFF.TO / ARDX.OQ / ACRX.OQ / ZTS.N / ANIP.OQ / AXGN.OQ / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / MRNS.OQ / CFRX.OQ / VNRX.A / VRAY.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / ACRS.OQ / CKPT.OQ / VERU.OQ / TXMD.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / XLY.V / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / STOK.OQ / SNDL.OQ / IMAB.OQ / ARQT.OQ / LUMO.OQ / AH.TO / PCVX.OQ / AWH.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / AZYO.OQ / 120551486</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / DURECT Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Village Farms International Inc / Ardelyx Inc / AcelRx Pharmaceuticals Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / Marinus Pharmaceuticals Inc / ContraFect Corp / VolitionRX Ltd / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Aclaris Therapeutics Inc / Checkpoint Therapeutics Inc / Veru Inc / TherapeuticsMD Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Auxly Cannabis Group Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / Stoke Therapeutics Inc / Sundial Growers Inc / I-Mab / Arcutis Biotherapeutics Inc / Lumos Pharma Inc / Aleafia Health Inc / Vaxcyte Inc / Aspira Women's Health Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Aziyo Biologics Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">03/10/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Morning Bite Flash</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">FR0000120073 / DE0006599905 / DE0007500001 / DE0005439004 / DE0007164600 / DE0005552004 / DK0010268606 / ES0143416115 / NO0010081235 / DE000A0D6554 / DE000TUAG000 / DE000KC01000 / AT0000908504 / DE000A0LR936 / ES0144580Y14 / GB00B0130H42 / DE000A1DAHH0 / DE000A1EWWW0 / DE000KSAG888 / DK0060448595 / DE000WAF3001 / DE000A2G8X31 / IE00BZ12WP82 / DE000ENER6Y0</td><td class="leftalignment">L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Merck KGaA / thyssenkrupp AG / Continental AG / SAP SE / Deutsche Post AG / Vestas Wind Systems A/S / Siemens Gamesa Renewable Energy SA / Nel ASA / Nordex SE / TUI AG / Kloeckner & Co SE / Vienna Insurance Group AG Wiener Versicherung Gruppe / Steico SE / Iberdrola SA / ITM Power PLC / Brenntag SE / Adidas AG / K&S AG / Coloplast A/S / Siltronic AG / Serviceware SE / Linde PLC / Siemens Energy AG</td><td class="leftalignment"></td><td class="leftalignment">Austria / Germany / Denmark / Spain / France / United Kingdom / Ireland / Norway</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Herr. Ingo-Martin Schachel, CFA</td></tr>
<tr class="even"><td class="leftalignment">03/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">2023607 / 2778844 / 2026242 / 2732635 / 2216850 / 2208073 / 2270726 / 2317087 / 2328915 / 2100920 / 2366799 / 2459020 / 2515030 / 2645409 / 2680905 / 2931034 / 2503529 / 7103065 / B121557 / 2713317 / 2983563 / B2R3PV1 / B4Y1MH7 / 2598246 / B4N0JJ6 / BCDWBX6 / BDZCRX3 / BTN1Y44 / BYVY8G0 / BYW36M8 / BJF8Q81 / BD8DJ71 / BP7RS48 / BYXJQG9 / BZ8VJQ8 / BKTNTR9 / BYYWPW6 / BJDX8Y8 / BRJ3GY4 / BGDW0N7 / BLBLMD5</td><td class="leftalignment">Amgen Inc / Merck & Co Inc / American Electric Power Company Inc / AutoNation Inc / Consolidated Edison Inc / Copart Inc / Walt Disney Co / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Gentex Corp / Intuit Inc / Lithia Motors Inc / NiSource Inc / PPL Corp / Vertex Pharmaceuticals Inc / World Wrestling Entertainment Inc / Novartis AG / Mastercard Inc / ACADIA Pharmaceuticals Inc / Carmax Inc / American Water Works Company Inc / KAR Auction Services Inc / Neogenomics Inc / Visteon Corp / ANI Pharmaceuticals Inc / RingCentral Inc / Walgreens Boots Alliance Inc / Alphabet Inc / PayPal Holdings Inc / IAA Inc / Snap Inc / Intersect Ent Inc / Spire Inc / Vistra Corp / ViacomCBS Inc / Beigene Ltd / Mirum Pharmaceuticals Inc / Xenon Pharmaceuticals Inc / Trevena Inc / Array Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / China / Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">03/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ANA.MC / KBH.N / MRK.N / PFE.N / PHM.N / TOL.N / FER.MC / EPR.N / LEN.N / XOM.N / GWW.N / NG.L / DHI.N / IG.MI / CVX.N / SRG.MI / TT.N / DKS.N / CASY.O / BIIB.O / TRN.MI / ATL.MI / GETP.PA / FTNT.O / CIO.N / PCRX.O / FANG.O / ABBV.N / TPH.N / TMHC.N / AENA.MC / 78667J108 / NTGY.MC / XERS.O / GMDA.OQ / OTRK.OQ / SHC.OQ</td><td class="leftalignment">Acciona SA / KB Home / Merck & Co Inc / Pfizer Inc / Pultegroup Inc / Toll Brothers Inc / Ferrovial SA / EPR Properties / Lennar Corp / Exxon Mobil Corp / W W Grainger Inc / National Grid PLC / D R Horton Inc / Italgas SpA / Chevron Corp / Snam SpA / Trane Technologies PLC / DICK'S Sporting Goods Inc / Caseys General Stores Inc / Biogen Inc / Terna Rete Elettrica Nazionale SpA / Atlantia SpA / Getlink SE / Fortinet Inc / City Office REIT Inc / Pacira Biosciences Inc / Diamondback Energy Inc / Abbvie Inc / Tri Pointe Homes Inc (Delaware) / Taylor Morrison Home Corp / Aena SME SA / SAGE Therapeutics Inc / Naturgy Energy Group SA / Xeris Biopharma Holdings Inc / Gamida Cell Ltd / Ontrak Inc / Sotera Health Co</td><td class="leftalignment"></td><td class="leftalignment">Spain / France / United Kingdom / Ireland / Israel / Italy / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">03/10/2021</td><td class="leftalignment">HSBC</td><td class="leftalignment">European Corporate Credit Quarterly:-Spring 2021 – Rolling on</td><td class="leftalignment">English</td><td class="rightalignment">92</td><td class="leftalignment">ACCP.PA / AIRP.PA / AKZO.AS / ASML.AS / BATS.L / BMWG.DE / BOUY.PA / BP.L / BT.L / CAPP.PA / CARR.PA / CNA.L / CPG.L / CRH.I / DANO.PA / DAST.PA / DGE.L / DSMN.AS / ENI.MI / ERICb.ST / EXHO.PA / HEIG.DE / HEIN.AS / IBE.MC / ITV.L / KPN.AS / LHAG.DE / LVMH.PA / MICP.PA / MKS.L / MRCG.F / NXT.L / OMVV.VI / PERP.PA / PHG.AS / PRTP.PA / PUBP.PA / RENA.PA / REP.MC / RR.L / RYA.I / SAPG.F / SCHN.PA / SGEF.PA / SGOB.PA / SOLB.BR / TEF.MC / TOTF.PA / TSCO.L / ULVR.L / VLOF.PA / VOD.L / VOLVb.ST / WLSNc.AS / WPP.L / VOWG_p.DE / CONG.DE / AZN.L / AAL.L / SASY.PA / TKAG.DE / ROG.S / ABBN.S / SIEGn.DE / NOVN.S / NOKIA.HE / RB.L / ENEI.MI / DTEGn.DE / IFXGn.DE / SZUG.DE / CARLb.CO / FREG.DE / TELA.VI / EZJ.L / DPWGn.DE / TEL.OL / GSK.L / TELIA.ST / REL.L / IHG.L / TLIT.MI / NESN.S / SESFd.PA / LXSG.DE / BTGGg.F / RDSa.L / EDF.PA / CFR.S / VIV.PA / EXPN.L / ATL.MI / MNDI.L / DAIGn.DE / BAES.L / ABI.BR / UPM.HE / BAYGn.DE / BASFn.DE / GLEN.L / SDFGn.DE / EVKn.DE / ORAN.PA / AIRG.DE / TUIT.L / ENGIE.PA / IMB.L / LHN.S / LDOF.MI / AD.AS / FORTUM.HE / TEVA.K / ORSTED.CO / EQNR.OL / NTGY.MC / ARRD.DE / STLA.MI</td><td class="leftalignment">Accor SA / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Akzo Nobel NV / ASML Holding NV / British American Tobacco PLC / Bayerische Motoren Werke AG / Bouygues SA / BP PLC / BT Group PLC / Capgemini SE / Carrefour SA / Centrica PLC / Compass Group PLC / CRH PLC / Danone SA / Dassault Systemes SE / Diageo PLC / Koninklijke DSM NV / Eni SpA / Telefonaktiebolaget LM Ericsson / Sodexo SA / HeidelbergCement AG / Heineken NV / Iberdrola SA / ITV PLC / Koninklijke KPN NV / Deutsche Lufthansa AG / LVMH Moet Hennessy Louis Vuitton SE / Compagnie Generale des Etablissements Michelin SCA / Marks and Spencer Group PLC / Merck KGaA / Next PLC / OMV AG / Pernod Ricard SA / Koninklijke Philips NV / Kering SA / Publicis Groupe SA / Renault SA / Repsol SA / Rolls-Royce Holdings PLC / Ryanair Holdings PLC / SAP SE / Schneider Electric SE / Vinci SA / Compagnie de Saint Gobain SA / Solvay SA / Telefonica SA / TotalEnergies SE / Tesco PLC / Unilever PLC / Valeo SE / Vodafone Group PLC / Volvo AB / Wolters Kluwer NV / WPP PLC / Volkswagen AG / Continental AG / AstraZeneca PLC / Anglo American PLC / Sanofi SA / thyssenkrupp AG / Roche Holding AG / Abb Ltd / Siemens AG / Novartis AG / Nokia Oyj / Reckitt Benckiser Group PLC / Enel SpA / Deutsche Telekom AG / Infineon Technologies AG / Suedzucker AG / Carlsberg A/S / Fresenius SE & Co KGaA / Telekom Austria AG / Easyjet PLC / Deutsche Post AG / Telenor ASA / GlaxoSmithKline PLC / Telia Company AB / Relx PLC / InterContinental Hotels Group PLC / Telecom Italia SpA / Nestle SA / SES SA / Lanxess AG / Bertelsmann SE & Co KGaA / Royal Dutch Shell PLC / Electricite de France SA / Compagnie Financiere Richemont SA / Vivendi SE / Experian PLC / Atlantia SpA / Mondi PLC / Daimler AG / BAE Systems PLC / Anheuser Busch Inbev SA / UPM-Kymmene Oyj / Bayer AG / BASF SE / Glencore PLC / K&S AG / Evonik Industries AG / Orange SA / Airbus SE / TUI AG / Engie SA / Imperial Brands PLC / Holcim AG / Leonardo SpA / Koninklijke Ahold Delhaize NV / Fortum Oyj / Teva Pharmaceutical Industries Ltd / Orsted A/S / Equinor ASA / Naturgy Energy Group SA / ArcelorMittal SA / Stellantis NV</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">Austria / Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / Norway / Sweden / United States / Jersey</td><td class="leftalignment">Aerospace / Air Transportation / Apparel & Textiles / Automotive / Beverages & Tobacco / Broadcasting & Cable / Building & Building Materials / Chemicals / Cosmetics & Personal Care / Defense / Electrical / Electronics / Engineering & Construction / Environmental Services / Food / Healthcare / Industrial Materials / Info. Tech./Software / Lodging & Restaurants / Machinery / Manufacturing / Media / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Publishing / Retailing / Semiconductors / Services / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / FIXED INCOME / MARKET COMMENT / HIGH YIELD BONDS / CREDIT / BOND</td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Jonathan R. White / Song Jin Lee / Dominic A. Kini / Tom Russell</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Short interest positioning read</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK.N / PFE.N / PCRX.O / ABBV.N</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Pacira Biosciences Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS.O / ACRX.O / EBS / HCM.L / JNJ / LLY / MRK / PFE / ALKS.O / JAZZ.O / CERS.O / OPTN.O / NCOX.PA / COLL.O / RMTI.O / AMRN.O / BDSI.O / BSLN.S / MNKD.O / NEOS.BO / ZTS / OMER.O / SPRO.O / ANIP.O / AXGN.O / AERI.O / HRTX.O / TRVN.O / EGRX.O / SCYX.O / ARDX.O / ALDX.O / CFRX.O / CDTX.O / SPNE.O / FBIO.O / MESO.O / VRAY.O / VERU.O / TXMD.O / CKPT.O / EYPT.O / UBX.O / EOLS.O / ARDS.O / ARAV.O / SIBN.O / ETTX.O / ARQT.O / PCVX.O / SRGA.O / VYNE.O / HGEN.O / AZYO.O / GRAY.O / IMAB.O / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / Emergent BioSolutions Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Cerus Corp / OptiNose Inc / Nicox SA / Collegium Pharmaceutical Inc / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Neo Corp International Ltd / Zoetis Inc / Omeros Corp / Spero Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / Ardelyx Inc / Aldeyra Therapeutics Inc / ContraFect Corp / Cidara Therapeutics Inc / SeaSpine Holdings Corp / Fortress Biotech Inc / Mesoblast Ltd / ViewRay Inc / Veru Inc / TherapeuticsMD Inc / Checkpoint Therapeutics Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Evolus Inc / Aridis Pharmaceuticals Inc / Aravive Inc / SI-BONE Inc / Entasis Therapeutics Holdings Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Humanigen Inc / Aziyo Biologics Inc / Graybug Vision Inc / I-Mab / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / India / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Expecting a strong 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr Daniel Wendorff</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Annual Update - Merck sinks 13.4% from 8 week high</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">under-the-radar catalyst:  Januvia IP</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Merck Group</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRK.N - Event Transcript of Merck & Co Inc conference call, Mar. 09, 2021 / 1:50PM ET</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Kepler Cheuvreux</td><td class="leftalignment">Merck KGAA | Buy | Good operations, but impacted by rotation</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David P. Evans</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">FDS=US / WISH=US / MRK=US / VECO=US / ALL=US / BK=US / AMD=US / MSFT=US / C=US / CG=US / GL=US / BAC=US / NTRS=US / STT=US / USB=US / WFC=US / GILD=US / GS=US / FRC=US / AXP=US / JPM=US / HBAN=US / MMC=US / MET=US / BRK=US / AIG=US / BEN=US / TROW=US / GSK=US / LNC=US / BLK=US / JNJ=US / PBCT=US / PNC=US / CB=US / AFL=US / UNM=US / PGR=US / HIG=US / CI=US / COF=US / AIZ=US / CME=US / DFS=US / DG=US / AJG=US / MS=US / MCO=US / TRV=US / PFG=US / APO=US / PRU=US / L=US / RE=US / CINF=US / ZION=US / RJF=US / SIVB=US / RF=US / AON=US / NDAQ=US / TFC=US / MRNA=US / ACAD=US / GOOG=US / MKTX=US / OLED=US / INO=US / PERI=US / AMP=US / ICE=US / IVZ=US / WRB=US / SPGI=US / KKR=US / 005930-KR=US / CBOE=US / CFG=US / MSCI=US / SYF=US / WBA=US / CERC=US / WLTW=US / SLNO=US / MWK=US / KRTX=US / FUBO=US / ONDS=US</td><td class="leftalignment">Factset Research Systems Inc / ContextLogic Inc / Merck & Co Inc / Veeco Instruments Inc / Allstate Corp / Bank of New York Mellon Corp / Advanced Micro Devices Inc / Microsoft Corp / Citigroup Inc / Carlyle Group Inc / Globe Life Inc / Bank of America Corp / Northern Trust Corp / State Street Corp / US Bancorp / Wells Fargo & Co / Gilead Sciences Inc / Goldman Sachs Group Inc / First Republic Bank / American Express Co / JPMorgan Chase & Co / Huntington Bancshares Inc / Marsh & McLennan Companies Inc / MetLife Inc / Brooks Macdonald Group PLC / American International Group Inc / Franklin Resources Inc / T Rowe Price Group Inc / GlaxoSmithKline PLC / Lincoln National Corp / BlackRock Inc / Johnson & Johnson / People's United Financial Inc / PNC Financial Services Group Inc / Chubb Ltd / Aflac Inc / Unum Group / Progressive Corp / Hartford Financial Services Group Inc / Cigna Corp / Capital One Financial Corp / Assurant Inc / CME Group Inc / Discover Financial Services / Dollar General Corp / Arthur J Gallagher & Co / Morgan Stanley / Moody's Corp / Travelers Companies Inc / Principal Financial Group Inc / Apollo Global Management Inc / Prudential Financial Inc / Loews Corp / Everest Re Group Ltd / Cincinnati Financial Corp / Zions Bancorporation NA / Raymond James Financial Inc / SVB Financial Group / Regions Financial Corp / Aon PLC / Nasdaq Inc / Truist Financial Corp / Moderna Inc / ACADIA Pharmaceuticals Inc / Alphabet Inc / Marketaxess Holdings Inc / Universal Display Corp / Inovio Pharmaceuticals Inc / Perion Network Ltd / Ameriprise Financial Inc / Intercontinental Exchange Inc / Invesco Ltd / W R Berkley Corp / S&P Global Inc / KKR & Co Inc / Farfetch Ltd / Cboe Global Markets Inc / Citizens Financial Group Inc / MSCI Inc / Synchrony Financial / Walgreens Boots Alliance Inc / Avalo Therapeutics Inc / Willis Towers Watson PLC / Soleno Therapeutics Inc / Aterian Inc / Karuna Therapeutics Inc / Fubotv Inc / Ondas Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Consumer / Financial Services / Healthcare / Info. Tech./Computers / Pharmaceuticals / Retailing / Semiconductors / Telecommunications</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 09 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">US0028241000 / US0231351067 / US0311621009 / US0463531089 / US1101221083 / US2358511028 / US3377381088 / US3755581036 / US37733W1053 / US4523271090 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US75886F1075 / US87612E1064 / US9021041085 / US91307C1027 / US9311421039 / US37940X1028 / US0042251084 / US0491642056 / US31620M1062 / US57636Q1040 / US92826C8394 / US00922R1059 / US58933Y1055 / US69404D1081 / US30303M1027 / US98978V1035 / US45845P1084 / US69366J2006 / US63009R1095 / US90184L1026 / US0396971071 / US78667J1088 / IE00BTN1Y115 / US81750R1023 / US6323071042 / US70450Y1038 / US8522341036 / US87164F1057 / US03236M2008 / US8760301072 / US05351X1019 / US09354A1007 / US26927E1047 / US46571Y1073 / VGG312491084 / US68373M1071 / US90184D1000 / US1255231003 / US62921N1054 / US05352A1007 / US92537N1081 / US68902V1070 / US07373B1098 / US56854Q2003 / CA67079A1021 / US74767V1098 / US21077C1071 / US7761531083 / US73739W1045 / US15961R1059</td><td class="leftalignment">Abbott Laboratories / Amazon.com Inc / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Danaher Corp / Fiserv Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Regeneron Pharmaceuticals Inc / Target Corp / II-VI Inc / United Therapeutics Corp / Walmart Inc / Global Payments Inc / ACADIA Pharmaceuticals Inc / Atlas Air Worldwide Holdings Inc / Fidelity National Information Services Inc / Mastercard Inc / Visa Inc / Air Transport Services Group Inc / Merck & Co Inc / Pacific Biosciences of California Inc / Meta Platforms Inc / Zoetis Inc / Intercept Pharmaceuticals Inc / PTC Therapeutics Inc / NanoString Technologies Inc / Twitter Inc / Ardelyx Inc / SAGE Therapeutics Inc / Medtronic PLC / Seres Therapeutics Inc / Natera Inc / PayPal Holdings Inc / Block Inc / Syndax Pharmaceuticals Inc / Amyris Inc / Tapestry Inc / Avaya Holdings Corp / Blink Charging Co / EVO Payments Inc / I3 Verticals Inc / Establishment Labs Holdings Inc / Opera Ltd / Twist Bioscience Corp / Cigna Corp / NGM Biopharmaceuticals Inc / Avantor Inc / Vertiv Holdings Co / Otis Worldwide Corp / Beam Global / Marinus Pharmaceuticals Inc / Nuvei Corp / Quantumscape Corp / ContextLogic Inc / Romeo Power Inc / Poshmark Inc / ChargePoint Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / United Kingdom / Ireland / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / WEN=US / AMZN=US / BLD=US / TEVA=US / GILD=US / LOW=US / CHRS=US / LEG=US / CI=US / CBRL=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / REGI=US / AMSF=US / DIN=US / BIIB=US / TPX=US / EXP=US / CRD.B=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SIBN=US / CMG=US / REX=US / RPRX=US / PGTI=US / GPRE=US / EHTH=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / JACK=US / TREX=US / FBHS=US / TILE=US / NDLS=US / LOCO=US / SHAK=US / WING=US / 82982L103 / PVAC=US / ANAB=US / JELD=US / SFIX=US / GOCO=US / AZEK=US / VTRS=US / DHT.UN=CA</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / Amazon.com Inc / TopBuild Corp / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Lowe's Companies Inc / Coherus BioSciences Inc / Leggett & Platt Inc / Cigna Corp / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / Amerisafe Inc / Dine Brands Global Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Crawford & Co / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / SI-BONE Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Royalty Pharma PLC / PGT Innovations Inc / Green Plains Inc / eHealth Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Interface Inc / Noodles & Co / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / SiteOne Landscape Supply Inc / Ranger Oil Corp / AnaptysBio Inc / JELD-WEN Holding Inc / Stitch Fix Inc / Gohealth Inc / Azek Company Inc / Viatris Inc / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ZNTL (BUY) - Previewing Upcoming ZN-c3 (WEE1 Inhibitor) Phase I Data at AACR</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMQ5T49 / 0989529 / 2778844</td><td class="leftalignment">Zentalis Pharmaceuticals Inc / AstraZeneca PLC / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Cowen Health Care Conference Topical Panel Wrap-Up</td><td class="leftalignment">English</td><td class="rightalignment">217</td><td class="leftalignment">US0028241000 / US0311621009 / US0463531089 / US1101221083 / US3755581036 / US37733W1053 / US4523271090 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US75886F1075 / US91307C1027 / US58933Y1055 / US69404D1081 / US98978V1035 / US45845P1084 / US69366J2006 / US63009R1095 / US78667J1088 / IE00BTN1Y115 / US03236M2008 / VGG312491084 / US90184D1000</td><td class="leftalignment">Abbott Laboratories / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Merck & Co Inc / Pacific Biosciences of California Inc / Zoetis Inc / Intercept Pharmaceuticals Inc / PTC Therapeutics Inc / NanoString Technologies Inc / SAGE Therapeutics Inc / Medtronic PLC / Amyris Inc / Establishment Labs Holdings Inc / Twist Bioscience Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United Kingdom / Ireland / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cowen Health Care Team / Cowen Washington Research</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">KOL Call Takeaways: HIV Therapeutic Landscape</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK=US / GILD=US / GSK=US / JNJ=US / MRNA=US / INO=US</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Johnson & Johnson / Moderna Inc / Inovio Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Equita SIM</td><td class="leftalignment">EQUITA SIM: MERCK (BUY; Unchanged) - 4Q20 results -</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Gianmarco Bonacina</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 26, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Litchfield Hills Research, LLC</td><td class="leftalignment">Milestone momentum for AI driven biotech, Predictive Oncology – Raising PT to $5 from $3</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">POAI.OQ / 4502.T / MRK.N / PFE.N / SNY.N / AZN.L / AZN.N / ROG.S / SYK.N / GSK.L / GSK.N / DXR.A / QBIO.PK / MYGN.OQ / BAYGN.DE / ZBH.N / CODX.OQ / DE000BAY0199 / ANPC.OQ</td><td class="leftalignment">Predictive Oncology Inc / Takeda Pharmaceutical Co Ltd / Merck & Co Inc / Pfizer Inc / Sanofi SA / AstraZeneca PLC / AstraZeneca PLC / Roche Holding AG / Stryker Corp / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Daxor Corp / Q BioMed Inc / Myriad Genetics Inc / Bayer AG / Zimmer Biomet Holdings Inc / Co-Diagnostics Inc / Bayer AG / AnPac Bio-Medical Science Co Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Japan / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS / SMALL CAPITAL / MORNING COMMENTS / GROWTH</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Theodore R. O'Neill</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Positive first efficacy data for oral antiviral molnupiravir in COVID-19</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Daily Credit Briefing</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">RWEG.DE / MRK.N / TEF.MC / VOWG.DE / EBKG.DE / O2Dn.DE / AIBG.I</td><td class="leftalignment">Rwe AG / Merck & Co Inc / Telefonica SA / Volkswagen AG / EnBW Energie Baden Wuerttemberg AG / Telefonica Deutschland Holding AG / Aib Group PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Spain / France / Ireland / Sweden / United States</td><td class="leftalignment">Advertising / Aerospace / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Biotechnology / Broadcasting & Cable / Building & Building Materials / Conglomerates / Consumer / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Financial Services / Healthcare / Household Products / Industrial Materials / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Shipping & Shipbuilding / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS / CREDIT</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Herr. Ulrich Scholz, CFA / Herr Sven Kreitmair, CFA / Herr Jonathan Schroer / Frau Silke Stegemann / Herr. Michael Teig / Herr. Stefan Kolek / Herr Tobias Keller</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / REGN.OQ / AMRN.OQ / BIIB.OQ / AERI.OQ / AGTC.OQ / AKBA.OQ / ALDX.OQ / ADVM.OQ / TVTY.OQ / EYPT.OQ / UBX.OQ / HGEN.OQ / GRAY.OQ</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Regeneron Pharmaceuticals Inc / Amarin Corporation PLC / Biogen Inc / Aerie Pharmaceuticals Inc / Applied Genetic Technologies Corp / Akebia Therapeutics Inc / Aldeyra Therapeutics Inc / Adverum Biotechnologies Inc / Tivity Health Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Humanigen Inc / Graybug Vision Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 08 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">US0079731008 / US00846U1016 / US0116591092 / US0382221051 / US0463531089 / US1101221083 / US1264081035 / US1925761066 / US22284P1057 / US2358511028 / US3021301094 / US37733W1053 / US4364401012 / US4433201062 / US4456581077 / US4523271090 / US4824801009 / US5012421013 / US5128071082 / US5150981018 / US5324571083 / US55306N1046 / US62855J1043 / US6558441084 / US66987V1098 / US6701002056 / US6795801009 / US68389X1054 / US7140461093 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US8807701029 / US8835561023 / US9029251066 / US9078181081 / US91347P1057 / US9418481035 / US9507551086 / CA1363751027 / US30063P1057 / CA13645T1003 / US4771431016 / US4198791018 / US80105N1054 / US1167941087 / US3463751087 / US2533931026 / US90385V1070 / US12541W2098 / US78709Y1055 / PAP310761054 / US75025X1000 / US01748X1028 / US2473617023 / US58933Y1055 / US1920051067 / US9100471096 / US69404D1081 / US9837931008 / US00287Y1091 / NL0010273215 / US98978V1035 / US09609G1004 / US63009R1095 / US8485771021 / US21240E1055 / US02376R1023 / US09062W2044 / US03937C1053 / CA0089118776 / US46185L1035 / US6323071042 / KYG4740B1059 / CA87241L1094 / NL0012169213 / US23753F1075 / US80689H1023 / US6904691010 / US03236M2008 / US4990491049 / US74766Q1013 / US2575541055 / US5904791358 / US28414H1032 / US40131M1099 / US90184D1000 / US05352A1007 / US71535D1063 / US00650F1093 / US24984K1051 / US88025U1097 / US30068X1037 / US75513E1010 / US12233L1070 / US7602731025 / GB00BMVP7Y09 / US57667L1070 / US0843101017 / US86646P1030 / US6873051022 / US81578P1066 / US65443P1021 / US03783T1034 / US12047B1052 / US67080N1019</td><td class="leftalignment">Advanced Energy Industries Inc / Agilent Technologies Inc / Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / Cohu Inc / Covenant Logistics Group Inc / Danaher Corp / Expeditors International of Washington Inc / GlaxoSmithKline PLC / Hologic Inc / Hub Group Inc / J B Hunt Transport Services Inc / Illumina Inc / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Landstar System Inc / Eli Lilly and Co / MKS Instruments Inc / Myriad Genetics Inc / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / Oracle Corp / PerkinElmer Inc / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Teradyne Inc / Thermo Fisher Scientific Inc / USA Truck Inc / Union Pacific Corp / Universal Display Corp / Waters Corp / Werner Enterprises Inc / Canadian National Railway Co / Exact Sciences Corp / Canadian Pacific Railway Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Bruker Corp / FormFactor Inc / DICK'S Sporting Goods Inc / Ultra Clean Holdings Inc / CH Robinson Worldwide Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / Codexis Inc / United Airlines Holdings Inc / Pacific Biosciences of California Inc / XPO Logistics Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / bluebird bio Inc / NanoString Technologies Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / BioLife Solutions Inc / ArcBest Corp / Air Canada / Invitae Corp / Natera Inc / Ichor Holdings Ltd / TFI International Inc / Qiagen NV / Daseke Inc / Schneider National Inc / Ovid Therapeutics Inc / Amyris Inc / Knight-Swift Transportation Holdings Inc / Quanterix Corp / Domo Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Guardant Health Inc / Twist Bioscience Corp / Avantor Inc / Personalis Inc / Adaptive Biotechnologies Corp / DermTech Inc / 10X Genomics Inc / Exagen Inc / Raytheon Technologies Corp / Burning Rock Biotech Ltd / Repare Therapeutics Inc / Royalty Pharma PLC / Match Group Inc / Berkeley Lights Inc / Sumo Logic Inc / Orphazyme A/S / Seer Inc / 908 Devices Inc. / AppHarvest Inc / Bumble Inc / Nuvation Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Molnupiravir Data Shows Hint of COVID-19 Activity, but Questions Linger</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Daina Graybosch, PHD</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">2259101 / 2000019 / 2778844 / 2026242 / 2045623 / 2216850 / 2317087 / 2328915 / 2613990 / 2459020 / 2630513 / 2689560 / 2048804 / B121557 / B2R3PV1 / 2598246 / B7JYSG3 / BDZCRX3 / BFZCHN7 / BYVY8G0 / BYNZGK1 / BD8DJ71 / B0SDJB4 / BJ5FZ74 / BYQNYR5 / BR4T3B3 / BWFKZT2 / BJJMGL2 / BZ8VJQ8 / BFXC911 / BD6D4Y5 / BK71LY6 / BDT5KT5 / BYQRFY1 / BZ0P3Z5 / BMG75B4 / BYQBFS7 / BD8Q1B8 / BYNPPC6 / BKT6B38 / BMC8SQ7</td><td class="leftalignment">Target Corp / Amazon.com Inc / Merck & Co Inc / American Electric Power Company Inc / ANSYS Inc / Consolidated Edison Inc / Entergy Corp / Nextera Energy Inc / Illumina Inc / Intuit Inc / New Jersey Resources Corp / PG&E Corp / Pinnacle West Capital Corp / Mastercard Inc / American Water Works Company Inc / Neogenomics Inc / Guidewire Software Inc / RingCentral Inc / Wix.Com Ltd / Alphabet Inc / Block Inc / Snap Inc / Zealand Pharma A/S / Adaptive Biotechnologies Corp / Senseonics Holdings Inc / HubSpot Inc / Cellectis SA / Fox Corp / Vistra Corp / Guardant Health Inc / Altair Engineering Inc / WW International Inc / Inspire Medical Systems Inc / Teladoc Health Inc / Tegna Inc / Inventiva SA / Tabula Rasa HealthCare Inc / Tivity Health Inc / DENTSPLY SIRONA Inc / SmileDirectClub Inc / BTRS Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Denmark / France / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AEP.N / AES.N / ALV.N / BAC.N / BBDb.TO / BK.N / C.N / CL.N / CMS.N / COF.N / CP.TO / DFDS.CO / ED.N / EIX.N / EL.N / ELE.MC / F.N / FITB.O / GM.N / JPM.N / KEY.N / KMB.N / KO.N / MRK.N / NTRS.O / PEG.N / PNC.N / PNW.N / RWEG.DE / SO.N / T.N / USB.N / VC.N / WFC.N / PEP.N / CMA.N / BFb.N / PG.N / WY.N / CFP.TO / CPB.N / TEN.N / AMGN.O / ETR.N / CNR.TO / DUK.N / HBAN.O / BWA.N / LEA.N / D.N / FE.N / PNM.N / NVDA.O / K.N / DT.N / DISH.O / GS.N / CLX.N / CAG.N / GIS.N / PCG.N / PPL.N / EPC.N / MGA.N / AMT.N / JAZZ.O / CONE.O / VZ.N / STT.N / EXEL.O / XEL.N / ARNA.O / STZ.N / APH.N / SRE.N / EXC.N / FISV.O / ADSK.O / CHTR.O / AXL.N / AWK.N / CHD.N / NWN.N / WSP.TO / MTB.N / BC.N / SAM.N / BMRN.O / REGN.O / ENR.N / FTT.TO / NCR.N / NET.N / TEL.N / RF.N / CNP.N / WCN.N / BKH.N / CPK.N / FRC.N / PII.N / ST.N / SR.N / GPN.N / MNST.O / SIVB.O / CASY.O / EQIX.O / STN.TO / ATDb.TO / WPK.TO / SNC.TO / TFC.N / 02209S103 / DLR.N / 427866108 / WEF.TO / SJW.N / MS.N / FIS.N / TEVA.N / HOG.N / BGS.N / GETP.PA / DAN.N / UTL.N / SPB.N / NEE.N / PCH.O / CJT.TO / CFX.TO / MSP.N / MTOR.N / IFP.TO / SPLK.OQ / RFP.N / PANW.N / MDLZ.OQ / GRT_u.TO / TSLA.N / PRGO.N / PRMW.N / TMUS.N / DOO.TO / COTY.N / PRTA.O / AGIO.O / 81762P102 / VRNS.O / FLXN.O / NEP.N / CFG.N / PYPL.OQ / MESO.O / RACE.MI / MP1.AX / TWLO.N / ADNT.N / PBYI.OQ / AQN.N / UNIT.O / OKTA.OQ / VST.N / ATUS.N / ATNX.O / AY.O / SAIL.N / APTV.N / ILPT.O / ZS.OQ / SMAR.N / VNE.N / KDP.N / XERS.O / AQST.O / CWEN.N / ESTC.N / NWL.O / CRWD.O / PING.N / CRNC.OQ / WTRG.N / REYN.O / GFL.N / NKLA.OQ / FOUR.N / 77311W101 / LUMN.N / ASAN.N / SUMO.O / WFG.N / TIXT.TO / AFRM.O / ATC.N / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Autoliv Inc / Bank of America Corp / Bombardier Inc / Bank of New York Mellon Corp / Citigroup Inc / Colgate-Palmolive Co / CMS Energy Corp / Capital One Financial Corp / Canadian Pacific Railway Ltd / DFDS AS / Consolidated Edison Inc / Edison International / Estee Lauder Companies Inc / Endesa SA / Ford Motor Co / Fifth Third Bancorp / General Motors Co / JPMorgan Chase & Co / KeyCorp / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / Northern Trust Corp / Public Service Enterprise Group Inc / PNC Financial Services Group Inc / Pinnacle West Capital Corp / Rwe AG / Southern Co / AT&T Inc / US Bancorp / Visteon Corp / Wells Fargo & Co / PepsiCo Inc / Comerica Inc / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canfor Corp / Campbell Soup Co / Tenneco Inc / Amgen Inc / Entergy Corp / Canadian National Railway Co / Duke Energy Corp / Huntington Bancshares Inc / Borgwarner Inc / Lear Corp / Dominion Energy Inc / FirstEnergy Corp / PNM Resources Inc / NVIDIA Corp / Kellogg Co / Dynatrace Inc / DISH Network Corp / Goldman Sachs Group Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / PG&E Corp / PPL Corp / Edgewell Personal Care Co / Magna International Inc / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / Verizon Communications Inc / State Street Corp / Exelixis Inc / Xcel Energy Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / Amphenol Corp / Sempra Energy / Exelon Corp / Fiserv Inc / Autodesk Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / WSP Global Inc / M&T Bank Corp / Brunswick Corp / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Finning International Inc / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Regions Financial Corp / CenterPoint Energy Inc / Waste Connections Inc / Black Hills Corp / Chesapeake Utilities Corp / First Republic Bank / Polaris Inc / Sensata Technologies Holding PLC / Spire Inc / Global Payments Inc / Monster Beverage Corp / SVB Financial Group / Caseys General Stores Inc / Equinix Inc / Stantec Inc / Alimentation Couche-Tard Inc / Winpak Ltd / SNC-Lavalin Group Inc / Truist Financial Corp / Altria Group Inc / Digital Realty Trust Inc / Hershey Co / Western Forest Products Inc / SJW Group / Morgan Stanley / Fidelity National Information Services Inc / Teva Pharmaceutical Industries Ltd / Harley-Davidson Inc / B&G Foods Inc / Getlink SE / Dana Inc / Unitil Corp / Spectrum Brands Holdings Inc / Nextera Energy Inc / Potlatchdeltic Corp / Cargojet Inc / Canfor Pulp Products Inc / Datto Holding Corp / Meritor Inc / Interfor Corp / Splunk Inc / Resolute Forest Products Inc / Palo Alto Networks Inc / Mondelez International Inc / Granite Real Estate Investment Trust / Tesla Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / BRP Inc / Coty Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / ServiceNow Inc / Varonis Systems Inc / Pacira Biosciences Inc / Nextera Energy Partners LP / Citizens Financial Group Inc / PayPal Holdings Inc / Mesoblast Ltd / Ferrari NV / Megaport Ltd / Twilio Inc / Adient PLC / Puma Biotechnology Inc / Algonquin Power & Utilities Corp / Uniti Group Inc / Okta Inc / Vistra Corp / Altice USA Inc / Athenex Inc / Atlantica Sustainable Infrastructure PLC / SailPoint Technologies Holdings Inc / Aptiv PLC / Industrial Logistics Properties Trust / Zscaler Inc / Smartsheet Inc / Veoneer Inc / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Clearway Energy Inc / Elastic NV / Newell Brands Inc / CrowdStrike Holdings Inc / Ping Identity Holding Corp / Cerence Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / GFL Environmental Inc / Nikola Corp / Shift4 Payments Inc / Rocket Companies Inc / Lumen Technologies Inc / Asana Inc / Sumo Logic Inc / West Fraser Timber Co Ltd / Telus International Cda Inc / Affirm Holdings Inc / Atotech Ltd / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">MRK: Molnupiravir Data at CROI Suggest Antiviral Efficacy and Robust Safety; Next Up Phase 2/3</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2778844</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Life Science Tools & Diagnostics: Top Questions for Management Teams</td><td class="leftalignment">English</td><td class="rightalignment">72</td><td class="leftalignment">4502.T / BMY.N / CI.N / CVS.N / GE.N / JPM.N / MCK.N / MRK.N / PFE.N / TMO.N / WMT.N / DGX.N / AZN.L / ROG.S / DHR.N / UNH.N / LH.N / MMM.N / CRL.N / IDXX.OQ / PDCO.OQ / XRAY.OQ / HSIC.OQ / AMZN.OQ / ALGN.OQ / STMN.S / PETS.OQ / ICLR.OQ / QGEN.N / BAYGN.DE / ZTS.N / PAHC.OQ / LNTH.OQ / ANTM.N / WBA.OQ / MEDP.OQ / FLGT.O / IQV.N / SYNH.OQ / ELAN.N / CVET.OQ / AVTR.N / CHWY.N / SDC.OQ / NVST.N / CNTG.OQ / MRVI.OQ / CERT.OQ / OCDX.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / General Electric Co / JPMorgan Chase & Co / Mckesson Corp / Merck & Co Inc / Pfizer Inc / Thermo Fisher Scientific Inc / Walmart Inc / Quest Diagnostics Inc / AstraZeneca PLC / Roche Holding AG / Danaher Corp / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / 3M Co / Charles River Laboratories International Inc / IDEXX Laboratories Inc / Patterson Companies Inc / DENTSPLY SIRONA Inc / Henry Schein Inc / Amazon.com Inc / Align Technology Inc / Straumann Holding AG / Petmed Express Inc / ICON PLC / Qiagen NV / Bayer AG / Zoetis Inc / Phibro Animal Health Corp / Lantheus Holdings Inc / Anthem Inc / Walgreens Boots Alliance Inc / Medpace Holdings Inc / Fulgent Genetics Inc / IQVIA Holdings Inc / Syneos Health Inc / Elanco Animal Health Inc / Covetrus Inc / Avantor Inc / Chewy Inc / SmileDirectClub Inc / Envista Holdings Corp / Centogene NV / Maravai LifeSciences Holdings Inc / Certara Inc / Ortho Clinical Diagnostics Holdings PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / United Kingdom / Ireland / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MedTech Recap and Preview: Contact Lens Expert Call Mon; SHC EPS Tues; CRT Weeks 3 and 4 Positive for TAVR and TMVR; Lumenis Deal to Boost BSX</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ALC.N / BSX.N / JNJ.N / SHC.OQ / ABT.N / BAX.N / BDX.N / MDT.N / MRK.N / TFX.N / SYK.N / RMD.AX / EW.N / HOLX.OQ / STAA.OQ / OFIX.OQ / MMSI.OQ / IART.OQ / INGN.OQ / NUVA.OQ / DXCM.OQ / ATRC.OQ / TEVA.N / PODD.OQ / TNDM.OQ / CSII.OQ / GMED.N / CNMD.N / AXGN.OQ / NVRO.N / VCEL.OQ / CFMS.OQ / GKOS.N / ZBH.N / PEN.N / LIVN.OQ / IRTC.OQ / SENSI.S / ORGO.OQ / ALCC.S / NVST.N / SILK.N</td><td class="leftalignment">Alcon AG / Boston Scientific Corp / Johnson & Johnson / Sotera Health Co / Abbott Laboratories / Baxter International Inc / Becton Dickinson and Co / Medtronic PLC / Merck & Co Inc / Teleflex Inc / Stryker Corp / Resmed Inc / Edwards Lifesciences Corp / Hologic Inc / STAAR Surgical Co / Orthofix Medical Inc / Merit Medical Systems Inc / Integra Lifesciences Holdings Corp / Inogen Inc / NuVasive Inc / Dexcom Inc / AtriCure Inc / Teva Pharmaceutical Industries Ltd / Insulet Corp / Tandem Diabetes Care Inc / Cardiovascular Systems Inc / Globus Medical Inc / Conmed Corp / AxoGen Inc / Nevro Corp / Vericel Corp / Conformis Inc / Glaukos Corp / Zimmer Biomet Holdings Inc / Penumbra Inc / LivaNova PLC / iRhythm Technologies Inc / Sensirion Holding AG / Organogenesis Holdings Inc / Alcon AG / Envista Holdings Corp / Silk Road Medical Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Matt S. Miksic / Vik Chopra / Daniel Aversano</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Feb 26, 2021: Focus on Novo GLP-1s</td><td class="leftalignment">English</td><td class="rightalignment">47</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / RB.L / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ / MNK.N^J20</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Reckitt Benckiser Group PLC / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc / Mallinckrodt PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Industrial End Market Analyser: Debating degrees of recovery and net price. Positioning for rotation to later-cycle</td><td class="leftalignment">English</td><td class="rightalignment">65</td><td class="leftalignment">BOY.L / NELES.HE / 2308.TW / 4507.T / 6501.T / ALSO.PA / ARCLK.IS / ASSAB.ST / ATCOA.ST / DAST.PA / ECM.L / ELUXB.ST / FLS.N / GE.N / GRI.L / HEXAB.ST / HLMA.L / IMI.L / IR.N / JNJ.N / MRK.N / PFE.N / PHG.AS / ROR.L / RSW.L / SAND.ST / SCHN.PA / SKFB.ST / SMIN.L / SPX.L / SWK.N / VOLVB.ST / VWS.CO / WEIR.L / ROK.N / AZN.L / TKR.N / TKAG.DE / ETN.N / WCC.N / MSM.N / ABBN.S / GEBN.S / SIEGN.DE / HON.N / MMM.N / EMR.N / WHR.N / LONN.S / PALF.VI / JCI.N / RXL.PA / RAAG.DE / GSK.L / SXS.L / NEXS.PA / NKT.CO / ANDR.VI / HUBB.N / ALFA.ST / FLS.CO / FAST.OQ / TT.N / CMCO.OQ / NVAX.OQ / AMZN.OQ / AYI.N / SUN.S / SCHP.S / FAG.ST / KNEBV.HE / CGCBV.HE / G1AG.DE / LEGD.PA / ZUMV.VI / PRY.MI / WEGE3.SA / 0656.HK / FLUI.MC / INO.OQ / WRT1V.HE / MRNA.OQ / KU2G.DE / SHLG.DE / XYL.N / MRON.L / VSVS.L / FLOW.N / PTCT.OQ / KGX.DE / 000333.SZ / ALLE.N / FCT.MI / DOKA.S / SHA_P.DE / LIGHT.AS / FTV.N / ATKR.N / AZRE.N / KCRA.HE / AVT.OQ / EPIRA.ST / KBX.DE / OTIS.N / MOCORP.HE / CVAC.OQ / ENR1N.DE</td><td class="leftalignment">Bodycote PLC / Neles Oyj / Delta Electronics Inc / Shionogi & Co Ltd / Hitachi Ltd / Alstom SA / Arcelik AS / Assa Abloy AB / Atlas Copco AB / Dassault Systemes SE / Electrocomponents PLC / Electrolux AB / Flowserve Corp / General Electric Co / Grainger PLC / Hexagon AB / Halma PLC / IMI PLC / Ingersoll Rand Inc / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Koninklijke Philips NV / Rotork PLC / Renishaw PLC / Sandvik AB / Schneider Electric SE / AB Skf / Smiths Group PLC / Spirax-Sarco Engineering PLC / Stanley Black & Decker Inc / Volvo AB / Vestas Wind Systems A/S / Weir Group PLC / Rockwell Automation Inc / AstraZeneca PLC / Timken Co / thyssenkrupp AG / Eaton Corporation PLC / Wesco International Inc / MSC Industrial Direct Co Inc / Abb Ltd / Geberit AG / Siemens AG / Honeywell International Inc / 3M Co / Emerson Electric Co / Whirlpool Corp / Lonza Group AG / Palfinger AG / Johnson Controls International PLC / Rexel SA / Rational AG / GlaxoSmithKline PLC / Spectris PLC / Nexans SA / Nkt A/S / Andritz AG / Hubbell Inc / Alfa Laval AB / FLSmidth & Co A/S / Fastenal Co / Trane Technologies PLC / Columbus McKinnon Corp / Novavax Inc / Amazon.com Inc / Acuity Brands Inc / Sulzer AG / Schindler Holding AG / Fagerhult AB / Kone Oyj / Cargotec Corp / GEA Group AG / Legrand SA / Zumtobel Group AG / Prysmian SpA / WEG SA / Fosun International Ltd / Fluidra SA / Inovio Pharmaceuticals Inc / Wartsila Oyj Abp / Moderna Inc / Kuka AG / Siemens Healthineers AG / Xylem Inc / Melrose Industries PLC / Vesuvius PLC / SPX FLOW Inc / PTC Therapeutics Inc / Kion Group AG / Midea Group Co Ltd / Allegion PLC / Fincantieri SpA / Dormakaba Holding AG / Schaeffler AG / Signify NV / Fortive Corp / Atkore Inc / Azure Power Global Ltd / Konecranes Abp / Avnet Inc / Epiroc AB / Knorr Bremse AG / Otis Worldwide Corp / Metso Outotec Corp / CureVac NV / Siemens Energy AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Austria / Brazil / Switzerland / China / Germany / Denmark / Spain / Finland / France / United Kingdom / Hong Kong / Ireland / Italy / Japan / Mauritius / Netherlands / Sweden / Turkey / Taiwan / United States</td><td class="leftalignment">Manufacturing</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Andre Kukhnin, CFA / Mr Max R. Yates / Ms. Iris Zheng / Mr. Artem Tokarenko</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck KGaA: Ownership Timelines & Shareholder Analytics (March 2021)</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / JAZZ.O / TEVA.N / PRGO.N / FLXN.O / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Jazz Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Perrigo Company PLC / Pacira Biosciences Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Big Cap Pharma Highlights From Cowen's 41st Annual Health Care Conference</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US00287Y1091 / US98978V1035 / US28414H1032 / GB00BMVP7Y09</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Abbvie Inc / Zoetis Inc / Elanco Animal Health Inc / Royalty Pharma PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/07/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">Emerging Markets Q4 update – China roars back, but EM growth still lags other geographies</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">00287Y109 / 0989529 / 5671735 / 0925288 / 7103065 / 7110388 / 717081103 / 110122108 / 532457108 / 58933Y105</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">03/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Call to Discuss The Potential Role Of, And Key Focus Areas For, ADCs In Oncology on Friday, April 9, 2021 at 1 pm ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N / PFE.N</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Working Through The Weekend, Positive Data Shows Promise For MRK's COVID Treatment</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N / JNJ.N</td><td class="leftalignment">Merck & Co Inc / Johnson & Johnson</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">03/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Most Key Metrics Continue To Move Favorably - Week 49</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/06/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">our take on Ph 2 COVID oral antiviral data</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 3.5.21</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">German stocks to own and to shed during persisting reflation</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">DE0007100000 / DE0006599905 / DE0005190003 / DE0008404005 / DE0005200000 / DE0005140008 / DE0008430026 / DE0006602006 / DE0006048432 / DE0006047004 / DE0005785802 / DE0006231004 / DE0005557508 / DE0005313704 / DE0007037129 / DE0008402215 / DE0007164600 / DE0006452907 / DE0005158703 / DE0008303504 / DE0005408116 / DE0005470405 / DE000SYM9999 / DE000A0LD6E6 / DE000A0LD2U1 / DE000A0HN5C6 / DE000ENAG999 / DE000BAY0017 / DE000BASF111 / DE000KSAG888 / DE000LEG1110 / DE000A1ML7J1 / LU0775917882 / DE000EVNK013 / DE0006062144 / NL0012169213 / IE00BZ12WP82 / DE000A2YN900</td><td class="leftalignment">Daimler AG / Merck KGaA / Bayerische Motoren Werke AG / Allianz SE / Beiersdorf AG / Deutsche Bank AG / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / GEA Group AG / Henkel AG & Co KGaA / HeidelbergCement AG / Fresenius Medical Care AG & Co KGaA / Infineon Technologies AG / Deutsche Telekom AG / Carl Zeiss Meditec AG / Rwe AG / Hannover Rueck SE / SAP SE / Nemetschek SE / Bechtle AG / TAG Immobilien AG / Aareal Bank AG / Lanxess AG / Symrise AG / Gerresheimer AG / alstria office REIT AG / Deutsche Wohnen SE / E.ON SE / Bayer AG / BASF SE / K&S AG / LEG Immobilien SE / Vonovia SE / Grand City Properties SA / Evonik Industries AG / Covestro AG / Qiagen NV / Linde PLC / TeamViewer AG</td><td class="leftalignment"></td><td class="leftalignment">Germany / Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Markus Wallner</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Societe Generale</td><td class="leftalignment">Merck KGaA (Hold, TP=€135) - 12m target upgrade - 4Q results and FY21 guidance broadly in line, but stronger Life Science outlook - F. Cespedes (5p)</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Florent Cespedes / Justin S. Smith / Manas Sarkar</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Mar 05 2021</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">EVAX=US / SNSE=US / MRK=US / BSX=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / MDT=US / WMT=US / INSP=US / CMS=US / DGX=US / CRIS=US / AZN=US / GSK=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ANGN=US / APLS=US / BCRX=US / BMRN=US / CHE=US / CYH=US / COO=US / DRRX=US / EW=US / GRTS=US / GEN=US / ICPT=US / PHG=US / LH=US / NBIX=US / PHAR=US / HOOK=US / USPH=US / UTHR=US / UHS=US / PRVB=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / MD=US / CMPI=US / SLF=US / ONCR=US / BIIB=US / MRNA=US / ACAD=US / GOOG=US / INO=US / LHCG=US / SNSS=US / AGRX=US / CHNG=US / TPTX=US / ORTX=US / EHC=US / CLDX=US / CVAC=US / ADUS=US / ACHC=US / SRPT=US / PRTA=US / MRTX=US / GNCA=US / CTRE=US / EKTAY=US / CLRB=US / WBA=US / NVTA=US / EVH=US / MCRB=US / CFMS=US / LIVN=US / CERC=US / IONS=US / SSKN=US / VRAY=US / SYRS=US / MDGL=US / FLGT=US / IRTC=US / AVDL=US / SLNO=US / VREX=US / ATNX=US / NCNA=US / RCKT=US / FIXX=US / ARVN=US / MRKR=US / XFOR=US / TMDX=US / BCYC=US / NEXI=US / KRTX=US / DMTK=US / BNTX=US / RCEL=US / PNTG=US / NNOX=US / TSHA=US / VIRX=US / PHVS=US</td><td class="leftalignment">Evaxion Biotech A/S / Sensei Biotherapeutics Inc / Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Medtronic PLC / Walmart Inc / Inspire Medical Systems Inc / CMS Energy Corp / Quest Diagnostics Inc / Curis Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Angion Biomedica Corp / Apellis Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Chemed Corp / Community Health Systems Inc / Cooper Companies Inc / DURECT Corp / Edwards Lifesciences Corp / Gritstone bio Inc / Genesis Healthcare Inc / Intercept Pharmaceuticals Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / Neurocrine Biosciences Inc / Pharming Group NV / HOOKIPA Pharma Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Provention Bio Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Checkmate Pharmaceuticals Inc / Sun Life Financial Inc / Oncorus Inc / Biogen Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / LHC Group Inc / Viracta Therapeutics Inc / Agile Therapeutics Inc / Change Healthcare Inc / Turning Point Therapeutics Inc / Orchard Therapeutics PLC / Encompass Health Corp / Celldex Therapeutics Inc / CureVac NV / Addus Homecare Corp / Acadia Healthcare Company Inc / Sarepta Therapeutics Inc / Prothena Corporation PLC / Mirati Therapeutics Inc / Genocea Biosciences Inc / CareTrust REIT Inc / Elekta AB (publ) / Cellectar Biosciences Inc / Walgreens Boots Alliance Inc / Invitae Corp / Evolent Health Inc / Seres Therapeutics Inc / Conformis Inc / LivaNova PLC / Avalo Therapeutics Inc / Ionis Pharmaceuticals Inc / STRATA Skin Sciences Inc / ViewRay Inc / Syros Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / Avadel Pharmaceuticals PLC / Soleno Therapeutics Inc / Varex Imaging Corp / Athenex Inc / NuCana PLC / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Arvinas Inc / Marker Therapeutics Inc / X4 Pharmaceuticals Inc / Transmedics Group Inc / Bicycle Therapeutics PLC / Neximmune Inc / Karuna Therapeutics Inc / DermTech Inc / BioNTech SE / AVITA Medical Inc / Pennant Group Inc / Nano-X Imaging Ltd / Taysha Gene Therapies Inc / Viracta Therapeutics Inc / Pharvaris NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Weekly: Gvoke Share of 12% a New High; Teva's Gx Nuvaring Gaining Share</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">TEVA.TA / MRK=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / GSK=US / ENDP=US / PRGO=US / BIIB=US / AMRX=US / ABBV=US / XERS=US / VTRS=US</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Merck & Co Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Endo International PLC / Perrigo Company PLC / Biogen Inc / Amneal Pharmaceuticals Inc / Abbvie Inc / Xeris Biopharma Holdings Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Ami Fadia</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending Feb 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Top-read notes in February</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / ENDP.O / TEVA.N / PCRX.O / ABBV.N / AMRX.N / XERS.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / Endo International PLC / Teva Pharmaceutical Industries Ltd / Pacira Biosciences Inc / Abbvie Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">India / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / A=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Agilent Technologies Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Daily Credit Briefing</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">IG.MI / ALVG.DE / CNPP.PA / CRH.I / MRCG.DE / AOXG.DE</td><td class="leftalignment">Italgas SpA / Allianz SE / CNP Assurances SA / CRH PLC / Merck KGaA / alstria office REIT AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / Ireland / Italy / Netherlands / Russian Federation / Turkey / United States</td><td class="leftalignment">Advertising / Aerospace / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Conglomerates / Consumer / Containers & Packing / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Healthcare / Household Products / Industrial Materials / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Shipping & Shipbuilding / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS / CREDIT</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Herr. Ulrich Scholz, CFA / Herr Sven Kreitmair, CFA / Frau. Jana Schuler / Herr Gianfranco Arcovito / Frau Silke Stegemann / Sergey Bolshakov / Herr. Michael Teig / Herr Natalie Tehrani Monfared / Ms. Elia Lattuga</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMGN.OQ / BIIB.OQ / 4502.T / JNJ.N / LLY.N / MRK.N / AZN.L / SASY.PA / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / GLPG.AS / ACRX.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Biogen Inc / Takeda Pharmaceutical Co Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / AstraZeneca PLC / Sanofi SA / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / France / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Yunhee Park / Jonathan Woo</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRCG.DE: Merck KGaA - 4Q20 - Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MRCG.DE / 4063.T / 4185.T / A.N / BDX.N / RECI.MI / TMO.N / WAT.N / DHR.N / LUN.CO / LONN.S / SATG.DE / PKI.N / WST.N / UCB.BR / TECH.OQ / CCMP.OQ / ENTG.OQ / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / VIFN.S / GMAB.CO</td><td class="leftalignment">Merck KGaA / Shin-Etsu Chemical Co Ltd / JSR Corp / Agilent Technologies Inc / Becton Dickinson and Co / Recordati Industria Chimica e Farmaceutica SpA / Thermo Fisher Scientific Inc / Waters Corp / Danaher Corp / H Lundbeck A/S / Lonza Group AG / Sartorius AG / PerkinElmer Inc / West Pharmaceutical Services Inc / Ucb SA / Bio-Techne Corp / CMC Materials Inc / Entegris Inc / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Mr Matthew J. Weston / Ms Jo Walton</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck KGaA : 2021: Expectations for strong growth confirmed; with scope for further upgrades</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Richard B. Vosser / James D. Gordon / Sarita Kapila / Ms. Laerke Engkilde</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Merck dips 2.6% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">54</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">China-sourced PD1s coming to a market near you!</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Kepler Cheuvreux</td><td class="leftalignment">Merck KGAA | Buy | Results supportive, all on track</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David P. Evans</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck KGaA : 4Q'20 First Take: Solid results, FY'21 guidance implies limited change to consensus at this point</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Richard B. Vosser / James D. Gordon / Sarita Kapila / Ms. Laerke Engkilde / Mr. Tycho W. Peterson</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Warburg Research GmbH</td><td class="leftalignment">Starke Zahlen für Q4/GJ 2020 und erster Ausblick für 2021 veröffentlicht</td><td class="leftalignment">German</td><td class="rightalignment">13</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr Ulrich Huwald</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRCG.DE - Event Transcript of Merck KGaA conference call, Mar. 04, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Q4 strong for the divisions, 2021 outlook positive</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr Daniel Wendorff</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Merck: Good 4Q20 results; encouraging outlook</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Falko Friedrichs / Herr Jan Koch / Sachin Gadilingappa</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Morning Bite Flash</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">DE0006599905 / DE0008232125 / DE0006602006 / DE0006048432 / DE0007231326 / DE0005773303 / AT0000730007 / DE000TUAG000 / DE000WCH8881 / IT0004056880 / DE000ENAG999 / DE000EVNK013 / DE000ZAL1111 / DE000UNSE018 / NL0012044747 / 114556048 / DE000KBX1006 / NL00150001Q9</td><td class="leftalignment">Merck KGaA / Deutsche Lufthansa AG / GEA Group AG / Henkel AG & Co KGaA / Sixt SE / Fraport AG Frankfurt Airport Services Worldwide / Andritz AG / TUI AG / Wacker Chemie AG / Amplifon SpA / E.ON SE / Evonik Industries AG / Zalando SE / Uniper SE / Shop Apotheke Europe NV / Stellantis NV / Knorr Bremse AG / Stellantis NV</td><td class="leftalignment"></td><td class="leftalignment">Austria / China / Germany / France / Italy / Netherlands</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Herr. Ingo-Martin Schachel, CFA</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 4 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">US02553E1064 / US1101221083 / US1156372096 / US45337C1027 / US4698141078 / US4781601046 / US87612E1064 / US1314761032 / US5380341090 / US1940141062 / US58933Y1055 / US4464131063 / US95058W1009 / US00287Y1091 / US98978V1035 / US8486371045 / KYG8807B1068 / US98936J1016 / US23283X2062 / US09627Y1091 / US30050B1017 / US9741551033 / US20717E1010 / US72703H1014 / US50127T1097 / US87164F1057 / US6301041074 / US90138F1021 / US7493971052 / US76674Q1076 / US55910K1088 / US2575541055 / US28414H1032 / US89377M1099 / CA16106R1091 / US39874R1014 / US09203E1055 / US76155X1000 / US8334451098</td><td class="leftalignment">American Eagle Outfitters Inc / Bristol-Myers Squibb Co / Brown-Forman Corp / Incyte Corp / Jacobs Engineering Group Inc / Johnson & Johnson / Target Corp / Calumet Specialty Products Partners LP / Live Nation Entertainment Inc / Colfax Corp / Merck & Co Inc / Huntington Ingalls Industries Inc / Wendys Co / Abbvie Inc / Zoetis Inc / Splunk Inc / Theravance Biopharma Inc / Zendesk Inc / Cytosorbents Corp / Blueprint Medicines Corp / Evolent Health Inc / Wingstop Inc / Conformis Inc / Planet Fitness Inc / Kura Oncology Inc / Syndax Pharmaceuticals Inc / NantHealth Inc / Twilio Inc / R1 RCM Inc / Rimini Street Inc / Magenta Therapeutics Inc / Domo Inc / Elanco Animal Health Inc / Transmedics Group Inc / Charlotte's Web Holdings Inc / Grocery Outlet Holding Corp / Black Diamond Therapeutics Inc / Revolution Medicines Inc / Snowflake Inc.</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Cowen Health Care Conference Big Cap Pharma Highlights - Day 3</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US1101221083 / US58933Y1055 / US00287Y1091 / US98978V1035 / US28414H1032</td><td class="leftalignment">Bristol-Myers Squibb Co / Merck & Co Inc / Abbvie Inc / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Warburg Research GmbH</td><td class="leftalignment">Strong Q4/FY 2020 figures and initial outlook for 2021 published</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr Ulrich Huwald</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRCG.DE: Merck KGaA - 4Q20- Initial Diagnosis</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Mr Matthew J. Weston / Ms Jo Walton</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck & Co Inc: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">03/03/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / SELB.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / ARNA.OQ / RIGL.OQ / BDSI.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / OMER.OQ / ARDX.OQ / ACRX.OQ / ZTS.N / TGTX.OQ / ANIP.OQ / AXGN.OQ / HTBX.OQ / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / ACRS.OQ / CKPT.OQ / VERU.OQ / TXMD.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / IMAB.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / NNOX.OQ / VYNE.OQ / GRAY.OQ / AZYO.OQ / 120551486</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Selecta Biosciences Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / Arena Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / AcelRx Pharmaceuticals Inc / Zoetis Inc / TG Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Heat Biologics Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Aclaris Therapeutics Inc / Checkpoint Therapeutics Inc / Veru Inc / TherapeuticsMD Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / I-Mab / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Nano-X Imaging Ltd / Vyne Therapeutics Inc / Graybug Vision Inc / Aziyo Biologics Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">03/03/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRK.N - Event Transcript of Merck & Co Inc conference call, Mar. 03, 2021 / 1:20PM ET</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/03/2021</td><td class="leftalignment">Warburg Research GmbH</td><td class="leftalignment">Vorschau: Q4/GJ 2020-Zahlen am oberen Ende der Guidance-Spanne erwartet</td><td class="leftalignment">German</td><td class="rightalignment">13</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr Ulrich Huwald</td></tr>
<tr class="even"><td class="leftalignment">03/03/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Daily Credit Briefing</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">GB0008220112 / MRK.N / PFE.N / SAPJ.J / TEF.MC / PIA.MI / SKG.I</td><td class="leftalignment">DS Smith PLC / Merck & Co Inc / Pfizer Inc / Sappi Ltd / Telefonica SA / Piaggio & C SpA / Smurfit Kappa Group PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Spain / United Kingdom / Ireland / Israel / Italy / United States / South Africa</td><td class="leftalignment">Advertising / Aerospace / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Biotechnology / Broadcasting & Cable / Building & Building Materials / Conglomerates / Consumer / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Financial Services / Healthcare / Household Products / Industrial Materials / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Shipping & Shipbuilding / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS / CREDIT</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Herr. Ulrich Scholz, CFA / Frau. Jana Schuler / Herr Jonathan Schroer / Frau Silke Stegemann / Herr Sven Kreitmair, CFA / Herr Gianfranco Arcovito / Herr Christian Aust / Herr. Michael Teig / Herr. Stefan Kolek</td></tr>
<tr class="odd"><td class="leftalignment">03/03/2021</td><td class="leftalignment">Warburg Research GmbH</td><td class="leftalignment">Preview: Q4/FY 2020 figures expected at upper end of given guidance range</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr Ulrich Huwald</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">RVMD (BUY) - Pipeline on Track Heading into Multiple 2021-2022 Milestones; Maintain BUY</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BL71K91 / 0989529 / 2516152 / 2023607 / 2778844 / BBPK0J0</td><td class="leftalignment">Revolution Medicines Inc / AstraZeneca PLC / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Mirati Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ZTS-US -  Dividend Quality Analysis, for the period ended March 01,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ZTS / LLY / MRK / PFE / ICCC.O / HSKA.O / PAHC.O / SNY.O</td><td class="leftalignment">Zoetis Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / ImmuCell Corp / Heska Corp / Phibro Animal Health Corp / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Merck in bottom 6% performers of S&P 500 Index in past quarter; Institutional Ownership down 3%</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Roxadustat Overhang Persists w/Adcom, but Minimal Fundamental Impact; PT to $63</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AZN=US / MRK=US / FGEN=US</td><td class="leftalignment">AstraZeneca PLC / Merck & Co Inc / FibroGen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Andrew S. Berens, MD</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Infinata</td><td class="leftalignment">Merck & Co., Inc. - Company Report</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Infinata</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Infinata</td><td class="leftalignment">Merck KGaA - Company Report</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Middle East</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Infinata</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Morning Bite Flash</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">DE0006599905 / DE0007231326 / DE0005408884 / IT0004056880 / DE0005168108 / DE000A1ML7J1 / DE000KGX8881 / DE000A161408 / IE00BF2NR112 / DE000A2NBTL2</td><td class="leftalignment">Merck KGaA / Sixt SE / Leoni AG / Amplifon SpA / Bauer AG / Vonovia SE / Kion Group AG / Hellofresh SE / Greencoat Renewables PLC / Schaltbau Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Germany / Ireland / Italy</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Herr. Ingo-Martin Schachel, CFA</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 2 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">NL0000226223 / DE0006231004 / US0378331005 / US0382221051 / US1011371077 / US1570851014 / US1727551004 / US2620371045 / US4581401001 / US5324571083 / US58155Q1031 / US5951121038 / US66987V1098 / US7392761034 / US7475251036 / US8168501018 / US8610121027 / US8807701029 / US91347P1057 / US92532F1003 / US9581021055 / CA8265161064 / US87157D1090 / US83088M1027 / US64111Q1040 / US1572101053 / US1281261099 / US6707041058 / US8936411003 / US1696561059 / US82706C1080 / US1717793095 / US58933Y1055 / NL0010273215 / US85916J4094 / US8486371045 / US63009R1095 / US00847X1046 / NL0010696654 / JE00BLG2ZQ72 / US0465131078 / US31572Q8087 / US74736K1016 / US05464T1043 / US98138J2069 / US00773U1088 / US02081G2012 / US45782B1044 / US91325V1089 / US87105L1044 / US5011471027 / US89854H1023 / US05351X1019 / US11135F1012 / US92537N1081 / US6833731044 / US8334451098 / US05479K1060 / US03476J1079 / US8808811074</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / Apple Inc / Applied Materials Inc / Boston Scientific Corp / Cerus Corp / Cirrus Logic Inc / Dril-Quip Inc / Intel Corp / Eli Lilly and Co / Mckesson Corp / Micron Technology Inc / Novartis AG / Power Integrations Inc / Qualcomm Inc / Semtech Corp / STMicroelectronics NV / Teradyne Inc / Universal Display Corp / Vertex Pharmaceuticals Inc / Western Digital Corp / Sierra Wireless Inc / Synaptics Inc / Skyworks Solutions Inc / NETGEAR Inc / CEVA Inc / CalAmp Corp / NuVasive Inc / TransDigm Group Inc / Chipotle Mexican Grill Inc / Silicon Motion Technology Corp / Ciena Corp / Merck & Co Inc / ASML Holding NV / Stereotaxis Inc / Splunk Inc / NanoString Technologies Inc / Agios Pharmaceuticals Inc / Uniqure NV / Quotient Ltd / Atara Biotherapeutics Inc / FibroGen Inc / Qorvo Inc / Axsome Therapeutics Inc / Workhorse Group Inc / Adverum Biotechnologies Inc / Alphatec Holdings Inc / Inseego Corp / Uniti Group Inc / Switch Inc / Krystal Biotech Inc / TTEC Holdings Inc / Avaya Holdings Corp / Broadcom Inc / Vertiv Holdings Co / Ontrak Inc / Snowflake Inc. / Aziyo Biologics Inc / Angion Biomedica Corp / Terns Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United Kingdom / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">EVAX=US / SRCL=US / AAPL=US / MRK=US / BSX=US / PFE=US / AMGN=US / BMY=US / AMD=US / TSM=US / AZN=US / GSK=US / ETN=US / ANGN=US / ACI=US / AZO=US / BCRX=US / KMX=US / GRTS=US / ICPT=US / PHG=US / ORLY=US / PHAR=US / WSC=US / RHHBY=US / BIIB=US / MRNA=US / INO=US / AGRX=US / TPTX=US / PRPL=US / CVAC=US / AMRC=US / 2454-TW=US / PRTA=US / GNCA=US / IONS=US / MDGL=US / IRTC=US / UAA=US / AVDL=US / CVNA=US / CSPR=US / ATNX=US / ZM=US / TMDX=US / BNTX=US / PHVS=US</td><td class="leftalignment">Evaxion Biotech A/S / Stericycle Inc / Apple Inc / Merck & Co Inc / Boston Scientific Corp / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Advanced Micro Devices Inc / Taiwan Semiconductor Manufacturing Co Ltd / AstraZeneca PLC / GlaxoSmithKline PLC / Eaton Corporation PLC / Angion Biomedica Corp / Albertsons Companies Inc / Autozone Inc / BioCryst Pharmaceuticals Inc / Carmax Inc / Gritstone bio Inc / Intercept Pharmaceuticals Inc / Koninklijke Philips NV / O'Reilly Automotive Inc / Pharming Group NV / Willscot Mobile Mini Holdings Corp / Roche Holding AG / Biogen Inc / Moderna Inc / Inovio Pharmaceuticals Inc / Agile Therapeutics Inc / Turning Point Therapeutics Inc / Purple Innovation Inc / CureVac NV / Ameresco Inc / MediaTek Inc / Prothena Corporation PLC / Genocea Biosciences Inc / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / iRhythm Technologies Inc / Under Armour Inc / Avadel Pharmaceuticals PLC / Carvana Co / Casper Sleep Inc / Athenex Inc / Zoom Video Communications Inc / Transmedics Group Inc / BioNTech SE / Pharvaris NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / United Kingdom / Ireland / Netherlands / Taiwan / United States</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Software / Pharmaceuticals / Retailing / Semiconductors / Services</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Cowen Health Care Conference Big Cap Pharma Highlights - Day 1</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US5324571083 / US66987V1098 / US58933Y1055</td><td class="leftalignment">Eli Lilly and Co / Novartis AG / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / WMB=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / WEN=US / T=US / BLD=US / TEVA=US / KMI=US / AMT=US / AKAM=US / CHTR=US / CONE=US / VZ=US / LOW=US / PAA=US / CCI=US / HSII=US / CHRS=US / BYD=US / LEG=US / TNL=US / KFRC=US / MGM=US / PENN=US / CMCSA=US / DISH=US / AIR=US / KFY=US / AMN=US / CBRL=US / DRI=US / EQIX=US / GFF=US / IBP=US / MAN=US / MAS=US / MPLX=US / MHK=US / MCRI=US / ASGN=US / OKE=US / PRGO=US / REGI=US / RHI=US / SBAC=US / SGMO=US / TRGP=US / TRUE=US / VRTX=US / EPD=US / SNOW=US / SGMS=US / CCRN=US / DCP=US / DIN=US / MMP=US / TPX=US / EXP=US / CZR=US / CDLX=US / BECN=US / DLR=US / PLAY=US / DENN=US / BLDR=US / GMS=US / NSP=US / SPWR=US / SCPL=US / CMG=US / REX=US / CCOI=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / PAGP=US / JACK=US / CLNY=US / TREX=US / HGV=US / NLSN=US / APTS=US / VAC=US / FBHS=US / ENPH=US / SMLP=US / TILE=US / TMUS=US / NDLS=US / CEQP=US / ASMB=US / LOCO=US / VCEL=US / SHAK=US / WING=US / SPNE=US / AXSM=US / ADVM=US / 82982L103 / CRSP=US / PVAC=US / GDS=US / JELD=US / ATNX=US / SWCH=US / RTLR=US / LHX=US / FERGY=US / RPAY=US / AZEK=US / CRMD.US / BALY=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Williams Companies Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / AT&T Inc / TopBuild Corp / Teva Pharmaceutical Industries Ltd / Kinder Morgan Inc / American Tower Corp / Akamai Technologies Inc / Charter Communications Inc / CyrusOne Inc / Verizon Communications Inc / Lowe's Companies Inc / Plains All American Pipeline LP / Crown Castle International Corp / Heidrick & Struggles International Inc / Coherus BioSciences Inc / Boyd Gaming Corp / Leggett & Platt Inc / Travel + Leisure Co / Kforce Inc / MGM Resorts International / Penn National Gaming Inc / Comcast Corp / DISH Network Corp / AAR Corp / Korn Ferry / AMN Healthcare Services Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Equinix Inc / Griffon Corp / Installed Building Products Inc / ManpowerGroup Inc / Masco Corp / MPLX LP / Mohawk Industries Inc / Monarch Casino & Resort Inc / ASGN Inc / ONEOK Inc / Perrigo Company PLC / Renewable Energy Group Inc / Robert Half International Inc / SBA Communications Corp / Sangamo Therapeutics Inc / Targa Resources Corp / TrueCar Inc / Vertex Pharmaceuticals Inc / Enterprise Products Partners LP / Snowflake Inc. / Scientific Games Corp / Cross Country Healthcare Inc / DCP Midstream LP / Dine Brands Global Inc / Magellan Midstream Partners LP / Tempur Sealy International Inc / Eagle Materials Inc / Caesars Entertainment Inc / Cardlytics Inc / Beacon Roofing Supply Inc / Digital Realty Trust Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / SunPower Corp / Sciplay Corp / Chipotle Mexican Grill Inc / REX American Resources Corp / Cogent Communications Holdings Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Plains GP Holdings LP / Jack in the Box Inc / DigitalBridge Group Inc / Trex Company Inc / Hilton Grand Vacations Inc / Nielsen Holdings PLC / Preferred Apartment Communities Inc / Marriott Vacations Worldwide Corp / Fortune Brands Home & Security Inc / Enphase Energy Inc / Summit Midstream Partners LP / Interface Inc / T-Mobile US Inc / Noodles & Co / Crestwood Equity Partners LP / Assembly Biosciences Inc / El Pollo Loco Holdings Inc / Vericel Corp / Shake Shack Inc / Wingstop Inc / SeaSpine Holdings Corp / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / SiteOne Landscape Supply Inc / CRISPR Therapeutics AG / Ranger Oil Corp / GDS Holdings Ltd / JELD-WEN Holding Inc / Athenex Inc / Switch Inc / Rattler Midstream LP / L3harris Technologies Inc / Ferguson PLC / Repay Holdings Corp / Azek Company Inc / CorMedix Inc / Bally's Corp / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">The Insight Partners</td><td class="leftalignment">Merck Kgaa (Mrk) In Dimethyl Carbonate Market, Company SWOT Analysis and Profile</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK=DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Chemicals / Industrial Materials</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BOLT (BUY) - Lightning Strikes Twice with Immune-Stimulating ADCs; Initiating with a BUY and $42 PT</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">BMDJ397 / 5671735 / 0989529 / 2126335 / 2516152 / 2023607 / 2778844 / 2369174 / 2457864 / 2684703 / 7103065 / 2982924 / BFDV8K0 / BMQ5T49 / BKVDFF7 / BYQHPK7 / BL71K91 / BN2R582 / BG0Q4Y1 / BF3NP05</td><td class="leftalignment">Bolt Biotherapeutics Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Gilead Sciences Inc / ImmunoGen Inc / Pfizer Inc / Novartis AG / Spectrum Pharmaceuticals Inc / MacroGenics Inc / Zentalis Pharmaceuticals Inc / Oric Pharmaceuticals Inc / Zymeworks Inc / Revolution Medicines Inc / Relay Therapeutics Inc / Exicure Inc / Mersana Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">AI-driven Oncology Story with Near-Term Catalysts: Initiate with Outperform, PT $18</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">EVAX=US / MRK=US / PFE=US / GSK=US / GRTS=US / MRNA=US / CVAC=US / GNCA=US / BNTX=US</td><td class="leftalignment">Evaxion Biotech A/S / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / Gritstone bio Inc / Moderna Inc / CureVac NV / Genocea Biosciences Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Denmark / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Kevin M. DeGeeter</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: February 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ABT.N / APD.N / AXP.N / BA.N / BAC.N / BBY.N / BSX.N / C.N / CCL.N / CIT.N / CL.N / CMS.N / CRM.N / DAL.N / ED.N / EOG.N / FCX.N / FDX.N / GE.N / HLT.N / IBM.N / JNJ.N / JPM.N / KO.N / LLY.N / LMT.N / LUV.N / MRK.N / NEM.N / OXY.N / PNW.N / SGEF.PA / SLB.N / T.N / TMO.N / U.N / WFC.N / WMT.N / AVB.N / EQR.N / SPG.N / PG.N / PXD.N / W.N / ETR.N / DUK.N / DHR.N / DIS.N / UNH.N / D.N / FE.N / URI.N / DE.N / PGR.N / CAT.N / MGM.N / KIM.N / GS.N / CLX.N / MCD.N / HON.N / VLO.N / HD.N / MRO.N / JWN.N / XRX.N / WEC.N / XOM.N / DVN.N / AMT.N / NKE.N / VZ.N / MUR.N / KSS.N / HRB.N / ORCL.N / LNC.N / HP.N / SRE.N / KMI.N / PWR.N / V.N / OKE.N / BXP.N / ACN.N / PLD.N / TWTR.N / AIV.N / LB.TO / CVX.N / FTI.N / COP.N / INTC.OQ / ABMD.OQ / ADBE.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / REGN.OQ / ROL.N / RGLD.OQ / SIVB.OQ / TT.N / QDEL.OQ / IDXX.OQ / QCOM.OQ / GILD.OQ / COST.OQ / AMZN.OQ / ZBRA.OQ / NVDA.OQ / SBAC.OQ / EXPE.OQ / BLUE.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / NFLX.OQ / WYNN.OQ / CMCSA.OQ / BIIB.OQ / NXST.OQ / SBNY.OQ / VIAC.OQ / WAL.N / DISCA.OQ / CDNS.OQ / LYV.N / MS.N / TDG.N / HES.N / MA.N / SPR.N / M.N / TDC.N / TNDM.OQ / MRNA.OQ / SWI.N / AVGO.OQ / CLNY.N / VRSK.OQ / SCHW.N / MU.OQ / GNRC.N / TSLA.OQ / ADSGN.F / HHC.N / LPLA.OQ / MSI.N / MSP.N / SABR.OQ / HFC.N / HZNP.OQ / SLM.OQ / ENPH.OQ / TRIP.OQ / SPLK.OQ / SRPT.OQ / FANG.OQ / ABBV.N / WEX.N / COTY.N / MAR.OQ / ESRT.N / AAL.OQ / NCLH.N / GOOGL.OQ / HUBS.N / OUT.N / ETSY.OQ / PYPL.OQ / SQ.N / IAC.OQ / TWLO.N / TTD.OQ / UAA.N / PK.N / AYX.N / CVNA.N / ROKU.OQ / PEP.OQ / XEL.OQ / BKNG.OQ / ZS.OQ / FB.PS / UAL.OQ / LNT.OQ / CPRI.N / PINS.N / ZM.OQ / CRWD.OQ / SPCE.N / RTX.N / CARR.N / APA.OQ / LMND.N / AEP.OQ</td><td class="leftalignment">Abbott Laboratories / Air Products and Chemicals Inc / American Express Co / Boeing Co / Bank of America Corp / Best Buy Co Inc / Boston Scientific Corp / Citigroup Inc / Carnival Corp / First-Citizens Bank & Trust Co / Colgate-Palmolive Co / CMS Energy Corp / Salesforce.Com Inc / Delta Air Lines Inc / Consolidated Edison Inc / EOG Resources Inc / Freeport-McMoRan Inc / FedEx Corp / General Electric Co / Hilton Worldwide Holdings Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Merck & Co Inc / Newmont Corporation / Occidental Petroleum Corp / Pinnacle West Capital Corp / Vinci SA / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Avalonbay Communities Inc / Equity Residential / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Wayfair Inc / Entergy Corp / Duke Energy Corp / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Dominion Energy Inc / FirstEnergy Corp / United Rentals Inc / Deere & Co / Progressive Corp / Caterpillar Inc / MGM Resorts International / Kimco Realty Corp / Goldman Sachs Group Inc / Clorox Co / McDonald's Corp / Honeywell International Inc / Valero Energy Corp / Home Depot Inc / Marathon Oil Corp / Nordstrom Inc / Xerox Holdings Corp / WEC Energy Group Inc / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Nike Inc / Verizon Communications Inc / Murphy Oil Corp / Kohls Corp / H & R Block Inc / Oracle Corp / Lincoln National Corp / Helmerich and Payne Inc / Sempra Energy / Kinder Morgan Inc / Quanta Services Inc / Visa Inc / ONEOK Inc / Boston Properties Inc / Accenture PLC / Prologis Inc / Twitter Inc / Apartment Investment and Management Co / Laurentian Bank of Canada / Chevron Corp / TechnipFMC PLC / Conocophillips / Intel Corp / ABIOMED Inc / Adobe Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Regeneron Pharmaceuticals Inc / Rollins Inc / Royal Gold Inc / SVB Financial Group / Trane Technologies PLC / Quidel Corp / IDEXX Laboratories Inc / Qualcomm Inc / Gilead Sciences Inc / Costco Wholesale Corp / Amazon.com Inc / Zebra Technologies Corp / NVIDIA Corp / SBA Communications Corp / Expedia Group Inc / bluebird bio Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Netflix Inc / Wynn Resorts Ltd / Comcast Corp / Biogen Inc / Nexstar Media Group Inc / Signature Bank / ViacomCBS Inc / Western Alliance Bancorp / Discovery Inc / Cadence Design Systems Inc / Live Nation Entertainment Inc / Morgan Stanley / TransDigm Group Inc / Hess Corp / Mastercard Inc / Spirit AeroSystems Holdings Inc / Macy's Inc / Teradata Corp / Tandem Diabetes Care Inc / Moderna Inc / SolarWinds Corp / Broadcom Inc / DigitalBridge Group Inc / Verisk Analytics Inc / Charles Schwab Corp / Micron Technology Inc / Generac Holdings Inc / Tesla Inc / Adidas AG / Howard Hughes Corp / LPL Financial Holdings Inc / Motorola Solutions Inc / Datto Holding Corp / Sabre Corp / HollyFrontier Corp / Horizon Therapeutics PLC / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Splunk Inc / Sarepta Therapeutics Inc / Diamondback Energy Inc / Abbvie Inc / WEX Inc / Coty Inc / Marriott International Inc / Empire State Realty Trust Inc / American Airlines Group Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / HubSpot Inc / OUTFRONT Media Inc / ETSY Inc / PayPal Holdings Inc / Block Inc / IAC/Interactivecorp / Twilio Inc / Trade Desk Inc / Under Armour Inc / Park Hotels & Resorts Inc / Alteryx Inc / Carvana Co / Roku Inc / PepsiCo Inc / Xcel Energy Inc / Booking Holdings Inc / Zscaler Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Alliant Energy Corp / Capri Holdings Ltd / Pinterest Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Virgin Galactic Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / APA Corp (US) / Lemonade Inc / American Electric Power Company Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Germany / France / United Kingdom / Ireland / Panama / Philippines / United States / Virgin Islands, British / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Merck sinks 8.9% from 6 week high</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 19, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Strengthening oncology pipeline a positive</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr Daniel Wendorff</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">EDIT=US / MRNA=US / ADAP=US / MRK=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / DRRX=US / ISEE=US / GRTS=US / ICPT=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / ALNY=US / INO=US / AVRO=US / FOLD=US / NK=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / VKTX=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / NTLA=US / ADVM=US / MDGL=US / CRSP=US / ALSEN=FR / 199800=KR / IVA=FR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / SIGHT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / CWBR=US / NGM=US / KOD=US / AXLA=US / STOK=US / AKRO=US / NBSE=US / ETNB=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Editas Medicine Inc / Moderna Inc / Adaptimmune Therapeutics PLC / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / DURECT Corp / Iveric Bio Inc / Gritstone bio Inc / Intercept Pharmaceuticals Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / Immunitybio Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Viking Therapeutics Inc / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Madrigal Pharmaceuticals Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Inventiva SA / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Gensight Biologics SA / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / CohBar Inc / NGM Biopharmaceuticals Inc / Kodiak Sciences Inc / Axcella Health Inc / Stoke Therapeutics Inc / Akero Therapeutics Inc / NeuBase Therapeutics Inc / 89Bio Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States / South Africa</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 1 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">DE0006231004 / US0116591092 / US0463531089 / US09058V1035 / US1101221083 / US2254471012 / US30231G1022 / US37733W1053 / US4781601046 / US5324571083 / US5370081045 / US66987V1098 / US6701002056 / US6821891057 / US7170811035 / US7392761034 / US7711951043 / US8308791024 / US8447411088 / US8610121027 / US9021041085 / US9311421039 / US1667641005 / US4771431016 / US4198791018 / US80105N1054 / US09062X1037 / US0042251084 / US02043Q1076 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US13100M5094 / NL0009538784 / US9100471096 / US00164V1035 / US00287Y1091 / US55405Y1001 / US8485771021 / US21240E1055 / US8086251076 / US02376R1023 / US70432V1026 / US69888T2078 / US0465131078 / CA0089118776 / US74736K1016 / US00653A1079 / US05464T1043 / US00773U1088 / SE0009414576 / US5904791358 / US0197701065 / US0144421072 / US09203E1055 / US26142R1041 / CH0499880968 / US30233G2093</td><td class="leftalignment">Infineon Technologies AG / Alaska Air Group Inc / AstraZeneca PLC / BioCryst Pharmaceuticals Inc / Bristol-Myers Squibb Co / Wolfspeed Inc / Exxon Mobil Corp / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Littelfuse Inc / Novartis AG / Novo Nordisk A/S / ON Semiconductor Corp / Pfizer Inc / Power Integrations Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / STMicroelectronics NV / II-VI Inc / Walmart Inc / Chevron Corp / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / Calix Inc / NXP Semiconductors NV / United Airlines Holdings Inc / AMC Networks Inc / Abbvie Inc / MACOM Technology Solutions Holdings Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Science Applications International Corp / American Airlines Group Inc / Paycom Software Inc / Par Pacific Holdings Inc / Atara Biotherapeutics Inc / Air Canada / Qorvo Inc / Adaptimmune Therapeutics PLC / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Oncopeptides AB / Mesa Air Group Inc / Allogene Therapeutics Inc / Alector Inc / Black Diamond Therapeutics Inc / DraftKings Inc / ADC Therapeutics SA / EyePoint Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">AEP.N / ALTR.O / ALV.N / AMAT.O / AMD.N / ANTO.L / BAC.N / BARC.L / BCE.TO / BK.N / BNPP.PA / C.N / CCI.N / CL.N / CMS.N / COF.N / CSGN.S / DGE.L / EIX.N / EL.N / EOG.N / F.N / FITB.O / GM.N / HSBA.L / JPM.N / KEY.N / KMB.N / KO.N / L.TO / MRK.N / NEM.N / NTRS.O / PFE.N / PNC.N / RIO.L / SO.N / SOGN.PA / T.N / T.TO / USB.N / VC.N / WFC.N / PEP.N / CMA.N / BFb.N / PG.N / WY.N / CNQ.TO / GILD.O / FNV.N / ASML.O / CPB.N / TEN.N / CMCSA.O / SJRb.TO / TA.TO / RCIb.TO / AMGN.O / FER.MC / AAL.L / CNR.TO / DUK.N / QBRb.TO / HBAN.O / BWA.N / LEA.N / PNM.N / ENB.TO / TRP.TO / NVDA.O / K.N / DT.N / DISH.O / IMO.TO / GS.N / DBKGn.DE / CLX.N / CAG.N / HON.N / MFC.TO / GIS.N / PCG.N / AEM.N / XOM.N / EPC.N / MGA.N / SBAC.O / AMT.N / BOL.ST / CONE.O / ADI.O / VZ.N / STT.N / EXEL.O / MDRX.O / ALA.TO / ARNA.O / STZ.N / APH.N / SRE.N / EXC.N / DSGX.O / FISV.O / SNPS.O / V.N / AXL.N / AWK.N / ARE.N / PLD.N / CHD.N / MTB.N / BC.N / FTS.TO / SAM.N / BMRN.O / OPTN.O / REGN.O / ENR.N / CVX.N / EMA.TO / MU.O / CAGR.PA / NCR.N / NET.N / TEL.N / RF.N / FLS.CO / CNP.N / APF.L / ENDP.O / MEOH.O / CPK.N / DOL.TO / FRC.N / PII.N / ST.N / SWN.N / WES.N / SEM.N / ADS.N / GPN.N / MNST.O / SIVB.O / CASY.O / EQIX.O / ATDb.TO / TFC.N / INGA.AS / 02209S103 / DLR.N / 427866108 / RDSb.L / BLDR.O / DISCA.O / CDNS.O / MS.N / FIS.N / CCOI.O / HICL.L / CTCa.TO / BLX.TO / MA.N / MWA.N / HOG.N / ATL.MI / BGS.N / PPL.TO / DAN.N / BIP.N / SII.TO / CLW.N / VALE.N / SPB.N / ENV.N / BHPB.L / NEE.N / NXT.AX / CAML.L / MTOR.N / GLEN.L / GEI.TO / PANW.N / MDLZ.OQ / ABBV.N / KPT.TO / TSLA.N / PRGO.N / PRMW.N / TMUS.N / DOO.TO / COTY.N / PRTA.O / BEP.N / AGIO.O / VRNS.O / AGRX.O / CFG.N / DEA.N / SHOP.N / PYPL.OQ / SQ.N / RACE.MI / UBSG.S / ADNT.N / FRTA.OQ / GDS.O / PBYI.OQ / AQN.N / VST.N / WOW.N / ATUS.N / GRPG.I / ATNX.O / AQUA.N / AY.O / SAIL.N / APTV.N / AMRX.N / VNE.N / KDP.N / ESTC.N / NWL.O / 269796108 / ZM.O / CRWD.O / GMAB.O / PING.N / CRNC.OQ / REYN.O / LUNE.ST / NKLA.OQ / APA.OQ / FOUR.N / 77311W101 / LUMN.N / PTVE.O / BSY.O / MAX.N / WFG.N / TIXT.TO / AFRM.O / ATC.N / 120681711</td><td class="leftalignment">American Electric Power Company Inc / Altair Engineering Inc / Autoliv Inc / Applied Materials Inc / Advanced Micro Devices Inc / Antofagasta PLC / Bank of America Corp / Barclays PLC / BCE Inc / Bank of New York Mellon Corp / BNP Paribas SA / Citigroup Inc / Crown Castle International Corp / Colgate-Palmolive Co / CMS Energy Corp / Capital One Financial Corp / Credit Suisse Group AG / Diageo PLC / Edison International / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / Fifth Third Bancorp / General Motors Co / HSBC Holdings PLC / JPMorgan Chase & Co / KeyCorp / Kimberly-Clark Corp / Coca-Cola Co / Loblaw Companies Ltd / Merck & Co Inc / Newmont Corporation / Northern Trust Corp / Pfizer Inc / PNC Financial Services Group Inc / Rio Tinto PLC / Southern Co / Societe Generale SA / AT&T Inc / Telus Corp / US Bancorp / Visteon Corp / Wells Fargo & Co / PepsiCo Inc / Comerica Inc / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canadian Natural Resources Ltd / Gilead Sciences Inc / Franco-Nevada Corp / ASML Holding NV / Campbell Soup Co / Tenneco Inc / Comcast Corp / Shaw Communications Inc / TransAlta Corp / Rogers Communications Inc / Amgen Inc / Ferrovial SA / Anglo American PLC / Canadian National Railway Co / Duke Energy Corp / Quebecor Inc / Huntington Bancshares Inc / Borgwarner Inc / Lear Corp / PNM Resources Inc / Enbridge Inc / TC Energy Corp / NVIDIA Corp / Kellogg Co / Dynatrace Inc / DISH Network Corp / Imperial Oil Ltd / Goldman Sachs Group Inc / Deutsche Bank AG / Clorox Co / Conagra Brands Inc / Honeywell International Inc / Manulife Financial Corp / General Mills Inc / PG&E Corp / Agnico Eagle Mines Ltd / Exxon Mobil Corp / Edgewell Personal Care Co / Magna International Inc / SBA Communications Corp / American Tower Corp / Boliden AB / CyrusOne Inc / Analog Devices Inc / Verizon Communications Inc / State Street Corp / Exelixis Inc / Allscripts Healthcare Solutions Inc / AltaGas Ltd / Arena Pharmaceuticals Inc / Constellation Brands Inc / Amphenol Corp / Sempra Energy / Exelon Corp / Descartes Systems Group Inc / Fiserv Inc / Synopsys Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Prologis Inc / Church & Dwight Co Inc / M&T Bank Corp / Brunswick Corp / Fortis Inc / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Chevron Corp / Emera Inc / Micron Technology Inc / Credit Agricole SA / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Regions Financial Corp / FLSmidth & Co A/S / CenterPoint Energy Inc / Anglo Pacific Group PLC / Endo International PLC / Methanex Corp / Chesapeake Utilities Corp / Dollarama Inc / First Republic Bank / Polaris Inc / Sensata Technologies Holding PLC / Southwestern Energy Co / Western Midstream Partners LP / Select Medical Holdings Corp / Alliance Data Systems Corp / Global Payments Inc / Monster Beverage Corp / SVB Financial Group / Caseys General Stores Inc / Equinix Inc / Alimentation Couche-Tard Inc / Truist Financial Corp / ING Groep NV / Altria Group Inc / Digital Realty Trust Inc / Hershey Co / Royal Dutch Shell PLC / Builders FirstSource Inc / Discovery Inc / Cadence Design Systems Inc / Morgan Stanley / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / HICL Infrastructure PLC / Canadian Tire Corporation Ltd / Boralex Inc / Mastercard Inc / Mueller Water Products Inc / Harley-Davidson Inc / Atlantia SpA / B&G Foods Inc / Pembina Pipeline Corp / Dana Inc / Brookfield Infrastructure Partners LP / Sprott Inc / Clearwater Paper Corp / Vale SA / Spectrum Brands Holdings Inc / Envestnet Inc / BHP Group PLC / Nextera Energy Inc / NEXTDC Ltd / Central Asia Metals PLC / Meritor Inc / Glencore PLC / Gibson Energy Inc / Palo Alto Networks Inc / Mondelez International Inc / Abbvie Inc / KP Tissue Inc / Tesla Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / BRP Inc / Coty Inc / Prothena Corporation PLC / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / Varonis Systems Inc / Agile Therapeutics Inc / Citizens Financial Group Inc / Easterly Government Properties Inc / Shopify Inc / PayPal Holdings Inc / Block Inc / Ferrari NV / UBS Group AG / Adient PLC / Forterra Inc / GDS Holdings Ltd / Puma Biotechnology Inc / Algonquin Power & Utilities Corp / Vistra Corp / WideOpenWest Inc / Altice USA Inc / Greencoat Renewables PLC / Athenex Inc / Evoqua Water Technologies Corp / Atlantica Sustainable Infrastructure PLC / SailPoint Technologies Holdings Inc / Aptiv PLC / Amneal Pharmaceuticals Inc / Veoneer Inc / Keurig Dr Pepper Inc / Elastic NV / Newell Brands Inc / Eagle Pharmaceuticals Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Genmab A/S / Ping Identity Holding Corp / Cerence Inc / Reynolds Consumer Products Inc / Lundin Energy AB / Nikola Corp / APA Corp (US) / Shift4 Payments Inc / Rocket Companies Inc / Lumen Technologies Inc / Pactiv Evergreen Inc / Bentley Systems Inc / Mediaalpha Inc / West Fraser Timber Co Ltd / Telus International Cda Inc / Affirm Holdings Inc / Atotech Ltd / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Ireland / Italy / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">MRNA (Buy): PT to $182 as new Covid-19 trials set to drive 2021 data flow</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRNA=US / MRK=US / AZN=US / LOGC=US / SGMO=US / FOLD=US / RGNX=US / QURE=US / AGTC=US / VYGR=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / 199800=KR / KRYS=US / SLDB=US / MGTX=US</td><td class="leftalignment">Moderna Inc / Merck & Co Inc / AstraZeneca PLC / LogicBio Therapeutics Inc / Sangamo Therapeutics Inc / Amicus Therapeutics Inc / Regenxbio Inc / Uniqure NV / Applied Genetic Technologies Corp / Voyager Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / ToolGen Inc / Krystal Biotech Inc / Solid Biosciences Inc / MeiraGTx Holdings PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / United Kingdom / Korea, Republic of / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">FORECASTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / DR. Gbola B. Amusa,  MD, CFA, CFA</td></tr>
<tr class="even"><td class="leftalignment">02/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / OPTN.O / ENDP.O / ABBV.N / PRGO.N / AGRX.O / AMRX.N / 269796108</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / OptiNose Inc / Endo International PLC / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Eagle Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">02/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials Up YoY for Most Companies- Week 48</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">HZNP-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">HZNP.O / MRK / PFE / AMGN.O / RDY / AZN.O / RDUS.O</td><td class="leftalignment">Horizon Therapeutics PLC / Merck & Co Inc / Pfizer Inc / Amgen Inc / Dr Reddy's Laboratories Ltd / AstraZeneca PLC / Radius Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / India / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 2.26.21</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Feb 26 2021</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">ICAD=US / LHCG=US / MRK=US / BSX=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / GBT=US / MDT=US / WMT=US / INCY=US / INSP=US / CMS=US / DGX=US / NVS=US / BWAY=US / SNN=US / RAD=US / JNJ=US / MMSI=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / APLS=US / ARNA=US / ATRC=US / BDX=US / BLUE=US / CHE=US / CYH=US / EW=US / GEN=US / ICPT=US / LH=US / NBIX=US / PHAR=US / REGN=US / SILK=US / USPH=US / UTHR=US / UHS=US / SAGE=US / CGEN=US / CCRN=US / CNC=US / ACA=US / ENSG=US / MD=US / NKTR=US / SLF=US / BIIB=US / MRNA=US / ACAD=US / ALNY=US / MNKD=US / GOOG=US / DXCM=US / SNSS=US / CHNG=US / PODD=US / EHC=US / TNDM=US / ADUS=US / BLRX=US / ACHC=US / ALSN=US / ABBV=US / AGIO=US / FATE=US / AERI=US / MDWD=US / CTRE=US / AUPH=US / OTIC=US / EKTAY=US / VBLT=US / VCEL=US / NVRO=US / WBA=US / EVH=US / GKOS=US / TDOC=US / NVCR=US / VYGR=US / IONS=US / EDIT=US / NTLA=US / SRTS=US / TCMD=US / IRTC=US / IOVA=US / KALA=US / ATNX=US / RCKT=US / ALLO=US / TMDX=US / PSNL=US / KRTX=US / PNTG=US / ARQT=US / FBRX=US / FMTX=US / CZMWY=US / BIOVF=US / VPAHF=US</td><td class="leftalignment">ICAD Inc / LHC Group Inc / Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Medtronic PLC / Walmart Inc / Incyte Corp / Inspire Medical Systems Inc / CMS Energy Corp / Quest Diagnostics Inc / Novartis AG / Brainsway Ltd / Smith & Nephew PLC / Rite Aid Corp / Johnson & Johnson / Merit Medical Systems Inc / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Apellis Pharmaceuticals Inc / Arena Pharmaceuticals Inc / AtriCure Inc / Becton Dickinson and Co / bluebird bio Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Genesis Healthcare Inc / Intercept Pharmaceuticals Inc / Laboratory Corporation of America Holdings / Neurocrine Biosciences Inc / Pharming Group NV / Regeneron Pharmaceuticals Inc / Silk Road Medical Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / SAGE Therapeutics Inc / Compugen Ltd / Cross Country Healthcare Inc / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Nektar Therapeutics / Sun Life Financial Inc / Biogen Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / MannKind Corp / Alphabet Inc / Dexcom Inc / Viracta Therapeutics Inc / Change Healthcare Inc / Insulet Corp / Encompass Health Corp / Tandem Diabetes Care Inc / Addus Homecare Corp / BioLine RX Ltd / Acadia Healthcare Company Inc / Allison Transmission Holdings Inc / Abbvie Inc / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Aerie Pharmaceuticals Inc / Mediwound Ltd / CareTrust REIT Inc / Aurinia Pharmaceuticals Inc / Otonomy Inc / Elekta AB (publ) / Vascular Biogenics Ltd / Vericel Corp / Nevro Corp / Walgreens Boots Alliance Inc / Evolent Health Inc / Glaukos Corp / Teladoc Health Inc / Novocure Ltd / Voyager Therapeutics Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Sensus Healthcare Inc / Tactile Systems Technology Inc / iRhythm Technologies Inc / Iovance Biotherapeutics Inc / Kala Pharmaceuticals Inc / Athenex Inc / Rocket Pharmaceuticals Inc / Allogene Therapeutics Inc / Transmedics Group Inc / Personalis Inc / Karuna Therapeutics Inc / Pennant Group Inc / Arcutis Biotherapeutics Inc / Forte Biosciences Inc / Forma Therapeutics Holdings Inc / Carl Zeiss Meditec AG / Swedish Orphan Biovitrum AB (publ) / Volpara Health Technologies Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / United Kingdom / Ireland / Israel / Netherlands / New Zealand / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">CRM=US / ICAD=US / AAPL=US / IBM=US / MRK=US / LSI=US / DIS=US / INTC=US / TWTR=US / ADI=US / GBT=US / MSFT=US / AMZN=US / QCOM=US / T=US / ORCL=US / VOD=US / WMT=US / TXN=US / RUN=US / AMT=US / DOX=US / NVDA=US / GS=US / AKAM=US / CHTR=US / NICE=US / STM=FR / VZ=US / SMTC=US / CCI=US / UPS=US / XLNX=US / SYMC=US / ASML=US / CMCSA=US / DISH=US / INTU=US / NUAN=US / AMED=US / APPS=US / AZO=US / AVGO=US / BDX=US / BYND=US / HRB=US / BLUE=US / CTL=US / CME=US / DCI=US / EGAN=US / EGHT=US / EQIX=US / FLS=US / ICPT=US / TREE=US / MCHP=US / NBIX=US / ORLY=US / PZZA=US / QUIK=US / SBAC=US / SHOP=US / SUNS=US / SNAP=US / UTHR=US / VGR=US / VG=US / WSC=US / RDWR=US / SNOW=US / CGEN=US / AAP=US / NET=US / CRNT=US / FB=US / SWKS=US / NFLX=US / VRNT=US / TWLO=US / ERIC=US / RNG=US / FTCH=US / CEVA=US / MRNA=US / SFM=US / DPZ=US / MNKD=US / GOOG=US / DLR=US / ORA=US / VIAC=US / LHCG=US / DISCA=US / CHNG=US / CCOI=US / FSLR=US / ANET=US / LLNW=US / VMW=US / LUMN=US / 005930-KR=US / ADUS=US / SLRC=US / TSLA=US / NXPI=US / MRAAY=US / NMFC=US / ANGI=US / TCPC=US / WDAY=US / ABBV=US / TMUS=US / AGIO=US / AERI=US / CHGG=US / GTT=US / AVYA=US / GOOGL=US / FIVN=US / BABA=US / EKTAY=US / VBLT=US / QRVO=US / OUT=US / SHAK=US / ETSY=US / AQMS=US / NVCR=US / HPE=US / VYGR=US / EDIT=US / NTLA=US / SRTS=US / DZSI=US / IRTC=US / TEUM=US / ATUS=US / IOVA=US / KALA=US / CARG=US / RCKT=US / ALLO=US / ZM=US / FSLY=US / PSNL=US / CMBM=US / FVRR=US / FMTX=US / VLDR=US / CZMWY=US / RXT=US / ABNB=US / DASH=US / ONDS=US / VPAHF=US</td><td class="leftalignment">Salesforce.Com Inc / ICAD Inc / Apple Inc / International Business Machines Corp / Merck & Co Inc / Life Storage Inc / Walt Disney Co / Intel Corp / Twitter Inc / Analog Devices Inc / Global Blood Therapeutics Inc / Microsoft Corp / Amazon.com Inc / Qualcomm Inc / AT&T Inc / Oracle Corp / Vodafone Group PLC / Walmart Inc / Texas Instruments Inc / Sunrun Inc / American Tower Corp / Amdocs Ltd / NVIDIA Corp / Goldman Sachs Group Inc / Akamai Technologies Inc / Charter Communications Inc / Nice Ltd / STMicroelectronics NV / Verizon Communications Inc / Semtech Corp / Crown Castle International Corp / United Parcel Service Inc / Xilinx Inc / NortonLifeLock Inc / ASML Holding NV / Comcast Corp / DISH Network Corp / Intuit Inc / Nuance Communications Inc / Amedisys Inc / Digital Turbine Inc / Autozone Inc / Broadcom Inc / Becton Dickinson and Co / Beyond Meat Inc / H & R Block Inc / bluebird bio Inc / Lumen Technologies Inc / CME Group Inc / Donaldson Company Inc / eGain Corp / 8x8 Inc / Equinix Inc / Flowserve Corp / Intercept Pharmaceuticals Inc / Lendingtree Inc / Microchip Technology Inc / Neurocrine Biosciences Inc / O'Reilly Automotive Inc / Papa John's International Inc / QuickLogic Corp / SBA Communications Corp / Shopify Inc / SLR Senior Investment Corp / Snap Inc / United Therapeutics Corp / Vector Group Ltd / Vonage Holdings Corp / Willscot Mobile Mini Holdings Corp / Radware Ltd / Snowflake Inc. / Compugen Ltd / Advance Auto Parts Inc / Cloudflare Inc / Ceragon Networks Ltd / Meta Platforms Inc / Skyworks Solutions Inc / Netflix Inc / Verint Systems Inc / Twilio Inc / Telefonaktiebolaget LM Ericsson / RingCentral Inc / Farfetch Ltd / CEVA Inc / Moderna Inc / Sprouts Farmers Market Inc / Domino's Pizza Inc / MannKind Corp / Alphabet Inc / Digital Realty Trust Inc / Ormat Technologies Inc / ViacomCBS Inc / LHC Group Inc / Discovery Inc / Change Healthcare Inc / Cogent Communications Holdings Inc / First Solar Inc / Arista Networks Inc / Limelight Networks Inc / VMware Inc / Lumen Technologies Inc / Farfetch Ltd / Addus Homecare Corp / SLR Investment Corp / Tesla Inc / NXP Semiconductors NV / Murata Manufacturing Co Ltd / New Mountain Finance Corp / Angi Inc / BlackRock TCP Capital Corp / Workday Inc / Abbvie Inc / T-Mobile US Inc / Agios Pharmaceuticals Inc / Aerie Pharmaceuticals Inc / Chegg Inc / GTT Communications Inc / Avaya Holdings Corp / Alphabet Inc / Five9 Inc / Alibaba Group Holding Ltd / Elekta AB (publ) / Vascular Biogenics Ltd / Qorvo Inc / OUTFRONT Media Inc / Shake Shack Inc / ETSY Inc / Aqua Metals Inc / Novocure Ltd / Hewlett Packard Enterprise Co / Voyager Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Sensus Healthcare Inc / DZS Inc / iRhythm Technologies Inc / Pareteum Corp / Altice USA Inc / Iovance Biotherapeutics Inc / Kala Pharmaceuticals Inc / CarGurus Inc / Rocket Pharmaceuticals Inc / Allogene Therapeutics Inc / Zoom Video Communications Inc / Fastly Inc / Personalis Inc / Cambium Networks Corp / Fiverr International Ltd / Forma Therapeutics Holdings Inc / Velodyne Lidar Inc / Carl Zeiss Meditec AG / Rackspace Technology Inc / Airbnb Inc / DoorDash Inc / Ondas Holdings Inc / Volpara Health Technologies Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Germany / United Kingdom / Israel / Japan / Netherlands / New Zealand / Sweden / United States / Jersey / Guernsey</td><td class="leftalignment">Biotechnology / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Retailing / Semiconductors / Services / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK.N / PFE.N / GSK.L / AMGN.OQ / COLL.OQ / CERS.OQ / MDRX.OQ / ZIOP.OQ / AGIO.OQ / AERI.OQ / ITCI.OQ / CDTX.OQ / EVH.N / GOSS.OQ / HCAT.OQ / PCVX.OQ / FMTX.OQ / HGEN.OQ</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / Amgen Inc / Collegium Pharmaceutical Inc / Cerus Corp / Allscripts Healthcare Solutions Inc / ZIOPHARM Oncology Inc / Agios Pharmaceuticals Inc / Aerie Pharmaceuticals Inc / Intra-Cellular Therapies Inc / Cidara Therapeutics Inc / Evolent Health Inc / Gossamer Bio Inc / Health Catalyst Inc / Vaxcyte Inc / Forma Therapeutics Holdings Inc / Humanigen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">2000019 / 2094670 / 2778844 / 2026242 / 2045623 / 2065159 / 2942605 / 2544960 / 2190750 / 2270726 / 2829515 / 2382892 / 2317087 / 2576941 / 2670519 / 2345022 / 2367480 / 2457864 / 2471950 / 2459020 / 2657802 / 2689560 / 2684703 / 2048804 / 2440637 / 2862532 / 2138158 / 2799351 / 2825933 / 2829601 / B1F76F9 / 2857817 / 2951452 / B0T7YX2 / B2R3PV1 / B1XGNW4 / B3P93Y7 / 2390817 / 2949758 / B7TL820 / BFRTDG1 / BCBVTX1 / B7VD3F2 / B8L2798 / BJ0XLZ3 / B9M2WX3 / BFDV8K0 / BBPK0J0 / B3X26D8 / BCGCR79 / B8DPDT7 / BFLR866 / BFH3N85 / BFZCHN7 / BZ07BW4 / BYVY8G0 / BD3W133 / BYNZGK1 / BFZNYB7 / BK7Y2V9 / BZBY005 / BD8DJ71 / BNFWR44 / BZ00V34 / BZ8VJQ8 / BKTNTR9 / BJVR9Y9 / BFWK4R7 / BYYWPW6 / BDH65C8 / BZ1LFG7 / BK71LY6 / BKC9SX3 / BZ0P3Z5 / BJMLSD2 / BMG75B4 / BYTJZL1 / BX7RSN3 / BWY4XV3 / BRJ3GY4 / BP84RX0 / BDRW1L7 / BKLCX50 / BKT6B38 / BQXZP64 / BGDQ8B3 / BFY7DC4</td><td class="leftalignment">Amazon.com Inc / Best Buy Co Inc / Merck & Co Inc / American Electric Power Company Inc / ANSYS Inc / Autodesk Inc / Avista Corp / Beasley Broadcast Group Inc / Chesapeake Utilities Corp / Walt Disney Co / Edison International / Audacy Inc / Entergy Corp / Exelixis Inc / Exelon Corp / Macy's Inc / Genuine Parts Co / ImmunoGen Inc / Incyte Corp / Intuit Inc / OGE Energy Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / E W Scripps Co / Sempra Energy / Sinclair Broadcast Group Inc / South Jersey Industries Inc / Southern Co / Western Union Co / Netflix Inc / J M Smucker Co / Live Nation Entertainment Inc / American Water Works Company Inc / Insulet Corp / Anheuser Busch Inbev SA / Gray Television Inc / Nexstar Media Group Inc / Meta Platforms Inc / Aerie Pharmaceuticals Inc / Agios Pharmaceuticals Inc / Duke Energy Corp / Hemisphere Media Group Inc / Heron Therapeutics Inc / Bath & Body Works Inc / MacroGenics Inc / Mirati Therapeutics Inc / Pacira Biosciences Inc / Sprouts Farmers Market Inc / Sarepta Therapeutics Inc / Twitter Inc / Veeva Systems Inc / Wix.Com Ltd / Monster Beverage Corp / Alphabet Inc / Keurig Dr Pepper Inc / Block Inc / Allogene Therapeutics Inc / Akero Therapeutics Inc / Merus NV / Snap Inc / Worldline SA / Zscaler Inc / Vistra Corp / ViacomCBS Inc / iHeartMedia Inc / PagSeguro Digital Ltd / Beigene Ltd / PetIQ Inc / Roku Inc / WW International Inc / Arcturus Therapeutics Holdings Inc / Tegna Inc / Karuna Therapeutics Inc / Inventiva SA / Zogenix Inc / Collegium Pharmaceutical Inc / Adaptimmune Therapeutics PLC / Xenon Pharmaceuticals Inc / Townsquare Media Inc / AnaptysBio Inc / Health Catalyst Inc / SmileDirectClub Inc / Wayfair Inc / Axonics Inc / Altimmune Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Cayman Islands / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ELAN: Diagnosing 4Q: Turnaround Story Now Underway; Upgrading to Outperform</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">ELAN.N / MRK.N / IDXX.OQ / PDCO.OQ / WOOF.OQ / PETS.OQ / ZTS.N / PAHC.OQ / CVET.OQ / CHWY.N</td><td class="leftalignment">Elanco Animal Health Inc / Merck & Co Inc / IDEXX Laboratories Inc / Patterson Companies Inc / Petco Health and Wellness Company Inc / Petmed Express Inc / Zoetis Inc / Phibro Animal Health Corp / Covetrus Inc / Chewy Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides / Matthew Urbik</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">UCB.BR: UCB - FY20 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">UCB.BR / RECI.MI / LUN.CO / MRCG.DE / LONN.S / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC</td><td class="leftalignment">Ucb SA / Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / AMGN.OQ / COLL.OQ / ICAD.OQ / ALKS.OQ / OPTN.OQ / GILD.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BIIB.OQ / ACAD.OQ / MNKD.OQ / MSB.AX / EBS.N / SPRO.OQ / OMER.OQ / ARDX.OQ / ACRX.OQ / ZTS.N / ANIP.OQ / AXGN.OQ / FATE.OQ / AUP.TO / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / TDOC.N / SPNE.OQ / GBT.OQ / ACRS.OQ / DRIO.OQ / TVTY.OQ / VERU.OQ / TXMD.OQ / EOLS.OQ / RCUS.N / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / 120551486</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Amgen Inc / Collegium Pharmaceutical Inc / ICAD Inc / Alkermes Plc / OptiNose Inc / Gilead Sciences Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / Biogen Inc / ACADIA Pharmaceuticals Inc / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / AcelRx Pharmaceuticals Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Fate Therapeutics Inc / Aurinia Pharmaceuticals Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / Teladoc Health Inc / SeaSpine Holdings Corp / Global Blood Therapeutics Inc / Aclaris Therapeutics Inc / DarioHealth Corp / Tivity Health Inc / Veru Inc / TherapeuticsMD Inc / Evolus Inc / Arcus Biosciences Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology / Consumer / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Raise PAND P/T to $60 and Downgrade to Market Perform Following MRK Acquisition</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">4Q20 Review: Commercial Work Paving the Future</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">MRNA=US / MRK=US</td><td class="leftalignment">Moderna Inc / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">It's On, ACIP Meeting Today Sets The Stage For The PCV Race This Year</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRK / PFE / PCVX.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Vaxcyte Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Stock Looks Fully Valued Based On Opportunities And Risks</td><td class="leftalignment">English</td><td class="rightalignment">94</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Pharmaceutical Industry Pulse</td><td class="leftalignment">English</td><td class="rightalignment">1138</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US00287Y1091 / US98978V1035 / US28414H1032 / GB00BMVP7Y09</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Abbvie Inc / Zoetis Inc / Elanco Animal Health Inc / Royalty Pharma PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Pandion acquisition -- IL-2 mutein & beyond</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Call to Discuss The Potential Role Of And Key Focus Areas For ADCs In Oncology on Friday, April 9, 2021 at 1 pm ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N / PFE.N</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">We Barely Knew Ya...MRK Acquisition at $60/sh Cash; 130% Premium - No Contest</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">ITOS - Key Takeaways from the SVB Leerink Global Healthcare Conference</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ITOS=US / MRK=US / MREO=US / RCUS=US</td><td class="leftalignment">Iteos Therapeutics Inc / Merck & Co Inc / Mereo Biopharma Group PLC / Arcus Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Daina Graybosch, PHD</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - February 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">AMAT.O / CMS.N / DGE.L / EOG.N / FLS.N / FOUG.PA / MRK.N / PFE.N / TOL.N / PXD.N / GILD.O / TEN.N / AGI.N / WLK.N / NVDA.O / HON.N / MFC.TO / HD.N / LOW.N / WM.N / JAZZ.O / MTG.N / TJX.N / OKE.N / DK.N / OPTN.O / FLS.CO / SLF.TO / ENDP.O / CHE.N / HCC.N / AMED.O / STN.TO / TCW.TO / TFC.N / INGA.AS / 878742204 / ACAD.O / VIAC.O / RDSb.L / STX.O / BKD.N / TEVA.N / MWA.N / ATL.MI / GETP.PA / PCRX.O / HFC.N / XYL.N / WDC.O / ABBV.N / PRGO.N / CEQP.N / IBP.N / FLXN.O / AGRX.O / RYAM.N / AUPH.O / SUM.N / 78667J108 / TDOC.N / GBT.OQ / SITE.N / IONS.O / TRHC.OQ / NTNX.O / CDEV.O / AQUA.N / APTV.N / AMRX.N / EQH.N / XERS.O / BHC.N / AQST.O / ESTC.N / OSMT.O / 269796108 / FIXX.O / PING.N / PNTG.OQ / TFII.N</td><td class="leftalignment">Applied Materials Inc / CMS Energy Corp / Diageo PLC / EOG Resources Inc / Flowserve Corp / Eiffage SA / Merck & Co Inc / Pfizer Inc / Toll Brothers Inc / Pioneer Natural Resources Co / Gilead Sciences Inc / Tenneco Inc / Alamos Gold Inc / Westlake Chemical Corp / NVIDIA Corp / Honeywell International Inc / Manulife Financial Corp / Home Depot Inc / Lowe's Companies Inc / Waste Management Inc / Jazz Pharmaceuticals PLC / MGIC Investment Corp / TJX Companies Inc / ONEOK Inc / Delek US Holdings Inc / OptiNose Inc / FLSmidth & Co A/S / Sun Life Financial Inc / Endo International PLC / Chemed Corp / Warrior Met Coal Inc / Amedisys Inc / Stantec Inc / Trican Well Service Ltd / Truist Financial Corp / ING Groep NV / Teck Resources Ltd / ACADIA Pharmaceuticals Inc / ViacomCBS Inc / Royal Dutch Shell PLC / Seagate Technology Holdings PLC / Brookdale Senior Living Inc / Teva Pharmaceutical Industries Ltd / Mueller Water Products Inc / Atlantia SpA / Getlink SE / Pacira Biosciences Inc / HollyFrontier Corp / Xylem Inc / Western Digital Corp / Abbvie Inc / Perrigo Company PLC / Crestwood Equity Partners LP / Installed Building Products Inc / Pacira Biosciences Inc / Agile Therapeutics Inc / Rayonier Advanced Materials Inc / Aurinia Pharmaceuticals Inc / Summit Materials Inc / SAGE Therapeutics Inc / Teladoc Health Inc / Global Blood Therapeutics Inc / SiteOne Landscape Supply Inc / Ionis Pharmaceuticals Inc / Tabula Rasa HealthCare Inc / Nutanix Inc / Centennial Resource Development Inc / Evoqua Water Technologies Corp / Aptiv PLC / Amneal Pharmaceuticals Inc / Equitable Holdings Inc / Xeris Biopharma Holdings Inc / Bausch Health Companies Inc / Aquestive Therapeutics Inc / Elastic NV / Osmotica Pharmaceuticals PLC / Eagle Pharmaceuticals Inc / Homology Medicines Inc / Ping Identity Holding Corp / Pennant Group Inc / TFI International Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / France / United Kingdom / Ireland / Israel / Italy / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">02/24/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Short interest positioning read</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / PCRX.O / ABBV.N / PRGO.N / FLXN.O / AGRX.O / AMRX.N / XERS.O / AQST.O / OSMT.O / 269796108</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Pacira Biosciences Inc / Abbvie Inc / Perrigo Company PLC / Pacira Biosciences Inc / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Osmotica Pharmaceuticals PLC / Eagle Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">02/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS.OQ / AERI.OQ / 0715.HK / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / AMGN.OQ / COLL.OQ / ALKS.OQ / OPTN.OQ / GILD.OQ / CERS.OQ / RMTI.OQ / BDSI.OQ / BIIB.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / NEOS.BO / OMER.OQ / ARDX.OQ / ACRX.OQ / AMRN.NS / ZTS.N / ANIP.OQ / AXGN.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / VERU.OQ / TXMD.OQ / EOLS.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / Aerie Pharmaceuticals Inc / China Oceanwide Holdings Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Amgen Inc / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Gilead Sciences Inc / Cerus Corp / Rockwell Medical Inc / BioDelivery Sciences International Inc / Biogen Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Neo Corp International Ltd / Omeros Corp / Ardelyx Inc / AcelRx Pharmaceuticals Inc / ADF Foods Ltd / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Veru Inc / TherapeuticsMD Inc / Evolus Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Switzerland / France / United Kingdom / India / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">02/24/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Daily Credit Briefing</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">REE.MC / ACCP.PA / BKT.MC / KPN.AS / MRK.N / RENA.PA / SCOR.PA / WBSV.VI / SASY.PA / GSK.L / AMXL.MX / ARLG.DE / TLIT.MI / VAKBN.IS / SEVI.PA / GT.O / 0RPN.L</td><td class="leftalignment">Red Electrica Corporacion SA / Accor SA / Bankinter SA / Koninklijke KPN NV / Merck & Co Inc / Renault SA / Scor SE / Wienerberger AG / Sanofi SA / GlaxoSmithKline PLC / America Movil SAB de CV / Aareal Bank AG / Telecom Italia SpA / Turkiye Vakiflar Bankasi TAO / Suez SA / Goodyear Tire & Rubber Co / Digi Communications NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Austria / Belgium / Germany / Spain / Finland / France / United Kingdom / Italy / Mexico / Netherlands / Romania / Turkey / United States</td><td class="leftalignment">Advertising / Aerospace / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Conglomerates / Consumer / Containers & Packing / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Healthcare / Household Products / Industrial Materials / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Shipping & Shipbuilding / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS / CREDIT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr. Ulrich Scholz, CFA / Herr Christian Aust / Herr Sven Kreitmair, CFA / Herr Gianfranco Arcovito / Herr Jonathan Schroer / Frau Silke Stegemann / Frau. Jana Schuler / Sergey Bolshakov / Herr. Michael Teig / Herr Tobias Keller / Herr Natalie Tehrani Monfared / Herr. Stefan Kolek</td></tr>
<tr class="even"><td class="leftalignment">02/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GMAB.CO: Genmab - 4Q20 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">GMAB.CO / JNJ.N / JPM.N / RECI.MI / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / LONN.S / UCB.BR / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / HZNP.OQ / ABBV.N / VIFN.S</td><td class="leftalignment">Genmab A/S / Johnson & Johnson / JPMorgan Chase & Co / Recordati Industria Chimica e Farmaceutica SpA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Lonza Group AG / Ucb SA / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Horizon Therapeutics PLC / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Ireland / Italy / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Merck & Co</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">February 2021 issue of "Monthly Controversies" report</td><td class="leftalignment">English</td><td class="rightalignment">165</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Stephens Inc.</td><td class="leftalignment">First Look: CTLT Acquires Delphi Genetics, Adding Plasmid Capabilities</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BP96PQ4 / MRK</td><td class="leftalignment">Catalent Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jacob Johnson, CFA / Mr. Mason O. Carrico, CFA</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / WMB=US / LLY=US / LSI=US / PFE=US / AMGN=US / MCD=US / OXY=US / WEN=US / TEVA=US / GL=US / AMT=US / REI=US / V=US / CCI=US / HSII=US / MGY=US / CHRS=US / SPOT=US / MRO=US / CVS=US / RCL=US / DISH=US / KFY=US / CBRL=US / ELY=US / DRI=US / ABG=US / OKE=US / REGI=US / SBAC=US / VRTX=US / GOLF=US / CVX=US / ADC=US / PRI=US / NHI=US / PRA=US / NLS=US / DIN=US / EXR=US / PLAY=US / DENN=US / XM=US / KBR=US / CMG=US / REX=US / MA=US / GPRE=US / AMRX=US / TAST=US / QSR=US / JACK=US / CLNY=US / HTA=US / TREX=US / GDOT=US / SBRA=US / PANW=US / FANG=US / TMUS=US / NDLS=US / FIVN=US / VNOM=US / LOCO=US / SHAK=US / SUM=US / NSA=US / BWXT=US / WING=US / ZG=US / SQ=US / FRTA=US / RDFN=US / BTAI=US / ZI=US / BIGC=US / VTRS=US / 100073616</td><td class="leftalignment">Merck & Co Inc / Williams Companies Inc / Eli Lilly and Co / Life Storage Inc / Pfizer Inc / Amgen Inc / McDonald's Corp / Occidental Petroleum Corp / Wendys Co / Teva Pharmaceutical Industries Ltd / Globe Life Inc / American Tower Corp / Ring Energy Inc / Visa Inc / Crown Castle International Corp / Heidrick & Struggles International Inc / Magnolia Oil & Gas Corp / Coherus BioSciences Inc / Spotify Technology SA / Marathon Oil Corp / CVS Health Corp / Royal Caribbean Cruises Ltd / DISH Network Corp / Korn Ferry / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Darden Restaurants Inc / Asbury Automotive Group Inc / ONEOK Inc / Renewable Energy Group Inc / SBA Communications Corp / Vertex Pharmaceuticals Inc / Acushnet Holdings Corp / Chevron Corp / Agree Realty Corp / Primerica Inc / National Health Investors Inc / ProAssurance Corp / Nautilus Inc / Dine Brands Global Inc / Extra Space Storage Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Qualtrics International Inc / KBR Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Mastercard Inc / Green Plains Inc / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Jack in the Box Inc / DigitalBridge Group Inc / Healthcare Trust Of America Inc / Trex Company Inc / Green Dot Corp / Sabra Health Care REIT Inc / Palo Alto Networks Inc / Diamondback Energy Inc / T-Mobile US Inc / Noodles & Co / Five9 Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / Summit Materials Inc / National Storage Affiliates Trust / BWX Technologies Inc / Wingstop Inc / Zillow Group Inc / Block Inc / Forterra Inc / Redfin Corp / BioXcel Therapeutics Inc / ZoomInfo Technologies Inc / Bigcommerce Holdings Inc / Viatris Inc / Kimco Realty Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / Liberia / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Takeaways on IO and Targeted Approaches from our GHC Lung Cancer Panel</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US / AMGN=US / AZN=US / JNJ=US / TPTX=US / MRTX=US / BPMC=US / HARP=US / BNTX=US / GMAB=US / RVMD=US</td><td class="leftalignment">Merck & Co Inc / Amgen Inc / AstraZeneca PLC / Johnson & Johnson / Turning Point Therapeutics Inc / Mirati Therapeutics Inc / Blueprint Medicines Corp / Harpoon Therapeutics Inc / BioNTech SE / Genmab A/S / Revolution Medicines Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Dr. Daina Graybosch, PHD / Dr. Andrew S. Berens, MD / Mr. Jonathan W. Chang, PHD</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Therapeutic Categories Outlook</td><td class="leftalignment">English</td><td class="rightalignment">3621</td><td class="leftalignment">US0311621009 / US0463531089 / US1101221083 / US30161Q1040 / US3755581036 / US37733W1053 / US4781601046 / US5324571083 / US66987V1098 / US7170811035 / US75886F1075 / US7711951043 / US91307C1027 / US92532F1003 / US80105N1054 / US09062X1037 / US58933Y1055 / IE00BJ3V9050</td><td class="leftalignment">Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Exelixis Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Sanofi SA / Biogen Inc / Merck & Co Inc / Endo International PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Health Care Team</td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">RECI.MI: Recordati - 4Q20 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">RECI.MI / LUN.CO / NOVN.S / MRCG.DE / LONN.S / UCB.BR / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / VIFN.S / GMAB.CO</td><td class="leftalignment">Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Novartis AG / Merck KGaA / Lonza Group AG / Ucb SA / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ALM.MC: Almirall - 4Q20 Second opinion</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ALM.MC / RECI.MI / LUN.CO / MRCG.DE / LONN.S / UCB.BR / IPN.PA / ORNBV.HE / GRLS.MC / VIFN.S / GMAB.CO</td><td class="leftalignment">Almirall SA / Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Ipsen SA / Orion Oyj / Grifols SA / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Merck KGaA</td><td class="leftalignment">English</td><td class="rightalignment">71</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N / NCOX.PA / AERI.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / HGEN.OQ / GRAY.OQ / OCUP.OQ</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Nicox SA / Aerie Pharmaceuticals Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Humanigen Inc / Graybug Vision Inc / Ocuphire Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Merck sinks 12.5% from 6 week high</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 12, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Feb 22 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">FR0000121014 / GB0004544929 / GB0002875804 / US0079731008 / US0116591092 / US0382221051 / US0463531089 / US1005571070 / US1101221083 / US1912161007 / US1925761066 / US2254471012 / US37733W1053 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US6556641008 / US66987V1098 / US6701002056 / US7134481081 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US8807701029 / US91347P1057 / US9182041080 / US4771431016 / US4198791018 / US80105N1054 / US02209S1033 / US3463751087 / US90385V1070 / US2538681030 / US19239V3024 / US2090341072 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US03027X1000 / US00287Y1091 / NL0010273215 / US4576693075 / US23283R1005 / US8485771021 / US21240E1055 / CH0210483332 / US02376R1023 / US3623931009 / US14862Q1004 / CA0089118776 / US22822V1017 / US29444U7000 / US36165L1089 / KYG4740B1059 / US78410G1040 / US91325V1089 / US83418M1036 / US87105L1044 / US19626G1085 / US5904791358 / KY30744W1070 / US76156B1070 / US55406W1036 / US82489W1071</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / Imperial Brands PLC / British American Tobacco PLC / Advanced Energy Industries Inc / Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Boston Beer Company Inc / Bristol-Myers Squibb Co / Coca-Cola Co / Cohu Inc / Wolfspeed Inc / GlaxoSmithKline PLC / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Nordstrom Inc / Novartis AG / Novo Nordisk A/S / PepsiCo Inc / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Teradyne Inc / Universal Display Corp / VF Corp / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Altria Group Inc / FormFactor Inc / Ultra Clean Holdings Inc / Digital Realty Trust Inc / Cogent Communications Holdings Inc / Consolidated Communications Holdings Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / American Tower Corp / Abbvie Inc / ASML Holding NV / Insmed Inc / CyrusOne Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Compagnie Financiere Richemont SA / American Airlines Group Inc / GTT Communications Inc / Castlight Health Inc / Air Canada / Crown Castle International Corp / Equinix Inc / GDS Holdings Ltd / Ichor Holdings Ltd / SBA Communications Corp / Uniti Group Inc / Solaris Oilfield Infrastructure Inc / Switch Inc / DigitalBridge Group Inc / Mesa Air Group Inc / Farfetch Ltd / Revolve Group Inc / MYT Netherlands Parent BV / Shoals Technologies Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - February 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">ALTR.O / ALV.N / AU.N / BP.L / CCI.N / CF.N / CL.N / CNA.L / CNE.L / EL.N / ENI.MI / EOG.N / F.N / FLS.N / FOUG.PA / GE.N / GM.N / KMB.N / KO.N / MRK.N / NA / NVA.TO / OXY.N / PD.TO / PFE.N / REP.MC / SGC.L / STO.AX / T.N / TLW.L / TOTF.PA / VC.N / WPL.AX / PEP.N / TRI.N / BFb.N / PG.N / PXD.N / CNQ.TO / CPB.N / TEN.N / CMCSA.O / AMGN.O / ETN.N / BWA.N / LEA.N / WCC.N / K.N / DISH.O / IMO.TO / SU.TO / BTE.TO / CLX.N / CAG.N / VLO.N / MRO.N / INTU.O / GIS.N / EMR.N / XOM.N / DVN.N / EPC.N / MGA.N / JAZZ.O / ORG.AX / CONE.O / GWW.N / VZ.N / EXEL.O / JCI.N / ARNA.O / STZ.N / APH.N / RRC.N / FISV.O / EQT.N / ADSK.O / CHTR.O / AXL.N / CHD.N / BC.N / DK.N / POU.TO / ESI.TO / SAM.N / FOG.L / BMRN.O / REGN.O / ENR.N / CVX.N / BPT.AX / SM.N / NCR.N / PSI.TO / TEL.N / COP.N / CPE.N / ENDP.O / PII.N / ST.N / SWN.N / TT.N / FCF.N / O.N / SGEN.OQ / GPN.N / MNST.O / EFX.TO / IMGN.O / CASY.O / ANSS.O / EQIX.O / ATDb.TO / FAR.AX / COE.AX / CVN.AX / TCW.TO / CFW.TO / 02209S103 / NTR.N / NVT.N / CR.TO / DLR.N / SCL.TO / NESTE.HE / 427866108 / WEF.TO / RDSb.L / KOS.N / DISCA.O / KAR.AX / FIS.N / SES.TO / ALD.AX / MWA.N / HOG.N / GALP.LS / BIR.TO / CLR.N / BGS.N / VMW.N / COI.AX / DAN.N / GTE.TO / NOG.A / PBF.N / EDPR.LS / WGO.AX / CPG.TO / AAV.TO / CEU.TO / SPB.N / ATH.TO / OAS.N / MEG.TO / VET.TO / TOU.TO / NXT.AX / ERF.TO / FRU.TO / PEY.TO / PCRX.O / MTOR.N / MPC.N / HFC.N / PXT.TO / MTDR.N / XYL.N / TVE.TO / PSX.N / PANW.N / MDLZ.OQ / FANG.O / KEL.TO / TSLA.N / PRMW.N / TMUS.N / DOO.TO / COTY.N / CJ.TO / QTWO.N / TSLX.N / PSK.TO / LXE.V / AXTA.N / SHOP.N / GLPG.O / SQ.N / MESO.O / RACE.MI / TWLO.N / ATKR.N / PARR.N / KNSL.OQ / ATS.AX / AKERBP.OL / NTNX.O / ADNT.N / GDS.O / CDEV.O / STEP.TO / ESTE.N / ATNX.O / APTV.N / ZS.OQ / ENOG.L / DBX.O / AMRX.N / VNE.N / KDP.N / FOCS.O / VEN.AX / ESTC.N / NWL.O / PIPE.V / LSPD.TO / 269796108 / CRWD.O / GMAB.O / PING.N / CRNC.OQ / EPAC.N / 2222.SE / OVV.N / REYN.O / CARR.N / LUNE.ST / NKLA.OQ / APA.OQ / FOUR.N / RXT.OQ / IBEX.O / LUMN.N / PLTR.N / MCFE.OQ / TPZ.TO / AFRM.O / 120291281 / 120681711</td><td class="leftalignment">Altair Engineering Inc / Autoliv Inc / AngloGold Ashanti Ltd / BP PLC / Crown Castle International Corp / CF Industries Holdings Inc / Colgate-Palmolive Co / Centrica PLC / Capricorn Energy PLC / Estee Lauder Companies Inc / Eni SpA / EOG Resources Inc / Ford Motor Co / Flowserve Corp / Eiffage SA / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / National Bank of Canada / Nuvista Energy Ltd / Occidental Petroleum Corp / Precision Drilling Corp / Pfizer Inc / Repsol SA / Stagecoach Group PLC / Santos Ltd / AT&T Inc / Tullow Oil PLC / TotalEnergies SE / Visteon Corp / Woodside Petroleum Ltd / PepsiCo Inc / Thomson Reuters Corp / Brown-Forman Corp / Procter & Gamble Co / Pioneer Natural Resources Co / Canadian Natural Resources Ltd / Campbell Soup Co / Tenneco Inc / Comcast Corp / Amgen Inc / Eaton Corporation PLC / Borgwarner Inc / Lear Corp / Wesco International Inc / Kellogg Co / DISH Network Corp / Imperial Oil Ltd / Suncor Energy Inc / Baytex Energy Corp / Clorox Co / Conagra Brands Inc / Valero Energy Corp / Marathon Oil Corp / Intuit Inc / General Mills Inc / Emerson Electric Co / Exxon Mobil Corp / Devon Energy Corp / Edgewell Personal Care Co / Magna International Inc / Jazz Pharmaceuticals PLC / Origin Energy Ltd / CyrusOne Inc / W W Grainger Inc / Verizon Communications Inc / Exelixis Inc / Johnson Controls International PLC / Arena Pharmaceuticals Inc / Constellation Brands Inc / Amphenol Corp / Range Resources Corp / Fiserv Inc / EQT Corp / Autodesk Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / Church & Dwight Co Inc / Brunswick Corp / Delek US Holdings Inc / Paramount Resources Ltd / Ensign Energy Services Inc / Boston Beer Company Inc / Falcon Oil & Gas Ltd / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Chevron Corp / Beach Energy Ltd / SM Energy Co / NCR Corp / Pason Systems Inc / TE Connectivity Ltd / Conocophillips / Callon Petroleum Co / Endo International PLC / Polaris Inc / Sensata Technologies Holding PLC / Southwestern Energy Co / Trane Technologies PLC / First Commonwealth Financial Corp / Realty Income Corp / Seagen Inc / Global Payments Inc / Monster Beverage Corp / Enerflex Ltd / ImmunoGen Inc / Caseys General Stores Inc / ANSYS Inc / Equinix Inc / Alimentation Couche-Tard Inc / FAR Ltd / Cooper Energy Ltd / Carnarvon Energy Ltd / Trican Well Service Ltd / Calfrac Well Services Ltd / Altria Group Inc / Nutrien Ltd / nVent Electric PLC / Crew Energy Inc / Digital Realty Trust Inc / Shawcor Ltd / Neste Oyj / Hershey Co / Western Forest Products Inc / Royal Dutch Shell PLC / Kosmos Energy Ltd / Discovery Inc / Karoon Energy Ltd / Fidelity National Information Services Inc / Secure Energy Services Inc / Ampol Ltd / Mueller Water Products Inc / Harley-Davidson Inc / Galp Energia SGPS SA / Birchcliff Energy Ltd / Continental Resources Inc / B&G Foods Inc / VMware Inc / Comet Ridge Ltd / Dana Inc / Gran Tierra Energy Inc / Northern Oil and Gas Inc / PBF Energy Inc / EDP Renovaveis SA / Warrego Energy Ltd / Crescent Point Energy Corp / Advantage Energy Ltd / CES Energy Solutions Corp / Spectrum Brands Holdings Inc / Athabasca Oil Corp / Oasis Petroleum Inc / MEG Energy Corp / Vermilion Energy Inc / Tourmaline Oil Corp / NEXTDC Ltd / Enerplus Corp / Freehold Royalties Ltd / Peyto Exploration & Development Corp / Pacira Biosciences Inc / Meritor Inc / Marathon Petroleum Corp / HollyFrontier Corp / Parex Resources Inc / Matador Resources Co / Xylem Inc / Tamarack Valley Energy Ltd / Phillips 66 / Palo Alto Networks Inc / Mondelez International Inc / Diamondback Energy Inc / Kelt Exploration Ltd / Tesla Inc / Primo Water Corp / T-Mobile US Inc / BRP Inc / Coty Inc / Cardinal Energy Ltd (Alberta) / Q2 Holdings Inc / Sixth Street Specialty Lending Inc / Prairiesky Royalty Ltd / Leucrotta Exploration Inc / Axalta Coating Systems Ltd / Shopify Inc / Galapagos NV / Block Inc / Mesoblast Ltd / Ferrari NV / Twilio Inc / Atkore Inc / Par Pacific Holdings Inc / Kinsale Capital Group Inc / Australis Oil & Gas Ltd / Aker BP ASA / Nutanix Inc / Adient PLC / GDS Holdings Ltd / Centennial Resource Development Inc / Step Energy Services Ltd / Earthstone Energy Inc / Athenex Inc / Aptiv PLC / Zscaler Inc / Energean PLC / Dropbox Inc / Amneal Pharmaceuticals Inc / Veoneer Inc / Keurig Dr Pepper Inc / Focus Financial Partners Inc / Vintage Energy Ltd / Elastic NV / Newell Brands Inc / Pipestone Energy Corp / Lightspeed Commerce Inc / Eagle Pharmaceuticals Inc / CrowdStrike Holdings Inc / Genmab A/S / Ping Identity Holding Corp / Cerence Inc / Enerpac Tool Group Corp / Saudi Arabian Oil Co / Ovintiv Inc / Reynolds Consumer Products Inc / Carrier Global Corp / Lundin Energy AB / Nikola Corp / APA Corp (US) / Shift4 Payments Inc / Rackspace Technology Inc / Ibex Ltd / Lumen Technologies Inc / Palantir Technologies Inc / Mcafee Corp / Topaz Energy Corp / Affirm Holdings Inc / Cenovus Energy Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / Spain / Finland / France / United Kingdom / Ireland / Italy / Netherlands / Norway / Papua New Guinea / Portugal / Saudi Arabia / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">REGN: Three for Three: Increasing our TP on three successful FDA approvals in Feb 2021, helping to diversify beyond Eylea and Dupixent</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">REGN.OQ / MRK.N / SASY.PA</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Merck & Co Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Feb 12, 2021: Focus on Jan 2021 Rx volumes for branded and generic drugs</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / RB.L / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ / MNK.N^J20</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Reckitt Benckiser Group PLC / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc / Mallinckrodt PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">02/21/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Call to Discuss The Potential Role Of And Key Focus Areas For ADCs In Oncology on Friday, April 9, 2021 at 1 pm ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK / PFE</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">02/21/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Questions for Management 2.21.21</td><td class="leftalignment">English</td><td class="rightalignment">76</td><td class="leftalignment">ADAP=US / MRK=US / BSX=US / CSII=US / PFE=US / ABT=US / AMGN=US / TMO=US / MDT=US / A=US / INCY=US / INSP=US / TEVA=US / GILD=US / MOR=DE / SAN=FR / GSK=GB / SYK=US / BAX=US / AZN=US / WAT=US / JNJ=US / MDRX=US / IMGN=US / NUAN=US / ABMD=US / ALKS=US / ALC=US / AMRN=US / ARNA=US / ATRC=US / BDX=US / BMRN=US / BLUE=US / CSTL=US / CALA=US / CERN=US / CNMD=US / EW=US / ENDP=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / INGN=US / ISRG=US / MYGN=US / NBIX=US / PRGO=US / PRTK=US / RARE=US / HOOK=US / REGN=US / RGEN=US / SENS=US / SIEN=US / SILK=US / TECH=US / TFX=US / VRTX=US / ALGN=US / SGEN=US / SAGE=US / OPT=US / PRVB=US / CGEN=US / ALVR=US / JAZZ=US / PHR=US / STSA=US / RNA=US / IMTX=US / MREO=US / NTRA=US / CPSI=US / NKTR=US / MRNS=US / AMTI=US / BIIB=US / ACRS=US / ARWR=US / APTX=US / NUVA=US / MRNA=US / ACAD=US / ALNY=US / MNKD=US / COGT=US / DXCM=US / CYRX=US / CBAY=US / GRAY=US / EQ=US / QTRX=US / AVRO=US / TPTX=US / AMRX=US / FOLD=US / PODD=US / TNDM=US / IFRX=US / ITRM=US / NXGN=US / FULC=US / LUN=US / ASND=US / AVEO=US / NEO=US / RCUS=US / MOLN / CTSO=US / ZGNX=US / PCRX=US / RGNX=US / CLVS=US / PBYI=US / AXGN=US / VCRA=US / CCXI=US / FGEN=US / SRPT=US / GMED=US / ABBV=US / EPZM=US / MRTX=US / AGIO=US / PINC=US / FATE=US / MGNX=US / VEEV=US / VCYT=US / KPTI=US / OM=US / ITCI=US / XNCR=US / HRTX=US / QURE=US / GNCA=US / TBPH=US / ARDX=US / RDUS=US / MASS=US / XENT=US / ASMB=US / HQY=US / TTOO=US / AUPH=US / AFMD=US / GNFT=US / DBVT=US / VCEL=US / XENE=US / NVRO=US / NVTA=US / RLMD=US / VKTX=US / BPMC=US / HTGM=US / ZBH=US / ABEO=US / TDOC=US / KURA=US / WVE=US / AXSM=US / IONS=US / BGNE=US / NTLA=US / ADVM=US / RETA=US / MDGL=US / PTGX=US / ACIU=US / TRHC=US / MYOV=US / ZYME=US / AVDL=US / OBSV=US / RCM=US / BHVN=US / MRSN=US / KALV=US / ATNX=US / SYBX=US / ZLAB=US / DCPH=US / SCPH=US / SLDB=US / GH=US / RCKT=US / EOLS=US / XERS=US / REPL=US / RUBY=US / CRNX=US / ALLK=US / SBTX=US / TWST=US / AXNX=US / MLND=US / OSMT=US / ORGO=US / HARP=US / GOSS=US / TCRR=US / IMUX=US / AXLA=US / BBIO=US / HCAT=US / BNTX=US / GMAB=US / IPHA=US / ETNB=US / PGNY=US / CNTG=US / IMVT=US / ONEM=US / RVMD=US / IMRA=US / ZNTL=US / KROS=US / FMTX=US / ACCD=US / ITOS=US / KDNY=US / GDRX=US / SPRB=US / SIOX=US / VTRS=US / ABCM=US / GLTO=US / TVTX=US / ABCL=US / KNTE=US / ELDN=US / PRTC=US / CGEM=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Pfizer Inc / Abbott Laboratories / Amgen Inc / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Incyte Corp / Inspire Medical Systems Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / MorphoSys AG / Sanofi SA / GlaxoSmithKline PLC / Stryker Corp / Baxter International Inc / AstraZeneca PLC / Waters Corp / Johnson & Johnson / Allscripts Healthcare Solutions Inc / ImmunoGen Inc / Nuance Communications Inc / ABIOMED Inc / Alkermes Plc / Alcon AG / Amarin Corporation PLC / Arena Pharmaceuticals Inc / AtriCure Inc / Becton Dickinson and Co / Biomarin Pharmaceutical Inc / bluebird bio Inc / Castle Biosciences Inc / Calithera Biosciences Inc / Cerner Corp / Conmed Corp / Edwards Lifesciences Corp / Endo International PLC / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Inogen Inc / Intuitive Surgical Inc / Myriad Genetics Inc / Neurocrine Biosciences Inc / Perrigo Company PLC / Paratek Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Senseonics Holdings Inc / Sientra Inc / Silk Road Medical Inc / Bio-Techne Corp / Teleflex Inc / Vertex Pharmaceuticals Inc / Align Technology Inc / Seagen Inc / SAGE Therapeutics Inc / Opthea Ltd / Provention Bio Inc / Compugen Ltd / Allovir Inc / Jazz Pharmaceuticals PLC / Phreesia Inc / Satsuma Pharmaceuticals Inc / Avidity Biosciences Inc / Immatics NV / Mereo Biopharma Group PLC / Natera Inc / Computer Programs and Systems Inc / Nektar Therapeutics / Marinus Pharmaceuticals Inc / Applied Molecular Transport Inc. / Biogen Inc / Aclaris Therapeutics Inc / Arrowhead Pharmaceuticals Inc / Aptinyx Inc / NuVasive Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / MannKind Corp / Cogent Biosciences Inc / Dexcom Inc / Cryoport Inc / Cymabay Therapeutics Inc / Graybug Vision Inc / Equillium Inc / Quanterix Corp / AVROBIO Inc / Turning Point Therapeutics Inc / Amneal Pharmaceuticals Inc / Amicus Therapeutics Inc / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Iterum Therapeutics PLC / NextGen Healthcare Inc / Fulcrum Therapeutics Inc / H Lundbeck A/S / Ascendis Pharma A/S / Aveo Pharmaceuticals Inc / Neogenomics Inc / Arcus Biosciences Inc / Molecular Partners AG / Cytosorbents Corp / Zogenix Inc / Pacira Biosciences Inc / Regenxbio Inc / Clovis Oncology Inc / Puma Biotechnology Inc / AxoGen Inc / Vocera Communications Inc / ChemoCentryx Inc / FibroGen Inc / Sarepta Therapeutics Inc / Globus Medical Inc / Abbvie Inc / Epizyme Inc / Mirati Therapeutics Inc / Agios Pharmaceuticals Inc / Premier Inc / Fate Therapeutics Inc / MacroGenics Inc / Veeva Systems Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Outset Medical Inc / Intra-Cellular Therapies Inc / Xencor Inc / Heron Therapeutics Inc / Uniqure NV / Genocea Biosciences Inc / Theravance Biopharma Inc / Ardelyx Inc / Radius Health Inc / 908 Devices Inc. / Intersect Ent Inc / Assembly Biosciences Inc / Healthequity Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Affimed NV / Genfit SA / DBV Technologies SA / Vericel Corp / Xenon Pharmaceuticals Inc / Nevro Corp / Invitae Corp / Relmada Therapeutics Inc / Viking Therapeutics Inc / Blueprint Medicines Corp / HTG Molecular Diagnostics Inc / Zimmer Biomet Holdings Inc / Abeona Therapeutics Inc / Teladoc Health Inc / Kura Oncology Inc / WAVE Life Sciences Ltd / Axsome Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Reata Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Protagonist Therapeutics Inc / AC Immune SA / Tabula Rasa HealthCare Inc / Myovant Sciences Ltd / Zymeworks Inc / Avadel Pharmaceuticals PLC / Obseva SA / R1 RCM Inc / Biohaven Pharmaceutical Holding Company Ltd / Mersana Therapeutics Inc / Kalvista Pharmaceuticals Inc / Athenex Inc / Synlogic Inc / Zai Lab Ltd / Deciphera Pharmaceuticals Inc / scPharmaceuticals Inc / Solid Biosciences Inc / Guardant Health Inc / Rocket Pharmaceuticals Inc / Evolus Inc / Xeris Biopharma Holdings Inc / Replimune Group Inc / Rubius Therapeutics Inc / Crinetics Pharmaceuticals Inc / Allakos Inc / Silverback Therapeutics Inc / Twist Bioscience Corp / Axonics Inc / Tempest Therapeutics Inc / Osmotica Pharmaceuticals PLC / Organogenesis Holdings Inc / Harpoon Therapeutics Inc / Gossamer Bio Inc / TCR2 Therapeutics Inc / Immunic Inc / Axcella Health Inc / BridgeBio Pharma Inc / Health Catalyst Inc / BioNTech SE / Genmab A/S / Innate Pharma SA / 89Bio Inc / Progyny Inc / Centogene NV / Immunovant Inc / 1Life Healthcare Inc / Revolution Medicines Inc / Imara Inc / Zentalis Pharmaceuticals Inc / Keros Therapeutics Inc / Forma Therapeutics Holdings Inc / Accolade Inc / Iteos Therapeutics Inc / Chinook Therapeutics Inc / Goodrx Holdings Inc / Spruce Biosciences Inc / Sio Gene Therapies Inc / Viatris Inc / Abcam PLC / Galecto Inc / Travere Therapeutics Inc / Abcellera Biologics Inc / Kinnate Biopharma Inc / Eledon Pharmaceuticals Inc / PureTech Health PLC / Cullinan Oncology Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / Singapore / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / ENDP.O / PCRX.O / AMRX.N / 269796108</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / Endo International PLC / Pacira Biosciences Inc / Amneal Pharmaceuticals Inc / Eagle Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">02/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Trial Activity Remains Positive - Week 47</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 2.19.21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Weekly: Gvoke Maintains 10% Share; Gx Vascepa Back to 10% Bottle Share</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / GSK=US / ENDP=US / PRGO=US / BIIB=US / AMRX=US / ABBV=US / XERS=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Endo International PLC / Perrigo Company PLC / Biogen Inc / Amneal Pharmaceuticals Inc / Abbvie Inc / Xeris Biopharma Holdings Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Ami Fadia</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Feb 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">UTHR=US / XAIR=US / MRK=US / BSX=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / GBT=US / MDT=US / WMT=US / TEVA=US / EPIX=US / CMS=US / DGX=US / SYK=US / IART=US / BWAY=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / BLUE=US / CHE=US / CYH=US / EW=US / EXAS=US / EXEL=US / GEN=US / ICPT=US / PHG=US / LH=US / REGN=US / USPH=US / UHS=US / VRTX=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / MD=US / SLF=US / MNKD=US / GOOG=US / LHCG=US / CHNG=US / MASI=US / EHC=US / SWAV=US / ADUS=US / ALPMY=US / ACHC=US / SRPT=US / AGIO=US / CTRE=US / OTIC=US / VBLT=US / WBA=US / NVTA=US / CLLS=US / VKTX=US / EVH=US / CFMS=US / CERC=US / EDIT=US / MDGL=US / IRTC=US / CRSP=US / VERU=US / MBIO=US / MDNA=US / SESN=US / ARVN=US / FREQ=US / BXRX=US / PNTG=US / TARA=US / AYLA=US / FMTX=US / MNKKQ=US / CHGCY=US</td><td class="leftalignment">United Therapeutics Corp / Beyond Air Inc / Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Medtronic PLC / Walmart Inc / Teva Pharmaceutical Industries Ltd / ESSA Pharma Inc / CMS Energy Corp / Quest Diagnostics Inc / Stryker Corp / Integra Lifesciences Holdings Corp / Brainsway Ltd / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / bluebird bio Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Exact Sciences Corp / Exelixis Inc / Genesis Healthcare Inc / Intercept Pharmaceuticals Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / Regeneron Pharmaceuticals Inc / US Physical Therapy Inc / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Sun Life Financial Inc / MannKind Corp / Alphabet Inc / LHC Group Inc / Change Healthcare Inc / Masimo Corp / Encompass Health Corp / Shockwave Medical Inc / Addus Homecare Corp / Astellas Pharma Inc / Acadia Healthcare Company Inc / Sarepta Therapeutics Inc / Agios Pharmaceuticals Inc / CareTrust REIT Inc / Otonomy Inc / Vascular Biogenics Ltd / Walgreens Boots Alliance Inc / Invitae Corp / Cellectis SA / Viking Therapeutics Inc / Evolent Health Inc / Conformis Inc / Avalo Therapeutics Inc / Editas Medicine Inc / Madrigal Pharmaceuticals Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Veru Inc / Mustang Bio Inc / Medicenna Therapeutics Corp / Sesen Bio Inc / Arvinas Inc / Frequency Therapeutics Inc / Baudax Bio Inc / Pennant Group Inc / Protara Therapeutics Inc / Ayala Pharmaceuticals Inc / Forma Therapeutics Holdings Inc / Mallinckrodt PLC / Chugai Pharmaceutical Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / France / Ireland / Israel / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending Feb 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck & Co Inc: Ownership Timelines & Shareholder Analytics (February 2021)</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">PharmaValues - Website Introduction Slides</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / CSL.AX / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / 4506.T / 4536.T / SASY.PA / ROG.S / LUN.CO / 4151.T / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / 4568.T / IPN.PA / HIK.L / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / 4578.T / 4581.T / SRPT.OQ / ABBV.N / QURE.OQ / BGNE.OQ / VIFN.S / 6160.HK / GMAB.CO</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Kyowa Kirin Co Ltd / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Daiichi Sankyo Co Ltd / Ipsen SA / Hikma Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / Sarepta Therapeutics Inc / Abbvie Inc / Uniqure NV / Beigene Ltd / Vifor Pharma AG / Beigene Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GMAB.CO: Genmab - Sensitivity to Darzalex Faspro adoption and model update ahead of FY20 results</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GMAB.CO / JNJ.N / RECI.MI / LUN.CO / MRCG.DE / LONN.S / UCB.BR / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / VIFN.S</td><td class="leftalignment">Genmab A/S / Johnson & Johnson / Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">02/18/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Merck in bottom 5% performers of NYSE market in past quarter; Institutional Ownership down 3%</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">02/18/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Bempeg Collaborations in SCCHN Revive Excitement</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NKTR=US / MRK=US</td><td class="leftalignment">Nektar Therapeutics / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Daina Graybosch, PHD</td></tr>
<tr class="even"><td class="leftalignment">02/18/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">V / 0989529 / 2868165 / 2516152 / 2681511 / 2486813 / 2778844 / 2050832 / 2026242 / 2732635 / 2113393 / 2270726 / 2542049 / 2829515 / 2100920 / 2415204 / 2457864 / 2459020 / 2515030 / 2645409 / 2657802 / 2689560 / 2048804 / 2440637 / 2416962 / 2862532 / 2900335 / 2931034 / B121557 / 2951452 / B02R1L6 / B2R3PV1 / B7TL820 / B7VD3F2 / BJ0KXV4 / BDZCRX3 / BFZCHN7 / BTN1Y44 / BVVN4Q8 / BYY8XK8 / BYVY8G0 / BYW36M8 / BXDZ9Z0 / BD8DJ71 / BJ9NDZ8 / BFZ1K46 / BLGJ610 / BFMXGR0 / BZ8VJQ8 / BZ1LFG7 / BWY52P3 / BKX9VD3 / BF2G3Y5 / BKS3RS7 / BFY7DC4</td><td class="leftalignment">Visa Inc / AstraZeneca PLC / Sysco Corp / Eli Lilly and Co / PepsiCo Inc / Kellogg Co / Merck & Co Inc / Ameren Corp / American Electric Power Company Inc / AutoNation Inc / Boston Beer Company Inc / Walt Disney Co / Dominion Energy Inc / Edison International / FirstEnergy Corp / Hawaiian Electric Industries Inc / ImmunoGen Inc / Intuit Inc / Lithia Motors Inc / NiSource Inc / OGE Energy Corp / PG&E Corp / Pinnacle West Capital Corp / CenterPoint Energy Inc / Henry Schein Inc / E W Scripps Co / Tractor Supply Co / Vertex Pharmaceuticals Inc / Mastercard Inc / J M Smucker Co / ALLETE Inc / American Water Works Company Inc / Meta Platforms Inc / Duke Energy Corp / ONE Gas Inc / RingCentral Inc / Wix.Com Ltd / Walgreens Boots Alliance Inc / Eversource Energy / WEC Energy Group Inc / Alphabet Inc / PayPal Holdings Inc / Shopify Inc / Snap Inc / NeuBase Therapeutics Inc / Spotify Technology SA / Warner Music Group Corp / Evergy Inc / Vistra Corp / Roku Inc / Blueprint Medicines Corp / Arcutis Biotherapeutics Inc / AVROBIO Inc / 10X Genomics Inc / Altimmune Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">02/18/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ZTS-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ZTS / LLY / MRK / PFE / ICCC.O / HSKA.O / PAHC.O / SNY.O</td><td class="leftalignment">Zoetis Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / ImmuCell Corp / Heska Corp / Phibro Animal Health Corp / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ZTS-US -  Dividend Quality Analysis, for the period ended December 01,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ZTS / LLY / MRK / PFE / ICCC.O / HSKA.O / PAHC.O / SNY.O</td><td class="leftalignment">Zoetis Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / ImmuCell Corp / Heska Corp / Phibro Animal Health Corp / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US -  Dividend Quality Analysis, for the period ended December 30,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Call to Discuss The Potential Role Of And Key Focuses For ADCs In Oncology on Friday, April 9, 2021 at 1 pm ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N / PFE.N</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">OlympiA Update Keeps Us Positive On Expanding Opportunities For Lynparza</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">TARA=US / ULTA=US / MRK=US / PFE=US / AMGN=US / BMY=US / INTC=US / AMD=US / GBT=US / MSFT=US / QCOM=US / EPIX=US / NVDA=US / SCI=US / BWAY=US / TSM=US / EMR=US / HUM=US / BKI=US / CVS=US / BLUE=US / EXAS=US / RBC=US / UTHR=US / VRTX=US / RHHBY=US / RNG=US / CEVA=US / MNKD=US / GOOG=US / DENN=US / RXN=US / SFTBY=US / AGIO=US / SABR=US / SEDG=US / CERC=US / EDIT=US / CRSP=US / VERU=US / MBIO=US / SESN=US / ARVN=US / BXRX=US / FMTX=US / CHGCY=US</td><td class="leftalignment">Protara Therapeutics Inc / Ulta Beauty Inc / Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Intel Corp / Advanced Micro Devices Inc / Global Blood Therapeutics Inc / Microsoft Corp / Qualcomm Inc / ESSA Pharma Inc / NVIDIA Corp / Service Corporation International / Brainsway Ltd / Taiwan Semiconductor Manufacturing Co Ltd / Emerson Electric Co / Humana Inc / Black Knight Inc / CVS Health Corp / bluebird bio Inc / Exact Sciences Corp / Regal Rexnord Corp / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Roche Holding AG / RingCentral Inc / CEVA Inc / MannKind Corp / Alphabet Inc / Denny's Corp / Zurn Water Solutions Corp / SoftBank Group Corp / Agios Pharmaceuticals Inc / Sabre Corp / Solaredge Technologies Inc / Avalo Therapeutics Inc / Editas Medicine Inc / CRISPR Therapeutics AG / Veru Inc / Mustang Bio Inc / Sesen Bio Inc / Arvinas Inc / Baudax Bio Inc / Forma Therapeutics Holdings Inc / Chugai Pharmaceutical Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Israel / Japan / Taiwan / United States</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Electrical / Financial Services / Healthcare / Household Products / Info. Tech./Computers / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Pharmaceuticals / Semiconductors</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Carefully Building an Oncology and Rare Disease Company; Initiate Outperform</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">TARA=US / MRK=US / PFE=US / BMY=US / RHHBY=US / CERC=US / SESN=US / CHGCY=US</td><td class="leftalignment">Protara Therapeutics Inc / Merck & Co Inc / Pfizer Inc / Bristol-Myers Squibb Co / Roche Holding AG / Avalo Therapeutics Inc / Sesen Bio Inc / Chugai Pharmaceutical Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">DNB / MRK=US / LLY=US / PFE=US / HD=US / MCD=US / EFX=US / WEN=US / DVN=US / TEVA=US / TRU=US / CRK=US / LOW=US / WLL=US / DIOD=US / CHRS=US / BYD=US / MAR=US / LEG=US / VMC=US / ESS=US / MGM=US / BKI=US / EQR=US / CVS=US / STZ=US / ARCC=US / CBRL=US / CSGP=US / DRI=US / EXAS=US / MEDP=US / MHK=US / REGI=US / SGMO=US / VRTX=US / WIX=US / NET=US / UDR=US / VNO=US / DIN=US / MGP=US / MOH=US / RNG=US / TPX=US / KAR=US / AINV=US / PLAY=US / DENN=US / CMG=US / REX=US / FIS=US / GPRE=US / AMRX=US / TAST=US / QSR=US / CLR=US / PNNT=US / PRPL=US / IAA=US / JACK=US / ZTS=US / SBRA=US / FBHS=US / PANW=US / NDLS=US / NMIH=US / 70806A106 / LOCO=US / SHAK=US / NXRT=US / GSBD=US / CHCT=US / WING=US / CRSP=US / PVAC=US / JELD=US / IMVT=US / VTRS=US</td><td class="leftalignment">Dun & Bradstreet Holdings Inc / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Home Depot Inc / McDonald's Corp / Equifax Inc / Wendys Co / Devon Energy Corp / Teva Pharmaceutical Industries Ltd / TransUnion / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Diodes Inc / Coherus BioSciences Inc / Boyd Gaming Corp / Marriott International Inc / Leggett & Platt Inc / Vulcan Materials Co / Essex Property Trust Inc / MGM Resorts International / Black Knight Inc / Equity Residential / CVS Health Corp / Constellation Brands Inc / Ares Capital Corp / Cracker Barrel Old Country Store Inc / CoStar Group Inc / Darden Restaurants Inc / Exact Sciences Corp / Medpace Holdings Inc / Mohawk Industries Inc / Renewable Energy Group Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Wix.Com Ltd / Cloudflare Inc / UDR Inc / Vornado Realty Trust / Dine Brands Global Inc / MGM Growth Properties LLC / Molina Healthcare Inc / RingCentral Inc / Tempur Sealy International Inc / KAR Auction Services Inc / Apollo Investment Corp / Dave & Buster's Entertainment Inc / Denny's Corp / Chipotle Mexican Grill Inc / REX American Resources Corp / Fidelity National Information Services Inc / Green Plains Inc / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Pennantpark Investment Corp / Purple Innovation Inc / IAA Inc / Jack in the Box Inc / Zoetis Inc / Sabra Health Care REIT Inc / Fortune Brands Home & Security Inc / Palo Alto Networks Inc / Noodles & Co / NMI Holdings Inc / PennantPark Floating Rate Capital Ltd / El Pollo Loco Holdings Inc / Shake Shack Inc / NexPoint Residential Trust Inc / Goldman Sachs BDC Inc / Community Healthcare Trust Inc / Wingstop Inc / CRISPR Therapeutics AG / Ranger Oil Corp / JELD-WEN Holding Inc / Immunovant Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">5671735 / 0989529 / 2367026 / 2577609 / 2126335 / 2516152 / 2778844 / 2026242 / 2208073 / 2280220 / 2270726 / 2542049 / 2100920 / 2415204 / 2459020 / 2684703 / 7103065 / 2822019 / B121557 / 2857817 / B2R3PV1 / B4Y1MH7 / BBFL7S1 / B7VD3F2 / B8CKK03 / BFZCHN7 / B95WG16 / BYRY499 / BYY8XK8 / BYVFC94 / BJF8Q81 / BDHF4K6 / BZ1HM42 / BLGJ610 / BFMXGR0 / BZ8VJQ8 / BGT3960 / BJRFSB7</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / General Mills Inc / CVS Health Corp / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / American Electric Power Company Inc / Copart Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / FirstEnergy Corp / Hawaiian Electric Industries Inc / Intuit Inc / Pfizer Inc / Novartis AG / Advance Auto Parts Inc / Mastercard Inc / Netflix Inc / American Water Works Company Inc / KAR Auction Services Inc / bluebird bio Inc / Duke Energy Corp / Mondelez International Inc / Wix.Com Ltd / Zoetis Inc / Kraft Heinz Co / WEC Energy Group Inc / US Foods Holding Corp / IAA Inc / CRISPR Therapeutics AG / Adyen NV / Warner Music Group Corp / Evergy Inc / Vistra Corp / Orchard Therapeutics PLC / Immunovant Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 05, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">VNDA-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">VNDA.O / BMY / JNJ / LLY / MRK / NVS / PFE / TTNP.O</td><td class="leftalignment">Vanda Pharmaceuticals Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Titan Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Global Pharma Model Sweep: Reopening and Washington Headwinds Should Abate in 2H21 as Key Potential Catalysts Approach</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">0989529 / 2126335 / 5671735 / 0925288 / 2516152 / 2778844 / 7103065 / BHC8X90</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Sanofi SA / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Kepler Cheuvreux</td><td class="leftalignment">Merck KGAA | Buy | Good dynamics expected in Q4 and 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David P. Evans</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Feb 16 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0116591092 / US0382221051 / US0463531089 / US0530151036 / US0997241064 / US1101221083 / US1311931042 / US30161Q1040 / US3614481030 / US3647601083 / US37733W1053 / US4234521015 / US4663671091 / US5324571083 / US66987V1098 / US6701002056 / US7043261079 / US7170811035 / US75886F1075 / US7711951043 / US7782961038 / US8308791024 / US8447411088 / US8552441094 / US8725401090 / US87612E1064 / US9311421039 / US3448491049 / US4771431016 / US4198791018 / US80105N1054 / US21036P1084 / US2533931026 / US25754A2015 / US0491642056 / US1696561059 / PAP310761054 / US79546E1047 / US01748X1028 / US2473617023 / US90384S3031 / US00922R1059 / US58933Y1055 / US9100471096 / US92335C1062 / US00287Y1091 / US5017971046 / IE00B4Q5ZN47 / US55345K1034 / US8485771021 / US21240E1055 / US1220171060 / CA05156V1022 / US02376R1023 / US70438V1061 / US70432V1026 / US0404131064 / US67576A1007 / IE00BQPVQZ61 / US0994061002 / CA0089118776 / US12685J1051 / US26856L1035 / US01345P1066 / CA1350861060 / US8760301072 / US15677J1088 / US5904791358 / CA39342L1085 / CA23126M1023 / US81181C1045 / US55406W1036</td><td class="leftalignment">Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Automatic Data Processing Inc / Borgwarner Inc / Bristol-Myers Squibb Co / Callaway Golf Co / Exelixis Inc / GATX Corp / Gap Inc / GlaxoSmithKline PLC / Helmerich and Payne Inc / Jack in the Box Inc / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Paychex Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / Ross Stores Inc / SkyWest Inc / Southwest Airlines Co / Starbucks Corp / TJX Companies Inc / Target Corp / Walmart Inc / Foot Locker Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Constellation Brands Inc / DICK'S Sporting Goods Inc / Domino's Pizza Inc / Atlas Air Worldwide Holdings Inc / Chipotle Mexican Grill Inc / Copa Holdings SA / Sally Beauty Holdings Inc / Allegiant Travel Co / Delta Air Lines Inc / Ulta Beauty Inc / Air Transport Services Group Inc / Merck & Co Inc / United Airlines Holdings Inc / Vera Bradley Inc / Abbvie Inc / Bath & Body Works Inc / Jazz Pharmaceuticals PLC / MRC Global Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Burlington Stores Inc / Aurinia Pharmaceuticals Inc / American Airlines Group Inc / Paylocity Holding Corp / Paycom Software Inc / Arista Networks Inc / Ocular Therapeutix Inc / Horizon Therapeutics PLC / Boot Barn Holdings Inc / Air Canada / Cable One Inc / elf Beauty Inc / Albireo Pharma Inc / Canada Goose Holdings Inc / Tapestry Inc / Ceridian HCM Holding Inc / Mesa Air Group Inc / Green Thumb Industries Inc / Curaleaf Holdings Inc / Seagen Inc / MYT Netherlands Parent BV</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / Ireland / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IO at ASCO-GU: Bounty of RCC Options, MIBC Comes Into Focus, & IL-2 Gets a Win</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">MRK=US / NKTR=US</td><td class="leftalignment">Merck & Co Inc / Nektar Therapeutics</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Dr. Daina Graybosch, PHD</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">2020 Was an Excellent Vintage for Biopharma IPO Returns, No Slowdown Yet in '21</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">MRK=US / TEVA=US / GILD=US / AZN=US / BMRN=US / OPT=US / ALVR=US / RNA=US / SNY=US / AMTI=US / BIIB=US / GRAY=US / LUN=US / SBTX=US / BNTX=US / RVMD=US / IMRA=US / ZNTL=US / KROS=US / FMTX=US / ITOS=US / SPRB=US / GLTO=US / ABCL=US / KNTE=US</td><td class="leftalignment">Merck & Co Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / AstraZeneca PLC / Biomarin Pharmaceutical Inc / Opthea Ltd / Allovir Inc / Avidity Biosciences Inc / Sanofi SA / Applied Molecular Transport Inc. / Biogen Inc / Graybug Vision Inc / H Lundbeck A/S / Silverback Therapeutics Inc / BioNTech SE / Revolution Medicines Inc / Imara Inc / Zentalis Pharmaceuticals Inc / Keros Therapeutics Inc / Forma Therapeutics Holdings Inc / Iteos Therapeutics Inc / Spruce Biosciences Inc / Galecto Inc / Abcellera Biologics Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">2126335 / 2516152 / 2023607 / 2778844 / 2026242 / 2111955 / 2280220 / 2270726 / 2542049 / 2576941 / 2100920 / 2455965 / 2457864 / 2459020 / 2048804 / 2730190 / 2402121 / 7103065 / B121557 / 2212922 / 2857817 / B125XQ6 / B2R3PV1 / B3D7K31 / B03PGL4 / B7TL820 / B7VD3F2 / BFLR866 / B76LYJ2 / BFH3N85 / BYY8XK8 / BP4GNK9 / BYW36M8 / BFZNYB7 / BD9GVY0 / BDHF4K6 / BZBY005 / BKS3SM8 / BQT3XY6 / BZ1HM42 / BR4T3B3 / BMQ5T49 / BWFKZT2 / BZ8VJQ8 / BKTNTR9 / BK6N347 / BJXBP30 / BYQHPK7 / BJ9NFQ3 / BK71LY6 / BM8MM05 / BP8XZL1</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / American Electric Power Company Inc / Borgwarner Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Exelixis Inc / FirstEnergy Corp / Biogen Inc / ImmunoGen Inc / Intuit Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / Nuance Communications Inc / Novartis AG / Mastercard Inc / NRG Energy Inc / Netflix Inc / Portland General Electric Co / American Water Works Company Inc / Discovery Inc / NorthWestern Corp / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Vocera Communications Inc / Veeva Systems Inc / WEC Energy Group Inc / SAGE Therapeutics Inc / PayPal Holdings Inc / Allogene Therapeutics Inc / Zai Lab Ltd / CRISPR Therapeutics AG / Merus NV / IGM Biosciences Inc / Cyberark Software Ltd / Adyen NV / HubSpot Inc / Zentalis Pharmaceuticals Inc / Cellectis SA / Vistra Corp / ViacomCBS Inc / Uber Technologies Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Neoleukin Therapeutics Inc / WW International Inc / Madison Square Garden Entertainment Corp / Healthequity Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - February 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">AC.TO / ALV.N / ANTO.L / BAER.S / BARC.L / BBDb.TO / BCE.TO / BHP.AX / BNPP.PA / CC.N / CI.N / CL.N / CP.TO / CSGN.S / EDP.LS / EL.N / ELE.MC / F.N / GM.N / HSBA.L / IBE.MC / IP.N / KBH.N / KMB.N / KO.N / LLOY.L / MRK.N / PFE.N / PHM.N / RIO.AX / RIO.L / RWEG.DE / SAN.MC / SOGN.PA / T.N / T.TO / TOL.N / VC.N / SSE.L / PEP.N / BFb.N / PG.N / HUM.N / CPB.N / TEN.N / CMCSA.O / CAE.TO / SJRb.TO / RCIb.TO / AMGN.O / THC.N / FER.MC / AAL.L / CNR.TO / QBRb.TO / UNH.N / BWA.N / LEA.N / CCA.TO / REE.MC / ENB.TO / K.N / DISH.O / LEN.N / TV.TO / DBKGn.DE / CLX.N / CAG.N / GIS.N / EPC.N / MGA.N / SBAC.O / BBVA.MC / JAZZ.O / ADI.O / NG.L / VZ.N / EXEL.O / DHI.N / STZ.N / APH.N / DVA.N / FISV.O / SNPS.O / CHTR.O / AXL.N / PLD.N / CHD.N / ATA.TO / BC.N / ARCC.O / SAM.N / FRAG.DE / REGN.O / ENR.N / VRTX.O / SWIR.O / FTT.TO / CAGR.PA / MHK.N / NCR.N / NET.N / TEL.N / APF.L / PII.N / ST.N / TYL.N / HCC.N / SGEN.OQ / GPN.N / MNST.O / NWG.L / CCLb.TO / IMGN.O / CASY.O / STN.TO / ATDb.TO / IGO.AX / TIH.TO / SNC.TO / FM.TO / INGA.AS / 02209S103 / 878742204 / DLR.N / HUN.N / 427866108 / 35671D857 / FIS.N / TEVA.N / CS.TO / HOG.N / 443628102 / 550372106 / ATL.MI / BGS.N / CBRO.L / DAN.N / EDPR.LS / OZL.AX / ABI.BR / SFR.AX / VALE.N / SPB.N / BHPB.L / CAML.L / MTOR.N / GLEN.L / TRL.TO / QLYS.O / FFHu.TO / MDLZ.OQ / 505440107 / TPH.N / TSLA.N / PRMW.N / TMUS.N / TMHC.N / DOO.TO / COTY.N / PRTA.O / 46579R104 / VRNS.O / CIA.TO / PAYC.N / RYAM.N / HUBS.N / ANTM.N / CIGI.O / PYPL.OQ / WRK.N / RPD.O / ABNd.AS / MESO.O / RACE.MI / UBSG.S / MTRO.L / MP1.AX / ADNT.N / GRPG.I / ATNX.O / ORSTED.CO / APTV.N / NEXA.TO / VNE.N / NTGY.MC / KDP.N / XERS.O / NWL.O / GMAB.O / DDOG.O / CRNC.OQ / VMUK.L / PEAK.N / PAGPA.L / REYN.O / SBSW.N / TFII.N / SLQT.N / NKLA.OQ / FOUR.N / LUMN.N / 900435207 / AFRM.O / 120681711</td><td class="leftalignment">Air Canada / Autoliv Inc / Antofagasta PLC / Julius Baer Gruppe AG / Barclays PLC / Bombardier Inc / BCE Inc / BHP Group Ltd / BNP Paribas SA / Chemours Co / Cigna Corp / Colgate-Palmolive Co / Canadian Pacific Railway Ltd / Credit Suisse Group AG / EDP Energias de Portugal SA / Estee Lauder Companies Inc / Endesa SA / Ford Motor Co / General Motors Co / HSBC Holdings PLC / Iberdrola SA / International Paper Co / KB Home / Kimberly-Clark Corp / Coca-Cola Co / Lloyds Banking Group PLC / Merck & Co Inc / Pfizer Inc / Pultegroup Inc / Rio Tinto Ltd / Rio Tinto PLC / Rwe AG / Banco Santander SA / Societe Generale SA / AT&T Inc / Telus Corp / Toll Brothers Inc / Visteon Corp / SSE PLC / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Humana Inc / Campbell Soup Co / Tenneco Inc / Comcast Corp / CAE Inc / Shaw Communications Inc / Rogers Communications Inc / Amgen Inc / Tenet Healthcare Corp / Ferrovial SA / Anglo American PLC / Canadian National Railway Co / Quebecor Inc / UnitedHealth Group Inc / Borgwarner Inc / Lear Corp / Cogeco Communications Inc / Red Electrica Corporacion SA / Enbridge Inc / Kellogg Co / DISH Network Corp / Lennar Corp / Trevali Mining Corp / Deutsche Bank AG / Clorox Co / Conagra Brands Inc / General Mills Inc / Edgewell Personal Care Co / Magna International Inc / SBA Communications Corp / Banco Bilbao Vizcaya Argentaria SA / Jazz Pharmaceuticals PLC / Analog Devices Inc / National Grid PLC / Verizon Communications Inc / Exelixis Inc / D R Horton Inc / Constellation Brands Inc / Amphenol Corp / DaVita Inc / Fiserv Inc / Synopsys Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / Prologis Inc / Church & Dwight Co Inc / ATS Automation Tooling Systems Inc / Brunswick Corp / Ares Capital Corp / Boston Beer Company Inc / Fraport AG Frankfurt Airport Services Worldwide / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Vertex Pharmaceuticals Inc / Sierra Wireless Inc / Finning International Inc / Credit Agricole SA / Mohawk Industries Inc / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Anglo Pacific Group PLC / Polaris Inc / Sensata Technologies Holding PLC / Tyler Technologies Inc / Warrior Met Coal Inc / Seagen Inc / Global Payments Inc / Monster Beverage Corp / Natwest Group PLC / CCL Industries Inc / ImmunoGen Inc / Caseys General Stores Inc / Stantec Inc / Alimentation Couche-Tard Inc / IGO Ltd / Toromont Industries Ltd / SNC-Lavalin Group Inc / First Quantum Minerals Ltd / ING Groep NV / Altria Group Inc / Teck Resources Ltd / Digital Realty Trust Inc / Huntsman Corp / Hershey Co / Freeport-McMoRan Inc / Fidelity National Information Services Inc / Teva Pharmaceutical Industries Ltd / Capstone Mining Corp / Harley-Davidson Inc / Hudbay Minerals Inc / Lundin Mining Corp / Atlantia SpA / B&G Foods Inc / Close Brothers Group PLC / Dana Inc / EDP Renovaveis SA / OZ Minerals Ltd / Anheuser Busch Inbev SA / Sandfire Resources Ltd / Vale SA / Spectrum Brands Holdings Inc / BHP Group PLC / Central Asia Metals PLC / Meritor Inc / Glencore PLC / Trilogy International Partners Inc / Qualys Inc / Fairfax Financial Holdings Ltd / Mondelez International Inc / Labrador Iron Ore Royalty Corp / Tri Pointe Homes Inc (Delaware) / Tesla Inc / Primo Water Corp / T-Mobile US Inc / Taylor Morrison Home Corp / BRP Inc / Coty Inc / Prothena Corporation PLC / Ivanhoe Mines Ltd / Varonis Systems Inc / Champion Iron Ltd / Paycom Software Inc / Rayonier Advanced Materials Inc / HubSpot Inc / Anthem Inc / Colliers International Group Inc / PayPal Holdings Inc / Westrock Co / Rapid7 Inc / ABN Amro Bank NV / Mesoblast Ltd / Ferrari NV / UBS Group AG / Metro Bank PLC / Megaport Ltd / Adient PLC / Greencoat Renewables PLC / Athenex Inc / Orsted A/S / Aptiv PLC / Nexa Resources SA / Veoneer Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Newell Brands Inc / Genmab A/S / Datadog Inc / Cerence Inc / Virgin Money UK PLC / Healthpeak Properties Inc / Paragon Banking Group PLC / Reynolds Consumer Products Inc / Sibanye Stillwater Ltd / TFI International Inc / SelectQuote Inc / Nikola Corp / Shift4 Payments Inc / Lumen Technologies Inc / Turquoise Hill Resources Ltd / Affirm Holdings Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Brazil / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / Portugal / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Trefis Report: Merck - $99.95 Trefis Price Estimate</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Trial Activity Remains Positive - Week 46</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">EXEL (BUY) - Updated Takeaways from ASCO GU & KOL Panel: Competitor Clearly Potent but Likely More Toxic Than CM-9ER</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2576941 / 2778844 / 2684703</td><td class="leftalignment">Exelixis Inc / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Yige Guo, Ph.D. / Kelsey Goodwin</td></tr>
<tr class="odd"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">02/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Weekly: Gvoke Back Above 10% Mkt Share; Viatris' Gx Advair Share Steady</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">VTRS.OQ / MRK=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / ENDP=US / PRGO=US / BIIB=US / AMRX=US / ABBV=US / XERS=US / VTRS=US</td><td class="leftalignment">Viatris Inc / Merck & Co Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Endo International PLC / Perrigo Company PLC / Biogen Inc / Amneal Pharmaceuticals Inc / Abbvie Inc / Xeris Biopharma Holdings Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Ami Fadia</td></tr>
<tr class="odd"><td class="leftalignment">02/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused next week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / TEVA.N / XERS.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Xeris Biopharma Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">02/15/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">EXEL-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">EXEL.O / BMY / JNJ / MRK / PFE / AMGN.O / GSK / CRIS.O / AVEO.O / SNY.O</td><td class="leftalignment">Exelixis Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Curis Inc / Aveo Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/15/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AZN-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AZN.O / ABT / BMY / JNJ / LLY / MRK / NVS / PFE / GSK / BIIB.O / SNY.O</td><td class="leftalignment">AstraZeneca PLC / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Biogen Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Feb 05, 2021: Focus on Dupixent's resilience</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / RB.L / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Reckitt Benckiser Group PLC / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">02/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IPN.PA: Ipsen - Keytruda + Lenvima adds incremental challenge for Cabometyx in 1L RCC</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">IPN.PA / BMY.N / MRK.N / PFE.N</td><td class="leftalignment">Ipsen SA / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 2.12.21</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">SGEN (BUY) – Takeaways from Guggenheim Oncology Day Fireside Chat with Mgmt: Long-Term Growth Story Intact</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">0989529 / 2778844</td><td class="leftalignment">AstraZeneca PLC / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--February 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">BNGO=US / INO=US / AAPL=US / MRK=US / BSX=US / CSII=US / PFE=US / ABT=US / BMY=US / MDT=US / WMT=US / INCY=US / EPIX=US / CMS=US / DGX=US / NVS=US / AZN=US / CRY=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ATRC=US / CHE=US / CYH=US / EW=US / EXEL=US / GEN=US / LH=US / NVAX=US / REGN=US / SILK=US / USPH=US / UTHR=US / UHS=US / VRTX=US / SGEN=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / SNY=US / MD=US / SLF=US / BIIB=US / ISR=US / MRNA=US / ALNY=US / GOOG=US / DXCM=US / LHCG=US / CHNG=US / INFI=US / ORTX=US / EHC=US / BAYRY=US / SPRO=US / SWAV=US / ADUS=US / ALPMY=US / ACHC=US / ARCT=US / ABBV=US / PRTA=US / ENTA=US / CTRE=US / WBA=US / NVTA=US / EVH=US / ZBH=US / IONS=US / EDIT=US / AVDL=US / MTEM=US / VERU=US / GMDA=US / NBSE=US / FREQ=US / RCEL=US / PNTG=US / TSHA=US / SIOX=US</td><td class="leftalignment">Bionano Genomics Inc / Inovio Pharmaceuticals Inc / Apple Inc / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Medtronic PLC / Walmart Inc / Incyte Corp / ESSA Pharma Inc / CMS Energy Corp / Quest Diagnostics Inc / Novartis AG / AstraZeneca PLC / CryoLife Inc / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / AtriCure Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Exelixis Inc / Genesis Healthcare Inc / Laboratory Corporation of America Holdings / Novavax Inc / Regeneron Pharmaceuticals Inc / Silk Road Medical Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Seagen Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / Sanofi SA / MEDNAX Inc / Sun Life Financial Inc / Biogen Inc / IsoRay Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Alphabet Inc / Dexcom Inc / LHC Group Inc / Change Healthcare Inc / Infinity Pharmaceuticals Inc / Orchard Therapeutics PLC / Encompass Health Corp / Bayer AG / Spero Therapeutics Inc / Shockwave Medical Inc / Addus Homecare Corp / Astellas Pharma Inc / Acadia Healthcare Company Inc / Arcturus Therapeutics Holdings Inc / Abbvie Inc / Prothena Corporation PLC / Enanta Pharmaceuticals Inc / CareTrust REIT Inc / Walgreens Boots Alliance Inc / Invitae Corp / Evolent Health Inc / Zimmer Biomet Holdings Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Avadel Pharmaceuticals PLC / Molecular Templates Inc / Veru Inc / Gamida Cell Ltd / NeuBase Therapeutics Inc / Frequency Therapeutics Inc / AVITA Medical Inc / Pennant Group Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / France / United Kingdom / Ireland / Israel / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / NVS=US / GSK=GB / AZN=US / GSK=US / JNJ=US / EXEL=US / ICPT=US / NVO=US / REGN=US / RHHBY=US / INVA=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Exelixis Inc / Intercept Pharmaceuticals Inc / Novo Nordisk A/S / Regeneron Pharmaceuticals Inc / Roche Holding AG / Innoviva Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">INO=US / TWOU=US / AAPL=US / MRK=US / WSM=US / NKE=US / PFE=US / BMY=US / HD=US / INTC=US / ADI=US / AMD=US / BWA=US / MSFT=US / AMZN=US / QCOM=US / BBY=US / TXN=US / EPIX=US / MPWR=US / NVS=US / SMTC=US / LOW=US / TSM=US / AZN=US / CRY=US / XLNX=US / EXPE=US / JNJ=US / UNH=US / ARCC=US / AVGO=US / BL=US / CRUS=US / IFX=US / FROG=US / MCHP=US / NVAX=US / REGN=US / TSCO=US / UTHR=US / VCTR=US / WTS=US / SGEN=US / RHHBY=US / PYPL=US / SWKS=US / ARES=US / DKS=US / BIIB=US / MRNA=US / ALNY=US / ENS=US / GOOG=US / BJRI=US / PBH=US / DXCM=US / XPO=US / LULU=US / GNRC=US / MXL=US / NXPI=US / ARCT=US / PRTA=US / VRNS=US / GDDY=US / UAA=US / CARG=US / DDOG=US / RCEL=US / SIOX=US</td><td class="leftalignment">Inovio Pharmaceuticals Inc / 2U Inc / Apple Inc / Merck & Co Inc / Williams-Sonoma Inc / Nike Inc / Pfizer Inc / Bristol-Myers Squibb Co / Home Depot Inc / Intel Corp / Analog Devices Inc / Advanced Micro Devices Inc / Borgwarner Inc / Microsoft Corp / Amazon.com Inc / Qualcomm Inc / Best Buy Co Inc / Texas Instruments Inc / ESSA Pharma Inc / Monolithic Power Systems Inc / Novartis AG / Semtech Corp / Lowe's Companies Inc / Taiwan Semiconductor Manufacturing Co Ltd / AstraZeneca PLC / CryoLife Inc / Xilinx Inc / Expedia Group Inc / Johnson & Johnson / UnitedHealth Group Inc / Ares Capital Corp / Broadcom Inc / Blackline Inc / Cirrus Logic Inc / Infineon Technologies AG / Jfrog Ltd / Microchip Technology Inc / Novavax Inc / Regeneron Pharmaceuticals Inc / Tractor Supply Co / United Therapeutics Corp / Victory Capital Holdings Inc / Watts Water Technologies Inc / Seagen Inc / Roche Holding AG / PayPal Holdings Inc / Skyworks Solutions Inc / Ares Management Corp / DICK'S Sporting Goods Inc / Biogen Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / EnerSys / Alphabet Inc / BJ's Restaurants Inc / Prestige Consumer Healthcare Inc / Dexcom Inc / XPO Logistics Inc / Lululemon Athletica Inc / Generac Holdings Inc / Maxlinear Inc / NXP Semiconductors NV / Arcturus Therapeutics Holdings Inc / Prothena Corporation PLC / Varonis Systems Inc / GoDaddy Inc / Under Armour Inc / CarGurus Inc / Datadog Inc / AVITA Medical Inc / Sio Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / United Kingdom / Ireland / Israel / Netherlands / Taiwan / United States</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Retailing / Semiconductors / Services</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFIZ.NS / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / RMTI.OQ / AMRN.OQ / BDSI.OQ / BSLN.S / ALNY.OQ / MNKD.OQ / MSB.AX / EBS.N / ACB.TO / FOLD.OQ / JAZZ.OQ / SPRO.OQ / OMER.OQ / ARDX.OQ / ACRX.OQ / VCRA.N / ABBV.N / ZTS.N / ANIP.OQ / AXGN.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / OTIC.OQ / CFRX.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / ACRS.OQ / CKPT.OQ / VERU.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / ARQT.OQ / PCVX.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / 120551486</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Ltd / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / Alnylam Pharmaceuticals Inc / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Aurora Cannabis Inc / Amicus Therapeutics Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / AcelRx Pharmaceuticals Inc / Vocera Communications Inc / Abbvie Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / Otonomy Inc / ContraFect Corp / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Aclaris Therapeutics Inc / Checkpoint Therapeutics Inc / Veru Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / France / United Kingdom / India / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">SGEN (BUY) - Good 4Q20, but 2021 Guide Below Street; Long-Term Growth/Diversification Story Intact; PT to $200</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">0925288 / 2778844</td><td class="leftalignment">GlaxoSmithKline PLC / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update- Happy Lunar New Year!</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / LLY.N / MRK.N / PFE.N / SASY.PA / ROG.S / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRNA.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Sanofi SA / Roche Holding AG / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Moderna Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IPN.PA: Ipsen - 4Q20 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">IPN.PA / RECI.MI / LUN.CO / MRCG.DE / LONN.S / UCB.BR / ORNBV.HE / ALM.MC / GMAB.CO</td><td class="leftalignment">Ipsen SA / Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Orion Oyj / Almirall SA / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Learning the ABCs of ADCs, Part 2</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">MRK.N / PFE.N</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">A DNA Medicines Disruptor Gaining Steam; Initiate at Outperform with $35 PT</td><td class="leftalignment">English</td><td class="rightalignment">93</td><td class="leftalignment">INO=US / MRK=US / PFE=US / AZN=US / JNJ=US / NVAX=US / REGN=US / UTHR=US / MRNA=US / ALNY=US / ARCT=US</td><td class="leftalignment">Inovio Pharmaceuticals Inc / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / Novavax Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Moderna Inc / Alnylam Pharmaceuticals Inc / Arcturus Therapeutics Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Merck & Co</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Movers & Shakers: Our Thoughts on Potential Upcoming Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">69</td><td class="leftalignment">ACRS.OQ / ACRX.OQ / 0715.HK / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BDSI.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / OMER.OQ / ARDX.OQ / ABBV.N / ZTS.N / ANIP.OQ / AXGN.OQ / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / CKPT.OQ / VERU.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / China Oceanwide Holdings Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / Abbvie Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Checkpoint Therapeutics Inc / Veru Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Here's Why Merck Is A Better Pick Over Johnson & Johnson Stock</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">EXEL (BUY) - Takeaways from Guggenheim Oncology Day Fireside Chat with Mgmt: Continued Near & Long-Term Growth</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2576941 / 2126335 / 2778844 / 2684703</td><td class="leftalignment">Exelixis Inc / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Yige Guo, Ph.D. / Kelsey Goodwin</td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">DCPH (BUY) - Takeaways from Guggenheim Oncology Day Fireside Chat with Mgmt: Multiple Key Milestones Through 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BZ1LFB2 / 2778844 / 2684703 / BBPK0J0 / BD9GVY0</td><td class="leftalignment">Deciphera Pharmaceuticals Inc / Merck & Co Inc / Pfizer Inc / Mirati Therapeutics Inc / Zai Lab Ltd</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck KGaA: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Vermilion Technical Research</td><td class="leftalignment">Short Shots - Charts highlighted: BTG, GOLD, HYLN, ROP, APD, FMC, AZN, BMY, MRK, PFE, BLUE, IMVT, REGN, VRTX, MDLZ, KO, PEP, CLX, PG, UL, WCN, FDS, DNB, CHKP, HUM, FMS, CHTR, LNT, AEP, PNW, XEL, UWMC, CNNE, PGR, SBAC, T, and VZ.</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">VZ.N / APD.N / BMY.N / FMC.N / KO.N / MRK.N / PFE.N / ULVR.L / PG.N / HUM.N / ROP.N / CLX.N / FDS.N / DNB.N / REGN.OQ / CHKP.OQ / CHTR.OQ / BLUE.OQ / VRTX.OQ / WCN.AX / BLHI.PK / AZN.V / MDLZ.OQ / CNNE.N / PEP.OQ / XEL.OQ / LNT.OQ / IMVT.OQ / HYLN.N / UWMC.N</td><td class="leftalignment">Verizon Communications Inc / Air Products and Chemicals Inc / Bristol-Myers Squibb Co / FMC Corp / Coca-Cola Co / Merck & Co Inc / Pfizer Inc / Unilever PLC / Procter & Gamble Co / Humana Inc / Roper Technologies Inc / Clorox Co / Factset Research Systems Inc / Dun & Bradstreet Holdings Inc / Regeneron Pharmaceuticals Inc / Check Point Software Technologies Ltd / Charter Communications Inc / bluebird bio Inc / Vertex Pharmaceuticals Inc / White Cliff Minerals Ltd / Blue Holdings Inc / AZN Capital Corp / Mondelez International Inc / Cannae Holdings Inc / PepsiCo Inc / Xcel Energy Inc / Alliant Energy Corp / Immunovant Inc / Hyliion Holdings Corp / UWM Holdings Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">STRATEGY / TECHNICAL ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David P. Nicoski, CMT</td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">MRTX (NEUTRAL) – Takeaways from Guggenheim Oncology Day Fireside Chat with Mgmt: Confidence Across KRAS & Pipeline</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BBPK0J0 / 0989529 / 2516152 / 2023607 / 2778844 / 2684703 / 7103065</td><td class="leftalignment">Mirati Therapeutics Inc / AstraZeneca PLC / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Pfizer Inc / Novartis AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Morning Bite Flash</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">FR0000120073 / DE0005909006 / DE0007100000 / DE0006599905 / DE0006602006 / DE0007030009 / DK0010272632 / DE0007037129 / DE0005810055 / DK0010268606 / DE0005773303 / DE0008019001 / DE000A0HN5C6 / DE000A0S8488 / DE000KSAG888 / DE000A1X3XX4 / DE0006062144 / DK0060094928 / DE000A161408</td><td class="leftalignment">L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Bilfinger SE / Daimler AG / Merck KGaA / GEA Group AG / Rheinmetall AG / GN Store Nord A/S / Rwe AG / Deutsche Boerse AG / Vestas Wind Systems A/S / Fraport AG Frankfurt Airport Services Worldwide / Deutsche Pfandbriefbank AG / Deutsche Wohnen SE / Hamburger Hafen und Logistik AG / K&S AG / DIC Asset AG / Covestro AG / Orsted A/S / Hellofresh SE</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / France</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Herr. Ingo-Martin Schachel, CFA</td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck & Co Inc: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BMY-US -  Dividend Quality Analysis, for the period ended February 01,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / JNJ / LLY / MRK / NVS / PFE / AMGN.O / AZN.O / BIIB.O / ABBV.K / SNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / AstraZeneca PLC / Biogen Inc / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK.N / CERN.OQ / ICAD.OQ / CPSI.OQ / BIIB.OQ / EVGN.TA / WEED.TO / DNLI.OQ / ORTX.OQ</td><td class="leftalignment">Merck & Co Inc / Cerner Corp / ICAD Inc / Computer Programs and Systems Inc / Biogen Inc / Evogene Ltd / Canopy Growth Corp / Denali Therapeutics Inc / Orchard Therapeutics PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">EXEL (BUY) - Re-Accelerating Cabo Growth Heading into Multiple Sources of Near-Term Upside; Maintain BUY, $32 PT</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">2576941 / 2126335 / 2778844</td><td class="leftalignment">Exelixis Inc / Bristol-Myers Squibb Co / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Yige Guo, Ph.D. / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Sector Flash - Health Care: COVID-19 - many question marks surrounding herd immunity</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AZN.L / PFE.N / MRCG.DE</td><td class="leftalignment">AstraZeneca PLC / Pfizer Inc / Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / United Kingdom / United States</td><td class="leftalignment">Aerospace / Air Transportation / Biotechnology / Conglomerates / Defense / Electrical / Engineering & Construction / Environmental Services / Healthcare / Industrial Materials / Machinery / Pharmaceuticals / Railroads / Shipping & Shipbuilding / Transportation</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CREDIT</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Frau Silke Stegemann</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Morning Bite Flash</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">FR0000120073 / DE0006070006 / DE0006599905 / DE0007500001 / DE0007037129 / DE0006569908 / DE0005408884 / FI0009013403 / DE000TUAG000 / CH0024638196 / DE000KC01000 / FR0010411983 / AT000000STR1 / DE000LED4000 / DE000A161N30 / DK0060738599 / NL0012169213 / DE000A2E4K43 / DE000A2YN900</td><td class="leftalignment">L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Hochtief AG / Merck KGaA / thyssenkrupp AG / Rwe AG / MLP SE / Leoni AG / Kone Oyj / TUI AG / Schindler Holding AG / Kloeckner & Co SE / Scor SE / STRABAG SE / Osram Licht AG / Grenke AG / Demant A/S / Qiagen NV / Delivery Hero SE / TeamViewer AG</td><td class="leftalignment"></td><td class="leftalignment">Austria / Switzerland / Germany / Denmark / Finland / France / Netherlands</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Herr. Ingo-Martin Schachel, CFA</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Merck & Co., Inc.(MRK) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">58933Y105</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IO Implications from ODAC's Neo-Adjuvant Keytruda Discussion</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Daina Graybosch, PHD</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IO Expansion to Early-Stage Continues with Opdivo Bladder Cancer Success</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK=US / BMY=US / RHHBY=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Roche Holding AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Dr. Daina Graybosch, PHD</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - February 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AMAT.O / AMD.N / CNA.L / DD.N / DFDS.CO / FLC.AX / INTC.O / MAS.N / MRK.N / TOTF.PA / INCY.O / THC.N / WCC.N / NVDA.O / EPC.N / FISV.O / ARE.N / WSP.TO / JKHY.O / OPTN.O / MU.O / NCR.N / URBN.O / ACGL.O / STN.TO / SNC.TO / NVT.N / FIS.N / ATL.MI / EONGn.DE / 759351604 / NGL.N / WDC.O / ABBV.N / FOXA.OQ / AGRX.O / FSV.O / RPD.O / AMRX.N / NTGY.MC / AQST.O / GMDA.OQ / REYN.O / CARR.N / 120291281</td><td class="leftalignment">Applied Materials Inc / Advanced Micro Devices Inc / Centrica PLC / Dupont De Nemours Inc / DFDS AS / Fluence Corporation Ltd / Intel Corp / Masco Corp / Merck & Co Inc / TotalEnergies SE / Incyte Corp / Tenet Healthcare Corp / Wesco International Inc / NVIDIA Corp / Edgewell Personal Care Co / Fiserv Inc / Alexandria Real Estate Equities Inc / WSP Global Inc / Jack Henry & Associates Inc / OptiNose Inc / Micron Technology Inc / NCR Corp / Urban Outfitters Inc / Arch Capital Group Ltd / Stantec Inc / SNC-Lavalin Group Inc / nVent Electric PLC / Fidelity National Information Services Inc / Atlantia SpA / E.ON SE / Reinsurance Group of America Inc / NGL Energy Partners LP / Western Digital Corp / Abbvie Inc / Fox Corp / Agile Therapeutics Inc / FirstService Corp / Rapid7 Inc / Amneal Pharmaceuticals Inc / Naturgy Energy Group SA / Aquestive Therapeutics Inc / Gamida Cell Ltd / Reynolds Consumer Products Inc / Carrier Global Corp / Cenovus Energy Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Italy / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Merck KGaA (MRK GY) - High tech, high valuation</td><td class="leftalignment">English</td><td class="rightalignment">49</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Biotechnology: GILD/GLPG: Mounting concerns on Galapagos' R&D engine as '1690 IPF trial stopped due to risk/benefit concern</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">GILD.OQ / GLPG.AS / MRCG.DE</td><td class="leftalignment">Gilead Sciences Inc / Galapagos NV / Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Animal Tracks: 4Q EPS Drivers in Animal Health; Sustained Strength in Companion Animal</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ELAN.N / LLY.N / MRK.N / VIRB.PA / IDXX.OQ / NEOG.OQ / PETS.OQ / BAYGN.DE / ZTS.N / CHWY.N</td><td class="leftalignment">Elanco Animal Health Inc / Eli Lilly and Co / Merck & Co Inc / Virbac SA / IDEXX Laboratories Inc / Neogen Corp / Petmed Express Inc / Bayer AG / Zoetis Inc / Chewy Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides / Matthew Urbik</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ORNBV.HE: Orion - 4Q20 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">ORNBV.HE / RECI.MI / LUN.CO / MRCG.DE / LONN.S / UCB.BR / IPN.PA / ALM.MC / GRLS.MC / VIFN.S / GMAB.CO</td><td class="leftalignment">Orion Oyj / Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Ipsen SA / Almirall SA / Grifols SA / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Short interest positioning read</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK.N / OPTN.O / ABBV.N / AGRX.O / AMRX.N / AQST.O</td><td class="leftalignment">Merck & Co Inc / OptiNose Inc / Abbvie Inc / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck KGaA : Pre 4Q'20 Consensus Comparison: c.3% above Cons. EPS (pre) for the quarter; 2021E Cons. seems 2-3% too low on EPS (pre)</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Richard B. Vosser / James D. Gordon / Sarita Kapila / Ms. Laerke Engkilde / Mr. Tycho W. Peterson</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Our Thoughts On AdCom To Discuss Keytruda for Neoadjuvant and Adjuvant TNBC</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MRK – FDA AdCom vote likely delays KEYTRUDA approval in high-risk, early-stage TNBC though we continue to see pathway to approval pending more mature data</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Randall S. Stanicky, CFA</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 29, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">IBK Securities</td><td class="leftalignment">Merck & Co-항암제에 회사 역량 집중-02/09/2021</td><td class="leftalignment">Korean</td><td class="rightalignment">10</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Gyeongjun Moon</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Q4 due 4 March - Strong finish on Life Science</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr Daniel Wendorff</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Morning Bite Flash</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">DE0005909006 / DE0005785604 / DE0007314007 / DE0006599905 / AT0000937503 / DE0005785802 / DE0007042301 / DE0005470405 / DE000LED4000 / DE000A161N30 / NL0012169213 / DE000A2YN900</td><td class="leftalignment">Bilfinger SE / Fresenius SE & Co KGaA / Heidelberger Druckmaschinen AG / Merck KGaA / voestalpine AG / Fresenius Medical Care AG & Co KGaA / Rhoen Klinikum AG / Lanxess AG / Osram Licht AG / Grenke AG / Qiagen NV / TeamViewer AG</td><td class="leftalignment"></td><td class="leftalignment">Austria / Germany / Netherlands</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Herr. Ingo-Martin Schachel, CFA</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">KOLs View Keytruda+Lenvima 1L RCC Efficacy As Differentiated; Safety Awaited</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Ms. Kathleen M. Miner, R.Ph., CFA</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">DNB / FISV=US / MRK=US / BSX=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / ADI=US / WEN=US / AMZN=US / BLD=US / TEVA=US / NVDA=US / SLG=US / LOW=US / ENR=US / DIOD=US / IGT=US / CHRS=US / BYD=US / TTWO=US / LEG=US / TTMI=US / ATVI=US / KFRC=US / MGM=US / HUM=US / PENN=US / BKI=US / AVGO=US / CBRL=US / DRI=US / EXEL=US / GFF=US / HAS=US / IBP=US / MAS=US / MHK=US / MCRI=US / REGI=US / SGMO=US / SPG=US / SGMS=US / GPN=US / AUTL=US / DIN=US / ECPG=US / PRAA=US / RRR=US / BIIB=US / TPX=US / EXP=US / CZR=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SCPL=US / CMG=US / REX=US / FIS=US / PGTI=US / GPRE=US / SAIA=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / JACK=US / CLNY=US / TREX=US / NXPI=US / FBHS=US / ZNGA=US / EA=US / ENPH=US / TILE=US / NDLS=US / VRNS=US / GOOGL=US / LOCO=US / HQY=US / OSH=US / SHAK=US / WING=US / TDOC=US / EDIT=US / 82982L103 / IRTC=US / JELD=US / MPWR-US / CARG=US / BTAI=US / ALLO=US / HARP=US / TCRR=US / FERGY=US / OPCH=US / DKNG=US / AZEK=US / BALY=US / VTRS=US</td><td class="leftalignment">Dun & Bradstreet Holdings Inc / Fiserv Inc / Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Analog Devices Inc / Wendys Co / Amazon.com Inc / TopBuild Corp / Teva Pharmaceutical Industries Ltd / NVIDIA Corp / SL Green Realty Corp / Lowe's Companies Inc / Energizer Holdings Inc / Diodes Inc / International Game Technology PLC / Coherus BioSciences Inc / Boyd Gaming Corp / Take-Two Interactive Software Inc / Leggett & Platt Inc / TTM Technologies Inc / Activision Blizzard Inc / Kforce Inc / MGM Resorts International / Humana Inc / Penn National Gaming Inc / Black Knight Inc / Broadcom Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Exelixis Inc / Griffon Corp / Hasbro Inc / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Monarch Casino & Resort Inc / Renewable Energy Group Inc / Sangamo Therapeutics Inc / Simon Property Group Inc / Scientific Games Corp / Global Payments Inc / Autolus Therapeutics PLC / Dine Brands Global Inc / Encore Capital Group Inc / PRA Group Inc / Red Rock Resorts Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Caesars Entertainment Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Sciplay Corp / Chipotle Mexican Grill Inc / REX American Resources Corp / Fidelity National Information Services Inc / PGT Innovations Inc / Green Plains Inc / Saia Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / DigitalBridge Group Inc / Trex Company Inc / NXP Semiconductors NV / Fortune Brands Home & Security Inc / Zynga Inc / Electronic Arts Inc / Enphase Energy Inc / Interface Inc / Noodles & Co / Varonis Systems Inc / Alphabet Inc / El Pollo Loco Holdings Inc / Healthequity Inc / Oak Street Health Inc / Shake Shack Inc / Wingstop Inc / Teladoc Health Inc / Editas Medicine Inc / SiteOne Landscape Supply Inc / iRhythm Technologies Inc / JELD-WEN Holding Inc / Monolithic Power Systems Inc / CarGurus Inc / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Ferguson PLC / Option Care Health Inc / DraftKings Inc / Azek Company Inc / Bally's Corp / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">2126335 / 2778844 / 2026242 / 2942605 / 2175672 / 2542049 / 2576941 / 2684703 / 2048804 / 2440637 / 2402121 / 2883878 / 2931034 / 2795393 / 2712013 / B121557 / B02R1L6 / B2R3PV1 / B3D7K31 / 2679204 / B3SWPT2 / B7TL820 / B7VD3F2 / BJ3V905 / BVVN4Q8 / BYY8XK8 / BQPVQZ6 / BYW36M8 / BDHF4K6 / BJFSR88 / BKTHM05 / BFMXGR0 / BKTNTR9 / BZ1LFG7 / BP8XZL1 / BN4NJG4</td><td class="leftalignment">Bristol-Myers Squibb Co / Merck & Co Inc / American Electric Power Company Inc / Avista Corp / Cardinal Health Inc / Dominion Energy Inc / Exelixis Inc / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / Nuance Communications Inc / Teva Pharmaceutical Industries Ltd / Vertex Pharmaceuticals Inc / Amerisourcebergen Corp / Global Payments Inc / Mastercard Inc / ALLETE Inc / American Water Works Company Inc / Discovery Inc / Align Technology Inc / Ameresco Inc / Meta Platforms Inc / Duke Energy Corp / Endo International PLC / Eversource Energy / WEC Energy Group Inc / Horizon Therapeutics PLC / PayPal Holdings Inc / CRISPR Therapeutics AG / Uniqure NV / Passage Bio Inc / Evergy Inc / ViacomCBS Inc / Roku Inc / Healthequity Inc / Freeline Therapeutics Holdings PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Lack of Key Details Makes CLEAR vs 9ER Comp Premature; Wait for Full Data @ ASCO GU</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">EXEL=US / MRK=US</td><td class="leftalignment">Exelixis Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Keytruda + Lenvima Shines in RCC: 3 Positive Signals, 4 Remaining Uncertainties</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK=US / BMY=US / EXEL=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Exelixis Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Daina Graybosch, PHD</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech: ASCO GU 2021 Hit List - Key Data in Kidney, Bladder & Prostate Cancers</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / BMY=US / EXEL=US / AUTL=US / ALLO=US / HARP=US / TCRR=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Exelixis Inc / Autolus Therapeutics PLC / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRCG.DE: Merck KGaA - Raising growth drivers for 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRCG.DE / 4063.T / 4185.T / A.N / BDX.N / RECI.MI / STDM.PA / TMO.N / WAT.N / DHR.N / LUN.CO / GLW.N / MTD.N / LONN.S / PKI.N / UCB.BR / TECH.OQ / CCMP.OQ / ENTG.OQ / IPN.PA / ORNBV.HE / QGEN.N / ALM.MC / WAFGN.DE / VIFN.S / GMAB.CO</td><td class="leftalignment">Merck KGaA / Shin-Etsu Chemical Co Ltd / JSR Corp / Agilent Technologies Inc / Becton Dickinson and Co / Recordati Industria Chimica e Farmaceutica SpA / Sartorius Stedim Biotech SA / Thermo Fisher Scientific Inc / Waters Corp / Danaher Corp / H Lundbeck A/S / Corning Inc / Mettler-Toledo International Inc / Lonza Group AG / PerkinElmer Inc / Ucb SA / Bio-Techne Corp / CMC Materials Inc / Entegris Inc / Ipsen SA / Orion Oyj / Qiagen NV / Almirall SA / Siltronic AG / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IPN.PA: Ipsen - Cabometyx readacross: Keynote-581 data mixed at upcoming ASCO GU</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">IPN.PA / BMY.N / MRK.N / PFE.N</td><td class="leftalignment">Ipsen SA / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">SGEN (BUY) - ASCO GU Abstract Takeaways: EV-301 Data Consistent; EV-201 Cohort 2 Extends Padcev's Lead</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2778844 / 2369174</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">FY due 23 February - pressure from Kabi and FMC</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">DE0005785604 / DE0006599905 / DE0005785802 / DE0007042301</td><td class="leftalignment">Fresenius SE & Co KGaA / Merck KGaA / Fresenius Medical Care AG & Co KGaA / Rhoen Klinikum AG</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Oliver Metzger</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Shinyoung Securities Co Ltd</td><td class="leftalignment">Global Stock Report Vol. 7: 혁신항암제를 갖는 자, 게임 체인저가 되다</td><td class="leftalignment">Korean</td><td class="rightalignment">38</td><td class="leftalignment">MRK.N / AZN.L / 000100.KS</td><td class="leftalignment">Merck & Co Inc / AstraZeneca PLC / Yuhan Corp</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United Kingdom / Korea, Republic of / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment">INVESTMENT STRATEGY / COMPANY REPORT</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy</td><td class="leftalignment">Mr. Myoung-sun Lee</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Merck & Co Inc: Information Content of Earnings Releases 2015-2020</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Daily Credit Briefing</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">RWEG.DE / AKBNK.IS / LVMH.PA / HNKG_p.DE / MRCG.DE / MAGN.RTS / ISP.MI / ATL.MI / SEVI.PA / CLNX.MC / ADNT.N</td><td class="leftalignment">Rwe AG / Akbank TAS / LVMH Moet Hennessy Louis Vuitton SE / Henkel AG & Co KGaA / Merck KGaA / Magnitogorskiy Metallurgicheskiy Kombinat PAO / Intesa Sanpaolo SpA / Atlantia SpA / Suez SA / Cellnex Telecom SA / Adient PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Spain / France / Ireland / Italy / Russian Federation / Turkey / United States</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Services / Shipping & Shipbuilding / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS / CREDIT</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Herr. Ulrich Scholz, CFA / Herr Christian Aust / Herr Sven Kreitmair, CFA / Frau Silke Stegemann / Herr Gianfranco Arcovito / Sergey Bolshakov / Herr. Michael Teig / Herr. Stefan Kolek</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Feb 8 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">NL0000226223 / US0079731008 / US0116591092 / US0382221051 / US0463531089 / US1005571070 / US1101221083 / US1156372096 / US1266501006 / US14149Y1082 / US1912161007 / US1925761066 / US2546871060 / US37733W1053 / US4781601046 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US66987V1098 / US6701002056 / US7134481081 / US7170811035 / US75886F1075 / US7711951043 / US8308791024 / US8447411088 / US8610121027 / US8807701029 / US9021041085 / US9029251066 / US91347P1057 / US03073E1055 / US98956P1021 / US4771431016 / US4198791018 / US80105N1054 / US21036P1084 / US3463751087 / US60855R1005 / US90385V1070 / US60871R2094 / US15135B1017 / RDSa.AS / PAP310761054 / US01748X1028 / US2473617023 / US25470F1049 / US58933Y1055 / US25470F3029 / US9100471096 / US00164V1035 / US00287Y1091 / NL0010273215 / US98978V1035 / US8485771021 / US21240E1055 / US02376R1023 / CA0089118776 / US61174X1090 / US87918A1051 / KYG4740B1059 / LGFb / LGFa / US53115L1044 / US05351X1019 / US49271V1008 / US5904791358 / US28414H1032 / US1255231003 / US35137L1052 / US92556H2067 / US92537N1081 / US6833731044 / US03044L1052 / US62955J1034 / US73739W1045 / 120175706 / 120404208</td><td class="leftalignment">STMicroelectronics NV / Advanced Energy Industries Inc / Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Boston Beer Company Inc / Bristol-Myers Squibb Co / Brown-Forman Corp / CVS Health Corp / Cardinal Health Inc / Coca-Cola Co / Cohu Inc / Walt Disney Co / GlaxoSmithKline PLC / Johnson & Johnson / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Novartis AG / Novo Nordisk A/S / PepsiCo Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / STMicroelectronics NV / Teradyne Inc / II-VI Inc / USA Truck Inc / Universal Display Corp / Amerisourcebergen Corp / Zimmer Biomet Holdings Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Constellation Brands Inc / FormFactor Inc / Molina Healthcare Inc / Ultra Clean Holdings Inc / Molson Coors Beverage Co / Centene Corp / Royal Dutch Shell PLC / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Discovery Inc / Merck & Co Inc / Discovery Inc / United Airlines Holdings Inc / AMC Networks Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Air Canada / Monster Beverage Corp / Teladoc Health Inc / Ichor Holdings Ltd / Lions Gate Entertainment Corp / Lions Gate Entertainment Corp / Liberty Oilfield Services Inc / Avaya Holdings Corp / Keurig Dr Pepper Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Cigna Corp / Fox Corp / ViacomCBS Inc / Vertiv Holdings Co / Ontrak Inc / American Well Corp / Nov Inc / Poshmark Inc / Cisco Systems Inc / MedAvail Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - February 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">AEP.N / AES.N / AFL.N / ALV.N / CB.N / CI.N / CL.N / CMS.N / CP.TO / EIX.N / EL.N / EMN.N / EOG.N / F.N / GM.N / IBE.MC / IP.N / JNJ.N / KMB.N / KO.N / MRK.N / NSC.N / PEG.N / PFE.N / RWEG.DE / SO.N / T.N / VC.N / PEP.N / BFb.N / PG.N / PXD.N / HUM.N / CPB.N / TEN.N / CMCSA.O / CAE.TO / CHKP.O / AMGN.O / AAPL.O / MET.N / FLEX.O / CNR.TO / DUK.N / DIS.N / BWA.N / LEA.N / K.N / DT.N / DISH.O / CSX.N / UNP.N / CLX.N / CAG.N / UNM.N / GIS.N / EPC.N / MGA.N / SBAC.O / JAZZ.O / NG.L / VZ.N / HCA.N / EXEL.O / ARNA.O / STZ.N / LNC.N / APH.N / FISV.O / CHTR.O / AXL.N / AWK.N / CHD.N / ATA.TO / BC.N / SAM.N / BMRN.O / REGN.O / ENR.N / PRU.N / NCR.N / TEL.N / CNP.N / CPK.N / MKL.N / PII.N / RLI.N / ST.N / SR.N / TT.N / SGEN.OQ / GPN.N / MNST.O / CCLb.TO / CASY.O / ORLY.O / ACGL.O / PCTY.O / ATDb.TO / 02209S103 / AINV.O / DLR.N / VIAC.O / 416515104 / 427866108 / DISCA.O / SJW.N / FIS.N / TEVA.N / HOG.N / AON.N / BGS.N / TDC.N / ENSG.O / DAN.N / VALE.N / FTNT.O / SPB.N / CHNG.O / CJT.TO / PCRX.O / MTOR.N / IFP.TO / AMCX.O / MDLZ.OQ / FANG.O / ABBV.N / TSLA.N / PRGO.N / PRMW.N / TMUS.N / DOO.TO / COTY.N / FOXA.OQ / PRTA.O / RYAM.N / SHOP.N / PYPL.OQ / WRK.N / MIME.OQ / RACE.MI / MP1.AX / BBU.N / ADNT.N / LGFB.N / TFII.TO / WOW.N / ATUS.N / ORSTED.CO / APTV.N / EAF.N / VNE.N / NTGY.MC / KDP.N / NWL.O / GMAB.O / DDOG.O / CRNC.OQ / NLOK.O / WTRG.N / REYN.O / NKLA.OQ / FOUR.N / LUMN.N / AFRM.O / TEEC.L / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Aflac Inc / Autoliv Inc / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / CMS Energy Corp / Canadian Pacific Railway Ltd / Edison International / Estee Lauder Companies Inc / Eastman Chemical Co / EOG Resources Inc / Ford Motor Co / General Motors Co / Iberdrola SA / International Paper Co / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / Rwe AG / Southern Co / AT&T Inc / Visteon Corp / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Pioneer Natural Resources Co / Humana Inc / Campbell Soup Co / Tenneco Inc / Comcast Corp / CAE Inc / Check Point Software Technologies Ltd / Amgen Inc / Apple Inc / MetLife Inc / Flex Ltd / Canadian National Railway Co / Duke Energy Corp / Walt Disney Co / Borgwarner Inc / Lear Corp / Kellogg Co / Dynatrace Inc / DISH Network Corp / CSX Corp / Union Pacific Corp / Clorox Co / Conagra Brands Inc / Unum Group / General Mills Inc / Edgewell Personal Care Co / Magna International Inc / SBA Communications Corp / Jazz Pharmaceuticals PLC / National Grid PLC / Verizon Communications Inc / HCA Healthcare Inc / Exelixis Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / Lincoln National Corp / Amphenol Corp / Fiserv Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / ATS Automation Tooling Systems Inc / Brunswick Corp / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Prudential Financial Inc / NCR Corp / TE Connectivity Ltd / CenterPoint Energy Inc / Chesapeake Utilities Corp / Markel Corp / Polaris Inc / Rli Corp / Sensata Technologies Holding PLC / Spire Inc / Trane Technologies PLC / Seagen Inc / Global Payments Inc / Monster Beverage Corp / CCL Industries Inc / Caseys General Stores Inc / O'Reilly Automotive Inc / Arch Capital Group Ltd / Paylocity Holding Corp / Alimentation Couche-Tard Inc / Altria Group Inc / Apollo Investment Corp / Digital Realty Trust Inc / ViacomCBS Inc / Hartford Financial Services Group Inc / Hershey Co / Discovery Inc / SJW Group / Fidelity National Information Services Inc / Teva Pharmaceutical Industries Ltd / Harley-Davidson Inc / Aon PLC / B&G Foods Inc / Teradata Corp / Ensign Group Inc / Dana Inc / Vale SA / Fortinet Inc / Spectrum Brands Holdings Inc / Change Healthcare Inc / Cargojet Inc / Pacira Biosciences Inc / Meritor Inc / Interfor Corp / AMC Networks Inc / Mondelez International Inc / Diamondback Energy Inc / Abbvie Inc / Tesla Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / BRP Inc / Coty Inc / Fox Corp / Prothena Corporation PLC / Rayonier Advanced Materials Inc / Shopify Inc / PayPal Holdings Inc / Westrock Co / Mimecast Ltd / Ferrari NV / Megaport Ltd / Brookfield Business Partners LP / Adient PLC / Lions Gate Entertainment Corp / TFI International Inc / WideOpenWest Inc / Altice USA Inc / Orsted A/S / Aptiv PLC / GrafTech International Ltd / Veoneer Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Newell Brands Inc / Genmab A/S / Datadog Inc / Cerence Inc / NortonLifeLock Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Nikola Corp / Shift4 Payments Inc / Lumen Technologies Inc / Affirm Holdings Inc / Triple Point Energy Efficiency Infrastructure Company Plc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / Germany / Denmark / Spain / United Kingdom / Ireland / Israel / Netherlands / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Door Looks Shut on a Rapid Approval for Keytruda in Early-Stage Breast Cancer</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Daina Graybosch, PHD</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GSK-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">GSK / MRK / NVS / PFE / AZN.O / DVAX.O / TEVA.K / SNY.O</td><td class="leftalignment">GlaxoSmithKline PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / AstraZeneca PLC / Dynavax Technologies Corp / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Major Pharmaceuticals : 4Q Earnings Season Takeaways - Solid Results, Mixed Stock Performance</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / ABBV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">China Healthcare Sector: China's vaccination roadmap: Deep-dive into clinical data and market potential</td><td class="leftalignment">English</td><td class="rightalignment">60</td><td class="leftalignment">2196.HK / 600196.SS / JNJ.N / MRK.N / PFE.N / AZN.L / SASY.PA / LONN.S / GSK.L / NVAX.OQ / MRNA.OQ / SVA.OQ / 300122.SZ / 300142.SZ / CVAC.OQ</td><td class="leftalignment">Shanghai Fosun Pharmaceutical Group Co Ltd / Shanghai Fosun Pharmaceutical Group Co Ltd / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Lonza Group AG / GlaxoSmithKline PLC / Novavax Inc / Moderna Inc / Sinovac Biotech Ltd / Chongqing Zhifei Biological Products Co Ltd / Walvax Biotechnology Co Ltd / CureVac NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Antigua and Barbuda / Switzerland / China / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">MRK - MRK 4Q20 Full Postview: Apart from modest miss, quiet – what will change the narrative?</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">58933Y105</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">02/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N / JAZZ.O / TEVA.N / ABBV.N</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">India / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">02/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Trial Activity Remains Positive - Week 45</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 2.5.21</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Weekly: Gx Vascepa Cracks 11% Mkt Share After Steady Growth in January</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / GSK=US / ENDP=US / PRGO=US / BIIB=US / AMRX=US / ABBV=US / XERS=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Endo International PLC / Perrigo Company PLC / Biogen Inc / Amneal Pharmaceuticals Inc / Abbvie Inc / Xeris Biopharma Holdings Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Ami Fadia</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Lots of changes ahead in 2021 including a new CEO, but we stay Sector Perform for now</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended January 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / NVS=US / GSK=GB / AZN=US / GSK=US / JNJ=US / EXEL=US / ICPT=US / NVO=US / REGN=US / RHHBY=US / INVA=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Exelixis Inc / Intercept Pharmaceuticals Inc / Novo Nordisk A/S / Regeneron Pharmaceuticals Inc / Roche Holding AG / Innoviva Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">FTNT=US / AAPL=US / IBM=US / MRK=US / BMY=US / DIS=US / INTC=US / ADI=US / AMD=US / MSFT=US / MDT=US / AMZN=US / T=US / ORCL=US / VOD=US / TXN=US / U=US / CG=US / GILD=US / AMT=US / DOX=US / GS=US / AKAM=US / YUM=US / MPWR=US / CHTR=US / GE=US / VZ=US / SMTC=US / CCI=US / UPS=US / AZN=US / ZEN=US / EXC=US / XLNX=US / CSL=US / ATVI=US / MGM=US / CMCSA=US / CI=US / DISH=US / NUAN=US / AMSC=US / AME=US / APPS=US / CMI=US / CAJ=US / CTL=US / CRUS=US / CME=US / EGHT=US / EQIX=US / PHG=US / NBIX=US / PCTY=US / QUIK=US / SBAC=US / SNAP=US / TOSYY=US / VG=US / APO=US / SNOW=US / NET=US / CRNT=US / SYNA=US / FB=US / NFLX=US / TWLO=US / GPRO=US / ERIC=US / PTON=US / RNG=US / CEVA=US / GOOG=US / DLR=US / VIAC=US / DISCA=US / ICE=US / CCOI=US / MWA=US / INFI=US / RSI=US / LLNW=US / LUMN=US / TDC=US / IAC=US / KLR=US / AGCO=US / 005930-KR=US / ALPMY=US / MXL=US / NXPI=US / ANGI=US / SRPT=US / TMUS=US / GTT=US / AVYA=US / GOOGL=US / PAYC=US / SIEGY=US / EKTAY=US / NEWR=US / BILL=US / HPE=US / VYGR=US / DZSI=US / YUMC=US / TEUM=US / HLNE=US / SLNO=US / ATUS=US / VREX=US / ZM=US / FSLY=US / CMBM=US / NLOK=US / DKNG=US / ONDS=US</td><td class="leftalignment">Fortinet Inc / Apple Inc / International Business Machines Corp / Merck & Co Inc / Bristol-Myers Squibb Co / Walt Disney Co / Intel Corp / Analog Devices Inc / Advanced Micro Devices Inc / Microsoft Corp / Medtronic PLC / Amazon.com Inc / AT&T Inc / Oracle Corp / Vodafone Group PLC / Texas Instruments Inc / Unity Software Inc / Carlyle Group Inc / Gilead Sciences Inc / American Tower Corp / Amdocs Ltd / Goldman Sachs Group Inc / Akamai Technologies Inc / Yum! Brands Inc / Monolithic Power Systems Inc / Charter Communications Inc / General Electric Co / Verizon Communications Inc / Semtech Corp / Crown Castle International Corp / United Parcel Service Inc / AstraZeneca PLC / Zendesk Inc / Exelon Corp / Xilinx Inc / Carlisle Companies Inc / Activision Blizzard Inc / MGM Resorts International / Comcast Corp / Cigna Corp / DISH Network Corp / Nuance Communications Inc / American Superconductor Corp / AMETEK Inc / Digital Turbine Inc / Cummins Inc / Canon Inc / Lumen Technologies Inc / Cirrus Logic Inc / CME Group Inc / 8x8 Inc / Equinix Inc / Koninklijke Philips NV / Neurocrine Biosciences Inc / Paylocity Holding Corp / QuickLogic Corp / SBA Communications Corp / Snap Inc / Toshiba Corp / Vonage Holdings Corp / Apollo Global Management Inc / Snowflake Inc. / Cloudflare Inc / Ceragon Networks Ltd / Synaptics Inc / Meta Platforms Inc / Netflix Inc / Twilio Inc / GoPro Inc / Telefonaktiebolaget LM Ericsson / Peloton Interactive Inc / RingCentral Inc / CEVA Inc / Alphabet Inc / Digital Realty Trust Inc / ViacomCBS Inc / Discovery Inc / Intercontinental Exchange Inc / Cogent Communications Holdings Inc / Mueller Water Products Inc / Infinity Pharmaceuticals Inc / Rush Street Interactive Inc / Limelight Networks Inc / Lumen Technologies Inc / Teradata Corp / IAC/Interactivecorp / Kaleyra Inc / AGCO Corp / Farfetch Ltd / Astellas Pharma Inc / Maxlinear Inc / NXP Semiconductors NV / Angi Inc / Sarepta Therapeutics Inc / T-Mobile US Inc / GTT Communications Inc / Avaya Holdings Corp / Alphabet Inc / Paycom Software Inc / Siemens AG / Elekta AB (publ) / New Relic Inc / Bill.com Holdings Inc / Hewlett Packard Enterprise Co / Voyager Therapeutics Inc / DZS Inc / Yum China Holdings Inc / Pareteum Corp / Hamilton Lane Inc / Soleno Therapeutics Inc / Altice USA Inc / Varex Imaging Corp / Zoom Video Communications Inc / Fastly Inc / Cambium Networks Corp / NortonLifeLock Inc / DraftKings Inc / Ondas Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Cayman Islands / Germany / United Kingdom / Ireland / Israel / Japan / Netherlands / Sweden / United States / Guernsey</td><td class="leftalignment">Biotechnology / Conglomerates / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Info. Tech./Software / Lodging & Restaurants / Machinery / Pharmaceuticals / Retailing / Semiconductors / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRK=US / BMY=US / ADI=US / RRC=US / T=US / TXN=US / GILD=US / AMT=US / PEB=US / DGX=US / H=US / CRM=US / V=US / MTN=US / VZ=US / MAR=US / ATVI=US / ESS=US / HLT=US / MANH=US / PENN=US / CI=US / RCL=US / AIR=US / ARCC=US / ARW=US / AVT=US / CCL=US / CHH=US / DRH=US / EXPO=US / MAIN=US / MCHP=US / ORCC=US / PCTY=US / SHOP=US / SNAP=US / VSEC=US / POST=US / LCI=US / AVTR=US / BDN=US / CPT=US / OFC=US / OHI=US / PTON=US / BIIB=US / FLT=US / AINV=US / SHO=US / MPW=US / HST=US / MA=US / EHTH=US / PNNT=US / WH=US / WYND=US / IAC=US / RCUS=US / HGV=US / NXPI=US / RLJ=US / VAC=US / ANGI=US / RHP=US / NCLH=US / TMUS=US / PTCT=US / TSLX=US / 70806A106 / NEWR=US / GSBD=US / ZG=US / WLTW=US / VVV=US / PK=US / LGF.B=US / PLYA=US / RDFN=US / MPWR-US / FSK=US / PLMR=US / BRBR=US / GOCO=US / ONEW=US / FSKR=US / BIGC=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Analog Devices Inc / Range Resources Corp / AT&T Inc / Texas Instruments Inc / Gilead Sciences Inc / American Tower Corp / Pebblebrook Hotel Trust / Quest Diagnostics Inc / Hyatt Hotels Corp / Salesforce.Com Inc / Visa Inc / Vail Resorts Inc / Verizon Communications Inc / Marriott International Inc / Activision Blizzard Inc / Essex Property Trust Inc / Hilton Worldwide Holdings Inc / Manhattan Associates Inc / Penn National Gaming Inc / Cigna Corp / Royal Caribbean Cruises Ltd / AAR Corp / Ares Capital Corp / Arrow Electronics Inc / Avnet Inc / Carnival Corp / Choice Hotels International Inc / Diamondrock Hospitality Co / Exponent Inc / Main Street Capital Corp / Microchip Technology Inc / Owl Rock Capital Corp / Paylocity Holding Corp / Shopify Inc / Snap Inc / VSE Corp / Post Holdings Inc / Lannett Company Inc / Avantor Inc / Brandywine Realty Trust / Camden Property Trust / Corporate Office Properties Trust / Omega Healthcare Investors Inc / Peloton Interactive Inc / Biogen Inc / Fleetcor Technologies Inc / Apollo Investment Corp / Sunstone Hotel Investors Inc / Medical Properties Trust Inc / Host Hotels & Resorts Inc / Mastercard Inc / eHealth Inc / Pennantpark Investment Corp / Wyndham Hotels & Resorts Inc / Travel + Leisure Co / IAC/Interactivecorp / Arcus Biosciences Inc / Hilton Grand Vacations Inc / NXP Semiconductors NV / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Angi Inc / Ryman Hospitality Properties Inc / Norwegian Cruise Line Holdings Ltd / T-Mobile US Inc / PTC Therapeutics Inc / Sixth Street Specialty Lending Inc / PennantPark Floating Rate Capital Ltd / New Relic Inc / Goldman Sachs BDC Inc / Zillow Group Inc / Willis Towers Watson PLC / Valvoline Inc / Park Hotels & Resorts Inc / Lions Gate Entertainment Corp / Playa Hotels & Resorts NV / Redfin Corp / Monolithic Power Systems Inc / FS KKR Capital Corp / Palomar Holdings Inc / Bellring Brands Inc / Gohealth Inc / OneWater Marine Inc / FS KKR Capital Corp / Bigcommerce Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Ireland / Liberia / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">V / 0989529 / 2126335 / 2000019 / 2496113 / 2778844 / 2973821 / 2219224 / 2229126 / 2270726 / 2542049 / 2328915 / 2369174 / 2121352 / 2515030 / 2623911 / 2630513 / 2632003 / 2048804 / 2825933 / 2503529 / 2181334 / 2795393 / 2212922 / 2857817 / B2R3PV1 / B570P91 / 2390817 / B7TL820 / B4V9661 / B7VD3F2 / B9M2WX3 / BBGVT40 / BVVN4Q8 / BYY8XK8 / BYVY8G0 / BYW36M8 / BF09HX3 / BD8DJ71 / BKDS4H5 / BR4T3B3 / BJ2Z0H2 / BFZ1K46 / BFMXGR0 / BYXJQG9 / BKTNTR9 / BZ1LFG7 / BMH0MR7 / BYQCZ35 / BZ4CHH2 / BNG3RZ7 / 021513106</td><td class="leftalignment">Visa Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Amazon.com Inc / Kohls Corp / Merck & Co Inc / Alliant Energy Corp / CMS Energy Corp / Columbia Sportswear Co / Walt Disney Co / Dominion Energy Inc / Nextera Energy Inc / Gilead Sciences Inc / Group 1 Automotive Inc / Lithia Motors Inc / Neurocrine Biosciences Inc / New Jersey Resources Corp / New York Times Co / Pinnacle West Capital Corp / South Jersey Industries Inc / World Wrestling Entertainment Inc / Check Point Software Technologies Ltd / Amerisourcebergen Corp / NRG Energy Inc / Netflix Inc / American Water Works Company Inc / Lear Corp / Gray Television Inc / Meta Platforms Inc / Ralph Lauren Corp / Duke Energy Corp / Bath & Body Works Inc / News Corp / Eversource Energy / WEC Energy Group Inc / Alphabet Inc / PayPal Holdings Inc / Tapestry Inc / Snap Inc / Bill.com Holdings Inc / HubSpot Inc / Pinterest Inc / Spotify Technology SA / Evergy Inc / Spire Inc / ViacomCBS Inc / Roku Inc / Zendesk Inc / Madison Square Garden Sports Corp / Soleno Therapeutics Inc / Leslie's Inc / Alto Ingredients Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">4Q20, Culture & Strategy Guide Transition to a New Generation of Leadership</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Daina Graybosch, PHD</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update- 4Q20 Earnings Edition</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMGN.OQ / BIIB.OQ / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / VRTX.OQ / GLPG.AS / ACRX.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Biogen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: February 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BA.N / BMY.N / CI.N / CNC.N / EL.N / GM.N / KO.N / MRK.N / PM.N / DUK.N / DIS.N / D.N / FE.N / ITW.N / LIN.N / TWTR.N / MCO.N / FISV.OQ / JKHY.OQ / REGN.OQ / TT.N / TTWO.OQ / ILMN.OQ / EQIX.OQ / GPN.N / DLR.N / FIS.N / TDG.N / CME.OQ / TMUS.OQ / SPG.NZ / IQV.N / PEP.OQ / NWL.OQ</td><td class="leftalignment">Boeing Co / Bristol-Myers Squibb Co / Cigna Corp / Centene Corp / Estee Lauder Companies Inc / General Motors Co / Coca-Cola Co / Merck & Co Inc / Philip Morris International Inc / Duke Energy Corp / Walt Disney Co / Dominion Energy Inc / FirstEnergy Corp / Illinois Tool Works Inc / Linde PLC / Twitter Inc / Moody's Corp / Fiserv Inc / Jack Henry & Associates Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Take-Two Interactive Software Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Digital Realty Trust Inc / Fidelity National Information Services Inc / TransDigm Group Inc / CME Group Inc / T-Mobile US Inc / Stride Property Ltd / IQVIA Holdings Inc / PepsiCo Inc / Newell Brands Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / New Zealand / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">LUN.CO: Lundbeck - 4Q20 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">LUN.CO / RECI.MI / MRCG.DE / LONN.S / UCB.BR / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / VIFN.S / GMAB.CO</td><td class="leftalignment">H Lundbeck A/S / Recordati Industria Chimica e Farmaceutica SpA / Merck KGaA / Lonza Group AG / Ucb SA / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck & Co., Inc. : 4Q Takeaways / Model Update - Core Products Well Positioned, Awaiting Biz Dev</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Raising estimates following 4Q results and ’21 guide; Maintain Buy, $96 PT</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Healthcare : 4Q20 Earnings Highlights — What Mattered for Credit Part IV</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK.N / CI.N / BAX.N / BDX.N / BMY.N / DGX.N / ABC.N</td><td class="leftalignment">Merck & Co Inc / Cigna Corp / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Quest Diagnostics Inc / Amerisourcebergen Corp</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH / INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">investor feedback on weakness</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">MRK - MRK 4Q20 - They said what?!  Highlights from conf call…and our impressions</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">58933Y105</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">KOL Thoughts on ASCO GU</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / BMY=US / AZN=US / INFI=US / ALPMY=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / AstraZeneca PLC / Infinity Pharmaceuticals Inc / Astellas Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Kevin M. DeGeeter</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on Feb 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PINS.N / APD.N / BAX.N / BDX.N / BMY.N / BP.L / CI.N / CMS.N / F.N / FLT.N / HIG.N / IBM.N / IP.N / MRK.N / PM.N / RL.N / SLB.N / DGX.N / HAL.N / LEA.N / CMI.N / IEX.N / PH.N / DBKGn.DE / CLX.N / YUM.N / UNM.N / WEC.N / XOM.N / HSY.N / AMT.N / MTD.N / BLL.N / SNA.N / ESS.N / ABC.N / PRU.N / AAPL.OQ / ATVI.OQ / MSFT.OQ / SBUX.OQ / ODFL.OQ / MCHP.OQ / GILD.OQ / TPR.N / AMZN.OQ / COLM.OQ / 0700.HK / ARWR.OQ / NOV.N / RDSa.L / ICE.N / 9999.HK / DECK.N / NWSA.OQ / FTNT.OQ / MSI.N / BKR.N / CG.OQ / TMUS.OQ / FTV.N / DXC.N / LYFT.OQ / BYND.OQ / UBER.N / ZM.OQ / NLOK.OQ / 9988.HK / 9618.HK / ABNB.OQ</td><td class="leftalignment">Pinterest Inc / Air Products and Chemicals Inc / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / BP PLC / Cigna Corp / CMS Energy Corp / Ford Motor Co / Fleetcor Technologies Inc / Hartford Financial Services Group Inc / International Business Machines Corp / International Paper Co / Merck & Co Inc / Philip Morris International Inc / Ralph Lauren Corp / Schlumberger NV / Quest Diagnostics Inc / Halliburton Co / Lear Corp / Cummins Inc / IDEX Corp / Parker-Hannifin Corp / Deutsche Bank AG / Clorox Co / Yum! Brands Inc / Unum Group / WEC Energy Group Inc / Exxon Mobil Corp / Hershey Co / American Tower Corp / Mettler-Toledo International Inc / Ball Corp / Snap-On Inc / Essex Property Trust Inc / Amerisourcebergen Corp / Prudential Financial Inc / Apple Inc / Activision Blizzard Inc / Microsoft Corp / Starbucks Corp / Old Dominion Freight Line Inc / Microchip Technology Inc / Gilead Sciences Inc / Tapestry Inc / Amazon.com Inc / Columbia Sportswear Co / Tencent Holdings Ltd / Arrowhead Pharmaceuticals Inc / Nov Inc / Royal Dutch Shell PLC / Intercontinental Exchange Inc / NetEase Inc / Deckers Outdoor Corp / News Corp / Fortinet Inc / Motorola Solutions Inc / Baker Hughes Co / Carlyle Group Inc / T-Mobile US Inc / Fortive Corp / DXC Technology Co / Lyft Inc / Beyond Meat Inc / Uber Technologies Inc / Zoom Video Communications Inc / NortonLifeLock Inc / Alibaba Group Holding Ltd / JD.Com Inc / Airbnb Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Germany / United Kingdom / United States / Curaçao</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">takeaways from earnings</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Staying Positive on MRK Despite 4Q20 Miss And Ahead Of Return To Growth For 2021+, Patience Will Be Rewarded When Value Is Unlocked</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck & Co., Inc. : Solid 2021 Guide; CEO Succession Plan Announced</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q4 Slight Miss But 2021 Guidance Above Expectations</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Decent Q and strong 2021 outlook; Not expecting big changes from new CEO</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">UnivDatos Market Insights (UMI)</td><td class="leftalignment">Global Preventive Healthcare Technologies and Services Market - Current Scenario and Forecast (2020-2027)</td><td class="leftalignment">English</td><td class="rightalignment">230</td><td class="leftalignment">500660=IN / MRK=US / MDT=US / DGX=US / 6645=JP / SAN=FR / HBOC=US / MCK=US / MYGN=US / null / 500674=IN / GLAXO=PK / GLAXO=IN / CLS1=DE / TVTY=US / GLAXOSMITH=NG</td><td class="leftalignment">GlaxoSmithKline Pharmaceuticals Ltd / Merck & Co Inc / Medtronic PLC / Quest Diagnostics Inc / Omron Corp / Sanofi SA / Lloyds Banking Group PLC / Mckesson Corp / Myriad Genetics Inc / One 97 Communications Ltd / Sanofi India Ltd / GlaxoSmithKline Pakistan Ltd / GlaxoSmithKline Pharmaceuticals Ltd / McKesson Europe AG / Tivity Health Inc / Glaxo Smithkline Consumer Nigeria PLC</td><td class="leftalignment"></td><td class="leftalignment">Canada / China / Germany / Spain / France / United Kingdom / India / Ireland / Italy / Japan / Nigeria / Pakistan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW / MERGER/ACQUISITION/DIVESTITURE / OPERATIONS / OPERATING RESULTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">univdatos Co / UMI Team</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MRK misses 4Q on top and bottom line but outlook above and should be the bigger focus; CEO transition announced</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Randall S. Stanicky, CFA</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">UnivDatos Market Insights (UMI)</td><td class="leftalignment">Global Nanotechnology in Drug Delivery Market: Current Analysis and Forecast (2020-2027)</td><td class="leftalignment">English</td><td class="rightalignment">241</td><td class="leftalignment">NANO=FR / MRK=US / PFE=US / NOVN=CH / SPL=AU / SELB=US / null / 500672=IN / 4571=JP / BAYN=DE</td><td class="leftalignment">Nanobiotix SA / Merck & Co Inc / Pfizer Inc / Novartis AG / Starpharma Holdings Ltd / Selecta Biosciences Inc / One 97 Communications Ltd / Novartis India Ltd / NanoCarrier Co Ltd / Bayer AG</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / China / Germany / Spain / France / United Kingdom / India / Italy / Japan / Korea, Republic of / Taiwan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW / MERGER/ACQUISITION/DIVESTITURE / OPERATIONS / OPERATING RESULTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">univdatos Co / UMI Team</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">MRK: 2021 Guidance Above Expectations Post Low-Quality 4Q; Organon Spin in 2Q21 & Rob Davis, CFO, MRK's Next CEO</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2778844</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRK.N - Event Brief of Merck & Co Inc conference call, Feb. 04, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRK.N - Event Transcript of Merck & Co Inc conference call, Feb. 04, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Morning Bite Flash</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">FR0000121329 / DE0005785604 / FI0009005870 / DE0007100000 / DE0006599905 / FR0000130650 / DE0008404005 / DE0008430026 / IT0000062072 / DE0005785802 / NL0000235190 / DE0006231004 / DK0010272632 / SE0000163628 / CH0011075394 / NL0000009538 / DE0007236101 / DE0008402215 / SN. / SE0000115446 / SE0000202624 / AT0000821103 / CH0012221716 / US0028241000 / US3696041033 / DE0006452907 / DE0005419105 / DE0005158703 / CH0012549785 / DE0005936124 / CH0012280076 / SE0000695876 / ES0143416115 / DE000A0D9PT0 / DE000TUAG000 / FR0010411983 / AT0000908504 / DE000A0TGJ55 / IT0003492391 / DE000BAY0017 / CH0126881561 / DE000TLX1005 / DK0060448595 / IE00BTN1Y115 / DK0060738599 / NL0012169213 / DE000A2E4K43 / FR0013280286 / DE000SHL1006 / DE000DWS1007 / IE00BZ12WP82 / ATFREQUENT09 / DE000TRAT0N7 / DE000ENER6Y0</td><td class="leftalignment">Thales SA / Fresenius SE & Co KGaA / Konecranes Abp / Daimler AG / Merck KGaA / Dassault Systemes SE / Allianz SE / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / Assicurazioni Generali SpA / Fresenius Medical Care AG & Co KGaA / Airbus SE / Infineon Technologies AG / GN Store Nord A/S / Elekta AB (publ) / Zurich Insurance Group AG / Koninklijke Philips NV / Siemens AG / Hannover Rueck SE / Smith & Nephew PLC / Volvo AB / Getinge AB / Uniqa Insurance Group AG / Abb Ltd / Abbott Laboratories / General Electric Co / Nemetschek SE / Cancom SE / Bechtle AG / Sonova Holding AG / OHB SE / Straumann Holding AG / Alfa Laval AB / Siemens Gamesa Renewable Energy SA / MTU Aero Engines AG / TUI AG / Scor SE / Vienna Insurance Group AG Wiener Versicherung Gruppe / Varta AG / DiaSorin SpA / Bayer AG / Swiss Re AG / Talanx AG / Coloplast A/S / Medtronic PLC / Demant A/S / Qiagen NV / Delivery Hero SE / Biomerieux SA / Siemens Healthineers AG / DWS Group GmbH & Co KgaA / Linde PLC / Frequentis AG / Traton SE / Siemens Energy AG</td><td class="leftalignment"></td><td class="leftalignment">Austria / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Italy / Netherlands / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Herr. Ingo-Martin Schachel, CFA</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q4 EPS, Revenue Slight Miss; 2021 Guidance Above Expectations; CEO Transition</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">First Look at 4Q20 Sales And EPS Miss, New CEO, And 2021 Outlook And Guidance</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: February 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BMY.N / BSX.N / CI.N / CNC.N / EL.N / GM.N / KO.N / MRK.N / MET.N / DUK.N / DIS.N / FE.N / ITW.N / HSY.N / LIN.N / TWTR.N / FISV.OQ / JKHY.OQ / REGN.OQ / TT.N / QCOM.OQ / TTWO.OQ / ILMN.OQ / EQIX.OQ / GPN.N / DLR.N / FIS.N / TDG.N / CME.OQ / ABBV.N / PYPL.OQ / SPG.NZ / IQV.N / PEP.OQ / CTVA.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Centene Corp / Estee Lauder Companies Inc / General Motors Co / Coca-Cola Co / Merck & Co Inc / MetLife Inc / Duke Energy Corp / Walt Disney Co / FirstEnergy Corp / Illinois Tool Works Inc / Hershey Co / Linde PLC / Twitter Inc / Fiserv Inc / Jack Henry & Associates Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Take-Two Interactive Software Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Digital Realty Trust Inc / Fidelity National Information Services Inc / TransDigm Group Inc / CME Group Inc / Abbvie Inc / PayPal Holdings Inc / Stride Property Ltd / IQVIA Holdings Inc / PepsiCo Inc / Corteva Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / New Zealand / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US -  Dividend Quality Analysis, for the period ended December 01,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US -  Dividend Quality Analysis, for the period ended January 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">VRTX-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">VRTX.O / BMY / JNJ / MRK / GILD.O / ENTA.O / ABBV.K / ENZN.PK</td><td class="leftalignment">Vertex Pharmaceuticals Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Gilead Sciences Inc / Enanta Pharmaceuticals Inc / Abbvie Inc / Enzon Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What To Expect From Bristol Myers Squibb's Q4?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Merck Q4 Earnings Preview: Keytruda And Gardasil In Focus</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MIME=US / MTCH=US / AAPL=US / MRK=US / AMZN=US / GWW=US / CHKP=US / SPOT=US / HUM=US / BOX=US / WIX=US / APO=US / DBX=US / GOOG=US / IAC=US / CNHI=US / CHGG=US / ETSY=US / CARG=US / CPRI=US / PDSB=US / MSGS=US</td><td class="leftalignment">Mimecast Ltd / Match Group Inc / Apple Inc / Merck & Co Inc / Amazon.com Inc / W W Grainger Inc / Check Point Software Technologies Ltd / Spotify Technology SA / Humana Inc / Box Inc / Wix.Com Ltd / Apollo Global Management Inc / Dropbox Inc / Alphabet Inc / IAC/Interactivecorp / CNH Industrial NV / Chegg Inc / ETSY Inc / CarGurus Inc / Capri Holdings Ltd / PDS Biotechnology Corp / Madison Square Garden Sports Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Luxembourg / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Software / Pharmaceuticals / Retailing</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / PFE=US / OXY=US / PLD=US / AMZN=US / BR=US / XOM=US / CHRS=US / HCA=US / MANH=US / CSGP=US / ABG=US / MAN=US / MPLX=US / MRCY=US / RHI=US / ST=US / VRTX=US / CVX=US / BDN=US / MTCH=US / DRE=US / COP=US / MMP=US / CMG=US / NXPI=US / ESTE=US / FBHS=US / EA=US / FEYE=US / GOOGL=US / ARCB=US / BABA=US / ARGX=US / WVE=US / VRNA=US / TENB=US / HARP=US / IMVT=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Occidental Petroleum Corp / Prologis Inc / Amazon.com Inc / Broadridge Financial Solutions Inc / Exxon Mobil Corp / Coherus BioSciences Inc / HCA Healthcare Inc / Manhattan Associates Inc / CoStar Group Inc / Asbury Automotive Group Inc / ManpowerGroup Inc / MPLX LP / Mercury Systems Inc / Robert Half International Inc / Sensata Technologies Holding PLC / Vertex Pharmaceuticals Inc / Chevron Corp / Brandywine Realty Trust / Match Group Inc / Duke Realty Corp / Conocophillips / Magellan Midstream Partners LP / Chipotle Mexican Grill Inc / NXP Semiconductors NV / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Electronic Arts Inc / Mandiant Inc / Alphabet Inc / ArcBest Corp / Alibaba Group Holding Ltd / argenx SE / WAVE Life Sciences Ltd / Verona Pharma PLC / Tenable Holdings Inc / Harpoon Therapeutics Inc / Immunovant Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / Netherlands / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: February 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BMY.N / BSX.N / CI.N / CNC.N / EL.N / GM.N / KO.N / MRK.N / PFE.N / PM.N / HUM.N / FE.N / ITW.N / XOM.N / LIN.N / TWTR.N / AMGN.OQ / FISV.OQ / JKHY.OQ / REGN.OQ / TT.N / QCOM.OQ / AMZN.OQ / TTWO.OQ / EQIX.OQ / GPN.N / FIS.N / TDG.N / CME.OQ / ABBV.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / SPG.NZ / IQV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Centene Corp / Estee Lauder Companies Inc / General Motors Co / Coca-Cola Co / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / Humana Inc / FirstEnergy Corp / Illinois Tool Works Inc / Exxon Mobil Corp / Linde PLC / Twitter Inc / Amgen Inc / Fiserv Inc / Jack Henry & Associates Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Equinix Inc / Global Payments Inc / Fidelity National Information Services Inc / TransDigm Group Inc / CME Group Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Stride Property Ltd / IQVIA Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / New Zealand / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: Eisai - 3Q FY3/21 results: Negative surprise from full-year guidance downgrade, forecast 4Q loss</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">4523.T / MRK.N / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Merck & Co Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: エーザイ - 3Q決算：会社通期予想を下方修正、4Q赤字転落はネガティブサプライズ</td><td class="leftalignment">Japanese</td><td class="rightalignment">6</td><td class="leftalignment">4523.T / MRK.N / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Merck & Co Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma: 2021 Catalysts & NPV sensitivity analysis</td><td class="leftalignment">English</td><td class="rightalignment">55</td><td class="leftalignment">BMY.N / CSL.AX / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S / ARGX.OQ / GMAB.CO</td><td class="leftalignment">Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG / argenx SE / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Italy / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck KGaA : 4Q'20 Results Preview: Strong quarter, expected 2021 guidance could lead to modest upgrades</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Richard B. Vosser / James D. Gordon / Sarita Kapila / Ms. Laerke Engkilde / Mr. Tycho W. Peterson</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Does CHRS PD-1 deal suggest no Keytruda cliff in 2028?</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US / CHRS=US</td><td class="leftalignment">Merck & Co Inc / Coherus BioSciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / BLD=US / EBAY=US / TXN=US / TEVA=US / GILD=US / PEB=US / CONE=US / LOW=US / FMS=US / HSII=US / DIOD=US / CHRS=US / TTWO=US / LEG=US / ATVI=US / KFRC=US / MAC=US / KFY=US / AMN=US / CBRL=US / CSTR=US / DRI=US / DRH=US / EQIX=US / GFF=US / IBP=US / MAN=US / MAS=US / MHK=US / ASGN=US / REGN=US / REGI=US / RHI=US / ROLL=US / SKY=US / THO=US / CCRN=US / MTCH=US / VNO=US / FFIN=US / GBCI=US / DIN=US / PTON=US / RPD=US / TPX=US / EXP=US / BECN=US / SHO=US / DLR=US / PLAY=US / BAH=US / WMG=US / DENN=US / BLDR=US / GMS=US / NSP=US / CMG=US / REX=US / HST=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / EHC=US / NMTR=US / IAC=US / JACK=US / RCUS=US / TREX=US / NXPI=US / WWD=US / RLJ=US / FBHS=US / ANGI=US / EA=US / RHP=US / TILE=US / IBTX=US / NDLS=US / PINC=US / CNCE=US / MTNB=US / LOCO=US / ANTM=US / WBA=US / SHAK=US / ON=US / WING=US / ARGX=US / 82982L103 / PK=US / GDS=US / JELD=US / SWCH=US / FERGY=US / ARQT=US / AZEK=US / CRMD.US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / eBay Inc / Texas Instruments Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Pebblebrook Hotel Trust / CyrusOne Inc / Lowe's Companies Inc / Fresenius Medical Care AG & Co KGaA / Heidrick & Struggles International Inc / Diodes Inc / Coherus BioSciences Inc / Take-Two Interactive Software Inc / Leggett & Platt Inc / Activision Blizzard Inc / Kforce Inc / Macerich Co / Korn Ferry / AMN Healthcare Services Inc / Cracker Barrel Old Country Store Inc / CapStar Financial Holdings Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Equinix Inc / Griffon Corp / Installed Building Products Inc / ManpowerGroup Inc / Masco Corp / Mohawk Industries Inc / ASGN Inc / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / Robert Half International Inc / RBC Bearings Inc / Skyline Champion Corp / Thor Industries Inc / Cross Country Healthcare Inc / Match Group Inc / Vornado Realty Trust / First Financial Bankshares Inc / Glacier Bancorp Inc / Dine Brands Global Inc / Peloton Interactive Inc / Rapid7 Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Digital Realty Trust Inc / Dave & Buster's Entertainment Inc / Booz Allen Hamilton Holding Corp / Warner Music Group Corp / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Host Hotels & Resorts Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Encompass Health Corp / 9 Meters Biopharma Inc / IAC/Interactivecorp / Jack in the Box Inc / Arcus Biosciences Inc / Trex Company Inc / NXP Semiconductors NV / Woodward Inc / RLJ Lodging Trust / Fortune Brands Home & Security Inc / Angi Inc / Electronic Arts Inc / Ryman Hospitality Properties Inc / Interface Inc / Independent Bank Group Inc / Noodles & Co / Premier Inc / Concert Pharmaceuticals Inc / Matinas BioPharma Holdings Inc / El Pollo Loco Holdings Inc / Anthem Inc / Walgreens Boots Alliance Inc / Shake Shack Inc / ON Semiconductor Corp / Wingstop Inc / argenx SE / SiteOne Landscape Supply Inc / Park Hotels & Resorts Inc / GDS Holdings Ltd / JELD-WEN Holding Inc / Switch Inc / Ferguson PLC / Arcutis Biotherapeutics Inc / Azek Company Inc / CorMedix Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Brazil / Canada / Cayman Islands / Germany / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2778844 / 2050832 / 2026242 / 2942605 / 2270726 / 2542049 / 2576941 / 2328915 / 2100920 / 2415204 / 2684703 / 2048804 / 2931034 / 7103065 / B121557 / 2212922 / 2857817 / B125XQ6 / B2R3PV1 / B3D7K31 / B1HJLW5 / 2390817 / B7TL820 / B7VD3F2 / BJ0XLZ3 / BH65L93 / BFLR866 / BYY8XK8 / BQPVQZ6 / BFNF1D6 / BJLKVS6 / BFZ1K46 / BLGJ610 / BFMXGR0 / BKTNTR9 / BKX9VD3 / BDVLM39 / BJRFSB7</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Ameren Corp / American Electric Power Company Inc / Avista Corp / Walt Disney Co / Dominion Energy Inc / Exelixis Inc / Nextera Energy Inc / FirstEnergy Corp / Hawaiian Electric Industries Inc / Pfizer Inc / Pinnacle West Capital Corp / Vertex Pharmaceuticals Inc / Novartis AG / Mastercard Inc / NRG Energy Inc / Netflix Inc / Portland General Electric Co / American Water Works Company Inc / Discovery Inc / Emergent BioSolutions Inc / Gray Television Inc / Meta Platforms Inc / Duke Energy Corp / Heron Therapeutics Inc / Seacoast Banking Corporation of Florida / Twitter Inc / WEC Energy Group Inc / Horizon Therapeutics PLC / Amneal Pharmaceuticals Inc / Phathom Pharmaceuticals Inc / Spotify Technology SA / Warner Music Group Corp / Evergy Inc / ViacomCBS Inc / Arcutis Biotherapeutics Inc / argenx SE / Immunovant Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">EXEL (BUY) - Competitor Data at ASCO GU 2021; Phase III CLEAR/KN-581 Regimen Likely Active, but CM-9ER Sets High Bar</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">2576941 / 2126335 / 2778844 / 2684703 / 7103065</td><td class="leftalignment">Exelixis Inc / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc / Novartis AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Seamus Fernandez</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: February 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BDX.N / BMY.N / BSX.N / CI.N / EL.N / MRK.N / PFE.N / PM.N / TMO.N / HUM.N / FE.N / HD.N / ITW.N / XOM.N / LIN.N / ARE.N / AMGN.OQ / JKHY.OQ / ATVI.OQ / REGN.OQ / TT.N / QCOM.OQ / GILD.OQ / AMZN.OQ / TTWO.OQ / GPN.N / VRTX.OQ / ICE.N / TDG.N / ABBV.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / SPG.NZ / OTIS.N</td><td class="leftalignment">Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Estee Lauder Companies Inc / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / Thermo Fisher Scientific Inc / Humana Inc / FirstEnergy Corp / Home Depot Inc / Illinois Tool Works Inc / Exxon Mobil Corp / Linde PLC / Alexandria Real Estate Equities Inc / Amgen Inc / Jack Henry & Associates Inc / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Gilead Sciences Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Intercontinental Exchange Inc / TransDigm Group Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Stride Property Ltd / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / New Zealand / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: January 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ABT.N / ALB.N / AXP.N / BA.N / BAC.N / BSX.N / C.N / CCL.N / CIT.N / CL.N / CRM.N / CVS.N / DAL.N / DD.N / EL.N / EOG.N / F.N / FCX.N / FDX.N / FLT.N / GM.N / HLT.N / IBM.N / JNJ.N / JPM.N / KO.N / LLY.N / LMT.N / LUV.N / MDT.N / MO.N / MRK.N / OXY.N / SLB.N / T.N / TMO.N / USB.N / WFC.N / WMT.N / CMA.N / PG.N / W.N / RIG.N / DHR.N / DIS.N / UNH.N / DE.N / PGR.N / CAT.N / MGM.N / RCL.N / SYY.N / HON.N / VLO.N / HD.N / LOW.N / MRO.N / SYK.N / JWN.N / XOM.N / NKE.N / LIN.N / TGT.N / VZ.N / SNV.N / KSS.N / ORCL.N / VFC.N / HP.N / MAC.N / KMI.N / KMX.N / PWR.N / EQT.N / V.N / OKE.N / HWM.N / ACN.N / WSM.N / AIV.N / LB.TO / BLK.N / CVX.N / IRM.N / NCR.N / COP.N / INTC.OQ / ABMD.OQ / ADBE.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / COHR.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / PII.N / REGN.OQ / ROL.N / SIVB.OQ / THO.N / QDEL.OQ / SNPS.OQ / SBUX.OQ / IDXX.OQ / QCOM.OQ / CREE.OQ / GILD.OQ / COST.OQ / CPRT.OQ / TRU.N / ACGL.OQ / SSNC.OQ / EEFT.OQ / VSAT.OQ / AMZN.OQ / MRCY.OQ / EBAY.OQ / NVDA.OQ / MFA.N / CHTR.OQ / NUAN.OQ / ISRG.OQ / ILMN.OQ / ALGN.OQ / GPN.N / PTEN.OQ / NFLX.OQ / WYNN.OQ / CMCSA.OQ / BIIB.OQ / SBNY.OQ / OSH.N / MOS.N / LVS.N / VIAC.OQ / DISCA.OQ / KOS.N / CDNS.OQ / MS.N / FIS.N / MA.N / SIX.N / SPR.N / CNK.N / IVZ.N / M.N / BGCP.OQ / PBF.N / MRNA.OQ / MSCI.N / CHNG.OQ / AVGO.OQ / FICO.N / CLNY.N / VRSK.OQ / SCHW.N / MU.OQ / NEE.N / TSLA.OQ / ADSGN.F / HHC.N / TWO.N / SABR.OQ / MPC.N / HFC.N / HZNP.OQ / AMD.OQ / ENPH.OQ / PSX.N / NOW.N / SRPT.OQ / BERY.N / FANG.OQ / ABBV.N / BFAM.N / COTY.N / FEYE.OQ / MAR.OQ / AAL.OQ / NCLH.N / GOOGL.OQ / PAYC.N / SAGE.OQ / HUBS.N / WBA.OQ / SEDG.OQ / ETSY.OQ / TDOC.N / PYPL.OQ / PEN.N / NVCR.OQ / TMUS.OQ / SQ.N / RETA.OQ / TWLO.N / SPG.NZ / TTD.OQ / CDEV.OQ / UAA.N / FTI.PA / CVNA.N / AXON.OQ / ROKU.OQ / PEP.OQ / BKNG.OQ / ZS.OQ / QRTEA.OQ / FB.PS / CDAY.N / UAL.OQ / STNE.OQ / ETRN.N / NWL.OQ / CPRI.N / PINS.N / BYND.OQ / ZM.OQ / FSLY.N / CRWD.OQ / PTON.OQ / SVC.OQ / SPCE.N / RTX.N / CARR.N / LMND.N / CHK.N^F20 / AMWL.N / LUMN.N / CHX.OQ</td><td class="leftalignment">Abbott Laboratories / Albemarle Corp / American Express Co / Boeing Co / Bank of America Corp / Boston Scientific Corp / Citigroup Inc / Carnival Corp / First-Citizens Bank & Trust Co / Colgate-Palmolive Co / Salesforce.Com Inc / CVS Health Corp / Delta Air Lines Inc / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / Freeport-McMoRan Inc / FedEx Corp / Fleetcor Technologies Inc / General Motors Co / Hilton Worldwide Holdings Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Medtronic PLC / Altria Group Inc / Merck & Co Inc / Occidental Petroleum Corp / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / US Bancorp / Wells Fargo & Co / Walmart Inc / Comerica Inc / Procter & Gamble Co / Wayfair Inc / Transocean Ltd / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Deere & Co / Progressive Corp / Caterpillar Inc / MGM Resorts International / Royal Caribbean Cruises Ltd / Sysco Corp / Honeywell International Inc / Valero Energy Corp / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / Stryker Corp / Nordstrom Inc / Exxon Mobil Corp / Nike Inc / Linde PLC / Target Corp / Verizon Communications Inc / Synovus Financial Corp / Kohls Corp / Oracle Corp / VF Corp / Helmerich and Payne Inc / Macerich Co / Kinder Morgan Inc / Carmax Inc / Quanta Services Inc / EQT Corp / Visa Inc / ONEOK Inc / Howmet Aerospace Inc / Accenture PLC / Williams-Sonoma Inc / Apartment Investment and Management Co / Laurentian Bank of Canada / BlackRock Inc / Chevron Corp / Iron Mountain Inc / NCR Corp / Conocophillips / Intel Corp / ABIOMED Inc / Adobe Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Coherent Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / Polaris Inc / Regeneron Pharmaceuticals Inc / Rollins Inc / SVB Financial Group / Thor Industries Inc / Quidel Corp / Synopsys Inc / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Wolfspeed Inc / Gilead Sciences Inc / Costco Wholesale Corp / Copart Inc / TransUnion / Arch Capital Group Ltd / SS&C Technologies Holdings Inc / Euronet Worldwide Inc / ViaSat Inc / Amazon.com Inc / Mercury Systems Inc / eBay Inc / NVIDIA Corp / MFA Financial Inc / Charter Communications Inc / Nuance Communications Inc / Intuitive Surgical Inc / Illumina Inc / Align Technology Inc / Global Payments Inc / Patterson-UTI Energy Inc / Netflix Inc / Wynn Resorts Ltd / Comcast Corp / Biogen Inc / Signature Bank / Oak Street Health Inc / Mosaic Co / Las Vegas Sands Corp / ViacomCBS Inc / Discovery Inc / Kosmos Energy Ltd / Cadence Design Systems Inc / Morgan Stanley / Fidelity National Information Services Inc / Mastercard Inc / Six Flags Entertainment Corp / Spirit AeroSystems Holdings Inc / Cinemark Holdings Inc / Invesco Ltd / Macy's Inc / BGC Partners Inc / PBF Energy Inc / Moderna Inc / MSCI Inc / Change Healthcare Inc / Broadcom Inc / Fair Isaac Corp / DigitalBridge Group Inc / Verisk Analytics Inc / Charles Schwab Corp / Micron Technology Inc / Nextera Energy Inc / Tesla Inc / Adidas AG / Howard Hughes Corp / Two Harbors Investment Corp / Sabre Corp / Marathon Petroleum Corp / HollyFrontier Corp / Horizon Therapeutics PLC / Advanced Micro Devices Inc / Enphase Energy Inc / Phillips 66 / ServiceNow Inc / Sarepta Therapeutics Inc / Berry Global Group Inc / Diamondback Energy Inc / Abbvie Inc / Bright Horizons Family Solutions Inc / Coty Inc / Mandiant Inc / Marriott International Inc / American Airlines Group Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Paycom Software Inc / SAGE Therapeutics Inc / HubSpot Inc / Walgreens Boots Alliance Inc / Solaredge Technologies Inc / ETSY Inc / Teladoc Health Inc / PayPal Holdings Inc / Penumbra Inc / Novocure Ltd / T-Mobile US Inc / Block Inc / Reata Pharmaceuticals Inc / Twilio Inc / Stride Property Ltd / Trade Desk Inc / Centennial Resource Development Inc / Under Armour Inc / TechnipFMC PLC / Carvana Co / Axon Enterprise Inc / Roku Inc / PepsiCo Inc / Booking Holdings Inc / Zscaler Inc / Qurate Retail Inc / San Miguel Food and Beverage Inc / Ceridian HCM Holding Inc / United Airlines Holdings Inc / StoneCo Ltd / Equitrans Midstream Corp / Newell Brands Inc / Capri Holdings Ltd / Pinterest Inc / Beyond Meat Inc / Zoom Video Communications Inc / Fastly Inc / CrowdStrike Holdings Inc / Peloton Interactive Inc / Service Properties Trust / Virgin Galactic Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / Lemonade Inc / Chesapeake Energy Corp / American Well Corp / Lumen Technologies Inc / ChampionX Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Germany / United Kingdom / Ireland / Liberia / New Zealand / Panama / Philippines / United States / Virgin Islands, British / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">LONN.S: Lonza - FY20 Results: Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">LONN.S / A.N / RECI.MI / TMO.N / AZN.L / LUN.CO / MRCG.DE / SATG.DE / UCB.BR / SFZN.S / YPSN.S / IPN.PA / GXIG.DE / ALM.MC / MRNA.OQ / 068270.KS / CTLT.N / 207940.KS / GMAB.CO</td><td class="leftalignment">Lonza Group AG / Agilent Technologies Inc / Recordati Industria Chimica e Farmaceutica SpA / Thermo Fisher Scientific Inc / AstraZeneca PLC / H Lundbeck A/S / Merck KGaA / Sartorius AG / Ucb SA / Siegfried Holding AG / Ypsomed Holding AG / Ipsen SA / Gerresheimer AG / Almirall SA / Moderna Inc / Celltrion Inc / Catalent Inc / Samsung Biologics Co Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Italy / Korea, Republic of / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFE.N / AMGN.OQ / GILD.OQ / AMRN.OQ / BSLN.S / AXSM.OQ / BHVN.N / ARAV.OQ / IMAB.OQ / ALXO.OQ</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Gilead Sciences Inc / Amarin Corporation PLC / Basilea Pharmaceutica AG / Axsome Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aravive Inc / I-Mab / ALX Oncology Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">TARO-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">TARO.K / JNJ / MRK / NVS / PFE / GSK / TEVA.K</td><td class="leftalignment">Taro Pharmaceutical Industries Ltd / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LLY-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">LLY / BMY / JNJ / MRK / NVS / PFE / AMGN.O / GSK / AZN.O / ABBV.K / SNY.O</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 22, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Litchfield Hills Research, LLC</td><td class="leftalignment">Initiating coverage – Patient-centric drug development, Predictive Oncology Inc.– Buy rating and $3 PT</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">POAI.OQ / 4502.T / MRK.N / PFE.N / SNY.N / AZN.L / AZN.N / ROG.S / SYK.N / GSK.L / GSK.N / DXR.A / QBIO.PK / MYGN.OQ / BAYGN.DE / ZBH.N / CODX.OQ / DE000BAY0199 / ANPC.OQ</td><td class="leftalignment">Predictive Oncology Inc / Takeda Pharmaceutical Co Ltd / Merck & Co Inc / Pfizer Inc / Sanofi SA / AstraZeneca PLC / AstraZeneca PLC / Roche Holding AG / Stryker Corp / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Daxor Corp / Q BioMed Inc / Myriad Genetics Inc / Bayer AG / Zimmer Biomet Holdings Inc / Co-Diagnostics Inc / Bayer AG / AnPac Bio-Medical Science Co Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Japan / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL / MORNING COMMENTS / GROWTH</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Theodore R. O'Neill</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Feb 01 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MOGa / US0079731008 / US0116591092 / US0311621009 / US0378331005 / US0382221051 / US0463531089 / US1101221083 / US1264081035 / US14149Y1082 / US1925761066 / US22284P1057 / US2910111044 / US3021301094 / US3695501086 / US37733W1053 / US4385161066 / US4433201062 / US4448591028 / US4456581077 / US4824801009 / US5012421013 / US5128071082 / US5150981018 / US5324571083 / US55306N1046 / US58155Q1031 / US6558441084 / US6668071029 / US66987V1098 / US6701002056 / US6795801009 / US7170811035 / US7711951043 / US7766961061 / US8308791024 / US8447411088 / US8552441094 / US87612E1064 / US8807701029 / US9029251066 / US9078181081 / US91324P1021 / US91347P1057 / US9311421039 / US9507551086 / CA1363751027 / US03073E1055 / CA13645T1003 / US4771431016 / US4198791018 / US2948216088 / US80105N1054 / US3463751087 / US09062X1037 / US90385V1070 / US25754A2015 / US0042251084 / US02043Q1076 / US15135B1017 / US12541W2098 / ACOR.OQ / US1696561059 / US78709Y1055 / PAP310761054 / US75025X1000 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US30303M1027 / US9837931008 / US00287Y1091 / NL0010273215 / US8485771021 / US60468T1051 / US21240E1055 / US02376R1023 / US03937C1053 / US0465131078 / CA0089118776 / US00653A1079 / US9741551033 / US70450Y1038 / US40434L1052 / US05464T1043 / US00773U1088 / US16119P1084 / IE00BY7QL619 / KYG4740B1059 / CA87241L1094 / US23753F1075 / US80689H1023 / US02156K1034 / US4990491049 / US1010441053 / US05351X1019 / US5904791358 / US0197701065 / US1255231003 / US8740602052 / US24703L2025 / US0144421072 / US55087P1049 / US90353T1007 / US18453H1068 / US70614W1009 / US09203E1055 / US4432011082 / CH0499880968</td><td class="leftalignment">Moog Inc / Advanced Energy Industries Inc / Alaska Air Group Inc / Amgen Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / Cardinal Health Inc / Cohu Inc / Covenant Logistics Group Inc / Emerson Electric Co / Expeditors International of Washington Inc / General Dynamics Corp / GlaxoSmithKline PLC / Honeywell International Inc / Hub Group Inc / Humana Inc / J B Hunt Transport Services Inc / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Landstar System Inc / Eli Lilly and Co / MKS Instruments Inc / Mckesson Corp / Norfolk Southern Corp / Northrop Grumman Corp / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / Pfizer Inc / Roche Holding AG / Roper Technologies Inc / SkyWest Inc / Southwest Airlines Co / Starbucks Corp / Target Corp / Teradyne Inc / USA Truck Inc / Union Pacific Corp / UnitedHealth Group Inc / Universal Display Corp / Walmart Inc / Werner Enterprises Inc / Canadian National Railway Co / Amerisourcebergen Corp / Canadian Pacific Railway Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Telefonaktiebolaget LM Ericsson / Sanofi SA / FormFactor Inc / Biogen Inc / Ultra Clean Holdings Inc / Domino's Pizza Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Centene Corp / CH Robinson Worldwide Inc / Acorda Therapeutics Inc / Chipotle Mexican Grill Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Meta Platforms Inc / XPO Logistics Inc / Abbvie Inc / ASML Holding NV / Spirit Airlines Inc / Mirati Therapeutics Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / ArcBest Corp / Atara Biotherapeutics Inc / Air Canada / Adaptimmune Therapeutics PLC / Wingstop Inc / PayPal Holdings Inc / HP Inc / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Charter Communications Inc / Johnson Controls International PLC / Ichor Holdings Ltd / TFI International Inc / Daseke Inc / Schneider National Inc / Altice USA Inc / Knight-Swift Transportation Holdings Inc / Boston Omaha Corp / Avaya Holdings Corp / Mesa Air Group Inc / Allogene Therapeutics Inc / Cigna Corp / Takeda Pharmaceutical Co Ltd / Dell Technologies Inc / Alector Inc / Lyft Inc / Uber Technologies Inc / Clear Channel Outdoor Holdings Inc / Peloton Interactive Inc / Black Diamond Therapeutics Inc / Howmet Aerospace Inc / ADC Therapeutics SA</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Japan / Mexico / Netherlands / Panama / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AOS=US / PNR=US / AAPL=US / MRK=US / BSX=US / PFE=US / ABT=US / AMGN=US / CAT=US / INTC=US / CHRW=US / WM=US / BWA=US / MDT=US / GLW=US / QCOM=US / RUN=US / MPWR=US / FCEL=US / PLUG=US / AXL=US / SBH=US / CRM=US / SMTC=US / UMC=US / VRTS=US / URI=US / TSM=US / UPS=US / ENR=US / CHRS=US / JCI=US / JNJ=US / LSTR=US / DE=US / DOV=US / FLO=US / RSG=US / ALB=US / AMED=US / ECOL=US / AMSC=US / ARRY=US / ATRC=US / AVNT=US / AVT=US / BOX=US / CMI=US / CALM=US / CENX=US / CREE=US / CYBR=US / DAKT=US / EW=US / EXAS=US / FIVE=US / HTLD=US / ITRI=US / LGND=US / MTRX=US / MMS=US / NVAX=US / ODFL=US / PZZA=US / RBC=US / ROK=US / ROP=US / POOL=US / TRMB=US / TYL=US / VG=US / WDFC=US / SGEN=US / CCRN=US / ACA=US / HR=US / NEP=US / UFCS=US / BIO=US / OSTK=US / ENSG=US / BE=US / AMSF=US / ARES=US / CLH=US / PETS=US / WCN=US / TCOM=US / RNG=US / CRI=US / NUVA=US / MRNA=US / DPZ=US / BDC=US / PBF=US / ENS=US / GOOG=US / TWIN=US / MKTX=US / ORA=US / FRPT=US / PBH=US / MORN=US / BIDU=US / AMRS=US / SPWR=US / ATNI=US / TPTX=US / TEL=US / CSIQ=US / EBS=US / FSLR=US / TRIT=US / MASI=US / DAN=US / WPRT=US / TBK=US / AGCO=US / 005930-KR=US / GNRC=US / RRTS=US / TSLA=US / AMRC=US / ENPH=US / YY=US / HASI=US / CNHI=US / QURE=US / DNOW=US / COUP=US / SYF=US / VCEL=US / NVTA=US / ETSY=US / SEDG=US / WING=US / TDOC=US / AQMS=US / WKHS=US / TRHC=US / FLGT=US / IRTC=US / HLNE=US / RDFN=US / ROKU=US / MDB=US / APTV=US / VOW3-DE=US / IQ=US / VNE=US / FOCS=US / CWEN=US / ZM=US / VLDR=US / 120376391</td><td class="leftalignment">A O Smith Corp / Pentair PLC / Apple Inc / Merck & Co Inc / Boston Scientific Corp / Pfizer Inc / Abbott Laboratories / Amgen Inc / Caterpillar Inc / Intel Corp / CH Robinson Worldwide Inc / Waste Management Inc / Borgwarner Inc / Medtronic PLC / Corning Inc / Qualcomm Inc / Sunrun Inc / Monolithic Power Systems Inc / Fuelcell Energy Inc / Plug Power Inc / American Axle & Manufacturing Holdings Inc / Sally Beauty Holdings Inc / Salesforce.Com Inc / Semtech Corp / United Microelectronics Corp / Virtus Investment Partners Inc / United Rentals Inc / Taiwan Semiconductor Manufacturing Co Ltd / United Parcel Service Inc / Energizer Holdings Inc / Coherus BioSciences Inc / Johnson Controls International PLC / Johnson & Johnson / Landstar System Inc / Deere & Co / Dover Corp / Flowers Foods Inc / Republic Services Inc / Albemarle Corp / Amedisys Inc / US Ecology Inc / American Superconductor Corp / Array Technologies Inc / AtriCure Inc / Avient Corp / Avnet Inc / Box Inc / Cummins Inc / Cal-Maine Foods Inc / Century Aluminum Co / Wolfspeed Inc / Cyberark Software Ltd / Daktronics Inc / Edwards Lifesciences Corp / Exact Sciences Corp / Five Below Inc / Heartland Express Inc / Itron Inc / Ligand Pharmaceuticals Inc / Matrix Service Co / Maximus Inc / Novavax Inc / Old Dominion Freight Line Inc / Papa John's International Inc / Regal Rexnord Corp / Rockwell Automation Inc / Roper Technologies Inc / Pool Corp / Trimble Inc / Tyler Technologies Inc / Vonage Holdings Corp / WD-40 Co / Seagen Inc / Cross Country Healthcare Inc / Arcosa Inc / Healthcare Realty Trust Inc / Nextera Energy Partners LP / United Fire Group Inc / Bio Rad Laboratories Inc / Overstock.com Inc / Ensign Group Inc / Bloom Energy Corp / Amerisafe Inc / Ares Management Corp / Clean Harbors Inc / Petmed Express Inc / Waste Connections Inc / Trip.com Group Ltd / RingCentral Inc / Carter's Inc / NuVasive Inc / Moderna Inc / Domino's Pizza Inc / Belden Inc / PBF Energy Inc / EnerSys / Alphabet Inc / Twin Disc Inc / Marketaxess Holdings Inc / Ormat Technologies Inc / Freshpet Inc / Prestige Consumer Healthcare Inc / Morningstar Inc / Baidu Inc / Amyris Inc / SunPower Corp / ATN International Inc / Turning Point Therapeutics Inc / TE Connectivity Ltd / Canadian Solar Inc / Emergent BioSolutions Inc / First Solar Inc / Triterras Inc / Masimo Corp / Dana Inc / Westport Fuel Systems Inc / Triumph Bancorp Inc / AGCO Corp / Farfetch Ltd / Generac Holdings Inc / Roadrunner Transportation Systems Inc / Tesla Inc / Ameresco Inc / Enphase Energy Inc / JOYY Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / CNH Industrial NV / Uniqure NV / NOW Inc / Coupa Software Inc / Synchrony Financial / Vericel Corp / Invitae Corp / ETSY Inc / Solaredge Technologies Inc / Wingstop Inc / Teladoc Health Inc / Aqua Metals Inc / Workhorse Group Inc / Tabula Rasa HealthCare Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / Hamilton Lane Inc / Redfin Corp / Roku Inc / MongoDB Inc / Aptiv PLC / Volkswagen AG / iQIYI Inc / Veoneer Inc / Focus Financial Partners Inc / Clearway Energy Inc / Zoom Video Communications Inc / Velodyne Lidar Inc / Proterra Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Ireland / Israel / Netherlands / Taiwan / United States / Jersey</td><td class="leftalignment">Biotechnology / Conglomerates / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Machinery / Retailing / Semiconductors / Services</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Merck & Co (MRK US) - Positive tailspin: the shape of what remains</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US58933Y1055</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / ENDP.O / TEVA.N / ABBV.N / AMRX.N / 269796108</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Amneal Pharmaceuticals Inc / Eagle Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: February 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BMY.N / BSX.N / CI.N / EL.N / LLY.N / MRK.N / PFE.N / PM.N / TMO.N / HUM.N / FE.N / CAT.N / HON.N / ITW.N / XOM.N / LIN.N / ARE.N / CVX.N / AMGN.OQ / JKHY.OQ / REGN.OQ / TT.N / QCOM.OQ / AMZN.OQ / TTWO.OQ / CHTR.OQ / GPN.N / VRTX.OQ / ABBV.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / SPG.NZ / OTIS.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Estee Lauder Companies Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / Thermo Fisher Scientific Inc / Humana Inc / FirstEnergy Corp / Caterpillar Inc / Honeywell International Inc / Illinois Tool Works Inc / Exxon Mobil Corp / Linde PLC / Alexandria Real Estate Equities Inc / Chevron Corp / Amgen Inc / Jack Henry & Associates Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Charter Communications Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Stride Property Ltd / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / New Zealand / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma 4Q Earnings Season : What to Watch for the Week Ahead (ABBV, BMY, MRK, PFE)</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK.N / ABBV.N / BMY.N / PFE.N / LLY.N</td><td class="leftalignment">Merck & Co Inc / Abbvie Inc / Bristol-Myers Squibb Co / Pfizer Inc / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Christopher T. Schott, CFA / Xiling Chen / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">01/31/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Still the Premium Player Among COVID-19 Vaccines; PT to $206</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA=US / MRK=US / PFE=US / JNJ=US / NVAX=US</td><td class="leftalignment">Moderna Inc / Merck & Co Inc / Pfizer Inc / Johnson & Johnson / Novavax Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/31/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">What's New At WCLC This Year; Takeaways Keep Us Positive on MRK, JNJ and HCM</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK / JNJ / HCM.L / LLY / PFE / AMGN.O / BSLN.S / ARAV.O / IMAB.O</td><td class="leftalignment">Merck & Co Inc / Johnson & Johnson / HUTCHMED (China) Ltd / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Basilea Pharmaceutica AG / Aravive Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">01/31/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Trial Activity Remains Above Jan 2020 Baseline- Week 45</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Merck down 1.9% in 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Merck vs Pfizer - Relative Performance of the Two Pharmaceutical Giants</td><td class="leftalignment">English</td><td class="rightalignment">128</td><td class="leftalignment">MRK.N / PFE.N</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 1.29.21</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Weekly: EpiPen Mkt Growth Strong; Vascepa Gx at High-Single Digit Share</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / GSK=US / ENDP=US / PRGO=US / BIIB=US / AMRX=US / ABBV=US / XERS=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Endo International PLC / Perrigo Company PLC / Biogen Inc / Amneal Pharmaceuticals Inc / Abbvie Inc / Xeris Biopharma Holdings Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Ami Fadia</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVS-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">NVS / ABT / BMY / JNJ / MRK / PFE / GSK / AZN.O / BAYRY.PK / TEVA.K / SNY.O</td><td class="leftalignment">Novartis AG / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Bayer AG / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">JNJ-US Company reports financial results for the quarter ended January 03,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">JNJ / ABT / LLY / MDT / MRK / NVS / PFE / SYK / GILD.O / GSK / SNY.O</td><td class="leftalignment">Johnson & Johnson / Abbott Laboratories / Eli Lilly and Co / Medtronic PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / Stryker Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended January 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / NVS=US / GSK=GB / AZN=US / GSK=US / JNJ=US / EXEL=US / ICPT=US / NVO=US / REGN=US / RHHBY=US / INVA=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Exelixis Inc / Intercept Pharmaceuticals Inc / Novo Nordisk A/S / Regeneron Pharmaceuticals Inc / Roche Holding AG / Innoviva Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update- 4Q20 Earnings Preview Edition</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / 4523.T / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / GSK.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / UTHR.OQ / BMRN.OQ / INSM.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / BAYGN.DE / ABBV.N / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Eisai Co Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Insmed Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Bayer AG / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / France / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: January 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BA.N / BMY.N / BSX.N / CI.N / EL.N / LLY.N / MRK.N / PFE.N / PM.N / TMO.N / HUM.N / DHR.N / CAT.N / MCD.N / HON.N / ITW.N / XOM.N / LIN.N / V.N / ARE.N / CVX.N / AMGN.OQ / REGN.OQ / TT.N / QCOM.OQ / AMZN.OQ / CHTR.OQ / EXPE.OQ / VRTX.OQ / CMCSA.OQ / MDLZ.OQ / ABBV.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / BKNG.OQ / OTIS.N</td><td class="leftalignment">Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Estee Lauder Companies Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / Thermo Fisher Scientific Inc / Humana Inc / Danaher Corp / Caterpillar Inc / McDonald's Corp / Honeywell International Inc / Illinois Tool Works Inc / Exxon Mobil Corp / Linde PLC / Visa Inc / Alexandria Real Estate Equities Inc / Chevron Corp / Amgen Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Amazon.com Inc / Charter Communications Inc / Expedia Group Inc / Vertex Pharmaceuticals Inc / Comcast Corp / Mondelez International Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Booking Holdings Inc / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for MRK</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">AMGN (NEUTRAL) - Sotorasib Registration Data at WCLC Looks Solid; Raises Bar for MRTX's Adagrasib</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2023607 / MRTX.OQ / 2516152 / 2778844 / 7103065 / BBPK0J0</td><td class="leftalignment">Amgen Inc / Mirati Therapeutics Inc / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Mirati Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma : 4Q Earnings Preview – 2021 Shaping Up To Be A Solid Year For The Group</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">ABBV.N / BMY.N / MRK.N / PFE.N</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: January 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ABT.N / BMY.N / BSX.N / CI.N / LLY.N / MRK.N / PFE.N / PM.N / T.N / TMO.N / HUM.N / DHR.N / CAT.N / MCD.N / HON.N / XOM.N / V.N / ARE.N / CVX.N / AMGN.OQ / AAPL.OQ / QCOM.OQ / GILD.OQ / AMZN.OQ / CHTR.OQ / VRTX.OQ / CMCSA.OQ / TSLA.OQ / EA.OQ / MDLZ.OQ / ABBV.N / GOOGL.OQ / PYPL.OQ / FB.PS / OTIS.N</td><td class="leftalignment">Abbott Laboratories / Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / AT&T Inc / Thermo Fisher Scientific Inc / Humana Inc / Danaher Corp / Caterpillar Inc / McDonald's Corp / Honeywell International Inc / Exxon Mobil Corp / Visa Inc / Alexandria Real Estate Equities Inc / Chevron Corp / Amgen Inc / Apple Inc / Qualcomm Inc / Gilead Sciences Inc / Amazon.com Inc / Charter Communications Inc / Vertex Pharmaceuticals Inc / Comcast Corp / Tesla Inc / Electronic Arts Inc / Mondelez International Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / San Miguel Food and Beverage Inc / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Bristol Myers Squibb Stock Can Offer Better Returns Over Eli Lilly</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">India Healthcare Sector: Digital health in India: Who benefits and who gets impacted?</td><td class="leftalignment">English</td><td class="rightalignment">58</td><td class="leftalignment">APLH.NS / METP.BO / AIG.N / AXAF.PA / HDBK.BO / MRK.N / PFE.N / RELI.BO / SASY.PA / TORP.BO / 0241.HK / AMZN.OQ / 2318.HK / 601318.SS / JD.OQ / BABA.N / TDOC.N / 9988.HK / TACN.BO / 9618.HK / AMWL.N</td><td class="leftalignment">Apollo Hospitals Enterprise Ltd / Metropolis Healthcare Ltd / American International Group Inc / AXA SA / HDFC Bank Ltd / Merck & Co Inc / Pfizer Inc / Reliance Industries Ltd / Sanofi SA / Torrent Pharmaceuticals Ltd / Alibaba Health Information Technology Ltd / Amazon.com Inc / Ping An Insurance Group Co of China Ltd / Ping An Insurance Group Co of China Ltd / JD.Com Inc / Alibaba Group Holding Ltd / Teladoc Health Inc / Alibaba Group Holding Ltd / Tata Consumer Products Ltd / JD.Com Inc / American Well Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / China / Cayman Islands / France / India / United States</td><td class="leftalignment">Consumer / Leisure & Entertainment / Lodging & Restaurants</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Anubhav Aggarwal / Sayantan Maji</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK.N / PFE.N / GILD.OQ / AMRN.OQ / EHTH.OQ / OMER.OQ / EVGN.TA / AUP.TO / AKTX.OQ / APLS.OQ / IAN.CD / GTII.CD / MMEN.CD / CURA.CD / TRUL.CD / CL.CD / CCHW.NLB / PHGE.A / SLQT.N / GOCO.OQ / ACRGau.CD / 120346301</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Amarin Corporation PLC / eHealth Inc / Omeros Corp / Evogene Ltd / Aurinia Pharmaceuticals Inc / Akari Therapeutics PLC / Apellis Pharmaceuticals Inc / Ianthus Capital Holdings Inc / Green Thumb Industries Inc / Medmen Enterprises Inc / Curaleaf Holdings Inc / Trulieve Cannabis Corp / Cresco Labs Inc / Columbia Care Inc / Biomx Inc / SelectQuote Inc / Gohealth Inc / Acreage Holdings Inc / Ayr Wellness Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Access to Medicine Foundation</td><td class="leftalignment">2021 Access to Medicine Index (26 Jan 2021)</td><td class="leftalignment">English</td><td class="rightalignment">237</td><td class="leftalignment">4502.T / 4503.T / 4523.T / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOb.CO / NOVN.S / MRCG.DE / GSK.L / GILD.OQ / 4568.T / BAYGn.DE / ABBV.N</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Eisai Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Gilead Sciences Inc / Daiichi Sankyo Co Ltd / Bayer AG / Abbvie Inc</td><td class="leftalignment">INDUSTRY OVERVIEW</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Team Index</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 15, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Daily Credit Briefing</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">IBE.MC / NLMK.MM / MRK.N / PFE.N / CONG.DE / AZN.L / TKAG.DE / DBKGn.DE / SAPG.DE / CHMF.RTS / EUFI.PA / IM00B7S9G985</td><td class="leftalignment">Iberdrola SA / Novolipetsk Steel PAO / Merck & Co Inc / Pfizer Inc / Continental AG / AstraZeneca PLC / thyssenkrupp AG / Deutsche Bank AG / SAP SE / Severstal' PAO / Eurofins Scientific SE / Playtech PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Spain / United Kingdom / Italy / Luxembourg / Russian Federation / Ukraine / United States / Isle of Man</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS / CREDIT</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Herr. Ulrich Scholz, CFA / Sergey Bolshakov / Herr Christian Aust / Herr Sven Kreitmair, CFA / Herr Gianfranco Arcovito / Frau Silke Stegemann / Frau. Jana Schuler / Herr. Michael Teig / Holger Kapitza</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">V / 0989529 / 2259101 / 2434209 / 2778844 / 2973821 / 2270726 / 2542049 / 2829515 / 2317087 / 2342034 / 2100920 / 2459020 / 2630513 / 2048804 / 2730190 / 2138158 / 2825933 / 2503529 / B2R3PV1 / 2598246 / B7TL820 / B7VD3F2 / B87ZMX0 / BYY8XK8 / BYVY8G0 / BYVFC94 / BD8DJ71 / BZ00V34 / BJJMGL2 / BFXC911 / BDFZSP1 / BP84RX0 / BQXZP64 / BGDQ8B3 / BN0XTW4</td><td class="leftalignment">Visa Inc / AstraZeneca PLC / Target Corp / Home Depot Inc / Merck & Co Inc / Alliant Energy Corp / Walt Disney Co / Dominion Energy Inc / Edison International / Entergy Corp / Fiserv Inc / FirstEnergy Corp / Intuit Inc / New Jersey Resources Corp / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / Sempra Energy / South Jersey Industries Inc / World Wrestling Entertainment Inc / American Water Works Company Inc / Neogenomics Inc / Meta Platforms Inc / Duke Energy Corp / Palo Alto Networks Inc / WEC Energy Group Inc / Alphabet Inc / US Foods Holding Corp / Snap Inc / Zscaler Inc / Fox Corp / Guardant Health Inc / Okta Inc / Townsquare Media Inc / Wayfair Inc / Axonics Inc / Orphazyme A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">LONN.S: Lonza - FY20 Preview CS in line for FY20 , 3% ahead on EPS by FY23</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LONN.S / AKZO.AS / DSMN.AS / JMAT.L / MRCG.DE / NZYMB.CO</td><td class="leftalignment">Lonza Group AG / Akzo Nobel NV / Koninklijke DSM NV / Johnson Matthey PLC / Merck KGaA / Novozymes A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / United Kingdom / Netherlands</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Microbiome Deep Dive: Key Players, Themes and Events for 2021</td><td class="leftalignment">English</td><td class="rightalignment">87</td><td class="leftalignment">EVGN.O / PHGE.K / MRK / PFE / GILD.O</td><td class="leftalignment">Evogene Ltd / Biomx Inc / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Kristen Kluska</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRK.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">Wolfe Pharma & Biotech* 4Q20 EPS Preview - Model Changes and Updated Perspectives</td><td class="leftalignment">English</td><td class="rightalignment">89</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Should You Buy Johnson & Johnson Stock At $160?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">JNJ.N / BMY.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Johnson & Johnson / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">MRK: Failed CoV2 Vaccine Effort Disappointing, but Molnupiravir Outcome Is More Important to MRK's Stock</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2778844</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MRK's discontinuance of its V590 and V591 COVID-19 vaccine programs is disappointing but also relatively low impact</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Randall S. Stanicky, CFA</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Competition for BTKs Heating Up With AZN's Positive H2H Topline Results</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">JNJ / LLY / MRK</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - January 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">NL0000226223 / DE0006231004 / US0079731008 / US0116591092 / US0378331005 / US0382221051 / US0463531089 / US1101221083 / US1264081035 / US1727551004 / US1924461023 / US1925761066 / US2017231034 / US22284P1057 / US2371941053 / US2829141009 / US3021301094 / US3156161024 / US37733W1053 / US4433201062 / US4456581077 / US4567881085 / US4581401001 / US4663671091 / US4824801009 / US5012421013 / US5128071082 / US5150981018 / US5324571083 / US55306N1046 / US5801351017 / US5949181045 / US5951121038 / US6558441084 / US66987V1098 / US6701002056 / US6703461052 / US6795801009 / US7170811035 / US7392761034 / US7475251036 / US7595091023 / US7711951043 / AN8068571086 / US8068821060 / US8168501018 / US8308791024 / US8447411088 / US8552441094 / US8581191009 / US8610121027 / US8807701029 / US9029251066 / US9078181081 / US91347P1057 / US9182041080 / US9507551086 / US9581021055 / CA1363751027 / CA13645T1003 / US9129091081 / US87157D1090 / US9884981013 / US4771431016 / US83088M1027 / US4198791018 / US80105N1054 / US3463751087 / US1572101053 / US90385V1070 / US12541W2098 / US1696561059 / US82706C1080 / US78709Y1055 / PAP310761054 / US75025X1000 / US3020811044 / US92932M1018 / US01748X1028 / US2473617023 / BMG3922B1072 / IE00B4BNMY34 / US58933Y1055 / US9100471096 / US95058W1009 / US03027X1000 / US29414B1044 / US9837931008 / US00287Y1091 / NL0010273215 / US45845P1084 / US8485771021 / US21240E1055 / US76680R2067 / CA05156V1022 / US02376R1023 / US03937C1053 / US8873991033 / LU0974299876 / CA0089118776 / US22822V1017 / CA76131D1033 / US74736K1016 / US8190471016 / US9741551033 / US5588681057 / US01345P1066 / KYG4740B1059 / US2067871036 / CA87241L1094 / US78410G1040 / CA35805P1071 / US23753F1075 / US23355L1061 / US80689H1023 / US4990491049 / US1858991011 / US30057T1051 / US89854H1023 / US05351X1019 / US11135F1012 / US05455M1009 / US29260V1052 / US5904791358 / US62921N1054 / CA59935V1076 / US4833791035 / US92537N1081 / US39813G1094 / 120175706</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / Advanced Energy Industries Inc / Alaska Air Group Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / Cirrus Logic Inc / Cognizant Technology Solutions Corp / Cohu Inc / Commercial Metals Co / Covenant Logistics Group Inc / Darden Restaurants Inc / 8x8 Inc / Expeditors International of Washington Inc / F5 Inc / GlaxoSmithKline PLC / Hub Group Inc / J B Hunt Transport Services Inc / Infosys Ltd / Intel Corp / Jack in the Box Inc / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Landstar System Inc / Eli Lilly and Co / MKS Instruments Inc / McDonald's Corp / Microsoft Corp / Micron Technology Inc / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Nucor Corp / Old Dominion Freight Line Inc / Pfizer Inc / Power Integrations Inc / Qualcomm Inc / Reliance Steel & Aluminum Co / Roche Holding AG / Schlumberger NV / Schnitzer Steel Industries Inc / Semtech Corp / SkyWest Inc / Southwest Airlines Co / Starbucks Corp / Steel Dynamics Inc / STMicroelectronics NV / Teradyne Inc / USA Truck Inc / Union Pacific Corp / Universal Display Corp / VF Corp / Werner Enterprises Inc / Western Digital Corp / Canadian National Railway Co / Canadian Pacific Railway Ltd / United States Steel Corp / Synaptics Inc / Yum! Brands Inc / JetBlue Airways Corp / Skyworks Solutions Inc / Hawaiian Holdings Inc / Sanofi SA / FormFactor Inc / CEVA Inc / Ultra Clean Holdings Inc / CH Robinson Worldwide Inc / Chipotle Mexican Grill Inc / Silicon Motion Technology Corp / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Exlservice Holdings Inc / WNS (Holdings) Ltd / Allegiant Travel Co / Delta Air Lines Inc / Genpact Ltd / Accenture PLC / Merck & Co Inc / United Airlines Holdings Inc / Wendys Co / American Tower Corp / Epam Systems Inc / XPO Logistics Inc / Abbvie Inc / ASML Holding NV / Intercept Pharmaceuticals Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / RingCentral Inc / Aurinia Pharmaceuticals Inc / American Airlines Group Inc / ArcBest Corp / TimkenSteel Corp / Globant SA / Air Canada / Crown Castle International Corp / Restaurant Brands International Inc / Qorvo Inc / Shake Shack Inc / Wingstop Inc / Madrigal Pharmaceuticals Inc / Albireo Pharma Inc / Ichor Holdings Ltd / Conduent Inc / TFI International Inc / SBA Communications Corp / Freshii Inc / Daseke Inc / DXC Technology Co / Schneider National Inc / Knight-Swift Transportation Holdings Inc / Cleveland-Cliffs Inc / Evoqua Water Technologies Corp / TTEC Holdings Inc / Avaya Holdings Corp / Broadcom Inc / AVROBIO Inc / Endava PLC / Mesa Air Group Inc / NGM Biopharmaceuticals Inc / Milestone Pharmaceuticals Inc / Kaleyra Inc / Vertiv Holdings Co / Grid Dynamics Holdings Inc / Cisco Systems Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / India / Ireland / Luxembourg / Mexico / Netherlands / Panama / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">V / 0925288 / 2126335 / 2000019 / 2293819 / 2778844 / 2026242 / 2216850 / 2270726 / 2542049 / 2576941 / 2328915 / 2366799 / 2689560 / 2680905 / 2048804 / 2138158 / B121557 / 2857817 / B02R1L6 / B2R3PV1 / B3D7K31 / B570P91 / B4N0JJ6 / B7TL820 / B783TY6 / B7VD3F2 / BBGVT40 / BYY8XK8 / BYVY8G0 / BFZ1K46 / BKTNTR9 / BJDX8Y8 / BQXZP64 / BMTVQT8</td><td class="leftalignment">Visa Inc / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Amazon.com Inc / eBay Inc / Merck & Co Inc / American Electric Power Company Inc / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Exelixis Inc / Nextera Energy Inc / Gentex Corp / PG&E Corp / PPL Corp / Pinnacle West Capital Corp / Sempra Energy / Mastercard Inc / Netflix Inc / ALLETE Inc / American Water Works Company Inc / Discovery Inc / Lear Corp / Visteon Corp / Meta Platforms Inc / Aptiv PLC / Duke Energy Corp / News Corp / WEC Energy Group Inc / Alphabet Inc / Spotify Technology SA / ViacomCBS Inc / Mirum Pharmaceuticals Inc / Wayfair Inc / Goodrx Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Luxembourg / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">PharmaValues 2021 Strategic Conclusions. Summary slides</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / CSL.AX / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / 4506.T / 4536.T / SASY.PA / ROG.S / LUN.CO / 4151.T / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / 4568.T / IPN.PA / HIK.L / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / 4578.T / 4581.T / SRPT.OQ / ABBV.N / QURE.OQ / BGNE.OQ / VIFN.S / 6160.HK / GMAB.CO</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Kyowa Kirin Co Ltd / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Daiichi Sankyo Co Ltd / Ipsen SA / Hikma Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / Sarepta Therapeutics Inc / Abbvie Inc / Uniqure NV / Beigene Ltd / Vifor Pharma AG / Beigene Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Ms Jo Walton / Mr Matthew J. Weston / Mr. Trung Huynh / Elizabeth Walton / Mr. Dominic Lunn</td></tr>
<tr class="even"><td class="leftalignment">01/24/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Trial Activity Remains Above Jan 2020 Baseline- Week 44</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">01/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Top of the Charts - A review of the week's best reads</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ANTO.L / AVMD.PA / BARC.L / BHP.AX / BNPP.PA / CRH.I / ERICB.ST / HEIN.AS / HSBA.L / JNJ.N / KGF.L / LLY.N / MRK.N / NHY.OL / PFE.N / PRU.L / RIO.AX / SAPJ.J / SHBA.ST / SOGN.PA / SOLB.BR / VOD.L / SASY.PA / ROG.S / DBKGN.F / NOVOB.CO / NOVN.S / BOL.ST / CARLB.CO / GSK.L / NWG.L / MAERSKB.CO / NKELYQ.L / ASOS.L / ABI.BR / 0486.HK / BNRGN.DE / BASFN.DE / 1299.HK / SHLG.DE / GLEN.L / ABBV.N / FBK.MI / IMB.L / UBSG.S / DHER.DE / TEPRF.PA</td><td class="leftalignment">Antofagasta PLC / Dassault Aviation SA / Barclays PLC / BHP Group Ltd / BNP Paribas SA / CRH PLC / Telefonaktiebolaget LM Ericsson / Heineken NV / HSBC Holdings PLC / Johnson & Johnson / Kingfisher PLC / Eli Lilly and Co / Merck & Co Inc / Norsk Hydro ASA / Pfizer Inc / Prudential PLC / Rio Tinto Ltd / Sappi Ltd / Svenska Handelsbanken AB / Societe Generale SA / Solvay SA / Vodafone Group PLC / Sanofi SA / Roche Holding AG / Deutsche Bank AG / Novo Nordisk A/S / Novartis AG / Boliden AB / Carlsberg A/S / GlaxoSmithKline PLC / Natwest Group PLC / AP Moeller - Maersk A/S / GMK Noril'skiy Nikel' PAO / ASOS PLC / Anheuser Busch Inbev SA / OK Rusal MKPAO / Brenntag SE / BASF SE / AIA Group Ltd / Siemens Healthineers AG / Glencore PLC / Abbvie Inc / FinecoBank Banca Fineco SpA / Imperial Brands PLC / UBS Group AG / Delivery Hero SE / Teleperformance SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / Germany / Denmark / France / United Kingdom / Hong Kong / Ireland / Italy / Netherlands / Norway / Russian Federation / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Joelle Anamooto Natzkoff / Mr. Richard A. Kersley / Samuel Burgess</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFE.N / AMGN.OQ / REGN.OQ / GILD.OQ / INCY.OQ / VRTX.OQ / BIIB.OQ / ACB.TO / IBIO.A / ZTS.N / WEED.TO / TLRY.OQ / OGI.TO / XGN.OQ / IMAB.OQ</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Biogen Inc / Aurora Cannabis Inc / Ibio Inc / Zoetis Inc / Canopy Growth Corp / Tilray Brands Inc / OrganiGram Holdings Inc / Exagen Inc / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused next week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N / ENDP.O / TEVA.N / PCRX.O / ABBV.N / PRGO.N / FLXN.O / AMRX.N / AQST.O</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Pacira Biosciences Inc / Abbvie Inc / Perrigo Company PLC / Pacira Biosciences Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Marka rises for a third consecutive year, a three-year rise of 186%</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRKP.WA</td><td class="leftalignment">Marka SA w restrukturyzacji</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Poland</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">EXEL (BUY) - FDA Approval in 1L Kidney Cancer as Expected & Should Represent Tailwind for Further Cabo TRx Growth</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2576941 / 2126335 / 2778844 / 2684703</td><td class="leftalignment">Exelixis Inc / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Seamus Fernandez</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Weekly: COVID Vaccine Rollout Driving Recent Growth in the EpiPen Market?</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / GSK=US / ENDP=US / PRGO=US / BIIB=US / AMRX=US / ABBV=US / XERS=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Endo International PLC / Perrigo Company PLC / Biogen Inc / Amneal Pharmaceuticals Inc / Abbvie Inc / Xeris Biopharma Holdings Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Ami Fadia</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">CALL STARTING SOON: Cantor Research Call - Healthcare Large Cap 4Q20 Preview</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">HCM.L / LLY / JNJ / MRK / PFE / ZTS / IMAB.O</td><td class="leftalignment">HUTCHMED (China) Ltd / Eli Lilly and Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Zoetis Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended January 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Morning Bite Flash</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">FI0009005870 / DE0006599905 / DE0006602006 / NL0000235190 / DE0006202005 / DE0007236101 / DE0006766504 / FI0009013403 / CH0024638212 / DE000WCH8881 / DE000WAF3001</td><td class="leftalignment">Konecranes Abp / Merck KGaA / GEA Group AG / Airbus SE / Salzgitter AG / Siemens AG / Aurubis AG / Kone Oyj / Schindler Holding AG / Wacker Chemie AG / Siltronic AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / Germany / Finland / Netherlands</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Herr. Ingo-Martin Schachel, CFA</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jan 22 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">FR0000121014 / CH0012221716 / US0028962076 / US02553E1064 / US0311001004 / US0320951017 / US0378331005 / US0463531089 / US0530151036 / US1011371077 / US1101221083 / US1264081035 / US1271903049 / US1924221039 / US22160K1051 / US2310211063 / US28176E1082 / US34354P1057 / US3647601083 / US37733W1053 / US45167R1041 / US4581401001 / US4698141078 / US5324571083 / US5949181045 / US66987V1098 / US6701002056 / US7010941042 / US7043261079 / US7170811035 / US7711951043 / US7739031091 / US7766961061 / US7782961038 / US8636671013 / US8725401090 / US87612E1064 / US8793601050 / US9078181081 / US9297401088 / US9311421039 / US9427491025 / US5645631046 / US80105N1054 / US0003752047 / US2538681030 / US6247581084 / US48242W1062 / US92932M1018 / US90384S3031 / US0231112063 / US1940141062 / CA0585861085 / CH0102993182 / US58933Y1055 / IE00B58JVZ52 / US9100471096 / US0995021062 / US7512121010 / US98419M1009 / US00287Y1091 / US98978V1035 / US81762P1021 / US72919P2020 / US23283R1005 / US8086251076 / US5253271028 / CH0210483332 / US70438V1061 / US70432V1026 / US98936J1016 / IE00BLS09M33 / US0994061002 / US29444U7000 / US72703H1014 / GB00BZ09BD16 / US45073V1089 / US34959J1088 / US90138F1021 / US36165L1089 / US74967X1037 / CA1350861060 / US05722G1004 / US87105L1044 / US8760301072 / US30057T1051 / GB00BFMBMT84 / US15677J1088 / US2575541055 / US0937121079 / US28414H1032 / KY30744W1070 / VGG1890L1076 / US70202L1026 / US35952H6018 / US76156B1070 / US88339P1012 / US30068X1037 / US6541101050 / GB00BMVP7Y09 / US6873051022</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / Abb Ltd / Abercrombie & Fitch Co / American Eagle Outfitters Inc / AMETEK Inc / Amphenol Corp / Apple Inc / AstraZeneca PLC / Automatic Data Processing Inc / Boston Scientific Corp / Bristol-Myers Squibb Co / CSX Corp / CACI International Inc / Cognex Corp / Costco Wholesale Corp / Cummins Inc / Edwards Lifesciences Corp / Flowserve Corp / Gap Inc / GlaxoSmithKline PLC / IDEX Corp / Intel Corp / Jacobs Engineering Group Inc / Eli Lilly and Co / Microsoft Corp / Novartis AG / Novo Nordisk A/S / Parker-Hannifin Corp / Paychex Inc / Pfizer Inc / Roche Holding AG / Rockwell Automation Inc / Roper Technologies Inc / Ross Stores Inc / Stryker Corp / TJX Companies Inc / Target Corp / Teledyne Technologies Inc / Union Pacific Corp / Westinghouse Air Brake Technologies Corp / Walmart Inc / Watts Water Technologies Inc / ManTech International Corp / Sanofi SA / Abb Ltd / Digital Realty Trust Inc / Mueller Water Products Inc / KBR Inc / WNS (Holdings) Ltd / Ulta Beauty Inc / Amarin Corporation PLC / Colfax Corp / Ballard Power Systems Inc / TE Connectivity Ltd / Merck & Co Inc / Seagate Technology Holdings PLC / United Airlines Holdings Inc / Booz Allen Hamilton Holding Corp / Ralph Lauren Corp / Xylem Inc / Abbvie Inc / Zoetis Inc / ServiceNow Inc / Plug Power Inc / CyrusOne Inc / Science Applications International Corp / Leidos Holdings Inc / Compagnie Financiere Richemont SA / Paylocity Holding Corp / Paycom Software Inc / Zendesk Inc / Pentair PLC / Boot Barn Holdings Inc / Equinix Inc / Planet Fitness Inc / Atlassian Corporation PLC / ITT Inc / Fortive Corp / Twilio Inc / GDS Holdings Ltd / RH / Canada Goose Holdings Inc / Baker Hughes Co / Switch Inc / Tapestry Inc / Evoqua Water Technologies Corp / Sensata Technologies Holding PLC / Ceridian HCM Holding Inc / Domo Inc / Bloom Energy Corp / Elanco Animal Health Inc / Farfetch Ltd / Capri Holdings Ltd / Parsons Corp / Fuelcell Energy Inc / Revolve Group Inc / RealReal Inc / Exagen Inc / Nikola Corp / Royalty Pharma PLC / Orphazyme A/S</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">China Biotech Sector: Pipeline updates and recent license-out deals accentuate LT potential of high-flying biotechs</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">1952.HK / BGNE.OQ / BMY.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVN.S / GSK.L / GILD.OQ / INCY.OQ / MGNX.OQ / TPB.N / ZLAB.OQ / 6160.HK / 1801.HK / 1877.HK / GTH.OQ</td><td class="leftalignment">Everest Medicines Ltd / Beigene Ltd / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / GlaxoSmithKline PLC / Gilead Sciences Inc / Incyte Corp / MacroGenics Inc / Turning Point Brands Inc / Zai Lab Ltd / Beigene Ltd / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd / Genetron Holdings Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q4:20 Results Preview/2021 Outlook</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US98978V1035 / US28414H1032 / GB00BMVP7Y09</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Zoetis Inc / Elanco Animal Health Inc / Royalty Pharma PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">01/21/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Merck up 0.6% in 2021</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BGNE (NEUTRAL) - Model Update Post NOVN Collaboration; Incremental Updates on 2021 Key Milestones; Maintain NEUTRAL</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BYYWPW6 / 5671735 / 0989529 / 0925288 / 2126335 / 2778844 / 2684703 / 2730190 / 7103065</td><td class="leftalignment">Beigene Ltd / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="odd"><td class="leftalignment">01/21/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">TOMORROW AM: Cantor Research Call - Healthcare Large Cap 4Q20 Preview</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">HCM.O / LLY / JNJ / MRK / PFE / ZTS / IMAB.O</td><td class="leftalignment">HUTCHMED (China) Ltd / Eli Lilly and Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Zoetis Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung</td></tr>
<tr class="even"><td class="leftalignment">01/21/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Buying opportunity after bintra-drop</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr Daniel Wendorff</td></tr>
<tr class="odd"><td class="leftalignment">01/21/2021</td><td class="leftalignment">Kepler Cheuvreux</td><td class="leftalignment">Merck KGAA | Buy | Disappointment for TGF Beta Trap, but not the end</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David P. Evans</td></tr>
<tr class="even"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK.N / MSB.AX / CKPT.OQ / BCYC.OQ</td><td class="leftalignment">Merck & Co Inc / Mesoblast Ltd / Checkpoint Therapeutics Inc / Bicycle Therapeutics PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Pareto Securities AS</td><td class="leftalignment">Merck-INTR@PID Lung 037 trial to be discontinued-01/20/2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr Dennis Berzhanin</td></tr>
<tr class="even"><td class="leftalignment">01/20/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Merck KGaA : TGF-beta discontinued in 1L lung, minor negative</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Richard B. Vosser / James D. Gordon / Sarita Kapila / Ms. Laerke Engkilde</td></tr>
<tr class="odd"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRCG.DE - Event Transcript of Merck KGaA conference call, Jan. 20, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRCG.DE</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Merck & Co., Inc.(MRK) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">58933Y105</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Merck KGaA: Technische Neubewertung</td><td class="leftalignment">German</td><td class="rightalignment">4</td><td class="leftalignment">DE0006599905</td><td class="leftalignment">Merck KGaA</td><td class="leftalignment"></td><td class="leftalignment">Germany</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Herr. Achim Matzke / Frau Petra von Kerssenbrock / Herr Thorsten Grisse</td></tr>
<tr class="even"><td class="leftalignment">01/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Vericiguat Approved, Now Here Comes Hard Part</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK=US</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Daina Graybosch, PHD</td></tr>
<tr class="odd"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SRRK: Perspectives on the Bintrafusp Alfa Discontinuation</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">SRRK.OQ / SASY.PA / MRCG.DE</td><td class="leftalignment">Scholar Rock Holding Corp / Sanofi SA / Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Martin Auster, M.D. / Mark Connolly / Mr. Tiago Fauth / Mr. Thomas Deal / Matthew Terwelp / Roger Xu</td></tr>
<tr class="even"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRCG.DE: Merck KGaA - Bintrafusp alfa fails in first-line lung cancer; update to our forecasts</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRCG.DE / 4063.T / 4185.T / A.N / BDX.N / RECI.MI / STDM.PA / TMO.N / WAT.N / DHR.N / LUN.CO / GLW.N / MTD.N / LONN.S / PKI.N / UCB.BR / TECH.OQ / CCMP.OQ / ENTG.OQ / IPN.PA / ORNBV.HE / ALM.MC / WAFGN.DE / VIFN.S / GMAB.CO</td><td class="leftalignment">Merck KGaA / Shin-Etsu Chemical Co Ltd / JSR Corp / Agilent Technologies Inc / Becton Dickinson and Co / Recordati Industria Chimica e Farmaceutica SpA / Sartorius Stedim Biotech SA / Thermo Fisher Scientific Inc / Waters Corp / Danaher Corp / H Lundbeck A/S / Corning Inc / Mettler-Toledo International Inc / Lonza Group AG / PerkinElmer Inc / Ucb SA / Bio-Techne Corp / CMC Materials Inc / Entegris Inc / Ipsen SA / Orion Oyj / Almirall SA / Siltronic AG / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HOLT Novo Nordisk: Concerns over sustainability of returns overdone</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">NOVOB.CO / BMY.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVN.S / MRCG.DE / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Sophia Graeff Buhl-Nielsen / HOLT Europe / Selim Gogus</td></tr>
<tr class="even"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">EU Pharmaceuticals: Target price changes with PharmaValues 2021</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">AZN.L / NOVN.S / RECI.MI / SASY.PA / ROG.S / LUN.CO / MRCG.DE / LONN.S / GSK.L / UCB.BR / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE</td><td class="leftalignment">AstraZeneca PLC / Novartis AG / Recordati Industria Chimica e Farmaceutica SpA / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Merck KGaA / Lonza Group AG / GlaxoSmithKline PLC / Ucb SA / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Italy / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ORNBV.HE: Orion - 2021E 8% EPS cut, but 15% increase in TP</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ORNBV.HE / RECI.MI / LUN.CO / MRCG.DE / LONN.S / UCB.BR / IPN.PA / ALM.MC / GMAB.CO</td><td class="leftalignment">Orion Oyj / Recordati Industria Chimica e Farmaceutica SpA / H Lundbeck A/S / Merck KGaA / Lonza Group AG / Ucb SA / Ipsen SA / Almirall SA / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Italy</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GRLS.MC: Grifols - Reduce our TP to Eu26, reiterate Neutral rating</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GRLS.MC / 4502.T / CSL.AX / RECI.MI / SN.L / STDM.PA / LUN.CO / FMEG.DE / MRCG.DE / LONN.S / QIA.DE / UCB.BR / GN.CO / HOLX.OQ / COLOB.CO / STMN.S / 006280.KS / 002007.SZ / IPN.PA / ORNBV.HE / ALM.MC / DIAS.MI / SOBIV.ST / DEMANT.CO / GMAB.CO</td><td class="leftalignment">Grifols SA / Takeda Pharmaceutical Co Ltd / CSL Ltd / Recordati Industria Chimica e Farmaceutica SpA / Smith & Nephew PLC / Sartorius Stedim Biotech SA / H Lundbeck A/S / Fresenius Medical Care AG & Co KGaA / Merck KGaA / Lonza Group AG / Qiagen NV / Ucb SA / GN Store Nord A/S / Hologic Inc / Coloplast A/S / Straumann Holding AG / Green Cross Corp / Hualan Biological Engineering Inc / Ipsen SA / Orion Oyj / Almirall SA / DiaSorin SpA / Swedish Orphan Biovitrum AB (publ) / Demant A/S / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Italy / Japan / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - Downgrade to Underperform</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">GSK.L / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / GILD.OQ / BAYGN.DE / ABBV.N</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Gilead Sciences Inc / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Pharmaceuticals: PharmaValues 2021 strategic conclusions</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / CSL.AX / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / 4506.T / 4536.T / SASY.PA / ROG.S / LUN.CO / 4151.T / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / 4568.T / IPN.PA / HIK.L / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / 4578.T / 4581.T / SRPT.OQ / ABBV.N / QURE.OQ / BGNE.OQ / VIFN.S / 6160.HK / GMAB.CO</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Kyowa Kirin Co Ltd / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Daiichi Sankyo Co Ltd / Ipsen SA / Hikma Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / Sarepta Therapeutics Inc / Abbvie Inc / Uniqure NV / Beigene Ltd / Vifor Pharma AG / Beigene Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Ms. Gretel Janu / Mr. Dominic Lunn / Mr. Matt S. Miksic / Mr. Fumiyoshi Sakai / Mr. Evan D. Seigerman / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVOb.CO: Novo Nordisk A/S - Downgrading to Neutral; Reiterate DKK470/share Price Target</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">NOVOB.CO / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVN.S / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 8, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFE.N / GILD.OQ / MSB.AX / ARDX.OQ / ZTS.N / BHVN.N / XELA.OQ / XGN.OQ / IMAB.OQ / ALXO.OQ</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Mesoblast Ltd / Ardelyx Inc / Zoetis Inc / Biohaven Pharmaceutical Holding Company Ltd / Exela Technologies Inc / Exagen Inc / I-Mab / ALX Oncology Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Merck up 1.7% in 2021, but lagging Pharmaceuticals sector</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">MRK.N</td><td class="leftalignment">Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Immuno-Oncology Round-up from ASCO-GI 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK=US / RCUS=US</td><td class="leftalignment">Merck & Co Inc / Arcus Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Dr. Daina Graybosch, PHD</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Animal Tracks: Survey Says: Continuing Robust Veterinary Demand in 4Q; Highlighting ZTS, CHWY</td><td class="leftalignment">English</td><td class="rightalignment">60</td><td class="leftalignment">CHWY.N / ZTS.N / MRK.N / VIRB.PA / WMT.N / DPH.L / ABC.N / IDXX.OQ / PDCO.OQ / HSIC.OQ / AMZN.OQ / HSKA.OQ / PETS.OQ / BAYGN.DE / PAHC.OQ / ELAN.N / CVET.OQ</td><td class="leftalignment">Chewy Inc / Zoetis Inc / Merck & Co Inc / Virbac SA / Walmart Inc / Dechra Pharmaceuticals PLC / Amerisourcebergen Corp / IDEXX Laboratories Inc / Patterson Companies Inc / Henry Schein Inc / Amazon.com Inc / Heska Corp / Petmed Express Inc / Bayer AG / Phibro Animal Health Corp / Elanco Animal Health Inc / Covetrus Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides / Matthew Urbik</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">European Pharma & Biotech : Key takeaways from J.P. Morgan Healthcare Conference 2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">SASY.PA / ROG.S / NOVOb.CO / NOVN.S / MRCG.DE / LONN.S / MORG.DE / DPH.L / GSK.L / UCB.BR / GLPG.AS / IPN.PA / HIK.L / ABCA.L / BAYGn.DE / MOLN.S / VIFN.S / IDIA.S / TAK.N / ALC.S / GMAB.CO</td><td class="leftalignment">Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Merck KGaA / Lonza Group AG / MorphoSys AG / Dechra Pharmaceuticals PLC / GlaxoSmithKline PLC / Ucb SA / Galapagos NV / Ipsen SA / Hikma Pharmaceuticals PLC / Abcam PLC / Bayer AG / Molecular Partners AG / Vifor Pharma AG / Idorsia Ltd / Takeda Pharmaceutical Co Ltd / Alcon AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Richard B. Vosser / James D. Gordon / Sarita Kapila / Ms. Laerke Engkilde</td></tr>
<tr class="odd"><td class="leftalignment">01/18/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">THIS FRIDAY: Cantor Research Call- Healthcare Large Cap 4Q20 Preview</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">HCM.O / LLY / JNJ / MRK / PFE / ZTS / IMAB.O</td><td class="leftalignment">HUTCHMED (China) Ltd / Eli Lilly and Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Zoetis Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung</td></tr>
<tr class="even"><td class="leftalignment">01/18/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">Autos, Basic Resources, Healthcare & Transport Calendar : January - April 2020</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">ACF / AIRP.PA / BAX.N / BDX.N / BHP.AX / BMWG.DE / BMY.N / CC.N / CCK.N / CCL.N / CE.N / CRH.I / DSMN.AS / EPED.PA / F.N / FGP.L / GM.N / GOG.L / HEIG.DE / JNJ.N / LHAG.DE / LLY.N / MCK.N / MRK.N / MWDP.PA / NEX.L / PFE.N / PLOF.PA / RENA.PA / RIO.AX / RR.L / RYA.I / SAPJ.J / SAS.ST / SCAb.ST / SCHN.PA / SGC.L / SGOB.PA / SMIN.L / SOLB.BR / SYD.AX / TCFP.PA / TMO.N / VLLP.PA / VOLVb.ST / VOWG.DE / WBSV.VI / STERV.HE / AIRF.PA / CONG.DE / AZN.L / AMGN.O / AAL.L / SASY.PA / TKAG.DE / ROG.S / SIEGn.F / HON.N / NOVN.S / MG.TO / FMEG.DE / BZU.MI / MRCG.DE / MGA.N / PSHG_p.DE / OI.N / BLL.N / GLAX.NS / PKI.N / FREG.DE / RXL.PA / EZJ.L / SUP.N / GSK.L / ESI.N / CC@US / MHK.N / TAMO.BO / FLWS.O / VOES.VI / MT.N / LXSG.DE / HUN.N / SAF.PA / TUIGn.DE / LEGD.PA / TEVA.N / SKG.I / MNDI.L / DAIGn.DE / BAES.L / BAYGn.DE / BASFn.DE / GLEN.L / CAR.O / SDFGn.DE / METSB.HE / LKQ.O / XPO.N / GT.O / ABBV.N / GEST.MC / CSTM.N / EVKn.F / CTLT.N / EUCAR.PA / ZBH.N / 1COV.DE / HLAG.DE / NVGR.LS / ADNT.N / BHC.N / 114556048 / VTRS.O</td><td class="leftalignment">Acrow Formwork and Construction Services Ltd / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Baxter International Inc / Becton Dickinson and Co / BHP Group Ltd / Bayerische Motoren Werke AG / Bristol-Myers Squibb Co / Chemours Co / Crown Holdings Inc / Carnival Corp / Celanese Corp / CRH PLC / Koninklijke DSM NV / Faurecia SE / Ford Motor Co / FirstGroup PLC / General Motors Co / Go-Ahead Group PLC / HeidelbergCement AG / Johnson & Johnson / Deutsche Lufthansa AG / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / Wendel SE / National Express Group PLC / Pfizer Inc / Compagnie Plastic Omnium SE / Renault SA / Rio Tinto Ltd / Rolls-Royce Holdings PLC / Ryanair Holdings PLC / Sappi Ltd / SAS AB / Svenska Cellulosa SCA AB / Schneider Electric SE / Stagecoach Group PLC / Compagnie de Saint Gobain SA / Smiths Group PLC / Solvay SA / Sydney Airport / Thales SA / Thermo Fisher Scientific Inc / Vallourec SA / Volvo AB / Volkswagen AG / Wienerberger AG / Stora Enso Oyj / Air France KLM SA / Continental AG / AstraZeneca PLC / Amgen Inc / Anglo American PLC / Sanofi SA / thyssenkrupp AG / Roche Holding AG / Siemens AG / Honeywell International Inc / Novartis AG / Magna International Inc / Fresenius Medical Care AG & Co KGaA / Buzzi Unicem SpA / Merck KGaA / Magna International Inc / Porsche Automobil Holding SE / O-I Glass Inc / Ball Corp / GlaxoSmithKline Pharmaceuticals Ltd / PerkinElmer Inc / Fresenius SE & Co KGaA / Rexel SA / Easyjet PLC / Superior Industries International Inc / GlaxoSmithKline PLC / Element Solutions Inc / Chemours Co / Mohawk Industries Inc / Tata Motors Ltd / 1-800-Flowers.Com Inc / voestalpine AG / ArcelorMittal SA / Lanxess AG / Huntsman Corp / Safran SA / TUI AG / Legrand SA / Teva Pharmaceutical Industries Ltd / Smurfit Kappa Group PLC / Mondi PLC / Daimler AG / BAE Systems PLC / Bayer AG / BASF SE / Glencore PLC / Avis Budget Group Inc / K&S AG / Metsa Board Oyj / LKQ Corp / XPO Logistics Inc / Goodyear Tire & Rubber Co / Abbvie Inc / Gestamp Automocion SA / Constellium SE / Evonik Industries AG / Catalent Inc / Europcar Mobility Group SA / Zimmer Biomet Holdings Inc / Covestro AG / Hapag Lloyd AG / Navigator Company SA / Adient PLC / Bausch Health Companies Inc / Stellantis NV / Viatris Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">Australia / Austria / Belgium / Canada / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Hong Kong / India / Ireland / Israel / Italy / Luxembourg / Netherlands / Norway / Panama / Portugal / Sweden / United States / South Africa / Jersey</td><td class="leftalignment">Aerospace / Air Transportation / Automotive / Biotechnology / Building & Building Materials / Chemicals / Conglomerates / Consumer / Containers & Packing / Defense / Electrical / Financial Services / Healthcare / Household Products / Industrial Materials / Leisure & Entertainment / Lodging & Restaurants / Machinery / Manufacturing / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Railroads / Retailing / Shipping & Shipbuilding / Tire & Rubber / Transportation / Wholesale</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Danielle Ward / Benjamin Defay / Stephanie Vincent / Mr. William W. Wade / Jemma Permalloo / Ed McGuinness / Mr. Adam Bodor</td></tr>
<tr class="odd"><td class="leftalignment">01/18/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (from 18 Jan): Sector continues to search for direction</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">4516.T / 4519.T / 4502.T / 4503.T / 4507.T / 4523.T / 4528.T / 4543.T / MRK.N / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / BIIB.OQ / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T</td><td class="leftalignment">Nippon Shinyaku Co Ltd / Chugai Pharmaceutical Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Merck & Co Inc / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Biogen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">01/18/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（1月18日～）: 方向感つかめず</td><td class="leftalignment">Japanese</td><td class="rightalignment">10</td><td class="leftalignment">4503.T / 4519.T / 4502.T / 4507.T / 4523.T / 4528.T / 4543.T / MRK.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / BIIB.OQ / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T</td><td class="leftalignment">Astellas Pharma Inc / Chugai Pharmaceutical Co Ltd / Takeda Pharmaceutical Co Ltd / Shionogi & Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Merck & Co Inc / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Biogen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
</tbody></table>
</body>
</html>